Citrus Sinensis ID: 003199
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 840 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.927 | 0.782 | 0.429 | 1e-180 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.954 | 0.802 | 0.415 | 1e-166 | |
| Q9LJM4 | 991 | Receptor-like protein kin | no | no | 0.934 | 0.792 | 0.394 | 1e-162 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.954 | 0.791 | 0.384 | 1e-149 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.925 | 0.774 | 0.383 | 1e-147 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.921 | 0.779 | 0.380 | 1e-146 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.914 | 0.766 | 0.378 | 1e-142 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.947 | 0.764 | 0.358 | 1e-142 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.927 | 0.707 | 0.381 | 1e-139 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.951 | 0.776 | 0.373 | 1e-139 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 632 bits (1629), Expect = e-180, Method: Compositional matrix adjust.
Identities = 362/843 (42%), Positives = 505/843 (59%), Gaps = 64/843 (7%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
+G +P F +NL L L NL G P + N++ L++L+ + NP F ++P
Sbjct: 144 FSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNP-FSPSRIP-PEF 201
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
LT L +M L C L GQIP S+G ++ L DL+L N + GHIPP +G L N+ Q+ELY
Sbjct: 202 GNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELY 261
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
N L G IP ELGNL L LD S+N L+GKIP+ + R+P L L LY N+L GE+ +
Sbjct: 262 -NNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEGELPAS 319
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
IA S L + ++ N LTG +P+DLG SPL LD+SEN+ SG LPA +C++G+L+ L+
Sbjct: 320 IALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLI 379
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
+ N FSGV+P+SLA C++L R R++ N GS+P G LPHV++++L NSFSG I+ +
Sbjct: 380 IHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKS 439
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIP-------------- 350
+G A NLS L + N+ +G +P EI +L ++ S N SG +P
Sbjct: 440 IGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDL 499
Query: 351 ----------SGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES 400
SGI + KKLN L L N+ IP+ + SL LN LDLS N+ +G IP S
Sbjct: 500 HGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVS 559
Query: 401 LCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKT 460
L L N +N S NRLSG +P SL K+ SF GNPGLC + LC
Sbjct: 560 LQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIK--------GLCGSENE 611
Query: 461 RRRLSSIWAV----VTSAVIIFIGL--LLFLKRRFSKQRAITEPDETLSSSFFPYDVKSF 514
++ +W + V +A+++ G+ F R F K RA+ TL SF
Sbjct: 612 AKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTL---------MSF 662
Query: 515 HRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQ 574
H++ F + EILE++ E N +G G SG VYK+ L +GE VAVK+LW+ K + D D +
Sbjct: 663 HKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETG-DCDPEK 721
Query: 575 ------LDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KG 626
D+ + EVETLG IRHKNIVKL+C S+ C LLVYEYMPNG+L D LH KG
Sbjct: 722 GYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKG 781
Query: 627 LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686
+ L W TR KI A+GL+YLHH + PI+HRDIKS NIL+D +Y +VADFG+AK +
Sbjct: 782 GM-LGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAV 840
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746
G + +VIAG+ GY+APEYAY+ + K D+YSFGVV++E++T ++PV+ + G+
Sbjct: 841 DLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGE- 899
Query: 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806
K+++ WV +D K GI V+D KL F++E+ ++L + + CTS P RP+M VV++
Sbjct: 900 KDLVKWVCSTLDQK-GIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKM 958
Query: 807 LAE 809
L E
Sbjct: 959 LQE 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 585 bits (1508), Expect = e-166, Method: Compositional matrix adjust.
Identities = 357/860 (41%), Positives = 505/860 (58%), Gaps = 58/860 (6%)
Query: 6 LTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
L+ T+P F + L L+L+ N +G P S+ N+T L+ L N F ++P S +
Sbjct: 151 LSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNL-FSPSQIP-SQL 208
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
LT+L+++ LA C L G IP S+ +TSL +L+LT N +TG IP I LK + Q+EL+
Sbjct: 209 GNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELF 268
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
N +G +PE +GN+T L D S+N L+GKIP+++ L L L L+ N L G +
Sbjct: 269 -NNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLL-NLESLNLFENMLEGPLPES 326
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
I S TL+ L L++N LTG +P LG SPL +DLS N+ SG +PA VC GKL+Y ++
Sbjct: 327 ITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLIL 386
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
+ N FSG + ++L +CK+L R R+SNN L G IP G LP +S+++LS NSF+G I T
Sbjct: 387 IDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKT 446
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLML 364
+ A+NLS L + +N+ SG IP+EI +++I ++N SG IP + LK+L+ L L
Sbjct: 447 IIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDL 506
Query: 365 QSNKLNSSIPNSLSSLKS------------------------LNVLDLSNNLLTGYIPES 400
N+L+ IP L K+ LN LDLS+N +G IP
Sbjct: 507 SKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLE 566
Query: 401 LCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKT 460
L L N +N S N LSG IP + F GNPGLCV + LC
Sbjct: 567 LQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLD--------GLCRKITR 618
Query: 461 RRRLSSIWAVVT----SAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHR 516
+ + +W ++T + ++ +G+++F+ + K RA+ TL++S + +SFH+
Sbjct: 619 SKNIGYVWILLTIFLLAGLVFVVGIVMFIA-KCRKLRALKS--STLAASKW----RSFHK 671
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKL-WSQRTKVSASDTDQLQL 575
+ F + EI + + EKN +G G SG VYK++L GEVVAVKKL S + +D L
Sbjct: 672 LHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDSLNR 731
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH---KGLVHLDW 632
D EVETLG IRHK+IV+L+C SS C LLVYEYMPNG+L D LH KG V L W
Sbjct: 732 DV-FAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGW 790
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
P R +IA A+GL+YLHH + PI+HRD+KS+NILLD +Y KVADFGIAKV Q G K
Sbjct: 791 PERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSK 850
Query: 693 D-STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
+ IAG+ GY+APEY Y+ + K D+YSFGVVL+EL+TG++P + + GD K++
Sbjct: 851 TPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD-KDMAK 909
Query: 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811
WV +D K G+ V+D KL F++E+ +V+ I + CTS P RP+M +VV +L E
Sbjct: 910 WVCTALD-KCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEVS 968
Query: 812 PCRFESCKFPNKSNKESSNA 831
C PN S + +
Sbjct: 969 GAV--PCSSPNTSKRSKTGG 986
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 573 bits (1477), Expect = e-162, Method: Compositional matrix adjust.
Identities = 337/855 (39%), Positives = 495/855 (57%), Gaps = 70/855 (8%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSI 64
+G P +Q L L L+ + +G FP S +L L LS +N F P I
Sbjct: 136 FSGEFPAIDSLQLLEFLSLNASGISGIFPWSSLKDLKRLSFLSVGDNR-FGSHPFPRE-I 193
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
LT L+ + L+ ++ G+IP I N+ L +LEL+ N I+G IP EI LKNLRQLE+Y
Sbjct: 194 LNLTALQWVYLSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIY 253
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISS 183
N L G +P NLT L + D S N L G + E LR L L L ++ N L+GEI
Sbjct: 254 SND-LTGKLPLGFRNLTNLRNFDASNNSLEGDLSE--LRFLKNLVSLGMFENRLTGEIPK 310
Query: 184 VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243
+ +L LSLY N LTG++P+ LG W+ +D+SEN L G +P +C +G + + L
Sbjct: 311 EFGDFKSLAALSLYRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLL 370
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303
+LQN F+G P+S A+CK L+R RVSNN L G IP GI LP++ +DL+ N F G +
Sbjct: 371 MLQNRFTGQFPESYAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTG 430
Query: 304 TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363
+GNA++L L + N+ SG +P +I A SLV ++L N SG +P G LK+L+ L+
Sbjct: 431 DIGNAKSLGSLDLSNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLI 490
Query: 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES----------------LCELLP- 406
L N L+ +IP SL SL L+ + N L+ IPES L ++P
Sbjct: 491 LDQNNLSGAIPKSLGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPV 550
Query: 407 -------NSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLC---- 455
+ ++ SNN+L+G +P SL+ SF GN GLC +S + C
Sbjct: 551 GLSALKLSLLDLSNNQLTGSVPESLVS----GSFEGNSGLC-----SSKIRYLRPCPLGK 601
Query: 456 PHTKTRRR-LSSIWAVVTSAVIIFIGLL----LFLKRRFSKQRAITEPDETLSSSFFPYD 510
PH++ +R+ LS + A I+ + L +F RR + + + ++ +
Sbjct: 602 PHSQGKRKHLSKVDMCFIVAAILALFFLFSYVIFKIRRDKLNKTVQKKND--------WQ 653
Query: 511 VKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDT 570
V SF ++F++ EI++ + +N +G+GG G VYK+ L SGE +AVK +W + + +
Sbjct: 654 VSSFRLLNFNEMEIIDEIKSENIIGRGGQGNVYKVSLRSGETLAVKHIWCPESSHESFRS 713
Query: 571 DQLQLDKG--------LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDA 622
L G + EV TL NI+H N+VKL+C + LLVYEYMPNG+LW+
Sbjct: 714 STAMLSDGNNRSNNGEFEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQ 773
Query: 623 LH--KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680
LH +G + W R +A G A+GL YLHHGL P+IHRD+KS+NILLD ++P++ADF
Sbjct: 774 LHERRGEQEIGWRVRQALALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADF 833
Query: 681 GIAKVLQARG-GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV 739
G+AK++QA +D + ++ GT GY+APEYAY++K K DVYSFGVVLMEL+TG+KP+
Sbjct: 834 GLAKIIQADSVQRDFSAPLVKGTLGYIAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPL 893
Query: 740 EDDFGDNKNIIYWV-SIKVDT-KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR 797
E DFG+N +I+ WV S+ +T +E +M+++D + ++++ ++VL IA+ CT KSP R
Sbjct: 894 ETDFGENNDIVMWVWSVSKETNREMMMKLIDTSIEDEYKEDALKVLTIALLCTDKSPQAR 953
Query: 798 PTMNEVVQLLAEADP 812
P M VV +L + +P
Sbjct: 954 PFMKSVVSMLEKIEP 968
|
Modulates the seed size by negatively regulating the cellularization of syncytial endosperm. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1366), Expect = e-149, Method: Compositional matrix adjust.
Identities = 334/869 (38%), Positives = 490/869 (56%), Gaps = 67/869 (7%)
Query: 6 LTGTL-PDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
L+G L D + +L LDL N F G P S NL L L + N +LP S +
Sbjct: 152 LSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNN--LTGELP-SVL 208
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
+L L +L G IP GN+ SL L+L ++G IP E+G LK+L L LY
Sbjct: 209 GQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLY 268
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
N GTIP E+G++T L LD S N L+G+IP I +L L++L L N LSG I
Sbjct: 269 ENN-FTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPA 327
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
I++ L +L L++N+L+GE+P DLG+ SPL LD+S N SG +P+ +C++G L ++
Sbjct: 328 ISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLIL 387
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
N F+G +P +L+ C++L+R R+ NN L GSIP G L + ++L+ N SG I
Sbjct: 388 FNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGD 447
Query: 305 VGNARNLSELFMQRNQ------------------------ISGFIPSEIYRAISLVKIDL 340
+ ++ +LS + RNQ ISG +P + SL +DL
Sbjct: 448 ISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDL 507
Query: 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES 400
S N L+G IPS I + +KL L L++N L IP ++++ +L VLDLSNN LTG +PES
Sbjct: 508 SSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPES 567
Query: 401 L-----CELLPNSINFSNNRLSGPIPLS-LIKEGLVESFSGNPGLCVSVSVNSSDKNFPL 454
+ ELL N S N+L+GP+P++ +K + GN GLC V S
Sbjct: 568 IGTSPALELL----NVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRAT 623
Query: 455 CPHTKTR-RRLSSIWAVVTSAVIIFIGLLLFLKRRFSKQRAITE--PDETLSSSFFPYDV 511
H+ +R+ + W ++ A ++ +G+L + R K+ DET S +P+ +
Sbjct: 624 SSHSSLHGKRIVAGW-LIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRL 682
Query: 512 KSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDT 570
+FHR+ F +IL + E N +G G +G VYK +++ S V+AVKKLW + T
Sbjct: 683 MAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTT 742
Query: 571 DQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH----KG 626
EV LG +RH+NIV+L + + ++VYE+M NGNL DA+H G
Sbjct: 743 GDFV------GEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAG 796
Query: 627 LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686
+ +DW +R+ IA GVA GLAYLHH P+IHRDIKS NILLD N ++ADFG+A+++
Sbjct: 797 RLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM 856
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746
AR K T +++AG+YGY+APEY Y+ K K D+YS+GVVL+EL+TGR+P+E +FG++
Sbjct: 857 -AR--KKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES 913
Query: 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGS--FRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804
+I+ WV K+ + E LD + ++EM+ VL+IA+ CT+K P RP+M +V+
Sbjct: 914 VDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVI 973
Query: 805 QLLAEADPCRFESCKFPNKSNKESSNATK 833
+L EA P R KSN N ++
Sbjct: 974 SMLGEAKPRR--------KSNSNEENTSR 994
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 522 bits (1344), Expect = e-147, Method: Compositional matrix adjust.
Identities = 332/866 (38%), Positives = 465/866 (53%), Gaps = 89/866 (10%)
Query: 6 LTGTLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNEN-------PGFKL 56
G+ PD S + NLR LD+ NN TG P+SV NLT L L N P +
Sbjct: 129 FNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGS 188
Query: 57 WKLPE--------------SSIFRLTKLRIMVLATC-ALHGQIPASIGNVTSLTDLELTG 101
W + E I LT LR + + A +P IGN++ L +
Sbjct: 189 WPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGAN 248
Query: 102 NFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI 161
+TG IPPEIG L+ L L L N +G + ELG L+ L +D+S N +G+IP S
Sbjct: 249 CGLTGEIPPEIGKLQKLDTLFLQVNV-FSGPLTWELGTLSSLKSMDLSNNMFTGEIPASF 307
Query: 162 LRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLS 221
L L +L L+ N L GEI I + L +L L++N+ TG +PQ LG+ L ++DLS
Sbjct: 308 AELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLS 367
Query: 222 ENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI 281
NKL+G LP +CS KL+ + L N G +PDSL +C++L R R+ N L GSIP+G+
Sbjct: 368 SNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGL 427
Query: 282 LSLPHVSIID------------------------LSYNSFSGPIANTVGNARNLSELFMQ 317
LP ++ ++ LS N SGP+ +GN + +L +
Sbjct: 428 FGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLD 487
Query: 318 RNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSL 377
N+ G IPSE+ + L KID S NL SG I I K L + L N+L+ IPN +
Sbjct: 488 GNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEI 547
Query: 378 SSLKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNNRLSGPIP-LSLIKEGLVESFSG 435
+++K LN L+LS N L G IP S+ + S++FS N LSG +P SF G
Sbjct: 548 TAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLG 607
Query: 436 NPGLC----------VSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIGLLLFL 485
NP LC V+ + S PL K L + + AV+ I
Sbjct: 608 NPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAII------ 661
Query: 486 KRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKI 545
K R++ + E+ + + + +F R+ F ++L+++ E N +G+GG+G VYK
Sbjct: 662 -----KARSLKKASESRA-----WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKG 711
Query: 546 DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605
+ +G++VAVK+L + S D G E++TLG IRH++IV+L + S+
Sbjct: 712 VMPNGDLVAVKRLAAMSRGSSH--------DHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 763
Query: 606 CNLLVYEYMPNGNLWDALH-KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664
NLLVYEYMPNG+L + LH K HL W TR+KIA A+GL YLHH I+HRD+KS
Sbjct: 764 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKS 823
Query: 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYS 724
NILLD N++ VADFG+AK LQ G + + IAG+YGY+APEYAY+ K K DVYS
Sbjct: 824 NNILLDSNFEAHVADFGLAKFLQDSGTSE-CMSAIAGSYGYIAPEYAYTLKVDEKSDVYS 882
Query: 725 FGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT-KEGIMEVLDKKLSGSFRDEMIQVL 783
FGVVL+EL+TGRKPV +FGD +I+ WV D+ K+ +++VLD +LS E+ V
Sbjct: 883 FGVVLLELVTGRKPV-GEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVF 941
Query: 784 RIAIRCTSKSPATRPTMNEVVQLLAE 809
+A+ C + RPTM EVVQ+L E
Sbjct: 942 YVAMLCVEEQAVERPTMREVVQILTE 967
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1338), Expect = e-146, Method: Compositional matrix adjust.
Identities = 336/884 (38%), Positives = 480/884 (54%), Gaps = 110/884 (12%)
Query: 6 LTGTLPDFSP-MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENP------------ 52
+G LP+FSP + LR L+L +NLFTG+ P S LT L+VL+ N NP
Sbjct: 135 FSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYL 194
Query: 53 -----------GFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTG 101
F +P S++ L+ L + L L G+IP SI N+ L +L+L
Sbjct: 195 TELTRLDLAYISFDPSPIP-STLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAM 253
Query: 102 NFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI 161
N +TG IP IG L+++ Q+ELY N+ L+G +PE +GNLTEL + D+S N+L+G++PE I
Sbjct: 254 NSLTGEIPESIGRLESVYQIELYDNR-LSGKLPESIGNLTELRNFDVSQNNLTGELPEKI 312
Query: 162 LRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLS 221
L +L L +N +G + V+A + L +++NS TG +P++LG++S + D+S
Sbjct: 313 AAL-QLISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVS 371
Query: 222 ENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI 281
N+ SG LP +C R KLQ + N SG +P+S C +L R+++N L G +P
Sbjct: 372 TNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARF 431
Query: 282 LSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLS 341
LP + + N G I ++ AR+LS+L + N SG IP ++ L IDLS
Sbjct: 432 WELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLS 491
Query: 342 DNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESL 401
N G IPS I LK L + +Q N L+ IP+S+SS L L+LSNN L G IP L
Sbjct: 492 RNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPEL 551
Query: 402 CEL-LPNSINFSNNRLSGPIPLSLIKEGLVE-----------------------SFSGNP 437
+L + N ++ SNN+L+G IP L++ L + SF GNP
Sbjct: 552 GDLPVLNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNP 611
Query: 438 GLCVSVSVNSSDKNFPLCPHTKTRRRLS----SIWAVVTSAVIIFIGLLLFLKRRFSKQR 493
LC + D P +TR L I A+ + V +FI KR+ +
Sbjct: 612 NLCAP----NLDPIRPCRSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTN 667
Query: 494 AITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVV 553
IT F R+ F + +I +TE N +G GGSG VY++ L SG+ +
Sbjct: 668 KIT----------------IFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTL 711
Query: 554 AVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEY 613
AVKKLW + + + S++ ++EVETLG +RH NIVKL + LVYE+
Sbjct: 712 AVKKLWGETGQKTESES-------VFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEF 764
Query: 614 MPNGNLWDALHKGLVH-----LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNIL 668
M NG+L D LH H LDW TR IA G AQGL+YLHH + PI+HRD+KS NIL
Sbjct: 765 MENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNIL 824
Query: 669 LDVNYQPKVADFGIAKVLQAR---GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSF 725
LD +P+VADFG+AK L+ G D + + +AG+YGY+APEY Y+SK K DVYSF
Sbjct: 825 LDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSF 884
Query: 726 GVVLMELITGRKPVEDDFGDNKNIIYWVSIKV------DTKEGIM------------EVL 767
GVVL+ELITG++P + FG+NK+I+ + ++G M +++
Sbjct: 885 GVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLV 944
Query: 768 DKKLSGSFR--DEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
D K+ S R +E+ +VL +A+ CTS P RPTM +VV+LL E
Sbjct: 945 DPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMRKVVELLKE 988
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 335/884 (37%), Positives = 466/884 (52%), Gaps = 116/884 (13%)
Query: 11 PDFSPMQNLRRLDLSNNLFTGQFPLSVFN-LTNLEVLS-FNENPGFKLWKLPESSIFRLT 68
P S + LR L+LSNN+F G FP + + L NL VL +N N LP S+ LT
Sbjct: 111 PQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNN---LTGDLP-VSLTNLT 166
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL-YYN- 126
+LR + L G+IPA+ G L L ++GN +TG IPPEIG L LR+L + YYN
Sbjct: 167 QLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNA 226
Query: 127 ------------------------------------QQL----------AGTIPEELGNL 140
Q+L GTI +ELG +
Sbjct: 227 FENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLI 286
Query: 141 TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNS 200
+ L +D+S N +G+IP S +L L +L L+ N L G I I L +L L++N+
Sbjct: 287 SSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENN 346
Query: 201 LTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARC 260
TG +PQ LG+ LV+LDLS NKL+G LP +CS +L + L N G +PDSL +C
Sbjct: 347 FTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKC 406
Query: 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIID-------------------------LSYN 295
++L R R+ N L GSIP+ + LP +S ++ LS N
Sbjct: 407 ESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNN 466
Query: 296 SFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN 355
SG + +GN + +L + N+ SG IP EI R L K+D S NL SG I I
Sbjct: 467 QLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISR 526
Query: 356 LKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNN 414
K L + L N+L+ IPN L+ +K LN L+LS N L G IP ++ + S++FS N
Sbjct: 527 CKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYN 586
Query: 415 RLSGPIP-LSLIKEGLVESFSGNPGLC------VSVSVNSSDKNFPLCPHTKTRRRLSSI 467
LSG +P SF GN LC + S PL TK L +
Sbjct: 587 NLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHVK-PLSATTKLLLVLGLL 645
Query: 468 WAVVTSAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEA 527
+ + A++ I K R++ E + + + +F R+ F ++L++
Sbjct: 646 FCSMVFAIVAII-----------KARSLRNASEAKA-----WRLTAFQRLDFTCDDVLDS 689
Query: 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+ E N +G+GG+G VYK + G++VAVK+L + S D G E++TLG
Sbjct: 690 LKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSH--------DHGFNAEIQTLG 741
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH-KGLVHLDWPTRHKIAFGVAQGL 646
IRH++IV+L + S+ NLLVYEYMPNG+L + LH K HL W TR+KIA A+GL
Sbjct: 742 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGL 801
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YLHH I+HRD+KS NILLD N++ VADFG+AK LQ G + + IAG+YGY+
Sbjct: 802 CYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSE-CMSAIAGSYGYI 860
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT-KEGIME 765
APEYAY+ K K DVYSFGVVL+ELITG+KPV +FGD +I+ WV D+ K+ +++
Sbjct: 861 APEYAYTLKVDEKSDVYSFGVVLLELITGKKPV-GEFGDGVDIVQWVRSMTDSNKDCVLK 919
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
V+D +LS E+ V +A+ C + RPTM EVVQ+L E
Sbjct: 920 VIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTE 963
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1302), Expect = e-142, Method: Compositional matrix adjust.
Identities = 323/901 (35%), Positives = 478/901 (53%), Gaps = 105/901 (11%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVL-SFNENPGFKLWKLPESS 63
L G+ P + L LD+S N F FP + L L+V +F+ N L S
Sbjct: 117 LEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNN----FEGLLPSD 172
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
+ RL L + G+IPA+ G + L + L GN + G +PP +GLL L+ +E+
Sbjct: 173 VSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQHMEI 232
Query: 124 YYNQ-----------------------QLAGTIPEELGNLTELTDLDMSVNHLSGKIPES 160
YN L+G++P+ELGNL+ L L + N +G+IPES
Sbjct: 233 GYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTGEIPES 292
Query: 161 ILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ--------- 211
L L++L +N LSG I S + LT LSL N+L+GEVP+ +G+
Sbjct: 293 YSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELTTLFL 352
Query: 212 WS---------------PLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256
W+ L +D+S N +G +P+ +C KL ++ NMF G LP S
Sbjct: 353 WNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKS 412
Query: 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFM 316
L RC++L RFR NN L G+IP G SL +++ +DLS N F+ I A L L +
Sbjct: 413 LTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNL 472
Query: 317 QRNQISGFIPSEIYRA-----------------------ISLVKIDLSDNLLSGPIPSGI 353
N +P I++A S +I+L N L+G IP I
Sbjct: 473 STNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVGCKSFYRIELQGNSLNGTIPWDI 532
Query: 354 GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESL-CELLPNSINFS 412
G+ +KL L L N LN IP +S+L S+ +DLS+NLLTG IP + N S
Sbjct: 533 GHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVS 592
Query: 413 NNRLSGPIPLSLIKEGLVESFSGNPGLC---VSVSVNS---SDKNFPLCPHTKTRRRLSS 466
N+L GPIP FS N GLC V NS + N + H K R +
Sbjct: 593 YNQLIGPIPSGSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKEERPKKT 652
Query: 467 IWAVV---TSAVIIFIGLLLFLKRRFSKQRA-ITEPDETLSSSFFPYDVKSFHRISFDQR 522
A+V +A+ + +L+ R F K + P+ + +F R++F
Sbjct: 653 AGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQRLNFTAD 712
Query: 523 EILEAMTEKNKV-GQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLK 580
+++E +++ + + G G +GTVYK ++ +GE++AVKKLW + + +++ K G+
Sbjct: 713 DVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKN-----KENGKIRRRKSGVL 767
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKG----LVHLDWPTRH 636
EV+ LGN+RH+NIV+L ++ C +L+YEYMPNG+L D LH G +W +
Sbjct: 768 AEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALY 827
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
+IA GVAQG+ YLHH I+HRD+K +NILLD +++ +VADFG+AK++Q D +
Sbjct: 828 QIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQT----DESM 883
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756
+V+AG+YGY+APEYAY+ + K D+YS+GV+L+E+ITG++ VE +FG+ +I+ WV K
Sbjct: 884 SVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWVRSK 943
Query: 757 VDTKEGIMEVLDKKLSGS---FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813
+ TKE + EVLDK + S R+EM Q+LRIA+ CTS+SP RP M +V+ +L EA P
Sbjct: 944 LKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAKPK 1003
Query: 814 R 814
R
Sbjct: 1004 R 1004
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-139, Method: Compositional matrix adjust.
Identities = 335/879 (38%), Positives = 484/879 (55%), Gaps = 100/879 (11%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
L G+LP +QNL L L N +G+ P SV N++ LEVL+ +EN + +P I
Sbjct: 223 LEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHEN--YFTGSIPRE-I 279
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
+LTK++ + L T L G+IP IGN+ +++ + N +TG IP E G + NL+ L L+
Sbjct: 280 GKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLF 339
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
N L G IP ELG LT L LD+S+N L+G IP+ + LP L LQL++N L G+I +
Sbjct: 340 ENI-LLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPL 398
Query: 185 I------------ANS------------TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDL 220
I ANS TL +LSL N L+G +P+DL L L L
Sbjct: 399 IGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLML 458
Query: 221 SENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEG 280
+N+L+G LP ++ + L + QN SG + L + KNL R R++NN+ G IP
Sbjct: 459 GDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPE 518
Query: 281 ILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340
I +L + ++S N +G I +G+ + L + N+ SG+I E+ + + L + L
Sbjct: 519 IGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRL 578
Query: 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNV-LDLSNNLLTGYIPE 399
SDN L+G IP G+L +L L L N L+ +IP L L SL + L++S+N L+G IP+
Sbjct: 579 SDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPD 638
Query: 400 SLCEL----------------LPNSI---------NFSNNRLSGPIPLSLIKEGLVES-F 433
SL L +P SI N SNN L G +P + + + + S F
Sbjct: 639 SLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNF 698
Query: 434 SGNPGLCVSVSVNSSDKNFPLCPHTKT----------RRRLSSIWAVVTSAV--IIFIGL 481
+GN GLC S + PL PH+ + R+++ +I +V +V I F+GL
Sbjct: 699 AGNHGLCNSQRSHCQ----PLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGL 754
Query: 482 LLFLKRR---FSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGG 538
+KRR F T+PD + S +FP ++ + R E + +G+G
Sbjct: 755 CWTIKRREPAFVALEDQTKPD-VMDSYYFPKKGFTYQGLVDATRNFSEDVV----LGRGA 809
Query: 539 SGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598
GTVYK +++ GEV+AVKKL S+ S+ D + E+ TLG IRH+NIVKLY
Sbjct: 810 CGTVYKAEMSGGEVIAVKKLNSRGEGASS--------DNSFRAEISTLGKIRHRNIVKLY 861
Query: 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLVH--LDWPTRHKIAFGVAQGLAYLHHGLLSP 656
+ NLL+YEYM G+L + L +G + LDW R++IA G A+GL YLHH
Sbjct: 862 GFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQ 921
Query: 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA 716
I+HRDIKS NILLD +Q V DFG+AK++ K + + +AG+YGY+APEYAY+ K
Sbjct: 922 IVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK--SMSAVAGSYGYIAPEYAYTMKV 979
Query: 717 TTKCDVYSFGVVLMELITGRKPVE--DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGS 774
T KCD+YSFGVVL+ELITG+ PV+ + GD ++ WV + +E+ D +L +
Sbjct: 980 TEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRRSIRNMIPTIEMFDARLDTN 1036
Query: 775 FR---DEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
+ EM VL+IA+ CTS SPA+RPTM EVV ++ EA
Sbjct: 1037 DKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEA 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1277), Expect = e-139, Method: Compositional matrix adjust.
Identities = 324/867 (37%), Positives = 473/867 (54%), Gaps = 68/867 (7%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFN-ENPGFKLWKLPESS 63
+G LP D L LD F G P S NL NL+ L + N G K+ K+
Sbjct: 161 FSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKV---- 216
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
I L+ L ++L G+IP G +T L L+L +TG IP +G LK L + L
Sbjct: 217 IGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYL 276
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183
Y N+ L G +P ELG +T L LD+S N ++G+IP + L L++L L N L+G I S
Sbjct: 277 YQNR-LTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPS 335
Query: 184 VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243
IA L +L L+ NSL G +P LG+ SPL LD+S NKLSG +P+ +C L +
Sbjct: 336 KIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLI 395
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303
+ N FSG +P+ + C L+R R+ NH+ GSIP G LP + ++L+ N+ +G I +
Sbjct: 396 LFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPD 455
Query: 304 TVG-----------------------NARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340
+ ++ NL N +G IP++I SL +DL
Sbjct: 456 DIALSTSLSFIDISFNHLSSLSSSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDL 515
Query: 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES 400
S N SG IP I + +KL L L+SN+L IP +L+ + L VLDLSNN LTG IP
Sbjct: 516 SFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPAD 575
Query: 401 L-----CELLPNSINFSNNRLSGPIPLSLIKEGL-VESFSGNPGLCVSVSVNSSDKNFPL 454
L E+L N S N+L GPIP +++ + + GN GLC V + K+ L
Sbjct: 576 LGASPTLEML----NVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLCGGV-LPPCSKSLAL 630
Query: 455 CPHTKTRRRLSSIWAV----VTSAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSF---- 506
+ R+ AV V ++VI+ +G++ FL R+ R + F
Sbjct: 631 SAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMM-FLAGRWIYTRWDLYSNFAREYIFCKKP 689
Query: 507 ---FPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEV--VAVKKLW-- 559
+P+ + +F R+ F +IL + E N +G G G VYK ++ + VAVKKLW
Sbjct: 690 REEWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRS 749
Query: 560 -SQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGN 618
S + + ++ + D L+ EV LG +RH+NIVK+ Y + ++VYEYMPNGN
Sbjct: 750 PSPQNDIEDHHQEEDEEDDILR-EVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGN 808
Query: 619 LWDALH---KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675
L ALH + + DW +R+ +A GV QGL YLH+ PIIHRDIKS NILLD N +
Sbjct: 809 LGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEA 868
Query: 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITG 735
++ADFG+AK++ K+ T +++AG+YGY+APEY Y+ K K D+YS GVVL+EL+TG
Sbjct: 869 RIADFGLAKMMLH---KNETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTG 925
Query: 736 RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR---DEMIQVLRIAIRCTSK 792
+ P++ F D+ +++ W+ KV E + EV+D ++G + +EM+ LRIA+ CT+K
Sbjct: 926 KMPIDPSFEDSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAK 985
Query: 793 SPATRPTMNEVVQLLAEADPCRFESCK 819
P RP++ +V+ +LAEA P R C+
Sbjct: 986 LPKDRPSIRDVITMLAEAKPRRKSVCQ 1012
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 840 | ||||||
| 224063397 | 925 | predicted protein [Populus trichocarpa] | 0.996 | 0.904 | 0.771 | 0.0 | |
| 255537886 | 956 | receptor protein kinase, putative [Ricin | 0.994 | 0.873 | 0.748 | 0.0 | |
| 349504495 | 958 | leucine rich repeat-containing protein [ | 0.988 | 0.866 | 0.759 | 0.0 | |
| 209168629 | 957 | putative leucine rich repeat transmembra | 0.988 | 0.867 | 0.760 | 0.0 | |
| 449437262 | 947 | PREDICTED: receptor-like protein kinase | 0.991 | 0.879 | 0.738 | 0.0 | |
| 297795729 | 964 | hypothetical protein ARALYDRAFT_495025 [ | 0.963 | 0.839 | 0.706 | 0.0 | |
| 359492518 | 956 | PREDICTED: receptor-like protein kinase | 0.985 | 0.866 | 0.743 | 0.0 | |
| 15240528 | 966 | putative leucine-rich repeat transmembra | 0.963 | 0.837 | 0.701 | 0.0 | |
| 26450865 | 966 | putative receptor protein kinase [Arabid | 0.963 | 0.837 | 0.699 | 0.0 | |
| 356510067 | 966 | PREDICTED: receptor-like protein kinase | 0.994 | 0.864 | 0.713 | 0.0 |
| >gi|224063397|ref|XP_002301126.1| predicted protein [Populus trichocarpa] gi|222842852|gb|EEE80399.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1299 bits (3362), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 648/840 (77%), Positives = 732/840 (87%), Gaps = 3/840 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
+SF++ TGT PDFSP+++LR LD+S N FTG+FP+SV NL+NLEVL+FNEN G LW+LP
Sbjct: 89 LSFLFATGTYPDFSPLKSLRILDVSYNRFTGEFPMSVTNLSNLEVLNFNENDGLHLWQLP 148
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
E+ I RLTKL+ M+L TC LHG IPASIGN+TSL DLEL+GNF++GHIP E+GLLKNL+Q
Sbjct: 149 EN-ISRLTKLKSMILTTCVLHGPIPASIGNMTSLVDLELSGNFLSGHIPVELGLLKNLQQ 207
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L+G IPEE GNLTEL DLD+SVN L+GKIPES+ RLPKL VLQLYNNSLSGE
Sbjct: 208 LELYYNYHLSGNIPEEFGNLTELVDLDISVNKLTGKIPESVCRLPKLEVLQLYNNSLSGE 267
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I S IA+STTL +LS+YDN LTGEVPQDLG S ++V+DLSEN+LSGPLP+ VC GKL
Sbjct: 268 IPSAIASSTTLRILSVYDNFLTGEVPQDLGHLSAMIVVDLSENRLSGPLPSDVCRGGKLL 327
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVL NMFSG LPDS A+CK LLRFR+S+NHLEGSIPEGIL LP VSIIDLSYN+FSGP
Sbjct: 328 YFLVLDNMFSGELPDSYAKCKTLLRFRLSHNHLEGSIPEGILGLPRVSIIDLSYNNFSGP 387
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I+NT+G ARNLSELF+Q N+ISG IP EI RAI+LVKIDLS NLL GPIPS IG LKKLN
Sbjct: 388 ISNTIGTARNLSELFVQSNKISGVIPPEISRAINLVKIDLSSNLLYGPIPSEIGYLKKLN 447
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LL+LQ NKLNSSIP SLS L+SLNVLDLSNNLLTG IPESL ELLPNSINFSNN LSGPI
Sbjct: 448 LLILQGNKLNSSIPKSLSLLRSLNVLDLSNNLLTGSIPESLSELLPNSINFSNNLLSGPI 507
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
PLSLIK GLVESFSGNPGLCV V V+SSD++FP+C HT R+RL+SIWA+ S I+ +G
Sbjct: 508 PLSLIKGGLVESFSGNPGLCVPVYVDSSDQSFPMCSHTYNRKRLNSIWAIGISVAILTVG 567
Query: 481 LLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSG 540
LLFLKR+FSK RA+ + DET +SSFF YDVKSFHRISFDQREILEAM +KN VG GGSG
Sbjct: 568 ALLFLKRQFSKDRAVKQHDETTASSFFSYDVKSFHRISFDQREILEAMVDKNIVGHGGSG 627
Query: 541 TVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600
TVY+I+L+SGEVVAVK+LWS+++K S S+ DQL LDK LKTEV TLG+IRHKNIVKLYCY
Sbjct: 628 TVYRIELSSGEVVAVKRLWSRKSKDSGSE-DQLLLDKELKTEVGTLGSIRHKNIVKLYCY 686
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
FSS CNLL+YEYMPNGNLWDALHKG +HL+WPTRH+IA GVAQGLAYLHH LL PIIHR
Sbjct: 687 FSSSDCNLLIYEYMPNGNLWDALHKGWIHLNWPTRHQIAVGVAQGLAYLHHDLLPPIIHR 746
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 720
DIKSTNILLD NY+PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC
Sbjct: 747 DIKSTNILLDANYRPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 806
Query: 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMI 780
DVYSFGVVLMELITG+KPVE D+G++KNII VS KVDTKEG+MEVLDK+LSGSFRDEMI
Sbjct: 807 DVYSFGVVLMELITGKKPVEADYGESKNIINLVSTKVDTKEGVMEVLDKRLSGSFRDEMI 866
Query: 781 QVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKNPSEL 840
QVLRIAIRCT K+PA RPTMNEVVQLL EA R +S + NKS KE+S+ TKIKN E+
Sbjct: 867 QVLRIAIRCTYKTPALRPTMNEVVQLLIEAGQNRVDSFRSSNKS-KEASDVTKIKNQFEI 925
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255537886|ref|XP_002510008.1| receptor protein kinase, putative [Ricinus communis] gi|223550709|gb|EEF52195.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1253 bits (3243), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 629/840 (74%), Positives = 718/840 (85%), Gaps = 5/840 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
+S +YL G +PDFSP+++LR LD+S N F FP+SV NLTNLE L+FNEN W+LP
Sbjct: 122 VSLLYLDGKIPDFSPLKSLRMLDMSYNNFRDDFPMSVTNLTNLEFLNFNENAELNYWELP 181
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
E+ I RLTKL+ M+L TC L+G IPA+IGN+TSL DLEL+GNF+TG IPPEIGLLKNL+Q
Sbjct: 182 EN-ISRLTKLKSMILTTCNLYGPIPATIGNMTSLIDLELSGNFLTGQIPPEIGLLKNLKQ 240
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L+G+IPEELGNLTEL DLDMSVN L+G IP SI RLPKL VLQ YNNSL+GE
Sbjct: 241 LELYYNYHLSGSIPEELGNLTELVDLDMSVNKLTGNIPASICRLPKLEVLQFYNNSLTGE 300
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I S IA STTL +LSLYDNSLTGE+P +LGQ S +VVLD+SEN+LSGPLP +VCS GKL
Sbjct: 301 IPSAIAESTTLRILSLYDNSLTGELPHNLGQLSGMVVLDVSENRLSGPLPTEVCSGGKLL 360
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVL NMFSG LP S A+CK LLRFRVS+N LEGSIPEG+L LPHVSIIDL YN+FSG
Sbjct: 361 YFLVLDNMFSGGLPSSYAKCKTLLRFRVSHNRLEGSIPEGLLGLPHVSIIDLGYNNFSGS 420
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I+NT+ ARNLSELF+Q N+ISG +P EI AI+LVKID+S+NLLSGP+P IG L KLN
Sbjct: 421 ISNTIRTARNLSELFLQSNKISGVLPPEISGAINLVKIDVSNNLLSGPVPFQIGYLTKLN 480
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LLMLQ N LNSSIP+SLS LKSLNVLDLSNNLLTG +PESL LLPNSI+FSNNRLSGPI
Sbjct: 481 LLMLQGNMLNSSIPDSLSFLKSLNVLDLSNNLLTGNVPESLSVLLPNSIDFSNNRLSGPI 540
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
PL LIK GL+ESFSGNPGLCV + V SD+NFP+C R+RL+SIW + S VI +G
Sbjct: 541 PLPLIKGGLLESFSGNPGLCVPIYV-VSDQNFPVCSRRYNRKRLNSIWVIGISVVIFIVG 599
Query: 481 LLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSG 540
L FLKR+ SK + +T DET+SSSFF Y+VKSFHRISFDQ+EILE M EKNKVGQGGSG
Sbjct: 600 ALFFLKRKLSKDK-LTGRDETMSSSFFSYEVKSFHRISFDQQEILEGMIEKNKVGQGGSG 658
Query: 541 TVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600
TVYKI+L+SGEV+AVK+LWS+R K SA + DQL DKGLKTEVETLG+IRHKNIVKLYCY
Sbjct: 659 TVYKIELSSGEVIAVKRLWSKRNKDSAIE-DQLLPDKGLKTEVETLGSIRHKNIVKLYCY 717
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
FSS +C+LLVYEYMPNGNL DAL K +HLDWPTRH+IA GVAQGLAYLHH LL+PIIHR
Sbjct: 718 FSSFHCSLLVYEYMPNGNLRDALDKNWIHLDWPTRHQIALGVAQGLAYLHHDLLTPIIHR 777
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 720
DIKSTNILLDV+YQPKVADFGIAKVLQARGGKDST+TV+AGTYGY+APEYAYSSKATTKC
Sbjct: 778 DIKSTNILLDVSYQPKVADFGIAKVLQARGGKDSTSTVVAGTYGYIAPEYAYSSKATTKC 837
Query: 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMI 780
DVYSFGVVLMELITG+KPVE+DFG+NKNI+ WVS KV+TKEG+MEVLDKKLSGSF +EMI
Sbjct: 838 DVYSFGVVLMELITGKKPVEEDFGENKNIVNWVSTKVETKEGVMEVLDKKLSGSFWNEMI 897
Query: 781 QVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKNPSEL 840
QVLRIAIRC K+PA RPTMNEVVQLL EADPCRF+SCK NK+ KE+SN TKI + +EL
Sbjct: 898 QVLRIAIRCICKTPAPRPTMNEVVQLLIEADPCRFDSCKSSNKA-KETSNVTKINSKNEL 956
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|349504495|gb|AEP84281.1| leucine rich repeat-containing protein [Corchorus capsularis] | Back alignment and taxonomy information |
|---|
Score = 1232 bits (3188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 635/836 (75%), Positives = 716/836 (85%), Gaps = 6/836 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS +YL T+PDFS M +LR LDLS NLF G FP+S+ NLTNLEVL NEN W+LP
Sbjct: 124 MSSVYLRATVPDFSRMTSLRVLDLSYNLFRGDFPMSITNLTNLEVLVSNENGELNPWQLP 183
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
E+ I RLTKL++MV +TC L+G+IPASIGN+TSL DLEL+GNF++G IP E+G+LKNL+
Sbjct: 184 EN-ISRLTKLKVMVFSTCMLYGRIPASIGNMTSLVDLELSGNFLSGQIPKELGMLKNLQG 242
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYNQ L+G IPEELGNLTEL DLDMSVN L G IPESI RLPKLRVLQ+YNNSL+GE
Sbjct: 243 LELYYNQHLSGIIPEELGNLTELRDLDMSVNQLRGSIPESICRLPKLRVLQIYNNSLTGE 302
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I VIA STTLTMLSLY N L+G+VPQ+LG SP++VLDLSEN L+G LP +VC GKL
Sbjct: 303 IPGVIAESTTLTMLSLYGNFLSGQVPQNLGHASPMIVLDLSENNLTGLLPTEVCRGGKLL 362
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVL NMFSG LP S A CK+LLRFRVS NHLEG IPEG+L LPHV+IIDL+YN+FSGP
Sbjct: 363 YFLVLDNMFSGKLPGSYANCKSLLRFRVSKNHLEGPIPEGLLGLPHVTIIDLAYNNFSGP 422
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
N+VGNARNLSELF+Q N++SG IP EI RA +LVKIDLS+N+LSGPIPS +GNLK LN
Sbjct: 423 FPNSVGNARNLSELFVQNNKLSGVIPPEISRARNLVKIDLSNNVLSGPIPSEMGNLKYLN 482
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LLMLQ N+L+SSIP+SLS LK LNVLDLSNNLLTG IPESL LLPNSINFSNN+LSGPI
Sbjct: 483 LLMLQGNQLSSSIPSSLSLLKLLNVLDLSNNLLTGNIPESLSALLPNSINFSNNKLSGPI 542
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
PLSLIK GLVESFSGNPGLCV V V +NFP+C HT +++L+S+WA++ S ++I IG
Sbjct: 543 PLSLIKGGLVESFSGNPGLCVPVHV----QNFPICSHTYNQKKLNSMWAIIISIIVITIG 598
Query: 481 LLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSG 540
LLFLKRRFSK RAI E DETLSSSFF YDVKSFHR+ FDQ EILEAM +KN VG GGSG
Sbjct: 599 ALLFLKRRFSKDRAIMEHDETLSSSFFSYDVKSFHRVCFDQHEILEAMVDKNIVGHGGSG 658
Query: 541 TVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600
TVY+I+L SGEVVAVKKLW + K SAS DQL LDKGLKTEVETLG IRHKNIVKLY Y
Sbjct: 659 TVYRIELGSGEVVAVKKLWGRTEKDSAS-ADQLVLDKGLKTEVETLGCIRHKNIVKLYSY 717
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
FS+ CNLLVYEYMPNGNLWDALHKG + LDWPTRH+IA GVAQGLAYLHH LL PIIHR
Sbjct: 718 FSNFDCNLLVYEYMPNGNLWDALHKGWIILDWPTRHQIALGVAQGLAYLHHDLLPPIIHR 777
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 720
DIKSTNILLDVNY+PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA+SSKATTKC
Sbjct: 778 DIKSTNILLDVNYRPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAFSSKATTKC 837
Query: 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMI 780
DVYSFGVVLMELITG+KPVE DFG+NKNI+YW+S K+DTKEG+MEVLDK+LSGSFRDEMI
Sbjct: 838 DVYSFGVVLMELITGKKPVESDFGENKNIVYWISTKLDTKEGVMEVLDKQLSGSFRDEMI 897
Query: 781 QVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKN 836
QVLRIA+RCT K+P+ RPTMNEVVQLL EADPCR +SCK + KE+SN TK+KN
Sbjct: 898 QVLRIAMRCTCKNPSQRPTMNEVVQLLIEADPCRLDSCKLTSNKTKEASNVTKVKN 953
|
Source: Corchorus capsularis Species: Corchorus capsularis Genus: Corchorus Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|209168629|gb|ACI42311.1| putative leucine rich repeat transmembrane protein kinase [Corchorus olitorius] | Back alignment and taxonomy information |
|---|
Score = 1229 bits (3179), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/836 (76%), Positives = 714/836 (85%), Gaps = 6/836 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS +YL T+PDFS M +LR LDLS NLF G FP+S+ NLTNLEVL NEN W+LP
Sbjct: 123 MSSVYLRTTVPDFSRMTSLRVLDLSYNLFRGDFPMSITNLTNLEVLVSNENGELNPWQLP 182
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
E+ I RLTKL++MV +TC L+G+IPASIGN+TSL DLEL+GNF++G IP E+G+LKNL+
Sbjct: 183 EN-ISRLTKLKVMVFSTCMLYGRIPASIGNMTSLVDLELSGNFLSGQIPKELGMLKNLQG 241
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYNQ L+GTIPEELGNLTEL DLDMSVN L G IPESI RLPKLRVLQ+YNNSL+GE
Sbjct: 242 LELYYNQHLSGTIPEELGNLTELRDLDMSVNQLRGSIPESICRLPKLRVLQIYNNSLTGE 301
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I VIA STTLTMLSLY N L+G+VPQ+LG SP++VLDLSEN L+G LP +VC GKL
Sbjct: 302 IPGVIAESTTLTMLSLYGNFLSGQVPQNLGHASPMIVLDLSENNLTGLLPTEVCRGGKLL 361
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVL NMF+G LP S A CK+LLRFRVSNNHLEG IPEG+L+LPHVSIIDL+YN+FSG
Sbjct: 362 YFLVLDNMFTGKLPASYANCKSLLRFRVSNNHLEGPIPEGLLNLPHVSIIDLAYNNFSGT 421
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
N GNARNLSELFMQ N++SG IP EI RA +LVKIDLS+NLLSGPIPS +GNLK LN
Sbjct: 422 FPNEFGNARNLSELFMQNNKVSGVIPPEISRARNLVKIDLSNNLLSGPIPSEMGNLKYLN 481
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LLMLQ N+L+SSIP+SLS LK LNVLDLSNNLLTG IPESL LLPNSINFSNN+LSGPI
Sbjct: 482 LLMLQGNQLSSSIPSSLSLLKLLNVLDLSNNLLTGNIPESLSALLPNSINFSNNKLSGPI 541
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
PLSLIK GLVESFSGNPGLCV V V +NFP+C HT +++L+S+WA++ S ++I IG
Sbjct: 542 PLSLIKGGLVESFSGNPGLCVPVHV----QNFPICSHTYNQKKLNSMWAIIISIIVITIG 597
Query: 481 LLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSG 540
LLFLKRRFSK RAI E DETLSSSFF YDVKSFHRI FDQ EILEAM +KN VG GGSG
Sbjct: 598 ALLFLKRRFSKDRAIMEHDETLSSSFFSYDVKSFHRICFDQHEILEAMVDKNIVGHGGSG 657
Query: 541 TVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600
TVY+I+L SGEVVAVKKLW + K SAS DQL LDKGLKTEVETLG IRHKNIVKLY Y
Sbjct: 658 TVYRIELGSGEVVAVKKLWGRTEKDSAS-ADQLVLDKGLKTEVETLGCIRHKNIVKLYSY 716
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
FS+ NLLVYEYMPNGNLWDALHKG + LDWPTRH+IA GVAQGLAYLHH LL PIIHR
Sbjct: 717 FSNFDVNLLVYEYMPNGNLWDALHKGWIILDWPTRHQIALGVAQGLAYLHHDLLPPIIHR 776
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 720
DIKSTNILLDVNY+PKVADFGIAKVLQA GGKDSTTTVIAGTYGYLAPEYA+SSKATTKC
Sbjct: 777 DIKSTNILLDVNYRPKVADFGIAKVLQATGGKDSTTTVIAGTYGYLAPEYAFSSKATTKC 836
Query: 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMI 780
DVYSFGVVLMELITG+KPVE DFG+NKNI+YW+S K+DTKEG+MEVLDK+LSGSFRDEMI
Sbjct: 837 DVYSFGVVLMELITGKKPVEADFGENKNIVYWISTKLDTKEGVMEVLDKQLSGSFRDEMI 896
Query: 781 QVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKN 836
QVLRIA+RCT K+P+ RPTMNEVVQLL EADPCR +SCK + KE+SN TK+KN
Sbjct: 897 QVLRIAMRCTCKNPSQRPTMNEVVQLLIEADPCRLDSCKLSSNKTKEASNVTKVKN 952
|
Source: Corchorus olitorius Species: Corchorus olitorius Genus: Corchorus Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437262|ref|XP_004136411.1| PREDICTED: receptor-like protein kinase HSL1-like [Cucumis sativus] gi|449516063|ref|XP_004165067.1| PREDICTED: receptor-like protein kinase HSL1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1223 bits (3165), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 620/840 (73%), Positives = 714/840 (85%), Gaps = 7/840 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS + L GTLPDFS ++ LR LDLS N FTG FPLSVF+LTNLE L+FNE+ FK W+LP
Sbjct: 115 MSSLSLMGTLPDFSSLKTLRILDLSYNNFTGDFPLSVFSLTNLESLNFNEDNNFKTWQLP 174
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
E+ + LTKL+ MVL TC L G+IPA+IGN+T+L DLEL+GNF+TG IP EIG LKNLR
Sbjct: 175 EN-VSGLTKLKSMVLTTCMLEGRIPATIGNMTALVDLELSGNFLTGKIPKEIGNLKNLRA 233
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L G IPEELGNLTEL DLDMSVN L+GK+PESI RLPKL VLQLYNNSL+GE
Sbjct: 234 LELYYNS-LVGEIPEELGNLTELVDLDMSVNKLTGKLPESICRLPKLEVLQLYNNSLTGE 292
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I I+NSTTLTMLSLYDN +TG+VP +LGQ+SP+VVLDLSEN SGPLP VC +GKL
Sbjct: 293 IPISISNSTTLTMLSLYDNYMTGQVPSNLGQFSPMVVLDLSENYFSGPLPTDVCGQGKLM 352
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVL+N FSG +P S C++LLRFRVS+N+LEG +P G+L LPHVSIID N+ SG
Sbjct: 353 YFLVLENKFSGQIPPSYGTCQSLLRFRVSSNNLEGPVPVGLLGLPHVSIIDFGNNNLSGE 412
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I N+ ARNLSELFMQ N+ISG +P EI +A +LVKIDLS+NLLSGPIPS IGNL+KLN
Sbjct: 413 IPNSFVKARNLSELFMQSNKISGVLPPEISKATNLVKIDLSNNLLSGPIPSEIGNLRKLN 472
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LL+LQ N LNSSIP SLS LKSLNVLDLS+N LTG IPESLCELLPNSINFSNN+LSGPI
Sbjct: 473 LLLLQGNHLNSSIPTSLSDLKSLNVLDLSDNRLTGNIPESLCELLPNSINFSNNQLSGPI 532
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
PLSLIK GLVESFSGNPGLCVSV +++SD+ FP+C ++RL+SIWA+ SA II IG
Sbjct: 533 PLSLIKGGLVESFSGNPGLCVSVYLDASDQKFPICSQNNNKKRLNSIWAIGISAFIILIG 592
Query: 481 LLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSG 540
L+L+RR S+++++ E DETLSSSFF YDVKSFHRISFD REI+E+M +KN VG GGSG
Sbjct: 593 AALYLRRRLSREKSVMEQDETLSSSFFSYDVKSFHRISFDPREIIESMVDKNIVGHGGSG 652
Query: 541 TVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600
TVYKI+L+SGE+VAVK+LWS++ K ++SD +QL LDK LKTEVETLG+IRHKNIVKLYCY
Sbjct: 653 TVYKIELSSGEMVAVKRLWSRKGKDTSSDQEQLYLDKELKTEVETLGSIRHKNIVKLYCY 712
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
FSSL C+LLVYEYMPNGNLWDALHKG +HLDWPTRH+IA G+AQGLAYLHH LL IIHR
Sbjct: 713 FSSLDCSLLVYEYMPNGNLWDALHKGWIHLDWPTRHQIALGIAQGLAYLHHDLLPSIIHR 772
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 720
DIK+TNILLDVNY PKVADFGIAKVLQAR GKDSTTTVIAGTYGYLAPEYAYSSKATTKC
Sbjct: 773 DIKTTNILLDVNYHPKVADFGIAKVLQARTGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 832
Query: 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMI 780
DVYSFG+VLMELITG+KPVE +FG+NKNIIYWVS KVDTKEG MEVLDK++S SF+DEMI
Sbjct: 833 DVYSFGIVLMELITGKKPVEAEFGENKNIIYWVSNKVDTKEGAMEVLDKRVSCSFKDEMI 892
Query: 781 QVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKNPSEL 840
+VLRIAIRCT K+PA RPTM EVVQLL EADPC+F+S NKS+K ++ TKI NP +L
Sbjct: 893 EVLRIAIRCTYKNPALRPTMKEVVQLLIEADPCKFDS---HNKSSKHTT--TKINNPFDL 947
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297795729|ref|XP_002865749.1| hypothetical protein ARALYDRAFT_495025 [Arabidopsis lyrata subsp. lyrata] gi|297311584|gb|EFH42008.1| hypothetical protein ARALYDRAFT_495025 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1166 bits (3016), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/813 (70%), Positives = 678/813 (83%), Gaps = 4/813 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS +YL GTLPDFSPM++LR +D+S N FTG FP+S+FNLT+LE L+FNENP LW LP
Sbjct: 127 MSSVYLKGTLPDFSPMKSLRVIDMSWNHFTGSFPISIFNLTDLEYLNFNENPELDLWTLP 186
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+ + +LTKL M+L TC LHG IP SIGN+TSL DLEL+GNF++G IP EIG L NLRQ
Sbjct: 187 DY-VSKLTKLTHMLLMTCMLHGNIPRSIGNLTSLVDLELSGNFLSGEIPKEIGNLSNLRQ 245
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L G+IPEE+GNL LTD+D+SV+ L+G IP+SI LPKLRVLQLYNNSL+GE
Sbjct: 246 LELYYNYHLTGSIPEEIGNLKNLTDIDISVSRLTGSIPDSICSLPKLRVLQLYNNSLTGE 305
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I + S TL +LSLYDN LTGE+P +LG SP++ LD+SEN+LSGPLPA VC GKL
Sbjct: 306 IPKSLGKSKTLKILSLYDNYLTGELPPNLGSSSPMIALDVSENRLSGPLPAHVCKSGKLL 365
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVLQN F+G +P++ CK L+RFRV++NHL G IP+G++SLPHVSIIDL+YNS SGP
Sbjct: 366 YFLVLQNQFTGSIPETYGSCKTLIRFRVASNHLVGFIPQGVMSLPHVSIIDLAYNSLSGP 425
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I N +GNA NLSELFMQ N+ISGF+P EI A +LVK+DLS+N LSGPIPS IG L+KLN
Sbjct: 426 IPNAIGNAWNLSELFMQGNRISGFLPHEISHATNLVKLDLSNNQLSGPIPSEIGRLRKLN 485
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LL+LQ N L+SSIP SLS+LKSLNVLDLS+NLLTG IPE L ELLP SINFS+NRLSGPI
Sbjct: 486 LLVLQGNHLDSSIPESLSNLKSLNVLDLSSNLLTGRIPEDLSELLPTSINFSSNRLSGPI 545
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFI- 479
P+SLI+ GLVESFS NP LCV + SSD FP+C + +++LSSIWA++ S I+ +
Sbjct: 546 PVSLIRGGLVESFSDNPNLCVPPTAGSSDLKFPMCQEPRGKKKLSSIWAILVSVFILVLG 605
Query: 480 GLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGS 539
G++ +L++R SK RA+ E DETL+SSFF YDVKSFHRISFDQREILEA+ +KN VG GGS
Sbjct: 606 GIMFYLRQRMSKNRAVIEQDETLASSFFSYDVKSFHRISFDQREILEALVDKNIVGHGGS 665
Query: 540 GTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599
GTVY+++L SGEVVAVKKLWSQ +K SAS+ D++ L+K LKTEVETLG+IRHKNIVKL+
Sbjct: 666 GTVYRVELKSGEVVAVKKLWSQSSKDSASE-DKMHLNKELKTEVETLGSIRHKNIVKLFS 724
Query: 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659
YFSSL C+LLVYEYMPNGNLWDALHKG VHL+W TRH+IA GVAQGLAYLHH L PIIH
Sbjct: 725 YFSSLDCSLLVYEYMPNGNLWDALHKGFVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIH 784
Query: 660 RDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTK 719
RDIKSTNILLDVNYQPKVADFGIAKVLQAR GKDSTTTV+AGTYGYLAPEYAYSSKAT K
Sbjct: 785 RDIKSTNILLDVNYQPKVADFGIAKVLQAR-GKDSTTTVMAGTYGYLAPEYAYSSKATIK 843
Query: 720 CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM 779
CDVYSFGVVLMELITG+KPV+ FG+NKNI+ WVS K+DTKEG++E LDK LS S + +M
Sbjct: 844 CDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKSLSESSKADM 903
Query: 780 IQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812
I LR+AIRCTS++P RPTMNEVVQLL +A P
Sbjct: 904 INALRVAIRCTSRTPTIRPTMNEVVQLLIDAAP 936
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492518|ref|XP_002283600.2| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1166 bits (3016), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 619/833 (74%), Positives = 702/833 (84%), Gaps = 5/833 (0%)
Query: 8 GTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL 67
GTLPD SPM++LR LDLS NLFTG+FPLS+ NLTNLE + FNEN GF LW LPE I RL
Sbjct: 129 GTLPDLSPMKSLRILDLSYNLFTGEFPLSITNLTNLEHIRFNENEGFNLWSLPED-ISRL 187
Query: 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
TKL+ M+L TC +HGQIP SIGN+TSL DL+L+GNF+ G IP E+GLLKNLR LELYYNQ
Sbjct: 188 TKLKSMILTTCMVHGQIPPSIGNMTSLVDLQLSGNFLNGQIPAELGLLKNLRLLELYYNQ 247
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIAN 187
+AG IPEELGNLTEL DLDMSVN L+GKIPESI +LPKLRVLQ YNNSL+GEI I N
Sbjct: 248 -IAGRIPEELGNLTELNDLDMSVNRLTGKIPESICKLPKLRVLQFYNNSLTGEIPEAIGN 306
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247
ST L MLS+YDN LTG VP+ LGQWSP+++LDLSEN LSG LP +VC G L YFLVL N
Sbjct: 307 STALAMLSIYDNFLTGGVPRSLGQWSPMILLDLSENHLSGELPTEVCKGGNLLYFLVLDN 366
Query: 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307
MFSG LP++ A+C++LLRFRVSNN LEG IPEG+L LP VSI+DL +N+ +G I T+G
Sbjct: 367 MFSGKLPENYAKCESLLRFRVSNNRLEGPIPEGLLGLPRVSILDLGFNNLNGQIGKTIGT 426
Query: 308 ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367
ARNLSELF+Q N+ISG +P EI +A +LVKIDLS+NLLSGPIPS IGNL KLNLL+LQ N
Sbjct: 427 ARNLSELFIQSNRISGALPPEISQATNLVKIDLSNNLLSGPIPSEIGNLNKLNLLLLQGN 486
Query: 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKE 427
K NS+IP SLSSLKS+NVLDLSNN LTG IPESL ELLPNSINF+NN LSGPIPLSLI+
Sbjct: 487 KFNSAIPKSLSSLKSVNVLDLSNNRLTGKIPESLSELLPNSINFTNNLLSGPIPLSLIQG 546
Query: 428 GLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIGLLLFLKR 487
GL ESFSGNP LCVSV VNSSD NFP+C T R++L+ IW + S+VI+ +G++LFLKR
Sbjct: 547 GLAESFSGNPHLCVSVYVNSSDSNFPICSQTDNRKKLNCIWVIGASSVIVIVGVVLFLKR 606
Query: 488 RFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDL 547
FSKQRA+ E DE +SSSFF Y VKSFHRI+FD REI+EA+ +KN VG GGSGTVYKI+L
Sbjct: 607 WFSKQRAVMEHDENMSSSFFSYAVKSFHRINFDPREIIEALIDKNIVGHGGSGTVYKIEL 666
Query: 548 NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607
++GEVVAVKKLWSQ+TK SAS+ DQL L K LKTEVETLG+IRHKNIVKLY FSS +
Sbjct: 667 SNGEVVAVKKLWSQKTKDSASE-DQLFLVKELKTEVETLGSIRHKNIVKLYSCFSSSDSS 725
Query: 608 LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNI 667
LLVYEYMPNGNLWDALH+G LDWP RH+IA G+AQGLAYLHH LL PIIHRDIKSTNI
Sbjct: 726 LLVYEYMPNGNLWDALHRGRTLLDWPIRHRIALGIAQGLAYLHHDLLPPIIHRDIKSTNI 785
Query: 668 LLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGV 727
LLD+NYQPKVADFGIAKVLQAR GKD TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGV
Sbjct: 786 LLDINYQPKVADFGIAKVLQAR-GKDFTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGV 844
Query: 728 VLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI 787
VLMELITG+KPVE +FG+NKNIIYWV+ KV T EG MEVLDK+LSGSFRDEM+Q+LRI +
Sbjct: 845 VLMELITGKKPVEAEFGENKNIIYWVATKVGTMEGAMEVLDKRLSGSFRDEMLQMLRIGL 904
Query: 788 RCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKNPSEL 840
RCTS SPA RPTMNEV QLL EADPCR +SCK K+ KE+SN TK KNP EL
Sbjct: 905 RCTSSSPALRPTMNEVAQLLTEADPCRVDSCKLSCKT-KETSNVTKTKNPFEL 956
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15240528|ref|NP_199777.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|10177638|dbj|BAB10911.1| receptor protein kinase [Arabidopsis thaliana] gi|224589711|gb|ACN59387.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332008459|gb|AED95842.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1159 bits (2999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/813 (70%), Positives = 679/813 (83%), Gaps = 4/813 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS +YL GTLPDFS M++LR +D+S N FTG FPLS+FNLT+LE L+FNENP LW LP
Sbjct: 129 MSSVYLKGTLPDFSQMKSLRVIDMSWNHFTGSFPLSIFNLTDLEYLNFNENPELDLWTLP 188
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+S + +LTKL M+L TC LHG IP SIGN+TSL DLEL+GNF++G IP EIG L NLRQ
Sbjct: 189 DS-VSKLTKLTHMLLMTCMLHGNIPRSIGNLTSLVDLELSGNFLSGEIPKEIGNLSNLRQ 247
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L G+IPEE+GNL LTD+D+SV+ L+G IP+SI LP LRVLQLYNNSL+GE
Sbjct: 248 LELYYNYHLTGSIPEEIGNLKNLTDIDISVSRLTGSIPDSICSLPNLRVLQLYNNSLTGE 307
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I + NS TL +LSLYDN LTGE+P +LG SP++ LD+SEN+LSGPLPA VC GKL
Sbjct: 308 IPKSLGNSKTLKILSLYDNYLTGELPPNLGSSSPMIALDVSENRLSGPLPAHVCKSGKLL 367
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVLQN F+G +P++ CK L+RFRV++N L G+IP+G++SLPHVSIIDL+YNS SGP
Sbjct: 368 YFLVLQNRFTGSIPETYGSCKTLIRFRVASNRLVGTIPQGVMSLPHVSIIDLAYNSLSGP 427
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I N +GNA NLSELFMQ N+ISG IP E+ + +LVK+DLS+N LSGPIPS +G L+KLN
Sbjct: 428 IPNAIGNAWNLSELFMQSNRISGVIPHELSHSTNLVKLDLSNNQLSGPIPSEVGRLRKLN 487
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LL+LQ N L+SSIP+SLS+LKSLNVLDLS+NLLTG IPE+L ELLP SINFS+NRLSGPI
Sbjct: 488 LLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGRIPENLSELLPTSINFSSNRLSGPI 547
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
P+SLI+ GLVESFS NP LC+ + SSD FP+C +++LSSIWA++ S I+ +G
Sbjct: 548 PVSLIRGGLVESFSDNPNLCIPPTAGSSDLKFPMCQEPHGKKKLSSIWAILVSVFILVLG 607
Query: 481 LLLF-LKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGS 539
+++F L++R SK RA+ E DETL+SSFF YDVKSFHRISFDQREILE++ +KN VG GGS
Sbjct: 608 VIMFYLRQRMSKNRAVIEQDETLASSFFSYDVKSFHRISFDQREILESLVDKNIVGHGGS 667
Query: 540 GTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599
GTVY+++L SGEVVAVKKLWSQ K SAS+ D++ L+K LKTEVETLG+IRHKNIVKL+
Sbjct: 668 GTVYRVELKSGEVVAVKKLWSQSNKDSASE-DKMHLNKELKTEVETLGSIRHKNIVKLFS 726
Query: 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659
YFSSL C+LLVYEYMPNGNLWDALHKG VHL+W TRH+IA GVAQGLAYLHH L PIIH
Sbjct: 727 YFSSLDCSLLVYEYMPNGNLWDALHKGFVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIH 786
Query: 660 RDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTK 719
RDIKSTNILLDVNYQPKVADFGIAKVLQAR GKDSTTTV+AGTYGYLAPEYAYSSKAT K
Sbjct: 787 RDIKSTNILLDVNYQPKVADFGIAKVLQAR-GKDSTTTVMAGTYGYLAPEYAYSSKATIK 845
Query: 720 CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM 779
CDVYSFGVVLMELITG+KPV+ FG+NKNI+ WVS K+DTKEG++E LDK+LS S + +M
Sbjct: 846 CDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSESSKADM 905
Query: 780 IQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812
I LR+AIRCTS++P RPTMNEVVQLL +A P
Sbjct: 906 INALRVAIRCTSRTPTIRPTMNEVVQLLIDATP 938
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|26450865|dbj|BAC42540.1| putative receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1158 bits (2996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 569/813 (69%), Positives = 679/813 (83%), Gaps = 4/813 (0%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS +YL GTLPDFS M++LR +D+S N FTG FPLS+FNLT+LE L+FNENP LW LP
Sbjct: 129 MSSVYLKGTLPDFSQMKSLRVIDMSWNHFTGSFPLSIFNLTDLEYLNFNENPELDLWTLP 188
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+S + +LTKL M+L TC LHG IP SIGN+TSL DLEL+GNF++G IP EIG L NLRQ
Sbjct: 189 DS-VSKLTKLTHMLLMTCMLHGNIPRSIGNLTSLVDLELSGNFLSGEIPKEIGNLSNLRQ 247
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L G+IPEE+GNL LTD+D+SV+ L+G IP+SI LP LRVLQLYNNSL+GE
Sbjct: 248 LELYYNYHLTGSIPEEIGNLKNLTDIDISVSRLTGSIPDSICSLPNLRVLQLYNNSLTGE 307
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I + NS TL +LSLYDN LTGE+P +LG SP++ LD+SEN+LSGPLPA VC GKL
Sbjct: 308 IPKSLGNSKTLKILSLYDNYLTGELPPNLGSSSPMIALDVSENRLSGPLPAHVCKSGKLL 367
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVLQN F+G +P++ CK L+RFRV++N L G+IP+G++SLPHVSIIDL+YNS SGP
Sbjct: 368 YFLVLQNRFTGSIPETYGSCKTLIRFRVASNRLVGTIPQGVMSLPHVSIIDLAYNSLSGP 427
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I N +GNA NLSELFMQ N+ISG IP E+ + +LVK+DLS+N LSGPIPS +G L+KLN
Sbjct: 428 IPNAIGNAWNLSELFMQSNRISGVIPHELSHSTNLVKLDLSNNQLSGPIPSEVGRLRKLN 487
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420
LL+LQ N L+SSIP+SLS+LKSLNVLDLS+NLLTG IPE+L ELLP SINFS+NRLSGPI
Sbjct: 488 LLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGRIPENLSELLPTSINFSSNRLSGPI 547
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
P+SLI+ GLVESFS NP LC+ + SSD FP+C +++LSSIWA++ S I+ +G
Sbjct: 548 PVSLIRGGLVESFSDNPNLCIPPTAGSSDLKFPMCQEPHGKKKLSSIWAILVSVFILVLG 607
Query: 481 LLLF-LKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGS 539
+++F L++R SK +A+ E DETL+SSFF YDVKSFHRISFDQREILE++ +KN VG GGS
Sbjct: 608 VIMFYLRQRMSKNKAVIEQDETLASSFFSYDVKSFHRISFDQREILESLVDKNIVGHGGS 667
Query: 540 GTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599
GTVY+++L SGEVVAVKKLWSQ K SAS+ D++ L+K LKTEVETLG+IRHKNIVKL+
Sbjct: 668 GTVYRVELKSGEVVAVKKLWSQSNKDSASE-DKMHLNKELKTEVETLGSIRHKNIVKLFS 726
Query: 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659
YFSSL C+LLVYEYMPNGNLWDALHKG VHL+W TRH+IA GVAQGLAYLHH L PIIH
Sbjct: 727 YFSSLDCSLLVYEYMPNGNLWDALHKGFVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIH 786
Query: 660 RDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTK 719
RDIKSTNILLDVNYQPKVADFGIAKVLQAR GKDSTTTV+AGTYGYLAPEYAYSSKAT K
Sbjct: 787 RDIKSTNILLDVNYQPKVADFGIAKVLQAR-GKDSTTTVMAGTYGYLAPEYAYSSKATIK 845
Query: 720 CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM 779
CDVYSFGVVLMELITG+KPV+ FG+NKNI+ WVS K+DTKEG++E LDK+LS S + +M
Sbjct: 846 CDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSESSKADM 905
Query: 780 IQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812
I LR+AIRCTS++P RPTMNEVVQLL +A P
Sbjct: 906 INALRVAIRCTSRTPTIRPTMNEVVQLLIDATP 938
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510067|ref|XP_003523762.1| PREDICTED: receptor-like protein kinase HSL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1149 bits (2971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 603/845 (71%), Positives = 693/845 (82%), Gaps = 10/845 (1%)
Query: 1 MSFMYLTGTLPDFSPMQ-NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKL 59
M+ M LTGTLPDFS ++ +LR LDLS N FTGQFP+SVFNLTNLE L+FNEN GF LW+L
Sbjct: 127 MNHMSLTGTLPDFSSLKKSLRVLDLSYNSFTGQFPMSVFNLTNLEELNFNENGGFNLWQL 186
Query: 60 PESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR 119
P + I RL KL++MVL TC +HGQIPASIGN+TSLTDLEL+GNF+TG IP E+G LKNL+
Sbjct: 187 P-ADIDRLKKLKVMVLTTCMVHGQIPASIGNITSLTDLELSGNFLTGQIPKELGQLKNLQ 245
Query: 120 QLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179
QLELYYN L G IPEELGNLTEL DLDMSVN +G IP S+ RLPKL+VLQLYNNSL+G
Sbjct: 246 QLELYYNYHLVGNIPEELGNLTELVDLDMSVNKFTGSIPASVCRLPKLQVLQLYNNSLTG 305
Query: 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239
EI I NST L MLSLYDN L G VP+ LGQ+S +VVLDLSENK SGPLP +VC G L
Sbjct: 306 EIPGAIENSTALRMLSLYDNFLVGHVPRKLGQFSGMVVLDLSENKFSGPLPTEVCKGGTL 365
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
YFLVL NMFSG +P S A C LLRFRVSNN LEGSIP G+L+LPHVSIIDLS N+ +G
Sbjct: 366 GYFLVLDNMFSGEIPQSYANCMMLLRFRVSNNRLEGSIPAGLLALPHVSIIDLSNNNLTG 425
Query: 300 PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKL 359
PI GN+RNLSELF+QRN+ISG I I RAI+LVKID S NLLSGPIPS IGNL+KL
Sbjct: 426 PIPEINGNSRNLSELFLQRNKISGVINPTISRAINLVKIDFSYNLLSGPIPSEIGNLRKL 485
Query: 360 NLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGP 419
NLLMLQ NKLNSSIP SLSSL+SLN+LDLSNNLLTG IPESL LLPNSINFS+N LSGP
Sbjct: 486 NLLMLQGNKLNSSIPGSLSSLESLNLLDLSNNLLTGSIPESLSVLLPNSINFSHNLLSGP 545
Query: 420 IPLSLIKEGLVESFSGNPGLCV-SVSVNSSDKNFPLCPHTKTR-RRLSSIWAVVTSAVII 477
IP LIK GLVESF+GNPGLCV V NSSD FP+C + +R+++IW S V+I
Sbjct: 546 IPPKLIKGGLVESFAGNPGLCVLPVYANSSDHKFPMCASAYYKSKRINTIWIAGVSVVLI 605
Query: 478 FIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQG 537
FIG LFLKRR SK A E ++TLSSSFF YDVKSFH+ISFDQREI+E++ +KN +G G
Sbjct: 606 FIGSALFLKRRCSKDTAAVEHEDTLSSSFFSYDVKSFHKISFDQREIVESLVDKNIMGHG 665
Query: 538 GSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKL 597
GSGTVYKI+L SG++VAVK+LWS +K SA + D+L +DK LK EVETLG+IRHKNIVKL
Sbjct: 666 GSGTVYKIELKSGDIVAVKRLWSHASKDSAPE-DRLFVDKALKAEVETLGSIRHKNIVKL 724
Query: 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPI 657
YC FSS C+LLVYEYMPNGNLWD+LHKG + LDWPTR++IA G+AQGLAYLHH LL PI
Sbjct: 725 YCCFSSYDCSLLVYEYMPNGNLWDSLHKGWILLDWPTRYRIALGIAQGLAYLHHDLLLPI 784
Query: 658 IHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT 717
IHRDIKSTNILLDV+ QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE+AYSS+AT
Sbjct: 785 IHRDIKSTNILLDVDNQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEFAYSSRAT 844
Query: 718 TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM--EVLDKKLSGSF 775
TKCDVYS+GV+LMEL+TG+KPVE +FG+N+NI++WVS KV+ KEG EVLD KLS SF
Sbjct: 845 TKCDVYSYGVILMELLTGKKPVEAEFGENRNIVFWVSNKVEGKEGARPSEVLDPKLSCSF 904
Query: 776 RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIK 835
+++MI+VLRIAIRCT K+P +RPTM EVVQLL EA+P +SCK S + SN T IK
Sbjct: 905 KEDMIKVLRIAIRCTYKAPTSRPTMKEVVQLLIEAEPRGSDSCKL---STNDVSNVTVIK 961
Query: 836 NPSEL 840
P EL
Sbjct: 962 KPYEL 966
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 840 | ||||||
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.963 | 0.837 | 0.674 | 1.6e-294 | |
| TAIR|locus:2024432 | 977 | LRR XI-23 [Arabidopsis thalian | 0.948 | 0.815 | 0.380 | 1.7e-137 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.932 | 0.786 | 0.379 | 2.3e-133 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.966 | 0.812 | 0.383 | 1e-130 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.964 | 0.799 | 0.361 | 2.6e-127 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.936 | 0.785 | 0.378 | 2.9e-126 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.964 | 0.807 | 0.368 | 9.9e-126 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.863 | 0.730 | 0.366 | 2.8e-122 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.942 | 0.704 | 0.366 | 5.2e-120 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.953 | 0.727 | 0.358 | 2.3e-119 |
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2828 (1000.6 bits), Expect = 1.6e-294, P = 1.6e-294
Identities = 548/813 (67%), Positives = 653/813 (80%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
MS +YL GTLPDFS M++LR +D+S N FTG FPLS+FNLT+LE L+FNENP LW LP
Sbjct: 129 MSSVYLKGTLPDFSQMKSLRVIDMSWNHFTGSFPLSIFNLTDLEYLNFNENPELDLWTLP 188
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+S + +LTKL M+L TC LHG IP SIGN+TSL DLEL+GNF++G IP EIG L NLRQ
Sbjct: 189 DS-VSKLTKLTHMLLMTCMLHGNIPRSIGNLTSLVDLELSGNFLSGEIPKEIGNLSNLRQ 247
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
LELYYN L G+IPEE+GNL LTD+D+SV+ L+G IP+SI LP LRVLQLYNNSL+GE
Sbjct: 248 LELYYNYHLTGSIPEEIGNLKNLTDIDISVSRLTGSIPDSICSLPNLRVLQLYNNSLTGE 307
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I + NS TL +LSLYDN LTGE+P +LG SP++ LD+SEN+LSGPLPA VC GKL
Sbjct: 308 IPKSLGNSKTLKILSLYDNYLTGELPPNLGSSSPMIALDVSENRLSGPLPAHVCKSGKLL 367
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
YFLVLQN F+G +P++ CK L+RFRV++N L G+IP+G++SLPHVSIIDL+YNS SGP
Sbjct: 368 YFLVLQNRFTGSIPETYGSCKTLIRFRVASNRLVGTIPQGVMSLPHVSIIDLAYNSLSGP 427
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I N +GNA NLSELFMQ N+ISG IP E+ + +LVK+DLS+N LSGPIPS +G L+KLN
Sbjct: 428 IPNAIGNAWNLSELFMQSNRISGVIPHELSHSTNLVKLDLSNNQLSGPIPSEVGRLRKLN 487
Query: 361 LLMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCELLPNSINFSNNRLSGPI 420
LL+LQ TG IPE+L ELLP SINFS+NRLSGPI
Sbjct: 488 LLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGRIPENLSELLPTSINFSSNRLSGPI 547
Query: 421 PLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIG 480
P+SLI+ GLVESFS NP LC+ + SSD FP+C +++LSSIWA++ S I+ +G
Sbjct: 548 PVSLIRGGLVESFSDNPNLCIPPTAGSSDLKFPMCQEPHGKKKLSSIWAILVSVFILVLG 607
Query: 481 LLLF-LKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGS 539
+++F L++R SK RA+ E DETL+SSFF YDVKSFHRISFDQREILE++ +KN VG GGS
Sbjct: 608 VIMFYLRQRMSKNRAVIEQDETLASSFFSYDVKSFHRISFDQREILESLVDKNIVGHGGS 667
Query: 540 GTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599
GTVY+++L SGEVVAVKKLWSQ K SAS+ D++ L+K LKTEVETLG+IRHKNIVKL+
Sbjct: 668 GTVYRVELKSGEVVAVKKLWSQSNKDSASE-DKMHLNKELKTEVETLGSIRHKNIVKLFS 726
Query: 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659
YFSSL C+LLVYEYMPNGNLWDALHKG VHL+W TRH+IA GVAQGLAYLHH L PIIH
Sbjct: 727 YFSSLDCSLLVYEYMPNGNLWDALHKGFVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIH 786
Query: 660 RDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTK 719
RDIKSTNILLDVNYQPKVADFGIAKVLQARG KDSTTTV+AGTYGYLAPEYAYSSKAT K
Sbjct: 787 RDIKSTNILLDVNYQPKVADFGIAKVLQARG-KDSTTTVMAGTYGYLAPEYAYSSKATIK 845
Query: 720 CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM 779
CDVYSFGVVLMELITG+KPV+ FG+NKNI+ WVS K+DTKEG++E LDK+LS S + +M
Sbjct: 846 CDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSESSKADM 905
Query: 780 IQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812
I LR+AIRCTS++P RPTMNEVVQLL +A P
Sbjct: 906 INALRVAIRCTSRTPTIRPTMNEVVQLLIDATP 938
|
|
| TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1346 (478.9 bits), Expect = 1.7e-137, P = 1.7e-137
Identities = 316/831 (38%), Positives = 467/831 (56%)
Query: 1 MSFMYLTGT-LPDFSPMQNLRR------LDLSNNLF--TGQFPLSVFNLTNLEVLSFNEN 51
+ F+YL + P ++LR L L +N F T FP+ V +L L L + N
Sbjct: 146 LQFLYLNNSAFSGVFPWKSLRNATSLVVLSLGDNPFDATADFPVEVVSLKKLSWL-YLSN 204
Query: 52 PGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPE 111
K+P + I LT+LR + ++ L G+IP+ I +T+L LEL N +TG +P
Sbjct: 205 CSIA-GKIPPA-IGDLTELRNLEISDSGLTGEIPSEISKLTNLWQLELYNNSLTGKLPTG 262
Query: 112 IGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171
G LKNL L+ N L G + EL +LT L L M N SG+IP L L
Sbjct: 263 FGNLKNLTYLDASTNL-LQGDL-SELRSLTNLVSLQMFENEFSGEIPLEFGEFKDLVNLS 320
Query: 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPA 231
LY N L+G + + + + +N LTG +P D+ + + L L +N L+G +P
Sbjct: 321 LYTNKLTGSLPQGLGSLADFDFIDASENLLTGPIPPDMCKNGKMKALLLLQNNLTGSIPE 380
Query: 232 KVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIID 291
+ LQ F V +N +G +P L L + N+ EG I I + + +
Sbjct: 381 SYANCLTLQRFRVSENNLNGTVPAGLWGLPKLEIIDIEMNNFEGPITADIKNGKMLGALY 440
Query: 292 LSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPS 351
L +N S + +G+ +L+++ + N+ +G IPS I + L + + N SG IP
Sbjct: 441 LGFNKLSDELPEEIGDTESLTKVELNNNRFTGKIPSSIGKLKGLSSLKMQSNGFSGEIPD 500
Query: 352 GIGNLKKLNLLMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCELLPNSINF 411
IG+ L+ + + +G IPESL L + ++
Sbjct: 501 SIGSCSMLSDVNMAQNSISGEIPHTLGSLPTLNALNLSDNKLSGRIPESLSSLRLSLLDL 560
Query: 412 SNNRLSGPIPLSLIKEGLVESFSGNPGLCVSVSVNSSDKNF-PLCPHTKTRRRLSSIWAV 470
SNNRLSG IPLSL SF+GNPGLC S ++ S ++ P H TR + +
Sbjct: 561 SNNRLSGRIPLSLSSYN--GSFNGNPGLC-STTIKSFNRCINPSRSHGDTR---VFVLCI 614
Query: 471 VTSAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTE 530
V +I+ L+ FL + K+ TE E S + +KSF ++SF + +I++++ E
Sbjct: 615 VFGLLILLASLVFFL---YLKK---TEKKEGRSLKHESWSIKSFRKMSFTEDDIIDSIKE 668
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASD-----TDQLQLDKGLKTEVET 585
+N +G+GG G VY++ L G+ VAVK + T+ + S T++ K +TEV+T
Sbjct: 669 ENLIGRGGCGDVYRVVLGDGKEVAVKHIRCSSTQKNFSSAMPILTEREGRSKEFETEVQT 728
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQ 644
L +IRH N+VKLYC +S +LLVYEY+PNG+LWD LH +L W TR+ IA G A+
Sbjct: 729 LSSIRHLNVVKLYCSITSDDSSLLVYEYLPNGSLWDMLHSCKKSNLGWETRYDIALGAAK 788
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GL YLHHG P+IHRD+KS+NILLD +P++ADFG+AK+LQA G +T V+AGTYG
Sbjct: 789 GLEYLHHGYERPVIHRDVKSSNILLDEFLKPRIADFGLAKILQASNGGPESTHVVAGTYG 848
Query: 705 YLAP-EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763
Y+AP EY Y+SK T KCDVYSFGVVLMEL+TG+KP+E +FG++K+I+ WVS + +KE +
Sbjct: 849 YIAPAEYGYASKVTEKCDVYSFGVVLMELVTGKKPIEAEFGESKDIVNWVSNNLKSKESV 908
Query: 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814
ME++DKK+ +R++ +++LRIAI CT++ P RPTM VVQ++ +A+PCR
Sbjct: 909 MEIVDKKIGEMYREDAVKMLRIAIICTARLPGLRPTMRSVVQMIEDAEPCR 959
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1307 (465.1 bits), Expect = 2.3e-133, P = 2.3e-133
Identities = 314/827 (37%), Positives = 461/827 (55%)
Query: 1 MSFMY--LTGTLPDF-SPMQNLRRLDLSNNLFT-GQFPLSVFNLTNLEVLSFNENPGFKL 56
+S +Y L GT+P F + L+ L+LS N F+ + P NLTNLEV+ E +
Sbjct: 161 LSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTEC--HLV 218
Query: 57 WKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLK 116
++P+S + +L+KL + LA L G IP S+G +T++ +EL N +TG IPPE+G LK
Sbjct: 219 GQIPDS-LGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLK 277
Query: 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176
+LR L+ NQ L G IP+EL + L L++ N+L G++P SI P L ++++ N
Sbjct: 278 SLRLLDASMNQ-LTGKIPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNR 335
Query: 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR 236
L+G + + ++ L L + +N +G++P DL L L + N SG +P +
Sbjct: 336 LTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADC 395
Query: 237 GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNS 296
L + N FSG +P ++ + NN G I + I ++S++ LS N
Sbjct: 396 RSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNE 455
Query: 297 FSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNL 356
F+G + +G+ NL++L N+ SG +P + L +DL N SG + SGI +
Sbjct: 456 FTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSW 515
Query: 357 KKLNLLMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCELLPNSINFSNNRL 416
KKLN L L +G IP SL L N +N S NRL
Sbjct: 516 KKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRL 575
Query: 417 SGPIPLSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAV----VT 472
SG +P SL K+ SF GNPGLC + LC ++ +W + V
Sbjct: 576 SGDLPPSLAKDMYKNSFIGNPGLCGDIK--------GLCGSENEAKKRGYVWLLRSIFVL 627
Query: 473 SAVIIFIGLLLF-LK-RRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTE 530
+A+++ G+ F K R F K RA+ TL S FH++ F + EILE++ E
Sbjct: 628 AAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMS---------FHKLGFSEHEILESLDE 678
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSAS-DTDQ-----LQLDKGLKTEVE 584
N +G G SG VYK+ L +GE VAVK+LW+ K + D ++ +Q D+ + EVE
Sbjct: 679 DNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQ-DEAFEAEVE 737
Query: 585 TLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVHLDWPTRHKIAFGV 642
TLG IRHKNIVKL+C S+ C LLVYEYMPNG+L D LH KG + L W TR KI
Sbjct: 738 TLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGM-LGWQTRFKIILDA 796
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A+GL+YLHH + PI+HRDIKS NIL+D +Y +VADFG+AK + G + +VIAG+
Sbjct: 797 AEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGS 856
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
GY+APEYAY+ + K D+YSFGVV++E++T ++PV+ + G+ K+++ WV +D K G
Sbjct: 857 CGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGE-KDLVKWVCSTLDQK-G 914
Query: 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
I V+D KL F++E+ ++L + + CTS P RP+M VV++L E
Sbjct: 915 IEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQE 961
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 328/855 (38%), Positives = 476/855 (55%)
Query: 6 LTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
L+ T+P F + L L+L+ N +G P S+ N+T L+ L N F ++P S +
Sbjct: 151 LSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNL-FSPSQIP-SQL 208
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
LT+L+++ LA C L G IP S+ +TSL +L+LT N +TG IP I LK + Q+EL+
Sbjct: 209 GNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELF 268
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
N +G +PE +GN+T L D S+N L+GKIP++ L L L L L+ N L G +
Sbjct: 269 -NNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDN-LNLLNLESLNLFENMLEGPLPES 326
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
I S TL+ L L++N LTG +P LG SPL +DLS N+ SG +PA VC GKL+Y ++
Sbjct: 327 ITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLIL 386
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
+ N FSG + ++L +CK+L R R+SNN L G IP G LP +S+++LS NSF+G I T
Sbjct: 387 IDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKT 446
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLML 364
+ A+NLS L + +N+ SG IP+EI +++I ++N SG IP + LK+L+ L L
Sbjct: 447 IIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDL 506
Query: 365 QXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCELLP--NSINFSNNRLSGPIPL 422
+G IP+ + +LP N ++ S+N+ SG IPL
Sbjct: 507 SKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEV-GILPVLNYLDLSSNQFSGEIPL 565
Query: 423 SL--IKEGLVE-SF---SGN-PGLCVS-VSVNSSDKNFPLCPHTK------TR-RRLSSI 467
L +K ++ S+ SG P L + + + N LC TR + + +
Sbjct: 566 ELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGLCRKITRSKNIGYV 625
Query: 468 WAVVTSAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEA 527
W ++T ++ + ++ + +K R + SS+ +SFH++ F + EI +
Sbjct: 626 WILLTIFLLAGLVFVVGIVMFIAKCRKLRA---LKSSTLAASKWRSFHKLHFSEHEIADC 682
Query: 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASD--TDQLQLDKGLKTEVET 585
+ EKN +G G SG VYK++L GEVVAVKKL ++ K + +D L D EVET
Sbjct: 683 LDEKNVIGFGSSGKVYKVELRGGEVVAVKKL-NKSVKGGDDEYSSDSLNRDV-FAAEVET 740
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH---KGLVHLDWPTRHKIAFGV 642
LG IRHK+IV+L+C SS C LLVYEYMPNG+L D LH KG V L WP R +IA
Sbjct: 741 LGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDA 800
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A+GL+YLHH + PI+HRD+KS+NILLD +Y KVADFGIAKV Q G K T ++G
Sbjct: 801 AEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSK--TPEAMSGI 858
Query: 703 YGYLAPEYAYSSKATTKCDVYS--FGV-VLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759
G A T + + S + V++ + K D +K++ WV +D
Sbjct: 859 AGSCG-YIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDKDMAKWVCTALD- 916
Query: 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCK 819
K G+ V+D KL F++E+ +V+ I + CTS P RP+M +VV +L E C
Sbjct: 917 KCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEVSGA--VPCS 974
Query: 820 FPNKSNKESSNATKI 834
PN S K S K+
Sbjct: 975 SPNTS-KRSKTGGKL 988
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
Identities = 305/844 (36%), Positives = 454/844 (53%)
Query: 5 YLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLE--VLSFNENPGFKLWKLPE 61
+ G+LP F +Q LR L LS N TG+ P + L +LE +L +NE FK PE
Sbjct: 175 FFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNE---FKGPIPPE 231
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
+ L+ + LA L G+IP+ +G + SL L L N TG IP EIG + L+ L
Sbjct: 232 FG--NINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVL 289
Query: 122 ELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI 181
+ + + L G IP E+ L L L++ N LSG IP +I L +L+VL+L+NN+LSGE+
Sbjct: 290 D-FSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGEL 348
Query: 182 SSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQY 241
S + ++ L L + NS +GE+P L L L L N +G +PA + + L
Sbjct: 349 PSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVR 408
Query: 242 FLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301
+ N+ +G +P + + L R ++ N L G IP I +S ID S N +
Sbjct: 409 VRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSL 468
Query: 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNL 361
+T+ + NL + N ISG +P + SL +DLS N L+G IPS I + +KL
Sbjct: 469 PSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVS 528
Query: 362 LMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESL-CELLPNSINFSNNRLSGPI 420
L L+ TG +PES+ +N S N+L+GP+
Sbjct: 529 LNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPV 588
Query: 421 PLS-LIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTR-RRLSSIWAVVTSAVIIF 478
P++ +K + GN GLC V S H+ +R+ + W + ++V+
Sbjct: 589 PINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLA- 647
Query: 479 IGLLLFLKRRFSKQRAITE--PDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQ 536
+G+L + R K+ DET S +P+ + +FHR+ F +IL + E N +G
Sbjct: 648 LGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGM 707
Query: 537 GGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIV 595
G +G VYK +++ S V+AVKKLW + T G EV LG +RH+NIV
Sbjct: 708 GATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFV---G---EVNLLGKLRHRNIV 761
Query: 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALH----KGLVHLDWPTRHKIAFGVAQGLAYLHH 651
+L + + ++VYE+M NGNL DA+H G + +DW +R+ IA GVA GLAYLHH
Sbjct: 762 RLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHH 821
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
P+IHRDIKS NILLD N ++ADFG+A+++ AR K T +++AG+YGY+APEY
Sbjct: 822 DCHPPVIHRDIKSNNILLDANLDARIADFGLARMM-AR--KKETVSMVAGSYGYIAPEYG 878
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL 771
Y+ K K D+YS+GVVL+EL+TGR+P+E +FG++ +I+ WV K+ + E LD +
Sbjct: 879 YTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV 938
Query: 772 SGS--FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESS 829
++EM+ VL+IA+ CT+K P RP+M +V+ +L EA P R + N+ N S
Sbjct: 939 GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNS---NEENTSRS 995
Query: 830 NATK 833
A K
Sbjct: 996 LAEK 999
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 313/827 (37%), Positives = 446/827 (53%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
LTG LP + + LR L L N F+G+ P + LE L+ + N K+P I
Sbjct: 154 LTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNE--LTGKIPPE-I 210
Query: 65 FRLTKLRIMVLATC-ALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
LT LR + + A +P IGN++ L + +TG IPPEIG L+ L L L
Sbjct: 211 GNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFL 270
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183
N GTI +ELG ++ L +D+S N +G+IP S +L L +L L+ N L G I
Sbjct: 271 QVNA-FTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPE 329
Query: 184 VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243
I L +L L++N+ TG +PQ LG+ LV+LDLS NKL+G LP +CS +L +
Sbjct: 330 FIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLI 389
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG--PI 301
L N G +PDSL +C++L R R+ N L GSIP+ + LP +S ++L N +G PI
Sbjct: 390 TLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPI 449
Query: 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNL 361
+ G + +L ++ + NQ+SG +P+ I + K+ L N SG IP IG L++L+
Sbjct: 450 SGG-GVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSK 508
Query: 362 LMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCEL-LPNSINFSNNRLSGPI 420
L +G IP L + + N +N S N L G I
Sbjct: 509 LDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSI 568
Query: 421 PLSLIK-EGLVE-SFSGN--PGLCVSV------SVNSSDKNFPLC-----PHTKTRRRLS 465
P+++ + L FS N GL S + S N LC P K +
Sbjct: 569 PVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSH 628
Query: 466 SIWAVVTSAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREIL 525
T+ +++ +GLL F F+ I +S + + +F R+ F ++L
Sbjct: 629 VKPLSATTKLLLVLGLL-FCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVL 687
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
+++ E N +G+GG+G VYK + G++VAVK+L T S D G E++T
Sbjct: 688 DSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL---ATMSHGSSHDH-----GFNAEIQT 739
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVHLDWPTRHKIAFGVA 643
LG IRH++IV+L + S+ NLLVYEYMPNG+L + LH KG HL W TR+KIA A
Sbjct: 740 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-GHLHWNTRYKIALEAA 798
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
+GL YLHH I+HRD+KS NILLD N++ VADFG+AK LQ G + + IAG+Y
Sbjct: 799 KGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSA-IAGSY 857
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT-KEG 762
GY+APEYAY+ K K DVYSFGVVL+ELITG+KPV +FGD +I+ WV D+ K+
Sbjct: 858 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV-GEFGDGVDIVQWVRSMTDSNKDC 916
Query: 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+++V+D +LS E+ V +A+ C + RPTM EVVQ+L E
Sbjct: 917 VLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTE 963
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1235 (439.8 bits), Expect = 9.9e-126, P = 9.9e-126
Identities = 321/872 (36%), Positives = 462/872 (52%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
LTG LP + + LR L L N F G+ P S + +E L+ + N + K+P I
Sbjct: 154 LTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNE--LVGKIPPE-I 210
Query: 65 FRLTKLRIMVLATC-ALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
LT LR + + A +P IGN++ L + +TG IPPEIG L+ L L L
Sbjct: 211 GNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFL 270
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183
N +G + ELG L+ L +D+S N +G+IP S L L +L L+ N L GEI
Sbjct: 271 QVNV-FSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPE 329
Query: 184 VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243
I + L +L L++N+ TG +PQ LG+ L ++DLS NKL+G LP +CS KL+ +
Sbjct: 330 FIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLI 389
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPH----------------- 286
L N G +PDSL +C++L R R+ N L GSIP+G+ LP
Sbjct: 390 TLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPV 449
Query: 287 ---VSI----IDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKID 339
VS+ I LS N SGP+ +GN + +L + N+ G IPSE+ + L KID
Sbjct: 450 AGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKID 509
Query: 340 LSDNLLSGPIPSGIGNLKKLNLLMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPE 399
S NL SG I I K L + L G IP
Sbjct: 510 FSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPG 569
Query: 400 SLCELLP-NSINFSNNRLSGPIP-LSLIKEGLVESFSGNPGLCVSVSVNSSDKNFPLCPH 457
S+ + S++FS N LSG +P SF GNP LC D
Sbjct: 570 SISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQ 629
Query: 458 TKTRRRLSSIWAVVTSAVIIFIGLLL----FLKRRFSKQRAITEPDETLSSSFFPYDVKS 513
+ ++ LS+ + +++ +GLL+ F K R++ + E+ + + + +
Sbjct: 630 SHSKGPLSA-----SMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRA-----WRLTA 679
Query: 514 FHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
F R+ F ++L+++ E N +G+GG+G VYK + +G++VAVK+L + ++ S+
Sbjct: 680 FQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGSSH----- 733
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVHLD 631
D G E++TLG IRH++IV+L + S+ NLLVYEYMPNG+L + LH KG HL
Sbjct: 734 --DHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-GHLH 790
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
W TR+KIA A+GL YLHH I+HRD+KS NILLD N++ VADFG+AK LQ G
Sbjct: 791 WDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGT 850
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
+ + IAG+YGY+APEYAY+ K K DVYSFGVVL+EL+TGRKPV +FGD +I+
Sbjct: 851 SECMSA-IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV-GEFGDGVDIVQ 908
Query: 752 WVSIKVDT-KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
WV D+ K+ +++VLD +LS E+ V +A+ C + RPTM EVVQ+L E
Sbjct: 909 WVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEI 968
Query: 811 DPCRFESCKFPNKSNKESSNATK--IKNPSEL 840
+ +S ES + K +++P +L
Sbjct: 969 PKLPPSKDQPMTESAPESELSPKSGVQSPPDL 1000
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 2.8e-122, Sum P(2) = 2.8e-122
Identities = 282/769 (36%), Positives = 418/769 (54%)
Query: 7 TGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
TG +P + + L+ L+L+ N +G P + LT L L F +P S++
Sbjct: 160 TGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDL-AYISFDPSPIP-STLG 217
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYY 125
L+ L + L L G+IP SI N+ L +L+L N +TG IP IG L+++ Q+ELY
Sbjct: 218 NLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYD 277
Query: 126 NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
N+ L+G +PE +GNLTEL + D+S N+L+G++PE I L +L L +N +G + V+
Sbjct: 278 NR-LSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAAL-QLISFNLNDNFFTGGLPDVV 335
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
A + L +++NS TG +P++LG++S + D+S N+ SG LP +C R KLQ +
Sbjct: 336 ALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITF 395
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTV 305
N SG +P+S C +L R+++N L G +P LP + + N G I ++
Sbjct: 396 SNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSI 455
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
AR+LS+L + N SG IP ++ L IDLS N G IPS I LK L + +Q
Sbjct: 456 SKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQ 515
Query: 366 XXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCEL-LPNSINFSNNRLSGPIPLSL 424
G IP L +L + N ++ SNN+L+G IP L
Sbjct: 516 ENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAEL 575
Query: 425 IKEGLVE-SFSGN------P-GLCVSVSVNSSDKNFPLC-PHT------KTRRRLSSIWA 469
++ L + + S N P G + S N LC P+ +++R I
Sbjct: 576 LRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETRYILP 635
Query: 470 VVTSAVIIFIGLLLFLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMT 529
+ ++ G L++L F K + + + ++ + F R+ F + +I +T
Sbjct: 636 ISILCIVALTGALVWL---FIKTKPLFKRKPKRTNK-----ITIFQRVGFTEEDIYPQLT 687
Query: 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
E N +G GGSG VY++ L SG+ +AVKKLW + + + S++ ++EVETLG +
Sbjct: 688 EDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESV-------FRSEVETLGRV 740
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH-----LDWPTRHKIAFGVAQ 644
RH NIVKL + LVYE+M NG+L D LH H LDW TR IA G AQ
Sbjct: 741 RHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQ 800
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR---GGKDSTTTVIAG 701
GL+YLHH + PI+HRD+KS NILLD +P+VADFG+AK L+ G D + + +AG
Sbjct: 801 GLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAG 860
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
+YGY+APEY Y+SK K DVYSFGVVL+ELITG++P + FG+NK+I+
Sbjct: 861 SYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIV 909
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1181 (420.8 bits), Expect = 5.2e-120, P = 5.2e-120
Identities = 303/827 (36%), Positives = 440/827 (53%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
L G +P + M++L++L L N G P + L+ + + F+EN ++P +
Sbjct: 289 LVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSEN--LLSGEIPVE-L 345
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
++++LR++ L L G IP + + +L L+L+ N +TG IPP L ++RQL+L+
Sbjct: 346 SKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLF 405
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
+N L+G IP+ LG + L +D S N LSGKIP I + L +L L +N + G I
Sbjct: 406 HNS-LSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPG 464
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
+ +L L + N LTG+ P +L + L ++L +N+ SGPLP ++ + KLQ +
Sbjct: 465 VLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHL 524
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
N FS LP+ +++ NL+ F VS+N L G IP I + + +DLS NSF G +
Sbjct: 525 AANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPE 584
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM- 363
+G+ L L + N+ SG IP I L ++ + NL SG IP +G L L + M
Sbjct: 585 LGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMN 644
Query: 364 LQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIP---ESLCELLPNSINFSNNRLSGPI 420
L +G IP E+L LL NFS N L+G +
Sbjct: 645 LSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLL--GCNFSYNNLTGQL 702
Query: 421 PLSLIKEGL-VESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWA---VVTSAVI 476
P + I + + + SF GN GLC + S D + PH + + S+ ++ S+VI
Sbjct: 703 PHTQIFQNMTLTSFLGNKGLCGG-HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVI 761
Query: 477 IFIGLLLF-LKRRFSKQRAI-TEPDETLSSSFFPY-DVKSFHRISFDQREILEAMT---E 530
I LLL + F + T P FF D+ + F ++ILEA +
Sbjct: 762 GGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHD 821
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
VG+G GTVYK + SG+ +AVKKL S R ++ + D + E+ TLG IR
Sbjct: 822 SYIVGRGACGTVYKAVMPSGKTIAVKKLESNR---EGNNNNSNNTDNSFRAEILTLGKIR 878
Query: 591 HKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGVAQGLA 647
H+NIV+LY CY NLL+YEYM G+L + LH G H +DWPTR IA G A+GLA
Sbjct: 879 HRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLA 938
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLHH IIHRDIKS NIL+D N++ V DFG+AKV+ K + + +AG+YGY+A
Sbjct: 939 YLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSK--SVSAVAGSYGYIA 996
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PEYAY+ K T KCD+YSFGVVL+EL+TG+ PV+ ++ W + E+L
Sbjct: 997 PEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEIL 1055
Query: 768 DKKLSGSFRD----EMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
D L+ D MI V +IA+ CT SP+ RPTM EVV +L E+
Sbjct: 1056 DPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIES 1102
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1175 (418.7 bits), Expect = 2.3e-119, P = 2.3e-119
Identities = 308/858 (35%), Positives = 452/858 (52%)
Query: 5 YLTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENP--GFKLWKLPE 61
Y TG++P + + ++RL L N TG+ P + NL + + F+EN GF +P+
Sbjct: 270 YFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGF----IPK 325
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
+ L+++ L L G IP +G +T L L+L+ N + G IP E+ L L L
Sbjct: 326 E-FGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDL 384
Query: 122 ELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI 181
+L+ NQ L G IP +G + + LDMS N LSG IP R L +L L +N LSG I
Sbjct: 385 QLFDNQ-LEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNI 443
Query: 182 SSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQY 241
+ +LT L L DN LTG +P +L L L+L +N LSG + A + L+
Sbjct: 444 PRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLER 503
Query: 242 FLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301
+ N F+G +P + ++ F +S+N L G IP+ + S + +DLS N FSG I
Sbjct: 504 LRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYI 563
Query: 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNL 361
A +G L L + N+++G IP L+++ L NLLS IP +G L L +
Sbjct: 564 AQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQI 623
Query: 362 -LMLQXXXXXXXXXXXXXXXXXXXXXXXXXXXXTGYIPESLCELLPNSI-NFSNNRLSGP 419
L + +G IP S+ L+ I N SNN L G
Sbjct: 624 SLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGT 683
Query: 420 IPLSLIKEGLVES-FSGNPGLCVSVSVNSSDKNFPLCPHTKT----------RRRLSSIW 468
+P + + + + S F+GN GLC S + PL PH+ + R+++ +I
Sbjct: 684 VPDTAVFQRMDSSNFAGNHGLCNSQRSHCQ----PLVPHSDSKLNWLINGSQRQKILTIT 739
Query: 469 AVVTSAV--IIFIGLLLFLKRR---FSKQRAITEPDETLSSSFFPYDVKSFHRISFDQRE 523
+V +V I F+GL +KRR F T+PD + S +FP ++ + R
Sbjct: 740 CIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPD-VMDSYYFPKKGFTYQGLVDATRN 798
Query: 524 ILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV 583
E + +G+G GTVYK +++ GEV+AVKKL S+ S+ D + E+
Sbjct: 799 FSEDVV----LGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS--------DNSFRAEI 846
Query: 584 ETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVH--LDWPTRHKIA 639
TLG IRH+NIVKLY CY + NLL+YEYM G+L + L +G + LDW R++IA
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQN--SNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIA 904
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
G A+GL YLHH I+HRDIKS NILLD +Q V DFG+AK++ K + + +
Sbjct: 905 LGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK--SMSAV 962
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759
AG+YGY+APEYAY+ K T KCD+YSFGVVL+ELITG+ PV+ +++ WV +
Sbjct: 963 AGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRN 1021
Query: 760 KEGIMEVLDKKLSGSFR---DEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA-DPCRF 815
+E+ D +L + + EM VL+IA+ CTS SPA+RPTM EVV ++ EA
Sbjct: 1022 MIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEARGSSSL 1081
Query: 816 ESCKFPNKSNKESSNATK 833
S +++ E +N++K
Sbjct: 1082 SSSSITSETPLEEANSSK 1099
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 840 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-99 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-55 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-99
Identities = 271/885 (30%), Positives = 419/885 (47%), Gaps = 118/885 (13%)
Query: 6 LTGTLPD--FSPMQNLRRLDLSNNLFTGQFPL-SVFNLTNLEVLSFNENPGFKLWKLPES 62
L+G +PD F+ +LR L+LSNN FTG P S+ NL L+ LS N G ++P
Sbjct: 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLD-LSNNMLSG----EIPN- 158
Query: 63 SIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLE 122
I + L+++ L L G+IP S+ N+TSL L L N + G IP E+G +K+L+ +
Sbjct: 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218
Query: 123 LYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEIS 182
L YN L+G IP E+G LT L LD+ N+L+G IP S+ L L+ L LY N LSG I
Sbjct: 219 LGYN-NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
Query: 183 SVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYF 242
I + L L L DNSL+GE+P+ + Q L +L L N +G +P + S +LQ
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL 337
Query: 243 LVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIA 302
+ N FSG +P +L + NL +S N+L G IPEG+ S ++ + L NS G I
Sbjct: 338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
Query: 303 NTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLL 362
++G R+L + +Q N SG +PSE + + +D+S+N L G I S ++ L +L
Sbjct: 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457
Query: 363 MLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL----------------LP 406
L NK +P+S S K L LDLS N +G +P L L +P
Sbjct: 458 SLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
Query: 407 N---------SINFSNNRLSGPIPLSLIK-------------------------EGLVE- 431
+ S++ S+N+LSG IP S + E LV+
Sbjct: 517 DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576
Query: 432 SFSGN------PGLCVSVSVNSS--DKNFPLC--------PHTKTRRRLSSIWAVVTSAV 475
+ S N P +++N+S N LC P K R+ S W +T +
Sbjct: 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTL 636
Query: 476 IIFIGLLL-------FLKRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAM 528
F+ L L R + + + D T FF V S +IL ++
Sbjct: 637 GAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSK----SITINDILSSL 692
Query: 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
E+N + +G G YK + V K +D + + +E+ +G
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVK--------EINDVNSIPS-----SEIADMGK 739
Query: 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
++H NIVKL S L++EY+ NL + L +L W R KIA G+A+ L +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRF 795
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
LH ++ ++ I++D +P + + +L T T + Y+AP
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-------CTDTKCFISSAYVAP 847
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768
E + T K D+Y FG++L+EL+TG+ P + +FG + +I+ W M + D
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI-D 906
Query: 769 KKLSG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
+ G ++E+++V+ +A+ CT+ P RP N+V++ L A
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 6e-56
Identities = 131/361 (36%), Positives = 198/361 (54%), Gaps = 5/361 (1%)
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVT-SLTDLELTGNFITGHIPPEIGLLKNLRQ 120
S+IFRL ++ + L+ L G IP I + SL L L+ N TG IP G + NL
Sbjct: 87 SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLET 144
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
L+L N L+G IP ++G+ + L LD+ N L GKIP S+ L L L L +N L G+
Sbjct: 145 LDLS-NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I + +L + L N+L+GE+P ++G + L LDL N L+GP+P+ + + LQ
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
Y + QN SG +P S+ + L+ +S+N L G IPE ++ L ++ I+ L N+F+G
Sbjct: 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
I + + L L + N+ SG IP + + +L +DLS N L+G IP G+ + L
Sbjct: 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF 383
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGP 419
L+L SN L IP SL + +SL + L +N +G +P +L L ++ SNN L G
Sbjct: 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR 443
Query: 420 I 420
I
Sbjct: 444 I 444
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 5e-55
Identities = 96/285 (33%), Positives = 136/285 (47%), Gaps = 46/285 (16%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G G GTVYK +G++VAVK L + K D+ + E+ L + H
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--------KDQTARREIRILRRLSH 57
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
NIV+L F LY LV EY G+L+D L +G L KIA + +GL Y
Sbjct: 58 PNIVRLIDAFEDKDHLY---LVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEY 113
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
LH +G IIHRD+K NILLD N K+ADFG+AK S+ T GT Y+A
Sbjct: 114 LHSNG----IIHRDLKPENILLDENGVVKIADFGLAKK---LLKSSSSLTTFVGTPWYMA 166
Query: 708 PE-YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766
PE + K DV+S GV+L EL+TG+ P + ++ + I +
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL------------IRRI 214
Query: 767 LDKKLSGSF------RDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
L L +E +++ +C +K P+ RPT E++Q
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIK---KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-54
Identities = 138/431 (32%), Positives = 215/431 (49%), Gaps = 33/431 (7%)
Query: 22 LDLSNNLFTGQFPLSVFNLTNLEV--LSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79
+DLS +G+ ++F L ++ LS N+ G +P+ + LR + L+
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG----PIPDDIFTTSSSLRYLNLSNNN 129
Query: 80 LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGN 139
G IP G++ +L L+L+ N ++G IP +IG +L+ L+L N L G IP L N
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN-VLVGKIPNSLTN 186
Query: 140 LTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
LT L L ++ N L G+IP + ++ L+ + L N+LSGEI I T+L L L N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 200 SLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLAR 259
+LTG +P LG L L L +NKLSGP+P + S KL + N SG +P+ + +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 260 CKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRN 319
+NL + +N+ G IP + SLP + ++ L N FSG I +G NL+ L + N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 320 QISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS 379
++G IP + + +L K+ L N L G IP +G + L + LQ N + +P+ +
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 380 LKSLNVLDLSNNLLTGYIPESLCEL----------------LPNS--------INFSNNR 415
L + LD+SNN L G I ++ LP+S ++ S N+
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 416 LSGPIPLSLIK 426
SG +P L
Sbjct: 487 FSGAVPRKLGS 497
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 84/279 (30%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+G+G G VY D +G++VA+K + ++ K + + + E++ L ++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK---------KDRERILREIKILKKLK 55
Query: 591 HKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
H NIV+LY F LY LV EY G+L+D L K L + L
Sbjct: 56 HPNIVRLYDVFEDEDKLY---LVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALE 111
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YLH G I+HRD+K NILLD + K+ADFG+A+ L T GT Y+
Sbjct: 112 YLHSKG----IVHRDLKPENILLDEDGHVKLADFGLARQLD----PGEKLTTFVGTPEYM 163
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766
APE D++S GV+L EL+TG+ P D D ++ I
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD--DQLLELFKK-IGKPKPPFPPP- 219
Query: 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ +S +D +I+ + K P R T E +Q
Sbjct: 220 -EWDISPEAKD-LIR------KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 82/277 (29%), Positives = 118/277 (42%), Gaps = 65/277 (23%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG GTVY D +G+ VA+K + + + + L E+E L + H
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE---------LLREIEILKKLNHP 51
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
NIVKLY F LV EY G+L D L + L +I + +GL YLH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS- 110
Query: 653 LLSPIIHRDIKSTNILLD-VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE-Y 710
+ IIHRD+K NILLD N + K+ADFG++K+L S I GT Y+APE
Sbjct: 111 --NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT---SDKSLLKTIVGTPAYMAPEVL 165
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
+ K D++S GV+L EL
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
E+ ++R + K P RP+ E+++ L
Sbjct: 188 ------PELKDLIR---KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 1e-48
Identities = 117/343 (34%), Positives = 178/343 (51%), Gaps = 33/343 (9%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149
N + + ++L+G I+G I I L ++ +++S
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQT-------------------------INLS 101
Query: 150 VNHLSGKIPESILRLP-KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQD 208
N LSG IP+ I LR L L NN+ +G I + L L L +N L+GE+P D
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159
Query: 209 LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRV 268
+G +S L VLDL N L G +P + + L++ + N G +P L + K+L +
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219
Query: 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328
N+L G IP I L ++ +DL YN+ +GPI +++GN +NL LF+ +N++SG IP
Sbjct: 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 329 IYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL 388
I+ L+ +DLSDN LSG IP + L+ L +L L SN IP +L+SL L VL L
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 389 SNNLLTGYIPESLCELLPNS---INFSNNRLSGPIPLSLIKEG 428
+N +G IP++L + N+ ++ S N L+G IP L G
Sbjct: 340 WSNKFSGEIPKNLGK--HNNLTVLDLSTNNLTGEIPEGLCSSG 380
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-45
Identities = 81/290 (27%), Positives = 125/290 (43%), Gaps = 45/290 (15%)
Query: 529 TEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV 583
T K+G+G G VYK VAVK L K AS+ + E
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-----KEDASEQQI----EEFLREA 52
Query: 584 ETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG 641
+ + H N+VKL C +V EYM G+L L K L A
Sbjct: 53 RIMRKLDHPNVVKLLGVCTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ 110
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+A+G+ YL IHRD+ + N L+ N K++DFG+++ L D G
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRG 162
Query: 702 T---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKV 757
++APE K T+K DV+SFGV+L E+ T G +P N+ ++ ++
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYL---- 216
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
K G L + + E+ ++ +C ++ P RPT +E+V++L
Sbjct: 217 --KNG--YRLPQPPNCP--PELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 6e-45
Identities = 86/290 (29%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 529 TEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV 583
T K+G+G G VYK VAVK L K AS+ + E
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-----KEDASEQQI----EEFLREA 52
Query: 584 ETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAF 640
+ + H NIVKL C +V EYMP G+L D L K L A
Sbjct: 53 RIMRKLDHPNIVKLLGVCTEEEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFAL 110
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
+A+G+ YL IHRD+ + N L+ N K++DFG+++ L D V
Sbjct: 111 QIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL----YDDDYYKVKG 163
Query: 701 G--TYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKV 757
G ++APE K T+K DV+SFGV+L E+ T G +P N ++ ++
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYL---- 217
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
K+G L K + E+ +++ +C ++ P RPT +E+V++L
Sbjct: 218 --KKG--YRLPKPPNCP--PELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 34/280 (12%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G G+VY +D ++GE++AVK + ++S ++L + L+ E+ L +++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSV-----ELSGDSEEEL---EALEREIRILSSLQ 57
Query: 591 HKNIVK-LYCYFSSLYCNLLVY-EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
H NIV+ L ++ EY+ G+L L K L P K + +GLAY
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAY 116
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
LH +G I+HRDIK NIL+D + K+ADFG AK L + T + + GT ++A
Sbjct: 117 LHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMA 171
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PE + D++S G ++E+ TG+ P + + N K+ G +
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP----WSELGN-PMAALYKI-GSSGEPPEI 225
Query: 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ LS +D LR +C + P RPT +LL
Sbjct: 226 PEHLSEEAKD----FLR---KCLRRDPKKRPT---ADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 60/294 (20%)
Query: 533 KVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
K+G+G G VYK + VAVK L K AS+ ++ + E +
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-----KEGASEEEREEF----LEEASIMK 56
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
+ H NIV+L C +V EYMP G+L D L K L ++A +A+G
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLY--IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG- 704
+ YL +HRD+ + N L+ N K++DFG+++ + +D G
Sbjct: 115 MEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIY----EDDYYRKRGGGKLP 167
Query: 705 --YLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKE 761
++APE K T+K DV+SFGV+L E+ T G +P + N
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSN------------- 210
Query: 762 GIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
EVL+ G +R DE+ +++ +C + P RPT +E+V+ L
Sbjct: 211 --EEVLELLEDG-YRLPRPENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+GG G VYK +G+ VA+K + + + + E++ L +H
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIIN-------EIQILKKCKH 56
Query: 592 KNIVKLYCYFSSLYCNL---LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
NIVK Y S +V E+ G+L D L L + + +GL Y
Sbjct: 57 PNIVKYYG---SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
LH +G IIHRDIK+ NILL + + K+ DFG++ L +++ + GT ++A
Sbjct: 114 LHSNG----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWMA 165
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PE K D++S G+ +EL G+ P + K + I G +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYS-ELPPMKALFK---IA---TNGPPGLR 218
Query: 768 D-KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ +K S F+D + + C K+P RPT QLL
Sbjct: 219 NPEKWSDEFKDFLKK-------CLQKNPEKRPT---AEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 4e-37
Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 59/299 (19%)
Query: 532 NKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
K+G+G G VYK + VAVK L K AS+ ++ LK E +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-----KEDASEEERKDF---LK-EARVMK 51
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK--------GLVHLDWPTRHK 637
+ H N+V+L C LV EYM G+L D L K L
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
A +A+G+ YL +HRD+ + N L+ + K++DFG+++ + T
Sbjct: 110 FAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 698 VIAGTYG-----YLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG--DNKNI 749
G ++APE T+K DV+SFGV+L E+ T G P + N+ +
Sbjct: 167 ------GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEV 216
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808
+ ++ ++G L K DE+ +++ C P RPT +E+V+ L
Sbjct: 217 LEYL------RKG--YRLPKPEYCP--DELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 86/292 (29%), Positives = 132/292 (45%), Gaps = 55/292 (18%)
Query: 530 EKNKV-GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
E+ KV GQG SG VYK +G++ A+KK+ D + + L E++TL
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQ---LLRELKTLR 54
Query: 588 NIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR--HKIAFGV 642
+ +VK Y F + +V EYM G+L D L K P IA +
Sbjct: 55 SCESPYVVKCYGAFYKEGEIS---IVLEYMDGGSLADLLKK---VGKIPEPVLAYIARQI 108
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
+GL YLH IIHRDIK +N+L++ + K+ADFGI+KVL+ + +T GT
Sbjct: 109 LKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT---FVGT 163
Query: 703 YGYLAPE------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756
Y++PE Y+Y++ D++S G+ L+E G+ P F ++
Sbjct: 164 VTYMSPERIQGESYSYAA------DIWSLGLTLLECALGKFP----FLPPGQPSFF---- 209
Query: 757 VDTKEGIMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ + I + L + F E + C K P RP+ +LL
Sbjct: 210 -ELMQAICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS---AAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 48/302 (15%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D RE+ + + K+G+G SG VYK D +G+ VA+KK+ ++ Q +
Sbjct: 16 DPRELYKNLE---KIGEGASGEVYKATDRATGKEVAIKKM-----RLRK------QNKEL 61
Query: 579 LKTEVETLGNIRHKNIVKLY-CYFSSLYCNLL--VYEYMPNGNLWDALHKGLVHLDWPTR 635
+ E+ + + +H NIV Y Y L + L V EYM G+L D + + V +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSY---LVGDELWVVMEYMDGGSLTDIITQNFVRM---NE 115
Query: 636 HKIAF---GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
+IA+ V QGL YLH +IHRDIKS NILL + K+ADFG A L K
Sbjct: 116 PQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
++ + GT ++APE K D++S G++ +E+ G P +
Sbjct: 173 RNS---VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ 223
Query: 753 VSIKVDTKEGIMEVLDK-KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811
++ + T +GI + + K S F+D L +C K P RP+ E++Q
Sbjct: 224 -ALFLITTKGIPPLKNPEKWSPEFKD----FLN---KCLVKDPEKRPSAEELLQHPFLKK 275
Query: 812 PC 813
C
Sbjct: 276 AC 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 22/212 (10%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ +G+G G VYK ++L +G+ VA+K++ + + L K + E++ L N+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQI-----SLEKIKEEAL---KSIMQEIDLLKNL 56
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GL 646
+H NIVK + ++ EY NG+L + K +P +A V Q GL
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK---FGPFP-ESLVAVYVYQVLQGL 112
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
AYLH +IHRDIK+ NIL + K+ADFG+A L D++ + GT ++
Sbjct: 113 AYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWM 166
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
APE S A+T D++S G ++EL+TG P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 45/288 (15%)
Query: 529 TEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
++G+G G VY + + G++ +K+ + S+ + + + L EV+ L
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKE-------IDLSNMSEKEREDALN-EVKILK 54
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ--- 644
+ H NI+K Y F +V EY G+L + K +I Q
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 645 GLAYLH--HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
L YLH I+HRDIK NI L N K+ DFGI+KVL D TV+ GT
Sbjct: 115 ALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVV-GT 166
Query: 703 YGYLAPE----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758
YL+PE Y+ K+ D++S G VL EL T + P E G+N +
Sbjct: 167 PYYLSPELCQNKPYNYKS----DIWSLGCVLYELCTLKHPFE---GENLLELAL------ 213
Query: 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806
I++ + + E+ ++ K P RP++ +++Q
Sbjct: 214 ---KILKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 91/288 (31%), Positives = 137/288 (47%), Gaps = 47/288 (16%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
NK+G G G VY ++L++GE++AVK++ Q + + K + E++ L ++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD--------NDPKTIKEIADEMKVLELLK 57
Query: 591 HKNIVKLY---CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
H N+VK Y + +Y + EY G L + L G + LD + +GLA
Sbjct: 58 HPNLVKYYGVEVHREKVY---IFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLA 113
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV------IA 700
YLH HG I+HRDIK NI LD N K+ DFG A L K++TTT+ +A
Sbjct: 114 YLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKL-----KNNTTTMGEEVQSLA 164
Query: 701 GTYGYLAPEYAYSSKATTK---CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757
GT Y+APE K D++S G V++E+ TG++P + + I++ V
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIMFHVGAG- 222
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
K I + L E L RC P RPT +E++Q
Sbjct: 223 -HKPPIPDSLQL------SPEGKDFLD---RCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 90/297 (30%), Positives = 128/297 (43%), Gaps = 51/297 (17%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD-K 577
D E++E +G G + VY I L + E VA+K++ D ++ Q
Sbjct: 1 DDYELIE------VIGVGATAVVYAAICLPNNEKVAIKRI----------DLEKCQTSVD 44
Query: 578 GLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH--LDWPTR 635
L+ EV+ + H N+VK Y F LV Y+ G+L D + LD
Sbjct: 45 ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAII 104
Query: 636 HKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
+ V +GL YLH +G IHRDIK+ NILL + K+ADFG++ L G +
Sbjct: 105 ATVLKEVLKGLEYLHSNGQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160
Query: 695 TT-TVIAGTYGYLAPE-----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK- 747
GT ++APE + Y KA D++SFG+ +EL TG P + K
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAPYS-KYPPMKV 215
Query: 748 --NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+ ++T KK S SFR MI C K P+ RPT E
Sbjct: 216 LMLTLQNDPPSLET-----GADYKKYSKSFRK-MIS------LCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 2e-29
Identities = 85/318 (26%), Positives = 127/318 (39%), Gaps = 25/318 (7%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH- 591
K+G+G G VY ++VA+K L + + + + E++ L ++ H
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVL-------AKKLESKSKEVERFLREIQILASLNHP 57
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH--LDWPTRHKIAFGVAQGLAYL 649
NIVKLY +F LV EY+ G+L D L K L I + L YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 650 HHGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIAKVLQARGGK---DSTTTVIAGTYGY 705
H IIHRDIK NILLD + K+ DFG+AK+L G + + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 706 LAPEYAYSS---KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
+APE A++ D++S G+ L EL+TG P E + + I
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPN 822
+ L +L+ + +K P R + + + A ES
Sbjct: 235 LASPLSPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 823 KSNKESSNATKIKNPSEL 840
+S+ PS
Sbjct: 292 LKPDDSAPLRLSLPPSLE 309
|
Length = 384 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 71/210 (33%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G GG G V + A+K + K +T Q + + +E E L H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQ---QEHIFSEKEILEECNHP 53
Query: 593 NIVKLYCYFS---SLYCNLLVYEYMPNGNLWDALHKGLVHLD-WPTRHKIAFGVAQGLAY 648
IVKLY F +Y ++ EY G LW L D + R IA V Y
Sbjct: 54 FIVKLYRTFKDKKYIY---MLMEYCLGGELWTILRD-RGLFDEYTARFYIAC-VVLAFEY 108
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
LH+ II+RD+K N+LLD N K+ DFG AK L+ G K T GT Y+AP
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQK---TWTFCGTPEYVAP 161
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKP 738
E + D +S G++L EL+TGR P
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 80/281 (28%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 532 NKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
++G G SG V K+ +G+++AVK + + +Q K + E++ L
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKT-------IRLEINEAIQ--KQILRELDILHKCN 57
Query: 591 HKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
IV Y ++++ ++ + EYM G+L L + + KIA V +GL YL
Sbjct: 58 SPYIVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
H IIHRD+K +NIL++ Q K+ DFG++ L K GT Y+APE
Sbjct: 117 HEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----VGTSSYMAPE 169
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
+ + K D++S G+ L+EL TGR P Y D +GI E+L
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFP------------YPPE--NDPPDGIFELLQY 215
Query: 770 KL--------SGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+ SG F + + C K P RP+ E
Sbjct: 216 IVNEPPPRLPSGKFSPDFQDFVN---LCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 73/223 (32%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + ++G++ A+K L K +++ TE L I H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL----KKKKIIKRKEVEH---TLTERNILSRINHP 53
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
IVKL+ F LY LV EY P G L+ L K A + L YL
Sbjct: 54 FIVKLHYAFQTEEKLY---LVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYL 109
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H G II+RD+K NILLD + K+ DFG+AK L + S T GT YLAP
Sbjct: 110 HSLG----IIYRDLKPENILLDADGHIKLTDFGLAKEL---SSEGSRTNTFCGTPEYLAP 162
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
E D +S GV+L E++TG+ P + +++ IY
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF---YAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 70/236 (29%), Positives = 100/236 (42%), Gaps = 54/236 (22%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVK-----KLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+G+G TV + + + A+K +L ++ KV K +K E E L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KV-----------KYVKIEKEVLT 56
Query: 588 NI-RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+ H I+KLY F +LY V EY PNG L + K LD F A
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLY---FVLEYAPNGELLQYIRK-YGSLDEKC---TRFYAA 109
Query: 644 Q---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ L YLH G IIHRD+K NILLD + K+ DFG AKVL +S
Sbjct: 110 EILLALEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 700 A-----------------GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
GT Y++PE A D+++ G ++ +++TG+ P
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/214 (33%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G G+VYK I +G+VVA+K + + D ++ K E+ L
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--------PVEEDLQEIIK----EISILKQCDS 57
Query: 592 KNIVKLY-CYFSSLYCNLLVYEYMPNGNLWD---ALHKGLVHLDWPTRHKIAF---GVAQ 644
IVK Y YF + +V EY G++ D +K L T +IA +
Sbjct: 58 PYIVKYYGSYFKNTDL-WIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTLK 110
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GL YLH + IHRDIK+ NILL+ Q K+ADFG++ L K TVI GT
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVI-GTPF 164
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
++APE K D++S G+ +E+ G+ P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 532 NKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
++G+G G V + N+GE VAVK L + +D + E+E L
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSD-------FEREIEIL 60
Query: 587 GNIRHKNIVKL--YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
+ H+NIVK C L+ EY+P+G+L D L + ++ + + +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ-------ARGGKDSTTT 697
G+ YL IHRD+ + NIL++ K++DFG+AKVL + +S
Sbjct: 121 GMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
+ APE +SK ++ DV+SFGV L EL T
Sbjct: 178 -------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 71/216 (32%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK---GLKT----E 582
K+G+G G VYK D +GE+VA+KK+ +LD G+ + E
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKI---------------RLDNEEEGIPSTALRE 48
Query: 583 VETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
+ L ++H NIVKL + LV+EY +L L K L I + +
Sbjct: 49 ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL 107
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+GLAY H H I+HRD+K NIL++ + K+ADFG+A+ + T V+
Sbjct: 108 LRGLAYCHSHR----ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-- 160
Query: 702 TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
T Y APE SK +T D++S G + E+ITG+
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 83/286 (29%), Positives = 123/286 (43%), Gaps = 39/286 (13%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
E + E +++G+G G+V K L + ++ K ++ LQ K + E+E
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT------ITTDPNPDLQ--KQILRELEI 52
Query: 586 LGNIRHKNIVKLYCYF-----SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH---- 636
+ + IVK Y F SS+ + EY G+L D+++K +
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIG---IAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG 108
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
KIA V +GL+YLH IIHRDIK +NILL Q K+ DFG++ L T
Sbjct: 109 KIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTF 163
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756
T GT Y+APE + DV+S G+ L+E+ R P + I +S
Sbjct: 164 T---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220
Query: 757 VDTKEGIM---EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT 799
V+ + K S F+D + Q C K P RPT
Sbjct: 221 VNMPNPELKDEPGNGIKWSEEFKDFIKQ-------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
++G G G VYK D+ +GE+VA+K + D ++ ++ E+ L R
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKV-------IKLEPGDDFEI---IQQEISMLKECR 58
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF---GVAQGLA 647
H NIV + + +V EY G+L D L + +IA+ +GLA
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETLKGLA 115
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLH + IHRDIK NILL + K+ADFG++ L A K + I GT ++A
Sbjct: 116 YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--RKSFI-GTPYWMA 169
Query: 708 PEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVED 741
PE A + KCD+++ G+ +EL + P+ D
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 72/211 (34%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
K+G G G V+ N VAVK L + S LQ E + + +RH
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPG----TMSPEAFLQ-------EAQIMKKLRHD 61
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHH 651
+V+LY S +V EYM G+L D L G L P +A +A+G+AYL
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT---YGYLAP 708
IHRD+ + NIL+ N K+ADFG+A+++ +D T G + AP
Sbjct: 122 ---RNYIHRDLAARNILVGENLVCKIADFGLARLI-----EDDEYTAREGAKFPIKWTAP 173
Query: 709 EYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
E A + T K DV+SFG++L E++T GR P
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTK----VSASDTDQLQLDKGLKTEVETL 586
++G+G G VYK + +GE+VA+KK+ + K ++A E++ L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA------------IREIKLL 52
Query: 587 GNIRHKNIVKLY-----CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG 641
+RH NIV+L S+Y +V+EYM + +L L V
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIY---MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ 108
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+ +GL YLH + I+HRDIK +NIL++ + K+ADFG+A+ R D T VI
Sbjct: 109 LLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-- 163
Query: 702 TYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR 736
T Y PE +++ + D++S G +L EL G+
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/212 (31%), Positives = 116/212 (54%), Gaps = 8/212 (3%)
Query: 534 VGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G VY +++ +GE++AVK++ T D+ Q + K L++E+ETL ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
NIV+ + ++ + EY+P G++ L + R V +GLAYLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYLHS- 126
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
I+HRD+K+ N+L+D + K++DFGI+K D + + G+ ++APE +
Sbjct: 127 --KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWMAPEVIH 183
Query: 713 SSKA--TTKCDVYSFGVVLMELITGRKPVEDD 742
S + K D++S G V++E+ GR+P D+
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 74/253 (29%), Positives = 107/253 (42%), Gaps = 45/253 (17%)
Query: 534 VGQGGSGTVY---KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+ +G G V+ K ++G++ A+K + +D + + TE + L +
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKV-------IKKADMIRKNQVDQVLTERDILSQAQ 51
Query: 591 HKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGL 646
+VKLY F +LY LV EY+P G+L L G + D R IA + L
Sbjct: 52 SPYVVKLYYSFQGKKNLY---LVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLAL 106
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV-LQARGGKDSTTTV----IA 700
YLH +G IIHRD+K NIL+D N K+ DFG++KV L R + I
Sbjct: 107 EYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 701 GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN----------KNII 750
GT Y+APE + D +S G +L E + G P F I
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP----FHGETPEEIFQNILNGKI 218
Query: 751 YWVSIKVDTKEGI 763
W + E I
Sbjct: 219 EWPEDVEVSDEAI 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 54/288 (18%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G G V D G+ VAVK L K ++ L E + +R
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-----KDDSTAAQAF-LA-----EASVMTTLR 58
Query: 591 HKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALH-KGLVHLDWPTRHKIAFGVAQGL 646
H N+V+L + LY +V EYM G+L D L +G + + A V +G+
Sbjct: 59 HPNLVQLLGVVLQGNPLY---IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YL +HRD+ + N+L+ + KV+DFG+AK +A G+DS + T
Sbjct: 116 EYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWT---- 166
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
APE K +TK DV+SFG++L E+ + GR P Y + + +
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------Y-------PRIPLKD 207
Query: 766 VLDKKLSGSFRDEMI-----QVLRIAIRCTSKSPATRPTMNEVVQLLA 808
V+ G +R E +V ++ C PA RPT ++ + LA
Sbjct: 208 VVPHVEKG-YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+G G G V++ N+ VAVK L + D L E + + +R
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG----TMDPKDFLA-------EAQIMKKLR 59
Query: 591 HKNIVKLYCYFSSLYCNL-----LVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQ 644
H +++LY C L +V E M G+L + L L P +A VA
Sbjct: 60 HPKLIQLYAV-----CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT-- 702
G+AYL IHRD+ + N+L+ N KVADFG+A+V+ K+ G
Sbjct: 115 GMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI-----KEDIYEAREGAKF 166
Query: 703 -YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ APE A ++ + K DV+SFG++L E++T GR P
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+GQG G VY D+++G +AVK + + + L+ E++ L N++H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVK-----QVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 593 NIVKLYCYFSSLYCNLLVY---EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
IV+ Y+ L + + EYMP G++ D L + TR K + +G+ YL
Sbjct: 65 RIVQ---YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYL 120
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
H + I+HRDIK NIL D K+ DFG +K LQ + + GT +++PE
Sbjct: 121 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKP 738
K DV+S G ++E++T + P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 73/210 (34%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
VG+G G V K + +GE+VA+KK K S D D + K EV+ L +RH
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-----KESEDDED---VKKTALREVKVLRQLRH 59
Query: 592 KNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
+NIV L F LY LV+EY+ L + L L + + Q +AY
Sbjct: 60 ENIVNLKEAFRRKGRLY---LVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
H H IIHRDIK NIL+ + K+ DFG A+ L+AR T V T Y A
Sbjct: 116 CHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA--TRWYRA 169
Query: 708 PEYAYSSKATTK-CDVYSFGVVLMELITGR 736
PE K DV++ G ++ EL+ G
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 23/219 (10%)
Query: 534 VGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G G+VY ++ +SGE++AVK++ S+ D + LD L E+ L ++H+
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLD-ALAREIALLKELQHE 66
Query: 593 NIVK-LYCYFSSLYCNLLVYEYMPNG------NLWDALHKGLVHLDWPTRHKIAFGVAQG 645
NIV+ L + + N+ + EY+P G N + A + LV + +G
Sbjct: 67 NIVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVR-------NFVRQILKG 118
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR---GGKDSTTTVIAGT 702
L YLH+ IIHRDIK NIL+D K++DFGI+K L+A + + G+
Sbjct: 119 LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
++APE + T K D++S G +++E++TG+ P D
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 531 KNKVGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
NK+G+G G V+K+ + V A+K+ + S ++ + ++ + E L +
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQ-------IDLSKMNRREREEAID-EARVLAKL 56
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL-----VHLDWPTRHKIAFGVAQ 644
I++ Y F +V EY NG+L L W + +
Sbjct: 57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILL 112
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GLA+LH I+HRDIKS N+ LD K+ D G+AK+L +T I GT
Sbjct: 113 GLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT---IVGTPY 166
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
YL+PE K DV++ GVVL E TG+ P + +N+ + I+
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI---------LKII 214
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806
+ +S + ++ Q++ +C +K RP ++++
Sbjct: 215 RGVFPPVSQMYSQQLAQLID---QCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G+G G V+K D +GE VA+KK+ +R + E++ L +H
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRL------EGGIPN--QALREIKALQACQH 58
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ----GLA 647
+VKL F +LV EYMP+ L + L + P + G+A
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLR----DEERPLPEAQVKSYMRMLLKGVA 113
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
Y+H + I+HRD+K N+L+ + K+ADFG+A++ + + V T Y A
Sbjct: 114 YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV--ATRWYRA 168
Query: 708 PEYAYSS-KATTKCDVYSFGVVLMELITGRK--PVEDD 742
PE Y + K D+++ G + EL+ G P E+D
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 77/288 (26%), Positives = 119/288 (41%), Gaps = 57/288 (19%)
Query: 533 KVGQGGSGTVYKIDLNS-GEVVAVKK----LWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
K+G+G G+VYK+ S + A+K+ SQ+ + A + E+ L
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN------------EIRILA 54
Query: 588 NIRHKNIVKLYCYF-SSLYCNLL--VYEYMPNGNLWDALHKGLV-------HLDWPTRHK 637
++ H NI+ Y + L N L V EY P G+L A+ K W +
Sbjct: 55 SVNHPNII---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----R 107
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
I + +GL LH I+HRD+KS NILL N K+ D GI+KVL+ K T
Sbjct: 108 IFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----T 160
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757
I GT Y+APE + K D++S G +L E+ T P E
Sbjct: 161 QI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE------------ARSMQ 207
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
D + + + + ++ +R P RP ++++
Sbjct: 208 DLRYKVQRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G G VYK D +GE+VA+KK+ R + S+ L+ E++ L + H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFE---SEGIPKT---ALR-EIKLLKELNH 57
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
NI+KL F LY LV+E+M + +L+ + L + + QGLA+
Sbjct: 58 PNIIKLLDVFRHKGDLY---LVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
H HG I+HRD+K N+L++ K+ADFG+A+ G T T Y A
Sbjct: 114 CHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRA 166
Query: 708 PEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
PE K +T D++S G + EL++ R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G + Y+ D+ +G ++AVK++ R S +Q ++ + L+ E+ + + H
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS----EQEEVVEALRKEIRLMARLNHP 63
Query: 593 NIVKLY---CYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFG----VAQ 644
+I+++ C S NL V E+M G++ L K G + + + +
Sbjct: 64 HIIRMLGATCEDSHF--NLFV-EWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLR 114
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQP-KVADFGIAKVLQARG-GKDSTTTVIAGT 702
GL+YLH + IIHRD+K N+L+D Q ++ADFG A L A+G G + GT
Sbjct: 115 GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
++APE + CDV+S G V++E+ T + P + N + K+ +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATT 228
Query: 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ + LS RD + +RC P RP E+++
Sbjct: 229 APSI-PEHLSPGLRD-------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 75/287 (26%), Positives = 126/287 (43%), Gaps = 49/287 (17%)
Query: 534 VGQGGSGTVYK--IDLNSGEV--VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G G G V + + L + VA+K L K +SD +L TE +G
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-----KAGSSDKQRL----DFLTEASIMGQF 62
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
H NI++L + +++ EYM NG+L L + + G+A G+ YL
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 650 -HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG--YL 706
+HRD+ + NIL++ N KV+DFG+++ L ++T T G +
Sbjct: 123 SEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRL---EDSEATYTTKGGKIPIRWT 175
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
APE K T+ DV+SFG+V+ E+++ G +P D N+++I
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD--MSNQDVI--------------- 218
Query: 766 VLDKKLSGSFR-----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
K + +R D + ++ + C K RPT +++V L
Sbjct: 219 ---KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+G+G VYK D +G +VA+KK+ K+ + ++ E++ L ++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKI-----KLGERKEAKDGINFTALREIKLLQELK 60
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA------- 643
H NI+ L F LV+E+M +L + ++ I A
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDL-----EKVIK-----DKSIVLTPADIKSYML 109
Query: 644 ---QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
+GL YLH + I+HRD+K N+L+ + K+ADFG+A+ + K T V+
Sbjct: 110 MTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV- 164
Query: 701 GTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKP 738
T Y APE + ++ D++S G + EL+ R P
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 80/287 (27%), Positives = 133/287 (46%), Gaps = 55/287 (19%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQL--QLDKGLKTEVETLGNIR 590
+G G G+VY+ ++L+ G+ AVK+ VS +D Q + K L+ E+ L ++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKE-------VSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 591 HKNIVKLYCYFSSLYCNLLVY-EYMPNGNL------WDALHKGLVHLDWPTRHKIAFGVA 643
H NIV+ Y NL ++ E +P G+L + + + ++ L TR +
Sbjct: 61 HPNIVQ-YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQILL---- 113
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
GL YLH +HRDIK NIL+D N K+ADFG+AK + S G+
Sbjct: 114 -GLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSP 165
Query: 704 GYLAPEY-----AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758
++APE Y A D++S G ++E+ TG+ P G K+
Sbjct: 166 YWMAPEVIAQQGGYGLAA----DIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIG 215
Query: 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ + + D LS +D +++ L+ + P+ RPT E+++
Sbjct: 216 RSKELPPIPD-HLSDEAKDFILKCLQ-------RDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 73/193 (37%), Positives = 99/193 (51%), Gaps = 23/193 (11%)
Query: 548 NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKL--YCYFSSLY 605
N+GEVVAVKKL S + L+ + E+E L +++H NIVK CY S+
Sbjct: 31 NTGEVVAVKKL-------QHSTAEHLR---DFEREIEILKSLQHDNIVKYKGVCY-SAGR 79
Query: 606 CNL-LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664
NL LV EY+P G+L D L K LD A + +G+ YL +HRD+ +
Sbjct: 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLAT 136
Query: 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG---TYGYLAPEYAYSSKATTKCD 721
NIL++ + K+ DFG+ KVL K+ G + Y APE SK + D
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQ--DKEYYKVREPGESPIFWY-APESLTESKFSVASD 193
Query: 722 VYSFGVVLMELIT 734
V+SFGVVL EL T
Sbjct: 194 VWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
++G G G+VY + +GE+VA+KK+ K S + + L EV++L
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNL-----REVKSLR 52
Query: 588 NI-RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQG 645
+ H NIVKL F V+EYM GNL+ + + I + + QG
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
LA++H HG HRD+K N+L+ K+ADFG+A+ +++R T V T
Sbjct: 112 LAHIHKHGFF----HRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTDYV--STRW 163
Query: 705 YLAPEY-----AYSSKATTKCDVYSFGVVLMELITGR 736
Y APE +YSS D+++ G ++ EL T R
Sbjct: 164 YRAPEILLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 30/283 (10%)
Query: 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
T+ +G+G GTVY N G+++AVK++ S + + +K L+ EV+ L +
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQV---ELDTSNVLAAEKEYEK-LQEEVDLLKS 58
Query: 589 IRHKNIVKLYCYFSSLY--CNLLVY-EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
++H NIV+ Y + + ++ E++P G++ L++ L P K + G
Sbjct: 59 LKHVNIVQ---YLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDG 114
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL---QARGGKDSTTTVIAGT 702
+AYLH+ + ++HRDIK N++L N K+ DFG A+ L G + + GT
Sbjct: 115 VAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
++APE S K D++S G + E+ TG+ P+ D ++++ G
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS--MDRLAAMFYIG----AHRG 225
Query: 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+M L S + D C ++ RP+ ++++
Sbjct: 226 LMPRLPDSFSAAAID-------FVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 34/225 (15%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSA---SDTDQLQLDKGLKTE 582
E T + K+G G G V++ LW R +V+ D L+ + E
Sbjct: 6 EEFTLERKLGSGYFGEVWE------------GLWKNRVRVAIKILKSDDLLKQQD-FQKE 52
Query: 583 VETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVHLDWPTRHKIAF 640
V+ L +RHK+++ L+ S ++ E M G+L L +G V L + +A
Sbjct: 53 VQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMAC 111
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD----STT 696
VA+G+AYL IHRD+ + NIL+ + KVADFG+A+++ K+ S+
Sbjct: 112 QVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLI-----KEDVYLSSD 163
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740
I Y + APE A +TK DV+SFG++L E+ T G+ P
Sbjct: 164 KKIP--YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 534 VGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G G+V K+ + +G V+A K + + A + + Q+ + E++ + R
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH-----IGAKSSVRKQILR----ELQIMHECRSP 63
Query: 593 NIVKLYCYFSSLYCN--LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL- 649
IV Y F L N + E+M G+L D ++K + KIA V +GL YL
Sbjct: 64 YIVSFYGAF--LNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 650 --HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
H I+HRDIK +NIL++ Q K+ DFG++ L +S GT Y++
Sbjct: 121 NVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-----INSIADTFVGTSTYMS 170
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PE K T K DV+S G+ ++EL G+ P D+ + I +D + I++
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-LDLLQQIVQEP 229
Query: 768 DKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804
+L S F +++ + C K P RPT ++
Sbjct: 230 PPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 73/275 (26%), Positives = 116/275 (42%), Gaps = 30/275 (10%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ +G G GTVYK L + ++AVK + T ++L K + +E+E L
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT---------VELQKQIMSELEILYKC 56
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
I+ Y F + E+M G+L D K + +IA V +GL YL
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRK----IPEHVLGRIAVAVVKGLTYL 111
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
L I+HRD+K +N+L++ Q K+ DFG++ L +S GT Y+APE
Sbjct: 112 W-SL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-----NSIAKTYVGTNAYMAPE 163
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
+ DV+S G+ MEL GR P + +++ ++ E +
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804
+ S F + Q C K P RP ++
Sbjct: 224 QFSEKFVHFITQ-------CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G+G G VYK ID + +VVA+K + + ++ + + + E++ L R
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVI-----DLEEAEDEIEDIQQ----EIQFLSQCRS 58
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF---GVAQG 645
I K Y F S L+ ++ EY G+ D L G + IAF V G
Sbjct: 59 PYITKYYGSFLKGSKLW---IIMEYCGGGSCLDLLKPGKLDET-----YIAFILREVLLG 110
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L YLH IHRDIK+ NILL K+ADFG++ L + K +T GT +
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---GTPFW 164
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
+APE S K D++S G+ +EL G P+ D
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 73/218 (33%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G G V + SG+ A+K L + K+ Q++ + E L +IRH
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLK----QVEH-VLNEKRILQSIRHP 61
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQ---G 645
+V LY F S+LY LV EY+P G L+ L K G F AQ
Sbjct: 62 FLVNLYGSFQDDSNLY---LVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLA 113
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L YLH I++RD+K N+LLD + K+ DFG AK ++ R T + GT Y
Sbjct: 114 LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEY 164
Query: 706 LAPEYAYSSKATTK-CDVYSFGVVLMELITGRKPVEDD 742
LAPE SK K D ++ G+++ E++ G P DD
Sbjct: 165 LAPE-IILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH- 591
+G+G G VY+ + +G VVA+K + DT + ++ EV L +R
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALK--------IINLDTPDDDVSD-IQREVALLSQLRQS 59
Query: 592 --KNIVKLY-CYF--SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
NI K Y Y L+ ++ EY G++ + G + I V L
Sbjct: 60 QPPNITKYYGSYLKGPRLW---IIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVAL 114
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
Y+H +IHRDIK+ NIL+ K+ DFG+A +L K ST GT ++
Sbjct: 115 KYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWM 168
Query: 707 APEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVED 741
APE K TK D++S G+ + E+ TG P D
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+GQG G VY D+++G +A K++ Q S + ++ L+ E++ L N++H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQV--QFDPESPETSKEVS---ALECEIQLLKNLQHE 64
Query: 593 NIVKLY-CYFSSLYCNLLVY-EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
IV+ Y C L ++ EYMP G++ D L K L K + +G++YLH
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
+ I+HRDIK NIL D K+ DFG +K LQ + + GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKP 738
K DV+S G ++E++T + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 88/281 (31%), Positives = 127/281 (45%), Gaps = 44/281 (15%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
E++ K+G G G V+ N VAVK L T S ++ Q+ K L
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKL------ 58
Query: 586 LGNIRHKNIVKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGV 642
RH +V+LY S +Y +V EYM G+L D L G L P +A V
Sbjct: 59 ----RHDKLVQLYAVVSEEPIY---IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV 111
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A G+AY+ IHRD++S NIL+ K+ADFG+A++++ D+ T G
Sbjct: 112 AAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIE-----DNEYTARQGA 163
Query: 703 ---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758
+ APE A + T K DV+SFG++L EL+T GR P +N+ ++ V
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG--MNNREVLEQV----- 216
Query: 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT 799
+ G + S + M+Q C K P RPT
Sbjct: 217 -ERGYRMPCPQDCPISLHELMLQ-------CWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 33/274 (12%)
Query: 534 VGQG--GSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G+G G T+Y+ + VV W + V+ + + + L E+ L ++H
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-----WKE---VNLTRLSEKERRDAL-NEIVILSLLQH 58
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYLH 650
NI+ Y +F L+ EY G L+D + + + F + ++Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
+ I+HRDIK+ NI L K+ DFGI+K+L G + S + GT Y++PE
Sbjct: 119 K---AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYMSPEL 172
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
K K D+++ G VL EL+T ++ + N + K+ V
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFD---ATNPLNLVV---KIVQGNYTPVV---- 222
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804
+ E+I ++ + P RPT +EV+
Sbjct: 223 --SVYSSELISLVH---SLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+T K+K+G G G VY V K +S V D +++++ LK E +
Sbjct: 8 ITMKHKLGGGQYGEVY---------EGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMK 57
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQ 644
I+H N+V+L C + ++ E+M GNL D L + ++ +A ++
Sbjct: 58 EIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT-- 702
+ YL IHRD+ + N L+ N+ KVADFG+++++ T T AG
Sbjct: 116 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-----GDTYTAHAGAKF 167
Query: 703 -YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
+ APE +K + K DV++FGV+L E+ T
Sbjct: 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
K+G+G G VYK L VAVK + T L + E E L H
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK---------TCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
NIVKL +V E +P G+L L K L +++ A G+ YL
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT----YGYLAP 708
IHRD+ + N L+ N K++DFG++ R + TV G + AP
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMS-----REEEGGIYTVSDGLKQIPIKWTAP 164
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITG 735
E + T++ DV+S+G++L E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 533 KVGQGGSGTVYKIDLNS--GEV--VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
K+G G G V + + ++ G+V VAVK L + K+S D L+ E + +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLK-------EAAIMHS 52
Query: 589 IRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQG 645
+ H+N+++LY L ++V E P G+L D L K L H T A +A G
Sbjct: 53 LDHENLIRLYGVVLTHPL---MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG 109
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+ YL IHRD+ + NILL + + K+ DFG+ + L + + +
Sbjct: 110 MRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
APE + + DV+ FGV L E+ T G +P W + + I+
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WAGL---SGSQIL 210
Query: 765 EVLDKKLSGSFRDEMI--QVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ +DK+ R E + + ++C + +PA RPT + + L E
Sbjct: 211 KKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 75/238 (31%), Positives = 114/238 (47%), Gaps = 53/238 (22%)
Query: 522 REILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLW--------SQRT--KVSASDT 570
+ IL K+G+G G V+K ID + EVVA+KK++ +QRT ++
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMF--- 59
Query: 571 DQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-----LYCNLLVYEYMPNGNLWDALHK 625
LQ LG+ H NIVKL + +Y LV+EYM +L +
Sbjct: 60 --LQ----------ELGD--HPNIVKLLNVIKAENDKDIY---LVFEYMET-DLHAVIRA 101
Query: 626 GL---VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682
+ VH + I + + + L Y+H G +IHRD+K +NILL+ + + K+ADFG+
Sbjct: 102 NILEDVH-----KRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL 153
Query: 683 AKVLQARGGKDST---TTVIAGTYGYLAPEYAYSSKATTK-CDVYSFGVVLMELITGR 736
A+ L T +A T Y APE S TK D++S G +L E++ G+
Sbjct: 154 ARSLSELEENPENPVLTDYVA-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 85/319 (26%), Positives = 138/319 (43%), Gaps = 71/319 (22%)
Query: 521 QREILEAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQ 574
QR+ + E +G+G G V+ + N E+VAVK L K +AS+ +
Sbjct: 3 QRDTIVLKRE---LGEGAFGKVFLGECYHLEPENDKELVAVKTL-----KETASNDARKD 54
Query: 575 LDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALH------KG 626
++ E E L N +H+NIVK Y C ++V+EYM +G+L L
Sbjct: 55 FER----EAELLTNFQHENIVKFYGVCTEGDPP--IMVFEYMEHGDLNKFLRSHGPDAAF 108
Query: 627 LVHLDWPTR-------HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679
L D P +IA +A G+ YL +HRD+ + N L+ + K+ D
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGD 165
Query: 680 FGIAKVLQARGGKDSTTT---VIAGT----YGYLAPEYAYSSKATTKCDVYSFGVVLMEL 732
FG+++ D TT + G ++ PE K TT+ DV+SFGVVL E+
Sbjct: 166 FGMSR--------DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
Query: 733 IT-GRKPVEDDFG-DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCT 790
T G++P +G N+ +I + +G + R +V I + C
Sbjct: 218 FTYGKQPW---YGLSNEEVIECI------TQGRLL-------QRPRTCPSEVYDIMLGCW 261
Query: 791 SKSPATRPTMNEVVQLLAE 809
+ P R + ++ + L +
Sbjct: 262 KRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
E++ K+GQG G V+ N VA+K L + + E +
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-----------KPGTMMPEAFLQEAQI 54
Query: 586 LGNIRHKNIVKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGV 642
+ +RH +V LY S +Y +V E+M G+L D L +G +L P +A +
Sbjct: 55 MKKLRHDKLVPLYAVVSEEPIY---IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI 111
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A G+AY+ IHRD+++ NIL+ N K+ADFG+A++++ D+ T G
Sbjct: 112 ADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIE-----DNEYTARQGA 163
Query: 703 ---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ APE A + T K DV+SFG++L EL+T GR P
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 75/221 (33%), Positives = 113/221 (51%), Gaps = 31/221 (14%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
E++ + K+GQG G V+ N VA+K L + S LQ E +
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQ-------EAQV 54
Query: 586 LGNIRHKNIVKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGLV--HLDWPTRHKIAFG 641
+ +RH+ +V+LY S +Y +V EYM G+L D L KG + +L P +A
Sbjct: 55 MKKLRHEKLVQLYAVVSEEPIY---IVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQ 110
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+A G+AY+ +HRD+++ NIL+ N KVADFG+A++++ D+ T G
Sbjct: 111 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-----DNEYTARQG 162
Query: 702 T---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ APE A + T K DV+SFG++L EL T GR P
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 538 GSGTVYKIDL--------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
G G K++L N+GE VAVK L + +D LK E+E L N+
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---------LKKEIEILRNL 63
Query: 590 RHKNIVKL--YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
H+NIVK C L+ E++P+G+L + L + ++ + K A + +G+
Sbjct: 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YL +HRD+ + N+L++ +Q K+ DFG+ K ++ + + + A
Sbjct: 124 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELIT 734
PE SK DV+SFGV L EL+T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 88/319 (27%), Positives = 142/319 (44%), Gaps = 70/319 (21%)
Query: 522 REILEAMTEKNKV-GQGGSGTVYK-IDLNSGE----VVAVKKLWSQRTKVSASDTDQLQL 575
R + E EK KV G G GTVYK + + GE VA+K L R + S ++ L
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL---REETSPKANKEI-L 57
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCY-FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
D+ + ++ H ++V+L SS L+ + MP G L D + ++ +
Sbjct: 58 DEAY-----VMASVDHPHVVRLLGICLSSQVQ--LITQLMPLGCLLDYVRNHKDNIG--S 108
Query: 635 RHKIAFGV--AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ---- 687
++ + + V A+G++YL L +HRD+ + N+L+ K+ DFG+AK+L
Sbjct: 109 QYLLNWCVQIAKGMSYLEEKRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
Query: 688 ---ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743
A GGK I ++A E T K DV+S+GV + EL+T G KP E
Sbjct: 165 EYHAEGGK----VPIK----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-- 214
Query: 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRP 798
+ E I ++L+K R I V + ++C +RP
Sbjct: 215 -------------IPAVE-IPDLLEKGE----RLPQPPICTIDVYMVLVKCWMIDAESRP 256
Query: 799 TMNEVVQLLAE--ADPCRF 815
T E++ ++ DP R+
Sbjct: 257 TFKELINEFSKMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 529 TEKNKVGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
T K+GQG SGTVY ID+ +G+ VA+K++ + + +L + E+ +
Sbjct: 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQM-------NLQQQPKKEL---IINEILVMR 71
Query: 588 NIRHKNIVKLYCYFSS-LYCNLL--VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
+H NIV Y S L + L V EY+ G+L D + + +D + Q
Sbjct: 72 ENKHPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQ 126
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
L +LH + +IHRDIKS NILL ++ K+ DFG + K ST + GT
Sbjct: 127 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPY 180
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
++APE K D++S G++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 29/218 (13%)
Query: 525 LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
L+ +T +G+G G V + + +G+ VAVK + + V+A Q L+ E
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNI---KCDVTA----QAFLE-----ETA 51
Query: 585 TLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALH-KGLVHLDWPTRHKIAFG 641
+ + HKN+V+L + LY +V E M GNL + L +G + + +
Sbjct: 52 VMTKLHHKNLVRLLGVILHNGLY---IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD 108
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
VA+G+ YL L +HRD+ + NIL+ + KV+DFG+A+V G D++ +
Sbjct: 109 VAEGMEYLESKKL---VHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKW 163
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
T APE K ++K DV+S+GV+L E+ + GR P
Sbjct: 164 T----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+GQG G VY D ++G +AVK++ Q S + ++ L+ E++ L N+ H+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQV--QFDPESPETSKEVN---ALECEIQLLKNLLHE 64
Query: 593 NIVKLY-CYFSSLYCNLLVY-EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
IV+ Y C + L ++ E+MP G++ D L K L K + +G++YLH
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
+ I+HRDIK NIL D K+ DFG +K LQ + + GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKP 738
K D++S G ++E++T + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK---GLKTEVETLGNI 589
+G+G G VY D ++G +AVK++ D D + K L+ E++ L N+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQV--------PFDPDSQETSKEVNALECEIQLLKNL 61
Query: 590 RHKNIVKLY-CYFSSLYCNLLVY-EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
RH IV+ Y C L ++ EYMP G++ D L K L + + QG++
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVS 120
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLH + I+HRDIK NIL D K+ DFG +K +Q + + GT +++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
PE K DV+S ++E++T + P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
+G+G G VYK +G++VA+K + D+ ++ +K E L H
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK--------IMDIIEDE---EEEIKEEYNILRKYSNH 62
Query: 592 KNIVKLY-CYFSSLYCNL-----LVYEYMPNGNLWDALHKGLVHLDWPTR-HKIAF---G 641
NI Y + LV E G++ D L KGL + IA+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRE 121
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+GLAYLH + +IHRDIK NILL N + K+ DFG++ L + G+ +T G
Sbjct: 122 TLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---G 175
Query: 702 TYGYLAPE-----YAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
T ++APE + + DV+S G+ +EL G+ P+ D
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 56/301 (18%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
+ +I E + E +G G G VYK + A K+ + ++L+
Sbjct: 2 NPNDIWEIIGE---LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELE---DF 49
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLL--VYEYMPNG---NLWDALHKGLVHLDWPT 634
E++ L +H NIV LY + Y N L + E+ G ++ L +GL P
Sbjct: 50 MVEIDILSECKHPNIVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERGL---TEPQ 104
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI-AKVLQARGGKD 693
+ + + L +LH +IHRD+K+ NILL ++ K+ADFG+ AK +D
Sbjct: 105 IRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161
Query: 694 STTTVIAGTYGYLAPEY---------AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFG 744
+ GT ++APE Y KA D++S G+ L+EL P +
Sbjct: 162 T----FIGTPYWMAPEVVACETFKDNPYDYKA----DIWSLGITLIELAQMEPPHHE--- 210
Query: 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804
N + V +K+ E K S SF D C K P RPT E++
Sbjct: 211 --LNPMR-VLLKILKSEPPTLDQPSKWSSSFND-------FLKSCLVKDPDDRPTAAELL 260
Query: 805 Q 805
+
Sbjct: 261 K 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + + ++ A+K + + + + + E L + H
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYM-------NKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNL-WDALHKGLVHLDWPTRHKIAFGVAQ---G 645
+V L+ F ++Y LV + + G+L + K + ++ F + +
Sbjct: 61 FLVNLWYSFQDEENMY---LVVDLLLGGDLRYHLSQKVKF-----SEEQVKFWICEIVLA 112
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L YLH IIHRDIK NILLD + DF IA + D+ TT +GT GY
Sbjct: 113 LEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT----PDTLTTSTSGTPGY 165
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
+APE + D +S GV E + G++P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 87/299 (29%), Positives = 131/299 (43%), Gaps = 50/299 (16%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
VG+G G V K +G++VA+KK D + K E+ L +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESE--------DDKMVKKIAMREIRMLKQLRH 59
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
+N+V L F LV+E++ + L D L K LD K F + +G+ + H
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
IIHRDIK NIL+ + K+ DFG A+ L A G + T +A T Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVA-TRWYRAPELL 172
Query: 712 Y-SSKATTKCDVYSFGVVLMELITGRK--PVEDD----------FGD---------NKNI 749
+K D+++ G ++ E++TG P + D G+ KN
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 750 IYWVSIKVDTKEGIMEVLDK---KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ + KE +E L+K KLSG D Q LRI P RP+ ++++
Sbjct: 233 LFAGMRLPEVKE--IEPLEKRFPKLSGLVLDLAKQCLRI-------DPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 50/295 (16%)
Query: 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLD----KGL 579
+E + E +G+G G+VYK+ +G +A+K++ +L+LD +
Sbjct: 3 IEVLDE---LGKGNYGSVYKVLHRPTGVTMAMKEI-------------RLELDESKFNQI 46
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH---LDWPTRH 636
E++ L IV Y F + EYM G+L D L+ G V +
Sbjct: 47 IMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR 105
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
+I + V +GL +L IIHRD+K TN+L++ N Q K+ DFG++ L A K +
Sbjct: 106 RITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI- 162
Query: 697 TVIAGTYGYLAPEYAYSSKA------TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
G Y+APE S T + DV+S G+ ++E+ GR P + NI
Sbjct: 163 ----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIF 216
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+S VD G L S +D +C +K P RPT ++++
Sbjct: 217 AQLSAIVD---GDPPTLPSGYSDDAQD-------FVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 8e-18
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 42/221 (19%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT--EVETLGNIR 590
+G G G V +D +G VA+KK+ S+ +D + E++ L ++R
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI---------SNVFDDLID-AKRILREIKLLRHLR 57
Query: 591 HKNIVKL--------YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK-IAFG 641
H+NI+ L F+ +Y +V E M D LHK ++ P I +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVY---IVTELMET----D-LHK-VIKSPQPLTDDHIQYF 108
Query: 642 VAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT- 697
+ Q GL YLH + +IHRD+K +NIL++ N K+ DFG+A+ + + T
Sbjct: 109 LYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 698 -VIAGTYGYLAPEYAYSSKATTK-CDVYSFGVVLMELITGR 736
V+ T Y APE SS TK D++S G + EL+T +
Sbjct: 166 YVV--TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 37/291 (12%)
Query: 534 VGQGGSGTV--YKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
+G+G G V Y D +GE+VAVK L + + Q G K E+ L
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ---------QNTSGWKKEINILKT 62
Query: 589 IRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ H+NIVK C L+ EY+P G+L D L K ++L A + +G+
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQICEGM 120
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA-----RGGKDSTTTVIAG 701
AYLH IHRD+ + N+LLD + K+ DFG+AK + R +D + V
Sbjct: 121 AYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-- 175
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD--T 759
+ A E +K + DV+SFGV L EL+T + K + K T
Sbjct: 176 ---WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS---PPKKFEEMIGPKQGQMT 229
Query: 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIR-CTSKSPATRPTMNEVVQLLAE 809
++E+L++ + Q + I ++ C RPT ++ +L E
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 65/229 (28%), Positives = 114/229 (49%), Gaps = 32/229 (13%)
Query: 520 DQREILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D R L+ K+G+G +G V D ++G VAVKK+ D + Q +
Sbjct: 16 DPRSYLDNFV---KIGEGSTGIVCIATDKSTGRQVAVKKM----------DLRKQQRREL 62
Query: 579 LKTEVETLGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR 635
L EV + + +H NIV++Y + L+ +V E++ G L D + ++
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELW---VVMEFLEGGALTDIVTH--TRMNEEQI 117
Query: 636 HKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGI-AKVLQARGGKD 693
+ V + L++LH G +IHRDIKS +ILL + + K++DFG A+V + +
Sbjct: 118 ATVCLAVLKALSFLHAQG----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173
Query: 694 STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
S + GT ++APE T+ D++S G++++E++ G P ++
Sbjct: 174 S----LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 48/226 (21%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKK-------LWSQRTKVSASDTDQLQLDKGLKTE 582
+ +G+G G V +G VA+KK + QRT L+ E
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT---------------LR-E 53
Query: 583 VETLGNIRHKNIVKL--------YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
++ L +H+NI+ + + F+ +Y +V E M L+K +
Sbjct: 54 IKILRRFKHENIIGILDIIRPPSFESFNDVY---IVQELMETD-----LYKLIKTQHLSN 105
Query: 635 RHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
H I + + Q GL Y+H + ++HRD+K +N+LL+ N K+ DFG+A++
Sbjct: 106 DH-IQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKC-DVYSFGVVLMELITGR 736
T T Y APE +SK TK D++S G +L E+++ R
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 33/281 (11%)
Query: 526 EAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
E T+ ++G+G G V+K ID + +VVA+K + + + D Q E+
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---------EIT 54
Query: 585 TLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
L + K Y + ++ EY+ G+ D L G D + + +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILK 112
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GL YLH IHRDIK+ N+LL K+ADFG+A L K +T GT
Sbjct: 113 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT---FVGTPF 166
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
++APE S +K D++S G+ +EL G P D ++ + + +
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD--------MHPMRVLFLIPKNNP 218
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
L + S F+ E I C +K P+ RPT E+++
Sbjct: 219 PTLTGEFSKPFK-EFIDA------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 530 EK-NKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
EK N++G+G G VY+ D SGE+VA+KK+ + D + + L+ E+ L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER------DGIPI-SSLR-EITLLL 61
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPN--GNLWDALHKGLVHLDWPTRHKIAFGVA 643
N+RH NIV+L L LV EY +L D + + +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE---SQVKCLMLQLL 118
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
+GL YLH IIHRD+K +N+LL K+ADFG+A+ K T V+ T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP-AKPMTPKVV--TL 172
Query: 704 GYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y APE TT D+++ G +L EL+ +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 32/216 (14%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
N++G G GTVYK I +G + A+K ++ DT + Q+ + E+E L ++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-----EDTVRRQICR----EIEILRDVN 130
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
H N+VK + F ++ E+M G+L + H D +A + G+AYLH
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIA----DEQFLADVARQILSGIAYLH 185
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
I+HRDIK +N+L++ K+ADFG++++L A+ ++V GT Y++PE
Sbjct: 186 R---RHIVHRDIKPSNLLINSAKNVKIADFGVSRIL-AQTMDPCNSSV--GTIAYMSPER 239
Query: 711 --------AYSSKATTKCDVYSFGVVLMELITGRKP 738
AY A D++S GV ++E GR P
Sbjct: 240 INTDLNHGAYDGYAG---DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + + N+G++ A KKL +R K + + L E E L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMAL-------LEKEILEKVNSP 53
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNL-WDALHKGLVHLDWPTRHKIAFGVAQ---GLAY 648
IV L F S LV M G+L + + G L+ ++ AQ G+ +
Sbjct: 54 FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM---ERVIHYSAQITCGILH 110
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
LH I++RD+K N+LLD +++D G+A ++ + GK T T AGT GY+AP
Sbjct: 111 LHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGK--TITQRAGTNGYMAP 163
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
E + D ++ G + E++ GR P +D
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 523 EILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
E+LE +G+G GTV K+ + G+++ K++ ++ + QL +
Sbjct: 3 EVLE------TIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLV------S 48
Query: 582 EVETLGNIRHKNIVKLYCYF-----SSLYCNLLVYEYMPNGNLWDALHKGLV---HLDWP 633
EV L ++H NIV+ Y +LY +V EY G+L + K +++
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLY---IVMEYCEGGDLAQLIQKCKKERKYIEEE 105
Query: 634 TRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
+I + L H+ ++HRD+K NI LD N K+ DFG+AK+L G
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GH 162
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
S GT Y++PE K D++S G ++ EL P
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 50/294 (17%)
Query: 528 MTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV 583
+T++ +G G G V++ L VA+K L T+ D +E
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---------FLSEA 57
Query: 584 ETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIAF- 640
+G H NI++L + +++ EYM NG L L H G ++ + +
Sbjct: 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGML 113
Query: 641 -GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
G+A G+ YL +HRD+ + NIL++ N + KV+DFG+++VL+ TT+
Sbjct: 114 RGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758
+ APE K T+ DV+SFG+V+ E+++ G +P YW +
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP------------YW---DMS 215
Query: 759 TKEGIMEVLDKKLSGSFR-----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
E +M K ++ FR D V ++ ++C + A RP ++V LL
Sbjct: 216 NHE-VM----KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 62/213 (29%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 534 VGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+ +G G+VY ++G+ A+K L SD +K E +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL-------KKSDMIAKNQVTNVKAERAIMMIQGES 56
Query: 593 -NIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLA 647
+ KLY F S LY LV EY+ G+ + G + DW + IA V G+
Sbjct: 57 PYVAKLYYSFQSKDYLY---LVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVE 111
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
LH IIHRDIK N+L+D K+ DFG+++ K GT YLA
Sbjct: 112 DLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--KK-----FVGTPDYLA 161
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
PE D +S G V+ E + G P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G G V+K + +G++VA+KK D + K E+ L ++H
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLKQLKH 59
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
N+V L F LV+EY + + + L K + KI + Q + + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
IHRD+K NIL+ Q K+ DFG A++L G D T +A T Y APE
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVA-TRWYRAPELL 172
Query: 712 Y-SSKATTKCDVYSFGVVLMELITG 735
++ DV++ G V EL+TG
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 74/227 (32%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D ++ + E +G G G VY D+ + EVVA+KK+ S K S ++ Q
Sbjct: 12 DPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQS---NEKWQ---D 61
Query: 579 LKTEVETLGNIRHKNIVKLY-CYFSSLYCNLLVYEYM--PNGNLWDALHKGLVHLDWPTR 635
+ EV L +RH N ++ CY LV EY ++ + K L ++
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTA-WLVMEYCLGSASDILEVHKKPLQEVEIAA- 119
Query: 636 HKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
I G QGLAYLH H IHRDIK+ NILL K+ADFG A ++ S
Sbjct: 120 --ICHGALQGLAYLHSHER----IHRDIKAGNILLTEPGTVKLADFGSASLV-------S 166
Query: 695 TTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKP 738
GT ++APE + + K DV+S G+ +EL RKP
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G G VYK + +GEVVA+KK+ DT+ + E+ L + H
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKI--------RLDTETEGVPSTAIREISLLKELNH 58
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNL---WDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
NIVKL + LV+E++ + +L DA + L P F + QGLA+
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAF 115
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H ++HRD+K N+L++ K+ADFG+A+ A G T T T Y AP
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEVVTLWYRAP 169
Query: 709 EYAYSSK-ATTKCDVYSFGVVLMELITGR 736
E K +T D++S G + E++T R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 77/281 (27%), Positives = 120/281 (42%), Gaps = 33/281 (11%)
Query: 526 EAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
E T+ ++G+G G VYK ID + EVVA+K + + + D Q E+
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---------EIT 54
Query: 585 TLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
L I + Y + ++ EY+ G+ D L G L+ I + +
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILK 112
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GL YLH IHRDIK+ N+LL K+ADFG+A L K +T GT
Sbjct: 113 GLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT---FVGTPF 166
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
++APE S K D++S G+ +EL G P D ++ + + +
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD--------LHPMRVLFLIPKNSP 218
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
L+ + S F++ C +K P RPT E+++
Sbjct: 219 PTLEGQYSKPFKE-------FVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 76/290 (26%), Positives = 115/290 (39%), Gaps = 50/290 (17%)
Query: 532 NKVGQGGSGTV----YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
++G G G+V Y + VAVK L K E +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTL---------KQEHIAAGKKEFLREASVMA 51
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI---AFGV 642
+ H IV+L C L +LV E P G L K L + A V
Sbjct: 52 QLDHPCIVRLIGVCKGEPL---MLVMELAPLG----PLLKYLKKRREIPVSDLKELAHQV 104
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A G+AYL +HRD+ + N+LL +Q K++DFG+++ L A G D AG
Sbjct: 105 AMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGR 159
Query: 703 Y--GYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759
+ + APE K ++K DV+S+GV L E + G KP +G+ K
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP----YGEMKG----------- 204
Query: 760 KEGIMEVLDKKLSGSFRDEM-IQVLRIAIRCTSKSPATRPTMNEVVQLLA 808
++ +L+ +E ++ I + C P RPT +E+
Sbjct: 205 -AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 23/246 (9%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V +L + E+ AVK L + + D + +K V L +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL-KKDVILQDDDVECTMTEK----RVLALAG-KHP 56
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH-H 651
+ +L+ F + V EY+ G+L + + D P A + GL +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
G II+RD+K N+LLD K+ADFG+ K + G +T+T GT Y+APE
Sbjct: 116 G----IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTST-FCGTPDYIAPEIL 168
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD-------NKNIIYWVSIKVDTKEGIM 764
D ++ GV+L E++ G+ P E D D + Y + + K +
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILK 228
Query: 765 EVLDKK 770
L K
Sbjct: 229 SFLTKN 234
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 520 DQREILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D R +LE K+G+G +G V + +SG VAVK + D + Q +
Sbjct: 18 DPRSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMM----------DLRKQQRREL 64
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI 638
L EV + + +H+N+V++Y + ++ E++ G L D + + L+ +
Sbjct: 65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATV 122
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD-STTT 697
V Q L YLH +IHRDIKS +ILL ++ + K++DFG A+ KD
Sbjct: 123 CESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISKDVPKRK 175
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
+ GT ++APE + T+ D++S G++++E++ G P
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 71/307 (23%)
Query: 534 VGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+G+G G V K + N VAVK L K A++ D L +E+E +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-----KDDATEKDLSDL----VSEMEMMK 70
Query: 588 NI-RHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALH-------KGLVHLDWPTRH 636
I +HKNI+ L + LY +V EY +GNL D L P
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLY---VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 637 KI--------AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688
+ A+ VA+G+ +L IHRD+ + N+L+ ++ K+ADFG+A+ +
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 689 RGGKDSTTTVIAG--TYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745
TT G ++APE + T + DV+SFGV+L E+ T G P
Sbjct: 185 IDYYRKTTN---GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP------- 234
Query: 746 NKNIIYWVSIKVDT-----KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800
+ I V+ KEG ++K + + E+ ++R C + P+ RPT
Sbjct: 235 ------YPGIPVEELFKLLKEG--YRMEKPQNCT--QELYHLMR---DCWHEVPSQRPTF 281
Query: 801 NEVVQLL 807
++V+ L
Sbjct: 282 KQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
++G+G G VYK D ++GE+VA+KK+ K T E++ L +
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT--------AIREIKILRQLN 64
Query: 591 HKNIVKLYCYFS-------------SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK 637
H+NIV L + + Y LV+EYM + +L L GLVH
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFY---LVFEYM-DHDLMGLLESGLVHFSEDHIKS 120
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+ +GL Y H +HRDIK +NILL+ Q K+ADFG+A++ + + T
Sbjct: 121 FMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 698 VIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGRKPV 739
VI T Y PE + DV+S G +L EL T +KP+
Sbjct: 178 VI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 533 KVGQGGSGTVY---KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+VGQGG G V+ K D +GE+VA+K++ + ++ + TE + L
Sbjct: 8 QVGQGGYGQVFLAKKKD--TGEIVALKRM-KKSLLFKLNEVRHV------LTERDILTTT 58
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQG 645
+ + +VKL F LY L EY+P G+ L + G++ D R +A
Sbjct: 59 KSEWLVKLLYAFQDDEYLY---LAMEYVPGGDFRTLLNNLGVLSEDH-ARFYMAEMFE-A 113
Query: 646 LAYLHH-GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
+ LH G IHRD+K N L+D + K+ DFG++K G + + G+
Sbjct: 114 VDALHELG----YIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPD 163
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN--KNIIYW 752
Y+APE D +S G +L E + G P + +N+ YW
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 74/251 (29%), Positives = 107/251 (42%), Gaps = 53/251 (21%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V+ + D ++G+V A+K L K +Q+ + E + L +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVL----RKSDMIKRNQIAHVR---AERDILADADSP 61
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAY 648
IVKLY F LY LV EYMP G+L + L K + + R F +A+ +
Sbjct: 62 WIVKLYYSFQDEEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-AR----FYIAELVLA 113
Query: 649 LH--HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL-------------------- 686
L H L IHRDIK NIL+D + K+ADFG+ K +
Sbjct: 114 LDSVHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 687 --QARGGKDSTTTVIA----GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
R V A GT Y+APE + +CD +S GV+L E++ G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF- 230
Query: 741 DDFGDNKNIIY 751
+ D Y
Sbjct: 231 --YSDTLQETY 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 528 MTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+ + ++G+G GTV K + SG ++AVK++ R+ V + +L +D ++ +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI---RSTVDEKEQKRLLMD------LDVV 56
Query: 587 GNIRH-KNIVKLY-CYFSSLYCNLLVYEYMPNG--NLWDALH-KGLVHLDWPTRHKIAFG 641
IVK Y F C + E M + ++ + KIA
Sbjct: 57 MRSSDCPYIVKFYGALFREGDC-WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT-TVIA 700
+ L YL L IIHRD+K +NILLD N K+ DFGI+ L DS T A
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIAKTRDA 168
Query: 701 GTYGYLAPEYAYSSKAT---TKCDVYSFGVVLMELITGRKP 738
G Y+APE S + DV+S G+ L E+ TG+ P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
VG G G V+ + D S A+K + + + +L+ ++ + E L + H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVM-------AIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
I++L+ ++ EY+P G L+ L + T A + L YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHS- 119
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
I++RD+K NILLD K+ DFG AK L+ R T + GT YLAPE
Sbjct: 120 --KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQ 171
Query: 713 SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
S D ++ G+++ E++ G P F DN IY
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPF---FDDNPFGIY 207
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
E++ K+G G G V+ N+ VAVK L V A E
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-----------FLEEANL 54
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGV 642
+ ++H +V+LY + ++ EYM G+L D L G V L P + +
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQI 112
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A+G+AY+ IHRD+++ N+L+ + K+ADFG+A+V++ D+ T G
Sbjct: 113 AEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIE-----DNEYTAREGA 164
Query: 703 ---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ APE T K DV+SFG++L E++T G+ P
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 72/220 (32%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+VG G G VYK +L++GE+ AVK + K+ D L ++ E+ + +H
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKII-----KLEPGDDFSL-----IQQEIFMVKECKH 65
Query: 592 KNIVKLYCYFSSLYCN---LLVYEYMPNGNLWDALHKGLVHLDWP-TRHKIAF---GVAQ 644
NIV YF S + EY G+L D + H+ P + +IA+ Q
Sbjct: 66 CNIV---AYFGSYLSREKLWICMEYCGGGSLQD-----IYHVTGPLSELQIAYVCRETLQ 117
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GLAYLH +HRDIK NILL N K+ADFG+A + A K + GT
Sbjct: 118 GLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS---FIGTPY 171
Query: 705 YLAPEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVED 741
++APE A K CD+++ G+ +EL + P+ D
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL--KTEVETLGNIR 590
VG+G G V+ ++V +K++ +Q+ D+ L + E + L +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQI----------PVEQMTKDERLAAQNECQVLKLLS 57
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLAYL 649
H NI++ Y F ++V EY P G L + + K LD T I Q L L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLAL 114
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQP-KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
HH I+HRD+K+ NILLD + K+ DFGI+K+L K TV+ GT Y++P
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVV-GTPCYISP 170
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
E K D+++ G VL EL + ++ E
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
K+G G G V+ N VA+K L A E + ++H
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-----------FLAEANLMKQLQHP 61
Query: 593 NIVKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGVAQGLAYL 649
+V+LY + +Y ++ EYM NG+L D L L +A +A+G+A++
Sbjct: 62 RLVRLYAVVTQEPIY---IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT---YGYL 706
IHRD+++ NIL+ K+ADFG+A+++ +D+ T G +
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLI-----EDNEYTAREGAKFPIKWT 170
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
APE T K DV+SFG++L E++T GR P
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 545 IDLNSGEVVAV-KKLWSQRTKVSASDTDQLQL-DKGLKTEVETLGNIRHKNIVKLY--CY 600
++ SG+ V W ++ KV+ + + ++ E + + + H +V+LY C
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
S C LV+E+M +G L D L T + V +G+AYL S +IHR
Sbjct: 70 ERSPIC--LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHR 124
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKC 720
D+ + N L+ N KV+DFG+ + + ST T + +PE SK ++K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFSKYSSKS 182
Query: 721 DVYSFGVVLMELIT-GRKPVED 741
DV+SFGV++ E+ + G+ P E+
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V+ +L + + A+K L ++ V D + + ++ V +L H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTM---VEKRVLSLA-WEHP 56
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGVAQGLAYLHH 651
+ LYC F + V EY+ G+L H H D P A + GL +LH
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
I++RD+K NILLD + K+ADFG+ K + G D+ T GT Y+APE
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLG-DAKTCTFCGTPDYIAPEIL 168
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKP 738
K T D +SFGV+L E++ G+ P
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G GTV+K + + E+VA+K+ V D D+ L+ E+ L ++H
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKR-------VRLDDDDEGVPSSALR-EICLLKELKH 58
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNG--NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
KNIV+LY S LV+EY +D+ + +D F + +GLA+
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFC 115
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
H ++HRD+K N+L++ N + K+ADFG+A+ S V T Y P+
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPD 169
Query: 710 YAYSSKA-TTKCDVYSFGVVLMELITGRKPV 739
+ +K +T D++S G + EL +P+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 526 EAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
E T+ K+G+G G V+K ID + +VVA+K + + + D Q E+
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---------EIT 54
Query: 585 TLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
L + K Y + ++ EY+ G+ D L G LD I + +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILK 112
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
GL YLH IHRDIK+ N+LL + + K+ADFG+A L K + GT
Sbjct: 113 GLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN---TFVGTPF 166
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
++APE S +K D++S G+ +EL G P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 26/163 (15%)
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
+ N +KLY ++L ++L+ +Y+ +G+L+D L K L KI + + L LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLH 126
Query: 651 -HGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H IIH DIK N+L D + + D+G+ K+ G T + GT Y +P
Sbjct: 127 KHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IG----TPSCYDGTLDYFSP 175
Query: 709 E------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
E Y S D ++ GV+ EL+TG+ P ++D +
Sbjct: 176 EKIKGHNYDVS------FDWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 43/227 (18%)
Query: 530 EKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVE 584
E ++G+G GTVYK DLN+G VA+KK+ +V S+ +G+ E+
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV-----RVPLSE-------EGIPLSTLREIA 50
Query: 585 TLGNIR---HKNIVKLY--CYFSSLYCNL---LVYEYMPNGNLWDALHKGLVH-----LD 631
L + H NIV+L C+ L LV+E++ D L L L
Sbjct: 51 LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLP 105
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
T + + +G+ +LH I+HRD+K NIL+ + Q K+ADFG+A++
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----S 158
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
+ T + T Y APE S T D++S G + EL R+P
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
T K+GQG SGTVY ID+ +G+ VA+K++ + Q + + E+ +
Sbjct: 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQM----------NLQQQPKKELIINEILVMR 71
Query: 588 NIRHKNIVKLYCYFSSLYCN---LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
++ NIV Y S +V EY+ G+L D + + +D + Q
Sbjct: 72 ENKNPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQ 126
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
L +LH + +IHRDIKS NILL ++ K+ DFG + K ST + GT
Sbjct: 127 ALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPY 180
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
++APE K D++S G++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 57/176 (32%), Positives = 79/176 (44%), Gaps = 34/176 (19%)
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
Q L +HH +IHRDIKS NILL N K+ DFG +K+ A D T GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTP 209
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763
Y+APE + K D++S GV+L EL+T ++P + E +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-------------------ENM 250
Query: 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCK 819
EV+ K L+G + D + P+ P M E+V L +DP R S
Sbjct: 251 EEVMHKTLAGRY-DPL-------------PPSISPEMQEIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G G VYK + +G VVA+KK+ K T E++ L ++H
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--------REIKILKKLKH 66
Query: 592 KNIVKLYCYF--------SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
N+V L +V YM + +L L V L +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ----------ARGGKD 693
+G+ YLH I+HRDIK+ NIL+D K+ADFG+A+ G +
Sbjct: 126 EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 694 STTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
T V+ T Y PE + TT D++ G V E+ T R
Sbjct: 183 YTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 56/296 (18%)
Query: 528 MTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+ ++G+G G V K+ + +G ++AVK++ + + + +Q +L L
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-----RATVNSQEQKRLLMDLDI----- 52
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVY---EYMPNG--NLWDALHKGLVHLDWPTRHKIAFG 641
++R + ++ +L+ V+ E M + ++ + + KIA
Sbjct: 53 -SMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS 111
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS-TTTVIA 700
+ + L YLH L +IHRD+K +N+L++ N Q K+ DFGI+ L DS T+ A
Sbjct: 112 IVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-----DSVAKTIDA 164
Query: 701 GTYGYLAPE--------YAYSSKATTKCDVYSFGVVLMELITGRKPVE---DDFGDNKNI 749
G Y+APE Y K+ DV+S G+ ++EL TGR P + F K +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKS----DVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ +E ++ +K S F+D +C K+ RP E++Q
Sbjct: 221 V---------EEPSPQLPAEKFSPEFQD-------FVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 582 EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG 641
E + + + H+ +V+LY + +V EYM NG L + L + ++
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK-VLQARGGKDSTTTVIA 700
V +G+AYL IHRD+ + N L+D KV+DFG+++ VL D T+ +
Sbjct: 109 VCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD-----DEYTSSVG 160
Query: 701 GTY--GYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740
+ + PE SK ++K DV++FGV++ E+ + G+ P E
Sbjct: 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 612 EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV 671
E+M G+L D + K + KI+ V +GL YL I+HRD+K +NIL++
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNS 135
Query: 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLME 731
+ K+ DFG++ L DS GT Y++PE + T + D++S G+ L+E
Sbjct: 136 RGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 732 LITGRKPV--------------EDDFGDNKNIIYWVSIKVDTKE---GIMEVLD------ 768
+ GR P+ G+ K VS I E+LD
Sbjct: 191 MAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP 250
Query: 769 --KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
K SG+F DE + C K+P R + E+ +
Sbjct: 251 PPKLPSGAFSDEFQDFVDK---CLKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 79/244 (32%), Positives = 112/244 (45%), Gaps = 52/244 (21%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D EI+E +G+G G VYK+ + G + AVK L SD D+
Sbjct: 22 DTWEIIET------IGKGTYGKVYKVTNKKDGSLAAVKIL------DPISDVDE------ 63
Query: 579 LKTEVETLGNI-----RHKNIVKLY-CYFSSLYCN----LLVYEYMPNGNLWDALHKGLV 628
E+E NI H N+VK Y ++ + LV E + NG L KGL+
Sbjct: 64 ---EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE-LCNGGSVTELVKGLL 119
Query: 629 ----HLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684
LD I +G GL +LH+ + IIHRD+K NILL K+ DFG++
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 685 VLQARGGKDSTTTVIAGTYGYLAPE-------YAYSSKATTKCDVYSFGVVLMELITGRK 737
L + + +T+ GT ++APE Y YS A +CDV+S G+ +EL G
Sbjct: 177 QLTSTRLRRNTSV---GTPFWMAPEVIACEQQYDYSYDA--RCDVWSLGITAIELGDGDP 231
Query: 738 PVED 741
P+ D
Sbjct: 232 PLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 87/320 (27%), Positives = 128/320 (40%), Gaps = 66/320 (20%)
Query: 501 TLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLW 559
T+ +P D+ + ++G G G VYK+ +G V+AVK++
Sbjct: 4 TIDGQKYPADLNDLENLG--------------EIGSGTCGQVYKMRFKKTGHVMAVKQM- 48
Query: 560 SQRTKVSASDTDQLQ-LDKGLKTEVETLGNIRH--KNIVKLYCYFSSLYCNLLVYEYMPN 616
+RT + L LD LK+ H IVK Y YF + + E M
Sbjct: 49 -RRTGNKEENKRILMDLDVVLKS---------HDCPYIVKCYGYFITDSDVFICMELM-- 96
Query: 617 GNLWDALHKGLVHLDWPTR--HKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVN 672
D L K + P K+ + + L YL HG +IHRD+K +NILLD +
Sbjct: 97 STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDAS 151
Query: 673 YQPKVADFGIAKVL---QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTK----CDVYSF 725
K+ DFGI+ L +A+ T AG Y+APE K DV+S
Sbjct: 152 GNVKLCDFGISGRLVDSKAK-------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204
Query: 726 GVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRI 785
G+ L+EL TG+ P N + V K+ +E ++ S F
Sbjct: 205 GISLVELATGQFPY-----KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCS-------F 252
Query: 786 AIRCTSKSPATRPTMNEVVQ 805
C +K RP E++Q
Sbjct: 253 VDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVETLG 587
K+G+G G VYK D +GE+VA+KK+ R + D+G+ + E+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI---RLE---------TEDEGVPSTAIREISLLK 53
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGL 646
+ H NIV+L S LV+E++ + +L + L LD P + + QG+
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
AY H ++HRD+K N+L+D K+ADFG+A+ A G T T T Y
Sbjct: 113 AYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR---AFGVPVRTYTHEVVTLWYR 166
Query: 707 APEYAYSSKA-TTKCDVYSFGVVLMELITGRKP 738
APE S+ +T D++S G + E++ R+P
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 535 GQGGSGTV----YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
G+G G V YK +GE+ A+K L K D+++ K ET + R
Sbjct: 8 GRGHFGKVLLAEYK---KTGELYAIKAL----KKGDIIARDEVESLMCEKRIFETANSER 60
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GLA 647
H +V L+ F + V EY G+L +H +H D + + F A GL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMH---IHTDVFSEPRAVFYAACVVLGLQ 115
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YLH + I++RD+K N+LLD K+ADFG+ K + G D T+T GT +L
Sbjct: 116 YLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST-FCGTPEFL 168
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
APE + T D + GV++ E++ G P D
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G G G V ID SG+ VA+KK+ A D L K E++ L + +H
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDV--PTLAKRTLRELKILRHFKH 63
Query: 592 KNIVKLY-------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP-TRHKIAFGVA 643
NI+ + F +Y +V + M + LH ++H D P T I + +
Sbjct: 64 DNIIAIRDILRPPGADFKDVY---VVMDLMESD-----LHH-IIHSDQPLTEEHIRYFLY 114
Query: 644 Q---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST--TTV 698
Q GL Y+H + +IHRD+K +N+L++ + + ++ DFG+A+ L + + T
Sbjct: 115 QLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 699 IAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPV 739
+A T Y APE S + TT D++S G + E++ GR+ +
Sbjct: 172 VA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
T K+GQG SGTV+ ID+ +G+ VA+K++ Q+ +++ + K LK
Sbjct: 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK------- 74
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
N N + + L+ +V EY+ G+L D + + +D + Q L
Sbjct: 75 NPNIVNFLDSFLVGDELF---VVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALE 129
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+LH + +IHRDIKS N+LL ++ K+ DFG + K ST + GT ++A
Sbjct: 130 FLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMA 183
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
PE K D++S G++ +E++ G P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 82/315 (26%), Positives = 133/315 (42%), Gaps = 69/315 (21%)
Query: 522 REILEAMTEKNKVGQGGSGTVYK---IDLNSGEV---VAVKKLWSQRTKVSASDTDQLQL 575
RE + + E +GQG G VY+ + GE VA+K + +AS ++++
Sbjct: 5 REKITLIRE---LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERIEF 56
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK------GLVH 629
E + ++V+L S+ L+V E M G+L L
Sbjct: 57 LN----EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG 112
Query: 630 LDWPTRHKI---AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686
L PT K A +A G+AYL +HRD+ + N ++ + K+ DFG+ + +
Sbjct: 113 LGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
Query: 687 QAR-----GGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-G 735
GGK G L APE TTK DV+SFGVVL E+ T
Sbjct: 170 YETDYYRKGGK-----------GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA 218
Query: 736 RKPVEDDFG-DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSP 794
+P + G N+ ++ +V G ++ L + D++++++R C +P
Sbjct: 219 EQPYQ---GLSNEEVLKFVI-----DGGHLD-----LPENCPDKLLELMR---MCWQYNP 262
Query: 795 ATRPTMNEVVQLLAE 809
RPT E+V L +
Sbjct: 263 KMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
T K+GQG SGTVY +D+ +G+ VA++++ + Q + + E+ +
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQM----------NLQQQPKKELIINEILVMR 72
Query: 588 NIRHKNIVKLYCYFSSLYCN---LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
++ NIV Y S +V EY+ G+L D + + +D + Q
Sbjct: 73 ENKNPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQ 127
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
L +LH + +IHRDIKS NILL ++ K+ DFG + K ST + GT
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPY 181
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
++APE K D++S G++ +E+I G P ++ + +Y ++ G
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATN-----GTP 234
Query: 765 EVLD-KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
E+ + +KLS FRD + RC R + E++Q
Sbjct: 235 ELQNPEKLSAIFRDFL-------NRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 80/257 (31%), Positives = 115/257 (44%), Gaps = 41/257 (15%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVY-KIDLN 548
S RA + D ++ FF D + ++ D REI G G G VY D+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPE---KLFTDLREI----------GHGSFGAVYFARDVR 48
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY-CYFSSLYCN 607
+ EVVA+KK+ S S + + + EV+ L I+H N ++ CY +
Sbjct: 49 TNEVVAIKKM-------SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-HTA 100
Query: 608 LLVYEYM--PNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665
LV EY +L + K L ++ I G QGLAYLH + IHRDIK+
Sbjct: 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHNM---IHRDIKAG 154
Query: 666 NILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDV 722
NILL Q K+ADFG A + S GT ++APE + + K DV
Sbjct: 155 NILLTEPGQVKLADFGSASIA-------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 207
Query: 723 YSFGVVLMELITGRKPV 739
+S G+ +EL + P+
Sbjct: 208 WSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 534 VGQGGSGTVY----KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+GQG G V+ ++G++ A+K L KV D+++ K E + L +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR----DRVRT----KMERDILAEV 55
Query: 590 RHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-G 645
H IVKL+ F + LY L+ +++ G+L+ L K ++ T + F +A+
Sbjct: 56 NHPFIVKLHYAFQTEGKLY---LILDFLRGGDLFTRLSKEVMF----TEEDVKFYLAELA 108
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
LA H H L II+RD+K NILLD K+ DFG++K ++ + GT
Sbjct: 109 LALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDH-EKKAYSFCGTVE 163
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
Y+APE T D +SFGV++ E++TG P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 34/233 (14%)
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVH-----LDW 632
+ EV L N++H NIV+ F +V +Y G+L+ ++ +G++ LDW
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
+ + L ++H I+HRDIKS NI L + K+ DFGIA+VL +
Sbjct: 107 FVQ------ICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--V 155
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
+ T I GT YL+PE + K D+++ G VL E+ T + E G+ KN++
Sbjct: 156 ELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLV-- 210
Query: 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+K+ G + S R+ + Q+ + ++P RP++N +++
Sbjct: 211 --LKI--IRGSYPPVSSHYSYDLRNLVSQLFK-------RNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 533 KVGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G G G VY D+ + EVVA+KK+ S +++ D + EV L +RH
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKM-----SYSGKQSNEKWQD--IIKEVRFLQKLRH 74
Query: 592 KNIVKLY-CYFSSLYCNLLVYEYM--PNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
N ++ CY + LV EY +L + K L ++ + G QGLAY
Sbjct: 75 PNTIQYRGCYLRE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAY 130
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
LH +IHRD+K+ NILL K+ DFG A ++ + GT ++AP
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGTPYWMAP 180
Query: 709 EYAYS---SKATTKCDVYSFGVVLMELITGRKP 738
E + + K DV+S G+ +EL RKP
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 74/297 (24%), Positives = 116/297 (39%), Gaps = 53/297 (17%)
Query: 525 LEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASD-TDQLQLDKGLKTE 582
L + K+G+G VYK I L G VVA+KK V + D LK E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK-------VQIFEMMDAKARQDCLK-E 52
Query: 583 VETLGNIRHKNIVKLYCYFSSLYCNLL--VYEYMPNGNLWDAL---HKGLVHLDWPTRHK 637
++ L + H N++K F + N L V E G+L + K + T K
Sbjct: 53 IDLLKQLDHPNVIKYLASF--IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+ L ++H I+HRDIK N+ + K+ D G+ + S+ T
Sbjct: 111 YFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKT 160
Query: 698 VIA----GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753
A GT Y++PE + + K D++S G +L E+ + P D
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----------- 209
Query: 754 SIKVDTKEGIMEVLDKKLSGSFR----DEMIQVLRIAI-RCTSKSPATRPTMNEVVQ 805
K + + K + D + LR + RC + P RP ++ V+Q
Sbjct: 210 ------KMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 77/225 (34%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D EI + E +G G G VY + ++ EVVAVKK+ S T++ D
Sbjct: 18 DPEEIFVGLHE---IGHGSFGAVYFATNSHTNEVVAVKKM-----SYSGKQTNEKWQD-- 67
Query: 579 LKTEVETLGNIRHKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK 637
+ EV+ L ++H N ++ CY + LV EY G+ D L L
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 125
Query: 638 IAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
I G QGLAYLH H + IHRDIK+ NILL Q K+ADFG A S
Sbjct: 126 ITHGALQGLAYLHSHNM----IHRDIKAGNILLTEPGQVKLADFGSASKS-------SPA 174
Query: 697 TVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKP 738
GT ++APE + + K DV+S G+ +EL RKP
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVETLG 587
K+G+G TVYK + +GE+VA+K++ L ++G + E+ +
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI-------------HLDAEEGTPSTAIREISLMK 53
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
++H+NIV+L+ + +LV+EYM + H LD T + + +G+
Sbjct: 54 ELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
A+ H + ++HRD+K N+L++ + K+ADFG+A+ S V T Y
Sbjct: 114 AFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYR 167
Query: 707 APEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
AP+ S+ +T D++S G ++ E+ITGR
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 57/176 (32%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIA---FGVAQ-- 644
H + L+C F + V EY+ G+L + H+ R A F A+
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDL-------MFHIQSSGRFDEARARFYAAEII 106
Query: 645 -GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
GL +LH II+RD+K N+LLD + K+ADFG+ K GK ST GT
Sbjct: 107 CGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTP 160
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759
Y+APE K D +SFGV+L E++ G+ P G++++ ++ SI D
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH---GEDEDELFD-SILNDR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + +G++ A KKL +R K + + ++ E + L + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-------KRKGEQMALNEKKILEKVSSR 53
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP--TRHKIAFGVAQ---GLA 647
IV L F + LV M G+L + ++ P + F AQ GL
Sbjct: 54 FIVSLAYAFETKDDLCLVMTLMNGGDL----KYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+LH I++RD+K N+LLD + +++D G+A L+ AGT GY+A
Sbjct: 110 HLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKGRAGTPGYMA 162
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
PE D ++ G L E+I GR P
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 50/285 (17%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQL--QLDKGLKTEVETLGNIR 590
K+G+G G +Y +A K S+ + D ++ + + K EV L ++
Sbjct: 7 KIGEGSFGKIY---------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVH-----LDWPTRHKIAFGVA 643
H NIV + F +V EY G+L ++ +G++ L W + ++
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------IS 111
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-PKVADFGIAKVLQARGGKDST--TTVIA 700
GL ++H I+HRDIKS NI L N K+ DFGIA+ L DS
Sbjct: 112 LGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-----DSMELAYTCV 163
Query: 701 GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760
GT YL+PE + K D++S G VL EL T + P E N ++ + +K+
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG------NNLHQLVLKI--C 215
Query: 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+G + S R + Q+ ++ SP RP++ +++
Sbjct: 216 QGYFAPISPNFSRDLRSLISQLFKV-------SPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 22/220 (10%)
Query: 520 DQREILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D RE L++ K+G+G +G V + ++G+ VAVKK+ D + Q +
Sbjct: 19 DPREYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKM----------DLRKQQRREL 65
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI 638
L EV + + H+N+V +Y + +V E++ G L D + ++ +
Sbjct: 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATV 123
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
V + L+YLH+ +IHRDIKS +ILL + + K++DFG + K +
Sbjct: 124 CLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--- 177
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
+ GT ++APE T+ D++S G++++E+I G P
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
++G G G V K+ ++ +KL K + + + E++ L
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--------IIRELQVLHECNSP 63
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
IV Y F S + E+M G+L D + K + K++ V +GLAYL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
I+HRD+K +NIL++ + K+ DFG++ L DS GT Y++PE
Sbjct: 123 --HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 175
Query: 713 SSKATTKCDVYSFGVVLMELITGRKPV 739
+ + + D++S G+ L+EL GR P+
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 64/193 (33%), Positives = 86/193 (44%), Gaps = 34/193 (17%)
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
IV+L+ F LY +V EYMP G+L + + + W R A V L +H
Sbjct: 105 IVQLHYAFQDDKYLY---MVMEYMPGGDLVNLMSNYDIPEKW-ARFYTA-EVVLALDAIH 159
Query: 651 H-GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
G IHRD+K N+LLD + K+ADFG + A G T V GT Y++PE
Sbjct: 160 SMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV--GTPDYISPE 213
Query: 710 YAYSSKATT----KCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
S +CD +S GV L E++ G P D S+ V T IM
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----------SL-VGTYSKIM- 260
Query: 766 VLDKKLSGSFRDE 778
D K S +F D+
Sbjct: 261 --DHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 87/307 (28%), Positives = 136/307 (44%), Gaps = 66/307 (21%)
Query: 534 VGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+GQG G V++ L E +VAVK L K AS +Q D + E +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASA--DMQAD--FQREAALMA 63
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK-------GLVHLDWPTRH-- 636
H NIVKL C C L++EYM G+L + L L H R
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 637 ------------KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA- 683
IA VA G+AYL +HRD+ + N L+ N K+ADFG++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDD 742
+ A K S I ++ PE + ++ TT+ DV+++GVVL E+ + G +P
Sbjct: 179 NIYSADYYKASENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY--- 233
Query: 743 FG-DNKNIIYWVSIKVDTKEG-IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800
+G ++ +IY+V ++G ++ D E+ ++R C SK P+ RP+
Sbjct: 234 YGMAHEEVIYYV------RDGNVLSCPDNCPL-----ELYNLMR---LCWSKLPSDRPSF 279
Query: 801 NEVVQLL 807
+ ++L
Sbjct: 280 ASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 38/223 (17%)
Query: 530 EKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
E+ +G+G G VY DL++ +A+K++ + ++ +++ L LK
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-------- 63
Query: 589 IRHKNIVKLYCYFSSLYCN---LLVYEYMPNGNLWDALHK--GLVHLDWPTRHKIAFGVA 643
H+NIV+ Y S N + E +P G+L L G + + T +
Sbjct: 64 --HRNIVQ---YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP--KVADFGIAKVLQARGGKDSTTTVIAG 701
+GL YLH + I+HRDIK N+L++ Y K++DFG +K L G + T G
Sbjct: 119 EGLKYLHD---NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRL---AGINPCTETFTG 171
Query: 702 TYGYLAPEY------AYSSKATTKCDVYSFGVVLMELITGRKP 738
T Y+APE Y + A D++S G ++E+ TG+ P
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-14
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 10/161 (6%)
Query: 338 IDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYI 397
+ L + L G IP+ I L+ L + L N + +IP SL S+ SL VLDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 398 PESLCELLPNSI-NFSNNRLSGPIPLSL---IKEGLVESFSGNPGLCVSVSVNSSDKNFP 453
PESL +L I N + N LSG +P +L + +F+ N GLC +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR------A 536
Query: 454 LCPHTKTRRRLSSIWAVVTSAVIIFIGLLLFLKRRFSKQRA 494
PH ++ + V + + + I + + KRR + RA
Sbjct: 537 CGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRA 577
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-14
Identities = 41/99 (41%), Positives = 60/99 (60%), Gaps = 3/99 (3%)
Query: 319 NQ-ISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSL 377
NQ + GFIP++I + L I+LS N + G IP +G++ L +L L N N SIP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 378 SSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNN 414
L SL +L+L+ N L+G +P +L L + S NF++N
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 19/227 (8%)
Query: 582 EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG 641
E +G H NI+ L + ++V EYM NG+L L K + G
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+A G+ YL +HRD+ + NIL++ N KV+DFG+++VL+ TT
Sbjct: 115 IASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760
+ APE K T+ DV+S+G+V+ E+++ G +P YW D
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP------------YWEMSNQDVI 219
Query: 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ I E +L D + ++ + C K RP ++V +L
Sbjct: 220 KAIEE--GYRLPAPM-DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 582 EVETLGNIRHKNIVKLYCYF----SSLYCNLLVYEYMPNGNLWDALH-KGLVHLDWPTRH 636
E + +RH N+V+L LY +V EYM G+L D L +G L
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
K + V + + YL + +HRD+ + N+L+ + KV+DFG+ K +A +D+
Sbjct: 106 KFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGK 160
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ T APE K +TK DV+SFG++L E+ + GR P
Sbjct: 161 LPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 74/316 (23%)
Query: 522 REILEAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQL 575
L A+ ++G+G G VYK +L S VA+K L + + ++
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL---------KENAEPKV 51
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVH---- 629
+ + E E + +++H NIV L C C L +EY+ +G+L H+ LV
Sbjct: 52 QQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDL----HEFLVRNSPH 105
Query: 630 ---------------LDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVN 672
LD IA +A G+ YL HH +HRD+ + N L+
Sbjct: 106 SDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEG 160
Query: 673 YQPKVADFGIAKVLQA----RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVV 728
K++DFG+++ + + R S V ++ PE K TT+ D++SFGVV
Sbjct: 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPV-----RWMPPEAILYGKFTTESDIWSFGVV 215
Query: 729 LMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI 787
L E+ + G +P +G + E I + ++L D +V + I
Sbjct: 216 LWEIFSYGLQPY---YGFSNQ------------EVIEMIRSRQLLPCPEDCPARVYALMI 260
Query: 788 RCTSKSPATRPTMNEV 803
C ++ PA RP ++
Sbjct: 261 ECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 47/232 (20%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
DQ E +E K+G+G G VYK D + E +A+KK+ + Q D+G
Sbjct: 2 DQYEKVE------KIGEGTYGVVYKARDRVTNETIALKKIRLE------------QEDEG 43
Query: 579 LKT----EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD--- 631
+ + E+ L ++H NIV+L S LV+EY+ +L L K H+D
Sbjct: 44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DL--DLKK---HMDSSP 95
Query: 632 -WPTRHKIA----FGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQPKVADFGIAKV 685
+ ++ + + +G+AY H ++HRD+K N+L+D K+ADFG+A+
Sbjct: 96 DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR- 151
Query: 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
A G T T T Y APE S+ +T D++S G + E++ +
Sbjct: 152 --AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + +G++ A KKL +R K + + +G E L + +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-------KRKGYEGAMVEKRILAKVHSR 53
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP--TRHKIAFGVAQ---GLA 647
IV L F + LV M G+L H V + P + F AQ GL
Sbjct: 54 FIVSLAYAFQTKTDLCLVMTIMNGGDL--RYHIYNVDEENPGFPEPRACFYTAQIISGLE 111
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+LH II+RD+K N+LLD + +++D G+A L+ S T AGT G++A
Sbjct: 112 HLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD---GQSKTKGYAGTPGFMA 165
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
PE + D ++ GV L E+I R P
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
+H + L+C F + V EY+ G+L + + D P A V L +L
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL 112
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H HG +I+RD+K NILLD K+ADFG+ K G TTT GT Y+AP
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAP 165
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD-------NKNIIY--WVS 754
E + D ++ GV++ E++ G+ P E D D + +++Y W+S
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 44/227 (19%)
Query: 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT-- 581
LE + +K+G+G TV+K + +VA+K++ +L+ ++G
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI-------------RLEHEEGAPCTA 50
Query: 582 --EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPN---------GNLWDALHKGLVHL 630
EV L N++H NIV L+ + C LV+EY+ + GNL ++H + +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLM-SMHNVKIFM 109
Query: 631 DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
F + +GL+Y H I+HRD+K N+L++ + K+ADFG+A+ A+
Sbjct: 110 ---------FQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR---AKS 154
Query: 691 GKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR 736
T + T Y P+ S++ +T D++ G +L E+ TGR
Sbjct: 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 44/257 (17%)
Query: 533 KVGQGGSGTVYK---IDLNSGEVVAVKKL---WSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G+G G VYK + G+ A+KK Q T +S S ++ L L
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIAL----------L 56
Query: 587 GNIRHKNIVKLYCYF-----SSLYCNLLVYEYMPNGNLWDALH----KGLVHLDWPTRHK 637
++H+N+V L F S+Y L+++Y + +LW + V +
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVY---LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL--DVNYQP--KVADFGIAKVLQA--RGG 691
+ + + G+ YLH + ++HRD+K NIL+ + + K+ D G+A++ A +
Sbjct: 113 LLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKC-DVYSFGVVLMELITGRKPVEDDFGDNKNII 750
D V+ T Y APE ++ TK D+++ G + EL+T G I
Sbjct: 170 ADLDPVVV--TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF---KGREAKIK 224
Query: 751 YWVSIKVDTKEGIMEVL 767
+ D E I EVL
Sbjct: 225 KSNPFQRDQLERIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 56/170 (32%), Positives = 87/170 (51%), Gaps = 19/170 (11%)
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNL-WDALHKGLVHLDWPTRHKIAFGVAQ---GLAYL 649
+ LYC F + V E++ G+L + KG L ++ F A+ GL +L
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFL 112
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
H II+RD+K N++LD + K+ADFG+ K D+ + GT Y+APE
Sbjct: 113 HS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAPE 166
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759
K T D +SFGV+L E++ G+ P GD+++ ++ SI+VDT
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH---GDDEDELF-ESIRVDT 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 523 EILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQ-RTKVSASDTDQLQLDKGLK 580
EI + VG G G V D +G+ VA+KK+ T V A T +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-------- 58
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNL-LVYEYMPNGNLWDALHKGLVH--LDWPTRHK 637
E++ L ++RH+NI+ L F S ++ V E + LH+ L L+
Sbjct: 59 -ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTD-----LHRLLTSRPLEKQFIQY 112
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+ + +GL Y+H + ++HRD+K +NIL++ N K+ DFG+A++ +D T
Sbjct: 113 FLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI------QDPQMT 163
Query: 698 VIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPV 739
T Y APE + K + D++S G + E++ G KP+
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 531 KNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K+ VG+G G V + + +G++ A+K + +++ + A +T + E + L
Sbjct: 6 KSLVGRGHFGEVQVVREKATGDIYAMKVM--KKSVLLAQETVSF-----FEEERDILSIS 58
Query: 590 RHKNIVKLYCYFS---SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
I +L F +LY LV EY P G+L L++ + D F +A+ +
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELV 112
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
+H +HRDIK N+L+D K+ADFG A L A +S V GT Y+
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV--GTPDYI 170
Query: 707 APEYAYS----SKAT--TKCDVYSFGVVLMELITGRKPVEDD 742
APE + K T +CD +S GV+ E+I GR P +
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
E++ + K+G G G V+ N VAVK + V A E
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-----------FLAEANV 54
Query: 586 LGNIRHKNIVKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGV 642
+ ++H +VKL+ + +Y ++ E+M G+L D L P + +
Sbjct: 55 MKTLQHDKLVKLHAVVTKEPIY---IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 111
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A+G+A++ IHRD+++ NIL+ + K+ADFG+A+V++ D+ T G
Sbjct: 112 AEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE-----DNEYTAREGA 163
Query: 703 ---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ APE T K DV+SFG++LME++T GR P
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 582 EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIA 639
E + + + H N+V+LY + +V EYM NG L + L KG + +W +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMC 106
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK-VLQARGGKDSTTTV 698
V + + YL + IHRD+ + N L+ + KV+DFG+A+ VL D T
Sbjct: 107 SDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL------DDQYTS 157
Query: 699 IAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRK 737
GT + PE S+ ++K DV+SFGV++ E+ + K
Sbjct: 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 78/294 (26%), Positives = 124/294 (42%), Gaps = 45/294 (15%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVA---VKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
+++G G G V + + G A VK+L + SA+ +QL + EV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKEL-----RASATPDEQLLFLQ----EVQPYRE 51
Query: 589 IRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL----DWPTRHKIAFGV 642
+ H N+++ C S Y LLV E+ P G+L + L + ++A V
Sbjct: 52 LNHPNVLQCLGQCIESIPY--LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A GL +LH + IH D+ N L + K+ D+G+A + Q T A
Sbjct: 110 ASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVP 165
Query: 703 YGYLAPEYAYS-------SKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVS 754
+LAPE T K +++S GV + EL T +P D ++ ++ V
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL--SDEQVLKQVV 223
Query: 755 IKVDTKEGIMEVLDK-KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ D K L K +L + D +V++ P TRPT EV +LL
Sbjct: 224 REQDIK------LPKPQLDLKYSDRWYEVMQFCWL----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 88/313 (28%), Positives = 137/313 (43%), Gaps = 63/313 (20%)
Query: 534 VGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V ID ++GE VA+KK+ VS D ++ + E++ L +RH
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS----DATRILR----EIKLLRLLRHP 59
Query: 593 NIVKLYCY--------FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
+IV++ F +Y +V+E M + LH+ + D T F + Q
Sbjct: 60 DIVEIKHIMLPPSRREFKDIY---VVFELMESD-----LHQVIKANDDLTPEHHQFFLYQ 111
Query: 645 ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
L Y+H + + HRD+K NIL + + + K+ DFG+A+V T
Sbjct: 112 LLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 702 TYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD- 758
T Y APE S SK T D++S G + E++TG KP+ F KN+++ + + D
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL---F-PGKNVVHQLDLITDL 223
Query: 759 ----TKEGIMEVLDKK---------------LSGSFRDEMIQVLRIAIRCTSKSPATRPT 799
+ E I V ++K S F + LR+ R + P RPT
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 800 MNEVVQLLAEADP 812
E A ADP
Sbjct: 284 AEE-----ALADP 291
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G G G VYK ++N+GE+ A+K + + D +Q E+ + + +H
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQ------QEIIMMKDCKH 65
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP-TRHKIAF---GVAQGLA 647
NIV + + + E+ G+L D + H+ P + +IA+ QGL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-----IYHVTGPLSESQIAYVSRETLQGLY 120
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLH +HRDIK NILL N K+ADFG++ + A K + GT ++A
Sbjct: 121 YLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS---FIGTPYWMA 174
Query: 708 PEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVED 741
PE A + CD+++ G+ +EL + P+ D
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 534 VGQGGSGTVYKIDL--NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-- 589
+G G G VYK+ N ++A+K++ + K + +++G+I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEI----------NVHNPAFGKDKRERDKSIGDIVS 57
Query: 590 ---------RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK 637
RH NIV+ Y F LY + + E P G +++L +
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
I + L YLH I+HRD+ NI+L + + + DFG+AK + +S T
Sbjct: 118 IFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLT 171
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757
+ GT Y PE + K DV++FG +L ++ T + P + N +S+
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---YSTNM-----LSLAT 223
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
E + E L + + ++I C + RP + +V ++++
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDVIT------SCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 52/306 (16%)
Query: 522 REILEAMTEKNKVGQGGSGTVYK-----IDLNSGE-VVAVKKLWSQRTKVSASDTDQLQL 575
R L+ +T +G+G G V+ I+ GE +V VK L + + LQ
Sbjct: 4 RSNLQEITT---LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-------QKTKDENLQS 53
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLD 631
+ + E++ + HKN+V+L C + + +L EY G+L L K
Sbjct: 54 E--FRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL--EYTDLGDLKQFLRATKSKDEKL 109
Query: 632 WP----TRHKIAFG--VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685
P T+ K+A +A G+ +L + + +HRD+ + N L+ + KV+ ++K
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166
Query: 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744
+ +I +LAPE +TK DV+SFGV++ E+ T G P
Sbjct: 167 VYNSEYYKLRNALIP--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY---- 220
Query: 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVL-RIAIRCTSKSPATRPTMNEV 803
+ +E + + KL + L ++ RC + +P RP+ +E+
Sbjct: 221 -----------GLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
Query: 804 VQLLAE 809
V L E
Sbjct: 270 VSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 74/236 (31%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV-ETLG--NI 589
+G+G G VY++ + + A+K L S++ V+ K EV T+G NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-SKKEIVA-------------KKEVAHTIGERNI 46
Query: 590 RHKN-------IVKLYCYF---SSLYCNLLVYEYMPNGNL-WDALHKGLVHLDWPTRHKI 638
+ IV L F S LY LV +YM G L W +G D +
Sbjct: 47 LVRTLLDESPFIVGLKFSFQTDSDLY---LVTDYMSGGELFWHLQKEGRFSED-----RA 98
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
F +A+ + L H I++RD+K NILLD + DFG++K A + TT
Sbjct: 99 KFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNT 155
Query: 699 IAGTYGYLAPEYAYSSKATTK-CDVYSFGVVLMELITGRKP--VEDDFGDNKNIIY 751
GT YLAPE K TK D +S GV++ E+ G P ED +NI +
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 72/310 (23%), Positives = 128/310 (41%), Gaps = 33/310 (10%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+++G G G V+K+ ++ +KL K + + + E++ L
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--------IIRELQVLHECNS 62
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
IV Y F S + E+M G+L D + K + K++ V +GL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
I+HRD+K +NIL++ + K+ DFG++ L DS GT Y++PE
Sbjct: 122 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL 174
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL 771
+ + + D++S G+ L+E+ GR P+ +++ ++ D E +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234
Query: 772 SGSFRDEMIQVLRIAIRCTSKSPATRPTMN--EVVQLLAEADPCRFESCKFPNKSNKESS 829
+S P +RP M E++ + P + S F ++
Sbjct: 235 GRPL--------------SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVF-GAEFQDFV 279
Query: 830 NATKIKNPSE 839
N IKNP+E
Sbjct: 280 NKCLIKNPAE 289
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 44/234 (18%)
Query: 531 KNKVGQGGSGTVYKID------LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
K ++G+G G V+ + +VAVK L L K + E E
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----------KDPTLAARKDFQREAE 59
Query: 585 TLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH----KGLVHLDWPTRHK--- 637
L N++H++IVK Y ++V+EYM +G+L L ++ +D R
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 638 --------IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA- 688
IA +A G+ YL +HRD+ + N L+ N K+ DFG+++ + +
Sbjct: 120 LGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 689 ---RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
R G + + ++ PE K TT+ DV+SFGV+L E+ T G++P
Sbjct: 177 DYYRVGGHTMLPI-----RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-13
Identities = 35/82 (42%), Positives = 51/82 (62%), Gaps = 1/82 (1%)
Query: 80 LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGN 139
L G IP I + L + L+GN I G+IPP +G + +L L+L YN G+IPE LG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN-SFNGSIPESLGQ 488
Query: 140 LTELTDLDMSVNHLSGKIPESI 161
LT L L+++ N LSG++P ++
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 33/239 (13%)
Query: 521 QREILEAMTEKNK-VGQGGSGTVYK-IDLNSGEVVAVKKL----WSQRTKVSASDTDQLQ 574
I E +K +G+G G V K D +G++VA+KK+ S
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 575 LDKGLKTEVETLGNIRHKNI---VKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD 631
+ E++ + I+H+NI V +Y + NL V + M +L + + + L
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYV--EGDFINL-VMDIM-ASDLKKVVDRK-IRLT 117
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA-------- 683
I + GL LH +HRD+ NI ++ K+ADFG+A
Sbjct: 118 ESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174
Query: 684 -----KVLQARGGKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR 736
K + ++ T+ V+ T Y APE + K D++S G + EL+TG+
Sbjct: 175 SDTLSKDETMQRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 87/305 (28%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 516 RISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
R D E+ E + E +G G G VYK +A K+ +++ D
Sbjct: 5 RRDLDPNEVWEIIGE---LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED------ 55
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDA----LHKGLVHLD 631
E+E L H IVKL F ++ E+ P G + DA L +GL
Sbjct: 56 ---YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTE-- 109
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA----KVLQ 687
P I + + L YLH IIHRD+K+ N+LL ++ K+ADFG++ K LQ
Sbjct: 110 -PQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165
Query: 688 ARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDD 742
R DS GT ++APE + K D++S G+ L+E+ +P +
Sbjct: 166 RR---DS----FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM-AQIEPPHHE 217
Query: 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+ V +K+ E K S FRD L+ A+ K P TRP+
Sbjct: 218 LNPMR-----VLLKIAKSEPPTLSQPSKWSMEFRD----FLKTAL---DKHPETRPS--- 262
Query: 803 VVQLL 807
QLL
Sbjct: 263 AAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 40/221 (18%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKK--LWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K+G+G G VYK + +G++VA+KK L S+ V ++ ++ L K L+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ--------- 57
Query: 590 RHKNIV----------KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIA 639
H NIV +LY F L +L +Y+ D+L KG ++D
Sbjct: 58 -HPNIVCLQDVLMQESRLYLIFEFLSMDL--KKYL------DSLPKG-QYMDAELVKSYL 107
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ + QG+ + H ++HRD+K N+L+D K+ADFG+A+ A G T
Sbjct: 108 YQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR---AFGIPVRVYTHE 161
Query: 700 AGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGRKPV 739
T Y APE S + +T D++S G + E+ T +KP+
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 73/248 (29%), Positives = 105/248 (42%), Gaps = 28/248 (11%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-H 591
+G+G G V L SG + AVK L + V D D + TE L R H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVL---KKDVILQDDDV----ECTMTEKRILSLARNH 55
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
+ +LYC F + V E++ G+L + K D A + L +LH
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHD 114
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
II+RD+K N+LLD K+ADFG+ K GK TT+ GT Y+APE
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGK--TTSTFCGTPDYIAPEIL 168
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD-------NKNIIY--WVSIKVDTKEG 762
D ++ GV+L E++ G P E + D N ++Y W+S
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS---QDAVD 225
Query: 763 IMEVLDKK 770
I++ K
Sbjct: 226 ILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 534 VGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+GG G V+++ ++G++ A+K L + DT K E L +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT------KAERNILEAV 57
Query: 590 RHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+H IV L F + LY L+ EY+ G L+ L + + ++ ++ ++ L
Sbjct: 58 KHPFIVDLIYAFQTGGKLY---LILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLAL 113
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
+LH II+RD+K NILLD K+ DFG+ K G + T GT Y+
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTIEYM 167
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
APE S D +S G ++ +++TG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 33/84 (39%), Positives = 49/84 (58%)
Query: 153 LSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW 212
L G IP I +L L+ + L NS+ G I + + T+L +L L NS G +P+ LGQ
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 213 SPLVVLDLSENKLSGPLPAKVCSR 236
+ L +L+L+ N LSG +PA + R
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 533 KVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G +G V + +SG++VAVKK+ D + Q + L EV + + +H
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM----------DLRKQQRRELLFNEVVIMRDYQH 76
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
+N+V++Y + +V E++ G L D + ++ + V + L+ LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHA 134
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFG----IAKVLQARGGKDSTTTVIAGTYGYLA 707
+IHRDIKS +ILL + + K++DFG ++K + R + GT ++A
Sbjct: 135 ---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-------LVGTPYWMA 184
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
PE + D++S G++++E++ G P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + +G++ A KKL +R K ++ L E + L + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-------EKQILEKVNSR 60
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNL-WDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
+V L + + LV M G+L + H G + A + GL LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
I++RD+K NILLD + +++D G+A + + T GT GY+APE
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVV 173
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVE 740
+ + T D ++ G +L E+I G+ P +
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G G VYK D N+G++VA+KK + + D+ + E+ L +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK--------TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 592 KN-IVKLYCYF--------SSLYCNLLVYEYMPNG--NLWDALHKGLVH-LDWPTRHKIA 639
IV+L SLY LV+EY+ + D+ +G L T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLY---LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 640 FGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP-KVADFGIAKVLQARGGKDSTTT 697
+ + +G+A+ H HG ++HRD+K N+L+D K+AD G+ + +
Sbjct: 117 YQLLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 698 VIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITG 735
V T Y APE S+ +T D++S G + E+
Sbjct: 173 V---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 65/254 (25%)
Query: 535 GQGGSGTVYKIDL-NSGEVVAVK----KLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
G+G G V+ + L +G++ A+K K +R KV K + TE E L +
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKV-----------KRVLTEQEILATL 58
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK------IAFGVA 643
H + LY F + LV +Y P G L+ L + K F A
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAA 110
Query: 644 Q---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK--------VLQARGGK 692
+ L YLH L I++RD+K NILL + ++DF ++K V +A
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 693 DSTTTVIA------------------GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
++V + GT Y+APE + D ++ G++L E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 735 GRKPVEDDFGDNKN 748
G P G N++
Sbjct: 228 GTTPF---KGSNRD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 49/230 (21%)
Query: 534 VGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G G VY ID + ++ AVK L ++ TD ++++ LK E + +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL----NRI----TDLEEVEQFLK-EGIIMKDF 53
Query: 590 RHKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK-----IAFG-- 641
H N++ L S L+V YM +G+L + + T + I FG
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS-------ETHNPTVKDLIGFGLQ 106
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA---------KVLQARGGK 692
VA+G+ YL +HRD+ + N +LD ++ KVADFG+A V G K
Sbjct: 107 VAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741
++A E + K TTK DV+SFGV+L EL+T G P D
Sbjct: 164 LPVK--------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V + S + V KL S+ + SD+ E + +
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSPW 104
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
+V+L+C F +V EYMP G+L + + V W F A+ + L
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVLALDAIH 159
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
+IHRD+K N+LLD + K+ADFG + G T V GT Y++PE S
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV--GTPDYISPEVLKS 217
Query: 714 SKAT----TKCDVYSFGVVLMELITGRKPVEDD 742
+CD +S GV L E++ G P D
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 79/317 (24%), Positives = 119/317 (37%), Gaps = 66/317 (20%)
Query: 529 TEKNKVGQGG----------SGTVYKIDLNSGEV-----VAVKKLWSQRTKVSASDTDQL 573
EK GQ G K + VAVK L + ASD +
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-----RPDASDNARE 64
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK------ 625
K EV+ L + NI +L C C ++ EYM NG+L L K
Sbjct: 65 DFLK----EVKILSRLSDPNIARLLGVCTVDPPLC--MIMEYMENGDLNQFLQKHVAETS 118
Query: 626 ----GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681
L + T +A +A G+ YL +HRD+ + N L+ NY K+ADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCLVGKNYTIKIADFG 175
Query: 682 IAKVLQAR-----GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-- 734
+++ L + G I ++A E K TTK DV++FGV L E++T
Sbjct: 176 MSRNLYSSDYYRVQG--RAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229
Query: 735 GRKPVE--DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSK 792
+P E D +N + D ++ + +D + + + C +
Sbjct: 230 REQPYEHLTDQQVIENAGH---FFRDDG---RQIYLPRPPNCPKD----IYELMLECWRR 279
Query: 793 SPATRPTMNEVVQLLAE 809
RPT E+ L
Sbjct: 280 DEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 66/206 (32%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 538 GSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G GT K+ L SG+ A+K L ++ + A D L TE L N RH
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKIL--KKEVIIAKDEVAHTL-----TESRVLKNTRHPF 56
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
+ L F + V EY+ G L+ L + V + TR A + L YLH G
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG- 114
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT-VIAGTYGYLAPEYAY 712
I++RD+K N++LD + K+ DFG+ K G D+ T GT YLAPE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 713 SSKATTKCDVYSFGVVLMELITGRKP 738
+ D + GVV+ E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V+K L VAVK D Q +L +E L H N
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK--------TCKEDLPQ-ELKIKFLSEARILKQYDHPN 53
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
IVKL + +V E +P G+ L K L K A A G+AYL
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--- 110
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
IHRD+ + N L+ N K++DFG+++ Q G S++ + + APE
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 714 SKATTKCDVYSFGVVLME 731
+ +++ DV+S+G++L E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 70/222 (31%), Positives = 113/222 (50%), Gaps = 34/222 (15%)
Query: 533 KVGQGGSGTVYK---IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++GQG G V + + E VA+KK+ + +K + + L+ E++ L +
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-------ILAKRALR-ELKLLRHF 58
Query: 590 R-HKNIVKLY---CYFSSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWP-TRHKIAFGVA 643
R HKNI LY F + L +YE L +A LH+ ++ P T +
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYE-----ELMEADLHQ-IIRSGQPLTDAHFQSFIY 112
Query: 644 Q---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS--TTTV 698
Q GL Y+H + ++HRD+K N+L++ + + K+ DFG+A+ G+++ T
Sbjct: 113 QILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 699 IAGTYGYLAPEYAYSSKATTKC-DVYSFGVVLMELITGRKPV 739
+A T Y APE S ++ TK DV+S G +L EL+ GRKPV
Sbjct: 170 VA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 64/224 (28%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 531 KNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G G G V +GE A+K L +R + + +K + E +
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCL-KKREILKMKQVQHVAQEKSILME------L 75
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-- 644
H IV + C F + +Y + E++ G L+ L K + VA+
Sbjct: 76 SHPFIVNMMCSFQDENRVY---FLLEFVVGGELFTHLRKA---------GRFPNDVAKFY 123
Query: 645 ------GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
YLH II+RD+K N+LLD KV DFG AK + R T
Sbjct: 124 HAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------TFT 174
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
+ GT YLAPE S D ++ GV+L E I G P DD
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
|
Length = 329 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K ++G+G G V+ + + K L + +T ASD + K E E L N++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNLQ 65
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKG------LVHLDWPTRHK------I 638
H++IVK Y ++V+EYM +G+L L + + P I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA----RGGKDS 694
A +A G+ YL +HRD+ + N L+ N K+ DFG+++ + + R G +
Sbjct: 126 AQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ ++ PE K TT+ DV+S GVVL E+ T G++P
Sbjct: 183 MLPI-----RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR- 590
++G G GTVYK D +SG VA+K + Q T++ L EV L +
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQ--------TNEDGLPLSTVREVALLKRLEA 58
Query: 591 --HKNIVKLYCYFSSLYCN-----LLVYEYMPNGNLWDALHKGLV-HLDWPTRHKIAFGV 642
H NIV+L ++ + LV+E++ + +L L K L T +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
+GL +LH + I+HRD+K NIL+ Q K+ADFG+A++ + T + T
Sbjct: 118 LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVVT 170
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV 739
Y APE S T D++S G + E+ RKP+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 52/271 (19%)
Query: 553 VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLV 610
VAVK L K +A +++ L LK + LGN H+NIV L C L++
Sbjct: 68 VAVKML-----KPTAHSSEREALMSELKI-MSHLGN--HENIVNLLGACTIGGPI--LVI 117
Query: 611 YEYMPNGNLWDALH-KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669
EY G+L + L K L ++ VA+G+A+L IHRD+ + N+LL
Sbjct: 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLL 174
Query: 670 DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY---GYLAPEYAYSSKATTKCDVYSFG 726
K+ DFG+A+ + DS V ++APE ++ T + DV+S+G
Sbjct: 175 THGKIVKICDFGLARDIM----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 230
Query: 727 VVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQ---- 781
++L E+ + G P + VD+K K + +R M Q
Sbjct: 231 ILLWEIFSLGSNPYPG-------------MPVDSK------FYKLIKEGYR--MAQPEHA 269
Query: 782 ---VLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ I C P RPT ++VQL+ +
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 36/219 (16%)
Query: 534 VGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + + E VA+KK+ + D + L+ E++ L ++ H+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAK---RTLR-EIKLLRHLDHE 64
Query: 593 NIVKL--------YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
N++ + F+ +Y +VYE M LH+ + + + + Q
Sbjct: 65 NVIAIKDIMPPPHREAFNDVY---IVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQ 116
Query: 645 ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
GL Y+H + ++HRD+K +N+LL+ N K+ DFG+A+ +G + V
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--- 170
Query: 702 TYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPV 739
T Y APE + S+ TT DV+S G + EL+ GRKP+
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 64/234 (27%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
N++ +G G VY+ D +GE+VA+KKL ++ K T L+ E+ L ++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPIT-------SLR-EINILLKLQ 62
Query: 591 HKNIV------------KLYCYFSSLYCNLLVYEYMPNGNLWDALH--KGLVHLDWPTRH 636
H NIV K+Y +V EY+ H K L+
Sbjct: 63 HPNIVTVKEVVVGSNLDKIY----------MVMEYVE--------HDLKSLM-----ETM 99
Query: 637 KIAFGVAQ----------GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686
K F ++ G+A+LH I+HRD+K++N+LL+ K+ DFG+A+
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPV 739
K T V+ T Y APE +K +T D++S G + EL+T +KP+
Sbjct: 157 G-SPLKPYTQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 34/85 (40%), Positives = 48/85 (56%)
Query: 126 NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
NQ L G IP ++ L L +++S N + G IP S+ + L VL L NS +G I +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLG 210
T+L +L+L NSL+G VP LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
+E +G H NI+ L + +++ E+M NG L L + +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR 113
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
G+A G+ YL +HRD+ + NIL++ N KV+DFG+++ L+ + T+ +
Sbjct: 114 GIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 701 GTYG--YLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741
G + APE K T+ DV+S+G+V+ E+++ G +P D
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 25/239 (10%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G V + L + + K+ + D D +Q +K + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NPF 57
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK--IAFGVAQGLAYLHH 651
+V L+ F + LV EY+ G+L + + P H A + L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE 114
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
II+RD+K N+LLD + K+ D+G+ K + G D+T+T GT Y+APE
Sbjct: 115 ---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTST-FCGTPNYIAPEIL 168
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
+ D ++ GV++ E++ GR P D DN ++ +T++ + +V+ +K
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPF-DIITDNPDM--------NTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K ++G+G G V+ + ++ K L + + AS++ + + E E L ++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR----EAELLTVLQ 65
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNL--------WDA--LHKG----LVHLDWPTRH 636
H++IV+ Y + L+V+EYM +G+L DA L G L
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR-----GG 691
IA +A G+ YL L +HRD+ + N L+ K+ DFG+++ + + GG
Sbjct: 126 AIASQIASGMVYLA-SL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ T I ++ PE K TT+ D++SFGVVL E+ T G++P
Sbjct: 183 R--TMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 35/235 (14%)
Query: 582 EVETLGNIRHKNIVKLYCYFSSLYCNL----LVYEYMPNGNLWDALHKGLVHLDWPTRHK 637
E++ L I NI+K+Y + + +L L+ EY G L + L K L + T+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLD 126
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+A +GL L+ P ++++ S + L+ NY+ K+ G+ K+L + K+
Sbjct: 127 MAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 698 VIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755
V Y + + S+ T K D+YS GVVL E+ TG+ P E+
Sbjct: 185 V------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-------------- 224
Query: 756 KVDTKEGIMEVLDKKLSGSFR---DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ TKE I +++ K + S + D +++ I CTS RP + E++ L
Sbjct: 225 -LTTKE-IYDLIINK-NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
++ +G+G G V K + + A+K R K AS D + E+E L
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIK-----RMKEYASKDDH----RDFAGELEVLC 62
Query: 588 NI-RHKNIVKLY--C-YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP---------- 633
+ H NI+ L C + LY L EY P+GNL D L K V P
Sbjct: 63 KLGHHPNIINLLGACEHRGYLY---LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 634 ---TRHKIAFG--VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688
++ + F VA+G+ YL IHRD+ + NIL+ NY K+ADFG+++
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---- 172
Query: 689 RGGKDSTTTVIAGTYG--YLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
G++ G ++A E S TT DV+S+GV+L E+++
Sbjct: 173 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 7/158 (4%)
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
TE L N RH + L F + V EY G L+ L + V + R A
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA- 102
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
+ L YLH +++RD+K N++LD + K+ DFG+ K + G +T
Sbjct: 103 EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFC 156
Query: 701 GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
GT YLAPE + D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
VG G G V D +G VA+KKL R SA K E+ L ++ H+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHA------KRTYRELRLLKHMDHE 74
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQ---G 645
N++ L F SSL VY L A L+ +V + I F V Q G
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTH---LMGADLNN-IVKCQKLSDDHIQFLVYQILRG 130
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L Y+H + IIHRD+K +NI ++ + + K+ DFG+A+ D T T Y
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH------TDDEMTGYVATRWY 181
Query: 706 LAPEYAYSSKATTK-CDVYSFGVVLMELITGR 736
APE + + D++S G ++ EL+TG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 523 EILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQ-RTKVSASDTDQLQLDKGLK 580
E+ E T +VG G G+V ID +GE VA+KKL ++++ A K
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA---------KRAY 62
Query: 581 TEVETLGNIRHKNIVKLYCYFSS------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
E+ L +++H+N++ L F+S LV YM L K + H +
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHP--LS 115
Query: 635 RHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
K+ + V Q GL Y+H + IIHRD+K N+ ++ + + K+ DFG+A+
Sbjct: 116 EDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR------H 166
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTK-CDVYSFGVVLMELITGR 736
D+ T T Y APE + + D++S G ++ E++TG+
Sbjct: 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V + E K+ ++ + + + ++ + L N++H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-----LLKNVKHPF 57
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
+V L+ F + V +Y+ G L+ L + L+ P A +A L YLH
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLHS-- 114
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
I++RD+K NILLD + DFG+ K + TT+ GT YLAPE +
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 714 SKATTKCDVYSFGVVLMELITGRKP 738
D + G VL E++ G P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 42/222 (18%)
Query: 534 VGQGGSGTVYK-IDLNSGEV----VAVKKL--WSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G G GTV+K I + G+ VA+K + S R TD + +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI-TDHML----------AM 63
Query: 587 GNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVH----LDWPTRHKI 638
G++ H IV+L C +SL LV + P G+L D + H+ + L+W +
Sbjct: 64 GSLDHAYIVRLLGICPGASLQ---LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ--- 117
Query: 639 AFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+A+G+ YL H + +HR++ + NILL + ++ADFG+A +L K +
Sbjct: 118 ---IAKGMYYLEEHRM----VHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYS 169
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
++A E + T + DV+S+GV + E+++ G +P
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 72/252 (28%), Positives = 112/252 (44%), Gaps = 38/252 (15%)
Query: 507 FPYDVKSFHRISF----DQREILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQ 561
FP K+ SF D EI+E +G+G G V+K+ + +G AVK L
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIET------IGKGTYGKVFKVLNKKNGSKAAVKIL--- 51
Query: 562 RTKVSASDTDQLQ-LDKGLKTEVETLGNIR-HKNIVKLY-CYFSSLYCN----LLVYEYM 614
D + +D+ ++ E L + H N+VK Y Y+ N LV E
Sbjct: 52 ---------DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102
Query: 615 PNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674
G++ D + L + IA+ + + L L H ++ IHRD+K NILL
Sbjct: 103 NGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG 162
Query: 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY-----AYSSKATTKCDVYSFGVVL 729
K+ DFG++ L + + +T+ GT ++APE S +CDV+S G+
Sbjct: 163 VKLVDFGVSAQLTSTRLRRNTSV---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219
Query: 730 MELITGRKPVED 741
+EL G P+ D
Sbjct: 220 IELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 523 EILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
E+ + + +VG G GTV +D +G VA+KKL+ + S+ K
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSEL----FAKRAYR 63
Query: 582 EVETLGNIRHKNIVKLYCYFS---SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI 638
E+ L +++H+N++ L F+ SL Y MP + L K L+ + + +I
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF--MGTDLGK-LMKHEKLSEDRI 120
Query: 639 AFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST 695
F V Q GL Y+H + IIHRD+K N+ ++ + + K+ DFG+A+ Q DS
Sbjct: 121 QFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QT----DSE 171
Query: 696 TTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGR 736
T T Y APE + T D++S G ++ E++TG+
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 533 KVGQGGSGTVYKI-DL-NSGEVVAVKKLWSQRTK--VSASDTDQLQLDKGLKTEVETLGN 588
++G+G G V+K DL N G VA+K++ Q + + S ++ + + L+T
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET------- 60
Query: 589 IRHKNIVKLY--CYFSSLYCNL---LVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGV 642
H N+V+L+ C S LV+E++ + +L L K + T + F +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
+GL +LH ++HRD+K NIL+ + Q K+ADFG+A++ + T + T
Sbjct: 120 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTSVVVT 172
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV 739
Y APE S T D++S G + E+ RKP+
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 50/282 (17%)
Query: 534 VGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
VG+G G + +NS + A+K++ R S+S + + E L ++H
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDS------RKEAVLLAKMKHP 58
Query: 593 NIVKLYCYFSS---LYCNLLVYEYMPNGNLWDA--LHKGLVH-----LDWPTRHKIAFGV 642
NIV F + LY +V EY G+L L +G + L W + +
Sbjct: 59 NIVAFKESFEADGHLY---IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------M 109
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
G+ ++H ++HRDIKS NI L N + K+ DFG A++L + G T GT
Sbjct: 110 CLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT---YVGT 163
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
Y+ PE + K D++S G +L EL T + P + KN+I V +G
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA--NSWKNLILKVC------QG 215
Query: 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804
+ L S R + Q+ + ++P +RP+ ++
Sbjct: 216 SYKPLPSHYSYELRSLIKQMFK-------RNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
+GL YLH + I+HRDIK N+L++ N K+ DFG+A+V + K T V+ T
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQ 168
Query: 704 GYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y APE S+ T+ D++S G + EL+ R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 534 VGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
VG+G G V + + G+ +KKL + +AS ++ K + E + L ++H
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRER----KAAEQEAQLLSQLKHP 59
Query: 593 NIVKLYCYFSSLYCNL-LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV--AQGLAYL 649
NIV + L +V + G+L+ L + L P + + V A L YL
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYL 118
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
H I+HRD+K+ N+ L KV D GIA+VL+ + D +T+I GT Y++PE
Sbjct: 119 HE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLI-GTPYYMSPE 172
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
+ K DV++ G + E+ T + + D +++Y +++
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAF--NAKDMNSLVY-------------RIIEG 217
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
KL +D ++ + SK P RP++ +++
Sbjct: 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 51/232 (21%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
VG G G VYK + +G++ A+K + V+ + ++++L+ + + H+
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTEDEEEEIKLEINMLKKYS-----HHR 73
Query: 593 NIVKLYCYF---------SSLYCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAF 640
NI Y F L+ LV E+ G++ D + + DW I
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLW---LVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICR 128
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
+ +GLA+LH +IHRDIK N+LL N + K+ DFG++ L G+ +T
Sbjct: 129 EILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 182
Query: 701 GTYGYLAPE-----------YAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
GT ++APE Y Y S D++S G+ +E+ G P+ D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRS------DIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 67/272 (24%), Positives = 105/272 (38%), Gaps = 59/272 (21%)
Query: 527 AMTEKNK-VGQGGSGTVY---KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+M K K +G G G V K+D N+ + A+K L +D +K E
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNA--LYAMKTL-------RKADVLMRNQAAHVKAE 51
Query: 583 VETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
+ L ++ +VKLY F V +Y+P G++ L + + + R IA +
Sbjct: 52 RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-EL 110
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA------------------- 683
+ +H IHRDIK NIL+D + K+ DFG+
Sbjct: 111 TCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 684 ------------------KVLQARGGKDSTTTV---IAGTYGYLAPEYAYSSKATTKCDV 722
K L+ R + + + GT Y+APE + T CD
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 723 YSFGVVLMELITGRKPVEDD--FGDNKNIIYW 752
+S GV+L E++ G+ P D +I W
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-11
Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 18/173 (10%)
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYC--NLL--VYEYMPNGNLWDALHKGLVHLDWPT 634
+ E + H NIV L S LL V+EY+P L + L L
Sbjct: 25 FRRETALCARLYHPNIVAL---LDSGEAPPGLLFAVFEYVPGRTLREVLAADGA-LPAGE 80
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGG 691
++ V LA H+ I+HRD+K NI++ V KV DFGI +L
Sbjct: 81 TGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 692 KDST----TTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
D TT + GT Y APE T D+Y++G++ +E +TG++ V+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 17/217 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G V + L E + K+ + D D +Q +K + + H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPF 57
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG--VAQGLAYLHH 651
+V L+ F + V EY+ G+L + + P H + ++ L YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE 114
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
II+RD+K N+LLD K+ D+G+ K G TT+ GT Y+APE
Sbjct: 115 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEIL 168
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748
D ++ GV++ E++ GR P D G + N
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPF-DIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 42/224 (18%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G GTVYK I + GE V + + + + +D+ L + ++ H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-----IMASMDHP 69
Query: 593 NIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHK------GLVHLDWPTRHKIAFGVAQ 644
++V+L C ++ LV + MP+G L D +H+ + L+W + +A+
Sbjct: 70 HLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAK 120
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ-------ARGGKDSTTT 697
G+ YL L +HRD+ + N+L+ K+ DFG+A++L+ A GGK
Sbjct: 121 GMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK- 176
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740
++A E + K T + DV+S+GV + EL+T G KP +
Sbjct: 177 -------WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
++G G G VYK V+A K+ +++ D E++ L + H
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---------YMVEIDILASCDHP 62
Query: 593 NIVKL---YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP-TRHKIAFGVAQ---G 645
NIVKL + Y ++L+ ++ E+ G + DA+ ++ L+ P T +I Q
Sbjct: 63 NIVKLLDAFYYENNLW---ILIEFCAGGAV-DAV---MLELERPLTEPQIRVVCKQTLEA 115
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI-AKVLQARGGKDSTTTVIAGTYG 704
L YLH + IIHRD+K+ NIL ++ K+ADFG+ AK + +DS GT
Sbjct: 116 LNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----FIGTPY 168
Query: 705 YLAPEYAYSSKATT-----KCDVYSFGVVLMELITGRKP 738
++APE + K DV+S G+ L+E+ P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G V ++L + K+ + D D +Q +K + ET N H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV---FETASN--HPF 57
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD----WPTRHK--IAFGVAQGLA 647
+V L+ F + V E++ G+L + H+ P H + ++ L
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDL-------MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG-GKDSTTTVIAGTYGYL 706
+LH II+RD+K N+LLD K+ D+G+ K G TT+ GT Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYI 163
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748
APE D ++ GV++ E++ GR P D G + N
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF-DIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 92/336 (27%), Positives = 135/336 (40%), Gaps = 33/336 (9%)
Query: 91 VTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSV 150
V S T I + P + +L L + +P L L L L S
Sbjct: 20 VLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSG 79
Query: 151 NHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLG 210
S E++L L L L L N L IS + T LT L L +N++T P
Sbjct: 80 IS-SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGL 137
Query: 211 QWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN 270
S L LDLS+NK+ LP L NL +S
Sbjct: 138 LKSNLKELDLSDNKIE-------------------------SLPSPLRNLPNLKNLDLSF 172
Query: 271 NHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY 330
N L +P+ + +L +++ +DLS N S + + L EL + N I + S +
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLS 229
Query: 331 RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390
+L ++LS+N L +P IGNL L L L +N+++S +SL SL +L LDLS
Sbjct: 230 NLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSG 286
Query: 391 NLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIK 426
N L+ +P LL + + + L L
Sbjct: 287 NSLSNALPLIALLLLLLELLLNLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 49/228 (21%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G +G V+ +D + + VAVKK+ TD + L+ E++ + + H
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI---------VLTDPQSVKHALR-EIKIIRRLDHD 62
Query: 593 NIVKLY-----------------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR 635
NIVK+Y +S+Y +V EYM +L + L +G +
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVY---IVQEYM-ETDLANVLEQGPL----SEE 114
Query: 636 HK--IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGIAKVLQ---AR 689
H + + +GL Y+H + ++HRD+K N+ ++ + K+ DFG+A+++ +
Sbjct: 115 HARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKC-DVYSFGVVLMELITGR 736
G S V T Y +P S TK D+++ G + E++TG+
Sbjct: 172 KGYLSEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 19/153 (12%)
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK------IAFGVAQGLA 647
+ +L+ F ++ V EY+ G+L + H+ + K A +A GL
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL-------MYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+LH II+RD+K N++LD K+ADFG+ K GGK TT GT Y+A
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGK--TTRTFCGTPDYIA 169
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
PE D ++FGV+L E++ G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 67/234 (28%), Positives = 100/234 (42%), Gaps = 52/234 (22%)
Query: 534 VGQGGSGTVYK------IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G G G VY+ + SG + VAVK L + A+D ++ + K E +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-----RKGATDQEKKEFLK----EAHLM 53
Query: 587 GNIRHKNIVKLY--CYFS-SLYCNLLVYEYMPNGNLWDALHKGLVH------LDWPTRHK 637
N H NIVKL C + Y ++ E M G+L L V L
Sbjct: 54 SNFNHPNIVKLLGVCLLNEPQY---IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP-----KVADFGIAKVL------ 686
I VA+G YL IHRD+ + N L+ K+ DFG+A+ +
Sbjct: 111 ICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
Query: 687 QARG-GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ G G ++APE K TT+ DV+SFGV++ E++T G++P
Sbjct: 168 RKEGEGLLPVR--------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 35/234 (14%)
Query: 582 EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG 641
E + + + H +V+LY + +V E+M NG L + L + L +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK-VLQARGGKDSTTTVIA 700
V +G+ YL + IHRD+ + N L+ KV+DFG+ + VL D T+
Sbjct: 109 VCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-----DEYTSSSG 160
Query: 701 GTY--GYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKV 757
+ + PE SK ++K DV+SFGV++ E+ T G+ P E
Sbjct: 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE----------------- 203
Query: 758 DTKEGIMEVLDKKLSGS--FRDEM--IQVLRIAIRCTSKSPATRPTMNEVVQLL 807
K+ EV++ G +R ++ + V + C + P RPT E+++ +
Sbjct: 204 --KKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTK--VSASDTDQLQLDKGLKTEVETLGNI 589
K+G+G TVYK I +G++VA+K + S +T+ V + + L KGLK
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLK--------- 61
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKI-AFGVAQGLA 647
H NIV L+ + V+EYM + H G +H P ++ F + +GLA
Sbjct: 62 -HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH---PYNVRLFMFQLLRGLA 117
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
Y+H I+HRD+K N+L+ + K+ADFG+A+ A+ T + T Y
Sbjct: 118 YIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRP 171
Query: 708 PEYAY-SSKATTKCDVYSFGVVLMELITGR 736
P+ ++ ++ D++ G + +E++ G+
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 82/318 (25%), Positives = 139/318 (43%), Gaps = 68/318 (21%)
Query: 522 REILEAMTEKNKV-GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
R + E +K KV G G GTVYK + + GE V + + + ++ ++ LD
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD--- 58
Query: 580 KTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HK---GLVHL-D 631
E + ++ + ++ +L C S++ L+ + MP G L D + HK G +L +
Sbjct: 59 --EAYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLN 113
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL----- 686
W + +A+G+ YL L +HRD+ + N+L+ K+ DFG+AK+L
Sbjct: 114 WCVQ------IAKGMNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164
Query: 687 --QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743
A GGK ++A E T + DV+S+GV + EL+T G KP +
Sbjct: 165 EYHAEGGKVPIK--------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-- 214
Query: 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDE----MIQVLRIAIRCTSKSPATRPT 799
+ E I +L+K G + I V I ++C +RP
Sbjct: 215 -------------IPASE-ISSILEK---GERLPQPPICTIDVYMIMVKCWMIDADSRPK 257
Query: 800 MNEVVQLLAEA--DPCRF 815
E++ ++ DP R+
Sbjct: 258 FRELIIEFSKMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 532 NKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+GQG G V+K + ++VA+KK+ + K T L+ E++ L ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT-------ALR-EIKILQLLK 69
Query: 591 HKNIVKLY--CYFSSLYCN------LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
H+N+V L C + N LV+E+ + +L L V K+ +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL-QARGGKDSTTTVIAG 701
GL Y+H + I+HRD+K+ NIL+ + K+ADFG+A+ ++ K + T
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 702 TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPV 739
T Y PE + D++ G ++ E+ T R P+
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 50/154 (32%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
L N++H +V L+ F + V +Y+ G L+ L + L+ P A VA
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASA 108
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK-DSTTTVIAGTYG 704
+ YLH II+RD+K NILLD + DFG+ K G + + TT+ GT
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPE 161
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
YLAPE D + G VL E++ G P
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 526 EAMTEKNKVGQGGSGTVYK--IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV 583
E + ++ +G+G G V + I + ++ A K+ K AS+ D + E+
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKM----LKEFASENDH----RDFAGEL 53
Query: 584 ETLGNI-RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT---RH--- 636
E L + H NI+ L + + EY P GNL D L K V P H
Sbjct: 54 EVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 637 ---------KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687
+ A VA G+ YL IHRD+ + N+L+ N K+ADFG+++
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR--- 167
Query: 688 ARGGKDSTTTVIAGTYG--YLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
G++ G ++A E S TTK DV+SFGV+L E+++
Sbjct: 168 ---GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKL--WSQRTKVSASDTDQLQLDKGLKTE--VETLGN 588
VG+G G V K + E+VA+KK + +V + +L++ + LK E VE
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 589 IRHKNIVKLYCYFSSLYCNLL-VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
R + KLY F + N+L + E MPNG + K+ + Q +
Sbjct: 69 FRRRG--KLYLVFEYVEKNMLELLEEMPNGVPPE---------------KVRSYIYQLIK 111
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+H + I+HRDIK N+L+ N K+ DFG A+ L G ++ T T Y +
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE--GSNANYTEYVATRWYRS 169
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGR 736
PE + D++S G +L EL G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 78/305 (25%), Positives = 125/305 (40%), Gaps = 58/305 (19%)
Query: 526 EAMTEKNKVGQGGSGTVYK-----IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGL 579
+++T +G G G VY+ D ++ E+ VAVK L S S+ D+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-----SCSEQDESDFLM-- 58
Query: 580 KTEVETLGNIRHKNIVKL--YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH- 636
E + H+NIV+L + ++ E M G+L L + + P+
Sbjct: 59 --EALIMSKFNHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLT 114
Query: 637 -----KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NYQPKVADFGIAKVLQA 688
A VA+G YL + IHRDI + N LL K+ADFG+A+ +
Sbjct: 115 MKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 689 -----RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDD 742
+GG+ I ++ PE T+K DV+SFGV+L E+ + G P
Sbjct: 172 ASYYRKGGR--AMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
Query: 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
N+ ++ +V T G ++ K G V RI C +P RP
Sbjct: 226 --TNQEVMEFV-----TGGGRLDP-PKGCPGP-------VYRIMTDCWQHTPEDRPNFAT 270
Query: 803 VVQLL 807
+++ +
Sbjct: 271 ILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 15/210 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V ++ + + K + VS S+ E L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTL------AERTVLAQVNCPF 54
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLAYLHHG 652
IV L F S LV ++ G L+ L + G L +R + F A+ L L +
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRAR--FYTAELLCALENL 109
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
+I+RD+K NILLD + DFG+ K+ D T GT YLAPE
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK---DDDKTNTFCGTPEYLAPELLL 166
Query: 713 SSKATTKCDVYSFGVVLMELITGRKPVEDD 742
T D ++ GV+L E++TG P D+
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-10
Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLV-HLDWPTRHKI 638
++E+ L H IVK + F S LL+ EY G+L + + L HL + +++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEV 171
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
Q + L ++HRD+KS NI L K+ DFG +K D ++
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS- 230
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758
GT YLAPE + + K D++S GV+L EL+T +P + G ++
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---GPSQR---------- 277
Query: 759 TKEGIMEVLDKKLSGSF-------RDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
E++ + L G + M +L + SK+PA RPT +++
Sbjct: 278 ------EIMQQVLYGKYDPFPCPVSSGMKALLDPLL---SKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 11/216 (5%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G G G V+ + SG KL++ + A+ + + + +TE + L +IR
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSG--KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 594 -IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
+V L+ F + L+ +Y+ G L+ L + ++ + + L H
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQIYSGEIVLALEHL 121
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
II+RDIK NILLD N + DFG++K + + + GT Y+AP+
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYMAPDIVR 179
Query: 713 SSKA--TTKCDVYSFGVVLMELITGRKPVEDDFGDN 746
D +S GV++ EL+TG P D N
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 55/277 (19%)
Query: 553 VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLVY 611
VAVK L S T+ SD L +E+E + I +HKNI+ L + ++
Sbjct: 53 VAVKMLKSDATEKDLSD---------LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 103
Query: 612 EYMPNGNLWDALH----KGLVHLDWPTRHKI-----------AFGVAQGLAYLHHGLLSP 656
EY GNL + L G+ + PT+ A+ VA+G+ YL
Sbjct: 104 EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KK 160
Query: 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA 716
IHRD+ + N+L+ + K+ADFG+A+ + TT ++APE +
Sbjct: 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIY 219
Query: 717 TTKCDVYSFGVVLMELIT--GRK----PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
T + DV+SFGV+L E+ T G PVE+ F K+ KEG +DK
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF------------KL-LKEG--HRMDKP 264
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ + +E+ ++R C P+ RPT ++V+ L
Sbjct: 265 SNCT--NELYMMMR---DCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 84/314 (26%), Positives = 134/314 (42%), Gaps = 72/314 (22%)
Query: 529 TEKNKV---GQGGSGTVYK-IDLNSGEVVAVK---KLWSQRTKVSASDTDQLQLDKGLKT 581
TE KV G G GTVYK I + GE V + K+ + T A +K +
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA--------NKEILD 58
Query: 582 EVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVH----LDWP 633
E + + + +L C S++ LV + MP G L D + +K + L+W
Sbjct: 59 EAYVMAGVGSPYVCRLLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115
Query: 634 TRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL------- 686
+ +A+G++YL L +HRD+ + N+L+ K+ DFG+A++L
Sbjct: 116 VQ------IAKGMSYLEEVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745
A GGK ++A E + T + DV+S+GV + EL+T G KP +
Sbjct: 167 HADGGKVPIK--------WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG---- 214
Query: 746 NKNIIYWVSIKVDTKEGIMEVLDK--KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
+ +E I ++L+K +L I V I ++C RP E+
Sbjct: 215 -----------IPARE-IPDLLEKGERLPQP-PICTIDVYMIMVKCWMIDSECRPRFREL 261
Query: 804 VQLLAEA--DPCRF 815
V + DP RF
Sbjct: 262 VDEFSRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 68/252 (26%), Positives = 104/252 (41%), Gaps = 69/252 (27%)
Query: 534 VGQGGSGTV---YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG----LKTEVETL 586
+G+G G V K D +G + A+KKL S+ L+K ++ E + L
Sbjct: 9 IGRGAFGEVRLVQKKD--TGHIYAMKKL-------RKSE----MLEKEQVAHVRAERDIL 55
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+ +VKLY F + LY L+ EY+P G++ L K D T + F +A
Sbjct: 56 AEADNPWVVKLYYSFQDENYLY---LIMEYLPGGDMMTLLMK----KDTFTEEETRFYIA 108
Query: 644 QGLAYLH--HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG----------- 690
+ + + H L IHRDIK N+LLD K++DFG+ L+
Sbjct: 109 ETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 691 --------------GKDSTTT------VIA----GTYGYLAPEYAYSSKATTKCDVYSFG 726
K T +A GT Y+APE + +CD +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 727 VVLMELITGRKP 738
V++ E++ G P
Sbjct: 227 VIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 9/159 (5%)
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
TE L N RH + L F + V EY G L+ L + V + R A
Sbjct: 44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA- 102
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD-STTTVI 699
+ L YLH +++RDIK N++LD + K+ DFG+ K G D +T
Sbjct: 103 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 155
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
GT YLAPE + D + GVV+ E++ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
VG G G VYK + +G++ A+K + V+ + +++ K E+ L H
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTGDEEEEI------KQEINMLKKYSHH 62
Query: 592 KNIVKLYCYF---------SSLYCNLLVYEYMPNGNLWDALH--KG-LVHLDWPTRHKIA 639
+NI Y F L+ LV E+ G++ D + KG + +W I
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLW---LVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 117
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ +GL++LH +IHRDIK N+LL N + K+ DFG++ L G+ +T
Sbjct: 118 REILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---F 171
Query: 700 AGTYGYLAPEYAYSSK---ATT--KCDVYSFGVVLMELITGRKPVED 741
GT ++APE + AT K D++S G+ +E+ G P+ D
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 51/159 (32%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
TE L N RH + L F + V EY G L+ L + V + R A
Sbjct: 44 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA- 102
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD-STTTVI 699
+ L YLH +++RD+K N++LD + K+ DFG+ K G KD +T
Sbjct: 103 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTF 156
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
GT YLAPE + D + GVV+ E++ GR P
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 12/176 (6%)
Query: 571 DQLQLDKGLK----TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKG 626
D + L G K E L N+ H +++++ S +V + + +L+ L K
Sbjct: 92 DPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR 150
Query: 627 LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686
L I + +GL YLH IIHRD+K+ NI ++ Q + D G A+
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
+AGT APE K +K D++S G+VL E++ + +D
Sbjct: 208 VV----APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259
|
Length = 357 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 526 EAMTEKNKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
E +T +G+G G VY+ + + ++ VAVK K S + + +K L+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-----CKNCTSPSVR---EKFLQ- 56
Query: 582 EVETLGNIRHKNIVKL--YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIA 639
E + H +IVKL + ++ +V E P G L L LD + +
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENPVW---IVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ ++ LAYL +HRDI + N+L+ K+ DFG+++ L+ ++ +
Sbjct: 114 YQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL 170
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLME-LITGRKPVEDDFG-DNKNII 750
++APE + T+ DV+ FGV + E L+ G KP G N ++I
Sbjct: 171 P--IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF---QGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G VY ++G++ A+K L +R K+ +T L L++ + + + G+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIMLSLVSTGDCPF- 58
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
IV + F + + + M G+L L + V + R A + GL ++H+
Sbjct: 59 -IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNR 116
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY-- 710
+++RD+K NILLD + +++D G+A + S GT+GY+APE
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQ 168
Query: 711 ---AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760
AY S A D +S G +L +L+ G P +K+ I +++ V+ +
Sbjct: 169 KGTAYDSSA----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 74/272 (27%), Positives = 118/272 (43%), Gaps = 40/272 (14%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + +G++ A KKL +R K + L E + L + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-------EKQILEKVNSR 60
Query: 593 NIVKL-YCYFSS-LYCNLLVYEYMPNGNLWDALHKGLVHLDWP--TRHKIAFGVAQ---G 645
+V L Y Y + C LV M G+L H + ++ P + F A+ G
Sbjct: 61 FVVSLAYAYETKDALC--LVLTLMNGGDL--KFH--IYNMGNPGFDEERAVFYAAEITCG 114
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L LH I++RD+K NILLD +++D G+A ++ G+ V GT GY
Sbjct: 115 LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV--GTVGY 167
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
+APE + + T D + G ++ E+I G+ P F K + ++ KE E
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKREEVERRVKE-DQE 222
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR 797
+K S + R Q+L +K P R
Sbjct: 223 EYSEKFSEAARSICRQLL-------TKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 51/296 (17%)
Query: 534 VGQGGSGTVYKIDLNSGEV----VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G G+V + L+ + VAVK + K+ +++ +E + +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTM-----KLDIHTYSEIE---EFLSEAACMKDF 58
Query: 590 RHKNIVKLY--CYFSS----LYCNLLVYEYMPNGNL-----WDALHKGLVHLDWPTRHKI 638
H N++KL C+ +S + +++ +M +G+L + L L T K
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA----RGGKDS 694
+A G+ YL + IHRD+ + N +L + VADFG++K + + R G+ +
Sbjct: 119 MVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWV 753
V ++A E T+K DV++FGV + E+ T G+ P G + IY
Sbjct: 176 KMPV-----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP---GVENHEIYDY 227
Query: 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ + + LD+ + + C P RPT ++ ++L
Sbjct: 228 LRHGNRLKQPEDCLDE------------LYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK------IAFGVAQGLA 647
+ +L+ F ++ V EY+ G+L + + R K A +A GL
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL-------MYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+LH II+RD+K N++LD K+ADFG+ K G TT GT Y+A
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIA 169
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
PE D ++FGV+L E++ G+ P E + D
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 46/123 (37%), Positives = 62/123 (50%), Gaps = 4/123 (3%)
Query: 304 TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNL-KKLNLL 362
T N+ + + + ISG I S I+R + I+LS+N LSGPIP I L L
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 363 MLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNNRLSGPIP 421
L +N SIP S+ +L LDLSNN+L+G IP + ++ N L G IP
Sbjct: 124 NLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 422 LSL 424
SL
Sbjct: 182 NSL 184
|
Length = 968 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-10
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 42/235 (17%)
Query: 533 KVGQGGSGTVY-KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G+GG G VY D VA+KK+ R +S + L K E + ++ H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI---REDLS----ENPLLKKRFLREAKIAADLIH 61
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMP--NG--------NLW--DALHKGL-VHLDWPTRHKI 638
IV +Y S VY MP G ++W ++L K L I
Sbjct: 62 PGIVPVYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA---------- 688
+ + Y+H ++HRD+K NILL + + + D+G A +
Sbjct: 119 FHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 689 --RGGKDSTTTV---IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
R S+ T+ I GT Y+APE A+ D+Y+ GV+L +++T P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 17/213 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V + S V KL S+ + SD+ E + +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSPW 104
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
+V+L+ F +V EYMP G+L + + V W + V L +H
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE--VVLALDAIHS-- 160
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
IHRD+K N+LLD + K+ADFG + G T V GT Y++PE S
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPDYISPEVLKS 217
Query: 714 SKAT----TKCDVYSFGVVLMELITGRKPVEDD 742
+CD +S GV L E++ G P D
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 36/223 (16%)
Query: 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT-- 581
LE + +K+G+G TVYK + +VA+K++ +L+ ++G
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-------------RLEHEEGAPCTA 51
Query: 582 --EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK--GLVHLDWPTRHK 637
EV L +++H NIV L+ + LV+EY+ + +L L +++ H
Sbjct: 52 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM-----HN 105
Query: 638 IA---FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
+ F + +GL Y H ++HRD+K N+L++ + K+ADFG+A+ A+
Sbjct: 106 VKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTK 159
Query: 695 TTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR 736
T + T Y P+ S+ +T+ D++ G + E+ TGR
Sbjct: 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 62/285 (21%)
Query: 552 VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611
+VAVK L + TK + +D E++ + +++ NI++L S ++
Sbjct: 46 LVAVKMLRADVTKTARND---------FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMIT 96
Query: 612 EYMPNGNLWDALHKGLVHLDWPTRHKI-----------AFGVAQGLAYLHHGLLSPIIHR 660
EYM NG+L L + + + + I A +A G+ YL +HR
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHR 153
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG----TYGYLAPEYAYSSKA 716
D+ + N L+ +Y K+ADFG+++ L + I G ++A E K
Sbjct: 154 DLATRNCLVGNHYTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMAWESILLGKF 208
Query: 717 TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR 776
TT DV++FGV L E+ T K E + + + E ++E FR
Sbjct: 209 TTASDVWAFGVTLWEMFTLCK--EQPY------------SLLSDEQVIE----NTGEFFR 250
Query: 777 DEMIQ------------VLRIAIRCTSKSPATRPTMNEVVQLLAE 809
++ Q V ++ +RC S+ RPT N++ L E
Sbjct: 251 NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 534 VGQGGSGTVY---KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+GG G VY K D +G++ A+K L +R K+ +T L L++ + + + G+
Sbjct: 2 IGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGET--LALNERIMLSLVSTGDCP 57
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
IV + F + + + M G+L H L + ++ F A+ + L
Sbjct: 58 F--IVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
H +++RD+K NILLD + +++D G+A + S GT+GY+APE
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEV 166
Query: 711 -----AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
AY S A D +S G +L +L+ G P +K+ I + +
Sbjct: 167 LQKGVAYDSSA----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------DRMTL 212
Query: 766 VLDKKLSGSFRDEMIQVLR 784
+ +L SF E+ +L
Sbjct: 213 TMAVELPDSFSPELRSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 524 ILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+L+ + +G G G V D G VAVKKL S +Q + + E
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-------SRPFQNQTHAKRAYR-E 70
Query: 583 VETLGNIRHKNIVKLYCYFS---------SLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
+ L + HKNI+ L F+ +Y LV E M + NL +H L H
Sbjct: 71 LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY---LVMELM-DANLCQVIHMELDH---- 122
Query: 634 TRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD 693
++++ + Q L + H + IIHRD+K +NI++ + K+ DFG+A+ +
Sbjct: 123 --ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----ACTN 176
Query: 694 STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITG 735
T T Y APE D++S G ++ EL+ G
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 533 KVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK----TEVETLG 587
K+G+G TVYK +G++VA+K + +LQ ++G E L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI-------------RLQEEEGTPFTAIREASLLK 58
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIAFGVAQG 645
++H NIV L+ + LV+EY+ + +L + H G +H + F + +G
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE--NVKLFLFQLLRG 115
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L+Y+H I+HRD+K N+L+ + K+ADFG+A+ S V T Y
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWY 169
Query: 706 LAPEYAYSSKATTKC-DVYSFGVVLMELITG 735
P+ S + C D++ G + +E+I G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 534 VGQGGSGTVYKIDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI- 589
+G+G G V K + + A+K++ K AS D + E+E L +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDH----RDFAGELEVLCKLG 53
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP-------------TRH 636
H NI+ L L EY P+GNL D L K V P ++
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 637 KIAFG--VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
+ F VA+G+ YL IHRD+ + NIL+ NY K+ADFG+++ G++
Sbjct: 114 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------GQEV 164
Query: 695 TTTVIAGTYG--YLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
G ++A E S TT DV+S+GV+L E+++
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 42/226 (18%)
Query: 525 LEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK--- 580
LE + +K+G+G TVYK +G++VA+K++ +L+ ++G
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------------RLEHEEGAPFTA 50
Query: 581 -TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDW------ 632
E L +++H NIV L+ + LV+EY+ L ++D
Sbjct: 51 IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLS 101
Query: 633 PTRHKI-AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
++ F + +GLAY H ++HRD+K N+L+ + K+ADFG+A+
Sbjct: 102 MHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158
Query: 692 KDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR 736
S V T Y P+ S++ +T D++ G + E+ TGR
Sbjct: 159 TYSNEVV---TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 30/77 (38%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
+ I +L L+ + L+ ++ G IP S+G++TSL L+L+ N G IP +G L +LR L
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495
Query: 122 ELYYNQQLAGTIPEELG 138
L N L+G +P LG
Sbjct: 496 NLNGN-SLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 48/224 (21%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
N +G G G VY+ I +++ E VA+KK+ LQ + E+ + N+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV--------------LQDPQYKNRELLIMKNLN 117
Query: 591 HKNIVKLYCYF---------SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI--- 638
H NI+ L Y+ +++ N+ V E++P +HK + H H +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNV-VMEFIPQ-----TVHKYMKHYA-RNNHALPLF 170
Query: 639 -----AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGK 692
++ + + LAY+H I HRD+K N+L+D N + K+ DFG AK L G+
Sbjct: 171 LVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--AGQ 225
Query: 693 DSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITG 735
S + + + Y APE ++ TT D++S G ++ E+I G
Sbjct: 226 RSVSYICSRFY--RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 68/296 (22%), Positives = 125/296 (42%), Gaps = 57/296 (19%)
Query: 535 GQGGSGTVYKIDLNSG-EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+ T +++ +G VAVK L K +AS ++ + L +E L + H +
Sbjct: 14 GKVVKATAFRLKGRAGYTTVAVKML-----KENASSSEL----RDLLSEFNLLKQVNHPH 64
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDAL---------------HKGLVHLDWPTRHKI 638
++KLY S LL+ EY G+L L ++ +LD P +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 639 AFG--------VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
G +++G+ YL L +HRD+ + N+L+ + K++DFG+++ +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKISDFGLSRDVYE-- 179
Query: 691 GKDSTTTVIAG--TYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNK 747
+DS G ++A E + TT+ DV+SFGV+L E++T G P +
Sbjct: 180 -EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
+ +++ E E ++ + + C + P RPT ++
Sbjct: 239 FNLLKTGYRMERPENCSE---------------EMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 25/195 (12%)
Query: 553 VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612
VA+ L + SD + G E TLG H NIV+L + ++V E
Sbjct: 36 VAIHTL-----RAGCSDKQRR----GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86
Query: 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672
YM NG L L K L + G+A G+ YL +H+ + + +L++ +
Sbjct: 87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSD 143
Query: 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYG-----YLAPEYAYSSKATTKCDVYSFGV 727
K++ F R +D + + G + APE ++ DV+SFG+
Sbjct: 144 LVCKISGFR-------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGI 196
Query: 728 VLMELIT-GRKPVED 741
V+ E+++ G +P D
Sbjct: 197 VMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 50/156 (32%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 586 LGNIRHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
L N++H +V L+ F + LY V +Y+ G L+ L + + R A +
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLY---FVLDYVNGGELFFHLQRERSFPEPRARFYAA-EI 105
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
A L YLH II+RD+K NILLD + DFG+ K TT+ GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH---SKTTSTFCGT 159
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
YLAPE D + G VL E++ G P
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 16/210 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V + + E + K+ ++ + ++T + E L N +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET------ACFREERNVLVNGDCQW 62
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
I L+ F LV +Y G+L L K D F +A+ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
+HRDIK N+LLD+N ++ADFG + G S+ V GT Y++PE +
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV--GTPDYISPEILQA 177
Query: 714 -----SKATTKCDVYSFGVVLMELITGRKP 738
K +CD +S GV + E++ G P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 7/147 (4%)
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
+ +L+ F ++ V EY+ G+L + + + P A ++ GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHR-- 119
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
II+RD+K N++LD K+ADFG+ K G TT GT Y+APE
Sbjct: 120 -RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAY 175
Query: 714 SKATTKCDVYSFGVVLMELITGRKPVE 740
D +++GV+L E++ G+ P +
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 25/79 (31%), Positives = 49/79 (62%)
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
G +P+ +++ ++L +S N + G+IP + S+ + ++DLSYNSF+G I ++G +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 311 LSELFMQRNQISGFIPSEI 329
L L + N +SG +P+ +
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
L N++H +V L+ F + V +++ G L+ L + + R A +A
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASA 108
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK--VLQARGGKDSTTTVIAGTY 703
L YLH I++RD+K NILLD + DFG+ K + Q+ TTT GT
Sbjct: 109 LGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-----DTTTTFCGTP 160
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
YLAPE D + G VL E++ G P
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 39/221 (17%)
Query: 533 KVGQGGSGTVYK--IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G G G V K + ++ VA+K L ++ K S D++ E E + +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK---SVRDEMM------REAEIMHQL 52
Query: 590 RHKNIVKL--YCYFSSLYCNLLVYEYMPNGNLWDALHKGLV-HLDWPTRHKIA---FGVA 643
+ IV++ C +L +LV E G L+K L D T + V+
Sbjct: 53 DNPYIVRMIGVCEAEAL---MLVMEMASGG----PLNKFLSGKKDEITVSNVVELMHQVS 105
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
G+ YL +HRD+ + N+LL + K++DFG++K L G DS A +
Sbjct: 106 MGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKAL---GADDSYYK--ARSA 157
Query: 704 G-----YLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
G + APE K +++ DV+S+G+ + E + G+KP
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 70/269 (26%), Positives = 114/269 (42%), Gaps = 34/269 (12%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + +G++ A KKL +R K + L E L + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-------EKRILEKVNSR 60
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNL-WDALHKGLVHLDWPTRHKIAFGVAQ---GLAY 648
+V L + + LV M G+L + + G D + F A+ GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLED 117
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
L I++RD+K NILLD +++D G+A +Q G+ V GT GY+AP
Sbjct: 118 LQR---ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV--GTVGYMAP 170
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768
E + K T D + G ++ E+I G+ P F K + + KE E +
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKERVKREEVDRRVKEDQEEYSE 226
Query: 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATR 797
K F ++ + R+ + +K+P R
Sbjct: 227 K-----FSEDAKSICRMLL---TKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 49/239 (20%)
Query: 525 LEAMTEKNKVGQGGSGTVYKIDLNSGE-VVAVKKLWSQRTKVSASDTDQLQLDKGLKT-- 581
+E + K+G+G TV+K E +VA+K++ +L+ ++G
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEI-------------RLEHEEGAPCTA 51
Query: 582 --EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPN---------GNLWDALHKGLVHL 630
EV L +++H NIV L+ + LV+EY+ GN+ ++H + L
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIM-SMHNVKIFL 110
Query: 631 DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
+ + +GLAY H ++HRD+K N+L++ + K+ADFG+A+ A+
Sbjct: 111 ---------YQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR---AKS 155
Query: 691 GKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR-----KPVEDDF 743
T + T Y P+ SS+ +T+ D++ G + E+ +GR VED+
Sbjct: 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 1/121 (0%)
Query: 170 LQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPL 229
L L N L G I + I+ L ++L NS+ G +P LG + L VLDLS N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSL-ARCKNLLRFRVSNNHLEGSIPEGILSLPHVS 288
P + L+ + N SG +P +L R + F ++N IP PH+S
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 289 I 289
+
Sbjct: 543 V 543
|
Length = 623 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G+G G V + L + + V K+ ++ + ++T + E + L N ++
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET------ACFREERDVLVNGDNQW 62
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL 653
I L+ F LV +Y G+L L K D F +A+ + +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS 713
+HRDIK NIL+D+N ++ADFG L G S+ V GT Y++PE +
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPEILQA 177
Query: 714 -----SKATTKCDVYSFGVVLMELITGRKP 738
K +CD +S GV + E++ G P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 27/176 (15%)
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
+F VA+G+ +L IHRD+ + NILL N K+ DFG+A+ + KD V
Sbjct: 180 SFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY----KDP-DYV 231
Query: 699 IAGT----YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWV 753
G+ ++APE + TT+ DV+SFGV+L E+ + G P +
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-------------YP 278
Query: 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
++++ +E + D + + ++ RI + C P RPT + +V++L +
Sbjct: 279 GVQIN-EEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 580 KTEVETLGNIRHKN-IVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR 635
+TE + L +R +V L+ F + L+ L+ +Y+ G L+ L+ + T
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLH---LILDYVNGGELFTHLY----QREHFTE 104
Query: 636 HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST 695
++ +A+ + L H II+RDIK NILLD + DFG++K A ++
Sbjct: 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA--EEEER 162
Query: 696 TTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746
GT Y+APE KA D +S GV+ EL+TG P D N
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAV---DWWSLGVLTFELLTGASPFTVDGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+GG G V + +G++ A K+L +R K ++ L E + L + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-------EKQILEKVNSQ 60
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP--TRHKIAFGVAQGLAYLH 650
+V L + + LV M G+L H + ++ P + F A+ L L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDL--KFH--IYNMGNPGFEEERALFYAAEILCGLE 116
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
++RD+K NILLD +++D G+A ++ G+ V GT GY+APE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV--GTVGYMAPEV 172
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKP 738
+ + T D + G ++ E+I G+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 534 VGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G G V D +G+ VA+KKL V+ + K E+ + + HK
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHA--------KRAYRELVLMKLVNHK 75
Query: 593 NIVKL---------YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
NI+ L F +Y LV E M + NL + L H ++++ +
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVY---LVMELM-DANLCQVIQMDLDH------ERMSYLLY 125
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
Q L + H + IIHRD+K +NI++ + K+ DFG+A+ G T T
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTR 181
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
Y APE D++S G ++ E+I G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 76/280 (27%), Positives = 117/280 (41%), Gaps = 55/280 (19%)
Query: 548 NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYC 606
N VAVK L T SD L +E+E + I +HKNI+ L +
Sbjct: 42 NKPVTVAVKMLKDDATDKDLSD---------LVSEMEMMKMIGKHKNIINLLGACTQDGP 92
Query: 607 NLLVYEYMPNGNL---------------WDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
++ EY GNL +D L + A+ VA+G+ YL
Sbjct: 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
IHRD+ + N+L+ + K+ADFG+A+ + TT ++APE
Sbjct: 153 ---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEAL 208
Query: 712 YSSKATTKCDVYSFGVVLMELITGRK------PVEDDFGDNKNIIYWVSIKVDTKEGIME 765
+ T + DV+SFGV+L E+ T PVE+ F K+ KEG
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF------------KL-LKEG--H 253
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+DK + + E+ ++R C P+ RPT ++V+
Sbjct: 254 RMDKPANCT--HELYMIMR---ECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 533 KVGQGGSGTV----YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
++G G GTV YK+ S + VAVK L +D + L L E +
Sbjct: 2 ELGSGNFGTVKKGMYKM-KKSEKTVAVKIL--------KNDNNDPALKDELLREANVMQQ 52
Query: 589 IRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ + IV++ C S +LV E G L L K H+ ++ V+ G+
Sbjct: 53 LDNPYIVRMIGICEAESW---MLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGM 108
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YL + +HRD+ + N+LL + K++DFG++K L A T +
Sbjct: 109 KYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY 165
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
APE K ++K DV+SFGV++ E + G+KP
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 31/85 (36%), Positives = 47/85 (55%)
Query: 270 NNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
N L G IP I L H+ I+LS NS G I ++G+ +L L + N +G IP +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 330 YRAISLVKIDLSDNLLSGPIPSGIG 354
+ SL ++L+ N LSG +P+ +G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 57/237 (24%), Positives = 105/237 (44%), Gaps = 41/237 (17%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
+ +T + + +G G ++ L + ++++ + K AS ++Q+ L E
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTL-LLQESCL 61
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLV-YEYMPNGNLWDALHKG-LVHLDWP----TRHKIA 639
L + H+NI+ + V Y YM GNL L + L + P T+ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 640 FG--VAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL---------- 686
+A G++YLH G +IH+DI + N ++D Q K+ D +++ L
Sbjct: 122 MAIQIACGMSYLHKRG----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 687 -QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741
+ R K ++A E + + ++ DV+SFGV+L EL+T G+ P +
Sbjct: 178 NENRPVK------------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 658 IHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS---- 713
+HRDIK N+LLD N ++ADFG L A G S V GT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--GTPDYISPEILQAMEDG 181
Query: 714 -SKATTKCDVYSFGVVLMELITGRKP 738
+ +CD +S GV + E++ G P
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 71/306 (23%), Positives = 135/306 (44%), Gaps = 56/306 (18%)
Query: 526 EAMTEKNKVGQGGSGTVYKIDLNSGEV-------VAVKKLWSQRTKVSASDTDQLQLDKG 578
E +T ++GQG G VY+ + G V VA+K + +AS ++++
Sbjct: 6 EKITMSRELGQGSFGMVYE-GIAKGVVKDEPETRVAIKTV-----NEAASMRERIEF--- 56
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH------KGLVHLDW 632
E + ++V+L S L++ E M G+L L +
Sbjct: 57 -LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 633 PTRHKI---AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA- 688
P+ K+ A +A G+AYL+ + +HRD+ + N ++ ++ K+ DFG+ + +
Sbjct: 116 PSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 689 ----RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743
+GGK +++PE TT DV+SFGVVL E+ T +P +
Sbjct: 173 DYYRKGGKGLLPV------RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-- 224
Query: 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
N+ ++ +V + G+++ D + D + +++R+ C +P RP+ E+
Sbjct: 225 MSNEQVLRFV-----MEGGLLDKPD-----NCPDMLFELMRM---CWQYNPKMRPSFLEI 271
Query: 804 VQLLAE 809
+ + E
Sbjct: 272 ISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 534 VGQGGSGT---VYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQ-LQLDKGLKTEVETLGN 588
+G+ G GT V K +G+ A+K + K +Q L E++ L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCM-----KKHFKSLEQVNNL-----REIQALRR 53
Query: 589 IR-HKNIVKLY-CYFSSLYCNL-LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
+ H NI++L F L LV+E M + NL++ + L + + +
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG--GKDSTTTVIAGTY 703
L ++H + I HRDIK NIL+ + K+ADFG RG K T I+ T
Sbjct: 113 LDHMHR---NGIFHRDIKPENILIK-DDILKLADFG-----SCRGIYSKPPYTEYIS-TR 162
Query: 704 GYLAPE-------YAYSSKATTKCDVYSFGVVLMELIT 734
Y APE Y K D+++ G V E+++
Sbjct: 163 WYRAPECLLTDGYYGP------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 68/277 (24%), Positives = 107/277 (38%), Gaps = 30/277 (10%)
Query: 533 KVGQGGSGTVYKIDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G+G G V+ L + VAVK S +T L E L H
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK---------SCRETLPPDLKAKFLQEARILKQYSH 52
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
NIV+L + +V E + G+ L L ++ A G+ YL
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
IHRD+ + N L+ K++DFG+++ + G ST + + APE
Sbjct: 113 ---KHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 712 YSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
+ +++ DV+SFG++L E + G P Y T+E I + +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVP------------YANLSNQQTREAIEQGVRLP 216
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
D V R+ RC P RP+ + V Q L
Sbjct: 217 CPELCPDA---VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 28/109 (25%)
Query: 6 LTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
L G +P D S +++L+ ++LS N G P S+ ++T+LEVL + N
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN------------- 476
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIG 113
+ +G IP S+G +TSL L L GN ++G +P +G
Sbjct: 477 --------------SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 10/207 (4%)
Query: 534 VGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
+G G G V+ + +G KL++ + A+ + + + +TE L ++R
Sbjct: 8 LGTGAYGKVFLVRKVTGH--DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 594 -IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
+V L+ F + L+ +Y+ G ++ L++ D + ++ F + + L H
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHL 121
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
I++RDIK NILLD + DFG++K + + T GT Y+APE
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE--EKERTYSFCGTIEYMAPEIIR 179
Query: 713 SSKATTKC-DVYSFGVVLMELITGRKP 738
K D +S G+++ EL+TG P
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 523 EILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQ-RTKVSASDTDQLQLDKGLK 580
E+ E + VG G G+V D +G VAVKKL ++ + A T +
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-------- 65
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
E+ L +++H+N++ L F+ + +L A +V T + F
Sbjct: 66 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 641 GVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+ Q GL Y+H + IIHRD+K +N+ ++ + + K+ DFG+ AR D T
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTDDEMTG 176
Query: 698 VIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGR 736
+A T Y APE + D++S G ++ EL+TGR
Sbjct: 177 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 44/236 (18%)
Query: 528 MTEKNKVGQGGSGTVYKIDL-----------------NSGEVVAVKKLWSQRTKVSASDT 570
+T K K+G+G G V+ + N +VAVK L K + +D
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 571 DQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL--------- 619
LK E++ + ++ NI++L C S C ++ EYM NG+L
Sbjct: 67 --------LK-EIKIMSRLKDPNIIRLLAVCITSDPLC--MITEYMENGDLNQFLSRHEP 115
Query: 620 -WDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678
A +V + + T +A +A G+ YL +HRD+ + N L+ NY K+A
Sbjct: 116 QEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIA 172
Query: 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
DFG+++ L G +++ E K TT DV++FGV L E++T
Sbjct: 173 DFGMSRNLY-SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 29/278 (10%)
Query: 531 KNKVGQGGSGTVYKI---DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+ ++G+G GTVY + + E + V K +++ ++T Q E + L
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPV-GELNPNETVQANQ------EAQLLS 57
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
+ H IVK + F ++ EY +L L + + +++ Q L
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+H+ I+HRD+K+ NI L N K+ DFG++++L G D TT GT Y++
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM--GSCDLATT-FTGTPYYMS 173
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PE +K D++S G +L E+ E G N ++S+ + EG L
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE---GQN-----FLSVVLRIVEGPTPSL 225
Query: 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ S M +L +K P+ RP+ E+++
Sbjct: 226 PETYSRQLNSIMQSML-------NKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 43/228 (18%)
Query: 534 VGQGGSGTV-----YKIDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
+G+G G V Y ID + + VAVK L K +A+D D L +E+E
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-----KDNATDKDL----ADLISEMEL 70
Query: 586 LGNI-RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-----------------HKGL 627
+ I +HKNI+ L + ++ EY GNL + L +
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 628 VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK-VL 686
L + A+ VA+G+ YL IHRD+ + N+L+ + K+ADFG+A+ V
Sbjct: 131 --LSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
K ++ + ++APE + T + DV+SFG+++ E+ T
Sbjct: 186 DIDYYKKTSNGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 43/184 (23%)
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL-----QARGGKD 693
+F VA+G+ +L IHRD+ + NILL N K+ DFG+A+ + R G D
Sbjct: 185 SFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-D 240
Query: 694 STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYW 752
+ + ++APE + T + DV+SFGV+L E+ + G P +
Sbjct: 241 ARLPL-----KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------------Y 282
Query: 753 VSIKVDT------KEGI-MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+K+D KEG M D EM Q + + C P+ RPT +E+V+
Sbjct: 283 PGVKIDEEFCRRLKEGTRMRAPDYTTP-----EMYQTM---LDCWHGEPSQRPTFSELVE 334
Query: 806 LLAE 809
L
Sbjct: 335 HLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 37/223 (16%)
Query: 535 GQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNI 594
+ K + +VAVKK + + + L+L L+ E+ T ++H NI
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKK-----INLDSCSKEDLKL---LQQEIITSRQLQHPNI 61
Query: 595 VKLYCYF---SSLYCNLLVYEYMPNGNLWDALHK----GLVHLDWPTRHKIAF---GVAQ 644
+ F S LY +V M G+ D L GL L IAF V
Sbjct: 62 LPYVTSFIVDSELY---VVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLN 112
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK----DSTTTVIA 700
L Y+H IHR +K+++ILL + + ++ + + G +
Sbjct: 113 ALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 701 GTYGYLAPEYAYSSKA--TTKCDVYSFGVVLMELITGRKPVED 741
+L+PE + K D+YS G+ EL G P +D
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 55/277 (19%)
Query: 553 VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLVY 611
VAVK L T+ SD L +E+E + I +HKNI+ L + ++
Sbjct: 50 VAVKMLKDDATEKDLSD---------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 100
Query: 612 EYMPNGNLWDALHK----GLVHL-------DWPTRHK----IAFGVAQGLAYLHHGLLSP 656
EY GNL + L G+ + D K + VA+G+ YL
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QK 157
Query: 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA 716
IHRD+ + N+L+ N K+ADFG+A+ + TT ++APE +
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVY 216
Query: 717 TTKCDVYSFGVVLMELIT--GRK----PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
T + DV+SFGV++ E+ T G PVE+ F K+ KEG +DK
Sbjct: 217 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------------KL-LKEG--HRMDKP 261
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ + +E+ ++R C P+ RPT ++V+ L
Sbjct: 262 ANCT--NELYMMMR---DCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 33/279 (11%)
Query: 531 KNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ K+G+G VY+ L G VA+KK V D + E++ L +
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKK-------VQIFDLMDAKARADCIKEIDLLKQL 59
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-----HKGLVHLDWPTRHKIAFGVAQ 644
H N++K Y F +V E G+L + K L+ P + + V Q
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI----PEKTVWKYFV-Q 114
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
+ L H ++HRDIK N+ + K+ D G+ + + K + + GT
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPY 171
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
Y++PE + + K D++S G +L E+ + P +GD N +Y + K++ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMN-LYSLCKKIEQCD--- 224
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
S + +E+ Q++ + C + P RP + V
Sbjct: 225 --YPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 43/184 (23%)
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
++ VA+G+++L IHRD+ + NILL K+ DFG+ AR ++ + V
Sbjct: 220 SYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGL-----ARDIRNDSNYV 271
Query: 699 IAGT----YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWV 753
+ G ++APE ++ T + DV+S+G++L E+ + G P +
Sbjct: 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP-------------YP 318
Query: 754 SIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ VD+K K + +R EM +++ C P RPT ++VQ
Sbjct: 319 GMPVDSK------FYKMIKEGYRMLSPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQ 369
Query: 806 LLAE 809
L+ +
Sbjct: 370 LIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 44/199 (22%)
Query: 618 NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677
+L D L + VAQG+ +L IHRD+ + N+LL K+
Sbjct: 210 DLDDLLR-------------FSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKI 253
Query: 678 ADFGIAKVLQARGGKDSTTTVIAGT----YGYLAPEYAYSSKATTKCDVYSFGVVLMELI 733
DFG+ AR + + V+ G ++APE + T + DV+S+G++L E+
Sbjct: 254 CDFGL-----ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308
Query: 734 T-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM--IQVLRIAIRCT 790
+ G+ P + I V++K M ++S R + ++ I C
Sbjct: 309 SLGKSP-------------YPGILVNSKFYKMVKRGYQMS---RPDFAPPEIYSIMKMCW 352
Query: 791 SKSPATRPTMNEVVQLLAE 809
+ P RPT +++ QL+
Sbjct: 353 NLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 48/204 (23%)
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI 638
+K E + L ++ +VKLY F V +Y+P G++ L + ++
Sbjct: 48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMEVFPEVLA 103
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA--------------- 683
F +A+ + IHRDIK NIL+D++ K+ DFG+
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163
Query: 684 --------------------------KVLQARGGKDSTTTV---IAGTYGYLAPEYAYSS 714
K L+ R K + + GT Y+APE
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223
Query: 715 KATTKCDVYSFGVVLMELITGRKP 738
T CD +S GV+L E++ G+ P
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 79/329 (24%), Positives = 130/329 (39%), Gaps = 84/329 (25%)
Query: 531 KNKVGQGGSGTVYKIDLNSGE-----------------VVAVKKLWSQRTKVSASDTDQL 573
K K+G+G G V+ ++ + + +VAVK L K + +D
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF--- 66
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL-------- 623
LK EV+ L ++ NI++L C C ++ EYM NG+L L
Sbjct: 67 -----LK-EVKILSRLKDPNIIRLLGVCVDEDPLC--MITEYMENGDLNQFLSSHHLDDK 118
Query: 624 -----------HKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672
H + + + +A +A G+ YL +HRD+ + N L+ N
Sbjct: 119 EENGNDAVPPAHCLPA-ISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGEN 174
Query: 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMEL 732
K+ADFG+++ L A G ++A E K TT DV++FGV L E+
Sbjct: 175 LTIKIADFGMSRNLYA-GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 733 ITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVL--------- 783
+ K E +G+ T E ++E FRD+ QV
Sbjct: 234 LMLCK--EQPYGEL------------TDEQVIE----NAGEFFRDQGRQVYLFRPPPCPQ 275
Query: 784 ---RIAIRCTSKSPATRPTMNEVVQLLAE 809
+ ++C S+ RP+ +++ L E
Sbjct: 276 GLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
NL+ LDLS+N P + NL NL+ L + N +
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND-------------------LS---- 176
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
+P + N+++L +L+L+GN I+ +PPEI LL L +L+L N + + L
Sbjct: 177 -----DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--ELLSSL 228
Query: 138 GNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLY 197
NL L+ L++S N+ +PESI L L L L NN +S S + + T L L L
Sbjct: 229 SNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLS 285
Query: 198 DNSLTGEVPQDLGQWSPLVVLDLSE 222
NSL+ +P L +L
Sbjct: 286 GNSLSNALPLIALLLLLLELLLNLL 310
|
Length = 394 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 44/238 (18%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + ++G V A+K L + + ++ ++ + E ++L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEADSLW----- 62
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
+VK++ F L+ E++P G++ L K D T + F +A+ + +
Sbjct: 63 -VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSI 117
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL----------------------QARG 690
IHRDIK N+LLD K++DFG+ L Q
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 691 GKDSTTT----------VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
K T GT Y+APE + CD +S GV++ E++ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 56/237 (23%), Positives = 102/237 (43%), Gaps = 37/237 (15%)
Query: 525 LEAMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
L A+ ++G+ G +YK L + ++VA+K L D + Q
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL---------KDINNPQQWGEF 54
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL--------------HK 625
+ E + + H NIV L + +++EY+ G+L + L
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 626 GLVH--LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683
G V LD IA +A G+ YL +H+D+ + NIL+ K++D G++
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLS 171
Query: 684 K-VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
+ + A + +++ ++ PE K ++ D++SFGVVL E+ + G +P
Sbjct: 172 REIYSADYYRVQPKSLLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 530 EKNKVGQGGSGTVYKIDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
E KVG+G G VYK G+ A+K++ +SA E+ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC------------REIALL 52
Query: 587 GNIRHKNIVKLYCYFSSLYCN--LLVYEYMPNGNLWDAL--------HKGLVHLDWPTRH 636
++H N++ L F S L+++Y + +LW + +K V L
Sbjct: 53 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 111
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP-----KVADFGIAKVLQARGG 691
+ + + G+ YLH ++HRD+K NIL+ + P K+AD G A++ +
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLK 167
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKC-DVYSFGVVLMELIT 734
+ + T+ Y APE ++ TK D+++ G + EL+T
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 4/105 (3%)
Query: 287 VSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS 346
+ + L G I N + R+L + + N I G IP + SL +DLS N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 347 GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSL----KSLNVLD 387
G IP +G L L +L L N L+ +P +L S N D
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524
|
Length = 623 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 51/294 (17%)
Query: 534 VGQGGSGTV----YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G G+V K + S + VAVK L + S+SD ++ L+ E +
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKML--KADIFSSSDIEEF-----LR-EAACMKEF 58
Query: 590 RHKNIVKLYCYF------SSLYCNLLVYEYMPNGNLWDALHKGLV-----HLDWPTRHKI 638
H N++KL L +++ +M +G+L L + L T +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA----RGGKDS 694
+A G+ YL IHRD+ + N +L+ N VADFG++K + + R G S
Sbjct: 119 MIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWV 753
V +LA E + TT DV++FGV + E++T G+ P G + IY
Sbjct: 176 KLPV-----KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA---GVENSEIYNY 227
Query: 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
IK + + + L+ V + +C S P RP+ + L
Sbjct: 228 LIKGNRLKQPPDCLE------------DVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 523 EILEAMTEKNKVGQGGSGTV-YKIDLNSGEVVAVKKLWSQ-RTKVSASDTDQLQLDKGLK 580
E+ E VG G G+V D + VAVKKL ++ + A T +
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-------- 63
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
E+ L +++H+N++ L F+ E NL A +V + + F
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 641 GVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+ Q GL Y+H + IIHRD+K +N+ ++ + + ++ DFG+ AR D T
Sbjct: 123 LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL-----ARQADDEMTG 174
Query: 698 VIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGR 736
+A T Y APE + D++S G ++ EL+ G+
Sbjct: 175 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 534 VGQGGSGTVYKIDLNSGEV--VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G G G V + + VA+K+ +++K+ Q Q+D + +E + L I H
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRF--EKSKI----IKQKQVDH-VFSERKILNYINH 90
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
V LY F LV E++ G + L + + +P F AQ + +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR---NKRFPNDVG-CFYAAQIVLIFEY 146
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
I++RD+K N+LLD + K+ DFG AKV+ R T + GT Y+APE
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCGTPEYIAPEIL 200
Query: 712 YSSKATTKCDVYSFGVVLMELITGRKP 738
+ D ++ G+ + E++ G P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 76/323 (23%), Positives = 133/323 (41%), Gaps = 68/323 (21%)
Query: 526 EAMTEKNKVGQGGSGTVYK---IDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGL 579
E +T ++GQG G VY+ D+ GE VAVK + SAS ++++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-----NESASLRERIEF---- 56
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH--- 636
E + ++V+L S L+V E M +G+L L +
Sbjct: 57 LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 637 ------KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA-- 688
++A +A G+AYL+ +HRD+ + N ++ ++ K+ DFG+ + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
Query: 689 ---RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744
+GGK ++APE TT D++SFGVVL E+ + +P +
Sbjct: 174 YYRKGGKGLLPV------RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-- 225
Query: 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDE-------MIQVLRIAIRCTSKSPATR 797
N+ ++ +V + G + D+ + ++R+ C +P R
Sbjct: 226 SNEQVLKFV-----------------MDGGYLDQPDNCPERVTDLMRM---CWQFNPKMR 265
Query: 798 PTMNEVVQLLAEADPCRFESCKF 820
PT E+V LL + F F
Sbjct: 266 PTFLEIVNLLKDDLHPSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 37/181 (20%)
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
+F VA+G+ +L IHRD+ + NILL N K+ DFG+A+ + KD V
Sbjct: 179 SFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY----KDP-DYV 230
Query: 699 IAGT----YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP-----VEDDFGDNKN 748
G ++APE + TT+ DV+SFGV+L E+ + G P ++++F
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR-- 288
Query: 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808
KEG + ++ I + C +P RPT +E+V++L
Sbjct: 289 ----------LKEGTR-------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331
Query: 809 E 809
+
Sbjct: 332 D 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 534 VGQGGSGTVYKIDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G G+V + LN + VAVK + K++ +++ +E +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTM-----KIAICTRSEME---DFLSEAVCMKEFD 58
Query: 591 HKNIVKL--YCYFSS----LYCNLLVYEYMPNGNLWDAL---HKGLVHLDWPTRHKIAF- 640
H N+++L C + +++ +M +G+L L G PT+ + F
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 641 -GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA----RGGKDST 695
+A G+ YL IHRD+ + N +L+ N VADFG++K + R G+ +
Sbjct: 119 TDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 696 TTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
V ++A E TTK DV+SFGV + E+ T G+ P
Sbjct: 176 MPV-----KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 39/112 (34%), Positives = 54/112 (48%), Gaps = 14/112 (12%)
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL----DWPT 634
++ E + L + IV LY S LV EY+ G++ K L+H+ D
Sbjct: 51 VQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDV-----KSLLHIYGYFDEEM 105
Query: 635 RHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685
K VA L YLH HG IIHRD+K N+L+ K+ DFG++KV
Sbjct: 106 AVKYISEVALALDYLHRHG----IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 68/246 (27%), Positives = 94/246 (38%), Gaps = 37/246 (15%)
Query: 496 TEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAV 555
EP ET SSS D S R+ Q IL ++T G G V+ V
Sbjct: 75 QEPCETTSSS----DPASVVRM---QYNILSSLTP------GSEGEVF---------VCT 112
Query: 556 KKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS--SLYCNLL-VYE 612
K QR KV K E++ L I H+ I+ L + S C ++ Y+
Sbjct: 113 KHGDEQRKKVIVKAVTG---GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672
+L+ + L I + + LAYLH IIHRD+K+ NI LD
Sbjct: 170 C----DLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEP 221
Query: 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMEL 732
+ DFG A L A +GT +PE K D++S G+VL E+
Sbjct: 222 ENAVLGDFGAACKLDAHPDTPQCYG-WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 733 ITGRKP 738
Sbjct: 281 SVKNVT 286
|
Length = 392 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 69/268 (25%), Positives = 108/268 (40%), Gaps = 62/268 (23%)
Query: 534 VGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + ++G++ A+K L K DQL +K E + L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTL----LKSEMFKKDQL---AHVKAERDVLAESDSP 61
Query: 593 NIVKLYCYFS-SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH 651
+V LY F + Y L++ E++P G+L L K + TR +A V + +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIM-EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL-AIEAVHK 119
Query: 652 -GLLSPIIHRDIKSTNILLDVNYQPKVADFGIA-------------KVLQARGGKDSTTT 697
G IHRDIK NIL+D K++DFG++ K+LQ + K+
Sbjct: 120 LGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 698 ---------------------------VIA----GTYGYLAPEYAYSSKATTKCDVYSFG 726
++A GT Y+APE +CD +S G
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235
Query: 727 VVLMELITGRKPV--EDDFGDNKNIIYW 752
++ E + G P E+ + II W
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 530 EKNKVGQGGSGTVYKIDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
E KVG+G G VYK G+ A+K++ +SA E+ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC------------REIALL 52
Query: 587 GNIRHKNIVKLYCYFSSLYCN--LLVYEYMPNGNLWDAL--------HKGLVHLDWPTRH 636
++H N++ L F S L+++Y + +LW + +K + L
Sbjct: 53 RELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP-----KVADFGIAKVLQARGG 691
+ + + G+ YLH ++HRD+K NIL+ + P K+AD G A++ +
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLK 167
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKC-DVYSFGVVLMELIT 734
+ + T+ Y APE ++ TK D+++ G + EL+T
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
N+V L+ Y S LV ++ G LW + K L ++ + A + L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHR- 103
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
I+ RD+ NILLD ++ F ++ ++ + Y APE
Sbjct: 104 --EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVGG 155
Query: 713 SSKATTKCDVYSFGVVLMELITGRKPVE 740
S+ T CD +S G +L EL+TG+ VE
Sbjct: 156 ISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 50/205 (24%)
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHK 637
+K E + L ++ +V+LY F V +Y+P G++ L + G+ D
Sbjct: 48 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLAR--- 104
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA-------------- 683
F +A+ + IHRDIK NIL+D + K+ DFG+
Sbjct: 105 --FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 684 ---------------------------KVLQARGGKDSTTTV---IAGTYGYLAPEYAYS 713
K L+ R + + + GT Y+APE
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 714 SKATTKCDVYSFGVVLMELITGRKP 738
+ T CD +S GV+L E++ G+ P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 44/238 (18%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + ++G + A+K L +D + + ++ E + L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKIL-------RKADMLEKEQVAHIRAERDILVEADGA 61
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG 652
+VK++ F L+ E++P G++ L K D + F +A+ + +
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAI 117
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL----------------------QARG 690
IHRDIK N+LLD K++DFG+ L Q
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 691 GKDSTTT----------VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
K T GT Y+APE + CD +S GV++ E++ G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 531 KNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ K+G+G VY+ L + VA+KK+ + + D ++ E++ L +
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-------EIDLLKQL 59
Query: 590 RHKNIVKLYCYFSSLYCNL---LVYEYMPNGNLWDAL-----HKGLVHLDWPTRHKIAFG 641
H N++K Y S + +V E G+L + K L+ P R +
Sbjct: 60 NHPNVIK---YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI----PERTVWKYF 112
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
V Q + + H ++HRDIK N+ + K+ D G+ + + K + + G
Sbjct: 113 V-QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVG 168
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
T Y++PE + + K D++S G +L E+ + P +GD N+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLF 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 534 VGQGGSGTV-YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G G G V D VA+KKL S +Q + + E+ + + HK
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 593 NIVKLYCYFS---SL--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
NI+ L F+ SL + ++ + + + NL + L H ++++ + Q L
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH------ERMSYLLYQMLC 137
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+ H + IIHRD+K +NI++ + K+ DFG+A+ G T T Y A
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRA 193
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGR 736
PE D++S G ++ E+I G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 27/61 (44%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 334 SLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392
+L +DLS+N L+ IP G L L +L L N L S P + S L SL LDLS N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 393 L 393
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 39/244 (15%)
Query: 578 GLKTEVETLGNIRHKNIVKLYCYFS--SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR 635
G TE L I H +I++L F+ C L++ Y + + A + + D
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTC-LILPRYKTDLYCYLAAKRNIAICDILA- 186
Query: 636 HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA----KVLQARGG 691
I V + + YLH + IIHRDIK+ NI ++ + DFG A + +
Sbjct: 187 --IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-- 239
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
AGT APE D++S G+VL E+ T + + G + +
Sbjct: 240 ----YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD--- 292
Query: 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMI---------QVLRIAIRCTSKSPATRPTMNE 802
D+ I ++ + SG+ +E + +A + +S+ P +RP
Sbjct: 293 -----CDSDRQIKLIIRR--SGTHPNEFPIDAQANLDEIYIGLAKK-SSRKPGSRPLWTN 344
Query: 803 VVQL 806
+ +L
Sbjct: 345 LYEL 348
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 524 ILEAMTEKNKVGQGGSGTV---YKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK 580
+L+ +G G G V Y L+ VA+KKL S +Q + +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR 65
Query: 581 TEVETLGNIRHKNIVKLYCYFS------SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
E+ + + HKNI+ L F+ LV E M + NL + L H
Sbjct: 66 -ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDH----- 118
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
++++ + Q L + H + IIHRD+K +NI++ + K+ DFG+A+ G
Sbjct: 119 -ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSF 173
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELI 733
T T Y APE D++S G ++ E++
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 31/170 (18%)
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYLH-H 651
+V ++C F + +V EY+ G+ L + G + +D R A V L YLH +
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFAETVL-ALEYLHNY 120
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV------------- 698
G I+HRD+K N+L+ K+ DFG++K+ G TT +
Sbjct: 121 G----IVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFL 172
Query: 699 ---IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
+ GT Y+APE D ++ G++L E + G P FGD
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 55/231 (23%), Positives = 86/231 (37%), Gaps = 43/231 (18%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLT---NLEVLSFNENP--GFKLWKLPESSIFRLTKLRI 72
L+ LDLS+N + +L +L+ L N N L L + L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 73 MVLATCALHGQIPASIGNV----TSLTDLELTGNFITG----HIPPEIGLLKNLRQLELY 124
+VL L G ++ L +L L N I + + NL L+L
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL- 200
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
N LTD S + E++ L L VL L +N+L+ ++
Sbjct: 201 --------------NNNGLTDEGAS------ALAETLASLKSLEVLNLGDNNLTDAGAAA 240
Query: 185 IAN-----STTLTMLSLYDNSLTGEVPQDLGQWSP----LVVLDLSENKLS 226
+A+ + +L LSL N +T + +DL + L+ LDL NK
Sbjct: 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 533 KVGQGGSGTVYKIDLNSG---EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G G G V ++NSG V VK+L +VSAS +Q++ E + ++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKEL-----RVSASVQEQMKF----LEEAQPYRSL 52
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK----GLVHLDWPTRHKIAFGVAQG 645
+H N+++ + + LLV E+ P G+L L L+ D T ++A +A G
Sbjct: 53 QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALG 112
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L +LH + IH D+ N LL + K+ D+G++ + + T + +
Sbjct: 113 LLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRW 168
Query: 706 LAPEYA-------YSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKV 757
+APE T + +V+S GV + EL G +P D + + Y V
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR-HLSDEQVLTYTV---- 223
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808
+E +++ +L D +V++ C + P RP+ EV LL+
Sbjct: 224 --REQQLKLPKPRLKLPLSDRWYEVMQF---CWLQ-PEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
++ VA G+ +L +HRD+ + N+L+ K+ DFG+A+ + +DS
Sbjct: 245 SYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIM----RDSNYIS 297
Query: 699 IAGTY---GYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
T+ ++APE +++ TT DV+SFG++L E+ T
Sbjct: 298 KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 7e-06
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 38/191 (19%)
Query: 579 LKTEVETLGNIRHKNIVKLYCYF-----SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
L EV + ++HKNIV+ F LY ++ E+ G+L + K
Sbjct: 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLY---ILMEFCDAGDLSRNIQKCYKMFGKI 115
Query: 634 TRHKIAFGVAQ---GLAYLHHGLLSP----IIHRDIKSTNILL---------------DV 671
H I Q LAY H+ P ++HRD+K NI L ++
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 672 NYQP--KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT--TKCDVYSFGV 727
N +P K+ DFG++K + G +S GT Y +PE + K D+++ G
Sbjct: 176 NGRPIAKIGDFGLSKNI----GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 728 VLMELITGRKP 738
++ EL +G+ P
Sbjct: 232 IIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 69/281 (24%), Positives = 106/281 (37%), Gaps = 61/281 (21%)
Query: 164 LPKLRVLQLYNNSLSGE----ISSVIANSTTLTMLSLYDNSL------TGEVPQDLGQWS 213
L L+VL+L N+L E ++S + +L L L N + Q L +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 214 PLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL 273
L LDLS+N L + S +L++ L ++NN L
Sbjct: 82 GLQELDLSDNALGPDGCGVLES--------LLRSSSLQELK-------------LNNNGL 120
Query: 274 EGS----IPEGILSLPH-VSIIDLSYNSFSG----PIANTVGNARNLSELFMQRNQISGF 324
+ +G+ LP + + L N G +A + R+L EL + N I
Sbjct: 121 GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180
Query: 325 -IPS--EIYRAIS-LVKIDLSDN--------LLSGPIPSGIGNLKKLNLLMLQSNKLNSS 372
I + E +A L +DL++N L+ + S LK L +L L N L +
Sbjct: 181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS----LKSLEVLNLGDNNLTDA 236
Query: 373 I-----PNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNS 408
LS SL L LS N +T + L E+L
Sbjct: 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK 277
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 619 LWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678
L D +GL LD + + VA+G+ +L +HRD+ + N+LL K+
Sbjct: 226 LSDDGSEGLTTLDLLS---FTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKIC 279
Query: 679 DFGIAKVLQARGGKDSTTTVIAGTY---GYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
DFG+A+ + DS T+ ++APE + + TT DV+S+G++L E+ +
Sbjct: 280 DFGLARDIM----HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 3/76 (3%)
Query: 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV-IAGTYGYLAPEYAYSSK 715
IIHRDIK+ N+L++ + DFG A ARG + IAGT APE
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACF--ARGSWSTPFHYGIAGTVDTNAPEVLAGDP 338
Query: 716 ATTKCDVYSFGVVLME 731
T D++S G+V+ E
Sbjct: 339 YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 579 LKTEVETLGNIRHKNIVKL--------YCYFSSLYCNLLVYEYMPNGNL-WDALHKGLVH 629
L+ E+ LG + H+NI+K+ Y + + +Y +M + W
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKD-----RP 264
Query: 630 LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
L TR I + + Y+H L IHRDIK NI L+ + + + DFG A +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
+++ GT +PE D++S G++L+++++
Sbjct: 321 --REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 28/89 (31%), Positives = 41/89 (46%)
Query: 218 LDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSI 277
L L L G +P + LQ + N G +P SL +L +S N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 278 PEGILSLPHVSIIDLSYNSFSGPIANTVG 306
PE + L + I++L+ NS SG + +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 23/61 (37%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 358 KLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNR 415
L L L +N+L + L +L VLDLS N LT PE+ LP+ S++ S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSG-LPSLRSLDLSGNN 59
Query: 416 L 416
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 41/231 (17%)
Query: 533 KVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
++G+ G VYK L + VA+K L D + L + K E
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL---------KDKAEGPLREEFKHEAMMR 62
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH---------------LD 631
++H NIV L + +++ Y + +L + L H L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 632 WPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK-VLQA 688
I +A G+ +L HH ++H+D+ + N+L+ K++D G+ + V A
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 689 RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKP 738
K +++ +++PE K + D++S+GVVL E+ + G +P
Sbjct: 178 DYYKLMGNSLLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 55/229 (24%), Positives = 83/229 (36%), Gaps = 44/229 (19%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
SL +L L+ N TG IP + L + L L +LD+S N
Sbjct: 52 SLKELCLSLNE-TGRIPRGLQSL------------------LQGLTKGCGLQELDLSDNA 92
Query: 153 LSGKIP---ESILRLPKLRVLQLYNNSLSGEISSVIANSTT-----LTMLSLYDNSLTGE 204
L ES+LR L+ L+L NN L ++A L L L N L G
Sbjct: 93 LGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA 152
Query: 205 VPQDLGQWSP----LVVLDLSENKLSGPLPAKVCSRGKLQ---YFLVLQNMF-----SGV 252
+ L + L L+L+ N + + K L L N +
Sbjct: 153 SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA 212
Query: 253 LPDSLARCKNLLRFRVSNNHL-EGSIPEGILSLPHVSI----IDLSYNS 296
L ++LA K+L + +N+L + +L +I + LS N
Sbjct: 213 LAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
+ HK+IV LY N++V E++ G L +H+ L P + K+A +A L+Y
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 649 LHHGLLSPIIHRDIKSTNILL-----DVNYQP--KVADFGIAKVLQARGGKDSTTTVIAG 701
L ++H ++ + NILL D P K++D GI + +R ++ +
Sbjct: 121 LED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERI--- 172
Query: 702 TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMEL-ITGRKPVED 741
++APE SK + D +SFG L E+ G P++D
Sbjct: 173 --PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 58/299 (19%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVA---VKKLWSQRTKVSASDTDQLQ-LDKGLKTEVETLGN 588
++G G G V ++ + VA VK+L K +AS +Q + L +G +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKEL-----KANASSKEQNEFLQQGDPYRI----- 51
Query: 589 IRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTR-------HKI 638
++H NI++ C + Y LLV+EY G+L K L W R ++
Sbjct: 52 LQHPNILQCLGQCVEAIPY--LLVFEYCELGDL-----KSYLSQEQWHRRNSQLLLLQRM 104
Query: 639 AFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
A +A G+ ++H H L H D+ N L + KV D+GI +R +D T
Sbjct: 105 ACEIAAGVTHMHKHNFL----HSDLALRNCFLTSDLTVKVGDYGIGP---SRYKEDYIET 157
Query: 698 --VIAGTYGYLAPEYA-------YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748
+LAPE +++ T +V++ GV L EL D +
Sbjct: 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-RE 216
Query: 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
++ V K+ +++ +L + + +VL+ SP R T EV +LL
Sbjct: 217 VLNHV-----IKDQQVKLFKPQLELPYSERWYEVLQFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 583 VETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
+ + HK++VKLY C N++V EY+ G L LH+ ++ + +A
Sbjct: 52 ASLMSQLSHKHLVKLYGVCVRDE---NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK 108
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILL-----DVNYQP--KVADFGIAKVLQARGGKD 693
+A L YL ++H ++ NIL+ + Y P K++D GI + +R +
Sbjct: 109 QLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 694 STTTVIAGTYGYLAPEYAY--SSKATTKCDVYSFGVVLMEL 732
++APE + T D +SFG L+E+
Sbjct: 166 ERIP-------WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 59/239 (24%), Positives = 92/239 (38%), Gaps = 35/239 (14%)
Query: 534 VGQGGSGTVYKID------LNSGEVVAVKKLWSQRTKVSAS-------DTDQLQLDKGLK 580
+G GG G VY+ +N+ V ++ L T V + D D++ L K +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENL-ENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW---PTRHK 637
NI H I K Y S C + Y ++ L + + +
Sbjct: 79 -------NIDHLGIPKYYGCGSFKRCRMY-YRFILLEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 638 IAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK---- 692
I + L Y+H HG I H DIK NI++D N + + D+GIA G
Sbjct: 131 IMKDMLTTLEYIHEHG----ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
+ GT Y + + T + D+ S G +++ G K FG N N+I+
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW-AGIKLPWKGFGHNGNLIH 244
|
Length = 294 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 33/156 (21%), Positives = 55/156 (35%), Gaps = 23/156 (14%)
Query: 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ G + VY + + V K+ R K + EV L +
Sbjct: 2 SIKLLKGGLTNRVYLLGTKDEDYVL--KINPSREK-----------GADREREVAILQLL 48
Query: 590 RHKNIV--KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
K + K+ S + L+ E++ G D + + IA +A+ LA
Sbjct: 49 ARKGLPVPKVLASGESDGWSYLLMEWIE-GETLD----EVSEEEKE---DIAEQLAELLA 100
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683
LH L + H D+ NIL+D + D+ A
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 840 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.19 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.55 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.54 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.53 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-94 Score=887.78 Aligned_cols=773 Identities=32% Similarity=0.545 Sum_probs=549.5
Q ss_pred ccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccc
Q 003199 2 SFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCAL 80 (840)
Q Consensus 2 ~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l 80 (840)
+.|.++|.+|. |+.+++|++|+|++|.+.+.+|..+.++++|++|+|++| .+....+..+.++++|++|+|++|.+
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n---~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN---QLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCC---CCcCcCChHHcCcCCccEEECcCCcc
Confidence 34455556664 666777777777777776667777777777777777777 44433445566777777777777777
Q ss_pred cccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCcc
Q 003199 81 HGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPES 160 (840)
Q Consensus 81 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (840)
.+.+|..++++++|++|+|++|.+.+..|..|..+++|+.|+|++|+ +.+.+|..+.++++|++|+|++|.+.+.+|..
T Consensus 225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 303 (968)
T PLN00113 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK-LSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303 (968)
T ss_pred CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCe-eeccCchhHhhccCcCEEECcCCeeccCCChh
Confidence 76777777777777777777777776677777777777777777775 45566667777777777777777777777777
Q ss_pred ccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCch
Q 003199 161 ILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240 (840)
Q Consensus 161 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 240 (840)
+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++..|..++.+++|+
T Consensus 304 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~ 383 (968)
T PLN00113 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF 383 (968)
T ss_pred HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777766777
Q ss_pred hhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCC------------
Q 003199 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA------------ 308 (840)
Q Consensus 241 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------ 308 (840)
.|++++|.+.+..|..+..+++|+.|++++|++++..|..+..++.|+.|++++|.+++..+..+..+
T Consensus 384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 463 (968)
T PLN00113 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463 (968)
T ss_pred EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce
Confidence 77777777766667667777777777777777776666666666666666666666665555444444
Q ss_pred -----------CCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhc
Q 003199 309 -----------RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSL 377 (840)
Q Consensus 309 -----------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 377 (840)
++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..|
T Consensus 464 ~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (968)
T PLN00113 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543 (968)
T ss_pred eeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhH
Confidence 455566666666666677777778888888888888888888888888889999999999988888888
Q ss_pred ccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccC-CCcccccCCCCCccccccCCCCCCCCCC
Q 003199 378 SSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKE-GLVESFSGNPGLCVSVSVNSSDKNFPLC 455 (840)
Q Consensus 378 ~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~-~~~~~~~~n~~~c~~~~~~~~~~~~~~c 455 (840)
..+++|+.|||++|+++|.+|..+..+ .++.+++++|+++|.+|..-... ....++.|||.+|+..... ..+.|
T Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~----~~~~c 619 (968)
T PLN00113 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS----GLPPC 619 (968)
T ss_pred hCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc----CCCCC
Confidence 889999999999999998888888777 56889999999999888642211 1235688999999864322 12344
Q ss_pred CCCccccc-cchhhhHHHHHHH-HHHHHHHhhhhhccccc-ccCCCCcccccccCccccccccccchhHHHHHHhcCccC
Q 003199 456 PHTKTRRR-LSSIWAVVTSAVI-IFIGLLLFLKRRFSKQR-AITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKN 532 (840)
Q Consensus 456 ~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~r~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (840)
........ ...++++++++++ +++++++++++|+++.+ +..+.... ......+. ......+...++...+...+
T Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 696 (968)
T PLN00113 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG-TWELQFFD--SKVSKSITINDILSSLKEEN 696 (968)
T ss_pred ccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccc-cccccccc--cccchhhhHHHHHhhCCccc
Confidence 32211111 1222222222222 22222222222222111 11111000 00000000 00111223455667788889
Q ss_pred eeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEE
Q 003199 533 KVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 611 (840)
.||+|+||.||+|.. .+|..||||++..... ...+|++++++++|||||+++++|.+....++||
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 999999999999976 5789999998843221 1124588899999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 612 EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 612 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
||+++|+|.++++ .++|.++..++.|+|+|++|||+.+.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred eCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999999996 37999999999999999999996555899999999999999999888875 665543211
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL 771 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (840)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....+.......|.+...... .....+++.+
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccc
Confidence 12236789999999999999999999999999999999999999766655666667765433222 2334445444
Q ss_pred CCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 772 SGS---FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 772 ~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.+. ..+...++.+++.+||+.||++||+|+||++.|+++..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 322 24566788899999999999999999999999998755
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=493.96 Aligned_cols=433 Identities=38% Similarity=0.550 Sum_probs=263.8
Q ss_pred ccccccccCCC--CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 2 SFMYLTGTLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 2 ~~~~~~~~~~~--~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
+.|.++|.+|. |.++++|++|+|++|.+++.+|. +.+++|++|+|++| .+....+..+..+++|++|+|++|.
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n---~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNN---MLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCC---cccccCChHHhcCCCCCEEECccCc
Confidence 45566666664 44666666666666666555543 33555555555555 3332233345555555555555555
Q ss_pred ccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCc
Q 003199 80 LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPE 159 (840)
Q Consensus 80 l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~ 159 (840)
+.+.+|..++++++|++|+|++|.+.+.+|..+..+++|+.|+|++|+ +.+.+|..+.++++|++|+|++|.+++..|.
T Consensus 176 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~ 254 (968)
T PLN00113 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN-LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254 (968)
T ss_pred ccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc-cCCcCChhHhcCCCCCEEECcCceeccccCh
Confidence 555555555555555555555555555555555555555555555554 3344555555555555555555555555555
Q ss_pred cccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCc
Q 003199 160 SILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239 (840)
Q Consensus 160 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 239 (840)
.|..+++|++|+|++|.+.+..|..+.++++|++|+|++|.+.+.+|..+.++++|+.|++++|.+.+..|..++.+++|
T Consensus 255 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L 334 (968)
T PLN00113 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334 (968)
T ss_pred hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCC
Confidence 55555555555555555554445555555555555555555554455445555555555555555554444444445555
Q ss_pred hhhhcccccccccCC------------------------cccccccCCceEEeeCceeeccCCccccCCCcccEEeccCC
Q 003199 240 QYFLVLQNMFSGVLP------------------------DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYN 295 (840)
Q Consensus 240 ~~L~l~~n~~~~~~~------------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 295 (840)
+.|++++|.+.+.+| ..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|
T Consensus 335 ~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred CEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 555555555444444 44444445555555555555555555555666666666666
Q ss_pred cccccCCcccCCCCCCceeecccceeeeccchhhcccC-----------------------cccEEEcCCCccCCCCCCc
Q 003199 296 SFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-----------------------SLVKIDLSDNLLSGPIPSG 352 (840)
Q Consensus 296 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-----------------------~L~~L~Ls~N~l~~~~p~~ 352 (840)
++++..|..|..+++|+.|+|++|.+++.+|..++.++ +|+.|+|++|++++.+|..
T Consensus 415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~ 494 (968)
T PLN00113 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494 (968)
T ss_pred EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChh
Confidence 66666666666677777777777766665555444433 3455566666666667777
Q ss_pred ccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccCC--C
Q 003199 353 IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKEG--L 429 (840)
Q Consensus 353 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~~--~ 429 (840)
+.++++|+.|+|++|++++.+|..+..+++|++|+|++|.++|.+|..+..+ .++.|++++|+++|.+|..+.... .
T Consensus 495 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 574 (968)
T PLN00113 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574 (968)
T ss_pred hhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccC
Confidence 7788888888888888888888888889999999999999999999888887 568899999999999997655432 3
Q ss_pred cccccCCCCCc
Q 003199 430 VESFSGNPGLC 440 (840)
Q Consensus 430 ~~~~~~n~~~c 440 (840)
...+.+|+..+
T Consensus 575 ~l~ls~N~l~~ 585 (968)
T PLN00113 575 QVNISHNHLHG 585 (968)
T ss_pred EEeccCCccee
Confidence 45677887665
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=424.04 Aligned_cols=284 Identities=46% Similarity=0.744 Sum_probs=241.5
Q ss_pred ccch-hHHHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCc
Q 003199 516 RISF-DQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNI 594 (840)
Q Consensus 516 ~~~~-~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 594 (840)
.+++ +...+++.|...+.||+|+||.||+|...+|+.||||++...... . .++|..|++++.+++|||+
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~---------~-~~eF~~Ei~~ls~l~H~Nl 133 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ---------G-EREFLNEVEILSRLRHPNL 133 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---------c-hhHHHHHHHHHhcCCCcCc
Confidence 3444 567889999999999999999999999999999999987433211 1 3459999999999999999
Q ss_pred ceeeeEEecCc-cceEEEeecCCCChHHHhhcCCC-CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 595 VKLYCYFSSLY-CNLLVYEYMPNGNLWDALHKGLV-HLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 595 v~l~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
|+++|||.+.+ +.+||||||++|+|.++++.... .++|.+|.+||.++|+||+|||+.+.++||||||||+|||+|++
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 99999999988 49999999999999999998765 88999999999999999999999888899999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecc-cccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC-CCCcchh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVI-AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNII 750 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~ 750 (840)
+++||+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... .....+.
T Consensus 214 ~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 99999999999654210 1111222 89999999999999999999999999999999999999887644 3444578
Q ss_pred hhhhhhhccccchhhhcccccC-CCcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLS-GSFR--DEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
.|........ .+.+++|+.+. ..+. ..+.++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 291 ~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 291 EWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8875544444 68899999986 5554 6788899999999999999999999999999665443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=396.17 Aligned_cols=257 Identities=36% Similarity=0.507 Sum_probs=210.9
Q ss_pred ccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc-cce
Q 003199 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY-CNL 608 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 608 (840)
..+.||+|+||+||+|.++....||||++...... ... .+.|.+|+.++.+++|||||+++|+|.+.. ..+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~-------~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFD-------DES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcC-------hHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 34559999999999999995455999998544321 111 778999999999999999999999999987 789
Q ss_pred EEEeecCCCChHHHhhc-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCEEEcCCC-CCeeecccchhh
Q 003199 609 LVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP-IIHRDIKSTNILLDVNY-QPKVADFGIAKV 685 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~ 685 (840)
+|||||++|+|.++++. ....+++..+..+|.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999988 36689999999999999999999999 77 99999999999999997 999999999987
Q ss_pred hhccCCCCcceecccccccccCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAY--SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... ... .
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~-------------~ 255 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQV-------------A 255 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHH-------------H
Confidence 64311 2334478999999999999 56899999999999999999999999986422 111 1
Q ss_pred hhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 764 MEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 764 ~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
..++....++.. ......+..++.+||..||++||++.+++..|+.+.....
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 222223333332 2356677788889999999999999999999987655444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.46 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=209.0
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.+..+.||+|..|+||++.++ +++.+|+|++.... +....+++.+|++++++++||+||+++|+|....
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---------~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---------DPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---------CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 3445678999999999999554 79999999984332 2455788999999999999999999999999988
Q ss_pred -cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 -CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++|||.+.+...+ .+++.....|+.+|++||.|||+. ++||||||||+|||++..|++||||||.++
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 4999999999999999998764 699999999999999999999954 899999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. .......||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... ....|... +.
T Consensus 228 ~lvn-----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~L-------l~ 292 (364)
T KOG0581|consen 228 ILVN-----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFEL-------LC 292 (364)
T ss_pred Hhhh-----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHH-------HH
Confidence 8753 255678999999999999999999999999999999999999999976411 12222221 12
Q ss_pred hhcccccCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRD-EMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.+++...+....+ ...++..++..|+++||.+||+++|+++|=
T Consensus 293 ~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 293 AIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 2222222222222 445566677799999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=373.31 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=210.9
Q ss_pred HHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
..+.|...+.+|+|+||.|-+| ..++|+.||||++.+........ .......+.+|+++|++++|||||++++++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~---~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR---AIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc---cccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 4456778899999999999998 66789999999996655332111 0112344689999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCCeeec
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN---YQPKVAD 679 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~D 679 (840)
..+..|||||||+||+|.+.+-.+. .+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999999998765 57788889999999999999999 999999999999999765 7799999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCC---CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
||+|+.. +......+.+|||.|.|||++.+..+ ..+.|+||+||++|-+++|.+||.+...+..-.
T Consensus 323 FGlAK~~----g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~------- 391 (475)
T KOG0615|consen 323 FGLAKVS----GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK------- 391 (475)
T ss_pred cchhhcc----ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH-------
Confidence 9999987 34556778999999999999977643 347899999999999999999998753322100
Q ss_pred hccccchhhhccccc---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 757 VDTKEGIMEVLDKKL---SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
..+...++ +..+.....+..+++.+|+..||++|||+.|++++=+
T Consensus 392 -------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 392 -------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred -------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 11111111 2233455667788899999999999999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.49 Aligned_cols=254 Identities=28% Similarity=0.381 Sum_probs=212.1
Q ss_pred CccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
...+.||+|.||+||.|.++....||||.++.... ..+.|.+|+++|++++|++||+++|+|..++..+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-----------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-----------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecccc-----------ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 45678999999999999999888999999965432 2467889999999999999999999999988999
Q ss_pred EEEeecCCCChHHHhhc-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhh
Q 003199 609 LVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 687 (840)
||||||+.|+|.++|+. ....+...+.+.++.|||+|++||++ +++|||||.++||||+++..|||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999997 45678999999999999999999999 999999999999999999999999999999543
Q ss_pred ccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 688 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
+ +.........-+..|.|||.+..+.++.|||||||||+||||+| |+.||.+... .+.+..+
T Consensus 355 d--~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------------~ev~~~l 417 (468)
T KOG0197|consen 355 D--DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------------EEVLELL 417 (468)
T ss_pred C--CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---------------HHHHHHH
Confidence 3 22333334445678999999999999999999999999999999 9999876311 1111122
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
......+....++..+.++|..||+.+|++|||++.+...++++...
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 22222344445667788899999999999999999999988876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=363.17 Aligned_cols=201 Identities=32% Similarity=0.482 Sum_probs=179.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||+||+|+.+ ++..||||.+....- ..+..+.+..|+++++.++|||||++++++..+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 45777778999999999999654 689999999854421 244567788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC------CCCeee
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN------YQPKVA 678 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~ 678 (840)
+..|+|||||+||+|.++++..+ .+++.+++.++.|+|.||++||+ ++||||||||.|||++.. -.+||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 99999999999999999999876 79999999999999999999999 999999999999999764 457999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
|||+|+.+.. .......+|++-|||||++...+|+.|+|+||+|+|+|||++|+.||+..
T Consensus 158 DFGfAR~L~~----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 158 DFGFARFLQP----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred ccchhhhCCc----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999853 34456789999999999999999999999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=381.10 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=209.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+|+.+|++.. .+|+.||+|++.+.... .....+.+.+||++.+.++|||||+++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-------k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-------KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-------CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence 5688899999999999999965 88999999999554322 133456788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...|+|.|+|++++|-.++.+. ..+++.+++.+.+||+.||.|||+ .+|+|||||..|+++++++++||+|||+|.
T Consensus 91 ~nVYivLELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred CceEEEEEecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceee
Confidence 9999999999999999988854 489999999999999999999999 999999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+..+ .....+.+|||.|+|||++....++..+||||+|||+|-|++|++||+... +... ..
T Consensus 167 ~le~~---~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vket----------y~ 228 (592)
T KOG0575|consen 167 QLEYD---GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKET----------YN 228 (592)
T ss_pred eecCc---ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHH----------HH
Confidence 88642 234557899999999999999999999999999999999999999998531 1111 11
Q ss_pred hhcccc-cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKK-LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+.... ..+ ........+|+.+++++||.+|||+++|+.+
T Consensus 229 ~Ik~~~Y~~P--~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 229 KIKLNEYSMP--SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHhcCcccc--cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111 111 1334455667779999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=347.62 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=205.8
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE-Eec
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY-FSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~ 603 (840)
..|.+.++||+|+||+||++ ...+|..||.|.+.-... +.+..++...|+.++++++|||||+++++ +.+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 45667788999999999998 567899999998853221 24556788999999999999999999983 444
Q ss_pred Ccc-ceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCEEEcCCCCCeee
Q 003199 604 LYC-NLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP-IIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~~~-~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+.. .++|||||..|+|.+.+.. ....+++.++|+++.|++.||.++|+...++ |+||||||.||+++.+|.+|++
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 444 7899999999999998764 3467999999999999999999999855443 7799999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++.+.. ........+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+. ++....
T Consensus 171 DfGL~r~l~s---~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~----- 237 (375)
T KOG0591|consen 171 DFGLGRFLSS---KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLC----- 237 (375)
T ss_pred cchhHhHhcc---hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHH-----
Confidence 9999998853 333445678999999999999999999999999999999999999999864 222111
Q ss_pred cccchhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 TKEGIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.++.....++.+ .....++..++..|+..||+.||+.-.++..+
T Consensus 238 -----~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 238 -----KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -----HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 112222333333 34566788888899999999999854444444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=356.25 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=204.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||.++. .+++.+|+|++.+..... ....+...+|..++.+++||.||+++-.|++
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-------~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-------KKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-------hhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 46788899999999999999955 479999999996655321 2345678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..|+|+||+.||.|+.+|++.. .+++..++-++..|+.||.|||+ ++||||||||+|||+|.+|+++|+|||++
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccc
Confidence 999999999999999999999765 79999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... ........+||+.|||||++.+..|+.++|.||+|+++|||++|.+||.+. +...+.+.
T Consensus 173 k~~~~---~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~-------- 236 (357)
T KOG0598|consen 173 KEDLK---DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDK-------- 236 (357)
T ss_pred hhccc---CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHH--------
Confidence 86533 233455689999999999999999999999999999999999999999763 11222211
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP----TMNEVVQ 805 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~evl~ 805 (840)
+...+......-...+..+++...+..||++|. ++.+|.+
T Consensus 237 --I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 237 --ILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred --HhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 111111111111233455667799999999996 4555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=337.07 Aligned_cols=264 Identities=25% Similarity=0.362 Sum_probs=208.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+...++|+|+||+||+++.+ +|+.||||+|.... +++...+-..+|++++++++|+|+|.++..|...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC--------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence 45677788999999999999655 79999999995433 3355567789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|||+. ++.+-++......+.+.+.++++|++.|+.|+|+ ++++||||||+|||++.+|.+|+||||.|+
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhH
Confidence 999999999965 5666666666678999999999999999999999 999999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc----
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT---- 759 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 759 (840)
.+... ....+..+.|+.|.|||.+.+ .+|...+||||+||++.||++|.+-|.+..+ -+...........
T Consensus 150 ~L~~p---gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 150 TLSAP---GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPR 224 (396)
T ss_pred hhcCC---cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHH
Confidence 98642 334556678999999999987 6899999999999999999999998876422 1111111111100
Q ss_pred -------cc-----chhhhccc-ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 -------KE-----GIMEVLDK-KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 -------~~-----~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .+.+..+. .+...++....-+++++..|++.||++|++.+|++.+
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00 00000011 1122333445567899999999999999999998865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=377.95 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=214.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+....+.||+|+||+||+|... +.+.||||.++... ..+..++|++|++.++.++|||||+++|.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---------~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---------ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---------cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3445678999999999998553 34679999985443 34567899999999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCC-------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGL-------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNI 667 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 667 (840)
|.+.+..++|+|||..|||.++|.... ..++..+.+.||.|||.|++||-+ +.+|||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhc
Confidence 999999999999999999999997432 127888999999999999999999 9999999999999
Q ss_pred EEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 003199 668 LLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDN 746 (840)
Q Consensus 668 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 746 (840)
||.++..|||+|||+++.....+. ........-..+|||||.+..++|+.+||||||||+|||+++ |+.||.+.-+
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDY-Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-- 711 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDY-YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-- 711 (774)
T ss_pred eeccceEEEecccccchhhhhhhh-hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--
Confidence 999999999999999988754322 222223345689999999999999999999999999999999 9999976321
Q ss_pred cchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
.+.+..+-+..+-+..+..+.++..|+..||+..|.+||+++||-..|+.....
T Consensus 712 -------------~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 712 -------------QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -------------HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 111222333444455567788899999999999999999999999999876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=355.23 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=209.2
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
.+|...+.||.|+|++|++| +..+++++|||++.+.. .-.....+.+..|-.+|.++ .||.|++++..|.+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~-------Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY-------IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH-------HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 56778899999999999999 55689999999984332 11233456778899999999 79999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....|+|+||+++|+|.+++.+.+ .+++..++.++.+|+.||+|||+ +|||||||||+|||+|++|+++|+|||.|
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999999999876 79999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCC----------CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 684 KVLQARGGK----------DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 684 ~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
+.+.+.... ......++||..|.+||++.....++++|+|+||||+|+|+.|++||.+.. .+..+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliFq 297 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIFQ 297 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHHH
Confidence 988543211 112256899999999999999999999999999999999999999997631 122211
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
++ + .++-.+++.+++.. .+|+.+.+..||.+|+++++|.+|
T Consensus 298 kI-~--------~l~y~fp~~fp~~a---~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KI-Q--------ALDYEFPEGFPEDA---RDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH-H--------HhcccCCCCCCHHH---HHHHHHHHccCccccccHHHHhhC
Confidence 11 1 12233455555444 455669999999999999999877
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=352.95 Aligned_cols=267 Identities=29% Similarity=0.398 Sum_probs=209.3
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..++||+|.||.||+| +..+|+.||+|++.....+ ........+||.+++++.||||+++.+...+.
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~--------~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK--------EGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC--------CcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 45666778999999999999 6678999999998544322 23345677999999999999999999998776
Q ss_pred --ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 605 --YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 605 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
...|||+|||+. ||.-++......|++.++..++.|++.||+|+|+ +||+|||||.+|||||.+|.+||+|||+
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccc
Confidence 678999999965 8888888877899999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-----------cchh
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDN-----------KNII 750 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------~~~~ 750 (840)
|+++... .....+..+-|..|.|||.+.+. .|+.+.|+||.|||+.||++|++.|++..+.. ....
T Consensus 265 Ar~y~~~--~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 265 ARFYTPS--GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred eeeccCC--CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 9988653 33446677889999999998775 69999999999999999999999998753311 1111
Q ss_pred hhhhhhhccccchhh--hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 751 YWVSIKVDTKEGIME--VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.|...++........ -....+.+.+.......++|+..++..||.+|.|+.++++.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 232111111110000 01111222233344567888889999999999999998865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=360.06 Aligned_cols=262 Identities=29% Similarity=0.398 Sum_probs=213.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+++...+.||+|+||+||+|.|.+ .||||++...... ....+.|+.|+.++++-+|.||+-+.|||..+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt--------~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPT--------PEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred HHHhhccceeccccccceeeccccc--ceEEEEEecCCCC--------HHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3455677899999999999999873 6999999544322 34678999999999999999999999999988
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
.. .||+.||+|-+|+.+++..+..++..+...||.|||+|+.|||. ++|||||||..||+++++++|||+|||++.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence 87 99999999999999999988889999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
..... ..........|...|||||++.. .+|++.+||||||+++|||+||..||... .++...|+... .
T Consensus 537 vk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~dqIifmVGr---G- 608 (678)
T KOG0193|consen 537 VKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRDQIIFMVGR---G- 608 (678)
T ss_pred eeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---ChhheEEEecc---c-
Confidence 65443 22334455568889999999864 36899999999999999999999999832 22223332110 0
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
...+.......+...++.+|+..||..++++||.+.+|+..|+++.+
T Consensus 609 ----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 ----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 01111222223455677788889999999999999999999988776
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.27 Aligned_cols=399 Identities=21% Similarity=0.217 Sum_probs=350.1
Q ss_pred CCEEecCCCcCcccCCccccCC--CCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNL--TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l--~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
-..||++++.+...--..+.++ +.-+.|++++| ++..+....|.++++|+++.+..|.++ .+|...+...+|+.
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnN---kl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~ 129 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNN---KLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEK 129 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeecccc---ccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeE
Confidence 4678999999884322223332 35567999999 888888889999999999999999998 67877777778999
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCC-cccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP-EELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 175 (840)
|+|.+|.|+..-.+.++.++.|+.|||+.|. ...+| ..|..-.++++|+|++|.|+.+....|..+.+|.+|.|++|
T Consensus 130 L~L~~N~I~sv~se~L~~l~alrslDLSrN~--is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrN 207 (873)
T KOG4194|consen 130 LDLRHNLISSVTSEELSALPALRSLDLSRNL--ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRN 207 (873)
T ss_pred EeeeccccccccHHHHHhHhhhhhhhhhhch--hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccC
Confidence 9999999998888899999999999999996 33444 45666678999999999999888899999999999999999
Q ss_pred ccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCc
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 255 (840)
+|+..++..|..+++|+.|+|..|+|.-..--.|.++++|+.|.|..|.|+..-...|..+.+++.|+|..|++...-.+
T Consensus 208 rittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g 287 (873)
T KOG4194|consen 208 RITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG 287 (873)
T ss_pred cccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc
Confidence 99999999999999999999999999855567899999999999999999988899999999999999999999999899
Q ss_pred ccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcc
Q 003199 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISL 335 (840)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 335 (840)
++.+++.|+.|++++|.|...-++++...++|+.|+|++|+|+...+..|..+..|++|+|++|++......+|..+.+|
T Consensus 288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL 367 (873)
T KOG4194|consen 288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL 367 (873)
T ss_pred cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh
Confidence 99999999999999999998889999999999999999999999999999999999999999999997777888899999
Q ss_pred cEEEcCCCccCCCCCC---cccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEcc
Q 003199 336 VKIDLSDNLLSGPIPS---GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFS 412 (840)
Q Consensus 336 ~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~ 412 (840)
+.|||++|.|+..+.+ .|.+|++|+.|.|.+|+|..+...+|.++++|++|||.+|.|...-|..|..+.++.|.+.
T Consensus 368 ~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~n 447 (873)
T KOG4194|consen 368 HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMN 447 (873)
T ss_pred hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhc
Confidence 9999999999876654 4778999999999999999888889999999999999999999888889988888888887
Q ss_pred CCCCcCcCCcc
Q 003199 413 NNRLSGPIPLS 423 (840)
Q Consensus 413 ~N~l~~~~p~~ 423 (840)
.-.+-|.|...
T Consensus 448 SssflCDCql~ 458 (873)
T KOG4194|consen 448 SSSFLCDCQLK 458 (873)
T ss_pred ccceEEeccHH
Confidence 77777766543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=349.37 Aligned_cols=267 Identities=25% Similarity=0.328 Sum_probs=210.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 600 (840)
.+.++|...++||.|.||.||+|+ ..+|+.||||+++.+-.. ...-.-.+|+..++++. ||||+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---------~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---------WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---------HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 456788999999999999999995 457999999998654322 11223468999999998 9999999999
Q ss_pred EecCc-cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 601 FSSLY-CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 601 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
+.+.+ ..++||||| ..+|++.+..+...+++.++..|+.||.+||+|+|. +|+.|||+||+|||+.....+||+|
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecc
Confidence 98888 999999999 679999999888899999999999999999999999 9999999999999999988999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
||+|+.+.. ..+.+..+.|+.|.|||++. .+.|+.+.||||+|||++|+.+-++-|.+..+- ..+.....+...
T Consensus 154 FGLARev~S----kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 154 FGLAREVRS----KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLGT 228 (538)
T ss_pred ccccccccc----CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhCC
Confidence 999998743 44567788999999999875 567899999999999999999999988764221 111111111100
Q ss_pred -cccchh--------------hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 -TKEGIM--------------EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 -~~~~~~--------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..+.+. .+....+..-......+..+++.+|+++||.+||||.|++++-
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000000 0111111111233557788999999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=369.71 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=218.1
Q ss_pred CccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 529 TEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+.++||.|.||.||+|.++- ...||||.++.... .+...+|..|+.||.+++||||+++.|.....
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt---------ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT---------EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCcc---------HHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 356789999999999997752 35799999965442 45578899999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...+||+|||++|+|..+|+.+..++.+.+...+.++||.|+.||.+ +++|||||.++|||++.+..+||+|||+++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999999999998889999999999999999999999 999999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.+.+............-+.+|.|||.+.-++++.+|||||||++|||.++ |..||-+..+ .+-+
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------------QdVI 844 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------------QDVI 844 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------------HHHH
Confidence 87654322222222233478999999999999999999999999999887 9999865311 1112
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
..+.+...-+-..+++..+.+|++.||++|-.+||.+.+|+.+|.++.....
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 2233333344556788899999999999999999999999999998766554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=318.39 Aligned_cols=267 Identities=25% Similarity=0.364 Sum_probs=209.4
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+++|+|.||.||+| +.++|+.||||+++....+. .......+||+.++.++|+||+.++++|...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--------GINRTALREIKLLQELKHPNIIELIDVFPHK 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--------CccHHHHHHHHHHHHccCcchhhhhhhccCC
Confidence 35677789999999999999 66789999999997654321 1234567899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..-+|+|||+ .+|...++.....+...++..++.++.+|++|||+ +.|+||||||.|+|++++|.+||+|||+|+
T Consensus 74 ~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 74 SNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred CceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchh
Confidence 99999999995 59999999888789999999999999999999999 999999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC-----------cchhhh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDN-----------KNIIYW 752 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------~~~~~~ 752 (840)
.+... .......+-|..|.|||.+.+. .|+...||||.|||+.||+-|.+-|.+..+-+ .....|
T Consensus 150 ~f~~p---~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 150 FFGSP---NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred ccCCC---CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 98653 2333344789999999998775 68999999999999999999887666542211 111112
Q ss_pred hhhh-hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 753 VSIK-VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 753 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
-.+. ..+...+...-.+....-+.....+.++++..++..||.+|++++|++++=
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 1111 011111111111112223445566779999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.72 Aligned_cols=272 Identities=28% Similarity=0.396 Sum_probs=211.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||.|..++||+|.. ..++.||||++..++.. ...+.+.+|+..|+.++||||++.+..|..+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---------~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---------NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---------hhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 4677888999999999999954 57899999999554422 2257899999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...|+||.||.+||+.+.+... ...+++..+..|.+++++||.|||+ +|.||||||+.|||++++|.+||+|||.+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999999999998765 3468999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcce-ecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 684 KVLQARGGKDSTT-TVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
..+.+.+...... ....||+.|||||++.. ..|+.|+||||||+...|+.+|..||.....-. -+. ....-...
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-vLl--~tLqn~pp 250 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-VLL--LTLQNDPP 250 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-HHH--HHhcCCCC
Confidence 7776654333333 56789999999999644 469999999999999999999999998642110 000 00000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCCCC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPCRF 815 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~~~ 815 (840)
.......+. +........+.+++..|+++||++|||+++++++ +.....+.+
T Consensus 251 ~~~t~~~~~---d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 251 TLLTSGLDK---DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred CcccccCCh---HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 000000010 0112223466778889999999999999999986 455444443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=344.27 Aligned_cols=257 Identities=30% Similarity=0.449 Sum_probs=200.2
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+...+.||+|+||+||++... +|+..|||....... .. .+.+.+|+.++++++|||||+.+|......
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---------~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---------PT-SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---------hh-HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 3456778999999999999665 599999998743310 11 567899999999999999999999855544
Q ss_pred --cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecccc
Q 003199 606 --CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGI 682 (840)
Q Consensus 606 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~ 682 (840)
.+++.|||+++|+|.+++.+.+..++++.+..+..||++||+|||+ +|||||||||+|||++. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 5889999999999999999865479999999999999999999999 99999999999999999 79999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++................||+.|||||++..+ ....++||||+||++.||+||+.||...... ..+. .....
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~~---~~ig~ 237 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEAL---LLIGR 237 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHHH---HHHhc
Confidence 98765322223344567899999999999853 3446999999999999999999999752100 0010 00000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.-..+.++.. ...+..+++.+|+..||++||||.+++++--.
T Consensus 238 ---~~~~P~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 238 ---EDSLPEIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ---cCCCCCCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 0011123333 33445556669999999999999999998643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.57 Aligned_cols=368 Identities=22% Similarity=0.242 Sum_probs=337.5
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCccccccc-ccccEEEecCccccccCCccccCCCCCcE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL-TKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
+-++||||+|.+..+-+..|.++++|+++++..| .++.+|. |... .+|+.|+|.+|.|.++-...+..++.|+.
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N---~Lt~IP~--f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrs 153 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKN---ELTRIPR--FGHESGHLEKLDLRHNLISSVTSEELSALPALRS 153 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccc---hhhhccc--ccccccceeEEeeeccccccccHHHHHhHhhhhh
Confidence 4567999999999999999999999999999999 7777775 4544 56999999999999888889999999999
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
|||+.|.|+...-..|..-.++++|+|++|+ +...-.+.|.++.+|..|.|++|+|+...+..|++|++|+.|+|..|+
T Consensus 154 lDLSrN~is~i~~~sfp~~~ni~~L~La~N~-It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ 232 (873)
T KOG4194|consen 154 LDLSRNLISEIPKPSFPAKVNIKKLNLASNR-ITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR 232 (873)
T ss_pred hhhhhchhhcccCCCCCCCCCceEEeecccc-ccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence 9999999996666789999999999999998 555556789999999999999999998888999999999999999999
Q ss_pred cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcc
Q 003199 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256 (840)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 256 (840)
|.-...-.|.++++|+.|.|..|.|.......|..+.++++|+|+.|++...-..++.++.+|+.|++++|.|..+.++.
T Consensus 233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 98555778999999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccc---hhhcccC
Q 003199 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIP---SEIYRAI 333 (840)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~ 333 (840)
..-+++|++|+|++|+|+...+..|..+..|+.|.|++|+++..-..+|..+++|+.|+|++|.|...+. ..|..++
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~ 392 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLP 392 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccch
Confidence 9999999999999999998888899999999999999999999888999999999999999999987654 3577799
Q ss_pred cccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcc
Q 003199 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392 (840)
Q Consensus 334 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 392 (840)
+|+.|+|.+|+|..+.-.+|.++..|+.|||.+|.|.++.|++|..+ +|++|.+..-.
T Consensus 393 ~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 393 SLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred hhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 99999999999996666689999999999999999999999999999 89999876533
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=348.37 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=206.4
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
.+.+++-||+|+.|.||.|++. ++.||||+++.- -..+|+.+++++|+||+.|.|.|....+
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-----------------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----------------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred HhhhhhhhccCcccceeeeecc-CceehhHHHhhh-----------------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 3455677999999999999998 799999987322 2347889999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
++||||||..|-|+..|..+. .+.-.....|..+||.|+.|||. +.|||||||.-||||..+..+||+|||-++..
T Consensus 187 yCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999999999998875 57777888999999999999999 99999999999999999999999999999877
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh-h
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM-E 765 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 765 (840)
.+ ......++||..|||||++.+...++|+||||||||||||+||..||.+. +.....|- +. +
T Consensus 263 ~~----~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV---dssAIIwG---------VGsN 326 (904)
T KOG4721|consen 263 SD----KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV---DSSAIIWG---------VGSN 326 (904)
T ss_pred hh----hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc---chheeEEe---------ccCC
Confidence 54 24455688999999999999999999999999999999999999999763 11122221 11 1
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCC
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFES 817 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 817 (840)
.+.- +-...++..+.-|+++||+..|..||++.+++.||.-+.+.-+..
T Consensus 327 sL~L---pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~ 375 (904)
T KOG4721|consen 327 SLHL---PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST 375 (904)
T ss_pred cccc---cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence 1111 112233445556777999999999999999999998877665543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.95 Aligned_cols=237 Identities=30% Similarity=0.420 Sum_probs=198.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||.|+||+|..++.+ +|..+|+|++.... .-..+..+...+|..+++.+.||.++++++.+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-------vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-------VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN 116 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-------HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence 45667788999999999999655 68999999985443 22345567889999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...+|||||++||-|+.++++.+ +++++.++-+|.+|+.|++|||+ .+|++||+||+|||+|++|.+||+|||.|+
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 99999999999999999999876 79999999999999999999999 999999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. .+.+.+|||.|+|||.+....+..++|.|||||++|||+.|.+||.+... ...+ .
T Consensus 193 ~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY-----------~ 251 (355)
T KOG0616|consen 193 RVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIY-----------E 251 (355)
T ss_pred EecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHH-----------H
Confidence 8643 36678999999999999999999999999999999999999999976422 1111 1
Q ss_pred hhcccc--cCCCcHHHHHHHHHHHHHccCCCCCCC
Q 003199 765 EVLDKK--LSGSFRDEMIQVLRIAIRCTSKSPATR 797 (840)
Q Consensus 765 ~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~R 797 (840)
+++..+ .+..+. .++.+|+...++.|-.+|
T Consensus 252 KI~~~~v~fP~~fs---~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 KILEGKVKFPSYFS---SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHhCcccCCcccC---HHHHHHHHHHHhhhhHhh
Confidence 122221 222222 344556668888888888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=345.87 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=207.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||||+.+ +.+.||+|.+.+.... .+..+.+.+|++++++++|||||.++++|+..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~--------~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~ 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN--------EKELKNLRQEVRILRSLKHPNIVEMLESFETS 73 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc--------hHHHHHHHHHHHHHHhcCCcchhhHHHhhccc
Confidence 45666778999999999999554 7899999998443321 34467789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
.+.++|+||+.| +|+.++.... .++++.+..|+.+++.||.|||+ .+|.|||+||.|||++..|++|+||||+|+
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhh
Confidence 999999999966 9999998875 79999999999999999999999 999999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. .....+...|||-|||||...++.|+..+|+||+|||+||+++|++||... .+...++....
T Consensus 149 ~m~~---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~------ 214 (808)
T KOG0597|consen 149 AMST---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILK------ 214 (808)
T ss_pred hccc---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhc------
Confidence 8753 445667788999999999999999999999999999999999999999642 11111111111
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
|+. .........+..++...+.+||.+|.+-.+++.|
T Consensus 215 ---d~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 215 ---DPV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CCC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111 1112444556667779999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.70 Aligned_cols=271 Identities=28% Similarity=0.368 Sum_probs=204.5
Q ss_pred CccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc--cCCCCcceeeeEEecCc-
Q 003199 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN--IRHKNIVKLYCYFSSLY- 605 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~- 605 (840)
+..+.||+|.||.||+|++. ++.||||++. .+..+.|..|-.+.+. ++|+||++++++-....
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-------------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-------------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC-------------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34567999999999999988 6999999983 3335667777777655 58999999999876655
Q ss_pred ---cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCCEEEcCCCCCe
Q 003199 606 ---CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL------LSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 606 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
.++||+||.+.|+|.++|..+ ..+|....+++..+++||+|||+.. .++|+|||||++|||+..|+++.
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 789999999999999999987 6899999999999999999999753 45799999999999999999999
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccCC------CCccccchhHHHHHHHHHhCCCCCC-CCCCCCcch
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK------ATTKCDVYSFGVVLMELITGRKPVE-DDFGDNKNI 749 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg~~p~~-~~~~~~~~~ 749 (840)
|+|||+|.++... .........+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-+. +..++ -..
T Consensus 357 IaDFGLAl~~~p~-~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~-Yql 434 (534)
T KOG3653|consen 357 IADFGLALRLEPG-KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE-YQL 434 (534)
T ss_pred eeccceeEEecCC-CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc-ccC
Confidence 9999999888642 2233344588999999999987642 2347899999999999999754332 11110 000
Q ss_pred hhhhhh-hhccccch-hhhcccccCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCC
Q 003199 750 IYWVSI-KVDTKEGI-MEVLDKKLSGSFRDE------MIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFES 817 (840)
Q Consensus 750 ~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 817 (840)
..-... ....-+.+ ..++.++.++.+++. +..+.+.+-.||+.||+.|.|+.=+-+.++++...+..+
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~ 510 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDS 510 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCcc
Confidence 000000 01111112 224444555555433 455778888999999999999999999998887777653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.37 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=205.5
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
...|+...+||+|+.|.||.| +..+++.||||++.... ....+-+.+|+.+|+..+|+|||.++..|..
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----------Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK----------QPKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc----------CCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 456777789999999999999 55678999999984433 2234668899999999999999999999988
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..|.|||||++|+|.+.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred cceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeee
Confidence 89999999999999999999876 58999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..+.. ........+|||.|||||+.....|++|.||||||++.+||+.|++||-.+..-. ..|. +....
T Consensus 417 aqi~~---~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---AlyL---Ia~ng-- 485 (550)
T KOG0578|consen 417 AQISE---EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL---IATNG-- 485 (550)
T ss_pred ecccc---ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HHHH---HhhcC--
Confidence 87754 2235567889999999999999999999999999999999999999996421111 1111 00000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+++ .........+.+++.+|++.||++|++++|+++|
T Consensus 486 ----~P~l-k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 ----TPKL-KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----CCCc-CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0011 1122334456667779999999999999999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=374.88 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=208.5
Q ss_pred hcCccCeeeccCCcEEEEEEeCC--Cc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNS--GE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..+..+.||+|+||.||+|.+.+ |. .||||.+.... ..+...+|.+|..+|+.++|||||+++|.
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---------~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---------SEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---------CHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 34456789999999999997653 43 38888874332 24557889999999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcC------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKG------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
|.+....++++|||++|+|..+|++. ...+...+...++.|||+|+.||++ +++|||||.++|+|++....
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCc
Confidence 99999999999999999999999987 5678899999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 753 (840)
|||+|||+|+.+.+.... .......-..+|||||.+..+.++.|+|||||||++||++| |..||.+... ...
T Consensus 841 VKIaDFGlArDiy~~~yy-r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v---- 913 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYY-RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEV---- 913 (1025)
T ss_pred EEEcccchhHhhhhchhe-eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHH----
Confidence 999999999965442211 11111244579999999999999999999999999999999 9999976311 111
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
+..+......+....+...+.+++.+||+.+|++||++..+++.+..+.+
T Consensus 914 ---------~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 914 ---------LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ---------HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11122222222233456678899999999999999999999998876543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.10 Aligned_cols=260 Identities=26% Similarity=0.327 Sum_probs=207.2
Q ss_pred ccCeeeccCCcEEEEEEeCC--C--cE-EEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 530 EKNKVGQGGSGTVYKIDLNS--G--EV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..++||+|+||.||+|.++. + .. ||||..+... .......++|.+|+++|+.++|||||+++|++...
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-------~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-------ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-------cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 44789999999999996653 2 23 8999885421 12245578899999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|||+|+||+|.++|.+....++..++..++.+.|+||+|||+ ++++||||.++|+|++.++.+||+|||+++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999987679999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.-.. .........-+.+|+|||.+....|++++|||||||++||+++ |..||.+.... .. .
T Consensus 311 ~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v-------~ 372 (474)
T KOG0194|consen 311 AGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EV-------K 372 (474)
T ss_pred CCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HH-------H
Confidence 5320 1111112234579999999999999999999999999999999 89999864211 00 1
Q ss_pred hhh-cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCC
Q 003199 764 MEV-LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFES 817 (840)
Q Consensus 764 ~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 817 (840)
..+ .+....+.....+..+..++.+||..+|+.||+|.++.+.++.+......+
T Consensus 373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111 111111112234455666777999999999999999999999887776654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.39 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=205.8
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 602 (840)
...|...+.||+|+||+|+.| ...+|+.||||++....... .. ....+.+.+|+.++++++ ||||++++.++.
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~----~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS----KS-QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc----cc-cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 456788899999999999999 55578999999664432110 01 123455668999999998 999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCCeeeccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADFG 681 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg 681 (840)
.....++||||+.+|+|.+++.. ...+.+.++..++.|++.|++|+|+ +||+||||||+||+++.+ +.+||+|||
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999999998 4478999999999999999999999 999999999999999999 999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK-AT-TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
++.... ..+......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. ...........
T Consensus 167 ~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRKIRKG 238 (370)
T ss_pred cccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcC
Confidence 998763 2344566789999999999999877 75 78999999999999999999998631 11111111111
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. .++.... ..++..++.+|+..||.+|+++.+++.+=
T Consensus 239 ~~--------~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 239 EF--------KIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred Cc--------cCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 10 1122221 55677788899999999999999999553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.45 Aligned_cols=260 Identities=27% Similarity=0.369 Sum_probs=200.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++..+ +||||++++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---------ASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---------hHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 5678889999999999999953 2356899998853221 12345688999999999 899999999
Q ss_pred eEEecCc-cceEEEeecCCCChHHHhhcCC--------------------------------------------------
Q 003199 599 CYFSSLY-CNLLVYEYMPNGNLWDALHKGL-------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------- 627 (840)
++|.... ..++||||+++|+|.+++....
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 9887644 5789999999999999886531
Q ss_pred -----------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcce
Q 003199 628 -----------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696 (840)
Q Consensus 628 -----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 696 (840)
..+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~~~ 233 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRK 233 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCc-chhcc
Confidence 237788999999999999999999 999999999999999999999999999997653211 11122
Q ss_pred ecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCc
Q 003199 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSF 775 (840)
Q Consensus 697 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 775 (840)
....+++.|+|||++.+..++.++|||||||++|||++ |..||.+..... . ..... .+.......
T Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~---~~~~~----------~~~~~~~~~ 299 (338)
T cd05102 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E---FCQRL----------KDGTRMRAP 299 (338)
T ss_pred cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H---HHHHH----------hcCCCCCCC
Confidence 23446688999999999899999999999999999997 999997532110 0 11100 000000011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 776 RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 776 ~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1223467788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=335.53 Aligned_cols=273 Identities=25% Similarity=0.327 Sum_probs=208.4
Q ss_pred hHHHHHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhh----HHHHHHHHHHHHHHhccCCCCc
Q 003199 520 DQREILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQ----LQLDKGLKTEVETLGNIRHKNI 594 (840)
Q Consensus 520 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~ni 594 (840)
+.+...++|+..+.||+|.||.|-+|. ..+++.||||++.+............ ....+...+||.+|+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 345567889999999999999999994 45799999999965543321111111 1123578999999999999999
Q ss_pred ceeeeEEec--CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 595 VKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 595 v~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
|+++.+..+ .+..|||+|||..|.+.. .......+++.++++++.+++.||+|||. +|||||||||+|+|++++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 999999976 457799999999887743 33333348999999999999999999999 999999999999999999
Q ss_pred CCCeeecccchhhhhcc--CCCCcceecccccccccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 003199 673 YQPKVADFGIAKVLQAR--GGKDSTTTVIAGTYGYLAPEYAYSSK----ATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 746 (840)
|++||+|||.+...... .+.+.......|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-+++.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999999998765321 12223334578999999999987732 36789999999999999999999976421
Q ss_pred cchhhhhhhhhccccchhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 747 KNIIYWVSIKVDTKEGIMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+.. ..+++...+ -+...+....+.+|+.+++.+||++|.+..+|..|.+-..
T Consensus 325 --~~l-----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 --LEL-----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred --HHH-----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 111 111222221 2333445566778888999999999999999999986433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.09 Aligned_cols=291 Identities=23% Similarity=0.292 Sum_probs=213.1
Q ss_pred HHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
-.++|+.++.|++|.||.||+| +.++++.||+|+++-...+.. .--.-.+||.++.+++|||||.+-....
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G--------FPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG--------FPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC--------CcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3467788899999999999999 556899999999965543211 1123468999999999999999987764
Q ss_pred --cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 603 --SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 603 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+-+..|+|||||+. +|...++.....+...++..++.|+++|++|||. ..|+|||||++|+|+...|.+||+||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEeccc
Confidence 45678999999965 9999998887789999999999999999999999 89999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-----------c
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNK-----------N 748 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------~ 748 (840)
|+|+.+.. .....+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+...-+. .
T Consensus 222 GLAR~ygs---p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 222 GLAREYGS---PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred chhhhhcC---CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 99998854 23456667789999999998775 689999999999999999999998876432111 1
Q ss_pred hhhhhhhhhcccc---chhhhcccccCCCcHHH--HHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC-CCCCCC---CC
Q 003199 749 IIYWVSIKVDTKE---GIMEVLDKKLSGSFRDE--MIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD-PCRFES---CK 819 (840)
Q Consensus 749 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~-~~~~~~---~~ 819 (840)
...|-....-... .........++..+... ...-++++...+..||.+|.|+.|.+++=.-.. |....+ -+
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPT 378 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCC
Confidence 1111111000000 00000011111222111 245567888999999999999999998843222 222222 34
Q ss_pred CCCCccccCC
Q 003199 820 FPNKSNKESS 829 (840)
Q Consensus 820 ~~~~~~~~~~ 829 (840)
||.+++.+..
T Consensus 379 ~P~k~~~~~~ 388 (419)
T KOG0663|consen 379 WPAKSEQQRV 388 (419)
T ss_pred CccccccccC
Confidence 5555555543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.63 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+.+.+||+|+||.||.|+.+ +|..+|+|++++... ......+.+..|-.+|....+|.||+++-.|++
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-------~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-------LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-------HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 456788899999999999999655 799999999965432 223446778889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..||||||++||++...|.+.. .+++..+..++.+++.|++.+|+ .|+|||||||+|+|||..|++||+|||++
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeecccccc
Confidence 999999999999999999998875 79999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccC-------------------CCCcc-------------------------eecccccccccCccccccCCCCcc
Q 003199 684 KVLQARG-------------------GKDST-------------------------TTVIAGTYGYLAPEYAYSSKATTK 719 (840)
Q Consensus 684 ~~~~~~~-------------------~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~ 719 (840)
.-+.... ..+.. ....+|||.|||||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 5442100 00000 012579999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCC--CcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCC
Q 003199 720 CDVYSFGVVLMELITGRKPVEDDFGD--NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR 797 (840)
Q Consensus 720 ~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 797 (840)
+|.||+|||+|||+.|.+||..+... ...+..|...- . .+...+...+..+||.+|+. ||++|
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------~-------fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------K-------FPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------c-------CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999999865321 12222232110 0 01111122566678889988 99999
Q ss_pred C---CHHHHHHH
Q 003199 798 P---TMNEVVQL 806 (840)
Q Consensus 798 p---s~~evl~~ 806 (840)
. .+.||.+|
T Consensus 434 LG~~G~~EIK~H 445 (550)
T KOG0605|consen 434 LGSKGAEEIKKH 445 (550)
T ss_pred cCcccHHHHhcC
Confidence 7 57787765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.48 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=209.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+....+++||+|.||.|..+....+..||||+++.... .....+|.+|+++|.+++|||||+++|.|..++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~---------~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT---------KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc---------hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 34566789999999999999998889999999855432 344688999999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCC-CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++|+|||++|+|.+++..+... ..-.....|+.|||.|++||.+ .++||||+.++|+|+|.++++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence 999999999999999999887432 2455667799999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT--GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
-+... ..........-+.+|||||.+..++++.+||||+||+.+||+++ .+.||.+..+ .+.+...........
T Consensus 686 ~lysg-~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~- 761 (807)
T KOG1094|consen 686 NLYSG-DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQG- 761 (807)
T ss_pred ccccC-CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCC-
Confidence 66442 22233344556789999999999999999999999999999876 7889875421 111111111111110
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
..+ ......-+...+.+++.+||..|-++||+++++...|.+.
T Consensus 762 -~~~----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 -RQV----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -cce----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 000 1111223456778999999999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=334.89 Aligned_cols=248 Identities=29% Similarity=0.393 Sum_probs=204.7
Q ss_pred hcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|+..+.||+|+||.||+| +..+++.||+|++.....+ ...+++..|+.++..++++||.+.||.+..+.
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~---------deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE---------DEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcc---------hhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 4566688999999999999 5568999999999544322 22467888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..+++||||.+|++.+.+..+. .+++..+..+.+++..|+.|+|. ++.+|||||+.||++..+|.+|++|||.+..
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeee
Confidence 9999999999999999998875 45888888999999999999999 9999999999999999999999999999977
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
+.. .......++||+.|||||++....|+.|+||||||++.+||.+|.+|+.+...- .+.-
T Consensus 161 l~~---~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlf 221 (467)
T KOG0201|consen 161 LTN---TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLF 221 (467)
T ss_pred eec---hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEE
Confidence 643 222336789999999999999889999999999999999999999999864220 0111
Q ss_pred hcccccCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFR-DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+.+..++.+. +....+.+++..|+.+||+.||+|.+++++
T Consensus 222 lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 LIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred eccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 12222222221 233445667779999999999999999887
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.25 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=208.3
Q ss_pred hcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
-|...+-||.|+.|.|-.|+ ..+|+.+|||++.+... ........+.+|+.+|+-+.|||++++++.+++..
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-------~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-------LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccc-------cccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 35567789999999999995 46899999999955431 11223567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
++|+|.||+++|-|++++-..+ .+++.++.+++.||+.|+.|+|. .+|+|||+||+|+|+|..+.+||+|||+|..
T Consensus 86 ~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeec
Confidence 9999999999999999998776 78999999999999999999999 8999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
- ..+....+.+|+|.|.|||++.+..| +.++||||.|||||.|+||+.||+++. -..+.. ++..
T Consensus 162 e----~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLl----KV~~----- 226 (786)
T KOG0588|consen 162 E----VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLL----KVQR----- 226 (786)
T ss_pred c----cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHH----HHHc-----
Confidence 4 23445567899999999999999988 578999999999999999999998641 111111 1110
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
+.+ .-......+..+|+.+|+..||++|.|++||++|-.=...
T Consensus 227 ----G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 227 ----GVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ----Ccc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 000 0112334566778889999999999999999999654333
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=327.35 Aligned_cols=268 Identities=28% Similarity=0.364 Sum_probs=213.3
Q ss_pred hhHHHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc--CCCCcce
Q 003199 519 FDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI--RHKNIVK 596 (840)
Q Consensus 519 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~ 596 (840)
+.++.+..+.+..+.||+|.||.||+|+|+ |+.||||+|.... +..+.+|.++++.+ +|+||+.
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-------------E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-------------ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc-------------hhhhhhHHHHHHHHHhccchhhh
Confidence 468889999999999999999999999999 8999999995433 34566777777664 8999999
Q ss_pred eeeEEec----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCE
Q 003199 597 LYCYFSS----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG-----LLSPIIHRDIKSTNI 667 (840)
Q Consensus 597 l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Ni 667 (840)
+++.=.. ..+.+||++|.+.|||+|+|.+. .++-....+++..+|.||+|||.. ..+.|.|||||+.||
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 9987533 24668999999999999999985 689999999999999999999952 346799999999999
Q ss_pred EEcCCCCCeeecccchhhhhcc-CCCCcceecccccccccCccccccCC------CCccccchhHHHHHHHHHhC-----
Q 003199 668 LLDVNYQPKVADFGIAKVLQAR-GGKDSTTTVIAGTYGYLAPEYAYSSK------ATTKCDVYSFGVVLMELITG----- 735 (840)
Q Consensus 668 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg----- 735 (840)
|+..++++.|+|+|+|...... +.-+......+||.+|||||++...- ....+||||||.|+||++-+
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999999999776543 33455667889999999999986542 23469999999999999864
Q ss_pred -----CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCc------HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003199 736 -----RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSF------RDEMIQVLRIAIRCTSKSPATRPTMNEVV 804 (840)
Q Consensus 736 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~Rps~~evl 804 (840)
+.||.+....+.... +....+...++++.. .+.+..+.+++..||..+|..|.|+-.+.
T Consensus 428 i~eey~~Pyyd~Vp~DPs~e----------eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFE----------EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred EehhhcCCcccCCCCCCCHH----------HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 456665433333221 112223333443332 35678899999999999999999999999
Q ss_pred HHhhhcCC
Q 003199 805 QLLAEADP 812 (840)
Q Consensus 805 ~~L~~~~~ 812 (840)
+.|.++..
T Consensus 498 Ktl~~l~~ 505 (513)
T KOG2052|consen 498 KTLAKLSN 505 (513)
T ss_pred HHHHHHhc
Confidence 99998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.96 Aligned_cols=260 Identities=28% Similarity=0.406 Sum_probs=215.5
Q ss_pred HHHHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeee
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYC 599 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 599 (840)
......|...+.+|+|..++|-++ ...+|...|+|++......... .......+.-..|+.+++++ .||+|+++.+
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~--e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESG--ETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCC--ccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 455677888999999999999886 6668999999998655443322 22455667788999999999 5999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
+|+.+...++|+|.|+.|.|++++... ..+++...+.|+.|+.+|++|||. +.||||||||+|||+|++..+||+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEec
Confidence 999999999999999999999999876 478999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY------SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
||.|..+.+ .......+|||+|.|||.+. ...|+...|+||.|||+|.++.|.+||- .
T Consensus 167 FGFa~~l~~----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw------------H 230 (411)
T KOG0599|consen 167 FGFACQLEP----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW------------H 230 (411)
T ss_pred cceeeccCC----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh------------H
Confidence 999988754 33456789999999999874 2468889999999999999999999984 2
Q ss_pred hhhhccccchhhhcccc---cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIKVDTKEGIMEVLDKK---LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+..+-. ...+...+ -.+.+.+......+|+.+|++.||.+|.|++|+++|
T Consensus 231 RkQmlM---LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 231 RKQMLM---LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHH---HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 221111 11112222 245666777778889999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.35 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=198.6
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec----Ccc
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS----LYC 606 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 606 (840)
...||+|++|.||+|.+ +|+.||||++..... ......+.+.+|+.++++++||||++++|++.+ ...
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-------GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEecccccc-------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 35799999999999988 489999999854321 112335678899999999999999999999866 346
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+++|+|.+++.... .++|.....++.+++.|++|||+. .+++||||||+||++++++.+||+|||+++.+
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 789999999999999998764 689999999999999999999972 37889999999999999999999999999865
Q ss_pred hccCCCCcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... . ...........
T Consensus 174 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~---~~~~~i~~~~~--- 239 (283)
T PHA02988 174 SSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--K---EIYDLIINKNN--- 239 (283)
T ss_pred ccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHHhcCC---
Confidence 321 123468899999999876 6889999999999999999999999975311 1 11111000000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
....+. +....+.+++.+||+.||++|||++|+++.|+...+
T Consensus 240 ---~~~~~~---~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 ---SLKLPL---DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---CCCCCC---cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 001111 234457778889999999999999999999987654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.66 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=210.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|.||.||.|.. +++-.||+|++.+.+ ....+...++.+|+++-+.++||||+++++||.+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-------i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-------ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-------HHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 46778899999999999999955 478899999996554 2234556789999999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
....|+++||..+|.++..+..+. ..+++.....++.|+|.|+.|+|. ++|+||||||+|+|++.++..|++|||.
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 999999999999999999998543 468999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+..- ......+.+||..|.+||...+..++...|+|++|++.||++.|.+||+... ....+....
T Consensus 171 sV~~-----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~--------- 235 (281)
T KOG0580|consen 171 SVHA-----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIR--------- 235 (281)
T ss_pred eeec-----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHH---------
Confidence 8643 2445667899999999999999999999999999999999999999998642 111111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.++-..+. .......+++.+|+..+|.+|.+..|++++=+
T Consensus 236 ---k~~~~~p~---~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 236 ---KVDLKFPS---TISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---HccccCCc---ccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11112222 23345567888999999999999999998743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.13 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=210.4
Q ss_pred HHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
...+|+..+.||+|.||+|-+| +...|+.||||.+++...+ +.+..-.+.+||++|..++||||++++..|+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-------deqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-------DEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-------cHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 3456677788999999999998 5578999999998655432 3455667899999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..+...+||||..+|.|++++.+.. .+++.+++.+++||+.|+.|+|. +++||||||.+|||+|+++.+||+|||+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccch
Confidence 9999999999999999999999876 79999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+..+.+ ..-...++|++-|.+||++.+..| .+..|-||+||++|.++.|..||++. +...++.
T Consensus 200 SNly~~----~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--Dhk~lvr---------- 263 (668)
T KOG0611|consen 200 SNLYAD----KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--DHKRLVR---------- 263 (668)
T ss_pred hhhhcc----ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--hHHHHHH----------
Confidence 988753 445567899999999999999887 68899999999999999999999863 1111111
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.+....... ++.+....-|+.||+..+|++|-|+.+|..|-+
T Consensus 264 ---QIs~GaYrE--P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 264 ---QISRGAYRE--PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---HhhcccccC--CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111111110 112334455777999999999999999988764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.69 Aligned_cols=256 Identities=24% Similarity=0.312 Sum_probs=201.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|.++ .+..||+|.+..... ......+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS---------DKQRRGFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC---------HHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 45778889999999999999653 357899998854321 22346788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++|+|.+++......+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.++++|||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCc
Confidence 99999999999999999999998765578999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
.+...... .........++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ......
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~-------- 220 (266)
T cd05064 153 RLQEDKSE--AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKA-------- 220 (266)
T ss_pred cccccccc--chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHH--------
Confidence 87653211 1111122345678999999988999999999999999999775 9999975311 111110
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
..+....+........+.+++.+||+.+|++||++.++.+.|+++
T Consensus 221 -----~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 -----VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011111111222345677788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=327.12 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=200.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-----------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 45777889999999999999988888999998743221 1356888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.++++.....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+|++|||.++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 9999999999999999998654468999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ..
T Consensus 150 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i---~~------ 216 (256)
T cd05114 150 VLDD--EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI---SR------ 216 (256)
T ss_pred cCCC--ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---HC------
Confidence 5321 1111222345668999999988889999999999999999999 8999865311 1111110 00
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.............+.+++.+||+.+|++||+++++++.|.
T Consensus 217 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 217 ----GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000001112346788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.12 Aligned_cols=253 Identities=26% Similarity=0.283 Sum_probs=198.5
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+.||+|+||.||+|.. .+|+.||||.+...... .......+.+|+.++++++|++++++++++.+.+.
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~ 74 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-------KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-------hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence 56678899999999999955 57999999988433211 12234567889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++..
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 99999999999999887643 3368999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... ........||..|+|||++.+..++.++|||||||++|||++|+.||......... ..... .. ..
T Consensus 152 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~-~~--~~---- 219 (285)
T cd05631 152 IPE----GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDR-RV--KE---- 219 (285)
T ss_pred cCC----CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHH-Hh--hc----
Confidence 532 11223457899999999999999999999999999999999999999753221100 00000 00 00
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
....... .....+.+++.+||+.||.+||+ +++++++
T Consensus 220 -~~~~~~~---~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSE---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCc---cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0001111 22345677888999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.84 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=200.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|... +|+.||+|++..... ...+..+.+.+|++++++++||||+++++++.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-------IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-------hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 5777889999999999999654 789999999843221 11233566889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 9999999999999999997754 68999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 151 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~------ 213 (291)
T cd05612 151 LRD------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAG------ 213 (291)
T ss_pred ccC------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC------
Confidence 532 12235689999999999988899999999999999999999999975311 0111100000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhh
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQLLA 808 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~L~ 808 (840)
...++... ...+.+++.+|++.||.+||+ +.+++++-.
T Consensus 214 --~~~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 214 --KLEFPRHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred --CcCCCccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 00111222 345667888999999999995 899887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.41 Aligned_cols=245 Identities=23% Similarity=0.304 Sum_probs=195.9
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 610 (840)
+.||+|+||.||+|.. .+|+.||||++..... ........+.+|+.++++++||||+++++++......++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEE
Confidence 4699999999999955 5789999999853221 1122345677899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-- 147 (323)
T cd05571 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-- 147 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--
Confidence 99999999999998754 68999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ...... .+..
T Consensus 148 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~---~~~~~~--------~~~~ 213 (323)
T cd05571 148 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKL---FELILM--------EEIR 213 (323)
T ss_pred -CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHH---HHHHHc--------CCCC
Confidence 12223446799999999999999999999999999999999999999965211 000 000000 0111
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
++.. ...++.+++.+|++.||++|| ++.+++++
T Consensus 214 ~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRT---LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCC---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2222 234566788899999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=320.44 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=196.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|...+.+|+|+||.||+|... +++.||||+.+..... --+|+++|+.++|||||++.-+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------------knrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------------KNRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------------CcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 4667789999999999999665 5799999998765432 136899999999999999988874422
Q ss_pred -----cceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCCe
Q 003199 606 -----CNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPK 676 (840)
Q Consensus 606 -----~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~k 676 (840)
+..+|||||+. +|.+.++.. ...++...+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ |.+|
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEE
Confidence 34689999964 888888742 3567888899999999999999999 999999999999999976 8999
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
|||||.|+.+.. ..+......|+.|.|||.+.+. .|+.+.||||.||++.||+-|++-|.++.+. .++....+.
T Consensus 167 icDFGSAK~L~~----~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~ 241 (364)
T KOG0658|consen 167 ICDFGSAKVLVK----GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKV 241 (364)
T ss_pred eccCCcceeecc----CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHH
Confidence 999999998854 2333556788999999998875 6899999999999999999999999874322 222222221
Q ss_pred -hhccccchhhhccc-------ccCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 -KVDTKEGIMEVLDK-------KLSG------SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 -~~~~~~~~~~~~~~-------~~~~------~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+++.+.....+ .+.+ .......+.++++.++++.+|.+|.++.|++.+
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 12222222221111 1111 112345678899999999999999999999876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.20 Aligned_cols=245 Identities=28% Similarity=0.382 Sum_probs=196.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
.++|...++||+|+||+|+++..+ +++.+|||++++...-. ....+..+.|..++... +||.+++++++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-------~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-------RDEVESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-------cccHHHHHHHHHHHHHhccCCeEeecccccc
Confidence 356788899999999999999765 68899999996654321 12234455666666666 6999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..++.|.||||+.||++..+.+.. .+++..+.-+|..|+.||+|||+ ++|||||||.+|||+|.+|++||+|||+
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~~--~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHTD--VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEecc--cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccc
Confidence 999999999999999965555543 79999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++.-- .....+.+++|||.|||||++.+..|+.++|.|||||+||||+.|+.||.++.++ .+.. ..+.
T Consensus 515 cKe~m---~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--e~Fd---sI~~---- 582 (694)
T KOG0694|consen 515 CKEGM---GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--EVFD---SIVN---- 582 (694)
T ss_pred ccccC---CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHH---HHhc----
Confidence 97532 2445678899999999999999999999999999999999999999999864221 1100 0000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 800 (840)
-+...+. ....+.+.++.+++.++|++|.-+
T Consensus 583 ----d~~~yP~---~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ----DEVRYPR---FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCCCC---cccHHHHHHHHHHhccCcccccCC
Confidence 0111122 234556677779999999999865
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=343.62 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=199.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|+..+.||+|+||.||+|.. .++..||||++..... ....+.+.+|+.+++.+ +||||++++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---------~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---------LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---------cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 4678889999999999999853 2456899999843221 12245688999999999 899999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------------------------------------------------
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL--------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 627 (840)
++|.+....++||||+++|+|.+++....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999886421
Q ss_pred -----------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 628 -----------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 628 -----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++|..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 262 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 262 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccce
Confidence 147889999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+. ....
T Consensus 263 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~---~~~~--- 334 (375)
T cd05104 263 DIRNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMI---KEGY--- 334 (375)
T ss_pred eccCccc-ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHH---HhCc---
Confidence 6543211 111122345678999999999999999999999999999998 88898653211 1111110 0000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
....+ .....++.+++.+||+.||++||++.|+++.|++
T Consensus 335 ----~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 ----RMLSP---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----cCCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00001 1123467788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=333.53 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=198.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-----------------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-----------------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 588 (840)
.+|...+.||+|+||.||+|..++ +..||+|.+.... .......+.+|++++.+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---------NKNARNDFLKEVKILSR 75 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---------CHHHHHHHHHHHHHHhh
Confidence 467788899999999999996532 3469999884322 12235678999999999
Q ss_pred cCCCCcceeeeEEecCccceEEEeecCCCChHHHhhcCC------------------CCCChHHHHHHHHHHHHHHHHHh
Q 003199 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL------------------VHLDWPTRHKIAFGVAQGLAYLH 650 (840)
Q Consensus 589 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH 650 (840)
++||||+++++++.+....++||||+++|+|.+++.... ..++|..+..++.|++.||+|||
T Consensus 76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999886431 24688899999999999999999
Q ss_pred hcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHH
Q 003199 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLM 730 (840)
Q Consensus 651 ~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 730 (840)
+ .+|+||||||+||+++.++.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|
T Consensus 156 ~---~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 156 S---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred H---CCccccCcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 9 999999999999999999999999999997653321 111222344578899999998889999999999999999
Q ss_pred HHHh--CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 731 ELIT--GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 731 el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
||++ +..||.... ......+......... ... ...........+.+++.+||+.||++|||+.+|.+.|+
T Consensus 232 el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 232 EILMLCKEQPYGELT--DEQVIENAGEFFRDQG--RQV----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHccCCCCCCcCC--HHHHHHHHHHHhhhcc--ccc----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 9987 556775421 1111111110000000 000 00011123356788899999999999999999999886
Q ss_pred h
Q 003199 809 E 809 (840)
Q Consensus 809 ~ 809 (840)
+
T Consensus 304 ~ 304 (304)
T cd05096 304 E 304 (304)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=339.67 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=200.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|... +|+.||||++..... ......+.+.+|+.++++++||||+++++++.+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-------LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-------hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 56788899999999999999665 689999999853221 1123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 99999999999999999998764 68899999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+.. .....
T Consensus 167 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~-i~~~~---- 231 (329)
T PTZ00263 167 KVPD------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PFRIYEK-ILAGR---- 231 (329)
T ss_pred EcCC------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HHHHHHH-HhcCC----
Confidence 6532 1223579999999999999899999999999999999999999996531 1101100 00000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
..++... ...+.+++.+|++.||++||+ ++++++|
T Consensus 232 ----~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 ----LKFPNWF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----cCCCCCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111112 234567888999999999996 7888876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=313.75 Aligned_cols=279 Identities=25% Similarity=0.356 Sum_probs=208.4
Q ss_pred HHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+...|...+.||+|+||.|+.| +..+|+.||||++...- +.....+...+|++.++.++|+||+.+.+.+.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--------~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--------hchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 3345555788999999999998 55689999999984322 22445678889999999999999999998875
Q ss_pred c-----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 603 S-----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 603 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
. ....|+|+|+| +.+|.+.++.+. .+....+..+++|+++||.|+|+ .+|+|||+||+|++++.+...||
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEe
Confidence 4 55779999999 679999998764 58999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh-
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI- 755 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 755 (840)
+|||+|+..... ......+....|..|.|||.+.. ..|+.+.||||.|||+.||++|++-|.+...... +......
T Consensus 167 ~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-l~lI~~~l 244 (359)
T KOG0660|consen 167 CDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-LQLILELL 244 (359)
T ss_pred ccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-HHHHHHhc
Confidence 999999987543 33444466778999999998754 5799999999999999999999998876321110 0000000
Q ss_pred hhccccc-----------hhhhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCCCCCC
Q 003199 756 KVDTKEG-----------IMEVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPCRFES 817 (840)
Q Consensus 756 ~~~~~~~-----------~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~~~~~ 817 (840)
.....+. ...-.....+..+ +......++|+.+|+..||.+|+|++|+++| ++...-...|+
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 0000000 0011111111122 2233567788889999999999999999998 44443333343
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=342.07 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=199.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|+..+.||+|+||.||+|... ++..||||++..... ......+.+|+++++.+ +|+||++++
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH---------TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC---------HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 46888899999999999998532 345799999854321 12245688999999999 899999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------------------------------------------------
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL--------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 627 (840)
++|......++||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999885421
Q ss_pred ------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 628 ------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 628 ------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
..+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 246888999999999999999999 99999999999999999999999999999765321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (840)
. .........++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ....... . ..
T Consensus 266 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~---~~~~~~~-~------~~ 333 (374)
T cd05106 266 S-NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K---FYKMVKR-G------YQ 333 (374)
T ss_pred c-ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H---HHHHHHc-c------cC
Confidence 1 1111222345678999999988899999999999999999997 999997532111 0 0000000 0 00
Q ss_pred cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 769 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
...+.. ...++.+++.+||+.||++||++.++++.|+++
T Consensus 334 ~~~~~~---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MSRPDF---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111 235677788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=332.23 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=197.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---------GAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4578889999999999999955 47899999998543211 1124567899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++ |+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCccee
Confidence 99999999997 59999887665568899999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh-hhcccc-
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI-KVDTKE- 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~- 761 (840)
.... .........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ......+. .....+
T Consensus 152 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 152 AKSV---PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEET 227 (288)
T ss_pred eccC---CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHH
Confidence 5432 1122234568899999998865 568999999999999999999999997532111 00000000 000000
Q ss_pred --------chhhhcccccCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 --------GIMEVLDKKLSGS-----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 --------~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......+..... ......+..+++.+|++.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000010110000 01123456788999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.70 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=201.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||.|.+.++..||||.+..... ....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45778889999999999999888777899998753221 1346889999999999999999999999988
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++......+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 8999999999999999998755578999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........++..|+|||...+..++.++||||||+++|||++ |+.||..... ...... ....
T Consensus 150 ~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~---~~~~----- 217 (256)
T cd05113 150 VLDD--EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEK---VSQG----- 217 (256)
T ss_pred cCCC--ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHH---HhcC-----
Confidence 5331 1111122345678999999988889999999999999999999 9999864211 111000 0000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
............+.+++.+||+.+|++||++.++++.++
T Consensus 218 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 -----LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000001112456778888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.53 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=203.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 5678889999999999999988888899999874321 12457889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999999998754 3468899999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........++..|+|||++....++.++||||||+++|||++ |+.||..... .....+.. ..
T Consensus 152 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~----~~--- 220 (261)
T cd05072 152 VIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQ----RG--- 220 (261)
T ss_pred ecCCC--ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHH----cC---
Confidence 65331 1111223345678999999988889999999999999999998 9999965311 11111110 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
. ..+.......++.+++.+|+..+|++||+++++.+.|+++
T Consensus 221 ---~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 ---Y---RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---C---CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 0011112334677888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.50 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=209.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+++|+|+||.++.+..+ ++..+++|.+...+... ...+..+.|+.+++++.|||||.+.+.|.++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--------PERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--------hhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 46777889999999999998554 67899999986554331 2233678899999999999999999999998
Q ss_pred cc-ceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 605 YC-NLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 605 ~~-~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
++ .+|||+|++||++.+.+.+.. ..++++.+..|+.|++.|+.|||+ .+|+|||||+.||+++.+..|||+|||+
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhh
Confidence 88 899999999999999998765 679999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
|+.+... ........||+.||+||.+.+..|..|+||||+||++|||++-+++|..... ..+
T Consensus 153 aK~l~~~---~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--~~L------------- 214 (426)
T KOG0589|consen 153 AKILNPE---DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--SEL------------- 214 (426)
T ss_pred hhhcCCc---hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--HHH-------------
Confidence 9998542 2245667899999999999999999999999999999999999999976310 001
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+..+......+.......++..++..|++.+|..||++.+++.+
T Consensus 215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11222222233334455566777789999999999999999987
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.10 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=203.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|+..+.||+|+||.||+|.... ...||+|.+.... .......+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---------~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---------EPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---------CHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 467788899999999999996543 2579999874322 1233567899999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 664 (840)
++......+++|||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||
T Consensus 76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp 152 (283)
T cd05048 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAA 152 (283)
T ss_pred EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccc
Confidence 9999889999999999999999987541 357889999999999999999999 9999999999
Q ss_pred CCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 003199 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743 (840)
Q Consensus 665 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~ 743 (840)
+||++++++.++|+|||+++...... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 153 ~Nil~~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 153 RNCLVGEGLTVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred ceEEEcCCCcEEECCCcceeeccccc-cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999997653321 1122234456788999999988899999999999999999998 999987531
Q ss_pred CCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
. ...... +..............++.+++.+||+.||++||++.||+++|+.+
T Consensus 232 ~--~~~~~~-------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 232 N--QEVIEM-------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H--HHHHHH-------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 111110 111111111223456778888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.78 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=202.6
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|... +|+.||||++..... ........+.+|++++..++||||+++++++.+..
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 74 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-------FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-------hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence 5778889999999999999665 689999999853321 11233467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 9999999999999999997654 68899999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .+..... ....
T Consensus 151 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~--~~~~i~~-~~~~--- 216 (333)
T cd05600 151 IVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--E--TWENLKY-WKET--- 216 (333)
T ss_pred ccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--H--HHHHHHh-cccc---
Confidence 532 233457999999999999989999999999999999999999999753211 0 0100000 0000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...+...........++.+++.+|+..+|.+||++.+++++-
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 000000000012345667788899999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=337.07 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=199.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-C-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-S-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
.++|...+.||+|+||.||+|... + +..||+|++..... ......+.+.+|+++++.++||||+++++++.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-------IKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-------hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 356888899999999999999654 3 36899998843221 11223456889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 9999999999999999999998764 68999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+... ...
T Consensus 178 a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~i-~~~--- 243 (340)
T PTZ00426 178 AKVVDT------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE----PLLIYQKI-LEG--- 243 (340)
T ss_pred CeecCC------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC----HHHHHHHH-hcC---
Confidence 976522 1234579999999999998889999999999999999999999997531 11111110 000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
....+... ...+.+++.+|++.||++|+ ++++++++
T Consensus 244 -----~~~~p~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 -----IIYFPKFL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00112222 23456788899999999995 89999887
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.34 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=194.9
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 610 (840)
+.||+|+||.||+|.. .+|+.||+|++...... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEE
Confidence 4699999999999965 47899999998543211 122345677899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-- 147 (323)
T cd05595 74 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 147 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccC--
Confidence 99999999999887654 68999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .... .. ....
T Consensus 148 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~--~~~~-~~--------~~~~ 213 (323)
T cd05595 148 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERL--FELI-LM--------EEIR 213 (323)
T ss_pred -CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHH--HHHH-hc--------CCCC
Confidence 11223345799999999999988999999999999999999999999964311 000 0000 00 0011
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
++..+ ...+.+++.+|++.||++|| ++.+++++
T Consensus 214 ~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCC---CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12222 34566778899999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.45 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=195.6
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 610 (840)
+.||+|+||.||++.. .+|+.||||++..... ........+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEE
Confidence 4699999999999955 4789999999854321 1122345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~-- 147 (328)
T cd05593 74 MEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-- 147 (328)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCC--
Confidence 99999999999887654 68999999999999999999999 9999999999999999999999999999875321
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........ .+..
T Consensus 148 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~---~~~~~~~~--------~~~~ 213 (328)
T cd05593 148 -DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E---KLFELILM--------EDIK 213 (328)
T ss_pred -cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--H---HHHHHhcc--------CCcc
Confidence 11223345799999999999988999999999999999999999999965311 0 11100000 0111
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
++..+ ..++.+++.+|++.||++|| ++.+++++
T Consensus 214 ~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTL---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 22222 34566777899999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.30 Aligned_cols=249 Identities=33% Similarity=0.506 Sum_probs=190.9
Q ss_pred cCeeeccCCcEEEEEEeC-----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 531 KNKVGQGGSGTVYKIDLN-----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+.||.|+||.||+|.+. .+..|+||++.... .....+.+.+|++.+++++||||++++|++....
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~---------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS---------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS---------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc---------ccccceeeeecccccccccccccccccccccccc
Confidence 468999999999999776 35789999984322 1233678899999999999999999999999888
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++|+||+++|+|.+++... ...+++.++..|+.|+++||+|||+ .+++|+||+++||++++++.+||+|||++.
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 899999999999999999987 5579999999999999999999999 899999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... ..........+...|+|||.+.+..++.++||||||+++|||++ |+.||.+. .... +..
T Consensus 152 ~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~---~~~--------- 216 (259)
T PF07714_consen 152 PISEK-SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEE---IIE--------- 216 (259)
T ss_dssp ETTTS-SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHH---HHH---------
T ss_pred ccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc---ccc---------
Confidence 66221 11122233456789999999988889999999999999999999 78898653 1111 111
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.+.+.............+.+++.+||+.||++||++.++++.|
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 217 -KLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111111111112344567788899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.19 Aligned_cols=265 Identities=21% Similarity=0.240 Sum_probs=198.9
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|..+ +++.||||++...... ....+.+.+|+++++.++||||+++++++...+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--------EEVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--------ccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 5778889999999999999665 6889999998543211 123456788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||++++.+..+... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 99999999998776654433 3468999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc-------
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD------- 758 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 758 (840)
.... .........|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 150 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 150 LSEG--SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cccc--ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHH
Confidence 6331 1222334568999999999988889999999999999999999999997532111 00000000000
Q ss_pred --cccc-hhhhccccc--CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 --TKEG-IMEVLDKKL--SGS-----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 --~~~~-~~~~~~~~~--~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... ......+.. ... .......+.+++.+|++.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000000 000 01123568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=320.82 Aligned_cols=257 Identities=28% Similarity=0.354 Sum_probs=204.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||+||+|.++. ...||||.+.... .......+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 467888999999999999997642 4579999874322 123356788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++++|.+++......+++..+..++.|++.|++|||+ ++|+||||||+||++++++.++++|||
T Consensus 75 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 75 TKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred ecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccc
Confidence 99999999999999999999998765578999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||.... ........
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~------- 221 (266)
T cd05033 152 LSRRLEDSE-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAV------- 221 (266)
T ss_pred hhhcccccc-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHH-------
Confidence 998774211 1111222345678999999998899999999999999999998 999986421 11111100
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
......+........+.+++.+|++.+|++||++.|++++|+++
T Consensus 222 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ------EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000011112345677889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.98 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=202.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|..||+|.+.... .......+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 46788899999999999999655 78899999884321 123356789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 99999999999999999997754 689999999999999999999982 369999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh-hcccc--
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK-VDTKE-- 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~-- 761 (840)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .....
T Consensus 153 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 153 QLID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGE 225 (331)
T ss_pred cccc-----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCC
Confidence 6532 1223456899999999999889999999999999999999999999643210 000000000 00000
Q ss_pred --------------------------ch---hh-hcccccCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 762 --------------------------GI---ME-VLDKKLSGS-FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 762 --------------------------~~---~~-~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. .. ......... ......++.+++.+||+.||++|||+.|++++-.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00 00 000000000 0113356788999999999999999999998853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.90 Aligned_cols=259 Identities=24% Similarity=0.325 Sum_probs=201.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.+|+..+.||+|+||.||+|.+. +|+ .||||++.... .....+.+.+|+.+++.++||||++++++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~l~~l~h~niv~~~g~ 77 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEILDEAYVMASVDNPHVCRLLGI 77 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45788899999999999999653 344 38999874321 12334678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
|... ..++|+||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 78 CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred EcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccc
Confidence 9764 5679999999999999998866678999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++.+.... .........++..|+|||++.+..++.++||||||+++|||++ |+.||.+... . .+......
T Consensus 154 G~a~~~~~~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~---~~~~~~~~- 226 (316)
T cd05108 154 GLAKLLGADE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--S---EISSILEK- 226 (316)
T ss_pred cccccccCCC-cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--H---HHHHHHhC-
Confidence 9998764321 1111122334678999999999999999999999999999998 9999865311 0 11110000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
. ...+........+.+++.+||..+|++||++.+++..+.++...
T Consensus 227 ~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 G---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 00011111234577888999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.25 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=193.0
Q ss_pred eeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||+|+||.||+|... +++.||+|++..... ........+.+|+.++++++||||+++++++......++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEc
Confidence 699999999999654 688999999843221 112334667889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCC
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 692 (840)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.... .
T Consensus 74 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---~ 146 (312)
T cd05585 74 FINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK---D 146 (312)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---C
Confidence 999999999997754 68999999999999999999999 9999999999999999999999999999875422 1
Q ss_pred CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccC
Q 003199 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS 772 (840)
Q Consensus 693 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 772 (840)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ........... ...++
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~--------~~~~~ 213 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQE--------PLRFP 213 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcC--------CCCCC
Confidence 122344579999999999999899999999999999999999999997531 11111111100 01112
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003199 773 GSFRDEMIQVLRIAIRCTSKSPATRPT---MNEVVQL 806 (840)
Q Consensus 773 ~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 806 (840)
.. ....+.+++.+|++.||++||+ +.|++++
T Consensus 214 ~~---~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DG---FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred Cc---CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 22 2345667788999999999975 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.96 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=202.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|+..+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|++++++++|+||+++++++....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----------cHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 45778899999999999999887788999998843221 1356888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||++++++.++|+|||+++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 9999999999999999997643 468999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... ..........+..|+|||++.+..++.++||||||+++|||++ |+.||..... ...+... ....
T Consensus 152 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~--~~~~-- 221 (261)
T cd05068 152 VIKED--IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQV--DQGY-- 221 (261)
T ss_pred EccCC--cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH--HcCC--
Confidence 76421 1111112223457999999998899999999999999999999 9999865311 0001100 0000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
. .+........+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 ----~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ----R---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----C---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 001112345677888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.36 Aligned_cols=266 Identities=24% Similarity=0.300 Sum_probs=202.3
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC-cceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN-IVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~ 602 (840)
...|...++||+|+||+||+| ...+|+.||+|++....... ..-....+|+.++++++|+| ||++++++.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--------G~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--------GVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--------CCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 455666778999999999999 55689999999996654321 12234568999999999999 999999998
Q ss_pred cCc------cceEEEeecCCCChHHHhhcCC---CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 603 SLY------CNLLVYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 603 ~~~------~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
... ..++|+||+ .-+|.+++.... ...+...+..+++|+++||+|||+ ++|+||||||.||+++++|
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSG 157 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCC
Confidence 877 778999999 569999998765 357778899999999999999999 9999999999999999999
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
.+||+|||+|+.+.- .....+...+|..|.|||++.+. .|+...||||+|||++||++++.-|.+..+. ..+...
T Consensus 158 ~lKlaDFGlAra~~i---p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~I 233 (323)
T KOG0594|consen 158 VLKLADFGLARAFSI---PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRI 233 (323)
T ss_pred cEeeeccchHHHhcC---CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHH
Confidence 999999999997642 23345667889999999999887 6899999999999999999999888764321 111111
Q ss_pred hh-hhhccccchhhhc---cc--cc-----CCCcHH----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 753 VS-IKVDTKEGIMEVL---DK--KL-----SGSFRD----EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 753 ~~-~~~~~~~~~~~~~---~~--~~-----~~~~~~----~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+ ........+..+. +- .. ...+.. ......+++.+|++.+|.+|.|++.++.|
T Consensus 234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 0111111111111 00 00 111111 12467889999999999999999999987
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=334.35 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=195.7
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
+|+..+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+++++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 72 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH--------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 72 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc--------chhHHHHHHHHHHHHhCCCCCEeeecceEeccC
Confidence 367788999999999999954 57899999988532111 12235678999999999999999999987543
Q ss_pred ----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 ----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
...++||||+. ++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 73 RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred CCCCceEEEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccC
Confidence 24699999995 78999887654 68999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh----
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS---- 754 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---- 754 (840)
|+++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... .......
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~ 225 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLG 225 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhC
Confidence 999765332222222344579999999998865 67899999999999999999999999753210 0000000
Q ss_pred ---------hhhccccchhhhcccccC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 ---------IKVDTKEGIMEVLDKKLS----GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ---------~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.................. ..+......+.+++.+|++.||++|||++|++++
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 0111123456788999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=337.02 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=201.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 598 (840)
++|...+.||+|+||.||+|... .+..||||++..... ....+.+.+|+++++++. ||||++++
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---------~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR---------SSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC---------hHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 46778899999999999998642 234799999843321 223467899999999996 99999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------------------------------------------------
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL--------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 627 (840)
+++.+....++||||+++|+|.+++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999886421
Q ss_pred --------------------------------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 003199 628 --------------------------------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIK 663 (840)
Q Consensus 628 --------------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 663 (840)
..+++..+..++.|++.||+|||+ .+|+|||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dik 264 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLA 264 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCC
Confidence 247788899999999999999999 999999999
Q ss_pred CCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 003199 664 STNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDD 742 (840)
Q Consensus 664 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~ 742 (840)
|+||+++.++.+||+|||+++...... .........++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDS-NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccc-cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999999999997653311 1112233456788999999988899999999999999999997 99998753
Q ss_pred CCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
..... . +.. ... .............+.+++.+||+.||++||++.++.+.|+++-+
T Consensus 344 ~~~~~-~--~~~--~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 344 IVDST-F--YNK--IKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred chhHH-H--HHH--Hhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 21110 0 000 000 00001112234567788999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.69 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=197.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---------GTPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---------ccchhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 56788899999999999999665 7899999998533211 1123567899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++ +++.+++......+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 76 ETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred CeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 99999999995 68888887765578999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc--cc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT--KE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 761 (840)
.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... ........... ..
T Consensus 152 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 227 (303)
T cd07869 152 AKSV---PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLERIFLVLGTPNED 227 (303)
T ss_pred eccC---CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhCCCChh
Confidence 5422 1222334568899999998765 4578899999999999999999999975321111 00000000000 00
Q ss_pred ch----------hhhcccccCCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GI----------MEVLDKKLSGSFRD------EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~----------~~~~~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .+............ ....+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 00000000001111 12356688889999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.87 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=199.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+|+..+.||+|+||.||+|..+++..+|+|.+..... ....+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 35677889999999999999888778999998743221 1245778999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCccccee
Confidence 9999999999999999998755578999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... +....
T Consensus 150 ~~~~--~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~--~~~~~-------- 215 (256)
T cd05059 150 VLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEV--VESVS-------- 215 (256)
T ss_pred cccc--cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHH--HHHHH--------
Confidence 5321 1111112234457999999998899999999999999999999 8999864311 111 11100
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
......... ....++.+++.+||..+|++|||+.|+++.|.
T Consensus 216 ~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 216 AGYRLYRPK---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred cCCcCCCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 000111111 23456778888999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.30 Aligned_cols=254 Identities=25% Similarity=0.308 Sum_probs=200.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|++|.||+|... +++.||+|.+.... ...+.+.+|++++++++|+|++++++++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----------hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 35677889999999999998654 68899999874221 1245688899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccc
Confidence 9999999999999999998754 3468999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
...... .........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .........
T Consensus 152 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~---- 220 (263)
T cd05052 152 RLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEK---- 220 (263)
T ss_pred cccccc--eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHC----
Confidence 765431 1111122334668999999988899999999999999999998 9999864211 111111000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
........ .....+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 221 ---~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 ---GYRMERPE---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00111111 2235677788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=293.44 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=203.3
Q ss_pred HhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|++.+.+|+|+|+.||.++ ..++..+|+|++.-.. .+..+...+|++..++++|||+++++++....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----------QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----------hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 578889999999999999995 5678999999985443 23456788999999999999999999887443
Q ss_pred c-----cceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCe
Q 003199 605 Y-----CNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 605 ~-----~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
. ..|++++|...|+|.+.+... +..+++.++++|+.+|.+||++||+.. .+++||||||.||++.+++.++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceE
Confidence 3 479999999999999988754 346899999999999999999999832 3599999999999999999999
Q ss_pred eecccchhhhhccCCC------CcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003199 677 VADFGIAKVLQARGGK------DSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 747 (840)
+.|||.++...-.-.. -........|..|.|||.+. +...++++|||||||++|+|+.|..||+.......
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 9999998765321000 11224456788999999874 44678999999999999999999999986544333
Q ss_pred chhhhhhhhhccccchhhhcccc--cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 748 NIIYWVSIKVDTKEGIMEVLDKK--LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.+...+ .... ++.. ......+.+++.+|++.||.+||++.+++.++.++.
T Consensus 250 SlaLAv-------------~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SLALAV-------------QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eEEEee-------------eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 222111 1111 1111 114556777888999999999999999999987654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.89 Aligned_cols=257 Identities=26% Similarity=0.344 Sum_probs=211.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC---C--cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS---G--EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+..+..+.||.|.||.||+|.+.+ | -.||||..+..- .....+.|..|..+|+.++||||++++|.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---------t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---------TPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---------ChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 344566789999999999996643 3 358888774322 12336789999999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
|.+. ..|+|||.++-|.|..+++.+...++..+...++.||..||+|||+ ..+|||||..+|||+.+...+|++||
T Consensus 460 ~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 460 CVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred eecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeeccc
Confidence 9875 5689999999999999999998889999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++.+.+.. ....+...-+..|||||-+.-++++.+||||-|||.+||++. |..||++..+.+
T Consensus 536 GLSR~~ed~~--yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------- 600 (974)
T KOG4257|consen 536 GLSRYLEDDA--YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------- 600 (974)
T ss_pred chhhhccccc--hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------
Confidence 9999986632 222334445679999999999999999999999999999988 999998753221
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.+..+......+..+.++..+..|+.+||..||.+||.+.|+...|+++..
T Consensus 601 --VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 --VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 122333334444555667788899999999999999999999998876443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=323.29 Aligned_cols=268 Identities=28% Similarity=0.352 Sum_probs=199.8
Q ss_pred CccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 529 TEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
...+.||+|+||+||++.+ .+++.||+|.+..... ......+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---------QQNTSGWKKEINILKTLYHENIVKYKGCCSE 77 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 6778999999999988642 3678999998843321 1234678889999999999999999998865
Q ss_pred C--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 604 L--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 604 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
. ...++||||+++++|.+++... .+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecc
Confidence 3 4578999999999999999775 58999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+++................++..|+|||.+.+..++.++||||||+++|||++|..||............+..... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~ 231 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVV 231 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc-chh
Confidence 9986643211111122234566799999998888999999999999999999999998653221111111100000 000
Q ss_pred chhhhcccccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
...+..+.... +........+.+++.+||+.+|++|||++++++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 01111111111 111223456778888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=306.68 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=209.1
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|.++.+||+|+||.||+| ...+|+.||||.+... ...+++..|+.+|++++.|++|++||.|...
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~ 100 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH 100 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------------chHHHHHHHHHHHHHcCCchhhhhhhhhccC
Confidence 34566778999999999998 5568999999987322 2356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...|+|||||..|+..+.++-....+.+.++..+..+.++||+|||. ..-+|||||+.|||++.+|.+|++|||.|.
T Consensus 101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccc
Confidence 99999999999999999999888899999999999999999999999 788999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.+ .-.....+.|||.|||||++..-.|+.++||||+|+...||..|++||.+-.. ...+
T Consensus 178 QLTD---TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------------MRAI- 238 (502)
T KOG0574|consen 178 QLTD---TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------------MRAI- 238 (502)
T ss_pred hhhh---hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------------ccee-
Confidence 7754 22345678999999999999999999999999999999999999999986321 1101
Q ss_pred hhcccccCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSF---RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
-.+..+.++.+ +....++.+++.+|+-+.|++|-|+.++++|
T Consensus 239 FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 239 FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11222233333 3445677888899999999999999998876
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.07 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=194.6
Q ss_pred CeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccc
Q 003199 532 NKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 607 (840)
+.||+|+||.||++.. .+++.||||++...... ........+.+|+++++.++||||+++++++......
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV------RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH------hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 5799999999999864 35789999998543211 1122345678899999999999999999999999999
Q ss_pred eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhh
Q 003199 608 LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 687 (840)
++||||+++|+|.+++.... .+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 99999999999999997754 57888999999999999999999 999999999999999999999999999987542
Q ss_pred ccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 688 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 152 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~-------- 215 (323)
T cd05584 152 HE---GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKG-------- 215 (323)
T ss_pred cC---CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcC--------
Confidence 21 1222345799999999999988899999999999999999999999975311 0111100000
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
...++.. ....+.+++.+|++.||++|| ++.+++++
T Consensus 216 ~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 KLNLPPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0111222 234566788899999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=330.38 Aligned_cols=259 Identities=28% Similarity=0.366 Sum_probs=199.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|... +++.||+|++..... ....+.+..|+.++.++ +|+||++++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~~E~~~~~~l~~h~niv~~~ 77 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---------ASEYKALMTELKILIHIGHHLNVVNLL 77 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---------HHHHHHHHHHHHHHHhhccCcchhhee
Confidence 46778899999999999998432 357899998843221 12245677899999999 799999999
Q ss_pred eEEec-CccceEEEeecCCCChHHHhhcCC--------------------------------------------------
Q 003199 599 CYFSS-LYCNLLVYEYMPNGNLWDALHKGL-------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------- 627 (840)
++|.. ....++||||+++++|.+++....
T Consensus 78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 98865 456789999999999999885421
Q ss_pred ----------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCccee
Q 003199 628 ----------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697 (840)
Q Consensus 628 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 697 (840)
..++|..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||+++.+.... ......
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-~~~~~~ 233 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKG 233 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-chhhcc
Confidence 257899999999999999999999 999999999999999999999999999998763311 111223
Q ss_pred cccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcH
Q 003199 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR 776 (840)
Q Consensus 698 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 776 (840)
...++..|+|||++.+..++.++|||||||++|||++ |..||.+..... ... .. .... ...... .
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~---~~-~~~~------~~~~~~---~ 299 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC---RR-LKEG------TRMRAP---E 299 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH---HH-Hhcc------CCCCCC---c
Confidence 3456678999999999999999999999999999998 999997532111 000 00 0000 000011 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 777 DEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 777 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
....++.+++.+||+.+|++||++.|++++|+++-
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22356778899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=340.45 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=207.7
Q ss_pred cCccCeeeccCCcEEEEEEeCCC-cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeE-Ee--
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSG-EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCY-FS-- 602 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~-- 602 (840)
+++.+.|.+|+|+.||.|....+ ..||+|++... ++.....+++||++|+.|+ |+|||.+++. ..
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----------de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----------DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----------CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 45677899999999999976655 99999998544 2566788999999999996 9999999983 21
Q ss_pred ---c-CccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 603 ---S-LYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 603 ---~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
. ..+.+|.||||++|.|-+++..+ ...|++.++++|+.|+++|+++||. +..+|||||||-+|||++.+++.||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEe
Confidence 1 24668999999999999999854 2459999999999999999999997 4467999999999999999999999
Q ss_pred ecccchhhhhccCCCCc------ceecccccccccCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 678 ADFGIAKVLQARGGKDS------TTTVIAGTYGYLAPEYA---YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
||||.|.-......... ..-...-|+.|+|||++ .+...++|+|||||||+||-|+....||++...
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---- 263 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---- 263 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----
Confidence 99999865432111110 01124578999999987 566889999999999999999999999986311
Q ss_pred hhhhhhhhhccccchhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCCCCCC
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFP 821 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~ 821 (840)
..+++.++ -+.+......+..||..||++||.+||++.+|+..+.++......-.+.+
T Consensus 264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 11222222 12234566677778889999999999999999999988776665444443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=346.03 Aligned_cols=251 Identities=24% Similarity=0.267 Sum_probs=197.6
Q ss_pred hcCccCeeeccCCcEEEEEEeC-C-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-S-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.|...+.||+|++|.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~----------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND----------ERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC----------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 3778889999999999999543 4 6788888763221 22345678899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
+..++||||+++|+|.+++... ...+++.++..++.|++.||+|+|+ ++|+||||||+|||++.++.+||+|||
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCc
Confidence 9999999999999999887642 2358899999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 215 la~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~-------- 280 (478)
T PTZ00267 215 FSKQYSDSV-SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIM-------- 280 (478)
T ss_pred CceecCCcc-ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH--------
Confidence 998764321 11223455799999999999998999999999999999999999999964210 0000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.........+........+.+++.+|++.||++||++.+++.+
T Consensus 281 --~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 281 --QQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --HHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0111111111111233457778889999999999999998754
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=323.02 Aligned_cols=272 Identities=25% Similarity=0.318 Sum_probs=201.9
Q ss_pred hcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.|+..+.||+|+||.||++.+ .++..||+|.+.... .....+.+.+|+++++.++|||++++++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---------GGNHIADLKKEIEILRNLYHENIVKYKGIC 75 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 356788999999999999863 357899999874321 123346789999999999999999999998
Q ss_pred ecC--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 602 SSL--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 602 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
... ...++||||+++++|.+++.+....++|.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|
T Consensus 76 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 76 TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred ecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECC
Confidence 775 56789999999999999997765568999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||+++................++..|+|||++.+..++.++||||||+++|||++++.|+....................
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 99998764322211222334567789999999888899999999999999999998776533211000000000000000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.............+........+.+++.+|++.+|++||++.++++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000001111111122345788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=300.62 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=203.2
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||+|+|+.||++ ...+|+.+|+|.+....-.. ...+.+.+|+.+-+.++||||+++...+.+.
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--------~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--------RDFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--------ccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 45666678999999999997 56689999999885443221 2356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg 681 (840)
...++|+|+|.|++|..-+-... .+++..+...+.||+++|.|+|. ++|||||+||+|+++-+ ..-+|++|||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccc
Confidence 99999999999999977655442 57788899999999999999999 99999999999999954 3358999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+|..+. .........|||+|||||++...+|+..+|||+.|||+|-++.|.+||.++. ..++ +.++ ....
T Consensus 159 vAi~l~----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rl--ye~I-~~g~- 228 (355)
T KOG0033|consen 159 LAIEVN----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRL--YEQI-KAGA- 228 (355)
T ss_pred eEEEeC----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHH--HHHH-hccc-
Confidence 998875 2344566889999999999999999999999999999999999999997631 1111 1111 1110
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.+ + ..+.+........+|+.+|+..||.+|.|+.|+++|=+-.+
T Consensus 229 --yd-~---~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 229 --YD-Y---PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred --cC-C---CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 00 1 12233344445566777999999999999999988755433
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.48 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=202.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
..|...+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----------DNARKDFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4577888999999999999864 234568999874321 233567889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNI 667 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 667 (840)
++......++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Ni 151 (288)
T cd05093 75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNC 151 (288)
T ss_pred EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceE
Confidence 9999999999999999999999987432 248999999999999999999999 9999999999999
Q ss_pred EEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 003199 668 LLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDN 746 (840)
Q Consensus 668 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 746 (840)
++++++.++|+|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 152 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-- 228 (288)
T cd05093 152 LVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-- 228 (288)
T ss_pred EEccCCcEEeccCCccccccCCc-eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999997653211 1111223345778999999998899999999999999999998 9999864311
Q ss_pred cchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
..... . ................+.+++.+|++.||.+|||+.++.+.|+++..
T Consensus 229 ~~~~~--~-----------i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 229 NEVIE--C-----------ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHH--H-----------HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11100 0 00000101111123457889999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=333.59 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=192.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 45566788999999999999654 78999999984322 123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999986532 35677888999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
..... ........||..|+|||++.. ...+.++|||||||++|||++|+.||...... .|.......
T Consensus 217 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~ 288 (353)
T PLN00034 217 ILAQT---MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAI 288 (353)
T ss_pred ecccc---cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHH
Confidence 65321 112234578999999998743 23456899999999999999999999732111 111110000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..............++.+++.+||+.||++||++.|++++-
T Consensus 289 -------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 289 -------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred -------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000111112334677888899999999999999999873
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=335.36 Aligned_cols=259 Identities=21% Similarity=0.244 Sum_probs=196.8
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..|...+.||+|+||.||+| +..+++.||+|... ...+.+|++++++++||||+++++++...
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------------~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------------RGGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 45888999999999999999 44578999999641 13467899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|++. ++|..++.... .+++.++..++.|++.||+|||+ ++||||||||+||+++.++.+||+|||+|+
T Consensus 156 ~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 156 KFTCLILPRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred CeeEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 99999999994 78988887653 68999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc------chhhhhhhhhc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK------NIIYWVSIKVD 758 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~ 758 (840)
..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....+... .+.........
T Consensus 231 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 231 FPVDI--NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccc--cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 54321 11223345799999999999988999999999999999999999988753221110 00000000000
Q ss_pred --------cccchhhhc---------ccccCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 --------TKEGIMEVL---------DKKLSGSF---RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 --------~~~~~~~~~---------~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
......... .....+.+ .....++.+++.+|++.||++|||++|++++=
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 000000000 00001111 12345788899999999999999999999753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=307.24 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=206.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|...+.||+|.-|+||+++.+ ++..+|+|++-+... .......+...|-+||+.+.||.++.+|+.++.+.
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-------~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-------ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-------hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 3445668999999999999777 458999999844332 22344567788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++|||||+||+|...++++ ...+++..++.++..|+-||+|||- .|||+|||||+||||.++|++-|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999999999998876 4679999999999999999999999 999999999999999999999999999875
Q ss_pred hhhcc--------------------------------CCC---------------------CcceecccccccccCcccc
Q 003199 685 VLQAR--------------------------------GGK---------------------DSTTTVIAGTYGYLAPEYA 711 (840)
Q Consensus 685 ~~~~~--------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~ 711 (840)
..... ... ......++||-.|.|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 43110 000 0112346799999999999
Q ss_pred ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccC-CCcHHHHHHHHHHHHHcc
Q 003199 712 YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS-GSFRDEMIQVLRIAIRCT 790 (840)
Q Consensus 712 ~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl 790 (840)
.+...+.++|+|+|||++|||+.|..||.+.... ++..+++-+.+. +.....+..+.+||.+.+
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 9999999999999999999999999999874321 223333333221 222355677888999999
Q ss_pred CCCCCCCCC----HHHHHHH
Q 003199 791 SKSPATRPT----MNEVVQL 806 (840)
Q Consensus 791 ~~dP~~Rps----~~evl~~ 806 (840)
.+||.+|.. ++||.+|
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999998 8898876
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.51 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=198.4
Q ss_pred hcCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... .......+.+..|+.+++.+ .|++|+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL------VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH------hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 367788999999999999854 3688999999853221 11123345678899999999 499999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999999999997654 68999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++.+... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 151 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~--- 224 (332)
T cd05614 151 LSKEFLSE--EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL--- 224 (332)
T ss_pred CCcccccc--CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh---
Confidence 99765331 12223345799999999998765 4788999999999999999999999753221111 00100000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQLL 807 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 807 (840)
..+..+.... ...+.+++.+|++.||++|| ++++++++-
T Consensus 225 -----~~~~~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 225 -----KCDPPFPSFI---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -----cCCCCCCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 0111122222 33456778899999999999 788888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.23 Aligned_cols=250 Identities=26% Similarity=0.322 Sum_probs=195.0
Q ss_pred eeeccCCcEEEEEEe---CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 533 KVGQGGSGTVYKIDL---NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.||+|+||.||+|.+ .++..||+|++..... .....+.+.+|+.+++.+.|+||+++++++.. +..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--------DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC--------cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEE
Confidence 589999999999954 3578999998843321 13345778999999999999999999998854 56789
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++.... .+++..+..++.|++.|++|+|+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 73 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 73 VMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999999999999997654 68999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (840)
...........++..|+|||.+....++.++||||||+++|||++ |+.||..... . .+..... ... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~---~~~~~i~-~~~------~ 216 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--N---EVTQMIE-SGE------R 216 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H---HHHHHHH-CCC------C
Confidence 111111222334678999999988889999999999999999998 9999975311 1 1111110 000 0
Q ss_pred cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 769 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
...+. ....++.+++.+||+.||++||++.+|++.|++.
T Consensus 217 ~~~~~---~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQ---RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCC---CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01111 2334567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.14 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=199.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.++|+..+.||+|+||.||+|... ++..||||++.... .......+.+|+.+++.++|+||++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 467888999999999999998643 35679999874321 112345688999999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL---------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 669 (840)
+++.+....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~ 152 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 152 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEE
Confidence 99999999999999999999999987532 235788999999999999999999 899999999999999
Q ss_pred cCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003199 670 DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKN 748 (840)
Q Consensus 670 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 748 (840)
++++.++|+|||+++...... .........+++.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 153 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~- 228 (277)
T cd05062 153 AEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--E- 228 (277)
T ss_pred cCCCCEEECCCCCccccCCcc-eeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H-
Confidence 999999999999987653211 1111122345778999999998889999999999999999999 7888864311 1
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
...... ...............+.+++.+|++.||++|||+.|++++|++
T Consensus 229 --~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 --QVLRFV----------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HHHHHH----------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111110 0111111111223457788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.55 Aligned_cols=255 Identities=26% Similarity=0.331 Sum_probs=211.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.++++.++||-|.||.||.|.|+. .-.||||.++... ...++|..|..+|+.++|||+|+++|.|..+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----------MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-----------hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 346788999999999999998874 4679999985433 3367899999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..+|||+|||..|+|.+++++.. ..++.-..+++|.||+.|++||.. +++|||||.++|+|+.++..+||+|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999998764 345666778999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.+..+ ...........+.|.|||-+.-..++.|+|||+|||+|||+.| |-.||.+.. + ..
T Consensus 413 RlMtgD--TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----l-----------Sq 474 (1157)
T KOG4278|consen 413 RLMTGD--TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----L-----------SQ 474 (1157)
T ss_pred hhhcCC--ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----H-----------HH
Confidence 998542 2222233345678999999988899999999999999999999 999997631 1 11
Q ss_pred hhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 763 IMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 763 ~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
+..++.+.+ .+..+.+..++.+|+..||+++|..||+++|+-+.++.+..
T Consensus 475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 233444443 23445567788999999999999999999999999987543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=329.29 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=194.8
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|... +++.||||++...... .....+.+.+|..++..+ +||||+++++++.+....++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-------~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-------DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEE
Confidence 46999999999999654 6899999998543211 122345678899999888 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR- 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc-
Confidence 999999999999887654 68999999999999999999999 9999999999999999999999999999864321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC---cchhhhhhhhhccccchhhh
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN---KNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 766 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .....+.......
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 219 (329)
T cd05588 149 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE------- 219 (329)
T ss_pred --CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-------
Confidence 1122334679999999999999999999999999999999999999996422111 1111111100000
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT------MNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~evl~~ 806 (840)
....++... ...+.+++.+|++.||.+||+ +.+++++
T Consensus 220 ~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 220 KQIRIPRSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 001112222 345667888999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=336.39 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=195.4
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|...+.||+|+||+||+|.. .+++.||||++..... ......+.+.+|+++++.++|+||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence 467788999999999999954 5789999999854321 11233567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 9999999999999999997754 68899999999999999999999 9999999999999999999999999999754
Q ss_pred hhccCCC--------------------------------------------CcceecccccccccCccccccCCCCcccc
Q 003199 686 LQARGGK--------------------------------------------DSTTTVIAGTYGYLAPEYAYSSKATTKCD 721 (840)
Q Consensus 686 ~~~~~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 721 (840)
+...... ........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 3210000 00012357999999999999888999999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHH--ccCCCCCCCCC
Q 003199 722 VYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIR--CTSKSPATRPT 799 (840)
Q Consensus 722 v~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rps 799 (840)
||||||++|||++|+.||....... . .... ..... ....+. ......++.+++.+ |+..+|..||+
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~--~--~~~i-~~~~~------~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTE--T--QLKV-INWEN------TLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHH--H--HHHH-Hcccc------ccCCCC-CCCCCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999999997532110 0 0000 00000 000111 01122344455555 56677777999
Q ss_pred HHHHHHH
Q 003199 800 MNEVVQL 806 (840)
Q Consensus 800 ~~evl~~ 806 (840)
+.|++++
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.59 Aligned_cols=255 Identities=28% Similarity=0.384 Sum_probs=205.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..+|+..+.||.|+||.||+|...++..||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----------hhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 35677888999999999999988889999999984432 22245688899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++|+|.+++... ...+++..+..++.|++.|++|||+ ++++||||||+||++++++.+||+|||.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccch
Confidence 9999999999999999999764 3468999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
...... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ........ .
T Consensus 152 ~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~---~----- 218 (261)
T cd05148 152 RLIKED---VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQI---T----- 218 (261)
T ss_pred hhcCCc---cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHH---H-----
Confidence 776331 111223346678999999988889999999999999999998 899996532 11111110 0
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.....+........+.+++.+|++.||++|||++++++.|+.+
T Consensus 219 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 -----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0000111122335677888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.91 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=195.0
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 610 (840)
+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 3699999999999965 478999999874221 123346788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||+++++|.+++......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+|++|||++......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 147 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG- 147 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccc-
Confidence 99999999999997655568999999999999999999999 99999999999999999999999999998754321
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ... ......
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~--------------~~~~~~ 211 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQT--------------REAIEQ 211 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHH--------------HHHHHc
Confidence 01111112223467999999988889999999999999999998 8888864211 000 000000
Q ss_pred ccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 770 KLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 770 ~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
... .........+.+++.+|++.+|++||++.++.+.|+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000 111122456778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.51 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=190.9
Q ss_pred hcCccCeeeccCCcEEEEEEe-C-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc---CCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-N-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI---RHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~ 601 (840)
+|+..+.||+|+||+||+|.. . +|+.||||++....... .....+.+|+.+++.+ .||||+++++++
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~ 73 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--------GMPLSTIREVAVLRHLETFEHPNVVRLFDVC 73 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--------CchHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence 577888999999999999965 3 46889999885433211 1123345566666555 699999999988
Q ss_pred e-----cCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 S-----SLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~-----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
. .....++||||++ ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 74 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred ecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCE
Confidence 5 3455789999996 6899988754 2458999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........||+.|+|||.+.+..++.++|||||||++|||++|++||.+.... ........
T Consensus 150 kl~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~ 223 (290)
T cd07862 150 KLADFGLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILD 223 (290)
T ss_pred EEccccceEeccC----CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHH
Confidence 9999999976532 12334556899999999998889999999999999999999999999763211 11100000
Q ss_pred hh--ccccchh-------hhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 KV--DTKEGIM-------EVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ~~--~~~~~~~-------~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ....... ........... .+....+.+++.+|++.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0000000 00000000001 1123456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.26 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=194.3
Q ss_pred eeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 533 KVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEE
Confidence 3899999999999654 35579999884332 12334678899999999999999999998864 46789
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++++|.+++......+++..+..++.|++.|++|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 999999999999997655578999999999999999999999 89999999999999999999999999999765332
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (840)
...........++..|+|||.+.+..++.++||||||+++||+++ |+.||.+... ....... ..
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~---~~---------- 213 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFI---EQ---------- 213 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH---HC----------
Confidence 111111222334578999999988889999999999999999996 9999975321 1110000 00
Q ss_pred cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 769 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
............++.+++.+||..+|++||++.+|.+.|+..
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 000111112345677788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.33 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=193.6
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|... +++.||+|++...... .....+.+..|+.++.++ +||||+++++++......++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-------chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEE
Confidence 46999999999999654 6889999998543211 122345677888888777 79999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~- 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-
Confidence 999999999999887654 68999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc---chhhhhhhhhccccchhhh
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK---NIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 766 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+.......
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------- 219 (329)
T cd05618 149 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------- 219 (329)
T ss_pred --CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-------
Confidence 11223346799999999999999999999999999999999999999964221111 111111100000
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT------MNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~evl~~ 806 (840)
....++.. ....+.+++.+|++.||++||+ +.+++++
T Consensus 220 ~~~~~p~~---~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 220 KQIRIPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCC---CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 00112222 2345667888999999999998 5677666
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.00 Aligned_cols=199 Identities=27% Similarity=0.442 Sum_probs=173.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|..||+|.+.... .......+.+|+++++.++|+||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence 56888899999999999999655 68899999874321 123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.... .+++..+..++.+++.|++|||+. .+++||||||+||++++++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 99999999999999999997754 588999999999999999999972 479999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 741 (840)
..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 153 QLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 65321 12335689999999999988899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=329.35 Aligned_cols=245 Identities=27% Similarity=0.329 Sum_probs=192.3
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|..+ +++.||||++..... ......+.+..|..++... .||||+++++++...+..++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEE
Confidence 36999999999999654 689999999853221 0112345567788888776 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~- 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF- 148 (320)
T ss_pred EEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-
Confidence 999999999999987764 68999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~--------~ 213 (320)
T cd05590 149 --NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE--------V 213 (320)
T ss_pred --CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCC--------C
Confidence 12223445799999999999988999999999999999999999999975311 01111000000 0
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTM------NEVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 806 (840)
..+.. ....+.+++.+|++.||++||++ ++++++
T Consensus 214 ~~~~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 VYPTW---LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCC---CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11111 23456678889999999999998 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=331.59 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=194.4
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 610 (840)
+.||+|+||.||+|.. .+|+.||+|++...... .......+..|++++..++||||+++++++......++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEE
Confidence 4699999999999954 57899999998543211 122345677899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||+++|+|..++.... .+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~-- 148 (325)
T cd05594 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 148 (325)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--
Confidence 99999999999887654 689999999999999999999962 6899999999999999999999999999875322
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........ ....
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~---~~~~~i~~--------~~~~ 214 (325)
T cd05594 149 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E---KLFELILM--------EEIR 214 (325)
T ss_pred -CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--H---HHHHHHhc--------CCCC
Confidence 11222345699999999999988999999999999999999999999965311 0 00000000 0111
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
++... ..++.+++.+|++.||++|+ ++.+++++
T Consensus 215 ~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTL---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCC---CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12222 34566778899999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.19 Aligned_cols=258 Identities=27% Similarity=0.382 Sum_probs=202.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc---EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+|+..+.||+|+||.||+|... +++ .||+|.+.... .....+.+..|++++++++|+|++++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 46777889999999999999664 333 79999874321 122346688999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
...+..++||||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||++++++.+|++|||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 76 TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred ccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCc
Confidence 99999999999999999999998765578999999999999999999999 899999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
++..................+..|+|||++....++.++|||||||++|||++ |+.||..... . .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~---~~~~~i~--- 224 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--H---EVMKAIN--- 224 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--H---HHHHHHh---
Confidence 98766432111111112223467999999988889999999999999999998 9999864311 1 1111110
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.....+...+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 225 -------~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 -------DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001111122345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=322.37 Aligned_cols=253 Identities=24% Similarity=0.277 Sum_probs=198.7
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|+||+||++.. .+++.||||++...... .......+.+|+.++++++|+||+++++++...+.
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-------KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-------hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence 66778999999999999865 47899999998432211 12234567789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||+++|+|.+++... ...+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999999999888654 3468999999999999999999999 8999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... ........|++.|+|||++.+..++.++||||+||++|||++|+.||.+..... . +... ..
T Consensus 152 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~--~~~~--------~~ 215 (285)
T cd05605 152 IPE----GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--K--REEV--------ER 215 (285)
T ss_pred cCC----CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--H--HHHH--------HH
Confidence 532 112234568999999999988889999999999999999999999997532110 0 0000 00
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
.+..............+.+++.+|++.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 216 RVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011100111112344567788899999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.23 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=199.7
Q ss_pred HhcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..|+..+.||+|+||.||+|.. .++..||+|.+.... .......+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 4567778999999999999964 246789999885322 12334678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCC----------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGL----------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 664 (840)
+......++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp 152 (283)
T cd05090 76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAA 152 (283)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhcccc
Confidence 999999999999999999999985321 247889999999999999999999 9999999999
Q ss_pred CCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 003199 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743 (840)
Q Consensus 665 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~ 743 (840)
+||++++++.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 153 RNILIGEQLHVKISDLGLSREIYSAD-YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred ceEEEcCCCcEEeccccccccccCCc-ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999998764321 1122233445778999999988889999999999999999998 999986421
Q ss_pred CCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
. ....... . .....+.......++.+++.+|++.||++||++.++.++|..
T Consensus 232 ~--~~~~~~~----~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 N--QEVIEMV----R---------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H--HHHHHHH----H---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0 0110000 0 000111111223456778889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.67 Aligned_cols=256 Identities=28% Similarity=0.411 Sum_probs=201.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
+.|...+.||+|+||.||+|... ++..||||.+..... ....+.+.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---------NDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---------HHHHHHHHHHHHHHHhcCCCCchheee
Confidence 45677789999999999999653 347899998843321 223568899999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC-------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL-------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 666 (840)
++......++||||+++++|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~n 152 (280)
T cd05049 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRN 152 (280)
T ss_pred EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccce
Confidence 9999999999999999999999997542 347889999999999999999999 899999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 745 (840)
|+++.++.++|+|||+++...... .........+++.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 153 ili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~- 230 (280)
T cd05049 153 CLVGYDLVVKIGDFGMSRDVYTTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN- 230 (280)
T ss_pred EEEcCCCeEEECCcccceecccCc-ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999987543211 1111223346788999999999999999999999999999998 9999865311
Q ss_pred CcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
....... ...............+.+++.+||+.||++||++.|+++.|++
T Consensus 231 -~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 -EEVIECI-------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHHHHH-------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111110 0111111111234567788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=333.85 Aligned_cols=205 Identities=25% Similarity=0.380 Sum_probs=174.7
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||+||+|.. .+++.||||++.... .........+.+|+.++.+++|+||+++++++.+..
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-------MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH-------HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 577889999999999999955 468999999984322 111233467888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 9999999999999999998754 68999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCC--------------------------------CcceecccccccccCccccccCCCCccccchhHHHHHHHHH
Q 003199 686 LQARGGK--------------------------------DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELI 733 (840)
Q Consensus 686 ~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 733 (840)
+...... ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence 4321100 00112357999999999999989999999999999999999
Q ss_pred hCCCCCCCC
Q 003199 734 TGRKPVEDD 742 (840)
Q Consensus 734 tg~~p~~~~ 742 (840)
+|+.||.+.
T Consensus 231 ~G~~Pf~~~ 239 (363)
T cd05628 231 IGYPPFCSE 239 (363)
T ss_pred hCCCCCCCC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=324.48 Aligned_cols=249 Identities=30% Similarity=0.408 Sum_probs=202.3
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||.|+||.||-| +..+.+.||||++.-... ...+...++..|+..+++++|||++.+-|||-.+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-------Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-------QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-------ccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 44667788999999999999 556789999998844332 2345568899999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...|+||||| -||-.+.+.-....+.+-++..|+.+.+.||+|||+ .+.||||||+.|||+++.|.||++|||.|.
T Consensus 99 ~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 99 HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred chHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchh
Confidence 9999999999 678888888777788999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
...+ ...++|||.|||||++. .++|+-|+||||+|+...|+...++|+.... +....+. +.
T Consensus 175 i~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMSALYH---IA--- 238 (948)
T KOG0577|consen 175 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYH---IA--- 238 (948)
T ss_pred hcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHHHHHH---HH---
Confidence 7643 45689999999999874 5789999999999999999999999985431 1111110 00
Q ss_pred chhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 762 GIMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.--.+.+ .+.+.+....+++ .|+++-|.+|||..+++++-
T Consensus 239 ---QNesPtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 239 ---QNESPTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---hcCCCCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHhhcc
Confidence 0001111 3345555555555 89999999999999998763
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.99 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=202.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
.+|...+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----------LAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----------HHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 45677789999999999998642 34568899874322 233467889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 664 (840)
++......++||||+++++|.+++.... ..++|..+..++.|++.|++|||+ ++++||||||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp 151 (291)
T cd05094 75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLAT 151 (291)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCc
Confidence 9999999999999999999999997532 247899999999999999999999 9999999999
Q ss_pred CCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 003199 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743 (840)
Q Consensus 665 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~ 743 (840)
+||+++.++.++|+|||++....... .........++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 152 ~Nil~~~~~~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 152 RNCLVGANLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ceEEEccCCcEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999997653311 1112233456788999999998899999999999999999999 999986532
Q ss_pred CCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
. ...... ................+.+++.+||+.+|++||++.++++.|+++..
T Consensus 231 ~--~~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 231 N--TEVIEC-------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H--HHHHHH-------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 111100 00111111111234567788899999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=328.89 Aligned_cols=248 Identities=26% Similarity=0.348 Sum_probs=192.6
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHH---HhccCCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET---LGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~ 603 (840)
|+..+.||+|+||.||+|.. .+|+.||||++...... .....+.+.+|+.+ ++.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~ 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQT 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence 45678999999999999965 47899999998543211 11223455566555 456789999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|..++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence 99999999999999999888764 68999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... .........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... . .........
T Consensus 149 ~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~---~~~~~i~~~---- 216 (324)
T cd05589 149 KEGMG---FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--E---EVFDSIVND---- 216 (324)
T ss_pred ccCCC---CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHhC----
Confidence 65322 12223456799999999999998999999999999999999999999975311 0 010000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
....+.. ....+.+++.+|++.||.+|| ++.+++++
T Consensus 217 ----~~~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ----EVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCC---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011112 234566788899999999999 57777775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=332.81 Aligned_cols=255 Identities=24% Similarity=0.277 Sum_probs=199.7
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||+||+|.. .+|+.||+|++..... ......+.+.+|+.+++.+.|+||+++++++.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-------LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 577888999999999999955 4789999999854321 11234567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999999999998765579999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAY------SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
.... .........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..........
T Consensus 152 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~ 224 (330)
T cd05601 152 LTAN--KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNF 224 (330)
T ss_pred CCCC--CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcC
Confidence 5431 112233457899999999886 45678999999999999999999999975321 0111100000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .. ..+ ........+.+++..|++ +|++||++.+++++
T Consensus 225 ~~----~~--~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QR----FL--KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC----cc--CCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 00 001 111123456677778997 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.40 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=202.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-C---CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-S---GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+|+..+.||+|+||.||+|... + +..||+|.+..... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---------EKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC---------HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 46778899999999999999653 2 33799998743211 12346788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
...+..++||||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 75 TKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCC
Confidence 99999999999999999999998765578999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
++..+..............++..|+|||++.+..++.++||||||+++||+++ |..||..... ....... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~---~--- 223 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAI---E--- 223 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHH---h---
Confidence 99876432111111122234568999999998889999999999999999887 9999865311 1111111 0
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+....+.....+..+.+++.+|++.+|.+||++.++++.|.++
T Consensus 224 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 -------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0000011112344667888899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.19 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=188.9
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|... +++.||||++...... .....+.+..|..++... .||||+++++++......++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 36999999999999664 6889999998543211 112233445566666654 89999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 74 v~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 999999999999987654 68999999999999999999999 99999999999999999999999999999754321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ... .... .. ...
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~--~~~i-~~--------~~~ 213 (316)
T cd05592 150 ---EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DEL--FDSI-LN--------DRP 213 (316)
T ss_pred ---CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHH--HHHH-Hc--------CCC
Confidence 1233456799999999999988999999999999999999999999975311 000 0000 00 001
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN-EVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~~ 806 (840)
.++... ..++.+++.+|++.||++||++. +++++
T Consensus 214 ~~~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 HFPRWI---SKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCC---CHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 112222 23456777899999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.34 Aligned_cols=252 Identities=31% Similarity=0.448 Sum_probs=199.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++.+ .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~ 73 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----------SPESFLEEAQIMKKLRHDKLVQLYAVVSE-E 73 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----------CHHHHHHHHHHHHhcCCCceEEEEeEECC-C
Confidence 46778889999999999999888888999999854321 12458899999999999999999998854 5
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++... ...+++.++..++.+++.|++|||+ .+++||||||+||++++++.++|+|||.+.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeee
Confidence 678999999999999999764 2458999999999999999999999 899999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.+.... ........++..|+|||+..+..++.++||||||+++|||++ |..||.+... .......
T Consensus 151 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~---------- 216 (260)
T cd05070 151 LIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQV---------- 216 (260)
T ss_pred eccCcc--cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----------
Confidence 653311 111122335668999999988889999999999999999999 8999865311 1111110
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
......+...+....+.+++.+|+.++|++|||+.++.+.|++
T Consensus 217 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ---ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000011112234567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.08 Aligned_cols=253 Identities=29% Similarity=0.399 Sum_probs=200.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..++||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++|+||+++++++.+ .
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~ 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----------CHHHHHHHHHHHHhCCCCCcceEEEEECC-C
Confidence 46888899999999999999877777899999853221 12468889999999999999999998754 5
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|+|+ .+++||||||+||++++++.++|+|||.++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCcee
Confidence 578999999999999999764 2357999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ........++..|+|||+..+..++.++||||||+++|||++ |+.||...... . .+..
T Consensus 151 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~--~~~~--------- 215 (262)
T cd05071 151 LIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--E--VLDQ--------- 215 (262)
T ss_pred eccccc--cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--H--HHHH---------
Confidence 654321 111223346678999999988899999999999999999999 88888653110 0 0000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
...........+....+.+++.+|++.||++||+++++++.|++.
T Consensus 216 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 216 --VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000000111123445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.01 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=198.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|...+.||+|+||+||+|.+. +|+ .|++|.+.... .......+..|+.+++++.||||++++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~~~~l~~l~h~~iv~~~~~ 77 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---------GRQTFQEITDHMLAMGSLDHAYIVRLLGI 77 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---------chHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 45677889999999999999764 455 36666652211 12334567888999999999999999998
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.. ...++|+||+++|+|.+++......++|..+..++.|++.||+|||+ ++++||||||+||++++++.+||+||
T Consensus 78 ~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 78 CPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred ECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCC
Confidence 864 45678999999999999998765678999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++..... ..........++..|+|||++.+..++.++||||||+++||+++ |+.||.+.... ...... ..
T Consensus 154 g~~~~~~~~-~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~----~~ 226 (279)
T cd05111 154 GVADLLYPD-DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLL----EK 226 (279)
T ss_pred ccceeccCC-CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----HC
Confidence 999865432 11122234557788999999988899999999999999999998 99999753211 011110 00
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.. ... ... .....+.+++.+||..||++|||+.|+.+.|..+.
T Consensus 227 ~~---~~~---~~~---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 227 GE---RLA---QPQ---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC---cCC---CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00 000 011 12245677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=343.74 Aligned_cols=254 Identities=26% Similarity=0.297 Sum_probs=198.8
Q ss_pred HhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||+|. ..+|+.||||++...... ......+.+|+.++..+.|+|++++++.+...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS--------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC--------HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 578888999999999999995 457999999998543211 23345678899999999999999998776433
Q ss_pred c--------cceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 605 Y--------CNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 605 ~--------~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
+ ..++||||+++|+|.+++... ...+++..+..++.|++.||+|+|+ ++|+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCC
Confidence 2 357999999999999988653 2468899999999999999999999 9999999999999999999
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....
T Consensus 181 ~vkL~DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~ 254 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVM 254 (496)
T ss_pred CEEEEecccCeeccccc-cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHH
Confidence 99999999997654321 1122334679999999999999999999999999999999999999997531 11111
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .......+.......++.+++.+||+.||.+||++.+++++
T Consensus 255 ~~----------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HK----------TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH----------HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 11111111112233457778889999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.90 Aligned_cols=268 Identities=28% Similarity=0.370 Sum_probs=198.6
Q ss_pred hcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 566778999999999999864 357899999874322 23346788999999999999999999987
Q ss_pred ec--CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 602 SS--LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 602 ~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
.. ....++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~d 151 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGD 151 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECC
Confidence 44 346789999999999999997765568999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||+++................++..|+|||++.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQG 228 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccccccc
Confidence 999987643211111111223445699999998888999999999999999999988776432110 00000000000
Q ss_pred c---cchhhhcccc-cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 760 K---EGIMEVLDKK-LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 760 ~---~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
. ....+.+... ..+........+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0000111111 0111122345677888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.12 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=194.9
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCC-CcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK-NIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~ 604 (840)
+|+..+.||+|+||.||+|... +++.||||++...... .....+.+..|++++..+.|+ +|+++++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Confidence 3677889999999999999655 6789999998543211 122345677899999999764 588899999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 99999999999999999987654 68999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... . ....
T Consensus 150 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~--~-i~~~----- 216 (324)
T cd05587 150 ENIF---GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQ--S-IMEH----- 216 (324)
T ss_pred ecCC---CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH--H-HHcC-----
Confidence 4321 12233456799999999999998999999999999999999999999975311 00000 0 0000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM-----NEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 806 (840)
....+.. ....+.+++.+|+..||.+|++. .++.++
T Consensus 217 ---~~~~~~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 ---NVSYPKS---LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111122 23456678889999999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.27 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=197.2
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEE
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 611 (840)
+.||+|+||.||+|...+++.||+|.+.... .......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVM 71 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC---------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEE
Confidence 3699999999999988889999999874322 1223456889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 612 EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 612 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
||+++++|.+++......+++..+..++.+++.||.|+|+ ++++||||||+||++++++.+|++|||++..... .
T Consensus 72 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~--~ 146 (250)
T cd05085 72 ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD--G 146 (250)
T ss_pred ECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccc--c
Confidence 9999999999997765568999999999999999999999 9999999999999999999999999999865432 1
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........++..|+|||++.+..++.++||||||+++||+++ |..||...... ... . ..... ....
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~--~--~~~~~------~~~~ 214 (250)
T cd05085 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAR--E--QVEKG------YRMS 214 (250)
T ss_pred ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHH--H--HHHcC------CCCC
Confidence 1111122344578999999988889999999999999999998 99998653111 000 0 00000 0001
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. ......+.+++.+|+..+|++||++.|+++.|.
T Consensus 215 ~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CP---QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11 123456778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.36 Aligned_cols=257 Identities=24% Similarity=0.277 Sum_probs=199.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-------IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-------hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 457888899999999999999654 789999999843211 112234557889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 99999999999999999998764 47888899999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS----KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
...... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+... ...
T Consensus 190 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i-~~~ 262 (370)
T cd05596 190 MKMDAN--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKI-MDH 262 (370)
T ss_pred eeccCC--CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHH-HcC
Confidence 765321 11122345799999999988653 478999999999999999999999975311 1111110 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT--RPTMNEVVQLL 807 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 807 (840)
.. . ...+. .......+.+++.+|++.+|.+ ||++.|++++-
T Consensus 263 ~~---~---~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 263 KN---S---LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CC---c---CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00 0 00111 1122345667888999999988 99999998873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=328.03 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=192.9
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|... +++.||||++...... .......+..|.+++..+ +||||+++++++......++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEE
Confidence 36999999999999654 6889999998543211 122345567788888866 79999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~- 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL- 148 (321)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceeccc-
Confidence 999999999999987654 68999999999999999999999 9999999999999999999999999999875422
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ........ .
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~---~~~i~~~~--------~ 213 (321)
T cd05591 149 --NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDL---FESILHDD--------V 213 (321)
T ss_pred --CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHH---HHHHHcCC--------C
Confidence 12223345689999999999988999999999999999999999999975311 111 11000000 0
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRP-------TMNEVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~evl~~ 806 (840)
..+.. ...++.+++.+|++.||++|| ++.+++++
T Consensus 214 ~~p~~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01111 224566788899999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=335.25 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=197.2
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||+||+|... +|+.||||++..... ........+.+|+.++..++||||+++++++.+..
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 5778899999999999999654 789999999853221 11233456788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++.
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 9999999999999999998764 68999999999999999999999 9999999999999999999999999999875
Q ss_pred hhccCCCC-----------------------------------cceecccccccccCccccccCCCCccccchhHHHHHH
Q 003199 686 LQARGGKD-----------------------------------STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLM 730 (840)
Q Consensus 686 ~~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 730 (840)
+....... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence 43211000 0011246999999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003199 731 ELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT---MNEVVQL 806 (840)
Q Consensus 731 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 806 (840)
||++|+.||...... ............. ..+.. ......+.+++.+|+. +|.+|++ +.|++++
T Consensus 231 el~~G~~Pf~~~~~~-----~~~~~i~~~~~~~------~~~~~-~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 231 EMLVGYPPFCSDNPQ-----ETYRKIINWKETL------QFPDE-VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HhhcCCCCCCCCCHH-----HHHHHHHcCCCcc------CCCCC-CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999999753210 0000000000000 00110 0122345566778886 9999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.39 Aligned_cols=257 Identities=27% Similarity=0.366 Sum_probs=202.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||+||+|... +|+.||||++...... .......+.+|++++..++|+||+++++++.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-------KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE 74 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-------hccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence 5778899999999999999665 7899999998533211 1123467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999999999999876 368999999999999999999999 9999999999999999999999999999977
Q ss_pred hhccCC--------------------------CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 003199 686 LQARGG--------------------------KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV 739 (840)
Q Consensus 686 ~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 739 (840)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 643210 011233457999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHh
Q 003199 740 EDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-MNEVVQLL 807 (840)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~L 807 (840)
..... ...+... ..... . . ..+ ........+.+++.+|+. ||.+||+ +.+++++-
T Consensus 231 ~~~~~----~~~~~~i-~~~~~---~-~--~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 231 YSDTL----QETYNKI-INWKE---S-L--RFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCCH----HHHHHHH-hccCC---c-c--cCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 75321 1111110 00000 0 0 011 111134556678889997 9999999 99999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=315.55 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=197.9
Q ss_pred cCccCeeeccCCcEEEEEEeC-C---CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-S---GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
|...+.||+|+||.||+|... + +..||||++...... ......+.+|++.++.++|+||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 72 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--------YSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC--------HHHHHHHHHHHHHHHhCCCCCeeeEEeeecc
Confidence 456788999999999999654 2 367999998543211 2234678899999999999999999998866
Q ss_pred Ccc------ceEEEeecCCCChHHHhhcC-----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 604 LYC------NLLVYEYMPNGNLWDALHKG-----LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 604 ~~~------~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
... .++|+||+++|+|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++++
T Consensus 73 ~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~ 149 (273)
T cd05035 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLRED 149 (273)
T ss_pred CCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCC
Confidence 554 68999999999999888542 2368999999999999999999999 999999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 751 (840)
+.+||+|||+++.+..... ........++..|+|||++.+..++.++||||||+++|||++ |..||.+... .....
T Consensus 150 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~ 226 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYD 226 (273)
T ss_pred CeEEECCccceeecccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence 9999999999986643211 112222345678999999988889999999999999999999 8899865321 11111
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+ .. ..............+.+++.+|++.||++||++.|+++.|+++
T Consensus 227 ~---~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 Y---LR----------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H---HH----------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11 0111111122345678888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.28 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=196.0
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++.+..
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-------FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-------HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 577889999999999999954 5789999999843211 11233567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999997654 68899999999999999999999 9999999999999999999999999999964
Q ss_pred hhccCCC----------Cc----------------------------------ceecccccccccCccccccCCCCcccc
Q 003199 686 LQARGGK----------DS----------------------------------TTTVIAGTYGYLAPEYAYSSKATTKCD 721 (840)
Q Consensus 686 ~~~~~~~----------~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 721 (840)
+...... .. ......||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 230 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence 3211000 00 001246999999999999889999999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCC---C
Q 003199 722 VYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR---P 798 (840)
Q Consensus 722 v~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---p 798 (840)
||||||++|||++|+.||...... ..+.. ....... ..++ ........+.+++.+|+. +|.+| +
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~----~~~~~-i~~~~~~------~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSH----ETYRK-IINWRET------LYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHH----HHHHH-HHccCCc------cCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999999999753210 00000 0000000 0011 111123455667778987 66665 5
Q ss_pred CHHHHHHHh
Q 003199 799 TMNEVVQLL 807 (840)
Q Consensus 799 s~~evl~~L 807 (840)
++.|++++-
T Consensus 298 ~~~~~l~hp 306 (377)
T cd05629 298 GAHEIKSHP 306 (377)
T ss_pred CHHHHhcCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=329.59 Aligned_cols=240 Identities=27% Similarity=0.355 Sum_probs=190.3
Q ss_pred CeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccc
Q 003199 532 NKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 607 (840)
+.||+|+||.||++.. .+|+.||+|++...... ......+..|++++++++||||+++++++.+....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEE
Confidence 5799999999999854 36899999998543211 12234567899999999999999999999999999
Q ss_pred eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhh
Q 003199 608 LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 687 (840)
++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 74 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999999997654 68999999999999999999999 999999999999999999999999999987653
Q ss_pred ccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 688 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ..........
T Consensus 150 ~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~---~~~~~i~~~~------- 214 (318)
T cd05582 150 DH---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--K---ETMTMILKAK------- 214 (318)
T ss_pred CC---CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--H---HHHHHHHcCC-------
Confidence 21 1223346799999999999888899999999999999999999999975311 0 0000000000
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 802 (840)
..++.. ....+.+++.+|++.||++||++.+
T Consensus 215 -~~~p~~---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -LGMPQF---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCC---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011122 2345667888999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.27 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=192.9
Q ss_pred eeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||+|+||+||+|.. .+|+.||||.+..... ......+.+..|+++++.++|+||+++.+++......++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-------KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-------hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEe
Confidence 69999999999855 4789999999843321 112234567889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 613 YMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 613 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
|+++|+|.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 9999999887743 23468999999999999999999999 99999999999999999999999999998765331
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ......
T Consensus 151 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~----------~~~~~~ 216 (280)
T cd05608 151 ---QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELK----------QRILND 216 (280)
T ss_pred ---CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHH----------Hhhccc
Confidence 11223457899999999999999999999999999999999999999753211110 0000 000000
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
. ..........+.+++.+|++.||++|| ++++++++
T Consensus 217 ~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 217 S-VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred C-CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0 011112334567788899999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.03 Aligned_cols=260 Identities=19% Similarity=0.269 Sum_probs=205.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|+..+.||+|+||.||+|.. .+++.||||.+..... ........+.+|+++++.++|||++++++++...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-------MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-------CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence 3577888999999999999965 4789999998743221 1123456788999999999999999999999998
Q ss_pred ccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
...++|+||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccc
Confidence 999999999999999988753 22357889999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.+...... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+....
T Consensus 152 ~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~----- 220 (267)
T cd08228 152 LGRFFSSK---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKI----- 220 (267)
T ss_pred cceeccch---hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHH-----
Confidence 98765331 11223346888999999998888999999999999999999999998643211 11111110
Q ss_pred chhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.....++.. ......+.+++.+||..+|++||++.++++.++.+.
T Consensus 221 -----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 -----EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----hcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 001111111 233456778888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.23 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=198.4
Q ss_pred hcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++..++||||++++++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 4556778999999999999653 25789999985322 12235678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKG---------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 665 (840)
+......++++||+++++|.+++... ...+++..+..++.|++.||+|+|+ ++|+||||||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~ 153 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATR 153 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 99999999999999999999998532 1247888999999999999999999 99999999999
Q ss_pred CEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 003199 666 NILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744 (840)
Q Consensus 666 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 744 (840)
||++++++.+||+|||+++...... .........+++.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 154 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 154 NVLVFDKLNVKISDLGLFREVYAAD-YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred heEecCCCceEecccccccccccch-heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999987653321 1112233446789999999988889999999999999999998 8888864211
Q ss_pred CCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
..+... +.+........+....+.+++.+|++.+|++||++++|++.|+.
T Consensus 233 -----~~~~~~----------i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -----QDVIEM----------IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----HHHHHH----------HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 11111111112234456778889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.62 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=202.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|++|.||+|.. .+++.||+|.+...... .......+.+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS-----PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc-----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 3577788999999999999954 57899999988543211 11123346789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++|+||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||+++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 99999999999999999987654 58899999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
................|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ......... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~--~~--- 223 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIAT--QP--- 223 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHHhc--cC---
Confidence 653311111111345678899999999998899999999999999999999999864311 100000000 00
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
....++. .....+.+++.+|+..+|.+||++.+++++.
T Consensus 224 --~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 224 --TNPQLPS---HVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred --CCCCCCc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0011111 2234566788899999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.19 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=189.7
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||+||+|... +++.||||++...... .......+..|..++... +||||+++++++.+.+..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEE
Confidence 46999999999999665 6789999998543211 011234456677777754 89999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML- 148 (316)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-
Confidence 999999999999997653 68999999999999999999999 9999999999999999999999999999864321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ... ....
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~--~i~---------~~~~ 213 (316)
T cd05619 149 --GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQ--SIR---------MDNP 213 (316)
T ss_pred --CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHH--HHH---------hCCC
Confidence 11223445789999999999988999999999999999999999999975311 11100 000 0011
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN-EVVQ 805 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 805 (840)
..+.. ....+.+++.+|++.||++||++. ++.+
T Consensus 214 ~~~~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRW---LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCcc---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11111 223466788899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.07 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=203.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.++|+..+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++|+||++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---------SLRERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 467888999999999999998543 24579999874221 122234578899999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL---------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 669 (840)
+++.+....++||||+++|+|.+++.... ...++..+..++.|++.||+|||+ ++|+||||||+||++
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili 152 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMV 152 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEE
Confidence 99999999999999999999999997531 234677889999999999999999 999999999999999
Q ss_pred cCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003199 670 DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKN 748 (840)
Q Consensus 670 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 748 (840)
++++.++++|||+++...... .........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 153 ~~~~~~~L~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~- 228 (288)
T cd05061 153 AHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--E- 228 (288)
T ss_pred cCCCcEEECcCCccccccccc-cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--H-
Confidence 999999999999987653211 1111222345678999999988899999999999999999999 7888864211 1
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCC
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFES 817 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 817 (840)
..... ..+.............+.+++.+|++.||++|||+.++++.+++.....+..
T Consensus 229 --~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 229 --QVLKF----------VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred --HHHHH----------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 11111 1111111111122356788888999999999999999999998765444443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.80 Aligned_cols=245 Identities=27% Similarity=0.350 Sum_probs=190.1
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|... +|+.||+|++...... .......+..|..++... +||||+++++++.+.+..++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEE
Confidence 46999999999999665 6899999998543211 011234456677777654 89999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF- 148 (316)
T ss_pred EECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-
Confidence 999999999999987654 68999999999999999999999 9999999999999999999999999999864321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. .+..... ...
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~--~~~~~~~---------~~~ 213 (316)
T cd05620 149 --GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DE--LFESIRV---------DTP 213 (316)
T ss_pred --CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HH--HHHHHHh---------CCC
Confidence 12233456799999999999999999999999999999999999999975311 11 1111000 011
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN-EVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~~ 806 (840)
..+.. ...++.+++.+|++.||++||++. ++.++
T Consensus 214 ~~~~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 214 HYPRW---ITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCC---CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11222 223566788899999999999984 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.71 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=193.9
Q ss_pred CccCeeeccCCcEEEEEEeCC-Cc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 529 TEKNKVGQGGSGTVYKIDLNS-GE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
...+.||+|+||.||+|...+ +. .||+|.+..... .....+.+.+|+++++.++|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 456789999999999997654 33 589998743221 123356788999999999999999999987432
Q ss_pred -----ccceEEEeecCCCChHHHhhcC-----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 605 -----YCNLLVYEYMPNGNLWDALHKG-----LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 605 -----~~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMN 150 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCC
Confidence 2468999999999999887421 2357899999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~ 753 (840)
+||+|||+++.+.... .........+++.|+|||+..+..++.++||||||+++|||++ |+.||.... .... +.
T Consensus 151 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~--~~ 225 (272)
T cd05075 151 VCVADFGLSKKIYNGD-YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEI--YD 225 (272)
T ss_pred EEECCCCcccccCccc-ceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH--HH
Confidence 9999999998764321 1111223346778999999998899999999999999999999 889986521 1111 11
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
... . .............+.+++.+||+.||++|||+.++++.|+++
T Consensus 226 ~~~-~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 YLR-Q----------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHH-c----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 0 000011112234567888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.47 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=199.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|...++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+|++++++++. ..
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-----------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QE 73 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-----------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cC
Confidence 56778899999999999999888899999998853321 1346888999999999999999999874 45
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.++++|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCccee
Confidence 689999999999999998653 3468999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........++..|+|||++....++.++||||||+++||+++ |+.||.+... ....... ..
T Consensus 151 ~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~---- 218 (260)
T cd05067 151 LIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNL----ER---- 218 (260)
T ss_pred ecCCC--CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH----Hc----
Confidence 65421 1111223345678999999988889999999999999999999 9999975321 1111100 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
....... .....++.+++.+|+..+|++||+++++...|+.
T Consensus 219 --~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 --GYRMPRP---DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000111 1223467788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.68 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=189.2
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHH-HHhccCCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE-TLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||+||+|... +|+.||||++...... .....+.+..|.. +++.++||||+++++++.+.+..++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-------KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-------hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEE
Confidence 36999999999999654 7999999998433211 1112234444544 5678999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~- 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE- 148 (323)
T ss_pred EEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-
Confidence 999999999999987654 68999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~--------~~ 213 (323)
T cd05575 149 --HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNK--------PL 213 (323)
T ss_pred --CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcC--------CC
Confidence 1222344579999999999999899999999999999999999999997531 01111000000 01
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN----EVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~----evl~~ 806 (840)
.+.+.. ...+.+++.+|++.||++||++. +++++
T Consensus 214 ~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 214 RLKPNI---SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCCC---CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 112222 34567788899999999999884 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.71 Aligned_cols=248 Identities=27% Similarity=0.312 Sum_probs=191.4
Q ss_pred eeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||+|+||.||++.. .+|+.||+|++...... .....+.+..|++++++++||||+++++++......++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-------KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-------cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEe
Confidence 69999999999965 46999999998432211 11123445669999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 613 YMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 613 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
|+++++|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~--- 147 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD--- 147 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---
Confidence 99999999888654 2458899999999999999999999 9999999999999999999999999999876532
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL 771 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (840)
........|+..|+|||++.+..++.++||||+||++|||++|+.||....... ....... .......
T Consensus 148 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~----------~~~~~~~ 215 (277)
T cd05607 148 -GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKR----------RTLEDEV 215 (277)
T ss_pred -CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHH----------Hhhcccc
Confidence 122234568999999999988889999999999999999999999997532111 1111100 0011111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 772 SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 772 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.........++.+++.+|++.||++||+++|+++.
T Consensus 216 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 10111233456778889999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.23 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=198.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|...+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+|++++++++.. .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----------MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-----------ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C
Confidence 4577788999999999999988877789999874322 123567889999999999999999998854 5
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccce
Confidence 6789999999999999997643 357999999999999999999999 899999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........++..|+|||+..+..++.++||||||+++|||++ |+.||.+... .....+.
T Consensus 151 ~~~~~--~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~---------- 216 (260)
T cd05069 151 LIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQV---------- 216 (260)
T ss_pred EccCC--cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----------
Confidence 65331 1111122345678999999988889999999999999999999 9999875321 1111110
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
...............+.+++.+|+.+||++||+++++++.|++
T Consensus 217 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 217 ---ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000011112334567788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.00 Aligned_cols=205 Identities=24% Similarity=0.362 Sum_probs=172.7
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|+..+.||+|+||+||+|.. .+++.||||++.... .........+.+|+.++++++|+||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-------~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-------VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-------hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence 477888999999999999955 578999999984322 111234567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999999999999997654 68899999999999999999999 9999999999999999999999999999753
Q ss_pred hhccCC--------------------------------------------CCcceecccccccccCccccccCCCCcccc
Q 003199 686 LQARGG--------------------------------------------KDSTTTVIAGTYGYLAPEYAYSSKATTKCD 721 (840)
Q Consensus 686 ~~~~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 721 (840)
+..... .........||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 311000 000012346999999999999989999999
Q ss_pred chhHHHHHHHHHhCCCCCCCC
Q 003199 722 VYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 722 v~slG~il~el~tg~~p~~~~ 742 (840)
|||+||++|||++|+.||...
T Consensus 231 iwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred EEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.89 Aligned_cols=245 Identities=27% Similarity=0.341 Sum_probs=193.4
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||+||+|... +++.||||++...... .......+..|.+++..+ +||||+++++++...+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-------QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 46999999999999665 6889999998543211 112345567888888877 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~- 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL- 148 (318)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCc-
Confidence 999999999999887764 68999999999999999999999 9999999999999999999999999999865321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ........ ..
T Consensus 149 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~---~~~~i~~~--------~~ 213 (318)
T cd05570 149 --GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDE---LFQSILED--------EV 213 (318)
T ss_pred --CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHH---HHHHHHcC--------CC
Confidence 1122234568999999999999999999999999999999999999997531 110 00000000 01
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTM-----NEVVQL 806 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 806 (840)
..+.. ....+.+++.+|++.||.+||++ .+++++
T Consensus 214 ~~~~~---~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRW---LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCc---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11111 23456778889999999999999 888775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.77 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=196.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-------IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 357888899999999999999665 688999999843221 112234567889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999999999764 57889999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS----KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
...... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...... ....
T Consensus 190 ~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~-i~~~ 262 (370)
T cd05621 190 MKMDET--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSK-IMDH 262 (370)
T ss_pred eecccC--CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHH-HHhC
Confidence 765321 11222456799999999998654 378899999999999999999999975311 000110 0000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT--RPTMNEVVQLL 807 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 807 (840)
.. ....+. .......+.+++..|+..+|.+ ||++.|++++-
T Consensus 263 ~~------~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 263 KN------SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred Cc------ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 00 000111 1112344556677888755543 89999999983
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=311.44 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=201.3
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|++|.||+|..+ +|+.|++|.+...... ....+.+.+|+++++.++|||++++++++.+...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--------RREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 566788999999999999654 6899999987432211 2335678899999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||+++++|.+++... ...+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEccccccee
Confidence 99999999999999999775 3578999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
.... ........|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..... ..
T Consensus 151 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~-------------~~ 212 (256)
T cd08529 151 LSDN---TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALI-------------LK 212 (256)
T ss_pred ccCc---cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHH-------------HH
Confidence 6432 112234568889999999999889999999999999999999999996532 10000 00
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
................+.+++.+||+.+|++||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 IIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111111111334567788889999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.60 Aligned_cols=366 Identities=29% Similarity=0.395 Sum_probs=309.9
Q ss_pred CCCCCEEecCCCcCc-ccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 16 MQNLRRLDLSNNLFT-GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 16 l~~L~~L~Ls~n~i~-~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
|+-.+-.|+++|.++ +..|.....++++++|.|++. ++. .+|+.++.+.+|
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt---~L~-------------------------~vPeEL~~lqkL 57 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRT---KLE-------------------------QVPEELSRLQKL 57 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechh---hhh-------------------------hChHHHHHHhhh
Confidence 344566899999999 678999999999999999988 443 345667777788
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
++|.+++|++. .+-.+++.|+.|+.+.+..|++-...+|..+..+..|+.||||+|+++ ..|..+...+++-+|+|++
T Consensus 58 EHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~ 135 (1255)
T KOG0444|consen 58 EHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY 135 (1255)
T ss_pred hhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEccc
Confidence 88888888887 667778888888888888888777788888889999999999999999 7888999999999999999
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccc-ccccC
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM-FSGVL 253 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~ 253 (840)
|+|..++...|.+++.|-.||||+|++. .+|+-...+..|++|+|++|.+.-.--..+-.+.+|+.|.+++.+ -...+
T Consensus 136 N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~ 214 (1255)
T KOG0444|consen 136 NNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI 214 (1255)
T ss_pred CccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcC
Confidence 9998888888889999999999999998 677778889999999999998764333334445677777777654 33467
Q ss_pred CcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccC
Q 003199 254 PDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI 333 (840)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 333 (840)
|.++..+.||..+|+|.|.+. .+|+.+..+++|+.|+||+|+|+. ..-..+.+.+|+.|+||.|+++ .+|.++++++
T Consensus 215 Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~ 291 (1255)
T KOG0444|consen 215 PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLT 291 (1255)
T ss_pred CCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhH
Confidence 888999999999999999998 899999999999999999999984 4445677889999999999998 8899999999
Q ss_pred cccEEEcCCCccC-CCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEc
Q 003199 334 SLVKIDLSDNLLS-GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINF 411 (840)
Q Consensus 334 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l 411 (840)
+|+.|++.+|+++ .-+|..++.+.+|+.+..++|.+. .+|+.++.|..|+.|.|++|+|- ++|+.+.-+ .+..||+
T Consensus 292 kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDl 369 (1255)
T KOG0444|consen 292 KLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDL 369 (1255)
T ss_pred HHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeec
Confidence 9999999999986 358999999999999999999997 88999999999999999999998 789888776 4688999
Q ss_pred cCCCCc
Q 003199 412 SNNRLS 417 (840)
Q Consensus 412 ~~N~l~ 417 (840)
..|+--
T Consensus 370 reNpnL 375 (1255)
T KOG0444|consen 370 RENPNL 375 (1255)
T ss_pred cCCcCc
Confidence 998644
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.08 Aligned_cols=255 Identities=27% Similarity=0.350 Sum_probs=211.5
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 600 (840)
...+.|+..+.||+|.||.||++..+ +|+.+|+|.+.+..... ......+.+|+.+|+++. |||||.+.+.
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-------~~~~~~v~~Ev~il~~l~~hpniv~l~~~ 104 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-------KEDREDVRREVAILQQLSGHPNIVQLKDA 104 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-------cccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 34456777889999999999999655 59999999996655321 113567899999999998 9999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CCCe
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN----YQPK 676 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~k 676 (840)
+++....++|||++.||.|.+.+... .+++.++..++.|++.|+.|||+ .||||||+||+|+|+... +.+|
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEE
Confidence 99999999999999999999999876 38999999999999999999999 999999999999999643 4799
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
++|||+|..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+........
T Consensus 180 ~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------- 248 (382)
T KOG0032|consen 180 LIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------- 248 (382)
T ss_pred EeeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------
Confidence 999999988643 445667899999999999999999999999999999999999999998753211111
Q ss_pred hccccchhhhcccc---cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 757 VDTKEGIMEVLDKK---LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 757 ~~~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.+.... ..+.+......+.+++..|+..||.+|+|+.++++|-+
T Consensus 249 --------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 249 --------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred --------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 111111 12334455666777888999999999999999999844
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=345.36 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=201.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-------~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-------ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-------cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence 4678889999999999999965 4689999999853221 1133456789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC----------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG----------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
+..++||||+++|+|.+++... ....++..+..++.||++||+|||+ ++|+||||||+||+++.++.
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGE 151 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCC
Confidence 9999999999999999988642 1245677889999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCC---------------CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 003199 675 PKVADFGIAKVLQARGGK---------------DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV 739 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 739 (840)
++|+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 999999999866211100 00112346999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhhc
Q 003199 740 EDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-TMNEVVQLLAEA 810 (840)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~ 810 (840)
....... .. ... . ...+.......+....+.+++.+|++.||++|| +++++.+.|+..
T Consensus 232 ~~~~~~k--i~-~~~-~---------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 232 RRKKGRK--IS-YRD-V---------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCcchhh--hh-hhh-h---------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7532111 00 000 0 000000011122345567788899999999996 567777777654
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.50 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=194.3
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 604 (840)
+|...+.||+|+||.||+|... +++.||||++...... .......+..|..++..+ .|++|+++++++.+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC
Confidence 3667889999999999999655 6789999998543211 112234566777888777 589999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence 99999999999999999987654 68999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ......
T Consensus 150 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~---~~i~~~----- 216 (323)
T cd05616 150 ENMW---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELF---QSIMEH----- 216 (323)
T ss_pred ecCC---CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHH---HHHHhC-----
Confidence 5322 12223456799999999999999999999999999999999999999975311 1110 000000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM-----NEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 806 (840)
....+.. ...++.+++.+|++.||++|++. .++.++
T Consensus 217 ---~~~~p~~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 217 ---NVAYPKS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---CCCCCCc---CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0011111 23456778889999999999984 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=318.78 Aligned_cols=257 Identities=27% Similarity=0.355 Sum_probs=200.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|+..+.||+|+||.||+|... ....||+|.+.... ..+....+.+|++++.++ +|+||++++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---------TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---------CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 46778889999999999999654 23679999874322 112345688999999999 799999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKG---------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIK 663 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 663 (840)
+++......++||||+++|+|.++++.. ...+++..+..++.|++.|++|||+ .+|+|||||
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlk 159 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLA 159 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccc
Confidence 9999999999999999999999998642 2468899999999999999999999 999999999
Q ss_pred CCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 003199 664 STNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDD 742 (840)
Q Consensus 664 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~ 742 (840)
|+||++++++.+||+|||+++.+.... .........++..|+|||+..+..++.++|||||||++||+++ |..||...
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHID-YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred eeeEEEcCCCeEEeCcccccccccccc-ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999999999998764321 1111222335678999999988899999999999999999998 99998642
Q ss_pred CCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.. ... .... ...............+.+++.+|++.||++|||+.|+++.|+++
T Consensus 239 ~~--~~~---~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 239 PV--EEL---FKLL----------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CH--HHH---HHHH----------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 10 000 0000 00000011112345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.85 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=198.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
.+|...++||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----------ESARQDFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----------HHHHHHHHHHHHHHhcCCCCCCceEEE
Confidence 45667889999999999998532 35688999874322 233567899999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC--------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL--------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 665 (840)
++......++||||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~ 151 (280)
T cd05092 75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATR 151 (280)
T ss_pred EEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHh
Confidence 9999999999999999999999987642 247899999999999999999999 99999999999
Q ss_pred CEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 003199 666 NILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744 (840)
Q Consensus 666 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 744 (840)
||++++++.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 152 nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 152 NCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred hEEEcCCCCEEECCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 9999999999999999987553211 1111223345678999999998899999999999999999998 9999864211
Q ss_pred CCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
... ....... ...... ......+.+++.+||+.||++||++.++.+.|++
T Consensus 231 --~~~---~~~~~~~-------~~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 231 --TEA---IECITQG-------RELERP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHH---HHHHHcC-------ccCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111 0000000 000111 1223456788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.16 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=197.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
+.|...+.||+|++|.||+|... .+..||+|.+.... .......+.+|+.++++++|+||+++++
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---------SEQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 56788899999999999999664 35678999773221 1233456889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
++.+....++||||+++++|.+++.... ..++|..+..++.||+.|++|||+ ++++||||||+||+++.++
T Consensus 77 ~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 77 VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccC
Confidence 9999889999999999999999987643 258999999999999999999999 8999999999999998754
Q ss_pred ---CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003199 674 ---QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNI 749 (840)
Q Consensus 674 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 749 (840)
.+||+|||+++...... ..........+..|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~ 230 (277)
T cd05036 154 PGRVAKIADFGMARDIYRAS-YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EV 230 (277)
T ss_pred CCcceEeccCccccccCCcc-ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 58999999998663211 1111122234568999999998899999999999999999997 99998753211 11
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
....... . ..... ......+.+++.+|++.+|++||++.+++++|.
T Consensus 231 ---~~~~~~~-~------~~~~~---~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ---MEFVTGG-G------RLDPP---KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHHHcC-C------cCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1100000 0 00111 122356778888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.95 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=207.0
Q ss_pred CccCeeeccCCcEEEEEEe-CCC----cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 529 TEKNKVGQGGSGTVYKIDL-NSG----EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
...++||+|+||+||+|.| ..| -+||+|++.... ..+...++.+|+-+|.+++|||+++++|+|..
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---------~~~~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---------SPKASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---------CchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 3467899999999999855 334 468888874433 23456789999999999999999999999987
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.. ..||++||+.|+|.++++.....+.-...+.|..|||+||.|||. +++|||||.++|||+.+-..+||+|||+|
T Consensus 770 s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 770 ST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred ch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchh
Confidence 76 789999999999999999888789999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.....+ .........-.+.|||=|.+..+.|+.++|||||||.+||++| |..||++... +.
T Consensus 846 ~ll~~d~-~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------------~e 908 (1177)
T KOG1025|consen 846 KLLAPDE-KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------------EE 908 (1177)
T ss_pred hccCccc-ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------HH
Confidence 9876532 2333333445678999999999999999999999999999999 9999976311 11
Q ss_pred hhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 763 IMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 763 ~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+.+.+.... -...+-...++..++.+||..|++.||+++++...+.++.
T Consensus 909 I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 909 IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 222222221 1223345677888999999999999999999999998654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.04 Aligned_cols=255 Identities=28% Similarity=0.328 Sum_probs=199.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 35688889999999999999965 5789999999843321 123457789999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..++||||+++++|.++++... .+++..+..++.|++.|++|||+ .+|+|||++|+||+++.++.++|+|||++
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999999999987654 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
...... ........|++.|+|||.+. ...++.++|||||||++|||++|+.||........ ...+. .
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~------~ 223 (267)
T cd06646 154 AKITAT---IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMS------K 223 (267)
T ss_pred eeeccc---ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeee------c
Confidence 765321 11223456889999999874 34578899999999999999999999864321110 00000 0
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
. ....... .........+.+++.+||+.+|++||+++++++++
T Consensus 224 ~---~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 S---NFQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C---CCCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0000001 01112335677888899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.68 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=200.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|+..+.||+|+||+||+|.+. +|+ .||+|++.... .....+.+.+|+.+++.+.|+||++++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---------SPKANKEILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---------CHHHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 46777889999999999999653 454 48999874322 12335678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+... ..++++||+++|+|.+++......+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+||
T Consensus 78 ~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 78 CLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCC
Confidence 8754 5679999999999999998765578999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++....... ........+++.|+|||...+..++.++|||||||++|||++ |..||..... .....+.. .
T Consensus 154 G~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~----~ 226 (279)
T cd05109 154 GLARLLDIDET-EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLE----K 226 (279)
T ss_pred Cceeecccccc-eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH----C
Confidence 99987643111 111112234678999999988899999999999999999998 9999864311 11111110 0
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
. ...+........+.+++.+||+.||++||++.++++.|+++...
T Consensus 227 ~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 227 G---------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C---------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 00011112344677888899999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.94 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=200.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|..+ +|. .+|+|.+.... .......+.+|++++.++ +|+||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---------SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---------CHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 46777889999999999999654 454 45777663221 123356788899999999 899999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 666 (840)
......++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ ++++||||||+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~N 154 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 154 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchhe
Confidence 99999999999999999999997542 257899999999999999999999 999999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 745 (840)
|++++++.+||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 229 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 229 (303)
T ss_pred EEecCCCcEEeCccccCcccch----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-
Confidence 9999999999999999863211 111122234668999999988889999999999999999998 9999864311
Q ss_pred CcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCC
Q 003199 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFE 816 (840)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 816 (840)
.. .... .... ..... .......+.+++.+|++.+|++||++.++++.++++-..+..
T Consensus 230 -~~---~~~~-~~~~------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 230 -AE---LYEK-LPQG------YRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred -HH---HHHH-HhcC------CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 10 1100 0000 00001 111234567888899999999999999999999887665553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.59 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=193.8
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||+||+|... +++.||+|++..... ......+.+.+|+.++.++ .||||+++++++.+....++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-------HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEE
Confidence 36999999999999654 678999999854321 1123345678899999888 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~- 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG- 148 (327)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccC-
Confidence 999999999999887654 68999999999999999999999 9999999999999999999999999999875321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-cchhhhhhhhhccccchhhhcc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN-KNIIYWVSIKVDTKEGIMEVLD 768 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 768 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+....... ..
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~ 219 (327)
T cd05617 149 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------KP 219 (327)
T ss_pred --CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------CC
Confidence 1222345679999999999999999999999999999999999999996422111 1111111000000 00
Q ss_pred cccCCCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003199 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRPT------MNEVVQL 806 (840)
Q Consensus 769 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~evl~~ 806 (840)
..++.. ....+.+++.+|++.||++||+ +.+++++
T Consensus 220 ~~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRF---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 111111 2244567888999999999998 4577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.51 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=206.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|+.||+|.++..... .....+.+.+|++++++++|+|++++++++...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-------DAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-------chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 35778889999999999999665 8999999988533211 123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
+..++||||+++++|.+++... ...+++.++..++.+++.|++|||+ .+++||||+|+||+++.++.++++|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccc
Confidence 9999999999999999988642 3458999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.... .........
T Consensus 152 ~~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~------ 219 (267)
T cd08224 152 LGRFFSSK---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK------ 219 (267)
T ss_pred eeeeccCC---CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh------
Confidence 98765321 112234568889999999988889999999999999999999999986432 111111110
Q ss_pred chhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.......+.. ......+.+++.+|+..+|++||++.++++.|+++.
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 ----IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0001111111 133456778888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.92 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=194.7
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|+..+.||+|+||.||+|.. .+++.||||++..... ........+.+|++++++++|+||+++++.+.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-------LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-------HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 477889999999999999955 4689999999843221 11223466889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+|..
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 9999999999999999998764 68889999999999999999999 9999999999999999999999999999753
Q ss_pred hhccCC----------------------------------------CCcceecccccccccCccccccCCCCccccchhH
Q 003199 686 LQARGG----------------------------------------KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSF 725 (840)
Q Consensus 686 ~~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 725 (840)
+..... .........||+.|+|||++.+..++.++|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 310000 0001123479999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC---CHHH
Q 003199 726 GVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP---TMNE 802 (840)
Q Consensus 726 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s~~e 802 (840)
||++|||++|+.||...... .+......... ... .. ........+.+++.+|+ .+|.+|+ ++.+
T Consensus 231 Gvilyell~G~~Pf~~~~~~-----~~~~~i~~~~~----~~~--~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPA-----ETQLKVINWET----TLH--IP-SQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred cceeeehhhCCCCCCCCCHH-----HHHHHHhccCc----ccc--CC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999999753211 00000000000 000 00 00112234455556665 4999999 8999
Q ss_pred HHHH
Q 003199 803 VVQL 806 (840)
Q Consensus 803 vl~~ 806 (840)
++++
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 9988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.04 Aligned_cols=262 Identities=25% Similarity=0.315 Sum_probs=197.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|...+.||+|+||.||+|.. .+|..||||++..... .......+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--------NQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--------chhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4568899999999999999999954 5789999999854321 122345677899999999999999999988
Q ss_pred ecCc------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSLY------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
.... ..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCE
Confidence 5443 46899999964 66666653 47889999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...|...
T Consensus 163 kl~Dfg~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~----~~~~~~~ 234 (359)
T cd07876 163 KILDFGLARTACT----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH----IDQWNKV 234 (359)
T ss_pred EEecCCCcccccc----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 9999999975422 2223345789999999999999999999999999999999999999975321 1111110
Q ss_pred hhcccc-----------chhhhcc--cccCC-----------------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003199 756 KVDTKE-----------GIMEVLD--KKLSG-----------------SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805 (840)
Q Consensus 756 ~~~~~~-----------~~~~~~~--~~~~~-----------------~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 805 (840)
...... ....... +...+ ........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0000000 00000 00011345778899999999999999999999
Q ss_pred Hh
Q 003199 806 LL 807 (840)
Q Consensus 806 ~L 807 (840)
+-
T Consensus 315 hp 316 (359)
T cd07876 315 HP 316 (359)
T ss_pred Cc
Confidence 74
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=312.46 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=201.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CC---cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SG---EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
..|...+.||+|+||.||+|... ++ ..||||++.... .......|..|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---------TEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---------CHHHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 45677889999999999999664 33 369999884321 123356789999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+....++||||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 75 TKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred CCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCc
Confidence 99999999999999999999998765578999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceeccc--ccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhc
Q 003199 682 IAKVLQARGGKDSTTTVIA--GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
++................. .+..|+|||++.+..++.++|||||||++|||++ |..||.... ......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~---- 225 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIE---- 225 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHH----
Confidence 9876543211111111111 2457999999998899999999999999999887 999986431 111111110
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.. .. .+...+.+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 226 ~~------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QD------YR---LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cC------Cc---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 011122344567888899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.56 Aligned_cols=258 Identities=27% Similarity=0.341 Sum_probs=198.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|..+ ++. .+++|.++... .....+.+.+|+++++++ +||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 72 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---------SENDHRDFAGELEVLCKLGHHPNIINLLGAC 72 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---------CHHHHHHHHHHHHHHHhhcCCCchhheEEEE
Confidence 45777889999999999999665 343 47888774321 122346788999999999 799999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 666 (840)
......++|+||+++|+|.+++.... ..+++..+..++.|++.|++|||+ ++|+||||||+|
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~N 149 (297)
T cd05089 73 ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARN 149 (297)
T ss_pred ccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcce
Confidence 99999999999999999999997532 247889999999999999999999 999999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 745 (840)
|++++++.+||+|||++..... .........+..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~- 224 (297)
T cd05089 150 VLVGENLASKIADFGLSRGEEV----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC- 224 (297)
T ss_pred EEECCCCeEEECCcCCCccccc----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 9999999999999999864211 111112233557999999988889999999999999999997 9999965311
Q ss_pred CcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
. ........ ....... ......+.+++.+|++.+|.+||++.++++.|+++...+
T Consensus 225 -~---~~~~~~~~-------~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 225 -A---ELYEKLPQ-------GYRMEKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -H---HHHHHHhc-------CCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 01100000 0001111 123345678888999999999999999999998766544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.58 Aligned_cols=251 Identities=28% Similarity=0.370 Sum_probs=195.3
Q ss_pred CeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccc
Q 003199 532 NKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 607 (840)
++||+|+||.||+|.+.. +..||+|.+..... ....+.+.+|+.+++.+.|+|++++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---------AAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-Cce
Confidence 469999999999995532 26899998843321 1335678899999999999999999998764 467
Q ss_pred eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhh
Q 003199 608 LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 687 (840)
++||||+++|+|.+++.... .+++..+..++.|++.|++|||. .+++||||||+||+++.++.+||+|||+++...
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceee
Confidence 99999999999999998765 68999999999999999999999 899999999999999999999999999998764
Q ss_pred ccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 688 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
.............++..|+|||...+..++.++||||||+++|||++ |+.||....+ .....+.. . ..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~---~-~~----- 215 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE---S-GE----- 215 (257)
T ss_pred cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH---c-CC-----
Confidence 32211111122234568999999988899999999999999999998 9999865311 11111110 0 00
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
...........+.+++.+|+..+|++||++.++.+.|+++.
T Consensus 216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00111122356778888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=311.14 Aligned_cols=253 Identities=30% Similarity=0.448 Sum_probs=202.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|..+++..||||.+..... ..+.+.+|+.++++++|+|++++++++....
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-----------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-----------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 56788899999999999999888888999998853221 1356889999999999999999999999888
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++.... ..+++.++..++.+++.|++|||+ .+++|+||||+||++++++.++++|||.+.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccce
Confidence 9999999999999999997653 468999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........++..|+|||.+.+..++.++||||+|+++||+++ |+.||.+... ....... . .
T Consensus 152 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~--~-~----- 219 (261)
T cd05034 152 LIEDD--EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQV--E-R----- 219 (261)
T ss_pred eccch--hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH--H-c-----
Confidence 65421 1111122234568999999998889999999999999999999 9999865311 1111100 0 0
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
....... ......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 220 --~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 --GYRMPRP---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000011 1123467788889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.29 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=188.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4688899999999999999965 468999999873221 1234699999999999999998876331
Q ss_pred --------ccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 605 --------YCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 605 --------~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
...++||||++ +++.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNT 207 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCC
Confidence 23568999997 477766643 23468999999999999999999999 9999999999999999665
Q ss_pred -CCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 003199 674 -QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 674 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 751 (840)
.+||+|||+|+.+... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.... ..+..
T Consensus 208 ~~vkL~DFGla~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~ 282 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAG----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVR 282 (440)
T ss_pred CceeeeccccchhccCC----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence 6999999999876431 122345689999999988654 6899999999999999999999999753211 11111
Q ss_pred hhhhhhc-cccchhh----hcccccC----CCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 752 WVSIKVD-TKEGIME----VLDKKLS----GSFR-----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 752 ~~~~~~~-~~~~~~~----~~~~~~~----~~~~-----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..+.... ..+.... ..+..++ .... ....++.+++.+||+.||.+|||+.|++++=
T Consensus 283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 1110000 0000000 0000000 0010 1234678899999999999999999999773
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.84 Aligned_cols=260 Identities=20% Similarity=0.293 Sum_probs=204.9
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|++|.||+|.. .+|+.||||.+.... .......+.+.+|+.+++.+.|+||+++++++.+.+
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-------hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 566778899999999999964 579999999874322 112334567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 606 CNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..++||||+++++|.+++.. ....+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++++|||+
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchh
Confidence 99999999999999998864 23468999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+...... ........|+..|+|||++.+..++.++||||||+++|||++|..||...... ...+.+..
T Consensus 153 ~~~~~~~---~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~------ 220 (267)
T cd08229 153 GRFFSSK---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI------ 220 (267)
T ss_pred hhccccC---CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh------
Confidence 8765331 11223456889999999998888999999999999999999999998643111 11111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.....+... .......+.+++.+||..||.+|||+.+|++.++++.
T Consensus 221 -~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 -EQCDYPPLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -hcCCCCCCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000001111 1123456778888999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.67 Aligned_cols=242 Identities=25% Similarity=0.298 Sum_probs=186.3
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHH-HHHhccCCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV-ETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||+||+|... +++.||+|++...... .......+..|. .+++.++|+||+++++++...+..++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEE
Confidence 36999999999999654 6789999998532211 111223344444 45678899999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++.... .+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~- 148 (325)
T cd05602 74 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 148 (325)
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc-
Confidence 999999999999997754 57888999999999999999999 9999999999999999999999999999875422
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ..
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~--------~~ 213 (325)
T cd05602 149 --HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNK--------PL 213 (325)
T ss_pred --CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhC--------Cc
Confidence 12223456799999999999999999999999999999999999999975311 1111100000 00
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 803 (840)
...+. ....+.+++.+|++.||.+||++.+.
T Consensus 214 ~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 214 QLKPN---ITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCC---CCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 11122 23455677789999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=327.22 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=199.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.+. .+..||||++..... ....+.+.+|++++.++. ||||++++
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---------~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR---------SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC---------hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 45677889999999999999753 346899999854321 122346889999999997 99999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------------------------------------------------
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL--------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 627 (840)
+++......++||||+++|+|.+++++..
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999986531
Q ss_pred ----------------------------------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 628 ----------------------------------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 628 ----------------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
..+++..+..++.|++.||+|||+ .+++|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCccc
Confidence 135777889999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||++++++.+||+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccc-ccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999997653211 1111223456789999999988889999999999999999998 899986
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
..... .. .+ .. ..... ....+ ......+.+++.+||..+|.+||+++|+++.|+++
T Consensus 344 ~~~~~--~~-~~-~~-~~~~~------~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 344 ELPMN--EQ-FY-NA-IKRGY------RMAKP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCch--HH-HH-HH-HHcCC------CCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 43110 00 00 00 00000 00011 12235677788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.49 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=198.1
Q ss_pred CeeeccCCcEEEEEEeCC--C--cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccc
Q 003199 532 NKVGQGGSGTVYKIDLNS--G--EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 607 (840)
+.||+|++|.||+|.+.+ + ..||||.+..... ....+.+.+|+.++++++|+||+++++.+.+ ...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc---------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeE
Confidence 468999999999996643 3 3699998844331 1446788999999999999999999999988 888
Q ss_pred eEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 608 LLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
++|+||+++++|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.+
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999999998754 468999999999999999999999 99999999999999999999999999999876
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....... ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~---~~~------ 216 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKI---DKE------ 216 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---Hhc------
Confidence 442222222234557789999999998899999999999999999999 9999864311 1111100 000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.............+.+++.+|++.+|++||++.++++.|.+
T Consensus 217 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 217 ---GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred ---CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 00000111234567788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.11 Aligned_cols=256 Identities=26% Similarity=0.339 Sum_probs=201.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++|+||+++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---------SMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---------CHHHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 56788899999999999998654 24689999874221 1223456889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC---------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL---------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
++......++||||+++|+|.+++.... ..++|..+..++.|++.||.|||+ .+++||||||+||+++
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~ 153 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVA 153 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEc
Confidence 9999999999999999999999986432 246889999999999999999999 9999999999999999
Q ss_pred CCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003199 671 VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNI 749 (840)
Q Consensus 671 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 749 (840)
+++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||.+.. ....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~ 230 (277)
T cd05032 154 EDLTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEV 230 (277)
T ss_pred CCCCEEECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHH
Confidence 999999999999987643211 112233456789999999988889999999999999999998 999986421 1111
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
..+.. . .. ....+.. ....+.+++.+||+.+|++|||+.++++.|++
T Consensus 231 ~~~~~---~-~~------~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 LKFVI---D-GG------HLDLPEN---CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHHh---c-CC------CCCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11110 0 00 0011111 24567788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.63 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=199.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|+++++++.|||++++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-----------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-----------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 35677889999999999999877788999998743221 1345788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......++++.+..++.+++.|++|||+ .+++||||||+||+++.++.++|+|||.+..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceee
Confidence 9999999999999999998765568999999999999999999999 8999999999999999999999999999875
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ... ..... .
T Consensus 150 ~~~~--~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~---~~~~~---~--- 216 (256)
T cd05112 150 VLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEV---VETIN---A--- 216 (256)
T ss_pred cccC--cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHH---HHHHh---C---
Confidence 5321 1111122335678999999988889999999999999999998 9999864311 111 10000 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
......... ....+.+++.+||+.+|++||++.+++++|.
T Consensus 217 -~~~~~~~~~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 217 -GFRLYKPRL---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCCCCC---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 000000111 2356778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.37 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=200.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
.+|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|+.+++++.|||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---------SADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---------CHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 46778889999999999999653 46789999884322 1233467889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC---------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL---------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPII 658 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 658 (840)
++......++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~ 152 (288)
T cd05050 76 VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFV 152 (288)
T ss_pred EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 9999999999999999999999987431 247888999999999999999999 9999
Q ss_pred ecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCC
Q 003199 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRK 737 (840)
Q Consensus 659 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~ 737 (840)
||||||+||++++++.++|+|||.+..+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred cccccHhheEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875532111 111222345678999999988899999999999999999998 888
Q ss_pred CCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 738 PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
||.+... ..... ...+............++.+++.+|++.||++|||+.|+++.|++
T Consensus 232 p~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 232 PYYGMAH-----EEVIY----------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCH-----HHHHH----------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8854211 01111 111111111111234567788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.60 Aligned_cols=240 Identities=26% Similarity=0.331 Sum_probs=185.6
Q ss_pred CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHH-HHHhccCCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV-ETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|... +|+.||+|++...... .......+..|. .+++.++||||+++++++.+.+..++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-------KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-------HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEE
Confidence 36999999999999664 6899999998433211 112233444554 46788999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE- 148 (321)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCC-
Confidence 999999999998887653 68889999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~--------~~ 213 (321)
T cd05603 149 --PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHK--------PL 213 (321)
T ss_pred --CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcC--------CC
Confidence 1122344578999999999998899999999999999999999999997531 11111100000 00
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN 801 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 801 (840)
.+++. ....+.+++.+|++.||.+||++.
T Consensus 214 ~~~~~---~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGG---KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCC---CCHHHHHHHHHHccCCHhhcCCCC
Confidence 11112 234566788899999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=320.76 Aligned_cols=196 Identities=26% Similarity=0.400 Sum_probs=159.3
Q ss_pred cCeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec--Cc
Q 003199 531 KNKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS--LY 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 605 (840)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. ..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------------SMSACREIALLRELKHPNVISLQKVFLSHADR 73 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCc
Confidence 468999999999999754 467899998843221 2346789999999999999999998854 45
Q ss_pred cceEEEeecCCCChHHHhhcC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCC
Q 003199 606 CNLLVYEYMPNGNLWDALHKG--------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL----DVNY 673 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~ 673 (840)
..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~ 149 (317)
T cd07868 74 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred EEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcC
Confidence 6789999995 5888877532 1258899999999999999999999 999999999999999 4567
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
.+||+|||+++................||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 8999999999876432222223345678999999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.34 Aligned_cols=264 Identities=21% Similarity=0.298 Sum_probs=197.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|..+ +++.||+|++...... .....+.+|++++++++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---------GAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---------CcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 46788899999999999999654 6889999998543211 1123466899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||++ +++.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccce
Confidence 99999999997 48888887665568999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-----------hhhh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN-----------IIYW 752 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------~~~~ 752 (840)
..... ........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.. ...|
T Consensus 153 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 153 AKSVP---TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ecCCC---ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 54321 122234467899999998765 46889999999999999999999999753211000 0001
Q ss_pred hhhhhccccchhhhcccccC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 753 VSIKVDTKEGIMEVLDKKLS-----GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... ..........+... ........++.+++.+|++.||.+|||+.|++++-
T Consensus 230 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 230 PGIS--SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhc--chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000 00000000000000 00112234567888999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.81 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=201.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.. .++..||||++..... ....+.+.+|+.+++++ +|+||++++
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---------SSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---------hHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 5688889999999999999853 2345799998743221 22346788999999999 799999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
+++......++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++++|+||||+||+++.++.+++
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999999997643 238999999999999999999999 89999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 756 (840)
+|||+++...... .........++..|+|||.+.+..++.++||||+||++|||++ |..||....... .....
T Consensus 183 ~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~---- 256 (302)
T cd05055 183 CDFGLARDIMNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKL---- 256 (302)
T ss_pred CCCcccccccCCC-ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHH----
Confidence 9999997653321 1111223346778999999998899999999999999999998 999987532111 00000
Q ss_pred hccccchhhhcccccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 757 VDTKEGIMEVLDKKLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
...... ........++.+++.+|+..+|++||++.|+++.|+++
T Consensus 257 ----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 ----------IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000 00111234677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.99 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=201.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC--------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcc
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN--------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIV 595 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 595 (840)
.++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|+.+++.+ +||||+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---------TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---------chHHHHHHHHHHHHHHhhccCCCch
Confidence 356778899999999999998531 34579999874321 122346788999999999 899999
Q ss_pred eeeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 003199 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660 (840)
Q Consensus 596 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 660 (840)
++++++......++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++++||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~ 161 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHR 161 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeec
Confidence 99999999999999999999999999987531 247888999999999999999999 999999
Q ss_pred CCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCC
Q 003199 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPV 739 (840)
Q Consensus 661 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~ 739 (840)
||||+||++++++.+||+|||.++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccc-cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999986643211 112223345678999999988889999999999999999998 78887
Q ss_pred CCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 740 EDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
.... ...+.... ... ............+.+++.+||+.+|.+||++.|+++.|+++...
T Consensus 241 ~~~~-----~~~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 241 PGIP-----VEELFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ccCC-----HHHHHHHH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 5421 11111110 000 00001112345677788899999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.35 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=197.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC---------------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS---------------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 590 (840)
.+|...+.||+|+||.||++.... ...||+|.+..... ......+.+|++++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---------KTARNDFLKEIKIMSRLK 75 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---------HHHHHHHHHHHHHHHhCC
Confidence 467888899999999999985532 23589998743211 223456889999999999
Q ss_pred CCCcceeeeEEecCccceEEEeecCCCChHHHhhcCC-----------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 003199 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL-----------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659 (840)
Q Consensus 591 h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 659 (840)
|+|++++++++......++||||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++|
T Consensus 76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H 152 (295)
T cd05097 76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVH 152 (295)
T ss_pred CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeec
Confidence 9999999999999999999999999999999986532 246889999999999999999999 99999
Q ss_pred cCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh--CCC
Q 003199 660 RDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT--GRK 737 (840)
Q Consensus 660 ~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~~ 737 (840)
|||||+||++++++.+||+|||++....... .........++..|+|||+..+..++.++||||||+++|||++ |..
T Consensus 153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~ 231 (295)
T cd05097 153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231 (295)
T ss_pred cccChhhEEEcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999997653321 1111223345678999999988889999999999999999998 566
Q ss_pred CCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 738 PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
||..... ............... ..............+.+++.+|++.||++||++.+|++.|++
T Consensus 232 p~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 232 PYSLLSD--EQVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCcccCh--HHHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 7754211 111110000000000 000000111123578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.09 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=198.7
Q ss_pred cCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
|+..+.||+|+||.||+|... ....||+|.+..... ......+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---------SSELRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---------HHHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 566788999999999998643 235788888743221 12346788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCC-----------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGL-----------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPII 658 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 658 (840)
......++|+||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~iv 149 (290)
T cd05045 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLV 149 (290)
T ss_pred ecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCee
Confidence 99999999999999999999886421 247899999999999999999999 9999
Q ss_pred ecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCC
Q 003199 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRK 737 (840)
Q Consensus 659 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~ 737 (840)
||||||+||++++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 228 (290)
T cd05045 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228 (290)
T ss_pred hhhhhhheEEEcCCCcEEeccccccccccCccc-hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999976533211 111223345678999999988889999999999999999998 999
Q ss_pred CCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 738 PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
||.+.. .... |..... ....... ......+.+++.+|++.+|++||+++|+++.|+++-
T Consensus 229 p~~~~~--~~~~--~~~~~~--------~~~~~~~---~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 229 PYPGIA--PERL--FNLLKT--------GYRMERP---ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCCCCC--HHHH--HHHHhC--------CCCCCCC---CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 986431 1111 111000 0000111 122346778888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.65 Aligned_cols=253 Identities=26% Similarity=0.314 Sum_probs=191.7
Q ss_pred CeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe-cCcc
Q 003199 532 NKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS-SLYC 606 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 606 (840)
+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++|||++++++++. .+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 71 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC---------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCC
Confidence 46899999999999653 23579999873221 1233567888999999999999999999775 4556
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||+.+|+|.+++........+..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccc
Confidence 789999999999999998765567888889999999999999999 89999999999999999999999999999765
Q ss_pred hccCCCC-cceecccccccccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 687 QARGGKD-STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITG-RKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
....... .......++..|+|||+..+..++.++||||||+++|||++| .+||.... .. .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~---~~~~~--------- 214 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SF---DITVY--------- 214 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HH---HHHHH---------
Confidence 3311101 111233456789999999888899999999999999999995 55665321 11 11110
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+............+..+.+++.+||+.+|++||++.++++.|+++-
T Consensus 215 -~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 215 -LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0000001111112346778889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=326.53 Aligned_cols=258 Identities=23% Similarity=0.277 Sum_probs=197.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-------IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-------hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 468899999999999999999655 688999999843221 112234567889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999998764 57888899999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS----KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
+..... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+... ...
T Consensus 190 ~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i-~~~ 262 (371)
T cd05622 190 MKMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKI-MNH 262 (371)
T ss_pred eEcCcC--CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHH-HcC
Confidence 765331 11223456799999999998653 378999999999999999999999975311 1111110 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT--RPTMNEVVQLLA 808 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L~ 808 (840)
.. ....+ ...+....+.+++.+|+..++.+ ||++.|++++..
T Consensus 263 ~~------~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 263 KN------SLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CC------cccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 00 00011 11123345566777899744433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.59 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=195.2
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc-
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY- 605 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 605 (840)
|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++|+||+++++++....
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 56778999999999999964 579999999874321 11223456889999999999999999999998766
Q ss_pred ----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 606 ----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 606 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
..++|+||+. ++|.+.+.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg 148 (372)
T cd07853 74 DPFEEIYVVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFG 148 (372)
T ss_pred cccceEEEEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccc
Confidence 7899999996 68888876553 68999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-cc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DT 759 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~ 759 (840)
+++..... .........+++.|+|||.+.+. .++.++||||+||++|||++|+.||....... .......... ..
T Consensus 149 ~a~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~ 225 (372)
T cd07853 149 LARVEEPD--ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPS 225 (372)
T ss_pred ceeecccC--ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence 99765321 11222344678999999998774 47899999999999999999999997532110 0000000000 00
Q ss_pred cc-------chhh-hccccc-CCC-------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 760 KE-------GIME-VLDKKL-SGS-------FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 760 ~~-------~~~~-~~~~~~-~~~-------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.+ .... +..... .+. ..+....+.+++.+|++.||++|||+.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00 0000 000000 000 011234677899999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.73 Aligned_cols=259 Identities=27% Similarity=0.329 Sum_probs=200.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
++|...+.||+|+||.||+|... ++..||+|.+..... ......+.+|+++++.+ +|+||++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---------EKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---------hHHHHHHHHHHHHHHHhcCCCCEee
Confidence 56888999999999999998642 235799998853211 12245688899999999 7999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++++......++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++++|||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~d 165 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRD 165 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCccccc
Confidence 9999999999999999999999999997532 247899999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||+++.++.+||+|||.++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999876532110 111122234568999999988889999999999999999998 888886
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
... ........ .. ............++.+++.+|+..+|++||++.++++.|.++.+
T Consensus 245 ~~~-----~~~~~~~~-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 245 GVP-----VEELFKLL-KE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred cCC-----HHHHHHHH-Hc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 421 11111100 00 00011112234567778889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.47 Aligned_cols=240 Identities=26% Similarity=0.304 Sum_probs=186.5
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHH-HHhccCCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE-TLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||+||+|.. .+|+.||||++...... .......+..|.. +++.++||||+++++++...+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEE
Confidence 4699999999999955 47899999998533211 1122344455554 5677899999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~- 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA- 148 (325)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-
Confidence 999999999999887654 68999999999999999999999 9999999999999999999999999999875321
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ......... ..
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~---~~~~~~~~~--------~~ 213 (325)
T cd05604 149 --QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--A---EMYDNILHK--------PL 213 (325)
T ss_pred --CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--H---HHHHHHHcC--------Cc
Confidence 12223456799999999999999999999999999999999999999975310 0 000000000 00
Q ss_pred ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 003199 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN 801 (840)
Q Consensus 770 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 801 (840)
...+. ....+.+++.+|++.+|.+||++.
T Consensus 214 ~~~~~---~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 214 VLRPG---ASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred cCCCC---CCHHHHHHHHHHhccCHHhcCCCC
Confidence 11111 234566788899999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.30 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=202.1
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|.....||+|++|.||+|.. .+++.||+|.+......... .....+..+.+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS-KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccch-hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 56678999999999999955 46899999988554322111 12223445788999999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997753 68899999999999999999999 89999999999999999999999999999876
Q ss_pred hccCCCC---cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 687 QARGGKD---STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 687 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
....... .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~--------~ 224 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFK--------I 224 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHH--------H
Confidence 4321111 1112345888999999998888999999999999999999999999753110 00000 0
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... ......+.+++.+||+.||.+||++.+++++
T Consensus 225 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASPEIP---SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCCcCC---cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011111111 1233556678889999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.57 Aligned_cols=258 Identities=24% Similarity=0.273 Sum_probs=201.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|...+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++|+|+++++++
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 76 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---------SEIQVTLLLQESCLLYGLSHQNILPILHV 76 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 567788999999999999997665 6889999874221 12335678899999999999999999998
Q ss_pred Eec-CccceEEEeecCCCChHHHhhcCC-------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 601 FSS-LYCNLLVYEYMPNGNLWDALHKGL-------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 601 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
+.. ....++++||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~ 153 (280)
T cd05043 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEE 153 (280)
T ss_pred EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCC
Confidence 765 567789999999999999987642 358899999999999999999999 999999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 751 (840)
+.+||+|||+++.+..... ........++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..
T Consensus 154 ~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~--- 227 (280)
T cd05043 154 LQVKITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FE--- 227 (280)
T ss_pred CcEEECCCCCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HH---
Confidence 9999999999976533111 111122345678999999988889999999999999999999 9999965311 11
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+...... .. .. .........+.+++.+||+.||++|||+.++++.|+++.
T Consensus 228 ~~~~~~~-~~--------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 228 MAAYLKD-GY--------RL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHHc-CC--------CC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111000 00 00 011112345778888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=320.79 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=193.0
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLY 605 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 605 (840)
|+..+.||+|+||+||+|.. .+|+.||+|++...... .....+.+..|..+++.+. |++|+++++++.+.+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-------QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 56678999999999999965 47899999998532210 1222456777888888885 577888999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 9999999999999999987654 68999999999999999999999 9999999999999999999999999999875
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... .........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... .......
T Consensus 151 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~---~~~i~~~------ 216 (323)
T cd05615 151 HMV---DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DEL---FQSIMEH------ 216 (323)
T ss_pred cCC---CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHH---HHHHHhC------
Confidence 422 11223345689999999999988899999999999999999999999975311 100 0000000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM-----NEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 806 (840)
....+.. ....+.+++.+|++.+|.+|++. +++.++
T Consensus 217 --~~~~p~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 217 --NVSYPKS---LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --CCCCCcc---CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 0011111 23456778889999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.45 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=196.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE-ecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF-SSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~ 604 (840)
++|...+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|+|++++++++ ...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc------------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 46778889999999999999766 7889999873221 135688999999999999999999976 455
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+|++|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccc
Confidence 67899999999999999997653 348899999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ......+.. . .
T Consensus 150 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~---~-~-- 215 (256)
T cd05082 150 KEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVE---K-G-- 215 (256)
T ss_pred eecccc------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHh---c-C--
Confidence 754321 122334568999999988889999999999999999998 999986421 111111100 0 0
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
...... ......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 216 ----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 ----YKMDAP---DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001111 12235667788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.09 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=200.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+|++++++++.+ .
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 73 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E 73 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-----------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence 5677889999999999999988778889999874321 124568889999999999999999999887 6
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCccee
Confidence 789999999999999999764 3467899999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........++..|+|||++....++.++||||||+++|++++ |+.||.... ......+.. ...
T Consensus 151 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~----~~~-- 220 (260)
T cd05073 151 VIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALE----RGY-- 220 (260)
T ss_pred eccCC--CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHh----CCC--
Confidence 65331 1112223345678999999988889999999999999999999 999987531 111111110 000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
..+........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 -------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112233567788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.88 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=200.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++|+|++++++++..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~ 88 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----------PKKELIINEILVMRENKNPNIVNYLDSYLV 88 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----------chHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 35677888999999999999964 5789999998843321 123567889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 99999999999999999998754 57899999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .+........
T Consensus 164 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~~~~~--- 233 (296)
T cd06654 164 AQITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIATNGT--- 233 (296)
T ss_pred hhcccc---ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHhcCCC---
Confidence 765321 112234568899999999988889999999999999999999999997532211 1110000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ..........+.+++.+|+..+|++||++.+++++
T Consensus 234 -----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 -----PE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----CC-CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 01112233456778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.74 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=197.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.++.++ +|+||++++
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---------HSEHRALMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---------hHHHHHHHHHHHHHHhccCCccHhhhc
Confidence 4688889999999999999953 3578999999843221 12245688899999999 689999999
Q ss_pred eEEecC-ccceEEEeecCCCChHHHhhcCC--------------------------------------------------
Q 003199 599 CYFSSL-YCNLLVYEYMPNGNLWDALHKGL-------------------------------------------------- 627 (840)
Q Consensus 599 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------- 627 (840)
+++... ...++||||+++|+|.+++....
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (343)
T cd05103 78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157 (343)
T ss_pred ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence 988654 45689999999999999886421
Q ss_pred ----------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 628 ----------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 628 ----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
..+++..+..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~- 233 (343)
T cd05103 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP- 233 (343)
T ss_pred cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCc-
Confidence 136788889999999999999999 999999999999999999999999999997653211
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ... .... ....
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~---~~~-~~~~------~~~~ 302 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEF---CRR-LKEG------TRMR 302 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHH---HHH-Hhcc------CCCC
Confidence 1111122345678999999988899999999999999999997 99998653111 000 000 0000 0001
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.+.. ...++.+++.+||+.||++||++.|++++|+.+-.
T Consensus 303 ~~~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 22457788899999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.55 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=194.6
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec--
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-- 603 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 603 (840)
.|+..+.||+|+||.||+|.. .++..||+|++...... ....+..+.+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES-----PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC-----chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 467788999999999999955 46899999987533211 1122345678899999999999999999998865
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++++||+++++|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 356689999999999999998754 58899999999999999999999 89999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+................++..|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~--------- 220 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFK--------- 220 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHH---------
Confidence 7653221112222335688999999999888899999999999999999999999974311 100000
Q ss_pred hhhcccccCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRD-EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......+.... ....+..++ +||..+|++||+++|++++
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 221 --IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000001111111 122333444 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.02 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=186.4
Q ss_pred CeeeccCCcEEEEEEeCC-------------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 532 NKVGQGGSGTVYKIDLNS-------------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
+.||+|+||.||+|.+.+ ...||+|.+.... ......+.+|+.+++.++||||++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----------~~~~~~~~~~~~~l~~l~hp~iv~~~ 70 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----------RDISLAFFETASMMRQVSHKHIVLLY 70 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----------hhHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 368999999999996542 2258888763221 23345788899999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC----
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---- 674 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---- 674 (840)
+++......++||||+++|+|..++......+++..+..++.|+++|++|||+ ++|+||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 71 GVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred EEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCC
Confidence 99999989999999999999999887665568999999999999999999999 99999999999999987654
Q ss_pred ---CeeecccchhhhhccCCCCcceecccccccccCccccc-cCCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCcch
Q 003199 675 ---PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELI-TGRKPVEDDFGDNKNI 749 (840)
Q Consensus 675 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~~~~~~ 749 (840)
++++|||++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||.......
T Consensus 148 ~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--- 217 (262)
T cd05077 148 GPFIKLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--- 217 (262)
T ss_pred CceeEeCCCCCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---
Confidence 89999999865422 12345788999999886 466899999999999999998 5888876421100
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
... ...... ....+....+.+++.+||+.||++||++.++++++
T Consensus 218 --~~~-----------~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 --KER-----------FYEGQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --HHH-----------HHhcCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 000000 00111234567888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.92 Aligned_cols=261 Identities=23% Similarity=0.295 Sum_probs=196.3
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
...++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--------NQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--------ChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 4567899999999999999999954 4689999998854321 122345677899999999999999999987
Q ss_pred ecC------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSL------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
... ...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCE
Confidence 543 346899999964 67776654 47899999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+...
T Consensus 159 kl~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~ 230 (355)
T cd07874 159 KILDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKV 230 (355)
T ss_pred EEeeCcccccCCC----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 9999999976432 2223345789999999999988999999999999999999999999975321 0001000
Q ss_pred hhc-----------cccchhhhcc---------------cc-cC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003199 756 KVD-----------TKEGIMEVLD---------------KK-LS---GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805 (840)
Q Consensus 756 ~~~-----------~~~~~~~~~~---------------~~-~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 805 (840)
... .......... .. .. .........+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000 0000000000 00 00 000112345678999999999999999999999
Q ss_pred H
Q 003199 806 L 806 (840)
Q Consensus 806 ~ 806 (840)
+
T Consensus 311 h 311 (355)
T cd07874 311 H 311 (355)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.13 Aligned_cols=258 Identities=21% Similarity=0.260 Sum_probs=197.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||+||++... +++.||+|++.... .........+.+|+.++..++|++|+++++++.+..
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-------MLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN 74 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 5778899999999999999654 68899999884321 111223456788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 9999999999999999998755578999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
.... .........||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ...........
T Consensus 152 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~ 224 (331)
T cd05624 152 MNQD--GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHE 224 (331)
T ss_pred ccCC--CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCC
Confidence 5331 1122234579999999998865 4678899999999999999999999975311 01111000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT--RPTMNEVVQLL 807 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 807 (840)
. ...++....+....+.+++.+|+..++++ |+++++++++-
T Consensus 225 ~------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 225 E------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred C------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 0 00111222223455667777888765544 56899998763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.69 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=200.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-----------------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-----------------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 588 (840)
++|+..+.||+|+||.||+|.... +..||+|.+..... ....+.+.+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---------DNAREDFLKEVKILSR 75 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---------HHHHHHHHHHHHHHHh
Confidence 467888999999999999985542 24589998743321 2345678999999999
Q ss_pred cCCCCcceeeeEEecCccceEEEeecCCCChHHHhhcCC----------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003199 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL----------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPII 658 (840)
Q Consensus 589 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 658 (840)
++|||++++++++......++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~ 152 (296)
T cd05051 76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFV 152 (296)
T ss_pred cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCcc
Confidence 999999999999999999999999999999999987653 258999999999999999999999 9999
Q ss_pred ecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh--CC
Q 003199 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT--GR 736 (840)
Q Consensus 659 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~ 736 (840)
||||||+||+++.++.++|+|||+++..... ..........+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSS-DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccC-cceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999998765332 11122234456788999999988889999999999999999998 67
Q ss_pred CCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 737 KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 737 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.||.... ................ .....+.......++.+++.+|++.||++|||+.|+++.|++
T Consensus 232 ~p~~~~~--~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 232 QPYEHLT--DQQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCCcC--hHHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 7775421 1111111100000000 000001111223568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.32 Aligned_cols=397 Identities=27% Similarity=0.378 Sum_probs=281.4
Q ss_pred ccccccccCCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc
Q 003199 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 2 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~ 81 (840)
+.|.++-.-+++.++..|.+|++++|.+. ..|.+++.+..++.|+.++| ++..+|++ +.++.+|+.|+.++|.+.
T Consensus 53 s~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n---~ls~lp~~-i~s~~~l~~l~~s~n~~~ 127 (565)
T KOG0472|consen 53 SHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHN---KLSELPEQ-IGSLISLVKLDCSSNELK 127 (565)
T ss_pred ccCchhhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccc---hHhhccHH-Hhhhhhhhhhhcccccee
Confidence 45666667777888888888888888888 77777888888888888887 55555543 566666666666666665
Q ss_pred ccCCccccCCCCCcEEEccCCcccccCchhhhc-----------------------CCCCCeeecccCccccccCCcccC
Q 003199 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGL-----------------------LKNLRQLELYYNQQLAGTIPEELG 138 (840)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~-----------------------l~~L~~L~L~~n~~~~~~~p~~l~ 138 (840)
.+|+.++.+-.|..|+..+|+|. ..|+.+.. ++.|++||+..|- .+.+|..++
T Consensus 128 -el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~--L~tlP~~lg 203 (565)
T KOG0472|consen 128 -ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNL--LETLPPELG 203 (565)
T ss_pred -ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhh--hhcCChhhc
Confidence 34444555555555555555554 33333333 5566666665554 667888888
Q ss_pred CCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCccee
Q 003199 139 NLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVL 218 (840)
Q Consensus 139 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 218 (840)
++.+|+-|+|.+|+|. .+| .|.++..|+.|+++.|+|...+.....++++|..|||++|+++ ..|..+.-+++|.+|
T Consensus 204 ~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rL 280 (565)
T KOG0472|consen 204 GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERL 280 (565)
T ss_pred chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhh
Confidence 8888888888888888 566 7888888888888888888666666668888888888888888 678888888888888
Q ss_pred ccccccccccCCccccCCCCchhhhccccccccc--------------------------------------CCccc---
Q 003199 219 DLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV--------------------------------------LPDSL--- 257 (840)
Q Consensus 219 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~--------------------------------------~~~~~--- 257 (840)
|+|+|.|+ ..|..++++ .|+.|.+-+|.+.++ .+..|
T Consensus 281 DlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~ 358 (565)
T KOG0472|consen 281 DLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDI 358 (565)
T ss_pred cccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccch
Confidence 88888887 566777777 777777777655210 00011
Q ss_pred ccccCCc--------------------------eEEeeCceeeccCCccccCCCcccE-EeccCCcccccCCcccCCCCC
Q 003199 258 ARCKNLL--------------------------RFRVSNNHLEGSIPEGILSLPHVSI-IDLSYNSFSGPIANTVGNARN 310 (840)
Q Consensus 258 ~~l~~L~--------------------------~L~l~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~ 310 (840)
..+.+.+ .++++.|++. ++|..+..+..+.+ +++++|.+ +.+|..++.+++
T Consensus 359 ~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~k 436 (565)
T KOG0472|consen 359 YAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQK 436 (565)
T ss_pred hhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhc
Confidence 1112233 3444445544 44444444443333 23333333 366777788888
Q ss_pred CceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcC
Q 003199 311 LSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390 (840)
Q Consensus 311 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 390 (840)
|..|+|++|-+. .+|.+++.+..|+.||+|+|++. .+|..+..+..++.+-.++|++....|..+.+|.+|..|||.+
T Consensus 437 Lt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~n 514 (565)
T KOG0472|consen 437 LTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQN 514 (565)
T ss_pred ceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCC
Confidence 888888888887 67888888888888888888887 6787777777777777777888766677799999999999999
Q ss_pred ccccccCCchhhcc-CCCeEEccCCCCc
Q 003199 391 NLLTGYIPESLCEL-LPNSINFSNNRLS 417 (840)
Q Consensus 391 N~l~~~~p~~~~~~-~~~~l~l~~N~l~ 417 (840)
|.+. .+|+.+.++ .++.|++.+|+|+
T Consensus 515 Ndlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 515 NDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred Cchh-hCChhhccccceeEEEecCCccC
Confidence 9998 888888888 5688999999998
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.46 Aligned_cols=249 Identities=28% Similarity=0.390 Sum_probs=200.8
Q ss_pred CeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccc
Q 003199 532 NKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 607 (840)
+.||+|+||.||+|.... +..||+|.+...... ...+.+.+|+++++.++|+|++++++++......
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---------EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---------hHHHHHHHHHHHHhhcCCCChheeeeeecCCCce
Confidence 469999999999996653 789999998543311 1356788999999999999999999999999999
Q ss_pred eEEEeecCCCChHHHhhcC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 608 LLVYEYMPNGNLWDALHKG--------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
++||||+++++|.+++... ...+++..+..++.|++.|++|||+ ++++||||||+||++++++.++|+|
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcc
Confidence 9999999999999999876 3578999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
||.+........ ........++..|+|||.+....++.++||||+|+++|||++ |..||.... ...... .
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~---~--- 219 (262)
T cd00192 149 FGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLE---Y--- 219 (262)
T ss_pred cccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHH---H---
Confidence 999987654221 122344567889999999988889999999999999999999 699987541 111111 0
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
...............++.+++.+|++.+|++|||+.|++++|+
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 -------LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0001111111222456778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.35 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=191.5
Q ss_pred CeeeccCCcEEEEEEeC-CCc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccc
Q 003199 532 NKVGQGGSGTVYKIDLN-SGE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 607 (840)
+.||+|+||.||+|... ++. .+|+|.++... .......+..|++++.++ +||||+++++++......
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 71 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 71 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCc
Confidence 36899999999999765 444 46888774321 122345788899999999 799999999999999999
Q ss_pred eEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 608 LLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||+++++
T Consensus 72 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~ 148 (270)
T cd05047 72 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGEN 148 (270)
T ss_pred eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCC
Confidence 99999999999999987532 247899999999999999999999 999999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 751 (840)
+.+|++|||++..... .........+..|+|||++....++.++||||||+++|||++ |..||..... ...
T Consensus 149 ~~~kl~dfgl~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~-- 220 (270)
T cd05047 149 YVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AEL-- 220 (270)
T ss_pred CeEEECCCCCccccch----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHH--
Confidence 9999999999853211 111112234567999999988889999999999999999997 9999964211 111
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.... . ..............+.+++.+|++.+|.+|||+.++++.|.++
T Consensus 221 -~~~~-~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 221 -YEKL-P---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -HHHH-h---------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1000 0 0000001112234677889999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.13 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=197.4
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|+||.||+|.. .+++.||||.+...... .......+..|+.++++++|++++++++.+.+.+.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-------KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-------chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence 55667899999999999855 47899999988433211 12233557789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++..
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 99999999999999988643 2368999999999999999999999 9999999999999999999999999999865
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... ........|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ....... ..
T Consensus 152 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~--------~~ 218 (285)
T cd05630 152 VPE----GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERL--------VK 218 (285)
T ss_pred cCC----CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhh--------hh
Confidence 432 1122234689999999999988999999999999999999999999975321110 0000000 00
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQLL 807 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~L 807 (840)
......... ....+.+++.+|++.||++||| +.|++++-
T Consensus 219 ~~~~~~~~~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 219 EVQEEYSEK---FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred hhhhhcCcc---CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 000111112 2345667888999999999999 88998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.29 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=199.4
Q ss_pred eeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEE
Q 003199 533 KVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 611 (840)
++|+|.||+||-|+.. +...+|||-+.... .+..+-+++||..-++++|.|||+++|.+.+.+..-+.|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFM 651 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----------SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFM 651 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc----------chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEe
Confidence 6999999999999554 56678999874332 233566889999999999999999999999999989999
Q ss_pred eecCCCChHHHhhcCCCCC--ChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCCeeecccchhhhhc
Q 003199 612 EYMPNGNLWDALHKGLVHL--DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 612 e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~ 688 (840)
|-++||+|.+.++..=..+ .+.++..+..||++||.|||+ ..|||||||-.|||++ -.|.+||+|||-++++.
T Consensus 652 EqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA- 727 (1226)
T KOG4279|consen 652 EQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA- 727 (1226)
T ss_pred ecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-
Confidence 9999999999998763344 778889999999999999999 8999999999999996 47899999999999875
Q ss_pred cCCCCcceecccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 689 RGGKDSTTTVIAGTYGYLAPEYAYSS--KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 689 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
+-...+..+.||..|||||++..+ .|+.++|||||||.+.||.||++||.......+..... .
T Consensus 728 --ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-----------G-- 792 (1226)
T KOG4279|consen 728 --GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-----------G-- 792 (1226)
T ss_pred --cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-----------c--
Confidence 345566788999999999999664 58999999999999999999999997543322211110 0
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.-+.-++-..+...+...++.+|..+||.+||+++++++.
T Consensus 793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 1111233344556677778889999999999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.93 Aligned_cols=271 Identities=26% Similarity=0.340 Sum_probs=203.9
Q ss_pred hcCccCeeeccCCcEEEEEEeC-----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.|+..+.||+|+||.||+|.+. ++..||||++..... ....+.+.+|+++++.+.|+||+++++++
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 4566789999999999999653 468999999853321 13456789999999999999999999998
Q ss_pred ec--CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 602 SS--LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 602 ~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
.. ....++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcc
Confidence 77 557899999999999999998766569999999999999999999999 8999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||.+.................++..|+|||...+..++.++||||||+++|||++|+.|+............... ....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~ 231 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ-GQMI 231 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc-cccc
Confidence 999987643211111122234556799999998889999999999999999999999998653221110000000 0000
Q ss_pred ccchhhhcccccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 760 KEGIMEVLDKKLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 760 ~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.....+.+..... ........++.+++.+|++.+|++||++.|++++|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000011111110 11112235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.78 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=198.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-----------------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-----------------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 588 (840)
++|+..+.||+|+||.||++... ++..||+|++.... .......+.+|+++++.
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---------CHHHHHHHHHHHHHHHh
Confidence 46788899999999999998532 23468999874322 12335678899999999
Q ss_pred cCCCCcceeeeEEecCccceEEEeecCCCChHHHhhcCC----------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003199 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL----------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPII 658 (840)
Q Consensus 589 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 658 (840)
++|+||+++++++...+..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+ .+++
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~ 152 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFV 152 (296)
T ss_pred CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCee
Confidence 999999999999999999999999999999999987642 246788999999999999999999 8999
Q ss_pred ecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh--CC
Q 003199 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT--GR 736 (840)
Q Consensus 659 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t--g~ 736 (840)
||||||+||++++++.++|+|||+++.+..... ........++..|+|||...++.++.++|||||||++|||++ |.
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred cccCChheEEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999976533111 111222344678999999888889999999999999999998 77
Q ss_pred CCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 737 KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 737 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.||..... .............. ......+........+.+++.+||+.||++||++.+|++.|++
T Consensus 232 ~p~~~~~~--~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 232 QPYSQLSD--EQVIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCccccCh--HHHHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 88864211 11110000000000 0000001111223567788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.87 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=204.3
Q ss_pred CccCeeeccCCcEEEEEEeC--CCc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 529 TEKNKVGQGGSGTVYKIDLN--SGE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
...++||+|.||.|++|.|. +|+ .||||.+..... .....+|.+|+.+|.+++|+|++++||...+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---------~~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---------NAIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---------chhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 34568999999999999775 444 589999854332 1256889999999999999999999999987
Q ss_pred ccceEEEeecCCCChHHHhhc-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....||||.++.|+|.+.|++ ....+.......++.|||.|+.||.+ +++|||||..+|+++-....+||+|||+.
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccce
Confidence 677899999999999999998 34567888889999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.+....+.........-...|+|||.+....++.++|||+|||.+|||+| |+.||.+-.+ ..
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~q-------------- 323 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQ-------------- 323 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HH--------------
Confidence 988654333323333344568999999999999999999999999999999 8999976311 00
Q ss_pred hhhhc-ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 763 IMEVL-DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 763 ~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
+.+.+ +++.-+..+.+..++.+++++||...|++|||+..|.+.+
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11222 2233344566778899999999999999999999998554
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.45 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=198.3
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||++... +++.||+|.+..... ....+.+.+|+.+++.++|+|++++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 3667789999999999999654 789999998843221 223466788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++... ...+++..+..++.|++.|+.|||+ ++++|+||||+||++++++.++++|||.+.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcce
Confidence 999999999999999988653 3457899999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .....
T Consensus 149 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~---------- 210 (255)
T cd08219 149 LLTSP---GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLIL---------- 210 (255)
T ss_pred eeccc---ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHH----------
Confidence 65331 1122345688999999999888899999999999999999999999975310 00000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.................+.+++.+||+.||++||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000011111111223456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.38 Aligned_cols=263 Identities=24% Similarity=0.288 Sum_probs=189.9
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc---CCCCcceeeeEEe
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI---RHKNIVKLYCYFS 602 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~ 602 (840)
+|+..+.||+|+||+||+|.. .+|+.||+|.+....... .....+.+|+++++.+ +||||+++++++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~ 72 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--------GLPLSTVREVALLKRLEAFDHPNIVRLMDVCA 72 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--------CCchHHHHHHHHHHHhhhcCCCCeeeeeeeec
Confidence 367788999999999999955 478999999885432111 1112344566666555 7999999999875
Q ss_pred c-----CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCe
Q 003199 603 S-----LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 603 ~-----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
. ....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 73 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 73 TSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred cccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 4 244689999997 58888887643 358999999999999999999999 9999999999999999999999
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+|||+++.... ........||..|+|||++.+..++.++||||+||++|||++|++||....... .........
T Consensus 149 l~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~ 223 (288)
T cd07863 149 LADFGLARIYSC----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLI 223 (288)
T ss_pred ECccCccccccC----cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHh
Confidence 999999976532 112234568899999999988899999999999999999999999986532110 010000000
Q ss_pred -hccccchh-------hhcccccCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 -VDTKEGIM-------EVLDKKLSG----SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 -~~~~~~~~-------~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ......... ...+....+.+++.+|++.||++|||+.|++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000000000 011233456788899999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.65 Aligned_cols=258 Identities=23% Similarity=0.269 Sum_probs=194.6
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||+||++... +++.||||++.... .......+.+.+|+.++..++|+||+++++++.+..
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-------MLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-------HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 5778899999999999999654 68999999984321 111223456888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.+....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 9999999999999999998755578999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
.... .........||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ...........
T Consensus 152 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~ 224 (331)
T cd05597 152 LLAD--GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHK 224 (331)
T ss_pred cCCC--CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC
Confidence 5331 1122233569999999999863 4578899999999999999999999975311 11111011000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSK--SPATRPTMNEVVQLL 807 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rps~~evl~~L 807 (840)
. . ..+..........+.+++.+|+.. ++..||++.+++++-
T Consensus 225 ~----~--~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 225 E----H--FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred C----c--ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 0 0 011111111233445566666544 444488999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=304.77 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=207.7
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..-|...+-||+|.|..|-.|+. -+|..||||++-+.+.. ......+..|++.|+-++|||||++|.....
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD--------~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc--------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 34455566799999999999844 48999999999544322 2234567789999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCCeeecccc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQPKVADFGI 682 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~ 682 (840)
....|||+|.=.+|+|++++.+....+.+.-+.+++.||+.|+.|+|+ .++|||||||+||.+- .-|-+|++|||+
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccc
Confidence 999999999999999999999988889999999999999999999999 8999999999999774 568899999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT-TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+..+.+ .......+|+..|-|||++.+..|+ ++.||||+|||+|.+++|+.||+...+. +
T Consensus 166 SNkf~P----G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------E 226 (864)
T KOG4717|consen 166 SNKFQP----GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------E 226 (864)
T ss_pred cccCCC----cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------h
Confidence 987754 3455678999999999999998885 6899999999999999999999864221 1
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
+...++|=++. -......++.+|+..|+..||.+|-+.+||..+-+
T Consensus 227 TLTmImDCKYt-vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 227 TLTMIMDCKYT-VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhhhhhccccc-CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 12222222211 12344567778888999999999999999987644
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.28 Aligned_cols=253 Identities=24% Similarity=0.281 Sum_probs=195.9
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|+||+||+|.. .+++.||+|.+...... .......+.+|+++++.++|+|++++.+++...+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-------KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-------hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence 55667899999999999855 47899999988433211 12223557789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 99999999999999888653 2368999999999999999999999 9999999999999999999999999999865
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... ........|+..|+|||++.+..++.++|+||||+++|||++|+.||........ ...+.. .. . .
T Consensus 152 ~~~----~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~-~~--~----~ 219 (285)
T cd05632 152 IPE----GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR-RV--L----E 219 (285)
T ss_pred cCC----CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hh--h----c
Confidence 422 1122345689999999999888999999999999999999999999975311100 000000 00 0 0
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
. ....... ....+.+++..|++.||++||+ +.+++++
T Consensus 220 ~-~~~~~~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 T-EEVYSAK---FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c-ccccCcc---CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 0111122 2334567888999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.67 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=195.9
Q ss_pred hcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|. ..+++.||+|++.... .......+.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 46677899999999999995 4578999999884321 1223467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|..+. .+++..+..++.|++.|++|||+ .+|+|+||||+||+++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 73 RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 999999999999996542 46888999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .+...... ...
T Consensus 145 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~----~~~ 214 (279)
T cd06619 145 LVN-----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQC----IVD 214 (279)
T ss_pred ccc-----ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHH----Hhc
Confidence 532 12234578999999999998899999999999999999999999997533221111 00000000 000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
....... ......++.+++.+|++.+|++||++.|++++-
T Consensus 215 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 215 EDPPVLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred cCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0001111 011234567788899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.02 Aligned_cols=190 Identities=25% Similarity=0.301 Sum_probs=163.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..|...+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++...
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------------~~~~E~~~l~~l~h~~iv~~~~~~~~~ 129 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------------TTLIEAMLLQNVNHPSVIRMKDTLVSG 129 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------------ccHHHHHHHHhCCCCCCcChhheEEeC
Confidence 45889999999999999999665 5789999974211 124589999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+||+ .++|.+++......+++..+..++.||+.||+|||+ ++||||||||+||+++.++.+||+|||+++
T Consensus 130 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 130 AITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred CeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 9999999999 568999887766679999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV 739 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 739 (840)
.... ........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 206 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 206 FPVV----APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccc----CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5321 12223456899999999999999999999999999999999965554
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.11 Aligned_cols=259 Identities=21% Similarity=0.234 Sum_probs=194.0
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|...+.||+|+||.||+|... +++.||||... ...+.+|++++++++|+|||++++++....
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------------YASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 5778889999999999999654 68899999531 123567999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|||++ .++|.+++......++|.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++.
T Consensus 234 ~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 234 LTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred EEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 999999999 579999887665579999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-C-c----chhhhhhhhhcc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD-N-K----NIIYWVSIKVDT 759 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~-~----~~~~~~~~~~~~ 759 (840)
..... .........||+.|+|||++.+..++.++|||||||++|||++|..|+...... . . .+..........
T Consensus 310 ~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 310 ARGSW-STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ccccc-ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 53211 111223456999999999999999999999999999999999987665321111 0 0 011111000000
Q ss_pred ccchhh------------hc----ccc-cCCCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIME------------VL----DKK-LSGSFR---DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~------------~~----~~~-~~~~~~---~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... .. ... ....+. .....+.+++.+|++.||++|||+.|++++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00 000 000111 122357789999999999999999999987
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.18 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=202.5
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
+|...+.||+|+||.||+|...+|+.+|||.+...... .....+..+.+.+|++++++++|+||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN----VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc----hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe
Confidence 36678899999999999998888999999988543221 11223345678999999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||+++++|.+++.+.. .+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||.+...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999999997654 67899999999999999999999 89999999999999999999999999999865
Q ss_pred hccCCC---CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 687 QARGGK---DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 687 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ........|+..|+|||++.+..++.++||||||+++|||++|+.||..... ....... .. ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~-~~-~~-- 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFYI-GA-HR-- 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHHHh-hh-cc--
Confidence 321111 1122345688999999999888899999999999999999999999964311 0000000 00 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+..... ....+.+++.+|++.+|++||++.+++++
T Consensus 225 --~~~~~~~~~---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 --GLMPRLPDS---FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --CCCCCCCCC---CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 001112222 23455677889999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.45 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=201.7
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||.|+||.||.+.. .+++.|++|.+...... ....+.+.+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS--------EKERRDALNEIVILSLLQHPNIIAYYNHFMDDN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc--------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC
Confidence 477788999999999999854 56899999987433211 233456789999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||+|+||++++++.+||+|||.+.
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 999999999999999999765 3468999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
...... .......|++.|+|||...+..++.++||||||+++|||++|+.||..... .....
T Consensus 150 ~~~~~~---~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~---------- 211 (256)
T cd08221 150 ILGSEY---SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVV---------- 211 (256)
T ss_pred Eccccc---ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHH----------
Confidence 653321 123345689999999999888889999999999999999999999864211 11110
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
................++.+++.+|++.+|++||++.++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111111111122345577788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=311.70 Aligned_cols=255 Identities=33% Similarity=0.473 Sum_probs=198.9
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|+||+||+|... +++.||+|++...... ........+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~--------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE--------EEEREENIREIKILRRLRHPNIVQILDVFQDDNY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH--------HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc--------ccccchhhhhhhcccccccccccccccccccccc
Confidence 566789999999999999665 5679999998554321 2223344569999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+++++|.+++... ..+++..+..++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+...
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 99999999999999999843 368999999999999999999999 99999999999999999999999999998754
Q ss_pred hccCCCCcceecccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
. ..........++..|+|||.+. +..++.++||||+|+++|+|++|..||..... ........... ..
T Consensus 149 ~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~------~~ 217 (260)
T PF00069_consen 149 S---ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL------KR 217 (260)
T ss_dssp T---STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH------HT
T ss_pred c---ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc------cc
Confidence 1 2233445667899999999988 78899999999999999999999999975310 00000000000 00
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... .........+.+++.+|++.||++||++.+++++
T Consensus 218 ~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 218 PLPSSS-QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHT-TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccc-cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000112678888999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.31 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=195.6
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||+||++..+ +++.||+|++..... ........+.+|+.++..++|++|+++++++.+..
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-------LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-------HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 5778889999999999999665 578899999843211 11223455888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.+....+++..+..++.|++.|++|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999999999998755578999999999999999999999 9999999999999999999999999999875
Q ss_pred hhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
.... .........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ............
T Consensus 152 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~ 224 (332)
T cd05623 152 LMED--GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHK 224 (332)
T ss_pred cccC--CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCC
Confidence 5321 122233457999999999885 3467899999999999999999999997531 111111111100
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSK--SPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rps~~evl~~ 806 (840)
. ....+.........+.+++.+|+.. ++..|+++.|++++
T Consensus 225 ~------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 E------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0011111222334556667777754 44447899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.20 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=199.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|...+ ...||||....... ....+.+.+|+.+++++.||||+++++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---------PSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC---------HHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 346778899999999999996543 24689998743321 23456788999999999999999999988
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+ ...++||||+++|+|.+++......+++..+..++.+++.|++|||+ .+++||||||+||+++.++.++++|||
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCc
Confidence 75 45689999999999999998765568999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++..... .........++..|+|||.+....++.++||||||+++||+++ |+.||..... .....+.. ..
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~----~~ 224 (270)
T cd05056 153 LSRYLEDE--SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRIE----NG 224 (270)
T ss_pred eeeecccc--cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH----cC
Confidence 98765432 1111222334568999999988889999999999999999996 9999975321 11111110 00
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
. .....+ .....+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 225 ~------~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 225 E------RLPMPP---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred C------cCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 001111 22346777888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.12 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=199.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---------EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG 74 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---------hHHHHHHHHHHHHHHcCCCCccHhhhcccccC
Confidence 4566677899999999999954 4688999998743221 22346789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++... .+++..+..++.|++.|+.|||+ ++++|+||+|+||++++++.++++|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 75 TKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CceEEEEEccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccc
Confidence 9999999999999999998764 58899999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........|+..|+|||++.+..++.++||||||+++|||++|+.|+....... ...+ . .
T Consensus 150 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~----~------~ 214 (277)
T cd06642 150 QLTDT---QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFL----I------P 214 (277)
T ss_pred cccCc---chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhh----h------h
Confidence 65331 122233467889999999998889999999999999999999999986432111 0000 0 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
......+. ......+.+++.+|++.+|++||++.+++++-
T Consensus 215 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 215 KNSPPTLE---GQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred cCCCCCCC---cccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 00011111 12345577888899999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=314.80 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=199.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
++|...+.||+|+||.||+|... .+..||+|.+.... .......+..|+.+++++ .||||++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---------TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---------ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 46778899999999999998542 24578999874321 122345688899999999 6999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++++......++||||+++|+|.+++.... ..++|.++..++.|++.||+|||+ ++++|||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~d 159 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRD 159 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecc
Confidence 9999999889999999999999999996531 348899999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||++++++.+||+|||.++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999765431111 11112234567999999988889999999999999999999 889986
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.... . ........ ............++.+++.+|+..+|++||++.|+++.|+++..
T Consensus 239 ~~~~--~---~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 239 GIPV--E---ELFKLLRE----------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCH--H---HHHHHHHc----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 4211 0 00100000 00000111223466778889999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.64 Aligned_cols=248 Identities=28% Similarity=0.396 Sum_probs=200.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|...+.||+|+||.||+|... |+.||||.+.... ...+.+.+|+.++++++|+|++++++++.+..
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-----------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccch-----------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 45677889999999999999876 8999999984332 13567889999999999999999999999888
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||.++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccc
Confidence 9999999999999999997653 368999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ....... ....
T Consensus 151 ~~~~~------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~----~~~~--- 215 (256)
T cd05039 151 EASQG------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPH----VEKG--- 215 (256)
T ss_pred ccccc------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH----HhcC---
Confidence 65321 112334568999999988889999999999999999997 999986421 0111000 0000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
...... ...+..+.+++.+|+..+|++||++.|+++.|..
T Consensus 216 ---~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 ---YRMEAP---EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---CCCCCc---cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 000111 1224567788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=326.76 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=194.7
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|+..+.||+|+||.||+|... +++.||||++..... ........+.+|+.++..++|++|+++++++.+..
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-------LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 5677889999999999999654 689999999853211 11233567888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 9999999999999999997654 68999999999999999999999 9999999999999999999999999999875
Q ss_pred hhccCCC--------------------------------CcceecccccccccCccccccCCCCccccchhHHHHHHHHH
Q 003199 686 LQARGGK--------------------------------DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELI 733 (840)
Q Consensus 686 ~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 733 (840)
....... ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 4321000 00112357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003199 734 TGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT---MNEVVQL 806 (840)
Q Consensus 734 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~ 806 (840)
+|+.||...... ..+.. ...... .. ..++. .....++.+++.+|+ .||.+|++ +.|+++|
T Consensus 231 tG~~Pf~~~~~~----~~~~~-i~~~~~----~~--~~p~~-~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 231 IGYPPFCSETPQ----ETYRK-VMNWKE----TL--VFPPE-VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred cCCCCCCCCCHH----HHHHH-HHcCCC----ce--ecCCC-CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 999999753211 00100 000000 00 01111 012234555666665 49999984 6787776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.08 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=196.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---------GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---------CchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 56788899999999999999654 6899999988533211 1123467899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++ ++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 69999887765578999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh--cccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV--DTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~ 761 (840)
..... ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .......... ....
T Consensus 153 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~ 227 (301)
T cd07873 153 AKSIP---TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEE 227 (301)
T ss_pred ccCCC---CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChh
Confidence 64321 1122334578899999987654 5788999999999999999999999753211 0000000000 0000
Q ss_pred chhhh---------cccccCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEV---------LDKKLSGSF-----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~---------~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ..+...... ......+.+++.+|++.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 000000000 1123456788889999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=342.64 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=194.6
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
...+|...+.||+|+||+||+|... ++..||+|.+...... ......+..|+.+++.++|||||+++++|.
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~--------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK--------EREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC--------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 3467888999999999999999554 6788999988533211 223467889999999999999999999885
Q ss_pred c--CccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcC----CCCeEecCCCCCCEEEcCC-
Q 003199 603 S--LYCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGL----LSPIIHRDIKSTNILLDVN- 672 (840)
Q Consensus 603 ~--~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlk~~Nill~~~- 672 (840)
. ....++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.+
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 45679999999999999998753 236899999999999999999999832 1359999999999999642
Q ss_pred ----------------CCCeeecccchhhhhccCCCCcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHh
Q 003199 673 ----------------YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELIT 734 (840)
Q Consensus 673 ----------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t 734 (840)
+.+||+|||++..+.. ........||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~----~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGI----ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccc----cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 3489999999976532 122234579999999998854 458899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 735 GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 735 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
|+.||..... ....... .... +.+. .......+.+++.+||+.+|.+||++.|++++
T Consensus 239 Gk~PF~~~~~----~~qli~~-lk~~--------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 239 GKTPFHKANN----FSQLISE-LKRG--------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCCcCCc----HHHHHHH-HhcC--------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9999964311 1111110 0000 0010 11123567788889999999999999999854
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.63 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=196.4
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--------NQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--------CchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 4567899999999999999999954 4789999999854321 122345677899999999999999999887
Q ss_pred ecC------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSL------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
... ...++||||++ +++.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcE
Confidence 543 35689999996 477777754 47899999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...
T Consensus 166 kL~DfG~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~~ 237 (364)
T cd07875 166 KILDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKV 237 (364)
T ss_pred EEEeCCCccccCC----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 9999999976532 2223345789999999999999999999999999999999999999975321 1111110
Q ss_pred hhcccc-----------chhh---------------hcccccC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003199 756 KVDTKE-----------GIME---------------VLDKKLS----GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805 (840)
Q Consensus 756 ~~~~~~-----------~~~~---------------~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 805 (840)
...... .... ....... .........+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0000 0000000 000011245778999999999999999999998
Q ss_pred Hh
Q 003199 806 LL 807 (840)
Q Consensus 806 ~L 807 (840)
+=
T Consensus 318 hp 319 (364)
T cd07875 318 HP 319 (364)
T ss_pred Cc
Confidence 73
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.41 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=195.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +|+.||||++...... ....+.+.+|+.++++++|||++++++++.++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--------EGVPSTAIREISLLKELQHPNIVCLQDVLMQES 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC
Confidence 3667789999999999999654 7899999988543211 122356778999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999999997 68888886532 468999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc----
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD---- 758 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 758 (840)
...... ........+++.|+|||++.+. .++.++||||||+++|||+||+.||........ ..........
T Consensus 149 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (285)
T cd07861 149 RAFGIP---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTED 224 (285)
T ss_pred eecCCC---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChh
Confidence 755321 1222334578899999987654 578999999999999999999999975321100 0000000000
Q ss_pred ------cccchhhhcccccC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 ------TKEGIMEVLDKKLS----GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ------~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.........+.... ........++.+++.+|++.||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000 0011123456788889999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.65 Aligned_cols=196 Identities=25% Similarity=0.401 Sum_probs=158.6
Q ss_pred cCeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec--Cc
Q 003199 531 KNKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS--LY 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 605 (840)
..+||+|+||+||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. ..
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------------SMSACREIALLRELKHPNVIALQKVFLSHSDR 73 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC
Confidence 357999999999999765 457899998843221 2346789999999999999999998843 55
Q ss_pred cceEEEeecCCCChHHHhhcC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCC
Q 003199 606 CNLLVYEYMPNGNLWDALHKG--------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL----DVNY 673 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~ 673 (840)
..++|+||++ ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~ 149 (317)
T cd07867 74 KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred eEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCC
Confidence 6789999996 5777776421 1357899999999999999999999 999999999999999 5667
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
.+||+|||+++................||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 8999999999876432222222344578999999998876 45799999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=307.99 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=201.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.+|...+.||+|+||.||+|..+ +|. .||+|.+..... ......+.+|+.++++++|+|+++++++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---------PKANKEILDEAYVMASVDHPHVVRLLGI 77 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 46778889999999999999654 343 588898743321 3345678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.. ...++||||+++|+|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+||
T Consensus 78 ~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 78 CLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred Eec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCC
Confidence 987 77899999999999999998766578999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|.++...... .........++..|+|||.+....++.++||||||+++||+++ |+.||..... ..+.....
T Consensus 154 g~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~-- 225 (279)
T cd05057 154 GLAKLLDVDE-KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLE-- 225 (279)
T ss_pred cccccccCcc-cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHh--
Confidence 9998764311 1111112224568999999988889999999999999999998 9999975311 11111100
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
..............+.+++.+||..+|.+||++.++++.|.++.
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 226 --------KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred --------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000111112345678888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.00 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=195.8
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|||++++++++.....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----------EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 566778999999999999665 57888999873221 2234668889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||+++++|..++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 999999999999999887655578999999999999999999999 99999999999999999999999999998764
Q ss_pred hccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
... ........++..|+|||++. +..++.++|||||||++|||++|+.||..... .... ... ....
T Consensus 154 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~---~~~-~~~~- 224 (282)
T cd06643 154 TRT---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVL---LKI-AKSE- 224 (282)
T ss_pred ccc---ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHH---HHH-hhcC-
Confidence 321 12223456889999999874 34577899999999999999999999865311 0000 000 0000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... .........+.+++.+||+.||.+||++.+++++-
T Consensus 225 ------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 225 ------PPTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ------CCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0000 00111234567788899999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=304.49 Aligned_cols=250 Identities=28% Similarity=0.365 Sum_probs=201.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|++++++++|+|++++++++.+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------------DLQEIIKEISILKQCDSPYIVKYYGSYFKN 70 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence 45777889999999999999776 47899999873221 156789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++++||+++++|.+++......+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||++.
T Consensus 71 ~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccch
Confidence 99999999999999999998766678999999999999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........++..|+|||++.+..++.++||||||+++|||++|+.||........ .... .
T Consensus 148 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~~--------~ 212 (256)
T cd06612 148 QLTDT---MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFMI--------P 212 (256)
T ss_pred hcccC---ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhhh--------c
Confidence 76432 1123345588899999999888999999999999999999999999975321110 0000 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... .........+.+++.+|++.||++|||+.|++++
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 NKPPPTL-SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCCCCCC-CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000000 0111223457778889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.25 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=199.5
Q ss_pred HhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||.|++|.||+|. ..+|+.||+|.+.... ....+.+.+|+++++.++|+|++++++++...
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----------QPKKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----------CchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 457788899999999999985 4679999999884322 11245678899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++|+||+++++|.+++... .+++.++..++.+++.|++|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 9999999999999999998764 58999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||........ . .......
T Consensus 164 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~---~~~~~~~----- 231 (296)
T cd06655 164 QITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L---YLIATNG----- 231 (296)
T ss_pred hcccc---cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H---HHHHhcC-----
Confidence 65331 1122345688999999999888899999999999999999999999975321100 0 0000000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.............+.+++.+||..||.+||++.+++++
T Consensus 232 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 ----TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ----CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000111223456678889999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.02 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=198.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|...+.||+|+||.||+|... +|+ .||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---------GPKANVEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---------CHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 45677889999999999999653 454 46888774321 12233468899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+... ..++|+||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 78 CLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred EcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccc
Confidence 8754 4679999999999999998766578999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++...... .........++..|+|||++.+..++.++||||||+++|||++ |+.||.+.. ......+.. .
T Consensus 154 g~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~----~ 226 (303)
T cd05110 154 GLARLLEGDE-KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLE----K 226 (303)
T ss_pred cccccccCcc-cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----C
Confidence 9998764321 1111223345678999999988899999999999999999997 999986531 111111110 0
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.. ..+........+.+++.+||..+|++||+++++++.|+++.
T Consensus 227 ~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 227 GE---------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 00011112346778888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.42 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=194.2
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
....|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|+|++++++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----------DEEEEIKQEINMLKKYSHHRNIATYYGAF 72 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----------ccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 345677788899999999999965 468899999884322 1134577899999998 699999999998
Q ss_pred ecC------ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 602 SSL------YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 602 ~~~------~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
... ...++||||+++++|.+++... ...+++..+..++.|++.|++|||+ ++|+||||||+||++++++.
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAE 149 (272)
T ss_pred eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCC
Confidence 653 4578999999999999998864 3468999999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 749 (840)
++|+|||++..... .........|+..|+|||++. +..++.++|||||||++|||++|+.||..... .
T Consensus 150 ~~l~Dfg~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~ 222 (272)
T cd06637 150 VKLVDFGVSAQLDR---TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----M 222 (272)
T ss_pred EEEccCCCceeccc---ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----H
Confidence 99999999876532 112234467899999999885 34578899999999999999999999864311 1
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... . .. ........ .....+.+++.+||..+|.+|||+.+++++
T Consensus 223 ~~~~~~--~-~~----~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 223 RALFLI--P-RN----PAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHH--h-cC----CCCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 111000 0 00 00000111 123456778889999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.75 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=187.9
Q ss_pred CeeeccCCcEEEEEEeCC---CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 532 NKVGQGGSGTVYKIDLNS---GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
+.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+.++++++||||+++++++.+....+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 71 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS---------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL 71 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC---------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcE
Confidence 368999999999996543 45789998743321 223456888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCC----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 609 LVYEYMPNGNLWDALHKGL----VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+||||+++|+|.+++.... ...++..+..++.|++.|++|||+ .+++||||||+||+++.++++|++|||.++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccc
Confidence 9999999999999997532 246778888999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccccC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSS-------KATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 756 (840)
..... ..........++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ..... .
T Consensus 149 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~---~ 222 (269)
T cd05087 149 NKYKE-DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTY---T 222 (269)
T ss_pred cccCc-ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHH---H
Confidence 54321 111122334577889999987542 35789999999999999996 99999653211 11000 0
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. .........+...... ...+.+++..|+ .+|++|||++||++.|+
T Consensus 223 ~--~~~~~~~~~~~~~~~~---~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 V--REQQLKLPKPRLKLPL---SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred h--hcccCCCCCCccCCCC---ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 0001111112222122 233556777898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.30 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=200.0
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||++.. .+|+.||+|++...... ....+.+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--------PKEREESRKEVAVLSNMKHPNIVQYQESFEENG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC
Confidence 367788999999999999854 57899999998543211 223457889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++|+||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||++.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 999999999999999998764 2357899999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ..... .
T Consensus 150 ~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~----------~ 211 (256)
T cd08218 150 VLNST---VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLV----------L 211 (256)
T ss_pred ecCcc---hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHH----------H
Confidence 65321 112223457889999999988889999999999999999999999986421 11111 1
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.................+.+++.+|++.+|++||++.+|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 KIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111111112234567788889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=312.50 Aligned_cols=263 Identities=26% Similarity=0.365 Sum_probs=200.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++||||+++++++.+.+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 5778889999999999999654 68889999874321 1223456888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++.... .+++..+..++.|+++||+|||+. .+++||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~lv~ey~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 73 EISICMEHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred EEEEEeeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999999999998763 689999999999999999999972 4899999999999999999999999999875
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc----
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE---- 761 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 761 (840)
.... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .....+.........
T Consensus 150 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 150 LIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCC
Confidence 4321 22345688999999998888899999999999999999999999864321 111111100000000
Q ss_pred ---------------chhhhccc---ccCCCc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 762 ---------------GIMEVLDK---KLSGSF--RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 762 ---------------~~~~~~~~---~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
...+..+. ...+.. .....++.+++.+|+..+|++||++.+++++-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000 000000 012345778999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=306.18 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=201.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||.|+||.||+|... +++.||+|++..... ....+.+.+|+++++++.|+|++++++++.+.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc---------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 45667788999999999999654 689999998843221 23356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++... .+++..+..++.|++.|++|+|+ .+++|+||+|+||+++.++.++++|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccce
Confidence 9999999999999999998764 57889999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........++..|+|||++.+..++.++||||||+++|||++|+.||....... . .
T Consensus 150 ~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~---~----------- 210 (277)
T cd06640 150 QLTD---TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--V---L----------- 210 (277)
T ss_pred eccC---CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--H---h-----------
Confidence 6532 1222234567889999999988889999999999999999999999987532110 0 0
Q ss_pred hhcccc-cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKK-LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...... ...........+.+++.+||+.+|++||++.+++++-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 000011 1111233456678899999999999999999998874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.09 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=205.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 45667789999999999998654 68999999874322 123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++.... .+++..+..++.+++.|+.|||+. ++++||||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 99999999999999999987754 689999999999999999999963 589999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc------chhhhhhhhhc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK------NIIYWVSIKVD 758 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~ 758 (840)
..... ......|+..|+|||++.+..++.++|||||||++||+++|+.||........ ....+.
T Consensus 153 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 222 (284)
T cd06620 153 ELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL----- 222 (284)
T ss_pred chhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH-----
Confidence 54221 12245689999999999888899999999999999999999999975432110 000111
Q ss_pred cccchhhhcccccCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 759 TKEGIMEVLDKKLSGS-FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
........... ..+....+.+++.+|++.||++||++.|++++..-+...+
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 223 -----QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred -----HHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 01111111110 1123456778888999999999999999999865444443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=316.01 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=192.8
Q ss_pred cCeeecc--CCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccc
Q 003199 531 KNKVGQG--GSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 531 ~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 607 (840)
.++||+| +||+||++.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++..++..
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc--------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 4579999 7789999854 5799999999843321 123355678899999999999999999999999999
Q ss_pred eEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 608 LLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+...
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999999999998654 2358999999999999999999999 99999999999999999999999999876443
Q ss_pred hccCCCC----cceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc-
Q 003199 687 QARGGKD----STTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT- 759 (840)
Q Consensus 687 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 759 (840)
...+... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 230 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCL 230 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCcccc
Confidence 2211110 01122356778999999876 4588999999999999999999999975321100 00000000000
Q ss_pred -------ccch-----hhhccc----------c--------cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 -------KEGI-----MEVLDK----------K--------LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 -------~~~~-----~~~~~~----------~--------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+.. ....+. . ..+........+.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 000000 0 000011234567889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=303.92 Aligned_cols=254 Identities=28% Similarity=0.352 Sum_probs=201.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||.|+||.||+|.. .+++.+|+|.+.... ....+.+.+|++++++++|||++++++++.+.
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 4577888999999999999965 467899999985332 11346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...+++|||+++++|.+++......+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccch
Confidence 99999999999999999988764578999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSS---KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .. .... .
T Consensus 150 ~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~---~~~~---~- 218 (262)
T cd06613 150 QLTAT---IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-AL---FLIS---K- 218 (262)
T ss_pred hhhhh---hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HH---HHHH---h-
Confidence 65431 1122345688899999998776 78999999999999999999999996531100 00 0000 0
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.................+.+++.+||..+|.+||++.+++++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 ---SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ---ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000001112334567889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.73 Aligned_cols=239 Identities=20% Similarity=0.288 Sum_probs=185.0
Q ss_pred eeeccCCcEEEEEEeCC-------------------------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHh
Q 003199 533 KVGQGGSGTVYKIDLNS-------------------------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 587 (840)
.||+|+||.||+|.... ...||+|++... .......+.+|+.+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----------~~~~~~~~~~~~~~~~ 71 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----------HRDIALAFFETASLMS 71 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----------HHHHHHHHHHHHHHHh
Confidence 59999999999986421 134888877322 1233467888999999
Q ss_pred ccCCCCcceeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 003199 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNI 667 (840)
Q Consensus 588 ~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 667 (840)
.++||||+++++++.+....++||||+++|+|..++......+++..+..++.|+++||+|||+ ++|+||||||+||
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Ni 148 (274)
T cd05076 72 QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNI 148 (274)
T ss_pred cCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccE
Confidence 9999999999999999999999999999999999997655578999999999999999999999 9999999999999
Q ss_pred EEcCCC-------CCeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHH-hCCCC
Q 003199 668 LLDVNY-------QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELI-TGRKP 738 (840)
Q Consensus 668 ll~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~-tg~~p 738 (840)
+++..+ .+|++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred EEeccCcccCccceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 997643 379999998754322 122357788999998865 56899999999999999995 69999
Q ss_pred CCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 739 VEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
|....... ...+.. . ....... ....+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~--~~~~~~----~--------~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 222 LKERTPSE--KERFYE----K--------KHRLPEP---SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccccChHH--HHHHHH----h--------ccCCCCC---CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 86532111 000000 0 0001111 1235778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.40 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=196.7
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 4667778899999999999965 468999999884332 11234577899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++++|.+++.... .+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeee
Confidence 99999999999999999987654 68999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.... .........|+..|+|||++. ...++.++|||||||++|||++|+.||........ .+.... .
T Consensus 155 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~--~-- 224 (267)
T cd06645 155 QITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTK--S-- 224 (267)
T ss_pred EccC---cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhc--c--
Confidence 6532 112233457899999999874 45688999999999999999999999864321110 000000 0
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... .......+.+++.+|++.+|++||++++++++
T Consensus 225 ---~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 ---NFQPPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---CCCCCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000100 01122346678889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.54 Aligned_cols=244 Identities=24% Similarity=0.291 Sum_probs=185.3
Q ss_pred eeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc---CCCCcceeeeEEecCccceE
Q 003199 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI---RHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 534 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~l 609 (840)
||+|+||+||+|.. .+|+.||||++...... .......+..|..++... .||||+++++++.+....++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEE
Confidence 69999999999965 46899999998432211 112223345566666655 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~- 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLT- 148 (330)
T ss_pred EEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-
Confidence 999999999999987654 68999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (840)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... . ..+..... . .
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~--~~~~~i~~-~--------~ 213 (330)
T cd05586 149 --DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--Q--QMYRNIAF-G--------K 213 (330)
T ss_pred --CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--H--HHHHHHHc-C--------C
Confidence 12223346799999999998764 479999999999999999999999965311 0 00000000 0 0
Q ss_pred cccCCCcHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 003199 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRP----TMNEVVQL 806 (840)
Q Consensus 769 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~evl~~ 806 (840)
..+... .....+.+++.+|++.||.+|| ++.+++++
T Consensus 214 ~~~~~~--~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 214 VRFPKN--VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCCCc--cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 011111 1233456778899999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.20 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=200.5
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
...+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++.
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 86 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----------QPKKELIINEILVMRENKNPNIVNYLDSYL 86 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----------cchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 446788899999999999999964 579999999884322 112355788999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
.....++||||+++++|.+++.+. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 999999999999999999998764 57899999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+...... ........+++.|+|||.+.+..++.++|||||||++|++++|+.||............+ ...
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~----~~~--- 231 (297)
T cd06656 162 CAQITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TNG--- 231 (297)
T ss_pred ceEccCC---ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec----cCC---
Confidence 8765321 112234568889999999988889999999999999999999999996532111100000 000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+ ...........+.+++.+|++.+|++||++.+++++
T Consensus 232 -----~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 -----TP-ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -----CC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000111223446678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.54 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=193.5
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+.....||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 334456899999999999964 467899999874322 223467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCC--ChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecccc
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHL--DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGI 682 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~ 682 (840)
..++|+||+++++|.+++......+ ++..+..++.|++.|++|||+ .+|+||||||+||+++. ++.++|+|||.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999999998653344 888899999999999999999 99999999999999986 67899999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS--KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+...... ........|++.|+|||++.+. .++.++||||||+++|||++|+.||..... .....+... ..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~--~~~~~~~~~-~~-- 227 (268)
T cd06624 156 SKRLAGI---NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE--PQAAMFKVG-MF-- 227 (268)
T ss_pred heecccC---CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC--hhhhHhhhh-hh--
Confidence 8765321 1122334578999999988654 378899999999999999999999864211 111111000 00
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+.+.. ....++.+++.+|++.+|.+|||+.|++++
T Consensus 228 -----~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -----KIHPEIPE---SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----ccCCCCCc---ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111111 223456678889999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=308.58 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=197.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||.|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|+|++++++++...
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS----------EEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC----------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 45777889999999999999665 58999999984321 23356788899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|..++......+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||.+.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999998887655578999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
.... .........+++.|+|||++. ...++.++|||||||++|||++|+.||..... . .........
T Consensus 159 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~-~~~~~~~~~ 230 (292)
T cd06644 159 KNVK---TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----M-RVLLKIAKS 230 (292)
T ss_pred eccc---cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----H-HHHHHHhcC
Confidence 5422 112223456888999999884 34568899999999999999999999865311 0 000000000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. .... ........++.+++.+||+.+|++||++.+++++
T Consensus 231 ~-------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 231 E-------PPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C-------CccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000 0111233456778889999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=305.81 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=200.9
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+.||+|+||.||+|.. .+|+.||+|.+..................+.+..|+.+++.++|+|++++++++.....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 56678899999999999954 46899999988543322111112223345678899999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+++++|.+++.... .+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++++|||+++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999998764 68999999999999999999999 89999999999999999999999999998765
Q ss_pred hccCCCCcceecccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........|+..|+|||.+.... ++.++||||||+++||+++|..||.... .......... .. ..
T Consensus 159 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~--~~-~~ 230 (272)
T cd06629 159 DDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFKLGN--KR-SA 230 (272)
T ss_pred cccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHHhhc--cc-cC
Confidence 3211 111223456889999999887654 7899999999999999999999986421 1111111000 00 00
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... .......+.+++.+|+..+|++||++.+++++
T Consensus 231 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDV---SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCccc---cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111 12234567778889999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=301.36 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=196.7
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEE
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 611 (840)
++||+|+||.||+|...+++.||+|.+..... ....+.+.+|+++++++.|+||+++++++.+....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEE
Confidence 36999999999999777699999998743321 133567889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 612 EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 612 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
||+++++|.+++......+++..+..++.+++.|++|||+ .+++||||||+||+++.++.++|+|||.+...... .
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~ 147 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG-I 147 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCC-c
Confidence 9999999999997755568899999999999999999999 89999999999999999999999999998765321 1
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ..... ..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~----~~~~~------~~- 214 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRER----IESGY------RM- 214 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHH----HhcCC------CC-
Confidence 1111112234567999999988889999999999999999999 8888865321 000000 00000 00
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.........+.+++.+|+..+|.+||++.|+++.|.
T Consensus 215 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 --PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011123456788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.28 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=195.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++.++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|+.++++++|+||+++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--------QSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 4567899999999999999999954 578999999884322 1122345677899999999999999999887
Q ss_pred ecC------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSL------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
... ...++++|++ +++|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCE
Confidence 532 3458999988 78998887653 58999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... .....+..
T Consensus 158 kl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~ 230 (343)
T cd07878 158 RILDFGLARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME 230 (343)
T ss_pred EEcCCccceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 9999999976432 1234568999999999876 56889999999999999999999999753210 00000000
Q ss_pred hhhccc-cc--------hhhhcc--cccCC-C----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDTK-EG--------IMEVLD--KKLSG-S----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~~-~~--------~~~~~~--~~~~~-~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... +. ...... +.... . +......+.+++.+|++.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 000000 00000 0 00112346788999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.67 Aligned_cols=258 Identities=27% Similarity=0.326 Sum_probs=199.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
.+|+..+.||+|+||.||+|... .+..||+|.+.... .....+.+.+|+++++++ +|+||++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---------TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---------CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 35788899999999999998542 12368999874321 123356788999999999 7999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKG---------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++++......++|+||+++|+|.+++... ...++|.++..++.|++.||+|||+ ++++|||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~d 159 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRD 159 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccc
Confidence 999999999999999999999999998753 1357889999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||++++++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999976532111 111122334567999999998899999999999999999998 888886
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
... ...+..... ..............+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 239 ~~~-----~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 239 GIP-----VEELFKLLK----------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCC-----HHHHHHHHH----------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 421 111111100 00001111123346778889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=303.03 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=197.6
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-C
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-L 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 604 (840)
.|+..+.||+|++|.||++.. .+++.||+|++..... .....+.+.+|++++++++|+|++++++.+.. .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC
Confidence 367788999999999999854 4678999999843221 12234568889999999999999999988764 4
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++++|.+++... ...+++.++..++.+++.|+++||+ .+++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 73 GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccce
Confidence 4578999999999999999764 3358999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ........+++.|+|||++.+..++.++||||+|+++|||++|+.||.... ...+...
T Consensus 150 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~-------- 213 (257)
T cd08223 150 RVLENQ---CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYR-------- 213 (257)
T ss_pred EEeccc---CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH--------
Confidence 765331 122334568899999999999889999999999999999999999986421 1111100
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
................+.+++.+|++.+|++||++.+++++
T Consensus 214 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 214 --IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --HHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00111111112234567788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.19 Aligned_cols=196 Identities=30% Similarity=0.409 Sum_probs=171.5
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-C-----CCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-H-----KNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~ 598 (840)
.+|.+.+.||+|+||.|-+| +..+++.||||+++... ....+-..|+.+|..++ | -|+|+++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-----------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-----------RFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-----------HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 38899999999999999999 67789999999996543 33556677999999997 4 5899999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN--YQP 675 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~ 675 (840)
+||.-..+.|||+|.+ .-+|++++..+. ..++...++.|+.||+.||.+||+ .+|||+||||+|||+.+. ..+
T Consensus 255 d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCce
Confidence 9999999999999999 569999998763 578999999999999999999999 999999999999999753 479
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
||+|||.|..... ... ..+-++.|.|||++.+.+|+.+.||||||||++||++|.+-|.++
T Consensus 331 KVIDFGSSc~~~q-----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 331 KVIDFGSSCFESQ-----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred eEEecccccccCC-----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 9999999987532 222 567788999999999999999999999999999999998888764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=282.62 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=195.3
Q ss_pred CccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCcc
Q 003199 529 TEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYC 606 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 606 (840)
.....||.|..|.||++..+ +|..+|||.+..... .+..+.+...+.++..-. +|.||+-+|||..+..
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N---------kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN---------KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCC---------HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 34557999999999999665 689999999855432 344567778888877664 8999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++.||.| .......+..-...+++.-+-++...+++||.||.+. ++|+|||+||+|||+|+.|.+|+||||.+.++
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccccccee
Confidence 99999999 4456666666656789999999999999999999985 78999999999999999999999999999887
Q ss_pred hccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.+ +...+...|-+.|||||.+.- ..|+.++||||||+.++|+.||+.||..-..+... .
T Consensus 243 vd----SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--------------l 304 (391)
T KOG0983|consen 243 VD----SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--------------L 304 (391)
T ss_pred ec----ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--------------H
Confidence 54 334455678899999999853 47899999999999999999999999863211111 1
Q ss_pred hhhcc---cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLD---KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+++ +.+++. ......+.+++..|+++|+.+||...+++++
T Consensus 305 tkvln~ePP~L~~~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 305 TKVLNEEPPLLPGH-MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHhcCCCCCCcc-cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11222 222221 1144566777789999999999999999876
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.07 Aligned_cols=240 Identities=20% Similarity=0.297 Sum_probs=186.6
Q ss_pred CeeeccCCcEEEEEEeC-CC-------cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 532 NKVGQGGSGTVYKIDLN-SG-------EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
+.||+|+||.||+|... .+ ..||+|.+... .....+.+.+|+.+++.+.|||++++++++..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~ 70 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC 70 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe
Confidence 36999999999999653 22 34777776221 12335678889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--------C
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ--------P 675 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~ 675 (840)
....++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +
T Consensus 71 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 71 GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceE
Confidence 899999999999999999998766578999999999999999999999 99999999999999988765 5
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCC-CCCCCCCCCCcchhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGR-KPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~~~~~~~ 753 (840)
+++|||.+..... .....+++.|+|||++.+. .++.++||||||+++|||++|. .|+..... ....
T Consensus 148 ~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~~~~ 215 (258)
T cd05078 148 KLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----QKKL 215 (258)
T ss_pred EecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----HHHH
Confidence 8999998865422 2234678899999998764 5799999999999999999985 55543210 0000
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. ... ...++. ....++.+++.+||+.||++|||++++++.|.
T Consensus 216 ~~-~~~--------~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QF-YED--------RHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HH-HHc--------cccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000 011111 12245778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.54 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=201.4
Q ss_pred cCccCeeeccCCcEEEEEEeCC--CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc-cCCCCcceeeeEEecC
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNS--GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN-IRHKNIVKLYCYFSSL 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 604 (840)
|+..+.||+|+||.||+|.... ++.+|+|.+....................+..|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5667889999999999997654 688999988654433222112223345667788888875 7999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
...++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+. .+++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988743 334689999999999999999999952 679999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.+...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... .......
T Consensus 160 ~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~------ 224 (269)
T cd08528 160 LAKQKQPE----SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATK------ 224 (269)
T ss_pred ceeecccc----cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHH------
Confidence 99765331 13345568899999999998889999999999999999999999986421 1111100
Q ss_pred chhhhcccccCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 762 GIMEVLDKKLSGS-FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 762 ~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.......+. .......+.+++.+||+.||++||++.|+..++++
T Consensus 225 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 225 ----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 000111100 01123457778889999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.25 Aligned_cols=256 Identities=25% Similarity=0.302 Sum_probs=196.0
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
+|+..+.||+|+||.||+|.. .+|..||||.+...... .......+.+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES-----PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC-----cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 577788999999999999965 46899999987432211 11123356788999999999999999999988663
Q ss_pred -ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 -YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 45679999999999999987653 57889999999999999999999 89999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+................|+..|+|||.+.+..++.++||||||+++|||++|+.||.... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~~------- 222 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAAIFKIA------- 222 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHHHHHHh-------
Confidence 765321111112234568899999999988889999999999999999999999996421 110000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...............+.+++.+|+. +|++||+++|++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 ---TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000111122334456677778884 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=307.60 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=198.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||.|++|.||+|... ++..||+|++.... ....+.+..|++++++++|+|++++++++...
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES----------EEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC----------HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 45777888999999999999664 68999999984321 23346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++......+++..+..++.|++.|+.|||+ .+|+|+||||+||+++.++.++|+|||.+.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccch
Confidence 99999999999999999998765579999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
..... ........+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ... ... ...
T Consensus 152 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~---~~~-~~~ 223 (280)
T cd06611 152 KNKST---LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVL---LKI-LKS 223 (280)
T ss_pred hhccc---ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHH---HHH-hcC
Confidence 65321 12223456899999999874 345678999999999999999999999753110 000 000 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+.+. ........+.+++.+||+.+|++||++.+++++
T Consensus 224 -------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 -------EPPTLD-QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------CCCCcC-CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000000 011123456678889999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.48 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=200.3
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 605 (840)
.|+..++||+|+.++||++...+.+.+|+|++.... .+.+....|..|+..|.+++ |.+||++++|-..++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--------ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--------cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 467788999999999999998888999999774322 23566789999999999995 999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..||||||= ..+|..+|.+.....+...+..+..|++.|+.+.|+ +||||.||||.|+|+-. |.+||+|||.|..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 999999976 679999999876444423788899999999999999 99999999999999965 5899999999988
Q ss_pred hhccCCCCcceecccccccccCccccccC-----------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-----------KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+..+ .........+||+.|||||.+... ..+.++||||+|||+|+|+.|+.||..-. -.|.+
T Consensus 509 I~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~aK 581 (677)
T KOG0596|consen 509 IQPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIAK 581 (677)
T ss_pred cCcc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHHH
Confidence 7653 445566778999999999988432 25689999999999999999999997421 01221
Q ss_pred hhhccccchhhhcccccCCCcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRD--EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ..+.++.-.-.|++ ...+++++++.|+..||.+||++.|++++
T Consensus 582 l--------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 L--------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H--------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1 11222211111111 11228899999999999999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.44 Aligned_cols=250 Identities=27% Similarity=0.363 Sum_probs=193.6
Q ss_pred CeeeccCCcEEEEEEeCC-------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 532 NKVGQGGSGTVYKIDLNS-------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.||+|+||.||+|...+ ++.||||.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN 71 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc---------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC
Confidence 369999999999996542 25799998743211 12245688899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY----- 673 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----- 673 (840)
...++||||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++|+||||+||+++.++
T Consensus 72 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 72 EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCc
Confidence 9999999999999999998753 2347899999999999999999999 8999999999999999877
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~ 752 (840)
.++++|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 149 ~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~ 225 (269)
T cd05044 149 VVKIGDFGLARDIYKSD-YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH 225 (269)
T ss_pred ceEECCccccccccccc-ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH
Confidence 89999999997653311 1111223345678999999998899999999999999999998 9999864311 111110
Q ss_pred hhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
. . ..............+.+++.+||..+|.+||++.++++.|.+
T Consensus 226 ~----~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 V----T---------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred H----h---------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0 000001112234567788889999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.89 Aligned_cols=260 Identities=21% Similarity=0.256 Sum_probs=195.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
.+|...+.||+|+||.||++... .+..||||.+... +...+|+++++.++||||+++++++.
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------------~~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------------KTPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence 46888999999999999998543 4578999987322 12457999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
.....++|||++. ++|.+++... ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.++|+|||+
T Consensus 157 ~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 157 WKSTVCMVMPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred eCCEEEEEehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999995 7888888544 478999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--hhhhhhhhh-cc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN--IIYWVSIKV-DT 759 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~-~~ 759 (840)
++..... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... +....+... ..
T Consensus 232 a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 232 ACKLDAH-PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred ccccCcc-cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 9765432 1112233567999999999999889999999999999999999999999764322110 000000000 00
Q ss_pred cc-------chhh---hcccccCCCc--H------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KE-------GIME---VLDKKLSGSF--R------DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~-------~~~~---~~~~~~~~~~--~------~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+ .... ......++.+ . ....++.+++.+|+..||++||++.|++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000 0000000000 0 112456778889999999999999999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=306.70 Aligned_cols=249 Identities=29% Similarity=0.381 Sum_probs=199.7
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||.|++|.||+|... +++.||+|++..... ......+.+|+++++.++|+|++++++++.+..
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence 4667788999999999999654 689999998843221 122456789999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||+++++|.+++... .+++..+..++.|++.|+.|||+ ++++||||+|+||++++++.++++|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccccccee
Confidence 999999999999999999875 68999999999999999999999 9999999999999999999999999999977
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
.... ........+++.|+|||++.+..++.++||||||+++|||++|+.||....... .... . ..
T Consensus 148 ~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~-~------~~ 212 (274)
T cd06609 148 LTST---MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFL-I------PK 212 (274)
T ss_pred eccc---ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHH-h------hh
Confidence 6432 122334568889999999998889999999999999999999999996532110 0000 0 00
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... .....+.+++.+|+..+|++||++++++++
T Consensus 213 ~~~~~~~~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 213 NNPPSLEGN--KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCCCCCccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001111111 023456778889999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=330.15 Aligned_cols=260 Identities=18% Similarity=0.199 Sum_probs=186.5
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC------CCCccee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR------HKNIVKL 597 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 597 (840)
..+|...+.||+|+||+||+|.. .+++.||||++.... .....+..|+++++.++ |.+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----------KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----------hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 45788899999999999999955 468899999984321 11223444555555554 4568889
Q ss_pred eeEEecC-ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---
Q 003199 598 YCYFSSL-YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY--- 673 (840)
Q Consensus 598 ~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--- 673 (840)
++++... ...++|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccc
Confidence 9888764 4678999988 788999887654 689999999999999999999972 4999999999999998765
Q ss_pred -------------CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 003199 674 -------------QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740 (840)
Q Consensus 674 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 740 (840)
.+||+|||.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccCCCCceEEECCCCccccC------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4899999987532 122345679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhhccc---------cchhhhccc--ccCC--------------CcH--HHHHHHHHHHHHccCCC
Q 003199 741 DDFGDNKNIIYWVSIKVDTK---------EGIMEVLDK--KLSG--------------SFR--DEMIQVLRIAIRCTSKS 793 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~--~~~~--------------~~~--~~~~~l~~l~~~cl~~d 793 (840)
..... .............. ....++.+. .+.+ ... -....+.+++.+|++.|
T Consensus 347 ~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 347 THDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 53211 00000000000000 000000000 0000 000 01245678999999999
Q ss_pred CCCCCCHHHHHHH
Q 003199 794 PATRPTMNEVVQL 806 (840)
Q Consensus 794 P~~Rps~~evl~~ 806 (840)
|++|||++|+++|
T Consensus 426 P~~R~ta~e~L~H 438 (467)
T PTZ00284 426 RQKRLNARQMTTH 438 (467)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=308.35 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=198.3
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|..+ +|+.||+|++...... ....+.+.+|+.++++++|+|++++++++....
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--------PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--------ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 5777889999999999999665 6899999988533211 112345788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||++++.+..+..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred EEEEEEeccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECcccccee
Confidence 9999999999988887776543 68999999999999999999999 9999999999999999999999999999977
Q ss_pred hhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+. ................
T Consensus 150 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 150 LTGPG---DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQ 225 (286)
T ss_pred cCCCc---ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHh
Confidence 64321 12233457889999998866 4578999999999999999999999975422111 1110000000000000
Q ss_pred hh----------ccccc--C----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EV----------LDKKL--S----GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~----------~~~~~--~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ..+.. . .........+.+++.+|++.+|++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 00000 0 0011224567889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=309.24 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=194.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|... +|+.||+|++...... ......+.+|++++++++|+|++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--------EGVPSSALREICLLKELKHKNIVRLYDVLHSDK 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--------ccCccchhHHHHHHHhcCCCCeeeHHHHhccCC
Confidence 3667789999999999999654 7899999998543211 112345678999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||++ ++|.+++......+++..+..++.||++||+|||+ ++++||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 9999999996 58888887654568999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc-ccc--
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD-TKE-- 761 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~-- 761 (840)
.... ........+++.|+|||++.+. .++.++|||||||++|||++|+.|+................... ...
T Consensus 149 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 149 FGIP---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred cCCC---CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 5321 1222344678899999988764 46899999999999999999998864322111100000000000 000
Q ss_pred -chhhhccc----ccCC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 -GIMEVLDK----KLSG------SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 -~~~~~~~~----~~~~------~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+. .... .......++.+++.+|++.||.+|||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 0000 001123466788889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.22 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=197.6
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|.. .+++.+|||++...... ....+.+.+|++++++++|||++++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDK 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc--------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCC
Confidence 367788999999999999855 47899999998533211 123467889999999999999999999999889
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a 683 (840)
..++||||+++++|.+++.... ..+++..+..++.+++.|++|||+ ++++|+||+|+||++++++ .+|++|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 9999999999999999997643 358999999999999999999999 9999999999999998654 5799999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... .
T Consensus 150 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~---~------- 213 (256)
T cd08220 150 KILSSK----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--PALVLK---I------- 213 (256)
T ss_pred eecCCC----ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--HHHHHH---H-------
Confidence 765331 222335688899999999888889999999999999999999999865311 111110 0
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...............+.+++.+||+.+|++|||+.|++++
T Consensus 214 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 214 ---MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---HhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000111111133456778889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.66 Aligned_cols=253 Identities=27% Similarity=0.388 Sum_probs=197.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|... +|..||+|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG 72 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence 5677889999999999999665 78999999884321 1222467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKG--LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..++||||+++++|..++... ...+++..+..++.+++.|+.|||+. .+++||||||+||+++.++.++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999999999999988764 23689999999999999999999962 58999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS------KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
..+.. .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......
T Consensus 151 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~----- 218 (286)
T cd06622 151 GNLVA-----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQ----- 218 (286)
T ss_pred ccccC-----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHH-----
Confidence 76532 122234578899999988554 348899999999999999999999964211 111000
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..............+...++.+++.+|++.+|++||++.+++++-
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 219 -----LSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred -----HHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 011111111111223445667788899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.17 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=198.0
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec--C
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS--L 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 604 (840)
|+..+.||.|+||.||+|.. .+|+.||+|++...... ....+.+..|+++++.++|+|++++++++.. .
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC--------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 66778999999999999954 57899999988533211 2334678899999999999999999998754 4
Q ss_pred ccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGL--LSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
...+++|||+++++|.+++... ...+++..++.++.+++.||+|||..+ ..+++|+||+|+||++++++.+|++|
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 4568999999999999998653 346899999999999999999999211 28999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||++...... ........+++.|+|||++.+..++.++||||||+++|+|++|+.||.... ... ..+.
T Consensus 154 ~g~~~~~~~~---~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~---~~~~---- 221 (265)
T cd08217 154 FGLAKILGHD---SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQ---LASK---- 221 (265)
T ss_pred ccccccccCC---cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHH---HHHH----
Confidence 9999876432 111234568999999999988889999999999999999999999997531 111 1110
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+.........+.+++.+|++.+|++||++.+|+++
T Consensus 222 ------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 ------IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00111111112334567788889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.61 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=200.4
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|++|.||+|.. .+|+.||||++...... ....+.+.+|+.++++++|+|++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--------GGIPNQALREIKALQACQHPYVVKLLDVFPHGS 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--------chhhHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 367788999999999999965 47899999998543311 122457889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+ +++|.+++......+++.++..++.|+++||+|||+ .+++|+||||+||++++++.++++|||.+..
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 999999999 999999997665678999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc--c--
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT--K-- 760 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~-- 760 (840)
..... ........|+..|+|||++.+. .++.++||||+|+++|||++|++||..... .....+....... .
T Consensus 149 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 149 FSEEE--PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEET 224 (286)
T ss_pred ccCCC--CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHH
Confidence 64321 1223345688999999988654 468999999999999999999888764321 1110000000000 0
Q ss_pred -------cchhhhc-ccc----cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 -------EGIMEVL-DKK----LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 -------~~~~~~~-~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... ... +.....+....+.+++.+|++.+|++||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 000 000111234677889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.20 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=194.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|+..+.||+|+||.||+|.. +++.||+|.+.... ....+.+|+.++++++|||++++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------------TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5678889999999999999875 57889999874321 135688899999999999999999998654
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||.+.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccce
Confidence 4789999999999999997643 357999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... ......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ........ .. .
T Consensus 149 ~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~-~~--~ 214 (254)
T cd05083 149 VGSMG------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVE-KG--Y 214 (254)
T ss_pred ecccc------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHh-CC--C
Confidence 54221 112234568999999988899999999999999999998 9999865311 11111000 00 0
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
..... ......+.+++.+|++.+|++||+++++++.|++
T Consensus 215 ----~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 ----RMEPP---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCCCC---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00011 1223556788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.96 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=199.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|.. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 74 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence 4567788999999999999965 468999999873221 122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++... .+++..+..++.+++.|+.|||+ .+++|+||+|+||+++.++.++++|||++.
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccce
Confidence 9999999999999999998764 58999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........++..|+|||++.+..++.++|||||||++|||++|..||..... ..+... ....
T Consensus 150 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~---- 216 (277)
T cd06641 150 QLTDT---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-IPKN---- 216 (277)
T ss_pred ecccc---hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-HhcC----
Confidence 65321 1122335678899999999888889999999999999999999999864211 001100 0000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+.+.. .....+.+++.+|++.+|.+||++.+++++
T Consensus 217 --~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 --NPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCCCc---ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011111 223456678889999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.83 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=199.3
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|++|.||+|... +++.||+|.+...... ....+..+.+.+|+.+++.++|+|++++++++.+...
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-----QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc-----ccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 566788999999999999765 7899999988443211 1123345678999999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.+||+|||.+...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999999998754 58899999999999999999999 89999999999999999999999999998765
Q ss_pred hccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... .......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ....... .....
T Consensus 153 ~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~~--~~~~~---- 218 (258)
T cd06632 153 VEF----SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFK--IGRSK---- 218 (258)
T ss_pred ccc----ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHHH--HHhcc----
Confidence 321 1233456889999999987766 8999999999999999999999986531 1000000 00000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+ .....+.+++.+|++.+|++||++.+++++
T Consensus 219 -~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 -ELPPIPD---HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -cCCCcCC---CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0001111 123456678889999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.91 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=202.2
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|++|.||+|.. .+++.||+|++...... ...+....+.+.+|++++++++|+|++++++++.+.+.
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT----SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC----chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 66778999999999999954 67899999998543311 12223456789999999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~ 685 (840)
.++|+||+++++|.+++.+.. .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||.+..
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999999997654 68899999999999999999999 9999999999999998776 589999999877
Q ss_pred hhccCCC-CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGK-DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
....... ........|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~--------- 223 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIFKI--------- 223 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHHHH---------
Confidence 6432111 11223346889999999998888999999999999999999999999643211 111111000
Q ss_pred hhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+ ........+.+++.+|++.+|++||++.+++++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 --ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000111 112334567788899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.65 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=184.9
Q ss_pred eeeccCCcEEEEEEeCC---CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 533 KVGQGGSGTVYKIDLNS---GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|+++++.++|+||+++++++......++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEE
Confidence 59999999999996543 3468888763221 12334678889999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCC----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 610 VYEYMPNGNLWDALHKGL----VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
||||+++|+|.+++.... ...++.....++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++..
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccc
Confidence 999999999999997643 234678889999999999999999 9999999999999999999999999999865
Q ss_pred hhccCCCCcceecccccccccCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS-------SKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
....+ .........++..|+|||+... ..++.++|||||||++|||++ |..||...... .... .. .
T Consensus 150 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~--~~-~ 223 (269)
T cd05042 150 QYPED-YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLK--QV-V 223 (269)
T ss_pred cccch-heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHH--HH-h
Confidence 42211 1111233345678999998643 356889999999999999999 78888653110 0000 00 0
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.........+.....+ ...+.+++..|| .||++||++++|++.|.
T Consensus 224 --~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 224 --REQDIKLPKPQLDLKY---SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --hccCccCCCCcccccC---CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000111111122222 234445666888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.04 Aligned_cols=250 Identities=30% Similarity=0.426 Sum_probs=197.3
Q ss_pred CccCeeeccCCcEEEEEEeCC-----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 529 TEKNKVGQGGSGTVYKIDLNS-----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
+..+.||+|+||.||+|.... +..||+|++..... ....+.+..|++++..++|+||+++++++.+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD---------EQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC---------hHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 456789999999999996653 38899999843321 1145678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCC-CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
....+++|||+++++|.+++...... +++..+..++.|++.|++|||+ .+++||||||+||++++++.++++|||+
T Consensus 73 ~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~ 149 (258)
T smart00219 73 EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGL 149 (258)
T ss_pred CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCC
Confidence 99999999999999999999875433 8999999999999999999999 8999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+........ .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.... ........
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~-------- 217 (258)
T smart00219 150 SRDLYDDDY--YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYL-------- 217 (258)
T ss_pred ceecccccc--cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH--------
Confidence 977643211 11112336789999999988889999999999999999998 888886421 11111110
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..............++.+++.+|+..||++|||+.|+++.|
T Consensus 218 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 -----KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00001111112345677888899999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.00 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=196.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|.....||+|+||.||++.. .++..||||.+.... ....+.+.+|+.+++.++|+|++++++.+...
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 91 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG 91 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC
Confidence 4444456799999999999965 468999999873221 23345688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++++|.+++... .+++.++..++.|++.|++|||+ ++|+||||||+||++++++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999999999988654 58899999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........|+..|+|||...+..++.++||||||+++|||++|+.||..... ... ... +.
T Consensus 167 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~---~~~-------~~ 231 (292)
T cd06658 167 QVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQA---MRR-------IR 231 (292)
T ss_pred hcccc---cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHH-------HH
Confidence 65321 1222345688999999999888899999999999999999999999864311 000 000 00
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... .......+.+++.+|+..||.+|||+++++++
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPRVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCcccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111 11123356677789999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.39 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||+|++|.||+|..+ +++.||||.+...... .....+.+|++++++++|+||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---------GAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---------CCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 56788889999999999999655 7899999998543211 1123456899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++ ++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECcccccc
Confidence 99999999997 59999988765578999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-hhhhhhccccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY-WVSIKVDTKEG 762 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 762 (840)
..... ........++..|+|||++.+ ..++.++||||+|+++|||++|+.||............ +..........
T Consensus 152 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 152 AKSVP---SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccCCC---CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 54221 111222346789999998865 45789999999999999999999999654211000000 00000000000
Q ss_pred hhhhc--------------ccccCCCcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVL--------------DKKLSGSFRD--EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~--------------~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ...+...... ....+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0000000001 12566788999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.32 Aligned_cols=256 Identities=30% Similarity=0.427 Sum_probs=201.0
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCC
Confidence 467788999999999999965 47899999998544321 234678899999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||+++++|.+++.... .+++..+..++.+++.|++|||+ .+++|+||+|+||++++++.+||+|||++..
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 9999999999999999998764 57899999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcc-eecccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 686 LQARGGKDST-TTVIAGTYGYLAPEYAYSSK---ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 686 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.......... .....++..|+|||++.+.. .+.++||||||+++||+++|+.||..... ....... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~----~~~~- 222 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFH----VGAG- 222 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHH----HhcC-
Confidence 6442221111 22356788999999987766 88999999999999999999999964311 1001000 0000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....++. .......+.+++.+|++.+|.+||++.+++.+
T Consensus 223 -----~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 -----HKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -----CCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0111111 11224456678889999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.96 Aligned_cols=238 Identities=23% Similarity=0.336 Sum_probs=186.9
Q ss_pred CeeeccCCcEEEEEEeCCCc-----------EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 532 NKVGQGGSGTVYKIDLNSGE-----------VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+.||+|+||.||+|...+.. .|++|.+.... .. ...+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----------~~-~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----------RD-SLAFFETASLMSQLSHKHLVKLYGV 69 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----------hh-HHHHHHHHHHHHcCCCcchhheeeE
Confidence 36999999999999765332 47777663221 11 5678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-------
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY------- 673 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~------- 673 (840)
+.. ...++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 70 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 70 CVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred Eec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCce
Confidence 988 77899999999999999998765578999999999999999999999 9999999999999999887
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccC--CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS--KATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~ 750 (840)
.+|++|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..... ....
T Consensus 146 ~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~ 216 (259)
T cd05037 146 FIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKE 216 (259)
T ss_pred eEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHH
Confidence 799999999876532 2234466789999998776 78999999999999999999 5777754311 1111
Q ss_pred hhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.+.. .. ..... .....+.+++.+||..+|.+||++.++++.|.
T Consensus 217 ~~~~----~~--------~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 217 RFYQ----DQ--------HRLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHh----cC--------CCCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1100 00 00000 01156778889999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.96 Aligned_cols=256 Identities=28% Similarity=0.402 Sum_probs=202.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||.|+||+||+|... ++..||+|++...... ...+.+.+|+++++.++|+|++++++.+....
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---------TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD 72 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---------hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence 5778889999999999999754 6889999988433211 13567899999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..++|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||++
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 9999999999999999997642 368999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCC-cceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 684 KVLQARGGKD-STTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 684 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
..+....... .......|+..|+|||++... .++.++||||||+++|||++|+.||....... ...... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~---~~--- 222 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTL---QN--- 222 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHh---cC---
Confidence 8775432221 122445688999999998776 78999999999999999999999997532111 010000 00
Q ss_pred chhhhcccccCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGS--FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ +......+.+++.+|++.||++||++.+++++
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -----DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -----CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111111 12334567788889999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.36 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=194.8
Q ss_pred cCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
|...+.||+|+||.||+|... +++.||||++..... .....+.+.+|++++++++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLR 72 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 455678999999999999653 468899999843321 12235668899999999999999999998854
Q ss_pred Cc------cceEEEeecCCCChHHHhhcC-----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 604 LY------CNLLVYEYMPNGNLWDALHKG-----LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 604 ~~------~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
.. ..++++||+++|+|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||+++++
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~ 149 (273)
T cd05074 73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNEN 149 (273)
T ss_pred CCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCC
Confidence 32 236889999999998877432 1357889999999999999999999 899999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 751 (840)
+.+|++|||+++...... .........+++.|++||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 150 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~ 226 (273)
T cd05074 150 MTVCVADFGLSKKIYSGD-YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYN 226 (273)
T ss_pred CCEEECcccccccccCCc-ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHH
Confidence 999999999998653311 1111223345678999999988889999999999999999999 8888864311 11111
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+. .... ..... ......+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 ~~---~~~~-------~~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YL---IKGN-------RLKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HH---HcCC-------cCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0000 00011 12335678889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.03 Aligned_cols=255 Identities=26% Similarity=0.345 Sum_probs=194.1
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 600 (840)
.+.++|+..+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|+||++++++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----------DIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----------chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 3556788889999999999999955 468899999873221 1134577899999999 69999999998
Q ss_pred Ee-----cCccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 601 FS-----SLYCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 601 ~~-----~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
+. .....++||||+++++|.+++.. ....+++..+..++.|++.|+.|||+ .+++||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 73 34567999999999999998753 22467899999999999999999999 999999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 747 (840)
+.++|+|||+++..... ........|++.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 161 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-- 235 (286)
T cd06638 161 GGVKLVDFGVSAQLTST---RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-- 235 (286)
T ss_pred CCEEEccCCceeecccC---CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--
Confidence 99999999998765321 112234468999999998753 45788999999999999999999998653110
Q ss_pred chhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...... . ........ .+. .....+.+++.+|++.||++|||+.|++++.
T Consensus 236 --~~~~~~--~-~~~~~~~~---~~~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 --RALFKI--P-RNPPPTLH---QPE---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --HHHhhc--c-ccCCCccc---CCC---CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000 0 00000000 011 1123577788899999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.62 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=199.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
+.|...+.||+|+||.||+|..+ +.+.||+|.+.... .....+.+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---------DENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---------chHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 46778889999999999999754 34679999773322 1223567889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC--------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL--------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV 671 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 671 (840)
++.+....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~ 152 (275)
T cd05046 76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSS 152 (275)
T ss_pred EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeC
Confidence 9999899999999999999999997543 158999999999999999999999 89999999999999999
Q ss_pred CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 003199 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750 (840)
Q Consensus 672 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~ 750 (840)
++.++++|||++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||.+.. .....
T Consensus 153 ~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~ 228 (275)
T cd05046 153 QREVKVSLLSLSKDVYNS--EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEVL 228 (275)
T ss_pred CCcEEEcccccccccCcc--cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHHH
Confidence 999999999998654221 1122233456778999999988888999999999999999999 888986421 11111
Q ss_pred hhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
... .... ....... .....+.+++.+|++.+|++||++.|+++.|.+
T Consensus 229 ~~~---~~~~------~~~~~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 229 NRL---QAGK------LELPVPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHH---HcCC------cCCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 110 0000 0000111 223467778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.07 Aligned_cols=349 Identities=30% Similarity=0.440 Sum_probs=309.6
Q ss_pred ccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc-ccCC
Q 003199 8 GTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH-GQIP 85 (840)
Q Consensus 8 ~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~ 85 (840)
+.+|+ ...+++++.|.|...++. .+|+.++.|.+|+.|.+++| .+.++- ..++.|+.|+.+++.+|++. .-+|
T Consensus 22 ~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN---~L~~vh-GELs~Lp~LRsv~~R~N~LKnsGiP 96 (1255)
T KOG0444|consen 22 DRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHN---QLISVH-GELSDLPRLRSVIVRDNNLKNSGIP 96 (1255)
T ss_pred CcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhh---hhHhhh-hhhccchhhHHHhhhccccccCCCC
Confidence 56665 778999999999999999 99999999999999999999 555554 34888999999999999996 3467
Q ss_pred ccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcc-cCCCCCCCeeeccCCcccccCCccccCC
Q 003199 86 ASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEE-LGNLTELTDLDMSVNHLSGKIPESILRL 164 (840)
Q Consensus 86 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~l 164 (840)
..+-.|..|+.|||++|+++ ..|..+..-+++-.|+||+|+ ...+|.. |-+|+.|-.||||+|++. .+|..+.++
T Consensus 97 ~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~--IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL 172 (1255)
T KOG0444|consen 97 TDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN--IETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRL 172 (1255)
T ss_pred chhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc--cccCCchHHHhhHhHhhhccccchhh-hcCHHHHHH
Confidence 77888999999999999999 899999999999999999998 6677764 678999999999999999 677789999
Q ss_pred CCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCc-ccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhh
Q 003199 165 PKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT-GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243 (840)
Q Consensus 165 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 243 (840)
..|++|.|++|.+.......+..+++|+.|.+++.+-+ .-+|.++..+.+|..+|||.|.+.
T Consensus 173 ~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp----------------- 235 (1255)
T KOG0444|consen 173 SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP----------------- 235 (1255)
T ss_pred hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-----------------
Confidence 99999999999987655556667888999999987654 457888999999999999999987
Q ss_pred cccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeee
Q 003199 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISG 323 (840)
Q Consensus 244 l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 323 (840)
.+|+.+.++++|+.|+||+|+|+ .+........+|++|+||.|+++ ..|.++..++.|+.|++.+|+++-
T Consensus 236 --------~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 236 --------IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred --------cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 77888889999999999999998 66667777889999999999998 788899999999999999999873
Q ss_pred -ccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccc
Q 003199 324 -FIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 324 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 394 (840)
-+|..++++..|+.+..++|.+. ..|+.++.+..|+.|.|++|++- ++|+++.-++.|+.|||..|+=-
T Consensus 306 eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 306 EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 57999999999999999999998 89999999999999999999997 89999999999999999999754
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.25 Aligned_cols=266 Identities=23% Similarity=0.282 Sum_probs=198.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... ......+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 56788889999999999999765 6899999998543321 12234567899999999999999999998776
Q ss_pred --ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 605 --YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 605 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
...++||||++ ++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 77 NLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred CCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCc
Confidence 88899999997 59999887765568999999999999999999999 8999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-----------hh
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN-----------II 750 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------~~ 750 (840)
+...... ........+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||......... ..
T Consensus 153 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 153 AREYGSP---LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred eeeccCC---ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 8766432 1222345578899999988654 4689999999999999999999999753211000 00
Q ss_pred hhhhhhhccc---cchhhhcccccCCCcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 751 YWVSIKVDTK---EGIMEVLDKKLSGSFRD--EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 751 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.|........ ..........+...+.. ....+.+++.+|++.+|++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0100000000 00000001111111222 24557788889999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.15 Aligned_cols=261 Identities=28% Similarity=0.365 Sum_probs=198.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+++++.++||||+++++++....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc--------chhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 5777889999999999999765 6899999987443211 123456788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||++++++..+..... .++|..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||++..
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred eEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 9999999999999988776543 58999999999999999999999 8999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh---cccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV---DTKE 761 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~ 761 (840)
.... ........++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+..... ....
T Consensus 150 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~ 222 (286)
T cd07846 150 LAAP---GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIP 222 (286)
T ss_pred ccCC---ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCch
Confidence 5332 122234567889999998865 4578899999999999999999999864321 111100000 0000
Q ss_pred chhhh----------cccccC------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEV----------LDKKLS------GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~----------~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ..+... .........+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 000000 0011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.47 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=196.3
Q ss_pred cCccCeeeccCCcEEEEEEeCC-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|.+...||.|+||+||+|..++ +-..|.|++-. ......+++.-||++++.+.||+||++++.|.-...
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----------kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----------KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----------cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 3445579999999999996653 44556677622 224456788899999999999999999999988999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++..|||.||.+...+-.-+..+.+.++..++++++.||.|||+ ..|+|||||+.|||++-+|.++++|||.+...
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccc
Confidence 999999999999988877766789999999999999999999999 99999999999999999999999999987543
Q ss_pred hccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
. ........+.|||.|||||+.. ..+|++++||||||+.|.||..+.+|-.... +.-+-.++...+
T Consensus 181 ~---~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKSe 251 (1187)
T KOG0579|consen 181 K---STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSE 251 (1187)
T ss_pred h---hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhcC
Confidence 2 1233456789999999999863 4689999999999999999999999965421 001111111000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+.+ -........+.++..+|+.+||..||+++++++|
T Consensus 252 ------PPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 ------PPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ------CCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111 0123344556677779999999999999999876
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=280.86 Aligned_cols=263 Identities=25% Similarity=0.317 Sum_probs=204.6
Q ss_pred hhHHHHHHhcCcc-CeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcc
Q 003199 519 FDQREILEAMTEK-NKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIV 595 (840)
Q Consensus 519 ~~~~~~~~~~~~~-~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 595 (840)
+.+..++++|... ++||-|-.|.|..+ ...+|+.+|+|++... ....+|++.--.. .|||||
T Consensus 54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------------~KARrEVeLHw~~s~h~~iV 118 (400)
T KOG0604|consen 54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------------PKARREVELHWMASGHPHIV 118 (400)
T ss_pred hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------------HHHHhHhhhhhhhcCCCceE
Confidence 4455677787764 57999999999997 5568999999988432 2345677765444 699999
Q ss_pred eeeeEEec----CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 596 KLYCYFSS----LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 596 ~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
++++.|.. ..+.++|||.|+||.|++.++..+ ..+++.++.+|+.||+.|+.|||+ ..|.||||||+|+|+.
T Consensus 119 ~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt 195 (400)
T KOG0604|consen 119 SIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYT 195 (400)
T ss_pred EeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeee
Confidence 99988744 567789999999999999998764 469999999999999999999999 9999999999999997
Q ss_pred C---CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003199 671 V---NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 671 ~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 747 (840)
. +..+|++|||+|+.... .......+.||.|.|||++...+|+...|+||+||++|-|++|.+||....+.
T Consensus 196 ~t~~na~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-- 269 (400)
T KOG0604|consen 196 TTSPNAPLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-- 269 (400)
T ss_pred cCCCCcceEecccccccccCC----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--
Confidence 4 45689999999987532 23445667899999999999999999999999999999999999999764331
Q ss_pred chhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.+..-++.++. .+..++ ..+++.....+..+++..++..+|++|.|+.+++++=+-..
T Consensus 270 aispgMk~rI~--~gqy~F----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 270 AISPGMKRRIR--TGQYEF----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cCChhHHhHhh--ccCccC----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 11111111111 111111 23455666677788888999999999999999998865433
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.27 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=184.0
Q ss_pred eeeccCCcEEEEEEeCCCc---EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 533 KVGQGGSGTVYKIDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.||+|+||.||+|...++. .+++|.+.... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEE
Confidence 5999999999999654443 45566552221 12335678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCC---CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 610 VYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
||||+++|+|.+++.+.. ...++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~ 149 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSR 149 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEeccccccccc
Confidence 999999999999997642 245677788999999999999999 89999999999999999999999999998543
Q ss_pred hccCCCCcceecccccccccCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhc
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYS-------SKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
... ..........++..|+|||++.. ..++.++||||||+++|||++ |..||.... ... ..... .
T Consensus 150 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~--~~~~~-~- 222 (268)
T cd05086 150 YKE-DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DRE--VLNHV-I- 222 (268)
T ss_pred Ccc-hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHH--HHHHH-H-
Confidence 211 11112234567889999998743 245789999999999999997 567875421 111 01110 0
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
........++.+...+. ..+.+++..|| .+|++||++++|++.|.
T Consensus 223 -~~~~~~~~~~~~~~~~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 -KDQQVKLFKPQLELPYS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -hhcccccCCCccCCCCc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 01111122222332333 34555677899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.79 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=195.6
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|.....||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.+.|||++++++++...+.
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----------cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 34455799999999999955 478999999984322 1123557889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||+++++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEEecCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 99999999999999987653 58999999999999999999999 99999999999999999999999999998765
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....... ....
T Consensus 168 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~----~~~~----- 233 (297)
T cd06659 168 SKD---VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRL----RDSP----- 233 (297)
T ss_pred ccc---cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----hccC-----
Confidence 331 1222345688999999999888899999999999999999999999964211 0000000 0000
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... .........+.+++.+|++.+|++||++++++++-
T Consensus 234 -~~~~-~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 234 -PPKL-KNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred -CCCc-cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 0000 00111234566788899999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.68 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=202.0
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +++.||+|++..... ....+.+.+|+++++++.||||+++++++....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---------EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC---------hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 4566778999999999999665 689999998844321 134567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||+++++|.+++......+++..+..++.|++.|++|+|+. .+++|+||||+||++++++.++|+|||.+..
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 99999999999999999987645789999999999999999999983 6899999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
..... .....++..|+|||++.+..++.++||||||+++|+|++|+.||..............+.
T Consensus 151 ~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 215 (265)
T cd06605 151 LVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY---------- 215 (265)
T ss_pred hHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH----------
Confidence 64311 111668889999999998899999999999999999999999997542211211111111
Q ss_pred hcccccCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRD-EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............ ....+.+++.+|+..||++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111111111 34567788889999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.73 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=198.5
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+.||+|++|.||+|.. .+|+.||||.+....... ........+..|++++++++|+||+++++++.+...
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE-----AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc-----ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 56678899999999999965 478999999985443221 112234567789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+ +|+|.+++......+++..+..++.|+++||+|||+ ++++|+||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 99999999 999999998765468999999999999999999999 99999999999999999999999999999766
Q ss_pred hccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh-hcccc---
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK-VDTKE--- 761 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~--- 761 (840)
... ........+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+.... .......... .....
T Consensus 153 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 153 GSP---NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWP 228 (298)
T ss_pred cCC---CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhh
Confidence 432 112233456788999998855 45789999999999999999998887653211 0000000000 00000
Q ss_pred ---chhhhcccc------cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 ---GIMEVLDKK------LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ---~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... ...........+.+++.+|++.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 000112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=303.31 Aligned_cols=252 Identities=29% Similarity=0.378 Sum_probs=196.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|...+.||+|+||.||+|... +|+.||+|++...... .....+.+.+|+++++.++|||++++++++.+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-------SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-------cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 355778889999999999999654 6899999988433211 12334678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++|+||+. |++.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcc
Confidence 999999999996 67777776544568999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
..... .....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ...... ....
T Consensus 163 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--~~~~~~----~~~~ 229 (307)
T cd06607 163 SLVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH----IAQN 229 (307)
T ss_pred eecCC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--HHHHHH----HhcC
Confidence 65422 12346788999999874 45688999999999999999999999864311 000000 0000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. .... ........+.+++.+||+.+|++||++.+++.+..
T Consensus 230 ~------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 230 D------SPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred C------CCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0 0000 01123446778888999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=314.87 Aligned_cols=378 Identities=28% Similarity=0.413 Sum_probs=311.1
Q ss_pred ccccccccCCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc
Q 003199 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 2 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~ 81 (840)
++|.+....+++..+.+|+.|+++.|.+. ++|+.++.+-.|+.|+..+| .+.++|++ +.++.+|..|++.+|.++
T Consensus 99 s~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N---~i~slp~~-~~~~~~l~~l~~~~n~l~ 173 (565)
T KOG0472|consen 99 SHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNN---QISSLPED-MVNLSKLSKLDLEGNKLK 173 (565)
T ss_pred ccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccc---ccccCchH-HHHHHHHHHhhccccchh
Confidence 45556655666888899999999999998 88888999999999999999 67777765 778889999999999998
Q ss_pred ccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccc
Q 003199 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI 161 (840)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (840)
...|..+. ++.|++||+-.|.++ .+|+.++.+.+|..|+|..|+ ...+| .|.++..|.+|+++.|+|. .+|...
T Consensus 174 ~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nk--i~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~ 247 (565)
T KOG0472|consen 174 ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNK--IRFLP-EFPGCSLLKELHVGENQIE-MLPAEH 247 (565)
T ss_pred hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcc--cccCC-CCCccHHHHHHHhcccHHH-hhHHHH
Confidence 55444444 999999999999998 889999999999999999998 55677 7899999999999999999 666555
Q ss_pred c-CCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccC-----------
Q 003199 162 L-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPL----------- 229 (840)
Q Consensus 162 ~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~----------- 229 (840)
. .+++|.+|||+.|+++ ..|+.++-+.+|+.||+++|.|+ .+|..++++ +|+.|-+.+|.+..+-
T Consensus 248 ~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~v 324 (565)
T KOG0472|consen 248 LKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEV 324 (565)
T ss_pred hcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHH
Confidence 4 7999999999999998 67888899999999999999999 678899999 9999999999875310
Q ss_pred --------------------------Cc-cc---cCCCCchhh--------------------------hcccccccccC
Q 003199 230 --------------------------PA-KV---CSRGKLQYF--------------------------LVLQNMFSGVL 253 (840)
Q Consensus 230 --------------------------~~-~~---~~l~~L~~L--------------------------~l~~n~~~~~~ 253 (840)
+. .| ...-+.+.| +++.|++. .+
T Consensus 325 LKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-el 403 (565)
T KOG0472|consen 325 LKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-EL 403 (565)
T ss_pred HHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hh
Confidence 00 00 011223333 34444444 34
Q ss_pred CcccccccCC-ceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhccc
Q 003199 254 PDSLARCKNL-LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRA 332 (840)
Q Consensus 254 ~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 332 (840)
|..+..++.+ +.+.+++|.+. .+|..+..+++|..|+|++|-+. .+|..++.+..|+.|+++.|++. .+|..+..+
T Consensus 404 Pk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~l 480 (565)
T KOG0472|consen 404 PKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYEL 480 (565)
T ss_pred hhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhH
Confidence 4444444443 45677777776 88999999999999999999998 46777888888999999999998 889999999
Q ss_pred CcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCch
Q 003199 333 ISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES 400 (840)
Q Consensus 333 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 400 (840)
..++.+-.++|++....|..+.+|++|..|||.+|.|. .+|..+++|++|++|+|+||+|. .|..
T Consensus 481 q~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~ 545 (565)
T KOG0472|consen 481 QTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH 545 (565)
T ss_pred HHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence 99999999999999777778999999999999999998 78889999999999999999998 4544
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.53 Aligned_cols=247 Identities=29% Similarity=0.402 Sum_probs=199.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +++.||+|++..... ......+.+.+|+++++++.||||+++++++.+..
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 5777889999999999999654 689999998843221 11233567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 9999999999999999998764 68999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
.... .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ....+... ...
T Consensus 151 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~~~------ 213 (290)
T cd05580 151 VKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----PIQIYEKI-LEG------ 213 (290)
T ss_pred cCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH-hcC------
Confidence 5331 234568899999999988888999999999999999999999996532 00001000 000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
...++... ...+.+++.+|+..||.+|| +++|++++
T Consensus 214 --~~~~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 --KVRFPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --CccCCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 01112222 34566788899999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=327.26 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=195.6
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
-..+|++.+.||+|+||.||+++.+ ||+.+|||++.... ..+....+.+|++.++++.|||||+++..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---------s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---------SDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---------HHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 5567888899999999999999776 89999999985443 2345677899999999999999999974320
Q ss_pred cC------------------------------------------------------------------------------
Q 003199 603 SL------------------------------------------------------------------------------ 604 (840)
Q Consensus 603 ~~------------------------------------------------------------------------------ 604 (840)
+.
T Consensus 548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg 627 (1351)
T KOG1035|consen 548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG 627 (1351)
T ss_pred ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence 00
Q ss_pred -----------------------------------------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHH
Q 003199 605 -----------------------------------------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643 (840)
Q Consensus 605 -----------------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~ 643 (840)
...||-||||+...+.+.++.+...-.-...+.++++|+
T Consensus 628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREIL 707 (1351)
T ss_pred cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHH
Confidence 123678999999888888887643224678899999999
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhh------c---------cCCCCcceecccccccccCc
Q 003199 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ------A---------RGGKDSTTTVIAGTYGYLAP 708 (840)
Q Consensus 644 ~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~------~---------~~~~~~~~~~~~gt~~y~aP 708 (840)
+||.|+|+ +|||||||||.||++|++..|||+|||+|+... + .+..+...+..+||.-|+||
T Consensus 708 EGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 99999999 999999999999999999999999999998832 0 11222345678899999999
Q ss_pred cccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCC---cHHHHHHH
Q 003199 709 EYAYSSK---ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGS---FRDEMIQV 782 (840)
Q Consensus 709 E~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 782 (840)
|.+.+.. |+.|+|+||+|||++||+. ||... +.....+..+-+..++.. +.+....-
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--------------MERa~iL~~LR~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--------------MERASILTNLRKGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCch--------------HHHHHHHHhcccCCCCCCcccccccchHH
Confidence 9987654 9999999999999999995 56431 111111222223333332 34455556
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 003199 783 LRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 783 ~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+++.++++.||.+||||.|+++.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhc
Confidence 778889999999999999999863
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.17 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=200.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||.|+||.||+|... +++.||+|.+..... ......+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-------VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-------cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC
Confidence 3677889999999999999665 689999999853321 11234578899999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||.+..
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 999999999999999999876 378999999999999999999999 8999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
.... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+.......
T Consensus 150 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~------ 216 (258)
T cd05578 150 VTPD----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET------ 216 (258)
T ss_pred cCCC----ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc------
Confidence 5331 1233456888999999998888999999999999999999999999754221 11111100000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM--NEVVQ 805 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~evl~ 805 (840)
.....+ ......+.+++.+||+.||.+||++ +|+++
T Consensus 217 -~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 -ADVLYP---ATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -ccccCc---ccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 001111 1223567788889999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.82 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=197.6
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||.||+|..+ +|..||+|.+...... ....+.+.+|+++++.++|+|++++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP--------VKEKEASKKEVILLAKMKHPNIVTFFASFQENG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc--------chhhHHHHHHHHHHHhCCCCChhhhhheeccCC
Confidence 3667789999999999999665 6889999988443211 122456788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-Ceeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-PKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfg~a 683 (840)
..++|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++. ++++|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 9999999999999999987643 357999999999999999999999 89999999999999998864 699999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ........|++.|+|||+..+..++.++||||||+++|||++|+.||.... ...+...
T Consensus 150 ~~~~~~---~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~-------- 213 (257)
T cd08225 150 RQLNDS---MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLK-------- 213 (257)
T ss_pred hhccCC---cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH--------
Confidence 766431 112233468899999999988889999999999999999999999986421 1111111
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
................+.+++.+|+..+|++|||+.|++++
T Consensus 214 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 214 --ICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --HhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111111223457778889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=311.60 Aligned_cols=264 Identities=28% Similarity=0.374 Sum_probs=200.6
Q ss_pred CccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC---
Q 003199 529 TEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL--- 604 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 604 (840)
...+.||+|+||.||+|+ ..+|+.||||.+.... .....+...+|++++++++|+|||++++.-++.
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc---------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 345679999999999997 5689999999986543 233456788999999999999999998875443
Q ss_pred ---ccceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCC--C
Q 003199 605 ---YCNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD--VNYQ--P 675 (840)
Q Consensus 605 ---~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~--~ 675 (840)
....+|||||.+|||+..+.+.. ..+++.+.+.+..+++.||.|||+ ++||||||||.||++- ++|+ .
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEE
Confidence 35589999999999999998753 679999999999999999999999 9999999999999984 3343 6
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-chhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK-NIIYWV 753 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~ 753 (840)
||+|||.|+.+.+ +......+||+.|.+||.... +.|+..+|.|||||++||++||..||.-..+... ....|.
T Consensus 164 KLtDfG~Arel~d----~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 164 KLTDFGAARELDD----NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred eeecccccccCCC----CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 9999999998743 447788999999999999884 7899999999999999999999999975433322 223344
Q ss_pred hhhhccccchhhhcccccCC-------------CcHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHhhh
Q 003199 754 SIKVDTKEGIMEVLDKKLSG-------------SFRDEMIQVLRIAIRCTSKSPATRP--TMNEVVQLLAE 809 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~l~~~cl~~dP~~Rp--s~~evl~~L~~ 809 (840)
....+.. .+........++ ........+.+....++..+|++|. ...+....+.+
T Consensus 240 ~~tkkp~-~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 240 IITKKPS-GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred hhccCCC-ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 3322221 122222222211 0123344556666678888999998 55555554443
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.49 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=194.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|.. .+|+.||+|++...... .....+.+|+.+++.++|+||+++.+++...
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---------GVPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---------CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 5678889999999999999955 47899999998543211 1123466899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+||+. +++.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 76 ETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 99999999995 78877776554467888999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-hhhhhhcc---
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY-WVSIKVDT--- 759 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~--- 759 (840)
..... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||+........+.. |.......
T Consensus 152 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 152 AKSIP---SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred ccCCC---CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 54321 1122334578899999988654 5788999999999999999999999753221111000 00000000
Q ss_pred -------ccchhhhcccccCCCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 -------KEGIMEVLDKKLSGSFR------DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 -------~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
................. .....+.+++.+|+..||++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000011110 113456788889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.36 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=194.9
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||.|++|.||+|... +|+.||||++...... ....+.+.+|++++++++||||+++++++.+...
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--------cccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 677889999999999999654 7899999988533211 1223568889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||+. ++|.+++... ...+++..+..++.|++.|++|||+ .+++||||+|+||++++++.+||+|||++..
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 999999995 6898888654 2468999999999999999999999 9999999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc--
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG-- 762 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 762 (840)
... .........++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ................
T Consensus 150 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 150 FGV---PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred ccc---CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhh
Confidence 532 112223345688999999886644 588999999999999999999999753211 1111000000000000
Q ss_pred --------hhhhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 --------IMEVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 --------~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............. ......+.+++.+|++.||++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000001111 1123456788999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.94 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=200.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +++.||+|.+..... ......+.+.+|+++++.++|+||+++++.+....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-------IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET 74 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-------chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence 5777889999999999999665 589999999854321 11234567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 999999999999999998764 2468999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCC--------------------------cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 003199 685 VLQARGGKD--------------------------STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738 (840)
Q Consensus 685 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 738 (840)
......... .......||..|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 543211100 011234688899999999988899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhhccccchhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 003199 739 VEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPT----MNEVVQL 806 (840)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~evl~~ 806 (840)
|...... ..+. ....... ..........+.+++.+|+..||++||+ +.|++++
T Consensus 232 f~~~~~~----~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 232 FKGSNRD----ETFS-----------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCchH----HHHH-----------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9753211 0111 1111111 0111114466778888999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=301.29 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=199.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++...
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----------QPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----------chHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 5778889999999999999954 478899999874221 12245688899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++|+||+++++|.+++.+. .+++.++..++.|++.|+.|||+ ++++||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999999999764 57899999999999999999999 999999999999999999999999999887
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........|++.|+|||.+....++.++||||||+++||+++|+.||........ .... ... .
T Consensus 164 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~---~~~-~---- 231 (293)
T cd06647 164 QITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI---ATN-G---- 231 (293)
T ss_pred ccccc---ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh---hcC-C----
Confidence 65432 1122334688899999999888899999999999999999999999975321110 0000 000 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... .........+.+++.+||..+|++||++.+++.+
T Consensus 232 ---~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 ---TPEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111233456678889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.33 Aligned_cols=261 Identities=29% Similarity=0.358 Sum_probs=198.2
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
+|...+.||.|++|.||+|.. .+++.||+|.+..... ......+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---------PDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 467788999999999999966 4689999998853221 13356788999999999999999999988653
Q ss_pred -ccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 -YCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 -~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
...++||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeec
Confidence 467999999999999887653 23457889999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|++...... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||.....................
T Consensus 150 g~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 150 GVSGELVNS-----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred ccccccccc-----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 998754321 112345788999999998889999999999999999999999999754221111111111111100
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. ........ .-......+.+++.+|++.+|++|||+.|++++-.
T Consensus 225 ~---~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 225 N---PELKDEPG-NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred c---hhhccCCC-CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 00000000 00123456778899999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=299.76 Aligned_cols=259 Identities=22% Similarity=0.256 Sum_probs=191.4
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecC-
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSL- 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 604 (840)
|+..+.||+|+||.||+|.. .+++.||+|++...... .. .....+|+.++.++. |+|++++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--------~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--------LE-QVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--------ch-hhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 45677899999999999965 47899999988543211 01 123346888898885 99999999999887
Q ss_pred -ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 -YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
+..++|+||++ |++.+.+......++|.++..++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccc
Confidence 88899999996 58888887655578999999999999999999999 99999999999999999 99999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-cccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DTKE 761 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~ 761 (840)
+..... .......++..|+|||+... ..++.++||||+||++|||++|+.||...... ....+..... ....
T Consensus 147 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~ 220 (282)
T cd07831 147 RGIYSK----PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDA 220 (282)
T ss_pred cccccC----CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCH
Confidence 765321 12223457889999997644 55788999999999999999999999753211 1111110000 0000
Q ss_pred ch---------hhh-----cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GI---------MEV-----LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~---------~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+ ... ....+..........+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 000 0000000011235678889999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.79 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=195.0
Q ss_pred HHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|. ..+|+.||||++.... .......+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---------HQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---------cchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 3578888999999999999995 4578999999884221 11234567789999999999999999988754
Q ss_pred C-----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 L-----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
. ...++|+||++ +++.+.+... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEC
Confidence 3 34689999996 5888877653 68999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|||++.................|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+... ...........
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~ 226 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVL 226 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHc
Confidence 99998765432222222234568899999998654 5689999999999999999999999965311 00000000000
Q ss_pred c--cccchhhhcc-----------cccCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 D--TKEGIMEVLD-----------KKLSGS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~--~~~~~~~~~~-----------~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ..+....... ...... ......++.+++.+|++.||++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000000 000000 11224567889999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=300.77 Aligned_cols=253 Identities=27% Similarity=0.373 Sum_probs=193.8
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
+.++|...+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----------DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----------cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 356788889999999999999965 578999999874321 1134567889999998 799999999998
Q ss_pred ecC-----ccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 602 SSL-----YCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 602 ~~~-----~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
... ...++||||+++++|.++++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence 653 357899999999999998863 23468999999999999999999999 9999999999999999999
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-----KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
.+||+|||++...... ........|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..
T Consensus 166 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~ 241 (291)
T cd06639 166 GVKLVDFGVSAQLTST---RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KT 241 (291)
T ss_pred CEEEeecccchhcccc---cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HH
Confidence 9999999998765431 1112334688899999987543 3688999999999999999999999753110 11
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+ .... .... .........+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~~---~~~~--------~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKI---PRNP--------PPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHH---hcCC--------CCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1000 0000 0000 0011223457788889999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=300.21 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=193.8
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
....|+..+.||.|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ .|+|++++++++
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----------DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----------HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 446778888999999999999965 568999999873321 1234577899999998 699999999998
Q ss_pred ec------CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 602 SS------LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 602 ~~------~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
.. ....++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+ .+++||||+|+||++++++.
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence 43 456799999999999999887642 357888899999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 749 (840)
++|+|||++...... ........|++.|+|||.+. ...++.++|||||||++|||++|+.||........ .
T Consensus 160 ~~l~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~ 235 (282)
T cd06636 160 VKLVDFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-L 235 (282)
T ss_pred EEEeeCcchhhhhcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-h
Confidence 999999998765321 11233456889999999875 34678899999999999999999999964311000 0
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ......... ........+.+++.+||+.||.+||++.|++++
T Consensus 236 ---~~--------~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 ---FL--------IPRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---hh--------HhhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 000000111 011233567788889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=296.69 Aligned_cols=284 Identities=24% Similarity=0.296 Sum_probs=220.0
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|..-++||+|+||.||-++.+ +|+.+|.|++.+++.+ ..+.......|-.++.+++.+.||.+--+|++.+
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-------kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-------KRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-------HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 4666789999999999998554 7999999988655433 2445566788999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++|+..|.||+|.=++... ...+++..+..++.+|+.||++||. .+||+||+||+|||+|+.|+++|+|.|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEE
Confidence 999999999999998877654 3579999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. ..+....+||.+|||||++.++.|+...|.||+||++|||+.|+.||..... -..|........
T Consensus 336 ei~~----g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke----Kvk~eEvdrr~~---- 403 (591)
T KOG0986|consen 336 EIPE----GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE----KVKREEVDRRTL---- 403 (591)
T ss_pred ecCC----CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh----hhhHHHHHHHHh----
Confidence 7743 2333445899999999999999999999999999999999999999975321 111111111111
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH--hhhcCCCCCCCC-----CCCCCccccCCccc
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL--LAEADPCRFESC-----KFPNKSNKESSNAT 832 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~--L~~~~~~~~~~~-----~~~~~~~~~~~~~~ 832 (840)
-.+.+++..+.++...+.+ ..+.+||.+|. .+++|.+| +.+++..+.+.- =.|.+..-+.+++-
T Consensus 404 -~~~~ey~~kFS~eakslc~---~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~ 479 (591)
T KOG0986|consen 404 -EDPEEYSDKFSEEAKSLCE---GLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVL 479 (591)
T ss_pred -cchhhcccccCHHHHHHHH---HHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhh
Confidence 1122344555566666555 78899999997 56678776 456665555442 23566666666665
Q ss_pred ccCC
Q 003199 833 KIKN 836 (840)
Q Consensus 833 ~~~~ 836 (840)
+|+.
T Consensus 480 DIeq 483 (591)
T KOG0986|consen 480 DIEQ 483 (591)
T ss_pred hhhh
Confidence 5543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=300.07 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=188.4
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHH-HhccCCCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET-LGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~ 604 (840)
+|+..+.||+|+||.||+|... +|+.||+|++...... .....+..|+.. ++...|||++++++++...
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---------QEQKRLLMDLDISMRSVDCPYTVTFYGALFRE 72 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---------HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence 5677889999999999999654 7999999988533211 112334455554 5667899999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
...++||||++ |+|.+++... ...+++..+..++.|++.||+|||+ + +++||||||+||+++.++.+||+||
T Consensus 73 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 73 GDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeec
Confidence 99999999996 6887776542 3468999999999999999999998 6 8999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+++.... ........|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||........... ..
T Consensus 149 g~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~- 220 (283)
T cd06617 149 GISGYLVD----SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---QV- 220 (283)
T ss_pred cccccccc----ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH---HH-
Confidence 99876532 112233568889999998754 4568899999999999999999999864211101000 00
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ......... ......+.+++.+|+..+|++||++.+++++
T Consensus 221 ~-------~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 V-------EEPSPQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred H-------hcCCCCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000011110 1123457788889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=298.76 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=195.9
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC---CCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR---HKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 603 (840)
|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+.++++++ |||++++++++.+
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 56678899999999999965 5789999998743221 122456778999999986 9999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++++|.+++... .+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++++|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 74 GPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence 99999999999999999998764 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
...... ........|+..|+|||.+.++ .++.++||||||+++|+|++|+.||...... .+...
T Consensus 149 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~------- 213 (277)
T cd06917 149 ALLNQN---SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML------- 213 (277)
T ss_pred eecCCC---ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-------
Confidence 776432 1223345688999999988654 4689999999999999999999999753211 00000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+.+... ....++.+++.+|++.||++||++.|++++
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 IPKSKPPRLEDN--GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cccCCCCCCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000001111111 134567788889999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.80 Aligned_cols=264 Identities=28% Similarity=0.341 Sum_probs=198.7
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +++.||||++..... .....+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 5777889999999999999665 688999998854321 1233467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||++++.+....... ..+++..+..++.+++.|++|||+ .+++||||+|+||++++++.+||+|||.+..
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 74 RLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 999999999987776655543 368999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-------
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV------- 757 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 757 (840)
..... ........++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..........
T Consensus 150 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 150 LRARP--ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSH 225 (288)
T ss_pred cCCCc--cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 64321 1133345678899999999887 7899999999999999999999999753211 0000000000
Q ss_pred ------ccccchhhhccccc----CCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 ------DTKEGIMEVLDKKL----SGSFR-DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ------~~~~~~~~~~~~~~----~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..........+... ...+. ....++.+++.+||..+|++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000000000 00011 124667889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.17 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=196.9
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|...+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|+.+++.+.|+|++++++++...+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC
Confidence 344567899999999999964 578999999873221 122456789999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||+++++|.+++... .+++..+..++.|++.|++|||+ ++++||||+|+||+++.++.++++|||.+..
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred eEEEEEeccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 999999999999999998873 68999999999999999999999 9999999999999999999999999998875
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... .........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .........
T Consensus 165 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~------- 229 (285)
T cd06648 165 VSK---EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRD------- 229 (285)
T ss_pred hcc---CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHh-------
Confidence 532 11122345688999999999888899999999999999999999999864211 111110000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... ........+.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 NLPPKLK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCCCCc-ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0000111 011123467788889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.30 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=196.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||.||++... +++.||+|.+.... .......+.+.+|+++++.++||||+++++.+....
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-------LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR 74 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence 4677889999999999999654 67899999874332 111233467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++++|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 9999999999999999997654 68999999999999999999999 9999999999999999999999999999864
Q ss_pred hhccCC------------CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 686 LQARGG------------KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 686 ~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
...... .........++..|+|||++.+..++.++|+||||+++|||++|+.||.+... ..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~ 225 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELF 225 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 211000 00011224578899999999888899999999999999999999999964311 0111
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
....... ....... ......+.+++.+|++.||++||++.++.+.++.
T Consensus 226 ~~~~~~~-----~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDD-----IEWPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhcc-----cCCCCcc---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000000 0000001 1233456788889999999999996555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.27 Aligned_cols=254 Identities=28% Similarity=0.382 Sum_probs=200.9
Q ss_pred hcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++.....||.|.||.||-| ...+|+..|||-++..... .+..+.+.+|+.++..++|||+|+.+|.-...+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--------cccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 3445678999999999997 6678999999987554432 344567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..+|.||||++|+|.+.++.+. ..++.....+-.|++.|++|||+ +|||||||||.||+++.+|.+|.+|||.|..
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999999998764 56777778889999999999999 9999999999999999999999999999988
Q ss_pred hhccC-CCCcceecccccccccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 686 LQARG-GKDSTTTVIAGTYGYLAPEYAYSS---KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 686 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+...- .-........||+.|||||++.+. ....++||||+|||+.||+||+.||...... |..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aI------- 1450 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAI------- 1450 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHH-------
Confidence 75531 111223457899999999999764 3567899999999999999999999753211 111
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+.++.....++.......+-.+++.+|++.||++|.++.|++++
T Consensus 1451 -My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 -MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11222222233232233344455669999999999999988765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=300.62 Aligned_cols=253 Identities=28% Similarity=0.320 Sum_probs=190.9
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 604 (840)
+|...+.||+|+||.||++.. .+|+.||+|.+..... ......+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 445567899999999999855 4689999998853221 133456888999999996 99999999999998
Q ss_pred ccceEEEeecCCCChHHH---hhc-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 YCNLLVYEYMPNGNLWDA---LHK-GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~---l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
...+++|||+. +++.+. +.. ....+++..+..++.+++.||+|||+. .+++||||||+||++++++.++|+||
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeec
Confidence 89999999985 455443 222 224689999999999999999999972 48999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS---KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|+++..... .......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ....... ..
T Consensus 153 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~-~~ 223 (288)
T cd06616 153 GISGQLVDS----IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLT-QV 223 (288)
T ss_pred chhHHhccC----CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHh-hh
Confidence 999776431 122334688899999998766 68999999999999999999999996531 0000000 00
Q ss_pred ccccchhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 DTKEGIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ..+.+.. ........+.+++.+|++.+|++|||+.+++++
T Consensus 224 ~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VKG------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCC------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011111 112244567788889999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.37 Aligned_cols=255 Identities=31% Similarity=0.420 Sum_probs=202.6
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
..+.|+..+.||+|++|.||+|... +++.||+|++..... ..+.+.+|+++++.++|+|++++++++.
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 85 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----------NKELIINEILIMKDCKHPNIVDYYDSYL 85 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----------hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence 3455677788999999999999665 789999999843221 3466888999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
.....++|+||+++++|.+++......+++..+..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccch
Confidence 9999999999999999999998765478999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+...... ........++..|+|||++.+..++.++||||||+++|+|++|+.||...... ........ ..
T Consensus 163 ~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~~~~--~~- 232 (286)
T cd06614 163 AAQLTKE---KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFLITT--KG- 232 (286)
T ss_pred hhhhccc---hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh--cC-
Confidence 8765331 11223445788999999998888999999999999999999999998643111 00000000 00
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. ... .........+.+++.+|++.+|.+||++.+++++-.
T Consensus 233 ~-----~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 233 I-----PPL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred C-----CCC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 0 000 011113356777888999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=281.00 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=201.9
Q ss_pred HHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
..++|...++||+|.||+|..++ ..+|+.+|+|++++...-. ......-..|-++++..+||.+..+--.|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-------kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-------KDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-------hHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34667788899999999999984 5589999999986554221 122344567889999999999999988899
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..+..++||||..||.|+-++.+.. .+++...+.+...|+.||.|||+ ++||.||+|.+|.|+|.+|++||+|||+
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeeccc
Confidence 9999999999999999999888754 78999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++.-- ........++|||.|.|||++....|+.+.|.|.+||++|||++|+.||..... ..+..
T Consensus 315 CKE~I---~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFe----------- 378 (516)
T KOG0690|consen 315 CKEEI---KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFE----------- 378 (516)
T ss_pred chhcc---cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHH-----------
Confidence 87532 234456789999999999999999999999999999999999999999975311 11110
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
..-..+-+.+....++... |....+.+||.+|. .++||.++
T Consensus 379 LIl~ed~kFPr~ls~eAkt---LLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 379 LILMEDLKFPRTLSPEAKT---LLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHhhhccCCccCCHHHHH---HHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1112233344444444444 45588899999996 56666654
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.01 Aligned_cols=254 Identities=29% Similarity=0.355 Sum_probs=197.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|.. .+|..||+|++..... ........+..|+++++.++|+|++++++++.+.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-------QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-------CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3466778899999999999965 4689999998743221 1123346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+. |++.+.+......++|.++..++.+++.|+.|||+ .+++||||+|+||+++.++.++|+|||++.
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCcc
Confidence 99999999996 58888776555578999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.... .....|++.|+|||++. .+.++.++|||||||++|||++|+.||.... ...........
T Consensus 174 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~~~~--- 239 (317)
T cd06635 174 IASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQN--- 239 (317)
T ss_pred ccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhc---
Confidence 5422 22346888999999874 4568999999999999999999999986431 00000000000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.............+.+++.+|++.+|.+||++.+++++.....
T Consensus 240 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -------ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000011123345677888999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=300.74 Aligned_cols=263 Identities=27% Similarity=0.341 Sum_probs=194.7
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||.|++|.||+|.. .+|..||+|++...... ......+.+|+++++.++|+|++++++++.+...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--------EGVPSTAIREISLLKELNHPNIVRLLDVVHSENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--------ccchhHHHHHHHHHHhcCCCCccCHhheeccCCe
Confidence 45678899999999999965 47999999988543211 1223457789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
.++||||++ ++|.+++.... ..+++..+..++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 999999994 68999887653 368999999999999999999999 8999999999999999999999999999875
Q ss_pred hhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc---
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE--- 761 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 761 (840)
.... ........++..|+|||++.+. .++.++||||||+++|||++|+.||...... .......+.......
T Consensus 149 ~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 149 FGVP---VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred cCCC---ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHh
Confidence 5321 1122233568899999987654 5788999999999999999999999753211 000000000000000
Q ss_pred -------chhhhccc----ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 -------GIMEVLDK----KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 -------~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ............+.+++.+|++.||++||+++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 0001111223567789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.23 Aligned_cols=252 Identities=28% Similarity=0.358 Sum_probs=195.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
..+|+..+.||+|++|.||+|..+ +++.|++|++.... ...+.+.+|+.+++++ .|+||+++++++.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----------DEEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----------hhHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 467888999999999999999664 67899999874322 1245688999999999 6999999999996
Q ss_pred cCc------cceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 603 SLY------CNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 603 ~~~------~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
... ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNA 150 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCC
Confidence 544 479999999999999988653 2468999999999999999999999 9999999999999999999
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
.++|+|||.+...... ........|+..|+|||++.. ..++.++||||||+++|||++|+.||...... .
T Consensus 151 ~~~l~d~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~- 225 (275)
T cd06608 151 EVKLVDFGVSAQLDST---LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-R- 225 (275)
T ss_pred eEEECCCccceecccc---hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-H-
Confidence 9999999998765321 122234568899999998753 34678999999999999999999999642110 0
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+.... ...... ........+.+++.+|+..||++|||+.+++++
T Consensus 226 --~~~~~~~~--------~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 --ALFKIPRN--------PPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --HHHHhhcc--------CCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00100000 000010 111234567788889999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.88 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+...|+..+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.++++++|+||+++++++
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--------NVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--------ChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 4567899999999999999999954 5799999998743221 122345567899999999999999999988
Q ss_pred ecC------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSL------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
... ...++||||+. ++|.+.+... +++..+..++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCE
Confidence 543 34689999995 5888887653 7899999999999999999999 899999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...|...
T Consensus 158 kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----~~~~~~~ 229 (353)
T cd07850 158 KILDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----IDQWNKI 229 (353)
T ss_pred EEccCccceeCCC----CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHH
Confidence 9999999976532 1122344678899999999999999999999999999999999999975321 0111110
Q ss_pred hhcc--------------------------ccchhhhcccccCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003199 756 KVDT--------------------------KEGIMEVLDKKLSGS-----FRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804 (840)
Q Consensus 756 ~~~~--------------------------~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 804 (840)
.... .....+.......+. .......+.+++.+|++.||++|||+.|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred HHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0000 000000000000000 112244577899999999999999999999
Q ss_pred HHh
Q 003199 805 QLL 807 (840)
Q Consensus 805 ~~L 807 (840)
++=
T Consensus 310 ~~~ 312 (353)
T cd07850 310 QHP 312 (353)
T ss_pred cCh
Confidence 873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=303.93 Aligned_cols=266 Identities=26% Similarity=0.321 Sum_probs=195.4
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|+.++++++|+|++++++++..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--------DGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--------CCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 35688889999999999999965 46999999998543211 1112345679999999999999999999865
Q ss_pred C--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 604 L--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 604 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
. +..++||||++ ++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 78 KHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred CCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccc
Confidence 4 46799999996 58888887655578999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc-
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT- 759 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 759 (840)
.+....... .......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||..... .............
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~ 228 (309)
T cd07845 154 LARTYGLPA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTP 228 (309)
T ss_pred eeeecCCcc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCC
Confidence 997764321 12223345788999998865 4578999999999999999999999975321 1100000000000
Q ss_pred -cc-----------chhhhccccc---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 760 -KE-----------GIMEVLDKKL---SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 760 -~~-----------~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. .......... ..........+.+++.+|++.||++|||+.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 0000000000 000111245567889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.63 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=195.8
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
.|...+.||+|+||.||+|.. .+|..||+|.+...... ....+....+.+|++++++++|+||+++++++.+.
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS-----QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc-----chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 577788999999999999954 56899999987432111 11233456789999999999999999999998664
Q ss_pred -ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 -YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++|+||+++++|.+++.... .+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 45789999999999999987654 57899999999999999999999 89999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+................++..|+|||.+.+..++.++|||||||++||+++|+.||..... .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~------ 223 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKIAT------ 223 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHHHc------
Confidence 7653211111122345688999999999888899999999999999999999999975311 100000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......++.. ....+.+++.+|++ +|..||++.+++.+
T Consensus 224 -~~~~~~~p~~---~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 -QPTKPMLPDG---VSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -CCCCCCCCcc---cCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0001112222 23456667779998 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.05 Aligned_cols=269 Identities=27% Similarity=0.358 Sum_probs=197.7
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
...+.|+..+.||+|+||.||+|..+ +|+.||||++...... ......+.+|++++++++|||++++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--------EGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--------cCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 34577888999999999999999765 6899999998543211 11234567899999999999999999998
Q ss_pred ecCc----------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 003199 602 SSLY----------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV 671 (840)
Q Consensus 602 ~~~~----------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 671 (840)
.+.. ..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+||++++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~ 151 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNN 151 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 7654 78999999975 7777777655578999999999999999999999 89999999999999999
Q ss_pred CCCCeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003199 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750 (840)
Q Consensus 672 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 750 (840)
++.+||+|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~ 228 (302)
T cd07864 152 KGQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLE 228 (302)
T ss_pred CCcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Confidence 99999999999976643211 22223356788999998764 4578999999999999999999999975321 11111
Q ss_pred hhhhhhhcc-ccchhhhc--------c------cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 751 YWVSIKVDT-KEGIMEVL--------D------KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 751 ~~~~~~~~~-~~~~~~~~--------~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+..... ......+. + ......+......+.+++.+|++.||++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110000000 00000000 0 00011111224567888999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.81 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=200.6
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+++++.++|+|++++++++.....
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 667789999999999999765 789999999854321 235678899999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++++||+++++|.+++......+++..+..++.+++.|++|||+ .+++||||+|+||++++++.++|+|||.+...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 999999999999999998765578999999999999999999999 99999999999999999999999999998766
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... . ..
T Consensus 149 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~--~--------~~ 212 (253)
T cd05122 149 SDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--MKALFKI--A--------TN 212 (253)
T ss_pred ccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHH--H--------hc
Confidence 43211 3445688999999999888899999999999999999999999875311 0000000 0 00
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... .......+.+++.+|++.||++|||+.|++++
T Consensus 213 ~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 213 GPPGLRN-PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCcCc-ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000100 01113567788889999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.28 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=185.8
Q ss_pred eeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHH---HhccCCCCcceeeeEEecCccce
Q 003199 533 KVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET---LGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
.||+|+||.||+|.. .+|+.||+|.+....... ......+.+|..+ +....|+|++.+++++...+..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-------KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-------chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEE
Confidence 489999999999965 468999999885433211 1111223334333 33447999999999999988999
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++++|||++.....
T Consensus 74 lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 9999999999999987654 68999999999999999999999 9999999999999999999999999999865432
Q ss_pred cCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 689 RGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 689 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
. ......|+..|+|||...+ ..++.++||||+||++|||++|+.||......... ...... ...
T Consensus 150 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~--------~~~ 214 (279)
T cd05633 150 K-----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT--------LTV 214 (279)
T ss_pred c-----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHh--------hcC
Confidence 1 1223468999999998864 56899999999999999999999999753221111 110000 001
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQLL 807 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 807 (840)
...+.+. ...++.+++.+|++.||++|| +++|++++-
T Consensus 215 ~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 215 NVELPDS---FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CcCCccc---cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 1112222 334566778899999999999 699998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.74 Aligned_cols=268 Identities=22% Similarity=0.325 Sum_probs=194.8
Q ss_pred cCccCeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
|...+.||+|++|.||+|... +++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-------YTGISQSACREIALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-------ccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence 667788999999999999664 4799999998653211 112234567899999999999999999999887
Q ss_pred --ccceEEEeecCCCChHHHhhcC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----CCC
Q 003199 605 --YCNLLVYEYMPNGNLWDALHKG----LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV----NYQ 674 (840)
Q Consensus 605 --~~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----~~~ 674 (840)
...++||||+++ ++.+.+... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.
T Consensus 75 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 75 ADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccce
Confidence 788999999964 676666432 1267889999999999999999999 99999999999999999 899
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch----
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI---- 749 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---- 749 (840)
+||+|||++.................+++.|+|||.+.+. .++.++||||||+++|||++|+.||..........
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 9999999998764432222233345678899999987664 57899999999999999999999997643322000
Q ss_pred ----hhhhh------------hhhccc-cch-hhhcccccC-CCcH-------HHHHHHHHHHHHccCCCCCCCCCHHHH
Q 003199 750 ----IYWVS------------IKVDTK-EGI-MEVLDKKLS-GSFR-------DEMIQVLRIAIRCTSKSPATRPTMNEV 803 (840)
Q Consensus 750 ----~~~~~------------~~~~~~-~~~-~~~~~~~~~-~~~~-------~~~~~l~~l~~~cl~~dP~~Rps~~ev 803 (840)
...+. ...... ... ......... .... ....++.+++.+|++.||++|||+.|+
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00000 000000 000 000000001 0111 223467889999999999999999999
Q ss_pred HHH
Q 003199 804 VQL 806 (840)
Q Consensus 804 l~~ 806 (840)
+++
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.92 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=195.5
Q ss_pred eeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||.|++|.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-------ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-------hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEe
Confidence 689999999999665 5899999998543211 12335678999999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCC
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 692 (840)
|+++++|.+++.+.. .+++..+..++.|++.||+|+|+ .+++|+||+|+||+++.++.++|+|||.++.....
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~--- 146 (262)
T cd05572 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--- 146 (262)
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---
Confidence 999999999998754 58999999999999999999999 99999999999999999999999999999876432
Q ss_pred CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccC
Q 003199 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS 772 (840)
Q Consensus 693 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 772 (840)
.......++..|+|||.+.+..++.++|+||+|+++|||++|..||.....+ ............. ....+
T Consensus 147 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~------~~~~~ 216 (262)
T cd05572 147 -QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILKGNG------KLEFP 216 (262)
T ss_pred -cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhccCC------CCCCC
Confidence 1223446888999999998888999999999999999999999999754221 1111111010000 00111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 773 GSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 773 ~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
.. ....+.+++.+||+.+|++||+ ++|++++
T Consensus 217 ~~---~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NY---IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cc---cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 11 1456788888999999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.79 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=192.4
Q ss_pred cCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc--c
Q 003199 531 KNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC--N 607 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~ 607 (840)
..+||+|+|-+||+| +-.+|-.||--.++... ........+.|..|+.+++.++||||++++.+|.+... .
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d------~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD------VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHH------hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 347999999999999 54568788754332211 11223446889999999999999999999999977655 6
Q ss_pred eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecccchhhh
Q 003199 608 LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGIAKVL 686 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~ 686 (840)
-+|+|.|..|+|+.|+.+.. ..+......|++||++||.|||+. .++|+|||||-+||+|+. .|.|||+|.|+|...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 78999999999999998875 678889999999999999999984 479999999999999975 689999999999987
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
.. .. .....|||.|||||+.. ..|++.+||||||+-++||+|+..||.. +.+....+ +.+
T Consensus 197 r~----s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIY----------KKV 256 (632)
T KOG0584|consen 197 RK----SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIY----------KKV 256 (632)
T ss_pred hc----cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHH----------HHH
Confidence 43 22 23378999999999765 7999999999999999999999999963 23222222 122
Q ss_pred cccccCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 767 LDKKLSGSFR-DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+..+..+. -...++.++|.+|+.. ..+|||+.|++++
T Consensus 257 ~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 257 TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2222222111 1124566677799999 9999999999876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.28 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=195.3
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||.|++|.||+|... +|+.||||++...... ...+.+.+|++++++++|+|++++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---------GTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 3677889999999999999765 6899999988543211 12345678999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++++|||++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999997 48888886543 458999999999999999999999 89999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh-hhcccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI-KVDTKE 761 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~ 761 (840)
...... ........++..|+|||++.+. .++.++||||||+++|||++|+.||.+..... ........ ......
T Consensus 148 ~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~ 223 (284)
T cd07836 148 RAFGIP---VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTES 223 (284)
T ss_pred hhhcCC---ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChh
Confidence 765321 1122334578899999987654 56889999999999999999999997542211 00000000 000000
Q ss_pred chhhh-----cccccCC--------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEV-----LDKKLSG--------SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~-----~~~~~~~--------~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ....... ........+.+++.+|++.||++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0000000 011223567788899999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=277.74 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=198.2
Q ss_pred CeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+|+.|--+ ...+|.++|||++-+.. ......+.+|++++.+++ |+||+++++||+++...||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC----------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 47999999999986 67789999999984432 233567889999999994 9999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---Ceeecccchhhh
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---PKVADFGIAKVL 686 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg~a~~~ 686 (840)
|||-|.||.|..++++.. .+++.++.++..+||.||.+||. +||.|||+||+|||..+... +||+||.++.-.
T Consensus 154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999999999999875 79999999999999999999999 99999999999999976554 799999987654
Q ss_pred hccCCCC----cceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 687 QARGGKD----STTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 687 ~~~~~~~----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
...+.-. ......+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.-+. ...|.+.+.
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~---dCGWdrGe~ 306 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA---DCGWDRGEV 306 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC---cCCccCCCc
Confidence 3322111 2224567899999999752 235889999999999999999999999875332 222322211
Q ss_pred c----------cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 D----------TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ..++..++-+ .++.....+..+++...+..|+..|.++.+++.+
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPd----kdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPD----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cHHHHHHHHHHHhccCCcCCh----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1 1111111111 2334455566677778888999999999999885
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=300.52 Aligned_cols=276 Identities=27% Similarity=0.357 Sum_probs=200.2
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 600 (840)
.+.++|+..+.||+|+||.||+|... +|+.||||++...... ......+.+|+.+++++ +|+||++++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--------ATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc--------chhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 45677888899999999999999654 6899999988432111 12234567899999999 99999999999
Q ss_pred EecC--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 601 FSSL--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 601 ~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+... ...++||||++ ++|.+++... .++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEe
Confidence 8653 35799999996 5999988765 68899999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCC--CcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--h----
Q 003199 679 DFGIAKVLQARGGK--DSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN--I---- 749 (840)
Q Consensus 679 Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~---- 749 (840)
|||++......... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999876432211 112234568899999998754 45789999999999999999999999653211000 0
Q ss_pred -----hhhhhhhhccccchhhhcccc----cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCC
Q 003199 750 -----IYWVSIKVDTKEGIMEVLDKK----LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADP 812 (840)
Q Consensus 750 -----~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~ 812 (840)
..+.................. ...........+.+++.+|++.||++|||+.+++++ +.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 000000000000000000000 000111134567889999999999999999999987 444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.70 Aligned_cols=272 Identities=21% Similarity=0.309 Sum_probs=196.2
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.+..+.|+..+.||+|+||.||+|... +++.||||.+...... ......+.+|++++++++||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 79 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--------EGFPITALREIKILQLLKHENVVNLIEI 79 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--------CCchhHHHHHHHHHHhCCCCCccceEEE
Confidence 345567889999999999999999654 6899999988543211 1122345679999999999999999999
Q ss_pred EecCcc--------ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 601 FSSLYC--------NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 601 ~~~~~~--------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
+..... .++||||+. +++.+.+......+++.++..++.|++.||+|||+ ++++|+||||+||+++.+
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 80 CRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKD 155 (310)
T ss_pred EecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCC
Confidence 866543 499999996 58888887665578999999999999999999999 899999999999999999
Q ss_pred CCCeeecccchhhhhccCCC-CcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003199 673 YQPKVADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 750 (840)
+.+||+|||++......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~ 234 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLT 234 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 99999999999876432211 1122344578899999987654 46889999999999999999999987532110 000
Q ss_pred hhhhhhhccccch------hhhcc-cccCCC----cHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 751 YWVSIKVDTKEGI------MEVLD-KKLSGS----FRD------EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 751 ~~~~~~~~~~~~~------~~~~~-~~~~~~----~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............. ....+ ...... ... ....+.+++.+|+..||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000000 00000 000000 000 12356689999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.30 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=191.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 604 (840)
+|+..+.||+|+||.||+|... +|+.||||.+...... ......+.+|+.+++.+. |+||+++++++...
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--------EGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--------cCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 5777889999999999999654 7899999987443211 112356778999999995 69999999998776
Q ss_pred cc-----ceEEEeecCCCChHHHhhcCC----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCC
Q 003199 605 YC-----NLLVYEYMPNGNLWDALHKGL----VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQ 674 (840)
Q Consensus 605 ~~-----~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~ 674 (840)
+. .++||||+++ ++.+++.... ..+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCe
Confidence 65 7999999975 8888876532 357999999999999999999999 99999999999999998 889
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
+||+|||.++.+... ........+++.|+|||++.+ ..++.++||||||+++|||++|..||....... ......
T Consensus 150 ~kl~dfg~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~ 225 (295)
T cd07837 150 LKIADLGLGRAFSIP---VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIF 225 (295)
T ss_pred EEEeecccceecCCC---ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH
Confidence 999999998765321 112223356888999998765 457899999999999999999999997532110 000000
Q ss_pred hhh-hccccchh---hh---------cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIK-VDTKEGIM---EV---------LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~-~~~~~~~~---~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ........ .. ...............+.+++.+|+..||.+||++.|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000000 00 0000000011234567788999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.94 Aligned_cols=263 Identities=27% Similarity=0.352 Sum_probs=197.0
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC--
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL-- 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 604 (840)
|+..+.||+|++|.||+|... +|+.||+|++..... .......+.+|++++++++|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE--------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc--------cccchHHHHHHHHHHHhccCCCeeeheeeEecCCC
Confidence 456788999999999999665 589999999854421 122245678899999999999999999999887
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+||++ ++|.+++......+++..+..++.|+++|++|||+ .+++|+||+|+||++++++.++|+|||.+.
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 73 GSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred CcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEcccccee
Confidence 78999999997 58988887764578999999999999999999999 899999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc--ccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD--TKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 761 (840)
...... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......... ...
T Consensus 149 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~ 224 (287)
T cd07840 149 PYTKRN--SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDE 224 (287)
T ss_pred eccCCC--cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchh
Confidence 764421 112233456788999997765 457899999999999999999999997532110 0000000000 000
Q ss_pred chhhh--------------cccccCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEV--------------LDKKLSGSFRD-EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~--------------~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ....+...+.. ....+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 00000011111 14578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=294.60 Aligned_cols=262 Identities=25% Similarity=0.275 Sum_probs=193.1
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc---CCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI---RHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 603 (840)
|+..+.||+|+||.||+|..+ +++.||+|++...... ......+.+|+.+++++ .|+|++++++++..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 72 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG 72 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEee
Confidence 456788999999999999776 5899999998543321 11123455677766655 59999999999988
Q ss_pred Ccc-----ceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 LYC-----NLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~~~-----~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.+. .+++|||+. ++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||
T Consensus 73 ~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 73 PRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred ccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEE
Confidence 776 899999996 58988887643 368999999999999999999999 89999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||.+...... .......++..|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+.....
T Consensus 149 ~dfg~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (287)
T cd07838 149 ADFGLARIYSFE----MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIG 223 (287)
T ss_pred eccCcceeccCC----cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcC
Confidence 999998765321 1222335788999999999888999999999999999999999998753211 11111110000
Q ss_pred c---cccc-----hhhhcccccCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 D---TKEG-----IMEVLDKKLSG----SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~---~~~~-----~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. .... ........... ...+....+.+++.+||+.||++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0000 00000111111 112334667789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.20 Aligned_cols=247 Identities=26% Similarity=0.310 Sum_probs=191.9
Q ss_pred eeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||+|+||+||+|.. .+|+.||+|.+...... .......+.+|+++++.++|||++++++++...+..++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-------KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-------hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEe
Confidence 68999999999854 47899999988543211 12234556789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 613 YMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
|+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||.+.....
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--- 147 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--- 147 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---
Confidence 999999999987653 368999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL 771 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 771 (840)
........++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ........ .....
T Consensus 148 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-----~~~~~ 217 (277)
T cd05577 148 -GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE----ELKRRTLE-----MAVEY 217 (277)
T ss_pred -CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH----HHHhcccc-----ccccC
Confidence 222234467889999999988889999999999999999999999996532111000 00000000 01111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 772 SGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 772 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
... ....+.+++.+|++.||++|| ++.+++.+
T Consensus 218 ~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDK---FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred Ccc---CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 122 244566788899999999999 77777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.40 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=202.6
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|++|.||+|... +++.||||++..... ....+.+.+|+.++.+++|+|++++++++....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 4677789999999999999665 599999998844321 133567899999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++... ..+++..+..++.|+++|++|||+. .+++||||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999999999875 3689999999999999999999974 6899999999999999999999999999876
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
.... ........++..|+|||...+..++.++||||||+++|||++|+.||...... . +.... ..
T Consensus 150 ~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~-------~~ 214 (264)
T cd06623 150 LENT---LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S---FFELM-------QA 214 (264)
T ss_pred cccC---CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---HHHHH-------HH
Confidence 6432 11222456788999999998888999999999999999999999999754220 1 11100 01
Q ss_pred hcccccCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRD-EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............ ....+.+++.+|+..+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 215 ICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111111112 34567788889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=289.89 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=201.0
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|++|.||++... +++.||+|++...... ....+.+.+|+++++.++|+|++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--------EKEREDALNEVKILKKLNHPNIIKYYESFEEKG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC--------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCC
Confidence 3667788999999999999654 6899999998443211 234566889999999999999999999999989
Q ss_pred cceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 606 CNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..++|+||+++++|.+++... ...+++..+..++.+++.|+.|||+ .+++|+||+|+||++++++.++|+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccc
Confidence 999999999999999999775 2578999999999999999999999 8999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... .......
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~------- 214 (258)
T cd08215 150 SKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALK------- 214 (258)
T ss_pred eeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHH-------
Confidence 97654321 22334568899999999988889999999999999999999999986431 1111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......+........+.+++.+|+..+|++||++.+++++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 215 ---ILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111111111233556778889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=293.97 Aligned_cols=268 Identities=20% Similarity=0.209 Sum_probs=184.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhh--HHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQ--LQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|...+.||+|+||+||+|...+ +..+|+|+....... ...+... .........+...+..+.|++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~-~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET-IVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc-hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 467888999999999999997654 345666653222111 0000000 001122334455667778999999998
Q ss_pred EEecCc----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 600 YFSSLY----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 600 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 775543 3367788763 46666665432 46788899999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCC----CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 003199 676 KVADFGIAKVLQARGGK----DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 751 (840)
+|+|||+|+.+...+.. ........||+.|+|||+..+..++.++|||||||++|||++|+.||....... ....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HHHH
Confidence 99999999876432111 112233569999999999999999999999999999999999999997642211 1111
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... + ....+...+. ........+.+++..|++.+|++||+++++++.+
T Consensus 245 ~~~~--~---~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKC--D---FIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHH--H---HHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 0 0011111111 0112235577788899999999999999999876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.57 Aligned_cols=269 Identities=25% Similarity=0.316 Sum_probs=194.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +++.||||++....... .....+.+|++++++++|+||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--------GFPITALREIKILKKLKHPNVVPLIDMAVE 78 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--------CcchhHHHHHHHHHhcCCCCccchhhheec
Confidence 467888999999999999999654 68999999885433211 112345689999999999999999988754
Q ss_pred Cc--------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 604 LY--------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 604 ~~--------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
.. ..++|+||+. +++...+......+++..+..++.|+++||+|||+ .+++||||||+||++++++.+
T Consensus 79 ~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 79 RPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred ccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence 33 4589999996 47777776655579999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCC--------CcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 003199 676 KVADFGIAKVLQARGGK--------DSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 746 (840)
+|+|||+++........ ........+++.|+|||.+.+. .++.++||||||+++|||++|++||.+.....
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999765432111 1122334678889999987654 57899999999999999999999997532110
Q ss_pred cchhhhhhh-hhccc------cchhh----hcccccCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 747 KNIIYWVSI-KVDTK------EGIME----VLDKKLSG----SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 747 ~~~~~~~~~-~~~~~------~~~~~----~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ..... ..... ........ .+......+.+++.+|++.||++|||+.|++.+
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 -QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred -HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 00000 00000 00001111 111223567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=289.91 Aligned_cols=248 Identities=27% Similarity=0.351 Sum_probs=199.8
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|++|.||++.. .+++.+|+|.+...... ......+.+|+++++.++|+||+++++++.+...
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--------QKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 66778999999999999854 47899999998433211 1234567789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 607 NLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.++|+||+++++|.+++... ...+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.+|++|||++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccch
Confidence 99999999999999998762 2468999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ......++..|+|||...+..++.++|+||+|+++|||++|+.||..... .....
T Consensus 151 ~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~------------ 211 (256)
T cd08530 151 KVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRY------------ 211 (256)
T ss_pred hhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH------------
Confidence 876432 22234578899999999988899999999999999999999999965311 00000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
................++.+++.+|++.+|++||++.+++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 212 -KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111112222344667889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.09 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=203.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..|...+.||+|.|++|..|.. .+|..||||.+.+.... ......+.+|+++|..+.|||||+++.+....
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln--------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN--------PSKRQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC--------hHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 3566778899999999999954 47999999988544322 22234488999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...|+||||+.+|.+++++.+... ..+..+..++.|+++|++|||+ +.|||||||++|||++.++.+||+|||++.
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccce
Confidence 999999999999999999998874 4448899999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.+. ........+|++.|.|||+..+..| .+.+|+||+|+++|-|+.|..||++..-. +--
T Consensus 204 ~~~----~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---------------~Lr 264 (596)
T KOG0586|consen 204 FFD----YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---------------ELR 264 (596)
T ss_pred eec----ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---------------ccc
Confidence 874 3445567899999999999988776 68999999999999999999999863100 000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
..++..+++ -......++-+++.+++-.+|.+|++++++.++-+
T Consensus 265 ~rvl~gk~r-Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 265 PRVLRGKYR-IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred chheeeeec-ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 111111111 11122345556777999999999999999998754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=321.83 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=202.1
Q ss_pred CccCeeeccCCcEEEEEEeC----C----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeee
Q 003199 529 TEKNKVGQGGSGTVYKIDLN----S----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYC 599 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 599 (840)
...+.+|+|+||.||+|... . ...||||+++.... ....+.+..|+++|+.+ .|+||+.++|
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---------~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---------SSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC---------cHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34458999999999998543 1 45799999854432 23467899999999999 5999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~ 664 (840)
+|......++|+||++.|+|.++++... ..+...+.+.++.|||.|++||++ .++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence 9999999999999999999999998765 348889999999999999999999 9999999999
Q ss_pred CCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 003199 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743 (840)
Q Consensus 665 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~ 743 (840)
+|||++++..+||+|||+|+.....+..........-...|||||.+....|+.++|||||||++|||+| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999865432211111111113456999999999999999999999999999999 999997521
Q ss_pred CCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
....+. ..+.+............++.+++..||+.+|++||++.++++.++..
T Consensus 527 -~~~~l~-------------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 -PTEELL-------------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -cHHHHH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 011111 11111222223333456777899999999999999999999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.75 Aligned_cols=269 Identities=22% Similarity=0.304 Sum_probs=198.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|+..+.||+|++|.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--------PTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc--------ccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 35788888999999999999954 47999999998543211 1224567789999999999999999988753
Q ss_pred ----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 604 ----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 604 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
....++||||+. |+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecc
Confidence 346789999995 68999887654 58999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCC-CcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 680 FGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 680 fg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
||++......... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.... ..........
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~ 228 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVL 228 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHh
Confidence 9999765432211 111234568899999998765 46899999999999999999999999753211 0000000000
Q ss_pred c----------cccchhhhc---ccccCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 758 D----------TKEGIMEVL---DKKLSGS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 758 ~----------~~~~~~~~~---~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. ......... ....... ......++.+++.+|++.+|++||++.+++.+-.
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0 000000000 0000001 1223467888999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.89 Aligned_cols=265 Identities=23% Similarity=0.308 Sum_probs=192.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|++|.||+|... +|+.||+|.+...... ....+.+.+|++++++++|+|++++++++.+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSE 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--------ccchHHHHHHHHHHHhccCCCEeeEEEEEecC
Confidence 45778889999999999999654 7899999987433211 12235678899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGI 682 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~ 682 (840)
...++||||++ +++.+++.... ..+++..+..++.||+.||+|||+ ++++||||+|+||+++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 74 KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEccccc
Confidence 99999999995 57888775532 346788889999999999999999 99999999999999985 55789999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh-hhccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI-KVDTK 760 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~ 760 (840)
+...... ........+++.|+|||++.+. .++.++||||+|+++|+|+||+.||....... ........ .....
T Consensus 150 ~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~ 225 (294)
T PLN00009 150 ARAFGIP---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNE 225 (294)
T ss_pred ccccCCC---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 9764321 1122334578899999988664 57899999999999999999999997532110 00000000 00000
Q ss_pred cc---------hhhhcccccCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EG---------IMEVLDKKLSGS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~---------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ............ .......+.+++.+|++.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000000000 11223456788889999999999999999975
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=289.01 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=188.2
Q ss_pred HHHhcCccCee--eccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeee
Q 003199 524 ILEAMTEKNKV--GQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYC 599 (840)
Q Consensus 524 ~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 599 (840)
..+.|...+.+ |+|+||.||++.. .++..+|+|.+...... . .|+.....+ +|+|++++++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------------~--~e~~~~~~~~~h~~iv~~~~ 76 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------------A--IEPMVHQLMKDNPNFIKLYY 76 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-------------h--hhHHHHHHhhcCCCEEEEEE
Confidence 34566666665 9999999999854 47889999987433211 0 012222112 6999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeee
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVA 678 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~ 678 (840)
++......++||||+++++|.+++.... .+++.++..++.|+++|++|||+ .+++||||||+||+++.++ .++|+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred EEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEe
Confidence 9999999999999999999999998765 78999999999999999999999 9999999999999999988 99999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++.... .....++..|+|||++.+..++.++||||+|+++|||++|+.||............+....
T Consensus 153 dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 223 (267)
T PHA03390 153 DYGLCKIIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-- 223 (267)
T ss_pred cCccceecCC-------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--
Confidence 9999875432 1234588999999999988899999999999999999999999975433221222221110
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-MNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~ 806 (840)
. ............+.+++.+|++.+|.+||+ +++++++
T Consensus 224 ---------~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 ---------Q-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------c-ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 000111234456777888999999999996 6998864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=291.83 Aligned_cols=245 Identities=23% Similarity=0.296 Sum_probs=185.9
Q ss_pred eeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHH---HHHHhccCCCCcceeeeEEecCccce
Q 003199 533 KVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTE---VETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
.||+|+||.||+|.. .+|+.||+|.+....... ......+..| ...++...||+|+++++++.+.+..+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-------KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 73 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc-------chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEE
Confidence 489999999999955 468999999885433211 0111122233 33455567999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
+||||+++|+|.+++.... .+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 74 ~v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 74 FILDLMNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 9999999999999887654 68999999999999999999999 9999999999999999999999999999875532
Q ss_pred cCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 689 RGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 689 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
. ......|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ .. ....
T Consensus 150 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--~~--------~~~~ 214 (278)
T cd05606 150 K-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RM--------TLTM 214 (278)
T ss_pred c-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--HH--------hhcc
Confidence 1 12234689999999998754 5899999999999999999999999754221111100 00 0001
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
...+... ....+.+++.+|+..+|.+|| ++.+++++
T Consensus 215 ~~~~~~~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCc---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1112222 235667788899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.08 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=198.3
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+.||+|++|.||+|... +|+.+|+|++...... ......+.+|++++++++|+||+++++++.....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--------EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--------chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC
Confidence 456678999999999999654 7899999988543311 1234577889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||+++ ++.+++......+++..+..++.+++.|++|||+ .+++|+||||+||+++.++.++|+|||.+...
T Consensus 73 ~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 73 LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred EEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 9999999965 8888887755578999999999999999999999 99999999999999999999999999998766
Q ss_pred hccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc-cccchh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD-TKEGIM 764 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 764 (840)
.... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ........... ......
T Consensus 149 ~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 149 GSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred CCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcc
Confidence 4321 122334578899999998776 78999999999999999999999996532100 00000000000 000000
Q ss_pred hh--------------cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EV--------------LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~--------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ..............++.+++.+||++||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0000001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=277.64 Aligned_cols=247 Identities=29% Similarity=0.383 Sum_probs=190.8
Q ss_pred ccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccc
Q 003199 530 EKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 607 (840)
....||.|+||+|+|- ...+|+..|||++..... ....+++..|.++..+- .+||||+++|++..++..
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---------~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---------EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---------hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 3457999999999996 556899999999955432 23456777888765554 699999999999999999
Q ss_pred eEEEeecCCCChHHHhh---c-CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 608 LLVYEYMPNGNLWDALH---K-GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
|+.||.| ..|+..+-. . ....+++.-.-.|..-.+.||.||... ..|+|||+||+|||+|..|.+|+||||.+
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccch
Confidence 9999999 456654322 1 234688888889999999999999985 68999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
..+.+ +...+...|-..|||||.+.. ..|+.+|||||+|+.+||+.||..||.+ |.....+
T Consensus 216 GqLv~----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----------w~svfeq--- 278 (361)
T KOG1006|consen 216 GQLVD----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----------WDSVFEQ--- 278 (361)
T ss_pred HhHHH----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----------HHHHHHH---
Confidence 87743 444566778899999999854 3589999999999999999999999974 3321111
Q ss_pred chhhhcccccC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLS-----GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+..++.+..+ ....+....+.+.+.-|+.+|-..||++.+++++
T Consensus 279 -l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 -LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1112211111 1112355677888889999999999999988754
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=315.76 Aligned_cols=279 Identities=19% Similarity=0.246 Sum_probs=190.3
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC--CCcEEEEEEecccccc-------cccCchhhHHHHHHHHHHHHHHhccCCC
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN--SGEVVAVKKLWSQRTK-------VSASDTDQLQLDKGLKTEVETLGNIRHK 592 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 592 (840)
....+.|...+.||+|+||+||++..+ ++..+++|.+...... ..............+.+|+.++++++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 445678999999999999999998554 2333333322111000 0000011123456688999999999999
Q ss_pred CcceeeeEEecCccceEEEeecCCCChHHHhhcCC----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 003199 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGL----VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNIL 668 (840)
Q Consensus 593 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil 668 (840)
||+++++++...+..++|+|++ .+++.+++.... .......+..++.|++.||+|||+ ++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 9999999999999999999999 467777765432 123356677899999999999999 99999999999999
Q ss_pred EcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC-CCCCCCCC-
Q 003199 669 LDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP-VEDDFGDN- 746 (840)
Q Consensus 669 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p-~~~~~~~~- 746 (840)
++.++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|..+ +.......
T Consensus 300 l~~~~~vkL~DFGla~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKE--REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred ECCCCCEEEEeCCCceecCcc--cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999876431 11222345799999999999999999999999999999999998754 43321111
Q ss_pred cchhhhhhhhh-cccc------chhhhcccc----cCCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 747 KNIIYWVSIKV-DTKE------GIMEVLDKK----LSGSFRD------EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 747 ~~~~~~~~~~~-~~~~------~~~~~~~~~----~~~~~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+........ ...+ ...+.++.. ....... ...++.+++.+|++.||.+|||+.|++++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000000 0000 000000000 0001111 12345677889999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.96 Aligned_cols=244 Identities=26% Similarity=0.381 Sum_probs=193.2
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 610 (840)
..||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++|+|++++++++...+..++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 5799999999999966 478999999873221 12356688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||+++++|.+++... .+++..+..++.|++.|++|||+ .+++||||+|+||+++.++.++|+|||.+.....
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~-- 168 (292)
T cd06657 96 MEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-- 168 (292)
T ss_pred EecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccc--
Confidence 9999999999988654 57999999999999999999999 8999999999999999999999999998865532
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........|++.|+|||++.+..++.++||||+|+++|||++|..||..... . ...... .......
T Consensus 169 -~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~---~~~~~~-------~~~~~~~ 235 (292)
T cd06657 169 -EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--L---KAMKMI-------RDNLPPK 235 (292)
T ss_pred -ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHH-------HhhCCcc
Confidence 11222345688999999999888889999999999999999999999864211 0 000000 0001111
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+. ........+.+++.+|++.+|.+||++.+++++
T Consensus 236 ~~-~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cC-CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 10 011123456678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=287.65 Aligned_cols=250 Identities=30% Similarity=0.417 Sum_probs=200.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++|+|++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Confidence 3667789999999999999654 6889999998544321 233567899999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++.... .+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEecccccee
Confidence 9999999999999999987763 68999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
..... .......++..|+|||...+..++.++||||+|+++|+|++|+.||.... .....|. ....
T Consensus 149 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~~~-~~~~------- 214 (254)
T cd06627 149 LNDVS---KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAALFR-IVQD------- 214 (254)
T ss_pred cCCCc---ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHH-Hhcc-------
Confidence 64321 11234568889999999888788999999999999999999999986431 1111111 0000
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... .....+.+++.+|+..+|++||++.+++.+
T Consensus 215 -~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 215 -DHPPLPE---GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCC---CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0011111 123456678889999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=295.92 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=191.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
+.|+..+.||+|++|.||+|... +++.||||++..... ......+.+|+.++.+. .|+||+++++++.+
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---------KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---------hHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 55777889999999999999776 489999999853321 12234566677766666 49999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+. +++.+.+......+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||+|||++
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccc
Confidence 999999999985 577776665444789999999999999999999972 48999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK----ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
..+... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ ........
T Consensus 163 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~ 234 (296)
T cd06618 163 GRLVDS----KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE----VLTKILQE 234 (296)
T ss_pred hhccCC----CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH----HHHHHhcC
Confidence 765321 1222345788999999986553 78899999999999999999999864211100 00000000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. ...... ......++.+++.+|++.||++||++.+++++-.
T Consensus 235 ~-------~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 235 E-------PPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred C-------CCCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0 000110 0112345778888999999999999999997743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.41 Aligned_cols=253 Identities=29% Similarity=0.391 Sum_probs=202.7
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC--
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL-- 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 604 (840)
|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++|+||+++++.+...
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--------EEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 566788999999999999665 7899999998544321 33467789999999999999999999999888
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+||+++++|.+++.... .+++..+..++.+++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~ 149 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAK 149 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEE
Confidence 88999999999999999998765 78999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
....... ........++..|+|||...+...+.++||||||+++|+|++|+.||..... .....+ ....
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~---~~~~----- 218 (260)
T cd06606 150 RLGDIET-GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALY---KIGS----- 218 (260)
T ss_pred ecccccc-cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHH---hccc-----
Confidence 7643211 0113445688999999999888899999999999999999999999975420 000000 0000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..............+.+++.+|++.+|++||++.+++++
T Consensus 219 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 ---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111112224567788889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.35 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=191.7
Q ss_pred eeecc--CCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 533 KVGQG--GSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.||+| +||+||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEE
Confidence 46666 9999999965 47999999998533211 2234678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 610 VYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
|+||+.++++.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+.....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 999999999999987642 358899999999999999999999 8999999999999999999999999987654432
Q ss_pred cCCCCc----ceecccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-----
Q 003199 689 RGGKDS----TTTVIAGTYGYLAPEYAYSS--KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV----- 757 (840)
Q Consensus 689 ~~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----- 757 (840)
.+.... ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 232 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLD 232 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCcc
Confidence 211111 01112345679999998763 47899999999999999999999997532110 0000000000
Q ss_pred ------------ccccc----hh----------hhcccccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 ------------DTKEG----IM----------EVLDKKLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ------------~~~~~----~~----------~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..... +. .+....+. +........+.+++.+|++.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00000 00 00000011 11123456788999999999999999999998774
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.80 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=195.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|...+.||+|+||+||+|.. .+|+.||||.+...... ......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 75 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN--------RIDAKRTLREIKLLRHLDHENVIAIKDIMPP 75 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc--------cchhHHHHHHHHHHHhcCCCCccchHHheec
Confidence 35688888999999999999954 57899999988532211 1223456789999999999999999998754
Q ss_pred C-----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 L-----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
. ...++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 76 PHREAFNDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred ccccccCcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEC
Confidence 3 34799999995 78988887654 68999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|||+++.....+ .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... ..........
T Consensus 151 Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~ 226 (337)
T cd07858 151 DFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLG 226 (337)
T ss_pred cCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhC
Confidence 999997654321 12234467889999998765 468999999999999999999999997532100 0000000000
Q ss_pred c-c--------ccchhhhc---c----cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 D-T--------KEGIMEVL---D----KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~-~--------~~~~~~~~---~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. . ........ . ............++.+++.+|++.+|++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0 00000000 0 00001112234567889999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.79 Aligned_cols=248 Identities=29% Similarity=0.365 Sum_probs=193.1
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.|...+.||+|+||+||+|.. .+|+.||+|++...... .....+.+.+|+++++.++|+|++++++++.+..
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-------TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH 94 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-------chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 356677899999999999965 46899999988433211 1223456888999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+. |++.+.+......+++.++..++.|++.|++|||+ .+++||||+|+||+++.++.++|+|||++..
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 9999999995 68888887655578999999999999999999999 8999999999999999999999999999854
Q ss_pred hhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
.. ......|+..|+|||++. ...++.++||||||+++|||++|..||..... ....... .. .
T Consensus 171 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~---~~-~-- 235 (313)
T cd06633 171 SS-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHI---AQ-N-- 235 (313)
T ss_pred cC-------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH---Hh-c--
Confidence 31 122456888999999874 45688999999999999999999999865311 1111000 00 0
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... ....+.+++.+|++.+|.+||++.+++.+
T Consensus 236 ---~~~~~~~~~---~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 ---DSPTLQSNE---WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCCCCCccc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001111 22346678889999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.58 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=196.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||+|+||.||+|... +++.||+|.+...... .......+.+|+++++.++|+|++++++++...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-------ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 34666788999999999999654 6889999987432111 122345678899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+. |++.+.+......+++.++..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||++.
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccce
Confidence 99999999996 68888776555568999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.... .....+++.|+|||.+. ...++.++|||||||++|||++|+.||...... ....
T Consensus 164 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----------- 224 (308)
T cd06634 164 IMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALY----------- 224 (308)
T ss_pred eecC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHH-----------
Confidence 5422 22346788999999874 356788999999999999999999998642110 0000
Q ss_pred chhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
......... ........+.+++.+||+.+|++||++.+++++-....
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 225 ---HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000000000 01123345677888999999999999999998866544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.07 Aligned_cols=269 Identities=25% Similarity=0.310 Sum_probs=195.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|...+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+.+++.++|+||+++++++..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 85 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--------EIFAKRAYRELTLLKHMQHENVIGLLDVFTS 85 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--------ccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence 35788889999999999999965 57999999988543211 1223457789999999999999999998865
Q ss_pred Cc------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 LY------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.. ..++|+||+. .++.++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred cccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEE
Confidence 43 4589999996 47766653 258999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh-
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI- 755 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~- 755 (840)
+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..... ........
T Consensus 159 ~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~ 231 (342)
T cd07879 159 LDFGLARHADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 231 (342)
T ss_pred eeCCCCcCCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 99999875421 1223467889999998866 468899999999999999999999997532100 00000000
Q ss_pred hhcccc--------chhhhc---c----cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCCCC
Q 003199 756 KVDTKE--------GIMEVL---D----KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPCRF 815 (840)
Q Consensus 756 ~~~~~~--------~~~~~~---~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~~~ 815 (840)
...... ...... . ..+...+......+.+++.+|++.||++||++.+++.+ ++.......
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 000000 000000 0 00000111223457789999999999999999999976 666655433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=293.48 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=194.8
Q ss_pred cCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 528 MTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
|+..+.||.|+||.||+|.. .+|+.||+|++..... .......+.+.+|+.+++++ .|+||+++++++.
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI------VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh------hhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence 56778999999999999865 3689999999854321 11123346678899999999 5999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
.....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence 9889999999999999999997654 68899999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS--KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+...... .........|+..|+|||.+... .++.++||||||+++|+|++|+.||..... ......+.......
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~- 227 (290)
T cd05613 152 SKEFHED--EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKS- 227 (290)
T ss_pred ceecccc--cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhcc-
Confidence 9765331 11222345688999999988653 467899999999999999999999864211 11111111110000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
....+. .....+.+++.+|++.||++|| ++.+++++
T Consensus 228 -------~~~~~~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -------EPPYPQ---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCCc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011111 1234566788899999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=293.91 Aligned_cols=258 Identities=23% Similarity=0.301 Sum_probs=197.5
Q ss_pred cCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 528 MTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
|+..+.||+|++|.||+|.. .+++.||||++..... .......+.+.+|++++.++ .|+||+++++.+.
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~ 75 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI------VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ 75 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH------HhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence 56678899999999999854 3578899999853321 11223456788999999999 5999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
.....++||||+++|+|.+++.... .+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++++|||+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcc
Confidence 9999999999999999999987653 68899999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
++..... .........|+..|+|||...+.. .+.++||||||+++|||++|..||...... .......+....
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~-- 226 (288)
T cd05583 152 SKEFLAE--EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILK-- 226 (288)
T ss_pred ccccccc--cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHc--
Confidence 8765432 111223346889999999987654 788999999999999999999998642111 111111110000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.....+.. ....+.+++.+|++.||++|||+.++.+.|..
T Consensus 227 ------~~~~~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 ------SKPPFPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------cCCCCCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111122 23456678889999999999998888777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=272.80 Aligned_cols=273 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCC----cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCccee
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSG----EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKL 597 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 597 (840)
+....|+....||+|.||.||+|.. ++. ..+|+|+++..+... .......+|+..++.++|||++.+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--------GiS~SAcREiaL~REl~h~nvi~L 92 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--------GISMSACREIALLRELKHPNVISL 92 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--------CcCHHHHHHHHHHHHhcCCcchhH
Confidence 4566788899999999999999943 322 278999997664321 122445689999999999999999
Q ss_pred eeEEec-CccceEEEeecCCCChHHHhhcC----CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 598 YCYFSS-LYCNLLVYEYMPNGNLWDALHKG----LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 598 ~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
...+-+ +...++++||.+. +|...++-. ...++-..+..|..||+.|+.|||+ .=|+||||||.|||+..+
T Consensus 93 v~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 93 VKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGD 168 (438)
T ss_pred HHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEecc
Confidence 988876 7888999999965 888877533 2578889999999999999999999 778999999999999877
Q ss_pred ----CCCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003199 673 ----YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 673 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 747 (840)
|.|||+|||+|+.+...-..-.....++-|..|.|||.+.+. .||.+.||||.|||+.||+|-++-|.+......
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 899999999999986543333344566789999999998875 589999999999999999999888876433111
Q ss_pred --------------------chhhhhhhhhcccc-c-hhhhcccccCCC-cHH-------HHHHHHHHHHHccCCCCCCC
Q 003199 748 --------------------NIIYWVSIKVDTKE-G-IMEVLDKKLSGS-FRD-------EMIQVLRIAIRCTSKSPATR 797 (840)
Q Consensus 748 --------------------~~~~~~~~~~~~~~-~-~~~~~~~~~~~~-~~~-------~~~~l~~l~~~cl~~dP~~R 797 (840)
....|-..+..... . +.++-....... ... .....++|...++..||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 01111111110000 0 000000000000 000 01236788889999999999
Q ss_pred CCHHHHHHHh
Q 003199 798 PTMNEVVQLL 807 (840)
Q Consensus 798 ps~~evl~~L 807 (840)
.|+.+++++.
T Consensus 329 Ita~qAleh~ 338 (438)
T KOG0666|consen 329 ITAEQALEHP 338 (438)
T ss_pred ccHHHHhccc
Confidence 9999998874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=292.43 Aligned_cols=247 Identities=26% Similarity=0.325 Sum_probs=199.1
Q ss_pred cCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 531 KNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.+.||+|.||+||-| ..++|+.||||++.+.+-. .+....+.+|+.++..+.||.||.+...|+..+..+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--------~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--------TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC--------CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 478999999999999 4568999999999554422 2334778999999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCCeeecccchhhh
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN---YQPKVADFGIAKVL 686 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg~a~~~ 686 (840)
|||-+.|.-|.-.+.....++++.....++.||+.||.|||. ++|||+||||+|||+.+. ..+||||||.|++.
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 999996555555566555689999999999999999999999 999999999999999653 47999999999998
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
. +..-.....|||.|.|||++.++.|...-|+||.|||+|--++|..||..+.+ +.+. +++.
T Consensus 718 g----EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQ----------IQNA 779 (888)
T KOG4236|consen 718 G----EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQ----------IQNA 779 (888)
T ss_pred c----hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHH----------hhcc
Confidence 4 34455678899999999999999999999999999999999999999975321 1110 1111
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.-...+.-+.+.....++++...++..=++|.|....+.+
T Consensus 780 aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111223345666677788888888888999988876654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.53 Aligned_cols=261 Identities=25% Similarity=0.323 Sum_probs=194.2
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLY 605 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 605 (840)
|...+.||+|++|+||+|... +++.||||++...... .......+|+..+++++ |+|++++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---------WEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 456788999999999999775 5789999988543211 11223456899999998 999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+ +|++.+.+.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||.+.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 889999887653 468999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-----------hhhh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN-----------IIYW 752 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------~~~~ 752 (840)
.... ........++..|+|||++. +..++.++|+||||+++|||++|+.||......... ...|
T Consensus 148 ~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 148 EIRS----RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eccC----CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 6532 11223356788999999874 445789999999999999999999998653211000 0001
Q ss_pred hhhhhccccchhhhcccccCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... .............. .......+.+++.+|++.+|++||+++|++.+
T Consensus 224 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLA-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhh-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000000000010 11123568889999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=277.42 Aligned_cols=257 Identities=21% Similarity=0.205 Sum_probs=202.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+++....+.+|.||+||+|.|. +.+.|.||.++... .......+..|-..+..+.|||+.++.+.
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---------S~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---------SQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---------cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4555667899999999999554 34567778764332 12345678889999999999999999998
Q ss_pred Eec-CccceEEEeecCCCChHHHhhcC-------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 003199 601 FSS-LYCNLLVYEYMPNGNLWDALHKG-------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672 (840)
Q Consensus 601 ~~~-~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~ 672 (840)
+.+ ....+.+|.++.-|+|..++... ...+.-.+...++.|++.|++|||. ++|||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 855 55668889999999999999821 2456667888899999999999999 999999999999999999
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~ 751 (840)
..+||+|=.+++.+-+.+ ..--......+..|||||.+.+..|+.++|||||||++|||+| |+.||.+-
T Consensus 433 LqVkltDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--------- 502 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--------- 502 (563)
T ss_pred eeEEeccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc---------
Confidence 999999999998775421 1112233445678999999999999999999999999999999 99998742
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+..+...-+.|+..-....+++.+++.++.-||..+|++||++++++.-|.++.
T Consensus 503 ------DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 503 ------DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ------CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111211223344433444566778899999999999999999999999998753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=289.32 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=194.9
Q ss_pred eeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||.|+||.||+|... +|+.||+|++..... ......+.+.+|++++++++|+|++++++.+......++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEe
Confidence 689999999999776 599999998843321 113446778899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCC
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 692 (840)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++.........
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 999999999998755 68999999999999999999999 99999999999999999999999999998765322110
Q ss_pred -----CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 693 -----DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 693 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
........++..|+|||...+...+.++||||||+++||+++|+.||..... . .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~~~~-------- 216 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--E---EIFQNILNG-------- 216 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHhcC--------
Confidence 1123445678899999999888899999999999999999999999965321 0 011000000
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
...... .......+.+++.+|++.+|++||++.++.+.|.
T Consensus 217 ~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 KIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000011 1112456778888999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=299.66 Aligned_cols=272 Identities=26% Similarity=0.320 Sum_probs=202.8
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|+..+.||+|++|.||+|... +|+.||||++..... .....+.+.+|+++++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPS 72 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccC
Confidence 3677889999999999999765 589999998854321 1233467889999999999999999999987765
Q ss_pred -----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 606 -----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 606 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
..++||||++ ++|.+++.... .+++..+..++.+++.||+|||+ .+|+||||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 73 PEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred cccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccc
Confidence 7799999997 58999887655 78999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc-
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD- 758 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 758 (840)
|.+.................++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ..........
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~ 225 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGT 225 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCC
Confidence 9998764422111223345678899999999887 78999999999999999999999997542100 0000000000
Q ss_pred ---------cccchhhhccc---c----cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCC
Q 003199 759 ---------TKEGIMEVLDK---K----LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPC 813 (840)
Q Consensus 759 ---------~~~~~~~~~~~---~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~ 813 (840)
........+.. . +..........+.+++.+||+.+|++||++.+++++ ++.....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00000000000 0 000011234567889999999999999999999987 5554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.20 Aligned_cols=244 Identities=24% Similarity=0.281 Sum_probs=185.0
Q ss_pred CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHH-HhccCCCCcceeeeEEecCccceE
Q 003199 532 NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET-LGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
+.||+|+||.||+|.. .+|+.||||++..... ........+..|..+ .....|+|++++++++...+..++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEE
Confidence 4699999999999965 4689999998843221 011122334445444 445589999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence 999999999999997654 68899999999999999999999 8999999999999999999999999999865422
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 769 (840)
.....++..|+|||.+.+..++.++||||||+++|||++|..||..... ...+...... ..
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~---------~~ 210 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSR---------RI 210 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhc---------cc
Confidence 2234688899999999888889999999999999999999999964311 1111111000 00
Q ss_pred ccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 770 KLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 770 ~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... ........+.+++.+|++.+|++||++.++.+.
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 0011 111234567788889999999999977544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.28 Aligned_cols=262 Identities=21% Similarity=0.202 Sum_probs=189.2
Q ss_pred eeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
.+|.|+++.||++.. +++.||||++..... .....+.+..|+++++.++|+||+++++++.+....+++||
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSC--------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEecccc--------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 345555555555544 699999999854311 12335678999999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 613 YMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 613 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
|+++|++.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+|++|||.+......+.
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 99999999999864 3468899999999999999999999 9999999999999999999999999998865532211
Q ss_pred C----CcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh----c---
Q 003199 692 K----DSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV----D--- 758 (840)
Q Consensus 692 ~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~--- 758 (840)
. ........++..|+|||++.. ..++.++|||||||++|||++|+.||....... .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCc
Confidence 1 111233457788999999866 357899999999999999999999997532110 0000000000 0
Q ss_pred ---cccchhh----hccccc-----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 ---TKEGIME----VLDKKL-----SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 ---~~~~~~~----~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
....... ..+... .........++.+++.+||+.||++|||+.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000000 000000 001122345678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.95 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=195.3
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..+.++|...+.||+|+||.||+|. ..+|+.||+|++..... .....+.+.+|+.++++++|+||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--------SIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--------hhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4456789999999999999999995 45799999998854321 12234567789999999999999999998
Q ss_pred EecC------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 601 FSSL------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 601 ~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
+... ...+++++++ +++|.+++... .+++..+..++.|+++|++|||+ .+|+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 7543 3457888887 78998888654 58999999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 159 ~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~ 231 (345)
T cd07877 159 LKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLIL 231 (345)
T ss_pred EEEecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 99999999875422 2233467889999998766 46788999999999999999999999653211 0000000
Q ss_pred hhhhccccchh------------hhcccccCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 754 SIKVDTKEGIM------------EVLDKKLSGSFR----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 754 ~~~~~~~~~~~------------~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
........... ..........+. .....+.+++.+|++.||.+||++.+++.+=
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00000000000 000000000011 1234577899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.58 Aligned_cols=264 Identities=28% Similarity=0.354 Sum_probs=197.7
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|+..+.||+|++|.||+|... +++.||+|++..... .....+.+..|++++++++|+|++++++++.+...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--------EEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc
Confidence 445678999999999999665 589999999854321 12224567789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++|+||++ ++|.+++......+++..+..++.+++.||+|||+ .+++||||+|+||++++++.++|+|||.++..
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 999999997 59999998764578999999999999999999999 89999999999999999999999999998765
Q ss_pred hccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-----------chhhhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNK-----------NIIYWVS 754 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------~~~~~~~ 754 (840)
... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ....|..
T Consensus 149 ~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 149 GIP---LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred CCC---ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 331 1122334567789999998766 789999999999999999999999965321100 0000100
Q ss_pred hhhcc--ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDT--KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ......................+.+++.+|++.||++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 00000000000001111224568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.57 Aligned_cols=276 Identities=21% Similarity=0.245 Sum_probs=196.2
Q ss_pred HhcCc-cCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccC----chhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTE-KNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSAS----DTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|.. .+.||+|+||+||+|.. .+++.||||.+.......... ..........+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 46799999999999964 479999999985433221000 0000111235788999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
++......++||||++ |+|.+++.... .+++.....++.|++.||+|||+ .+++||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 68999887643 68999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCC-----------CCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003199 680 FGIAKVLQARGG-----------KDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 680 fg~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 747 (840)
||.++....... .........++..|+|||.+.+. .++.++||||+|+++|||++|+.||.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999976541110 01112234567889999988764 46899999999999999999999997542211
Q ss_pred chhhhhhhhhcc-ccchh------------hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 748 NIIYWVSIKVDT-KEGIM------------EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 748 ~~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.+.......... ...+. ................++.+++.+|++.+|++||++.|++.+-
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 000000000000 00000 0000000011112235677889999999999999999999764
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=291.41 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=200.7
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 604 (840)
+|...+.||+|++|.||+|... +|+.||+|++...... .....+.+.+|+++++++. |+||+++++++...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 5777889999999999999654 7999999998442211 1233467889999999998 99999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++++|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence 99999999999999999998764 69999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCC-----------------CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003199 685 VLQARGGK-----------------DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 685 ~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 747 (840)
........ ........++..|+|||...+..++.++||||||++++++++|+.||.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--- 227 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--- 227 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---
Confidence 66432110 1222345678899999998888899999999999999999999999975320
Q ss_pred chhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 003199 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM----NEVVQL 806 (840)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~evl~~ 806 (840)
. ........ .....+..+ ...+.+++.+|++.+|.+||++ .+++++
T Consensus 228 -~-~~~~~~~~--------~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 -Y-LTFQKILK--------LEYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -H-HHHHHHHh--------cCCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 00000000 011111122 3456778889999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.95 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=193.1
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+|...+.||+|+||.||+|... .+..+++|.++....... .......+..|+.+++.++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-----NPNETVQANQEAQLLSKLDHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc-----CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence 3667789999999999998554 455677776643221110 1112334667899999999999999999999988
Q ss_pred cceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 606 CNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..++||||+++++|.+++.. ....+++..+..++.|++.|+.|||+ .+++|+||+|+||++++ +.++|+|||.
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCc
Confidence 99999999999999998864 23468999999999999999999999 99999999999999976 5699999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++..... ........|++.|+|||...+..++.++|+||||+++|+|++|..||.... .......
T Consensus 152 ~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~------- 216 (260)
T cd08222 152 SRLLMGS---CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLR------- 216 (260)
T ss_pred eeecCCC---cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH-------
Confidence 8765432 122234567889999999888888999999999999999999999986421 1111110
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+.........+.+++.+|++.+|++||++.|++++
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 217 ---IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---HHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11111111112334567788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=301.03 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=190.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||.|+||.||+|.. .+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----------QSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----------chHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 4677888999999999999955 5789999998844331 2245678899999999999999999776543
Q ss_pred --------------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 605 --------------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 605 --------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
...++||||++ ++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEc
Confidence 35689999996 5898888654 58899999999999999999999 8999999999999998
Q ss_pred C-CCCCeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 671 V-NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 671 ~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
. ++.++++|||.++................++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~- 227 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ- 227 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 4 557899999999765332111112233457889999997654 5678899999999999999999999975321000
Q ss_pred hhhhhhh-hhccc---c----chhhhcc--cccCC-C----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 749 IIYWVSI-KVDTK---E----GIMEVLD--KKLSG-S----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 749 ~~~~~~~-~~~~~---~----~~~~~~~--~~~~~-~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... ..... . ....... ..... . ......++.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 00000 0 0000000 00000 0 01123567788999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.86 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=194.8
Q ss_pred HHHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|+..+.||+|+||.||+|. ..+|..||||++..... .....+.+.+|++++++++|+||+++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--------SELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--------chHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 345678889999999999999995 55799999998843221 122345678999999999999999999988
Q ss_pred ecCc------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSLY------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
.... ..++||||+ +++|.+++... .+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCE
Confidence 6543 348999999 77998888653 68999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+++|||++..... ......+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||...... ........
T Consensus 158 kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~ 230 (343)
T cd07880 158 KILDFGLARQTDS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMK 230 (343)
T ss_pred EEeeccccccccc------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999999876432 1223457889999998866 45889999999999999999999999753210 00000000
Q ss_pred hhhccc---------cchhhh---cccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDTK---------EGIMEV---LDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~~---------~~~~~~---~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... ...... +.......+ ......+.+++.+|++.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 000000001 1223457789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=311.44 Aligned_cols=257 Identities=24% Similarity=0.290 Sum_probs=200.5
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|.++++||+|+||.|..++. .+++.||+|++.+...- ......-|.+|-.+|..-..+=|++++-+|.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-------Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-------KRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-------hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 56788899999999999999965 47899999998542211 01224568888889988888999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..+.|+|||||+||+|-..+.+.. .+++.-++.+...|+-||.-+|+ .|+|||||||+|||+|..|++|++|||.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999999987 79999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccc----c-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY----S-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
-.+.. .+.......+|||.|+|||++. + +.|+...|.||+||++|||+.|..||..+ .++..+...+.
T Consensus 223 lkm~~--dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDA--DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMN 295 (1317)
T ss_pred HhcCC--CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhc
Confidence 77754 2334556778999999999884 2 57899999999999999999999999753 22222222222
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT---MNEVVQLL 807 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~~L 807 (840)
..+.+ .+++ ..+......+||.+.+. +|+.|.. +.++..|-
T Consensus 296 hk~~l------~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 296 HKESL------SFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhhc------CCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 21110 1121 11123334444445443 7888887 88888774
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=290.97 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=194.9
Q ss_pred HHHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|+..+.||.|+||.||+|. ..+|+.||||++...... ....+.+.+|+++++.++|||++++.+++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 78 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--------PVLAKRTYRELKLLKHLRHENIISLSDIF 78 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--------cchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence 356778899999999999999995 447999999987433211 12245677899999999999999999988
Q ss_pred ec-CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 602 SS-LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 602 ~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
.. ....++|+||+ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+||
T Consensus 79 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 79 ISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred ecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcc
Confidence 65 55778999999 67898888754 57888899999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|.+..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+.......
T Consensus 153 g~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~ 225 (328)
T cd07856 153 GLARIQDP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTP 225 (328)
T ss_pred ccccccCC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99875422 1123457889999998765 568999999999999999999999996532100 000000000000
Q ss_pred c---------cchhhhccc-ccCC--Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 K---------EGIMEVLDK-KLSG--SF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~---------~~~~~~~~~-~~~~--~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ....+.... .... .. ......+.+++.+|++.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000 0000 00 1123567788899999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=294.89 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=196.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++.++|+..+.||+|++|.||+|... +++.||||++..... .....+.+.+|+.+++.+.|+|++++.+++
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--------SAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--------hhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 34567888899999999999999665 688999998743221 122345677899999999999999999887
Q ss_pred ecCcc------ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 602 SSLYC------NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 602 ~~~~~------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
...+. .++|+||+ +++|.+++... .+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCE
Confidence 65554 79999999 67999988764 68999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+.....
T Consensus 158 kL~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~ 230 (343)
T cd07851 158 KILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN 230 (343)
T ss_pred EEccccccccccc------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Confidence 9999999976532 1233467889999998765 36789999999999999999999999753211 00000000
Q ss_pred hhhcc---------ccchhhh---cccccCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDT---------KEGIMEV---LDKKLSGSFR----DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~---------~~~~~~~---~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ....... ........+. ....++.+++.+|++.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000000 0001111111 124578889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=288.60 Aligned_cols=265 Identities=24% Similarity=0.307 Sum_probs=190.1
Q ss_pred cCccCeeeccCCcEEEEEEeC-C--CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-S--GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
|+..+.||+|+||.||+|... + +..||+|++..... .....+.+.+|+++++++ .||||+++++++..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--------KKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--------cchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 667788999999999999654 4 78999998743211 112345677899999999 59999999987532
Q ss_pred ----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 604 ----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 604 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
....++++||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCc
Confidence 245678889885 68999887654 68999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCC-CcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh-------
Q 003199 680 FGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII------- 750 (840)
Q Consensus 680 fg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------- 750 (840)
||+++........ ........|+..|+|||+..+ ..++.++||||+|+++|+|++|+.||...... ....
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhC
Confidence 9999765432111 111233568999999998765 46899999999999999999999998753210 0000
Q ss_pred ----hh-hhhhhccccchhhhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 751 ----YW-VSIKVDTKEGIMEVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 751 ----~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+ ......................+ ......+.+++.+|++.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00000000000000000000001 1123567788999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=313.06 Aligned_cols=148 Identities=29% Similarity=0.357 Sum_probs=130.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|... +++.||||++..... ........+..|+.+++.++|+||+++++++...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-------INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 56788899999999999999665 789999999854321 1123346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+.+++|.+++.... .+++..++.++.||+.||+|||. .+||||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999997654 58899999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=291.24 Aligned_cols=243 Identities=23% Similarity=0.259 Sum_probs=192.0
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
.+.|.....+|.|+|+.|-.+ ...+++..+||++.... .+-.+|+.++... .|||++++.+.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------------~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------------DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc--------------cccccccchhhhhcCCCcceeecceec
Confidence 456666777999999999887 55678999999984441 1233567666666 6999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-cCCCCCeeeccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL-DVNYQPKVADFG 681 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfg 681 (840)
+..+.|+|||.+.++-+.+.+.... .+. .++.+|+.+|+.|+.|||+ +|||||||||+|||+ ++.++++|+|||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEec
Confidence 9999999999999998888877653 222 7888899999999999999 999999999999999 689999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.++..... ....+-|..|.|||++....+++++|+||||++||+|++|+.||....++ ...
T Consensus 462 ~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei---------- 522 (612)
T KOG0603|consen 462 FWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEI---------- 522 (612)
T ss_pred hhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHH----------
Confidence 99876442 33446688999999999999999999999999999999999999864332 000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
...+..+....... ....+|+.+|++.||.+||+|.++..+=.-
T Consensus 523 -~~~i~~~~~s~~vS---~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 523 -HTRIQMPKFSECVS---DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -HHhhcCCccccccC---HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 01111111222223 344556669999999999999999987555
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=275.78 Aligned_cols=242 Identities=30% Similarity=0.383 Sum_probs=192.8
Q ss_pred eeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||+|+||.||++... +++.||+|++...... .......+..|+.++++++|+|++++++.+......++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-------KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-------chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEe
Confidence 689999999999665 5899999988543211 12345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCC
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 692 (840)
|+++++|.+++.... .+++..+..++.|++.|+.|+|+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--- 146 (250)
T cd05123 74 YAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--- 146 (250)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccC---
Confidence 999999999998764 68999999999999999999999 99999999999999999999999999998765331
Q ss_pred CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccC
Q 003199 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS 772 (840)
Q Consensus 693 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 772 (840)
........++..|+|||...+...+.++|+||||+++||+++|+.||..... ... ...... .....+
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~---~~~~~~--------~~~~~~ 213 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEI---YEKILK--------DPLRFP 213 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH---HHHHhc--------CCCCCC
Confidence 1223455688899999999888889999999999999999999999964311 111 100000 001111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH---HHHHH
Q 003199 773 GSFRDEMIQVLRIAIRCTSKSPATRPTM---NEVVQ 805 (840)
Q Consensus 773 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~---~evl~ 805 (840)
... ...+.+++.+|+..||++||++ .++.+
T Consensus 214 ~~~---~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFL---SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCC---CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 111 3556778889999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=272.94 Aligned_cols=242 Identities=25% Similarity=0.334 Sum_probs=190.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
..+|..+.+||+|+||+|..|..+ +.+.+|||++++...-+.. + .+--..|-++++.- +-|.+++++.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD----D---vectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD----D---VECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC----c---ccceehhhhheecCCCCchHHHHHHHhh
Confidence 456788889999999999999666 5678999998654422111 1 12223466666655 5788999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..+..|.||||+.||+|--++++.+ .+.++.+..+|..||-||-+||+ +||+.||||..|||+|.+|++||+|||+
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccc
Confidence 9999999999999999988887765 68899999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++.-- -....+...+|||.|+|||++.-.+|+.++|.|||||+||||+.|++||+++.++ .+
T Consensus 497 cKEni---~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--el------------- 558 (683)
T KOG0696|consen 497 CKENI---FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--EL------------- 558 (683)
T ss_pred ccccc---cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HH-------------
Confidence 87532 2345667899999999999999999999999999999999999999999874221 11
Q ss_pred hhhhcccc--cCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 003199 763 IMEVLDKK--LSGSFRDEMIQVLRIAIRCTSKSPATRP 798 (840)
Q Consensus 763 ~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 798 (840)
...+.+.. .+.. ...+...+....+.+.|.+|.
T Consensus 559 F~aI~ehnvsyPKs---lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 FQAIMEHNVSYPKS---LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHccCcCccc---ccHHHHHHHHHHhhcCCcccc
Confidence 11111111 1222 334445556688889999995
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.95 Aligned_cols=219 Identities=23% Similarity=0.232 Sum_probs=172.7
Q ss_pred cCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEeecC
Q 003199 537 GGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMP 615 (840)
Q Consensus 537 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 615 (840)
|.+|.||++. ..+|+.||+|++.... .+..|...+....|||++++++++.+.+..++||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCC
Confidence 8999999984 4578999999984321 12234444455579999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcc
Q 003199 616 NGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST 695 (840)
Q Consensus 616 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 695 (840)
+|+|.+++.+.. .+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++++|||.+..... .
T Consensus 69 ~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------~ 138 (237)
T cd05576 69 GGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------S 138 (237)
T ss_pred CCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccc------c
Confidence 999999987654 58999999999999999999999 9999999999999999999999999998765532 1
Q ss_pred eecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCc
Q 003199 696 TTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSF 775 (840)
Q Consensus 696 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 775 (840)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+...... . .......++..
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~------~~~~~~~~~~~- 200 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------I------NTHTTLNIPEW- 200 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------c------ccccccCCccc-
Confidence 22334567899999998888899999999999999999999887532100 0 00000011122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH
Q 003199 776 RDEMIQVLRIAIRCTSKSPATRPTM 800 (840)
Q Consensus 776 ~~~~~~l~~l~~~cl~~dP~~Rps~ 800 (840)
....+.+++.+|++.||++||++
T Consensus 201 --~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 201 --VSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred --CCHHHHHHHHHHccCCHHHhcCC
Confidence 22456678889999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=281.65 Aligned_cols=254 Identities=25% Similarity=0.314 Sum_probs=204.8
Q ss_pred cCccCeeeccCCcEEEEEEeCCCc-EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGE-VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
+....-||-|+||.|=.+..+... .+|+|++++.... +.+..+.+..|-.+|..++.|.||++|..|.+...
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-------dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-------DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-------chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 334456899999999998776433 3899988655432 23345677889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.|+.||-|-||.++..++..+ .++..++..++..+++|++|||+ ++||+|||||+|.++|.+|-+||.|||.|+.+
T Consensus 495 vYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999999999876 79999999999999999999999 99999999999999999999999999999998
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
. ....+.+++|||.|.|||++.+...+.++|.||+|+++||+++|.+||.+...- .........
T Consensus 571 ~----~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----ktYn~ILkG------- 634 (732)
T KOG0614|consen 571 G----SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----KTYNLILKG------- 634 (732)
T ss_pred c----cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----HHHHHHHhh-------
Confidence 4 456678899999999999999999999999999999999999999999864211 111111111
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhhc
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQLLAEA 810 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~L~~~ 810 (840)
+|.. ..+........+++.+.+..+|.+|.- +.+|.+|-+-.
T Consensus 635 id~i--~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 635 IDKI--EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred hhhh--hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 1110 011222344566777888999999985 88998886643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=240.24 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=195.5
Q ss_pred cCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...++||+|.||+|++|+ +.+++.||+|+.+..... ...-....+|+-+++.++|.|||++++....+..
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrldddd--------egvpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD--------EGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC--------CCCcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 4455689999999999995 457899999998544322 2223456789999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.-+|+||| .-+|..+...-...++.+.++.++.|+.+|+.++|+ +++.|||+||.|.+++.+|+.|++|||+|+-+
T Consensus 76 ltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 76 LTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred eEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 99999999 458888887766678999999999999999999999 99999999999999999999999999999887
Q ss_pred hccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhh-hhhccccc-
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVS-IKVDTKEG- 762 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~- 762 (840)
.- .-...+...-|..|.+|.++.+.. |+...|+||.|||+.|+.. |++-|.+..- ..++..... .....++.
T Consensus 152 gi---pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 152 GI---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred CC---ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccC
Confidence 42 233455667889999999998765 7889999999999999998 6666655321 111111111 11111111
Q ss_pred --hhhhcccccCCCc------HHHHHH----HHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 --IMEVLDKKLSGSF------RDEMIQ----VLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 --~~~~~~~~~~~~~------~~~~~~----l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+...-|-+..+.+ ...+.+ =.++....+.-+|..|.++++++++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1112222222222 122222 2345556677799999999998875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=268.15 Aligned_cols=268 Identities=27% Similarity=0.361 Sum_probs=198.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|-.++.||+|+|+.||+| +....+.||||+-...+. ..++......+...+|..+-+.+.||.||++++|+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~---WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKN---WRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccc---hhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 45567778889999999999998 677789999997643321 12223333456778899999999999999999999
Q ss_pred e-cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCCee
Q 003199 602 S-SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NYQPKV 677 (840)
Q Consensus 602 ~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl 677 (840)
. +.+.++-|+|||+|.+|.-++.... ..++.+++.|+.||+.||.||.+. ..+|+|-||||.|||+.. -|.+||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 5 4566788999999999999998775 689999999999999999999974 378999999999999954 467999
Q ss_pred ecccchhhhhccCCCC----cceecccccccccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 003199 678 ADFGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYS----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 749 (840)
+|||+++++.+..... ..+....||..|++||.+.- ...+.|+||||+|||+|.++.|+.||........ +
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-I 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-I 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-H
Confidence 9999999986543221 23356789999999997642 3578899999999999999999999965321110 1
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 805 (840)
+ ...++...-.-.++... ....+...++.+|++..-+.|....++..
T Consensus 694 L--------qeNTIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 L--------QENTILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred H--------hhhchhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 11111111111111111 12233445666999999888887776654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=259.30 Aligned_cols=268 Identities=23% Similarity=0.344 Sum_probs=194.4
Q ss_pred HhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-
Q 003199 526 EAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS- 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 603 (840)
..|....+||+|.||.||+|+ .++|+.||+|+..-...+. ..-..-.+|+.++..++|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--------GfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--------GFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--------CCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 345556689999999999994 4578889998764332221 112345679999999999999999988743
Q ss_pred -------CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCe
Q 003199 604 -------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 604 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
....|+||.+|+. +|.-.+......++..++.+++.++..||.|+|. ..|+|||+||.|||++.++.+|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEE
Confidence 2346899999964 8888888777789999999999999999999999 8999999999999999999999
Q ss_pred eecccchhhhhccC-CCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCC--------
Q 003199 677 VADFGIAKVLQARG-GKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDN-------- 746 (840)
Q Consensus 677 l~Dfg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------- 746 (840)
|+|||+|+.+..+. ......+..+-|..|.+||.+.+ +.|+++.|||+.|||+.||.||.+-+++..+..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 99999998775432 22223455667899999998876 468999999999999999999998887643211
Q ss_pred ------------cchhhhhhhhhc-cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 747 ------------KNIIYWVSIKVD-TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 747 ------------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..+..|...... -.+.....+.....+... ..+..+|+-.++..||.+|+.+.+++.+.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k--d~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK--DDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccC--ChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111111111 000000111111111000 12455677789999999999999998874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-33 Score=307.40 Aligned_cols=386 Identities=28% Similarity=0.388 Sum_probs=222.1
Q ss_pred CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCC
Q 003199 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVT 92 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 92 (840)
..+.-+|+.||||+|++. ..|..+..+.+|+.|++++| .|..+| ....++.+|++|.|.+|.+. ..|..+..+.
T Consensus 41 ~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n---~i~~vp-~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lk 114 (1081)
T KOG0618|consen 41 VEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN---YIRSVP-SSCSNMRNLQYLNLKNNRLQ-SLPASISELK 114 (1081)
T ss_pred hhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh---hHhhCc-hhhhhhhcchhheeccchhh-cCchhHHhhh
Confidence 344455999999999998 89999999999999999999 777777 56889999999999999987 7899999999
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCcc------------------ccccCCcccCCCCCCCeeeccCCccc
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ------------------LAGTIPEELGNLTELTDLDMSVNHLS 154 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~------------------~~~~~p~~l~~l~~L~~L~L~~n~l~ 154 (840)
+|++|++++|++. ..|..+..+..+..+..++|.. +.+.++..+..++. .|+|++|.+.
T Consensus 115 nl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~ 191 (1081)
T KOG0618|consen 115 NLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME 191 (1081)
T ss_pred cccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh
Confidence 9999999999999 7888888777777777777721 22233333333333 4777777776
Q ss_pred ccCCccccCCCCCcEEEeeccccccccc------------------hhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcc
Q 003199 155 GKIPESILRLPKLRVLQLYNNSLSGEIS------------------SVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLV 216 (840)
Q Consensus 155 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------------~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 216 (840)
.. .+..+.+|+.|....|++....- ..-.-..+|+++++++|+++ .+|.++..+.+|+
T Consensus 192 ~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle 267 (1081)
T KOG0618|consen 192 VL---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLE 267 (1081)
T ss_pred hh---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccce
Confidence 21 23333444444444443331110 01111245666666666666 3446666666666
Q ss_pred eeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccC-CC-cccEEeccC
Q 003199 217 VLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LP-HVSIIDLSY 294 (840)
Q Consensus 217 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~-~L~~L~L~~ 294 (840)
.|+..+|+++ .+|..+....+|++|....|.+. -+|....+++.|++|+|..|+|. ..|+.+.. +. .|..|..+.
T Consensus 268 ~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~ 344 (1081)
T KOG0618|consen 268 ALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSS 344 (1081)
T ss_pred EecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhh
Confidence 6666666663 45555555666666666666665 34445556666777777777665 44432221 11 122222222
Q ss_pred CcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcc
Q 003199 295 NSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374 (840)
Q Consensus 295 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 374 (840)
|++.......=..++.|+.|++.+|.+++..-+.+.++..|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|
T Consensus 345 n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp 423 (1081)
T KOG0618|consen 345 NKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLP 423 (1081)
T ss_pred ccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhh
Confidence 2222111111112233444455555554444444444445555555555554222223444455555555555554 344
Q ss_pred hhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCc
Q 003199 375 NSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLS 417 (840)
Q Consensus 375 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~ 417 (840)
..+..+..|++|...+|+|. ..| .+..+ .++.+|+|.|+|+
T Consensus 424 ~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 424 DTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred HHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 44444444444444444444 334 22222 3344444444444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=245.08 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=194.1
Q ss_pred HhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 603 (840)
++|+..+++|+|.+++|+.|. ..+.++++||+++. ...+.+.+|+.++..++ ||||+++++...+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------------VkkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------------VKKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------------HHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 456677889999999999994 45789999999843 33577999999999997 9999999999876
Q ss_pred C--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCCeeecc
Q 003199 604 L--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADF 680 (840)
Q Consensus 604 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Df 680 (840)
+ ....+|+||+++.+....-. .++..++..++.++++||.|+|+ +||+|||+||.|||+|.. -..+++|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeec
Confidence 4 45579999999988776554 46778899999999999999999 999999999999999964 57899999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+|.++.+ .........+..|--||.+..- .|+..-|+|||||++..|+..+.||-...+...+++...+.. .
T Consensus 178 GLAEFYHp----~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL--G 251 (338)
T KOG0668|consen 178 GLAEFYHP----GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL--G 251 (338)
T ss_pred chHhhcCC----CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh--C
Confidence 99999865 2334556677889999998764 578999999999999999999999965443333333322211 0
Q ss_pred ccchhh-------hccccc--------CCCcH--------H-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIME-------VLDKKL--------SGSFR--------D-EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~-------~~~~~~--------~~~~~--------~-~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+.... .+++.. +..+. . ...+.++++-..+..|-.+|||++|++.|
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000110 111111 11111 1 12566777779999999999999999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=291.64 Aligned_cols=244 Identities=28% Similarity=0.406 Sum_probs=188.4
Q ss_pred ccCeeeccCCcE-EEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccc
Q 003199 530 EKNKVGQGGSGT-VYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 530 ~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 607 (840)
..+++|.|+.|+ ||+|.+. |+.||||++.. ...+-..+|+..++.- .|||||++++.-.+....
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhh-------------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 345789999986 6899887 89999999832 2345567899999988 599999999999999999
Q ss_pred eEEEeecCCCChHHHhhcC--CC-CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C--CCCeeec
Q 003199 608 LLVYEYMPNGNLWDALHKG--LV-HLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---N--YQPKVAD 679 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~--~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~D 679 (840)
|+..|.| ..+|.+++... .. ...-...+.+..|+++||+|||+ -+||||||||.||||+. + ..++|+|
T Consensus 579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecc
Confidence 9999999 67999999873 11 11114557788999999999999 89999999999999975 3 4689999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
||+++.+......-.......||-+|+|||++....-+.++||||+||++|+.++ |.+||.+......++...
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~------ 728 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG------ 728 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC------
Confidence 9999988543222233466789999999999999888889999999999999999 599998753332222211
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+. .+.+.. +. ...+|+.+|+.+||..||++.+|+.|
T Consensus 729 ----~~~L~--~L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 729 ----NYTLV--HLEPLP-DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----cccee--eeccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00110 011111 11 55678889999999999999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=265.64 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=198.6
Q ss_pred HHHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-C-C----Ccce
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-H-K----NIVK 596 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~ 596 (840)
+..+|.++..+|+|.||.|.++ +...+..||||+++.-. +..+...-|++++.++. + | -+|+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----------kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----------KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----------HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 4678899999999999999997 55568999999984332 23455667999999994 2 2 2788
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---- 671 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---- 671 (840)
+.+||+-..+.++|+|.+ |-|+++++..+ ...++...++.++.|+++++++||+ .+++|-||||+||++.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 889999999999999999 77999999885 4679999999999999999999999 99999999999999842
Q ss_pred ----------------CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhC
Q 003199 672 ----------------NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITG 735 (840)
Q Consensus 672 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 735 (840)
+..++|+|||.|+.-.. .....+.|..|.|||++.+-.++..+||||+||||+|+.||
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceecc------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 23489999999986432 22556789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhhccccch--------------------------hhhccccc-----CCCcHHHHHHHHH
Q 003199 736 RKPVEDDFGDNKNIIYWVSIKVDTKEGI--------------------------MEVLDKKL-----SGSFRDEMIQVLR 784 (840)
Q Consensus 736 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~-----~~~~~~~~~~l~~ 784 (840)
..-|+...+ .+.+.....+..+....+ ..+.+.-. ...-..+..++++
T Consensus 306 ~~LFqtHen-~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 306 ETLFQTHEN-LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred ceecccCCc-HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 998876431 111111111000000000 00000000 0011245678999
Q ss_pred HHHHccCCCCCCCCCHHHHHHH
Q 003199 785 IAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 785 l~~~cl~~dP~~Rps~~evl~~ 806 (840)
|+..|+..||.+|+|+.|++.+
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=295.88 Aligned_cols=257 Identities=18% Similarity=0.176 Sum_probs=167.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-C----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-S----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
.++|...+.||+|+||.||+|... + +..||||++..... .+....| .+....+.+++.++.
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------------~e~~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------------VEIWMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------------hHHHHHH--HHHhhchhhHHHHHH
Confidence 457888999999999999999665 4 68999998743210 0001111 111112222222221
Q ss_pred E------EecCccceEEEeecCCCChHHHhhcCCCC-------------------CChHHHHHHHHHHHHHHHHHhhcCC
Q 003199 600 Y------FSSLYCNLLVYEYMPNGNLWDALHKGLVH-------------------LDWPTRHKIAFGVAQGLAYLHHGLL 654 (840)
Q Consensus 600 ~------~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~ 654 (840)
. +......++||||+++++|.+++...... ..+..+..++.|++.||+|||+
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--- 273 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--- 273 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---
Confidence 1 24566789999999999999988754211 1123456799999999999999
Q ss_pred CCeEecCCCCCCEEEcC-CCCCeeecccchhhhhccCCCCcceecccccccccCccccccC-------------------
Q 003199 655 SPIIHRDIKSTNILLDV-NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS------------------- 714 (840)
Q Consensus 655 ~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------- 714 (840)
++|+||||||+|||+++ ++.+||+|||+|+.+.. +.........+|+.|+|||.+...
T Consensus 274 ~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~--~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l 351 (566)
T PLN03225 274 TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV--GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 351 (566)
T ss_pred CCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccc--ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence 99999999999999986 57899999999976533 222333456789999999965322
Q ss_pred ---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc---cchhhhcccccCCCcH-------HHHHH
Q 003199 715 ---KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK---EGIMEVLDKKLSGSFR-------DEMIQ 781 (840)
Q Consensus 715 ---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~ 781 (840)
.++.++|||||||++|||+++..|+... ............ ..+............. .....
T Consensus 352 ~~~~~~~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 352 WQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred ccccCCCCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 2345679999999999999987665421 111110000000 0001111111111100 01223
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 782 VLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 782 l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+++.+|++.||++|||++|+++|
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCC
Confidence 4578899999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=239.39 Aligned_cols=196 Identities=29% Similarity=0.384 Sum_probs=162.5
Q ss_pred ccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccc
Q 003199 530 EKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 607 (840)
....||+|++|.|-+.++ .+|+..|||++...-. .+..+...+|+.+..+. .+|.+|.++|.+.+....
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---------hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 455799999999988744 5799999999844321 24456778888886665 799999999999999999
Q ss_pred eEEEeecCCCChHHHhh---cCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 608 LLVYEYMPNGNLWDALH---KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
++.||.| ..||..+-. +.+...++...-+||..+++||.|||+. ..++|||+||+|||++.+|++|+||||.+.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 457655433 2345789999999999999999999995 679999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCC
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS----SKATTKCDVYSFGVVLMELITGRKPVED 741 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~tg~~p~~~ 741 (840)
++.+ +...+...|-..|||||.+.. ..|+-||||||+|+.+.||.+++.||+.
T Consensus 198 ~L~d----SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVD----SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehh----hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 7743 334445678889999998853 3789999999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=281.96 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=198.2
Q ss_pred hcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe--
Q 003199 527 AMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS-- 602 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 602 (840)
.|++.+.||.|.+|.||++. .++|+.+|||+..... ...+++..|+++++.. .|||++.++|++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----------d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----------DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----------cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 45667789999999999994 4578999999873322 2245677899999888 5999999999984
Q ss_pred ---cCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 603 ---SLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 603 ---~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
.++..|||||||.+||..+.+..- ...+.|+.+..|++.++.|+.+||. ..++|||+|-.|||++.++.+|++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 367889999999999999988754 3578999999999999999999999 899999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
|||.+..+.. ......+..||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+.+.....+
T Consensus 166 DFGvSaQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------ 236 (953)
T KOG0587|consen 166 DFGVSAQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 236 (953)
T ss_pred eeeeeeeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------
Confidence 9999977642 3345567889999999999843 3578899999999999999999999876421100
Q ss_pred hhhhccccchhhhcccccCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIKVDTKEGIMEVLDKKLSG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.-.+....++ .......++.+.+..|+.+|-++||++.+++++
T Consensus 237 ----------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 ----------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0011112222 224456778889999999999999999988765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=281.59 Aligned_cols=268 Identities=23% Similarity=0.257 Sum_probs=180.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-----------------CCCcEEEEEEecccccccccCchh----hHHHHHHHHHHH
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-----------------NSGEVVAVKKLWSQRTKVSASDTD----QLQLDKGLKTEV 583 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~~----~~~~~~~~~~E~ 583 (840)
.++|...++||+|+||+||+|.. ..++.||||++............. .....+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45788899999999999999853 235689999985432110000000 001123345577
Q ss_pred HHHhccCCCCc-----ceeeeEEec--------CccceEEEeecCCCChHHHhhcCC-----------------------
Q 003199 584 ETLGNIRHKNI-----VKLYCYFSS--------LYCNLLVYEYMPNGNLWDALHKGL----------------------- 627 (840)
Q Consensus 584 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------- 627 (840)
.++.+++|.++ ++++++|.. ....++||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888876654 677777743 346799999999999999886421
Q ss_pred CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccC
Q 003199 628 VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707 (840)
Q Consensus 628 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a 707 (840)
..++|..+..++.|++.||+|+|+ .+|+||||||+||+++.++.+||+|||++..... +.........+|+.|+|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~--~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT--GINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCcccccc--CCccCccccCCCcceeC
Confidence 134678899999999999999999 8999999999999999999999999999976532 11112223345789999
Q ss_pred ccccccCCC----------------------CccccchhHHHHHHHHHhCCC-CCCCCCCCC-------cchhhhhhhhh
Q 003199 708 PEYAYSSKA----------------------TTKCDVYSFGVVLMELITGRK-PVEDDFGDN-------KNIIYWVSIKV 757 (840)
Q Consensus 708 PE~~~~~~~----------------------~~~~Dv~slG~il~el~tg~~-p~~~~~~~~-------~~~~~~~~~~~ 757 (840)
||.+..... ..+.||||+||++|||++|.. |+....... .....|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 234799999999999999875 664321100 11111111100
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSP---ATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~evl~~L 807 (840)
. ..+ +. .+........+++.+++..+| .+|+|++|+++|-
T Consensus 459 ~-------~~~--~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 459 Q-------KYD--FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred c-------CCC--cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0 000 00 112233556778888998765 7899999999873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=261.25 Aligned_cols=240 Identities=32% Similarity=0.423 Sum_probs=190.6
Q ss_pred CCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEeecCC
Q 003199 538 GSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPN 616 (840)
Q Consensus 538 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 616 (840)
+||.||+|... +|+.||+|++...... ...+.+.+|++.+++++|+|++++++++......++|+||+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---------KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 58999999776 5899999998543321 1157889999999999999999999999998999999999999
Q ss_pred CChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcce
Q 003199 617 GNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696 (840)
Q Consensus 617 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 696 (840)
++|.+++.... .+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++++|||.+...... ...
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----~~~ 143 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG----GLL 143 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccc----ccc
Confidence 99999987754 38999999999999999999999 89999999999999999999999999999776432 133
Q ss_pred ecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcH
Q 003199 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR 776 (840)
Q Consensus 697 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 776 (840)
....++..|+|||...+..++.++||||+|+++|++++|..||.... .......+ ...... .......
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~---~~~~~~--------~~~~~~~ 211 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKK---IGKPKP--------PFPPPEW 211 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHH---HhccCC--------CCccccc
Confidence 45568889999999988889999999999999999999999986521 11111110 000000 0000000
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 777 DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 777 ~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....++.+++.+|+..+|++||++.+++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 034567788889999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=269.32 Aligned_cols=209 Identities=25% Similarity=0.365 Sum_probs=174.0
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+-||-|+||+|.++... +...+|+|.+.+... -........+.|-.||+.-..+=||+++-.|.+.+.
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-------l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-------LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-------HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 555678999999999998554 567899998854432 223445677889999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
+|+||+|++||++-..|.+.+ .|.+.-++.++..+.+|+++.|. .|+|||||||+|||||.+|++||+|||++.-+
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccc
Confidence 999999999999999887765 68888999999999999999999 99999999999999999999999999997433
Q ss_pred ---------hccC--CC----------------------------CcceecccccccccCccccccCCCCccccchhHHH
Q 003199 687 ---------QARG--GK----------------------------DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGV 727 (840)
Q Consensus 687 ---------~~~~--~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 727 (840)
+..+ .. .......+||+.|+|||++....++...|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1100 00 00112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCc
Q 003199 728 VLMELITGRKPVEDDFGDNK 747 (840)
Q Consensus 728 il~el~tg~~p~~~~~~~~~ 747 (840)
|||||+.|++||.++...+.
T Consensus 860 il~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcc
Confidence 99999999999987655444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=252.43 Aligned_cols=203 Identities=24% Similarity=0.352 Sum_probs=170.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
.+|...++||+|+|.+|..+.+ ++.+.+|+|+++++....... ..=.+.|-.+..+- +||.+|-+..+|..
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-------idwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-------IDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-------chhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 4577788999999999999855 478999999986654322111 11123344444444 69999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
+...++|.||++||+|--+++++. .++++.++.+...|.-||.|||+ +||+.||+|..|||+|..|++|++|+|+.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchh
Confidence 999999999999999977776654 79999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
+.--. ....++.++|||.|+|||++.+..|....|.|++||+++||+.|+.||+..
T Consensus 399 ke~l~---~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 399 KEGLG---PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred hcCCC---CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 75322 334567889999999999999999999999999999999999999999753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-31 Score=251.27 Aligned_cols=272 Identities=25% Similarity=0.328 Sum_probs=195.5
Q ss_pred ccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC----
Q 003199 530 EKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL---- 604 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 604 (840)
..+.||.|+||.||.+ +-++|+.||.|++..- .......+.+-+|++++..++|+|++..++...-.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv--------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV--------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchH--------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence 4567999999999998 5568999999987332 22344567888999999999999999988776432
Q ss_pred -ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 -YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+.|.|+|.| ..+|.+.+-... .++-..+.-+.+||++||.|||+ .+|.||||||.|.+++++...||||||+|
T Consensus 129 FqEiYV~TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 129 FQELYVLTELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccc
Confidence 3557888988 457776665443 67888889999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh---------h
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW---------V 753 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~---------~ 753 (840)
+.-.. ......+...-|..|.|||.+.+. .|+.+.||||.|||+.|++.++.-|+....-. .+... .
T Consensus 204 Rvee~--d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-QL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 204 RTWDQ--RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-QLQMIIDLLGTPSQE 280 (449)
T ss_pred cccch--hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH-HHHHHHHHhCCCcHH
Confidence 87543 233344556678899999999875 58999999999999999999998887643211 11000 0
Q ss_pred hhhhccccchhhhcccccC-CCc---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh-hcCCCCCCC
Q 003199 754 SIKVDTKEGIMEVLDKKLS-GSF---------RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA-EADPCRFES 817 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~-~~~---------~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~-~~~~~~~~~ 817 (840)
..+...+.....++..... +.. .+.-.+...+..+++..||++|.+..+.+.++. +-...++-+
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~s 355 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHS 355 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeee
Confidence 0011111111112211111 111 122234556677899999999999999998874 333334433
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=293.75 Aligned_cols=389 Identities=28% Similarity=0.360 Sum_probs=277.2
Q ss_pred ccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccC
Q 003199 6 LTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQI 84 (840)
Q Consensus 6 ~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 84 (840)
..+.+|. ++.+.+|+.|.++.|.|. ..|.+..++.+|++|+|.+| ++..+|. .+..+.+|+.|+++.|.+. ..
T Consensus 56 ~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n---~l~~lP~-~~~~lknl~~LdlS~N~f~-~~ 129 (1081)
T KOG0618|consen 56 QISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNN---RLQSLPA-SISELKNLQYLDLSFNHFG-PI 129 (1081)
T ss_pred ccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccc---hhhcCch-hHHhhhcccccccchhccC-CC
Confidence 3445553 777778888888888887 77777778888888888888 5666654 3777888888888888765 44
Q ss_pred CccccCCCCCc-------------------EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCC-----
Q 003199 85 PASIGNVTSLT-------------------DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNL----- 140 (840)
Q Consensus 85 ~~~~~~l~~L~-------------------~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l----- 140 (840)
|..+..++.++ .++|..|.+.+.++..+..+.. .|+|++|.+. .. .+..+
T Consensus 130 Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--~~--dls~~~~l~~ 203 (1081)
T KOG0618|consen 130 PLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--VL--DLSNLANLEV 203 (1081)
T ss_pred chhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh--hh--hhhhccchhh
Confidence 44444444444 4444444454455555555555 5888877633 11 12222
Q ss_pred ---------------CCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccC
Q 003199 141 ---------------TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEV 205 (840)
Q Consensus 141 ---------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 205 (840)
++|+.|+.++|.+....+. ..-.+|+++++++|+++..+ +.++.+.+|+.|...+|+++ .+
T Consensus 204 l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~l 279 (1081)
T KOG0618|consen 204 LHCERNQLSELEISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-AL 279 (1081)
T ss_pred hhhhhcccceEEecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hh
Confidence 3455555555555522211 12357888899999988554 88888999999999999996 67
Q ss_pred CcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccC-CceEEeeCceeeccCC-ccccC
Q 003199 206 PQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKN-LLRFRVSNNHLEGSIP-EGILS 283 (840)
Q Consensus 206 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~-~~~~~ 283 (840)
|..+..+++|+.|++..|.++ -+|....++..|+.|+|..|++....+..|..+.. |..|..+.|++. ..| ..=..
T Consensus 280 p~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~ 357 (1081)
T KOG0618|consen 280 PLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENN 357 (1081)
T ss_pred HHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchh
Confidence 777888888999999999887 56667777888899999999888554444444443 777788888887 334 22224
Q ss_pred CCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhc
Q 003199 284 LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363 (840)
Q Consensus 284 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 363 (840)
++.|+.|.+.+|.+++.....+.+.++|+.|+|++|+|..+....+.++..|++|+||+|+|+ .+|..+.+++.|++|.
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 677888888888888877777888888888888888888666667778888888888888888 6788888888888888
Q ss_pred ccCCccCCCcchhcccccCCCEEECcCccccc-cCCchhhccCCCeEEccCCC
Q 003199 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG-YIPESLCELLPNSINFSNNR 415 (840)
Q Consensus 364 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~~~l~l~~N~ 415 (840)
..+|+|. .+| .+..++.|+.+|||.|.|+. .+|.....-.+++||++||.
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 8888887 667 77888888888888888874 34444333456788888887
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=267.43 Aligned_cols=204 Identities=27% Similarity=0.373 Sum_probs=175.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC---CCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR---HKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 601 (840)
..|+..+.+|+|+||.|+.|.++ ....|+||.+++++.-......+ +..-.+..||++|..++ |+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrD--rkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRD--RKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcc--cccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45888899999999999999554 56789999998776543222111 12345678999999997 99999999999
Q ss_pred ecCccceEEEeec-CCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 602 SSLYCNLLVYEYM-PNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 602 ~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
++++.+||+||-. ++.+|++++.... .+++.++..|++||+.|+++||+ .+|||||||-+||.++.+|-+||+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 9999999999986 4568999998764 78999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCC
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVE 740 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~ 740 (840)
|.|.+. +..+...+.||..|.|||++.+..| ...-|||++|+++|.++....||.
T Consensus 715 gsaa~~-----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT-----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh-----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999875 4556778999999999999999887 566899999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=235.56 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=197.6
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeee
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYC 599 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 599 (840)
-+..+.|++.+.+|+|.||.+-.+..+ +.+.+++|-+..+.. ..++|.+|..---.+ .|.||+.-++
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-----------t~~dF~rEfhY~~~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-----------TQADFVREFHYSFFLSPHQHIIDTYE 88 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-----------hHHHHHHHhccceeeccchhhhHHHH
Confidence 345677888899999999999999665 678999998755442 356788887655555 4899998875
Q ss_pred -EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-C-CCCCe
Q 003199 600 -YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-V-NYQPK 676 (840)
Q Consensus 600 -~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~-~~~~k 676 (840)
.|+..+.+++++||++.|+|.+.+... .+.+.....++.|+++|+.|+|+ +.+||||||.+|||+- . ...+|
T Consensus 89 vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 89 VAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEE
Confidence 467778888999999999999998875 47788889999999999999999 9999999999999993 3 34799
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-----KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 751 (840)
+||||.++.... .......+..|.+||..... ...+.+|||.||+++|.++||..||+..-..+..+..
T Consensus 164 lcDFG~t~k~g~------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~ 237 (378)
T KOG1345|consen 164 LCDFGLTRKVGT------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE 237 (378)
T ss_pred eeecccccccCc------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH
Confidence 999999875421 22223345679999976432 3578899999999999999999999976667777777
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHh
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR---PTMNEVVQLL 807 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~evl~~L 807 (840)
|.++... ..++.+..+......+.++..+-+..+|++| .+++...+.+
T Consensus 238 ~~~w~~r--------k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 238 WEQWLKR--------KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred HHHHhcc--------cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 7765322 2234555555566677777889999999999 4444444433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=240.55 Aligned_cols=258 Identities=25% Similarity=0.325 Sum_probs=194.8
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|..++.+|.|+- .|..| +.-.++.||+|+...+..- ....+...+|...+..+.|+|+++++.++.-
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--------~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--------QTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--------CccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 346677788999988 56565 5557899999987554211 2334667789999999999999999998843
Q ss_pred ------CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 ------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
....|+|||+| .++|...+.. .++..++..+.+|+..|++|||+ .||+||||||+||++..++.+||
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheee
Confidence 34668999999 6789888873 57889999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
.|||+|+.-. .+...+....|..|.|||++.+-.+.+.+||||.||++.||++|+.-|.+. ..+-.|.+...
T Consensus 160 ~dfg~ar~e~----~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~ 231 (369)
T KOG0665|consen 160 LDFGLARTED----TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIE 231 (369)
T ss_pred ccchhhcccC----cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHH
Confidence 9999997642 233456677899999999999988999999999999999999999988642 22223322211
Q ss_pred ccccc-----------hhh----------------hcccccCCCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 DTKEG-----------IME----------------VLDKKLSGSFR---DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~~~~~-----------~~~----------------~~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... ... +.|..++...+ -......+++.+|+-.+|++|.|++++++|
T Consensus 232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000 000 01111111110 112345678889999999999999999988
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=234.41 Aligned_cols=212 Identities=37% Similarity=0.563 Sum_probs=182.4
Q ss_pred eeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 534 VGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 534 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
||+|++|.||++... +++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 689999999999765 48999999985443210 34678899999999999999999999999899999999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecccchhhhhccCC
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 691 (840)
|+++++|.+++......+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 999999999998753468999999999999999999999 89999999999999999 89999999999976543211
Q ss_pred CCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
......+...|++||..... ..+.++|+|++|++++++
T Consensus 149 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 149 ---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred ---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 23345578899999998777 788999999999999999
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3566788899999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=240.63 Aligned_cols=131 Identities=28% Similarity=0.366 Sum_probs=111.0
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-----C---CCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-----H---KNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~ 596 (840)
.+|...++||-|.|++||++ +..+.+.||+|+.+... ...+....||+++++++ | ..||+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-----------hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-----------HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-----------HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 46788899999999999998 66778999999985433 23456678999999984 2 46999
Q ss_pred eeeEEe----cCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 597 LYCYFS----SLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 597 l~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
++++|. .+.+.+||+|++ |.+|..++... .+.++...+.+|++||+.||.|||.. .||+|-||||+|||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 999884 456889999999 88999988765 46799999999999999999999997 5899999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=256.09 Aligned_cols=250 Identities=30% Similarity=0.383 Sum_probs=195.2
Q ss_pred HhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|....++|+|.||.|||+ +..+++..|||+++...... .+.+..|+-+++.++|+|||.++|-+...
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd----------~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD----------FSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc----------ccccccceeeeecCCCcChHHHHhhhhhh
Confidence 45677789999999999999 55689999999996654322 34567799999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..+++||||.+|+|.+.-+... .+.+.++..+++...+|++|||+ ++-+|||||-.||++++.|.+|++|||.+.
T Consensus 85 dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchh
Confidence 99999999999999998776554 68888999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCcceecccccccccCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYA---YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.+.. .-.....+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|..+.. ..... .+....
T Consensus 161 qita---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh---pmr~l----~LmTkS 230 (829)
T KOG0576|consen 161 QITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH---PMRAL----FLMTKS 230 (829)
T ss_pred hhhh---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc---hHHHH----HHhhcc
Confidence 6632 33445678899999999976 45678999999999999999998888754321 11000 111111
Q ss_pred chhhhccccc--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003199 762 GIMEVLDKKL--SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805 (840)
Q Consensus 762 ~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~ 805 (840)
..+ .+.+ ...+.+. +-.+++.|+.++|++||+++.+++
T Consensus 231 ~~q---pp~lkDk~kws~~---fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQ---PPTLKDKTKWSEF---FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCC---CCcccCCccchHH---HHHHHHHHhcCCCccCCChhhhee
Confidence 000 1111 1122233 335666899999999999987664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=237.24 Aligned_cols=268 Identities=26% Similarity=0.339 Sum_probs=197.9
Q ss_pred HHHHHHhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcc
Q 003199 521 QREILEAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIV 595 (840)
Q Consensus 521 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 595 (840)
...+.+.|...++||+|.|++||++... ..+.||+|.+..... -..+..|++++..+ .+.||+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------------p~ri~~El~~L~~~gG~~ni~ 98 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------------PSRILNELEMLYRLGGSDNII 98 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------------chHHHHHHHHHHHhccchhhh
Confidence 4556778889999999999999998433 467899998854432 24578899999999 599999
Q ss_pred eeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCC
Q 003199 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQ 674 (840)
Q Consensus 596 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~ 674 (840)
++.+++...+...+|+||++.....++... ++...+..+++.+..||+++|+ .|||||||||+|++.+. .+.
T Consensus 99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred cchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCC
Confidence 999999999999999999999988888764 6788999999999999999999 99999999999999975 456
Q ss_pred Ceeecccchhhhhcc------------------C-----------------------CCCcceecccccccccCcccccc
Q 003199 675 PKVADFGIAKVLQAR------------------G-----------------------GKDSTTTVIAGTYGYLAPEYAYS 713 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~------------------~-----------------------~~~~~~~~~~gt~~y~aPE~~~~ 713 (840)
-.|.|||+|...... + ..........||++|.|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 799999999732110 0 00111234679999999999866
Q ss_pred C-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh----------ccc------c---chh---------
Q 003199 714 S-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV----------DTK------E---GIM--------- 764 (840)
Q Consensus 714 ~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~------~---~~~--------- 764 (840)
. ..+.+.||||.|||+.-+++++.||-....+...+...+.+.. ... . ...
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 4 5688999999999999999999999765443332222111000 000 0 000
Q ss_pred --hhccc------ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 --EVLDK------KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 --~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
+.+.+ ............++++..+|+..||.+|.|++++++|-
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 00000 00001111223567888899999999999999999873
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=243.71 Aligned_cols=261 Identities=24% Similarity=0.271 Sum_probs=197.1
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC------CCCccee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR------HKNIVKL 597 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 597 (840)
-.+|.+....|+|-|++|.+| +..-|+.||||+|.... ...+.=..|+++|+++. ..+++++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----------VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----------HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 356777788999999999999 44568899999995543 22344567999999995 3578999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-C
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-Q 674 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~ 674 (840)
+..|....+.|||+|-+ ..+|.+.+.+.+ ..+....+..++.|+.-||..|.. .+|+|.||||.|||+++.- .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 99999999999999988 678999998764 467788999999999999999999 8999999999999998754 5
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+||||||.|..... ...+...-+..|.|||++.+-.|+...|+||+||.|||+.||+..|.+..+... +...+.
T Consensus 576 LKLCDfGSA~~~~e-----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M-Lrl~me 649 (752)
T KOG0670|consen 576 LKLCDFGSASFASE-----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM-LRLFME 649 (752)
T ss_pred eeeccCcccccccc-----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH-HHHHHH
Confidence 79999999987643 223334456789999999999999999999999999999999999887432110 000000
Q ss_pred hh-------------------------------hcccc--chhhhccc------------ccCCCcHHHHHHHHHHHHHc
Q 003199 755 IK-------------------------------VDTKE--GIMEVLDK------------KLSGSFRDEMIQVLRIAIRC 789 (840)
Q Consensus 755 ~~-------------------------------~~~~~--~~~~~~~~------------~~~~~~~~~~~~l~~l~~~c 789 (840)
.+ +-..+ .+...+.+ .++.+-......+.+|+-.|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 00 00000 00000111 12222234456778888899
Q ss_pred cCCCCCCCCCHHHHHHH
Q 003199 790 TSKSPATRPTMNEVVQL 806 (840)
Q Consensus 790 l~~dP~~Rps~~evl~~ 806 (840)
+..||++|.|..++++|
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.96 Aligned_cols=200 Identities=35% Similarity=0.486 Sum_probs=170.9
Q ss_pred cCccCeeeccCCcEEEEEEeCC-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+.||.|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 4456789999999999997764 899999998543211 245688899999999999999999999999899
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++++||+++++|.+++......+++..+..++.+++.++.+||+ .+++|+|++|+||+++.++.++|+|||.+...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 999999999999999998764338999999999999999999999 89999999999999999999999999998876
Q ss_pred hccCCCCcceecccccccccCcccc-ccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYA-YSSKATTKCDVYSFGVVLMELITGRKPVED 741 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 741 (840)
.... ........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 149 ~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDL--AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcc--cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4321 1122345677889999988 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-28 Score=242.24 Aligned_cols=382 Identities=20% Similarity=0.231 Sum_probs=207.4
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecC-ccccccCCccccCCCCCcEEE
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT-CALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 98 (840)
..++|..|+|+.+.|.+|..+++|++|||++| .|+.|.+++|.+|++|.+|.+.+ |+|+....+.|++|..|+.|.
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N---~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKN---NISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceeccccc---chhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 34455555555444445555555555555555 44444455555555444444443 444433334455555555555
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCc-ccCCCCCCCeeeccCCc------------ccccCCccccCCC
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE-ELGNLTELTDLDMSVNH------------LSGKIPESILRLP 165 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~-~l~~l~~L~~L~L~~n~------------l~~~~~~~~~~l~ 165 (840)
+.-|++.-...+.|..+++|..|.+..|. ...++. .|..+..++++++..|. +-...|..+++..
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~--~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar 224 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNK--IQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR 224 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchh--hhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence 55555544444445555555555555443 222332 44445555555554444 1112233333333
Q ss_pred CCcEEEeeccccccccchhhhcC-CCCCEEEccCCcCcccCC-cCCCCCCCcceeccccccccccCCccccCCCCchhhh
Q 003199 166 KLRVLQLYNNSLSGEISSVIANS-TTLTMLSLYDNSLTGEVP-QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243 (840)
Q Consensus 166 ~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 243 (840)
...-..+.++++..+.+..|... ..+..=..+.+.+..+.| ..|..+++|+.|+|++|+|+.+.+.+|.+...++.|.
T Consensus 225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~ 304 (498)
T KOG4237|consen 225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY 304 (498)
T ss_pred ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence 33333344444433333333221 112111122222222333 3577888888888888888888888888888888888
Q ss_pred cccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccc---------------c--CCcccC
Q 003199 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG---------------P--IANTVG 306 (840)
Q Consensus 244 l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------------~--~~~~~~ 306 (840)
|..|++..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|.|-.|.+.= . .|. =+
T Consensus 305 L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~-Cq 383 (498)
T KOG4237|consen 305 LTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR-CQ 383 (498)
T ss_pred cCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCC-CC
Confidence 88888888878888888888888888888888888888888888888888776530 0 011 01
Q ss_pred CCCCCceeecccceeee---ccchhhcc---------cCcccE-EEcCCCccCCCCCCcccCccccchhcccCCccCCCc
Q 003199 307 NARNLSELFMQRNQISG---FIPSEIYR---------AISLVK-IDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSI 373 (840)
Q Consensus 307 ~l~~L~~L~L~~N~l~~---~~p~~~~~---------l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 373 (840)
....++.+.++++.+.. ..|++.+- .+-+.+ ..-|+..++ .+|..+. ....+|++.+|.++ .+
T Consensus 384 ~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~v 459 (498)
T KOG4237|consen 384 SPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SV 459 (498)
T ss_pred CCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-cc
Confidence 22345666666665532 12222211 222333 234444444 5555443 34667888888887 55
Q ss_pred chhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCC
Q 003199 374 PNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNN 414 (840)
Q Consensus 374 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N 414 (840)
|.. .+.+| .+|+++|+++-.--..|.++ ++..|-+++|
T Consensus 460 p~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 460 PDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 555 55666 78888888773323333333 2344444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=273.16 Aligned_cols=198 Identities=16% Similarity=0.177 Sum_probs=142.6
Q ss_pred cCC-CCcceeeeEE-------ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 003199 589 IRH-KNIVKLYCYF-------SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660 (840)
Q Consensus 589 l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 660 (840)
++| +||+++++++ ......+.++||+ +++|.+++......+++.++..++.||++||+|||+ ++||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence 445 5777788776 2334567789988 679999998765579999999999999999999999 999999
Q ss_pred CCCCCCEEEcC-------------------CCCCeeecccchhhhhccCCC-------------CcceecccccccccCc
Q 003199 661 DIKSTNILLDV-------------------NYQPKVADFGIAKVLQARGGK-------------DSTTTVIAGTYGYLAP 708 (840)
Q Consensus 661 Dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~~-------------~~~~~~~~gt~~y~aP 708 (840)
||||+|||++. ++.+|++|||+++........ ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 455677777777643110000 0011224588999999
Q ss_pred cccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHH
Q 003199 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIR 788 (840)
Q Consensus 709 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 788 (840)
|++.+..++.++|||||||++|||++|..|+.... .. .. ... ... .++...........++.+
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~---~~-~~~-----~~~----~~~~~~~~~~~~~~~~~~ 247 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RT---MS-SLR-----HRV----LPPQILLNWPKEASFCLW 247 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HH---HH-HHH-----Hhh----cChhhhhcCHHHHHHHHH
Confidence 99999999999999999999999999988865310 00 00 000 000 111111123345577789
Q ss_pred ccCCCCCCCCCHHHHHHHh
Q 003199 789 CTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 789 cl~~dP~~Rps~~evl~~L 807 (840)
|++++|.+||+|.|++++-
T Consensus 248 ~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred hCCCChhhCcChHHHhhch
Confidence 9999999999999998864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-28 Score=240.83 Aligned_cols=379 Identities=21% Similarity=0.207 Sum_probs=259.8
Q ss_pred cccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCC-CCCCccCCCCcccccccccccEEEecCccc
Q 003199 3 FMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNE-NPGFKLWKLPESSIFRLTKLRIMVLATCAL 80 (840)
Q Consensus 3 ~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~-N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l 80 (840)
+|.|+-+.|. |+.+++|+.||||+|+|+.+-|++|.+|.+|..|-+.+ | +|+++|...|.+|..|+.|.+.-|++
T Consensus 76 qN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N---kI~~l~k~~F~gL~slqrLllNan~i 152 (498)
T KOG4237|consen 76 QNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN---KITDLPKGAFGGLSSLQRLLLNANHI 152 (498)
T ss_pred cCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC---chhhhhhhHhhhHHHHHHHhcChhhh
Confidence 4566655554 99999999999999999999999999999999988877 6 89999999999999999999999999
Q ss_pred cccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCcccc-----------ccCCcccCCCCCCCeeecc
Q 003199 81 HGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLA-----------GTIPEELGNLTELTDLDMS 149 (840)
Q Consensus 81 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~-----------~~~p~~l~~l~~L~~L~L~ 149 (840)
.-+..+.|..|++|..|.+..|.+....-..|..+..++.+.+..|..+. ...|..+++..-..-..+.
T Consensus 153 ~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~ 232 (498)
T KOG4237|consen 153 NCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLY 232 (498)
T ss_pred cchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHH
Confidence 98989999999999999999999994444599999999999999887221 1234455666666666666
Q ss_pred CCcccccCCccccCC-CCCc-EEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 150 VNHLSGKIPESILRL-PKLR-VLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 150 ~n~l~~~~~~~~~~l-~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
++++..+.+..|... ..+. .+....+....-+...|..+++|+.|+|++|+|+.+.+.+|.+...+++|.|..|+|..
T Consensus 233 ~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~ 312 (498)
T KOG4237|consen 233 YKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEF 312 (498)
T ss_pred HHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHH
Confidence 666665444433321 2221 12222223333334456666667777777777666666666666666677777776666
Q ss_pred cCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeec-----cCCccc-----------cCCCcccEEe
Q 003199 228 PLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG-----SIPEGI-----------LSLPHVSIID 291 (840)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~-----~~~~~~-----------~~l~~L~~L~ 291 (840)
+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+.- .+.+++ ..-..++.++
T Consensus 313 v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~ 392 (498)
T KOG4237|consen 313 VSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIP 392 (498)
T ss_pred HHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhcccc
Confidence 666666666666667777777766667777777777777766665530 000000 1112455666
Q ss_pred ccCCccccc---CCcc---------cCCCCCCce-eecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccc
Q 003199 292 LSYNSFSGP---IANT---------VGNARNLSE-LFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKK 358 (840)
Q Consensus 292 L~~N~l~~~---~~~~---------~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 358 (840)
++++.+... .|+. -...+-+.. ...|++.++ .+|..+. ...++|++.+|.++ .+|.. .+++
T Consensus 393 ~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~ 466 (498)
T KOG4237|consen 393 ISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRS 466 (498)
T ss_pred chhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhh
Confidence 666555321 1111 112223332 234444444 4554433 24678899999998 66766 6677
Q ss_pred cchhcccCCccCCCcchhcccccCCCEEECcCc
Q 003199 359 LNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391 (840)
Q Consensus 359 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 391 (840)
| .+++|+|++...--..|.+++.|.+|-|+.|
T Consensus 467 l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 467 L-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred h-hcccccCceehhhcccccchhhhheeEEecC
Confidence 8 8999999998666678899999999988876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=264.16 Aligned_cols=307 Identities=21% Similarity=0.266 Sum_probs=180.1
Q ss_pred cccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeec
Q 003199 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDM 148 (840)
Q Consensus 69 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L 148 (840)
+|+.|++.++.+. .+|..| ...+|+.|+|.+|++. .+|..+..+++|+.|+|++|.. ...+| .+..+++|++|+|
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~-l~~ip-~ls~l~~Le~L~L 664 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKN-LKEIP-DLSMATNLETLKL 664 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCC-cCcCC-ccccCCcccEEEe
Confidence 3555555555544 334444 2345555555555555 3444455555555555554431 22333 2444555555555
Q ss_pred cCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccccc
Q 003199 149 SVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP 228 (840)
Q Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 228 (840)
++|.....+|..+..+++|+.|++++|......|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.+. .
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~ 739 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-E 739 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-c
Confidence 5544333445555555555555555543222223222 4555555555555433233321 234555555555554 2
Q ss_pred CCccccCCCCchhhhcccccc-------cccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccC
Q 003199 229 LPAKVCSRGKLQYFLVLQNMF-------SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301 (840)
Q Consensus 229 ~~~~~~~l~~L~~L~l~~n~~-------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 301 (840)
+|..+ .+++|.+|.+..+.. ....+..+...++|+.|++++|...+.+|..+..+++|+.|++++|..-+.+
T Consensus 740 lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~L 818 (1153)
T PLN03210 740 FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETL 818 (1153)
T ss_pred ccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCee
Confidence 33322 344444444443221 1112222334568888888888776678888888888888888887544455
Q ss_pred CcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccC-CccCCCcchhcccc
Q 003199 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS-NKLNSSIPNSLSSL 380 (840)
Q Consensus 302 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l 380 (840)
|..+ .+++|+.|+|++|.....+|.. ..+|+.|+|++|.++ .+|..+..+++|+.|+|++ |+++ .+|..+..+
T Consensus 819 P~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L 892 (1153)
T PLN03210 819 PTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKL 892 (1153)
T ss_pred CCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccc
Confidence 5544 6888889999887554444442 357889999999998 6788888999999999988 4555 577778889
Q ss_pred cCCCEEECcCcc
Q 003199 381 KSLNVLDLSNNL 392 (840)
Q Consensus 381 ~~L~~L~l~~N~ 392 (840)
++|+.|++++|.
T Consensus 893 ~~L~~L~l~~C~ 904 (1153)
T PLN03210 893 KHLETVDFSDCG 904 (1153)
T ss_pred cCCCeeecCCCc
Confidence 999999999884
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=262.84 Aligned_cols=335 Identities=24% Similarity=0.294 Sum_probs=152.6
Q ss_pred CCCCCCCCEEecCCCc------CcccCCccccCCC-CCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCC
Q 003199 13 FSPMQNLRRLDLSNNL------FTGQFPLSVFNLT-NLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIP 85 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~------i~~~~p~~~~~l~-~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 85 (840)
|.+|++|+.|.+..+. +...+|..|..++ +|+.|.+.+| .+..+|.. | ...+|+.|++.+|.+. .++
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~---~l~~lP~~-f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKY---PLRCMPSN-F-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCC---CCCCCCCc-C-CccCCcEEECcCcccc-ccc
Confidence 4555555555554332 1223344444443 3555555555 33344432 2 3445555555555554 334
Q ss_pred ccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCC
Q 003199 86 ASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLP 165 (840)
Q Consensus 86 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 165 (840)
..+..+++|+.|+|++|.....+| .++.+++|+.|+|++|. ....+|..+..+++|+.|++++|..-..+|..+ +++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~-~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCS-SLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCC-CccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 444555555555555443222333 24455555555555543 233445555555555555555543222334333 455
Q ss_pred CCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc-------ccCCccccCCCC
Q 003199 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS-------GPLPAKVCSRGK 238 (840)
Q Consensus 166 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~~ 238 (840)
+|+.|+|++|......|.. ..+|++|+|++|.+. .+|..+ .+++|+.|++.++... ...+..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 5555555555432222221 234555555555554 233322 3445555555442211 111111222244
Q ss_pred chhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeeccc
Q 003199 239 LQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQR 318 (840)
Q Consensus 239 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 318 (840)
|+.|++++|...+.+|..++.+++|+.|++++|..-+.+|..+ .+++|+.|++++|......|.. .++|+.|+|++
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~ 855 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSR 855 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCC
Confidence 5555555555444555555555555555555543222444433 4455555555554332222221 23455555555
Q ss_pred ceeeeccchhhcccCcccEEEcCCC-ccCCCCCCcccCccccchhcccCC
Q 003199 319 NQISGFIPSEIYRAISLVKIDLSDN-LLSGPIPSGIGNLKKLNLLMLQSN 367 (840)
Q Consensus 319 N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 367 (840)
|.++ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|++++|
T Consensus 856 n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 856 TGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 5554 34555555555555555553 233 34444445555555555444
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=211.78 Aligned_cols=167 Identities=20% Similarity=0.175 Sum_probs=126.6
Q ss_pred CChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcce
Q 003199 617 GNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696 (840)
Q Consensus 617 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 696 (840)
|+|.+++......++|.+++.++.|++.||+|||+ .+ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 78999998765579999999999999999999999 55 999999999999999 9998765321
Q ss_pred ecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcH
Q 003199 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR 776 (840)
Q Consensus 697 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 776 (840)
...||+.|||||++.+..++.++|||||||++|||++|+.||............+... .. . ..........
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~------~-~~~~~~~~~~ 133 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MP------A-DDPRDRSNLE 133 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hc------c-CCccccccHH
Confidence 1258899999999999999999999999999999999999996532211111111100 00 0 0000011112
Q ss_pred HHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 777 DEMI--QVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 777 ~~~~--~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.... .+.+++.+|+..+|++||++.|+++++...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2222 588899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=212.97 Aligned_cols=247 Identities=21% Similarity=0.367 Sum_probs=185.8
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEE
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 611 (840)
-+|.+...|+.|+|+|+ |..+++|++...... .....+|.+|.-.++-+.||||+.++|.|..+....++.
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t--------~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVT--------ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhccCCCccccccccc-Ccchhhhhhhhhhcc--------hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 35888999999999998 556667877443322 344577899999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeE-ecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 612 EYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPII-HRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 612 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
.||+.|+|+..++++. ...+..++.+++.++|+|++|||+. .+++ ---+.+..|++|++.+++|+- +-+++
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarism-ad~kf---- 339 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF---- 339 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheec-cccee----
Confidence 9999999999999863 4567789999999999999999984 4555 446899999999999988752 11111
Q ss_pred CCCCcceecccccccccCccccccCCC---CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
+.......-.|.||+||.+...+. -.++|+|||.+++||+.|...||.+-..-+- ..++ ..+-
T Consensus 340 ---sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmki-----aleg 405 (448)
T KOG0195|consen 340 ---SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKI-----ALEG 405 (448)
T ss_pred ---eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhh-----hhcc
Confidence 111223345689999999977654 4579999999999999999999976321100 0000 1112
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+...+++.... .+.+++.-|+..||.+||.+..|+-.|+++.
T Consensus 406 lrv~ippgis~---hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISR---HMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccH---HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22333444433 4455666799999999999999999998764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=240.07 Aligned_cols=227 Identities=27% Similarity=0.364 Sum_probs=136.4
Q ss_pred CCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecc
Q 003199 141 TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDL 220 (840)
Q Consensus 141 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 220 (840)
++|++|+|++|+|+. +|.. .++|+.|+|++|.|+.+ |.. ..+|+.|+|++|+++. +|.. .++|+.|+|
T Consensus 242 ~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~L-p~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdL 309 (788)
T PRK15387 242 PELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTHL-PAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSV 309 (788)
T ss_pred CCCcEEEecCCccCc-ccCc---ccccceeeccCCchhhh-hhc---hhhcCEEECcCCcccc-cccc---ccccceeEC
Confidence 344444444444442 2221 23444555555544422 111 1334445555555542 2221 234555555
Q ss_pred ccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCccccc
Q 003199 221 SENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300 (840)
Q Consensus 221 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 300 (840)
++|++++. |.. ..+|..|.+++|.+.+ +|.. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+.
T Consensus 310 S~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~- 376 (788)
T PRK15387 310 SDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS- 376 (788)
T ss_pred CCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-
Confidence 55555432 211 1234444444554443 3321 147888888888888 45543 3467778888888885
Q ss_pred CCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccc
Q 003199 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSL 380 (840)
Q Consensus 301 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 380 (840)
+|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+..+
T Consensus 377 LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L 444 (788)
T PRK15387 377 LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHL 444 (788)
T ss_pred Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhc
Confidence 3432 3578888888888884 4543 2578889999999884 66533 46788999999997 678888889
Q ss_pred cCCCEEECcCccccccCCchhhcc
Q 003199 381 KSLNVLDLSNNLLTGYIPESLCEL 404 (840)
Q Consensus 381 ~~L~~L~l~~N~l~~~~p~~~~~~ 404 (840)
++|+.|+|++|+|+|.+|..+..+
T Consensus 445 ~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 445 SSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred cCCCeEECCCCCCCchHHHHHHHH
Confidence 999999999999998888776443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=237.21 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=142.1
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
.+-..|+|++|.++ .+|..+. ++|+.|++++| .++.+|. .+++|++|+|++|.|+. +|.. .++|+.
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N---~Lt~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~ 266 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDN---NLTSLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLE 266 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCC---cCCCCCC----CCCCCcEEEecCCccCc-ccCc---ccccce
Confidence 45678899999998 7777765 47888999988 5555553 24567777777777763 3432 246666
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
|+|++|.++ .+|..+ ++|+.|+|++|+ ...+|. .+++|+.|+|++|++++ +|.. ..+|+.|++++|+
T Consensus 267 L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~--Lt~LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~ 333 (788)
T PRK15387 267 LSIFSNPLT-HLPALP---SGLCKLWIFGNQ--LTSLPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQ 333 (788)
T ss_pred eeccCCchh-hhhhch---hhcCEEECcCCc--cccccc---cccccceeECCCCcccc-CCCC---cccccccccccCc
Confidence 777777666 334322 345566666665 223333 13455555666655553 2321 1234455555555
Q ss_pred cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcc
Q 003199 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256 (840)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 256 (840)
|+++ |.. ..+|++|+|++|+|+. +|.. ..+|+.|++++|+|+
T Consensus 334 L~~L-P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~------------------------------ 375 (788)
T PRK15387 334 LTSL-PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT------------------------------ 375 (788)
T ss_pred cccc-ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc------------------------------
Confidence 5432 211 1244455555555442 2221 123344444444443
Q ss_pred cccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCccc
Q 003199 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLV 336 (840)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 336 (840)
.+|.. ..+|+.|++++|+|++. |.. .++|+.|++++|+|++ +|... .+|+
T Consensus 376 -------------------~LP~l---~~~L~~LdLs~N~Lt~L-P~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~ 425 (788)
T PRK15387 376 -------------------SLPAL---PSGLKELIVSGNRLTSL-PVL---PSELKELMVSGNRLTS-LPMLP---SGLL 425 (788)
T ss_pred -------------------cCccc---ccccceEEecCCcccCC-CCc---ccCCCEEEccCCcCCC-CCcch---hhhh
Confidence 22221 12344444444444432 111 2345555555555553 34321 2456
Q ss_pred EEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhccc
Q 003199 337 KIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS 379 (840)
Q Consensus 337 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 379 (840)
.|+|++|+|+ .+|..++++++|+.|+|++|+|++..+..+..
T Consensus 426 ~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 426 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred hhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 6667777766 56666667777777777777777666665533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=196.88 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=194.2
Q ss_pred hcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 604 (840)
.|.+.++||+|+||+++.| .+-+++.||||.=..+. ..-+++.|....+.+ ..++|..++-|..++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC------------CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 4678899999999999999 44579999999532111 124567788888888 479999999888999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----CCeeec
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-----QPKVAD 679 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~D 679 (840)
.+..||+|.+ |.||.+.+.-.++.|+..++..+|.|++.-++|+|+ +.+|.|||||+|+||..-+ .+.++|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEe
Confidence 9999999999 899999998877899999999999999999999999 9999999999999997543 478999
Q ss_pred ccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 680 FGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 680 fg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|+.+.++.... .......||.+||+-....++..+.+.|+=|+|-++.+.+-|..||++...+.... .+.++
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-kYeKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-KYEKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-HHHHh
Confidence 99999987654432 23355779999999999999999999999999999999999999999864432211 11111
Q ss_pred h-hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 756 K-VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 756 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
. ......+.+ +...+++++..-++.+. ..+-.+-|..+-+...+.
T Consensus 252 Ge~Kr~T~i~~-----Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 252 GETKRSTPIEV-----LCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFD 297 (449)
T ss_pred ccccccCCHHH-----HHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHH
Confidence 1 111111111 22234444444444433 347778888776655544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=215.56 Aligned_cols=182 Identities=18% Similarity=0.142 Sum_probs=134.9
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC--CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN--SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.+...|...+.||+|+||+||+|... +++.||||++...... .......+.+.+|++++++++|+|+++.+..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~-----~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW-----WSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc-----cccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 34567889999999999999999654 5788899987422100 0012235679999999999999999853322
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCCCeeec
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDI-KSTNILLDVNYQPKVAD 679 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~D 679 (840)
+ ...++||||+++++|... ... . ...++.++++||+|||+ +||+|||| ||+|||++.++.+||+|
T Consensus 90 ~---~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 T---GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred c---CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 2 357999999999999632 111 1 14678899999999999 99999999 99999999999999999
Q ss_pred ccchhhhhccCCCCc-----ceecccccccccCccccccCC------CCccccch
Q 003199 680 FGIAKVLQARGGKDS-----TTTVIAGTYGYLAPEYAYSSK------ATTKCDVY 723 (840)
Q Consensus 680 fg~a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~ 723 (840)
||+|+.+...+.... ......+++.|+|||++...+ .+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999998755432211 113567888999999885442 23446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=189.33 Aligned_cols=261 Identities=22% Similarity=0.237 Sum_probs=193.3
Q ss_pred HHhcCccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC-CCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH-KNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~ 602 (840)
...|..+++||+|+||.+|.| ...+|+.||||+=..... ...+..|..+.+.++| ..|..+..|..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------------hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------------HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC------------CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 456888999999999999999 556899999997532221 2346678888888874 77888888888
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---CCeeec
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY---QPKVAD 679 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~D 679 (840)
+.....+||+.+ |.||.+.+.-....++..+++-.+-|++.-++|+|. ++++||||||+|.|..-+- .+.++|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEe
Confidence 999999999999 899999988777789999999999999999999999 9999999999999997543 578999
Q ss_pred ccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 680 FGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 680 fg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|+.+.+..... .......||.+|.+-....+...+.+.|+-|+|.++.+.--|..||++..+..... .+.++
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-KyEkI 236 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-KYEKI 236 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-HHHHH
Confidence 99999886543221 23345679999999888777788999999999999999999999999754322111 11111
Q ss_pred hhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 756 KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.........+++ +...+.++.-.+.-|-..--++-|...-+-+.+.-
T Consensus 237 ~EkK~s~~ie~L-------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 237 SEKKMSTPIEVL-------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHhhcCCCHHHH-------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 000000001111 11223344445556777777777877666655544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=206.88 Aligned_cols=263 Identities=22% Similarity=0.235 Sum_probs=189.8
Q ss_pred hcCccCeeeccCCcEEEEEEeCCC--cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC----CCcceeeeE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSG--EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH----KNIVKLYCY 600 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~ 600 (840)
+|...+.||+|+||.||.|..... ..+|+|.-....... ...+..|+.++..+.. +++..+++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----------~~~l~~E~~vl~~l~~~~~~~~~~~~~~~ 88 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----------PSVLKIEIQVLKKLEKKNGPSHFPKLLDH 88 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----------CccchhHHHHHHHHhhhcCCCCCCEEEEe
Confidence 788899999999999999966543 578888764432111 1145677888887762 688889888
Q ss_pred E-ecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----C
Q 003199 601 F-SSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-----Y 673 (840)
Q Consensus 601 ~-~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-----~ 673 (840)
+ ......++||+.+ |.+|.+...... ..++..++..|+.|++.+|+++|+ .|++||||||.|+++... .
T Consensus 89 G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 89 GRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred ccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccc
Confidence 8 5777889999988 889999886554 689999999999999999999999 999999999999999865 3
Q ss_pred CCeeecccchh--hhhccCCC----Ccc-eecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 003199 674 QPKVADFGIAK--VLQARGGK----DST-TTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746 (840)
Q Consensus 674 ~~kl~Dfg~a~--~~~~~~~~----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 746 (840)
.+++.|||+|+ .+....+. ... .....||..|+++....+...+.+.|+||++.++.|+..|..||.......
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 58999999998 33222221 111 234669999999999999999999999999999999999999996542211
Q ss_pred cchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
. .....+.. . ...... .....+.... ++...+-..+..++|....+...+++.....
T Consensus 245 ~-~~~~~~~~---~---~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 245 L-KSKFEKDP---R---KLLTDR-FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred h-HHHHHHHh---h---hhcccc-ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1 11100000 0 000000 1112223333 3333444579999999999999987654443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=229.88 Aligned_cols=271 Identities=20% Similarity=0.254 Sum_probs=198.4
Q ss_pred ccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 530 EKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
..+.+|.|++|.|+.+. .......+.|.+... .. ...........+..|+.+-..+.|+|++..+..+.+.....
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~---~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK---PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cC---CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 45689999999887763 334555666654321 10 11222333344888999999999999988887777766666
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
-+||||++ +|+..+.... .+...++..++.|+..|++|+|+ .||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 66999999 9999998763 57888999999999999999999 9999999999999999999999999999987754
Q ss_pred cCCC-CcceecccccccccCccccccCCCCc-cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 689 RGGK-DSTTTVIAGTYGYLAPEYAYSSKATT-KCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 689 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
.... .......+|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+..... ..... ...
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~~~---~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNYSD---QRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hcccc---ccc
Confidence 3221 24556788999999999999999876 589999999999999999999764333222100 00000 000
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCCCCC
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPCRFE 816 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~~~~ 816 (840)
+......-..........++.++++.||.+|-|+++|++. ++++.-|..+
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD 597 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence 1111111223445566778889999999999999999865 5566666554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=225.99 Aligned_cols=291 Identities=25% Similarity=0.387 Sum_probs=149.8
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
.+.+.|+|++++++ .+|..+. ++|+.|+|++| ++..+|...+ ++|++|++++|.++ .+|..+. .+|+.
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N---~LtsLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~ 245 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNN---ELKSLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQE 245 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCC---CCCcCChhhc---cCCCEEECCCCccc-cCChhhh--ccccE
Confidence 34667777777777 5665543 46777777777 4555554322 35566666666555 3343332 24555
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
|+|++|.+. .+|..+. + +|+.|+|++|+|+ .+|..+. ++|+.|+|++|+
T Consensus 246 L~Ls~N~L~-~LP~~l~--s-------------------------~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~ 294 (754)
T PRK15370 246 MELSINRIT-ELPERLP--S-------------------------ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNS 294 (754)
T ss_pred EECcCCccC-cCChhHh--C-------------------------CCCEEECcCCccC-ccccccC--CCCcEEECCCCc
Confidence 555555555 3443332 2 4455555555554 2333332 345555555555
Q ss_pred cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcc
Q 003199 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256 (840)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 256 (840)
|+.++ ..+ .++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +| ..
T Consensus 295 Lt~LP-~~l--p~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP------------------------~~ 343 (754)
T PRK15370 295 IRTLP-AHL--PSGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LP------------------------AS 343 (754)
T ss_pred cccCc-ccc--hhhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CC------------------------hh
Confidence 55322 222 1346666666666653 333222 456666666666652 12 11
Q ss_pred cccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhh----ccc
Q 003199 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI----YRA 332 (840)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l 332 (840)
+ .++|+.|++++|+|+ .+|..+. ++|+.|+|++|+++..++ .+. ..|+.|++++|+|. .+|..+ ..+
T Consensus 344 l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~-~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~ 414 (754)
T PRK15370 344 L--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPE-NLP--AALQIMQASRNNLV-RLPESLPHFRGEG 414 (754)
T ss_pred h--cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCH-hHH--HHHHHHhhccCCcc-cCchhHHHHhhcC
Confidence 1 135566666666665 3444332 456666666666664322 222 25666777777776 344433 334
Q ss_pred CcccEEEcCCCccCCCCCCcccCccccchhcccCCccCC-CcchhcccccCCCEEECcCccccccC
Q 003199 333 ISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS-SIPNSLSSLKSLNVLDLSNNLLTGYI 397 (840)
Q Consensus 333 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~ 397 (840)
+.+..|+|.+|+++. ..+.+|+.| ++.+.+.| .++...+.+.+++....-.+.+++++
T Consensus 415 ~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~Wl 473 (754)
T PRK15370 415 PQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQGWL 473 (754)
T ss_pred CCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHhccC
Confidence 667788888887762 345556666 44455543 22333334444444333444444433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-22 Score=221.40 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=185.6
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
++...+.+|++.|=+|.+|+...|. |+||++.+......- ...++..+|++ ....+|||.+++.-+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL------~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISL------RPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCc------hHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence 4556778999999999999888777 999999766544322 11233334455 555689999999888878888
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.|||-+|+ .-+|+|.+..+. -+...+...|+.|++.|+..+|. .||+|||||.+|||+++..-+.|+||..-+..
T Consensus 96 AylvRqyv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 96 AYLVRQYV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHHH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCc
Confidence 89999999 559999998764 46677888999999999999999 99999999999999999999999999877665
Q ss_pred hccCCCCcceeccccc----ccccCccccccC-----------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 003199 687 QARGGKDSTTTVIAGT----YGYLAPEYAYSS-----------KATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~ 750 (840)
.-+.+.......+..| ..|+|||.+... ..+++.||||+||+++|+++ |++||.-. ++.
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~ 245 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL 245 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH
Confidence 4433333334333333 479999987542 25788999999999999999 78888631 111
Q ss_pred hhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.+ +.........++. ++.+ ..+..++..|++.||++|.++++.++.-..
T Consensus 246 aY---r~~~~~~~e~~Le-~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 AY---RSGNADDPEQLLE-KIED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hH---hccCccCHHHHHH-hCcC------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11 1111111111111 1111 145678889999999999999999988443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-19 Score=197.23 Aligned_cols=263 Identities=31% Similarity=0.375 Sum_probs=195.7
Q ss_pred cCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCC-CcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK-NIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~ 606 (840)
|...+.||.|+||.||++... ..+|+|.+....... ......+.+|+.+++.+.|+ +++++.+.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESK-------SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccc-------hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence 456678999999999999776 789999885443221 13467789999999999988 79999999977777
Q ss_pred ceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeeecccch
Q 003199 607 NLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIA 683 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a 683 (840)
.+++++|+.++++.+.+.... ..+.......++.+++.+++|+|+ .+++|||+||+||+++..+ .++++|||.+
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 899999999999997776653 268889999999999999999999 8999999999999999988 7999999999
Q ss_pred hhhhccCCCC---cceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 684 KVLQARGGKD---STTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 684 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+......... .......||..|+|||.+.+ ..+....|+||+|++++++++|..||............+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 8654322111 13467789999999999987 57899999999999999999999997653221000011100000
Q ss_pred ccccchhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 DTKEGIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... .......... ......+.+++..|+..+|..|.++.+....
T Consensus 230 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTP----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCc----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000 0000000000 1223456677789999999999999887765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=217.67 Aligned_cols=246 Identities=23% Similarity=0.404 Sum_probs=143.6
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
+...|+|+++.++ .+|..+. ++|+.|+|++|+ ...+|..+. .+|++|+|++|+++ .+|..+. ++|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~--LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNE--LKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCC--CCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 4566666666666 4554442 356666666665 224554432 36667777777666 3444332 35677777
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 252 (840)
++|++..+ |..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|++++ +|..+
T Consensus 249 s~N~L~~L-P~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l------------------- 302 (754)
T PRK15370 249 SINRITEL-PERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHL------------------- 302 (754)
T ss_pred cCCccCcC-ChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccc-------------------
Confidence 77776633 33332 46777777777776 3454443 367777777776663 22211
Q ss_pred CCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhccc
Q 003199 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRA 332 (840)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 332 (840)
. ++|+.|++++|+++ .+|..+. ++|+.|++++|.+++ +|..+ .++|+.|+|++|+|+ .+|..+.
T Consensus 303 -----p--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~-~LP~~lp-- 366 (754)
T PRK15370 303 -----P--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQIT-VLPETLP-- 366 (754)
T ss_pred -----h--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhh--cCcccEEECCCCCCC-cCChhhc--
Confidence 1 23444555555554 2333222 456666666666654 23323 256777777777776 4555443
Q ss_pred CcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhc----ccccCCCEEECcCcccc
Q 003199 333 ISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSL----SSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 333 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~ 394 (840)
++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ ..++++..|+|.+|+|+
T Consensus 367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 47788888888887 4555443 36888888888887 445443 34577888888888887
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=199.53 Aligned_cols=219 Identities=26% Similarity=0.383 Sum_probs=166.4
Q ss_pred HhccCCCCcceeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCe-EecCCCC
Q 003199 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPI-IHRDIKS 664 (840)
Q Consensus 586 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dlk~ 664 (840)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......++|.-...++++++.||+|+|. .+| +|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 356789999999999999999999999999999999999887889999999999999999999998 444 9999999
Q ss_pred CCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccC-------CCCccccchhHHHHHHHHHhCCC
Q 003199 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-------KATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 665 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~el~tg~~ 737 (840)
+|+++|..+.+|++|||+....... ..........-..-|.|||.+.+. ..+.++||||||++++|+++.+.
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999998765321 111111222234569999988663 24678999999999999999999
Q ss_pred CCCCCCCCCcc--hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 738 PVEDDFGDNKN--IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 738 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
||+........ ....++ . .......+.+.... +....+..++.+||..+|.+||++++|-..++.+.....
T Consensus 157 ~~~~~~~~~~~~eii~~~~--~----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVK--K----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred ccccccccCChHHHHHHHH--h----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 99864333222 111111 0 01111111111110 233468889999999999999999999999988777653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=184.26 Aligned_cols=183 Identities=11% Similarity=0.114 Sum_probs=134.5
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.-+..+|...+.+|.|+||.||.++. ++..+|||.+.......... ...-.....+.+|+..+.++.|++|..+..++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~-~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERF-LKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHH-HHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34456788999999999999999866 47789999996543221000 00000123368999999999999999998886
Q ss_pred ecC--------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 602 SSL--------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 602 ~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
... ...++||||++|.+|.++.. ++. ....+++.++..+|. .|++|||+||+||+++.++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 532 35789999999999987732 222 245699999999999 9999999999999999988
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 734 (840)
++++|||..+..... ... ..+.....+..++|+||||+.+.....
T Consensus 173 -i~liDfg~~~~~~e~----~a~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQR----KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccch----hhH-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999988654221 000 113344556789999999998876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=177.50 Aligned_cols=148 Identities=16% Similarity=0.159 Sum_probs=109.8
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccC----------------chhhHHHHHHHHHHHHHHhccCCCCcc
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSAS----------------DTDQLQLDKGLKTEVETLGNIRHKNIV 595 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~----------------~~~~~~~~~~~~~E~~~l~~l~h~niv 595 (840)
..||+|++|.||+|...+|+.||||+++......... .............|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999987789999999996543211100 000001123345699999999887764
Q ss_pred eeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL-HHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 596 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
....+.. ...++||||++++++....... ..+++.+...++.|++.+|+|+ |+ .+|+||||||+||+++ ++.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence 4333222 2338999999988776543222 3688999999999999999999 67 8999999999999998 478
Q ss_pred Ceeecccchhhh
Q 003199 675 PKVADFGIAKVL 686 (840)
Q Consensus 675 ~kl~Dfg~a~~~ 686 (840)
++++|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-19 Score=168.85 Aligned_cols=191 Identities=15% Similarity=0.080 Sum_probs=138.3
Q ss_pred ccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCccce
Q 003199 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 608 (840)
....|++|+||+||.+.. .+.+++.+.+...... ........+.+|+++++++. |+++++++++ ...+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWW------LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhh------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 456899999999998766 5788887766322210 01112335889999999995 5889999886 3468
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCCCeeecccchhhhh
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDI-KSTNILLDVNYQPKVADFGIAKVLQ 687 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfg~a~~~~ 687 (840)
++|||++|.+|.+..... ...++.+++.+++++|+ .||+|||| ||+|||++.++.++|+|||+|....
T Consensus 75 lvmeyI~G~~L~~~~~~~--------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPRG--------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEEeeecCccHHhhhhhh--------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 999999999987544221 23577899999999999 99999999 7999999999999999999998654
Q ss_pred ccCCC----C-c-----ceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 688 ARGGK----D-S-----TTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 688 ~~~~~----~-~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
..+.. . . .......++.|++|+...- ..--.+.+.++-|.-+|.++||+.|.-.+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 32210 0 0 0011235677777774321 22235789999999999999999887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=171.82 Aligned_cols=149 Identities=19% Similarity=0.211 Sum_probs=112.4
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccC----------------chhhHHHHHHHHHHHHHHhccCCCCc
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSAS----------------DTDQLQLDKGLKTEVETLGNIRHKNI 594 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~----------------~~~~~~~~~~~~~E~~~l~~l~h~ni 594 (840)
...||+|++|.||+|...+|+.||||++.......... ..........+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999987789999999986653211000 00111123345689999999999987
Q ss_pred ceeeeEEecCccceEEEeecCCCChHHH-hhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 595 VKLYCYFSSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 595 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
.....+... ..++||||++++++... +.. ..++..+...++.+++.++.++|+. .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CC
Confidence 554444332 24899999998855433 433 2567888999999999999999984 6999999999999999 78
Q ss_pred CCeeecccchhhh
Q 003199 674 QPKVADFGIAKVL 686 (840)
Q Consensus 674 ~~kl~Dfg~a~~~ 686 (840)
.++|+|||+++..
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-20 Score=197.60 Aligned_cols=187 Identities=30% Similarity=0.403 Sum_probs=158.0
Q ss_pred eeccCCcEEEEEE----eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCccce
Q 003199 534 VGQGGSGTVYKID----LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 534 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 608 (840)
+|.|+||.|+.+. ...|..+|+|+.+.......... ....|..++..++ ||.+|++.-++..+...+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--------~t~~er~il~~~~~~~f~v~lhyafqt~~kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--------HTKQERIILAFVHNTPFLVKLHYAFQTDGKLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--------ccccHHHHHhhccCCCceeeeeeeeccccchh
Confidence 7899999999852 23477899998876654432221 2344667777776 999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
++++|..+|++...+.... .+++.....+...++-+++++|+ .+++|||+|++||+++.+|++++.|||+++...+
T Consensus 74 l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred HhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 9999999999999988765 67888888888899999999999 9999999999999999999999999999987654
Q ss_pred cCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003199 689 RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741 (840)
Q Consensus 689 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 741 (840)
.. ..+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 150 ~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 150 EK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 21 128999999999887 678899999999999999999999974
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.3e-21 Score=205.87 Aligned_cols=55 Identities=20% Similarity=0.261 Sum_probs=29.6
Q ss_pred EEecCcccc-ccCCccccCCCCCcEEEccCCccccc----CchhhhcCCCCCeeecccCc
Q 003199 73 MVLATCALH-GQIPASIGNVTSLTDLELTGNFITGH----IPPEIGLLKNLRQLELYYNQ 127 (840)
Q Consensus 73 L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~L~~n~ 127 (840)
|+|..+.+. ......+..+.+|+.|++++|.+++. ++..+...++|++|+++.+.
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~ 62 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE 62 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccc
Confidence 455555554 23334445555666666666666421 33344455556666665554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.9e-21 Score=169.28 Aligned_cols=163 Identities=31% Similarity=0.540 Sum_probs=99.5
Q ss_pred cCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceE
Q 003199 187 NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRF 266 (840)
Q Consensus 187 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 266 (840)
++..++.|.|++|+++ .+|+.+..+.+|+.|++++|+|+ .+|..++.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-------------------------~lp~~issl~klr~l 84 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-------------------------ELPTSISSLPKLRIL 84 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-------------------------hcChhhhhchhhhhe
Confidence 3445555556666665 44555555666666666666555 455566666777777
Q ss_pred EeeCceeeccCCccccCCCcccEEeccCCcccc-cCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCcc
Q 003199 267 RVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLL 345 (840)
Q Consensus 267 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 345 (840)
+++-|++. .+|.+|+.+|.|+.|||.+|.+.. ..|..|-.+..|+.|+|++|.+. .+|..++++.+|+.|.+..|.+
T Consensus 85 nvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 85 NVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred ecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 77777776 677777777777777777777653 34455555566666666666665 5555666666666666666655
Q ss_pred CCCCCCcccCccccchhcccCCccCCCcchhccc
Q 003199 346 SGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS 379 (840)
Q Consensus 346 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 379 (840)
- .+|.+++.+.+|++|++.+|+++ .+|..+++
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 5 45556666666666666666665 44444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=174.70 Aligned_cols=232 Identities=21% Similarity=0.242 Sum_probs=144.9
Q ss_pred CccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC----------CCccee
Q 003199 529 TEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH----------KNIVKL 597 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l 597 (840)
...+.||.|+++.||.+.. .+|+++|||++...... .....+.+++|.-....+.+ -.++.-
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~-------~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA-------SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT-------HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEeccccc-------chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3456899999999999955 57999999998665521 12335666667655555332 112211
Q ss_pred eeE---------EecC---c-----cceEEEeecCCCChHHHhhc---CCC---CCChHHHHHHHHHHHHHHHHHhhcCC
Q 003199 598 YCY---------FSSL---Y-----CNLLVYEYMPNGNLWDALHK---GLV---HLDWPTRHKIAFGVAQGLAYLHHGLL 654 (840)
Q Consensus 598 ~~~---------~~~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~ 654 (840)
++. +... . ..+++|+-+ .+||.+.+.. ... .+....+..+..|+++.+++||+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~--- 163 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS--- 163 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---
Confidence 111 1111 1 225677777 6788776542 211 23344566777899999999999
Q ss_pred CCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccC--------CCCccccchhHH
Q 003199 655 SPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS--------KATTKCDVYSFG 726 (840)
Q Consensus 655 ~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~slG 726 (840)
.|+||+||+|+|++++++|.++|+||+....... .......+..|.+||..... .++.+.|.|++|
T Consensus 164 ~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 164 YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred cceEecccceeeEEEcCCCCEEEcChHHHeecCc------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 9999999999999999999999999988765422 11113455789999976432 478899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCC
Q 003199 727 VVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR 797 (840)
Q Consensus 727 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 797 (840)
+++|.|.+|+.||.......... | .+.... +.+..+..|+..+++.+|.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~~--~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADPE--W-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTSG--G-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCcccccc--c-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999997531111100 0 222222 555667778889999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.8e-21 Score=168.96 Aligned_cols=166 Identities=32% Similarity=0.519 Sum_probs=141.5
Q ss_pred CCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCccc
Q 003199 209 LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVS 288 (840)
Q Consensus 209 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 288 (840)
+..+.+.+.|.|++|+++ .+|..++.+.+|+.|++++|+++ .+|..+.++++|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-------------------------~vppnia~l~nlevln~~nnqie-~lp~~issl~klr 82 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-------------------------VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLR 82 (264)
T ss_pred ccchhhhhhhhcccCcee-------------------------ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhh
Confidence 345566677777777776 56667888899999999999998 7888999999999
Q ss_pred EEeccCCcccccCCcccCCCCCCceeecccceeee-ccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCC
Q 003199 289 IIDLSYNSFSGPIANTVGNARNLSELFMQRNQISG-FIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367 (840)
Q Consensus 289 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 367 (840)
.|+++-|++. ..|..|+.++.|+.|+|+.|.+.. .+|..|+.+..|+.|+|+.|.+. .+|..++++++|+.|.+..|
T Consensus 83 ~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 83 ILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred heecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence 9999999997 778889999999999999998864 67888888999999999999998 78888999999999999999
Q ss_pred ccCCCcchhcccccCCCEEECcCccccccCCchhhcc
Q 003199 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL 404 (840)
Q Consensus 368 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 404 (840)
.+- ..|..++.++.|++|.+.+|+|+ .+|+.++.+
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 987 78888999999999999999998 777776655
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-20 Score=201.74 Aligned_cols=59 Identities=19% Similarity=0.115 Sum_probs=35.2
Q ss_pred EEeCCCCCCCccCCCCcccccccccccEEEecCccccc----cCCccccCCCCCcEEEccCCccc
Q 003199 45 VLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHG----QIPASIGNVTSLTDLELTGNFIT 105 (840)
Q Consensus 45 ~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~ 105 (840)
.|+|+++.+. ...+ ...|..+..|+.|++++|.++. .++..+...++|++|+++++.+.
T Consensus 2 ~l~L~~~~l~-~~~~-~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~ 64 (319)
T cd00116 2 QLSLKGELLK-TERA-TELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG 64 (319)
T ss_pred ccccccCccc-ccch-HHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence 3556665321 1111 2345566778888888887743 24455666677788888777766
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.8e-18 Score=171.43 Aligned_cols=198 Identities=25% Similarity=0.302 Sum_probs=135.7
Q ss_pred CCCCcceeeeEEecC---------------------------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHH
Q 003199 590 RHKNIVKLYCYFSSL---------------------------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642 (840)
Q Consensus 590 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i 642 (840)
+|||||++.++|.+. ...|+||..+ ..+|..++..+ ..+.....-+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence 599999998776332 2457888887 45898888775 35556677788999
Q ss_pred HHHHHHHhhcCCCCeEecCCCCCCEEE--cCCC--CCeeecccchhhhhccC---CCCcceecccccccccCccccccCC
Q 003199 643 AQGLAYLHHGLLSPIIHRDIKSTNILL--DVNY--QPKVADFGIAKVLQARG---GKDSTTTVIAGTYGYLAPEYAYSSK 715 (840)
Q Consensus 643 ~~~l~~LH~~~~~~ivH~Dlk~~Nill--~~~~--~~kl~Dfg~a~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~ 715 (840)
++|+.|||. +||.|||+|++|||+ |+|+ ..+|+|||++---...+ ..........|...-||||+....+
T Consensus 351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 999999999999999 3444 35889999873221110 0112223345777899999875432
Q ss_pred ------CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHc
Q 003199 716 ------ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRC 789 (840)
Q Consensus 716 ------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 789 (840)
...|+|.|+.|.+.||+++...||....... .+... .++- .++.-.......+.+++...
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----------L~~r~-Yqe~---qLPalp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----------LDTRT-YQES---QLPALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----------echhh-hhhh---hCCCCcccCChHHHHHHHHH
Confidence 2468999999999999999999997632110 11111 1111 12222223344566777789
Q ss_pred cCCCCCCCCCHHHHHHHh
Q 003199 790 TSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 790 l~~dP~~Rps~~evl~~L 807 (840)
++.||.+|++..-.-..|
T Consensus 494 L~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hcCCccccCCccHHHhHH
Confidence 999999999876555443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=160.90 Aligned_cols=136 Identities=17% Similarity=0.239 Sum_probs=104.5
Q ss_pred CccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-----CCCCcceeeeEEec
Q 003199 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-----RHKNIVKLYCYFSS 603 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~ 603 (840)
...+.||+|+||.||. ...++.. +||++..... ...+.+.+|+.+++.+ .||||++++|++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~----------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD----------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc----------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 4557899999999996 4445555 6888744221 1245689999999999 57999999999988
Q ss_pred Cc---cce-EEEee--cCCCChHHHhhcCCCCCChHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCCEEEcC----C
Q 003199 604 LY---CNL-LVYEY--MPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL-AYLHHGLLSPIIHRDIKSTNILLDV----N 672 (840)
Q Consensus 604 ~~---~~~-lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlk~~Nill~~----~ 672 (840)
.. ..+ +|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+ ++||||||||+||+++. +
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCC
Confidence 64 323 78999 5579999999764 35554 35677888777 99999 99999999999999974 3
Q ss_pred CCCeeecccch
Q 003199 673 YQPKVADFGIA 683 (840)
Q Consensus 673 ~~~kl~Dfg~a 683 (840)
+.++|+||+-+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 47999995443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=189.87 Aligned_cols=250 Identities=19% Similarity=0.195 Sum_probs=176.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|.+.+.||+|+||+||+|...+|+.||+|+=+.+..- .-....+++..++ . .--+-|..+..++.-.+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-------EfYI~~q~~~RLk-~--~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-------EFYICLQVMERLK-P--QMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-------eeeehHHHHHhhc-h--hhhcchHHHHHHHccCC
Confidence 346677889999999999997777999999985433321 1111222222222 0 01234555555666667
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CCCCeee
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-------NYQPKVA 678 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~~kl~ 678 (840)
..++|+||.+.|+|.+++... ...+|.-+..+..|+++.+++||. .+|||+||||+|.|+.. ...++|+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 778999999999999999854 478999999999999999999999 99999999999999942 3358999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||.+-.+..- .........++|-.+-.+|+..++.+++..|-|.+..+++-|+.|+..-. .
T Consensus 844 DfG~siDm~lf-p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~--~--------------- 905 (974)
T KOG1166|consen 844 DFGRSIDMKLF-PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV--K--------------- 905 (974)
T ss_pred ecccceeeeEc-CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh--c---------------
Confidence 99999665432 12245567788999999999999999999999999999999999975310 0
Q ss_pred cccchhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 759 TKEGIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.+....++.+++..+ .+.+.+++.+ ++.+|-..=|...++...+++.-.
T Consensus 906 --~g~~~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 --NGSSWMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred --CCcceeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHHHH
Confidence 000111112222222 3455566664 444555555777777777766543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=163.83 Aligned_cols=142 Identities=20% Similarity=0.304 Sum_probs=116.3
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEE
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVY 611 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 611 (840)
+.||+|++|.||+|.. +|..|+||+........ ...+.......+.+|++++..+.|+++.....++......++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRH--PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcC--hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 57889999864332111 11112223456889999999999999888777777777889999
Q ss_pred eecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 612 EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 612 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
||++|++|.+.+.... + ++..++.+++.++.++|+ .+++|||++|+||+++ ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999987532 2 888999999999999999 9999999999999999 78899999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=161.66 Aligned_cols=150 Identities=17% Similarity=0.165 Sum_probs=112.1
Q ss_pred cCccCeeeccCCcEEEEEE--eCCCcEEEEEEeccccccccc--------------CchhhHHHHHHHHHHHHHHhccCC
Q 003199 528 MTEKNKVGQGGSGTVYKID--LNSGEVVAVKKLWSQRTKVSA--------------SDTDQLQLDKGLKTEVETLGNIRH 591 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~~~~~~~~E~~~l~~l~h 591 (840)
|...+.||+|++|.||+|. ..+|+.||||++......... ...........+.+|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567889999999999997 568999999998654321100 000111123456789999999975
Q ss_pred CC--cceeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCEE
Q 003199 592 KN--IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP-IIHRDIKSTNIL 668 (840)
Q Consensus 592 ~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nil 668 (840)
.. +.+++++ ...++||||++++++........ .....+...++.|++.++++||+ .+ ++||||||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEE
Confidence 33 4444443 23489999999988876543322 45566678999999999999999 88 999999999999
Q ss_pred EcCCCCCeeecccchhhh
Q 003199 669 LDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 669 l~~~~~~kl~Dfg~a~~~ 686 (840)
++ ++.++++|||.+...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=158.24 Aligned_cols=138 Identities=20% Similarity=0.312 Sum_probs=109.6
Q ss_pred eeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
.||+|++|.||+|.+ +|..|++|+....... ....+.......+.+|++++..+.|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYR--HPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCc--CchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999985 4789999986433211 0111222334678899999999998876665555566667789999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
|++|++|.+.+..... .++.+++.+|.++|+ .+++|||++|+||+++ ++.++++|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988765321 789999999999999 9999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=156.39 Aligned_cols=145 Identities=19% Similarity=0.169 Sum_probs=109.9
Q ss_pred cCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCc------------hhhHHHHHHHHHHHHHHhccCCCC--
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASD------------TDQLQLDKGLKTEVETLGNIRHKN-- 593 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~n-- 593 (840)
|...+.||+|+||.||+|...+|+.||||++........... ............|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 556788999999999999888899999999764331110000 001112334678899999998774
Q ss_pred cceeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 594 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
+...++. ...++||||+++++|...... .....++.+++.++.++|+ .+++||||||+||++++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCC
Confidence 4444432 345899999999998765431 3456788999999999999 9999999999999999999
Q ss_pred CCeeecccchhhh
Q 003199 674 QPKVADFGIAKVL 686 (840)
Q Consensus 674 ~~kl~Dfg~a~~~ 686 (840)
.++|+|||.+...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-17 Score=174.96 Aligned_cols=175 Identities=23% Similarity=0.345 Sum_probs=132.7
Q ss_pred cceEEEeecCCCChHHHhhcC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 606 CNLLVYEYMPNGNLWDALHKG--LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
+.++.|++|+..+|.+|+... ....+|.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999644 3567889999999999999999 47899999999999999999999999998
Q ss_pred hhhhccCC---CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 684 KVLQARGG---KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
........ .....+...||..||+||.+.+..|+.|+||||+|++++|++. +|... ....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~--------------~er~ 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQ--------------FERI 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccH--------------HHHH
Confidence 76644220 1223456789999999999999999999999999999999997 22211 0111
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 803 (840)
.+..++-+..+++.+......-..+..+++.+.|.+||++.++
T Consensus 467 ~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 1122333444444443333344567779999999999955544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=175.07 Aligned_cols=144 Identities=19% Similarity=0.273 Sum_probs=114.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
..|...+.||+|+||+||+|.+.+ ..+++|+....... ....+.....+.+.+|+++++.++|++++....++....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYR--HPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-ccceeEEEeccccc--chhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344667899999999999998764 44555543222111 011122233567889999999999999998888887777
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++. ....++.++++++.|||+ .+++|||+||+||++ +++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999998875 356799999999999999 999999999999999 677999999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-16 Score=176.05 Aligned_cols=209 Identities=21% Similarity=0.277 Sum_probs=135.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..|...+.|..|+||.||.++.+ +.+.+|+| +.+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~---------------lilRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN---------------LILRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc---------------hhhhc--cccccCCccee---------
Confidence 35666788999999999999655 57788884 31111 11111 22222233332
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
|+=...+...+ .++. +++.+++|+|+ .+|||||+||+|.+|+.-|++|++|||+++
T Consensus 136 ------------gDc~tllk~~g-~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIG-PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ------------chhhhhcccCC-CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhh
Confidence 33223333221 2221 23789999999 999999999999999999999999999986
Q ss_pred hhhccC------------CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 685 VLQARG------------GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 685 ~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
.-.... .........+||+.|+|||++....|...+|+|++|+|+||.+.|..||.++..+. + +
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--l--f 267 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--L--F 267 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--H--H
Confidence 642110 01112245689999999999999999999999999999999999999998752110 0 0
Q ss_pred hhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP 798 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 798 (840)
.+...+. ..+.+.......+..+++.+.++.+|..|.
T Consensus 268 g~visd~---------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 GQVISDD---------IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhh---------ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0000000 011111112233455566688889999995
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-16 Score=177.48 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=193.4
Q ss_pred cCccCeeeccCCcEEEEEEeC--CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecC
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN--SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSL 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 604 (840)
|...+.||+|+|+.|-..... ....+|+|.+..... .....+.+..|..+-..+. |+|++++++...+.
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~--------~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK--------SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCC--------ccchhhhcCccccccccccccccccccCCccCCC
Confidence 445566999999999887543 234566666533321 1122344555777777776 99999999999999
Q ss_pred ccceEEEeecCCCChHHHh-hcCCCCCChHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCCEEEcCCC-CCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNY-QPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg 681 (840)
...+++.+|..++++.+-+ +......+......++.|+..++.|+| . .+++|||+||+|.+++..+ ..+++|||
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCch
Confidence 9999999999999999988 544335677788889999999999999 7 8999999999999999999 99999999
Q ss_pred chhhhhccCCCCcceecccc-cccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 682 IAKVLQARGGKDSTTTVIAG-TYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
+|..+..-.+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|...+...
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF 250 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence 99888663455555666778 9999999998874 457889999999999999999999987554444444443322110
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
. ...+........++...++..+|..|.+.+++...=
T Consensus 251 ~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 251 T-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred c-----------cCccccCChhhhhcccccccCCchhccccccccccc
Confidence 0 011122233445566678889999999998886553
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=142.32 Aligned_cols=146 Identities=20% Similarity=0.190 Sum_probs=99.6
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhh--------------HHHHHHHHHHHHHHhccCCCC--c
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQ--------------LQLDKGLKTEVETLGNIRHKN--I 594 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--------------~~~~~~~~~E~~~l~~l~h~n--i 594 (840)
.+.||+|+||+||+|...+|+.||||++.............. .........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 457999999999999887899999999864332111000000 001112245666666664432 4
Q ss_pred ceeeeEEecCccceEEEeecCCCChHH-HhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 595 VKLYCYFSSLYCNLLVYEYMPNGNLWD-ALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 595 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|.. .+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CC
Confidence 444443 23589999999854321 121111 11 56788999999999999974 6899999999999999 88
Q ss_pred CCeeecccchhhh
Q 003199 674 QPKVADFGIAKVL 686 (840)
Q Consensus 674 ~~kl~Dfg~a~~~ 686 (840)
.++++|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-14 Score=143.33 Aligned_cols=145 Identities=17% Similarity=0.132 Sum_probs=107.9
Q ss_pred cCeee-ccCCcEEEEEEeCCCcEEEEEEeccccccc--ccCc-hhhHHHHHHHHHHHHHHhccCCCCc--ceeeeEEecC
Q 003199 531 KNKVG-QGGSGTVYKIDLNSGEVVAVKKLWSQRTKV--SASD-TDQLQLDKGLKTEVETLGNIRHKNI--VKLYCYFSSL 604 (840)
Q Consensus 531 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~-~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 604 (840)
...|| .|+.|+||.+... +..++||++....... .... .........+.+|++++.++.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999776 7889999885432110 0000 0011234667889999999998775 6677664332
Q ss_pred c----cceEEEeecCC-CChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 605 Y----CNLLVYEYMPN-GNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 605 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
. ..++||||+++ .+|.+++... .++.. .+.+++.++.++|+ .||+||||||+|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 22599999997 6898888653 34433 35689999999999 9999999999999999988999999
Q ss_pred ccchhh
Q 003199 680 FGIAKV 685 (840)
Q Consensus 680 fg~a~~ 685 (840)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-14 Score=134.52 Aligned_cols=135 Identities=22% Similarity=0.175 Sum_probs=112.4
Q ss_pred ccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC--CCcceeeeEEecCccc
Q 003199 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH--KNIVKLYCYFSSLYCN 607 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~ 607 (840)
+.+.||+|.++.||++...+ ..+++|+...... ...+.+|+.+++.++| ..+++++++....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------------GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 34679999999999998764 7899998743321 3467889999999976 5899999988888889
Q ss_pred eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 608 LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 608 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
++++||++++.+... +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999988777543 5567788899999999999985445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=8e-14 Score=161.02 Aligned_cols=109 Identities=39% Similarity=0.562 Sum_probs=58.3
Q ss_pred ccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccC
Q 003199 335 LVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSN 413 (840)
Q Consensus 335 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~ 413 (840)
++.|+|++|.+++.+|..++.+++|+.|+|++|.++|.+|..+..+++|+.|||++|+|+|.+|..+..+ .++.|++++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 4445555555555555555555555555555555555555555555555555555555555555555444 344555555
Q ss_pred CCCcCcCCcccccC---CCcccccCCCCCcccc
Q 003199 414 NRLSGPIPLSLIKE---GLVESFSGNPGLCVSV 443 (840)
Q Consensus 414 N~l~~~~p~~~~~~---~~~~~~~~n~~~c~~~ 443 (840)
|+++|.+|..+... .....+.+|+++|+.+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC
Confidence 55555555433221 1234677888888754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.7e-15 Score=156.95 Aligned_cols=201 Identities=25% Similarity=0.418 Sum_probs=108.2
Q ss_pred EEeeccccccccchhhh-cCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccc
Q 003199 170 LQLYNNSLSGEISSVIA-NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248 (840)
Q Consensus 170 L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 248 (840)
|.|++-++...+.+.+. .+.--...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|++++++.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 44444444433322222 2334445566666666 55666666666666666666665 444455555555555555555
Q ss_pred ccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchh
Q 003199 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328 (840)
Q Consensus 249 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 328 (840)
++ .+|..++.+ -|+.|-+++|+++ ..|..++.+..|..|+.+.|.+. .+|..
T Consensus 133 lS-------------------------~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsq 184 (722)
T KOG0532|consen 133 LS-------------------------HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQ 184 (722)
T ss_pred hh-------------------------cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHH
Confidence 44 444444333 2444444555554 33444444555555555555554 44555
Q ss_pred hcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc
Q 003199 329 IYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL 404 (840)
Q Consensus 329 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 404 (840)
++.+.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .+|-.|..|+.|++|-|.+|+|+ +.|..+|..
T Consensus 185 l~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 185 LGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred hhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 555556666666666655 344444433 3566666666665 56666666666666666666666 566666554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.6e-15 Score=157.01 Aligned_cols=214 Identities=29% Similarity=0.429 Sum_probs=176.2
Q ss_pred eeeccCCcccccCCcccc-CCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccc
Q 003199 145 DLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223 (840)
Q Consensus 145 ~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 223 (840)
.|.|++-++.......+. .+..-...||+.|++. .+|..++.+-.|+.|.|..|.+. .+|..+.++..|++|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 356666666633222222 3555677899999998 67788889999999999999998 78999999999999999999
Q ss_pred cccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCc
Q 003199 224 KLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303 (840)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 303 (840)
+++ ..|..+|.++ |+.|-+++|+++ .+|+.++.++.|..||.+.|.+.. .|.
T Consensus 132 qlS-~lp~~lC~lp-------------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-lps 183 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-------------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPS 183 (722)
T ss_pred hhh-cCChhhhcCc-------------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhh-chH
Confidence 998 6777666543 778889999998 889999989999999999999984 566
Q ss_pred ccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccC-
Q 003199 304 TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKS- 382 (840)
Q Consensus 304 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~- 382 (840)
.++++.+|+.|.+..|++. .+|.+++ ...|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|+ .+|..+.....
T Consensus 184 ql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkV 259 (722)
T KOG0532|consen 184 QLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKV 259 (722)
T ss_pred HhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccce
Confidence 6889999999999999998 6788887 567999999999999 89999999999999999999998 67777654433
Q ss_pred --CCEEECcCcc
Q 003199 383 --LNVLDLSNNL 392 (840)
Q Consensus 383 --L~~L~l~~N~ 392 (840)
.++|+..-++
T Consensus 260 HIFKyL~~qA~q 271 (722)
T KOG0532|consen 260 HIFKYLSTQACQ 271 (722)
T ss_pred eeeeeecchhcc
Confidence 4566666553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.8e-13 Score=146.90 Aligned_cols=158 Identities=22% Similarity=0.230 Sum_probs=106.6
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCch--------------------h----------h
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDT--------------------D----------Q 572 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~----------~ 572 (840)
+....|. .+.||+|++|.||+|.+++|+.||||+.+....+....+. + .
T Consensus 115 ~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 193 (437)
T TIGR01982 115 ELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKT 193 (437)
T ss_pred HHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHH
Confidence 3344444 3689999999999999999999999998543211100000 0 0
Q ss_pred HHHHHHHHHHHHHHhccC----CCCcceeeeEE-ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHH-HH
Q 003199 573 LQLDKGLKTEVETLGNIR----HKNIVKLYCYF-SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-GL 646 (840)
Q Consensus 573 ~~~~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~l 646 (840)
...+-+|.+|...+.++. |.+-+.+-..+ ......++||||++|+++.+......... .+..++..++. .+
T Consensus 194 l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 194 LRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFL 270 (437)
T ss_pred HHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHH
Confidence 011124566676666663 33333333333 22345689999999999988765322122 34557777766 46
Q ss_pred HHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhh
Q 003199 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687 (840)
Q Consensus 647 ~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 687 (840)
..+|. .|++|+|++|.||+++.++.++++|||++..+.
T Consensus 271 ~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 78888 899999999999999999999999999987663
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.7e-13 Score=150.18 Aligned_cols=197 Identities=35% Similarity=0.490 Sum_probs=110.2
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCC-CCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLT-ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
.|++..|.+. .....+..++.++.|++.+|+ ...++.....+. +|+.|++++|++. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~--i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNN--ITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcc--cccCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 4666666664 233344455666666666665 344555555553 6666666666666 3444556666666666666
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCC
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 254 (840)
|++... +.....++.|+.|++++|++. .+|........|++|++++|++. ..+
T Consensus 173 N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-------------------------~~~ 225 (394)
T COG4886 173 NDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-------------------------ELL 225 (394)
T ss_pred chhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-------------------------ecc
Confidence 666633 333335566666666666666 34444344445666666666422 233
Q ss_pred cccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccc
Q 003199 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIP 326 (840)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 326 (840)
..+..+.++..+.+.+|++. ..+..+..++.++.|++++|.++.... ++.+.+++.|++++|.+....|
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 44555556666666666665 334555555556666666666654333 5555566666666665554433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.8e-13 Score=148.96 Aligned_cols=198 Identities=31% Similarity=0.455 Sum_probs=111.2
Q ss_pred EEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccc-cccEEEecCccccccCCccccCCCCCcEEEc
Q 003199 21 RLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT-KLRIMVLATCALHGQIPASIGNVTSLTDLEL 99 (840)
Q Consensus 21 ~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 99 (840)
.|+++.|.+. .....+..++.++.|++..| .+.++++. ...++ +|+.|++++|.+. .+|..++.+++|+.|++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n---~i~~i~~~-~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l 170 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNN---NITDIPPL-IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCc---ccccCccc-cccchhhcccccccccchh-hhhhhhhcccccccccc
Confidence 4566666554 33334445566666666666 33333321 22332 5666666666665 33445666666666666
Q ss_pred cCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccc
Q 003199 100 TGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179 (840)
Q Consensus 100 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 179 (840)
++|++. .+|.....+++|+.|++++|+ ...+|.....+..|++|.+++|.+. ..+..+..+.++..|.+.+|++..
T Consensus 171 ~~N~l~-~l~~~~~~~~~L~~L~ls~N~--i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNK--ISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred CCchhh-hhhhhhhhhhhhhheeccCCc--cccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 666666 455555566666666666665 4445554444455666666666433 244455566666666666666652
Q ss_pred ccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCc
Q 003199 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPA 231 (840)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 231 (840)
.+..+..+++|++|++++|+++.+.. ++.+.+|+.|++++|.+....+.
T Consensus 247 -~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 247 -LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 24455566666666666666663322 55666666666666666544444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.2e-13 Score=144.16 Aligned_cols=252 Identities=21% Similarity=0.204 Sum_probs=182.4
Q ss_pred HhcCccCeeec--cCCcEEEEEEe---CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeee
Q 003199 526 EAMTEKNKVGQ--GGSGTVYKIDL---NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 599 (840)
+.+...+.+|. |.+|.||.+.. .++..+|+|+-+.+... ......=.+|+..-+.+ .|+|.++.+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~--------p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP--------PLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC--------ccccccccchhhcccccCccccccccCc
Confidence 34566778999 99999999855 47889999974333221 01111223466666666 4999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCCEEEcCC-CC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ----GLAYLHHGLLSPIIHRDIKSTNILLDVN-YQ 674 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~ 674 (840)
.+.+.+..++-+|++ +.++..+.+.....++....+.+..+..+ |+.++|+ .+++|-|+||.||+...+ ..
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccce
Confidence 999999999999999 57888888877656788888888888888 9999999 899999999999999999 88
Q ss_pred CeeecccchhhhhccCCCC-c-ceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 675 PKVADFGIAKVLQARGGKD-S-TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~-~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
++++|||+...+.+.+-.. . ......|...|++||.. .+.++.++|+|++|.+..+-.++..+.... ....|
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g-----~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG-----KNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC-----CCCCc
Confidence 9999999998876532111 1 11222678899999965 457899999999999999999987654321 11123
Q ss_pred hhhhhccccchhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+... ..+..++ .....++...+.++++.+|..|++.+.+.++
T Consensus 336 ~~~r~-----------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 SQLRQ-----------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccc-----------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 22110 0011111 1122334447789999999999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-12 Score=127.28 Aligned_cols=205 Identities=22% Similarity=0.319 Sum_probs=139.3
Q ss_pred HHhccCCCCcceeeeEEecCc-----cceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 003199 585 TLGNIRHKNIVKLYCYFSSLY-----CNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSP 656 (840)
Q Consensus 585 ~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 656 (840)
-+-.+.|.|+|+++.|+.+.. ...++.|||+.|++..+|++. ...+....-.+|+-||..||.|||+ |.++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 344556999999999986543 457899999999999999764 3456677778899999999999997 5689
Q ss_pred eEecCCCCCCEEEcCCCCCeeecccchhhhhc--cCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh
Q 003199 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQA--RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734 (840)
Q Consensus 657 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 734 (840)
|+|+++..+-|++..+|-+|+.-- -...... ............+-++|.|||+-.....+.++|||+||+-..||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999988887421 1111100 0011122233456789999998777778889999999999999998
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 735 GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 735 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
|..--..... . ....+.+..+.-..-.+. -...+..|++..|..||+|.+++.|.-.
T Consensus 278 lEiq~tnseS---~--------~~~ee~ia~~i~~len~l-------qr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 278 LEIQSTNSES---K--------VEVEENIANVIIGLENGL-------QRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred heeccCCCcc---e--------eehhhhhhhheeeccCcc-------ccCcCcccccCCCCCCcchhhhhcCcee
Confidence 8654211100 0 000111111110000000 0124558999999999999999877544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.2e-12 Score=138.60 Aligned_cols=157 Identities=18% Similarity=0.186 Sum_probs=98.1
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeCC-CcEEEEEEecccccccccC--------------------c----hhhHHHH
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSAS--------------------D----TDQLQLD 576 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~--------------------~----~~~~~~~ 576 (840)
.++...|+. +.||+|++|.||+|..++ |+.||||+.+......... . .--.+..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 455666776 789999999999999887 9999999986442111000 0 0000112
Q ss_pred ------HHHHHHHHHHhccC----CCCcceeeeEEec-CccceEEEeecCCCChHHH--hhcCCCCCChHHHHHHHHHHH
Q 003199 577 ------KGLKTEVETLGNIR----HKNIVKLYCYFSS-LYCNLLVYEYMPNGNLWDA--LHKGLVHLDWPTRHKIAFGVA 643 (840)
Q Consensus 577 ------~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~~i~ 643 (840)
-++.+|...+.+++ +.+.+.+-..+.+ ....++||||++|+.+.+. +... ..+ +..++...+
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d---~~~la~~~v 269 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTD---MKLLAERGV 269 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCC---HHHHHHHHH
Confidence 23445555544442 3433443333332 3456899999999999774 3222 122 122222222
Q ss_pred H-HHHHHhhcCCCCeEecCCCCCCEEEcCCC----CCeeecccchhhhh
Q 003199 644 Q-GLAYLHHGLLSPIIHRDIKSTNILLDVNY----QPKVADFGIAKVLQ 687 (840)
Q Consensus 644 ~-~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a~~~~ 687 (840)
. -+..+.. .|++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 270 ~~~~~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 270 EVFFTQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 2 1222344 7999999999999999888 89999999987663
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3e-12 Score=150.70 Aligned_cols=211 Identities=25% Similarity=0.307 Sum_probs=155.6
Q ss_pred CCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCcccc
Q 003199 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIG 89 (840)
Q Consensus 10 ~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 89 (840)
+|+.......+...+-+|.+. .++....+ ++|+.|-+..|.. .+..++...|..++.|++|||++|.-.+.+|..++
T Consensus 516 ~~~~~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~-~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~ 592 (889)
T KOG4658|consen 516 IPQVKSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSD-WLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG 592 (889)
T ss_pred cccccchhheeEEEEeccchh-hccCCCCC-CccceEEEeecch-hhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh
Confidence 677777788999999999998 66665544 4899999999931 16677777799999999999999988889999999
Q ss_pred CCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcc--cccCCccccCCCCC
Q 003199 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHL--SGKIPESILRLPKL 167 (840)
Q Consensus 90 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l--~~~~~~~~~~l~~L 167 (840)
.|.+|++|+|+++.|+ .+|..+.+|++|.+|++..+. ....+|.....+++|++|.+..-.. +...-..+..+.+|
T Consensus 593 ~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~-~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L 670 (889)
T KOG4658|consen 593 ELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG-RLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHL 670 (889)
T ss_pred hhhhhhcccccCCCcc-ccchHHHHHHhhheecccccc-ccccccchhhhcccccEEEeeccccccchhhHHhhhcccch
Confidence 9999999999999999 899999999999999999887 3344577777799999999876542 22233445566677
Q ss_pred cEEEeeccccccccchhhhcCCCCC----EEEccCCcCcccCCcCCCCCCCcceecccccccccc
Q 003199 168 RVLQLYNNSLSGEISSVIANSTTLT----MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP 228 (840)
Q Consensus 168 ~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 228 (840)
+.|....... .....+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+...
T Consensus 671 ~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 671 ENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred hhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchh
Confidence 7776654443 1111223333333 3333333333 4555677788888888888877643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.2e-11 Score=116.49 Aligned_cols=131 Identities=19% Similarity=0.185 Sum_probs=94.0
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcc-eeeeEEecCccceE
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIV-KLYCYFSSLYCNLL 609 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~l 609 (840)
.+.++.|.++.||++... +..|++|....... ....+..|+++++.+.+.+++ +++.+.. ...++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeE
Confidence 356899999999999876 78899998743221 112356788888888655544 4444432 34589
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL--LSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
||||+++.++.+. . .....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 69 v~e~i~G~~l~~~--~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 69 ITEFIEGSELLTE--D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEEecCCCccccc--c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999999877643 0 112345678999999999821 11259999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=107.49 Aligned_cols=138 Identities=25% Similarity=0.335 Sum_probs=106.5
Q ss_pred eeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEe
Q 003199 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 612 (840)
.+++|+-+.+|.+.+. |..+++|.=..+.- .....+..-....-.+|+.++++++--.|.-.+-+..+.+...|+||
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~Y--R~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRY--RHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCccc--CChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 5789999999999886 44566664322221 11223334455677889999999876666666667777788889999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
|++|..|.+.+... ...++..+-.-+.-||. .||||+|+.++||++..+. +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888765 25577788888889999 9999999999999998775 89999999864
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.5e-12 Score=124.23 Aligned_cols=130 Identities=23% Similarity=0.252 Sum_probs=78.8
Q ss_pred cCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEc
Q 003199 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340 (840)
Q Consensus 261 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 340 (840)
+.|+++||++|.|+ .+-++..-.|.++.|++|+|.+..+. .+..+++|+.|+|++|.++ .+..+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 44555555555555 44444445556666666666665322 2555666666666666665 33334445566777777
Q ss_pred CCCccCCCCCCcccCccccchhcccCCccCCCc-chhcccccCCCEEECcCcccccc
Q 003199 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSI-PNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 341 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
++|.|.. -..++.+-+|..||+++|+|.... ...++++|-|+.|-|.+|+|.+.
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 7777652 234556667777777777776321 24577788888888888888854
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=111.92 Aligned_cols=145 Identities=15% Similarity=0.175 Sum_probs=100.4
Q ss_pred CeeeccCCcEEEEEEeCC-------CcEEEEEEecccccccccCch----h--------hHHHHHHH----HHHHHHHhc
Q 003199 532 NKVGQGGSGTVYKIDLNS-------GEVVAVKKLWSQRTKVSASDT----D--------QLQLDKGL----KTEVETLGN 588 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~----~--------~~~~~~~~----~~E~~~l~~ 588 (840)
..||.|.-+.||.|...+ +..+|||+++........... + .....+.+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999996543 479999998643322111100 0 00112233 389999999
Q ss_pred cCC--CCcceeeeEEecCccceEEEeecCCCChHH-HhhcCCCCCChHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCC
Q 003199 589 IRH--KNIVKLYCYFSSLYCNLLVYEYMPNGNLWD-ALHKGLVHLDWPTRHKIAFGVAQGLAYL-HHGLLSPIIHRDIKS 664 (840)
Q Consensus 589 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk~ 664 (840)
+.. -++.+++++ ...++||||+.++.+.. .+... .++..+...+..+++.++..+ |. .++||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 566667754 45689999997654422 22221 344456677889999999999 77 8999999999
Q ss_pred CCEEEcCCCCCeeecccchhhh
Q 003199 665 TNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 665 ~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.||++++ +.++++|||.|...
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeC
Confidence 9999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.6e-12 Score=124.14 Aligned_cols=156 Identities=22% Similarity=0.214 Sum_probs=87.3
Q ss_pred ccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCC
Q 003199 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143 (840)
Q Consensus 64 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L 143 (840)
+.-+++|.++.++.|.-..+. +....-+.|+.+...+..+.. .| .+-....+..+.-..-....+..-......+.|
T Consensus 210 l~~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L 286 (490)
T KOG1259|consen 210 LNAFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTWQEL 286 (490)
T ss_pred hHHhhhhheeeeeccchhhee-ceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchHhhh
Confidence 344566666666766544222 112223677888777776662 22 111112222221111111222222234445567
Q ss_pred CeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccc
Q 003199 144 TDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223 (840)
Q Consensus 144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 223 (840)
++|||++|.|+ .+..+..-+|.++.|++++|.|..+ +.+..+++|++|||++|.++ .+..+-..+-+.++|.|++|
T Consensus 287 telDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 287 TELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 78888888887 4556666777788888888877643 33677777777777777776 33344445566666666666
Q ss_pred ccc
Q 003199 224 KLS 226 (840)
Q Consensus 224 ~l~ 226 (840)
.|.
T Consensus 363 ~iE 365 (490)
T KOG1259|consen 363 KIE 365 (490)
T ss_pred hHh
Confidence 664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-12 Score=132.07 Aligned_cols=215 Identities=21% Similarity=0.193 Sum_probs=118.8
Q ss_pred ccccccEEEecCccccccCC-ccccCCCCCcEEEccCCccccc--CchhhhcCCCCCeeecccCccccccCCcccCCCCC
Q 003199 66 RLTKLRIMVLATCALHGQIP-ASIGNVTSLTDLELTGNFITGH--IPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTE 142 (840)
Q Consensus 66 ~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~--~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~ 142 (840)
++.+|+...|.++.+..... +....+++++.|||++|-+... +-.....|++|+.|+|+.|++....-...-..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 45566666666666542111 3455677777777777766632 22334556777777777776322211111224566
Q ss_pred CCeeeccCCccccc-CCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCC--cCCCCCCCcceec
Q 003199 143 LTDLDMSVNHLSGK-IPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP--QDLGQWSPLVVLD 219 (840)
Q Consensus 143 L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~ 219 (840)
|+.|.|+.|.++.. +......+|+|+.|+|..|....+......-+..|++|+|++|++-. .+ ...+.++.|..|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhh
Confidence 77777777776632 11233446667777777764332333444455666777777666652 22 2344566666666
Q ss_pred cccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeecc-CCccccCCCcccEEeccCCccc
Q 003199 220 LSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS-IPEGILSLPHVSIIDLSYNSFS 298 (840)
Q Consensus 220 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 298 (840)
++.+.|..+-.... ...+-...+++|++|+++.|++... .-..+..+++|+.|.+..|.++
T Consensus 278 ls~tgi~si~~~d~------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 278 LSSTGIASIAEPDV------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccCcchhcCCCc------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 66666553211110 0001134567788888888888511 1234555777888888888876
Q ss_pred c
Q 003199 299 G 299 (840)
Q Consensus 299 ~ 299 (840)
.
T Consensus 340 ~ 340 (505)
T KOG3207|consen 340 K 340 (505)
T ss_pred c
Confidence 4
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.2e-13 Score=133.40 Aligned_cols=218 Identities=25% Similarity=0.315 Sum_probs=112.0
Q ss_pred cccCCCCCcEEEccCCccccc----CchhhhcCCCCCeeecccCcccccc----CCc-------ccCCCCCCCeeeccCC
Q 003199 87 SIGNVTSLTDLELTGNFITGH----IPPEIGLLKNLRQLELYYNQQLAGT----IPE-------ELGNLTELTDLDMSVN 151 (840)
Q Consensus 87 ~~~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~L~~n~~~~~~----~p~-------~l~~l~~L~~L~L~~n 151 (840)
.+..+..++.|+|++|.+... +...+...++|+..+++.= +++. +|. ++...++|+.|+||+|
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~--ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM--FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh--hcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 345567788888888888743 3445666777888777643 2332 222 2223334555555555
Q ss_pred cccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCc-------------CCCCCCCccee
Q 003199 152 HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQ-------------DLGQWSPLVVL 218 (840)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------------~l~~l~~L~~L 218 (840)
.+....+..| -..+.++..|++|.|.+|.+.-.... ....-+.|+++
T Consensus 103 A~G~~g~~~l--------------------~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~ 162 (382)
T KOG1909|consen 103 AFGPKGIRGL--------------------EELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVF 162 (382)
T ss_pred ccCccchHHH--------------------HHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEE
Confidence 4443222221 11233445555555555554411111 11222345555
Q ss_pred ccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeec----cCCccccCCCcccEEeccC
Q 003199 219 DLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG----SIPEGILSLPHVSIIDLSY 294 (840)
Q Consensus 219 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~L~~ 294 (840)
..++|++...... .+...|...+.|+.+.++.|.|.. .+..+|..+++|+.|||.+
T Consensus 163 i~~rNrlen~ga~--------------------~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~D 222 (382)
T KOG1909|consen 163 ICGRNRLENGGAT--------------------ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRD 222 (382)
T ss_pred EeeccccccccHH--------------------HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeeccc
Confidence 5555554421111 223456666777777777777741 1123455667777777777
Q ss_pred Cccccc----CCcccCCCCCCceeecccceeeeccchhhcc-----cCcccEEEcCCCccC
Q 003199 295 NSFSGP----IANTVGNARNLSELFMQRNQISGFIPSEIYR-----AISLVKIDLSDNLLS 346 (840)
Q Consensus 295 N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~ 346 (840)
|-++.. ....+..+++|++|++++|.+......++.+ .++|+.|.|.+|.|+
T Consensus 223 Ntft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 223 NTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred chhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 776532 2345556667777777777766544333321 334455555555444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4e-12 Score=130.53 Aligned_cols=211 Identities=20% Similarity=0.146 Sum_probs=150.3
Q ss_pred CCCCCCCEEecCCCcCcccCC--ccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCcc-ccC
Q 003199 14 SPMQNLRRLDLSNNLFTGQFP--LSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPAS-IGN 90 (840)
Q Consensus 14 ~~l~~L~~L~Ls~n~i~~~~p--~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~ 90 (840)
+++.+|++..|.++.+. ..+ .....+++++.|||++|-+.++.. -......|++|+.|.|+.|.+..-.... -..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~-v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFP-VLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHH-HHHHHHhcccchhcccccccccCCccccchhh
Confidence 35678999999999887 444 366778999999999993332221 2345667899999999999886322222 235
Q ss_pred CCCCcEEEccCCcccc-cCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccC-CccccCCCCCc
Q 003199 91 VTSLTDLELTGNFITG-HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKI-PESILRLPKLR 168 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~ 168 (840)
+++|+.|.|+.|.++- .+......+|+|+.|+|..|. ...........+..|++|+|++|++-... -.....++.|+
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~-~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANE-IILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccc-ccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence 7889999999999982 234456678999999999995 22222334556788999999999987432 14466789999
Q ss_pred EEEeecccccccc-chh-----hhcCCCCCEEEccCCcCcccC-CcCCCCCCCcceeccccccccc
Q 003199 169 VLQLYNNSLSGEI-SSV-----IANSTTLTMLSLYDNSLTGEV-PQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 169 ~L~L~~N~l~~~~-~~~-----~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
.|+++.+.|+.+- |+. ...+++|++|++..|+|...- ...+..+.+|+.|....|.+..
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 9999999987543 222 356789999999999996321 1234557788888888888874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4e-10 Score=103.28 Aligned_cols=150 Identities=24% Similarity=0.325 Sum_probs=111.0
Q ss_pred ccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
....+-+|+-+.|+++.+. |+...||.-..+.-.. ...+..-..+..+.|++.+.++.--.|.-..-++.+.....+
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRH--P~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRH--PALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccc--hHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 3557889999999999988 7888888543333221 123334456778899999999875555555556667777789
Q ss_pred EEeecCC-CChHHHhhcCCCCCChHHH-HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---Ceeecccchh
Q 003199 610 VYEYMPN-GNLWDALHKGLVHLDWPTR-HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---PKVADFGIAK 684 (840)
Q Consensus 610 V~e~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg~a~ 684 (840)
+|||+++ .++.+++......-..... ..++..|-+.+.-||. .+|+|+||..+||++.+++. +.++|||++.
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999976 4778877655322333333 7889999999999999 89999999999999976653 4799999985
Q ss_pred h
Q 003199 685 V 685 (840)
Q Consensus 685 ~ 685 (840)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-11 Score=115.70 Aligned_cols=84 Identities=25% Similarity=0.298 Sum_probs=22.5
Q ss_pred ccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhh-hcCCCCCeeecccCccccccCCcccCCCCCCCee
Q 003199 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146 (840)
Q Consensus 68 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~-~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L 146 (840)
.+|+.|+|++|.|+.. +.+..+++|+.|++++|+|+. +++.+ ..+++|+.|+|++|++-.-..-..+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 3344444444444322 234445556666666666652 32223 3455555555555542111111223344445555
Q ss_pred eccCCccc
Q 003199 147 DMSVNHLS 154 (840)
Q Consensus 147 ~L~~n~l~ 154 (840)
+|.+|.+.
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 55555444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.8e-12 Score=138.51 Aligned_cols=267 Identities=26% Similarity=0.289 Sum_probs=141.9
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
.++.++...+.+....-. ...+..++.++++.|. ...+-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~--i~~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNL--IAKILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDL 125 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhh--hhhhhcccccccceeeeeccccchhhc-ccchhhhhcchheec
Confidence 344455555444421111 1455566666676665 222333456667777777777777633 222566677777777
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 252 (840)
++|.|+.+. .+..++.|+.|++++|.|+.+ ..+..+..|+.+++++|++....+.
T Consensus 126 s~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~--------------------- 180 (414)
T KOG0531|consen 126 SFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND--------------------- 180 (414)
T ss_pred ccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhh---------------------
Confidence 777776442 345556677777777776632 3344466666666666666533220
Q ss_pred CCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCC--CCceeecccceeeeccchhhc
Q 003199 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR--NLSELFMQRNQISGFIPSEIY 330 (840)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~ 330 (840)
. ...+.+++.+++.+|.+. ....+..+..+..+++..|.++..-+ +..+. .|+.+++++|++. ..+..+.
T Consensus 181 --~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~ 252 (414)
T KOG0531|consen 181 --E-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLE 252 (414)
T ss_pred --h-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-ccccccc
Confidence 1 234455555555555554 22233334444444555665553221 11122 2666666666665 3334455
Q ss_pred ccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCC---cchh-cccccCCCEEECcCccccccCC
Q 003199 331 RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSS---IPNS-LSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 331 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~l~~N~l~~~~p 398 (840)
.+..+..|++++|++... ..+...+.+..+.++.|.+... .... ....+.++.+++.+|+.....+
T Consensus 253 ~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 253 NLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 556666667776666532 2244455666666666666521 1111 3445566666666666664433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-11 Score=137.38 Aligned_cols=126 Identities=31% Similarity=0.390 Sum_probs=58.8
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
.++.+++..|.|.. +-..+..+++|..|++..|+ ...+...+..+++|++|+|++|.|+.+. .+..++.|+.|++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~--i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNK--IEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL 147 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccc--hhhcccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence 33333444444441 22234444444444444443 2222222444555555555555555332 2444455555555
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCC-cCCCCCCCcceecccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP-QDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 226 (840)
++|.|+.+ ..+..++.|+.+++++|++..+.+ . ...+.+|+.+++++|.+.
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 55555422 223345555555555555553322 1 345555666666666554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.1e-11 Score=127.40 Aligned_cols=249 Identities=19% Similarity=0.197 Sum_probs=170.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC--CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN--SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
..+|..+..||.|.|+.|++...+ ++..+++|......... .++.. -..|+.+...+ .|.++++.+..+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~----~~di~----sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF----ASDIF----SLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch----Hhhhc----chhhhhHhhHhhcccccCCCCCCc
Confidence 445677889999999999998554 67789998774433221 11111 12345555555 588888888777
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCCeeecc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADF 680 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Df 680 (840)
......++--||+++++........ ..++...++.+..|++.++.++|+ +.++|+|+||+||++..+ +..++.||
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccc
Confidence 7777888999999999987766322 357778889999999999999999 999999999999999876 78899999
Q ss_pred cchhhhhccCCCCcceecccccccc-cCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGY-LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|.+..+.-. ......++..| .+|+......+-.+.|+||||.-+.|.++|.+--.. ...|.
T Consensus 412 ~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~------ 473 (524)
T KOG0601|consen 412 GCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSL------ 473 (524)
T ss_pred cccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccce------
Confidence 998753211 11111223334 355555666788899999999999999998642211 01111
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
.+....... .......+..+...+..+++..||.+.+...+.+.
T Consensus 474 -----~i~~~~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 -----TIRSGDTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----eeecccccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 001111111 11112445566667899999999999988776554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9e-10 Score=120.27 Aligned_cols=167 Identities=17% Similarity=0.190 Sum_probs=123.5
Q ss_pred EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceEEEeecCCCChHHHhhc
Q 003199 546 DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK 625 (840)
Q Consensus 546 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 625 (840)
...++.+|.|..+..... .......+.++.++.++||||++++..+...+..|+|+|.+. -|..++.+
T Consensus 33 ~k~~~~~vsVF~~~~~~~----------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~ 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG----------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE 100 (690)
T ss_pred eeccCCceEEEEEeCCCc----------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH
Confidence 455788898888743331 223456678889999999999999999999999999999884 34555543
Q ss_pred CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccc
Q 003199 626 GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705 (840)
Q Consensus 626 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 705 (840)
+........+.||+.||.+||.. .+++|+++.-..|++++.|+.||++|.++......+. ......--..|
T Consensus 101 ----l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~ 171 (690)
T KOG1243|consen 101 ----LGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESF 171 (690)
T ss_pred ----hHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcc
Confidence 23456667788999999999864 6899999999999999999999999998865432111 11111122346
Q ss_pred cCccccccCCCCccccchhHHHHHHHHHhC
Q 003199 706 LAPEYAYSSKATTKCDVYSFGVVLMELITG 735 (840)
Q Consensus 706 ~aPE~~~~~~~~~~~Dv~slG~il~el~tg 735 (840)
..|+.+.... -..|.|-||++++|++.|
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 6666443222 346999999999999999
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.4e-11 Score=111.86 Aligned_cols=126 Identities=25% Similarity=0.284 Sum_probs=43.9
Q ss_pred ccccCCceEEeeCceeeccCCcccc-CCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhh-cccCcc
Q 003199 258 ARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI-YRAISL 335 (840)
Q Consensus 258 ~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L 335 (840)
.+..++++|+|++|+|+ .+ +.+. .+.+|+.|+|++|.|+... .+..++.|+.|++++|+|+.. +..+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred ccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcc-ccchHHhCCcC
Confidence 34456788888888887 33 3454 4778888888888887542 466778888888888888744 3334 357788
Q ss_pred cEEEcCCCccCCCC-CCcccCccccchhcccCCccCCCc---chhcccccCCCEEEC
Q 003199 336 VKIDLSDNLLSGPI-PSGIGNLKKLNLLMLQSNKLNSSI---PNSLSSLKSLNVLDL 388 (840)
Q Consensus 336 ~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~l 388 (840)
+.|+|++|+|...- -..++.+++|+.|+|.+|+++... ...+..+|+|+.||-
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 88888888886421 134556777777777777776331 123566777777653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-10 Score=134.87 Aligned_cols=112 Identities=37% Similarity=0.578 Sum_probs=103.5
Q ss_pred CCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECc
Q 003199 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS 389 (840)
Q Consensus 310 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 389 (840)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCchhhcc--CCCeEEccCCCCcCcCC
Q 003199 390 NNLLTGYIPESLCEL--LPNSINFSNNRLSGPIP 421 (840)
Q Consensus 390 ~N~l~~~~p~~~~~~--~~~~l~l~~N~l~~~~p 421 (840)
+|+|+|.+|..+... ....+++.+|...|..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999998765 34578999998766555
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.2e-12 Score=125.37 Aligned_cols=216 Identities=22% Similarity=0.282 Sum_probs=132.8
Q ss_pred CCCCCCCCCCEEecCCCcCcc----cCCccccCCCCCCEEeCCCCCCCccC-CCCc------ccccccccccEEEecCcc
Q 003199 11 PDFSPMQNLRRLDLSNNLFTG----QFPLSVFNLTNLEVLSFNENPGFKLW-KLPE------SSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 11 ~~~~~l~~L~~L~Ls~n~i~~----~~p~~~~~l~~L~~L~L~~N~~~~l~-~l~~------~~~~~l~~L~~L~L~~n~ 79 (840)
+....+..++.|+||+|.|.. .+...+...++|++-++++--..++. .+|+ .++...++|++|+|++|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 346678899999999999873 34556777888999998875211211 2221 334456788888888888
Q ss_pred ccccCCc----cccCCCCCcEEEccCCcccccCchh-------------hhcCCCCCeeecccCcccccc---CCcccCC
Q 003199 80 LHGQIPA----SIGNVTSLTDLELTGNFITGHIPPE-------------IGLLKNLRQLELYYNQQLAGT---IPEELGN 139 (840)
Q Consensus 80 l~~~~~~----~~~~l~~L~~L~L~~n~i~~~~p~~-------------~~~l~~L~~L~L~~n~~~~~~---~p~~l~~ 139 (840)
+....+. .+..+..|++|.|.+|.+...--.. ...-++|+++...+|++..+. +...|..
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~ 183 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQS 183 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHh
Confidence 8644333 3455678888888888887321111 223456777777777622111 1123555
Q ss_pred CCCCCeeeccCCccccc----CCccccCCCCCcEEEeeccccccc----cchhhhcCCCCCEEEccCCcCcccCCcCC--
Q 003199 140 LTELTDLDMSVNHLSGK----IPESILRLPKLRVLQLYNNSLSGE----ISSVIANSTTLTMLSLYDNSLTGEVPQDL-- 209 (840)
Q Consensus 140 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-- 209 (840)
.+.|+.+.++.|.|... ....|..+++|++|||+.|-++.. ....++.+++|++|++++|.+......+|
T Consensus 184 ~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~ 263 (382)
T KOG1909|consen 184 HPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD 263 (382)
T ss_pred ccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH
Confidence 66777777777776532 123456677777777777776532 23455666677777777777764332222
Q ss_pred ---CCCCCcceecccccccc
Q 003199 210 ---GQWSPLVVLDLSENKLS 226 (840)
Q Consensus 210 ---~~l~~L~~L~L~~N~l~ 226 (840)
...++|+.|.|.+|.|+
T Consensus 264 al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 264 ALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHhccCCCCceeccCcchhH
Confidence 22566777777777665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-09 Score=109.25 Aligned_cols=144 Identities=19% Similarity=0.205 Sum_probs=108.3
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC--CCcceeeeEEecCc---
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH--KNIVKLYCYFSSLY--- 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--- 605 (840)
.+.|+.|..+.||++...+|+.+++|........ .....+..|+++++.+.+ .++.+++.+.....
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC---------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 3568999999999998776789999987433211 123457789999999875 44677777776542
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL-------------------------------- 653 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 653 (840)
..++||||+++.++.+.+.. ..++......++.++++++.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 56899999999888775532 24667777788888888888888521
Q ss_pred ---------------------CCCeEecCCCCCCEEEcC--CCCCeeecccchhh
Q 003199 654 ---------------------LSPIIHRDIKSTNILLDV--NYQPKVADFGIAKV 685 (840)
Q Consensus 654 ---------------------~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~ 685 (840)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56688999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.7e-09 Score=101.03 Aligned_cols=135 Identities=26% Similarity=0.280 Sum_probs=87.4
Q ss_pred EEEEEEeCCCcEEEEEEeccccccccc----------------CchhhHHHHHHHHHHHHHHhccCCC--CcceeeeEEe
Q 003199 541 TVYKIDLNSGEVVAVKKLWSQRTKVSA----------------SDTDQLQLDKGLKTEVETLGNIRHK--NIVKLYCYFS 602 (840)
Q Consensus 541 ~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 602 (840)
.||.|...+|..||||..+........ .............+|++.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389998888999999998643222100 0122333456778999999999765 566666543
Q ss_pred cCccceEEEeecC--CCChHHHhhcCCCCCChHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 603 SLYCNLLVYEYMP--NGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY-LHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 603 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
...+||||++ |..+....... ++......++.+++..+.. +|. .|+||+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 4579999998 54454433321 2245567788888886666 467 899999999999999988 999999
Q ss_pred ccchhhh
Q 003199 680 FGIAKVL 686 (840)
Q Consensus 680 fg~a~~~ 686 (840)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.5e-10 Score=132.55 Aligned_cols=129 Identities=26% Similarity=0.280 Sum_probs=76.0
Q ss_pred ccccEEEecCccccccCCccccCCCCCcEEEccCCc--ccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCe
Q 003199 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNF--ITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTD 145 (840)
Q Consensus 68 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~ 145 (840)
...+...+-+|.+. .++.... .+.|++|-+.+|. +....++.|..++.|+.|||++|. -.+.+|..++.|-+|+.
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~-~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNS-SLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCC-ccCcCChHHhhhhhhhc
Confidence 34455555555554 2222222 2356666666664 443334446666666666666664 44566666666677777
Q ss_pred eeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCc
Q 003199 146 LDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNS 200 (840)
Q Consensus 146 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (840)
|+|+++.++ .+|..+.+++.|.+|++..+.-...+++....+.+|++|.+..-.
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 777777766 566666777777777776665444446666666777777665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.4e-10 Score=128.68 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=160.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.+...+.+.+|+++.+.-+.-. .|...+.|+......-.. ...+....+-.+.-...||-++...--+.-.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-------~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-------NDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhcc-------ccccccCCccCccccCCCCceecccCCCCCC
Confidence 34445567889999999887444 344444443311110000 0011111111112222345555444334455
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|++|+.+++|...++... ..+.+..+.....+..+.+|||. ..++|||++|.|.+...+++.+++|||...
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccc
Confidence 66789999999999999998765 35555666677788899999998 669999999999999999999999998433
Q ss_pred hhhcc---------------------C-------CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCC
Q 003199 685 VLQAR---------------------G-------GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736 (840)
Q Consensus 685 ~~~~~---------------------~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 736 (840)
..... . +.........||+.|.+||...+......+|+|++|+.++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22110 0 0011234467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhhccccchhhhccc--ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 003199 737 KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK--KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN 801 (840)
Q Consensus 737 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 801 (840)
.||.+...... +..+... .++...........+++...+..+|.+|-.|.
T Consensus 1033 pp~na~tpq~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99987533211 1111111 11222223334445566677788888887766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=9.2e-08 Score=98.61 Aligned_cols=257 Identities=15% Similarity=0.155 Sum_probs=155.0
Q ss_pred ccCeeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE------E
Q 003199 530 EKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY------F 601 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~ 601 (840)
..+.||+|+.+.+|-. ... . .+.|+++.+.... .. ..++.|... .||-+-.-+.| .
T Consensus 15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~----------~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAA----------QA---QKVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCccccCCccceeeecchhh--c-hhheeecCCCchH----------HH---HHHHHhccCCCCcchhhhhcccHHHhhC
Confidence 4567999999999974 332 2 3457776554321 11 123334443 46544331221 1
Q ss_pred ecC-ccceEEEeecCCCCh-HHHh-----hcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 602 SSL-YCNLLVYEYMPNGNL-WDAL-----HKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 602 ~~~-~~~~lV~e~~~~gsL-~~~l-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
.+. ....+.|..+++.-= ..+. ++.....+|.-.+.+++.+|.+.+.||. .|.+-+|+.++|+|+.+++.
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~ 155 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSK 155 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCce
Confidence 122 224567777765421 1111 1223568999999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCCC--CC
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITG-RKPVEDDFG--DN 746 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg-~~p~~~~~~--~~ 746 (840)
+.+.|=..-... ..+.......|...|.+||.-. +-..+...|-|.+|+++++++.| ++||.+-.. +.
T Consensus 156 V~LVdsDsfqi~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a 231 (637)
T COG4248 156 VVLVDSDSFQIN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA 231 (637)
T ss_pred EEEEcccceeec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence 999876543322 2344555677899999999643 33457789999999999999985 999976321 10
Q ss_pred cchhh--hhhh-hhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHhhh
Q 003199 747 KNIIY--WVSI-KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKS--PATRPTMNEVVQLLAE 809 (840)
Q Consensus 747 ~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rps~~evl~~L~~ 809 (840)
..-.. .... -....+............-+.-....+..+..+|+... +.-|||++-.+..|.+
T Consensus 232 p~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 232 PNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred CCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 00000 0000 00000000000000011111223355666777898653 6789999988777654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-09 Score=83.23 Aligned_cols=60 Identities=37% Similarity=0.514 Sum_probs=33.5
Q ss_pred CCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcC
Q 003199 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201 (840)
Q Consensus 142 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 201 (840)
+|++|++++|+++.+.+..|.++++|++|++++|.++.+.++.|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555555555555555555555555555555555555555543
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.4e-09 Score=83.04 Aligned_cols=61 Identities=36% Similarity=0.464 Sum_probs=55.5
Q ss_pred CCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccc
Q 003199 165 PKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKL 225 (840)
Q Consensus 165 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 225 (840)
++|++|++++|+|+.+.++.|.++++|++|++++|+++.+.+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999988888999999999999999999988888999999999999999975
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.3e-08 Score=98.75 Aligned_cols=150 Identities=14% Similarity=0.063 Sum_probs=102.1
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEeccccccc-ccCchhhHHHHHHHHHHHHHHhccCCC--CcceeeeEEec-----
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKV-SASDTDQLQLDKGLKTEVETLGNIRHK--NIVKLYCYFSS----- 603 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----- 603 (840)
+.+-......|+++.+. |+.|.||+........ ...-.........+.+|...+.++... ..+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 45555555567787664 7899999874333110 000000001112477899988888533 34455666543
Q ss_pred CccceEEEeecCCC-ChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CCC
Q 003199 604 LYCNLLVYEYMPNG-NLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-------NYQ 674 (840)
Q Consensus 604 ~~~~~lV~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~ 674 (840)
....++|+|++++. +|.+++... ....+...+..++.+++..+..||. .||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999886 788887532 1234566778899999999999999 99999999999999975 467
Q ss_pred Ceeecccchhh
Q 003199 675 PKVADFGIAKV 685 (840)
Q Consensus 675 ~kl~Dfg~a~~ 685 (840)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=92.88 Aligned_cols=142 Identities=23% Similarity=0.208 Sum_probs=99.6
Q ss_pred ccCeeeccCCcEEEEEEeCCCcEEEEEEeccccccccc------------CchhhHHHHHHHHHHHHHHhccCCC--Ccc
Q 003199 530 EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSA------------SDTDQLQLDKGLKTEVETLGNIRHK--NIV 595 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~h~--niv 595 (840)
....||-|.-+.||.|....|.++|||.=+..+..... ...+.........+|.++|.++... .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 45789999999999999889999999964333222110 0011233445678899999998654 666
Q ss_pred eeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 596 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
+.+++ ....+||||++|--|...- ++.+....++..|++-+..+-. .|+||+|+++-||+++++|.+
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCE
Confidence 66654 3457999999886654322 1233344455556655555556 899999999999999999999
Q ss_pred eeecccchh
Q 003199 676 KVADFGIAK 684 (840)
Q Consensus 676 kl~Dfg~a~ 684 (840)
+++||=-+.
T Consensus 242 ~vIDwPQ~v 250 (304)
T COG0478 242 VVIDWPQAV 250 (304)
T ss_pred EEEeCcccc
Confidence 999996554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.2e-10 Score=121.65 Aligned_cols=114 Identities=27% Similarity=0.336 Sum_probs=78.6
Q ss_pred cCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcc
Q 003199 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYR 331 (840)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 331 (840)
.+..++.-++.|+.|+|++|+++. .+.+..+++|++|||++|.+..++--...++. |+.|.+.+|.++.. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~--v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTK--VDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhh--hHHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 344556667778888888888863 23677788888888888888754333333344 88888888887743 35667
Q ss_pred cCcccEEEcCCCccCCCCC-CcccCccccchhcccCCccC
Q 003199 332 AISLVKIDLSDNLLSGPIP-SGIGNLKKLNLLMLQSNKLN 370 (840)
Q Consensus 332 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 370 (840)
+.+|+.||+|+|-|.+.-. ..++.|..|+.|+|.+|.+-
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7788888888887765322 23556778888888888886
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.4e-09 Score=94.27 Aligned_cols=137 Identities=23% Similarity=0.306 Sum_probs=88.9
Q ss_pred ccEEeccCCcccccCCc---ccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhc
Q 003199 287 VSIIDLSYNSFSGPIAN---TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363 (840)
Q Consensus 287 L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 363 (840)
+..+||+.|++.. +++ .+.....|+..+|++|.+....+......+.++.|+|++|+|+ .+|.+++.++.|+.|+
T Consensus 29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 3445555555531 222 2233445556677777776443333344557788888888887 5777788888888888
Q ss_pred ccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccC
Q 003199 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKE 427 (840)
Q Consensus 364 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~ 427 (840)
++.|.+. ..|..+..|.+|..||.-+|.+. .||..+... .+...++.++++.+..|..++.+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 8888886 67777777888888888888887 566553222 23345667777777777655443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5e-07 Score=95.91 Aligned_cols=167 Identities=23% Similarity=0.300 Sum_probs=124.0
Q ss_pred CCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe----cCccceEEEe
Q 003199 538 GSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS----SLYCNLLVYE 612 (840)
Q Consensus 538 ~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e 612 (840)
-..+.|++ ...||..|+.|+++..+..... ....-+++++++.|.|+|++...+. .+...++||+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n----------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYD 357 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN----------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYD 357 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc----------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEe
Confidence 34678998 4458999999999555433211 1123477889999999999988775 2445689999
Q ss_pred ecCC-CChHHHhhc--------------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 613 YMPN-GNLWDALHK--------------GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 613 ~~~~-gsL~~~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
|.++ ++|.+.--. .....++...|.++.|+..||.++|+ .|...+-|.+++|+++.+..++|
T Consensus 358 YyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIri 434 (655)
T KOG3741|consen 358 YYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRI 434 (655)
T ss_pred cCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEE
Confidence 9986 466653321 12356789999999999999999999 89999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCC
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 737 (840)
+..|....+..+. . |-+.+ -.+-|.-.||.+++.+.||..
T Consensus 435 S~C~i~Dvl~~d~---------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 435 SGCGIMDVLQEDP---------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecccceeeecCCC---------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 9888765543311 0 11111 236788899999999999954
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.8e-08 Score=108.31 Aligned_cols=155 Identities=23% Similarity=0.366 Sum_probs=99.7
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC-----CC-cceecccccccccCccccc
Q 003199 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG-----KD-STTTVIAGTYGYLAPEYAY 712 (840)
Q Consensus 639 ~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~-~~~~~~~gt~~y~aPE~~~ 712 (840)
+.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+........ .+ ...........|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999985 7899999999999999999999999998755432111 00 1111223446799999999
Q ss_pred cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCC
Q 003199 713 SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSK 792 (840)
Q Consensus 713 ~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 792 (840)
+...+.++|+||+|+++|.+..|..+.-...+..... ..... ..+......-.....++.+=+.+++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~~~~-------~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SFSRN-------LLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh----hhhhc-------ccccccccccccCcHHHHHHHHHHhcC
Confidence 9889999999999999999995444432211111000 00000 001111111122334555556678899
Q ss_pred CCCCCCCHHHHHHH
Q 003199 793 SPATRPTMNEVVQL 806 (840)
Q Consensus 793 dP~~Rps~~evl~~ 806 (840)
++..||++.++...
T Consensus 252 ~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSI 265 (700)
T ss_pred CcccCcchhhhhcc
Confidence 99999987776543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.8e-09 Score=100.96 Aligned_cols=62 Identities=21% Similarity=0.223 Sum_probs=27.5
Q ss_pred CcccEEeccCCcccccCC-cccCCCCCCceeecccceeeecc-chhhcccCcccEEEcCCCccC
Q 003199 285 PHVSIIDLSYNSFSGPIA-NTVGNARNLSELFMQRNQISGFI-PSEIYRAISLVKIDLSDNLLS 346 (840)
Q Consensus 285 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 346 (840)
|++..+.+..|.+..... ..+..++.+.-|+|+.|+|.+.. -+++.+++.|..|.+++|.|.
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 344444444454433221 22333444445555555554321 123444455555555555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.7e-09 Score=92.47 Aligned_cols=140 Identities=24% Similarity=0.192 Sum_probs=102.6
Q ss_pred CCceEEeeCceeeccCCcccc---CCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEE
Q 003199 262 NLLRFRVSNNHLEGSIPEGIL---SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKI 338 (840)
Q Consensus 262 ~L~~L~l~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 338 (840)
.+..++|++++|. .+++... ....|+..+|++|.+...++..-...+.++.|+|++|+|. .+|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4556777777775 4454443 4456777889999998766665556678899999999998 678889999999999
Q ss_pred EcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccC
Q 003199 339 DLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELL 405 (840)
Q Consensus 339 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 405 (840)
+++.|.+. ..|..+..+.+|-.|+..+|.+. .+|-.+-.-...-..++.+++|.+.-|.-+..+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence 99999998 67777777899999999999887 4444433223344455688888887776555443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.3e-08 Score=98.08 Aligned_cols=211 Identities=22% Similarity=0.230 Sum_probs=119.4
Q ss_pred CCCeeeccCCcccccCC-ccc-cCCCCCcEEEeecccccc--ccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcce
Q 003199 142 ELTDLDMSVNHLSGKIP-ESI-LRLPKLRVLQLYNNSLSG--EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVV 217 (840)
Q Consensus 142 ~L~~L~L~~n~l~~~~~-~~~-~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 217 (840)
-++-|.+.++.|..... ..| ..++.++.|||.+|.|++ .+...+.++|.|+.|+|+.|++...+...-..+.+|++
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 34455566666653221 112 235678888888888763 34556778888888888888887544333245677888
Q ss_pred eccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcc
Q 003199 218 LDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSF 297 (840)
Q Consensus 218 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 297 (840)
|-|.+..+..... ...+..+|.+++|.|+.|.+. .+++..|.+
T Consensus 126 lVLNgT~L~w~~~-----------------------~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~ 168 (418)
T KOG2982|consen 126 LVLNGTGLSWTQS-----------------------TSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCI 168 (418)
T ss_pred EEEcCCCCChhhh-----------------------hhhhhcchhhhhhhhccchhh--------------hhccccccc
Confidence 8888777653211 122334445555555555332 122222222
Q ss_pred cccCCc--ccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCC-CCcccCccccchhcccCCccCCC-c
Q 003199 298 SGPIAN--TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPI-PSGIGNLKKLNLLMLQSNKLNSS-I 373 (840)
Q Consensus 298 ~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~-~ 373 (840)
....+. .+...+.+..++++-|++.. .++++..+-+..|.|...- -..+..++.+.-|+|+.|+|.+- -
T Consensus 169 e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswas 241 (418)
T KOG2982|consen 169 EDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWAS 241 (418)
T ss_pred cccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHH
Confidence 211111 11122333334444444432 2345666667777665322 23455677778899999988531 1
Q ss_pred chhcccccCCCEEECcCcccccc
Q 003199 374 PNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 374 ~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
-+++..++.|..|-+++|+|...
T Consensus 242 vD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 242 VDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred HHHHcCCchhheeeccCCccccc
Confidence 34677888899999999988743
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-08 Score=98.98 Aligned_cols=222 Identities=22% Similarity=0.270 Sum_probs=115.8
Q ss_pred CCCCcEEEccCCcccccCc----hhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCC
Q 003199 91 VTSLTDLELTGNFITGHIP----PEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPK 166 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~~~p----~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 166 (840)
+..+..++||+|.|...-. ..+.+-.+|+..+++.-- ++...+.+.. ++. .+-.++.+||+
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~f--tgr~kde~~~------------~L~-~Ll~aLlkcp~ 93 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAF--TGRDKDELYS------------NLV-MLLKALLKCPR 93 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhh--hcccHHHHHH------------HHH-HHHHHHhcCCc
Confidence 5667777777777774433 334445666666665432 2222111100 000 11123344455
Q ss_pred CcEEEeeccccccccc----hhhhcCCCCCEEEccCCcCcccCCcC-------------CCCCCCcceeccccccccccC
Q 003199 167 LRVLQLYNNSLSGEIS----SVIANSTTLTMLSLYDNSLTGEVPQD-------------LGQWSPLVVLDLSENKLSGPL 229 (840)
Q Consensus 167 L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~-------------l~~l~~L~~L~L~~N~l~~~~ 229 (840)
|+..+||.|.+....| +.++..+.|.+|.|++|.+.-+.-.. ...-+.|++++...|++....
T Consensus 94 l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs 173 (388)
T COG5238 94 LQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGS 173 (388)
T ss_pred ceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCc
Confidence 5555555554442222 23444555666666666554211111 122344555555555554110
Q ss_pred CccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccC-----CccccCCCcccEEeccCCccccc----
Q 003199 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSI-----PEGILSLPHVSIIDLSYNSFSGP---- 300 (840)
Q Consensus 230 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~---- 300 (840)
.. .....|..-.+|+.+.+..|.|.-.. -..+..+.+|+.|||.+|-++..
T Consensus 174 ~~--------------------~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~ 233 (388)
T COG5238 174 KE--------------------LSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRY 233 (388)
T ss_pred HH--------------------HHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHH
Confidence 00 11122334457888888888876110 11234467889999999988742
Q ss_pred CCcccCCCCCCceeecccceeeeccchhhcc------cCcccEEEcCCCccCC
Q 003199 301 IANTVGNARNLSELFMQRNQISGFIPSEIYR------AISLVKIDLSDNLLSG 347 (840)
Q Consensus 301 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~ 347 (840)
....+..++.|++|.+.+|-++.....++.+ .++|..|-+.+|...+
T Consensus 234 La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 234 LADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred HHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence 3345667778888888888887655444332 3466666666666543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=86.25 Aligned_cols=106 Identities=25% Similarity=0.285 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhccC--CCCcceeeeEEecCc----cceEEEeecCCC-ChHHHhhcCCCCCChHHHHHHHHHHHHHHHH
Q 003199 576 DKGLKTEVETLGNIR--HKNIVKLYCYFSSLY----CNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648 (840)
Q Consensus 576 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 648 (840)
.....+|...+..+. .-.+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 345677888877775 344566677665422 348999999884 7988887643 25666788999999999999
Q ss_pred HhhcCCCCeEecCCCCCCEEEcCCC---CCeeecccchhh
Q 003199 649 LHHGLLSPIIHRDIKSTNILLDVNY---QPKVADFGIAKV 685 (840)
Q Consensus 649 LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfg~a~~ 685 (840)
||. .||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 9999999999999999887 789999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 840 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-47 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-47 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-38 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-33 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-26 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 6e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-07 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 6e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 6e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 840 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-119 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-118 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-108 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-105 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-86 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-81 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-108 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-105 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-103 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-81 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-80 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-76 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-66 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-40 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-16 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-08 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-07 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-04 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-72 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-70 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-68 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-67 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-67 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-54 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-50 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-68 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-66 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-49 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-33 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-13 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-65 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-64 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-62 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-61 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-60 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-29 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-26 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-64 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-58 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-29 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-16 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-62 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-62 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-61 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-58 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-58 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-57 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-56 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-55 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-51 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-50 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-46 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-28 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-47 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-47 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-27 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-10 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-48 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-25 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-15 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-44 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-42 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-37 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-30 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-39 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-38 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-37 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-41 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-40 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-38 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-36 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-39 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-38 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-34 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-18 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-12 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-39 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-30 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-17 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-38 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-38 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-37 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-37 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-37 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-37 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-37 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-36 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-30 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-25 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-11 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-36 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-36 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-36 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-36 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-29 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-36 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-36 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-36 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-28 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-11 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-30 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-29 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-25 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-21 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-10 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-34 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-34 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-34 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-17 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-10 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-34 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-34 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-34 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-34 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 8e-34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-34 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-33 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-33 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-33 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-33 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-33 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-33 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-33 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-33 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-33 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-33 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-33 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-33 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-33 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-32 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-32 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-32 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-32 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-32 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-32 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-32 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-32 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 8e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 8e-32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-31 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-31 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-31 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-28 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-31 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-31 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-31 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-31 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-31 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-30 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-30 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-30 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-30 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-27 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-19 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 8e-30 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-29 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-29 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-29 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-24 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-23 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 7e-29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-28 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-28 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-28 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-28 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-28 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 7e-28 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-28 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-28 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-27 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-27 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-27 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-27 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-27 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 8e-27 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-24 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-26 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-26 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-16 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-26 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-26 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 9e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-26 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-25 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-14 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-08 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-25 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-24 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-24 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-24 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 5e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-24 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 7e-24 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-23 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-23 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-23 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-07 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-22 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-22 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-22 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-22 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-06 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-05 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-22 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 8e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-07 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-22 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-21 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-21 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-21 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-21 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-21 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-21 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-21 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 6e-21 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 7e-21 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-21 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-20 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-20 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-20 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-19 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-08 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-06 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-19 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-19 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-19 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-19 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-19 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 5e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-18 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-18 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-16 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-11 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-17 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-12 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-16 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-16 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-06 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 9e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-14 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-10 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-15 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-11 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-05 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-04 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-12 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-06 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 8e-11 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 9e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-09 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 7e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 9e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 5e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 8e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 5e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 9e-05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 6e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-119
Identities = 122/428 (28%), Positives = 203/428 (47%), Gaps = 19/428 (4%)
Query: 6 LTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKL-WKLPESS 63
L+G S L+ L++S+N F G P L +L+ LS EN K ++P+
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN---KFTGEIPDFL 289
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPE-IGLLKNLRQLE 122
L + L+ +G +P G+ + L L L+ N +G +P + + ++ L+ L+
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 123 LYYNQQLAGTIPEELGNLT-ELTDLDMSVNHLSGKIPESI--LRLPKLRVLQLYNNSLSG 179
L +N+ +G +PE L NL+ L LD+S N+ SG I ++ L+ L L NN +G
Sbjct: 350 LSFNE-FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239
+I ++N + L L L N L+G +P LG S L L L N L G +P ++ L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
+ ++ N +G +P L+ C NL +SNN L G IP+ I L +++I+ LS NSFSG
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 300 PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKL 359
I +G+ R+L L + N +G IP+ + ++ N ++G I N
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAA----MFKQSGKIAANFIAGKRYVYIKNDGMK 584
Query: 360 NLLMLQSN--KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRL 416
N + L+ L + N ++++ + G+ + ++ S N L
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 417 SGPIPLSL 424
SG IP +
Sbjct: 645 SGYIPKEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-118
Identities = 143/435 (32%), Positives = 209/435 (48%), Gaps = 19/435 (4%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFP--LSVFNLTNLEVLSFNENPGFKLWK 58
+S ++ G++ F +L LDLS N +G S+ + + L+ L+ + N +
Sbjct: 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSN--TLDFP 141
Query: 59 LPESSIFRLTKLRIMVLATCALHGQIPASI---GNVTSLTDLELTGNFITGHIPPEIGLL 115
S +L L ++ L+ ++ G L L ++GN I+G + +
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRC 199
Query: 116 KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175
NL L++ N + IP LG+ + L LD+S N LSG +I +L++L + +N
Sbjct: 200 VNLEFLDVSSNN-FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDL-GQWSPLVVLDLSENKLSGPLPAKVC 234
G I +L LSL +N TGE+P L G L LDLS N G +P
Sbjct: 258 QFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 235 SRGKLQYFLVLQNMFSGVLP-DSLARCKNLLRFRVSNNHLEGSIPEGILSL-PHVSIIDL 292
S L+ + N FSG LP D+L + + L +S N G +PE + +L + +DL
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 293 SYNSFSGPIANTVGN--ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIP 350
S N+FSGPI + L EL++Q N +G IP + LV + LS N LSG IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 351 SGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLP-NSI 409
S +G+L KL L L N L IP L +K+L L L N LTG IP L N I
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 410 NFSNNRLSGPIPLSL 424
+ SNNRL+G IP +
Sbjct: 496 SLSNNRLTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-108
Identities = 116/440 (26%), Positives = 187/440 (42%), Gaps = 24/440 (5%)
Query: 2 SFMYLTGTL----PDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLW 57
S L + L L LSN+ G +L L + N
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN-SLSGP 115
Query: 58 KLPESSIFRLTKLRIMVLATCALHGQIPASIG-NVTSLTDLELTGNFITGHIPPEI---G 113
+S+ + L+ + +++ L S G + SL L+L+ N I+G
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 114 LLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY 173
L+ L + N +++G + + L LD+S N+ S IP + L+ L +
Sbjct: 176 GCGELKHLAISGN-KISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDIS 231
Query: 174 NNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKV 233
N LSG+ S I+ T L +L++ N G +P L L L+ENK +G +P +
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFL 289
Query: 234 CSR-GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIID 291
L + N F G +P C L +S+N+ G +P L + + ++D
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 292 LSYNSFSGPIANTVGNAR-NLSELFMQRNQISGFIPSEI--YRAISLVKIDLSDNLLSGP 348
LS+N FSG + ++ N +L L + N SG I + +L ++ L +N +G
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 349 IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN- 407
IP + N +L L L N L+ +IP+SL SL L L L N+L G IP+ L +
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-VKTL 468
Query: 408 -SINFSNNRLSGPIPLSLIK 426
++ N L+G IP L
Sbjct: 469 ETLILDFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-105
Identities = 136/442 (30%), Positives = 207/442 (46%), Gaps = 37/442 (8%)
Query: 6 LTGTLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFNLT-NLEVLSFNENPGFKLW-KLPE 61
+G LP M+ L+ LDLS N F+G+ P S+ NL+ +L L + N +
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN---NFSGPILP 386
Query: 62 S-SIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+ L+ + L G+IP ++ N + L L L+ N+++G IP +G L LR
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
L+L+ N L G IP+EL + L L + N L+G+IP + L + L NN L+GE
Sbjct: 447 LKLWLNM-LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
I I L +L L +NS +G +P +LG L+ LDL+ N +G +PA + Q
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK----Q 561
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNN--HLEGSIPEGILSLPHVSIIDLSYNSFS 298
+ N +G + + N +G E + L + +++ +
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 299 GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKK 358
G + T N ++ L M N +SG+IP EI L ++L N +SG IP +G+L+
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 359 LNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSG 418
LN+L L SNKL+ IP ++S+L L +DLSNN L+G IPE F
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-----GQFETFPP----- 731
Query: 419 PIPLSLIKEGLVESFSGNPGLC 440
F NPGLC
Sbjct: 732 ------------AKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 1e-86
Identities = 100/371 (26%), Positives = 165/371 (44%), Gaps = 19/371 (5%)
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYY 125
++T + + + +S+ ++T L L L+ + I G + +L L+L
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSR 109
Query: 126 NQQLAGTIPE--ELGNLTELTDLDMSVNHLSGKIP-ESILRLPKLRVLQLYNNSLSGEIS 182
N L+G + LG+ + L L++S N L L+L L VL L NS+SG
Sbjct: 110 N-SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 183 SVIA---NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239
L L++ N ++G+V + + L LD+S N S +P + L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
Q+ + N SG +++ C L +S+N G IP L + + L+ N F+G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSLAENKFTG 283
Query: 300 PI-ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIP-SGIGNLK 357
I G L+ L + N G +P L + LS N SG +P + ++
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 358 KLNLLMLQSNKLNSSIPNSLSSLK-SLNVLDLSNNLLTGYIPESLCELLPNSINF---SN 413
L +L L N+ + +P SL++L SL LDLS+N +G I +LC+ N++ N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 414 NRLSGPIPLSL 424
N +G IP +L
Sbjct: 404 NGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 6e-81
Identities = 98/353 (27%), Positives = 158/353 (44%), Gaps = 20/353 (5%)
Query: 90 NVTSLTDLELTGNFIT---GHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146
+T ++L+ + + + L L L L + + G++ LT L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS-HINGSVS-GFKCSASLTSL 105
Query: 147 DMSVNHLSGKIPE--SILRLPKLRVLQLYNNSLSGEIS-SVIANSTTLTMLSLYDNSLTG 203
D+S N LSG + S+ L+ L + +N+L S +L +L L NS++G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 204 EVPQDL---GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARC 260
L L +S NK+SG + C L++ V N FS +P L C
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV--NLEFLDVSSNNFSTGIP-FLGDC 222
Query: 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQ 320
L +S N L G I + + ++++S N F GPI ++L L + N+
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI--PPLPLKSLQYLSLAENK 280
Query: 321 ISGFIPSEIYRAI-SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP-NSLS 378
+G IP + A +L +DLS N G +P G+ L L L SN + +P ++L
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 379 SLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSLIKEGL 429
++ L VLDLS N +G +PESL L + +++ S+N SGPI +L +
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-108
Identities = 110/301 (36%), Positives = 171/301 (56%), Gaps = 24/301 (7%)
Query: 518 SFDQREILEAMT----EKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
F RE+ A + KN +G+GG G VYK L G +VAVK+L +
Sbjct: 19 RFSLRELQVA-SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL---------KEERTQ 68
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH---KGLVHL 630
+ +TEVE + H+N+++L + + LLVY YM NG++ L + L
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 631 DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
DWP R +IA G A+GLAYLH IIHRD+K+ NILLD ++ V DFG+AK++
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-- 186
Query: 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF---GDNK 747
TT + GT G++APEY + K++ K DV+ +GV+L+ELITG++ + D+
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806
++ WV + K+ + ++D L G++ +E+ Q++++A+ CT SP RP M+EVV++
Sbjct: 247 MLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 807 L 807
L
Sbjct: 306 L 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-105
Identities = 108/335 (32%), Positives = 159/335 (47%), Gaps = 38/335 (11%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMT----EKNKVGQGGSGTVYKI 545
SK T SS + +S +R+ LE T K +G G G VYK
Sbjct: 3 SKYSKATNSINDALSSSYLVPFES-YRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 546 DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605
L G VA+K+ + Q + +TE+ETL RH ++V L +
Sbjct: 59 VLRDGAKVALKRR----------TPESSQGIEEFETEIETLSFCRHPHLVSLIGF----- 103
Query: 606 CN-----LLVYEYMPNGNLWDALH---KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPI 657
C+ +L+Y+YM NGNL L+ + + W R +I G A+GL YLH I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AI 160
Query: 658 IHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT 717
IHRD+KS NILLD N+ PK+ DFGI+K + +TV+ GT GY+ PEY + T
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219
Query: 718 TKCDVYSFGVVLMELITGRKPVEDDFGDNK-NIIYWVSIKVDTKEGIMEVLDKKLSGSFR 776
K DVYSFGVVL E++ R + N+ W + + +++D L+ R
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIR 278
Query: 777 -DEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
+ + + A++C + S RP+M +V+ L A
Sbjct: 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-103
Identities = 102/306 (33%), Positives = 154/306 (50%), Gaps = 34/306 (11%)
Query: 518 SFDQREILEA---------MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSAS 568
SF E+ NK+G+GG G VYK +N VAVKKL + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITT-- 70
Query: 569 DTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN-----LLVYEYMPNGNLWDAL 623
+L + E++ + +H+N+V+L + + LVY YMPNG+L D L
Sbjct: 71 ----EELKQQFDQEIKVMAKCQHENLVELLGF-----SSDGDDLCLVYVYMPNGSLLDRL 121
Query: 624 H--KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681
G L W R KIA G A G+ +LH IHRDIKS NILLD + K++DFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 178
Query: 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
+A+ + + T+ I GT Y+APE + T K D+YSFGVVL+E+ITG V D
Sbjct: 179 LAR-ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV-D 235
Query: 742 DFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN 801
+ + + ++ D ++ I + +DKK++ + + + +A +C + RP +
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 802 EVVQLL 807
+V QLL
Sbjct: 296 KVQQLL 301
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 9e-81
Identities = 64/444 (14%), Positives = 135/444 (30%), Gaps = 46/444 (10%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
+T + LR+ + N+ F + + N E +
Sbjct: 195 ITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-------ED-LKWD 246
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFIT--------GHIPPEIGLLKN 117
L L + + C ++P + + + + + N + + +
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 118 LRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177
++ + + YN + L + +L L+ N L G + KL L L N +
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQI 365
Query: 178 SGEISSVIANSTTLTMLSLYDNSLTGEVPQ--DLGQWSPLVVLDLSENKLSG-------P 228
+ ++ + + LS N L +P D S + +D S N++ P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 229 LPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG-------SIPEGI 281
L + + N S + + L + N L E
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 282 LSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340
+ ++ IDL +N + L + + N S P++ + +L +
Sbjct: 485 KNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543
Query: 341 SDNL------LSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394
+ P GI L L + SN + + + +++VLD+ +N
Sbjct: 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNI 600
Query: 395 GYIPESLCELLP-NSINFSNNRLS 417
+C + ++
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 5e-80
Identities = 72/454 (15%), Positives = 148/454 (32%), Gaps = 46/454 (10%)
Query: 5 YLTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESS 63
++ ++ +N T +V LT L + +
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS------PFVAEN 222
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
I + + N+ LTD+E+ +P + L ++ + +
Sbjct: 223 ICEAWENE--NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280
Query: 124 YYNQ-------QLAGTIPEELGNLTELTDLDMSVNHL-SGKIPESILRLPKLRVLQLYNN 175
N+ + + ++ + + N+L + + S+ ++ KL +L+ N
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340
Query: 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG-PLPAKVC 234
L G++ + + L L+L N +T G + L + NKL P
Sbjct: 341 QLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 235 SRGKLQYFLVLQNMFSGV-------LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHV 287
S + N V L + + N+ +SNN + E + +
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 288 SIIDLSYNSFSG-------PIANTVGNARNLSELFMQRNQISGFIPSEIYRA--ISLVKI 338
S I+L N + N L+ + ++ N+++ + + LV I
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGI 518
Query: 339 DLSDNLLSGPIPSGIGNLKKL------NLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392
DLS N S P+ N L N Q N+ P ++ SL L + +N
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 393 LTGYIPESLCELLPNSINFSNNRLSGPIPLSLIK 426
+ + E + + + ++ +N +
Sbjct: 578 IRK-VNEKITPNI-SVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 9e-76
Identities = 67/447 (14%), Positives = 138/447 (30%), Gaps = 41/447 (9%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVL--SFNENPGFKLWKLPESSIFRLTKL 70
+ + L L +G+ P ++ LT LEVL + + P I
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP-KGISANMSD 135
Query: 71 RIMVLATCALHGQIPASIG--NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
+ + L + + I + Q+ N
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN- 194
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ + + LT+L M + + N
Sbjct: 195 -ITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNL 248
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKL--------SGPLPAKVCSRGKLQ 240
LT + +Y+ ++P L + +++++ N+ A K+Q
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308
Query: 241 YFLVLQNMF-SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
+ N + + SL + K L N LEG +P S ++ ++L+YN +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE 367
Query: 300 PIANTVGNARNLSELFMQRNQISGFIPS-EIYRAISLVKIDLSDNLLSG-------PIPS 351
AN G + L N++ + + ID S N + P+
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 352 GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSI-- 409
++ + L +N+++ S+ L+ ++L N+LT IP++ + +
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKN 486
Query: 410 -------NFSNNRLSGPIPLSLIKEGL 429
+ N+L+ + L
Sbjct: 487 TYLLTSIDLRFNKLTK-LSDDFRATTL 512
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 8e-66
Identities = 53/363 (14%), Positives = 113/363 (31%), Gaps = 23/363 (6%)
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ---QLAGTIP 134
Q S+ + +T L L G +G +P IG L L L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 135 EELGNLTELTDLDMSVNHLSGKIPESI--LRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
+ + H + L + ++ I + T
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252
+ N++T V + + + + L + + + +Y
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKT 240
Query: 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSF--------SGPIANT 304
K+L V N +P + +LP + +I+++ N
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 305 VGNARNLSELFMQRNQI-SGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363
+ +++ N + + + + + + L ++ N L G +P+ G+ KL L
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLN 359
Query: 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIP 421
L N++ N + + L ++N L + + +I+FS N +
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 422 LSL 424
+
Sbjct: 420 KNF 422
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-40
Identities = 40/313 (12%), Positives = 89/313 (28%), Gaps = 28/313 (8%)
Query: 126 NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
N G + N +LDM S+ ++ L L SG + I
Sbjct: 46 NWSQQGFGTQPGANWNFNKELDMWGAQ----PGVSLNSNGRVTGLSLEGFGASGRVPDAI 101
Query: 186 ANSTTLTMLSLYDNSLTG----EVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRG--KL 239
T L +L+L + P+ + L
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
+ + + S + +N++ + + ++ L + + + F
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVA 220
Query: 300 PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKL 359
N Q + L +++ + +P+ + L ++
Sbjct: 221 ENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 360 NLLMLQSNKLNS--------SIPNSLSSLKSLNVLDLS-NNLLTGYIPESLCELLPN--S 408
L+ + N+ S + + ++ + NNL T + SL + +
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK-MKKLGM 334
Query: 409 INFSNNRLSGPIP 421
+ N+L G +P
Sbjct: 335 LECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 15/141 (10%), Positives = 44/141 (31%), Gaps = 8/141 (5%)
Query: 291 DLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGP-- 348
+ + + ++ + ++ L ++ SG +P I + L + L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 349 --IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNV--LDLSNNLLTGYIPESLCEL 404
P GI + + ++ ++++ I +S
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 405 LP-NSINFSNNRLSGPIPLSL 424
L I +N ++ + ++
Sbjct: 183 LKDTQIGQLSNNITF-VSKAV 202
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 11/122 (9%), Positives = 36/122 (29%), Gaps = 9/122 (7%)
Query: 327 SEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVL 386
+ + + ++ + + ++ L L+ + +P+++ L L VL
Sbjct: 51 GFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVL 110
Query: 387 DLSNNLLTG----YIPESLCELLP-NSINFSNNRLSGPIPLSLIKEGLVE----SFSGNP 437
L ++ + P+ + + +E + + +P
Sbjct: 111 ALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDP 170
Query: 438 GL 439
Sbjct: 171 QQ 172
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-76
Identities = 77/334 (23%), Positives = 121/334 (36%), Gaps = 47/334 (14%)
Query: 499 DETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKL 558
S + + + + +G G V+K L E VAVK
Sbjct: 6 HHHSSGVDLGTEN-------LYFQSM--PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55
Query: 559 WSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKL--YCYFSSLYCN--LLVYEYM 614
D Q + EV +L ++H+NI++ + L+ +
Sbjct: 56 -------PIQDKQSWQN----EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 615 PNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS-------PIIHRDIKSTNI 667
G+L D L + + W IA +A+GLAYLH + I HRDIKS N+
Sbjct: 105 EKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162
Query: 668 LLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA-----YSSKATTKCDV 722
LL N +ADFG+A +A T GT Y+APE + A + D+
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 723 YSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME-VLDKKLSGSFRDE--- 778
Y+ G+VL EL + + + + + E + E V+ KK RD
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK 281
Query: 779 ---MIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
M + C R + V + + +
Sbjct: 282 HAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 9e-75
Identities = 76/300 (25%), Positives = 133/300 (44%), Gaps = 30/300 (10%)
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITG--HIPPEIGLLKNLRQLELYYNQQLAGTIPE 135
G + + + +L+L+G + IP + L L L + L G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 136 ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLS 195
+ LT+L L ++ ++SG IP+ + ++ L L N+LSG + I++ L ++
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 196 LYDNSLTGEVPQDLGQWSPLV-VLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
N ++G +P G +S L + +S N+L+G +P
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK------------------------IP 191
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
+ A NL +S N LEG S + I L+ NS + + VG ++NL+ L
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGL 249
Query: 315 FMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
++ N+I G +P + + L +++S N L G IP G GNL++ ++ +NK P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 3e-71
Identities = 84/365 (23%), Positives = 137/365 (37%), Gaps = 79/365 (21%)
Query: 83 QIPASIGNVTSL----TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGT--IPEE 136
QI +GN T+L + G + + L+L L IP
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN-LPKPYPIPSS 71
Query: 137 LGNLTELTDLDMS-VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLS 195
L NL L L + +N+L G IP +I +L +L L + + ++SG I ++ TL L
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
N+L+G +P + LV + N++SG +P D
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP------------------------D 167
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELF 315
S L + +S N +G I T N NL+ +
Sbjct: 168 SYGSFSKLFTS-----------------------MTISRNRLTGKIPPTFANL-NLAFVD 203
Query: 316 MQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPN 375
+ RN + G + KI L+ N L+ + +G K LN L L++N++ ++P
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 376 SLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSG 435
L+ LK L+ L++S N L G IP+ N + +++
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGG--------NLQR--------FDVS------AYAN 300
Query: 436 NPGLC 440
N LC
Sbjct: 301 NKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 24/99 (24%), Positives = 28/99 (28%), Gaps = 32/99 (32%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVL--SFNENPGFKLWKLPESS 63
L L +NL LDL NN G P + L L L SFN
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN------------- 279
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGN 102
L G+IP GN+ N
Sbjct: 280 ----------------LCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 14/49 (28%), Positives = 24/49 (48%), Gaps = 2/49 (4%)
Query: 6 LTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPG 53
+ GTLP + ++ L L++S N G+ P NL +V ++ N
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 7e-72
Identities = 87/437 (19%), Positives = 150/437 (34%), Gaps = 30/437 (6%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+ L+ L+L +N + + TNL L N + K+ + + L
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN---SIQKIKNNPFVKQKNLIT 125
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKN--LRQLELYYNQQLA 130
+ L+ L + + +L +L L+ N I E+ + N L++LEL N Q+
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN-QIK 184
Query: 131 GTIPEELGNLTELTDLDMSVNHLSGKIPESI---LRLPKLRVLQLYNNSLSGEISSVIAN 187
P + L L ++ L + E + L +R L L N+ LS ++
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244
Query: 188 --STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
T LTML L N+L L L N + + ++Y +
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 246 QNMFSGVL---------PDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYN- 295
++ + S K L + +N + G L ++ + LS +
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 296 -SFSGPIANTVGN--ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG 352
S T + L L + +N+IS L +DL N + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 353 -IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG--YIPESLCELLPN-- 407
L+ + + L NK NS + + SL L L L P L N
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP-LRNLT 483
Query: 408 SINFSNNRLSGPIPLSL 424
++ SNN ++ L
Sbjct: 484 ILDLSNNNIANINDDML 500
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-70
Identities = 81/431 (18%), Positives = 155/431 (35%), Gaps = 30/431 (6%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ D S+ T Q P + TN+ VL+ N +L +LP ++ R ++L + +
Sbjct: 5 SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHN---QLRRLPAANFTRYSQLTSLDVGF 58
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
+ P + L L L N ++ NL +L L N +
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN-SIQKIKNNPF 117
Query: 138 GNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIA--NSTTLTMLS 195
L LD+S N LS + ++L L+ L L NN + S + +++L L
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ---NMFSGV 252
L N + P L L L+ +L L K+C L + S
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 253 LPDSLARCK--NLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
+ K NL +S N+L + LP + L YN+ ++++ N
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 311 LSELFMQRN---------QISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNL 361
+ L ++R+ + L +++ DN + G + L L
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 362 LMLQSNKLNSSIPNSLS----SLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNR 415
L L ++ + + + + L++L+L+ N ++ ++ L + ++ N
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW-LGHLEVLDLGLNE 416
Query: 416 LSGPIPLSLIK 426
+ + +
Sbjct: 417 IGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 3e-68
Identities = 84/440 (19%), Positives = 151/440 (34%), Gaps = 33/440 (7%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF---NLTNLEVLSFNENPGFKLWKLPESSIF--R 66
F + L L L+N + T++ LS + + +L ++ +
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS---QLSTTSNTTFLGLK 246
Query: 67 LTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYN 126
T L ++ L+ L+ S + L L N I + L N+R L L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 127 Q--------QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178
L L L L+M N + G L L+ L L N+ S
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 179 GEISSVIA----NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKV- 233
+ + L +L+L N ++ L VLDL N++ L +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 234 CSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG--SIPEGILSLPHVSIID 291
+ + N + + +S A +L R + L+ S P L +++I+D
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 292 LSYNSFSGPIANTVGNARNLSELFMQRNQIS--------GFIPSEIYRAISLVKIDLSDN 343
LS N+ + + + L L +Q N ++ G + L ++L N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCE 403
+L +L ++ L N LN+ + ++ SL L+L NL+T +
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 404 LLPN--SINFSNNRLSGPIP 421
N ++ N
Sbjct: 607 AFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-67
Identities = 95/454 (20%), Positives = 162/454 (35%), Gaps = 41/454 (9%)
Query: 6 LTGTLPD-FSPMQNLRRLDLSNNLFTG--QFPLSVFNLTNLEVLSFNENPGFKLWKLPES 62
L+ T ++NL+ L LSNN L +F ++L+ L + N ++ +
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN---QIKEFSPG 189
Query: 63 SIFRLTKLRIMVLATCALHGQIPASIG---NVTSLTDLELTGNFITGHIPPEIGLLK--N 117
+ +L + L L + + TS+ +L L+ + ++ LK N
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
Query: 118 LRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN-- 175
L L+L YN L + L +L + N++ S+ L +R L L +
Sbjct: 250 LTMLDLSYNN-LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 176 -------SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS-G 227
SL L L++ DN + G L L LS + S
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 228 PLPAKVCS---RGKLQYFLVLQ-NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS 283
L + L L L N S + D+ + +L + N + +
Sbjct: 369 TLTNETFVSLAHSPLHI-LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 284 -LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGF--IPSEIYRAISLVKIDL 340
L ++ I LSYN + N+ +L L ++R + PS +L +DL
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS--------SIPNSLSSLKSLNVLDLSNNL 392
S+N ++ + L+KL +L LQ N L L L L++L+L +N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 393 LTGYIPESLCELLPN--SINFSNNRLSGPIPLSL 424
E +L I+ N L+
Sbjct: 548 FDEIPVEVFKDL-FELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 9e-67
Identities = 95/471 (20%), Positives = 154/471 (32%), Gaps = 35/471 (7%)
Query: 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPE 61
L D +L++L+LS+N P + L L N
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGN--VTSLTDLELTGNFITGHIPPEIGLLKNLR 119
T +R + L+ L + T+LT L+L+ N + L L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 120 QLELYYNQQLAGTIPEELGNLTELTDLDM---------SVNHLSGKIPESILRLPKLRVL 170
L YN + L L + L++ S+ L S L L L
Sbjct: 276 YFFLEYNN-IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334
Query: 171 QLYNNSLSGEISSVIANSTTLTMLSLYDN-----SLTGEVPQDLGQWSPLVVLDLSENKL 225
+ +N + G S++ L LSL ++ +LT E L SPL +L+L++NK+
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKI 393
Query: 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLP-DSLARCKNLLRFRVSNNHLEGSIPEGILSL 284
S G L+ + N L +N+ +S N +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 285 PHVSIIDLSYNSFSG--PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342
P + + L + + RNL+ L + N I+ + L +DL
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 343 NLLS--------GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394
N L+ G + L L++L L+SN + L L ++DL N L
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573
Query: 395 GYIPESLCELLPN--SINFSNNRLSGPIPLSLIK--EGLVE-SFSGNPGLC 440
+ S+N N ++ L E NP C
Sbjct: 574 TLPASVFNNQ-VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-66
Identities = 94/443 (21%), Positives = 166/443 (37%), Gaps = 37/443 (8%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPES--SIFRLTKL 70
F +NL LDLS+N + + L NL+ L + N K+ L IF + L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN---KIQALKSEELDIFANSSL 173
Query: 71 RIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL---LKNLRQLELYYNQ 127
+ + L++ + P + L L L + + ++ L ++R L L +
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS- 232
Query: 128 QLAGTIPEELGNL--TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
QL+ T L T LT LD+S N+L+ +S LP+L L N++ S +
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
+ L+L + +S L L++ +
Sbjct: 293 HGLFNVRYLNLKRS---------------FTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI----LSLPHVSIIDLSYNSFSGPI 301
N G+ + NL +SN+ L+ + I++L+ N S
Sbjct: 338 DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 302 ANTVGNARNLSELFMQRNQISGFIP-SEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
++ +L L + N+I + E ++ +I LS N + + L
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 361 LLMLQSNKLNS--SIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRL 416
LML+ L + S P+ L++L +LDLSNN + I + + E L ++ +N L
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNL 516
Query: 417 SGPIPLSLIKEGLVESFSGNPGL 439
+ + G + G L
Sbjct: 517 AR-LWKHANPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-54
Identities = 80/416 (19%), Positives = 140/416 (33%), Gaps = 27/416 (6%)
Query: 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNEN------PG 53
+S+ L D F+ + L L N F S+ L N+ L+ +
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 54 FKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIG 113
L K+ + S L L + + + G + +L L L+ +F +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 114 L----LKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLR 168
L L L N+ ++ + L L LD+ +N + ++ R L +
Sbjct: 375 FVSLAHSPLHILNLTKNK-ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 169 VLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTG--EVPQDLGQWSPLVVLDLSENKLS 226
+ L N + A +L L L +L P L +LDLS N ++
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA 493
Query: 227 GPLPAKVCSRGKLQYFLVLQN---------MFSGVLPDSLARCKNLLRFRVSNNHLEGSI 277
+ KL+ L LQ+ G L +L + +N +
Sbjct: 494 NINDDMLEGLEKLEI-LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552
Query: 278 PEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-SLV 336
E L + IIDL N+ + A+ N +L L +Q+N I+ A +L
Sbjct: 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612
Query: 337 KIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP-NSLSSLKSLNVLDLSNN 391
++D+ N S + +N +L+S N+ V +
Sbjct: 613 ELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-50
Identities = 80/357 (22%), Positives = 125/357 (35%), Gaps = 38/357 (10%)
Query: 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVN 151
S + + +T +P L N+ L L +NQ L ++LT LD+ N
Sbjct: 4 VSHEVADCSHLKLT-QVPD--DLPTNITVLNLTHNQ-LRRLPAANFTRYSQLTSLDVGFN 59
Query: 152 HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ 211
+S PE +LP L+VL L +N LS A T LT
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLT------------------- 100
Query: 212 WSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNN 271
L L N + + L + N S + + +NL +SNN
Sbjct: 101 -----ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 272 HLEGSIPE--GILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
++ E I + + ++LS N L LF+ Q+ + ++
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 330 YRAI---SLVKIDLSDNLLSGPIPSGIGNLKKLNL--LMLQSNKLNSSIPNSLSSLKSLN 384
+ S+ + LS++ LS + LK NL L L N LN +S + L L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 385 VLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSLIKEGLVESFSGNPGL 439
L N + SL L N +N + I L+ + + SF L
Sbjct: 276 YFFLEYNNIQHLFSHSLHG-LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 6e-68
Identities = 89/298 (29%), Positives = 136/298 (45%), Gaps = 43/298 (14%)
Query: 513 SFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQ 572
S H I + + E+ E VG+G G V K + VA+K++ S+
Sbjct: 1 SLHMIDYKEIEVEE------VVGRGAFGVVCKAKWR-AKDVAIKQIESE----------- 42
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK--GLVHL 630
K E+ L + H NIVKLY + C LV EY G+L++ LH L +
Sbjct: 43 -SERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYY 99
Query: 631 DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-PKVADFGIAKVLQAR 689
+QG+AYLH +IHRD+K N+LL K+ DFG A
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---- 155
Query: 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749
+ T G+ ++APE S + KCDV+S+G++L E+IT RKP + + G
Sbjct: 156 --IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFR 212
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
I W T+ +++ L K + ++ RC SK P+ RP+M E+V+++
Sbjct: 213 IMWAVHN-GTRPPLIKNLPKPIE-----SLMT------RCWSKDPSQRPSMEEIVKIM 258
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-66
Identities = 79/473 (16%), Positives = 162/473 (34%), Gaps = 58/473 (12%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQF------PLSVFNLTNLEVLSFNENPGFKLWKLPESS 63
P+ P++ R+ L + ++ LT L+++ F + +
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS---PFTYDNIA- 466
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
+ S N+ LTD+EL +P + L L+ L +
Sbjct: 467 ----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
Query: 124 YYNQ--------QLAGTIPEELGNLTELTDLDMSVNHLSGKIPES--ILRLPKLRVLQLY 173
N+ + ++ ++ M N+L P S + ++ KL +L
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCV 581
Query: 174 NNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSG-PLPA 231
+N + + + + LT L L N + E+P+D ++ + L S NKL P
Sbjct: 582 HNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIF 638
Query: 232 KVCSRGKLQYFLVLQNMFSGVLPDSLA-----RCKNLLRFRVSNNHLEGSIPEGILSLPH 286
S + N + + N +S N ++ E +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 287 VSIIDLSYNSFS-------GPIANTVGNARNLSELFMQRNQISGFIPSEIY--RAISLVK 337
+S I LS N + P N L+ + ++ N+++ + + L
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSN 757
Query: 338 IDLSDNLLSGPIPSGIGNLKKLNLLMLQ------SNKLNSSIPNSLSSLKSLNVLDLSNN 391
+D+S N S P+ N +L ++ N++ P +++ SL L + +N
Sbjct: 758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 392 LLTGYIPESLCELLPNSINFSNNRL-SGPIP--LSLIKEGLVE-SFSGNPGLC 440
+ + E L L ++ ++N S + I+ G+ + +
Sbjct: 817 DIRK-VDEKLTPQL-YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIR 867
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-62
Identities = 68/444 (15%), Positives = 131/444 (29%), Gaps = 48/444 (10%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
+T + L+ + +N+ FT + N + EN E S
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE--------ELSWS 488
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITG---------HIPPEIGLLK 116
L L + L C Q+P + ++ L L + N + +
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176
++ + YN L + +L LD N + E+ KL L+L N
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQ 606
Query: 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQD--LGQWSPLVVLDLSENKLSGPLPAKVC 234
+ A + + L N L +P + +D S NK+ +
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNIS 664
Query: 235 SRGKLQYFLVLQ------NMFSGVLPDSLARCKNLLRFRVSNNHLE-------GSIPEGI 281
+ N + A + +SNN +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 282 LSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340
+ ++ IDL +N + LS + + N S P++ + L +
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783
Query: 341 SDNL------LSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN-LL 393
+ P+GI L L + SN + + L L +LD+++N +
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNI 840
Query: 394 TGYIPESLCELLPNSINFSNNRLS 417
+ + + ++
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-55
Identities = 68/441 (15%), Positives = 134/441 (30%), Gaps = 43/441 (9%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+ L L+ G+ P ++ LT L+VLSF + +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH---SETVSGRLFGDEELTPDM 375
Query: 73 MVLATCALHGQI-PASIGNVTSLTDLELTGNFITGH---IPPEIGLLKNLRQLELYYNQQ 128
+ + L +L + I + P + +L+ ++
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
I + + LT+L + + + + +N
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNL 490
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
LT + LY+ ++P L L L+++ N+
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL---------------KA 535
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGN 307
L D + F + N+LE L + + ++D +N G
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGT 593
Query: 308 ARNLSELFMQRNQISGFIPSEI-YRAISLVKIDLSDNLLSG-PIPSGIGNLKKLNLLMLQ 365
L++L + NQI IP + + + S N L P ++ + +
Sbjct: 594 NVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652
Query: 366 SNKLNSSIPNSLSSL-----KSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSG 418
NK+ S N S+ + + + LS N + P L +I SNN ++
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTS 711
Query: 419 PIPLSLIKEGLVESFSGNPGL 439
IP + + + ++ L
Sbjct: 712 -IPENSL-KPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-49
Identities = 54/357 (15%), Positives = 109/357 (30%), Gaps = 35/357 (9%)
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
Q + N +T L L G G +P IG L L+ L + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH-SETVSGRLFG 367
Query: 138 GNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLS-----GEISSVIANSTTL 191
+ + + + L +L + L ++++ I S
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251
T + N +T + + + + + L ++ + + + A +
Sbjct: 428 TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYE 481
Query: 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311
S + K+L + N +P+ + LP + ++++ N R
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR-- 539
Query: 312 SELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSG-PIPSGIGNLKKLNLLMLQSNKLN 370
+ + + + N L P + + + KL LL NK+
Sbjct: 540 -------------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV- 585
Query: 371 SSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSG-PIPLSL 424
+ + L L L N + IPE C + FS+N+L P +
Sbjct: 586 -RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNA 640
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-33
Identities = 34/326 (10%), Positives = 95/326 (29%), Gaps = 24/326 (7%)
Query: 115 LKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174
LK + + N + + + + ++ + + ++ L L
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAG 332
Query: 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVC 234
G + I T L +LS +S T + + + ++++
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 235 SRG-KLQYFLVLQNMFSGV-----LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVS 288
+L +LQ+ + + + N + I + I L +
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQ 451
Query: 289 IIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGP 348
II + + F+ + + + L ++L +
Sbjct: 452 IIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 349 IPSGIGNLKKLNLLMLQSNKLNS---------SIPNSLSSLKSLNVLDLSNNLLTGYIPE 399
+P + +L +L L + N+ S + + + + + + N L +
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS 566
Query: 400 SLCELLPN--SINFSNNRLSGPIPLS 423
+ + + ++ +N++
Sbjct: 567 ASLQKMVKLGLLDCVHNKVRHLEAFG 592
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 5e-13
Identities = 17/142 (11%), Positives = 44/142 (30%), Gaps = 8/142 (5%)
Query: 290 IDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPI 349
+ + + + N ++ L + G +P I + L + + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 350 PSGIGNLKKLNLLMLQSNKLNSSIPN-SLSSLKSLNVLDLSNNLLTGY------IPESLC 402
++ + +++ L + LN+ DL + + +S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 403 ELLPNSINFSNNRLSGPIPLSL 424
L I NR++ I ++
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAI 444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-65
Identities = 76/309 (24%), Positives = 135/309 (43%), Gaps = 40/309 (12%)
Query: 508 PYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVS 566
+ ++ ++ E + ++G+GG G V+K + VVA+K L ++
Sbjct: 7 EFPKSRLPTLADNEIEYEK------QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 567 ASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKG 626
++ Q + EV + N+ H NIVKLY + +V E++P G+L+ L
Sbjct: 61 TEMIEKFQE---FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK 115
Query: 627 LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-----VNYQPKVADFG 681
+ W + ++ +A G+ Y+ + PI+HRD++S NI L KVADFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 682 IAKVLQARGGKDSTTTVIAGTYGYLAPE--YAYSSKATTKCDVYSFGVVLMELITGRKPV 739
+++ + + + G + ++APE A T K D YSF ++L ++TG P
Sbjct: 175 LSQQ------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP- 227
Query: 740 EDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI-RCTSKSPATRP 798
F + I + ++ L + ++ LR I C S P RP
Sbjct: 228 ---FDEYSYGKIKF---------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275
Query: 799 TMNEVVQLL 807
+ +V+ L
Sbjct: 276 HFSYIVKEL 284
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-64
Identities = 83/463 (17%), Positives = 147/463 (31%), Gaps = 47/463 (10%)
Query: 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTG-QFPLSVFNLTNLEVLSFNENPGFKLWK 58
L ++ L+ L++++NL + P NLTNLE L + N K+
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN---KIQS 163
Query: 59 LPESSIFRLTKLRIMV----LATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL 114
+ + + L ++ ++ L+ ++ I L L L NF + ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 115 -LKNLRQLELYYNQ-----QLAGTIPEELGNLTELTDLDMSVNHLS---GKIPESILRLP 165
L L L + L L L LT + + +L I + L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW------------- 212
+ L + ++ + + L L + L
Sbjct: 283 NVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA 340
Query: 213 ------SPLVVLDLSENKLS--GPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLL 264
L LDLS N LS G L+Y + N + + + L
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE 399
Query: 265 RFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISG 323
+++L+ + SL ++ +D+S+ +L L M N
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 324 FIPSEI-YRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKS 382
+I +L +DLS L P+ +L L +L + N S L S
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 383 LNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLS 423
L VLD S N + + L + +N + N +
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-62
Identities = 77/422 (18%), Positives = 146/422 (34%), Gaps = 30/422 (7%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ + LDLS N S F+ L+VL + ++ + + + L+ L ++L
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC---EIQTIEDGAYQSLSHLSTLILTG 85
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
+ + ++SL L + IG LK L++L + +N + +PE
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 138 GNLTELTDLDMSVNHLSGKIPESILRLPKLRV----LQLYNNSLSGEISSVIANSTTLTM 193
NLT L LD+S N + + L ++ + L L N ++ L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHK 204
Query: 194 LSLYDNSLTGEVPQDLGQW-SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ------ 246
L+L +N + V + Q + L V L + + + L+ L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 247 ---NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303
+ + + D N+ F + + +E ++L F
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF--GWQHLELVNCKFGQFPTL 322
Query: 304 TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS--GPIPSGIGNLKKLNL 361
+ + + L+ + + SL +DLS N LS G L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLP-----SLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 362 LMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGP 419
L L N + ++ ++ L+ L LD ++ L S+ L N ++ S+
Sbjct: 378 LDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 420 IP 421
Sbjct: 437 FN 438
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-61
Identities = 77/452 (17%), Positives = 149/452 (32%), Gaps = 49/452 (10%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+ + +L L L+ N + L++L+ L E L L I L L+
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET---NLASLENFPIGHLKTLKE 128
Query: 73 MVLATCALHG-QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR----QLELYYNQ 127
+ +A + ++P N+T+L L+L+ N I ++ +L + L+L N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGE------ 180
+ P + L L + N S + ++ + L L V +L E
Sbjct: 189 -MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP---LVVLDLSENKLSGPLPAKVCSRG 237
S + LT+ L + + ++ + L +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-- 304
Query: 238 KLQYFLVLQNMFSGVLPDSLARCKNLLRFR-------------------VSNNHL--EGS 276
Q+ ++ F L K L +S N L +G
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 277 IPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-SL 335
+ + +DLS+N +++ L L Q + + ++ ++ +L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 336 VKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSI-PNSLSSLKSLNVLDLSNNLLT 394
+ +D+S L L +L + N + P+ + L++L LDLS L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 395 GYIPESLCELLPN--SINFSNNRLSGPIPLSL 424
P + L + +N S+N
Sbjct: 484 QLSPTAFNSL-SSLQVLNMSHNNFFSLDTFPY 514
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-60
Identities = 74/460 (16%), Positives = 140/460 (30%), Gaps = 50/460 (10%)
Query: 6 LTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSI 64
+ FS + +L++L + +L L+ L+ N +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN---LIQSFKLPEY 144
Query: 65 FR-LTKLRIMVLATCALHGQIPASIGNVTSLT----DLELTGNFITGHIPPEIGLLKNLR 119
F LT L + L++ + + + + L+L+ N + I P L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 120 QLELYYNQQLAGTIPEELGNLTELTDLDMSVN------HLSGKIPESILRLPKLRVLQL- 172
+L L N + + L L + + +L ++ L L + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 173 --YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLP 230
Y + +I + T ++ SL ++ +D L+L K P
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FP 320
Query: 231 AKVCSRGKLQYFLVL----------------------QNMFSGVLPDSLARCKNLLRFRV 268
K F F G S +L +
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI-ANTVGNARNLSELFMQRNQISGFIPS 327
S N + + L L + +D +++ + + RNL L +
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 328 EIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVL 386
SL + ++ N I L+ L L L +L P + +SL SL VL
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 387 DLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSL 424
++S+N L + +++S N + L
Sbjct: 500 NMSHNNFFSLDTFPYKCL-NSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-29
Identities = 46/216 (21%), Positives = 74/216 (34%), Gaps = 32/216 (14%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKL 59
+SF + +F ++ L LD ++ SVF +L NL L +
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH------- 432
Query: 60 PESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNL 118
++SL L++ GN + P+I L+NL
Sbjct: 433 --------------------TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178
L+L QL P +L+ L L+MS N+ L L+VL N +
Sbjct: 473 TFLDLSQC-QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 179 GEISSVIANS-TTLTMLSLYDNSLTGEVP-QDLGQW 212
+ + ++L L+L N Q QW
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 29/158 (18%), Positives = 56/158 (35%), Gaps = 5/158 (3%)
Query: 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328
+ IP+ + +DLS+N + + + L L + R +I
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 329 IYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL 388
L + L+ N + L L L+ L S + LK+L L++
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 389 SNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSL 424
++NL+ + L N ++ S+N++ L
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 7e-64
Identities = 80/301 (26%), Positives = 126/301 (41%), Gaps = 46/301 (15%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
I F + + E +G GG G VY+ G+ VAVK D D Q
Sbjct: 4 IDFAELTLEE------IIGIGGFGKVYRAFWI-GDEVAVKAARHD------PDEDISQTI 50
Query: 577 KGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
+ ++ E + ++H NI+ L C C LV E+ G L L +
Sbjct: 51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC--LVMEFARGGPLNRVLSGK--RIPPDI 106
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP--------KVADFGIAKVL 686
A +A+G+ YLH + PIIHRD+KS+NIL+ + K+ DFG+A+
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166
Query: 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746
+T AG Y ++APE +S + DV+S+GV+L EL+TG P D
Sbjct: 167 H-----RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG--IDG 219
Query: 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806
+ Y V++ I + + ++ C + P +RP+ ++
Sbjct: 220 LAVAYGVAMNKLALP-IPSTCPEPFA-----------KLMEDCWNPDPHSRPSFTNILDQ 267
Query: 807 L 807
L
Sbjct: 268 L 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 36/297 (12%)
Query: 517 ISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
+ D +I + K K+G G GTV++ + + G VAVK L +++
Sbjct: 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKIL-----MEQDFHAERVN- 79
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVH--LD 631
EV + +RH NIV +V EY+ G+L+ LHK LD
Sbjct: 80 --EFLREVAIMKRLRHPNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
R +A+ VA+G+ YLH+ PI+HR++KS N+L+D Y KV DFG++++ +
Sbjct: 136 ERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF- 193
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
++ AGT ++APE + K DVYSFGV+L EL T ++P +
Sbjct: 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN---------- 241
Query: 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI-RCTSKSPATRPTMNEVVQLL 807
++ + + V K + + I C + P RP+ ++ LL
Sbjct: 242 -----LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-63
Identities = 77/433 (17%), Positives = 148/433 (34%), Gaps = 26/433 (6%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ L+ S N+ + L NL L +++ + E + +L +VL
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC---QIYWIHEDTFQSQHRLDTLVLTA 90
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
L ++ +L L I+ + K L L L N ++ +
Sbjct: 91 NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN-HISSIKLPKG 149
Query: 138 GNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY--NNSLSGEISSVIANSTTLTMLS 195
+L LD N + E + L + L L N ++ I +S L+
Sbjct: 150 FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLN 208
Query: 196 LYDNSLTGEVPQDLG--QWSPLVVLDLSENKLSGPLPA--KVCSRGKLQYFLVLQNMFSG 251
+ + L L + + PA + ++ + ++ F
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311
+ ++ L ++ HL +P G++ L + + LS N F + N +L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 312 SELFMQRNQISGFIPSE-IYRAISLVKIDLSDNLL--SGPIPSGIGNLKKLNLLMLQSNK 368
+ L ++ N + + + +L ++DLS + + S + NL L L L N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSLIK 426
S + L +LDL+ L +S + L +N S++ L
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE----- 442
Query: 427 EGLVESFSGNPGL 439
+ F G P L
Sbjct: 443 ----QLFDGLPAL 451
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-58
Identities = 79/425 (18%), Positives = 145/425 (34%), Gaps = 19/425 (4%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+ L L L +N + F L+VL F N + L + + L +
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN---AIHYLSKEDMSSLQQATN 181
Query: 73 MVLATCALH-GQIPASIGNVTSLTDLELTGNFITGHIPPEIGL--LKNLRQLELYYNQ-- 127
+ L I + L G I + +++L
Sbjct: 182 LSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIAN 187
++ + E L ++ + +++ ++ + L+ L L LS E+ S +
Sbjct: 242 DISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQ 246
+TL L L N + L L + N L L+ L L
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE-LDLS 358
Query: 247 N---MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303
+ S L +L +S N E P + ++DL++ A
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 304 TV-GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPI---PSGIGNLKKL 359
+ N L L + + + +L ++L N + + L +L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
Query: 360 NLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGP 419
+L+L L+S ++ +SLK +N +DLS+N LT E+L L +N ++N +S
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISII 538
Query: 420 IPLSL 424
+P L
Sbjct: 539 LPSLL 543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-56
Identities = 70/418 (16%), Positives = 137/418 (32%), Gaps = 21/418 (5%)
Query: 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79
+ + N + P ++ N + E L F+ N L + ++ RL L + L C
Sbjct: 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFN---VLPTIQNTTFSRLINLTFLDLTRCQ 68
Query: 80 LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGN 139
++ + + L L LT N + + K L+ L ++ L N
Sbjct: 69 IYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT-GISSIDFIPLHN 127
Query: 140 LTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLY-- 197
L L + NH+S KL+VL NN++ +++ T LSL
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 198 DNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPA--KVCSRGKLQYFLVLQNMFSGVLPD 255
N + + + L+ + + K + L + P
Sbjct: 188 GNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 256 SLARCK--NLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSE 313
++ + ++ + +DL+ S + + + L +
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKK 305
Query: 314 LFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG-IGNLKKLNLLMLQSNKLNSS 372
L + N+ SL + + N + +G + NL+ L L L + + +S
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 373 --IPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSLIK 426
L +L L L+LS N + + P ++ + RL S +
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-55
Identities = 78/425 (18%), Positives = 127/425 (29%), Gaps = 42/425 (9%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
S + L+ L + + + N LE L N + + F KL++
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN---HISSIKLPKGFPTEKLKV 157
Query: 73 MVLATCALHGQIPASIGNVTSLTDLEL--TGNFITGHIPPEIGLLKNLRQLELYYNQQLA 130
+ A+H + ++ T+L L GN I I P + L Q L
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLL 216
Query: 131 GTIPEELGN-LTELTDLDMSVNHLSGKIPESI--LRLPKLRVLQLYNNSLSGEISSVIAN 187
+ + L P L + + L + S+
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247
+ L L L L+ E+P L S L L LS NK
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF---------------------- 313
Query: 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYN--SFSGPIANT 304
+ S + +L + N + G L L ++ +DLS++ S
Sbjct: 314 --ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLM 363
+ N +L L + N+ L +DL+ L NL L +L
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL--LPN--SINFSNNRLSGP 419
L + L+ S L +L L+L N + L L + S LS
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 420 IPLSL 424
+
Sbjct: 492 DQHAF 496
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-51
Identities = 79/423 (18%), Positives = 137/423 (32%), Gaps = 27/423 (6%)
Query: 12 DFSPMQNLRR--LDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
D S +Q L+L+ N G F+ + L+F + +
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI-FKGLKNSTIQS 229
Query: 70 LRIMVLATCALHGQIPASIGNV--TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
L + PA + S+ + L ++ L++L+L
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI-SSVIA 186
+P L L+ L L +S N S P L L + N+ E+ + +
Sbjct: 290 --LSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
Query: 187 NSTTLTMLSLYDNSLT--GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFL 243
N L L L + + L S L L+LS N+ L + +L+ L
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLEL-L 405
Query: 244 VLQ-NMFSGVLPDS-LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301
L S L +S++ L+ S + LP + ++L N F
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465
Query: 302 ---ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKK 358
N++ L L + +S + +DLS N L+ + +LK
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 359 LNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL--LPNSINFSNNRL 416
+ L L SN ++ +P+ L L ++L N L C + +L
Sbjct: 526 IYLN-LASNHISIILPSLLPILSQQRTINLRQNPLDC-----TCSNIYFLEWYKENMQKL 579
Query: 417 SGP 419
Sbjct: 580 EDT 582
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-29
Identities = 41/246 (16%), Positives = 78/246 (31%), Gaps = 29/246 (11%)
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247
+ + L E+P L L+ S N L
Sbjct: 11 KEVNKTYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPT-------------------- 47
Query: 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307
+ + +R NL ++ + + S + + L+ N +
Sbjct: 48 ----IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 308 ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367
+ L LF + IS ++ +L + L N +S +KL +L Q+N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 368 KLNSSIPNSLSSLKSLNV--LDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLI 425
++ +SSL+ L+L+ N + G P + + S+NF + I L
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 426 KEGLVE 431
+
Sbjct: 224 NSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-16
Identities = 40/204 (19%), Positives = 78/204 (38%), Gaps = 8/204 (3%)
Query: 1 MSFMYLTGTLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWK 58
++F L F + L+ L+LS++L L L+ L+ N K
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
Query: 59 LPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNL 118
+S+ L +L I+VL+ C L + ++ + ++L+ N +T + LK +
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178
L L N ++ +P L L++ +++ N L + L
Sbjct: 527 -YLNLASN-HISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFL----EWYKENMQKLE 580
Query: 179 GEISSVIANSTTLTMLSLYDNSLT 202
++ N L + L D +L+
Sbjct: 581 DTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-62
Identities = 85/298 (28%), Positives = 135/298 (45%), Gaps = 33/298 (11%)
Query: 516 RISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQ 574
R + D EI +T ++G G GTVYK + G+V AVK L V+A QLQ
Sbjct: 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDV-AVKML-----NVTAPTPQQLQ 65
Query: 575 LDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
K EV L RH NI+ L +V ++ +L+ LH +
Sbjct: 66 A---FKNEVGVLRKTRHVNILLFMGYSTAPQLA---IVTQWCEGSSLYHHLHASETKFEM 119
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
IA A+G+ YLH IIHRD+KS NI L + K+ DFG+A ++R
Sbjct: 120 KKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSG 175
Query: 693 DSTTTVIAGTYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749
++G+ ++APE S+ + + DVY+FG+VL EL+TG+ P + +N++
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN--INNRDQ 233
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
I + + G + K+ + M +++ C K RP+ ++ +
Sbjct: 234 IIEMVGR-----GSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-61
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 43/305 (14%)
Query: 518 SFDQREI-LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQL 575
S R + +G+G G K+ +GEV+ +K+L D +
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-------DEETQ-- 51
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
+ EV+ + + H N++K Y + EY+ G L + W
Sbjct: 52 -RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN--FITEYIKGGTLRGIIKSMDSQYPWS 108
Query: 634 TRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ------ 687
R A +A G+AYLH IIHRD+ S N L+ N VADFG+A+++
Sbjct: 109 QRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 688 -----ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
+ + G ++APE K DV+SFG+VL E+I
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-- 223
Query: 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
++ +D + LD+ + I +RC P RP+ +
Sbjct: 224 --------DYLPRTMDFGLNVRGFLDRYCP---PNCPPSFFPITVRCCDLDPEKRPSFVK 272
Query: 803 VVQLL 807
+ L
Sbjct: 273 LEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-58
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 49/304 (16%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
I F+Q EI E +G+G G VY + GEV A++ + + + DQL+
Sbjct: 30 IPFEQLEIGE------LIGKGRFGQVYHGRWH-GEV-AIRLI-----DIERDNEDQLKA- 75
Query: 577 KGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
K EV RH+N+V C ++ L+ + + LD
Sbjct: 76 --FKREVMAYRQTRHENVVLFMGACMSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNK 131
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV--LQARGGK 692
+IA + +G+ YLH I+H+D+KS N+ D N + + DFG+ + + G +
Sbjct: 132 TRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187
Query: 693 DSTTTVIAGTYGYLAPE---------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF 743
+ + G +LAPE + DV++ G + EL P +
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ- 246
Query: 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
+ II+ + + + D I + C + RPT ++
Sbjct: 247 -PAEAIIWQMG-----TGMKPNLSQIGMGKEISD-------ILLFCWAFEQEERPTFTKL 293
Query: 804 VQLL 807
+ +L
Sbjct: 294 MDML 297
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 69/311 (22%), Positives = 117/311 (37%), Gaps = 47/311 (15%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G+G G VYK L+ VAVK S ++ + + + + H
Sbjct: 19 ELIGRGRYGAVYKGSLD-ERPVAVKVF-------SFANRQNFIN----EKNIYRVPLMEH 66
Query: 592 KNIVKLYCYFSSLYCN-----LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
NI + + + LLV EY PNG+L L DW + ++A V +GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGL 124
Query: 647 AYLHHGLLS------PIIHRDIKSTNILLDVNYQPKVADFGIAKV-----LQARGGKDST 695
AYLH L I HRD+ S N+L+ + ++DFG++ L G +D+
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 696 TTVIAGTYGYLAPEYAYSS-------KATTKCDVYSFGVVLMELITGRKPVEDDFGDNK- 747
GT Y+APE + A + D+Y+ G++ E+ + +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 748 NIIYWVSIKVDTKEGIME--VLDKKLSGSFRDE-------MIQVLRIAIRCTSKSPATRP 798
+ + + M+ V +K F + + + C + R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 799 TMNEVVQLLAE 809
T + +AE
Sbjct: 305 TAQXAEERMAE 315
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-58
Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 46/298 (15%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
I F Q L K+ + SG ++K G + VK L + + + D
Sbjct: 7 IDFKQLNFLT------KLNENHSGELWKGRWQ-GNDIVVKVLKVRD------WSTRKSRD 53
Query: 577 KGLKTEVETLGNIRHKNIVKLY-CYFSSLYCNL-LVYEYMPNGNLWDALHKGL-VHLDWP 633
E L H N++ + S + L+ +MP G+L++ LH+G +D
Sbjct: 54 --FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS 111
Query: 634 TRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD 693
K A +A+G+A+LH L I + S ++++D + +++ + Q+ G
Sbjct: 112 QAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-- 168
Query: 694 STTTVIAGTYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
++APE D++SF V+L EL+T P D
Sbjct: 169 ------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD--------- 213
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI-RCTSKSPATRPTMNEVVQLL 807
+ E M+V + L + + + + C ++ PA RP + +V +L
Sbjct: 214 ------LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-57
Identities = 76/313 (24%), Positives = 125/313 (39%), Gaps = 40/313 (12%)
Query: 521 QREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK 580
QR + +T VG+G G V++ GE VAVK S+ D +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR-------DEKSWFRET--- 51
Query: 581 TEVETLGNIRHKNIVKLY--CYFSSLYCN--LLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
E+ +RH+NI+ S L+ Y G+L+D L LD +
Sbjct: 52 -ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCL 108
Query: 637 KIAFGVAQGLAYLHHGLLS-----PIIHRDIKSTNILLDVNYQPKVADFGIAKVL-QARG 690
+I +A GLA+LH + I HRD+KS NIL+ N Q +AD G+A + Q+
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 691 GKDSTTTVIAGTYGYLAPE------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFG 744
D GT Y+APE + + D+++FG+VL E+ +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--NGIV 226
Query: 745 DNKNIIY--WVSIKVDTKEGIMEVLDKKL-----SGSFRDEMIQVLRIAI-RCTSKSPAT 796
++ + V ++ V + + F D + L + C ++P+
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSA 286
Query: 797 RPTMNEVVQLLAE 809
R T + + L +
Sbjct: 287 RLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-56
Identities = 80/329 (24%), Positives = 130/329 (39%), Gaps = 45/329 (13%)
Query: 503 SSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQR 562
S S P V R Q ++++ ++G+G G V+ GE VAVK ++
Sbjct: 23 SGSGLPLLV---QRTIAKQIQMVK------QIGKGRYGEVWMGKWR-GEKVAVKVFFTTE 72
Query: 563 TKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCN--LLVYEYMPNGN 618
+TE+ +RH+NI+ + L+ +Y NG+
Sbjct: 73 EA-----------SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 619 LWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS-----PIIHRDIKSTNILLDVNY 673
L+D L LD + K+A+ GL +LH + S I HRD+KS NIL+ N
Sbjct: 122 LYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 674 QPKVADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPE------YAYSSKATTKCDVYSFG 726
+AD G+A + + D GT Y+ PE ++ D+YSFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 727 VVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL-----SGSFRDEMIQ 781
++L E+ V ++ V KKL + DE ++
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299
Query: 782 VLR-IAIRCTSKSPATRPTMNEVVQLLAE 809
+ + C + +PA+R T V + LA+
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-55
Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 40/315 (12%)
Query: 519 FDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
QR I + + +G+G G V++ GE VAVK S+ + +
Sbjct: 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------EERSWFR---- 83
Query: 579 LKTEVETLGNIRHKNIVKLYCY---FSSLYCNL-LVYEYMPNGNLWDALHKGLVHLDWPT 634
+ E+ +RH+NI+ + + L LV +Y +G+L+D L++ +
Sbjct: 84 -EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEG 140
Query: 635 RHKIAFGVAQGLAYLHHGLLS-----PIIHRDIKSTNILLDVNYQPKVADFGIAKVL-QA 688
K+A A GLA+LH ++ I HRD+KS NIL+ N +AD G+A A
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 689 RGGKDSTTTVIAGTYGYLAPE------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
D GT Y+APE ++ + D+Y+ G+V E+
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--GG 258
Query: 743 FGDNKNIIYWVSIKVDTKEGIME--VLDKKL-----SGSFRDEMIQVLR-IAIRCTSKSP 794
++ + Y+ + D M V ++KL + E ++V+ I C +
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318
Query: 795 ATRPTMNEVVQLLAE 809
A R T + + L++
Sbjct: 319 AARLTALRIKKTLSQ 333
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-51
Identities = 90/446 (20%), Positives = 144/446 (32%), Gaps = 34/446 (7%)
Query: 1 MSFMYLTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKL 59
+SF L FS L+ LDLS + L +L L N +
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN---PIQSF 95
Query: 60 PESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNL 118
S LT L +V L IG + +L L + NFI +P L NL
Sbjct: 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL 155
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTD----LDMSVNHLSGKIPESILRLPKLRVLQLYN 174
++L YN + +L L E LDMS+N + I + + KL L L
Sbjct: 156 VHVDLSYN-YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRG 213
Query: 175 NSLSGEI-SSVIANSTTLTMLSLYDNSLTGEVPQDLGQ--------WSPLVVLDLSENKL 225
N S I + + N L + L E ++ + + L+
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLP 285
K + + + + + + + L+ P L LP
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK-QFPT--LDLP 328
Query: 286 HVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS--EIYRAISLVKIDLSDN 343
+ + L+ N S +LS L + RN +S SL +DLS N
Sbjct: 329 FLKSLTLTMNKGSISFKKV--ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNS-LSSLKSLNVLDLSNNLLTGYIPESLC 402
+ + L++L L Q + L S SL+ L LD+S
Sbjct: 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 403 ELLPN--SINFSNNRLSGPIPLSLIK 426
L + ++ + N ++
Sbjct: 446 G-LTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 7e-50
Identities = 71/431 (16%), Positives = 134/431 (31%), Gaps = 32/431 (7%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFR-LTKLR 71
FS + +L L + L L+ L+ N + + F LT L
Sbjct: 100 FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN---FIHSCKLPAYFSNLTNLV 156
Query: 72 IMVLATCALHGQIPASIGNVTSLTD----LELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
+ L+ + + + L+++ N I I + L +L L N
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNF 215
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR------LPKLRVLQLY--NNSLSG 179
+ + L NL L + + + I L + + + +
Sbjct: 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS 275
Query: 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239
+ ++ +SL S+ +D+ + L + +L P L
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPTLDLPF--L 330
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPE--GILSLPHVSIIDLSYNSF 297
+ + N S + +L +S N L S L + +DLS+N
Sbjct: 331 KSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 298 SGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-SLVKIDLSDNLLSGPIPSGIGNL 356
++ L L Q + + + ++ L+ +D+S L
Sbjct: 389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 357 KKLNLLMLQSNKLNSSIP-NSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSN 413
LN L + N + N ++ +L LDLS L I + + L +N S+
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSH 506
Query: 414 NRLSGPIPLSL 424
N L
Sbjct: 507 NNLLFLDSSHY 517
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-47
Identities = 82/427 (19%), Positives = 137/427 (32%), Gaps = 37/427 (8%)
Query: 12 DFSPMQNLR----RLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL 67
D ++ LD+S N F L L+ N F + ++ + L
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGN--FNSSNIMKTCLQNL 228
Query: 68 TKLRIMVLATCALHGQIPASIGN--------VTSLTDLELTGNFITGHIPPEIGLLKNLR 119
L + L + I ++ + LT + L N+
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 120 QLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179
+ L E++ + L + L LP L+ L L N S
Sbjct: 289 AMSLAGVSI---KYLEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNKGS- 341
Query: 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP--LVVLDLSENKLSGPLPAKVCSRG 237
IS +L+ L L N+L+ L LDLS N + A
Sbjct: 342 -ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLE 399
Query: 238 KLQYFLVLQ-NMFSGVLPDS-LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYN 295
+LQ+ L Q + V S + LL +S + + L L ++ + ++ N
Sbjct: 400 ELQH-LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 296 SFSGPI-ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIG 354
SF +N N NL+ L + + Q+ L +++S N L S
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 355 NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL--LPNSINFS 412
L L+ L N++ +S KSL +L+NN + +CE +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-----CICEHQKFLQWVKEQ 573
Query: 413 NNRLSGP 419
L
Sbjct: 574 KQFLVNV 580
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-46
Identities = 80/423 (18%), Positives = 140/423 (33%), Gaps = 35/423 (8%)
Query: 22 LDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81
+ + + P + ++ + + + N L L S ++L+ + L+ C +
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFN---PLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLT 141
+ + L++L LTGN I P L +L L +LA +G L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET-KLASLESFPIGQLI 128
Query: 142 ELTDLDMSVNHLSG-KIPESILRLPKLRVLQLYNNSLSGEISSVIAN----STTLTMLSL 196
L L+++ N + K+P L L + L N + + + L +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQNMFSG---- 251
N + + Q L L L N S + L ++ F
Sbjct: 189 SLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 252 --VLPDSLARCKNL--LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307
P + ++ FR++ + L +VS + L+ S
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--K 305
Query: 308 ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367
L + R Q+ F ++ L + L+ N S I L L+ L L N
Sbjct: 306 HFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRN 360
Query: 368 KLNSSIPNSLSSLK--SLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLS 423
L+ S S S L SL LDLS N + + L ++F ++ L S
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG-LEELQHLDFQHSTLKRVTEFS 418
Query: 424 LIK 426
Sbjct: 419 AFL 421
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-40
Identities = 55/356 (15%), Positives = 112/356 (31%), Gaps = 24/356 (6%)
Query: 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLT 141
G + I V ++T + ++ +P + + + ++L +N L N +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPD--DIPSSTKNIDLSFNP-LKILKSYSFSNFS 56
Query: 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201
EL LD+S + ++ L L L L N + + T+L L + L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 202 TGEVPQDLGQWSPLVVLDLSENKLSG-PLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARC 260
+GQ L L+++ N + LPA + L + + N + + L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 261 KNLLRFRV----SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA-RNLSELF 315
+ + + S N ++ I + + + L N S I T L
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 316 MQRNQISGFIPSEI--------YRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367
+ + EI +++ + L+ L ++ + L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLS 423
+ + L + L + L L S+ + N+ S
Sbjct: 296 SIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL--KSLTLTMNKGSISFKKV 347
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 7/221 (3%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFT--GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFR 66
+ +L LDLS N + G S +L L + N + +
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN---GAIIMSAN-FMG 397
Query: 67 LTKLRIMVLATCALHGQIPAS-IGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYY 125
L +L+ + L S ++ L L+++ L +L L++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 126 NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
N T+ N T LT LD+S L L +L++L + +N+L SS
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
+L+ L N + L +L+ N ++
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-49
Identities = 86/430 (20%), Positives = 160/430 (37%), Gaps = 36/430 (8%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + + + L T + +L + L + + + L
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI-----DGVEYLNN 69
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + + L P + N+T L D+ + N I + L NL L L+ NQ
Sbjct: 70 LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI- 124
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
T + L NLT L L++S N +S ++ L L+ L N +AN T
Sbjct: 125 --TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLT 177
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMF 249
TL L + N ++ L + + L L + N++S P + + L + N
Sbjct: 178 TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQL 233
Query: 250 SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309
+ +LA NL ++NN + P + L ++ + L N S +
Sbjct: 234 KDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT 287
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L+ L + NQ+ P I +L + L N +S P + +L KL L +NK+
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 370 NSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGL 429
+ +SL++L ++N L +N ++ P + + + ++ + +
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTPLANLTRI-TQLGLNDQAWTNAPVNYKANVSI 400
Query: 430 VESFSGNPGL 439
+ G
Sbjct: 401 PNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-47
Identities = 99/412 (24%), Positives = 165/412 (40%), Gaps = 36/412 (8%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
++ + NL +++ SNN T PL NLT L + N N ++ + + LT
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNN---QIADITP--LANLT 112
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
L + L + P + N+T+L LEL+ N I+ + L +L+QL
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV- 167
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
T + L NLT L LD+S N +S + +L L L NN +S +
Sbjct: 168 ---TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
T L LSL N L L + L LDL+ N++S P + KL + N
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLT--KLTELKLGANQ 276
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
S + LA L ++ N LE P I +L +++ + L +N+ S V +
Sbjct: 277 ISNI--SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSL 330
Query: 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
L LF N++S S + ++ + N +S P + NL ++ L L
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNNRLSGP 419
++ N +++ N + L P ++ + + + N S
Sbjct: 387 WTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-47
Identities = 93/416 (22%), Positives = 162/416 (38%), Gaps = 36/416 (8%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+ + + L + L NL ++F+ N +L + + LT
Sbjct: 38 DTVSQTDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNN---QLTDITP--LKNLT 90
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
KL +++ + P + N+T+LT L L N IT P + L NL +LEL N
Sbjct: 91 KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI 146
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ L LT L L + + L L L + +N +S SV+A
Sbjct: 147 ---SDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDI--SVLAKL 198
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
T L L +N ++ P LG + L L L+ N+L + L + N
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLT--NLTDLDLANNQ 254
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
S + P L+ L ++ N + P + L ++ ++L+ N + N
Sbjct: 255 ISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL 308
Query: 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
+NL+ L + N IS P + L ++ +N +S S + NL +N L N+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQ 364
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLS 423
++ P L++L + L L++ T + +PN++ L P +S
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 23/293 (7%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+ + + NL L +NN + PL LTNL+ LS N N +L + ++ LT
Sbjct: 191 DISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGN---QLKDIG--TLASLT 243
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
L + LA + P + +T LT+L+L N I+ + L L LEL NQ
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQ- 298
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ NL LT L + N++S P + L KL+ L YNN +S S +AN
Sbjct: 299 --LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANL 352
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
T + LS N ++ P L + + L L++ + P + + V
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPN-TVKNVT 408
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301
+ + P +++ + ++ N E + I +FSG +
Sbjct: 409 GALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 34/176 (19%), Positives = 59/176 (33%), Gaps = 35/176 (19%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+ S ++NL L L N + P+S +LT L+ L F N K+ + + LT
Sbjct: 301 DISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNN---KVSDVSS--LANLT 353
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
+ + + P + N+T +T L L T P N+ N
Sbjct: 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNY--KANVSIPNTVKNVT 408
Query: 129 LAGTIPEELGNLTELTDLDMSVNHL-----------------------SGKIPESI 161
A P + + T+ D++ N SG + + +
Sbjct: 409 GALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-48
Identities = 81/385 (21%), Positives = 137/385 (35%), Gaps = 53/385 (13%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + + R L T L ++ L K+ + I LT
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGE---KVASIQG--IEYLTN 67
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + L + P + N+ LT+L + N IT + L NLR+L L +
Sbjct: 68 LEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI- 122
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
+ L NLT++ L++ NH + + L L + + + + IAN T
Sbjct: 123 --SDISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLT 177
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMF 249
L LSL N + P L + L N+++
Sbjct: 178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD---------------------- 213
Query: 250 SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309
+A L ++ NN + P + +L ++ +++ N S N V +
Sbjct: 214 ----ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLT 265
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L L + NQIS S + L + L++N L IG L L L L N +
Sbjct: 266 KLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 370 NSSIPNSLSSLKSLNVLDLSNNLLT 394
P L+SL ++ D +N ++
Sbjct: 324 TDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-47
Identities = 84/400 (21%), Positives = 153/400 (38%), Gaps = 56/400 (14%)
Query: 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATC 78
L FP + +L + + + L + +V+A
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDV-----VTQEELESITKLVVAGE 54
Query: 79 ALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELG 138
+ I I +T+L L L GN IT P + L L L + N+ T L
Sbjct: 55 KVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI---TDISALQ 107
Query: 139 NLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYD 198
NLT L +L ++ +++S P + L K+ L L N ++S ++N T L L++ +
Sbjct: 108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTE 164
Query: 199 NSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLA 258
+ + + + L L L+ N++ LA
Sbjct: 165 SKVKD--VTPIANLTDLYSLSLNYNQIEDI--------------------------SPLA 196
Query: 259 RCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQR 318
+L F N + P + ++ ++ + + N + + N L+ L +
Sbjct: 197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT 252
Query: 319 NQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLS 378
NQIS + + L +++ N +S S + NL +LN L L +N+L + +
Sbjct: 253 NQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 379 SLKSLNVLDLSNNLLTGYIP-ESLCELLPNSINFSNNRLS 417
L +L L LS N +T P SL ++ +S +F+N +
Sbjct: 309 GLTNLTTLFLSQNHITDIRPLASLSKM--DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 63/331 (19%), Positives = 116/331 (35%), Gaps = 49/331 (14%)
Query: 94 LTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHL 153
L I I P L + L T L +T L ++ +
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKAS---VTDVVTQEELESITKLVVAGEKV 56
Query: 154 SGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWS 213
+ + I L L L L N ++ S ++N LT L + N +T L +
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLT 110
Query: 214 PLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL 273
L L L+E+ +S LA + + NH
Sbjct: 111 NLRELYLNEDNISDI--------------------------SPLANLTKMYSLNLGANHN 144
Query: 274 EGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI 333
S + ++ ++ + ++ + + N +L L + NQI P +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLT 199
Query: 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
SL N ++ P + N+ +LN L + +NK+ P L++L L L++ N +
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
Query: 394 TGYIP-ESLCELLPNSINFSNNRLSGPIPLS 423
+ + L +L +N +N++S L+
Sbjct: 256 SDINAVKDLTKL--KMLNVGSNQISDISVLN 284
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 18/225 (8%)
Query: 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPE 61
+ L S M L L ++ + P++ NLT+L LS N N ++ +
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYN---QIEDI-- 192
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
S + LT L + P + N+T L L++ N IT P + L L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWL 248
Query: 122 ELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI 181
E+ NQ + + +LT+L L++ N +S + L +L L L NN L E
Sbjct: 249 EIGTNQI---SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 182 SSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
VI T LT L L N +T P L S + D + +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-45
Identities = 87/446 (19%), Positives = 151/446 (33%), Gaps = 49/446 (10%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
F L+ LDLS + +L++L L N + L + L+ L
Sbjct: 47 SFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN---PIQSLALGAFSGLSSL 102
Query: 71 RIMVLATCALHGQIPASIGNVTSLTDLELTGNFIT-GHIPPEIGLLKNLRQLELYYNQQL 129
+ +V L IG++ +L +L + N I +P L NL L+L N ++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN-KI 161
Query: 130 AGTIPEELGNLTELT----DLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS-V 184
+L L ++ LD+S+N ++ I + +L L L NN S +
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 185 IANSTTLTMLSLYDNSLTGEVPQ---DLGQWSPLVVLDLSENKLSG------PLPAKVCS 235
I L + L E D L L + E +L+ +
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 236 RGKLQYFLVLQNMFSGVLPDSLAR-------------------CKNLLRFRVSNNHLEGS 276
+ F ++ V S K+L R ++N +
Sbjct: 281 LTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA 340
Query: 277 IPEGILSLPHVSIIDLSYN--SFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334
E + LP + +DLS N SF G + + +L L + N + + S
Sbjct: 341 FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 397
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
L +D + L + +L+ L L + + + L SL VL ++ N
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 394 TGYIPESLCELLPN--SINFSNNRLS 417
+ L N ++ S +L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-43
Identities = 82/443 (18%), Positives = 157/443 (35%), Gaps = 48/443 (10%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ + LDLS N S F+ L+VL + ++ + + + L+ L ++L
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC---EIQTIEDGAYQSLSHLSTLILTG 85
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
+ + ++SL L + IG LK L++L + +N + +PE
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 138 GNLTELTDLDMSVNHLSGKIPESILRLPKLRV----LQLYNNSLSGEISSVIANSTTLTM 193
NLT L LD+S N + + L ++ + L L N ++ I L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK 204
Query: 194 LSLYDNSLTGEVPQD-LGQWSPLVVLDLSENK---------LSGPLPAKVCSRGKLQYFL 243
L+L +N + V + + + L V L + +C+ ++ L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI--------------------LS 283
+ + + D N+ F + + +E + + L
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLK 323
Query: 284 LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQIS--GFIPSEIYRAISLVKIDLS 341
L + + + N + + +L L + RN +S G + SL +DLS
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 342 DNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNS-LSSLKSLNVLDLSNNLLTGYIPES 400
N + + S L++L L Q + L S SL++L LD+S+
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNG 439
Query: 401 LCELLPN--SINFSNNRLSGPIP 421
+ L + + + N
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 77/446 (17%), Positives = 143/446 (32%), Gaps = 51/446 (11%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFR-LTKLR 71
FS + +L++L + +L L+ L+ N + F LT L
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN---LIQSFKLPEYFSNLTNLE 152
Query: 72 IMVLATCALHGQIPASIGNVTSLT----DLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
+ L++ + + + + L+L+ N + I P L +L L N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNF 211
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSG-----KIPESIL-RLPKLRVLQLYNNSLSG-- 179
+ + L L + + K +S L L L + + L
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 180 -EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP--------------------LVVL 218
+I + T ++ SL ++ V + L L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 330
Query: 219 DLSENKLSGPLPAKVCSRGKLQYFLVLQN---MFSGVLPDSLARCKNLLRFRVSNNHLEG 275
+ NK L++ L L F G S +L +S N +
Sbjct: 331 TFTSNKGGNAFSEVDLP--SLEF-LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 276 SIPEGILSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334
++ L L + +D +++ + + RNL L + S
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
L + ++ N I L+ L L L +L P + +SL SL VL++++N L
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
Query: 394 TGYIPESLCELLPN--SINFSNNRLS 417
+P+ + + L + I N
Sbjct: 507 K-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-34
Identities = 72/394 (18%), Positives = 129/394 (32%), Gaps = 47/394 (11%)
Query: 12 DFSPMQNLR----RLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL 67
D + + LDLS N F L L+ N F + ++ I L
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNN--FDSLNVMKTCIQGL 224
Query: 68 TKLRIMVLATCALHGQI------PASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
L + L + +++ + +LT E ++ ++ I L L +
Sbjct: 225 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284
Query: 122 ELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI 181
+ + ++ L++ P L+L L+ L +N
Sbjct: 285 SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAF 341
Query: 182 SSVIANSTTLTMLSLYDNSLT--GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239
S V + +L L L N L+ G Q + L LDLS N +
Sbjct: 342 SEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI------------- 386
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFS 298
+ + + L +++L+ + SL ++ +D+S+
Sbjct: 387 ------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 299 GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-SLVKIDLSDNLLSGPIPSGIGNLK 357
+L L M N +I+ + +L +DLS L P+ +L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 358 KLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
L +L + SN+L S L SL + L N
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 63/371 (16%), Positives = 124/371 (33%), Gaps = 41/371 (11%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTE 142
+IP ++ S +L+L+ N + L+ L+L ++ +L+
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC-EIQTIEDGAYQSLSH 77
Query: 143 LTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202
L+ L ++ N + + L L+ L +L+ + I + TL L++ N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 203 -GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYF---LVLQNMFSGVLPDSLA 258
++P+ + L LDLS NK+ + ++ L L +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 259 RCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSG------PIANTVGNARNL 311
+ L + + NN ++ + + L + + L F + + NL
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 312 SELFMQRNQISGF---IPSEIYRAISLVKIDLSDNLLSG-PIPSGIGNLKKLNL------ 361
+ + + + I ++ L + S + L L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 362 ------------LMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT--GYIPESLCELLP- 406
L SNK ++ S L SL LDLS N L+ G +S
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 407 NSINFSNNRLS 417
++ S N +
Sbjct: 376 KYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 77/369 (20%), Positives = 125/369 (33%), Gaps = 44/369 (11%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGF---KLWKLPESSIFRLTKLRIM 73
L +L L NN + + L LEV L K +S++ L L I
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 74 VLATCALHG---QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLA 130
L I +T+++ L I + + LEL +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKF-- 316
Query: 131 GTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS--GEISSVIANS 188
G P L L L + N E + LP L L L N LS G S +
Sbjct: 317 GQFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
T+L L L N + + + L LD + L ++ F V ++
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-----------QMSEFSVFLSL 420
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTV-G 306
+NL+ +S+ H GI + L + ++ ++ NSF +
Sbjct: 421 ------------RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366
RNL+ L + + Q+ P+ SL ++++ N L L L + L +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527
Query: 367 NKLNSSIPN 375
N + S P
Sbjct: 528 NPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 58/298 (19%), Positives = 99/298 (33%), Gaps = 40/298 (13%)
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
IP+ L +LD+S N L S P+L+VL L + + + L+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252
L L N + S L L E L + +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNL------------------------ASL 115
Query: 253 LPDSLARCKNLLRFRVSNNHL-EGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311
+ K L V++N + +PE +L ++ +DLS N + +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 312 S----ELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG-IGNLKKLNLLMLQ- 365
L + N ++ FI ++ I L K+ L +N S + I L L + L
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 366 -----SNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSG 418
L ++L L +L + + L Y + + +L N S+ L
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD-YYLDDIIDLFNCLTNVSSFSLVS 291
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 46/258 (17%), Positives = 80/258 (31%), Gaps = 43/258 (16%)
Query: 8 GTLPDFSPMQNLRRLDLSNNLFT--GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
G + +L LDLS N + G S F T+L+ L + N
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN-------------- 383
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL--LKNLRQLEL 123
+ + ++ + L L+ + + + L+NL L++
Sbjct: 384 GVI--------------TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDI 428
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEIS 182
+ L+ L L M+ N I L L L L L
Sbjct: 429 SHT-HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 183 SVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYF 242
+ + ++L +L++ N L + + L + L N CS ++ Y
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYL 540
Query: 243 LVLQNMFSGVLPDSLARC 260
N S S A+C
Sbjct: 541 SRWLNKNSQKEQGS-AKC 557
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-21
Identities = 47/236 (19%), Positives = 82/236 (34%), Gaps = 32/236 (13%)
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
+ + ++P +L LDLS N L +
Sbjct: 14 CMELNFY-KIPDNLPFS--TKNLDLSFNPLRH------------------------LGSY 46
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELF 315
S L +S ++ SL H+S + L+ N +L +L
Sbjct: 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
Query: 316 MQRNQISGFIPSEIYRAISLVKIDLSDNLL-SGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
++ I +L +++++ NL+ S +P NL L L L SNK+ S
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 375 NSLSSLKSLNV----LDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIK 426
L L + + LDLS N + P + E+ + + NN S + + I+
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-15
Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 32/187 (17%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKL 59
+SF + +F ++ L LD ++ SVF +L NL L +
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT---HTRVA 436
Query: 60 PESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNL 118
L+ L + L++ GN + P+I L+NL
Sbjct: 437 FNGIFNGLSSLEV------------------------LKMAGNSFQENFLPDIFTELRNL 472
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSL 177
L+L QL P +L+ L L+M+ N L +P+ I RL L+ + L+ N
Sbjct: 473 TFLDLSQC-QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
Query: 178 SGEISSV 184
+
Sbjct: 531 DCSCPRI 537
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G+G TVYK +D + VA +L Q K++ S+ + + E E L ++H
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFK------EEAEMLKGLQH 84
Query: 592 KNIVKLY-CYFSSLYCNLLVY---EYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
NIV+ Y + S++ + E M +G L L + + + +GL
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQ 143
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+LH PIIHRD+K NI + K+ D G+A + +A K + GT +
Sbjct: 144 FLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-----VIGTPEF 196
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
+APE Y K DVY+FG+ ++E+ T P + N IY + T
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIY----RRVTSGVKPA 249
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
DK ++ I C ++ R + + LL
Sbjct: 250 SFDKVAIPEVKE-------IIEGCIRQNKDERYS---IKDLL 281
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-42
Identities = 71/408 (17%), Positives = 140/408 (34%), Gaps = 19/408 (4%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
++ LDLS N T + NL+VL + ++ + + + L L + L+
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSS---RINTIEGDAFYSLGSLEHLDLSD 83
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNLRQLELYYNQQLAGTIPEE 136
L + G ++SL L L GN + L NL+ L + + + +
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196
LT L +L++ L +S+ + + L L+ + + + +++ L L
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256
D +L L + + S L L +
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD------ESFNELLKLLRYILELSEVE 257
Query: 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFM 316
C + + + G + + + + ++ + + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 317 QRNQISGFIPSEIYRAISLVKIDLSDNLLS---GPIPSGIGNLKKLNLLMLQSNKLNS-- 371
+ +++ S SL +DLS+NL+ + G L L+L N L S
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 372 SIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
L +LK+L LD+S N +P+S C+ +N S+ +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDS-CQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-38
Identities = 76/422 (18%), Positives = 154/422 (36%), Gaps = 44/422 (10%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFR-LTKL 70
F + +L LDLS+N + S F L++L+ L+ N L +S+F LT L
Sbjct: 70 FYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGN---PYQTLGVTSLFPNLTNL 125
Query: 71 RIMVLATCALHGQIPA-SIGNVTSLTDLELTGNFITGHIPPE-IGLLKNLRQLELYYNQQ 128
+ + + +I +TSL +LE+ + + + + ++++ L L+ + +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS-E 183
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS-------GEI 181
A + L+ + L++ +L+ + ++ S E+
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 182 SSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQY 241
++ L+ + D +L G + D + ++ ++
Sbjct: 244 LKLLRYILELSEVEFDDCTLNG-------------LGDFNPSESDVVSELGKVETVTIRR 290
Query: 242 FLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGP 300
+ Q L + + + R V N+ + +P L + +DLS N
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 301 IANT---VGNARNLSELFMQRNQIS--GFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN 355
G +L L + +N + + +L +D+S N P+P
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 356 LKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNR 415
+K+ L L S + + + ++L VLD+SNN L L L + S N+
Sbjct: 409 PEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRL--QELYISRNK 462
Query: 416 LS 417
L
Sbjct: 463 LK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 5e-37
Identities = 77/431 (17%), Positives = 168/431 (38%), Gaps = 42/431 (9%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
F P+ +L+ L+L N + S+F NLTNL+ L ++ LT L
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE--TFSEIRRIDFAGLTSLN 151
Query: 72 IMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ--L 129
+ + +L S+ ++ + L L + + +L ++R LEL
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 130 AGTIPEELGNLTELTDLDMSVNHLS----GKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
+ + + L + L+ ++ + + + +L ++ + +L+G
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP 271
Query: 186 A-----------NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVC 234
+ + T+ L + L ++ + + + +K+ +P
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFS 330
Query: 235 SR-GKLQYFLVL-QNMFSGVLPDS---LARCKNLLRFRVSNNHLE--GSIPEGILSLPHV 287
L++ L L +N+ + +L +S NHL E +L+L ++
Sbjct: 331 QHLKSLEF-LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 288 SIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSG 347
+ +D+S N+F P+ ++ + L + I + + I + +L +D+S+N L
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLDS 445
Query: 348 PIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN 407
+ L++L + NKL ++P++ S L V+ +S N L +P+ + + L +
Sbjct: 446 -FSLFLPRLQELYI---SRNKL-KTLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTS 498
Query: 408 --SINFSNNRL 416
I N
Sbjct: 499 LQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 69/363 (19%), Positives = 136/363 (37%), Gaps = 35/363 (9%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPE-IGLLKNLRQLELYYNQQLAGTIPEE-LGNL 140
IP+ + ++ L+L+ N IT +I + NL+ L L ++ TI + +L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI--NTIEGDAFYSL 73
Query: 141 TELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSG-EISSVIANSTTLTMLSLYD 198
L LD+S NHLS + S L L+ L L N ++S+ N T L L + +
Sbjct: 74 GSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 199 NSLTGEVP-QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSL 257
E+ D + L L++ L + S + + + + + +L
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 258 ARCKNLLRFRVSNNHLEGSIPEGI-----------LSLPHVSIIDLSYNSFSGPIANTVG 306
++ + + +L + L+ + D S+N + +
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYIL 251
Query: 307 NARNLSELFMQRNQISGFIPSEI--------YRAISLVKIDLSDNLLSGPIPSGIGNLKK 358
+ N + F PSE +++ ++ + L + + L+K
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 359 LNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT--GYIPESLCELLPN--SINFSNN 414
+ + ++++K+ + LKSL LDLS NL+ + P+ ++ S N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 415 RLS 417
L
Sbjct: 372 HLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-20
Identities = 53/264 (20%), Positives = 100/264 (37%), Gaps = 24/264 (9%)
Query: 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWK 58
+ YL L +S ++ ++R+ + N+ P S +L +LE L +EN + +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 59 LPESSIFRLTKLRIMVLATCALH--GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLK 116
+ L+ +VL+ L + + + +LT L+++ N +P +
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410
Query: 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176
+R L L + + + L LD+S N+L L LP+L+ L + N
Sbjct: 411 KMRFLNLSSTG-IR-VVKTCI--PQTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNK 462
Query: 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR 236
L + + L ++ + N L + + L + L N CS
Sbjct: 463 LK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW-------DCSC 513
Query: 237 GKLQYFLVLQNMFSGVLPDSLARC 260
++ Y N S S A+C
Sbjct: 514 PRIDYLSRWLNKNSQKEQGS-AKC 536
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 31/143 (21%), Positives = 50/143 (34%), Gaps = 7/143 (4%)
Query: 282 LSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340
LS + D SF+ P T + L + N+I+ ++ +L + L
Sbjct: 2 LSCDASGVCDGRSRSFTSIPSGLT----AAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES 400
+ ++ +L L L L N L+S + L SL L+L N S
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 401 LCELLPN--SINFSNNRLSGPIP 421
L L N ++ N I
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIR 140
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-41
Identities = 84/368 (22%), Positives = 135/368 (36%), Gaps = 62/368 (16%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPEIG-------------LLKNLRQLELYYNQQL 129
++P NV S T+ + + PP G L + +LEL
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL- 83
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
++PE +L L S N L+ ++PE L L V +LS
Sbjct: 84 -SSLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL------ 132
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMF 249
L L + +N L ++P +L S L ++D+ N L LP L++ N
Sbjct: 133 -LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQL 185
Query: 250 SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309
LP+ L L NN L+ +P+ LSL I N + N
Sbjct: 186 E-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNILEEL--PELQNLP 237
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L+ ++ N + +P SL +++ DN L+ +P +L L++ + L
Sbjct: 238 FLTTIYADNNLLKT-LPDLP---PSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGL 292
Query: 370 NSSIP---------NSLSSL----KSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRL 416
+ P N + SL SL L++SNN L +P L + S N L
Sbjct: 293 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL--ERLIASFNHL 349
Query: 417 SGPIPLSL 424
+ +P
Sbjct: 350 AE-VPELP 356
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-39
Identities = 73/410 (17%), Positives = 139/410 (33%), Gaps = 65/410 (15%)
Query: 9 TLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL 67
+P +++ + + + P + V +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL--------------D 70
Query: 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
+ + L L +P + L L + N +T +P LK+L
Sbjct: 71 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIAN 187
+ + L L +S N L K+PE + L+++ + NNSL ++ + +
Sbjct: 126 -----LSDLPPLLEY---LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS 174
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247
L ++ +N L E+P +L L + N L LP S L+ + N
Sbjct: 175 ---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPLS---LESIVAGNN 225
Query: 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307
+ L L NN L+ ++P+ SL +++ N + + +
Sbjct: 226 ILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLTD-LPELPQS 278
Query: 308 ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367
L + +S P +L ++ S N + + +L++LN + +N
Sbjct: 279 LTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LCDLPPSLEELN---VSNN 327
Query: 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLS 417
KL +P L+ L S N L +PE L ++ N L
Sbjct: 328 KL-IELPALPPRLE---RLIASFNHLA-EVPELPQNL--KQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-38
Identities = 82/419 (19%), Positives = 147/419 (35%), Gaps = 72/419 (17%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPES------------- 62
+L L S N T + P +L +L V + N L LP
Sbjct: 90 PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK---ALSDLPPLLEYLGVSNNQLEK 145
Query: 63 --SIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+ + L+I+ + +L ++P + L + N + PE+ L L
Sbjct: 146 LPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE--ELPELQNLPFLTA 199
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
+ N L +P+ +L + N L + LP L + NN L
Sbjct: 200 IYADNNS-LK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-T 251
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
+ + + L L++ DN LT ++P+ + L V + + LS P L
Sbjct: 252 LPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLY 300
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
Y N L D +L VSNN L +P L + S+N +
Sbjct: 301 YLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLAE- 351
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
+ N L +L ++ N + P S+ + ++ +L +P NLK+L+
Sbjct: 352 VPELPQN---LKQLHVEYNPLR-EFPDIPE---SVEDLRMNSHLAE--VPELPQNLKQLH 402
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
+ ++N L P+ S++ L +++ + E E F ++
Sbjct: 403 V---ETNPL-REFPDIPESVEDL---RMNSERVV-DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-37
Identities = 74/362 (20%), Positives = 130/362 (35%), Gaps = 53/362 (14%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
LP+ L+ +D+ NN + P +LE ++ N +L +LPE + L
Sbjct: 145 KLPELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNN---QLEELPE--LQNLP 195
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
L + +L ++P + L + N + PE+ L L + N
Sbjct: 196 FLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLL 249
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
T+P+ +L L D N+L+ +PE L L V + + LS +
Sbjct: 250 --KTLPDLPPSLEALNVRD---NYLT-DLPELPQSLTFLDVSENIFSGLSELPPN----- 298
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
L L+ N + + L L++S NKL LPA +L+ + N
Sbjct: 299 --LYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPA---LPPRLERLIASFNH 348
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
+ +P+ K L V N L P+ S+ DL NS +
Sbjct: 349 LA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPELPQ-- 396
Query: 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
NL +L ++ N + P S+ + ++ + P KL + + +
Sbjct: 397 -NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
Query: 369 LN 370
+
Sbjct: 452 HH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 73/325 (22%), Positives = 120/325 (36%), Gaps = 48/325 (14%)
Query: 107 HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRL-- 164
I P L++ + + L +P E N+ T+ + + P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSN-LT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 165 -----------PKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWS 213
+ L+L N LS + + + L L NSLT E+P+
Sbjct: 60 MAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLK 114
Query: 214 PLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL 273
L+V + + LS P L+Y L + N LP+ L L V NN L
Sbjct: 115 SLLVDNNNLKALSDLPP-------LLEY-LGVSNNQLEKLPE-LQNSSFLKIIDVDNNSL 165
Query: 274 EGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI 333
+ +P+ SL I N + N L+ ++ N + +P +
Sbjct: 166 K-KLPDLPPSL---EFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLP---L 215
Query: 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
SL I +N+L + NL L + +N L ++P+ SL++LN + +N L
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLL-KTLPDLPPSLEALN---VRDNYL 269
Query: 394 TGYIPESLCELLPNSINFSNNRLSG 418
T +PE L ++ S N SG
Sbjct: 270 TD-LPELPQSL--TFLDVSENIFSG 291
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-41
Identities = 52/377 (13%), Positives = 105/377 (27%), Gaps = 75/377 (19%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
L + + + N W+ S+ ++ L
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH--SAWRQANSNNPQIETRTGRAL 68
Query: 76 ATCALHGQIPASIGNVTS--LTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTI 133
+ + T LEL + P + L +L+ + + L +
Sbjct: 69 KA------TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA-GLM-EL 119
Query: 134 PEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS----- 188
P+ + L L ++ N L +P SI L +LR L + E+ +A++
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 189 ----TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
L L L + +P + L L + + LS
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA----------------- 220
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
L ++ L + + P
Sbjct: 221 --------LGPAIHHLPKLEELDLRGCTALRNYPPIF----------------------- 249
Query: 305 VGNARNLSELFMQ-RNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363
G L L ++ + + +P +I+R L K+DL + +PS I L +++
Sbjct: 250 -GGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307
Query: 364 LQSNKLNSSIPNSLSSL 380
+ + + +
Sbjct: 308 VPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 53/372 (14%), Positives = 102/372 (27%), Gaps = 58/372 (15%)
Query: 63 SIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLE 122
+ + + + + H N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIET 62
Query: 123 LYYNQQLAGTIPEELGNLTE--LTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
+ L + T+ L++ L + P+ RL L+ + + L E
Sbjct: 63 RTGRA--LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
+ + L L+L N L +P + + L L + LP + S
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD--- 174
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
NL R+ + S+P I
Sbjct: 175 ------------ASGEHQGLVNLQSLRLEWTGIR-SLPASI------------------- 202
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
N +NL L ++ + +S + I+ L ++DL P G L
Sbjct: 203 -----ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-----LPNSINFSNNR 415
L+L+ ++P + L L LDL + +P + +L + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL 316
Query: 416 LSGPIPLSLIKE 427
P++ E
Sbjct: 317 DQ-HRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 18/232 (7%)
Query: 9 TLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL 67
PD + +L+ + + + P ++ LE L+ N L LP S I L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN---PLRALPAS-IASL 149
Query: 68 TKLRIMVLATCALHGQIPASIGNV---------TSLTDLELTGNFITGHIPPEIGLLKNL 118
+LR + + C ++P + + +L L L I +P I L+NL
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178
+ L++ + L+ + + +L +L +LD+ P L+ L L + S
Sbjct: 209 KSLKIRNSP-LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 179 GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLP 230
+ I T L L L +P + Q ++ + + +
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-41
Identities = 67/332 (20%), Positives = 120/332 (36%), Gaps = 46/332 (13%)
Query: 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVN 151
L + + +T +P + ++ L + N L ++P L L ++S N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNN-LT-SLPALPPELRTL---EVSGN 91
Query: 152 HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ 211
L+ +P L +L + L S L L ++ N LT +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPPG 142
Query: 212 WSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNN 271
L L +S+N+L+ LPA L N + LP L VS+N
Sbjct: 143 ---LQELSVSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLP---SGLQELSVSDN 191
Query: 272 HLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYR 331
L S+P L + + S L EL + N+++ +P
Sbjct: 192 QLA-SLPTLPSELYKLWAYNNRLTSLPALP-------SGLKELIVSGNRLTS-LPVLP-- 240
Query: 332 AISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
L ++ +S N L+ +P L L++ N+L + +P SL L S ++L N
Sbjct: 241 -SELKELMVSGNRLTS-LPMLPSGLLSLSV---YRNQL-TRLPESLIHLSSETTVNLEGN 294
Query: 392 LLTGYIPESLCELLPNSINFSNNRLSGPIPLS 423
L+ + ++ +S + + +
Sbjct: 295 PLS-ERTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-36
Identities = 82/427 (19%), Positives = 139/427 (32%), Gaps = 75/427 (17%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
L++ + T P + ++ L +N LT L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDN--------------NLTSL------- 76
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL 137
PA L LE++GN +T +P L L +P
Sbjct: 77 -------PALPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH-----LPALP 120
Query: 138 GNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLY 197
L +L + N L+ +P P L+ L + +N L+ + ++ + L L Y
Sbjct: 121 SGLCKL---WIFGNQLT-SLPVLP---PGLQELSVSDNQLA-SLPALPSE---LCKLWAY 169
Query: 198 DNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSL 257
+N LT +P L L +S+N+L+ LP +L N + LP
Sbjct: 170 NNQLT-SLPMLPSG---LQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALP 220
Query: 258 ARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQ 317
+ L VS N L S+P L + +S N + + L L +
Sbjct: 221 S---GLKELIVSGNRLT-SLPVLPSEL---KELMVSGNRLTS-LPMLPSG---LLSLSVY 269
Query: 318 RNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSL 377
RNQ++ +P + S ++L N LS L+++ S +
Sbjct: 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ---ALREITSAPGYSGPIIRFDMAGA 325
Query: 378 SSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNP 437
S+ + L L+ E F + L L + E+F +
Sbjct: 326 SAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDA 385
Query: 438 GLCVSVS 444
G +S
Sbjct: 386 GFKAQIS 392
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 34/255 (13%)
Query: 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
L +L + N T P+ L L +S N +L LP L KL
Sbjct: 121 SGLCKLWIFGNQLT-SLPVLPPGLQELS-VSDN-----QLASLPA-LPSELCKLW---AY 169
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEE 136
L +P L +L ++ N + +P L +L Y N +L ++P
Sbjct: 170 NNQLT-SLPMLPSG---LQELSVSDNQLA-SLPTLPS---ELYKLWAYNN-RLT-SLPAL 219
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196
L E L +S N L+ +P +L+ L + N L+ + + + L LS+
Sbjct: 220 PSGLKE---LIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLPSG---LLSLSV 268
Query: 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256
Y N LT +P+ L S ++L N LS + + + S
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGAS 326
Query: 257 LARCKNLLRFRVSNN 271
R L ++
Sbjct: 327 APRETRALHLAAADW 341
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-40
Identities = 57/420 (13%), Positives = 142/420 (33%), Gaps = 28/420 (6%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMV 74
+ ++++ Q S+ + N++ L + N L ++ + + TKL ++
Sbjct: 9 GNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGN---PLSQISAADLAPFTKLELLN 64
Query: 75 LATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP 134
L++ L+ + ++++L L+L N++ E+ + ++ L N +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN--ISRVS 115
Query: 135 EELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG-EISSVIANSTTLTM 193
++ ++ N ++ +++ L L N + + + A+S TL
Sbjct: 116 CS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 194 LSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVL 253
L+L N + +V + ++ L LDLS NKL+ + + S + + + N ++
Sbjct: 174 LNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 254 PDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSE 313
+L +NL F + N + + ++ + +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 314 LFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSG----PIPSGIGNLKKLNLLMLQSNKL 369
R I+L + + + G + N + + +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 370 NSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGL 429
+ I ++ L+ L + ++ + + G I L E
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA--ELDGTLQQAVGQIELQHATEEQ 406
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 61/389 (15%), Positives = 125/389 (32%), Gaps = 28/389 (7%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+P L L+LS+N+ L +L+ L L N N + + +
Sbjct: 54 LAPFTKLELLNLSSNVLYETLDLE--SLSTLRTLDLNNN------YV--QELLVGPSIET 103
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGT 132
+ A + ++ S G ++ L N IT + G ++ L+L N+
Sbjct: 104 LHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
E + L L++ N + + ++ KL+ L L +N L+ + ++ +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252
+SL +N L + + L L DL N S+ + V + +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN-QRVQTVAKQTVKKL 275
Query: 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGI------LSLPHVSIIDLSYNSFSGPIANTVG 306
+ C E +P L +++ + +
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETER-LECERE 333
Query: 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366
N E+ + Q I R + + ++ L + +G +L+ + Q+
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 367 NKLN--SSIPNSLSSLKSLNVLDLSNNLL 393
S L+ L + +
Sbjct: 394 VGQIELQHATEEQSPLQLLRAIVKRYEEM 422
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-36
Identities = 56/288 (19%), Positives = 95/288 (32%), Gaps = 19/288 (6%)
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
I E N ++ + L + ++ L L N LS ++ +A T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS--GPLPAKVCSRGKLQYFLVLQNMFS 250
+L+L N L DL S L LDL+ N + P ++ N S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGP-------SIETLHAANNNIS 112
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG-PIANTVGNAR 309
V + ++NN + V +DL N A ++
Sbjct: 113 RVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L L +Q N I + ++ L +DLS N L+ + + + + L++NKL
Sbjct: 170 TLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
Query: 370 NSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLS 417
I +L ++L DL N + +
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 32/149 (21%), Positives = 64/149 (42%), Gaps = 9/149 (6%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISL 335
+I E + I ++ +S +A+ +A N+ EL + N +S +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 336 VKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395
++LS N+L + + +L L L L +N + L S+ L +NN ++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 396 YIPESLCELLPNSINFSNNRLSGPIPLSL 424
+ S + N I +NN+++ L
Sbjct: 113 RVSCSRGQGKKN-IYLANNKITMLRDLDE 140
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-39
Identities = 82/425 (19%), Positives = 149/425 (35%), Gaps = 46/425 (10%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+ RL LS N S L L++L + + + + L LRI
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ--YTPLTIDKEAFRNLPNLRI 77
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL--LKNLRQLELYYNQQLA 130
+ L + ++ P + + L +L L ++ + + LK L +L+L NQ +
Sbjct: 78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137
Query: 131 GTIPEELGNLTELTDLDMSVNHLSGKIPESI--LRLPKLRVLQLYNNSLSGEISSVIANS 188
+ G L L +D S N + + L+ L L NSL +S
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
+ L +LD+S N + + N
Sbjct: 198 MNPF------------------RNMVLEILDVSGNGWTVDITG------------NFSNA 227
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSI--IDLSYNSFSGPIANTV 305
S SL +++ ++++ + + L S+ +DLS+ +
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
++L L + N+I+ Y +L ++LS NLL S L K+ + LQ
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNNLLTG-YIPESLCELLPNSINFSNNRLSGPIPLSL 424
N + + L+ L LDL +N LT + S+ ++ S N+L ++L
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI-----FLSGNKLVTLPKINL 401
Query: 425 IKEGL 429
+
Sbjct: 402 TANLI 406
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-38
Identities = 104/539 (19%), Positives = 187/539 (34%), Gaps = 78/539 (14%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSI--FRLTK 69
F ++ L RLDLS N + F L +L+ + F+ N +++ + E + +
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN---QIFLVCEHELEPLQGKT 175
Query: 70 LRIMVLATCALHGQIPASIGNV------TSLTDLELTGNFITGHIP------------PE 111
L LA +L+ ++ G L L+++GN T I
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 112 IGLLKNLRQLELYYNQ-------------------------QLAGTIPEELGNLTELTDL 146
+ L ++ ++ + L +L L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 147 DMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP 206
+++ N ++ E+ L L+VL L N L SS + + L N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 207 QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRF 266
Q L LDL +N L+ + + + N + + NL+
Sbjct: 356 QTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTL--PKINLTANLIHL 408
Query: 267 RVSNNHLEG-SIPEGILSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGF 324
S N LE I +L +PH+ I+ L+ N FS T +L +LF+ N +
Sbjct: 409 --SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 325 IPSEIYRAI-----SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS 379
+E+ + L + L+ N L+ P +L L L L SN+L N L +
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA 526
Query: 380 LKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGL 439
+L +LD+S N L P+ L + ++ ++N+ LS L + G
Sbjct: 527 --NLEILDISRNQLLAPNPDVFVSL--SVLDITHNKFICECELSTFINWLNHTNVTIAGP 582
Query: 440 CVSVSVNS--SDKNFPL-------CPHTKTRRRLSSIWAVVTSAVIIFIGLLLFLKRRF 489
+ S L C + + L +V + + + + +F
Sbjct: 583 PADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKF 641
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-34
Identities = 66/365 (18%), Positives = 123/365 (33%), Gaps = 37/365 (10%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEELGNLT 141
Q+P + + L L+ N+I + L+ L+ LEL E NL
Sbjct: 18 QVPQVL---NTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP 73
Query: 142 ELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEI--SSVIANSTTLTMLSLYD 198
L LD+ + + + + L L L+LY LS + N LT L L
Sbjct: 74 NLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 199 NSLTG-EVPQDLGQWSPLVVLDLSENKLSGPLPA--KVCSRGKLQYFLVLQNMFSGVLPD 255
N + + G+ + L +D S N++ + L +F + N +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 256 SLARCKNLLRFR------------------VSNNHLEGSIPEGILSLPHVSIIDLSYNSF 297
+C N R +N + S ++ H+ +++
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252
Query: 298 SGPIANTVGN--ARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-G 354
P NT ++ L + + L ++L+ N ++ I
Sbjct: 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK-IADEAFY 311
Query: 355 NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFS 412
L L +L L N L ++ L + +DL N + I + + L +++
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLR 370
Query: 413 NNRLS 417
+N L+
Sbjct: 371 DNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-18
Identities = 42/276 (15%), Positives = 83/276 (30%), Gaps = 32/276 (11%)
Query: 171 QLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLP 230
++ ++ V T L L N + L +L+L +
Sbjct: 7 RIAFYRFCN-LTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 231 AKVCSR-GKLQYFLVLQ-NMFSGVLPDSLARCKNLLRFRVSNNHL-EGSIPEGILS-LPH 286
+ L+ L L + + PD+ +L R+ L + + +G L
Sbjct: 66 KEAFRNLPNLRI-LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 287 VSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIY--RAISLVKIDLSDN 343
++ +DLS N + + G +L + NQI E+ + +L L+ N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 344 LLSGPIPSGIGNLKK------LNLLMLQSNKLNSSIPN------------SLSSLKSLNV 385
L + G L +L + N I SL +
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
Query: 386 LDLSNNLLTGYIPESLCELLPNS----INFSNNRLS 417
+ + ++ L S ++ S+ +
Sbjct: 245 AGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 9e-12
Identities = 49/282 (17%), Positives = 82/282 (29%), Gaps = 42/282 (14%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
L + ++ + LS N L L ++ N + L++
Sbjct: 374 LTTIHFIPSIPDIFLSGN-----------KLVTLPKINLTAN------------LIHLSE 410
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPE--IGLLKNLRQLELYYNQ 127
R+ L I + V L L L N + + +L QL L N
Sbjct: 411 NRLENL-------DILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENM 462
Query: 128 ----QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183
+ L+ L L ++ N+L+ P L LR L L +N L+ S
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV--LS 520
Query: 184 VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243
L +L + N L P L VLD++ NK +
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNHTNV 577
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLP 285
+ + + + F +S + L
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFS 619
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 57/307 (18%), Positives = 98/307 (31%), Gaps = 61/307 (19%)
Query: 529 TEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
K+G+GG V + L+ G A+K+ + + + + E +
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKR-------ILCHEQQDREE---AQREADMHR 81
Query: 588 NIRHKNIVKLYCYFSSLYCN----LLVYEYMPNGNLWDALHKGLV---HLDWPTRHKIAF 640
H NI++L Y L+ + G LW+ + + L +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
G+ +GL +H HRD+K TNILL QP + D G +
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 701 ------GTYGYLAPE----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
T Y APE ++ + DV+S G VL ++ G P + F
Sbjct: 199 DWAAQRCTISYRAPELFSVQSH-CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----- 252
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNE 802
+ + + + Q+L + P RP +
Sbjct: 253 -------------GDSVALAVQNQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPL 296
Query: 803 VVQLLAE 809
++ L
Sbjct: 297 LLSQLEA 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 61/293 (20%)
Query: 532 NKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G GG G V+K G+ +K++ K + EV+ L +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA--------------EREVKALAKLD 62
Query: 591 HKNIVKLYCYF-------------SSLYCNLLVY---EYMPNGNLWDALHK-GLVHLDWP 633
H NIV + SS ++ E+ G L + K LD
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 634 TRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
++ + +G+ Y+H +I+RD+K +NI L Q K+ DFG+ L+
Sbjct: 123 LALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK----N 174
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
D T GT Y++PE S + D+Y+ G++L EL+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF------------ 222
Query: 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+T + ++ D +S F + +L+ + SK P RP +E+++
Sbjct: 223 -----ETSKFFTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILR 267
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 59/321 (18%), Positives = 104/321 (32%), Gaps = 19/321 (5%)
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
I E N ++ + L + ++ L L N LS ++ +A T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS--GPLPAKVCSRGKLQYFLVLQNMFS 250
+L+L N L DL S L LDL+ N + P ++ N S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGP-------SIETLHAANNNIS 112
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG-PIANTVGNAR 309
V + ++NN + V +DL N A ++
Sbjct: 113 RVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L L +Q N I + ++ A L +DLS N L+ + + + + L++NKL
Sbjct: 170 TLEHLNLQYNFIYD-VKGQVVFA-KLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
Query: 370 NSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGL 429
I +L ++L DL N + + + + +
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 430 VESFSGNPGLCVSVSVNSSDK 450
C + +D+
Sbjct: 286 PTLGHYGAYCCEDLPAPFADR 306
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 53/342 (15%), Positives = 119/342 (34%), Gaps = 42/342 (12%)
Query: 67 LTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYN 126
+ +I + +L + + + ++ +L+L+GN ++ ++ L L L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 127 QQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIA 186
+L +L+ L LD++ N++ +L P + L NN++S +S
Sbjct: 69 VL---YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 187 NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ 246
+ L +N +T D G S + LDL N++ +
Sbjct: 120 QG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VN---------------- 160
Query: 247 NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVG 306
+ A L + N + + + + +DLS N + +
Sbjct: 161 ------FAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQ 211
Query: 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS-GPIPSGIGNLKKLNLLMLQ 365
+A ++ + ++ N++ I + + +L DL N G + +++ + Q
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN 407
+ K + ++ L +P + L
Sbjct: 271 TVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 48/311 (15%), Positives = 114/311 (36%), Gaps = 46/311 (14%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
+ ++++ Q S+ + N++ L + N L ++ + + TKL
Sbjct: 6 KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGN---PLSQISAADLAPFTKLE 61
Query: 72 IMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAG 131
++ L++ L+ + + ++++L L+L N++ E+ + ++ L N
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN--IS 112
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG-EISSVIANSTT 190
+ ++ ++ N ++ +++ L L N + + + A+S T
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 191 LTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFS 250
L L+L N + +V + ++ L LDLS NKL+
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA------------------------ 204
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFS-GPIANTVGNAR 309
+ + + NN L I + + ++ DL N F G + + +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 310 NLSELFMQRNQ 320
+ + Q +
Sbjct: 263 RVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 48/286 (16%), Positives = 98/286 (34%), Gaps = 23/286 (8%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+P L L+LS+N+ L + +L+ L L N N + + +
Sbjct: 54 LAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNN------YV--QELLVGPSIET 103
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGT 132
+ A + ++ S G ++ L N IT + G ++ L+L N+
Sbjct: 104 LHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
E + L L++ N + + ++ KL+ L L +N L+ + ++ +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252
+SL +N L + + L L DL N + + V + +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFS 298
+ C + + +P +I L ++
Sbjct: 276 TGQNEEECT-VPTLGHYGAYCCEDLPAPFAD----RLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 9/149 (6%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISL 335
+I E + I ++ +S +A+ +A N+ EL + N +S +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 336 VKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395
++LS N+L + + +L L L L +N + L S+ L +NN ++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 396 YIPESLCELLPNSINFSNNRLSGPIPLSL 424
+ S + +I +NN+++ L
Sbjct: 113 RVSCSRGQGK-KNIYLANNKITMLRDLDE 140
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 49/291 (16%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G GGS V+++ ++ A+K + + + E+ L ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTL------DSYRNEIAYLNKLQQ 85
Query: 592 KN--IVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ I++LY Y +Y +V E N +L L K +D R + + +
Sbjct: 86 HSDKIIRLYDYEITDQYIY---MVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAV 140
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+H HG I+H D+K N L+ + K+ DFGIA +Q + + GT Y
Sbjct: 141 HTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 194
Query: 706 LAPE-----------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
+ PE SK + K DV+S G +L + G+ P F N I +
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLH 250
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+D I +D VL+ C + P R ++ E++
Sbjct: 251 AIIDPNHEI--EFPDIPEKDLQD----VLK---CCLKRDPKQRISIPELLA 292
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
+ ++ RE + MT + +VG+G G V++ D +G AVK +++L
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---------------KVRL 93
Query: 576 DKGLKTEVETLGNIRHKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
+ E+ + IV LY + N+ E + G+L + + L
Sbjct: 94 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNI-FMELLEGGSLGQLIKQMG-CLPEDR 151
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGKD 693
+GL YLH I+H D+K+ N+LL + + + DFG A LQ G
Sbjct: 152 ALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208
Query: 694 STTTV--IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
S T I GT ++APE K D++S +++ ++ G P
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 73/309 (23%), Positives = 131/309 (42%), Gaps = 45/309 (14%)
Query: 503 SSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQ 561
SS ++ + S ++ L+ K+G+G G + G +K++
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQ------KIGEGSFGKAILVKSTEDGRQYVIKEI--N 58
Query: 562 RTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGN 618
+++S+ + ++ + EV L N++H NIV+ F SLY +V +Y G+
Sbjct: 59 ISRMSSKEREESR------REVAVLANMKHPNIVQYRESFEENGSLY---IVMDYCEGGD 109
Query: 619 LWDALHK-GLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPK 676
L+ ++ V + L ++H I+HRDIKS NI L + +
Sbjct: 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHRDIKSQNIFLTKDGTVQ 165
Query: 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
+ DFGIA+VL + I GT YL+PE + K D+++ G VL EL T +
Sbjct: 166 LGDFGIARVLN--STVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
Query: 737 KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT 796
E KN++ K+ G + S R ++ + ++P
Sbjct: 223 HAFEAG--SMKNLVL----KI--ISGSFPPVSLHYSYDLRS-LVS------QLFKRNPRD 267
Query: 797 RPTMNEVVQ 805
RP++N +++
Sbjct: 268 RPSVNSILE 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G G G KI + G+++ K+L ++ ++ L +EV L ++H
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLV------SEVNLLRELKH 64
Query: 592 KNIVKLYCYFSSLYCNLL--VYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGVAQGL 646
NIV+ Y L V EY G+L + KG +LD ++ + L
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 647 AYLH--HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
H ++HRD+K N+ LD K+ DFG+A++L T + GT
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFV-GTPY 181
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
Y++PE K D++S G +L EL P + ++ K+ +EG
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFS---QKELAGKI--REGKF 233
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806
+ + S + +I R + RP++ E+++
Sbjct: 234 RRIPYRYSDELNE-IIT------RMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 58/305 (19%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
E +GQG G V K + A+KK+ + +L + +EV L
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKI----------RHTEEKLST-ILSEVMLLA 57
Query: 588 NIRHKNIVKLYCYFSSLYCNL-------------LVYEYMPNGNLWDALHKGLVHLDWPT 634
++ H+ +V+ Y + + + EY NG L+D +H ++
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 635 RHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA----- 688
++ + + L+Y+H G IIHRD+K NI +D + K+ DFG+AK +
Sbjct: 118 YWRLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 689 -------RGGKDSTTTVIAGTYGYLAPE-YAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
G D+ T+ I GT Y+A E + K D+YS G++ E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800
+ K + + +E + +++R P RP
Sbjct: 233 ERVNILKKL----------RSVSIE-FPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGA 278
Query: 801 NEVVQ 805
++
Sbjct: 279 RTLLN 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 49/291 (16%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G GGS V+++ ++ A+K + + + E+ L ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTL------DSYRNEIAYLNKLQQ 66
Query: 592 KN--IVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ I++LY Y +Y +V E N +L L K +D R + + +
Sbjct: 67 HSDKIIRLYDYEITDQYIY---MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAV 121
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+H HG I+H D+K N L+ + K+ DFGIA +Q + + GT Y
Sbjct: 122 HTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 175
Query: 706 LAPE-----------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
+ PE SK + K DV+S G +L + G+ P F N I +
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLH 231
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+D I +D VL+ C + P R ++ E++
Sbjct: 232 AIIDPNHEI--EFPDIPEKDLQD----VLK---CCLKRDPKQRISIPELLA 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 77/311 (24%), Positives = 125/311 (40%), Gaps = 51/311 (16%)
Query: 520 DQREILEA-MTEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
D E + +++G+G G+V + N+G +VAVK+L + S D
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-----QHSGPDQQ-- 68
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD 631
+ + E++ L + IVK Y LV EY+P+G L D L + LD
Sbjct: 69 ---RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 632 WPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
+ + +G+ YL +HRD+ + NIL++ K+ADFG+AK+L
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPL- 179
Query: 690 GGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743
KD G APE + + + DV+SFGVVL EL T K
Sbjct: 180 -DKDYYV---VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235
Query: 744 GDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPAT 796
++ + ++ +L + L R +V + C + SP
Sbjct: 236 E-------FLRMMGCERDVPALSRLL-ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQD 287
Query: 797 RPTMNEVVQLL 807
RP+ + + L
Sbjct: 288 RPSFSALGPQL 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 3e-37
Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 38/276 (13%)
Query: 535 GQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G VY+ +++G VA+K + + + + + + ++ EV+ ++H +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMI--DKKAMYKAG-----MVQRVQNEVKIHCQLKHPS 72
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
I++LY YF +Y LV E NG + L + + G+ YLH
Sbjct: 73 ILELYNYFEDSNYVY---LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 651 -HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
HG I+HRD+ +N+LL N K+ADFG+A L+ K T + GT Y++PE
Sbjct: 130 SHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPE 182
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
A S + DV+S G + L+ GR P + D + D + +
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDT---DTVKNTLNKVVLADYE------MPS 233
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
LS +D + Q+LR ++PA R +++ V+
Sbjct: 234 FLSIEAKDLIHQLLR-------RNPADRLSLSSVLD 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-37
Identities = 65/307 (21%), Positives = 111/307 (36%), Gaps = 57/307 (18%)
Query: 517 ISFDQREIL-EAMTEKNKVGQGGSGTVYKIDLNSGEV-VAVKKLWSQRTKVSASDTDQLQ 574
+ D+ + E + ++G+G G V+ L + VAVK + + + +
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-----RETLPPDLKAK 158
Query: 575 LDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
L+ E L H NIV+L C +V E + G+ L L
Sbjct: 159 F---LQ-EARILKQYSHPNIVRLIGVCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRV 212
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
T ++ A G+ YL IHRD+ + N L+ K++DFG+++
Sbjct: 213 KTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA----- 264
Query: 693 DSTTTVIAGTYGY----LAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNK 747
D G APE + +++ DV+SFG++L E + G P
Sbjct: 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP--------- 315
Query: 748 NIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTM 800
Y + + + G R V R+ +C + P RP+
Sbjct: 316 ---YP---------NLSNQQTREFVEKG-GRLPCPELCPDAVFRLMEQCWAYEPGQRPSF 362
Query: 801 NEVVQLL 807
+ + Q L
Sbjct: 363 STIYQEL 369
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 56/316 (17%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
D + +G+G G V N+GE VAVK L K +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-----KPESGGNHI- 67
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD 631
LK E+E L N+ H+NIVK C L+ E++P+G+L + L K ++
Sbjct: 68 ---ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 632 WPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
+ K A + +G+ YL +HRD+ + N+L++ +Q K+ DFG+ K ++
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIET- 178
Query: 690 GGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFG 744
K+ T APE SK DV+SFGV L EL+T +
Sbjct: 179 -DKEYYT---VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT--------YC 226
Query: 745 DNKNIIYWVSIKVDTKE-GIMEVLD--KKLSGSFR--------DEMIQVLRIAIRCTSKS 793
D+ + + +K+ G M V L R DE+ Q++R +C
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMR---KCWEFQ 283
Query: 794 PATRPTMNEVVQLLAE 809
P+ R + +++
Sbjct: 284 PSNRTSFQNLIEGFEA 299
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 41/276 (14%)
Query: 535 GQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G G VY + S ++A+K L + ++ + ++ L+ EVE ++RH N
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVL--FKAQLE-----KAGVEHQLRREVEIQSHLRHPN 70
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
I++LY YF +Y L+ EY P G ++ L K L D +A L+Y H
Sbjct: 71 ILRLYGYFHDATRVY---LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCH 126
Query: 651 -HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
+IHRDIK N+LL + K+ADFG + S T + GT YL PE
Sbjct: 127 SKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTLDYLPPE 177
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
K D++S GV+ E + G+ P E + Y +V+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT------FPD 228
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ RD + ++L+ +P+ RP + EV++
Sbjct: 229 FVTEGARDLISRLLK-------HNPSQRPMLREVLE 257
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 60/321 (18%), Positives = 120/321 (37%), Gaps = 61/321 (19%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G+GG G V++ + A+K++ ++ + + + + EV+ L + H
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRI-----RLPNRELAR----EKVMREVKALAKLEH 62
Query: 592 KNIVKLYCYF---------SSLYCNLLVY---EYMPNGNLWDALH--KGLVHLDWPTRHK 637
IV+ + + + +Y + NL D ++ + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 638 IAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ--------- 687
I +A+ + +LH G ++HRD+K +NI ++ KV DFG+ +
Sbjct: 123 IFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747
+ T GT Y++PE + + + K D++S G++L EL+ P +
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF---STQME 232
Query: 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ + + L + M+Q S SP RP +++
Sbjct: 233 RVRTLTDV----RNLKFPPLFTQKYPCEYV-MVQ------DMLSPSPMERPEAINIIE-- 279
Query: 808 AEADPCRFESCKFPNKSNKES 828
+ FE FP K+
Sbjct: 280 ---NAV-FEDLDFPGKTVLRQ 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 62/304 (20%), Positives = 115/304 (37%), Gaps = 40/304 (13%)
Query: 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G+G VY+ L G VA+KK V D + E++ L + H
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKK-------VQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL---HKGLVHLDWPTRHKIAFGVAQG 645
N++K Y F + L +V E G+L + K + T K +
Sbjct: 92 PNVIKYYASFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
L ++H ++HRDIK N+ + K+ D G+ + ++ + + GT Y
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGTPYY 202
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
++PE + + K D++S G +L E+ + P D + ++ K++ +
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQCD-YPP 257
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSN 825
+ S R ++ C + P RP + V + R +C + +
Sbjct: 258 LPSDHYSEELRQ-LVN------MCINPDPEKRPDVTYVYDV-----AKRMHACTASSLEH 305
Query: 826 KESS 829
Sbjct: 306 HHHH 309
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 76/377 (20%), Positives = 147/377 (38%), Gaps = 54/377 (14%)
Query: 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATC 78
+ + F L N ++++F + + KLP + + ++ ++ L
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS---TMRKLPAALLDSFRQVELLNLNDL 79
Query: 79 ALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEIGL-LKNLRQLELYYNQQLAGTIPEE 136
+ +I ++ L + N I ++PP + + L L L N L+ ++P
Sbjct: 80 QIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND-LS-SLPRG 135
Query: 137 L-GNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTML 194
+ N +LT L MS N+L +I + + L+ LQL +N L+ S+I + L
Sbjct: 136 IFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS---LFHA 191
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
++ N L+ L + LD S N ++ V+
Sbjct: 192 NVSYNLLS-----TLAIPIAVEELDASHNSIN-------------------------VVR 221
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
+ L ++ +N+L +L+ P + +DLSYN + + + L L
Sbjct: 222 GPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277
Query: 315 FMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
++ N++ + +L +DLS N L + +L L L N + ++
Sbjct: 278 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI-VTLK 334
Query: 375 NSLSSLKSLNVLDLSNN 391
LS+ +L L LS+N
Sbjct: 335 --LSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-32
Identities = 64/339 (18%), Positives = 131/339 (38%), Gaps = 25/339 (7%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143
I +++ D+ + + E L N + + + + L + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQV 71
Query: 144 TDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202
L+++ + +I ++ L + N++ V N LT+L L N L+
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 203 GEVPQDLGQWSP-LVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQNMFSGVLPDSLARC 260
+P+ + +P L L +S N L + LQ + N + V +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDLSLI--- 185
Query: 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQ 320
+L VS N L ++ V +D S+NS + L+ L +Q N
Sbjct: 186 PSLFHANVSYNLLS-TLA----IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNN 237
Query: 321 ISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSS 379
++ + + LV++DLS N L I +++L L + +N+L ++
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRL-VALNLYGQP 293
Query: 380 LKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNNRLS 417
+ +L VLDLS+N L ++ + + ++ +N +
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 68/370 (18%), Positives = 131/370 (35%), Gaps = 54/370 (14%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
+ + L+L++ + F ++ L N + LP + L
Sbjct: 65 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN---AIRYLPPHVFQNVPLLT 120
Query: 72 IMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQL 129
++VL L +P I N LT L ++ N + I + +L+ L+L N+
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
+ L + L ++S N LS ++ + L +NS++ + +
Sbjct: 179 --HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVE- 227
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMF 249
LT+L L N+LT + L + LV +DLS N+L
Sbjct: 228 -LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNEL------------------------ 260
Query: 250 SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309
++ + + L R +SNN L ++ +P + ++DLS+N +
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 318
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L L++ N I + + +L + LS N + + + +
Sbjct: 319 RLENLYLDHNSIV-TLKLSTHH--TLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQ 373
Query: 370 NSSIPNSLSS 379
+ I L
Sbjct: 374 HCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 53/296 (17%), Positives = 104/296 (35%), Gaps = 20/296 (6%)
Query: 126 NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185
Q I L D+ + + + L +++ N+++ ++++
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFLV 244
+ + +L+L D + + L + N + LP V L ++
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVL 124
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIAN 303
+N S + L +SNN+LE I + + + LS N +
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT---HV 180
Query: 304 TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363
+ +L + N + S + I++ ++D S N ++ + + +L +L
Sbjct: 181 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILK 232
Query: 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
LQ N L L + L +DLS N L I + + SNNRL
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 24/120 (20%), Positives = 40/120 (33%), Gaps = 10/120 (8%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRL 67
L +DLS N + F + LE L + N +L L +
Sbjct: 240 DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNN---RLVALNL-YGQPI 294
Query: 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
L+++ L+ L + + L +L L N I + L+ L L +N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHND 350
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 64/291 (21%), Positives = 112/291 (38%), Gaps = 49/291 (16%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G GGS V+++ ++ A+K + + + E+ L ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTL------DSYRNEIAYLNKLQQ 113
Query: 592 KN--IVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ I++LY Y +Y +V E N +L L K +D R + + +
Sbjct: 114 HSDKIIRLYDYEITDQYIY---MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAV 168
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+H HG I+H D+K N L+ + K+ DFGIA +Q + + G Y
Sbjct: 169 HTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GAVNY 222
Query: 706 LAPE-----------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
+ PE SK + K DV+S G +L + G+ P F N I +
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLH 278
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+D I +D VL+ C + P R ++ E++
Sbjct: 279 AIIDPNHEI--EFPDIPEKDLQD----VLK---CCLKRDPKQRISIPELLA 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 82/294 (27%), Positives = 121/294 (41%), Gaps = 54/294 (18%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G GG TVY D VA+K ++ + L K + EV + H
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIP----PREKEETL---KRFEREVHNSSQLSH 70
Query: 592 KNIVKLY-------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
+NIV + CY+ LV EY+ L + + L T +
Sbjct: 71 QNIVSMIDVDEEDDCYY-------LVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILD 122
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT---VIA 700
G+ + H I+HRDIK NIL+D N K+ DFGIAK L +++ T +
Sbjct: 123 GIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-----ETSLTQTNHVL 173
Query: 701 GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760
GT Y +PE A D+YS G+VL E++ G P G+ VSI
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN---GETA-----VSI----- 220
Query: 761 EGIMEVLDK--KLSGSFRDEMIQVL-RIAIRCTSKSPATRP-TMNEVVQLLAEA 810
I + D ++ R ++ Q L + +R T K A R T+ E+ L+
Sbjct: 221 -AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 74/310 (23%), Positives = 122/310 (39%), Gaps = 53/310 (17%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEV----VAVKKLWSQRTKVSASDTDQLQ 574
I + + K+G G G V + + ++ VAVK L K +
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-----KPDVLSQPEAM 65
Query: 575 LDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
D EV + ++ H+N+++LY + +V E P G+L D L K H
Sbjct: 66 DD--FIREVNAMHSLDHRNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLL 120
Query: 633 PTRHKIAFGVAQGLAYL-HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
T + A VA+G+ YL IHRD+ + N+LL K+ DFG+ + L
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRAL---PQ 173
Query: 692 KDSTTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNK 747
D + + + APE + + D + FGV L E+ T G++P
Sbjct: 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------- 224
Query: 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNE 802
+ ++ + I+ +DK G R + + ++C + P RPT
Sbjct: 225 ---WI---GLNGSQ-ILHKIDK--EG-ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 274
Query: 803 VVQLLAEADP 812
+ L EA P
Sbjct: 275 LRDFLLEAQP 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 64/333 (19%), Positives = 124/333 (37%), Gaps = 38/333 (11%)
Query: 92 TSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEE-LGNLTELTDLDMS 149
T L+L N I + + +L +LEL N + NL L L +
Sbjct: 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENI--VSAVEPGAFNNLFNLRTLGLR 88
Query: 150 VNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQD 208
N L IP + L L L + N + + + + L L + DN L +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147
Query: 209 LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRV 268
+ L L L + L + + ++L+ L+ R+
Sbjct: 148 FSGLNSLEQLTLEKCNL------------------------TSIPTEALSHLHGLIVLRL 183
Query: 269 SNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS 327
+ ++ +I + L + ++++S+ + + NL+ L + ++
Sbjct: 184 RHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242
Query: 328 EIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVL 386
+ + L ++LS N +S I + L +L + L +L P + L L VL
Sbjct: 243 AVRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL 301
Query: 387 DLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
++S N LT + ES+ + N ++ +N L+
Sbjct: 302 NVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 60/316 (18%), Positives = 114/316 (36%), Gaps = 36/316 (11%)
Query: 107 HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LP 165
+P G+ R L+L N+ + +E + L +L+++ N +S + L
Sbjct: 25 AVPE--GIPTETRLLDLGKNR-IKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLF 80
Query: 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKL 225
LR L L +N L V + LT L + +N + + L L++ +N L
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-L 284
+ FSG L +L + + +L SIP LS L
Sbjct: 141 V----------------YISHRAFSG-LN-------SLEQLTLEKCNLT-SIPTEALSHL 175
Query: 285 PHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNL 344
+ ++ L + + + + L L + + ++L + ++
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 345 LSGPIPSG-IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCE 403
L+ +P + +L L L L N +++ + L L L + L L +
Sbjct: 236 LTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
Query: 404 LLPN--SINFSNNRLS 417
L +N S N+L+
Sbjct: 294 GLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-29
Identities = 62/318 (19%), Positives = 122/318 (38%), Gaps = 42/318 (13%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
+F+ +L L+L+ N+ + F NL NL L N +L +P L+ L
Sbjct: 51 EFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN---RLKLIPLGVFTGLSNL 106
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQ 128
+ ++ + + + ++ +L LE+ N + +I L +L QL L
Sbjct: 107 TKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN- 163
Query: 129 LAGTIPEE-LGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIA 186
+IP E L +L L L + +++ I + + L +L+VL++ + ++
Sbjct: 164 -LTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 187 NSTTLTMLSLYDNSLTGEVPQD-LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
LT LS+ +LT VP + L L+LS N +S +
Sbjct: 222 YGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST-IEG-------------- 265
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANT 304
+M L ++ L + L ++ ++++S N + +
Sbjct: 266 -SMLHE--------LLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315
Query: 305 VGNARNLSELFMQRNQIS 322
+ NL L + N ++
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 73/312 (23%), Positives = 126/312 (40%), Gaps = 77/312 (24%)
Query: 532 NKVGQGGSGTVYK----IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G G GTVYK + ++ VA+K+L + + S ++ L E +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEI---LD-EAYVM 71
Query: 587 GNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
++ + ++ +L C S++ L+ + MP G L D + + ++ +A+
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 645 GLAYL-HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL-------QARGGKDSTT 696
G+ YL L +HRD+ + N+L+ K+ DFG+AK+L A GGK
Sbjct: 129 GMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK---- 180
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSI 755
I A E T + DV+S+GV + EL+T G KP Y
Sbjct: 181 VPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------YD--- 221
Query: 756 KVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
GI E+ G R ++ ++R +C +RP E++
Sbjct: 222 ------GIPASEISSILEKG-ERLPQPPICTIDVYMIMR---KCWMIDADSRPKFRELII 271
Query: 806 LLAE--ADPCRF 815
++ DP R+
Sbjct: 272 EFSKMARDPQRY 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-36
Identities = 61/303 (20%), Positives = 111/303 (36%), Gaps = 55/303 (18%)
Query: 516 RISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
+ISF +++L G G GT+ + VAVK++ +
Sbjct: 23 KISFCPKDVL---------GHGAEGTIVYRGMFDNRDVAVKRI-------------LPEC 60
Query: 576 DKGLKTEVETLGNI-RHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLD 631
EV+ L H N+++ +C Y + E L + + +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQY---IAIELCA-ATLQEYVEQKDFAHL 116
Query: 632 WPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILL-----DVNYQPKVADFGIAKV 685
+ GLA+LH I+HRD+K NIL+ + ++DFG+ K
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 686 LQARGGKDSTTTVIAGTYGYLAPEY---AYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
L S + + GT G++APE T D++S G V +I+
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---P 229
Query: 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
FG + + + + + + +K R+ +I+ + + P RP+
Sbjct: 230 FGKSLQRQANILLGACSLDCLHP--EKHEDVIARE-LIE------KMIAMDPQKRPSAKH 280
Query: 803 VVQ 805
V++
Sbjct: 281 VLK 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 7e-36
Identities = 76/287 (26%), Positives = 116/287 (40%), Gaps = 35/287 (12%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G GG V+ DL VAVK L + D + + E + + H
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLA------RDPSFYLR-FRREAQNAAALNH 71
Query: 592 KNIVKLYCY----FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
IV +Y + +V EY+ L D +H + ++ Q L
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALN 130
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
+ H +G IIHRD+K NI++ KV DFGIA+ + G + T + GT YL
Sbjct: 131 FSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766
+PE A + DVYS G VL E++TG P GD+ VS+ V
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSP-----VSV------AYQHV 232
Query: 767 LDKKLSGSFRDEMI--QVLRIAIRCTSKSPATRP-TMNEVVQLLAEA 810
+ + S R E + + + ++ +K+P R T E+ L
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 46/311 (14%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
D + + ++G+G G+V + N+GEVVAVKKL + T++
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----Q---HSTEEH 54
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD 631
D + E+E L +++H NIVK CY + L+ EY+P G+L D L K +D
Sbjct: 55 LRD--FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 112
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
+ + +G+ YL IHRD+ + NIL++ + K+ DFG+ KVL
Sbjct: 113 HIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL----- 164
Query: 692 KDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT---GRKPVEDDF 743
G APE SK + DV+SFGVVL EL T K +F
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRP 798
+ V +++ L + R ++ I C + + RP
Sbjct: 225 MRMIGNDKQGQMIV------FHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277
Query: 799 TMNEVVQLLAE 809
+ ++ + +
Sbjct: 278 SFRDLALRVDQ 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 66/314 (21%), Positives = 104/314 (33%), Gaps = 53/314 (16%)
Query: 498 PDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVK 556
+ S + P +SF + SF + L ++G G G V+K G + AVK
Sbjct: 38 SETLQSPGYDPSRPESFFQQSF---QRLS------RLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 557 KLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF---SSLYCNLLVYE 612
+ D+ + EV + + +H V+L + LY L E
Sbjct: 89 RS----MSPFRGPKDRARK----LAEVGSHEKVGQHPCCVRLEQAWEEGGILY---LQTE 137
Query: 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN 672
+L L LA+LH ++H D+K NI L
Sbjct: 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPR 193
Query: 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMEL 732
+ K+ DFG+ L G V G Y+APE T DV+S G+ ++E+
Sbjct: 194 GRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEV 248
Query: 733 ITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM-EVLDKKLSGSFRDEMIQVLRIAIRCTS 791
+ G+ + +G + LS R VL
Sbjct: 249 ACNMELPHG--GEGWQQLR---------QGYLPPEFTAGLSSELRS----VLV---MMLE 290
Query: 792 KSPATRPTMNEVVQ 805
P R T ++
Sbjct: 291 PDPKLRATAEALLA 304
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 82/392 (20%), Positives = 137/392 (34%), Gaps = 34/392 (8%)
Query: 41 TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASI-GNVTSLTDLEL 99
++ + + N + +L E+S RL L+ + + I + ++SL L+L
Sbjct: 30 AHVNYVDLSLN---SIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 100 TGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEEL-GNLTELTDLDMSVNHLSGKI 157
N + L NL L L + LT L L + N++
Sbjct: 87 DYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145
Query: 158 PESIL-RLPKLRVLQLYNNSLSGEISSVIAN--STTLTMLSLYDNSLTGEVPQDLGQWSP 214
P S + + VL L N + + N T+L L +L LG
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 215 --------LVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRF 266
+ LDLS N + + L S + S +
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--GHTNFK- 262
Query: 267 RVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIP 326
N +G L V DLS + + + + +L +L + +N+I+ I
Sbjct: 263 DPDNFTFKG------LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 327 SEI-YRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLN 384
+ L+K++LS N L I S + NL KL +L L N + + S L +L
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK 374
Query: 385 VLDLSNNLLTGYIPESLCELLPN--SINFSNN 414
L L N L +P+ + + L + I N
Sbjct: 375 ELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-31
Identities = 77/391 (19%), Positives = 142/391 (36%), Gaps = 45/391 (11%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
FS +Q+L+ L + + F L++L +L + N + +L + L L
Sbjct: 49 SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN---QFLQLETGAFNGLANL 105
Query: 71 RIMVLATCALHG-QIPASI-GNVTSLTDLELTGNFITGHIPPEI--GLLKNLRQLELYYN 126
++ L C L G + + +TSL L L N I I P ++ L+L +N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFN 164
Query: 127 QQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIA 186
+ + ++ E L+ H ++LRL + + + L E
Sbjct: 165 K---------VKSICEEDLLNFQGKHF------TLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 187 NSTTLTMLSLYDNSLTGEVPQ---DLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243
+T++T L L N + + D + + L LS + G +
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG----SSFGHTNFKD-- 263
Query: 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIA 302
N L S + +S + + ++ + + S + + L+ N +
Sbjct: 264 -PDNFTFKGLEAS-----GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDD 316
Query: 303 NTVGNARNLSELFMQRNQISGFIPSEIYRA-ISLVKIDLSDNLLSGPIPSGI-GNLKKLN 360
N +L +L + +N + I S ++ L +DLS N + + L L
Sbjct: 317 NAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLK 374
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
L L +N+L S L SL + L N
Sbjct: 375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 60/347 (17%), Positives = 120/347 (34%), Gaps = 37/347 (10%)
Query: 92 TSLTDLELTGNFITGHIPPE-IGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSV 150
+ ++L+ N I + L++L+ L++ L+ L L +
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 151 NHLSGKIPESIL-RLPKLRVLQLYNNSLSGEI--SSVIANSTTLTMLSLYDNSLTGEVPQ 207
N ++ L L VL L +L G + + T+L ML L DN++ P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 208 DL-GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL-----------QNMFSGVLPD 255
VLDL+ NK+ + + + ++F +L +
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVS-IIDLSYNSFSGPIANTVGNA-RNLSE 313
+ + ++ +S N + S+ + + I L ++ ++ ++
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266
Query: 314 LFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSS 372
+ + S + DLS + + + + + L L L N++N
Sbjct: 267 FTFKGLEAS-----------GVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKI 314
Query: 373 IPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
N+ L L L+LS N L I + E L ++ S N +
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 36/167 (21%)
Query: 15 PMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIM 73
++ DLS + SVF + T+LE L+ +N ++ K+ +++ + LT
Sbjct: 273 EASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQN---EINKIDDNAFWGLT----- 323
Query: 74 VLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGT 132
L L L+ NF+ I + L L L+L YN
Sbjct: 324 -------------------HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH--IRA 361
Query: 133 IPEEL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSL 177
+ ++ L L +L + N L +P+ I RL L+ + L+ N
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 81/340 (23%), Positives = 134/340 (39%), Gaps = 46/340 (13%)
Query: 489 FSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREI-LEAMTEKNKVGQGGSGTVYK--- 544
+ + D + + + D + + ++G+G G+V
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRY 62
Query: 545 --IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CY 600
+ N+GEVVAVKKL + T++ D + E+E L +++H NIVK CY
Sbjct: 63 DPLQDNTGEVVAVKKL-----Q---HSTEEHLRD--FEREIEILKSLQHDNIVKYKGVCY 112
Query: 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHR 660
+ L+ EY+P G+L D L K +D + + +G+ YL IHR
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHR 169
Query: 661 DIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSK 715
D+ + NIL++ + K+ DFG+ KVL G APE SK
Sbjct: 170 DLATRNILVENENRVKIGDFGLTKVL-----PQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 716 ATTKCDVYSFGVVLMELIT---GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS 772
+ DV+SFGVVL EL T K +F + V ++ + L
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV------FHLI-ELLK 277
Query: 773 GSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ R ++ I C + + RP+ ++ +
Sbjct: 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-35
Identities = 75/425 (17%), Positives = 140/425 (32%), Gaps = 75/425 (17%)
Query: 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATC 78
+ + F L N ++++F + + KLP + + ++ +
Sbjct: 29 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS---TMRKLPAALLDSFRQVEL------ 79
Query: 79 ALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEE- 136
L L I I +++L + +N + +P
Sbjct: 80 ------------------LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN-AIR-YLPPHV 118
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLS 195
N+ LT L + N LS +P I PKL L + NN+L +T+L L
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
L N LT V L L ++S N LS
Sbjct: 178 LSSNRLT-HVD--LSLIPSLFHANVSYNLLS----------------------------- 205
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELF 315
+LA + S+N + + + ++I+ L +N+ + + N L E+
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVD 260
Query: 316 MQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPN 375
+ N++ + + L ++ +S+N L + + L +L L N L +
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL-LHVER 318
Query: 376 SLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSG 435
+ L L L +N + + S L N + S+N +L + +
Sbjct: 319 NQPQFDRLENLYLDHNSIV-TLKLSTHHTLKN-LTLSHNDWDCNSLRALFRNVARPAVDD 376
Query: 436 NPGLC 440
C
Sbjct: 377 ADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 64/348 (18%), Positives = 133/348 (38%), Gaps = 23/348 (6%)
Query: 74 VLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTI 133
V + I +++ D+ + + E L N + + + +
Sbjct: 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS-TMRKLP 67
Query: 134 PEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLT 192
L + ++ L+++ + +I ++ L + N++ V N LT
Sbjct: 68 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126
Query: 193 MLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQNMFS 250
+L L N L+ +P+ + +P L L +S N L + LQ + N +
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT 184
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
V + +L VS N L ++ V +D S+NS +
Sbjct: 185 HVDLSLI---PSLFHANVSYNLLS-TLAI----PIAVEELDASHNSIN---VVRGPVNVE 233
Query: 311 LSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN 370
L+ L +Q N ++ + + LV++DLS N L + +++L L + +N+L
Sbjct: 234 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL- 290
Query: 371 SSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNNRLS 417
++ + +L VLDLS+N L ++ + + ++ +N +
Sbjct: 291 VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 69/370 (18%), Positives = 132/370 (35%), Gaps = 54/370 (14%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
+ + L+L++ + F ++ L N + LP + L
Sbjct: 71 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN---AIRYLPPHVFQNVPLLT 126
Query: 72 IMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQL 129
++VL L +P I N LT L ++ N + I + +L+ L+L N +L
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSN-RL 183
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
+ L + L ++S N LS ++ + L +NS++ + +
Sbjct: 184 T-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVE- 233
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMF 249
LT+L L N+LT + L + LV +DLS N+L
Sbjct: 234 -LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNEL------------------------ 266
Query: 250 SGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309
++ + + L R +SNN L ++ +P + ++DLS+N +
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 324
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKL 369
L L++ N I + + +L + LS N + + + +
Sbjct: 325 RLENLYLDHNSIV-TLKLSTHH--TLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQ 379
Query: 370 NSSIPNSLSS 379
+ I L
Sbjct: 380 HCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 54/304 (17%), Positives = 107/304 (35%), Gaps = 24/304 (7%)
Query: 122 ELYYNQQL----AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177
+ YN + I L D+ + + + L +++ N+++
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 178 SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR- 236
++++ + + +L+L D + + L + N + LP V
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNV 122
Query: 237 GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYN 295
L ++ +N S + L +SNN+LE I + + + LS N
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSN 181
Query: 296 SFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN 355
+ + +L + N + S + I++ ++D S N ++ + +
Sbjct: 182 RLT---HVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV-- 230
Query: 356 LKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSN 413
+L +L LQ N L L + L +DLS N L I + + SN
Sbjct: 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISN 287
Query: 414 NRLS 417
NRL
Sbjct: 288 NRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 5e-21
Identities = 68/421 (16%), Positives = 130/421 (30%), Gaps = 42/421 (9%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
F +L+ L LS+N T LS+ +L + + N S++ +
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYN--------LLSTLAIPIAVEE 215
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGT 132
+ + +++ + + LT L+L N +T + L +++L YN+
Sbjct: 216 LDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL--EK 268
Query: 133 IPEE-LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTL 191
I + L L +S N L + +P L+VL L +N L + L
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
Query: 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251
L L NS+ + L L L LS N R + +N+
Sbjct: 327 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-----NSLRA------LFRNVARP 372
Query: 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311
+ D+ CK + E P L ++++ + + + N
Sbjct: 373 AVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINS 432
Query: 312 SELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNL--KKLNLLMLQSNKL 369
+ G +P + +++ N L + ++ L L +
Sbjct: 433 VQSLSHYITQQGGVPLQ-----GNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487
Query: 370 NSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGL 429
+ L D N + T +L + L +E +
Sbjct: 488 TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENI 547
Query: 430 V 430
Sbjct: 548 A 548
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 24/120 (20%), Positives = 40/120 (33%), Gaps = 10/120 (8%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRL 67
L +DLS N + F + LE L + N +L L +
Sbjct: 246 DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNN---RLVALNL-YGQPI 300
Query: 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
L+++ L+ L + + L +L L N I + L+ L L +N
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHND 356
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 77/315 (24%), Positives = 119/315 (37%), Gaps = 52/315 (16%)
Query: 503 SSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQ 561
SS + + + + L ++G+G G+V K + SG+++AVK++
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLG------EIGRGAYGSVNKMVHKPSGQIMAVKRI--- 55
Query: 562 RTKVSASDTDQLQ--LDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNL 619
R+ V + QL LD +++ IV+ Y + E M + +
Sbjct: 56 RSTVDEKEQKQLLMDLDVVMRS-------SDCPYIVQFYGALFREGDCWICMELM-STSF 107
Query: 620 WDALHKGLVHLDWPTRH----KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675
LD KI + L +L L IIHRDIK +NILLD +
Sbjct: 108 DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNI 165
Query: 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE----YAYSSKATTKCDVYSFGVVLME 731
K+ DFGI+ L K T G Y+APE A + DV+S G+ L E
Sbjct: 166 KLCDFGISGQLVDSIAK--TRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
Query: 732 LITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME----VLDKKLSGSFRDEMIQVLRIAI 787
L TGR P + ++ D +++ L F I +
Sbjct: 222 LATGRFP----YPKWNSVF-------DQLTQVVKGDPPQLSNSEEREFSPSFINFVN--- 267
Query: 788 RCTSKSPATRPTMNE 802
C +K + RP E
Sbjct: 268 LCLTKDESKRPKYKE 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 68/332 (20%), Positives = 122/332 (36%), Gaps = 52/332 (15%)
Query: 500 ETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKL 558
+ F + + D E + ++G G G V+K SG V+A K +
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKIS------ELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 559 WSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGN 618
+ + Q+ + E++ L IV Y F S + E+M G+
Sbjct: 67 -----HLEIKPAIRNQIIR----ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 619 LWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678
L D + K + K++ V +GL YL I+HRD+K +NIL++ + K+
Sbjct: 118 L-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 174
Query: 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
DFG++ L DS GT Y++PE + + + D++S G+ L+E+ GR P
Sbjct: 175 DFGVSGQLI-----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 739 VEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI----------- 787
+ +++ ++ D E + +
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
Query: 788 -----------------RCTSKSPATRPTMNE 802
+C K+PA R + +
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 67/300 (22%), Positives = 111/300 (37%), Gaps = 40/300 (13%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ +GQG + V++ +G++ A+K +S + E E L +
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVF----NNISFLRPVDV-----QMREFEVLKKL 64
Query: 590 RHKNIVKLYCYFSSLYCNL--LVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIAFGVAQG 645
HKNIVKL+ L+ E+ P G+L+ L L + V G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNYQP----KVADFGIAKVLQARGGKDSTTTVIA 700
+ +L +G I+HR+IK NI+ + K+ DFG A+ L+ D +
Sbjct: 125 MNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE----DDEQFVSLY 176
Query: 701 GTYGYLAPE--------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
GT YL P+ + K D++S GV TG P G +N
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812
I G + + K +G + ++ S + + V+ + EAD
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL-----SRGLQVLLTPVLANILEADQ 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 52/313 (16%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
D + + +G+G G V + +GE+VAVK L K A +
Sbjct: 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KADAGPQHR- 77
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD 631
G K E++ L + H++I+K C + LV EY+P G+L D L + +
Sbjct: 78 ---SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIG 132
Query: 632 WPTRHKIAFGVAQGLAYLH--HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
A + +G+AYLH H IHRD+ + N+LLD + K+ DFG+AK +
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE- 186
Query: 690 GGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDF 743
G + G APE K DV+SFGV L EL+T
Sbjct: 187 -GHEYYR---VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
Query: 744 GDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPAT 796
++ + + + + + + G R +V + C +
Sbjct: 243 K-------FLELIGIAQGQMTVLRLTELLERG-ERLPRPDKCPAEVYHLMKNCWETEASF 294
Query: 797 RPTMNEVVQLLAE 809
RPT ++ +L
Sbjct: 295 RPTFENLIPILKT 307
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 63/286 (22%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLKTEVETLGNIR 590
K+G+G G V+K ID + +VVA+K + D ++ + + ++ E+ L
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKII----------DLEEAEDEIEDIQQEITVLSQCD 78
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF---GVAQGLA 647
+ K Y + ++ EY+ G+ D L G + +IA + +GL
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL-----DETQIATILREILKGLD 133
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLH IHRDIK+ N+LL + + K+ADFG+A L K +T GT ++A
Sbjct: 134 YLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMA 187
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV- 766
PE S +K D++S G+ +EL G P + M+V
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-------------------LHPMKVL 228
Query: 767 ----------LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
L+ S ++ ++ C +K P+ RPT E
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKE-FVE------ACLNKEPSFRPTAKE 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 66/299 (22%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVETLG 587
VG+GG G VY+ D +VA+K + ++ L D +T E T G
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-----------SETLSSDPVFRTRMQREARTAG 89
Query: 588 NIRHKNIVKLY---CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
++ ++V ++ LY + + +L L + L P I +
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLY---VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGS 145
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT---VIA 700
L H G HRD+K NIL+ + + DFGIA D T
Sbjct: 146 ALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIA-----SATTDEKLTQLGNTV 196
Query: 701 GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY--------W 752
GT Y+APE S AT + D+Y+ VL E +TG P + GD +++
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ---GDQLSVMGAHINQAIPR 253
Query: 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR-PTMNEVVQLLAEA 810
S + GI D + R +K+P R T ++ A
Sbjct: 254 PS---TVRPGIPVAFD---------------AVIARGMAKNPEDRYVTCGDLSAAAHAA 294
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 33/273 (12%)
Query: 535 GQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+GG ++I D ++ EV A K + ++ + Q +K + E+ ++ H++
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPH----QREK-MSMEISIHRSLAHQH 76
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH-HG 652
+V + +F +V E +L + LHK L P + G YLH +
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
+IHRD+K N+ L+ + + K+ DFG+A ++ G + + GT Y+APE
Sbjct: 136 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 188
Query: 713 SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS 772
+ + DV+S G ++ L+ G+ P E Y +++ K+ + K ++
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFET---SCLKETY---LRI--KKNEYS-IPKHIN 239
Query: 773 GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+IQ + P RPT+NE++
Sbjct: 240 PVAAS-LIQ------KMLQTDPTARPTINELLN 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 56/296 (18%)
Query: 530 EKNKVGQGGSGTVYKIDLN--SGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
++G G G+V + ++ VA+K L T++ ++ ++ E + +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--------KQGTEKADTEEMMR-EAQIM 64
Query: 587 GNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
+ + IV+L C +L LV E G L L + ++ V+
Sbjct: 65 HQLDNPYIVRLIGVCQAEALM---LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 645 GLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
G+ YL + +HRD+ + N+LL + K++DFG++K L A DS T +
Sbjct: 122 GMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAG 173
Query: 703 ---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758
+ APE K +++ DV+S+GV + E ++ G+KP + K
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKG---------- 219
Query: 759 TKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
EV+ G R E ++ + C RP V Q +
Sbjct: 220 -----PEVMAFIEQG-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 49/239 (20%), Positives = 92/239 (38%), Gaps = 38/239 (15%)
Query: 535 GQGGSGTVYKIDLNSGEVVAVKKL-------WSQRTKVSASDTDQLQLDKGLKTEVETLG 587
QG + + + A+KK TK + K E++ +
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 588 NIRHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH-------K 637
+I+++ + ++ +Y ++YEYM N ++ V T
Sbjct: 99 DIKNEYCLTCEGIITNYDEVY---IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
I V +Y+H+ I HRD+K +NIL+D N + K++DFG ++ + D
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV-----DKKIK 208
Query: 698 VIAGTYGYLAPE-----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
GTY ++ PE +Y+ K D++S G+ L + P + ++
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNVVPFSLK--ISLVELF 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 40/355 (11%), Positives = 97/355 (27%), Gaps = 61/355 (17%)
Query: 486 KRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK- 544
R + E ++++ +P + ++ Q E + + G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE--RKLKLVEPLRVGDRSVVFLV 81
Query: 545 IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604
D+ E A+K + + S S+ ++L + ++ + L
Sbjct: 82 RDVERLEDFALKVF-TMGAENSRSELERL------HEATFAAARLLGESPEEARDRRRLL 134
Query: 605 YCN--------------------------LLVYEYM-----PNGNLWDALHKGLVHLDWP 633
+ LL+ + D ++
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 634 TRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
H + + + A L G ++H N+ + + + + D +
Sbjct: 195 ALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV------ 244
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKA--TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
+ + Y E+ +S A T + + G+ + + P K
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
S++V + + L + +I R + R E ++
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RFLNFDRRRRLLPLEAME 352
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 61/308 (19%), Positives = 118/308 (38%), Gaps = 63/308 (20%)
Query: 517 ISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
+ + EI + +T ++G G G V VA+K + K + D+
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFI- 67
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR 635
E + + N+ H+ +V+LY + ++ EYM NG L + L +
Sbjct: 68 -----EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL 122
Query: 636 HKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD 693
++ V + + YL +HRD+ + N L++ KV+DFG+++ + D
Sbjct: 123 LEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-----D 172
Query: 694 STTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNI 749
T G+ + PE SK ++K D+++FGV++ E+ + G+ P
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----------- 221
Query: 750 IYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPT 799
Y E + G R +++ ++ C + RPT
Sbjct: 222 -YE---------RFTNSETAEHIAQG-LRLYRPHLASEKVYTIMY---SCWHEKADERPT 267
Query: 800 MNEVVQLL 807
++ +
Sbjct: 268 FKILLSNI 275
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 44/302 (14%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ +GQG + V++ +G++ A+K +S E E L +
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVF----NNISFLRPVD-----VQMREFEVLKKL 64
Query: 590 RHKNIVKLYCYFSSLYCNL--LVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIAFGVAQG 645
HKNIVKL+ L+ E+ P G+L+ L L + V G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNYQP----KVADFGIAKVLQARGGKDSTTTVIA 700
+ +L +G I+HR+IK NI+ + K+ DFG A+ L+ D +
Sbjct: 125 MNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE----DDEQFVSLY 176
Query: 701 GTYGYLAPE--------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
GT YL P+ + K D++S GV TG P G +N
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 753 VSIKVDTKEGIMEVLDKKLSGS--FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
I G + + K +G + +M + S + + V+ + EA
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL-------SRGLQVLLTPVLANILEA 289
Query: 811 DP 812
D
Sbjct: 290 DQ 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 68/319 (21%)
Query: 511 VKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-----IDLNSGEVVAVKKLWSQRTKV 565
+K RI F + E+ + +G G GTV+K + V +K + +
Sbjct: 3 MKVLARI-FKETEL----RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-----ED 52
Query: 566 SASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL 623
+ + + +G++ H +IV+L C SSL LV +Y+P G+L D +
Sbjct: 53 KSGRQSFQAV---TD-HMLAIGSLDHAHIVRLLGLCPGSSLQ---LVTQYLPLGSLLDHV 105
Query: 624 HKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681
+ L +A+G+ YL H ++HR++ + N+LL Q +VADFG
Sbjct: 106 RQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFG 160
Query: 682 IAKVLQARGGKDSTTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRK 737
+A +L D + + ++A E + K T + DV+S+GV + EL+T G +
Sbjct: 161 VADLLP----PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 738 PVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCT 790
P Y G+ EV D G R I V + ++C
Sbjct: 217 P------------YA---------GLRLAEVPDLLEKG-ERLAQPQICTIDVYMVMVKCW 254
Query: 791 SKSPATRPTMNEVVQLLAE 809
RPT E+
Sbjct: 255 MIDENIRPTFKELANEFTR 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 41/276 (14%)
Query: 535 GQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G G VY + + ++A+K L ++++ ++ ++ L+ E+E ++RH N
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVL--FKSQL-----EKEGVEHQLRREIEIQSHLRHPN 75
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
I+++Y YF +Y L+ E+ P G L+ L K D +A L Y H
Sbjct: 76 ILRMYNYFHDRKRIY---LMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH 131
Query: 651 -HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
+IHRDIK N+L+ + K+ADFG + A + T GT YL PE
Sbjct: 132 ERK----VIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTM---CGTLDYLPPE 182
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
K D++ GV+ E + G P + + + + VD K
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS---PSHTETHRRIVNVDLK------FPP 233
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
LS +D + ++LR P R + V++
Sbjct: 234 FLSDGSKDLISKLLR-------YHPPQRLPLKGVME 262
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 534 VGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G VY DL++ +A+K+ + D+ Q L E+ +++HK
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-------IPERDSRYSQP---LHEEIALHKHLKHK 79
Query: 593 NIVKLYCYFSSLYCNLLVY---EYMPNGNLWDAL--HKGLVHLDWPTRHKIAFGVAQGLA 647
NIV+ Y S N + E +P G+L L G + + T + +GL
Sbjct: 80 NIVQ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 648 YLHHGLLSPIIHRDIKSTNILLD-VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YLH + I+HRDIK N+L++ + K++DFG +K L T GT Y+
Sbjct: 137 YLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYM 190
Query: 707 APEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
APE D++S G ++E+ TG+ P + G+ + ++ KV +
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAMF----KVGMFKVHP 245
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
E + + +S + +++ C P R LL
Sbjct: 246 E-IPESMSAEAKAFILK-------CFEPDPDKRAC---ANDLL 277
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 62/276 (22%), Positives = 114/276 (41%), Gaps = 39/276 (14%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+GG ++ D ++ EV A K + ++ + Q +K + E+ ++ H++
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPH----QREK-MSMEISIHRSLAHQH 102
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH-HG 652
+V + +F +V E +L + LHK L P + G YLH +
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY 712
+IHRD+K N+ L+ + + K+ DFG+A ++ G + + GT Y+APE
Sbjct: 162 ----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 214
Query: 713 SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLS 772
+ + DV+S G ++ L+ G+ P E + E +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFET-------------------SCLKETYLRIKK 255
Query: 773 GSFR--DEMIQVLRIAI-RCTSKSPATRPTMNEVVQ 805
+ + V I + P RPT+NE++
Sbjct: 256 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 67/308 (21%)
Query: 515 HRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
++ + E L ++G G G V+K +G V+AVK++ R + + ++
Sbjct: 20 YQAEINDLENLG------EMGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRI 70
Query: 574 QLDKGLKTEVETLGN-IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
+++ + IV+ + F + + E M + +
Sbjct: 71 L------MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE 123
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
K+ + + L YL +IHRD+K +NILLD Q K+ DFGI+ L K
Sbjct: 124 RILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181
Query: 693 DSTTTVIAGTYGYLAPE-----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747
D + AG Y+APE + DV+S G+ L+EL TG+ P ++
Sbjct: 182 DRS----AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC----- 232
Query: 748 NIIYWVSIKVDTKEGIMEVL-------------DKKLSGSFRDEMIQVLRIAIRCTSKSP 794
+ EVL SG F+ ++ C +K
Sbjct: 233 -------------KTDFEVLTKVLQEEPPLLPGHMGFSGDFQS-FVK------DCLTKDH 272
Query: 795 ATRPTMNE 802
RP N+
Sbjct: 273 RKRPKYNK 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 62/295 (21%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
++G G G V+ + + VA+K + + A + E E + +
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-----REGAMSEEDFI------EEAEVMMKLS 61
Query: 591 HKNIVKLY--CYFSS-LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
H +V+LY C + + LV E+M +G L D L T + V +G+A
Sbjct: 62 HPKLVQLYGVCLEQAPIC---LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 648 YL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT--- 702
YL +IHRD+ + N L+ N KV+DFG+ + + D T GT
Sbjct: 119 YLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFP 168
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKE 761
+ +PE S+ ++K DV+SFGV++ E+ + G+ P Y
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP------------YE--------- 207
Query: 762 GI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
EV++ +G FR V +I C + P RP + +++ LAE
Sbjct: 208 NRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D EI E++ + K+G G G V+ N VAVK + K + +
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFL---- 231
Query: 579 LKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPT 634
E + ++H +VKL+ +Y ++ E+M G+L D L +G P
Sbjct: 232 --AEANVMKTLQHDKLVKLHAVVTKEPIY---IITEFMAKGSLLDFLKSDEGS-KQPLPK 285
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
+ +A+G+A++ IHRD+++ NIL+ + K+ADFG+A+V++ D+
Sbjct: 286 LIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE-----DN 337
Query: 695 TTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750
T G + APE T K DV+SFG++LME++T GR P
Sbjct: 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP------------ 385
Query: 751 YWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEV 803
Y G+ EV+ G +R ++ I +RC P RPT +
Sbjct: 386 YP---------GMSNPEVIRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 435
Query: 804 VQLL 807
+L
Sbjct: 436 QSVL 439
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 64/312 (20%)
Query: 518 SFDQREI-LEAMTEKNKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQ 572
S EI E + +G+G G V++ + + + VA+K K SD+
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDS-- 58
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL 630
+K L+ E T+ H +IVKL + ++ ++ E G L L L
Sbjct: 59 -VREKFLQ-EALTMRQFDHPHIVKLIGVITENPVW---IIMELCTLGELRSFLQVRKYSL 113
Query: 631 DWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688
D + A+ ++ LAYL +HRDI + N+L+ N K+ DFG+++ ++
Sbjct: 114 DLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYME- 167
Query: 689 RGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDD 742
DST + G L APE + T+ DV+ FGV + E++ G KP
Sbjct: 168 ----DSTYYKASK--GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---- 217
Query: 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATR 797
F KN +V+ + +G R M + + +C + P+ R
Sbjct: 218 FQGVKN---------------NDVIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRR 261
Query: 798 PTMNEVVQLLAE 809
P E+ L+
Sbjct: 262 PRFTELKAQLST 273
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 521 QREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
E+ E +T ++G G G V VAVK + K + D+
Sbjct: 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-----KEGSMSEDEFF----- 51
Query: 580 KTEVETLGNIRHKNIVKLY--CYFSS-LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
E +T+ + H +VK Y C +Y +V EY+ NG L + L L+
Sbjct: 52 -QEAQTMMKLSHPKLVKFYGVCSKEYPIY---IVTEYISNGCLLNYLRSHGKGLEPSQLL 107
Query: 637 KIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
++ + V +G+A+L H IHRD+ + N L+D + KV+DFG+ + + D
Sbjct: 108 EMCYDVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-----DD 157
Query: 695 TTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750
GT + APE + K ++K DV++FG+++ E+ + G+ P + N
Sbjct: 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP----YDLYTN-- 211
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNE 802
EV+ K G R D + Q++ C + P RPT +
Sbjct: 212 -------------SEVVLKVSQG-HRLYRPHLASDTIYQIMY---SCWHELPEKRPTFQQ 254
Query: 803 VVQLL 807
++ +
Sbjct: 255 LLSSI 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 66/272 (24%), Positives = 114/272 (41%), Gaps = 30/272 (11%)
Query: 491 KQRAITEPDE---TLSSSF-FPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-I 545
K+R + E +LS + F + + S + + + +G G G V
Sbjct: 96 KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155
Query: 546 DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF--SS 603
+ + + VA++ + + K + + ++TE+E L + H I+K+ +F
Sbjct: 156 ERKTCKKVAIRII--SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213
Query: 604 LYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRD 661
Y +V E M G L+D + L T + + + YLH +G IIHRD
Sbjct: 214 YY---IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG----IIHRD 264
Query: 662 IKSTNILLDVNYQP---KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE---YAYSSK 715
+K N+LL + K+ DFG +K+L G+ S + GT YLAPE ++
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSVGTAG 320
Query: 716 ATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747
D +S GV+L ++G P +
Sbjct: 321 YNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 68/309 (22%), Positives = 115/309 (37%), Gaps = 68/309 (22%)
Query: 515 HRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
+ D E + ++G+G G V K + SG+++AVK++ + + + +Q
Sbjct: 2 MEVKADDLEPIM------ELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQK 50
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
+L L ++ + V Y + E M + +L D +K ++
Sbjct: 51 RLLMDLDI---SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQT 105
Query: 634 TR----HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
KIA + + L +LH L +IHRD+K +N+L++ Q K+ DFGI+ L
Sbjct: 106 IPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163
Query: 690 GGKDSTTTVIAGTYGYLAPE----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
K G Y+APE + K D++S G+ ++EL R P +
Sbjct: 164 VAK---DIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW--- 216
Query: 746 NKNIIYWVSIKVDTKEGIMEVL------------DKKLSGSFRDEMIQVLRIAIRCTSKS 793
+ L K S F D +C K+
Sbjct: 217 ---------------GTPFQQLKQVVEEPSPQLPADKFSAEFVD-FTS------QCLKKN 254
Query: 794 PATRPTMNE 802
RPT E
Sbjct: 255 SKERPTYPE 263
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 50/358 (13%), Positives = 108/358 (30%), Gaps = 79/358 (22%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLN 548
+ + + D +S+S + + F S + +GQ + D
Sbjct: 39 TSEYMQSAADSLVSTSLWNTG-QPFRVESELGERPRTLVRGT-VLGQEDPYAYLEATDQE 96
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQL-------QLDKGLKTEVETLGNIR----------- 590
+GE V + ++ Q+ +L +G+K + + ++R
Sbjct: 97 TGESFEVHVP-YFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 591 -HKNIVKLYCYFSSLY-CNLLVYEYMPNGNLWDALHKGLVH------LDWPTRHKIAFGV 642
K ++++ ++ + NL L H L R ++ V
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+ LA LH +G ++H ++ +I+LD + F +D V +
Sbjct: 216 IRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV-------RDGARVVSSV 264
Query: 702 TYGYLAPEY-----------AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
+ G+ PE + T D ++ G+V+ + P
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITK----- 315
Query: 751 YWVSIKVDTKEGIMEVL---DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
D G E + K + R +++ R + ++
Sbjct: 316 -------DAALGGSEWIFRSCKNIPQPVRA-LLE------GFLRYPKEDRLLPLQAME 359
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 74/310 (23%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 532 NKVGQGGSGTVYK----IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G G GTVYK + ++ VA+K+L + + S ++ L E +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEI---LD-EAYVM 71
Query: 587 GNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ 644
++ + ++ +L C S++ L+ + MP G L D + + ++ +A+
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 645 GLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL-------QARGGKDST 695
G+ YL ++HRD+ + N+L+ K+ DFG+AK+L A GGK
Sbjct: 129 GMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--- 180
Query: 696 TTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVS 754
I A E T + DV+S+GV + EL+T G KP Y
Sbjct: 181 -VPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------YD-- 221
Query: 755 IKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEVVQLL 807
GI E+ G R I V I ++C +RP E++
Sbjct: 222 -------GIPASEISSILEKG-ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
Query: 808 AE--ADPCRF 815
++ DP R+
Sbjct: 274 SKMARDPQRY 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-33
Identities = 59/290 (20%), Positives = 99/290 (34%), Gaps = 62/290 (21%)
Query: 533 KVGQGGSGTVYK-IDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+ GG G +Y +D N +G V +K L V + D + + E + L +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGL------VHSGDAEAQAM---AMAERQFLAEVV 137
Query: 591 HKNIVKLYCY--------FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
H +IV+++ + Y +V EY+ +L + + L +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGY---IVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEI 191
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
L+YLH G +++ D+K NI+L Q K+ D G + +S + G
Sbjct: 192 LPALSYLHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLY-G 239
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761
T G+ APE + T D+Y+ G L L +
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRY---------------VDG 283
Query: 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-TMNEVVQLLAEA 810
+ K S+ R+ R P R T E+ L
Sbjct: 284 LPEDDPVLKTYDSYG-------RLLRRAIDPDPRQRFTTAEEMSAQLTGV 326
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
T K+GQG SGTVY +D+ +G+ VA++++ + +L + E+ +
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKEL-----IINEILVMR 72
Query: 588 NIRHKNIVKLY-CYF--SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF---G 641
++ NIV Y L+ +V EY+ G+L D + + + IA
Sbjct: 73 ENKNPNIVNYLDSYLVGDELW---VVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRE 124
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
Q L +LH + +IHRDIKS NILL ++ K+ DFG + K ST + G
Sbjct: 125 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVG 178
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
T ++APE K D++S G++ +E+I G P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 57/306 (18%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQ 574
REI + + +G G SG V +V VA+K L K ++ +
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-----KAGYTERQRRD 96
Query: 575 LDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
L E +G H NI++L + ++V EYM NG+L L
Sbjct: 97 F---LS-EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ 152
Query: 635 RHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
+ GV G+ YL +HRD+ + N+L+D N KV+DFG+++VL+
Sbjct: 153 LVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE----- 202
Query: 693 DSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDN 746
D T G + APE ++ DV+SFGVV+ E++ G +P + +
Sbjct: 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP----YWNM 258
Query: 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMN 801
N +V+ G +R + ++ + C K A RP +
Sbjct: 259 TN---------------RDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFS 302
Query: 802 EVVQLL 807
++V +L
Sbjct: 303 QIVSVL 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 34/226 (15%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D R +L++ K+G+G +G V + +SG VAVK + + +L
Sbjct: 42 DPRLLLDSY---VKIGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRREL----- 88
Query: 579 LKTEVETLGNIRHKNIVKLY-CYF--SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR 635
L EV + + +H N+V++Y Y L+ ++ E++ G L D + + +
Sbjct: 89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELW---VLMEFLQGGALTDIVSQVRL-----NE 140
Query: 636 HKIAF---GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
+IA V Q LAYLH +IHRDIKS +ILL ++ + K++DFG + K
Sbjct: 141 EQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
+ + GT ++APE S T+ D++S G++++E++ G P
Sbjct: 198 RKS---LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 68/316 (21%), Positives = 118/316 (37%), Gaps = 70/316 (22%)
Query: 517 ISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEV----VAVKKLWSQRTKVSASDTD 571
+ Q I E + +G+G G VY+ + + VAVK K +
Sbjct: 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLD- 55
Query: 572 QLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVH 629
+K + E + N+ H +IVKL + ++ E P G L L +
Sbjct: 56 --NKEKFMS-EAVIMKNLDHPHIVKLIGIIEEEPTW---IIMELYPYGELGHYLERNKNS 109
Query: 630 LDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687
L T + + + +AYL + +HRDI NIL+ K+ DFG+++ ++
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164
Query: 688 ARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741
D + L +PE + TT DV+ F V + E+++ G++P
Sbjct: 165 -----DEDYYKASV--TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP--- 214
Query: 742 DFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKS 793
F +N +V+ G R + ++ RC
Sbjct: 215 -FFWLEN---------------KDVIGVLEKG-DRLPKPDLCPPVLYTLMT---RCWDYD 254
Query: 794 PATRPTMNEVVQLLAE 809
P+ RP E+V L++
Sbjct: 255 PSDRPRFTELVCSLSD 270
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 76/290 (26%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLKTEVETLGNIR 590
+G G + V E VA+K++ + ++ Q L E++ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRI----------NLEKCQTSMDELLKEIQAMSQCH 71
Query: 591 HKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR----HKIAF--- 640
H NIV Y F L+ LV + + G++ D + + + + IA
Sbjct: 72 HPNIVSYYTSFVVKDELW---LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 641 GVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST---T 696
V +GL YLH +G IHRD+K+ NILL + ++ADFG++ L G
Sbjct: 129 EVLEGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 697 TVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDD------FGDNKNI 749
T + GT ++APE + K D++SFG+ +EL TG P
Sbjct: 185 TFV-GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM----LT 239
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT 799
+ ++T E + KK SFR MI C K P RPT
Sbjct: 240 LQNDPPSLETGVQDKE-MLKKYGKSFRK-MIS------LCLQKDPEKRPT 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 71/293 (24%), Positives = 112/293 (38%), Gaps = 56/293 (19%)
Query: 533 KVGQGGSGTVYKIDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G G GTV K +V VAVK L K A D D+ L E + +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNEA--NDPALKDELLA-EANVMQQL 75
Query: 590 RHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
+ IV++ C S LV E G L L + H+ ++ V+ G+
Sbjct: 76 DNPYIVRMIGICEAESWM---LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMK 131
Query: 648 YL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT--- 702
YL + +HRD+ + N+LL + K++DFG++K L+A ++
Sbjct: 132 YLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWP 183
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKE 761
+ APE K ++K DV+SFGV++ E + G+KP + K
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKG------------- 226
Query: 762 GIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
EV G R ++ + C + RP V L
Sbjct: 227 --SEVTAMLEKG-ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 74/337 (21%), Positives = 121/337 (35%), Gaps = 58/337 (17%)
Query: 529 TEKNKVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+ + +GG VY+ D+ SG A+K+ + +++ ++ + + EV +
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKR-------LLSNEEEKNRA---IIQEVCFMK 80
Query: 588 NIR-HKNIVKLYCYFSSLY-------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRH--K 637
+ H NIV+ S L+ + G L + L K K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
I + + + ++H PIIHRD+K N+LL K+ DFG A + +
Sbjct: 141 IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 698 VIA---------GTYGYLAPE--YAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
A T Y PE YS+ K D+++ G +L L + P ED
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED---- 255
Query: 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIR-CTSKSPATRPTMNEVV 804
+ +++ K S D V IR +P R ++ EVV
Sbjct: 256 ---------------GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300
Query: 805 QLLAEADPCRFESCKFPNKS----NKESSNATKIKNP 837
L E R + K P N +AT + P
Sbjct: 301 HQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 41/351 (11%), Positives = 90/351 (25%), Gaps = 66/351 (18%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLN 548
+ + + D +S+S + +R +GQ + D
Sbjct: 44 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV--LGQEDPYAYLEATDQE 101
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQLQ-------LDKGLKTEVETLGNIR---------HK 592
+GE V + ++ Q++ L +G+K + + ++R
Sbjct: 102 TGESFEVHVP-YFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 593 NIVKLYC-------YFSSLYCNLLVYEYMPNGNLWDALHKGLV---HLDWPTRHKIAFGV 642
K+ + L + L L R ++ V
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+ LA LH +G ++H ++ +I+LD + F A S
Sbjct: 221 IRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA--VSPIGRGFA 274
Query: 702 TYGYLAPEYAYSSKA-----TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756
A + T D ++ G+ + + P D
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTD----------- 319
Query: 757 VDTKEGIMEVLDKKLSGSFR--DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ + + + +L R + ++
Sbjct: 320 ----DAALGGSEWIFRSCKNIPQPVRALLE---GFLRYPKEDRLLPLQAME 363
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 70/315 (22%), Positives = 113/315 (35%), Gaps = 72/315 (22%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQ 572
I ++ +G+G G VY ID + A+K L
Sbjct: 16 IPHERVVT----HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-----SRITEMQQV 66
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL 630
+ E + + H N++ L ++ YM +G+L + +
Sbjct: 67 EAFLR----EGLLMRGLNHPNVLALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRNP 121
Query: 631 DWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688
VA+G+ YL +HRD+ + N +LD ++ KVADFG+A+ +
Sbjct: 122 TVKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDIL- 175
Query: 689 RGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDD 742
+V + L A E + + TTK DV+SFGV+L EL+T G P
Sbjct: 176 ---DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---- 228
Query: 743 FGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSK 792
Y I ++ G R D + QV++ +C
Sbjct: 229 --------YR---------HIDPFDLTHFLAQG-RRLPQPEYCPDSLYQVMQ---QCWEA 267
Query: 793 SPATRPTMNEVVQLL 807
PA RPT +V +
Sbjct: 268 DPAVRPTFRVLVGEV 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-32
Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL-GNI 589
+ +G G SGTV G VAVK++ + E++ L +
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRM-------------LIDFCDIALMEIKLLTESD 66
Query: 590 RHKNIVKLYCYFSS---LYCNLLVYEYMPNGNLWD------ALHKGLVHLDWPTRHKIAF 640
H N+++ YC ++ LY + E N NL D + L +
Sbjct: 67 DHPNVIRYYCSETTDRFLY---IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 641 GVAQGLAYLH-HGLLSPIIHRDIKSTNILLDV-------------NYQPKVADFGIAKVL 686
+A G+A+LH IIHRD+K NIL+ N + ++DFG+ K L
Sbjct: 123 QIASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 687 QA-RGGKDSTTTVIAGTYGYLAPE-------YAYSSKATTKCDVYSFGVVLMELIT-GRK 737
+ + + +GT G+ APE + T D++S G V +++ G+
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 738 PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR 797
P D + NII + + + + + D+ L D +I + P R
Sbjct: 239 PFGDKYSRESNIIR----GIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKR 287
Query: 798 PTMNEVVQ 805
PT +V++
Sbjct: 288 PTAMKVLR 295
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 66/295 (22%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
++G G G V+ N VAVK L K + D E + ++
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFL------AEANLMKQLQ 66
Query: 591 HKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIAFGVAQGL 646
H+ +V+LY +Y ++ EYM NG+L D L G+ L +A +A+G+
Sbjct: 67 HQRLVRLYAVVTQEPIY---IITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGM 122
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT---Y 703
A++ IHRD+++ NIL+ K+ADFG+A+++ +D+ T G
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-----EDNEYTAREGAKFPI 174
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
+ APE T K DV+SFG++L E++T GR P Y G
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------------YP---------G 213
Query: 763 I--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ EV+ G +R +E+ Q++R C + P RPT + + +L
Sbjct: 214 MTNPEVIQNLERG-YRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-32
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 29/221 (13%)
Query: 532 NKVGQGGS--GTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
+G+G TV +GE V V+++ + A + + L+ E+
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-----NLEACSNEMVTF---LQGELHVSKL 82
Query: 589 IRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVH-LDWPTRHKIAFGVAQ 644
H NIV F + L+ +V +M G+ D + + ++ I GV +
Sbjct: 83 FNHPNIVPYRATFIADNELW---VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA--- 700
L Y+H G +HR +K+++IL+ V+ + ++ + + G +
Sbjct: 140 ALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 701 -GTYGYLAPEYAYSSKA--TTKCDVYSFGVVLMELITGRKP 738
+L+PE + K D+YS G+ EL G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 57/306 (18%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGE----VVAVKKLWSQRTKVSASDTDQLQ 574
+E+ ++ VG G G V L VA+K L KV ++ +
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQR-- 90
Query: 575 LDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
+ E +G H NI++L + ++V EYM NG+L L K
Sbjct: 91 --RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 635 RHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
+ G+A G+ YL +HRD+ + NIL++ N KV+DFG+ +VL+
Sbjct: 149 LVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLE----- 198
Query: 693 DSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDN 746
D G + +PE K T+ DV+S+G+VL E+++ G +P + +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEM 254
Query: 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMN 801
N +V+ G +R + ++ + C K RP
Sbjct: 255 SN---------------QDVIKAVDEG-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 802 EVVQLL 807
++V +L
Sbjct: 299 QIVSIL 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 86/304 (28%), Positives = 133/304 (43%), Gaps = 55/304 (18%)
Query: 517 ISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
++ D EI E++ + K+GQG G V+ N VA+K L K +
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFL- 227
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLD 631
E + + +RH+ +V+LY +Y +V EYM G+L D L G +L
Sbjct: 228 -----QEAQVMKKLRHEKLVQLYAVVSEEPIY---IVTEYMSKGSLLDFLKGETGK-YLR 278
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
P +A +A G+AY+ +HRD+++ NIL+ N KVADFG+A++++
Sbjct: 279 LPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE--DN 333
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750
+ + + APE A + T K DV+SFG++L EL T GR P
Sbjct: 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP------------ 381
Query: 751 YWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEV 803
Y G+ EVLD+ G +R + + +C K P RPT +
Sbjct: 382 YP---------GMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 431
Query: 804 VQLL 807
L
Sbjct: 432 QAFL 435
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 78/309 (25%), Positives = 130/309 (42%), Gaps = 58/309 (18%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEV-----VAVKKLWSQRTKVSASDTDQL 573
EI +T + +G G G VYK L + VA+K L K ++ ++
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRV 91
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
L E +G H NI++L S +++ EYM NG L L +
Sbjct: 92 DF---LG-EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 147
Query: 634 TRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
+ G+A G+ YL + +HRD+ + NIL++ N KV+DFG+++VL+
Sbjct: 148 QLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLE---- 198
Query: 692 KDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745
D + G + APE K T+ DV+SFG+V+ E++T G +P + +
Sbjct: 199 -DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----YWE 253
Query: 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTM 800
N EV+ G FR + ++ ++C + A RP
Sbjct: 254 LSN---------------HEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKF 297
Query: 801 NEVVQLLAE 809
++V +L +
Sbjct: 298 ADIVSILDK 306
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 73/300 (24%), Positives = 116/300 (38%), Gaps = 68/300 (22%)
Query: 532 NKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+G+G G VY +D + ++ AVK L + Q E +
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRITDIGEVSQFLT----EGIIMK 81
Query: 588 NIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
+ H N++ L C S L+V YM +G+L + + + VA+G
Sbjct: 82 DFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 646 LAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
+ YL +HRD+ + N +LD + KVADFG+A+ + +V T
Sbjct: 141 MKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMY----DKEYYSVHNKTG 191
Query: 704 GYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKV 757
L A E + K TTK DV+SFGV+L EL+T G P Y
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------YP----- 234
Query: 758 DTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ ++ L G R D + +V+ +C RP+ +E+V +
Sbjct: 235 ----DVNTFDITVYLLQG-RRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+G+G G+VYK I +G++VA+K++ LQ + E+ +
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV---------PVESDLQE---IIKEISIMQQCD 82
Query: 591 HKNIVKLY-CYF--SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
++VK Y YF + L+ +V EY G++ D + L I +GL
Sbjct: 83 SPHVVKYYGSYFKNTDLW---IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLH IHRDIK+ NILL+ K+ADFG+A L K TVI GT ++A
Sbjct: 140 YLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVI-GTPFWMA 193
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
PE D++S G+ +E+ G+ P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 1e-31
Identities = 64/300 (21%), Positives = 118/300 (39%), Gaps = 56/300 (18%)
Query: 526 EAMTEKNKVGQGGSGTVYK--IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+ ++G G G+V + + ++ VA+K L T++ ++ ++ E
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--------KQGTEKADTEEMMR-E 386
Query: 583 VETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
+ + + + IV+L C +L LV E G L L + ++
Sbjct: 387 AQIMHQLDNPYIVRLIGVCQAEALM---LVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 641 GVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
V+ G+ YL + +HR++ + N+LL + K++DFG++K L A DS T
Sbjct: 444 QVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTA 495
Query: 699 IAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVS 754
+ + APE K +++ DV+S+GV + E ++ G+KP + K
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKG------ 545
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
EV+ G R E ++ + C RP V Q +
Sbjct: 546 ---------PEVMAFIEQG-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 78/307 (25%), Positives = 129/307 (42%), Gaps = 61/307 (19%)
Query: 518 SFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEV-VAVKKLWSQRTKVSASDTDQLQL 575
++D+ E+ +T K+K+G G G VY+ + VAVK L K + ++
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFL- 264
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSS-LYCNLLVYEYMPNGNLWDALHK-GLVHLD 631
E + I+H N+V+L C Y ++ E+M GNL D L + +
Sbjct: 265 -----KEAAVMKEIKHPNLVQLLGVCTREPPFY---IITEFMTYGNLLDYLRECNRQEVS 316
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
+A ++ + YL IHR++ + N L+ N+ KVADFG+++++
Sbjct: 317 AVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT---- 369
Query: 692 KDSTTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNK 747
T T AG + APE +K + K DV++FGV+L E+ T G P
Sbjct: 370 -GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------- 419
Query: 748 NIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTM 800
Y GI +V + +R E +V + C +P+ RP+
Sbjct: 420 ---YP---------GIDLSQVYELLEKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSF 466
Query: 801 NEVVQLL 807
E+ Q
Sbjct: 467 AEIHQAF 473
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 78/312 (25%), Positives = 133/312 (42%), Gaps = 71/312 (22%)
Query: 518 SFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEV-VAVKKLWSQRTKVSASDTDQLQL 575
++D+ E+ +T K+K+G G G VY+ + VAVK L K + ++
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFL- 57
Query: 576 DKGLKTEVETLGNIRHKNIVKLY--CYFSS-LYCNLLVYEYMPNGNLWDALHK-GLVHLD 631
E + I+H N+V+L C Y ++ E+M GNL D L + +
Sbjct: 58 -----KEAAVMKEIKHPNLVQLLGVCTREPPFY---IITEFMTYGNLLDYLRECNRQEVS 109
Query: 632 WPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
+A ++ + YL + IHRD+ + N L+ N+ KVADFG+++++
Sbjct: 110 AVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT-- 162
Query: 690 GGKDSTTTVIAGT---YGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745
T T AG + APE +K + K DV++FGV+L E+ T G P
Sbjct: 163 ---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------- 212
Query: 746 NKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPA 795
Y GI +V + +R +++ +++R C +P+
Sbjct: 213 -----YP---------GIDLSQVYELLEKD-YRMERPEGCPEKVYELMR---ACWQWNPS 254
Query: 796 TRPTMNEVVQLL 807
RP+ E+ Q
Sbjct: 255 DRPSFAEIHQAF 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 74/411 (18%), Positives = 143/411 (34%), Gaps = 49/411 (11%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+ + L +L ++N T L + TNL L+ + N KL + LT
Sbjct: 56 DMTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSN------KLTNLDVTPLT 106
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
KL + T L + LT L N +T I + L +L+ + N++
Sbjct: 107 KLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK 160
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ ++ T+LT LD S N ++ + + L L N+++ ++ + +
Sbjct: 161 I---TKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQN 211
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
LT L N LT D+ + L D S N L+ L S KL +Q
Sbjct: 212 IQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDVSTLS--KLTTLHCIQTD 265
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
+ L L+ F+ + + + ++D + +
Sbjct: 266 LLEI---DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQN 317
Query: 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
L L++ +++ S L + + + S +G + LN +
Sbjct: 318 PKLVYLYLNNTELTELDVSHN---TKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQ 372
Query: 369 LNSSIPNSLSSLK-----SLNVLDLSNNLLT-GYIPESLCELLPNSINFSN 413
+ +L++ S ++LD N + + + N+I + N
Sbjct: 373 TITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWEN 423
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 66/357 (18%), Positives = 119/357 (33%), Gaps = 38/357 (10%)
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
+ F V A + S + +LT L+ + IT I L L +L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKL 69
Query: 122 ELYYNQQLAGTIPE-ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
N I +L T LT L N L+ + + L KL L N L+
Sbjct: 70 ICTSNN-----ITTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-- 119
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
++ + LT L+ N+LT D+ + L LD NK L + +L
Sbjct: 120 -KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQT--QLT 173
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300
N + + +++ K L R N++ + + ++ +D S N +
Sbjct: 174 TLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-- 225
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
V L+ N ++ S + L + L I + + +L
Sbjct: 226 -EIDVTPLTQLTYFDCSVNPLTELDVSTL---SKLTTLHCIQTDLLE-ID--LTHNTQLI 278
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLS 417
+ + + ++ L +LD +T + S L + +N L+
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDLSQNPKL-VYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 64/406 (15%), Positives = 132/406 (32%), Gaps = 43/406 (10%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+ D+ P N + +S L L L + + + + I +LT
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNS---SITDMTG--IEKLT 64
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
L ++ + + + + T+LT L N +T ++ + L L L N+
Sbjct: 65 GLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ + LT L+ + N L+ +I + +L L + N ++ +
Sbjct: 119 --TKLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQ 169
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
T LT L N +T D+ Q L L+ N ++ L +L + N
Sbjct: 170 TQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK-LDLNQNI--QLTFLDCSSNK 223
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
+ + + L F S N L + +L ++ + + +
Sbjct: 224 LTEI---DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL---EIDLTHN 274
Query: 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
L + + + ++ L +D ++ + + KL L L + +
Sbjct: 275 TQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTE 329
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNN 414
L + + +S L L N + + L N+
Sbjct: 330 L-TELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQ 372
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-31
Identities = 77/313 (24%), Positives = 122/313 (38%), Gaps = 65/313 (20%)
Query: 511 VKSFHRISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASD 569
V + + ++ + +G+G G V D G VAVK + K A+
Sbjct: 177 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATA 230
Query: 570 TDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSS--LYCNLLVYEYMPNGNLWDALHK 625
L E + +RH N+V+L LY +V EYM G+L D L
Sbjct: 231 QAFLA-------EASVMTQLRHSNLVQLLGVIVEEKGGLY---IVTEYMAKGSLVDYLRS 280
Query: 626 -GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684
G L K + V + + YL + +HRD+ + N+L+ + KV+DFG+ K
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 685 VL--QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741
GK + + APE K +TK DV+SFG++L E+ + GR P
Sbjct: 338 EASSTQDTGK------LP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--- 386
Query: 742 DFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSP 794
Y I +V+ + G ++ + V + C
Sbjct: 387 ---------YP---------RIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMKNCWHLDA 427
Query: 795 ATRPTMNEVVQLL 807
ATRPT ++ + L
Sbjct: 428 ATRPTFLQLREQL 440
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 86/306 (28%), Positives = 133/306 (43%), Gaps = 55/306 (17%)
Query: 515 HRISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
++ D EI E++ + K+GQG G V+ N VA+K L K +
Sbjct: 255 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAF 309
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVH 629
E + + +RH+ +V+LY +Y +V EYM G+L D L G +
Sbjct: 310 L------QEAQVMKKLRHEKLVQLYAVVSEEPIY---IVTEYMSKGSLLDFLKGETGK-Y 359
Query: 630 LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
L P +A +A G+AY+ +HRD+++ NIL+ N KVADFG+A++++
Sbjct: 360 LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-- 414
Query: 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKN 748
+ + + APE A + T K DV+SFG++L EL T GR P
Sbjct: 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---------- 464
Query: 749 IIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSKSPATRPTMN 801
Y G+ EVLD+ G +R + + +C K P RPT
Sbjct: 465 --YP---------GMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFE 512
Query: 802 EVVQLL 807
+ L
Sbjct: 513 YLQAFL 518
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-31
Identities = 75/299 (25%), Positives = 119/299 (39%), Gaps = 44/299 (14%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K ++G GG G V + I ++GE VA+K+ R ++S + ++ E++ + +
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQC---RQELSPKNRERW------CLEIQIMKKL 69
Query: 590 RHKNIVKLYCYFSSL------YCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHKIAFG 641
H N+V L LL EY G+L L + L +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 642 VAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP---KVADFGIAKVLQARGGKDSTTT 697
++ L YLH + IIHRD+K NI+L Q K+ D G AK L + T
Sbjct: 130 ISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD----QGELCT 181
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-----------GDN 746
GT YLAPE K T D +SFG + E ITG +P ++ N
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++I+ + + K + LSG ++ + L+ + R T +
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW---HQRQRGTDPQNPN 297
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 75/302 (24%), Positives = 117/302 (38%), Gaps = 84/302 (27%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G G V D G VAVK + K A+ L E + +R
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCI-----KNDATAQAFLA-------EASVMTQLR 72
Query: 591 HKNIVKLY--CYFSS--LYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQG 645
H N+V+L LY +V EYM G+L D L G L K + V +
Sbjct: 73 HSNLVQLLGVIVEEKGGLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 646 LAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL--QARGGKDSTTTVIAG 701
+ YL ++ +HRD+ + N+L+ + KV+DFG+ K GK
Sbjct: 130 MEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--------- 175
Query: 702 TYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSI 755
L APE K +TK DV+SFG++L E+ + GR P Y
Sbjct: 176 ----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------YP--- 216
Query: 756 KVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
I +V+ + G ++ + +V++ C A RP+ ++ +
Sbjct: 217 ------RIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMK---NCWHLDAAMRPSFLQLRE 266
Query: 806 LL 807
L
Sbjct: 267 QL 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-31
Identities = 84/392 (21%), Positives = 154/392 (39%), Gaps = 83/392 (21%)
Query: 438 GLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIGLLLFLKRRFSKQRAITE 497
G C V N + ++F + P + R L SI + + +++ + ++
Sbjct: 316 GYCRLV--NGATQSFIIRPQKEGERALPSIPKLANN------------EKQGVRSHTVSV 361
Query: 498 PDETLSSSFFPYDVKSFHRISFDQREIL-EAMTEKNKVGQGGSGTVYK---IDLNSGEV- 552
+ + + ++ S EI E + +G+G G V++ + + +
Sbjct: 362 SETDDYAEIIDEE-DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMA 420
Query: 553 VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLV 610
VA+K K SD+ +K L+ E T+ H +IVKL + ++ ++
Sbjct: 421 VAIKTC-----KNCTSDS---VREKFLQ-EALTMRQFDHPHIVKLIGVITENPVW---II 468
Query: 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNIL 668
E G L L LD + A+ ++ LAYL +HRDI + N+L
Sbjct: 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVL 523
Query: 669 LDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVY 723
+ N K+ DFG+++ ++ DST + G L APE + T+ DV+
Sbjct: 524 VSSNDCVKLGDFGLSRYME-----DSTYY--KASKGKLPIKWMAPESINFRRFTSASDVW 576
Query: 724 SFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM- 779
FGV + E++ G KP + G+ +V+ + +G R M
Sbjct: 577 MFGVCMWEILMHGVKP------------FQ---------GVKNNDVIGRIENG-ERLPMP 614
Query: 780 ----IQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ + +C + P+ RP E+ L
Sbjct: 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 58/309 (18%), Positives = 114/309 (36%), Gaps = 75/309 (24%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
E K+G G G+V+K + G + A+K+ S++ + D EV
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNAL------REVYAHA 65
Query: 588 NI-RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL---HKGLVHLDWPTRHKIAF 640
+ +H ++V+ + + + + EY G+L DA+ ++ + + +
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHML---IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP-------------------KVADFG 681
V +GL Y+H ++H DIK +NI + P K+ D G
Sbjct: 123 QVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 682 IAKVLQARGGKDSTTTVIAGTYGYLAPE-----YAYSSKATTKCDVYSFGVVLMELITGR 736
+ S+ V G +LA E Y + KA D+++ + ++
Sbjct: 180 HVTRI-------SSPQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAE 228
Query: 737 KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT 796
+N W I ++G + + + LS F + +++ P
Sbjct: 229 PL-------PRNGDQWHEI----RQGRLPRIPQVLSQEFTE-LLK------VMIHPDPER 270
Query: 797 RPTMNEVVQ 805
RP+ +V+
Sbjct: 271 RPSAMALVK 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
++G G G VYK + +G + A K + ++L+ E+E L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKV-------IETKSEEELED---YIVEIEILATCD 74
Query: 591 HKNIVKLY-CYF--SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF---GVAQ 644
H IVKL Y+ L+ ++ E+ P G + + + L T +I + +
Sbjct: 75 HPYIVKLLGAYYHDGKLW---IMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLE 128
Query: 645 GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
L +LH IIHRD+K+ N+L+ + ++ADFG++ K + I GT
Sbjct: 129 ALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFI-GTPY 182
Query: 705 YLAPEYAYSSKAT-----TKCDVYSFGVVLMELITGRKP 738
++APE K D++S G+ L+E+ P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 26/242 (10%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
+S + + + +G G G V + + + VA+K + + K + +
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKII--SKRKFAIGSAREADP 58
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYF--SSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDW 632
++TE+E L + H I+K+ +F Y +V E M G L+D + L
Sbjct: 59 ALNVETEIEILKKLNHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNK--RLKE 113
Query: 633 PTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQA 688
T + + + YLH +G IIHRD+K N+LL + + K+ DFG +K+L
Sbjct: 114 ATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 689 RGGKDSTTTVIAGTYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
G+ S + GT YLAPE ++ D +S GV+L ++G P +
Sbjct: 168 --GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225
Query: 746 NK 747
Sbjct: 226 VS 227
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 75/302 (24%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-R 590
VG G G VYK + +G++ A+K + V+ + ++++ E+ L
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTGDEEEEIK------QEINMLKKYSH 79
Query: 591 HKNIVKLY-CYFSSLYCNL-----LVYEYMPNGNLWDALHKGLVHLDWP-TRHKIAF--- 640
H+NI Y + + LV E+ G++ D + IA+
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK---NTKGNTLKEEWIAYICR 136
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
+ +GL++LH +IHRDIK N+LL N + K+ DFG++ L G+ T I
Sbjct: 137 EILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFI- 190
Query: 701 GTYGYLAPEYAYSSKAT-----TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755
GT ++APE + K D++S G+ +E+ G P+ D
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-------------- 236
Query: 756 KVDTKEGIMEVL------------DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
M L KK S F+ + C K+ + RP ++
Sbjct: 237 -----MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIES-------CLVKNHSQRPATEQL 284
Query: 804 VQ 805
++
Sbjct: 285 MK 286
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 71/299 (23%), Positives = 115/299 (38%), Gaps = 66/299 (22%)
Query: 532 NKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+G+G G VY +D + ++ AVK L + Q E +
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRITDIGEVSQFLT----EGIIMK 145
Query: 588 NIRHKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ H N++ L S L+V YM +G+L + + + VA+G+
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 647 AYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
+L +HRD+ + N +LD + KVADFG+A+ + +V T
Sbjct: 206 KFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMY----DKEFDSVHNKTGA 256
Query: 705 YL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758
L A E + K TTK DV+SFGV+L EL+T G P Y
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------YP------ 298
Query: 759 TKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ ++ L G R D + +V+ +C RP+ +E+V +
Sbjct: 299 ---DVNTFDITVYLLQG-RRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 350
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 84/335 (25%), Positives = 125/335 (37%), Gaps = 85/335 (25%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLN 548
+ RA + D ++ FF D + L ++G G G VY D+
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLF-------SDLR------EIGHGSFGAVYFARDVR 77
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY-CYF--SSLY 605
+ EVVA+KK+ + ++ Q + EV L +RH N ++ CY + +
Sbjct: 78 NSEVVAIKKM----SYSGKQSNEKWQD---IIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130
Query: 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF---GVAQGLAYLHHGLLSPIIHRDI 662
LV EY G+ D L L +IA G QGLAYLH +IHRD+
Sbjct: 131 ---LVMEYCL-GSASDLLEVHKKPLQ---EVEIAAVTHGALQGLAYLHS---HNMIHRDV 180
Query: 663 KSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATT---K 719
K+ NILL K+ DFG A ++ + + GT ++APE + K
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASIMAPA------NSFV-GTPYWMAPEVILAMDEGQYDGK 233
Query: 720 CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL------------ 767
DV+S G+ +EL + P+ + M L
Sbjct: 234 VDVWSLGITCIELAERKPPLFN-------------------MNAMSALYHIAQNESPALQ 274
Query: 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
S FR+ + C K P RPT
Sbjct: 275 SGHWSEYFRN-FVD------SCLQKIPQDRPTSEV 302
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 78/316 (24%), Positives = 122/316 (38%), Gaps = 89/316 (28%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
++ +G+G G V K + + A+K++ K AS D E+E L
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAG----ELEVLC 80
Query: 588 NI-RHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL---------------WDALHKGLVH 629
+ H NI+ L C L EY P+GNL + +
Sbjct: 81 KLGHHPNIINLLGACEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 630 LDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687
L A VA+G+ YL IHRD+ + NIL+ NY K+ADFG+++
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--- 190
Query: 688 ARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741
+ T G L A E S TT DV+S+GV+L E+++ G P
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--- 241
Query: 742 DFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTS 791
Y G+ E+ +K G +R DE+ ++R +C
Sbjct: 242 ---------YC---------GMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMR---QCWR 279
Query: 792 KSPATRPTMNEVVQLL 807
+ P RP+ +++ L
Sbjct: 280 EKPYERPSFAQILVSL 295
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-30
Identities = 91/426 (21%), Positives = 160/426 (37%), Gaps = 34/426 (7%)
Query: 22 LDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81
+D S N P + +L+ ++N + +L S I L+KLRI++++ +
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQN---YISELWTSDILSLSKLRILIISHNRIQ 58
Query: 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLT 141
+ L L+L+ N + I NL+ L+L +N A I +E GN++
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201
+L L +S HL I L +VL + + + SL+
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFP 173
Query: 202 TGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS----- 256
T + + S V +L + + L CS + N L +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 257 ---------LARCKNLLRFRVSNNHLEGSIPEGIL-----SLPHVSIIDLSYNSFSGPIA 302
L + F +SN L+G + SL +SI + + F P +
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 303 NTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLL 362
N++ + + + +D S+NLL+ + G+L +L L
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 363 MLQSNKLNS--SIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSG 418
+LQ N+L I + +KSL LD+S N ++ + C + S+N S+N L+
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 419 PIPLSL 424
I L
Sbjct: 414 TIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 86/435 (19%), Positives = 157/435 (36%), Gaps = 44/435 (10%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF- 65
L F Q L LDLS+N +S NL+ L + N LP F
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNA---FDALPICKEFG 112
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYY 125
+++L+ + L+T L I ++ L + G P L++ L+
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHI 170
Query: 126 NQQLAGTIPE------------ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY 173
EL N+ + + + LS I + PKL L L
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS--ILAKLQTNPKLSNLTLN 228
Query: 174 NNSLSGEISSVI---ANSTTLTMLSLYDNSLTGEVPQDLGQWSP-----LVVLDLSENKL 225
N + I TT+ S+ + L G++ +S L + + +
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
Query: 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPD-SLARCKNLLRFRVSNNHLEGSIPEGILSL 284
P + + + ++ ++ L SNN L ++ E L
Sbjct: 289 GFP-QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 285 PHVSIIDLSYNSFS--GPIANTVGNARNLSELFMQRNQISGFIPSEI-YRAISLVKIDLS 341
+ + L N IA ++L +L + +N +S SL+ +++S
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 342 DNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESL 401
N+L+ I + ++ +L L SNK+ SIP + L++L L++++N L +P+ +
Sbjct: 408 SNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK-SVPDGI 463
Query: 402 CELLPN--SINFSNN 414
+ L + I N
Sbjct: 464 FDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 8e-19
Identities = 62/302 (20%), Positives = 107/302 (35%), Gaps = 38/302 (12%)
Query: 5 YLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNL---TNLEVLSFNENP--GFKLWKL 59
Y L L L L+N T + + L T + S + G ++
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 60 PESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR 119
+ S L L I + + +++ T + +
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 120 QLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLS--GKIPESILRLPKLRVLQLYNNSL 177
L+ N L T+ E G+LTEL L + +N L KI E ++ L+ L + NS+
Sbjct: 328 HLDFSNNL-LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 178 -SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR 236
E + + +L L++ N LT + + L + VLDL NK+
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK---------- 434
Query: 237 GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYN 295
+P + + + L V++N L+ S+P+GI L + I L N
Sbjct: 435 ---------------SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
Query: 296 SF 297
+
Sbjct: 479 PW 480
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 61/315 (19%), Positives = 109/315 (34%), Gaps = 82/315 (26%)
Query: 531 KNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
++G+ G VYK GE VA+K L K A + + E
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-----KDKAEGPLREEFRH----EAM 64
Query: 585 TLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL---------------WDALHKGL 627
++H N+V L +++ Y +G+L D
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 628 VHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685
L+ P + +A G+ YL HH ++H+D+ + N+L+ K++D G+ +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 686 LQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPV 739
+ + L APE K + D++S+GVVL E+ + G +P
Sbjct: 178 VY------AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP- 230
Query: 740 EDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFRDEM-----IQVLRIAIRCTSK 792
Y G +V++ + V + I C ++
Sbjct: 231 -----------YC---------GYSNQDVVEMIRNR-QVLPCPDDCPAWVYALMIECWNE 269
Query: 793 SPATRPTMNEVVQLL 807
P+ RP ++ L
Sbjct: 270 FPSRRPRFKDIHSRL 284
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 75/335 (22%), Positives = 117/335 (34%), Gaps = 83/335 (24%)
Query: 509 YDVKSFHRISFDQREI-LEAMTEKNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQ 561
Y D +E+ + +T +G G G VY+ + + VAVK L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--- 68
Query: 562 RTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL 619
S+ D+L E + H+NIV+ S ++ E M G+L
Sbjct: 69 --PEVCSEQDELDFLM----EALIISKFNHQNIVRCIGVSLQSLPRF--ILMELMAGGDL 120
Query: 620 WDALHKGLVHLDWPTR------HKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDV 671
L + P+ +A +A G YL +H IHRDI + N LL
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTC 175
Query: 672 ---NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVY 723
K+ DFG+A+ + + S G L PE T+K D +
Sbjct: 176 PGPGRVAKIGDFGMARDIY----RASYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 724 SFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR---- 776
SFGV+L E+ + G P Y EVL+ SG R
Sbjct: 230 SFGVLLWEIFSLGYMP------------YP---------SKSNQEVLEFVTSG-GRMDPP 267
Query: 777 ----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ +++ +C P RP +++ +
Sbjct: 268 KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 299
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 78/357 (21%), Positives = 134/357 (37%), Gaps = 89/357 (24%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK-----IDLNSGEV-VAVKKLWSQRTKVSASDTDQ 572
D+ E+ E +T ++GQG G VY+ + + E VA+K + +AS ++
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 72
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL------- 623
++ E + ++V+L ++ E M G+L L
Sbjct: 73 IEFLN----EASVMKEFNCHHVVRLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAM 126
Query: 624 --HKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679
+ L ++A +A G+AYL + +HRD+ + N ++ ++ K+ D
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGD 181
Query: 680 FGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT 734
FG+ + + T G G L +PE TT DV+SFGVVL E+ T
Sbjct: 182 FGMTRDIY------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
Query: 735 -GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVL 783
+P Y G+ +VL + G D + +++
Sbjct: 236 LAEQP------------YQ---------GLSNEQVLRFVMEG-GLLDKPDNCPDMLFELM 273
Query: 784 RIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKSNKESSNATKIKNPSEL 840
R C +P RP+ E++ + E F F S K+ P EL
Sbjct: 274 R---MCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF------YYSEENKLPEPEEL 321
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 68/309 (22%), Positives = 115/309 (37%), Gaps = 76/309 (24%)
Query: 531 KNKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G+G G+V + + + VAVK + ++S + + E +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM----KLDNSSQREIEEFLS----EAACM 90
Query: 587 GNIRHKNIVKLY--CYFSSLYCN---LLVYEYMPNGNLWDAL-----HKGLVHLDWPTRH 636
+ H N+++L C S +++ +M G+L L G H+ T
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 637 KIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
K +A G+ YL + +HRD+ + N +L + VADFG++K + D
Sbjct: 151 KFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIY---SGDY 202
Query: 695 TTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKN 748
G + A E T+K DV++FGV + E+ T G P
Sbjct: 203 YR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---------- 249
Query: 749 IIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRP 798
Y G+ E+ D L G R DE+ +++ C P RP
Sbjct: 250 --YP---------GVQNHEMYDYLLHG-HRLKQPEDCLDELYEIMY---SCWRTDPLDRP 294
Query: 799 TMNEVVQLL 807
T + + L
Sbjct: 295 TFSVLRLQL 303
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 76/330 (23%), Positives = 129/330 (39%), Gaps = 90/330 (27%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQ 572
+ I + K ++G+G G V+ +L+ + +VAVK L K + +
Sbjct: 8 HVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-----K-DPTLAAR 61
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL----------- 619
+ E E L N++H++IVK Y C +V+EYM +G+L
Sbjct: 62 KDFQR----EAELLTNLQHEHIVKFYGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDA 115
Query: 620 ----WDALHKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNY 673
+ L IA +A G+ YL H +HRD+ + N L+ N
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANL 170
Query: 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVV 728
K+ DFG+++ + + D G + L PE K TT+ DV+SFGV+
Sbjct: 171 LVKIGDFGMSRDVYST---DYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 729 LMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------D 777
L E+ T G++P ++ + EV++ G
Sbjct: 225 LWEIFTYGKQP------------WF---------QLSNTEVIECITQG-RVLERPRVCPK 262
Query: 778 EMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
E+ V+ C + P R + E+ ++L
Sbjct: 263 EVYDVML---GCWQREPQQRLNIKEIYKIL 289
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 67/336 (19%), Positives = 133/336 (39%), Gaps = 50/336 (14%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
L ++ + + +P L + L+L N+ + + NL L L + N
Sbjct: 32 HLRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNK 87
Query: 153 LSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT---GEVPQD 208
+S KI L KL L L N L E+ + + L L +++N +T V
Sbjct: 88 IS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEITKVRKSVFNG 143
Query: 209 LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRV 268
L Q ++V++L N L SG+ + K L R+
Sbjct: 144 LNQ---MIVVELGTNPLK----------------------SSGIENGAFQGMKKLSYIRI 178
Query: 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328
++ ++ +IP+G+ P ++ + L N + A ++ NL++L + N IS
Sbjct: 179 ADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 329 IYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS------SIPNSLSSLKS 382
+ L ++ L++N L +P G+ + K + ++ L +N +++ P + S
Sbjct: 236 LANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294
Query: 383 LNVLDLSNNLLT-GYIPESLCELLPN--SINFSNNR 415
+ + L +N + I S + ++ N +
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 72/381 (18%), Positives = 128/381 (33%), Gaps = 111/381 (29%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ LDL NN +T ++ F
Sbjct: 53 DTALLDLQNN-----------KITEIKDGDF----------------------------- 72
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL-LKNLRQLELYYNQQLAGTIPEE 136
N+ +L L L N I+ I P L L +L L N QL +PE+
Sbjct: 73 -----------KNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN-QLK-ELPEK 118
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSL-SGEISS-VIANSTTLTM 193
+ L +L + N ++ K+ +S+ L ++ V++L N L S I + L+
Sbjct: 119 M--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175
Query: 194 LSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVL 253
+ + D ++T +PQ L L L L NK+ + V
Sbjct: 176 IRIADTNIT-TIPQGL--PPSLTELHLDGNKI------------------------TKVD 208
Query: 254 PDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNARNLS 312
SL NL + +S N + ++ G L+ PH+ + L+ N + + + + +
Sbjct: 209 AASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQ 266
Query: 313 ELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSS 372
+++ N IS I S + P + + L SN +
Sbjct: 267 VVYLHNNNIS-AIGSNDFCP-----------------PGYNTKKASYSGVSLFSNPVQYW 308
Query: 373 I--PNSLSSLKSLNVLDLSNN 391
P++ + + L N
Sbjct: 309 EIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFR-LTK 69
DF ++NL L L NN + + F L LE L ++N +L +LP + + L +
Sbjct: 71 DFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN---QLKELP-EKMPKTLQE 125
Query: 70 LRIMVLATCALHGQIPASI-GNVTSLTDLELTGNFIT-GHIPPEI-GLLKNLRQLELYYN 126
LR + + ++ S+ + + +EL N + I +K L + +
Sbjct: 126 LR---VHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 127 QQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVI 185
+ TIP+ L LT+L + N ++ K+ + L L L L L NS+S + +
Sbjct: 182 -NIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
AN+ L L L +N L +VP L + V+ L N +S +
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA----------------IG 279
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLE-GSIPEGILS-LPHVSIIDLSYN 295
N F P + + + +N ++ I + + + L
Sbjct: 280 SNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 10/96 (10%)
Query: 325 IPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLN 384
+P ++ +DL +N ++ NLK L+ L+L +NK++ P + + L L
Sbjct: 46 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 385 VLDLSNNLLT---GYIPESLCELLPNSINFSNNRLS 417
L LS N L +P++L EL N ++
Sbjct: 104 RLYLSKNQLKELPEKMPKTLQEL-----RVHENEIT 134
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 65/310 (20%), Positives = 113/310 (36%), Gaps = 77/310 (24%)
Query: 531 KNKVGQGGSGTVYK---IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G+G G+V + + V VAVK L K + ++ E +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-----KADIIASSDIE---EFLREAACM 79
Query: 587 GNIRHKNIVKLY--CY----FSSLYCNLLVYEYMPNGNLWDAL-----HKGLVHLDWPTR 635
H ++ KL L +++ +M +G+L L + +L T
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 636 HKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD 693
+ +A G+ YL + IHRD+ + N +L + VADFG+++ +
Sbjct: 140 VRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIY------ 188
Query: 694 STTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNK 747
S G L A E + T DV++FGV + E++T G+ P
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--------- 239
Query: 748 NIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATR 797
Y GI E+ + + G R +E+ ++ +C S P R
Sbjct: 240 ---YA---------GIENAEIYNYLIGG-NRLKQPPECMEEVYDLMY---QCWSADPKQR 283
Query: 798 PTMNEVVQLL 807
P+ + L
Sbjct: 284 PSFTCLRMEL 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 70/227 (30%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K+G G G V D + A+K + ++T VS S +L EV L +
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKII--RKTSVSTSSNSKL------LEEVAVLKLL 93
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAY 648
H NI+KLY +F LV E G L+D + H+ + I V G+ Y
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTY 151
Query: 649 LH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
LH H I+HRD+K N+LL + + K+ DFG++ V + GT
Sbjct: 152 LHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE----NQKKMKERLGTAY 203
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
Y+APE K KCDV+S GV+L L+ G P G I
Sbjct: 204 YIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPF---GGQTDQEIL 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 73/324 (22%), Positives = 115/324 (35%), Gaps = 83/324 (25%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQ 572
D +E+ + +T +G G G VY+ + + VAVK L S+ D+
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDE 118
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL 630
L E + H+NIV+ S ++ E M G+L L +
Sbjct: 119 LDFLM----EALIISKFNHQNIVRCIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRP 172
Query: 631 DWPTR------HKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDV---NYQPKVAD 679
P+ +A +A G YL +H IHRDI + N LL K+ D
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 680 FGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT 734
FG+A+ + + G L PE T+K D +SFGV+L E+ +
Sbjct: 228 FGMARDIY----RAGYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 735 -GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVL 783
G P Y EVL+ SG R + +++
Sbjct: 282 LGYMP------------YP---------SKSNQEVLEFVTSG-GRMDPPKNCPGPVYRIM 319
Query: 784 RIAIRCTSKSPATRPTMNEVVQLL 807
+C P RP +++ +
Sbjct: 320 T---QCWQHQPEDRPNFAIILERI 340
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 54/338 (15%), Positives = 106/338 (31%), Gaps = 82/338 (24%)
Query: 529 TEKNKVGQGGSGTVYKI-DLNSGEVVAVKKL----------------------------- 558
+G+GG G V++ + A+K++
Sbjct: 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 559 -------------------WSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599
+ + + ++ + KN V
Sbjct: 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH--KIAFGVAQGLAYLH-HGLLSP 656
S + + NL D +++ D I +A+ + +LH G
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---- 184
Query: 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT---------TVIAGTYGYLA 707
++HRD+K +NI ++ KV DFG+ + + + T GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PE + + + K D++S G++L EL+ + I D + +L
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRII-----TDVRNLKFPLL 294
Query: 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ M+Q S SP RP ++++
Sbjct: 295 FTQKYPQEHM-MVQ------DMLSPSPTERPEATDIIE 325
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 72/305 (23%), Positives = 113/305 (37%), Gaps = 68/305 (22%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVK-----KLWSQRTKVSASDTDQLQLDKG---------- 578
G+G G V + N A+K KL Q + G
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 579 -LKTEVETLGNIRHKNIVKLYCYF-----SSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
+ E+ L + H N+VKL LY +V+E + G + + L
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY---MVFELVNQGPVMEVPTLK--PLSE 136
Query: 633 PTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
+ +G+ YLH IIHRDIK +N+L+ + K+ADFG++ +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 692 KDSTTTVIAGTYGYLAPE------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD 745
S T GT ++APE +S KA DV++ GV L + G+ P D
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKA---LDVWAMGVTLYCFVFGQCPFMD---- 242
Query: 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR----DEMIQVLRIAI-RCTSKSPATRPTM 800
E IM + K S + ++ + L+ I R K+P +R +
Sbjct: 243 ---------------ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287
Query: 801 NEVVQ 805
E+
Sbjct: 288 PEIKL 292
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K +G+G S V + I + + AVK + S S + +L + EV+ L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKII-DVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 590 -RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQ 644
H NI++L + + + LV++ M G L+D L K L KI + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFF---LVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 135
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
+ LH I+HRD+K NILLD + K+ DFG + L + GT
Sbjct: 136 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLD----PGEKLREVCGTP 187
Query: 704 GYLAPE------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
YLAPE + D++S GV++ L+ G P F + ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLML 238
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVK---KLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
K+G G G V + N A+K K + + S + + + + + E+ L
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQG 645
++ H NI+KL+ F LV E+ G L++ + ++ D I + G
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSG 158
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+ YLH H I+HRDIK NILL + K+ DFG++ KD G
Sbjct: 159 ICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS----KDYKLRDRLG 210
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
T Y+APE K KCDV+S GV++ L+ G P
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 72/366 (19%), Positives = 132/366 (36%), Gaps = 93/366 (25%)
Query: 486 KRRFSKQ-RAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK 544
K ++ + + I + + P + + F + + +G G G V +
Sbjct: 9 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNL----QFGKTLGAGAFGKVVE 64
Query: 545 ---IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKL 597
L + VAVK L K +A ++ L E++ + ++ +H+NIV L
Sbjct: 65 ATAFGLGKEDAVLKVAVKML-----KSTAHADEKEALMS----ELKIMSHLGQHENIVNL 115
Query: 598 Y--CYFSSLYCNLLVYEYMPNGNLWDAL-------------HKGLVHLDWPTRHKIAFGV 642
C ++ EY G+L + L + V
Sbjct: 116 LGACTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 643 AQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
AQG+A+L + IHRD+ + N+LL + K+ DFG+A+ + + + I
Sbjct: 174 AQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIM------NDSNYIV 222
Query: 701 GTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVS 754
L APE + T + DV+S+G++L E+ + G P Y
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP------------YP-- 268
Query: 755 IKVDTKEGIM---EVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEV 803
GI+ + G ++ + +++ C + P RPT ++
Sbjct: 269 -------GILVNSKFYKLVKDG-YQMAQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQI 317
Query: 804 VQLLAE 809
L E
Sbjct: 318 CSFLQE 323
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 75/331 (22%), Positives = 124/331 (37%), Gaps = 89/331 (26%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQ 572
I + K ++G+G G V+ +L + +VAVK L K AS++ +
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----K-EASESAR 87
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL----------- 619
+ E E L ++H++IV+ + C +V+EYM +G+L
Sbjct: 88 QDFQR----EAELLTMLQHQHIVRFFGVCTEGRPLL--MVFEYMRHGDLNRFLRSHGPDA 141
Query: 620 ---WDALHKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQ 674
L +A VA G+ YL H +HRD+ + N L+
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLV 196
Query: 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVL 729
K+ DFG+++ + V G L PE K TT+ DV+SFGVVL
Sbjct: 197 VKIGDFGMSRDIY----STDYYRV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 730 MELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DE 778
E+ T G++P ++ + E +D G E
Sbjct: 251 WEIFTYGKQP------------WY---------QLSNTEAIDCITQG-RELERPRACPPE 288
Query: 779 MIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ ++R C + P R ++ +V L
Sbjct: 289 VYAIMR---GCWQREPQQRHSIKDVHARLQA 316
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 28/253 (11%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLN 548
+K+ +P T + F + +E + K+ +G+G S V + +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYF---SSL 604
+G AVK + + T S ++ + + E L + H +I+ L + S +
Sbjct: 118 TGHEFAVKIM--EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 605 YCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDI 662
+ LV++ M G L+D L K L I + + +++LH + I+HRD+
Sbjct: 176 F---LVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN----IVHRDL 226
Query: 663 KSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE------YAYSSKA 716
K NILLD N Q +++DFG + L+ + GT GYLAPE
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLE----PGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 717 TTKCDVYSFGVVL 729
+ D+++ GV+L
Sbjct: 283 GKEVDLWACGVIL 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 79/321 (24%), Positives = 122/321 (38%), Gaps = 91/321 (28%)
Query: 531 KNKVGQGGSGTVYK-----IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+G+G G V ID + + VAVK L K A++ D L E
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSDLVS----E 136
Query: 583 VETLGNI-RHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL---------------WDALH 624
+E + I +HKNI+ L C ++ EY GNL +D
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 625 KGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682
+ + + +A+G+ YL IHRD+ + N+L+ N K+ADFG+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 683 AKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GR 736
A+ + + T G L APE + T + DV+SFGV++ E+ T G
Sbjct: 250 ARDIN------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 737 KPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIA 786
P Y GI E+ G R +E+ ++R
Sbjct: 304 SP------------YP---------GIPVEELFKLLKEG-HRMDKPANCTNELYMMMR-- 339
Query: 787 IRCTSKSPATRPTMNEVVQLL 807
C P+ RPT ++V+ L
Sbjct: 340 -DCWHAVPSQRPTFKQLVEDL 359
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 96/326 (29%)
Query: 531 KNKVGQGGSGTVYK-----IDLNSGEV-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
+G+G G V K + +G VAVK L K +AS ++ L E
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLS----EFN 78
Query: 585 TLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNLWDAL------------------- 623
L + H +++KLY C L+ EY G+L L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 624 ----HKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKV 677
H L A+ ++QG+ YL ++HRD+ + NIL+ + K+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKI 191
Query: 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMEL 732
+DFG+++ + + + + G + A E + TT+ DV+SFGV+L E+
Sbjct: 192 SDFGLSRDVY------EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 733 IT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQ 781
+T G P Y GI + + +G R +EM +
Sbjct: 246 VTLGGNP------------YP---------GIPPERLFNLLKTG-HRMERPDNCSEEMYR 283
Query: 782 VLRIAIRCTSKSPATRPTMNEVVQLL 807
++ +C + P RP ++ + L
Sbjct: 284 LML---QCWKQEPDKRPVFADISKDL 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 54/307 (17%), Positives = 99/307 (32%), Gaps = 75/307 (24%)
Query: 531 KNKVGQGGSGTVYK-------IDLNSGEV-VAVKKLWSQRTKVSASDTDQ--LQLDKGLK 580
+GQG ++K E V +K L + + + +
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-----DKAHRNYSESFFE------ 61
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
+ + HK++V Y N+LV E++ G+L L K ++ + ++A
Sbjct: 62 -AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 641 GVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQP--------KVADFGIAKVLQARG 690
+A + +L + +IH ++ + NILL K++D GI+ +
Sbjct: 121 QLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--- 172
Query: 691 GKDSTTTVIAGTYGYLAPE-YAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKN 748
KD I PE D +SFG L E+ + G KP +
Sbjct: 173 PKDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP----LSALDS 224
Query: 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFR------DEMIQVLRIAIRCTSKSPATRPTMNE 802
L + E+ ++ C P RP+
Sbjct: 225 ---------------QRKLQFYEDR-HQLPAPKAAELANLIN---NCMDYEPDHRPSFRA 265
Query: 803 VVQLLAE 809
+++ L
Sbjct: 266 IIRDLNS 272
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 75/318 (23%), Positives = 116/318 (36%), Gaps = 81/318 (25%)
Query: 531 KNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
+G+G G V + ++ VAVK L K A+ ++ L E++
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMS----ELK 82
Query: 585 TLGNI-RHKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDAL---------------HKGL 627
L +I H N+V L +++ E+ GNL L
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 628 VHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685
L +F VA+G+ +L IHRD+ + NILL K+ DFG+A+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 686 LQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPV 739
+ + L APE + T + DV+SFGV+L E+ + G P
Sbjct: 198 IY------KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP- 250
Query: 740 EDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTS 791
Y +K+D E + G R EM Q + C
Sbjct: 251 -----------YP-GVKIDE-----EFCRRLKEG-TRMRAPDYTTPEMYQTML---DCWH 289
Query: 792 KSPATRPTMNEVVQLLAE 809
P+ RPT +E+V+ L
Sbjct: 290 GEPSQRPTFSELVEHLGN 307
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+ +G+G G V D +G+ AVK + + +V + L EV+ L +
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVI--SKRQVKQKTDKES-----LLREVQLLKQL 83
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAY 648
H NI+KLY +F LV E G L+D + + +I V G+ Y
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITY 141
Query: 649 LH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
+H + I+HRD+K N+LL + ++ DFG++ + GT
Sbjct: 142 MHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE----ASKKMKDKIGTAY 193
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
Y+APE KCDV+S GV+L L++G P
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 69/234 (29%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G G V K D + + AVK + + DT + EVE L +
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVI--NKASAKNKDTSTI------LREVELLKKL 78
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQG 645
H NI+KL+ SS Y +V E G L+D + + +I V G
Sbjct: 79 DHPNIMKLFEILEDSSSFY---IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSG 133
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+ Y+H H I+HRD+K NILL + + K+ DFG++ +++ G
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF----QQNTKMKDRIG 185
Query: 702 TYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
T Y+APE Y KCDV+S GV+L L++G P F G N+ I
Sbjct: 186 TAYYIAPEVLRGTYD----EKCDVWSAGVILYILLSGTPP----FYGKNEYDIL 231
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 79/323 (24%), Positives = 122/323 (37%), Gaps = 91/323 (28%)
Query: 531 KNKVGQGGSGTVYK-----IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+G+G G V ID + + VAVK L K A++ D L E
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSDLVS----E 90
Query: 583 VETLGNI-RHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL---------------WDALH 624
+E + I +HKNI+ L C ++ EY GNL +D
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 625 KGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682
+ + + +A+G+ YL IHRD+ + N+L+ N K+ADFG+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGL 203
Query: 683 AKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GR 736
A+ + + T G L APE + T + DV+SFGV++ E+ T G
Sbjct: 204 ARDIN------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 737 KPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIA 786
P Y GI E+ G R +E+ ++R
Sbjct: 258 SP------------YP---------GIPVEELFKLLKEG-HRMDKPANCTNELYMMMR-- 293
Query: 787 IRCTSKSPATRPTMNEVVQLLAE 809
C P+ RPT ++V+ L
Sbjct: 294 -DCWHAVPSQRPTFKQLVEDLDR 315
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 66/277 (23%), Positives = 103/277 (37%), Gaps = 60/277 (21%)
Query: 522 REILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK 580
E+ + K +GQG G V I+ + + A+K + + K+ + ++ +K
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM--NKNKIRQINPKDVE---RIK 76
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
TEV + + H NI +LY + LV E G+L D L+ + +
Sbjct: 77 TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 641 G---------------------------------------VAQGLAYLH-HGLLSPIIHR 660
+ L YLH G I HR
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHR 192
Query: 661 DIKSTNILL--DVNYQPKVADFGIAKVLQ-ARGGKDSTTTVIAGTYGYLAPE--YAYSSK 715
DIK N L + +++ K+ DFG++K G+ T AGT ++APE +
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 716 ATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
KCD +S GV+L L+ G P F G N
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP----FPGVNDADTI 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 67/234 (28%), Positives = 100/234 (42%), Gaps = 42/234 (17%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G G V K D + + AVK + + DT + EVE L +
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVI--NKASAKNKDTSTI------LREVELLKKL 78
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH-------KIAFGV 642
H NI+KL+ +V E G L+D + K + +I V
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK--------RKRFSEHDAARIIKQV 130
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTV 698
G+ Y+H H I+HRD+K NILL + + K+ DFG++ Q +++
Sbjct: 131 FSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----QNTKMKD 182
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
GT Y+APE KCDV+S GV+L L++G P F G N+ I
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP----FYGKNEYDIL 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K K+G G G V+ + +SG +K + R++V ++ E+E L ++
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ---------IEAEIEVLKSL 77
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-- 644
H NI+K++ F ++Y +V E G L + + + +A + Q
Sbjct: 78 DHPNIIKIFEVFEDYHNMY---IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 645 -GLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
LAY H ++H+D+K NIL + K+ DFG+A++ + D +T
Sbjct: 135 NALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK----SDEHSTNA 186
Query: 700 AGTYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
AGT Y+APE + KCD++S GVV+ L+TG P F G + +
Sbjct: 187 AGTALYMAPEVFKRDVT----FKCDIWSAGVVMYFLLTGCLP----FTGTSLEEVQ 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 37/274 (13%), Positives = 77/274 (28%), Gaps = 36/274 (13%)
Query: 498 PDETLSSSFFPYDVK-SFHRISFDQREILEAMTEKNKVGQGGSGTVYK------IDLNSG 550
+ + F + K + + + + + + +G+G VY+ D +
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 551 EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLV 610
+ +K +E L +K Y ++LV
Sbjct: 96 QKFVLKVQ----------KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145
Query: 611 YEYMPNGNLWDALHKGLVH----LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666
E G L +A++ + A + + +H IIH DIK N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202
Query: 667 ILLDVNYQP-----------KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK 715
+L + + D G + ++ T T G+ E +
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKP 261
Query: 716 ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749
+ D + + ++ G + G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 60/302 (19%), Positives = 104/302 (34%), Gaps = 57/302 (18%)
Query: 121 LELYYNQ--QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178
+YN + + N + E ++ + LQL +LS
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFSELQLNRLNLS 72
Query: 179 GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGK 238
+ + +T+L + N+L +P+ L LD +N+LS
Sbjct: 73 -SLPDNLPPQ--ITVLEITQNALI-SLPELPAS---LEYLDACDNRLS------------ 113
Query: 239 LQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFS 298
LP+ A K+L V NN L +PE L I+ N +
Sbjct: 114 -------------TLPELPASLKHL---DVDNNQLT-MLPELPALL---EYINADNNQLT 153
Query: 299 GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKK 358
+ + L L ++ NQ++ F+P SL +D+S NLL +P+
Sbjct: 154 M-LPELPTS---LEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLES-LPAVPVRNHH 204
Query: 359 L----NLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNN 414
+ N++ + IP ++ SL + L +N L+ I ESL +
Sbjct: 205 SEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
Query: 415 RL 416
Sbjct: 264 IY 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 64/324 (19%), Positives = 118/324 (36%), Gaps = 60/324 (18%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQ--QLAGTIPEELGNL 140
I I N SL+ N I+G + + L + + E L +
Sbjct: 3 IMLPINNNFSLSQNSFY-NTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 141 TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNS 200
+ ++L ++ +LS +P+++ P++ VL++ N+L + + A+ L L DN
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNR 111
Query: 201 LTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARC 260
L+ +P+ L LD+ N+L+ LP L+Y N + +LP+
Sbjct: 112 LS-TLPELPAS---LKHLDVDNNQLTM-LPELP---ALLEYINADNNQLT-MLPELP--- 159
Query: 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQ 320
+L V NN L +PE +L L + N
Sbjct: 160 TSLEVLSVRNNQLT-FLPELP---------------------------ESLEALDVSTNL 191
Query: 321 ISGFIPSEIYRAISL----VKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNS 376
+ +P+ R + +N ++ IP I +L ++L+ N L+S I S
Sbjct: 192 LES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRES 249
Query: 377 LSSLKSLNVLDLSNNLLTGYIPES 400
LS + + +
Sbjct: 250 LSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 51/321 (15%), Positives = 101/321 (31%), Gaps = 34/321 (10%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+L + L L+ + P ++ + VL +N L LPE
Sbjct: 51 SLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQN---ALISLPEL----PA 100
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
L + L +P + L L++ N +T +P L + NQ
Sbjct: 101 SLEYLDACDNRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPA---LLEYINADNNQ- 151
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG---EISSVI 185
+PE +L L + N L+ +PE L L + N L
Sbjct: 152 -LTMLPELPTSLEV---LSVRNNQLT-FLPEL---PESLEALDVSTNLLESLPAVPVRNH 203
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
+ T +N +T +P+++ P + L +N LS + S+ Q
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHG 261
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTV 305
++ + + + + + H + N+FS + +
Sbjct: 262 PRIYFSMSDGQQNTL-HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA-FLDRL 319
Query: 306 GNARNLSELFMQRNQISGFIP 326
+ + R Q++ ++
Sbjct: 320 SDTVSARNTSGFREQVAAWLE 340
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 60/309 (19%), Positives = 111/309 (35%), Gaps = 34/309 (11%)
Query: 15 PMQNLRRL--DLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
P+ N L + N +G + E + + L + + + +
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGT 132
+ L L +P ++ +T LE+T N + +P +L L+ N+ L+ T
Sbjct: 64 LQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNR-LS-T 114
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
+PE +L L D+ N L+ +PE L + NN L+ + + + L
Sbjct: 115 LPELPASLKHL---DVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPTS---LE 163
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL----QNM 248
+LS+ +N LT +P+ L LD+S N L LPA + + +N
Sbjct: 164 VLSVRNNQLT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENR 218
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
+ +P+++ + +N L I E + FS
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
Query: 309 RNLSELFMQ 317
R L++
Sbjct: 278 RPLADAVTA 286
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 82/353 (23%), Positives = 135/353 (38%), Gaps = 100/353 (28%)
Query: 500 ETLSSSFFPYDVK---SFHRISFDQREILEAMTEKNKVGQGGSGTVYK-----IDLNSGE 551
+ + PYD K +R+SF + +G G G V + + +
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLSFGK-----------TLGAGAFGKVVEATAYGLIKSDAA 53
Query: 552 V-VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY--CYFSSLYCN 607
+ VAVK L K SA T++ L E++ L + H NIV L C
Sbjct: 54 MTVAVKML-----KPSAHLTEREALMS----ELKVLSYLGNHMNIVNLLGACTIGGPTL- 103
Query: 608 LLVYEYMPNGNL-----------------WDALHKGLVHLDWPTRHKIAFGVAQGLAYL- 649
++ EY G+L + + LD ++ VA+G+A+L
Sbjct: 104 -VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162
Query: 650 -HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL-- 706
+ IHRD+ + NILL K+ DFG+A+ ++ + + + L
Sbjct: 163 SKN-----CIHRDLAARNILLTHGRITKICDFGLARDIK------NDSNYVVKGNARLPV 211
Query: 707 ---APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
APE ++ T + DV+S+G+ L EL + G P + + VD+
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-------------YPGMPVDS--- 255
Query: 763 IMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ G FR EM +++ C P RPT ++VQL+
Sbjct: 256 --KFYKMIKEG-FRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLI 302
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 48/238 (20%)
Query: 521 QREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
R+ ++ + GQG GTV + ++G VA+KK+ +Q D
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--------------IQ-DPRF 62
Query: 580 KT----EVETLGNIRHKNIVKLYCYFSS--------LYCNLLVYEYMPNGNLWDALHKGL 627
+ ++ L + H NIV+L YF + +Y N+ V EY+P D LH+
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV-VMEYVP-----DTLHRCC 116
Query: 628 VHLDW-----PTRHK--IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVAD 679
+ P F + + + LH ++ + HRDIK N+L++ + K+ D
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCD 175
Query: 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
FG AK L + I Y Y APE + ++ TT D++S G + E++ G
Sbjct: 176 FGSAKKL---SPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 35/232 (15%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K ++G+G V + + +G A K + K+SA D +L + E +
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKII--NTKKLSARDFQKL------EREARICRKL 62
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQG 645
+H NIV+L+ S Y LV++ + G L++ + + + +
Sbjct: 63 QHPNIVRLHDSIQEESFHY---LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILES 117
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+AY H +G I+HR++K N+LL K+ADFG+A + AG
Sbjct: 118 IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN----DSEAWHGFAG 169
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIYW 752
T GYL+PE + D+++ GV+L L+ G P F ++++ +Y
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP----FWDEDQHRLYA 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 80/326 (24%), Positives = 123/326 (37%), Gaps = 96/326 (29%)
Query: 531 KNKVGQGGSGTVYK---IDLNSGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
+G+G G V++ L E +VAVK L K AS Q + E
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADMQADFQR----EAA 102
Query: 585 TLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL----------------------- 619
+ + NIVKL C C L++EYM G+L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 620 WDALHKGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKV 677
G L + IA VA G+AYL +HRD+ + N L+ N K+
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKI 215
Query: 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMEL 732
ADFG+++ + S A + PE + ++ TT+ DV+++GVVL E+
Sbjct: 216 ADFGLSRNIY------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 733 IT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQ 781
+ G +P Y+ G+ EV+ G E+
Sbjct: 270 FSYGLQP------------YY---------GMAHEEVIYYVRDG-NILACPENCPLELYN 307
Query: 782 VLRIAIRCTSKSPATRPTMNEVVQLL 807
++R C SK PA RP+ + ++L
Sbjct: 308 LMR---LCWSKLPADRPSFCSIHRIL 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 66/315 (20%), Positives = 112/315 (35%), Gaps = 46/315 (14%)
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTL 191
+P+E+ + T LD+ N +S + L L L L NN +S + L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251
L + N L E+P +L S LV L + +N++
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRK------------------------ 137
Query: 252 VLPDSLARCKNLLRFRVSNNHL-EGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
V + +N+ + N L G ++ + +S +G +
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP---ET 194
Query: 311 LSELFMQRNQISGFIPSEIYRAI-SLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNK 368
L+EL + N+I I E L ++ L N + I +G L L L L +NK
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNK 252
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSN---NRLSG-PIPLSL 424
L S +P L LK L V+ L N +T + + + + + L P+P
Sbjct: 253 L-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 425 IKEGLVESFSGNPGL 439
++ +F
Sbjct: 311 VQPA---TFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 55/311 (17%), Positives = 110/311 (35%), Gaps = 26/311 (8%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
L ++ + + +P EI + L+L N ++ ++ L L L + N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNK 89
Query: 153 LSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ 211
+S KI E L KL+ L + N L EI + +S L L ++DN +
Sbjct: 90 IS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSS--LVELRIHDNRIRKVPKGVFSG 145
Query: 212 WSPLVVLDLSENKL-SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN 270
+ +++ N L + KL Y + + +G+ D L + +
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPE---TLNELHLDH 202
Query: 271 NHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
N ++ +I L + + L +N ++ L EL + N++S +P+ +
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 330 YRAISLVKIDLSDNLLSGPIPSGI-------GNLKKLNLLMLQSNKLNSSI--PNSLSSL 380
L + L N ++ + N + L +N + P + +
Sbjct: 261 PDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319
Query: 381 KSLNVLDLSNN 391
+ N
Sbjct: 320 TDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 59/293 (20%), Positives = 102/293 (34%), Gaps = 44/293 (15%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
DF +Q+L L L NN + + L L+ L ++N L ++P + L +LR
Sbjct: 73 DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN---HLVEIPPNLPSSLVELR 129
Query: 72 IMVLATCALHG----QIPASI-GNVTSLTDLELTGNFIT-GHIPPEIGLLKNLRQLELYY 125
+H ++P + + ++ +E+ GN + P L L +
Sbjct: 130 --------IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 126 NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSV 184
+ IP++L L +L + N + I L R KL L L +N + +
Sbjct: 182 AKL--TGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGS 236
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
++ TL L L +N L+ VP L L V+ L N ++ V
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK----------------V 279
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLE-GSIPEGILS-LPHVSIIDLSYN 295
N F V + + NN + + + I
Sbjct: 280 GVNDFCPVGF--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 61/315 (19%), Positives = 107/315 (33%), Gaps = 50/315 (15%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+ LDL NN + + F L +L L N K+ K+ E + L KL+ + ++
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNN---KISKIHEKAFSPLRKLQKLYIS 110
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
L +IP ++ +SL +L + N I +P + L+N+ +E+ N
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 136 ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS-VIANSTTLTML 194
+ +L L +S L+ IP+ + L L L +N + I + + L L
Sbjct: 167 GAFDGLKLNYLRISEAKLT-GIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
L N + L L L L NKLS +P
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-------------------------RVP 257
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGI-------LSLPHVSIIDLSYN--SFSGPIANTV 305
L K L + N++ + + + + I L N + T
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 306 GNARNLSELFMQRNQ 320
+ + +
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 46/224 (20%), Positives = 79/224 (35%), Gaps = 47/224 (20%)
Query: 13 FSPMQNLRRLDLSNN-LFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
FS ++N+ +++ N L F F+ L L +E +LT
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA--------------KLTG-- 186
Query: 72 IMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLA 130
IP +L +L L N I I E L +L L +NQ
Sbjct: 187 ------------IPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ--I 229
Query: 131 GTIPEE-LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS------ 183
I L L L +L + N LS ++P + L L+V+ L+ N+++ ++
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPV 287
Query: 184 -VIANSTTLTMLSLYDNSLT-GEVPQDLGQWSP-LVVLDLSENK 224
+SL++N + EV + + + K
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 81/321 (25%), Positives = 122/321 (38%), Gaps = 91/321 (28%)
Query: 531 KNKVGQGGSGTVYK---IDLNSGE-----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+G+G G V I L+ + VAVK L K A++ D L E
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEKDLSDLIS----E 124
Query: 583 VETLGNI-RHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL---------------WDALH 624
+E + I +HKNI+ L C ++ EY GNL ++ H
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 625 KGLVHLDWPTRHKIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682
L A+ VA+G+ YL IHRD+ + N+L+ + K+ADFG+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 683 AKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GR 736
A+ + T G L APE + T + DV+SFGV+L E+ T G
Sbjct: 238 ARDIH------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 737 KPVEDDFGDNKNIIYWVSIKVDTKEGI--MEVLDKKLSGSFR--------DEMIQVLRIA 786
P Y G+ E+ G R +E+ ++R
Sbjct: 292 SP------------YP---------GVPVEELFKLLKEG-HRMDKPSNCTNELYMMMR-- 327
Query: 787 IRCTSKSPATRPTMNEVVQLL 807
C P+ RPT ++V+ L
Sbjct: 328 -DCWHAVPSQRPTFKQLVEDL 347
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 45/222 (20%), Positives = 87/222 (39%), Gaps = 14/222 (6%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQF--PLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
F + L +L LS+N + + S F T+L+ L + N + + S+ L +
Sbjct: 47 VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN---GVITMS-SNFLGLEQ 102
Query: 70 LRIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQ 127
L + L S+ ++ +L L+++ I L +L L++ N
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIA 186
+P+ L LT LD+S L ++ + L L+VL + +N+ +
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 187 NSTTLTMLSLYDNSLTGEVPQDL--GQWSPLVVLDLSENKLS 226
+L +L N + + S L L+L++N +
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 61/294 (20%)
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLS--GEISSVIANS 188
++P + + T L++ N L +P + +L +L L L +N LS G S +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
T+L L L N + + + L LD + L + ++
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ---------------MSEFSV 121
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPI-ANTVG 306
F +NL+ +S+ H GI + L + ++ ++ NSF +
Sbjct: 122 FLS--------LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
Query: 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366
RNL+ L + + Q+ LS + L L +L +
Sbjct: 173 ELRNLTFLDLSQCQLE----------------QLSPTAFNS--------LSSLQVLNMSH 208
Query: 367 NKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNS---INFSNNRLS 417
N S L SL VLD S N + + + P+S +N + N +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/307 (19%), Positives = 98/307 (31%), Gaps = 64/307 (20%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
S T++ +T +P G+ + +LEL N +L LT+LT L +S N
Sbjct: 8 SGTEIRCNSKGLT-SVPT--GIPSSATRLELESN-KLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 153 LSGK--IPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT----GEVP 206
LS K +S L+ L L N + +SS L L ++L V
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 207 QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRF 266
L L+ LD+S +L
Sbjct: 123 LSLRN---LIYLDISHTHTRV-AF-----------------------NGIFNGLSSLEVL 155
Query: 267 RVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFI 325
+++ N + + I + L +++ +DLS + +L L M N +
Sbjct: 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SL 214
Query: 326 PSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSL-KSLN 384
+ Y+ L L +L N + +S L SL
Sbjct: 215 DTFPYK-----------------------CLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251
Query: 385 VLDLSNN 391
L+L+ N
Sbjct: 252 FLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 56/272 (20%), Positives = 94/272 (34%), Gaps = 45/272 (16%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQ-QLAGTIPEELGNL 140
+P I +S T LEL N + +P + L L +L L N G +
Sbjct: 21 SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 141 TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEIS--SVIANSTTLTMLSLYD 198
T L LD+S N + + + L L +L L +++L ++S SV + L L +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISH 135
Query: 199 NSLTGEVP----QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
L L VL ++ N LP
Sbjct: 136 THTR-VAFNGIFNGLSS---LEVLKMAGNSFQ-----------------------ENFLP 168
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNARNLSE 313
D +NL +S LE + + L + ++++S+N+F +L
Sbjct: 169 DIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 314 LFMQRNQISGFIPSEIYRAI--SLVKIDLSDN 343
L N I + + SL ++L+ N
Sbjct: 228 LDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 78/373 (20%), Positives = 135/373 (36%), Gaps = 96/373 (25%)
Query: 486 KRRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQR-EI-LEAMTEKNKVGQGGSGTVY 543
+ R+ Q + + SS Y F +D + E E + +G G G V
Sbjct: 6 QFRYESQL---QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM 62
Query: 544 K---IDLNSGEV---VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596
++ V VAVK L K A +++ + L +E++ + + H+NIV
Sbjct: 63 NATAYGISKTGVSIQVAVKML-----KEKADSSER----EALMSELKMMTQLGSHENIVN 113
Query: 597 LY--CYFSSLYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRH---------------- 636
L C S L++EY G+L + L + D
Sbjct: 114 LLGACTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 637 ----KIAFGVAQGLAYL--HHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
A+ VA+G+ +L +HRD+ + N+L+ K+ DFG+A+ +
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIM--- 223
Query: 691 GKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744
S + + L APE + T K DV+S+G++L E+ + G P
Sbjct: 224 ---SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------ 274
Query: 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVLRIAIRCTSKSPAT 796
Y I VD +G F+ +E+ +++ C +
Sbjct: 275 ------YP-GIPVDA-----NFYKLIQNG-FKMDQPFYATEEIYIIMQ---SCWAFDSRK 318
Query: 797 RPTMNEVVQLLAE 809
RP+ + L
Sbjct: 319 RPSFPNLTSFLGC 331
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 24/229 (10%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G V + I+ +G+ AVK + K ++S + LK E +
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIV--DVAKFTSSPGLSTE---DLKREASICHML 83
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GL 646
+H +IV+L +SS +V+E+M +L + K + + + Q L
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 647 AYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
Y H + IIHRD+K +LL + + K+ FG+A L G GT
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG---RVGT 196
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
++APE DV+ GV+L L++G P F K ++
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKERLF 241
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 56/284 (19%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G V + +G VA+K + +T+++ + +L EV + + H N
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKL------FREVRIMKILNHPN 75
Query: 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYLH-H 651
IVKL+ + L+ EY G ++D L G + + + Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK 133
Query: 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY- 710
I+HRD+K+ N+LLD + K+ADFG + GGK G Y APE
Sbjct: 134 R----IVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLDAF---CGAPPYAAPELF 185
Query: 711 ---AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
Y + DV+S GV+L L++G P + + + E+
Sbjct: 186 QGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG-------------------QNLKELR 223
Query: 768 DKKLSGSFR------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ L G +R + +L+ R +P R T+ ++++
Sbjct: 224 ERVLRGKYRIPFYMSTDCENLLK---RFLVLNPIKRGTLEQIMK 264
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 47/241 (19%)
Query: 518 SFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
S I + +G G V+ +G++ A+K + D
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI----------KKSPAFRD 50
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDW 632
L+ E+ L I+H+NIV L + + Y LV + + G L+D L +G
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYY---LVMQLVSGGELFDRILERG------ 101
Query: 633 PTRH-------KIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFG 681
+ V + YLH +G I+HRD+K N+L + N + + DFG
Sbjct: 102 ---VYTEKDASLVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741
++K+ ++ + GT GY+APE + D +S GV+ L+ G P +
Sbjct: 155 LSKME-----QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
Query: 742 D 742
+
Sbjct: 210 E 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 48/235 (20%)
Query: 521 QREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
R + T+ +G G G VY+ +SGE+VA+KK+ DK
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------------LQDKRF 93
Query: 580 KT-EVETLGNIRHKNIVKLYCYFSS-------LYCNLLVYEYMPNGNLWDALHKGLVHLD 631
K E++ + + H NIV+L +F S +Y NL V +Y+P + +++ H
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL-VLDYVP-----ETVYRVARHYS 147
Query: 632 W-----PTRHK--IAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVN-YQPKVADFGI 682
P + + + + LAY+H G I HRDIK N+LLD + K+ DFG
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGS 203
Query: 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
AK L G+ + + + + Y APE + + T+ DV+S G VL EL+ G+
Sbjct: 204 AKQLVR--GEPNVSYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G TV +L + A+K L +R + + + E + + + H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKIL-EKRHIIKENKVPYV------TRERDVMSRLDHP 90
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GL 646
VKLY F LY Y NG L + K + TR F A+ L
Sbjct: 91 FFVKLYFTFQDDEKLY---FGLSYAKNGELLKYIRKIGSFDETCTR----FYTAEIVSAL 143
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
YLH G IIHRD+K NILL+ + ++ DFG AKVL + + GT Y
Sbjct: 144 EYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQY 198
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
++PE A D+++ G ++ +L+ G P N+ +I+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIF 241
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 75/405 (18%), Positives = 143/405 (35%), Gaps = 29/405 (7%)
Query: 41 TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASI-GNVTSLTDLEL 99
+ LS ++N + +L I L++LR++ L+ + + + L L++
Sbjct: 52 PRTKALSLSQN---SISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 100 TGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPE 159
+ N + +I + +LR L+L +N + +E GNLT+LT L +S ++
Sbjct: 108 SHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDL 163
Query: 160 SILRLPKLRVLQLYNNSLS---GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLV 216
+ L + L S GE S+ +TT+ L + NSL +
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 217 VL------DLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD--SLARCKNLLRFRV 268
L D + +L L L L + + +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 269 SNNHLEGSIPEGI-----LSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISG 323
N + I +L + I + F ++ + +
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 324 FIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS--SIPNSLSSLK 381
S ++ + N+ + + G LK+L L+LQ N L + + ++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 382 SLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLSL 424
SL LD+S N L + + C + +N S+N L+G + L
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 80/401 (19%), Positives = 147/401 (36%), Gaps = 32/401 (7%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
PM +LR LDLS N F F NLT L L + K +L + L
Sbjct: 117 CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA---KFRQLDLLPVAHLHLSC 173
Query: 72 IMV-LATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ--- 127
I++ L + + G S+ + T L L + + + L L+L +
Sbjct: 174 ILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLND 232
Query: 128 ---QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRL---PKLRVLQLYNNSLSGEI 181
Q T EL L ++ + + K + + + L +YN +++ I
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292
Query: 182 SSVIANSTTLTMLSLYDNSLTGEVPQDLGQW-----SPLVVLDLSENKLSGPLPAKVCSR 236
+ + SL + +V + + + + LS + VC
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM--VCPP 350
Query: 237 G--KLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEG---ILSLPHVSIID 291
+ QN+F+ + + K L + N L+ + + ++ + +D
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLD 409
Query: 292 LSYNSF-SGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIP 350
+S NS S T A ++ L + N ++G + + + +DL +N + IP
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IP 466
Query: 351 SGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
+ +L+ L L + SN+L S L SL + L +N
Sbjct: 467 KDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 54/351 (15%), Positives = 106/351 (30%), Gaps = 45/351 (12%)
Query: 107 HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI-LRLP 165
H+P L + L L N ++ ++ L+EL L +S N + + + L
Sbjct: 45 HVPK--DLPPRTKALSLSQN-SISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQ 100
Query: 166 KLRVLQLYNNSL----------------------SGEISSVIANSTTLTMLSLYDNSLTG 203
L L + +N L + N T LT L L
Sbjct: 101 DLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 204 EVPQDLGQWS-PLVVLDLSENKLSGPLPAKVCSRG--KLQYFLVLQNMFSGVLPDSLARC 260
+ ++LDL + G + L ++FS + S+
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 261 KNL----LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN---ARNLSE 313
+L ++ N + + P + + L + + + + R +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 314 LFMQRNQISGFIPSEIYRAI-----SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
L + I+ I E + SL+ + + + + ++N+ ML +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
S S L+ + N+ T C L ++ N L
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 45/259 (17%)
Query: 182 SSVIAN-STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240
+ V + LSL NS++ D+ S L VL LS N++ L V
Sbjct: 44 THVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFL----- 97
Query: 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSF-S 298
++L VS+N L+ +I + SL H +DLS+N F
Sbjct: 98 ------------------FNQDLEYLDVSHNRLQ-NISCCPMASLRH---LDLSFNDFDV 135
Query: 299 GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG------ 352
P+ GN L+ L + + + + L I L +L+S I G
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQ-LDLLPVAHLHLSCILL--DLVSYHIKGGETESLQ 192
Query: 353 IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS-NNLLTGYIPESLCELLPNS--- 408
I N L+L+ ++ + + S+++L L + ++ N+ + L EL
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252
Query: 409 -INFSNNRLSGPIPLSLIK 426
+ + + + L +
Sbjct: 253 NVTLQHIETTWKCSVKLFQ 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 57/243 (23%), Positives = 104/243 (42%), Gaps = 30/243 (12%)
Query: 519 FDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK 577
F Q+++ + ++G G V K + ++G A K + ++++ S + +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR----E 60
Query: 578 GLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK 637
++ EV L + H N++ L+ + + +L+ E + G L+D L + + +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF----LAQKESLSEEE 116
Query: 638 IAFGVAQ---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP----KVADFGIAKVLQAR 689
+ Q G+ YLH I H D+K NI+L P K+ DFG+A ++
Sbjct: 117 ATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-- 170
Query: 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKN 748
I GT ++APE + D++S GV+ L++G P F GD K
Sbjct: 171 --DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQ 224
Query: 749 IIY 751
Sbjct: 225 ETL 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G G V + +D + AVK L ++ K+ + + K E++ L +RHKN
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKIL--KKKKLRRIPNGEANV----KKEIQLLRRLRHKN 67
Query: 594 IVKLY--CYFSS---LYCNLLVYEYMPNGN--LWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+++L Y +Y +V EY G + D++ + H + GL
Sbjct: 68 VIQLVDVLYNEEKQKMY---MVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFCQLIDGL 122
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
YLH G I+H+DIK N+LL K++ G+A+ L D+ T G+ +
Sbjct: 123 EYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAF 177
Query: 706 LAPEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDD 742
PE A + K D++S GV L + TG P E D
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
K ++G+G V + + +G A K + K+SA D +L + E +
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKII--NTKKLSARDFQKL------EREARICRKL 85
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAY 648
+H NIV+L+ + LV++ + G L++ + + + + +AY
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAY 143
Query: 649 LH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
H +G I+HR++K N+LL K+ADFG+A + AGT G
Sbjct: 144 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN----DSEAWHGFAGTPG 195
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIYW 752
YL+PE + D+++ GV+L L+ G P F ++++ +Y
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP----FWDEDQHRLYA 240
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/244 (23%), Positives = 103/244 (42%), Gaps = 30/244 (12%)
Query: 518 SFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
+F Q+++ + ++G G V K + ++G A K + K + + +
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFI----KKRQSRASRRGVCR 59
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
+ ++ EV L + H NI+ L+ + + +L+ E + G L+D L + +
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF----LAQKESLSEE 115
Query: 637 KIAFGVAQ---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP----KVADFGIAKVLQA 688
+ + Q G+ YLH I H D+K NI+L P K+ DFG+A ++
Sbjct: 116 EATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 689 RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNK 747
I GT ++APE + D++S GV+ L++G P F GD K
Sbjct: 171 ---DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTK 223
Query: 748 NIIY 751
Sbjct: 224 QETL 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 52/228 (22%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G+G V + + + +G+ A + K+SA D +L + E +
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMII--NTKKLSARDHQKL------EREARICRLL 67
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQGLAY 648
+H NIV+L+ S + L+++ + G L++ + + + + + + +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLH 125
Query: 649 LH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
H G ++HR++K N+LL K+ADFG+A ++ G + + AGT G
Sbjct: 126 CHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFG-FAGTPG 178
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
YL+PE D+++ GV+L L+ G P F ++++ +Y
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP----FWDEDQHRLY 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 69/288 (23%), Positives = 110/288 (38%), Gaps = 63/288 (21%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G G G V+ +D + V VK + ++ KV + + E+ L + H N
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFI--KKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGN-LWDAL-HKGLVHLDWPTRHKIAFGVAQGLAY 648
I+K+ F + LV E +G L+ + LD P I + + Y
Sbjct: 91 IIKVLDIFENQGFFQ---LVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGY 145
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
L IIHRDIK NI++ ++ K+ DFG A L+ RG T GT Y AP
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTF---CGTIEYCAP 198
Query: 709 EY----AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII-------YWVSIKV 757
E Y + +++S GV L L+ P F + + + Y VS
Sbjct: 199 EVLMGNPYRGP---ELEMWSLGVTLYTLVFEENP----FCELEETVEAAIHPPYLVS--- 248
Query: 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ +M ++ ++Q P R T+ ++V
Sbjct: 249 ---KELMSLVSG---------LLQP----------VPERRTTLEKLVT 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 63/288 (21%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK- 592
G GG G+VY I ++ VA+K + ++ ++S D +L + EV L +
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHV--EKDRIS--DWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 593 -NIVKLYCYFSSLYCNLLVYEY-MPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYL 649
+++L +F +L+ E P +L+D + +G L + V + + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHC 165
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
H G ++HRDIK NIL+D+N + K+ DFG +L KD+ T GT Y
Sbjct: 166 HNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDGTRVYSP 216
Query: 708 PEY----AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763
PE+ Y + V+S G++L +++ G P E D
Sbjct: 217 PEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHD--------------------- 252
Query: 764 MEVLDKKLSGSFR------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ + G E ++R C + P+ RPT E+
Sbjct: 253 ----EEIIRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 293
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 55/335 (16%), Positives = 107/335 (31%), Gaps = 39/335 (11%)
Query: 67 LTKLRIMVLATCALHGQIPASI-----GNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121
+ V+ + + + + + L IP GL + ++ L
Sbjct: 6 WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN------SIPS--GLTEAVKSL 57
Query: 122 ELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGE 180
+L N+ + +L L L ++ N ++ I E L L L L N LS
Sbjct: 58 DLSNNR-ITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNL 115
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSGPLPAKVCSR-GK 238
SS ++LT L+L N L L +L + + K +
Sbjct: 116 SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175
Query: 239 LQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSF 297
L+ + + P SL +N+ + + E + V ++L
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDL 234
Query: 298 SGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLK 357
+++S + + + + + ++D L + + +
Sbjct: 235 DTF----------------HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 358 KLNLLMLQSNKLNSSIPNS-LSSLKSLNVLDLSNN 391
L L N+L S+P+ L SL + L N
Sbjct: 278 GLLELEFSRNQL-KSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 59/294 (20%), Positives = 102/294 (34%), Gaps = 47/294 (15%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
++ LDLSNN T S NL+ L N + + E S L L + L+
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN---GINTIEEDSFSSLGSLEHLDLS 108
Query: 77 TCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI--GLLKNLRQLELYYNQQLAGTI 133
L + +S ++SLT L L GN + L L+ L + I
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT-KI 165
Query: 134 PEE-LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLT 192
+ LT L +L++ + L P+S+ + + L L+ + + ++++
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 193 MLSLYDN--------SLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
L L D L+ L + + +++ L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF------------------ 267
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSF 297
+ L + LL S N L+ S+P+GI L + I L N +
Sbjct: 268 -------QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 56/262 (21%), Positives = 101/262 (38%), Gaps = 31/262 (11%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFR-LTKL 70
FS + +L LDLS N + S F L++L L+ N L E+S+F LTKL
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGN---PYKTLGETSLFSHLTKL 151
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQ 128
+I+ + +I +T L +LE+ + + P+ ++N+ L L+ Q
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQH 210
Query: 129 LAGTIPEEL-GNLTELTDLDMSVNHLSGKIPESI--------LRLPKLRVLQLYNNSLSG 179
+ E + + L++ L + ++ R +++ + SL
Sbjct: 211 --ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267
Query: 180 EISSVIANSTTLTMLSLYDNSLTGEVPQD-LGQWSPLVVLDLSENKLSGPLPAKVCSRGK 238
++ ++ + L L N L VP + + L + L N CS +
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW-------DCSCPR 319
Query: 239 LQYFLVLQNMFSGVLPDSLARC 260
+ Y N S S A+C
Sbjct: 320 IDYLSRWLNKNSQKEQGS-AKC 340
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 38/269 (14%), Positives = 93/269 (34%), Gaps = 37/269 (13%)
Query: 158 PESILRLPKLRVLQLYNNSLSGEISSVIAN-STTLTMLSLYDNSLTGEVPQDLGQWSPLV 216
++ L + + + + SL+ S+ + + + L L +N +T DL + L
Sbjct: 24 NQASLSCDRNGICKGSSGSLN----SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQ 79
Query: 217 VLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS 276
L L+ N ++ + FS + +L +S N+L +
Sbjct: 80 ALVLTSNGINT-IEEDS---------------FSSL--------GSLEHLDLSYNYLS-N 114
Query: 277 IPEGILS-LPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEI-YRAI 333
+ L ++ ++L N + + + L L + I +
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
L ++++ + L P + +++ ++ L+L + + + S+ L+L + L
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234
Query: 394 TG----YIPESLCELLPNSINFSNNRLSG 418
+ L F N +++
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITD 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 53/225 (23%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT-EVETLGNIR 590
+G G G V++ + S EV A+KK+ DK K E++ + ++
Sbjct: 47 VIGNGSFGVVFQAKLVESDEV-AIKKV---------------LQDKRFKNRELQIMRIVK 90
Query: 591 HKNIVKLYCYFSS---------LYCNLLVYEYMPNGNLWDALHKGLVHLDW-----PTRH 636
H N+V L +F S L LV EY+P + +++ H P
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLN---LVLEYVP-----ETVYRASRHYAKLKQTMPMLL 142
Query: 637 --KIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGK 692
+ + + LAY+H G I HRDIK N+LLD K+ DFG AK+L G+
Sbjct: 143 IKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGE 196
Query: 693 DSTTTVIAGTYGYLAPEYAY-SSKATTKCDVYSFGVVLMELITGR 736
+ + + + Y APE + ++ TT D++S G V+ EL+ G+
Sbjct: 197 PNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVETL 586
VG+G G V K + ++G +VA+KK S DK +K E++ L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LES-------DDDKMVKKIAMREIKLL 78
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+RH+N+V L Y LV+E++ + + D L LD+ K F +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWY---LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII 134
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
G+ + H H IIHRDIK NIL+ + K+ DFG A+ L A G+ V T
Sbjct: 135 NGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVA--T 187
Query: 703 YGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y APE DV++ G ++ E+ G
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 43/235 (18%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG-N 588
K +G G + I + AVK + + E+E L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP--------------TEEIEILLRY 72
Query: 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH-------KIAFG 641
+H NI+ L + +V E M G L D + + + + F
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--------QKFFSEREASAVLFT 124
Query: 642 VAQGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQP-KVADFGIAKVLQARGGKDSTT 696
+ + + YLH G ++HRD+K +NIL N + ++ DFG AK L+A G T
Sbjct: 125 ITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT- 179
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
T ++APE CD++S GV+L ++TG P + D I
Sbjct: 180 --PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 44/234 (18%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+N +G+G G V + + A KK+ ++ K E+E + ++
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKI----------PKYFVEDVDRFKQEIEIMKSL 63
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQG 645
H NI++LY F + +Y LV E G L++ +HK +I V
Sbjct: 64 DHPNIIRLYETFEDNTDIY---LVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSA 118
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+AY H + HRD+K N L + K+ DFG+A + G
Sbjct: 119 VAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----PGKMMRTKVG 170
Query: 702 TYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
T Y++P+ Y +CD +S GV++ L+ G P F + +
Sbjct: 171 TPYYVSPQVLEGLYG----PECDEWSAGVMMYVLLCGYPP----FSAPTDSEVM 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVETL 586
K+G+G G V+K + ++G++VA+KK S + D +K E+ L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LES-------EDDPVIKKIALREIRML 56
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
++H N+V L F L+ LV+EY + + L + + I +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLH---LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
Q + + H H IHRD+K NIL+ + K+ DFG A++L V T
Sbjct: 113 QAVNFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVA--T 165
Query: 703 YGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y +PE DV++ G V EL++G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 36/234 (15%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G G V K +G+ A K + +R S + + ++ EV L I
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR----EEIEREVNILREI 65
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-- 644
RH NI+ L+ F + + L+ E + G L+D L + T + + Q
Sbjct: 66 RHPNIITLHDIFENKTDVV---LILELVSGGELFDF----LAEKESLTEDEATQFLKQIL 118
Query: 645 -GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP----KVADFGIAKVLQARGGKDSTTTV 698
G+ YLH I H D+K NI+L P K+ DFGIA ++ +
Sbjct: 119 DGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----AGNEFKN 170
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
I GT ++APE + D++S GV+ L++G P F G+ K
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGETKQETL 220
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 68/290 (23%), Positives = 110/290 (37%), Gaps = 65/290 (22%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL----GNI 589
G+GG GTV+ L VA+K + R +V EV L
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVI--PRNRVLGWSPLSDS--VTCPLEVALLWKVGAGG 95
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEY-MPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLA 647
H +++L +F + +LV E +P +L+D + KG L V +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQ 153
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNYQP-KVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+ H G ++HRDIK NIL+D+ K+ DFG +L D T GT Y
Sbjct: 154 HCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALL-----HDEPYTDFDGTRVY 204
Query: 706 LAPEY----AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761
PE+ Y + V+S G++L +++ G P E D
Sbjct: 205 SPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERD------------------- 242
Query: 762 GIMEVLDKKLSGSFR------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ L + ++R RC + P++RP++ E++
Sbjct: 243 ------QEILEAELHFPAHVSPDCCALIR---RCLAPKPSSRPSLEEILL 283
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/263 (23%), Positives = 101/263 (38%), Gaps = 48/263 (18%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HK 592
G+G V I+L + + AVK + + + + EVE L + H+
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKII----------EKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 593 NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH-------KIAFGVAQG 645
N+++L +F LV+E M G++ +HK RH + VA
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--------RRHFNELEASVVVQDVASA 123
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNYQP---KVADFGIAKVLQARGGKDSTTTV--- 698
L +LH G I HRD+K NIL + Q K+ DF + ++ G +T
Sbjct: 124 LDFLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 699 -IAGTYGYLAPE-----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
G+ Y+APE +S +CD++S GV+L L++G P F
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGSDCG 235
Query: 753 VSIKVDTKEGIMEVLDKKLSGSF 775
+ + G +
Sbjct: 236 WDRGEACPACQNMLFESIQEGKY 258
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLKT----EVET 585
K+G+G GTV+K + + E+VA+K++ +L D G+ + E+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-------------RLDDDDEGVPSSALREICL 54
Query: 586 LGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
L ++HKNIV+L+ L LV+E+ +L LD F +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLT---LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
+GL + H ++HRD+K N+L++ N + K+A+FG+A+ + + V+
Sbjct: 111 LKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV-- 163
Query: 702 TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKP 738
T Y P+ + +K +T D++S G + EL +P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G G G V +G VAVK L R K+ + D + +K E++ L RH +
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLD-----VVGKIKREIQNLKLFRHPH 72
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYL 649
I+KLY S+ + +V EY+ G L+D + G ++ ++ + + Y
Sbjct: 73 IIKLYQVISTPTDFF---MVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYC 127
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H H ++HRD+K N+LLD + K+ADFG++ + + G T+ G+ Y AP
Sbjct: 128 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTS---CGSPNYAAP 179
Query: 709 E------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
E YA + D++S GV+L L+ G P +D+
Sbjct: 180 EVISGRLYAGP-----EVDIWSCGVILYALLCGTLPFDDE 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 62/307 (20%), Positives = 94/307 (30%), Gaps = 42/307 (13%)
Query: 129 LAGTIPEELGNLTELTDLDMSVN-HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIA- 186
L E G L L V+ I++ L+ L + + I
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 187 --NSTTLTMLSLYDNSLTGEVPQDLGQ--WSPLVVLDLSENKLSGPLPAKVCSRGKLQYF 242
+ L L+L + +TG P L + L +L+L +
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA------------ 138
Query: 243 LVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI- 301
+ L L L ++ H E + P +S +DLS N G
Sbjct: 139 ------WLAELQQWLK--PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 302 ---ANTVGNARNLSELFMQRNQ---ISGFIPSEIYRAISLVKIDLSDNLLSG-PIPSGIG 354
A L L ++ SG + + L +DLS N L
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 355 NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFS 412
+LN L L L +P L + L+VLDLS N L P LP +++
Sbjct: 251 WPSQLNSLNLSFTGL-KQVPKGLPA--KLSVLDLSYNRLDR-NPSPDE--LPQVGNLSLK 304
Query: 413 NNRLSGP 419
N
Sbjct: 305 GNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 60/305 (19%), Positives = 93/305 (30%), Gaps = 62/305 (20%)
Query: 7 TGTLPDFSPMQNLRRLDLSNNLFTGQFP---LSVFNLTNLEVLSFNENPGFKLWKLPESS 63
G D +L+RL + + L V ++ L+ L+ ++
Sbjct: 58 LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENL---EVTGTAPPP 114
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
+ T + +L ++ NV+ T L L+ L +
Sbjct: 115 LLEATGPDLNIL-----------NLRNVSWATRDAWLAELQQ-------WLKPGLKVLSI 156
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI----LRLPKLRVLQLYNN---S 176
E++ L+ LD+S N G+ L+ P L+VL L N +
Sbjct: 157 AQA-HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSGPLPAKVCS 235
SG S++ A L L L NSL W L L+LS L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-------- 267
Query: 236 RGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYN 295
+P L L +S N L+ P LP V + L N
Sbjct: 268 -----------------VPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGN 306
Query: 296 SFSGP 300
F
Sbjct: 307 PFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 46/235 (19%), Positives = 75/235 (31%), Gaps = 19/235 (8%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLT--NLEVLSFNEN--PGFKLWKLPE 61
+ + L+ L L N TG P + T +L +L+ W L E
Sbjct: 84 ILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW-LAE 142
Query: 62 SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL----LKN 117
+ L+++ +A + +L+ L+L+ N G L
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
Query: 118 LRQLELYYNQ--QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI-LRLPKLRVLQLYN 174
L+ L L +G +L LD+S N L +L L L
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262
Query: 175 NSLSGEISSVIANSTTLTMLSLYDNSLTG-EVPQDLGQWSPLVVLDLSENKLSGP 228
L ++ + L++L L N L P +L Q + L L N
Sbjct: 263 TGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELPQ---VGNLSLKGNPFLDS 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 30/230 (13%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
++ D + + + + +G+G TVYK D N+ ++VA+KK+ K+ +
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRS----EA 51
Query: 576 DKGLKT----EVETLGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLV 628
G+ E++ L + H NI+ L F S++ LV+++M +L + +
Sbjct: 52 KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS---LVFDFMET-DLEVIIKDNSL 107
Query: 629 HLDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ 687
L QGL YLH H I+HRD+K N+LLD N K+ADFG+AK
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
Query: 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
+ + T V+ T Y APE + ++ D+++ G +L EL+
Sbjct: 164 S-PNRAYTHQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 530 EKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN 588
++G+G V + I ++G+ A K L ++ + ++ E+ L
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEI------LHEIAVLEL 84
Query: 589 IRH-KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQ-- 644
+ ++ L+ + + +L+ EY G ++ + + + + + + Q
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVIRLIKQIL 141
Query: 645 -GLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
G+ YLH + I+H D+K NILL K+ DFG+++ + G I
Sbjct: 142 EGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----GHACELREI 193
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
GT YLAPE TT D+++ G++ L+T P F G++ Y
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP----FVGEDNQETY 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 55/270 (20%), Positives = 105/270 (38%), Gaps = 33/270 (12%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLN 548
+ T + F + + +L+ ++G G G V++ +
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608
+G A K + SD + + + E++T+ +RH +V L+ F +
Sbjct: 181 TGNNFAAKFV----MTPHESDKETV------RKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLH-HGLLSPIIHRDIKS 664
++YE+M G L++ + + + + + Q GL ++H + +H D+K
Sbjct: 231 MIYEFMSGGELFEKVADEHNKM---SEDEAVEYMRQVCKGLCHMHENN----YVHLDLKP 283
Query: 665 TNILLDVNYQP--KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDV 722
NI+ K+ DFG+ L + V GT + APE A D+
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLD----PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 339
Query: 723 YSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
+S GV+ L++G P F G+N +
Sbjct: 340 WSVGVLSYILLSGLSP----FGGENDDETL 365
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 56/253 (22%), Positives = 99/253 (39%), Gaps = 50/253 (19%)
Query: 526 EAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE 584
+ + +G+G K + S + AVK + + + + E+
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEAN-----------TQKEIT 57
Query: 585 TLGNIR-HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH------- 636
L H NIVKL+ F LV E + G L++ + K +H
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--------KKHFSETEAS 109
Query: 637 KIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGK 692
I + ++++H G ++HRD+K N+L + N + K+ DFG A++
Sbjct: 110 YIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
T T Y APE + CD++S GV+L +++G+ P F +
Sbjct: 166 LKT---PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP----FQSHDR---- 214
Query: 753 VSIKVDTKEGIME 765
S+ + IM+
Sbjct: 215 -SLTCTSAVEIMK 226
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 58/267 (21%), Positives = 94/267 (35%), Gaps = 41/267 (15%)
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTT 190
+P+ + + L++ N++ I R L L VLQL NS+ +
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS 124
Query: 191 LTMLSLYDNSLTG---EVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247
L L L+DN LT + L + L L L N +
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSK---LRELWLRNNPI---------------------- 159
Query: 248 MFSGVLPDSLARCKNLLRFRVS-NNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTV 305
+ + R +L+R + LE I EG L ++ ++L + +
Sbjct: 160 --ESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKDM--PNL 214
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG-IGNLKKLNLLML 364
L EL M N P + SL K+ + ++ +S I L L L L
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNL 273
Query: 365 QSNKLNSSIPNSLSSLKSLNVLDLSNN 391
N L+S + + L+ L L L +N
Sbjct: 274 AHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 63/254 (24%), Positives = 95/254 (37%), Gaps = 23/254 (9%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
F + +L L L N Q + F L +L L +N L +P + L+KL
Sbjct: 94 TFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN---WLTVIPSGAFEYLSKL 149
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTG-NFITGHIPPEI-GLLKNLRQLELYYNQ 127
R + L + IP+ V SL L+L + +I L NL+ L L
Sbjct: 150 RELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCN 207
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIAN 187
+ +P L L L +L+MS NH P S L L+ L + N+ +S +
Sbjct: 208 -IK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264
Query: 188 STTLTMLSLYDNSLTGEVPQD-LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ 246
+L L+L N+L+ +P D LV L L N P C + +
Sbjct: 265 LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN----PW---NCDC-DILWLAWWL 315
Query: 247 NMFSGVLPDSLARC 260
+ RC
Sbjct: 316 REYIPTNSTCCGRC 329
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 56/326 (17%), Positives = 105/326 (32%), Gaps = 84/326 (25%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
+ + T ++ +P G+ N R L L N + + +L L L + N
Sbjct: 55 QFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNS 110
Query: 153 LSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ 211
+ +I L L L+L++N L+ + + L +
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT---------------------VIPSGAFEYLSK 148
Query: 212 WSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN- 270
L L L N + + + R +L+R +
Sbjct: 149 ---LRELWLRNNPIES------------------------IPSYAFNRVPSLMRLDLGEL 181
Query: 271 NHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY 330
LE I EG NL L + I +P+ +
Sbjct: 182 KKLE-YISEGAFE-----------------------GLFNLKYLNLGMCNIK-DMPN-LT 215
Query: 331 RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390
+ L ++++S N P L L L + +++++ N+ L SL L+L++
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275
Query: 391 NLLTGYIPESLCELLPN--SINFSNN 414
N L+ +P L L ++ +N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 11/212 (5%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
N R L+L N + +L +LEVL N + ++ + L L + L
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN---SIRQIEVGAFNGLASLNTLELFD 132
Query: 78 CALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
L IP+ ++ L +L L N I IP + +L +L+L ++L I E
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISE 189
Query: 136 E-LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTML 194
L L L++ + ++ +P ++ L L L++ N ++L L
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
+ ++ ++ + LV L+L+ N LS
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 21/96 (21%), Positives = 42/96 (43%), Gaps = 7/96 (7%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRL 67
+P+ +P+ L L++S N F + F L++L+ L + ++ + ++ L
Sbjct: 210 DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNS---QVSLIERNAFDGL 265
Query: 68 TKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGN 102
L + LA L +P + + L +L L N
Sbjct: 266 ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 65/291 (22%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G G V ++ + E VAVK + + + + +K E+ + H+N
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIV--DMKRA-------VDCPENIKKEICINKMLNHEN 66
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHK----IAFGVAQ 644
+VK Y + Y L EY G L+D + G+ D + +A
Sbjct: 67 VVKFYGHRREGNIQY---LFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMA----- 116
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS--TTTVIAG 701
G+ YLH G I HRDIK N+LLD K++DFG+A V + ++ G
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMC--G 169
Query: 702 TYGYLAPE----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757
T Y+APE + ++ DV+S G+VL ++ G P + + W
Sbjct: 170 TLPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---- 222
Query: 758 DTKEGIMEVLDKKLSGSFRD---EMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ KK+ + +++ +P+ R T+ ++ +
Sbjct: 223 --EKKTYLNPWKKIDSAPLALLHKILVE----------NPSARITIPDIKK 261
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 36/234 (15%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G G V K + ++G A K + +RTK S + + ++ EV L I
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEI 71
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-- 644
+H N++ L+ + + + L+ E + G L+D L + T + + Q
Sbjct: 72 QHPNVITLHEVYENKTDVI---LILELVAGGELFDF----LAEKESLTEEEATEFLKQIL 124
Query: 645 -GLAYLH-HGLLSPIIHRDIKSTNILL----DVNYQPKVADFGIAKVLQARGGKDSTTTV 698
G+ YLH I H D+K NI+L + K+ DFG+A + +
Sbjct: 125 NGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKN 176
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
I GT ++APE + D++S GV+ L++G P F GD K
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETL 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+G G V++ ++ +S + K + KV +D + K E+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFV-----KVKGTDQVLV------KKEISILNIA 58
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GL 646
RH+NI+ L+ F S+ ++++E++ ++++ ++ L +I V Q L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL---NEREIVSYVHQVCEAL 115
Query: 647 AYLH-HGLLSPIIHRDIKSTNILL--DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
+LH H I H DI+ NI+ + K+ +FG A+ L+ ++
Sbjct: 116 QFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRLLFTAP 167
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
Y APE +T D++S G ++ L++G P F + I
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQII 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL-KT---EVETL 586
+K+G+G TVYK + +VA+K++ +L+ ++G T EV L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-------------RLEHEEGAPCTAIREVSLL 54
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+++H NIV L+ SL LV+EY+ +L L ++ F +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLT---LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
+GLAY H ++HRD+K N+L++ + K+ADFG+A+ K V+ T
Sbjct: 111 RGLAYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVV--T 163
Query: 703 YGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y P+ S +T+ D++ G + E+ TGR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 33/229 (14%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G G G V++ ++ +G V K + D + K E+ + +
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFI----NTPYPLDKYTV------KNEISIMNQL 105
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GL 646
H ++ L+ F Y +L+ E++ G L+D + + + ++ + Q GL
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMRQACEGL 162
Query: 647 AYLH-HGLLSPIIHRDIKSTNILL--DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
++H H I+H DIK NI+ K+ DFG+A L D V T
Sbjct: 163 KHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLN----PDEIVKVTTATA 214
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
+ APE D+++ GV+ L++G P F G++
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETL 259
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 65/291 (22%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G G V ++ + E VAVK + + + + +K E+ + H+N
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIV--DMKRA-------VDCPENIKKEICINKMLNHEN 66
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDAL--HKGLVHLDWPTRHK----IAFGVAQ 644
+VK Y + Y L EY G L+D + G+ + + +A
Sbjct: 67 VVKFYGHRREGNIQY---LFLEYCSGGELFDRIEPDIGMP--EPDAQRFFHQLMA----- 116
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS--TTTVIAG 701
G+ YLH G I HRDIK N+LLD K++DFG+A V + ++ G
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMC--G 169
Query: 702 TYGYLAPE----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757
T Y+APE + ++ DV+S G+VL ++ G P + + W
Sbjct: 170 TLPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---- 222
Query: 758 DTKEGIMEVLDKKLSGSFRD---EMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ KK+ + +++ +P+ R T+ ++ +
Sbjct: 223 --EKKTYLNPWKKIDSAPLALLHKILVE----------NPSARITIPDIKK 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 40/240 (16%)
Query: 512 KSFHRIS-FDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSAS 568
+F+ + D +L+ +G G G V D VA+KKL ++ +
Sbjct: 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL----SRPFQN 64
Query: 569 DTDQLQLDKGLKTEVETLGNIRHKNIVKLY---------CYFSSLYCNLLVYEYMPNGNL 619
T K E+ + + HKNI+ L F +Y +V E M NL
Sbjct: 65 QTHA----KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY---IVMELMDA-NL 116
Query: 620 WDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676
+ L ++++ + Q G+ +LH IIHRD+K +NI++ + K
Sbjct: 117 CQVIQMEL------DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167
Query: 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
+ DFG+A+ G T T Y APE D++S G ++ E+I G
Sbjct: 168 ILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 40/240 (16%)
Query: 512 KSFHRIS-FDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSAS 568
F+ + D +L+ +G G G V D VA+KKL ++ +
Sbjct: 46 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL----SRPFQN 101
Query: 569 DTDQLQLDKGLKTEVETLGNIRHKNIVKLY---------CYFSSLYCNLLVYEYMPNGNL 619
T K E+ + + HKNI+ L F +Y LV E M NL
Sbjct: 102 QTHA----KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY---LVMELMDA-NL 153
Query: 620 WDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676
+ L ++++ + Q G+ +LH IIHRD+K +NI++ + K
Sbjct: 154 CQVIQMEL------DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 204
Query: 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
+ DFG+A+ G T T Y APE D++S G ++ E++ +
Sbjct: 205 ILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLKT----EVET 585
K+GQG G V+K +G+ VA+KK+ ++ +K G E++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-------------LMENEKEGFPITALREIKI 69
Query: 586 LGNIRHKNIVKLY-----------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
L ++H+N+V L S+Y LV+++ + +L L LV
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIY---LVFDFCEH-DLAGLLSNVLVKFTLSE 125
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK---VLQARGG 691
++ + GL Y+H + I+HRD+K+ N+L+ + K+ADFG+A+ + +
Sbjct: 126 IKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
T V+ T Y PE + D++ G ++ E+ T
Sbjct: 183 NRYTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 13/211 (6%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+R+ L N + S NL +L + N L ++ ++ L L + L+
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSN---VLARIDAAAFTGLALLEQLDLSD 89
Query: 78 CALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
A + + + L L L + + P + L L+ L L N L +P+
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA-LQ-ALPD 146
Query: 136 E-LGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTM 193
+ +L LT L + N +S +PE R L L L L+ N ++ + L
Sbjct: 147 DTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 194 LSLYDNSLTGEVPQD-LGQWSPLVVLDLSEN 223
L L+ N+L+ +P + L L L L++N
Sbjct: 206 LYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 61/266 (22%)
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTT 190
+P + + + N +S +P + R L +L L++N L+ ++
Sbjct: 25 AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 191 LTMLSLYDNSLTGEVP----QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ 246
L L L DN+ V LG+ L L L L L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGR---LHTLHLDRCGLQE-LG---------------- 121
Query: 247 NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTV 305
P L + +N L+ ++P+ L +++ + L N S
Sbjct: 122 -------PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
+L L + +N+++ + +R +L +L L L
Sbjct: 174 RGLHSLDRLLLHQNRVA-HVHPHAFR-----------------------DLGRLMTLYLF 209
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNN 391
+N L++ +L+ L++L L L++N
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 13/170 (7%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
F+ + L +LDLS+N + F L L L + L +L L L+
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC---GLQELGPGLFRGLAALQ 132
Query: 72 IMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQL 129
+ L AL +P ++ +LT L L GN I+ +P L +L +L L+ N ++
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQN-RV 189
Query: 130 AGTIPEE-LGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSL 177
A + +L L L + N+LS +P L L L+ L+L +N
Sbjct: 190 A-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 47/262 (17%), Positives = 85/262 (32%), Gaps = 56/262 (21%)
Query: 157 IPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLV 216
+P I + + L+ N +S ++ LT+L L+ N L + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 217 VLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS 276
LDLS+N + P + L + L+
Sbjct: 84 QLDLSDNAQLRSVD-----------------------PATFHGLGRLHTLHLDRCGLQ-E 119
Query: 277 IPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRA-ISL 335
+ G+ L L++Q N + +P + +R +L
Sbjct: 120 LGPGLFR-----------------------GLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155
Query: 336 VKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394
+ L N +S +P L L+ L+L N++ P++ L L L L N L+
Sbjct: 156 THLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 395 GYIPESLCELLPN--SINFSNN 414
+P L + ++N
Sbjct: 215 -ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 325 IPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLN 384
+P I + +I L N +S + + L +L L SN L + + L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 385 VLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
LDLS+N + + L +++ L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 9/98 (9%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIF 65
LPD F + NL L L N + P F L +L+ L ++N ++ + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQN---RVAHVHPHAFR 198
Query: 66 RLTKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGN 102
L +L + L L +P + +L L L N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 31/295 (10%), Positives = 72/295 (24%), Gaps = 86/295 (29%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
G ++ +D VA+ + Q D LQ + L I
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQ----GVLPDDVLQE---TLSRTLRLSRIDK 90
Query: 592 KNIVKLY--------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+ ++ +V E++ G+L + + +A
Sbjct: 91 PGVARVLDVVHTRAGGL--------VVAEWIRGGSLQEVADTSP---SPVGAIRAMQSLA 139
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
H G + + + + ++ +A
Sbjct: 140 AAADAAHRAG----VALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762
+ A + D+ G L L+ R P+ +
Sbjct: 175 --TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA----------------GVRS 209
Query: 763 IMEVLDKKLSG------SFRDEMIQVLR-IAIRCTSKSPATRPTMNEVVQLLAEA 810
+ ++ +G ++ + +A R R ++ L+ +A
Sbjct: 210 GLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQA 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 528 MTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+++ +G G G V+K + +G +A K + T ++ + +K E+ +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKII----------KTRGMKDKEEVKNEISVM 140
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ-- 644
+ H N+++LY F S +LV EY+ G L+D + +L T + Q
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL---TELDTILFMKQIC 197
Query: 645 -GLAYLH-HGLLSPIIHRDIKSTNILL--DVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
G+ ++H I+H D+K NIL Q K+ DFG+A+ + V
Sbjct: 198 EGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK----PREKLKVNF 249
Query: 701 GTYGYLAPE---YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
GT +LAPE Y + S D++S GV+ L++G P F GDN
Sbjct: 250 GTPEFLAPEVVNYDFVSFP---TDMWSVGVIAYMLLSGLSP----FLGDNDAETL 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 40/229 (17%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++++G+G + VY+ + + A+K L + V ++TE+ L +
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVL---KKTVDKKI---------VRTEIGVLLRL 105
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQ- 644
H NI+KL F + + LV E + G L+D + KG + + A V Q
Sbjct: 106 SHPNIIKLKEIFETPTEIS---LVLELVTGGELFDRIVEKG--YY---SERDAADAVKQI 157
Query: 645 --GLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTV 698
+AYLH +G I+HRD+K N+L + K+ADFG++K+++
Sbjct: 158 LEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE----HQVLMKT 209
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747
+ GT GY APE + D++S G++ L+ G +P D+ GD
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-22
Identities = 51/263 (19%), Positives = 85/263 (32%), Gaps = 33/263 (12%)
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTL 191
+P+ + T L++ N + S L L +LQL N + L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251
L L+DN LT S L L L N +
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI------------------------ES 150
Query: 252 VLPDSLARCKNLLRFRVS-NNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNAR 309
+ + R +L R + L I EG L ++ ++L+ + +
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLI 207
Query: 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG-IGNLKKLNLLMLQSNK 368
L EL + N +S P + L K+ + + + I NL+ L + L N
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNN 266
Query: 369 LNSSIPNSLSSLKSLNVLDLSNN 391
L + + L L + L +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 6e-22
Identities = 62/254 (24%), Positives = 98/254 (38%), Gaps = 23/254 (9%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
F +++L L LS N + F L NL L +N +L +P + L+KL
Sbjct: 83 SFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN---RLTTIPNGAFVYLSKL 138
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTG-NFITGHIPPEI-GLLKNLRQLELYYNQ 127
+ + L + IP+ + SL L+L ++ +I L NLR L L
Sbjct: 139 KELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCN 196
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIA 186
L IP L L +L +LD+S NHLS I + L L+ L + + + +
Sbjct: 197 -LR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252
Query: 187 NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ 246
N +L ++L N+LT L + L N P C+ + +
Sbjct: 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN----PW---NCNC-DILWLSWWI 304
Query: 247 NMFSGVLPDSLARC 260
+ ARC
Sbjct: 305 KDMAPSNTACCARC 318
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-22
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 37/278 (13%)
Query: 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201
+ + + +L ++P+ I R+L L+ N + + + L +L L N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 202 TGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCK 261
+ L L+L +N+L+ +P F L
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTT-IPN---------------GAFVY-LS------- 136
Query: 262 NLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLS-YNSFSGPIANTVGNARNLSELFMQRN 319
L + NN +E SIP + +P + +DL S NL L +
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 320 QISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLS 378
+ IP+ + I L ++DLS N LS I G L L L + +++ N+
Sbjct: 196 NLR-EIPN-LTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252
Query: 379 SLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNN 414
+L+SL ++L++N LT +P L L + I+ +N
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
N R L+L N S +L +LE+L + N + + + L L + L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN---HIRTIEIGAFNGLANLNTLELFD 121
Query: 78 CALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
L IP ++ L +L L N I IP + +LR+L+L ++L+ I E
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISE 178
Query: 136 E-LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTML 194
L+ L L++++ +L +IP ++ L KL L L N LS L L
Sbjct: 179 GAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
+ + + LV ++L+ N L+
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 7/96 (7%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRL 67
+P+ +P+ L LDLS N + F L +L+ L ++ ++ + ++ L
Sbjct: 199 EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQS---QIQVIERNAFDNL 254
Query: 68 TKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGN 102
L + LA L +P + + L + L N
Sbjct: 255 QSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLKT----EVETL 586
K+G+G G VYK N GE A+KK+ +L+ + G+ + E+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI-------------RLEKEDEGIPSTTIREISIL 54
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
++H NIVKLY L LV+E++ +L L L+ T +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLV---LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
G+AY H ++HRD+K N+L++ + K+ADFG+A+ + T ++ T
Sbjct: 111 NGIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIV--T 163
Query: 703 YGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y AP+ SK +T D++S G + E++ G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT----EVETL 586
K+G G TVYK ++ +G VA+K++ +L ++G + E+ +
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV-------------KLDSEEGTPSTAIREISLM 57
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPN--GNLWDALHKGLVHLDWPTRH--KIA 639
++H+NIV+LY + L LV+E+M N D+ G
Sbjct: 58 KELKHENIVRLYDVIHTENKLT---LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ + QGLA+ H I+HRD+K N+L++ Q K+ DFG+A+ ++ V+
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVV 170
Query: 700 AGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
T Y AP+ S+ +T D++S G +L E+ITG+
Sbjct: 171 --TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G V + + +G+V A+K + ++ + + + E + L N +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIM-NKWDMLKRGEVSCF------REERDVLVNGDRR 121
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP-TRHKIAFGVAQGLAY 648
I +L+ F + LY LV EY G+L L K + R +A + +
Sbjct: 122 WITQLHFAFQDENYLY---LVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDS 177
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+H G +HRDIK NILLD ++ADFG L+A G S V GT YL+
Sbjct: 178 VHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV--GTPDYLS 231
Query: 708 PE-------YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
PE + +CD ++ GV E+ G+ P + D+ Y
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF---YADSTAETY 279
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 43/222 (19%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G G G D + E+VAVK + +R +D+ ++ E+ ++RH N
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYI--ERGAA---------IDENVQREIINHRSLRHPN 77
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTR--HKIAFGVAQGLA 647
IV+ + L ++ EY G L++ + + G D ++ GV +
Sbjct: 78 IVRFKEVILTPTHLA---IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV----S 130
Query: 648 YLH-HGLLSPIIHRDIKSTNILLDVNYQP--KVADFGIAKVLQARGGKDSTTTVIAGTYG 704
Y H I HRD+K N LLD + P K+ DFG +K + +T GT
Sbjct: 131 YCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST---VGTPA 182
Query: 705 YLAPE----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
Y+APE Y K DV+S GV L ++ G P ED
Sbjct: 183 YIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDP 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 45/251 (17%)
Query: 515 HRISFDQREILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQL 573
++FD EIL A +G+G G V + N + ++ A+K + K + +++
Sbjct: 10 EDVNFDHFEILRA------IGKGSFGKVCIVQKNDTKKMYAMKYM----NKQKCVERNEV 59
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHL 630
+ + E++ + + H +V L+ F ++ +V + + G+L HL
Sbjct: 60 ---RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF---MVVDLLLGGDL-------RYHL 106
Query: 631 DWPTR---HKIAFGVAQ---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683
+ + + L YL IIHRD+K NILLD + + DF IA
Sbjct: 107 QQNVHFKEETVKLFICELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIA 162
Query: 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVE 740
+L +++ T +AGT Y+APE S K + D +S GV EL+ GR+P
Sbjct: 163 AMLP----RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218
Query: 741 DDFGDNKNIIY 751
+ I
Sbjct: 219 IRSSTSSKEIV 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 70/273 (25%), Positives = 110/273 (40%), Gaps = 46/273 (16%)
Query: 492 QRAITEPDETLSSSFFPYDVKSFHRISFDQREILEA--MTEKN----KV-GQGGSGTVYK 544
Q + L + F + S + + F Q + LEA M E +V G+GG G V+
Sbjct: 144 QPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFA 203
Query: 545 IDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF-- 601
+ +G++ A KKL K +G E + L + + IV L F
Sbjct: 204 CQMKATGKLYACKKL---NKKRLKKRKGY----QGAMVEKKILAKVHSRFIVSLAYAFET 256
Query: 602 -SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG----------VAQGLAYLH 650
+ L LV M G++ H+ F + GL +LH
Sbjct: 257 KTDLC---LVMTIMNGGDI-------RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 651 -HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE 709
II+RD+K N+LLD + +++D G+A + + G+ T AGT G++APE
Sbjct: 307 QRN----IIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKG-YAGTPGFMAPE 359
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
+ D ++ GV L E+I R P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GLKT----EVETL 586
KVG+G G VYK + G +VA+K++ +L + G+ + E+ L
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI-------------RLDAEDEGIPSTAIREISLL 73
Query: 587 GNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+ H NIV L L LV+E+M +L L + L + +
Sbjct: 74 KELHHPNIVSLIDVIHSERCLT---LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
+G+A+ H H I+HRD+K N+L++ + K+ADFG+A+ + T V+ T
Sbjct: 130 RGVAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV--T 182
Query: 703 YGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
Y AP+ SK +T D++S G + E+ITG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + L N+ +V A+K L ++ + ++T + E + L N K
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACF------REERDVLVNGDSK 134
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GL 646
I L+ F ++LY LV +Y G+L L K L F +A+ +
Sbjct: 135 WITTLHYAFQDDNNLY---LVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVIAI 188
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+H +HRDIK NIL+D+N ++ADFG L G S+ V GT Y
Sbjct: 189 DSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDY 242
Query: 706 LAPE-----YAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
++PE + +CD +S GV + E++ G P + ++ Y
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETY 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 35/219 (15%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G G G V +G VAVK L R K+ + D + ++ E++ L RH +
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKIL--NRQKIRSLD-----VVGKIRREIQNLKLFRHPH 77
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHK---IAFGVAQGL 646
I+KLY S+ ++ +V EY+ G L+D + G + +R I GV
Sbjct: 78 IIKLYQVISTPSDIF---MVMEYVSGGELFDYICKNGRLDEK-ESRRLFQQILSGVD--- 130
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
Y H H ++HRD+K N+LLD + K+ADFG++ + + G T+ G+ Y
Sbjct: 131 -YCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTS---CGSPNY 181
Query: 706 LAPEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDD 742
APE S + A + D++S GV+L L+ G P +DD
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 58/285 (20%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593
G+G G V + + VA+K + R + SD + ++ E+ L +RH +
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSD-----MHMRVEREISYLKLLRHPH 70
Query: 594 IVKLYCYFSS---LYCNLLVYEYMPNGNLWDAL-HKGLVHLDWPTRHKIAFGVAQGLAYL 649
I+KLY ++ + +V EY G L+D + K + + + + Y
Sbjct: 71 IIKLYDVITTPTDIV---MVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYC 124
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H H I+HRD+K N+LLD N K+ADFG++ + G T+ G+ Y AP
Sbjct: 125 HRHK----IVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTS---CGSPNYAAP 176
Query: 709 EYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766
E + K A + DV+S G+VL ++ GR P +D E I +
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-------------------EFIPNL 216
Query: 767 LDKKLSGSFR------DEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
K S + ++R R P R T+ E+ +
Sbjct: 217 FKKVNSCVYVMPDFLSPGAQSLIR---RMIVADPMQRITIQEIRR 258
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 35/219 (15%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG-N 588
K +G G +G V + +G+ A+K L D+ + EV+
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLL---------YDS------PKARQEVDHHWQA 78
Query: 589 IRHKNIVKLYCYFSSLY----CNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVA 643
+IV + + +++ C L++ E M G L+ +G +I +
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 644 QGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ +LH H I HRD+K N+L + + K+ DFG AK T
Sbjct: 139 TAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQT---P 189
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
T Y+APE K CD++S GV++ L+ G P
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 72/273 (26%), Positives = 110/273 (40%), Gaps = 40/273 (14%)
Query: 487 RRFSKQRAITEPDETLSSSFFP-YDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKI 545
++ S+Q ++ E F ++ S + DQ + ++ +G G G V +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT------LGTGSFGRVMLV 60
Query: 546 -DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF--- 601
SG A+K L K Q++ E L + +VKL F
Sbjct: 61 KHKESGNHYAMKIL----DKQKVVKLKQIE---HTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPII 658
S+LY +V EY+ G ++ L + + R F AQ YLH +I
Sbjct: 114 SNLY---MVMEYVAGGEMFSHLRRIGRFSEPHAR----FYAAQIVLTFEYLHS---LDLI 163
Query: 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATT 718
+RD+K N+L+D +V DFG AK + K T T + GT LAPE S
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWT-LCGTPEALAPEIILSKGYNK 217
Query: 719 KCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
D ++ GV++ E+ G P F D IY
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF---FADQPIQIY 247
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 44/242 (18%)
Query: 512 KSFHRIS-FDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSAS 568
F+R E+ + VG G G V +D +G VA+KKL + S
Sbjct: 9 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL----YRPFQS 64
Query: 569 DTDQLQLDKGLKTEVETLGNIRHKNIVKLY---------CYFSSLYCNLLVYEYMPNGNL 619
+ K E+ L ++RH+N++ L F+ Y LV +M
Sbjct: 65 ELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY---LVMPFM----- 112
Query: 620 WDA-LHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675
L K L+ + +I F V Q GL Y+H IIHRD+K N+ ++ + +
Sbjct: 113 -GTDLGK-LMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 167
Query: 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELIT 734
K+ DFG+ AR T + T Y APE + T D++S G ++ E+IT
Sbjct: 168 KILDFGL-----ARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
Query: 735 GR 736
G+
Sbjct: 222 GK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 534 VGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + ++ +V A+K L S+ + SD+ E + +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFF------WEERDIMAFANSP 129
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
+V+L+ F LY +V EYMP G+L + + V W R A V L +
Sbjct: 130 WVVQLFYAFQDDRYLY---MVMEYMPGGDLVNLMSNYDVPEKW-ARFYTA-EVVLALDAI 184
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H G IHRD+K N+LLD + K+ADFG + G T V GT Y++P
Sbjct: 185 HSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPDYISP 238
Query: 709 EYAYSSKATTK----CDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
E S CD +S GV L E++ G P + D+ Y
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVGTY 282
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 43/241 (17%)
Query: 512 KSFHRIS-FDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSAS 568
K F++ E+ + VG G G+V ID SGE VA+KKL ++ S
Sbjct: 8 KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQS 63
Query: 569 DTDQLQLDKGLKTEVETLGNIRHKNIVKLY---------CYFSSLYCNLLVYEYMPNGNL 619
+ K E+ L +++H+N++ L F Y LV +M +L
Sbjct: 64 EIFA----KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY---LVMPFMQT-DL 115
Query: 620 WDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676
+ + KI + V Q GL Y+H ++HRD+K N+ ++ + + K
Sbjct: 116 QKIMGLKF------SEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 166
Query: 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITG 735
+ DFG+ AR T + T Y APE S D++S G ++ E++TG
Sbjct: 167 ILDFGL-----ARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 736 R 736
+
Sbjct: 221 K 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-21
Identities = 62/258 (24%), Positives = 96/258 (37%), Gaps = 78/258 (30%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+ +G G G V + D+ SG+ A+KK+ LQ + E++ +
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKV--------------LQDPRYKNRELDIMK 55
Query: 588 NIRHKNIVKLYCYFSS---------------------------------------LYCNL 608
+ H NI+KL YF + Y N+
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 609 LVYEYMPNGNLWDALHKGLVHLDW-----PTRHK--IAFGVAQGLAYLH-HGLLSPIIHR 660
+ EY+P D LHK L P + + + + ++H G I HR
Sbjct: 116 -IMEYVP-----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHR 165
Query: 661 DIKSTNILLDVN-YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TT 718
DIK N+L++ K+ DFG AK L + S + + Y APE + T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYIC--SRFYRAPELMLGATEYTP 221
Query: 719 KCDVYSFGVVLMELITGR 736
D++S G V ELI G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 53/240 (22%), Positives = 87/240 (36%), Gaps = 29/240 (12%)
Query: 512 KSFHRISFDQR--EILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASD 569
+ T + + G G V + G VA+K++++ + +
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 570 TDQLQLD-KGLKTEVETLGNIRHKNIVKLY--------CYFSSLYCNLLVYEYMPNGNLW 620
K + E+ L + H NI+ L LY LV E M +L
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY---LVTELMRT-DLA 121
Query: 621 DALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677
+H + + + I + + GL LH ++HRD+ NILL N +
Sbjct: 122 QVIHDQRIVI---SPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI 175
Query: 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
DF +A+ A D+ T Y APE K T D++S G V+ E+ +
Sbjct: 176 CDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 41/221 (18%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK-GL-KT---EVET 585
K+G+G G VYK ID + E VA+K++ +L+ ++ G+ T EV
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI-------------RLEHEEEGVPGTAIREVSL 86
Query: 586 LGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
L ++H+NI++L L+ L++EY N +L + K + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLH---LIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQL 141
Query: 643 AQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP-----KVADFGIAKVLQARGGKDSTT 696
G+ + H +HRD+K N+LL V+ K+ DFG+A+ + T
Sbjct: 142 INGVNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTH 196
Query: 697 TVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
+I T Y PE S+ +T D++S + E++
Sbjct: 197 EII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 65/274 (23%), Positives = 107/274 (39%), Gaps = 31/274 (11%)
Query: 492 QRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNK--------VGQGGSGTVY 543
Q I E + L F ++S F Q + +E +G+GG G VY
Sbjct: 147 QPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 544 KIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF- 601
++G++ A+K L +R K L + + + IV + F
Sbjct: 207 GCRKADTGKMYAMKCLDKKRIK----MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262
Query: 602 --SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPII 658
L + + M G+L L + V + R A + GL ++H ++
Sbjct: 263 TPDKLS---FILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF----VV 314
Query: 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATT 718
+RD+K NILLD + +++D G+A K GT+GY+APE A
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHA-SVGTHGYMAPEVLQKGVAYD 369
Query: 719 KC-DVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
D +S G +L +L+ G P +K+ I
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 16/186 (8%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+ L LS NL F L+ T L L+ + +L KL L L + L+
Sbjct: 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRA---ELTKLQVDG--TLPVLGTLDLS 85
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
L +P + +LT L+++ N +T +P L L++L L N +L T+P
Sbjct: 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGN-ELK-TLPP 141
Query: 136 EL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTM 193
L +L L ++ N+L+ ++P +L L L L L NSL I S L
Sbjct: 142 GLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPF 199
Query: 194 LSLYDN 199
L+ N
Sbjct: 200 AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 49/215 (22%), Positives = 71/215 (33%), Gaps = 37/215 (17%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143
+P + T L L+ N + + L QL L + T + G L L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL---TKLQVDGTLPVL 79
Query: 144 TDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT- 202
LD+S N L +P LP L VL + N L+ + L L L N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 203 --GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARC 260
+ + L L L+ N L+ LPA + + L
Sbjct: 139 LPPGLLTPTPK---LEKLSLANNNLTE-LPA---------------GLL-----NGLE-- 172
Query: 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYN 295
NL + N L +IP+G + L N
Sbjct: 173 -NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 42/169 (24%), Positives = 56/169 (33%), Gaps = 34/169 (20%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
L + L LDLS+N PL L L VL + N +L LP R
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN---RLTSLPL-GALR-- 121
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQ 127
+ L +L L GN + +PP + L +L L N
Sbjct: 122 ---------------------GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANN- 158
Query: 128 QLAGTIPEEL-GNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175
L +P L L L L + N L IP+ L L+ N
Sbjct: 159 NLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 52/258 (20%), Positives = 79/258 (30%), Gaps = 82/258 (31%)
Query: 139 NLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYD 198
+ +++ +L+ +P + +L L N L + + T LT L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 199 NSLTG-EVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSL 257
LT +V L L LDLS N+L LP
Sbjct: 65 AELTKLQVDGTLPV---LGTLDLSHNQLQ-------------------------SLPLLG 96
Query: 258 ARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQ 317
L VS N L S+P G G L EL+++
Sbjct: 97 QTLPALTVLDVSFNRLT-SLPLGA---------------LRGL--------GELQELYLK 132
Query: 318 RNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNS 376
N++ +P G+ KL L L +N L
Sbjct: 133 GNELKT-------------------------LPPGLLTPTPKLEKLSLANNNLTELPAGL 167
Query: 377 LSSLKSLNVLDLSNNLLT 394
L+ L++L+ L L N L
Sbjct: 168 LNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 36/151 (23%), Positives = 60/151 (39%), Gaps = 9/151 (5%)
Query: 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328
+L ++P + +I+ LS N T+ L++L + R +++
Sbjct: 18 DKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QV 72
Query: 329 IYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL 388
L +DLS N L +P L L +L + N+L S +L L L L L
Sbjct: 73 DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 389 SNNLLTGYIPESLCELLPN--SINFSNNRLS 417
N L +P L P ++ +NN L+
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 49/228 (21%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV------- 583
++G G GTVYK D +SG VA+K + ++ G +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV-------------RVPNGGGGGGGLPISTVRE 61
Query: 584 ----ETLGNIRHKNIVKLY--------CYFSSLYCNLLVYEYMPN--GNLWDALHKGLVH 629
L H N+V+L + LV+E++ D
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT---LVFEHVDQDLRTYLD--KAPPPG 116
Query: 630 LDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688
L T + +GL +LH + I+HRD+K NIL+ K+ADFG+A++
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 689 RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
+ T V+ T Y APE S T D++S G + E+ +
Sbjct: 173 Q--MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 31/264 (11%)
Query: 492 QRAITEPDETLSSSFFPYDVKSFHRISFDQREILEA--MTEKN----KV-GQGGSGTVYK 544
Q E LS + F + S + F Q + LE +T+ +V G+GG G V
Sbjct: 143 QELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA 202
Query: 545 IDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603
+ +G++ A KKL K + E + L + + +V L + +
Sbjct: 203 CQVRATGKMYACKKL---EKKRIKKRKGE----AMALNEKQILEKVNSRFVVSLAYAYET 255
Query: 604 ---LYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPII 658
L LV M G+L ++ G A + GL LH I+
Sbjct: 256 KDALC---LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER----IV 308
Query: 659 HRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATT 718
+RD+K NILLD + +++D G+A + + T GT GY+APE + + T
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHV----PEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 719 KCDVYSFGVVLMELITGRKPVEDD 742
D ++ G +L E+I G+ P +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQR 388
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 34/227 (14%)
Query: 523 EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
++ T + +G+G G V D + VA+KK+ + +
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC---------QRTLR 74
Query: 582 EVETLGNIRHKNIVKLY--------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
E++ L RH+NI+ + +Y +V + M D L+K L+
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVY---IVQDLMET----D-LYK-LLKTQHL 125
Query: 634 TRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
+ I + + Q GL Y+H ++HRD+K +N+LL+ K+ DFG+A+V
Sbjct: 126 SNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 691 GKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
T T Y APE +SK T D++S G +L E+++ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 49/262 (18%)
Query: 530 EKNKVGQGGSGTVYK---IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
E KVG+G G VYK D + A+K++ +SA E+ L
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------------REIALL 72
Query: 587 GNIRHKNIVKLYCYF-----SSLYCNLLVYEYMP-------NGNLWDALHKGLVHLDWPT 634
++H N++ L F ++ L+++Y + +K V L
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVW---LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 635 RHKIAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQP----KVADFGIAKVLQA- 688
+ + + G+ YLH + ++HRD+K NIL+ K+AD G A++ +
Sbjct: 130 VKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 689 -RGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDF-GD 745
+ D V+ T+ Y APE ++ T D+++ G + EL+T +P+ F
Sbjct: 186 LKPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI---FHCR 239
Query: 746 NKNIIYWVSIKVDTKEGIMEVL 767
++I D + I V+
Sbjct: 240 QEDIKTSNPYHHDQLDRIFNVM 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 65/263 (24%), Positives = 106/263 (40%), Gaps = 25/263 (9%)
Query: 492 QRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKV-GQGGSGTVYKIDL-NS 549
R+ + D + + K HR++ ++ E L K+ G+G G V + +
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYL-------KLLGKGTFGKVILVKEKAT 172
Query: 550 GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609
G A+K L + V+ + TE L N RH + L F +
Sbjct: 173 GRYYAMKIL-KKEVIVAKDEVAHT------LTENRVLQNSRHPFLTALKYSFQTHDRLCF 225
Query: 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669
V EY G L+ L + V + R A + L YLH +++RD+K N++L
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEK--NVVYRDLKLENLML 282
Query: 670 DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVL 729
D + K+ DFG+ K +T GT YLAPE + D + GVV+
Sbjct: 283 DKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 730 MELITGRKPVEDDFGDNKNIIYW 752
E++ GR P + + ++
Sbjct: 340 YEMMCGRLPF---YNQDHEKLFE 359
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 34/165 (20%), Positives = 67/165 (40%), Gaps = 11/165 (6%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
M +L + L+N T + N++ L+ N + I L+ L + +
Sbjct: 43 MNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNY-----NPISGLSNLERLRI 95
Query: 76 ATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE 135
+ ++ +TSLT L+++ + I +I L + ++L YN + T
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI--TDIM 153
Query: 136 ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
L L EL L++ + + I PKL L ++ ++ G+
Sbjct: 154 PLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 22/140 (15%), Positives = 51/140 (36%), Gaps = 6/140 (4%)
Query: 87 SIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146
+ + SLT + L +T + I N++ L + T + L+ L L
Sbjct: 39 TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIH---ATNYNPISGLSNLERL 93
Query: 147 DMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP 206
+ ++ ++ L L +L + +++ I + I + + L N ++
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152
Query: 207 QDLGQWSPLVVLDLSENKLS 226
L L L++ + +
Sbjct: 153 MPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 28/165 (16%), Positives = 67/165 (40%), Gaps = 11/165 (6%)
Query: 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQ 320
K L + + + SL ++++ +++ +G + A N+ +L +
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIH 77
Query: 321 ISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSL 380
+ + + I +L ++ + ++ + L L LL + + + SI +++L
Sbjct: 78 ATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 381 KSLNVLDLSNNLLTGYIP--ESLCELLPNSINFSNNRLSGPIPLS 423
+N +DLS N I ++L EL S+N + + +
Sbjct: 136 PKVNSIDLSYNGAITDIMPLKTLPEL--KSLNIQFDGVHDYRGIE 178
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 31/239 (12%), Positives = 76/239 (31%), Gaps = 60/239 (25%)
Query: 157 IPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLV 216
IP+S + L +S + I+ A +LT ++L + ++T + +
Sbjct: 17 IPDSTFK--AYLNGLLGQSSTA-NIT--EAQMNSLTYITLANINVTDLTG--IEYAHNIK 69
Query: 217 VLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS 276
L ++ + P ++ NL R R+ +
Sbjct: 70 DLTINNIHATNYNP--------------------------ISGLSNLERLRIMGKDVTSD 103
Query: 277 IPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLV 336
+ L ++++D+S+++ I + ++ + + N
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA--------------- 148
Query: 337 KIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395
++D + L +L L +Q + ++ + LN L + + G
Sbjct: 149 ---ITD-------IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 15/118 (12%), Positives = 35/118 (29%), Gaps = 30/118 (25%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+P+ S + +L LD+S++ + L + + + N +T
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG-------------AITD 151
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
+ + + L L + + + + I L QL +
Sbjct: 152 I---------------MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 16/196 (8%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
F L+ LDLS + +L++L L N + L + L+ L
Sbjct: 47 SFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN---PIQSLALGAFSGLSSL 102
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQ 128
+ +V L + G++ +L +L + N I PE L NL L+L N +
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN-K 160
Query: 129 LAGTIPEE----LGNLTELT-DLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183
+ +I L + L LD+S+N ++ I + +L+ L L N L
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDG 218
Query: 184 VIANSTTLTMLSLYDN 199
+ T+L + L+ N
Sbjct: 219 IFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 16/214 (7%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+ + LDLS N F + L+VL + ++ + + + L+ L ++L
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRC---EIQTIEDGAYQSLSHLSTLILT 84
Query: 77 TCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIP 134
+ + ++SL L + + G LK L++L + +N + +P
Sbjct: 85 GNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 135 EELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRV----LQLYNNSLSGEISSVIANST 189
E NLT L LD+S N + I + L L ++ + L L N ++ I
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223
L L+L N L + + L + L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 45/226 (19%), Positives = 83/226 (36%), Gaps = 27/226 (11%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEEL-GNLT 141
IP ++ S +L+L+ N + H+ L+ L+L ++ TI + +L+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRC-EIQ-TIEDGAYQSLS 76
Query: 142 ELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANS-TTLTMLSLYDN 199
L+ L ++ N + + L L+ L +L+ + + TL L++ N
Sbjct: 77 HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134
Query: 200 SLTGEVPQD-----LGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYF---LVLQNMFS 250
+ L L LDLS NK+ + ++ L L
Sbjct: 135 LIQ-SFKLPEYFSNLTN---LEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYN 295
+ + L + N L+ S+P+GI L + I L N
Sbjct: 190 NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 45/212 (21%), Positives = 77/212 (36%), Gaps = 14/212 (6%)
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQ- 246
+ L L N L + L VLDLS ++ + L L+L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLST-LILTG 85
Query: 247 NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSF-SGPIANT 304
N + + + +L + +L S+ + L + +++++N S +
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRA-----ISLVKIDLSDNLLSGPIPSGIGNLKKL 359
N NL L + N+I I R + + +DLS N ++ I G +L
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 360 NLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
L L +N+L S L SL + L N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 55/266 (20%), Positives = 90/266 (33%), Gaps = 59/266 (22%)
Query: 108 IPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPK 166
IP L + + L+L +N L + EL LD+S + I + L
Sbjct: 22 IPD--NLPFSTKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 167 LRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN---SLTGEVPQDLGQWSPLVVLDLSEN 223
L L L N + + ++L L + SL L L L+++ N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT---LKELNVAHN 134
Query: 224 KLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL- 282
+ L FS L NL +S+N ++ SI L
Sbjct: 135 LIQ---------------SFKLPEYFSN-LT-------NLEHLDLSSNKIQ-SIYCTDLR 170
Query: 283 SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342
L + +++L L + N ++ FI ++ I L ++ L
Sbjct: 171 VLHQMPLLNL--------------------SLDLSLNPMN-FIQPGAFKEIRLKELALDT 209
Query: 343 NLLSGPIPSGI-GNLKKLNLLMLQSN 367
N L +P GI L L + L +N
Sbjct: 210 NQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 32/147 (21%), Positives = 60/147 (40%), Gaps = 10/147 (6%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY-RAIS 334
IP+ + +DLS+N + + + L L + R +I I Y
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSL-SSLKSLNVLDLSNNL 392
L + L+ N + + G L L L+ L +S+ N LK+L L++++NL
Sbjct: 78 LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNL 135
Query: 393 LTGYIPESLCELLPN--SINFSNNRLS 417
+ + L N ++ S+N++
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 41/184 (22%), Positives = 71/184 (38%), Gaps = 12/184 (6%)
Query: 243 LVLQ-NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGP 300
L L N + S L +S ++ +I +G L H+S + L+ N
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN-LLSGPIPSGIGNLKKL 359
+L +L ++ I +L +++++ N + S +P NL L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 360 NLLMLQSNKLNSSIPN----SLSSLKSLNV-LDLSNNLLTGYIPESLCELLP-NSINFSN 413
L L SNK+ SI L + LN+ LDLS N + +I + + +
Sbjct: 152 EHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDT 209
Query: 414 NRLS 417
N+L
Sbjct: 210 NQLK 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 42/233 (18%)
Query: 534 VGQGGSGTVY----KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G+GG G V+ N+G++ A+K L + + + K E L +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL---KKAMIVRNAKDT---AHTKAERNILEEV 78
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR---HKIAFGVA 643
+H IV L F LY L+ EY+ G L + L+ F +A
Sbjct: 79 KHPFIVDLIYAFQTGGKLY---LILEYLSGGEL-------FMQLEREGIFMEDTACFYLA 128
Query: 644 Q---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ L +LH G II+RD+K NI+L+ K+ DFG+ K + T
Sbjct: 129 EISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVTHTF 181
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF-GDNKNIIY 751
GT Y+APE S D +S G ++ +++TG P F G+N+
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGENRKKTI 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 55/247 (22%), Positives = 100/247 (40%), Gaps = 48/247 (19%)
Query: 513 SFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTD 571
S + F ++ + +G GG+G V+ +D + + VA+KK+ S
Sbjct: 1 SMNIHGF---DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKHA- 55
Query: 572 QLQLDKGLKTEVETLGNIRHKNIVKLY-----------------CYFSSLYCNLLVYEYM 614
L+ E++ + + H NIVK++ +S+Y +V EYM
Sbjct: 56 -------LR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY---IVQEYM 104
Query: 615 PNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLD- 670
D L L H + Q GL Y+H ++HRD+K N+ ++
Sbjct: 105 ET----D-LANVLEQGPLLEEH-ARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINT 155
Query: 671 VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVL 729
+ K+ DFG+A+++ + T Y +P S T D+++ G +
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 730 MELITGR 736
E++TG+
Sbjct: 216 AEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 57/268 (21%), Positives = 99/268 (36%), Gaps = 51/268 (19%)
Query: 512 KSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDT 570
++ + + + K+ +G+G G VY D N+ + VA+KK+ ++
Sbjct: 12 ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV----NRMFEDLI 67
Query: 571 DQLQLDKGLKTEVETLGNIRHKNIVKLY--------CYFSSLYCNLLVYEYMPNGNLWDA 622
D K + E+ L ++ I++LY F LY +V E D
Sbjct: 68 DC----KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY---IVLEIAD----SD- 115
Query: 623 LHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679
L K + T I + G ++H IIHRD+K N LL+ + KV D
Sbjct: 116 LKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCD 172
Query: 680 FGIAKVLQARGGKDSTTTVIAGTYG-------------------YLAPEYAYSSKA-TTK 719
FG+A+ + + + + Y APE + T
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 720 CDVYSFGVVLMELITGRKPVEDDFGDNK 747
D++S G + EL+ + +D +
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRF 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 58/242 (23%), Positives = 89/242 (36%), Gaps = 46/242 (19%)
Query: 535 GQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHK 592
G G +G V + + + E A+K L D + EVE +
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKML---------QDC------PKARREVELHWRASQCP 115
Query: 593 NIVKLYCYF----SSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFGVAQGLA 647
+IV++ + + C L+V E + G L+ +G +I + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 648 YLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
YLH I HRD+K N+L N K+ DFG AK TT T
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPC--YTP 227
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763
Y+APE K CD++S GV++ L+ G P F N + G+
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHG--------LAISPGM 275
Query: 764 ME 765
Sbjct: 276 KT 277
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 70/255 (27%), Positives = 112/255 (43%), Gaps = 48/255 (18%)
Query: 512 KSFHRISFDQREILEAMTEKNKV-GQGGSGTVY----KIDLNSGEVVAVKKLWSQRTKVS 566
+ + Q E+L KV GQG G V+ ++ ++ A+K L K +
Sbjct: 16 EGHEKADPSQFELL-------KVLGQGSFGKVFLVKKISGSDARQLYAMKVL----KKAT 64
Query: 567 ASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDAL 623
D+++ K E + L + H IVKL+ F LY L+ +++ G+L+ L
Sbjct: 65 LKVRDRVRT----KMERDILVEVNHPFIVKLHYAFQTEGKLY---LILDFLRGGDLFTRL 117
Query: 624 HK-GLVHLDWPTRHKIAFGVAQ---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVA 678
K + + + F +A+ L +LH G II+RD+K NILLD K+
Sbjct: 118 SKEVMFTEED-VK----FYLAELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLT 168
Query: 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738
DFG++K + GT Y+APE T D +SFGV++ E++TG P
Sbjct: 169 DFGLSKE---SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 739 VEDDF-GDNKNIIYW 752
F G ++
Sbjct: 226 ----FQGKDRKETMT 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 55/263 (20%), Positives = 105/263 (39%), Gaps = 46/263 (17%)
Query: 487 RRFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-I 545
S+ R T+ + ++ Y+ H + + + K+G+G V++ I
Sbjct: 3 PVPSRARVYTDVNTHRPREYWDYES---HVVEW---GNQDDYQLVRKLGRGKYSEVFEAI 56
Query: 546 DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYF--S 602
++ + E V VK L + K +K E++ L N+R NI+ L
Sbjct: 57 NITNNEKVVVKIL-------------KPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103
Query: 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLH-HGLLSPII 658
LV+E++ N + + L T + I F + + L Y H G I+
Sbjct: 104 VSRTPALVFEHVNNTDF----KQLYQTL---TDYDIRFYMYEILKALDYCHSMG----IM 152
Query: 659 HRDIKSTNILLDV-NYQPKVADFGIAKVLQARGGKDSTT-TVIAGTYGYLAPEYAYSSKA 716
HRD+K N+++D + + ++ D+G+ A V + + PE +
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGL-----AEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 717 -TTKCDVYSFGVVLMELITGRKP 738
D++S G +L +I ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEP 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 54/305 (17%), Positives = 107/305 (35%), Gaps = 45/305 (14%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149
+ + + + +T L + L + T E + L L L++
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV---TTIEGVQYLNNLIGLELK 71
Query: 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDL 209
N ++ + L K+ L+L N L +S+ IA ++ L L +T L
Sbjct: 72 DNQITD--LAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPL 125
Query: 210 GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVS 269
S L VL L N+++ LA NL +
Sbjct: 126 AGLSNLQVLYLDLNQITN--------------------------ISPLAGLTNLQYLSIG 159
Query: 270 NNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
N + + + +L ++ + N S + + + NL E+ ++ NQIS S +
Sbjct: 160 NAQVS-DL-TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDV--SPL 213
Query: 330 YRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS 389
+L + L++ ++ NL N+ ++ P ++S + +L+
Sbjct: 214 ANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV--VKGPSGAPIAPATISDNGTYASPNLT 271
Query: 390 NNLLT 394
NL +
Sbjct: 272 WNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 43/258 (16%), Positives = 93/258 (36%), Gaps = 18/258 (6%)
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196
L + ++++ + ++ L + L + ++ I + L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256
DN +T L + + L+LS N L + ++ + + V
Sbjct: 71 KDNQIT--DLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDV--TP 124
Query: 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFM 316
LA NL + N + +I + L ++ + + S + N L+ L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 317 QRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNS 376
N+IS S + +L+++ L +N +S S + N L ++ L + + +
Sbjct: 181 DDNKISDI--SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFY 236
Query: 377 LSSLKSLNVLDLSNNLLT 394
++L NV+ +
Sbjct: 237 NNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
T+ + NL L+L +N T PL NLT + L + N L + S+I L
Sbjct: 55 TIEGVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGN---PLKNV--SAIAGLQ 107
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
++ + L + + P + +++L L L N IT +I P + L NL+ L + Q
Sbjct: 108 SIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV 163
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ L NL++LT L N +S I + LP L + L NN +S S +AN+
Sbjct: 164 ---SDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANT 216
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLP 230
+ L +++L + ++T + + LVV ++ + P+
Sbjct: 217 SNLFIVTLTNQTITNQPVFYN---NNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 65/348 (18%), Positives = 121/348 (34%), Gaps = 79/348 (22%)
Query: 33 FPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVT 92
FP L N ++ ++ +T + ++
Sbjct: 13 FPDP--ALANAIKIAAGKS--------------NVTDT---------------VTQADLD 41
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
+T L G +T I + L NL LEL NQ T L NLT++T+L++S N
Sbjct: 42 GITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI---TDLAPLKNLTKITELELSGNP 96
Query: 153 LSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW 212
L K +I L ++ L L + ++ +++ +A + L +L L N +T P L
Sbjct: 97 L--KNVSAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP--LAGL 150
Query: 213 SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNH 272
+ L L + ++S LA L + +N
Sbjct: 151 TNLQYLSIGNAQVSD--------------------------LTPLANLSKLTTLKADDNK 184
Query: 273 LEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRA 332
+ I + SLP++ + L N S + N NL + + I+
Sbjct: 185 IS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 333 ISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSL 380
+ N++ GP + I + S L ++ + ++++
Sbjct: 241 VVP-------NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + + L T + L NL L +N ++ L + + LTK
Sbjct: 34 TVTQADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDN---QITDL--APLKNLTK 86
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
+ + L+ L + ++I + S+ L+LT IT + P + L NL+ L L NQ
Sbjct: 87 ITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQ-- 140
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
T L LT L L + +S + + L KL L+ +N +S +IS +A+
Sbjct: 141 -ITNISPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLP 195
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
L + L +N ++ P L S L ++ L+ ++
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 63/308 (20%), Positives = 112/308 (36%), Gaps = 50/308 (16%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
+ N ++ + T + +L + LS +T +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGT--------------GVTTI----- 56
Query: 76 ATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE 135
+ + +L LEL N IT + P + L + +LEL N
Sbjct: 57 ----------EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNP---LKNVS 101
Query: 136 ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLS 195
+ L + LD++ ++ P + L L+VL L N ++ IS +A T L LS
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLS 157
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
+ + ++ P L S L L +NK+S P + S L + N S V P
Sbjct: 158 IGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP- 212
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIA-NTVGNARNLSEL 314
LA NL ++N + + P + ++ + ++ PIA T+ + +
Sbjct: 213 -LANTSNLFIVTLTNQTIT-NQP--VFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASP 268
Query: 315 FMQRNQIS 322
+ N S
Sbjct: 269 NLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/147 (19%), Positives = 55/147 (37%), Gaps = 12/147 (8%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + + NL+ L + N + PL+ NL+ L L ++N K+ + S + L
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDN---KISDI--SPLASLPN 196
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + L + P + N ++L + LT IT + NL +
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSG 251
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGK 156
A P + + +++ N S
Sbjct: 252 APIAPATISDNGTYASPNLTWNLTSFI 278
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 42/243 (17%)
Query: 510 DVKSFHRIS-FDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVS 566
+ +F+R E+ E + VG G G+V D +G VAVKKL ++
Sbjct: 11 ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPF 66
Query: 567 ASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY---------CYFSSLYCNLLVYEYMPNG 617
S K E+ L +++H+N++ L F+ +Y LV M
Sbjct: 67 QSIIHA----KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY---LVTHLMGA- 118
Query: 618 NLWDALHKGLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674
D L+ + H + F + Q GL Y+H IIHRD+K +N+ ++ + +
Sbjct: 119 ---D-LNNIVKCQKLTDDH-VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 170
Query: 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELI 733
K+ DFG+ AR D T +A T Y APE + D++S G ++ EL+
Sbjct: 171 LKILDFGL-----ARHTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 734 TGR 736
TGR
Sbjct: 225 TGR 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 532 NKVGQGGSGTVYK-IDL-NSGEVVAVKKLWSQRTK--VSASDTDQLQLDKGLKTEVETLG 587
++G+G G V+K DL N G VA+K++ Q + + S ++ + + L+T
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----- 71
Query: 588 NIRHKNIVKLY--------CYFSSLYCNLLVYEYMPN--GNLWDALHKGLVHLDWPTRHK 637
H N+V+L+ + L LV+E++ D + T
Sbjct: 72 --EHPNVVRLFDVCTVSRTDRETKLT---LVFEHVDQDLTTYLD--KVPEPGVPTETIKD 124
Query: 638 IAFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
+ F + +GL +LH H ++HRD+K NIL+ + Q K+ADFG+A++ + T+
Sbjct: 125 MMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTS 178
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
V+ T Y APE S T D++S G + E+ +
Sbjct: 179 VVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 66/305 (21%)
Query: 486 KRRFSKQRAITEPDETLSSSFFPYDVKSFHRIS--FDQREILEAMTEKNKVGQGGSGTVY 543
+ Q ++ + + K + +I + ++ +G G G V
Sbjct: 11 QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70
Query: 544 K-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT---EVETLGNIRHKNIVKLY- 598
+ D VVA+KK+ +V D K E+ L + H ++VK+
Sbjct: 71 EAYDKLEKRVVAIKKI----LRVFEDLID-------CKRILREIAILNRLNHDHVVKVLD 119
Query: 599 -------CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---GLAY 648
F LY +V E D K + T I + G+ Y
Sbjct: 120 IVIPKDVEKFDELY---VVLEIAD----SD-FKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG--- 704
+H G I+HRD+K N L++ + KV DFG+A+ + +S +
Sbjct: 172 VHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 705 ---------------------YLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDD 742
Y APE + T DV+S G + EL+ K
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 743 FGDNK 747
D
Sbjct: 288 HADRG 292
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 43/235 (18%)
Query: 523 EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
I K+ +G+G G V +GE+VA+KK+ + A
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---------LRTLR 58
Query: 582 EVETLGNIRHKNIVKLY--------CYFSSLYCNLLVYEYMPNGNLWDA-LHKGLVHLDW 632
E++ L + +H+NI+ ++ F+ +Y ++ E M LH+ +
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVY---IIQELM------QTDLHRVISTQML 109
Query: 633 PTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689
H I + + Q + LH +IHRD+K +N+L++ N KV DFG+A+++
Sbjct: 110 SDDH-IQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 690 GGKDSTTTVIAG-------TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGR 736
+S T T Y APE +S + DV+S G +L EL R
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 534 VGQGGSGTVY---KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G G G V+ +G A+K L K Q++ E L +
Sbjct: 14 LGTGSFGRVHLIRSRH--NGRYYAMKVL----KKEIVVRLKQVE---HTNDERLMLSIVT 64
Query: 591 HKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ--- 644
H I++++ F ++ ++ +Y+ G L+ L K + + F A+
Sbjct: 65 HPFIIRMWGTFQDAQQIF---MIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAEVCL 117
Query: 645 GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
L YLH II+RD+K NILLD N K+ DFG AK + D T T + GT
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYT-LCGTP 167
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
Y+APE + D +SFG+++ E++ G P + N Y
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF---YDSNTMKTY 212
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 9e-18
Identities = 52/328 (15%), Positives = 96/328 (29%), Gaps = 67/328 (20%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149
L +T L ++ Q+ + + + L +T L ++
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD---IKSVQGIQYLPNVTKLFLN 73
Query: 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDL 209
N L+ I + + L L L L N + ++SS + + L LSL N ++ L
Sbjct: 74 GNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--DINGL 127
Query: 210 GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVS 269
L L L NK++ L+R L +
Sbjct: 128 VHLPQLESLYLGNNKITDI--------------------------TVLSRLTKLDTLSLE 161
Query: 270 NNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
+N + I+ L+ L L++ +N IS +
Sbjct: 162 DNQIS-------------DIVPLA-------------GLTKLQNLYLSKNHISDL--RAL 193
Query: 330 YRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS 389
+L ++L + NL N + L + P +S ++
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVK 251
Query: 390 NNLLTGYIPESLCELLPNSINFSNNRLS 417
+L S P +I + R
Sbjct: 252 WHLPEFTNEVSFIFYQPVTIGKAKARFH 279
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 8e-17
Identities = 45/219 (20%), Positives = 82/219 (37%), Gaps = 18/219 (8%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + ++ ++ +N+ + L N+ L N N KL + + L
Sbjct: 36 AVTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGN---KLTDI--KPLTNLKN 88
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + L + + S+ ++ L L L N I+ I + L L L L N+
Sbjct: 89 LGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNK-- 142
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
T L LT+L L + N +S I + L KL+ L L N +S ++ + +A
Sbjct: 143 -ITDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLK 197
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP 228
L +L L+ + + ++ L P
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 5e-16
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 42/217 (19%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + +L T + L +++ + N + +
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNS--------------DIKS 57
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
++ I + ++T L L GN +T I P + LKNL L L N+
Sbjct: 58 VQ---------------GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI- 99
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
L +L +L L + N +S I ++ LP+L L L NN ++ +I+ ++ T
Sbjct: 100 --KDLSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLT 153
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
L LSL DN ++ VP L + L L LS+N +S
Sbjct: 154 KLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 43/211 (20%), Positives = 72/211 (34%), Gaps = 28/211 (13%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNEN-----PGFK-LWKLPE- 61
++ + N+ +L L+ N T PL+ NL NL L +EN K L KL
Sbjct: 57 SVQGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSSLKDLKKLKSL 114
Query: 62 ----------SSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPE 111
+ + L +L + L + + +T L L L N I+ I P
Sbjct: 115 SLEHNGISDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP- 170
Query: 112 IGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171
+ L L+ L L N + L L L L++ K L ++
Sbjct: 171 LAGLTKLQNLYLSKNHI---SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
Query: 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202
+ SL I++ ++ +
Sbjct: 228 NTDGSLVTPEI--ISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 1e-11
Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 11/182 (6%)
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELF 315
+ ++ + +N+ ++ S+ +GI LP+V+ + L+ N + I + N +NL LF
Sbjct: 38 TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLF 93
Query: 316 MQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPN 375
+ N+I + + L + L N +S +G+ +L +L L L +NK+ + I
Sbjct: 94 LDENKIKDLSSLKDLK--KLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI-TDITV 148
Query: 376 SLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSG 435
LS L L+ L L +N ++ +P + L ++ S N +S L+ +K V
Sbjct: 149 -LSRLTKLDTLSLEDNQISDIVPLAGLTKL-QNLYLSKNHISDLRALAGLKNLDVLELFS 206
Query: 436 NP 437
Sbjct: 207 QE 208
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 40/236 (16%)
Query: 534 VGQGGSGTVY----KIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
+G G G V+ ++G++ A+K L A T+ +TE + L +I
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT------RTERQVLEHI 115
Query: 590 RHKN-IVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR---HKIAFGV 642
R +V L+ F + L+ L+ +Y+ G L HL R H++ V
Sbjct: 116 RQSPFLVTLHYAFQTETKLH---LILDYINGGEL-------FTHLSQRERFTEHEVQIYV 165
Query: 643 AQ---GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
+ L +LH G II+RDIK NILLD N + DFG++K + +
Sbjct: 166 GEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYD 219
Query: 699 IAGTYGYLAPE-YAYSSKATTK-CDVYSFGVVLMELITGRKP-VEDDFGDNKNIIY 751
GT Y+AP+ K D +S GV++ EL+TG P D +++ I
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 58/230 (25%), Positives = 88/230 (38%), Gaps = 38/230 (16%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK 592
+G+G G V + +G A+K L + ++ + TE L N RH
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHT------VTESRVLQNTRHP 65
Query: 593 NIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTR---HKIAFGVAQ-- 644
+ L F L V EY G L HL + F A+
Sbjct: 66 FLTALKYAFQTHDRLC---FVMEYANGGEL-------FFHLSRERVFTEERARFYGAEIV 115
Query: 645 -GLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGT 702
L YLH +++RDIK N++LD + K+ DFG+ K +T GT
Sbjct: 116 SALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGT 168
Query: 703 YGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
YLAPE + D + GVV+ E++ GR P + + ++
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHERLFE 215
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 72/281 (25%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR- 590
K+G G TV+ D+ + VA+K + + A+ + E++ L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-----------EDEIKLLQRVND 74
Query: 591 ----------HKNIVKLYCYFSSLYCNL------LVYEYMPNGNLWDAL----HKGLVHL 630
+I+KL +F+ + +V+E + NL + H+G+
Sbjct: 75 ADNTKEDSMGANHILKLLDHFN--HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI--- 128
Query: 631 DWPTRH--KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP------KVADFGI 682
P + +I+ + GL Y+H IIH DIK N+L+++ P K+AD G
Sbjct: 129 --PLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG- 183
Query: 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRK--PVE 740
A + T I T Y +PE + D++S ++ ELITG +
Sbjct: 184 ----NACWYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238
Query: 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQ 781
+ K+ D I+E+L G +++
Sbjct: 239 EGHSYTKD--------DDHIAQIIELL-----GELPSYLLR 266
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 49/303 (16%), Positives = 96/303 (31%), Gaps = 60/303 (19%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
S + +T IP L +N +L + L +L +++S N
Sbjct: 10 SNRVFLCQESKVT-EIPS--DLPRNAIELRFVLTK-LRVIQKGAFSGFGDLEKIEISQND 65
Query: 153 LSGKIPESILR-LPKLRVLQLYN-NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLG 210
+ I + LPKL +++ N+L N L L + + + +P
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124
Query: 211 QWSP-LVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVS 269
S V+LD+ +N + N F G+ + ++
Sbjct: 125 IHSLQKVLLDIQDNINIHTIER---------------NSFVGL-------SFESVILWLN 162
Query: 270 NNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
N ++ I + + N + +P+++
Sbjct: 163 KNGIQ-EIHNSAFNGT-----------------------QLDELNLSDNNNLE-ELPNDV 197
Query: 330 -YRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL 388
+ A V +D+S + +PS L+ L L +S +P +L L +L L
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLP-TLEKLVALMEASL 253
Query: 389 SNN 391
+
Sbjct: 254 TYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 36/195 (18%), Positives = 67/195 (34%), Gaps = 12/195 (6%)
Query: 12 DFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
FS +L ++++S N VF NL L + + L + + L L
Sbjct: 49 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN--NLLYINPEAFQNLPNL 106
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI--GLLKNLRQLELYYNQ 127
+ ++++ + +P + L++ N I GL L L N
Sbjct: 107 QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 128 QLAGTIPEELGNLTELTDLD-MSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVI 185
I N T+L +L+ N+L ++P + +L + + S +
Sbjct: 166 I--QEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGL 222
Query: 186 ANSTTLTMLSLYDNS 200
N L S Y+
Sbjct: 223 ENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 42/261 (16%), Positives = 84/261 (32%), Gaps = 34/261 (13%)
Query: 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227
RV + ++ EI S + L L + L +++S+N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 228 PLPAKVCSR-GKLQYFLVLQ-NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI-LSL 284
+ A V S KL + + N + P++ NL +SN ++ +P+ +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 285 PHVSIIDLSYNSFSGPIANTV--GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342
++D+ N I G + L++ +N I ++ +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ----------------EIHN 171
Query: 343 NLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLC 402
+ +G + L + +N L + +LD+S + +P
Sbjct: 172 SAFNG--------TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL 222
Query: 403 ELLPNSINFSNNRLSGPIPLS 423
E L S L L
Sbjct: 223 ENLKKLRARSTYNLKKLPTLE 243
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 48/310 (15%), Positives = 90/310 (29%), Gaps = 71/310 (22%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ R + T + P + N L F KL + + + F
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLT---KLRVIQKGA-FS----------- 51
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEE 136
L +E++ N + I ++ L L ++ + L PE
Sbjct: 52 ------------GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEA 99
Query: 137 LGNLTELTDLDMSVNHLSGKIPESI-LRLPKLRVLQLYNNSLSGEISSVIANS-----TT 190
NL L L +S + +P+ + + +L + +N I ++ NS
Sbjct: 100 FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI---NIHTIERNSFVGLSFE 155
Query: 191 LTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFS 250
+L L N + E+ + L L+LS+N N
Sbjct: 156 SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN-----------------------NNLE 191
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIANTVGNAR 309
+ D + +S + S+P L +L + + V
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTLEKLV---- 246
Query: 310 NLSELFMQRN 319
L E +
Sbjct: 247 ALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 14/168 (8%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLT-KL 70
F + NL+ L +SN P + +L +N + + +S L+ +
Sbjct: 100 FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI--NIHTIERNSFVGLSFES 156
Query: 71 RIMVLATCALHGQIPASIGNVTSLTDLELTG-NFITGHIPPEI-GLLKNLRQLELYYNQQ 128
I+ L + +I S N T L +L L+ N + +P ++ L++ +
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTR- 213
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176
+ L NL +L S +L K+P ++ +L L L S
Sbjct: 214 IHSLPSYGLENLKKLRAR--STYNLK-KLP-TLEKLVALMEASLTYPS 257
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
+G+G G V + + E+ AVK L + + D + E L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECT------MVEKRVLALPGKP 401
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
+ +L+ F LY V EY+ G+L + + + A +A GL +
Sbjct: 402 PFLTQLHSCFQTMDRLY---FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFF 457
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
L G II+RD+K N++LD K+ADFG+ K TT GT Y+A
Sbjct: 458 LQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIA 510
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
PE D ++FGV+L E++ G+ P E G++++ ++
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQ 552
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 67/253 (26%), Positives = 104/253 (41%), Gaps = 58/253 (22%)
Query: 516 RISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQ 574
R+ +L K+G+G G V+K ID +GEVVAVKK+ + TD
Sbjct: 2 RVDR---HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI----FDAFQNSTD--- 51
Query: 575 LDKGLKT--EVETLGNIR-HKNIVKLY-----CYFSSLYCNLLVYEYMPNGNLWDA-LHK 625
+T E+ L + H+NIV L +Y LV++YM + LH
Sbjct: 52 ---AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY---LVFDYM------ETDLHA 99
Query: 626 GLVHLDWPTRHKIAFGVAQ---GLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682
++ + + V Q + YLH G ++HRD+K +NILL+ KVADFG+
Sbjct: 100 -VIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155
Query: 683 AKVLQARGGKDSTTTVIAGTYG------------------YLAPEYAYSSKA-TTKCDVY 723
++ + + Y APE S T D++
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215
Query: 724 SFGVVLMELITGR 736
S G +L E++ G+
Sbjct: 216 SLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 51/248 (20%), Positives = 84/248 (33%), Gaps = 67/248 (27%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
+G G +G V + + + E A+K L D + EVE
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKML---------QDC------PKARREVELHW 65
Query: 588 NI-RHKNIVKLYCYFSSLYCN----LLVYEYMPNGNLWDA-LHKGLVHLDWPTRHKIAFG 641
+ +IV++ + +LY L+V E + G L+ +G +I
Sbjct: 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 642 VAQGLAYLH-HGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTT 697
+ + + YLH I HRD+K N+L N K+ DFG AK
Sbjct: 126 IGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------ 169
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757
Y CD++S GV++ L+ G P F + + +
Sbjct: 170 TTGEKYD-------------KSCDMWSLGVIMYILLCGYPP----F--------YSNHGL 204
Query: 758 DTKEGIME 765
G+
Sbjct: 205 AISPGMKT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-16
Identities = 74/450 (16%), Positives = 155/450 (34%), Gaps = 85/450 (18%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVF----NLTNLEVLSFNEN----PGFK-LWKLPESSIFR 66
+Q + + L + T + L L+ N G + + ++ +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 67 LTKLRI---MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI--GLLKN---L 118
+ KL + + + +++ + +L +L L+ N + + GLL L
Sbjct: 87 IQKLSLQNCCLTGAGCGV--LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 119 RQLELYYNQ---QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI---LRLP--KLRVL 170
+L+L Y + L + +L +S N ++ + L+ +L L
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204
Query: 171 QLYNNSLSGE----ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW-----SPLVVLDLS 221
+L + ++ + + ++A+ +L L+L N L +L S L L +
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264
Query: 222 ENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI 281
E ++ AK C L L ++L ++ N L EG
Sbjct: 265 ECGIT----AKGCGD----------------LCRVLRAKESLKELSLAGNELG---DEGA 301
Query: 282 LSL--------PHVSIIDLSYNSFSG----PIANTVGNARNLSELFMQRNQISGFIPSEI 329
L + + + SF+ ++ + R L EL + N++ E+
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361
Query: 330 YRAI-----SLVKIDLSDNLLS----GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLS-S 379
+ + L + L+D +S + + + L L L +N L + L S
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421
Query: 380 LKS----LNVLDLSNNLLTGYIPESLCELL 405
++ L L L + + + + L L
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEEMEDRLQALE 451
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-15
Identities = 71/452 (15%), Positives = 145/452 (32%), Gaps = 94/452 (20%)
Query: 17 QNLRRLDLSNNLFTGQ-FPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
+++ LD+ + + + L +V+ ++ LT+ R +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC--------------GLTEARCKDI 48
Query: 76 ATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIG-LLKN----LRQLELYYNQ--- 127
++ + +L +L L N + + L+ +++L L
Sbjct: 49 SSA---------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 99
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGK----IPESILRL-PKLRVLQLYNNSLSGE-- 180
G + L L L +L +S N L + E +L +L LQL SLS
Sbjct: 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159
Query: 181 --ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ-----WSPLVVLDLSENKLSGPLPAKV 233
++SV+ L++ +N + + L Q L L L ++ +
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT----SDN 215
Query: 234 CSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS----IPEGIL-SLPHVS 288
C L +A +L + +N L + G+L +
Sbjct: 216 CR----------------DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 289 IIDLSYNSFSGP----IANTVGNARNLSELFMQRNQISGFIPSEIYRAI-----SLVKID 339
+ + + + + +L EL + N++ + + L +
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 340 LSDNLLSG----PIPSGIGNLKKLNLLMLQSNKLNSSIPNSLS-SLKS----LNVLDLSN 390
+ + S + + L L + +N+L + L L L VL L++
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379
Query: 391 NLLTGYIPESLCELLPN-----SINFSNNRLS 417
++ SL L ++ SNN L
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 47/248 (18%), Positives = 88/248 (35%), Gaps = 38/248 (15%)
Query: 14 SPMQNLRRLDLSNNLFTGQFPLSVF----NLTNLEVLSFNEN----PGFK-LWKLPESSI 64
P L +L L + + + + L+ + N G + L + + S
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNV----TSLTDLELTGNFITGH-----IPPEIGLL 115
+L L+ L +C + + + SL +L L N + P +
Sbjct: 199 CQLEALK---LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS 255
Query: 116 KNLRQLELYYNQ---QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRL-----PKL 167
LR L ++ + G + L L +L ++ N L + + +L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 168 RVLQLYNNSLSGE----ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW-----SPLVVL 218
L + + S + SSV+A + L L + +N L ++L Q S L VL
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375
Query: 219 DLSENKLS 226
L++ +S
Sbjct: 376 WLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 45/247 (18%), Positives = 76/247 (30%), Gaps = 36/247 (14%)
Query: 14 SPMQNLRRLDLSNNLFTGQ----FPLSVFNLTNLEVLSFNENP----GFKLWKLPESSIF 65
L L L + T V + +L L+ N G L +
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAE--LCPGLLH 253
Query: 66 RLTKLRIMVLATCALHGQ----IPASIGNVTSLTDLELTGNFITGHIPPEIGLL-----K 116
++LR + + C + + + + SL +L L GN + +
Sbjct: 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC 313
Query: 117 NLRQLELYYNQ---QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI---LRLP--KLR 168
L L + L L +L +S N L + L P LR
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 169 VLQLYNNSLSGE----ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ-----WSPLVVLD 219
VL L + +S +++ + + +L L L +N L L + L L
Sbjct: 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 433
Query: 220 LSENKLS 226
L + S
Sbjct: 434 LYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 41/259 (15%), Positives = 79/259 (30%), Gaps = 49/259 (18%)
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQW-SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ 246
S + L + L+ +L V+ L + L+ C
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT----EARCK----------- 46
Query: 247 NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI---LSLPHVSI--IDLSYNSFS--- 298
+ +L L + +N L + L P I + L +
Sbjct: 47 -----DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 101
Query: 299 -GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-----SLVKIDLSDNLLS----GP 348
G +++T+ L EL + N + + + L K+ L LS P
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161
Query: 349 IPSGIGNLKKLNLLMLQSNKLNSS----IPNSLSSLK-SLNVLDLSNNLLTGYIPESLCE 403
+ S + L + +N +N + + L L L L + +T LC
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 404 LLPNS-----INFSNNRLS 417
++ + + +N+L
Sbjct: 222 IVASKASLRELALGSNKLG 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-16
Identities = 63/235 (26%), Positives = 92/235 (39%), Gaps = 47/235 (20%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG-NIRH 591
+G+G G V AVK L + K ++ K + +E L N++H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEE----KHIMSERNVLLKNVKH 98
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG------- 641
+V L+ F LY V +Y+ G L HL + + F
Sbjct: 99 PFLVGLHFSFQTADKLY---FVLDYINGGEL-------FYHL----QRERCFLEPRARFY 144
Query: 642 ---VAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTT 697
+A L YLH I++RD+K NILLD + DFG+ K +STT+
Sbjct: 145 AAEIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTS 197
Query: 698 VIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
GT YLAPE + D + G VL E++ G P + N +Y
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF---YSRNTAEMYD 249
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 36/210 (17%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+ ++LDL +N + P F LT L +L N+N KL LP L L
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDN---KLQTLPAGIFKELKNL------ 87
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
L +T N + +P + L NL +L L NQ L ++P
Sbjct: 88 ------------------ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQ-LK-SLPP 126
Query: 136 EL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTM 193
+ +LT+LT L + N L +P+ + +L L+ L+LYNN L T L
Sbjct: 127 RVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT 185
Query: 194 LSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223
L L +N L L +L L EN
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 56/170 (32%), Positives = 79/170 (46%), Gaps = 18/170 (10%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFN-LTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
F + LR L L++N P +F L NLE L +N KL LP +L L
Sbjct: 57 FHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN---KLQALPIGVFDQLVNLA 112
Query: 72 IMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEIGL---LKNLRQLELYYNQ 127
+ L L +P + ++T LT L L N + +P G+ L +L++L LY NQ
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK--GVFDKLTSLKELRLYNNQ 168
Query: 128 QLAGTIPEEL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
+PE LTEL L + N L ++PE L KL++LQL N
Sbjct: 169 --LKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 30/206 (14%)
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQN 247
L L N L+ + + + L +L L++NKL LPA + L+ V N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307
+ + NL R+ N L+ S+P + L+
Sbjct: 96 KLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD-------SLT-------------- 133
Query: 308 ARNLSELFMQRNQISGFIPSEIYRA-ISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQ 365
L+ L + N++ +P ++ SL ++ L +N L +P G L +L L L
Sbjct: 134 --KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLD 189
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNN 391
+N+L + SL+ L +L L N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 269 SNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS 327
+N L S+P L + ++ L+ N A +NL L++ N++ +P
Sbjct: 45 QSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPI 102
Query: 328 EIYRA-ISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSL-SSLKSLN 384
++ ++L ++ L N L +P + +L KL L L N+L S+P + L SL
Sbjct: 103 GVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLK 160
Query: 385 VLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
L L NN L +PE + L ++ NN+L
Sbjct: 161 ELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK 194
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 50/328 (15%), Positives = 94/328 (28%), Gaps = 72/328 (21%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149
L +T L ++ Q+ + + + L +T L ++
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD---IKSVQGIQYLPNVTKLFLN 76
Query: 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDL 209
N L+ I + + L L L L N + ++SS + + L LSL N ++ L
Sbjct: 77 GNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS--DINGL 130
Query: 210 GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVS 269
L L L NK++ L+R L +
Sbjct: 131 VHLPQLESLYLGNNKITDI--------------------------TVLSRLTKLDTLSLE 164
Query: 270 NNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI 329
+N + I+ L+ L L++ +N IS +
Sbjct: 165 DNQIS-------------DIVPLA-------------GLTKLQNLYLSKNHISDL--RAL 196
Query: 330 YRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS 389
+L ++L + NL N + L + P +S ++
Sbjct: 197 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVK 254
Query: 390 NNLLTG-----YIPESLCELLPNSINFS 412
+L +I + F
Sbjct: 255 WHLPEFTNEVSFIFYQPVTIGKAKARFH 282
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 43/219 (19%), Positives = 80/219 (36%), Gaps = 18/219 (8%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + ++ ++ +N+ + L N+ L N N + + L
Sbjct: 39 AVTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDI-----KPLANLKN 91
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + L + + S+ ++ L L L N I+ I + L L L L N+
Sbjct: 92 LGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNK-- 145
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
T L LT+L L + N +S I + L KL+ L L N +S ++ + +A
Sbjct: 146 -ITDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLK 200
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP 228
L +L L+ + + ++ L P
Sbjct: 201 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 44/219 (20%), Positives = 82/219 (37%), Gaps = 24/219 (10%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + +L T + L +++ + N + + I L
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV-----QGIQYLPN 69
Query: 70 LRIMVLATCALHGQIP--ASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
+ + L ++ + N+ +L L L N + + + LK L+ L L +N
Sbjct: 70 VTKLFLN----GNKLTDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNG 123
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIAN 187
+ L +L +L L + N ++ I + RL KL L L +N +S +I +A
Sbjct: 124 ---ISDINGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAG 176
Query: 188 STTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
T L L L N ++ + L L VL+L +
Sbjct: 177 LTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 16/194 (8%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
++ + N+ +L L+ N T PL+ NL NL L +EN K+ L SS+ L
Sbjct: 60 SVQGIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDEN---KVKDL--SSLKDLK 112
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
KL+ + L + I + ++ L L L N IT I + L L L L NQ
Sbjct: 113 KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 168
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
+ L LT+L +L +S NH+S + ++ L L VL+L++ + + +N
Sbjct: 169 ---SDIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNL 223
Query: 189 TTLTMLSLYDNSLT 202
+ D SL
Sbjct: 224 VVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 52/260 (20%), Positives = 89/260 (34%), Gaps = 40/260 (15%)
Query: 135 EELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTML 194
E ++ ++ + ++ L + + N+ + + I +T L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
L N LT P L L L L ENK+ L
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVK-----------DL--------------- 105
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
SL K L + +N + I G++ LP + + L N + + L L
Sbjct: 106 SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161
Query: 315 FMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
++ NQIS + L + LS N +S + LK L++L L S + +
Sbjct: 162 SLEDNQISDI--VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 217
Query: 375 NSLSSLKSLNVLDLSNNLLT 394
N S+L N + ++ L
Sbjct: 218 NHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 36/193 (18%), Positives = 66/193 (34%), Gaps = 16/193 (8%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
+ + ++NL L L N L +L L+ LS N + + + + L +
Sbjct: 83 IKPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHN---GISDI--NGLVHLPQ 135
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + L + + +T L L L N I+ I P + L L+ L L N
Sbjct: 136 LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNH-- 189
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
+ L L L L++ K L ++ + SL +I++
Sbjct: 190 -ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP--EIISDDG 246
Query: 190 TLTMLSLYDNSLT 202
++ +
Sbjct: 247 DYEKPNVKWHLPE 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
+G+G G V + +G++ AVK L + + D + TE L H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL-KKDVILQDDDVECT------MTEKRILSLARNH 83
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
+ +L+C F L+ V E++ G+L + K + R A + L +
Sbjct: 84 PFLTQLFCCFQTPDRLF---FVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EIISALMF 139
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
LH G II+RD+K N+LLD K+ADFG+ K TT GT Y+A
Sbjct: 140 LHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIA 192
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
PE D ++ GV+L E++ G P E +N++ ++
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
+G+G G V + + E+ AVK L + + D + E L +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECT------MVEKRVLALPGKP 80
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
+ +L+ F LY V EY+ G+L + + + A +A GL +
Sbjct: 81 PFLTQLHSCFQTMDRLY---FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFF 136
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
L G II+RD+K N++LD K+ADFG+ K TT GT Y+A
Sbjct: 137 LQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIA 189
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
PE D ++FGV+L E++ G+ P E G++++ ++
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQ 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 28/227 (12%)
Query: 533 KV-GQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG-NI 589
K+ G+G G V+ + + + A+K L K D + + E L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDV---ECTMVEKRVLSLAW 75
Query: 590 RHKNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
H + ++C F +L+ V EY+ G+L + A + GL
Sbjct: 76 EHPFLTHMFCTFQTKENLF---FVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGL 131
Query: 647 AYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGY 705
+LH G I++RD+K NILLD + K+ADFG+ K D+ T GT Y
Sbjct: 132 QFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDY 184
Query: 706 LAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
+APE K D +SFGV+L E++ G+ P G ++ ++
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFH 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
+G+G V + L + + A+K + + D D + +TE H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVV-KKELVNDDEDIDWV------QTEKHVFEQASNH 69
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQ---G 645
+V L+ F S L+ V EY+ G+L + + + R F A+
Sbjct: 70 PFLVGLHSCFQTESRLF---FVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLA 122
Query: 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
L YLH G II+RD+K N+LLD K+ D+G+ K TT+ GT
Sbjct: 123 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 175
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP------VEDDFGDNKNIIYWV 753
Y+APE D ++ GV++ E++ GR P ++ + ++ ++ V
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 54/359 (15%), Positives = 116/359 (32%), Gaps = 80/359 (22%)
Query: 93 SLTDLELTGNFITG----HIPPEIGLLKNLRQLELYYNQ---QLAGTIPEELGNLTELTD 145
S+ L + IT + + +++++ L N + A + E + + +L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 146 LDMSVNHLSGK----------IPESILRLPKLRVLQLYNNSLSGE----ISSVIANSTTL 191
+ S + +++L+ PKL ++L +N+ + ++ T L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 192 TMLSLYDNSLTGE-------------VPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGK 238
L L++N L + V + PL + N+L K
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMK------ 177
Query: 239 LQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL-----EGSIPEGILSLPHVSIIDLS 293
+ + L ++ N + E + EG+ + ++DL
Sbjct: 178 -------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224
Query: 294 YNSFSGP----IANTVGNARNLSELFMQRNQISGFIPSEIYRAI------SLVKIDLSDN 343
N+F+ +A + + NL EL + +S + + A L + L N
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284
Query: 344 LLSGPIPSGIG-----NLKKLNLLMLQSNKLN------SSIPNSLSSLKSLNVLDLSNN 391
+ + + L L L N+ + I S+ + +L +
Sbjct: 285 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 343
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 55/337 (16%), Positives = 111/337 (32%), Gaps = 77/337 (22%)
Query: 137 LGNLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQLYNNSLSGE----ISSVIANS 188
+ + + + ++ ++ + + +L ++ + L N++ E +S IA+
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 189 TTLTMLSLYDNS---LTGEVPQDLGQWSP-------LVVLDLSENKLSGPLPAKVCSRGK 238
L + D + E+P+ L L + LS+N GP +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF-GPTAQEPLI--- 115
Query: 239 LQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL-------------EGSIPEGILSLP 285
D L++ L + NN L E ++ + + P
Sbjct: 116 ----------------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAP 159
Query: 286 HVSIIDLSYNSFSGP----IANTVGNARNLSELFMQRNQI-----SGFIPSEIYRAISLV 336
+ I N A T + R L + M +N I + + L
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 337 KIDLSDNLLSGP----IPSGIGNLKKLNLLMLQSNKLNS----SIPNSLSSL--KSLNVL 386
+DL DN + + + + L L L L++ ++ ++ S L L L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279
Query: 387 DLSNNLLTG----YIPESLCELLPN--SINFSNNRLS 417
L N + + + E +P+ + + NR S
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 45/237 (18%), Positives = 74/237 (31%), Gaps = 41/237 (17%)
Query: 17 QNLRRLDLSNNLFT--GQFPLSVF--NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
L + LS+N F Q PL F T LE L + N L
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN--------------GLGPQAG 139
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITG----HIPPEIGLLKNLRQLELYYNQ- 127
+A + N L + N + + L +++ N
Sbjct: 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 199
Query: 128 ---QLAGTIPEELGNLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQLYNNSLSGE 180
+ + E L EL LD+ N + + ++ P LR L L + LS
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
Query: 181 ----ISSVIAN--STTLTMLSLYDNSLTGEVPQDLGQ-----WSPLVVLDLSENKLS 226
+ + + L L L N + + + L L+ L+L+ N+ S
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 55/326 (16%), Positives = 106/326 (32%), Gaps = 83/326 (25%)
Query: 16 MQNLRRLDLSNNLFT--GQFPLSVF--NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
+++ + LS N LS + +LE+ F++ ++ ++ L +
Sbjct: 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ-- 88
Query: 72 IMVLATCALHGQIPASIGNVTSLTDLELTGNFITG----HIPPEIGLLKNLRQLELYYNQ 127
L C L + L+ N + + L L L+ N
Sbjct: 89 --ALLKC-------------PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 133
Query: 128 -------QLAGTIPE-----ELGNLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQ 171
++A + E + N L + N L ++ L ++
Sbjct: 134 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 193
Query: 172 LYNNSLSGE-----ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ----WSPLVVLDLSE 222
+ N + E + +A L +L L DN+ T L W L L L++
Sbjct: 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253
Query: 223 NKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKN--LLRFRVSNNHLEGSIPEG 280
LS +RG + D+ ++ +N L R+ N +E +
Sbjct: 254 CLLS--------ARGAAA------------VVDAFSKLENIGLQTLRLQYNEIE---LDA 290
Query: 281 ILSL--------PHVSIIDLSYNSFS 298
+ +L P + ++L+ N FS
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 30/232 (12%)
Query: 534 VGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RH 591
+G+G V + L + + A++ + + D D + +TE H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVV-KKELVNDDEDIDWV------QTEKHVFEQASNH 112
Query: 592 KNIVKLYCYF---SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
+V L+ F S L+ V EY+ G+L + + + R A ++ L Y
Sbjct: 113 PFLVGLHSCFQTESRLF---FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 168
Query: 649 LH-HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
LH G II+RD+K N+LLD K+ D+G+ K TT+ GT Y+A
Sbjct: 169 LHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIA 221
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKP------VEDDFGDNKNIIYWV 753
PE D ++ GV++ E++ GR P ++ + ++ ++ V
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 36/206 (17%), Positives = 70/206 (33%), Gaps = 24/206 (11%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRL 67
+P P + + L L P F NL N+ + + + L +L S + L
Sbjct: 25 RIPSLPP--STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV--TLQQLESHSFYNL 79
Query: 68 TKLRIMVLA-TCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPE--IGLLKNLRQLEL 123
+K+ + + T L I + L L + + P + LE+
Sbjct: 80 SKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137
Query: 124 YYNQQLAGTIPEE-LGNLT-ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI 181
N + +IP L E L + N + + KL + L N +
Sbjct: 138 TDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY---L 192
Query: 182 SSVIANS-----TTLTMLSLYDNSLT 202
+ + ++ + ++L + S+T
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 36/201 (17%), Positives = 75/201 (37%), Gaps = 14/201 (6%)
Query: 92 TSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEEL-GNLTELTDLDMS 149
S L+L + IP L N+ ++ + + L + NL+++T +++
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIR 88
Query: 150 VNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIA--NSTTLTMLSLYDNSLTGEVP 206
I L+ LP L+ L ++N L + ++ +L + DN +P
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 207 QDL--GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP-DSLARCKNL 263
+ G + + L L N + + + KL + +N + V+ D+ +
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 264 LRF-RVSNNHLEGSIPEGILS 283
VS + ++P L
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 28/169 (16%), Positives = 53/169 (31%), Gaps = 13/169 (7%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFR-LTKL 70
F + + +++ N L L+ L L P+ +
Sbjct: 76 FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT---GLKMFPDLTKVYSTDIF 132
Query: 71 RIMVLATCALHGQIPASI--GNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
I+ + IP + G L+L N T + L + L N+
Sbjct: 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY 191
Query: 129 LAGTIPEEL--GNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYN 174
L I ++ G + + LD+S ++ +P L L +L +
Sbjct: 192 LT-VIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 28/166 (16%), Positives = 59/166 (35%), Gaps = 12/166 (7%)
Query: 259 RCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQR 318
C FRV+ ++ IP P + L ++ N N+S +++
Sbjct: 9 ECHQEEDFRVTCKDIQ-RIPSL---PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 319 NQISGFIPSEIYRA-ISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPN- 375
+ + S + + I++ + I L L L + + L P+
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDL 123
Query: 376 -SLSSLKSLNVLDLSNNLLTGYIPESLCELLPN---SINFSNNRLS 417
+ S +L++++N IP + + L N ++ NN +
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 29/186 (15%), Positives = 62/186 (33%), Gaps = 14/186 (7%)
Query: 243 LVLQ-NMFSGVLPDSLARCKNLLRFRVS-NNHLEGSIPEGILS-LPHVSIIDLSYNSFSG 299
L L + + + N+ R VS + L+ + L V+ I++
Sbjct: 36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 300 PI-ANTVGNARNLSELFMQRNQISGFIPSE--IYRAISLVKIDLSDNLLSGPIPSGI--G 354
I + + L L + + P +Y ++++DN IP G
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 355 NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINF--- 411
+ L L +N +S+ + L+ + L+ N I + + + +
Sbjct: 154 LCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDV 212
Query: 412 SNNRLS 417
S ++
Sbjct: 213 SQTSVT 218
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGL--LKNLRQLELYYNQQLAGTIPEE-LGNL 140
+P S+ + L+L+ N ++ + E L NL L L +N I E +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNH--LNFISSEAFVPV 87
Query: 141 TELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
L LD+S NHL + E + L L VL LYNN + + + L L L N
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 200 SLTGEVP----QDLGQWSPLVVLDLSENKLS 226
++ P +D + L++LDLS NKL
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 16/169 (9%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
LDLS+N + LTNL L + N L + + + LR + L+
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN---HLNFISSEAFVPVPNLRYLDLS 96
Query: 77 TCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIP 134
+ LH + + ++ +L L L N I + + L++L L NQ ++ P
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ-IS-RFP 152
Query: 135 EE----LGNLTELTDLDMSVNHLSGKIPESILRLPKL--RVLQLYNNSL 177
E L +L LD+S N L + +LP L L+NN L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 23/180 (12%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTV-GNARNLSELFMQRNQISGFIPSEIYRAI- 333
++P+ + + +++DLS+N+ S A NL L + N ++ FI SE + +
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 334 SLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392
+L +DLS N L + + +L+ L +L+L +N + N+ + L L LS N
Sbjct: 89 NLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 393 LTGYIPESL---CELLPN--SINFSNNRLSGPIPL-------SLIKEGLVESFSGNPGLC 440
++ P L LP ++ S+N+L +PL + +K GL NP C
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGL--YLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 38/142 (26%), Positives = 58/142 (40%), Gaps = 12/142 (8%)
Query: 90 NVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEE-LGNLTELTDLD 147
+T+L L L+ N + I E + NLR L+L N L T+ E +L L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH-LH-TLDEFLFSDLQALEVLL 118
Query: 148 MSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEISSVIANS---TTLTMLSLYDNSLTG 203
+ NH+ + + + +L+ L L N +S +I + L +L L N L
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 204 EVPQDLGQWSPLVV--LDLSEN 223
DL + V L L N
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 51/243 (20%), Positives = 74/243 (30%), Gaps = 84/243 (34%)
Query: 157 IPESILRLPKLRVLQLYNNSLSGEISS--VIANSTTLTMLSLYDNSLTGEVP----QDLG 210
+P+S+ +L L +N+LS + + T L L L N L + +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 211 QWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN 270
L LDLS N L L + + L + N
Sbjct: 89 N---LRYLDLSSNHLHT-LD-----------------------EFLFSDLQALEVLLLYN 121
Query: 271 NHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY 330
NH+ + +F L +L++ +NQIS P E+
Sbjct: 122 NHIV-VVDRN---------------AFED--------MAQLQKLYLSQNQIS-RFPVELI 156
Query: 331 RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSL--NVLDL 388
+ L KL LL L SNKL L L + N L L
Sbjct: 157 K--------------------DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 389 SNN 391
NN
Sbjct: 197 HNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 23/102 (22%), Positives = 42/102 (41%), Gaps = 12/102 (11%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPE---S 62
TL + FS +Q L L L NN + F ++ L+ L ++N ++ + P
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN---QISRFPVELIK 157
Query: 63 SIFRLTKLRIMVLATCALHGQIPASIGNVTSLT--DLELTGN 102
+L KL ++ L++ L + + + L L N
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 523 EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
E+L+ + G+G G V K D + VA+K + +++ +
Sbjct: 100 EVLKVI------GKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----------AE 142
Query: 582 EVETLGNIRHK------NIVKLYCYFSSLYCN--LLVYEYMPNGNLWDALHKG-LVHLDW 632
E+ L ++R + N++ + F + N + +E + + NL++ + K
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLENF--TFRNHICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP--KVADFGIAKVLQARG 690
P K A + Q L LH + IIH D+K NILL + KV DFG +
Sbjct: 200 PLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--- 253
Query: 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
T I + Y APE ++ D++S G +L EL+TG
Sbjct: 254 --QRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+ +G+G G V K D E VA+K + +++ ++ + + EV L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----------QIEVRLLELMN 108
Query: 591 H------KNIVKLYCYFSSLYCN--LLVYEYMPNGNLWDALHK-GLVHLDWPTRHKIAFG 641
IV L +F ++ N LV+E + + NL+D L + K A
Sbjct: 109 KHDTEMKYYIVHLKRHF--MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP--KVADFGIAKVLQARGGKDSTTTVI 699
+ L +L LS IIH D+K NILL + K+ DFG + L I
Sbjct: 166 MCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-----QRIYQYI 219
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
+ Y +PE D++S G +L+E+ TG
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 57/266 (21%), Positives = 92/266 (34%), Gaps = 45/266 (16%)
Query: 558 LWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNG 617
L S+R + T + +G +++ + S+ +
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
Query: 618 NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677
L +F VA+G+ +L IHRD+ + NILL K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 234
Query: 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYL-----APEYAYSSKATTKCDVYSFGVVLMEL 732
DFG+A+ + + L APE + T + DV+SFGV+L E+
Sbjct: 235 CDFGLARDIY------KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
Query: 733 IT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFR--------DEMIQVL 783
+ G P Y +K+D E + G R EM Q +
Sbjct: 289 FSLGASP------------YP-GVKIDE-----EFCRRLKEG-TRMRAPDYTTPEMYQTM 329
Query: 784 RIAIRCTSKSPATRPTMNEVVQLLAE 809
C P+ RPT +E+V+ L
Sbjct: 330 L---DCWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 32/132 (24%)
Query: 506 FFPYDVKSF----HRISFDQREILEAMTEKNKVGQGGSGTVYK------IDLNSGEVVAV 555
PYD + R+ + +G+G G V + + VAV
Sbjct: 9 RLPYDASKWEFPRDRLKLGK-----------PLGRGAFGQVIEADAFGIDKTATCRTVAV 57
Query: 556 KKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY-CYFSSLYCNLLVYEY 613
K L K A+ ++ + L +E++ L +I H N+V L +++ E+
Sbjct: 58 KML-----KEGATHSEH----RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 108
Query: 614 MPNGNLWDALHK 625
GNL L
Sbjct: 109 CKFGNLSTYLRS 120
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 8e-13
Identities = 67/392 (17%), Positives = 115/392 (29%), Gaps = 112/392 (28%)
Query: 456 PHTKTR-RRLSSIWAVV---TSAVIIFIGLLL-----FLKRRFSKQRAITEPDETL---- 502
+ RL W ++ V F+ +L FL ++ +
Sbjct: 58 KDAVSGTLRL--FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 503 -------SSSFFPYDV---KSFHRISFDQREILEAMTEKNKV---GQGGSG-TVYKID-L 547
+ F Y+V + + ++ R+ L + V G GSG T +D
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKL----RQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 548 NSGEVVAV---KKLW--SQRTKVSASDTDQLQ-----LDKGLKTEVETLGNIRHKNIVKL 597
S +V K W + + + LQ +D + + NI+ I +
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL-RIHSI 230
Query: 598 YCYFSSL-----YCN-LLVYEYMPNGNLWDALH---KGLVHLDWPTRHKIAFGVAQGLAY 648
L Y N LLV + N W+A + K L+ TR K
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL----TTRFKQVTDFLSAATT 286
Query: 649 LHHGL--LSPIIHRDIKSTNIL---LDVNYQ--PKVADFG-------IAKVLQ------- 687
H L S + D + ++L LD Q P+ IA+ ++
Sbjct: 287 THISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 688 --ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVY-SFGVVLMELITGRKPVEDDFG 744
D TT+I + L P ++ V F
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYR--------KMFDRLSV---------------FP 382
Query: 745 DNKNI------IYWVSIKVDTKEGIMEVLDKK 770
+ +I + W + ++ L K
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 4e-10
Identities = 88/641 (13%), Positives = 178/641 (27%), Gaps = 223/641 (34%)
Query: 26 NNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIP 85
+ L+ + +N++ L+ KL ++ L +LR + G
Sbjct: 117 DRLYNDNQVFAKYNVSRLQ----------PYLKLRQA----LLELRPAKNVL--IDGV-- 158
Query: 86 ASIGNVTSLT-----DLELTGNF------IT-GHIPPEIGLLKNLRQLELYYNQQLAGTI 133
G T + ++ + + +L+ L++L Y Q+
Sbjct: 159 LGSGK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--LY--QIDP-- 211
Query: 134 PEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTM 193
N T +D ++ I + RL K + Y N L
Sbjct: 212 -----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP---YENCL---------------- 247
Query: 194 LSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVL 253
+VL V + F +
Sbjct: 248 ----------------------LVLL------------NVQNAKAWNAFNL--------- 264
Query: 254 PDSLARCKNLL--RFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311
CK LL RF+ + L + H+S+ S + T ++L
Sbjct: 265 -----SCKILLTTRFKQVTDFLSAATTT------HISLDHHS-MTL------TPDEVKSL 306
Query: 312 SELFMQRNQISGFIPSEIY----RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367
++ + +P E+ R +S++ + D + N K +N +
Sbjct: 307 LLKYL--DCRPQDLPREVLTTNPRRLSIIAESIRDG------LATWDNWKHVNC-----D 353
Query: 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKE 427
KL + I +SL+ L+ + + + L + P S + IP L
Sbjct: 354 KLTTIIESSLNVLEPAEYRKM-------F--DRL-SVFPPSAH---------IPTIL--- 391
Query: 428 GLVESFSGNPGLCVSVSVNSSDKNFPLCPHTKTRRRLSSIWAVVTSAVIIFIGLLLFLKR 487
LS IW V + ++ + + K
Sbjct: 392 ------------------------------------LSLIWFDVIKSDVMVV-VNKLHKY 414
Query: 488 ----RFSKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVY 543
+ K+ I+ P L + + HR D I + + + Y
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY 474
Query: 544 -------KIDLNSGEVVAVKKL-----WSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K + + + + + ++ K+ T + + TL ++
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ-KIRHDST----AWNASGSILNTLQQLKF 529
Query: 592 --KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL 630
I + L +L + NL + + L+ +
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 4e-04
Identities = 62/384 (16%), Positives = 118/384 (30%), Gaps = 100/384 (26%)
Query: 509 YDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYKID--LNSGEVVAVKK--------- 557
DV+ + + EI + K+ V SGT+ L+ E + V+K
Sbjct: 36 KDVQDMPKSILSKEEIDHIIMSKDAV----SGTLRLFWTLLSKQEEM-VQKFVEEVLRIN 90
Query: 558 ---LWSQ---RTKVSASDTDQL--QLDKGLKTEVETL--GNI-RHKNIVKLYCYFSSLYC 606
L S + + T Q D+ L + + N+ R + +KL
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDR-LYNDNQVFAKYNVSRLQPYLKL--------- 140
Query: 607 NLLVYEYMPNGNLWDALH--KG--------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSP 656
+ E P N+ + G V L + + K+ F + +L+
Sbjct: 141 RQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKI----FWLNLKN--- 191
Query: 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY-GYLAPEYAYSSK 715
+ +L + YQ I +R D ++ + + SK
Sbjct: 192 -CNSPETVLEMLQKLLYQ-------IDPNWTSRS--DHSSNIKLRIHSIQAELRRLLKSK 241
Query: 716 ATTKC-----DVYS------FGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD---TKE 761
C +V + F + L+T R DF + T +
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA---DPCRFESC 818
+ +L K L +D +VL +P + ++AE+ +++
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTT-------NPR-------RLSIIAESIRDGLATWDNW 347
Query: 819 KFPNKSNKESSNATKIKN--PSEL 840
K N + + + P+E
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEY 371
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 20/174 (11%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRL 67
++ + N+R L L N +S LTNL L N +L LP +L
Sbjct: 55 SVQGIQYLPNVRYLALGGNKLH---DISALKELTNLTYLILTGN---QLQSLPNGVFDKL 108
Query: 68 TKLRIMVLATCALHGQIPASIGN-VTSLTDLELTGNFITGHIPPEIGL---LKNLRQLEL 123
T L+ +VL L +P + + +T+LT L L N + +P G+ L NL +L+L
Sbjct: 109 TNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS-LPK--GVFDKLTNLTELDL 164
Query: 124 YYNQQLAGTIPEEL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
YNQ + +PE + LT+L DL + N L +P+ + RL L+ + L++N
Sbjct: 165 SYNQLQS--LPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 47/207 (22%), Positives = 70/207 (33%), Gaps = 28/207 (13%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ-QLAGTIPEELGNLTE 142
P L +T + L ++ Q+ + + I L
Sbjct: 13 FPDDAF--AETIKANLKKKSVT-DAVTQNEL-NSIDQIIANNSDIKSVQGIQY----LPN 64
Query: 143 LTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202
+ L + N L I ++ L L L L N L + V T L L L +N L
Sbjct: 65 VRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
Query: 203 ---GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR-GKLQYFLVLQNMFSGVLP---- 254
V L L L+L+ N+L LP V + L + N LP
Sbjct: 123 SLPDGVFDKLTN---LTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF 177
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGI 281
D L L R+ N L+ S+P+G+
Sbjct: 178 DKLT---QLKDLRLYQNQLK-SVPDGV 200
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 54/257 (21%), Positives = 90/257 (35%), Gaps = 66/257 (25%)
Query: 141 TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNS 200
E ++ ++ L + + N+ + I + L+L N
Sbjct: 19 AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNK 74
Query: 201 LTGEVPQDLGQWSPLV---VLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSL 257
L D+ L L L+ N+L LP V D L
Sbjct: 75 L-----HDISALKELTNLTYLILTGNQLQS-LPNGV--------------------FDKL 108
Query: 258 ARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQ 317
NL + N L+ S+P+G+ F NL+ L +
Sbjct: 109 ---TNLKELVLVENQLQ-SLPDGV---------------FDKLT--------NLTYLNLA 141
Query: 318 RNQISGFIPSEIY-RAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPN 375
NQ+ +P ++ + +L ++DLS N L +P G+ L +L L L N+L S +P+
Sbjct: 142 HNQLQS-LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPD 198
Query: 376 -SLSSLKSLNVLDLSNN 391
L SL + L +N
Sbjct: 199 GVFDRLTSLQYIWLHDN 215
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 4e-12
Identities = 54/318 (16%), Positives = 98/318 (30%), Gaps = 64/318 (20%)
Query: 94 LTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHL 153
L L + ++ L ++ + +L ++SV
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRP--ECWCRDSATDEQLFRCELSVEKS 361
Query: 154 SGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWS 213
+ + + +L+ L+ N I I L L +L +S
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQ--------YFS 409
Query: 214 PLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL 273
L +D Y L++ F ++ +++ L
Sbjct: 410 TLKAVDPMR----------------AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 274 EGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI 333
++ + L V+ +DLS+N +P +
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLRA-------------------------LPPALAALR 486
Query: 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS-SIPNSLSSLKSLNVLDLSNNL 392
L + SDN L G+ NL +L L+L +N+L + L S L +L+L N
Sbjct: 487 CLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
Query: 393 LT---GYIPESLCELLPN 407
L G E L E+LP+
Sbjct: 545 LCQEEGIQ-ERLAEMLPS 561
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 31/200 (15%), Positives = 67/200 (33%), Gaps = 11/200 (5%)
Query: 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPE 61
S L P+ L + ++ + L+ + +
Sbjct: 370 SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKF 429
Query: 62 SSIFRLTKLRIMVLATCALHG---QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNL 118
+ K+ + L + + + +T L+L+ N + +PP + L+ L
Sbjct: 430 LLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSG-KIPESILRLPKLRVLQLYNNSL 177
L+ N + + NL L +L + N L + ++ P+L +L L NSL
Sbjct: 489 EVLQASDNAL---ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
Query: 178 S---GEISSVIANSTTLTML 194
G + +++ +
Sbjct: 546 CQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 39/256 (15%), Positives = 75/256 (29%), Gaps = 41/256 (16%)
Query: 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKL 225
L L + + S + L +D L +LS K
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLL-KDRPECWCRDSATDEQLFRCELSVEKS 361
Query: 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLP 285
+ + +L+ LQ + L + E +
Sbjct: 362 T-------VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE-----KETLQYFS 409
Query: 286 HVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLL 345
+ +D + L R++ + + L+ L
Sbjct: 410 TLKAVDPM----------------RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 346 SGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL- 404
+ + + L + L L N+L ++P +L++L+ L VL S+N L ++ +
Sbjct: 454 T--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE-----NVDGVA 505
Query: 405 -LPN--SINFSNNRLS 417
LP + NNRL
Sbjct: 506 NLPRLQELLLCNNRLQ 521
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 11/115 (9%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGL---LKNLRQLELYYNQQLAGTIPEEL-GNLTELTD 145
L ++L+ N I+ + P L++L L LY N+ + +P+ L L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAP--DAFQGLRSLNSLVLYGNK-IT-ELPKSLFEGLFSLQL 108
Query: 146 LDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
L ++ N ++ + L L +L LY+N L + + + L N
Sbjct: 109 LLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 31/162 (19%), Positives = 53/162 (32%), Gaps = 36/162 (22%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+ + L N P F L + + N ++ +L + L
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNN---QISELAPDAFQGLR-------- 80
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPE 135
SL L L GN IT +P + L +L+ L L N+ + +
Sbjct: 81 ----------------SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK-IN-CLRV 121
Query: 136 EL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
+ +L L L + N L I + L ++ + L N
Sbjct: 122 DAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 33/143 (23%), Positives = 60/143 (41%), Gaps = 9/143 (6%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEI-YRAIS 334
IP + ++ I L N+ + L + + NQIS + + S
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
L + L N ++ +P + L L LL+L +NK+N ++ L +LN+L L +N L
Sbjct: 82 LNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 394 TGYIPESLCELLPN--SINFSNN 414
I + L +++ + N
Sbjct: 141 QT-IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 32/118 (27%), Positives = 55/118 (46%), Gaps = 11/118 (9%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFN-LTNLEVLSFNENPGFKLWKLPESSIF-RLTKL 70
FSP + LRR+DLSNN + + F L +L L N K+ +LP S+F L L
Sbjct: 52 FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN---KITELP-KSLFEGLFSL 106
Query: 71 RIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYN 126
++++L ++ + ++ +L L L N + I L+ ++ + L N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 30/136 (22%), Positives = 55/136 (40%), Gaps = 12/136 (8%)
Query: 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP----QDLGQWSPLVVLDLSEN 223
++L N++ + L + L +N ++ E+ Q L L L L N
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS---LNSLVLYGN 90
Query: 224 KLSGPLPAKVCSR-GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL 282
K++ LP + LQ L+ N + + D+ NL + +N L+ +I +G
Sbjct: 91 KITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 283 -SLPHVSIIDLSYNSF 297
L + + L+ N F
Sbjct: 149 SPLRAIQTMHLAQNPF 164
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 38/211 (18%), Positives = 76/211 (36%), Gaps = 43/211 (20%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
+ N + +L T L+ ++ + + + + L
Sbjct: 18 LANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNS--------------NIQSL----- 56
Query: 76 ATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE 135
A + T+L +L L+ N I+ + P + L L +L + N+
Sbjct: 57 ----------AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL---KNLN 101
Query: 136 ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLS 195
+ + L+ L + N L +S++ L L +L + NN L I + + L +L
Sbjct: 102 GIPSAC-LSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLD 156
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
L+ N +T L + + +DL+ K
Sbjct: 157 LHGNEIT--NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 49/280 (17%), Positives = 83/280 (29%), Gaps = 66/280 (23%)
Query: 115 LKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174
L N + L T L+ + + + +++ + + L+ L L +
Sbjct: 18 LANAVKQNLGKQS---VTDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSH 72
Query: 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVC 234
N +S ++S + + T L LS+ N L + L L L N+L
Sbjct: 73 NQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELRD------- 120
Query: 235 SRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSY 294
DSL KNL + NN L+ SI+ L
Sbjct: 121 -------------------TDSLIHLKNLEILSIRNNKLK-------------SIVMLG- 147
Query: 295 NSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIG 354
L L + N+I+ + R + IDL+
Sbjct: 148 ------------FLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQP 193
Query: 355 NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394
L N + + S P +S+ S + L
Sbjct: 194 ELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 43/203 (21%), Positives = 74/203 (36%), Gaps = 43/203 (21%)
Query: 24 LSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ 83
FP L N + + +T L
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQ--------------SVTDL------------- 34
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143
S ++ + + + I + + NL++L L +NQ + L +LT+L
Sbjct: 35 --VSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQ---ISDLSPLKDLTKL 87
Query: 144 TDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTG 203
+L ++ N L + + + L L L NN L + S + + L +LS+ +N L
Sbjct: 88 EELSVNRNRLK-NL--NGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLKS 142
Query: 204 EVPQDLGQWSPLVVLDLSENKLS 226
V LG S L VLDL N+++
Sbjct: 143 IVM--LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 36/208 (17%), Positives = 64/208 (30%), Gaps = 40/208 (19%)
Query: 88 IGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLD 147
+ + L +T + L ++ + + T L +L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNI---QSLAGMQFFTNLKELH 69
Query: 148 MSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQ 207
+S N +S + + L KL L + N L ++ + S L+ L L +N L
Sbjct: 70 LSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRD--TD 122
Query: 208 DLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFR 267
L L +L + NKL + L L
Sbjct: 123 SLIHLKNLEILSIRNNKLK-----------SI---------------VMLGFLSKLEVLD 156
Query: 268 VSNNHLEGSIPEGILSLPHVSIIDLSYN 295
+ N + + G+ L V+ IDL+
Sbjct: 157 LHGNEIT-NT-GGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 31/193 (16%), Positives = 63/193 (32%), Gaps = 41/193 (21%)
Query: 10 LPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTK 69
L + ++ + N+ + TNL+ L + N +++
Sbjct: 34 LVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHLSHN--------------QISD 77
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQL 129
L + + ++T L +L + N + ++ L +L L N+
Sbjct: 78 L---------------SPLKDLTKLEELSVNRNRLK-NLNGIPSA--CLSRLFLDNNEL- 118
Query: 130 AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANST 189
+ L +L L L + N L I + L KL VL L+ N ++ +
Sbjct: 119 --RDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLK 172
Query: 190 TLTMLSLYDNSLT 202
+ + L
Sbjct: 173 KVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 39/252 (15%), Positives = 85/252 (33%), Gaps = 40/252 (15%)
Query: 164 LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223
L L S++ ++ S + + + ++++ + ++ L L LS N
Sbjct: 18 LANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHN 73
Query: 224 KLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS 283
++S L L L V+ N L+ ++ +
Sbjct: 74 QIS-----------DL---------------SPLKDLTKLEELSVNRNRLK-NLNG--IP 104
Query: 284 LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343
+S + L N +++ + +NL L ++ N++ + L +DL N
Sbjct: 105 SACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGN 160
Query: 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLN-VLDLSNNLLTGYIPESLC 402
++ G+ LKK+N + L K + L N V D ++ Y +
Sbjct: 161 EITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGG 218
Query: 403 ELLPNSINFSNN 414
+ + +
Sbjct: 219 SYVDGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 16/169 (9%)
Query: 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFM 316
N ++ + + + L V + ++ +A + NL EL +
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHL 70
Query: 317 QRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNL--LMLQSNKLNSSIP 374
NQIS P + L ++ ++ N L + + L L L +N+L
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKN-----LNGIPSACLSRLFLDNNEL-RDTD 122
Query: 375 NSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLS 423
+ L LK+L +L + NN L + L ++ N ++ L+
Sbjct: 123 S-LIHLKNLEILSIRNNKLKSIVMLGFLSKL-EVLDLHGNEITNTGGLT 169
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 41/195 (21%), Positives = 73/195 (37%), Gaps = 19/195 (9%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+L NL+ L LS+N + PL +LT LE LS N N +L +
Sbjct: 55 SLAGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRN------RLKNLNGIPSA 106
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
L + L L + S+ ++ +L L + N + I +G L L L+L+ N+
Sbjct: 107 CLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEI 162
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVL-QLYNNSLSGEISSVIAN 187
T L L ++ +D++ E + P+L + + + I+N
Sbjct: 163 ---TNTGGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISN 216
Query: 188 STTLTMLSLYDNSLT 202
+ +
Sbjct: 217 GGSYVDGCVLWELPV 231
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 34/144 (23%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTV-GNARNLSELFMQRNQISGFIPSEIYRAIS 334
IPE I + + + L+ N F+ A + L ++ N+I+ A
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPN-SLSSLKSLNVLDLSNNL 392
+ +I L+ N L + + L+ L LML+SN++ + + N S L S+ +L L +N
Sbjct: 83 VNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQ 140
Query: 393 LTGYIPESLCELLPN--SINFSNN 414
+T + + L + ++N N
Sbjct: 141 ITT-VAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 27/123 (21%), Positives = 50/123 (40%), Gaps = 10/123 (8%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGL--LKNLRQLELYYNQQLAGTIPEE-LGNL 140
IP I +L L N T + L LR++ N+ I E
Sbjct: 26 IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNK--ITDIEEGAFEGA 80
Query: 141 TELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
+ + ++ ++ N L + + L L+ L L +N ++ + +++ +LSLYDN
Sbjct: 81 SGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139
Query: 200 SLT 202
+T
Sbjct: 140 QIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 30/163 (18%), Positives = 59/163 (36%), Gaps = 35/163 (21%)
Query: 17 QNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
Q L L+NN FT +F L L ++F+ N K+ + E + +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN---KITDIEEGAFEGASG------ 82
Query: 76 ATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIP 134
+ ++ LT N + + ++ L++L+ L L N ++ +
Sbjct: 83 ------------------VNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSN-RIT-CVG 121
Query: 135 EEL-GNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
+ L+ + L + N ++ + L L L L N
Sbjct: 122 NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 29/164 (17%), Positives = 54/164 (32%), Gaps = 37/164 (22%)
Query: 41 TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELT 100
L N N + L + IF+ + L + +
Sbjct: 32 QYTAELRLNNN---EFTVLEATGIFK-----------------------KLPQLRKINFS 65
Query: 101 GNFITGHIPPEIGL---LKNLRQLELYYNQQLAGTIPEEL-GNLTELTDLDMSVNHLSGK 156
N IT I G + ++ L N+ L + ++ L L L + N ++
Sbjct: 66 NNKIT-DIEE--GAFEGASGVNEILLTSNR-LE-NVQHKMFKGLESLKTLMLRSNRIT-C 119
Query: 157 IPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
+ L +R+L LY+N ++ +L+ L+L N
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 25/117 (21%), Positives = 45/117 (38%), Gaps = 9/117 (7%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFN-LTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
F + LR+++ SNN T F + + + N +L + L L+
Sbjct: 53 FKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN---RLENVQHKMFKGLESLK 108
Query: 72 IMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYN 126
++L + + + ++S+ L L N IT + P L +L L L N
Sbjct: 109 TLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIF 65
+ + F + + L++N +F L +L+ L N ++ + S
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSN---RITCVGNDSFI 126
Query: 66 RLTKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGN 102
L+ +R++ L + + + SL+ L L N
Sbjct: 127 GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 25/133 (18%), Positives = 54/133 (40%), Gaps = 5/133 (3%)
Query: 168 RVLQLYNNSLSG-EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
L+L NN + E + + L ++ +N +T S + + L+ N+L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 227 GPLPAKVCSR-GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SL 284
+ K+ L+ ++ N + V DS ++ + +N + ++ G +L
Sbjct: 95 N-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 285 PHVSIIDLSYNSF 297
+S ++L N F
Sbjct: 153 HSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 18/96 (18%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 325 IPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSL 383
IP I ++ L++N + +GI L +L + +NK+ + +
Sbjct: 26 IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 384 NVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLS 417
N + L++N L + + + L + ++ +NR++
Sbjct: 84 NEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT 118
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 14/161 (8%)
Query: 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79
+LDL + + LT L L+ + N +L L LT+L + LA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYN---QLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 80 LHGQIPASI-GNVTSLTDLELTGNFITGHIPPEIGL---LKNLRQLELYYNQQLAGTIPE 135
L +P + ++T L L L GN + +P G+ L L++L L NQ + IP
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPS--GVFDRLTKLKELRLNTNQLQS--IPA 148
Query: 136 EL-GNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175
LT L L +S N L + RL KL+ + L+ N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 42/148 (28%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL-GNLTE 142
+P+ I L+L + L L L L YNQ T+ + +LTE
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ--LQTLSAGVFDDLTE 84
Query: 143 LTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201
L L ++ N L+ +P + L +L L L N L S V T L L L N L
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 202 TGEVPQ----DLGQWSPLVVLDLSENKL 225
+P L L L LS N+L
Sbjct: 144 Q-SIPAGAFDKLTN---LQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 46/205 (22%), Positives = 68/205 (33%), Gaps = 52/205 (25%)
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
L L L + L L+L N+L L A V
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGV--------------- 78
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNA 308
D L L ++NN L S+P G+ F
Sbjct: 79 -----FDDL---TELGTLGLANNQLA-SLPLGV---------------FDHLT------- 107
Query: 309 RNLSELFMQRNQISGFIPSEIY-RAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQS 366
L +L++ NQ+ +PS ++ R L ++ L+ N L IP+G L L L L +
Sbjct: 108 -QLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLST 164
Query: 367 NKLNSSIPNSLSSLKSLNVLDLSNN 391
N+L S + L L + L N
Sbjct: 165 NQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 36/133 (27%), Positives = 56/133 (42%), Gaps = 6/133 (4%)
Query: 265 RFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGF 324
+ + + L L ++ ++L YN A + L L + NQ++
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 325 IPSEIY-RAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSL-SSLK 381
+P ++ L K+ L N L +PSG+ L KL L L +N+L SIP L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLT 155
Query: 382 SLNVLDLSNNLLT 394
+L L LS N L
Sbjct: 156 NLQTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/123 (33%), Positives = 55/123 (44%), Gaps = 9/123 (7%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIF 65
TL F + L L L+NN PL VF +LT L+ L N +L LP
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGN---QLKSLPSGVFD 128
Query: 66 RLTKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
RLTKL+ + L T L IPA +T+L L L+ N + L L+ + L+
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 125 YNQ 127
NQ
Sbjct: 188 GNQ 190
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 49/342 (14%), Positives = 119/342 (34%), Gaps = 70/342 (20%)
Query: 123 LYYNQQL---AGTIPEELGNLTELTDLDMSVNHLSGKIPESILRL-----PKLRVLQLYN 174
+ Y L + + E +T LD+S+N+L +++ + L L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 175 NSLSGEISSVIA-----NSTTLTMLSLYDNSLTGEVPQDLGQW-----SPLVVLDLSENK 224
NSL + S + +T L+L N L+ + +L + + VLDL N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 225 LSGPLPAKVCSRGKLQYFLVLQNMFSGV--LPDSLARC-KNLLRFRVSNNHL--EG--SI 277
S + + ++ + N L + +
Sbjct: 121 FSS----------------------KSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158
Query: 278 PEGILSLP-HVSIIDLSYNSFSGPIANTVGNA-----RNLSELFMQRNQISGFIPSEIYR 331
+ + ++P +V+ ++L N+ + + +++ L + N + +E+
Sbjct: 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218
Query: 332 AI-----SLVKIDLSDNLLSGP----IPSGIGNLKKLNLLMLQSNKLNS-------SIPN 375
+V ++L N L GP + +LK L + L + + + ++
Sbjct: 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278
Query: 376 SLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLS 417
+ +++ + ++D + + + L+ ++ + S
Sbjct: 279 AFPNIQKIILVDKNGKEIHPSHSIPISNLI-RELSGKADVPS 319
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/309 (13%), Positives = 94/309 (30%), Gaps = 67/309 (21%)
Query: 17 QNLRRLDLSNNLFT--GQFPLS---VFNLTNLEVLSFNENP-----GFKLWKLPESSIFR 66
+ LDLS N L ++ L+ + N +L ++ +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 67 LTKLRIMVLATCALHGQIPASIGNV-----TSLTDLELTGNFITGHIPPEIGLL-----K 116
+T L L+ L + + ++T L+L N + E
Sbjct: 82 VTSLN---LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 117 NLRQLELYYNQ-------QLAGTIPEELGNLTELTDLDMSVNHLSGK----IPESILRLP 165
++ L L N +L + N+ L ++ N+L+ K + + + +P
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSL---NLRGNNLASKNCAELAKFLASIP 195
Query: 166 K-LRVLQLYNNSLSGEISSVIA-----NSTTLTMLSLYDNSLTGEVPQDLGQW----SPL 215
+ L L N L + + +A + L+L N L G ++L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 216 VVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG 275
+ L + + + + L + + ++ + +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKA-----------------LGAAFPNIQKIILVDKNGKEIH- 297
Query: 276 SIPEGILSL 284
P + +
Sbjct: 298 --PSHSIPI 304
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/256 (16%), Positives = 87/256 (33%), Gaps = 49/256 (19%)
Query: 14 SPMQNLRRLDLSNNLFTGQ------FPLSVFNLTNLEVLSFNENP----GFKLWKLPESS 63
+ ++ L+LS N + L+ N+ L+ + N L ++
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIP-ANVTSLNLSGNFLSYKSSDE--LVKTL 104
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNV-----TSLTDLELTGNFITGHIPPEIGLL--- 115
+ ++ L + + S+T L L GN + E+ +
Sbjct: 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164
Query: 116 --KNLRQLELYYN-------QQLAGTIPEELGNLTELTDLDMSVNHLSGK----IPESIL 162
N+ L L N +LA + ++T LD+S N L K +
Sbjct: 165 IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS---LDLSANLLGLKSYAELAYIFS 221
Query: 163 RLP-KLRVLQLYNNSLSGE----ISSVIANSTTLTMLSLYDNSL---TGEVPQDLGQWSP 214
+P + L L N L G + + + L + L + + + E + LG P
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 215 ----LVVLDLSENKLS 226
++++D + ++
Sbjct: 282 NIQKIILVDKNGKEIH 297
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 8e-11
Identities = 31/205 (15%), Positives = 58/205 (28%), Gaps = 42/205 (20%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQ---- 572
+ F E + K+G+G G V++ + VA+K + + + +
Sbjct: 11 VPFSHCLPTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 573 -----------LQLDKGLKTEVETLGNIRHKNIVK---------LYCYFSSLYCNL---- 608
L + E + + V+ + +++S +
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 609 ---------LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659
+V E+ G D T I + LA L H
Sbjct: 130 DFFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEH 185
Query: 660 RDIKSTNILLDVNYQPKVADFGIAK 684
RD+ N+LL K+ K
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 50/255 (19%), Positives = 90/255 (35%), Gaps = 70/255 (27%)
Query: 519 FDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
+ ++ M G G G V +++ + AVK + + + ++
Sbjct: 33 LNNAFLVIRKM------GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------- 78
Query: 577 KGLKTEVETLGNIRH-----KNIVKLYCYFSSLYCN--LLVYEYMPNGNLWDAL----HK 625
K E + L I++ NIVK + F +Y + L++E + +L++ + +
Sbjct: 79 ---KIEADILKKIQNDDINNNNIVKYHGKF--MYYDHMCLIFEPL-GPSLYEIITRNNYN 132
Query: 626 GLVHLDWPTRH--KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL-DVNYQPKVADFGI 682
G + + L YL + H D+K NILL D ++ +
Sbjct: 133 GF-----HIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR 184
Query: 683 AKVLQARGGKDSTTTVI------AGTYG------------YLAPE----YAYSSKATTKC 720
+ + +T I T+ Y APE +
Sbjct: 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWD----VSS 240
Query: 721 DVYSFGVVLMELITG 735
D++SFG VL EL TG
Sbjct: 241 DMWSFGCVLAELYTG 255
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 24/96 (25%), Positives = 38/96 (39%), Gaps = 3/96 (3%)
Query: 108 IPPEIGLLKNLRQLELYYNQQLAGTIPEE-LGNLTELTDLDMSVNHLSGKIPESILRLPK 166
+ +NL +L + Q L + L L EL +L + + L P++ P+
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 167 LRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202
L L L N+L +S +L L L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 20/106 (18%), Positives = 38/106 (35%), Gaps = 5/106 (4%)
Query: 74 VLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPE-IGLLKNLRQLELYYNQQLAGT 132
+ T + +LT+L + H+ + L LR L + + L
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS-GLR-F 70
Query: 133 IPEE-LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177
+ + L+ L++S N L + ++ L+ L L N L
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 1/93 (1%)
Query: 325 IPSEIYRAISLVKIDLSDNLLSGPIPSG-IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSL 383
+ A +L ++ + + + + L +L L + + L P++ L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 384 NVLDLSNNLLTGYIPESLCELLPNSINFSNNRL 416
+ L+LS N L +++ L + S N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 20/105 (19%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLP 60
+ +L +NL L + N L L L L+ ++ L +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS---GLRFVA 72
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFIT 105
+ +L + L+ AL + SL +L L+GN +
Sbjct: 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 6e-06
Identities = 20/88 (22%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 309 RNLSELFMQRNQISGFIPSE-IYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQS 366
NL+EL+++ Q + + L + + + L + +L+ L L
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSF 89
Query: 367 NKLNSSIPNSLSSLKSLNVLDLSNNLLT 394
N L S+ SL L LS N L
Sbjct: 90 NAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 13/97 (13%), Positives = 34/97 (35%), Gaps = 4/97 (4%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPI-ANTVGNARNLSELFMQRNQISGFIPSEIYRAI- 333
+ +++ + + + + L L + ++ + F+ + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN 370
L +++LS N L + L L+L N L+
Sbjct: 81 RLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 15/91 (16%), Positives = 31/91 (34%), Gaps = 2/91 (2%)
Query: 254 PDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLSYNSFSGPIANTVGNARNLS 312
L +NL + N + L L + + + + + LS
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 313 ELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343
L + N + + + + +SL ++ LS N
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 60/268 (22%), Positives = 94/268 (35%), Gaps = 65/268 (24%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G G G +Y D+ +GE VA+K T QL E + ++
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHI----ESKIYKMMQG 63
Query: 592 -KNIVKLYCYFSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
I + + N++V E + G +L D + T +A + + Y+
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPK---VADFGIAK---------VLQARGGKDSTTT 697
H IHRD+K N L+ + + + DFG+AK + R K+ T T
Sbjct: 122 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 698 VIAGTYGYLAPEYAYSSKATTKC-------DVYSFGVVLMELITGRKPVEDDFGDNKNII 750
Y+S T D+ S G VLM G P
Sbjct: 179 AR------------YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP------------ 214
Query: 751 YWVSIKVDTK-EGIMEVLDKKLSGSFRD 777
W +K TK + + +KK+S
Sbjct: 215 -WQGLKAATKRQKYERISEKKMSTPIEV 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 65/265 (24%), Positives = 90/265 (33%), Gaps = 79/265 (29%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR- 590
K+G G TV+ D+ + VA+K V S + E+ L ++R
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK--------VVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 591 -------HKNIVKLYCYFS------SLYCNLLVYEYMPNG-NLWDALHKGLVH-LDWPTR 635
+ +V+L F + C +V+E + G +L + K L P
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHIC--MVFEVL--GHHLLKWIIKSNYQGLPLPCV 148
Query: 636 HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN----------------------- 672
KI V QGL YLH IIH DIK NILL VN
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 673 ------------------YQPKVADFG---IAKVLQARGGKDSTTTVIAGTYGYLAPEYA 711
+PK A+ IA + A T I T Y + E
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI-QTRQYRSLEVL 265
Query: 712 YSSKATTKCDVYSFGVVLMELITGR 736
S T D++S + EL TG
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGD 290
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 8/118 (6%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL-GNLTE 142
+P I +T+L L GN T +P E+ K+L ++L N+ T+ + N+T+
Sbjct: 25 LPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNR--ISTLSNQSFSNMTQ 79
Query: 143 LTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
L L +S N L IP L LR+L L+ N +S + + L+ L++ N
Sbjct: 80 LLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 4/84 (4%)
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSL 177
+L L NQ +P+EL N LT +D+S N +S + + +L L L N L
Sbjct: 34 TELYLDGNQ--FTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90
Query: 178 SGEISSVIANSTTLTMLSLYDNSL 201
+L +LSL+ N +
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 313 ELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNS 371
EL++ NQ + +P E+ L IDLS+N +S + + N+ +L L+L N+L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRC 92
Query: 372 SIPNSLSSLKSLNVLDLSNNLL 393
P + LKSL +L L N +
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 24/99 (24%), Positives = 44/99 (44%), Gaps = 7/99 (7%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSI 64
T + S ++L +DLSNN + F N+T L L + N +L +P +
Sbjct: 43 FTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN---RLRCIPPRTF 98
Query: 65 FRLTKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGN 102
L LR++ L + +P ++++L+ L + N
Sbjct: 99 DGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 5e-09
Identities = 27/149 (18%), Positives = 54/149 (36%), Gaps = 18/149 (12%)
Query: 92 TSLTDLELTGNFITGHIPPEIG--LLKNLRQLELYY--NQQLAGTIPEEL------GNLT 141
+L LE+ + + +I L NL +L LY
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 142 ELTDLDMSVNHLSGKIPESILR---LPKLRVLQLYNNSLSGE----ISSVIANSTTLTML 194
L L + + E L LP+L + + L+ E + + L +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223
++ N L+ E+ ++L + P + +D+S++
Sbjct: 313 NMKYNYLSDEMKKELQKSLP-MKIDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 5e-07
Identities = 26/221 (11%), Positives = 68/221 (30%), Gaps = 21/221 (9%)
Query: 213 SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNH 272
+ + ENK + + + L L L ++
Sbjct: 124 CSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT- 182
Query: 273 LEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR--NLSEL---FMQRNQISGFIPS 327
++ G P++ +++ + + + NL +L + +
Sbjct: 183 --NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240
Query: 328 EIYRAIS------LVKIDLSDNLLSGPIPSGIGN---LKKLNLLMLQSNKLNSS----IP 374
S L + + D + L +L + + + L +
Sbjct: 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLL 300
Query: 375 NSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNR 415
+ + +K L +++ N L+ + + L + LP I+ S+++
Sbjct: 301 DHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 27/198 (13%), Positives = 63/198 (31%), Gaps = 24/198 (12%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTN----LEVLSFNENPGFKLWKLPESSIFRLT 68
+ L + F + +S + L+ + N K
Sbjct: 135 KEKFAHFEGLFWGDIDFE-EQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRP 193
Query: 69 KLRIMVLATCALHGQIPASIG--NVTSLTDLEL---TGNFITGHIPPEI------GLLKN 117
L+ + + + L + I ++ +L L L ++ N
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253
Query: 118 LRQLELYYNQQLAGTIPEELGN---LTELTDLDMSVNHLSGK----IPESILRLPKLRVL 170
L+ L + + + E L +L +D+S L+ + + + + ++ L+ +
Sbjct: 254 LKWLGIVDAE-EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 171 QLYNNSLSGEISSVIANS 188
+ N LS E+ + S
Sbjct: 313 NMKYNYLSDEMKKELQKS 330
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 54/271 (19%), Positives = 93/271 (34%), Gaps = 69/271 (25%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G+G G +++ +L + + VA+K +R+ L+ E T +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAP-----------QLRDEYRTYKLLAG 64
Query: 592 -KNIVKLYCYFSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
I +Y + N+LV + + G +L D L T A + + +
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPK-----VADFGIAKV---------LQARGGKDS 694
H +++RDIK N L+ V DFG+ K + R K+
Sbjct: 123 HEKS----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKC-------DVYSFGVVLMELITGRKPVEDDFGDNK 747
+ T Y S T D+ + G V M + G P
Sbjct: 179 SGTAR------------YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--------- 217
Query: 748 NIIYWVSIKVDTKEGIME-VLDKKLSGSFRD 777
W +K T + E + +KK S R+
Sbjct: 218 ----WQGLKAATNKQKYERIGEKKQSTPLRE 244
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 44/241 (18%), Positives = 83/241 (34%), Gaps = 55/241 (22%)
Query: 523 EILEAMTEKNKVGQGGSGTVYK-IDLNSG-EVVAVKKLWSQRTKVSASDTDQLQLDKGLK 580
EI+ + G+G G V + +D G VA+K + + A+ +
Sbjct: 22 EIVGNL------GEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----------R 64
Query: 581 TEVETLGNIRHK------NIVKLYCYFSSLYCN--LLVYEYMPNGNLWDALHK-GLVHLD 631
E+ L I+ K V + +F + + +E + N ++ L +
Sbjct: 65 LEINVLKKIKEKDKENKFLCVLMSDWF--NFHGHMCIAFELL-GKNTFEFLKENNFQPYP 121
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
P +A+ + L +LH + + H D+K NIL + + + + ++
Sbjct: 122 LPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 692 KD-------STTTVIAGTYGYL------APE----YAYSSKATTKCDVYSFGVVLMELIT 734
S T + PE ++ CDV+S G +L E
Sbjct: 179 TSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWA----QPCDVWSIGCILFEYYR 234
Query: 735 G 735
G
Sbjct: 235 G 235
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 31/110 (28%), Positives = 46/110 (41%), Gaps = 6/110 (5%)
Query: 92 TSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEEL-GNLTELTDLDMS 149
+L +L L N + +P + L L L+L NQ +P + L L +L M
Sbjct: 64 INLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTV--LPSAVFDRLVHLKELFMC 120
Query: 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
N L+ ++P I RL L L L N L ++LT L+ N
Sbjct: 121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 43/160 (26%), Positives = 64/160 (40%), Gaps = 37/160 (23%)
Query: 20 RRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIF-RLTKLRIMVLAT 77
+ L L +N T + VF +L NL+ L N +L LP +F LT+
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSN---QLGALP-VGVFDSLTQ-------- 89
Query: 78 CALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQQLAGTIPEE 136
LT L+L N +T +P + L +L++L + N+ +P
Sbjct: 90 ----------------LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNK--LTELPRG 130
Query: 137 LGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
+ LT LT L + N L IP RL L L+ N
Sbjct: 131 IERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 43/120 (35%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL-GNLTE 142
+PA I T+ L L N IT P L NL++L L N QL +P + +LT+
Sbjct: 34 VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN-QLG-ALPVGVFDSLTQ 89
Query: 143 LTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201
LT LD+ N L+ +P ++ RL L+ L + N L+ E+ I T LT L+L N L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 7/120 (5%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY-RAIS 334
S+P GI + + I+ L N + + NL EL++ NQ+ +P ++
Sbjct: 33 SVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
L +DL N L+ +PS + L L L + NKL + +P + L L L L N L
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 3/83 (3%)
Query: 310 NLSELFMQRNQISGFIPSEIY-RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
L+ L + NQ++ +PS ++ R + L ++ + N L+ +P GI L L L L N+
Sbjct: 89 QLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ 146
Query: 369 LNSSIPNSLSSLKSLNVLDLSNN 391
L S + L SL L N
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 35/117 (29%), Positives = 52/117 (44%), Gaps = 10/117 (8%)
Query: 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT---GEVPQDLGQWSPLVVLDLSENK 224
++L L++N ++ V + L L L N L V L Q L VLDL N+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLGTNQ 99
Query: 225 LSGPLPAKVCSR-GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEG 280
L+ LP+ V R L+ + N + LP + R +L + N L+ SIP G
Sbjct: 100 LTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHG 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 33/97 (34%), Positives = 43/97 (44%), Gaps = 8/97 (8%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFN-LTNLEVLSFNENPGFKLWKLPESSIF 65
LP F + L LDL N T P +VF+ L +L+ L N KL +LP I
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCN---KLTELPR-GIE 132
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGN 102
RLT L + L L + ++SLT L GN
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 58/268 (21%), Positives = 97/268 (36%), Gaps = 65/268 (24%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR- 590
K+G G G +Y ++ + E VA+K T QL E + ++
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLLY----ESKIYRILQG 61
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
I + + N+LV + + G +L D + L T +A + + ++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 650 HHGLLSPIIHRDIKSTNILLDVNYQPK---VADFGIAKV---------LQARGGKDSTTT 697
H +HRDIK N L+ + + + DFG+AK + R K+ T T
Sbjct: 120 HS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 698 VIAGTYGYLAPEYAYSSKATTKC-------DVYSFGVVLMELITGRKPVEDDFGDNKNII 750
Y+S T D+ S G VLM + G P
Sbjct: 177 AR------------YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP------------ 212
Query: 751 YWVSIKVDTK-EGIMEVLDKKLSGSFRD 777
W +K TK + ++ +KK++ S
Sbjct: 213 -WQGLKAGTKKQKYEKISEKKVATSIEA 239
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 48/246 (19%), Positives = 92/246 (37%), Gaps = 65/246 (26%)
Query: 523 EILEAMTEKNKVGQGGSGTVYK-IDLNSG-EVVAVKKLWSQRTKVSASDTDQLQLDKGLK 580
EI++ + G+G G V + ID +G VAVK + + A+ +
Sbjct: 17 EIVDTL------GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----------R 59
Query: 581 TEVETLGNIRHK------NIVKLYCYFSSLYCN--LLVYEYMPNGNLWDAL----HKGLV 628
+E++ L ++ V++ +F + +V+E + + +D +
Sbjct: 60 SEIQVLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELL-GLSTYDFIKENGFLPF- 115
Query: 629 HLDWPTRH--KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686
H K+A+ + + + +LH + + H D+K NIL + + + I +
Sbjct: 116 ----RLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
Query: 687 QARGGKD-------STTTVIAGTYGYL------APE----YAYSSKATTKCDVYSFGVVL 729
+ D S T + APE +S CDV+S G +L
Sbjct: 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWS----QPCDVWSIGCIL 224
Query: 730 MELITG 735
+E G
Sbjct: 225 IEYYLG 230
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 9/120 (7%)
Query: 276 SIPEGILSLP-HVSIIDLSYNSFSGPIANTV-GNARNLSELFMQRNQISGFIPSEIYRAI 333
IP I P H + + L+ N ++ + G +L +L ++RNQ++G P+ A
Sbjct: 22 EIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 334 SLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPN-SLSSLKSLNVLDLSNN 391
+ ++ L +N + I + + L +L L L N++ S + S L SL L+L++N
Sbjct: 79 HIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 31/120 (25%), Positives = 51/120 (42%), Gaps = 10/120 (8%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGL--LKNLRQLELYYNQQLAGTIPEEL-GNL 140
IP I T+L L N + I + L +L +LEL NQ I
Sbjct: 23 IPRDIP--LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQ--LTGIEPNAFEGA 77
Query: 141 TELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
+ + +L + N + +I + L +L+ L LY+N +S + + +LT L+L N
Sbjct: 78 SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 2/85 (2%)
Query: 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSL 177
+L L N+ + G L L L++ N L+ I + ++ LQL N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 178 SGEISSVIANSTTLTMLSLYDNSLT 202
+ + L L+LYDN ++
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 313 ELFMQRNQISGFIPSEIY-RAISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLN 370
EL + N++ ++ R LVK++L N L+G I + L L NK+
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI- 90
Query: 371 SSIPNSL-SSLKSLNVLDLSNNLLTGYIPE 399
I N + L L L+L +N ++ +
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISC-VMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 5/91 (5%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLR 71
F + +L +L+L N TG + F ++++ L EN K+ ++ L +L+
Sbjct: 50 FGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGEN---KIKEISNKMFLGLHQLK 105
Query: 72 IMVLATCALHGQIPASIGNVTSLTDLELTGN 102
+ L + +P S ++ SLT L L N
Sbjct: 106 TLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 53/266 (19%), Positives = 87/266 (32%), Gaps = 69/266 (25%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G G G + +L + E VA+K L +++ L E +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP-----------QLHLEYRFYKQLGS 63
Query: 592 -KNIVKLYCYFSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
I ++Y + N +V E + G +L D T IA + + Y+
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 650 H-HGLLSPIIHRDIKSTNILLDVNYQPK-----VADFGIAK---------VLQARGGKDS 694
H +I+RD+K N L+ + DF +AK + R K
Sbjct: 122 HSKN----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKC-------DVYSFGVVLMELITGRKPVEDDFGDNK 747
T T Y S T D+ + G + M + G P
Sbjct: 178 TGTAR------------YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP--------- 216
Query: 748 NIIYWVSIKVDTKEGIME-VLDKKLS 772
W +K DT + + + D K +
Sbjct: 217 ----WQGLKADTLKERYQKIGDTKRA 238
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 115 LKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174
++EL+ + L L L +S N++ KI S+ + LR+L L
Sbjct: 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGR 79
Query: 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
N + +I ++ A + TL L + N + + + L VL +S NK++
Sbjct: 80 NLIK-KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 33/131 (25%), Positives = 58/131 (44%), Gaps = 17/131 (12%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEI-GL--LKNLRQLELYYNQQLAGTIPEELGNL 140
+ A++ + + L L+ N I +I L ++NLR L L N E L +
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLI---KKIENLDAV 91
Query: 141 TE-LTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV--IANSTTLTMLSLY 197
+ L +L +S N ++ + I +L LRVL + NN ++ + +A L L L
Sbjct: 92 ADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLA 148
Query: 198 DNSLTGEVPQD 208
N L + ++
Sbjct: 149 GNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 30/174 (17%), Positives = 59/174 (33%), Gaps = 21/174 (12%)
Query: 260 CKNLLRFRVSNNHLEGSIPEGI-LSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQR 318
K+ +R + + E + L I + + + L +
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDAT---------LSTLKACKHLALST 57
Query: 319 NQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLS 378
N I S + +L + L NL+ I + L L + N++ +S+ +
Sbjct: 58 NNIEKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQI-ASLSG-IE 112
Query: 379 SLKSLNVLDLSNNLLTGYIPESLCEL--LPN--SINFSNNRLSGPIPLSLIKEG 428
L +L VL +SNN +T + + +L L + + N L +
Sbjct: 113 KLVNLRVLYMSNNKITNW--GEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 31/137 (22%), Positives = 48/137 (35%), Gaps = 14/137 (10%)
Query: 94 LTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP--EELGNLTELTDLDMSVN 151
+L I + + LK + L L N I L + L L + N
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNN-----IEKISSLSGMENLRILSLGRN 80
Query: 152 HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT--GEVPQDL 209
+ KI L L + N ++ +S I L +L + +N +T GE+ L
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKL 136
Query: 210 GQWSPLVVLDLSENKLS 226
L L L+ N L
Sbjct: 137 AALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 32/165 (19%), Positives = 52/165 (31%), Gaps = 39/165 (23%)
Query: 21 RLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCAL 80
L ++ L + L+ + N + K+
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTN--------------NIEKIS--------- 64
Query: 81 HGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ--QLAGTIPEELG 138
S+ + +L L L N I I + L +L + YNQ L+G +
Sbjct: 65 ------SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IE 112
Query: 139 NLTELTDLDMSVNHLSG-KIPESILRLPKLRVLQLYNNSLSGEIS 182
L L L MS N ++ + + L KL L L N L +
Sbjct: 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 38/167 (22%), Positives = 59/167 (35%), Gaps = 42/167 (25%)
Query: 14 SPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIM 73
S ++ + L LS N LS + NL +LS N + K
Sbjct: 45 STLKACKHLALSTNNIEKISSLS--GMENLRILSLGRN--------------LIKK---- 84
Query: 74 VLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTI 133
I +L +L ++ N I + I L NLR L + N+
Sbjct: 85 ----------IENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGE 132
Query: 134 PEELGNLTELTDLDMSVNHLSGKIPES----------ILRLPKLRVL 170
++L L +L DL ++ N L E+ + RLP L+ L
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 49/279 (17%), Positives = 86/279 (30%), Gaps = 67/279 (24%)
Query: 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL---------DKGLKTEV 583
+GQGG G +Y D+NS E V KV SD L +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPC--VVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 584 ETLGNIRHKNIVKLYCY----FSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKI 638
+++ + K + + ++ + G +L T ++
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQL 157
Query: 639 AFGVAQGLAYLH-HGLLSPIIHRDIKSTNILLDVNYQPKV--ADFGIAKVLQARGGKDST 695
+ + L Y+H H +H DIK++N+LL+ +V D+G+A
Sbjct: 158 SLRILDILEYIHEHEY----VHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-----CPEG 208
Query: 696 TTV---------IAGTYGYLAPEYAYSSKATTKC-------DVYSFGVVLMELITGRKPV 739
GT E+ S D+ G +++ +TG P
Sbjct: 209 VHKAYAADPKRCHDGT-----IEFT--SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP- 260
Query: 740 EDDFGDNKNIIYWVSIKVDTK-EGIMEVLDKKLSGSFRD 777
W D K ++ ++ S D
Sbjct: 261 ------------WEDNLKDPKYVRDSKIRYRENIASLMD 287
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 11/118 (9%)
Query: 90 NVTSLTDLELTGNFIT-GHIPPEIGLLKNLRQLELYYNQ--QLAGTIPEELGNLTELTDL 146
++ +L L G I NL L L ++ L L +L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-----LPKLPKLKKL 76
Query: 147 DMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV--IANSTTLTMLSLYDNSLT 202
++S N + G + +LP L L L N L +IS++ + L L L++ +T
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLL 393
+L + L + L S + L KL L L N++ + L +L L+LS N L
Sbjct: 50 NLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 394 T 394
Sbjct: 108 K 108
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 38/120 (31%), Positives = 53/120 (44%), Gaps = 7/120 (5%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGN-LTE 142
+P I T L+L N + L +L QL L N +L ++P + N LT
Sbjct: 22 VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN-KLQ-SLPNGVFNKLTS 77
Query: 143 LTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201
LT L++S N L +P + +L +L+ L L N L V T L L LY N L
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 34/121 (28%), Positives = 61/121 (50%), Gaps = 8/121 (6%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY-RAIS 334
S+P GI + + +DL NS +L++L++ N++ +P+ ++ + S
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSL-SSLKSLNVLDLSNNL 392
L ++LS N L +P+G+ L +L L L +N+L S+P+ + L L L L N
Sbjct: 78 LTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQ 135
Query: 393 L 393
L
Sbjct: 136 L 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 9 TLPD--FSPMQNLRRLDLSNNLFTGQFPLSVFN-LTNLEVLSFNENPGFKLWKLPESSIF 65
+LP+ F+ + +L L+LS N P VF+ LT L+ L+ N N +L LP+
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTN---QLQSLPDGVFD 121
Query: 66 RLTKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGN 102
+LT+L+ + L L +P + +TSL + L N
Sbjct: 122 KLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 13/120 (10%)
Query: 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDL-GQWSPLVVLDLSENKLS 226
L L NSL + V T+LT L L N L +P + + + L L+LS N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 227 GPLPAKVCSR-GKLQYFLVLQNMFSGVLP----DSLARCKNLLRFRVSNNHLEGSIPEGI 281
LP V + +L+ + N LP D L L R+ N L+ S+P+G+
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT---QLKDLRLYQNQLK-SVPDGV 143
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 3/88 (3%)
Query: 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366
NA EL ++ +I I + ID SDN + + G L++L L++ +
Sbjct: 17 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73
Query: 367 NKLNSSIPNSLSSLKSLNVLDLSNNLLT 394
N++ +L L L L+NN L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 29/117 (24%), Positives = 45/117 (38%), Gaps = 11/117 (9%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP--EELGNLTELTDLD 147
N +L+L G I I L ++ N+ I + L L L
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE-----IRKLDGFPLLRRLKTLL 70
Query: 148 MSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV--IANSTTLTMLSLYDNSLT 202
++ N + LP L L L NNSL E+ + +A+ +LT L + N +T
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 31/130 (23%), Positives = 52/130 (40%), Gaps = 11/130 (8%)
Query: 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELG-NLTELTDLDMSVNHLSG 155
++LT I + R+L+L + + E LG L + +D S N +
Sbjct: 2 VKLTAELIEQ--AAQYTNAVRDRELDLRGYKI---PVIENLGATLDQFDAIDFSDNEIR- 55
Query: 156 KIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT--GEVPQDLGQWS 213
K+ + L +L+ L + NN + + LT L L +NSL G++ L
Sbjct: 56 KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLK 113
Query: 214 PLVVLDLSEN 223
L L + N
Sbjct: 114 SLTYLCILRN 123
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 33/118 (27%), Positives = 52/118 (44%), Gaps = 7/118 (5%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEEL-GNLTE 142
+P I +S T LEL N + L L +L L NQ ++P+ + LT+
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ--IQSLPDGVFDKLTK 77
Query: 143 LTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
LT L + N L +P + +L +L+ L L N L + T+L + L+ N
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 6/118 (5%)
Query: 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY-RAIS 334
S+P GI S + ++L N L++L + +NQI +P ++ +
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 335 LVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
L + L +N L +P+G+ L +L L L +N+L S L SL + L N
Sbjct: 78 LTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLE-LYYNQQLAGTIPEELGNLTELTDLDM 148
+ + +L L + GL +LE L +I L L +L L++
Sbjct: 15 TPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLEL 71
Query: 149 SVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV--IANSTTLTMLSLYDNSLT 202
S N +SG + + P L L L N + ++S++ + L L L++ +T
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 21/113 (18%), Positives = 44/113 (38%), Gaps = 9/113 (7%)
Query: 307 NARNLSELFMQRNQIS-GFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
++ EL + ++ + G + L + + L+ + + L KL L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL--LPN--SINFSNN 414
N+++ + +L L+LS N + ++ L L N S++ N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 23/112 (20%), Positives = 42/112 (37%), Gaps = 26/112 (23%)
Query: 115 LKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174
++++L L ++ G + EL L L+ I ++ +L KL+ L+L +
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
N +SG + + LT L+LS NK+
Sbjct: 74 NRVSGGLEVLAEKCPNLT------------------------HLNLSGNKIK 101
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 34/169 (20%), Positives = 61/169 (36%), Gaps = 28/169 (16%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQL--------QLDKGLKTEV 583
K+G GG G +Y N E A + KV + L ++ K +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVV-----KVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 584 -ETLGNIRHKNIVKLYCYFSSLYC----NLLVYEYMPNG-NLWDALHKGLVHLDWPTRHK 637
+ + I Y + + +V E + G +L + T +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQ 155
Query: 638 IAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV--ADFGIAK 684
+ + L Y+H + +H DIK+ N+LL +V AD+G++
Sbjct: 156 LGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 92 TSLTDLELTGNFITGHIPPEIGLL--------KNLRQLELYYNQQLAGTIPEE-----LG 138
+SL L L G +T P + ++ L ++ L Q + L
Sbjct: 72 SSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQ-----LDPAGLRTLLP 123
Query: 139 NLTELTDLDMSVNHLSGKIPESI---LRLPK--LRVLQLYNNSLSGE----ISSVIANST 189
L + +N L + + + L + + L+L NN L+ + +A +T
Sbjct: 124 VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNT 183
Query: 190 TLTMLSLYDNSLTGEVPQDLGQW----SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
++T LSL L E + L L L+++ N G A
Sbjct: 184 SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA-GDTAAL------------- 229
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHL--EG--SIPEGILSLPHVSIIDLSYNSFSGPI 301
L + +L + N L EG + + + + + +S +
Sbjct: 230 ------ALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGT--- 280
Query: 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN- 360
A + + LSE +QRN S + + + R + L+ DL D+ + P L ++
Sbjct: 281 AVSEYWSVILSE--VQRNLNS-WDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEG 337
Query: 361 ---LLMLQSNKLNS 371
L+ Q S
Sbjct: 338 EVRALLEQLGSSGS 351
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 46/336 (13%), Positives = 94/336 (27%), Gaps = 85/336 (25%)
Query: 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNL-EVLSFNENPGFKLWKLPESSIFRLTKLRIMV 74
+ +LR+L+L+ ++ T + VL
Sbjct: 71 LSSLRQLNLAGV------RMTPVKCTVVAAVLGSGR------------------------ 100
Query: 75 LATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL------LKNLRQLELYYNQ- 127
+L ++ L + GL R+L L N
Sbjct: 101 -----------------HALDEVNLASCQLD-----PAGLRTLLPVFLRARKLGLQLNSL 138
Query: 128 --QLAGTIPEEL-GNLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQLYNNSLSGE 180
+ + + L + ++T L +S N L+ + E + + L L + L E
Sbjct: 139 GPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
Query: 181 ----ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW----SPLVVLDLSENKLSGPLPAK 232
+++ + + L L++ N L + L +L L N+L +
Sbjct: 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL-SSEGRQ 257
Query: 233 V--CSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSII 290
V G + + + S L + + N + + + L L +
Sbjct: 258 VLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLEL---LLR 314
Query: 291 DLSYNSFSGPIANTVGNA----RNLSELFMQRNQIS 322
DL + + + L Q
Sbjct: 315 DLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 48/351 (13%), Positives = 98/351 (27%), Gaps = 62/351 (17%)
Query: 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGE 180
L +N+ + + + NL L + L + + L L +
Sbjct: 6 LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF--QN 63
Query: 181 ISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ-----WSPLVVLDLSENKLSGPLPAKVCS 235
++L L+L +T + L ++L+ +L
Sbjct: 64 QRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD----PAGLR 119
Query: 236 RGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGI------LSLPHVSI 289
L R + L + N L PE L I
Sbjct: 120 T----------------LLPVFLRARKL---GLQLNSLG---PEACKDLRDLLLHDQCQI 157
Query: 290 --IDLSYNSFSGP----IANTVGNARNLSELFMQRNQIS----GFIPSEIYRAISLVKID 339
+ LS N + + + +++ L + + + +++ R L +++
Sbjct: 158 TTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELN 217
Query: 340 LSDNLLSGP----IPSGIGNLKKLNLLMLQSNKLN-------SSIPNSLSSLKSLNVLDL 388
++ N + L LL L N+L+ + + + V
Sbjct: 218 VAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLT 277
Query: 389 SNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGL 439
++ Y L E+ N S +R L L+ L +S
Sbjct: 278 EGTAVSEYWSVILSEVQRN--LNSWDRARVQRHLELLLRDLEDSRGATLNP 326
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 42/271 (15%), Positives = 86/271 (31%), Gaps = 53/271 (19%)
Query: 532 NKVGQGGSGTVYK-IDLNSG--------EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTE 582
+ + G +Y+ ++ + ++K L ++ ++ + K L+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 583 VE-TLGNIRHKNIVKLYCYFSSLY-CNLLVYEYMPNG-NLWDALHK-GLVHLDWPTRHKI 638
L + I + LV + G +L AL L + ++
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQV 164
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV--ADFGIAKVLQARGG----K 692
A + L +LH + +H ++ + NI +D Q +V A +G A G
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKC-------DVYSFGVVLMELITGRKPVEDDFGD 745
+ + + G E+ S K D+ S G +++ + G P
Sbjct: 222 EGSRSPHEGD-----LEFI--SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP------- 267
Query: 746 NKNIIYWVSIKVDT-KEGIMEVLDKKLSGSF 775
W + +T + G F
Sbjct: 268 ------WTNCLPNTEDIMKQKQKFVDKPGPF 292
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 38/99 (38%), Positives = 47/99 (47%), Gaps = 17/99 (17%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGL---LKNLRQLELYYNQQLAGTIPEELG-- 138
+PA I T L L N IT + P G+ L NL+QL N+ A IP G
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITK-LEP--GVFDHLVNLQQLYFNSNKLTA--IPT--GVF 77
Query: 139 -NLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
LT+LT LD++ NHL IP L L + LYNN
Sbjct: 78 DKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 26/93 (27%), Positives = 41/93 (44%), Gaps = 5/93 (5%)
Query: 108 IPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPK 166
+P I + ++L L NQ + P +L L L + N L+ IP + +L +
Sbjct: 27 VPAGI--PTDKQRLWLNNNQ-ITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 167 LRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199
L L L +N L N +LT + LY+N
Sbjct: 83 LTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 32/99 (32%), Positives = 43/99 (43%), Gaps = 17/99 (17%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGL---LKNLRQLELYYNQQLAGTIPEELG-- 138
+P I T+ L L N IT + P G+ L L +L+L NQ +P G
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITK-LEP--GVFDRLTQLTRLDLDNNQLTV--LPA--GVF 74
Query: 139 -NLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNN 175
LT+LT L ++ N L IP L L + L NN
Sbjct: 75 DKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 113 GLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESIL-RLPKLRVLQ 171
G+ + L LY NQ + P LT+LT LD+ N L+ +P + +L +L L
Sbjct: 27 GIPTTTQVLYLYDNQ-ITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLS 84
Query: 172 LYNNSLSGEISSVIANSTTLTMLSLYDN 199
L +N L N +LT + L +N
Sbjct: 85 LNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 43/240 (17%), Positives = 81/240 (33%), Gaps = 32/240 (13%)
Query: 59 LPESSIFRLTKLRIMVLATCALH-GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKN 117
P + F +++ M L+ + + + + L +L L G ++ I + N
Sbjct: 84 QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 143
Query: 118 LRQLELYYNQQL-AGTIPEELGNLTELTDLDMS-VNHLSGKIPESILR--LPKLRVLQL- 172
L +L L + L + + L +L++S + K + + + L L
Sbjct: 144 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203
Query: 173 -YNNSLSGE-ISSVIANSTTLTMLSLYD-NSLTGEVPQDLGQWSPLVVLDLSENKLSGPL 229
Y +L +S+++ L L L D L + Q+ Q + L L LS
Sbjct: 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR------- 256
Query: 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSI 289
C L L +V +G++ +LPH+ I
Sbjct: 257 ----CYD------------IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 38/245 (15%), Positives = 74/245 (30%), Gaps = 38/245 (15%)
Query: 13 FSPMQNLRRLDLSN-NLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL---- 67
F +R+LDL L T + NLEVL + + + L
Sbjct: 289 FPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET-------RNVIGDRGLEVLAQYC 341
Query: 68 TKLRIMVLATCALHGQIPASIGNVT------------SLTDLELTGNFIT----GHIPPE 111
+L+ + + A + G V+ L + + + IT I
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401
Query: 112 IGLLKNLRQLELYYNQQLAGTIPEE-----LGNLTELTDLDMSVN--HLSGKIPESILRL 164
+ L + R + L +++ + L +L + L+ I +
Sbjct: 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQY 461
Query: 165 -PKLRVLQLYNNSLSGE-ISSVIANSTTLTMLSLYDNSLTGE-VPQDLGQWSPLVVLDLS 221
P +R + L S E + L L + + + + + L L +
Sbjct: 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521
Query: 222 ENKLS 226
+ S
Sbjct: 522 GYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 52/428 (12%), Positives = 114/428 (26%), Gaps = 67/428 (15%)
Query: 18 NLRRLDLSNNLFT--GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVL 75
L+ + + + L+ +LE L ++ GF + +
Sbjct: 113 QLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT-----TDGLLSIVT------ 161
Query: 76 ATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLL----KNLRQLELYYNQQLAG 131
+ + L + + + + L +L L Y +
Sbjct: 162 --------------HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKI 207
Query: 132 T---IPEELGNLTELTDLDMS-VNHLSGKIPESIL-RLPKLRVLQLYNNSLSGEISSVIA 186
+ + N L + + L L + L + E +
Sbjct: 208 SPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267
Query: 187 NSTTLTMLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
L L L + L ++ + LDL L + + L
Sbjct: 268 FPRKLCRLGLSY--MGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET 325
Query: 246 QNMFSGVLPDSLAR-CKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
+N+ + LA+ CK L R R+ E + + + +I L+
Sbjct: 326 RNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG--------- 376
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRA------ISLVKIDLSDNLLSGPIPSGIG---- 354
+ L + + + I+ I LV +D + + P+ +G+
Sbjct: 377 ---CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI 433
Query: 355 ---NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SI 409
L++ + Q + + ++ + L + PN +
Sbjct: 434 GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKL 493
Query: 410 NFSNNRLS 417
S
Sbjct: 494 EMRGCCFS 501
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 37/270 (13%), Positives = 87/270 (32%), Gaps = 23/270 (8%)
Query: 143 LTDLDMSVNHLSGKIPESILRL----PKLRVLQLYNNSLSGE-ISSVIANSTTLTMLSLY 197
D ++ + G + I + L ++L ++ + + + + +L L
Sbjct: 79 FADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLS 138
Query: 198 D-NSLTGEVPQDLGQWSP-LVVLDLSENKLSGP----LPAKVCSRGKLQYFLVLQNMFSG 251
+ + + L LDL E+ + L + L L + + S
Sbjct: 139 SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS-LNISCLASE 197
Query: 252 VLPDSL----ARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSY------NSFSGPI 301
V +L RC NL +++ + + P + + +
Sbjct: 198 VSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGL 257
Query: 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD-NLLSGPIPSGIGNLKKLN 360
+ + + L L + + ++P+ L ++LS + S + + KL
Sbjct: 258 SVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQ 317
Query: 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390
L + ++ + S+ K L L +
Sbjct: 318 RLWVLDYIEDAGLEVLASTCKDLRELRVFP 347
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 65/415 (15%), Positives = 142/415 (34%), Gaps = 64/415 (15%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF----NLTNLEVLSFNENPGFKLWKLPESSIFRLTK---- 69
NL+ LDL + + T+L L+ + ++ S++ RL
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLAS----EVSFSALERLVTRCPN 212
Query: 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGL------LKNLRQLEL 123
L+ + L ++ + L +L G GL K LR L
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSG 272
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-LPKLRVLQLYNNSLSGEIS 182
+++ A +P + LT L++S + +L PKL+ L + + +
Sbjct: 273 FWDAVPAY-LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331
Query: 183 SVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYF 242
+ + L L ++ + + + + + +S P KL+
Sbjct: 332 VLASTCKDLRELRVFPS-------EPFVMEPNVALTEQGLVSVSMGCP-------KLESV 377
Query: 243 LVLQNMFSGVLPDSLAR-CKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301
L + ++AR N+ RFR+ I + +D+
Sbjct: 378 LYFCRQMTNAALITIARNRPNMTRFRLC------IIEPKAPDYLTLEPLDIG-------F 424
Query: 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGP---------IPSG 352
V + ++L L +SG + +++ I + ++ + SG
Sbjct: 425 GAIVEHCKDLRRL-----SLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG 479
Query: 353 IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN 407
+L+KL + + ++ + S L+++ L +S+ ++ + L + +P
Sbjct: 480 CDSLRKLEI--RDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPK 532
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 840 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.7 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.52 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.29 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.21 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.96 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.27 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.21 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.04 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.64 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.42 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 83.57 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-57 Score=539.12 Aligned_cols=437 Identities=35% Similarity=0.525 Sum_probs=351.2
Q ss_pred CccccccccCCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccc
Q 003199 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCAL 80 (840)
Q Consensus 1 ~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l 80 (840)
++.|.+++.+|.|..+++|++|+|++|.+++.+|..+.++++|++|+|++|.+ ....+.. .+++|++|+|++|.+
T Consensus 207 Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l---~~~~~~~--~l~~L~~L~L~~n~l 281 (768)
T 3rgz_A 207 VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF---VGPIPPL--PLKSLQYLSLAENKF 281 (768)
T ss_dssp CCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCC---EESCCCC--CCTTCCEEECCSSEE
T ss_pred CcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcc---cCccCcc--ccCCCCEEECcCCcc
Confidence 35677888888899999999999999999988899999999999999999843 3211111 455555555555555
Q ss_pred cccCCccccCC-CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcc-cCCCCCCCeeeccCCcc-----
Q 003199 81 HGQIPASIGNV-TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEE-LGNLTELTDLDMSVNHL----- 153 (840)
Q Consensus 81 ~~~~~~~~~~l-~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~-l~~l~~L~~L~L~~n~l----- 153 (840)
++.+|..+..+ ++|++|+|++|.+++..|..|..+++|++|+|++|+ +.+.+|.. +..+++|++|+|++|.+
T Consensus 282 ~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p 360 (768)
T 3rgz_A 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN-FSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360 (768)
T ss_dssp EESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSE-EEEECCHHHHTTCTTCCEEECCSSEEEECCC
T ss_pred CCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCc-ccCcCCHHHHhcCCCCCEEeCcCCccCcccc
Confidence 55555555443 555555555555555555555555555555555554 33344433 44455555555555544
Q ss_pred --------------------cccCCccccC--CCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCC
Q 003199 154 --------------------SGKIPESILR--LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ 211 (840)
Q Consensus 154 --------------------~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 211 (840)
++..|..+.. +++|++|++++|.+++..|..+.++++|++|+|++|++++..|..+..
T Consensus 361 ~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 440 (768)
T 3rgz_A 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440 (768)
T ss_dssp TTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred HHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhc
Confidence 4444444444 567788888888887788888999999999999999999889999999
Q ss_pred CCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEe
Q 003199 212 WSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIID 291 (840)
Q Consensus 212 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 291 (840)
+++|+.|+|++|++++.+|..+..+++|++|++++|.+.+.+|..+..+++|++|++++|++++.+|.++..+++|+.|+
T Consensus 441 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 520 (768)
T 3rgz_A 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred CCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccCCcccCCCCCCceeecccceeeeccchhhcc----------------------------------------
Q 003199 292 LSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYR---------------------------------------- 331 (840)
Q Consensus 292 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------------------------------------- 331 (840)
|++|++++.+|..++.+++|+.|+|++|++++.+|..++.
T Consensus 521 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (768)
T 3rgz_A 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600 (768)
T ss_dssp CCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCC
T ss_pred CCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999877765533
Q ss_pred ------------------------------cCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhccccc
Q 003199 332 ------------------------------AISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLK 381 (840)
Q Consensus 332 ------------------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 381 (840)
+++|+.|||++|+++|.+|..++++++|+.|+|++|+++|.+|..|+.++
T Consensus 601 ~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~ 680 (768)
T 3rgz_A 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR 680 (768)
T ss_dssp GGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred chhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCC
Confidence 46789999999999999999999999999999999999999999999999
Q ss_pred CCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCccc--ccCCCcccccCCCCCccccc
Q 003199 382 SLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSL--IKEGLVESFSGNPGLCVSVS 444 (840)
Q Consensus 382 ~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~n~~~c~~~~ 444 (840)
+|+.|||++|+|+|.+|..+..+ .++.||+++|+++|.+|..- ..+ ...++.|||++||.+.
T Consensus 681 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~-~~~~~~gN~~Lcg~~l 745 (768)
T 3rgz_A 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF-PPAKFLNNPGLCGYPL 745 (768)
T ss_dssp TCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGS-CGGGGCSCTEEESTTS
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccC-CHHHhcCCchhcCCCC
Confidence 99999999999999999999998 57999999999999999752 222 4567999999999764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=499.19 Aligned_cols=428 Identities=32% Similarity=0.475 Sum_probs=359.7
Q ss_pred ccccccccCCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc
Q 003199 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 2 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~ 81 (840)
+.|.++|.+|. ..+++|++|+|++|.+++.+|. ++++++|++|+|++| .+....+..|..+++|++|+|++|.+.
T Consensus 186 s~n~l~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n---~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 260 (768)
T 3rgz_A 186 SGNKISGDVDV-SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGN---KLSGDFSRAISTCTELKLLNISSNQFV 260 (768)
T ss_dssp CSSEEESCCBC-TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSS---CCCSCHHHHTTTCSSCCEEECCSSCCE
T ss_pred CCCcccccCCc-ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCC---cCCCcccHHHhcCCCCCEEECCCCccc
Confidence 34555655543 7888899999999998877776 888999999999999 566555677889999999999999998
Q ss_pred ccCCccccCCCCCcEEEccCCcccccCchhhhcC-CCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCcc
Q 003199 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLL-KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPES 160 (840)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l-~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (840)
+..|.. .+++|++|+|++|++++.+|..+..+ ++|++|+|++|+ +.+.+|..|+.+++|++|+|++|.+++.+|..
T Consensus 261 ~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~ 337 (768)
T 3rgz_A 261 GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH-FYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337 (768)
T ss_dssp ESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSE-EEECCCGGGGGCTTCCEEECCSSEEEEECCHH
T ss_pred CccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCc-CCCccchHHhcCCCccEEECCCCcccCcCCHH
Confidence 777765 78899999999999998889888775 999999999997 67789999999999999999999999777765
Q ss_pred -ccCCCCCcEEEeeccccccccchhhhcCC-C--------------------------CCEEEccCCcCcccCCcCCCCC
Q 003199 161 -ILRLPKLRVLQLYNNSLSGEISSVIANST-T--------------------------LTMLSLYDNSLTGEVPQDLGQW 212 (840)
Q Consensus 161 -~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~--------------------------L~~L~L~~N~l~~~~~~~l~~l 212 (840)
+..+++|++|++++|++++..|..+..++ + |++|+|++|++++.+|..+..+
T Consensus 338 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l 417 (768)
T 3rgz_A 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417 (768)
T ss_dssp HHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGC
T ss_pred HHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcC
Confidence 89999999999999999877777666554 4 5555555555555666677777
Q ss_pred CCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEec
Q 003199 213 SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDL 292 (840)
Q Consensus 213 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 292 (840)
++|++|+|++|++++..|..+..+++|+.|++++|.+.+.+|..+..+++|++|++++|++++.+|..+..+++|+.|+|
T Consensus 418 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 497 (768)
T 3rgz_A 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497 (768)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEc
Confidence 78888888888888888888888888888888888888888888888888888888888888888888888899999999
Q ss_pred cCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcc-------------------
Q 003199 293 SYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI------------------- 353 (840)
Q Consensus 293 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------- 353 (840)
++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus 498 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~ 577 (768)
T 3rgz_A 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVY 577 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEE
T ss_pred cCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccc
Confidence 9999988888889999999999999999998999999999999999999998887776543
Q ss_pred ---------------------------------------------------cCccccchhcccCCccCCCcchhcccccC
Q 003199 354 ---------------------------------------------------GNLKKLNLLMLQSNKLNSSIPNSLSSLKS 382 (840)
Q Consensus 354 ---------------------------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 382 (840)
+.+++|+.|+|++|+++|.+|..++.+++
T Consensus 578 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~ 657 (768)
T 3rgz_A 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY 657 (768)
T ss_dssp EECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTT
T ss_pred cccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhcccc
Confidence 33567888999999999999999999999
Q ss_pred CCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccCC--CcccccCCC
Q 003199 383 LNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKEG--LVESFSGNP 437 (840)
Q Consensus 383 L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~~--~~~~~~~n~ 437 (840)
|+.|||++|+++|.+|..+..+ .++.||+++|+++|.+|..+.... ....+++|+
T Consensus 658 L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred CCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence 9999999999999999999988 578999999999999998766543 345666665
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=441.56 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=207.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|...+.||+|+||+||+|.+. ++..||||++.... ....+.|.+|++++++++|||||+++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----------~~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----------DNARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC----------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC----------hHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 45777889999999999999764 47889999985321 234578999999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcC------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKG------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNI 667 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni 667 (840)
+|.+.+..++|||||++|+|.++++.. ...++|.++..|+.|||+||+|||+ ++||||||||+||
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NI 159 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNC 159 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhE
Confidence 999999999999999999999999753 2469999999999999999999999 9999999999999
Q ss_pred EEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 003199 668 LLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDN 746 (840)
Q Consensus 668 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~ 746 (840)
|+++++.+||+|||+|+...... .........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.. .
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~ 236 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--N 236 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--H
T ss_pred EECCCCcEEECCcccceecCCCC-ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--H
Confidence 99999999999999998764421 1122234569999999999999999999999999999999999 999997531 1
Q ss_pred cchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 747 KNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
..... .+......+.....+.++.+++.+||+.||++|||++||.+.|+++.
T Consensus 237 ~~~~~-------------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 237 NEVIE-------------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH-------------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 11111111112223456778888999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=441.37 Aligned_cols=257 Identities=22% Similarity=0.329 Sum_probs=207.9
Q ss_pred hcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.+...+.||+|+||+||+|.+. +++.||||++..... ....+.|.+|+.++++++|||||+++|+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~---------~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE---------GPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC---------C-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC---------hHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3456678999999999999763 468899999854321 1234679999999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 665 (840)
|.+....++|||||++|+|.+++.... ..++|.++..|+.|||+||+|||+ ++||||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence 999999999999999999999996431 358999999999999999999999 99999999999
Q ss_pred CEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 003199 666 NILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744 (840)
Q Consensus 666 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 744 (840)
|||+++++.+||+|||+|+...... .........||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~- 252 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS- 252 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-
T ss_pred ceEECCCCCEEECCcccceeccCCC-ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999998765421 2223345679999999999999999999999999999999999 899997531
Q ss_pred CCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
...... .+......+...+.+..+.+++.+||+.||++||||+||+++|+.+.
T Consensus 253 -~~~~~~-------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 253 -NQDVVE-------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -HHHHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HHHHHH-------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111111 11111112222334456778899999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=436.74 Aligned_cols=262 Identities=28% Similarity=0.400 Sum_probs=203.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+++...++||+|+||+||+|.+++ .||||+++.... ..+..+.|.+|++++++++|||||+++|++.+ +
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~--------~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP--------TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC--------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 345677899999999999998763 699999853321 13345789999999999999999999999865 5
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|||||++|+|.++++.....++|.++..|+.|||.||+|||+ ++||||||||+|||+++++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 6899999999999999998776689999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
.... ..........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+... ...... ....
T Consensus 182 ~~~~-~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~---~~~~--- 252 (307)
T 3omv_A 182 KSRW-SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIF---MVGR--- 252 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHH---HHHT---
T ss_pred cccC-CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHH---HHhc---
Confidence 6432 12233455689999999999854 4689999999999999999999999975321 111111 0000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
....+.+.....+....+.+++.+||+.||++||||.||+++|+.+..
T Consensus 253 --~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 253 --GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp --TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred --CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 011112222223344567788889999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=442.78 Aligned_cols=257 Identities=26% Similarity=0.345 Sum_probs=201.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|...++||+|+||+||+|.++ +++.||||++.... ....+.|.+|++++++++|||||+++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----------~~~~~~f~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----------ESARQDFQREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS----------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC----------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 35666789999999999999764 47899999984321 234578999999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC--------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL--------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 665 (840)
+|.+....++|||||++|+|.++++... ..++|.++..|+.|||+||+|||+ ++||||||||+
T Consensus 111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~ 187 (329)
T 4aoj_A 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATR 187 (329)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHh
Confidence 9999999999999999999999997642 358999999999999999999999 99999999999
Q ss_pred CEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 003199 666 NILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744 (840)
Q Consensus 666 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 744 (840)
|||+++++.+||+|||+|+..... ..........||+.|||||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~-~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~- 265 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYST-DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS- 265 (329)
T ss_dssp GEEEETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-
T ss_pred hEEECCCCcEEEcccccceeccCC-CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-
Confidence 999999999999999999876432 12223345679999999999999999999999999999999999 999997531
Q ss_pred CCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.......+ ... .....+. ....++.+++.+||+.||++||||+||+++|+.+.
T Consensus 266 -~~~~~~~i---~~g-------~~~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 266 -NTEAIDCI---TQG-------RELERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp -HHHHHHHH---HHT-------CCCCCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHH---HcC-------CCCCCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 11111110 000 0111122 23456778888999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=437.41 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=200.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS--------SKEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC--------HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 5788999999999999999965 57999999999544321 23356789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
+..|+|||||++|+|.+++.... ..+++.+++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 99999999999999999997543 457899999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.+.. ........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. ......
T Consensus 173 ~~~~~---~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~--------- 235 (350)
T 4b9d_A 173 RVLNS---TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVL--------- 235 (350)
T ss_dssp SCCCH---HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHH---------
T ss_pred eeecC---CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHH---------
Confidence 87632 1122345679999999999999999999999999999999999999997531 111111
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+......+.......++.+++.+||+.||++|||++|++++
T Consensus 236 -~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 236 -KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111112233456778889999999999999999875
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=466.82 Aligned_cols=436 Identities=21% Similarity=0.205 Sum_probs=281.7
Q ss_pred CccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++.|.+++..|. |+++++|++|+|++|.|++..|.+|.++++|++|+|++| .+..+++..|..+++|++|+|++|.
T Consensus 40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~l~~L~~L~L~~n~ 116 (606)
T 3t6q_A 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN---PLIFMAETALSGPKALKHLFFIQTG 116 (606)
T ss_dssp CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC---CCSEECTTTTSSCTTCCEEECTTSC
T ss_pred ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC---cccccChhhhcccccccEeeccccC
Confidence 356777777664 888888888888888888777888888888888888888 5666677778888888888888888
Q ss_pred ccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCC--eeeccCCcccccC
Q 003199 80 LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELT--DLDMSVNHLSGKI 157 (840)
Q Consensus 80 l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~--~L~L~~n~l~~~~ 157 (840)
+++..|..++++++|++|+|++|++++..+..+..+++|++|++++|+ +.+..|..+..+++|+ +|++++|.+++..
T Consensus 117 i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~ 195 (606)
T 3t6q_A 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA-IHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195 (606)
T ss_dssp CSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC-CCEECHHHHHTTTTCCSEEEECTTCCCCEEC
T ss_pred cccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc-ccccChhhhhhhcccceeEEecCCCccCccC
Confidence 877667778888888888888888875443444557788888887776 4444455566666666 6666666666544
Q ss_pred CccccCC---------------------------------------------------CCCcEEEeeccccccccchhhh
Q 003199 158 PESILRL---------------------------------------------------PKLRVLQLYNNSLSGEISSVIA 186 (840)
Q Consensus 158 ~~~~~~l---------------------------------------------------~~L~~L~L~~N~l~~~~~~~~~ 186 (840)
|..|... .+|+.|++++|.+++..+..|.
T Consensus 196 ~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~ 275 (606)
T 3t6q_A 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH 275 (606)
T ss_dssp TTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTT
T ss_pred hhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhc
Confidence 4333210 0344444444444444444455
Q ss_pred cCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCcccc-------------------------CCCCchh
Q 003199 187 NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVC-------------------------SRGKLQY 241 (840)
Q Consensus 187 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-------------------------~l~~L~~ 241 (840)
.+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+. .+++|++
T Consensus 276 ~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~ 354 (606)
T 3t6q_A 276 CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354 (606)
T ss_dssp TCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCE
T ss_pred cccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCE
Confidence 5555555555555555 3444555555555555555555544444444 4455555
Q ss_pred hhcccccccccC--CcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCc-ccCCCCCCceeeccc
Q 003199 242 FLVLQNMFSGVL--PDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN-TVGNARNLSELFMQR 318 (840)
Q Consensus 242 L~l~~n~~~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~ 318 (840)
|++++|.+.+.. +..+..+++|++|++++|++.+..|..+..+++|+.|++++|++++..+. .+..+++|+.|++++
T Consensus 355 L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 434 (606)
T 3t6q_A 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434 (606)
T ss_dssp EECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTT
T ss_pred EECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCC
Confidence 555555554443 44555556666666666666555555666666666666666666554433 356666666666666
Q ss_pred ceeeeccchhhcccCcccEEEcCCCccCCC---CCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 319 NQISGFIPSEIYRAISLVKIDLSDNLLSGP---IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 319 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
|.+++..|..+..+++|+.|+|++|++++. .+..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++
T Consensus 435 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 514 (606)
T 3t6q_A 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514 (606)
T ss_dssp CCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCG
T ss_pred CccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCc
Confidence 666666666666666777777777766642 22456667777777777777776667777777777777777777777
Q ss_pred cCCchhhccCCCeEEccCCCCcCcCCccccc--CCCcccccCCCCCcc
Q 003199 396 YIPESLCELLPNSINFSNNRLSGPIPLSLIK--EGLVESFSGNPGLCV 441 (840)
Q Consensus 396 ~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~~--~~~~~~~~~n~~~c~ 441 (840)
.+|..+..+....|++++|++++..|..+.. ......+.+|||.|.
T Consensus 515 ~~~~~l~~l~~L~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 515 SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp GGGGGGTTCCSCEEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred CChhHhCcccccEEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 7777777663227777888877766654322 224567888888883
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=480.69 Aligned_cols=433 Identities=22% Similarity=0.262 Sum_probs=252.2
Q ss_pred ccccccccCCC-CCCCCCCCEEecCCCcCcccC-CccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 2 SFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQF-PLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 2 ~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~-p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++|.+++..|. |.++++|++|+|++|.+.+.+ |.+|.++++|++|+|++| .+..+.+..|.++++|++|+|++|.
T Consensus 32 s~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N---~l~~~~p~~~~~l~~L~~L~Ls~n~ 108 (844)
T 3j0a_A 32 SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS---KIYFLHPDAFQGLFHLFELRLYFCG 108 (844)
T ss_dssp ESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC---CCCEECTTSSCSCSSCCCEECTTCC
T ss_pred CCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC---cCcccCHhHccCCcccCEeeCcCCC
Confidence 34555555443 556666666666665333232 555566666666666666 4445555555566666666666666
Q ss_pred ccccCCcc--ccCCCCCcEEEccCCcccccCc-hhhhcCCCCCeeecccCccccccCCcccCCC--CCCCeeeccCCccc
Q 003199 80 LHGQIPAS--IGNVTSLTDLELTGNFITGHIP-PEIGLLKNLRQLELYYNQQLAGTIPEELGNL--TELTDLDMSVNHLS 154 (840)
Q Consensus 80 l~~~~~~~--~~~l~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l--~~L~~L~L~~n~l~ 154 (840)
+.+..|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|. +.+..+..+..+ ++|+.|+|++|.+.
T Consensus 109 l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~-i~~~~~~~l~~l~~~~L~~L~L~~n~l~ 187 (844)
T 3j0a_A 109 LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ-IFLVCEHELEPLQGKTLSFFSLAANSLY 187 (844)
T ss_dssp CSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC-CCCCCSGGGHHHHHCSSCCCEECCSBSC
T ss_pred CCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc-CCeeCHHHcccccCCccceEECCCCccc
Confidence 55444333 5556666666666666554433 355556666666665554 333333333333 34444444444444
Q ss_pred ccCCccccCCCC------CcEEEeeccccccccchhhhc--------------------------------------CCC
Q 003199 155 GKIPESILRLPK------LRVLQLYNNSLSGEISSVIAN--------------------------------------STT 190 (840)
Q Consensus 155 ~~~~~~~~~l~~------L~~L~L~~N~l~~~~~~~~~~--------------------------------------l~~ 190 (840)
+..|..+..+++ |+.|++++|.+++..+..+.. .++
T Consensus 188 ~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~ 267 (844)
T 3j0a_A 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267 (844)
T ss_dssp CCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSC
T ss_pred cccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCC
Confidence 333333333222 444444444433222221111 134
Q ss_pred CCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeC
Q 003199 191 LTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN 270 (840)
Q Consensus 191 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 270 (840)
|++|+|++|.+.+..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|.+.+..+..|..+++|+.|++++
T Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 347 (844)
T 3j0a_A 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347 (844)
T ss_dssp CCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCS
T ss_pred ccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCC
Confidence 55555555555544455555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ceeeccCCccccCCCcccEEeccCCcccccCC----------------------------------------cccCCCCC
Q 003199 271 NHLEGSIPEGILSLPHVSIIDLSYNSFSGPIA----------------------------------------NTVGNARN 310 (840)
Q Consensus 271 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----------------------------------------~~~~~l~~ 310 (840)
|++.+..+..|..+++|+.|+|++|.+++... ..+..+++
T Consensus 348 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~ 427 (844)
T 3j0a_A 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH 427 (844)
T ss_dssp CCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTT
T ss_pred CCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCc
Confidence 55554444445555555555555555443110 01235566
Q ss_pred Cceeecccceeeeccch-hhcccCcccEEEcCCCccC-----CCCCCcccCccccchhcccCCccCCCcchhcccccCCC
Q 003199 311 LSELFMQRNQISGFIPS-EIYRAISLVKIDLSDNLLS-----GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLN 384 (840)
Q Consensus 311 L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 384 (840)
|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|..+++|+
T Consensus 428 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 507 (844)
T 3j0a_A 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507 (844)
T ss_dssp CCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCS
T ss_pred cceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhh
Confidence 66666666666644332 2344567777777777775 33446688899999999999999999999999999999
Q ss_pred EEECcCccccccCCchhhccCCCeEEccCCCCcCcCCcccccCCCcccccCCCCCc
Q 003199 385 VLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLC 440 (840)
Q Consensus 385 ~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~n~~~c 440 (840)
.|+|++|+|++..|..+. ..++.|++++|+++|..|..+... ....+.+|||.|
T Consensus 508 ~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~~L-~~l~l~~Np~~C 561 (844)
T 3j0a_A 508 GLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFVSL-SVLDITHNKFIC 561 (844)
T ss_dssp EEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCSSC-CEEEEEEECCCC
T ss_pred eeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhCCc-CEEEecCCCccc
Confidence 999999999976666555 567899999999999999776533 567899999999
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=424.92 Aligned_cols=269 Identities=23% Similarity=0.289 Sum_probs=215.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++|||||++++++.+.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4688999999999999999955 5799999999854321 1122356789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..|+||||+++|+|.+++.+.. .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 99999999999999999998764 69999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+... .........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. ...........
T Consensus 181 ~~~~~-~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~----- 249 (311)
T 4aw0_A 181 VLSPE-SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKIIKL----- 249 (311)
T ss_dssp ECCTT-TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHT-----
T ss_pred ecCCC-CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC-----
Confidence 76432 22233456789999999999999999999999999999999999999997531 11111111110
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCCCCCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPN 822 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~ 822 (840)
+..++..+ ..++.+++.+|+++||++|||++|+..+-+-.....|...+|..
T Consensus 250 ---~~~~p~~~---s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 250 ---EYDFPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp ---CCCCCTTC---CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ---CCCCCccc---CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 01122222 33566788899999999999999976554444455555555544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=429.61 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=204.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++++.++|||||++++++.+.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----------RRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----------SGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----------HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4578888999999999999965 47999999998543211 123477899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..|+|||||++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCce
Confidence 9999999999999999999875 58999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. ........+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ........ .
T Consensus 219 ~~~~---~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i--------~ 283 (346)
T 4fih_A 219 QVSK---EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMI--------R 283 (346)
T ss_dssp ECCS---SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHH--------H
T ss_pred ecCC---CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHH--------H
Confidence 7643 2223456789999999999999999999999999999999999999997531 11111100 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+ ........++.+++.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSCCCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001111 1122234566778889999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=425.11 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=201.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...++||+|+||+||+|.. .+|+.||||++..... ..+|+.++++++|||||++++++.+.
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------------~~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------------RVEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4577788999999999999965 5799999999854321 13699999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a 683 (840)
...|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred CEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 99999999999999999998764 69999999999999999999999 9999999999999999987 6999999999
Q ss_pred hhhhccCCCC--cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 684 KVLQARGGKD--STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 684 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+.+...+... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+..... ....+ .....
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i---~~~~~ 273 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKI---ASEPP 273 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHH---HHSCC
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHH---HcCCC
Confidence 8775432111 12234679999999999999999999999999999999999999997643221 11110 00000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
. ...+++.+ ...+.+++.+||++||++|||+.|++++|...
T Consensus 274 ~-----~~~~~~~~---s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 274 P-----IREIPPSC---APLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp G-----GGGSCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----chhcCccC---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0 01122222 34566778899999999999999999988653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=426.42 Aligned_cols=272 Identities=25% Similarity=0.278 Sum_probs=200.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|...+.||+|+||+||+|.+. |+.||||++.... .....+..|+..+.+++|||||+++++|.+.+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-----------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-----------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 45677789999999999999885 8999999984321 11223445777778899999999999997654
Q ss_pred ----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCCCe
Q 003199 606 ----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG-----LLSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 606 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
..+||||||++|+|.++++.. .++|+.+..++.|++.||+|||+. +.++||||||||+|||++.++.+|
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 568999999999999999875 589999999999999999999973 123999999999999999999999
Q ss_pred eecccchhhhhccCCC-CcceecccccccccCccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 003199 677 VADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYSS------KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 749 (840)
|+|||+|+........ ........||+.|||||++.+. .++.++|||||||++|||+||+.||..........
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 9999999876432111 1223346799999999998764 36789999999999999999988875432211111
Q ss_pred hhhhhhhhccccchhhhcc----cccCCCc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 750 IYWVSIKVDTKEGIMEVLD----KKLSGSF--RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
..+.............+.. +.++..+ .+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1100000000000011112 2222222 245667889999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=416.23 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=194.6
Q ss_pred CccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec----
Q 003199 529 TEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS---- 603 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 603 (840)
...++||+|+||+||+|.. .++..||||++...... ....+.|.+|++++++++|||||+++++|.+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 3456799999999999965 47899999998543311 2335679999999999999999999999865
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcC-CCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLDV-NYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~-~~~~kl~Df 680 (840)
....++|||||++|+|.+++.+.. .+++..+..|+.||+.||+|||+ ++ ||||||||+|||++. ++.+||+||
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeC
Confidence 355799999999999999998764 69999999999999999999998 66 999999999999984 789999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+|+... .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... ............
T Consensus 177 Gla~~~~-----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~~ 246 (290)
T 3fpq_A 177 GLATLKR-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGV 246 (290)
T ss_dssp TGGGGCC-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTC
T ss_pred cCCEeCC-----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcCC
Confidence 9997532 223445689999999998865 699999999999999999999999964311 111111100000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ...++.+++.+||+.||++|||++|+++|
T Consensus 247 ------~~~~~~~~---~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 ------KPASFDKV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------CCGGGGGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCCcc---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111111 12356778889999999999999999976
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=453.74 Aligned_cols=416 Identities=21% Similarity=0.190 Sum_probs=372.2
Q ss_pred CccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++.|.+++..|+ |+++++|++|+|++|.+++..|..|.++++|++|+|++| .+..+++..|..+++|++|++++|.
T Consensus 64 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n---~i~~l~~~~~~~l~~L~~L~L~~n~ 140 (606)
T 3t6q_A 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT---GISSIDFIPLHNQKTLESLYLGSNH 140 (606)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTS---CCSCGGGSCCTTCTTCCEEECCSSC
T ss_pred CCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecccc---CcccCCcchhccCCcccEEECCCCc
Confidence 456778888776 999999999999999999888999999999999999999 6777777779999999999999999
Q ss_pred ccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCC--eeecccCcccccc-------------------------
Q 003199 80 LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR--QLELYYNQQLAGT------------------------- 132 (840)
Q Consensus 80 l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~--~L~L~~n~~~~~~------------------------- 132 (840)
+.+..+..+..+++|++|+|++|.+++..|..|..+++|+ .|++++|++ .+.
T Consensus 141 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l-~~~~~~~~~~~~L~~L~l~~~~~~~~~~ 219 (606)
T 3t6q_A 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIF 219 (606)
T ss_dssp CCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC-CEECTTTTTTCEEEEEECTTCSCHHHHH
T ss_pred ccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc-CccChhHhhhccccccccCCchhHHHHh
Confidence 9875545555699999999999999988888899999888 778877752 221
Q ss_pred --------------------------------------------------CCcccCCCCCCCeeeccCCcccccCCcccc
Q 003199 133 --------------------------------------------------IPEELGNLTELTDLDMSVNHLSGKIPESIL 162 (840)
Q Consensus 133 --------------------------------------------------~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (840)
.+..|..+++|++|++++|+++ .+|..+.
T Consensus 220 ~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~ 298 (606)
T 3t6q_A 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV 298 (606)
T ss_dssp HHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCC
T ss_pred hhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhc
Confidence 2233777899999999999999 6788899
Q ss_pred CCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCc-CCCCCCCcceeccccccccccC--CccccCCCCc
Q 003199 163 RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQ-DLGQWSPLVVLDLSENKLSGPL--PAKVCSRGKL 239 (840)
Q Consensus 163 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L 239 (840)
.+++|++|++++|.+.+..+..+..+++|++|++++|.+.+.++. .+..+++|++|++++|++++.. +..+..+++|
T Consensus 299 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L 378 (606)
T 3t6q_A 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378 (606)
T ss_dssp SCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTC
T ss_pred ccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCC
Confidence 999999999999999988888999999999999999999855554 5899999999999999999876 7889999999
Q ss_pred hhhhcccccccccCCcccccccCCceEEeeCceeeccCCc-cccCCCcccEEeccCCcccccCCcccCCCCCCceeeccc
Q 003199 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPE-GILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQR 318 (840)
Q Consensus 240 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 318 (840)
++|++++|.+.+..+..|..+++|++|++++|++++..+. .+..+++|+.|++++|.+++..+..++.+++|++|+|++
T Consensus 379 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 458 (606)
T 3t6q_A 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458 (606)
T ss_dssp CEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCC
Confidence 9999999999999999999999999999999999977665 488999999999999999999999999999999999999
Q ss_pred ceeeec---cchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 319 NQISGF---IPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 319 N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
|++++. .+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..|..+++| .|+|++|++++
T Consensus 459 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~ 537 (606)
T 3t6q_A 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI 537 (606)
T ss_dssp CBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCC
T ss_pred CCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccc
Confidence 999863 33678999999999999999999889999999999999999999999999999999999 99999999998
Q ss_pred cCCchhhcc-CCCeEEccCCCCcCcCCc
Q 003199 396 YIPESLCEL-LPNSINFSNNRLSGPIPL 422 (840)
Q Consensus 396 ~~p~~~~~~-~~~~l~l~~N~l~~~~p~ 422 (840)
.+|..+..+ .++.+++++|++.|.++.
T Consensus 538 ~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 538 ILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred cCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 888888777 679999999999999884
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=410.95 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=190.5
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|+..+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|++++++++|||||++++++.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-------KSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 46799999999999999999965 57999999998543321 12335678999999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..++||||+ +|+|.+++.+.. .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred CCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCC
Confidence 99999999999 789999998765 69999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.... ........||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.. .....+......
T Consensus 160 ~~~~~----~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~-- 228 (275)
T 3hyh_A 160 NIMTD----GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGV-- 228 (275)
T ss_dssp -------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC--
T ss_pred eecCC----CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC--
Confidence 87643 223345789999999999988876 579999999999999999999997531 111111111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..++... ..++.+++.+|++.||++|||++|++++
T Consensus 229 ------~~~p~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ------YTLPKFL---SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CCCCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCCC---CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1112222 3456678889999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=430.40 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=204.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----------RRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----------SGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----------HHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 4588889999999999999965 57999999998543211 124578999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..|+|||||++|+|.+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccce
Confidence 9999999999999999999765 58999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. ........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.. .. ...... .
T Consensus 296 ~~~~---~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~-~~~~~i-------~ 360 (423)
T 4fie_A 296 QVSK---EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PL-KAMKMI-------R 360 (423)
T ss_dssp ECCS---SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HH-HHHHHH-------H
T ss_pred ECCC---CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HH-HHHHHH-------H
Confidence 7643 2223456789999999999999999999999999999999999999997531 11 111100 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......+ ........++.+++.+||+.||++|||+.|+++|
T Consensus 361 ~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 361 DNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCCCCC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011111 1111233456678889999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=424.63 Aligned_cols=258 Identities=26% Similarity=0.342 Sum_probs=205.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC-CCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH-KNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~ 598 (840)
++|+..+.||+|+||+||+|.+.. ++.||||++..... ....+.|.+|++++++++| ||||+++
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~---------~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---------HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC---------HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---------hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 578889999999999999997542 36899999854321 2335679999999999975 8999999
Q ss_pred eEEecC-ccceEEEeecCCCChHHHhhcC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 003199 599 CYFSSL-YCNLLVYEYMPNGNLWDALHKG---------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDI 662 (840)
Q Consensus 599 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 662 (840)
|+|.+. ...++|||||++|+|.++++.. ...++|.++..++.|||+||+|||+ ++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCcc
Confidence 999664 5689999999999999999753 1348999999999999999999999 99999999
Q ss_pred CCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 003199 663 KSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVED 741 (840)
Q Consensus 663 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~ 741 (840)
||+|||+++++.+||+|||+|+.+... ..........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~-~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CccceeeCCCCCEEECcchhhhhcccC-CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876432 12233445679999999999999999999999999999999998 9999975
Q ss_pred CCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 742 DFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.... ...... +. .-.....+. ....++.+++.+||+.||++|||++||+++|+++
T Consensus 291 ~~~~-~~~~~~----i~------~g~~~~~p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKID-EEFCRR----LK------EGTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCS-HHHHHH----HH------HTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHH----HH------cCCCCCCCc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 3211 111110 00 000111122 2234677888899999999999999999999865
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=454.77 Aligned_cols=437 Identities=21% Similarity=0.208 Sum_probs=259.0
Q ss_pred ccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccc
Q 003199 2 SFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCAL 80 (840)
Q Consensus 2 ~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l 80 (840)
+.|.+++..+. |+++++|++|+|++|.+++..|..|.++++|++|+|++| .+..++...|..+++|++|+|++|.+
T Consensus 33 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n---~l~~l~~~~~~~l~~L~~L~L~~n~l 109 (680)
T 1ziw_A 33 THNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN---ELSQLSDKTFAFCTNLTELHLMSNSI 109 (680)
T ss_dssp CSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS---CCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC---ccCccChhhhccCCCCCEEECCCCcc
Confidence 34555555543 666666666666666666666666666666666666666 45555655566666666666666666
Q ss_pred cccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCcc-------------------------ccccCCc
Q 003199 81 HGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ-------------------------LAGTIPE 135 (840)
Q Consensus 81 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~-------------------------~~~~~p~ 135 (840)
.+..|..|+++++|++|+|++|.+++..|..|..+++|++|++++|++ +.+..|.
T Consensus 110 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 189 (680)
T 1ziw_A 110 QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189 (680)
T ss_dssp CCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTT
T ss_pred CccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChh
Confidence 655555566666666666666666655555555555555555555531 1111111
Q ss_pred ---------------------------------------------------ccCCC--CCCCeeeccCCcccccCCcccc
Q 003199 136 ---------------------------------------------------ELGNL--TELTDLDMSVNHLSGKIPESIL 162 (840)
Q Consensus 136 ---------------------------------------------------~l~~l--~~L~~L~L~~n~l~~~~~~~~~ 162 (840)
.|.++ ++|++|+|++|.+++..|..|.
T Consensus 190 ~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~ 269 (680)
T 1ziw_A 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269 (680)
T ss_dssp GGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTT
T ss_pred hhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCccccc
Confidence 11122 1255555555555555555555
Q ss_pred CCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcc-----cCC----cCCCCCCCcceeccccccccccCCccc
Q 003199 163 RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTG-----EVP----QDLGQWSPLVVLDLSENKLSGPLPAKV 233 (840)
Q Consensus 163 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----~~~----~~l~~l~~L~~L~L~~N~l~~~~~~~~ 233 (840)
.+++|++|++++|++.+..+..|.++++|++|++++|...+ .+| ..|..+++|++|++++|++++..+..|
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 349 (680)
T 1ziw_A 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349 (680)
T ss_dssp TCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTT
T ss_pred CcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHh
Confidence 55555555555555554444333332222222222211110 000 023334444444444455544444444
Q ss_pred cCCCCchhhh----------------------------cccccccccCCcccccccCCceEEeeCceeeccCC-ccccCC
Q 003199 234 CSRGKLQYFL----------------------------VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIP-EGILSL 284 (840)
Q Consensus 234 ~~l~~L~~L~----------------------------l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l 284 (840)
..+++|++|+ +++|.+.+..|.+|..+++|+.|++++|.+.+.+| ..|..+
T Consensus 350 ~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l 429 (680)
T 1ziw_A 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429 (680)
T ss_dssp TTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTC
T ss_pred ccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCc
Confidence 4333333333 23334444445555555555555555555554333 344445
Q ss_pred CcccEEeccCCc------------------------cc--ccCCcccCCCCCCceeecccceeeeccchhhcccCcccEE
Q 003199 285 PHVSIIDLSYNS------------------------FS--GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKI 338 (840)
Q Consensus 285 ~~L~~L~L~~N~------------------------l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 338 (840)
++|+.|++++|+ ++ +..|..|+.+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 430 ~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L 509 (680)
T 1ziw_A 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509 (680)
T ss_dssp TTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEE
Confidence 555555555554 43 3456677778888888888888887777778888888888
Q ss_pred EcCCCccCCCCC--------CcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeE
Q 003199 339 DLSDNLLSGPIP--------SGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSI 409 (840)
Q Consensus 339 ~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l 409 (840)
+|++|++++..+ ..++++++|+.|+|++|+++...+..|..+++|+.|||++|+|++..+..+..+ .++.|
T Consensus 510 ~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 589 (680)
T 1ziw_A 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589 (680)
T ss_dssp ECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred eCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEE
Confidence 888888875422 236788889999999999986656678999999999999999996555555555 67899
Q ss_pred EccCCCCcCcCCcccc---cCCCcccccCCCCCcc
Q 003199 410 NFSNNRLSGPIPLSLI---KEGLVESFSGNPGLCV 441 (840)
Q Consensus 410 ~l~~N~l~~~~p~~~~---~~~~~~~~~~n~~~c~ 441 (840)
++++|++++..|..+. .......+.+|||.|.
T Consensus 590 ~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp ECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred ECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 9999999987776433 2335678899999995
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=450.67 Aligned_cols=428 Identities=22% Similarity=0.210 Sum_probs=311.9
Q ss_pred ccccccccCC-CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccc
Q 003199 2 SFMYLTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCAL 80 (840)
Q Consensus 2 ~~~~~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l 80 (840)
+.|.+++..+ .|.++++|++|+|++|.|++..|.+|.++++|++|+|++| .+..+++..|.++++|++|+|++|.+
T Consensus 40 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n---~l~~~~p~~~~~l~~L~~L~L~~n~l 116 (606)
T 3vq2_A 40 SFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN---PIQSFSPGSFSGLTSLENLVAVETKL 116 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC---CCCCCCTTSSTTCTTCCEEECTTSCC
T ss_pred CCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC---cccccChhhcCCcccCCEEEccCCcc
Confidence 4456666666 4677777777777777777666667777777777777777 55666666677777777777777777
Q ss_pred cccCCccccCCCCCcEEEccCCcccc-cCchhhhcCCCCCeeecccCccccccCCcccCCCCCCC----eeeccCCcccc
Q 003199 81 HGQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELT----DLDMSVNHLSG 155 (840)
Q Consensus 81 ~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~----~L~L~~n~l~~ 155 (840)
.+..+..|+++++|++|+|++|.+++ .+|..|.++++|++|+|++|+ +.+..|..+..+++|+ +|++++|.+++
T Consensus 117 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~ 195 (606)
T 3vq2_A 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY-IQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195 (606)
T ss_dssp CCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC-CCEECTTTTHHHHHCTTCCCEEECTTCCCCE
T ss_pred ccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc-ceecChhhhhhhhccccccceeeccCCCcce
Confidence 66665667777777777777777764 346677777777777777775 3444444454444333 56666666654
Q ss_pred cCCccccCCCCCcEEEeecccccc--------------------------------------------------------
Q 003199 156 KIPESILRLPKLRVLQLYNNSLSG-------------------------------------------------------- 179 (840)
Q Consensus 156 ~~~~~~~~l~~L~~L~L~~N~l~~-------------------------------------------------------- 179 (840)
..+..+... +|+.|++++|.+.+
T Consensus 196 ~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~ 274 (606)
T 3vq2_A 196 IQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274 (606)
T ss_dssp ECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTC
T ss_pred eCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccc
Confidence 433333322 55555555554420
Q ss_pred --ccch---------------------hhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCC
Q 003199 180 --EISS---------------------VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR 236 (840)
Q Consensus 180 --~~~~---------------------~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 236 (840)
..+. .+..+++|++|++++|++. .+| .+ .+++|+.|++++|+..+.. .+..+
T Consensus 275 ~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l 349 (606)
T 3vq2_A 275 SDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGSISF--KKVAL 349 (606)
T ss_dssp CGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSCEEC--CCCCC
T ss_pred cccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCccch--hhccC
Confidence 1111 2333445555555555552 334 23 5555555555555433222 45677
Q ss_pred CCchhhhccccccccc--CCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCC-cccCCCCCCce
Q 003199 237 GKLQYFLVLQNMFSGV--LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIA-NTVGNARNLSE 313 (840)
Q Consensus 237 ~~L~~L~l~~n~~~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~ 313 (840)
++|++|++++|.+.+. .+..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++.+..+ ..+..+++|+.
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 8888888888888776 3788889999999999999998 467889999999999999999998877 68899999999
Q ss_pred eecccceeeeccchhhcccCcccEEEcCCCccCC-CCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcc
Q 003199 314 LFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSG-PIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392 (840)
Q Consensus 314 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 392 (840)
|++++|++++..|..+..+++|+.|++++|++++ .+|..++.+++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 9999999999899999999999999999999997 478899999999999999999998889999999999999999999
Q ss_pred ccccCCchhhcc-CCCeEEccCCCCcCcCCcccccC---CCcccccCCCCCcc
Q 003199 393 LTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKE---GLVESFSGNPGLCV 441 (840)
Q Consensus 393 l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~---~~~~~~~~n~~~c~ 441 (840)
+++.+|..+..+ .++.|++++|+++ .+|..+... .....+.+|||.|.
T Consensus 509 l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 509 LLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccC
Confidence 999889998887 5789999999998 566554443 34568899999984
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=416.38 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=196.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||+||+|.. .+++.||||++........ ....+.+|++++++++|||||++++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--------DRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--------ECC------CCCCCCCCTTEECEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--------HHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 4688999999999999999965 2578999999865432211 123477899999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+.+..|+|||||++|+|.+++.+.. .+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999999998765 69999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+|+..... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. . ..........
T Consensus 172 la~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~--~~~~~~i~~~-- 241 (304)
T 3ubd_A 172 LSKESIDH---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---R--KETMTMILKA-- 241 (304)
T ss_dssp EEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---H--HHHHHHHHHC--
T ss_pred cceeccCC---CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---H--HHHHHHHHcC--
Confidence 99865432 223345789999999999999999999999999999999999999997531 1 1111111110
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
....+.. ...++.+++.+||+.||++||| ++|+++|
T Consensus 242 ------~~~~p~~---~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 ------KLGMPQF---LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ------CCCCCTT---SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ------CCCCCCc---CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0111222 2345667888999999999998 4677765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=406.42 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=191.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 74 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---------RELAREKVMREVKALAKLEHPGIVRYFNAWLE 74 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 45789999999999999999965 479999999985432 12335678999999999999999999999865
Q ss_pred Cc------------cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 003199 604 LY------------CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669 (840)
Q Consensus 604 ~~------------~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 669 (840)
.+ ..|+|||||++|+|.+++.... ...++..++.++.||+.||+|||+ ++||||||||+|||+
T Consensus 75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl 151 (299)
T 4g31_A 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFF 151 (299)
T ss_dssp EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEE
Confidence 43 3689999999999999998653 234567789999999999999999 999999999999999
Q ss_pred cCCCCCeeecccchhhhhccCCCC---------cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 003199 670 DVNYQPKVADFGIAKVLQARGGKD---------STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740 (840)
Q Consensus 670 ~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 740 (840)
+.++.+||+|||+|+.+....... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.
T Consensus 152 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 999999999999998875422111 12234579999999999999999999999999999999996 775
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .... .....+.....++.+.+......+++.+||+.||++|||+.|++++
T Consensus 229 ~~----~~~~----------~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 229 TQ----MERV----------RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp SH----HHHH----------HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cc----cHHH----------HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 31 0000 0011112222333334444566788999999999999999999875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=437.21 Aligned_cols=410 Identities=20% Similarity=0.191 Sum_probs=358.7
Q ss_pred CccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++.|.+++..|+ |.++++|++|+|++|.|++..|..|.++++|++|+|++| .+..+++..|..+++|++|++++|.
T Consensus 63 Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n---~l~~~~~~~~~~l~~L~~L~L~~n~ 139 (606)
T 3vq2_A 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET---KLASLESFPIGQLITLKKLNVAHNF 139 (606)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS---CCCCSSSSCCTTCTTCCEEECCSSC
T ss_pred CCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC---ccccccccccCCCCCCCEEeCCCCc
Confidence 456788888785 899999999999999999888999999999999999999 7778887789999999999999999
Q ss_pred ccc-cCCccccCCCCCcEEEccCCcccccCchhhhcCCCCC----eeecccCccccccCCcc------------------
Q 003199 80 LHG-QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR----QLELYYNQQLAGTIPEE------------------ 136 (840)
Q Consensus 80 l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~----~L~L~~n~~~~~~~p~~------------------ 136 (840)
+.+ .+|..|+++++|++|+|++|++++..|..|..+++|+ .|++++|+ +.+..+..
T Consensus 140 l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~-l~~~~~~~~~~~~L~~L~L~~n~~~~ 218 (606)
T 3vq2_A 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP-IDFIQDQAFQGIKLHELTLRGNFNSS 218 (606)
T ss_dssp CCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCC-CCEECTTTTTTCEEEEEEEESCCSCH
T ss_pred ccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCC-cceeCcccccCceeeeeeccCCccch
Confidence 986 5699999999999999999999988888777766554 56666665 22111111
Q ss_pred --------------------------------------------------------------cCCCCCCCeeeccCCccc
Q 003199 137 --------------------------------------------------------------LGNLTELTDLDMSVNHLS 154 (840)
Q Consensus 137 --------------------------------------------------------------l~~l~~L~~L~L~~n~l~ 154 (840)
+..+++|+.|++++|.+.
T Consensus 219 ~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 298 (606)
T 3vq2_A 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298 (606)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCC
T ss_pred hHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccch
Confidence 334566666777777766
Q ss_pred ccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccccc--CCcc
Q 003199 155 GKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP--LPAK 232 (840)
Q Consensus 155 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~~~ 232 (840)
.+| .+..+++|++|++++|.+. .+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. .+..
T Consensus 299 -~l~-~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~ 371 (606)
T 3vq2_A 299 -YLE-DVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYS 371 (606)
T ss_dssp -CCC-CCCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHH
T ss_pred -hhh-hccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhh
Confidence 344 7888899999999999995 555 45 9999999999999665433 678999999999999999977 4888
Q ss_pred ccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCC-ccccCCCcccEEeccCCcccccCCcccCCCCCC
Q 003199 233 VCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIP-EGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311 (840)
Q Consensus 233 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 311 (840)
+..+++|++|++++|.+.+ +|..+..+++|+.|++++|++.+..| ..+..+++|+.|++++|++++..+..++.+++|
T Consensus 372 ~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 450 (606)
T 3vq2_A 372 DLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450 (606)
T ss_dssp HHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred hccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC
Confidence 9999999999999999886 55889999999999999999998777 688999999999999999999999999999999
Q ss_pred ceeecccceeee-ccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcC
Q 003199 312 SELFMQRNQISG-FIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390 (840)
Q Consensus 312 ~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 390 (840)
++|+|++|++++ ..|..+..+++|+.|+|++|++++..|..++++++|+.|+|++|++++.+|..|..+++|++|||++
T Consensus 451 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 530 (606)
T 3vq2_A 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530 (606)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTT
T ss_pred CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCC
Confidence 999999999997 4788999999999999999999999999999999999999999999998899999999999999999
Q ss_pred ccccccCCchhhccC--CCeEEccCCCCcCcCCcc
Q 003199 391 NLLTGYIPESLCELL--PNSINFSNNRLSGPIPLS 423 (840)
Q Consensus 391 N~l~~~~p~~~~~~~--~~~l~l~~N~l~~~~p~~ 423 (840)
|+|+ .+|..+..+. ++.+++++|++.|.++..
T Consensus 531 N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 531 NRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp SCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 9999 7888788773 789999999999998864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=451.35 Aligned_cols=413 Identities=24% Similarity=0.260 Sum_probs=301.8
Q ss_pred cccccccC-C-CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCC--CCcccccccccccEEEecCc
Q 003199 3 FMYLTGTL-P-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWK--LPESSIFRLTKLRIMVLATC 78 (840)
Q Consensus 3 ~~~~~~~~-~-~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~--l~~~~~~~l~~L~~L~L~~n 78 (840)
.|+..+.+ | .|+++++|++|+|++|.|++..|..|.++++|++|+|++| .+.. .+...|..+++|++|+|++|
T Consensus 57 ~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~~~L~~L~~L~Ls~N 133 (844)
T 3j0a_A 57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC---GLSDAVLKDGYFRNLKALTRLDLSKN 133 (844)
T ss_dssp TTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTC---CCSSCCSTTCCCSSCSSCCEEEEESC
T ss_pred CCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCC---CCCcccccCccccccCCCCEEECCCC
Confidence 34455565 4 3999999999999999999888999999999999999999 5554 23345899999999999999
Q ss_pred cccccCC-ccccCCCCCcEEEccCCcccccCchhhhcC--CCCCeeecccCccccccCCcccCCCCC------CCeeecc
Q 003199 79 ALHGQIP-ASIGNVTSLTDLELTGNFITGHIPPEIGLL--KNLRQLELYYNQQLAGTIPEELGNLTE------LTDLDMS 149 (840)
Q Consensus 79 ~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~~n~~~~~~~p~~l~~l~~------L~~L~L~ 149 (840)
.+.+..+ ..|+++++|++|+|++|.+++..+..|..+ ++|+.|+|+.|. +.+..|..+..+++ |++|+|+
T Consensus 134 ~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~-l~~~~~~~~~~~~~~~~~~~L~~L~Ls 212 (844)
T 3j0a_A 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS-LYSRVSVDWGKCMNPFRNMVLEILDVS 212 (844)
T ss_dssp CCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSB-SCCCCCCCCCSSSCTTTTCCBSEEBCS
T ss_pred cccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCc-cccccccchhhcCCccccCceeEEecC
Confidence 9987755 579999999999999999998888888877 777777777775 44444444433333 5555555
Q ss_pred CCcccccCCccccC--------------------------------------CCCCcEEEeeccccccccchhhhcCCCC
Q 003199 150 VNHLSGKIPESILR--------------------------------------LPKLRVLQLYNNSLSGEISSVIANSTTL 191 (840)
Q Consensus 150 ~n~l~~~~~~~~~~--------------------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L 191 (840)
+|.+++..+..+.. .++|+.|+|++|.+.+..+..|..+++|
T Consensus 213 ~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 292 (844)
T 3j0a_A 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL 292 (844)
T ss_dssp SCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCC
T ss_pred CCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCC
Confidence 55544333222211 1345555555555555555555555555
Q ss_pred CEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCc
Q 003199 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNN 271 (840)
Q Consensus 192 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N 271 (840)
+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+.+..+..|..+++|+.|++++|
T Consensus 293 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N 372 (844)
T 3j0a_A 293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372 (844)
T ss_dssp CEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETC
T ss_pred CEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCC
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred eeec------------------cCCc----------------------cccCCCcccEEeccCCcccccCCc-ccCCCCC
Q 003199 272 HLEG------------------SIPE----------------------GILSLPHVSIIDLSYNSFSGPIAN-TVGNARN 310 (840)
Q Consensus 272 ~l~~------------------~~~~----------------------~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~ 310 (840)
.+++ .+|. .+..+++|+.|+|++|++++..+. .+..+++
T Consensus 373 ~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 452 (844)
T 3j0a_A 373 ALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452 (844)
T ss_dssp CSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTT
T ss_pred CCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCc
Confidence 5442 2221 133688999999999999876544 4667899
Q ss_pred Cceeecccceee-----eccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCE
Q 003199 311 LSELFMQRNQIS-----GFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNV 385 (840)
Q Consensus 311 L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 385 (840)
|+.|+|++|.++ +..+..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++..+. ++|+.
T Consensus 453 L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~ 530 (844)
T 3j0a_A 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEI 530 (844)
T ss_dssp CCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCE
T ss_pred cccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccE
Confidence 999999999997 34456788899999999999999999999999999999999999999988777776 89999
Q ss_pred EECcCccccccCCchhhccCCCeEEccCCCCcCcCCcc
Q 003199 386 LDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLS 423 (840)
Q Consensus 386 L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~ 423 (840)
|||++|+|++.+|..+. .+..+++++|++.|.++..
T Consensus 531 L~Ls~N~l~~~~~~~~~--~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 531 LDISRNQLLAPNPDVFV--SLSVLDITHNKFICECELS 566 (844)
T ss_dssp EEEEEECCCCCCSCCCS--SCCEEEEEEECCCCSSSCC
T ss_pred EECCCCcCCCCChhHhC--CcCEEEecCCCcccccccH
Confidence 99999999999998775 4689999999999998853
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=441.85 Aligned_cols=416 Identities=19% Similarity=0.252 Sum_probs=212.7
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCcc----C------CCCcc--------------------ccc-
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKL----W------KLPES--------------------SIF- 65 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l----~------~l~~~--------------------~~~- 65 (840)
.+++.|+|++|+++|.+|.++++|++|+.|+|++|.+... . .+|.. .+.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 5799999999999999999999999999999999943000 0 00000 000
Q ss_pred ------------------ccccccEEEec--CccccccCCccccCCCCCcEEEccCCccccc-----------------C
Q 003199 66 ------------------RLTKLRIMVLA--TCALHGQIPASIGNVTSLTDLELTGNFITGH-----------------I 108 (840)
Q Consensus 66 ------------------~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-----------------~ 108 (840)
....++.+.+. +|.+++ +|..|+++++|++|+|++|.+++. +
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 00001111111 344444 455555555555555555555542 4
Q ss_pred chhhh--cCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCc-ccc-cCCccccCC------CCCcEEEeeccccc
Q 003199 109 PPEIG--LLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH-LSG-KIPESILRL------PKLRVLQLYNNSLS 178 (840)
Q Consensus 109 p~~~~--~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~N~l~ 178 (840)
|..++ .+++|++|+|++|+ +.+.+|..|+++++|++|+|++|+ +++ .+|..+..+ ++|++|+|++|+++
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCP-NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCT-TCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred chhhhhcccCCCCEEEecCCc-CCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 55544 55555555555554 344455555555555555555554 544 444444443 55555555555555
Q ss_pred cccch--hhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCC-chhhhcccccccccCCc
Q 003199 179 GEISS--VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGK-LQYFLVLQNMFSGVLPD 255 (840)
Q Consensus 179 ~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~n~~~~~~~~ 255 (840)
.+|. .+.++++|++|+|++|++++.+| .|..+++|+.|+|++|+++ .+|..+..+++ |++|++++|.+. .+|.
T Consensus 319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~ 394 (636)
T 4eco_A 319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPN 394 (636)
T ss_dssp -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCS
T ss_pred -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccch
Confidence 3333 45555555555555555554444 4555555555555555555 44444555555 555555555555 3444
Q ss_pred cccccc--CCceEEeeCceeeccCCcccc-------CCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccc
Q 003199 256 SLARCK--NLLRFRVSNNHLEGSIPEGIL-------SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIP 326 (840)
Q Consensus 256 ~~~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 326 (840)
.+..++ +|+.|++++|++++..|..+. .+++|+.|+|++|+++...+..+..+++|++|+|++|+++ .+|
T Consensus 395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~ 473 (636)
T 4eco_A 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIP 473 (636)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCC
T ss_pred hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcC
Confidence 444332 455555555555555554444 4445555555555555433333444555555555555555 333
Q ss_pred hhhcccC--------cccEEEcCCCccCCCCCCccc--CccccchhcccCCccCCCcchhcccccCCCEEEC------cC
Q 003199 327 SEIYRAI--------SLVKIDLSDNLLSGPIPSGIG--NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL------SN 390 (840)
Q Consensus 327 ~~~~~l~--------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l------~~ 390 (840)
..+.... +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++
T Consensus 474 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~ 551 (636)
T 4eco_A 474 KNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551 (636)
T ss_dssp SSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTC
T ss_pred HHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCccccc
Confidence 3222211 4555555555555 3444443 55555555555555554 4455555555555555 33
Q ss_pred ccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccCCCcccccCCCCCccc
Q 003199 391 NLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLCVS 442 (840)
Q Consensus 391 N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~n~~~c~~ 442 (840)
|++.+.+|..+..+ .++.|++++|++ +.+|..+........+.+||+.|..
T Consensus 552 N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 552 NRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred CcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 44555555555444 344555555555 4445443333334445555555543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=432.14 Aligned_cols=426 Identities=21% Similarity=0.240 Sum_probs=255.1
Q ss_pred cccccccCC-CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc
Q 003199 3 FMYLTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 3 ~~~~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~ 81 (840)
.|.+++..+ .|.++++|++|+|++|.|++..|..|.++++|++|+|++| .+..+++..|.++++|++|++++|.++
T Consensus 37 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n---~l~~~~~~~~~~l~~L~~L~L~~n~l~ 113 (570)
T 2z63_A 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN---PIQSLALGAFSGLSSLQKLVAVETNLA 113 (570)
T ss_dssp SCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC---CCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred CCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC---cCCccCHhhhcCccccccccccccccc
Confidence 344444444 3556666666666666666555555666666666666666 445555555666666666666666665
Q ss_pred ccCCccccCCCCCcEEEccCCcccc-cCchhhhcCCCCCeeecccCccccccCCcccCCCCCC----CeeeccCCccccc
Q 003199 82 GQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL----TDLDMSVNHLSGK 156 (840)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L----~~L~L~~n~l~~~ 156 (840)
+..+..++++++|++|+|++|.+++ .+|..|.++++|++|++++|+ +.+..+..+..+++| ++|++++|.+++.
T Consensus 114 ~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~ 192 (570)
T 2z63_A 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192 (570)
T ss_dssp CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSC-CCEECGGGGHHHHTCTTCCCEEECTTCCCCEE
T ss_pred cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCc-cceecHHHccchhccchhhhhcccCCCCceec
Confidence 4444455666666666666666654 245556666666666666654 333334445555555 5556666655554
Q ss_pred CCccccCCCCCcEEEeecc----------------------------------------------------------ccc
Q 003199 157 IPESILRLPKLRVLQLYNN----------------------------------------------------------SLS 178 (840)
Q Consensus 157 ~~~~~~~l~~L~~L~L~~N----------------------------------------------------------~l~ 178 (840)
.+..|..+ +|+.|++++| .+.
T Consensus 193 ~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~ 271 (570)
T 2z63_A 193 QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271 (570)
T ss_dssp CTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEE
T ss_pred CHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhh
Confidence 44444433 4555555554 222
Q ss_pred cccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccc
Q 003199 179 GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLA 258 (840)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 258 (840)
+..+..|..+++|++|++++|.++ .+|..+..+ +|+.|++++|.+. .+|. ..+++|+.|++.+|.+.+..+. .
T Consensus 272 ~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~ 344 (570)
T 2z63_A 272 DDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--V 344 (570)
T ss_dssp SCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--C
T ss_pred hhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--c
Confidence 233445566677777777777777 466666666 7777777777776 3333 3455566666666665544443 5
Q ss_pred cccCCceEEeeCceeeccC--CccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccc-hhhcccCcc
Q 003199 259 RCKNLLRFRVSNNHLEGSI--PEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIP-SEIYRAISL 335 (840)
Q Consensus 259 ~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L 335 (840)
.+++|++|++++|++++.. |..+..+++|+.|++++|++.+..+. +..+++|++|++++|.+.+..| ..+..+++|
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence 5666777777777666433 45566666777777777766655444 6666677777777777665544 355666677
Q ss_pred cEEEcCCCccCCCCCCcccCccccchhcccCCccC-CCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccC
Q 003199 336 VKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN-SSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSN 413 (840)
Q Consensus 336 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~ 413 (840)
+.|++++|++++..|..+.++++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++..|..+..+ .++.|++++
T Consensus 424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 77777777766666666666677777777777665 4566666667777777777777766666666655 456677777
Q ss_pred CCCcCcCCcccccC--CCcccccCCCCCcc
Q 003199 414 NRLSGPIPLSLIKE--GLVESFSGNPGLCV 441 (840)
Q Consensus 414 N~l~~~~p~~~~~~--~~~~~~~~n~~~c~ 441 (840)
|++++..|..+... .....+.+||+.|.
T Consensus 504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 77666655433322 13445666666663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=434.41 Aligned_cols=416 Identities=20% Similarity=0.215 Sum_probs=277.5
Q ss_pred cccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc
Q 003199 3 FMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 3 ~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~ 81 (840)
.|.+++..+. |+++++|++|+|++|.+++..|..|.++++|++|+|++| .+..+++..|..+++|++|++++|.++
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN---GLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSS---CCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCC---cccccCchhhcccccCCEEEccCCccc
Confidence 3444444432 666666666666666666555555666666666666666 344444444444555555555544444
Q ss_pred c--------------------------cCCccccCC---------------------------CCCcEEEccCCcccccC
Q 003199 82 G--------------------------QIPASIGNV---------------------------TSLTDLELTGNFITGHI 108 (840)
Q Consensus 82 ~--------------------------~~~~~~~~l---------------------------~~L~~L~L~~n~i~~~~ 108 (840)
+ ..|..+..+ ++|+.|++++|.+++..
T Consensus 159 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~ 238 (680)
T 1ziw_A 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238 (680)
T ss_dssp CBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEEC
T ss_pred ccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccC
Confidence 3 333322221 22233333333333333
Q ss_pred chhhhcCCC--CCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccc-------------------------
Q 003199 109 PPEIGLLKN--LRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI------------------------- 161 (840)
Q Consensus 109 p~~~~~l~~--L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~------------------------- 161 (840)
|..|..++. |+.|+|++|+ +.+..|..|..+++|++|+|++|++++..|..|
T Consensus 239 ~~~~~~l~~~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~l 317 (680)
T 1ziw_A 239 NTTFLGLKWTNLTMLDLSYNN-LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317 (680)
T ss_dssp TTTTGGGGGSCCCEEECTTSC-CCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------C
T ss_pred hhHhhccCcCCCCEEECCCCC-cCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccc
Confidence 334444433 6666666665 344445556666666666666666665544433
Q ss_pred --------cCCCCCcEEEeeccccccccchhhhcCCCCCEEEcc----------------------------CCcCcccC
Q 003199 162 --------LRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLY----------------------------DNSLTGEV 205 (840)
Q Consensus 162 --------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~----------------------------~N~l~~~~ 205 (840)
..+++|++|++++|.+++..+..|.++++|++|+++ +|+++++.
T Consensus 318 p~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~ 397 (680)
T 1ziw_A 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred cccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence 344555555555555555555555555555444444 34444445
Q ss_pred CcCCCCCCCcceeccccccccccCC-ccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceee--ccCCcccc
Q 003199 206 PQDLGQWSPLVVLDLSENKLSGPLP-AKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLE--GSIPEGIL 282 (840)
Q Consensus 206 ~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~ 282 (840)
+..|..+++|+.|+|++|++++.++ ..|..+++|++|++++|.+.+..+..|..+++|+.|++++|.+. +..|..|.
T Consensus 398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~ 477 (680)
T 1ziw_A 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence 5556666666666666666655443 45666666666666666666666666666777777777777665 46788889
Q ss_pred CCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccch--------hhcccCcccEEEcCCCccCCCCCCccc
Q 003199 283 SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS--------EIYRAISLVKIDLSDNLLSGPIPSGIG 354 (840)
Q Consensus 283 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~--------~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 354 (840)
.+++|+.|++++|++++..+..|..+++|++|+|++|++++..+. .+..+++|+.|+|++|+++...+..|.
T Consensus 478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 557 (680)
T 1ziw_A 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence 999999999999999999999999999999999999999865332 378889999999999999965556799
Q ss_pred CccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhh-cc-CCCeEEccCCCCcCcCCc
Q 003199 355 NLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLC-EL-LPNSINFSNNRLSGPIPL 422 (840)
Q Consensus 355 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~-~~~~l~l~~N~l~~~~p~ 422 (840)
++++|+.|+|++|+|++.++..|..+++|+.|+|++|+|++..|..+. .+ .++.+++++|++.|.++.
T Consensus 558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999999999988888899999999999999999987777665 33 578999999999999884
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=432.65 Aligned_cols=407 Identities=20% Similarity=0.275 Sum_probs=322.2
Q ss_pred CccccccccCCC-CCCCCCCCEEecCCCcCc------c---------------------------cCCcccc--------
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFT------G---------------------------QFPLSVF-------- 38 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~------~---------------------------~~p~~~~-------- 38 (840)
++.+.+.|.+|. |+.|++|++|+|++|.++ + .+|..+.
T Consensus 88 L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~ 167 (636)
T 4eco_A 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167 (636)
T ss_dssp CTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred ecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhh
Confidence 355788999986 999999999999999762 1 1111111
Q ss_pred -----------CCCCCCEEeCC--CCCCCccCCCCcccccccccccEEEecCcccccc-----------------CCccc
Q 003199 39 -----------NLTNLEVLSFN--ENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ-----------------IPASI 88 (840)
Q Consensus 39 -----------~l~~L~~L~L~--~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~ 88 (840)
....++.+.+. .| .+..+|. .|.++++|++|+|++|.+++. +|..+
T Consensus 168 ~~l~~~~~~~~~~~~l~~l~l~~~~n---~l~~ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l 243 (636)
T 4eco_A 168 SDPQQKSIKKSSRITLKDTQIGQLSN---NITFVSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243 (636)
T ss_dssp HCTTSCCCCCCCCCCCCTTTTTCCSC---EEEEECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred cCccccccccccccchhhhhhccccC---CCccCCH-HHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence 11122222222 34 5555654 588888888888888888875 88888
Q ss_pred c--CCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccc-cCCcccCCC------CCCCeeeccCCcccccCCc
Q 003199 89 G--NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAG-TIPEELGNL------TELTDLDMSVNHLSGKIPE 159 (840)
Q Consensus 89 ~--~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~-~~p~~l~~l------~~L~~L~L~~n~l~~~~~~ 159 (840)
+ ++++|++|+|++|.+.+.+|..|.++++|++|+|++|+.+.+ .+|..++.+ ++|++|+|++|+++ .+|.
T Consensus 244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 8 888888888888888888888888888888888888864555 677777665 88888888888888 6777
Q ss_pred --cccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCC-cceeccccccccccCCccccCC
Q 003199 160 --SILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSGPLPAKVCSR 236 (840)
Q Consensus 160 --~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l 236 (840)
.+..+++|++|++++|++++.+| .|..+++|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+...
T Consensus 323 ~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~ 399 (636)
T 4eco_A 323 ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399 (636)
T ss_dssp HHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTT
T ss_pred hhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhc
Confidence 78888888888888888886677 7888888888888888888 67777888888 888888888888 667777665
Q ss_pred C--CchhhhcccccccccCCcccc-------cccCCceEEeeCceeeccCCcc-ccCCCcccEEeccCCcccccCCcccC
Q 003199 237 G--KLQYFLVLQNMFSGVLPDSLA-------RCKNLLRFRVSNNHLEGSIPEG-ILSLPHVSIIDLSYNSFSGPIANTVG 306 (840)
Q Consensus 237 ~--~L~~L~l~~n~~~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~ 306 (840)
. +|++|++++|.+.+..|..+. .+++|++|++++|+++ .+|.. +..+++|+.|+|++|+++...+..+.
T Consensus 400 ~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~ 478 (636)
T 4eco_A 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478 (636)
T ss_dssp CSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSE
T ss_pred ccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhc
Confidence 4 788888888888888888887 7788999999999998 45544 45688999999999999855555554
Q ss_pred CCC-------CCceeecccceeeeccchhhc--ccCcccEEEcCCCccCCCCCCcccCccccchhcc------cCCccCC
Q 003199 307 NAR-------NLSELFMQRNQISGFIPSEIY--RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLML------QSNKLNS 371 (840)
Q Consensus 307 ~l~-------~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~ 371 (840)
... +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+
T Consensus 479 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~ 556 (636)
T 4eco_A 479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556 (636)
T ss_dssp ETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCC
T ss_pred cccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccc
Confidence 433 8999999999998 6777776 88999999999999986 8888888999999998 5677888
Q ss_pred CcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcC
Q 003199 372 SIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPI 420 (840)
Q Consensus 372 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~ 420 (840)
.+|..+..+++|++|+|++|++ +.+|..+. -.++.|++++|++....
T Consensus 557 ~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 557 EWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNISID 603 (636)
T ss_dssp CCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCEEE
T ss_pred cChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCcccc
Confidence 9999999999999999999999 58888766 46789999999877543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=436.38 Aligned_cols=414 Identities=21% Similarity=0.247 Sum_probs=351.7
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeC-CCCCC------------------------------------------
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSF-NENPG------------------------------------------ 53 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L-~~N~~------------------------------------------ 53 (840)
..++.|+|++|+++|.+|..|++|++|+.|+| ++|.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57889999999999999999999999999999 66621
Q ss_pred --------------------------------CccCCCCcccccccccccEEEecCccccc-----------------cC
Q 003199 54 --------------------------------FKLWKLPESSIFRLTKLRIMVLATCALHG-----------------QI 84 (840)
Q Consensus 54 --------------------------------~~l~~l~~~~~~~l~~L~~L~L~~n~l~~-----------------~~ 84 (840)
..+..+|. .|.++++|+.|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~-~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISK-AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhH-HHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 01222554 59999999999999999998 38
Q ss_pred Ccccc--CCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccc-cCCcccCCC-------CCCCeeeccCCccc
Q 003199 85 PASIG--NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAG-TIPEELGNL-------TELTDLDMSVNHLS 154 (840)
Q Consensus 85 ~~~~~--~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~-~~p~~l~~l-------~~L~~L~L~~n~l~ 154 (840)
|..++ ++++|++|+|++|.+.+.+|..|..+++|+.|+|++|+.+.+ .+|..++.+ ++|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 99988 999999999999999999999999999999999999974555 677655544 59999999999999
Q ss_pred ccCCc--cccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCC-cceeccccccccccCCc
Q 003199 155 GKIPE--SILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP-LVVLDLSENKLSGPLPA 231 (840)
Q Consensus 155 ~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~ 231 (840)
.+|. .|..+++|+.|+|++|+++ .+| .|..+++|++|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 7888 8999999999999999999 556 8999999999999999999 78888999999 999999999999 6788
Q ss_pred cccCCCC--chhhhcccccccccCCccc---c--cccCCceEEeeCceeeccCCcccc-CCCcccEEeccCCcccccCCc
Q 003199 232 KVCSRGK--LQYFLVLQNMFSGVLPDSL---A--RCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIAN 303 (840)
Q Consensus 232 ~~~~l~~--L~~L~l~~n~~~~~~~~~~---~--~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~ 303 (840)
.+..... |+.|++++|.+.+.+|... . .+++|+.|+|++|.++ .+|..+. .+++|+.|+|++|+++.....
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~ 715 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPEN 715 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChH
Confidence 8877754 9999999999998766432 2 3458999999999999 6676654 789999999999999965555
Q ss_pred ccCCC-------CCCceeecccceeeeccchhhc--ccCcccEEEcCCCccCCCCCCcccCccccchhcccC------Cc
Q 003199 304 TVGNA-------RNLSELFMQRNQISGFIPSEIY--RAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS------NK 368 (840)
Q Consensus 304 ~~~~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~ 368 (840)
.+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |+
T Consensus 716 ~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~ 793 (876)
T 4ecn_A 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNR 793 (876)
T ss_dssp SSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCB
T ss_pred HhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccc
Confidence 55433 39999999999999 7888887 99999999999999997 799999999999999976 88
Q ss_pred cCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcCCcccccC--CCcccccCCCCCcc
Q 003199 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKE--GLVESFSGNPGLCV 441 (840)
Q Consensus 369 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~~~--~~~~~~~~n~~~c~ 441 (840)
+.+.+|..|..+++|+.|+|++|+| +.+|..+.. .++.|++++|++....+..+... .....+.+|++.|.
T Consensus 794 l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~-~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I 866 (876)
T 4ecn_A 794 ILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP-QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866 (876)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCS-SSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEE
T ss_pred ccccChHHHhcCCCCCEEECCCCCC-CccCHhhcC-CCCEEECCCCCCCccChHHccccccchheeecCCCcccc
Confidence 8899999999999999999999999 689988764 67899999999986655443221 13456667777663
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=426.68 Aligned_cols=409 Identities=20% Similarity=0.238 Sum_probs=358.4
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
+++++|+|++|.|++..+.+|.++++|++|+|++| .+..+++..|.++++|++|+|++|.+++..|..|+++++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n---~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC---EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTC---CCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCC---cCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccc
Confidence 57999999999999888889999999999999999 778888889999999999999999999888899999999999
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCC----cEEEe
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKL----RVLQL 172 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L 172 (840)
|+|++|.+++..+..|+.+++|++|+|++|.+....+|..|+++++|++|++++|.+++..+..+..+++| +.|++
T Consensus 105 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l 184 (570)
T 2z63_A 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184 (570)
T ss_dssp EECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred ccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhccc
Confidence 99999999966666799999999999999984333578999999999999999999998888888888888 89999
Q ss_pred eccccccccchhhhcCCCCCEEEccCC-----------------------------------------------------
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDN----------------------------------------------------- 199 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N----------------------------------------------------- 199 (840)
++|.+.+..+..|... +|+.|++++|
T Consensus 185 ~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~ 263 (570)
T 2z63_A 185 SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263 (570)
T ss_dssp TTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEE
T ss_pred CCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhh
Confidence 9999998888888766 7999988887
Q ss_pred -----cCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceee
Q 003199 200 -----SLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLE 274 (840)
Q Consensus 200 -----~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (840)
.+.+..+..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|. ..+++|+.|++++|.+.
T Consensus 264 l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~ 338 (570)
T 2z63_A 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGG 338 (570)
T ss_dssp EEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSC
T ss_pred hhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccc
Confidence 333455677788899999999999998 577778888 9999999999998 4444 47889999999999998
Q ss_pred ccCCccccCCCcccEEeccCCcccccC--CcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCC-C
Q 003199 275 GSIPEGILSLPHVSIIDLSYNSFSGPI--ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIP-S 351 (840)
Q Consensus 275 ~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~ 351 (840)
+..+. ..+++|+.|++++|++++.. +..+..+++|++|++++|++.+..+. +..+++|+.|++++|.+++..| .
T Consensus 339 ~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~ 415 (570)
T 2z63_A 339 NAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFS 415 (570)
T ss_dssp CBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSC
T ss_pred ccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchh
Confidence 66554 78999999999999998764 67788999999999999999976555 9999999999999999998766 5
Q ss_pred cccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccc-ccCCchhhcc-CCCeEEccCCCCcCcCCcccccCC-
Q 003199 352 GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT-GYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKEG- 428 (840)
Q Consensus 352 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~~- 428 (840)
.+.++++|+.|+|++|++++..|..|..+++|++|+|++|.++ +.+|..+..+ .++.|++++|++++..|..+....
T Consensus 416 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 495 (570)
T 2z63_A 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495 (570)
T ss_dssp TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccC
Confidence 7899999999999999999999999999999999999999998 6789888877 578999999999998887654432
Q ss_pred -CcccccCCC
Q 003199 429 -LVESFSGNP 437 (840)
Q Consensus 429 -~~~~~~~n~ 437 (840)
....+.+|.
T Consensus 496 L~~L~l~~n~ 505 (570)
T 2z63_A 496 LQVLNMASNQ 505 (570)
T ss_dssp CCEEECCSSC
T ss_pred CCEEeCCCCc
Confidence 345566664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=435.53 Aligned_cols=403 Identities=21% Similarity=0.270 Sum_probs=348.3
Q ss_pred CccccccccCCC-CCCCCCCCEEec-CCCcCccc----------------------------------------------
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDL-SNNLFTGQ---------------------------------------------- 32 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~L-s~n~i~~~---------------------------------------------- 32 (840)
++.+.+.|.+|. |+.|++|++|+| ++|.+.+.
T Consensus 330 Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~ 409 (876)
T 4ecn_A 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409 (876)
T ss_dssp CTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred CccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhh
Confidence 355788999996 999999999999 77755433
Q ss_pred ------------------------------CCccccCCCCCCEEeCCCCCCCccCC------------------CCccc-
Q 003199 33 ------------------------------FPLSVFNLTNLEVLSFNENPGFKLWK------------------LPESS- 63 (840)
Q Consensus 33 ------------------------------~p~~~~~l~~L~~L~L~~N~~~~l~~------------------l~~~~- 63 (840)
+|..|+++++|+.|+|++| .+.. +|...
T Consensus 410 ~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N---~Lsg~~i~~~~~~~s~n~~~g~iP~~l~ 486 (876)
T 4ecn_A 410 RNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS---PFTYDNIAVDWEDANSDYAKQYENEELS 486 (876)
T ss_dssp TCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESC---CCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred hCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCC---cCCCCcccccccccccccccccCChhhh
Confidence 7889999999999999999 5555 66653
Q ss_pred ccccccccEEEecCccccccCCccccCCCCCcEEEccCCc-ccc-cCchhhhcCC-------CCCeeecccCccccccCC
Q 003199 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNF-ITG-HIPPEIGLLK-------NLRQLELYYNQQLAGTIP 134 (840)
Q Consensus 64 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~-~~p~~~~~l~-------~L~~L~L~~n~~~~~~~p 134 (840)
|.++++|+.|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+..++ +|+.|+|++|+ +. .+|
T Consensus 487 f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~-L~-~ip 564 (876)
T 4ecn_A 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN-LE-EFP 564 (876)
T ss_dssp GGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC-CC-BCC
T ss_pred hccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc-CC-ccC
Confidence 4499999999999999999999999999999999999998 987 7888888776 99999999998 33 888
Q ss_pred c--ccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCC-CCEEEccCCcCcccCCcCCCC
Q 003199 135 E--ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTT-LTMLSLYDNSLTGEVPQDLGQ 211 (840)
Q Consensus 135 ~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~l~~ 211 (840)
. .+.++++|++|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..
T Consensus 565 ~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~ 640 (876)
T 4ecn_A 565 ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA 640 (876)
T ss_dssp CHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCT
T ss_pred ChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhc
Confidence 8 8999999999999999999 777 8999999999999999999 67778999999 999999999999 67888877
Q ss_pred CCC--cceeccccccccccCCcccc-----CCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCC
Q 003199 212 WSP--LVVLDLSENKLSGPLPAKVC-----SRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSL 284 (840)
Q Consensus 212 l~~--L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 284 (840)
++. |+.|+|++|++++.+|...+ ...+|+.|++++|.+....+..+..+++|+.|+|++|+++ .+|..+...
T Consensus 641 ~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~ 719 (876)
T 4ecn_A 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKP 719 (876)
T ss_dssp TCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSC
T ss_pred cccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhcc
Confidence 654 99999999999987664332 3458999999999999554455568999999999999999 677655543
Q ss_pred --------CcccEEeccCCcccccCCcccC--CCCCCceeecccceeeeccchhhcccCcccEEEcCC------CccCCC
Q 003199 285 --------PHVSIIDLSYNSFSGPIANTVG--NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD------NLLSGP 348 (840)
Q Consensus 285 --------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~ 348 (840)
++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.
T Consensus 720 ~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ 797 (876)
T 4ecn_A 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797 (876)
T ss_dssp TTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCC
T ss_pred ccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccccccc
Confidence 29999999999999 5666676 89999999999999997 799999999999999977 888889
Q ss_pred CCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcC
Q 003199 349 IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSG 418 (840)
Q Consensus 349 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~ 418 (840)
+|..+.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..++.. ....+.+.+|++..
T Consensus 798 ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 798 WPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp CCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred ChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence 999999999999999999999 68888765 699999999999997767776665 45667788887653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=400.92 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=200.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS- 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|+++|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--------chHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 4688899999999999999955 5899999999954321 12335678899999999999999999998754
Q ss_pred -----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 -----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
....|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEEC
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEe
Confidence 356799999995 78999998764 79999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCC-CCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 679 DFGIAKVLQARGG-KDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 679 Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|||+|+.+..... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.... ..+.......
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~ 279 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVL 279 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhc
Confidence 9999987643211 22334567899999999998775 5699999999999999999999999763210 0000000000
Q ss_pred hccc-cc--------hhh---hcccccCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 VDTK-EG--------IME---VLDKKLSGSFR----DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 ~~~~-~~--------~~~---~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... .. ... ......+..+. ....++.+|+.+|+..||++|||+.|+++|
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00 000 00001111111 123467788999999999999999999987
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=419.25 Aligned_cols=412 Identities=20% Similarity=0.175 Sum_probs=308.9
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
++|++|+|++|.|++..|..|.++++|++|+|++| .+..+++..|.++++|++|+|++|.+++..|..|+++++|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n---~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 102 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS---RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTS---CCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCE
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCC---CcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcE
Confidence 78999999999999888999999999999999999 777888889999999999999999999887788999999999
Q ss_pred EEccCCccccc-CchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecc
Q 003199 97 LELTGNFITGH-IPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175 (840)
Q Consensus 97 L~L~~n~i~~~-~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 175 (840)
|+|++|.+++. .|..|..+++|++|++++|+.+....+..+.++++|++|++++|.+++..|..+..+++|++|+++.|
T Consensus 103 L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182 (549)
T ss_dssp EECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred EECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccC
Confidence 99999999863 56789999999999999997444444468999999999999999999989999999999999999999
Q ss_pred ccccccchhhhcCCCCCEEEccCCcCcccC--C-cCCCCCCCcceeccccccccccCCccc----cC-------------
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEV--P-QDLGQWSPLVVLDLSENKLSGPLPAKV----CS------------- 235 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~-~~l~~l~~L~~L~L~~N~l~~~~~~~~----~~------------- 235 (840)
.+.......+..+++|++|++++|++++.. + .....+++|+.|++++|.+++..+..+ ..
T Consensus 183 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~ 262 (549)
T 2z81_A 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262 (549)
T ss_dssp BSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCE
T ss_pred cccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccc
Confidence 988665555677999999999999998642 1 222345566666666665543221111 11
Q ss_pred ----------------------------------------------CCCchhhhcccccccccCCccc-ccccCCceEEe
Q 003199 236 ----------------------------------------------RGKLQYFLVLQNMFSGVLPDSL-ARCKNLLRFRV 268 (840)
Q Consensus 236 ----------------------------------------------l~~L~~L~l~~n~~~~~~~~~~-~~l~~L~~L~l 268 (840)
.++|+.|++++|.+. .+|..+ ..+++|++|++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~L 341 (549)
T 2z81_A 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341 (549)
T ss_dssp EECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEEC
T ss_pred ccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEc
Confidence 234555555555554 334333 45677777777
Q ss_pred eCceeeccCC---ccccCCCcccEEeccCCcccccCC--cccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCC
Q 003199 269 SNNHLEGSIP---EGILSLPHVSIIDLSYNSFSGPIA--NTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343 (840)
Q Consensus 269 ~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 343 (840)
++|++++..| ..+..+++|+.|++++|++++..+ ..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|
T Consensus 342 s~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N 420 (549)
T 2z81_A 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420 (549)
T ss_dssp CSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTS
T ss_pred cCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCC
Confidence 7777765443 235566777777777777765432 34666777777777777776 45666666677777777777
Q ss_pred ccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcCCcc
Q 003199 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLS 423 (840)
Q Consensus 344 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~ 423 (840)
+++ .+|..+. ++|+.|+|++|+|++.+ ..+++|++|+|++|+|+ .+|....-..++.|++++|++++..|..
T Consensus 421 ~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~ 492 (549)
T 2z81_A 421 GIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGI 492 (549)
T ss_dssp CCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTG
T ss_pred Ccc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHH
Confidence 766 3343332 46777777777776532 47889999999999998 7776433226789999999999988865
Q ss_pred cccCC--CcccccCCCCCcc
Q 003199 424 LIKEG--LVESFSGNPGLCV 441 (840)
Q Consensus 424 ~~~~~--~~~~~~~n~~~c~ 441 (840)
+.... ....+.+|||.|.
T Consensus 493 ~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 493 FDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp GGGCTTCCEEECCSSCBCCC
T ss_pred HhcCcccCEEEecCCCccCC
Confidence 54432 4568889999884
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.35 Aligned_cols=200 Identities=24% Similarity=0.386 Sum_probs=168.2
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
+.+.|+..+.||+|+||+||+|..+ +++.||||++.... ....+.+|+++++.+ .|||||+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------------~~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------------HPIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------------CHHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------------CHHHHHHHHHHHHHhcCCCCCceEE
Confidence 3467999999999999999999542 47899999884332 124577899999988 699999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCCee
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKV 677 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl 677 (840)
+++.+.+..++||||+++|+|.+++. .+++.++..++.|++.||+|||+ +|||||||||+|||++.+ +.+||
T Consensus 87 ~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 87 YCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEE
Confidence 99999999999999999999999984 48999999999999999999999 999999999999999876 79999
Q ss_pred ecccchhhhhccCCC-------------------------CcceecccccccccCccccccC-CCCccccchhHHHHHHH
Q 003199 678 ADFGIAKVLQARGGK-------------------------DSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLME 731 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~e 731 (840)
+|||+|+...+.... .......+||+.|||||++.+. .++.++||||+||++||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 999999765331100 1122345799999999998775 58999999999999999
Q ss_pred HHhCCCCCCCC
Q 003199 732 LITGRKPVEDD 742 (840)
Q Consensus 732 l~tg~~p~~~~ 742 (840)
|++|+.||...
T Consensus 240 ll~G~~Pf~~~ 250 (361)
T 4f9c_A 240 LLSGRYPFYKA 250 (361)
T ss_dssp HHHTCSSSSCC
T ss_pred HHHCCCCCCCC
Confidence 99999999643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=409.55 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=200.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++........ ...........++.+++.++|||||++++++.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~----~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK----QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh----hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4688889999999999999965 4799999999954332110 1112222334456778888999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..|+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999998765 69999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.+.. ......+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+....... ........
T Consensus 341 ~~~~-----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~----- 408 (689)
T 3v5w_A 341 DFSK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT----- 408 (689)
T ss_dssp ECSS-----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHH-----
T ss_pred ecCC-----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcC-----
Confidence 7633 22345689999999999964 57999999999999999999999999753221111 11111100
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
....++..+ ..++.+++.+|++.||++|++ ++||++|
T Consensus 409 ---~~~~~p~~~---S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 409 ---MAVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---CCCCCCTTS---CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---CCCCCCccC---CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011122222 345667788999999999998 7888876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=414.93 Aligned_cols=407 Identities=20% Similarity=0.218 Sum_probs=328.3
Q ss_pred CccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++.|.+++..|. |.++++|++|+|++|.|++..|.+|.++++|++|+|++| .+..+++..|..+++|++|+|++|.
T Consensus 33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~l~~L~~L~Ls~n~ 109 (549)
T 2z81_A 33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN---HLSSLSSSWFGPLSSLKYLNLMGNP 109 (549)
T ss_dssp CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS---CCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC---ccCccCHHHhccCCCCcEEECCCCc
Confidence 456788888775 999999999999999999888899999999999999999 7888888889999999999999999
Q ss_pred ccc-cCCccccCCCCCcEEEccCCc-ccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccC
Q 003199 80 LHG-QIPASIGNVTSLTDLELTGNF-ITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKI 157 (840)
Q Consensus 80 l~~-~~~~~~~~l~~L~~L~L~~n~-i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 157 (840)
+++ ..|..++++++|++|+|++|. +....+..|..+++|++|++++|+ +.+..|..+..+++|++|++++|.+....
T Consensus 110 l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~l~~n~~~~~~ 188 (549)
T 2z81_A 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS-LRNYQSQSLKSIRDIHHLTLHLSESAFLL 188 (549)
T ss_dssp CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT-CCEECTTTTTTCSEEEEEEEECSBSTTHH
T ss_pred ccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc-ccccChhhhhccccCceEecccCcccccc
Confidence 986 357789999999999999998 554445789999999999999998 66677888888888888888777776333
Q ss_pred CccccCCCCCcEEEeecccccccc-------------------------------chhhhcCCCCCEEEccCCcCcccCC
Q 003199 158 PESILRLPKLRVLQLYNNSLSGEI-------------------------------SSVIANSTTLTMLSLYDNSLTGEVP 206 (840)
Q Consensus 158 ~~~~~~l~~L~~L~L~~N~l~~~~-------------------------------~~~~~~l~~L~~L~L~~N~l~~~~~ 206 (840)
...+..+++|++|++++|++++.. +..+..+++|+.|++++|.+.+...
T Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~ 268 (549)
T 2z81_A 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268 (549)
T ss_dssp HHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSC
T ss_pred hhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccccccc
Confidence 223345777777777777776531 1122344555666666655543210
Q ss_pred ---------cCC--------------------------CCCCCcceeccccccccccCCccc-cCCCCchhhhccccccc
Q 003199 207 ---------QDL--------------------------GQWSPLVVLDLSENKLSGPLPAKV-CSRGKLQYFLVLQNMFS 250 (840)
Q Consensus 207 ---------~~l--------------------------~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~n~~~ 250 (840)
..+ ....+|+.|++++|+++ .+|..+ ..+++|++|++++|.+.
T Consensus 269 ~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~ 347 (549)
T 2z81_A 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347 (549)
T ss_dssp CCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCC
T ss_pred ccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccc
Confidence 001 11246888888888887 456555 57999999999999999
Q ss_pred ccCC---cccccccCCceEEeeCceeeccCC--ccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeecc
Q 003199 251 GVLP---DSLARCKNLLRFRVSNNHLEGSIP--EGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFI 325 (840)
Q Consensus 251 ~~~~---~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 325 (840)
+..| ..++.+++|++|++++|++++..+ ..+..+++|+.|++++|+++ .+|..+..+++|++|+|++|++++ +
T Consensus 348 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l 425 (549)
T 2z81_A 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-V 425 (549)
T ss_dssp HHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-C
T ss_pred cccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-c
Confidence 8764 347889999999999999985432 45888999999999999999 467788899999999999999984 4
Q ss_pred chhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-
Q 003199 326 PSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL- 404 (840)
Q Consensus 326 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~- 404 (840)
|..+. ++|+.|+|++|++++.+ ..+++|+.|+|++|+|+ .+|. ...+++|++|||++|+|++.+|..+..+
T Consensus 426 ~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 497 (549)
T 2z81_A 426 KTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLT 497 (549)
T ss_dssp CTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCT
T ss_pred cchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCc
Confidence 54442 58999999999999643 57899999999999998 5665 4679999999999999999888888877
Q ss_pred CCCeEEccCCCCcCcCCc
Q 003199 405 LPNSINFSNNRLSGPIPL 422 (840)
Q Consensus 405 ~~~~l~l~~N~l~~~~p~ 422 (840)
.++.|++++|++.|.+|.
T Consensus 498 ~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 498 SLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp TCCEEECCSSCBCCCHHH
T ss_pred ccCEEEecCCCccCCCcc
Confidence 578999999999999983
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=408.77 Aligned_cols=254 Identities=21% Similarity=0.343 Sum_probs=206.8
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 224 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----------ESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 346799999999999999999955 579999999985432 223467889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CCCeeecc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN--YQPKVADF 680 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Df 680 (840)
+....++|||||++|+|.+++......+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+||
T Consensus 225 ~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp CSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeec
Confidence 9999999999999999999997665579999999999999999999999 999999999999999854 78999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+|+.+.. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ... ........
T Consensus 302 G~a~~~~~----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~---~~~i~~~~ 372 (573)
T 3uto_A 302 GLTAHLDP----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DET---LRNVKSCD 372 (573)
T ss_dssp SSCEECCT----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHH---HHHHHTTC
T ss_pred cceeEccC----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHH---HHHHHhCC
Confidence 99987632 3344566899999999999999999999999999999999999999975311 111 10000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .. ...+......+.+++.+||+.||.+|||+.|+++|
T Consensus 373 ~~----~~---~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 373 WN----MD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CC----CC---SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC----CC---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 01112223456678889999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=393.08 Aligned_cols=370 Identities=19% Similarity=0.157 Sum_probs=236.9
Q ss_pred EEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccc-cCCccccCCCCCcEEEc
Q 003199 21 RLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHG-QIPASIGNVTSLTDLEL 99 (840)
Q Consensus 21 ~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L 99 (840)
.++.++++++ .+|. + .++|++|+|++| .+..+++..|.++++|++|+|++|.+.+ ..+..|.++++|++|+|
T Consensus 14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n---~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 14 NAICINRGLH-QVPE-L--PAHVNYVDLSLN---SIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp EEECCSSCCS-SCCC-C--CTTCCEEECCSS---CCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCcCCCCcc-cCCC-C--CCccCEEEecCC---ccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 4555555555 4444 2 145555555555 4444445555555555555555555542 22345555666666666
Q ss_pred cCCcccccCchhhhcCCCCCeeecccCccccccCCc--ccCCCCCCCeeeccCCcccccCCcc-ccCCCCCcEEEeeccc
Q 003199 100 TGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE--ELGNLTELTDLDMSVNHLSGKIPES-ILRLPKLRVLQLYNNS 176 (840)
Q Consensus 100 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~--~l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~ 176 (840)
++|++++..|..|..+++|++|+|++|+ +.+..+. .+..+++|++|+|++|.+++..|.. +..+++|++|++++|+
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCN-LDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSC-CBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCccCccChhhccCcccCCEEeCCCCC-CCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 6666655555556666666666666555 2222222 2555666666666666665554443 5556666666666666
Q ss_pred cccccchhhhcC--CCCCEEEccCCcCcccCCcC--------CCCCCCcceeccccccccccCCccccCC---CCchhhh
Q 003199 177 LSGEISSVIANS--TTLTMLSLYDNSLTGEVPQD--------LGQWSPLVVLDLSENKLSGPLPAKVCSR---GKLQYFL 243 (840)
Q Consensus 177 l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~--------l~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~ 243 (840)
+++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|+|++|++++..|..+... .+|+.|+
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 655555555544 45666666666665433322 2234556666666666655555544433 4555555
Q ss_pred cccccccc----------cCCcccccc--cCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCC
Q 003199 244 VLQNMFSG----------VLPDSLARC--KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNL 311 (840)
Q Consensus 244 l~~n~~~~----------~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 311 (840)
+++|.+.+ ..+..+..+ ++|+.|++++|++.+..|..+..+++|+.|+|++|++++..+..|+.+++|
T Consensus 246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 325 (455)
T 3v47_A 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL 325 (455)
T ss_dssp CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccC
Confidence 55553332 222333333 578888888888887778888888888888888888888778888888888
Q ss_pred ceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCc
Q 003199 312 SELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391 (840)
Q Consensus 312 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 391 (840)
++|+|++|++++..|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 326 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 405 (455)
T 3v47_A 326 LKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405 (455)
T ss_dssp CEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCC
Confidence 88888888888777888888888888888888888777888888888888888888888766677788888888888888
Q ss_pred cccccCC
Q 003199 392 LLTGYIP 398 (840)
Q Consensus 392 ~l~~~~p 398 (840)
++++.+|
T Consensus 406 ~l~~~~~ 412 (455)
T 3v47_A 406 PWDCSCP 412 (455)
T ss_dssp CBCCCTT
T ss_pred CcccCCC
Confidence 8887777
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=399.61 Aligned_cols=419 Identities=21% Similarity=0.239 Sum_probs=319.4
Q ss_pred CccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 1 MSFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 1 ~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++.+.+++ +|. +. ++|++|+|++|.|++..|..|.++++|++|+|++| ++..+++..|.++++|++|+|++|.
T Consensus 7 ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 7 RSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHN---RIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp CTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSS---CCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred cCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCC---ccCCcChHHhhcccCCCEEecCCCc
Confidence 35677775 554 54 89999999999999888889999999999999999 7778888889999999999999999
Q ss_pred ccccCCccccCCCCCcEEEccCCcccc-cCchhhhcCCCCCeeecccCccccccCCcccCCCCCC--CeeeccCCcc--c
Q 003199 80 LHGQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL--TDLDMSVNHL--S 154 (840)
Q Consensus 80 l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L--~~L~L~~n~l--~ 154 (840)
+++ +|.. .+++|++|+|++|++++ ..|..|+.+++|++|+|++|++ .+ ..+..+++| ++|+|++|.+ .
T Consensus 81 l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l-~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 81 LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL-EK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSC-CG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred eee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCccc-ch---hhccccccceeeEEEeeccccccc
Confidence 984 5555 79999999999999996 3689999999999999999983 32 356777888 9999999999 5
Q ss_pred ccCCccccC--------------------------CCCCcEEEeeccc-------cccccchhhhcCCCCCEEEccCCcC
Q 003199 155 GKIPESILR--------------------------LPKLRVLQLYNNS-------LSGEISSVIANSTTLTMLSLYDNSL 201 (840)
Q Consensus 155 ~~~~~~~~~--------------------------l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~N~l 201 (840)
+..|..+.. +++|+.|++++|. +.+.++ .+..+++|++|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 566655554 6678888888876 555444 677788888888887777
Q ss_pred cccCCcCCC---CCCCcceeccccccccccCCccc-----cCCCCchhhhcccccccccCC-cccccc---cCCceEEee
Q 003199 202 TGEVPQDLG---QWSPLVVLDLSENKLSGPLPAKV-----CSRGKLQYFLVLQNMFSGVLP-DSLARC---KNLLRFRVS 269 (840)
Q Consensus 202 ~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~n~~~~~~~-~~~~~l---~~L~~L~l~ 269 (840)
++..+..+. ..++|+.|++++|++++.+|..+ ..+.+|+.+++++|.+ .+| ..+..+ .+|+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~ 310 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS 310 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence 643221111 13578888888888888888877 7788888888888888 344 455544 568888888
Q ss_pred CceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeee--ccchhhcccCcccEEEcCCCccCC
Q 003199 270 NNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISG--FIPSEIYRAISLVKIDLSDNLLSG 347 (840)
Q Consensus 270 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~ 347 (840)
+|.+... + .+..+++|++|++++|++++..+..++.+++|++|+|++|++++ .+|..+..+++|+.|+|++|++++
T Consensus 311 ~n~l~~~-~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 388 (520)
T 2z7x_B 311 GTRMVHM-L-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388 (520)
T ss_dssp SSCCCCC-C-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred CCccccc-c-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence 8887632 2 12567788888888888887777788888888888888888876 455677888888888888888886
Q ss_pred CCCC-cccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcc-c
Q 003199 348 PIPS-GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLS-L 424 (840)
Q Consensus 348 ~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~-~ 424 (840)
.+|. .+..+++|+.|+|++|++++..|..+. ++|+.|||++|+++ .+|..+..+ .++.|++++|++++ +|.. +
T Consensus 389 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~ 464 (520)
T 2z7x_B 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIF 464 (520)
T ss_dssp CGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTT
T ss_pred ccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHh
Confidence 4554 477788888888888888777766654 67888888888888 677766655 56788888888874 5543 3
Q ss_pred ccC--CCcccccCCCCCcc
Q 003199 425 IKE--GLVESFSGNPGLCV 441 (840)
Q Consensus 425 ~~~--~~~~~~~~n~~~c~ 441 (840)
... .....+.+||+.|.
T Consensus 465 ~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 465 DRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp TTCTTCCEEECCSSCBCCC
T ss_pred ccCCcccEEECcCCCCccc
Confidence 222 23456778888774
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=401.65 Aligned_cols=402 Identities=21% Similarity=0.213 Sum_probs=257.1
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
+++++|||++|.|++..|.+|.++++|++|+|++| .|..+++.+|.++++|++|+|++|.+++..++.|.++++|++
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N---~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~ 128 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC---EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 128 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC---CCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCC---cCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCE
Confidence 36888888888888777778888888888888888 677778888888888888888888888777777888888888
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCC----cEEEe
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKL----RVLQL 172 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L 172 (840)
|+|++|+|++..+..|+.+++|++|+|++|++.....|..+..+++|++|+|++|++++..+..|..+.++ ..+++
T Consensus 129 L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l 208 (635)
T 4g8a_A 129 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 208 (635)
T ss_dssp EECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred EECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence 88888888866666788888888888888874444567778888888888888888876666555443322 23334
Q ss_pred eccccccccch---------------------------------------------------------------------
Q 003199 173 YNNSLSGEISS--------------------------------------------------------------------- 183 (840)
Q Consensus 173 ~~N~l~~~~~~--------------------------------------------------------------------- 183 (840)
+.|.+..+.+.
T Consensus 209 s~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~ 288 (635)
T 4g8a_A 209 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 288 (635)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred ccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence 33333221111
Q ss_pred ----------------------------------hhhcCCCCCEEEccCCcCcccCCcC-------------------CC
Q 003199 184 ----------------------------------VIANSTTLTMLSLYDNSLTGEVPQD-------------------LG 210 (840)
Q Consensus 184 ----------------------------------~~~~l~~L~~L~L~~N~l~~~~~~~-------------------l~ 210 (840)
.+.....|+.|++.+|.+....+.. ..
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~ 368 (635)
T 4g8a_A 289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 368 (635)
T ss_dssp ECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCC
T ss_pred hhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccc
Confidence 1122234444444444443222111 11
Q ss_pred CCCCcceeccccccccc--cCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCC-ccccCCCcc
Q 003199 211 QWSPLVVLDLSENKLSG--PLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIP-EGILSLPHV 287 (840)
Q Consensus 211 ~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L 287 (840)
.+++|+.|++++|.+.. ..+..+..+.+|+++++..|.+.. .+..+..+++|+.+++++|......+ ..+..++++
T Consensus 369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l 447 (635)
T 4g8a_A 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 447 (635)
T ss_dssp BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC
T ss_pred cccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccc
Confidence 23344444444444421 223333344444444444444432 23345556666666666666553333 345556667
Q ss_pred cEEeccCCcccccCCcccCCCCCCceeecccceee-eccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccC
Q 003199 288 SIIDLSYNSFSGPIANTVGNARNLSELFMQRNQIS-GFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366 (840)
Q Consensus 288 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 366 (840)
+.+++++|.+.+..+..+..++.|+.|+|++|.+. +..|..+..+++|+.|+|++|+|++..|..|+++++|+.|+|++
T Consensus 448 ~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~ 527 (635)
T 4g8a_A 448 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 527 (635)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCC
Confidence 77777777776666666666777777777776643 34556666667777777777777766666677777777777777
Q ss_pred CccCCCcchhcccccCCCEEECcCccccccCCchhhcc--CCCeEEccCCCCcCcCCc
Q 003199 367 NKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL--LPNSINFSNNRLSGPIPL 422 (840)
Q Consensus 367 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--~~~~l~l~~N~l~~~~p~ 422 (840)
|+|++..|..|..+++|++|||++|+|++..|..+..+ .++.|++++|++.|.|..
T Consensus 528 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 528 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp SCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 77776666667777777777777777776666666655 356677777777766653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=367.33 Aligned_cols=273 Identities=35% Similarity=0.548 Sum_probs=220.9
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..++|+..+.||+|+||.||+|..++|+.||||++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES----------SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC----------SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC----------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 446788899999999999999998889999999874432 1234678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCC---CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
....++||||+++|+|.+++.... ..++|..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997653 358999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-Ccchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGD-NKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~ 759 (840)
|+++..... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......|......
T Consensus 184 g~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 261 (321)
T 2qkw_B 184 GISKKGTEL-DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN- 261 (321)
T ss_dssp TTCEECSSS-SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-
T ss_pred ccccccccc-cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-
Confidence 999764321 1122234456899999999998889999999999999999999999999764332 2223333322111
Q ss_pred ccchhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 760 KEGIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 760 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.......+++.... ...+....+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11223334444433 33567788999999999999999999999999998653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=394.33 Aligned_cols=404 Identities=21% Similarity=0.248 Sum_probs=344.3
Q ss_pred CccccccccCC-CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc
Q 003199 1 MSFMYLTGTLP-DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79 (840)
Q Consensus 1 ~~~~~~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 79 (840)
++.|.+++..| .|+++++|++|+|++|.|++..|..|.++++|++|+|++| .+..+|.. .+++|++|+|++|.
T Consensus 28 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N---~l~~lp~~---~l~~L~~L~L~~N~ 101 (520)
T 2z7x_B 28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN---KLVKISCH---PTVNLKHLDLSFNA 101 (520)
T ss_dssp CCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS---CCCEEECC---CCCCCSEEECCSSC
T ss_pred CCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC---ceeecCcc---ccCCccEEeccCCc
Confidence 45678888776 4999999999999999999888999999999999999999 56667765 89999999999999
Q ss_pred ccc-cCCccccCCCCCcEEEccCCcccccCchhhhcCCCC--CeeecccCccc-cccCCcccC-----------------
Q 003199 80 LHG-QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNL--RQLELYYNQQL-AGTIPEELG----------------- 138 (840)
Q Consensus 80 l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L--~~L~L~~n~~~-~~~~p~~l~----------------- 138 (840)
+++ .+|..|+++++|++|+|++|.+++ ..+..+++| +.|++++|++. .+..|..+.
T Consensus 102 l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~ 178 (520)
T 2z7x_B 102 FDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178 (520)
T ss_dssp CSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCC
T ss_pred cccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcch
Confidence 987 478999999999999999999985 468888888 99999999731 344444444
Q ss_pred ---------CCCCCCeeeccCCc-------ccccCCccccCCCCCcEEEeeccccccccchhhh---cCCCCCEEEccCC
Q 003199 139 ---------NLTELTDLDMSVNH-------LSGKIPESILRLPKLRVLQLYNNSLSGEISSVIA---NSTTLTMLSLYDN 199 (840)
Q Consensus 139 ---------~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N 199 (840)
.+++|+.|++++|. +.+.++ .+..+++|+.|++++|.+++..+..+. ..++|++|++++|
T Consensus 179 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n 257 (520)
T 2z7x_B 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257 (520)
T ss_dssp CCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEE
T ss_pred hhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecc
Confidence 47788889999887 665555 788999999999999998754332221 2569999999999
Q ss_pred cCcccCCcCC-----CCCCCcceeccccccccccCC-ccccCC---CCchhhhcccccccccCCcccccccCCceEEeeC
Q 003199 200 SLTGEVPQDL-----GQWSPLVVLDLSENKLSGPLP-AKVCSR---GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN 270 (840)
Q Consensus 200 ~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 270 (840)
++++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++
T Consensus 258 ~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~ 333 (520)
T 2z7x_B 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSN 333 (520)
T ss_dssp EEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCS
T ss_pred cccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeEC
Confidence 9998889888 8999999999999999 344 455544 67999999999987543 136889999999999
Q ss_pred ceeeccCCccccCCCcccEEeccCCcccc--cCCcccCCCCCCceeecccceeeeccch-hhcccCcccEEEcCCCccCC
Q 003199 271 NHLEGSIPEGILSLPHVSIIDLSYNSFSG--PIANTVGNARNLSELFMQRNQISGFIPS-EIYRAISLVKIDLSDNLLSG 347 (840)
Q Consensus 271 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 347 (840)
|++++..|..+..+++|+.|++++|++++ ..|..++.+++|++|+|++|++++.+|. .+..+++|+.|++++|++++
T Consensus 334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 99998899999999999999999999997 4557799999999999999999985665 47888999999999999998
Q ss_pred CCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCch-hhcc-CCCeEEccCCCCcCcCCc
Q 003199 348 PIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES-LCEL-LPNSINFSNNRLSGPIPL 422 (840)
Q Consensus 348 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~-~~~~l~l~~N~l~~~~p~ 422 (840)
..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+ .++.|++++|+++|.++.
T Consensus 414 ~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 8877665 79999999999998 78887789999999999999999 56665 6665 578999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=391.72 Aligned_cols=403 Identities=22% Similarity=0.241 Sum_probs=222.4
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
...+++++++|+++ .+|..+. ++|++|+|++| .+..+++..|..+++|++|+|++|.+++..|+.|+++++|++
T Consensus 31 ~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N---~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 104 (562)
T 3a79_B 31 ELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQN---SISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104 (562)
T ss_dssp --CCEEECTTSCCC-SCCTTSC--TTCCEEECCSS---CCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred CCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCC---CccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence 33456666666666 4554443 56666666666 455556566666666666666666666666666666666666
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCC--cEEEeec
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKL--RVLQLYN 174 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~ 174 (840)
|+|++|+|+ .+|.. .+++|++|+|++|++....+|..|.++++|++|+|++|.++.. .+..+++| +.|++++
T Consensus 105 L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~ 178 (562)
T 3a79_B 105 LDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDL 178 (562)
T ss_dssp EECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEE
T ss_pred EECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeec
Confidence 666666666 34443 5666666666666522223345666666666666666666542 23333444 6666666
Q ss_pred ccc--ccccchhhhc--------------------------CCCCCEEEccCCc--------------------------
Q 003199 175 NSL--SGEISSVIAN--------------------------STTLTMLSLYDNS-------------------------- 200 (840)
Q Consensus 175 N~l--~~~~~~~~~~--------------------------l~~L~~L~L~~N~-------------------------- 200 (840)
|.+ ++..+..+.. +++|+.|++++|+
T Consensus 179 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~ 258 (562)
T 3a79_B 179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258 (562)
T ss_dssp SSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEE
T ss_pred ccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecC
Confidence 666 4444433333 2344444444442
Q ss_pred --Cccc----CCcCCCCCCCcceeccccccccccCCccc-----cCCCCchhhhcccccccccCC-cccccc---cCCce
Q 003199 201 --LTGE----VPQDLGQWSPLVVLDLSENKLSGPLPAKV-----CSRGKLQYFLVLQNMFSGVLP-DSLARC---KNLLR 265 (840)
Q Consensus 201 --l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~n~~~~~~~-~~~~~l---~~L~~ 265 (840)
+.+. .+..+ ..++|++|++++|++++.+|..+ ..+..|+.+++..+.+ .+| ..+..+ .+|++
T Consensus 259 ~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~ 335 (562)
T 3a79_B 259 IETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKM 335 (562)
T ss_dssp EEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSE
T ss_pred CcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceE
Confidence 2110 00011 12377888888888887777766 5555555555555554 222 222222 45666
Q ss_pred EEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeec--cchhhcccCcccEEEcCCC
Q 003199 266 FRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGF--IPSEIYRAISLVKIDLSDN 343 (840)
Q Consensus 266 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N 343 (840)
|++++|.+... + ....+++|++|++++|++++..+..++.+++|++|+|++|++++. .|..+..+++|+.|+|++|
T Consensus 336 L~l~~n~~~~~-~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N 413 (562)
T 3a79_B 336 LSISDTPFIHM-V-CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413 (562)
T ss_dssp EEEESSCCCCC-C-CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTS
T ss_pred EEccCCCcccc-c-CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCC
Confidence 66666665421 1 114556666666666666665666666666666666666666642 2345566666666666666
Q ss_pred ccCCCCCC-cccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCC
Q 003199 344 LLSGPIPS-GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIP 421 (840)
Q Consensus 344 ~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p 421 (840)
++++.+|. .+..+++|+.|+|++|++++..|..+. ++|++|+|++|+|+ .+|..+..+ .++.|++++|++++ +|
T Consensus 414 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~ 489 (562)
T 3a79_B 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VP 489 (562)
T ss_dssp CCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CC
T ss_pred cCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CC
Confidence 66653333 355666666666666666555444433 46666666666666 455554444 34566666666663 34
Q ss_pred cc-cccC--CCcccccCCCCCc
Q 003199 422 LS-LIKE--GLVESFSGNPGLC 440 (840)
Q Consensus 422 ~~-~~~~--~~~~~~~~n~~~c 440 (840)
.. +... .....+.+|||.|
T Consensus 490 ~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 490 DGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp TTSTTTCTTCCCEECCSCCBCC
T ss_pred HHHHhcCCCCCEEEecCCCcCC
Confidence 32 2211 1234556666665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=381.42 Aligned_cols=371 Identities=19% Similarity=0.178 Sum_probs=325.6
Q ss_pred CEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccc-cCchhhhcCCCCCeee
Q 003199 44 EVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNLRQLE 122 (840)
Q Consensus 44 ~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~ 122 (840)
+.++.+++ .+..+|. -.++|++|+|++|.+++..|..|+++++|++|+|++|.+.+ ..+..|..+++|++|+
T Consensus 13 ~~~~c~~~---~l~~lp~----l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 13 YNAICINR---GLHQVPE----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp TEEECCSS---CCSSCCC----CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred cccCcCCC---CcccCCC----CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 45777777 5666665 22789999999999999989999999999999999999974 4467899999999999
Q ss_pred cccCccccccCCcccCCCCCCCeeeccCCcccccCCcc--ccCCCCCcEEEeeccccccccchh-hhcCCCCCEEEccCC
Q 003199 123 LYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPES--ILRLPKLRVLQLYNNSLSGEISSV-IANSTTLTMLSLYDN 199 (840)
Q Consensus 123 L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N 199 (840)
|++|+ +.+..|..|.++++|++|+|++|.+++..+.. |..+++|++|+|++|++++..+.. +.++++|++|+|++|
T Consensus 86 Ls~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 86 LDYNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp CTTCT-TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred CCCCc-cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99998 56677889999999999999999999755444 899999999999999999887765 899999999999999
Q ss_pred cCcccCCcCCCCC--CCcceeccccccccccCCccc--------cCCCCchhhhcccccccccCCcccccc---cCCceE
Q 003199 200 SLTGEVPQDLGQW--SPLVVLDLSENKLSGPLPAKV--------CSRGKLQYFLVLQNMFSGVLPDSLARC---KNLLRF 266 (840)
Q Consensus 200 ~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~--------~~l~~L~~L~l~~n~~~~~~~~~~~~l---~~L~~L 266 (840)
++++..+..+..+ .+|+.|++++|.+.+..+..+ ..+++|++|++++|.+.+..+..+... ++|+.|
T Consensus 165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 9998888888776 789999999999997665543 366899999999999999888887765 899999
Q ss_pred EeeCceeeccC----------CccccC--CCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCc
Q 003199 267 RVSNNHLEGSI----------PEGILS--LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334 (840)
Q Consensus 267 ~l~~N~l~~~~----------~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 334 (840)
++++|.+.+.. +..+.. .++|+.|++++|++++..+..|+.+++|++|+|++|++++..|..+..+++
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 99998665321 122222 368999999999999999999999999999999999999999999999999
Q ss_pred ccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccC
Q 003199 335 LVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSN 413 (840)
Q Consensus 335 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~ 413 (840)
|+.|+|++|++++..|..|+++++|+.|+|++|++++..|.+|..+++|++|+|++|++++..+..+..+ .++.|++++
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 404 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccC
Confidence 9999999999998888999999999999999999998889999999999999999999997666666666 578999999
Q ss_pred CCCcCcCCc
Q 003199 414 NRLSGPIPL 422 (840)
Q Consensus 414 N~l~~~~p~ 422 (840)
|+++|.+|.
T Consensus 405 N~l~~~~~~ 413 (455)
T 3v47_A 405 NPWDCSCPR 413 (455)
T ss_dssp SCBCCCTTT
T ss_pred CCcccCCCc
Confidence 999999994
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=367.81 Aligned_cols=279 Identities=38% Similarity=0.645 Sum_probs=222.6
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
....++|...+.||+|+||.||+|...+|+.||||++...... .....+.+|+++++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---------GGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---------hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3456789999999999999999998888999999998543321 1122588999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCC---CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
......++||||+++|+|.+++.... ..++|..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998653 348999999999999999999999222299999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC---CCCCcchhhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD---FGDNKNIIYWVSI 755 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~---~~~~~~~~~~~~~ 755 (840)
|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||+.. .........|...
T Consensus 177 Dfg~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 177 DFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCSSCEECCS--SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred cCccccccCc--ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999987643 2223344556999999999998888999999999999999999999999631 1222333344332
Q ss_pred hhccccchhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 756 KVDTKEGIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.... .......+..... ...+....+.+++.+|++.||++|||+.|++++|++...
T Consensus 255 ~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred Hhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 2222 2233444444433 336677889999999999999999999999999986433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=367.94 Aligned_cols=261 Identities=26% Similarity=0.342 Sum_probs=207.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+|...+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.++++++||||+++++++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---------TERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 56788899999999999999764 34569999985332 123456789999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+....++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCC
Confidence 99999999999999999999998766679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~--------- 265 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVIS--------- 265 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHH---------
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHH---------
Confidence 99876543223333344556789999999998899999999999999999999 9999965311 11100
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
.+......+........+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 266 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 ----SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0001111111122335677788899999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.68 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=204.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--------NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 4688889999999999999965 6899999999854321 123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred CEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 99999999999999999997764 68999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT-TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.... ........||+.|+|||++.+..++ .++||||+||++|||++|+.||.+.. ............
T Consensus 163 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~--- 230 (328)
T 3fe3_A 163 EFTV----GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLRGK--- 230 (328)
T ss_dssp GGSS----SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC---
T ss_pred ecCC----CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC---
Confidence 7643 2234556799999999999887765 89999999999999999999997531 111111100000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...+.. ....+.+++.+|++.||.+|||++|++++-
T Consensus 231 -----~~~p~~---~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 231 -----YRIPFY---MSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp -----CCCCTT---SCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred -----CCCCCC---CCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 011111 234566788899999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.54 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=207.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-----------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-----------CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 46788899999999999999988899999999854321 1356889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccc
Confidence 9999999999999999998776679999999999999999999999 9999999999999999999999999999986
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... . ...... .
T Consensus 156 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~---~~~~~~-------~ 221 (269)
T 4hcu_A 156 VLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--S---EVVEDI-------S 221 (269)
T ss_dssp BCCH--HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H---HHHHHH-------H
T ss_pred cccc--ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--H---HHHHHH-------h
Confidence 5321 1112234456788999999998899999999999999999999 9999975311 1 000000 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.......+.. ....+.+++.+|++.||++|||+.+++++|+++.
T Consensus 222 ~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 222 TGFRLYKPRL---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp TTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccCCCCCc---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 0001111111 2345677888999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=372.95 Aligned_cols=260 Identities=27% Similarity=0.355 Sum_probs=197.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+|...+.||+|+||.||+|... ++..||||++.... .....+.+.+|+.++++++||||+++++++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---------TEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46888899999999999999764 57789999984322 123456799999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+....++||||+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 99999999999999999999998876679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++................+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ..... ..
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~---~~----- 262 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVI---KA----- 262 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--HHHHH---HH-----
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHH---HH-----
Confidence 99876543222222233446788999999999999999999999999999998 999996531 11110 00
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
+......+........+.+++.+||+.||++||++.++++.|+++..
T Consensus 263 -----i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 263 -----VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -----HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 00000111112234567788889999999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=369.59 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=206.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe--------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL--------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
++|...+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+++++++ +||||++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---------TEKDLSDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---------BHHHHHHHHHHHHHHHHSCCCTTBCC
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---------CHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 5678889999999999999965 245679999985332 123456789999999999 8999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++++.+....++||||+++|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+|||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrD 228 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRD 228 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccc
Confidence 9999999999999999999999999997643 247899999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+|||++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchhhEEECCCCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999998664321 1122334567889999999999999999999999999999999 999997
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+.. ....... +...............+.+++.+||+.||++||++.|++++|+++
T Consensus 308 ~~~--~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 308 GIP--VEELFKL-------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp TCC--GGGHHHH-------------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC--HHHHHHH-------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 531 1111100 000001111112334577788899999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.18 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=208.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|..+++..||||++..... ..+.+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY 76 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-----------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 56788899999999999999999888999999854321 1356889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 9999999999999999998765569999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
... ..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... .....
T Consensus 154 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~--~~~~~-------- 219 (268)
T 3sxs_A 154 VLD--DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEV--VLKVS-------- 219 (268)
T ss_dssp CCT--TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHH--HHHHH--------
T ss_pred cch--hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHH--HHHHH--------
Confidence 543 12222334456778999999988889999999999999999999 9999975311 000 00000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
.......+.. ....+.+++.+|++.||++|||+.|++++|+.+...
T Consensus 220 ~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 220 QGHRLYRPHL---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTCCCCCCTT---SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cCCCCCCCCc---ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0000011111 224567788899999999999999999999988653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=358.83 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=209.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD----------EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC----------HHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 4677889999999999999966 478999999884321 34457789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 99999999999999999998866689999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCC-----------cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 685 VLQARGGKD-----------STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 685 ~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
......... .......||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~- 235 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN- 235 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-
Confidence 764321111 11124679999999999999999999999999999999999999987532221111100
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.....+...+... ...+.+++.+||+.||++|||+.++++.|+++..
T Consensus 236 ---------~~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 ---------VRGFLDRYCPPNC---PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ---------HHHHHHHTCCTTC---CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------hhccccccCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111111 2346678889999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.41 Aligned_cols=259 Identities=32% Similarity=0.450 Sum_probs=199.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+|+..+.||+|+||+||+|... |+.||||++..... .....+.+.+|++++++++||||+++++++.+..
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF--------HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC--------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred hHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC--------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 56888899999999999999774 89999999854321 1233567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCCCeeeccc
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999998753 238999999999999999999999 88 9999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+++.... .........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ ..
T Consensus 185 ~a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~~~--~~--- 254 (309)
T 3p86_A 185 LSRLKAS---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVG--FK--- 254 (309)
T ss_dssp --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHHHHH--HS---
T ss_pred CCccccc---cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH--hc---
Confidence 9976432 12223456799999999999999999999999999999999999999975311 11110000 00
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
......+.. ....+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 255 ----~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 ----CKRLEIPRN---LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----CCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----CCCCCCCcc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 001111222 234567788899999999999999999999877554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.92 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=204.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----------PKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----------cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 35788899999999999999964 5799999999854321 123568899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999999999875 58999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 164 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~--- 233 (297)
T 3fxz_A 164 AQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGT--- 233 (297)
T ss_dssp EECCS---TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHCS---
T ss_pred eecCC---cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCC---
Confidence 76543 22233456799999999999999999999999999999999999999975311 100000000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. ..........+.+++.+||+.||++|||+.|++++-
T Consensus 234 -----~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 234 -----PE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp -----CC-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred -----CC-CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 00 001122334567788899999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.17 Aligned_cols=280 Identities=35% Similarity=0.544 Sum_probs=222.8
Q ss_pred hHHHHHHhcCcc------CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC
Q 003199 520 DQREILEAMTEK------NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN 593 (840)
Q Consensus 520 ~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 593 (840)
+...++..|... +.||+|+||.||+|.. +++.||||++...... ......+.+.+|+.++++++|||
T Consensus 19 ~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI------TTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp HHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS------CTTTHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc------chHHHHHHHHHHHHHHHhcCCCC
Confidence 344555666655 8999999999999987 4899999998543211 11234567899999999999999
Q ss_pred cceeeeEEecCccceEEEeecCCCChHHHhhcC--CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 003199 594 IVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKG--LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV 671 (840)
Q Consensus 594 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 671 (840)
|+++++++.+....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998743 3468999999999999999999999 99999999999999999
Q ss_pred CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 003199 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 672 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 751 (840)
++.+||+|||+++..... ..........||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......
T Consensus 169 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKF-AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSC-SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS-SSBTTH
T ss_pred CCcEEEeecccccccccc-cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc-hHHHHH
Confidence 999999999999765331 11222334579999999998765 588999999999999999999999976432 222222
Q ss_pred hhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
+..........+...+++............+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222222233344556666666667778889999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.89 Aligned_cols=268 Identities=27% Similarity=0.321 Sum_probs=204.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+|+..+.||+|+||+||+|... ++.||||++.... .....+.+|+.++++++||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-----------KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-----------hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 46788899999999999999876 8999999984321 22344566999999999999999999997754
Q ss_pred c----ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCC----------CeEecCCCCCCEEEcC
Q 003199 606 C----NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS----------PIIHRDIKSTNILLDV 671 (840)
Q Consensus 606 ~----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dlk~~Nill~~ 671 (840)
. .++||||+++|+|.+++... .++|..+..++.|++.||+|||+ . +|+||||||+||+++.
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECT
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECC
Confidence 3 59999999999999999875 58999999999999999999998 7 9999999999999999
Q ss_pred CCCCeeecccchhhhhccCCCCcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 003199 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746 (840)
Q Consensus 672 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 746 (840)
++.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~kL~DFg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TCCEEECCCTTCEEECTTS-CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCeEEEccCCccccccccc-CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999997764321 1222334679999999999876 355678999999999999999999997643322
Q ss_pred cchhhhhhhhhccccchhh-hccccc----CCCc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 747 KNIIYWVSIKVDTKEGIME-VLDKKL----SGSF--RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
................... ...... ...+ ......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111000000000000111 111111 1111 234566889999999999999999999999998764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=385.01 Aligned_cols=400 Identities=19% Similarity=0.237 Sum_probs=324.5
Q ss_pred ccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccc
Q 003199 2 SFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCAL 80 (840)
Q Consensus 2 ~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l 80 (840)
+.+.+++ +|. +. ++|++|+|++|.|++..|..|.++++|++|+|++| .+..+++..|.++++|++|+|++|.+
T Consensus 39 s~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N---~l~~~~~~~~~~l~~L~~L~Ls~N~l 112 (562)
T 3a79_B 39 SNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHN---RIRSLDFHVFLFNQDLEYLDVSHNRL 112 (562)
T ss_dssp TTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSC---CCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCC---CCCcCCHHHhCCCCCCCEEECCCCcC
Confidence 4456675 454 43 89999999999999888889999999999999999 77888888999999999999999999
Q ss_pred cccCCccccCCCCCcEEEccCCccccc-CchhhhcCCCCCeeecccCccccccCCcccCCCCCC--CeeeccCCcc--cc
Q 003199 81 HGQIPASIGNVTSLTDLELTGNFITGH-IPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL--TDLDMSVNHL--SG 155 (840)
Q Consensus 81 ~~~~~~~~~~l~~L~~L~L~~n~i~~~-~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L--~~L~L~~n~l--~~ 155 (840)
+ .+|.. .+++|++|+|++|++++. .|..|.++++|++|+|++|++ .. ..+..+++| ++|+|++|.+ ++
T Consensus 113 ~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l-~~---~~~~~l~~L~L~~L~L~~n~l~~~~ 185 (562)
T 3a79_B 113 Q-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF-RQ---LDLLPVAHLHLSCILLDLVSYHIKG 185 (562)
T ss_dssp C-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBC-CT---TTTGGGTTSCEEEEEEEESSCCCCS
T ss_pred C-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcc-cc---CchhhhhhceeeEEEeecccccccc
Confidence 8 45655 799999999999999963 468999999999999999983 32 245555666 9999999999 66
Q ss_pred cCCccccC--------------------------CCCCcEEEeeccc----------------------------cccc-
Q 003199 156 KIPESILR--------------------------LPKLRVLQLYNNS----------------------------LSGE- 180 (840)
Q Consensus 156 ~~~~~~~~--------------------------l~~L~~L~L~~N~----------------------------l~~~- 180 (840)
..|..+.. +++|+.|++++|+ +.+.
T Consensus 186 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~ 265 (562)
T 3a79_B 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265 (562)
T ss_dssp SSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHH
T ss_pred cCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHH
Confidence 66665554 4466677777663 1110
Q ss_pred ---cchhhhcCCCCCEEEccCCcCcccCCcCC-----CCCCCcceeccccccccccCC-ccccC---CCCchhhhccccc
Q 003199 181 ---ISSVIANSTTLTMLSLYDNSLTGEVPQDL-----GQWSPLVVLDLSENKLSGPLP-AKVCS---RGKLQYFLVLQNM 248 (840)
Q Consensus 181 ---~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~---l~~L~~L~l~~n~ 248 (840)
.+. ....++|++|++++|++++.+|..+ ..++.|+.++++.|.+ .+| ..+.. ..+|+.|++++|.
T Consensus 266 ~~~~~~-~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~ 342 (562)
T 3a79_B 266 SVKLFQ-FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTP 342 (562)
T ss_dssp HHHHHH-HHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSC
T ss_pred HHHHHH-hhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCC
Confidence 011 1123489999999999998888877 7788888888888877 334 23322 3679999999998
Q ss_pred ccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccC--CcccCCCCCCceeecccceeeeccc
Q 003199 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI--ANTVGNARNLSELFMQRNQISGFIP 326 (840)
Q Consensus 249 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p 326 (840)
+.... ....+++|++|++++|++++..|..+..+++|+.|++++|++++.. +..++.+++|++|+|++|++++.+|
T Consensus 343 ~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 420 (562)
T 3a79_B 343 FIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420 (562)
T ss_dssp CCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCS
T ss_pred ccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccC
Confidence 86432 1267899999999999999889999999999999999999999743 4678999999999999999998455
Q ss_pred h-hhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCch-hhcc
Q 003199 327 S-EIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPES-LCEL 404 (840)
Q Consensus 327 ~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~ 404 (840)
. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+
T Consensus 421 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l 496 (562)
T 3a79_B 421 DRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRL 496 (562)
T ss_dssp SCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTC
T ss_pred hhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcC
Confidence 4 577889999999999999987777664 78999999999998 67776779999999999999999 56765 6665
Q ss_pred -CCCeEEccCCCCcCcCCcc
Q 003199 405 -LPNSINFSNNRLSGPIPLS 423 (840)
Q Consensus 405 -~~~~l~l~~N~l~~~~p~~ 423 (840)
.++.+++++|++.|.+|..
T Consensus 497 ~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 497 TSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp TTCCCEECCSCCBCCCHHHH
T ss_pred CCCCEEEecCCCcCCCcchH
Confidence 5688999999999998853
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=384.04 Aligned_cols=415 Identities=20% Similarity=0.187 Sum_probs=320.9
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEE
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 98 (840)
-++.+-++.+++ .+|..+. +++++|+|++| .|+.+++..|.++++|++|+|++|.|+++.|++|.++++|++|+
T Consensus 33 ~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N---~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~ 106 (635)
T 4g8a_A 33 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFN---PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 106 (635)
T ss_dssp TTEEECTTSCCS-SCCSSSC--TTCCEEECTTS---CCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCCcC-ccCCCCC--cCCCEEEeeCC---CCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEE
Confidence 356788888898 7887553 48999999999 78889999999999999999999999998899999999999999
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCccccc-CCccccCCCCCcEEEeecccc
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGK-IPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l 177 (840)
|++|+|++..+..|.++++|++|+|++|+ +.+..+..|+++++|++|+|++|.+++. .|..+..+++|++|+|++|+|
T Consensus 107 Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~-l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 107 LTGNPIQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp CTTCCCCEECGGGGTTCTTCCEEECTTSC-CCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccCCcCCCCCHHHhcCCCCCCEEECCCCc-CCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 99999998778899999999999999998 4555556799999999999999999864 578889999999999999999
Q ss_pred ccccchhhhcCCCCC----EEEccCCcCcccCCcCCCCC-----------------------------------------
Q 003199 178 SGEISSVIANSTTLT----MLSLYDNSLTGEVPQDLGQW----------------------------------------- 212 (840)
Q Consensus 178 ~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l----------------------------------------- 212 (840)
++..+..|..+.+++ .++++.|.+..+.+..+...
T Consensus 186 ~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~ 265 (635)
T 4g8a_A 186 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 265 (635)
T ss_dssp CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSC
T ss_pred cccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccc
Confidence 988888887665443 67777777764333222211
Q ss_pred --------------------------------------------------------------CCcceeccccccccccCC
Q 003199 213 --------------------------------------------------------------SPLVVLDLSENKLSGPLP 230 (840)
Q Consensus 213 --------------------------------------------------------------~~L~~L~L~~N~l~~~~~ 230 (840)
..|+.|++.+|.+....+
T Consensus 266 ~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~ 345 (635)
T 4g8a_A 266 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 345 (635)
T ss_dssp CCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCC
T ss_pred ccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCc
Confidence 122222333332221111
Q ss_pred cc-------------------ccCCCCchhhhcccccccc--cCCcccccccCCceEEeeCceeeccCCccccCCCcccE
Q 003199 231 AK-------------------VCSRGKLQYFLVLQNMFSG--VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSI 289 (840)
Q Consensus 231 ~~-------------------~~~l~~L~~L~l~~n~~~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 289 (840)
.. ...+++|+.++++.|.+.. ..+..+..+.+|+.+++..|.+. ..+..+..+++|+.
T Consensus 346 ~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~ 424 (635)
T 4g8a_A 346 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEH 424 (635)
T ss_dssp CBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCE
T ss_pred ccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccc
Confidence 10 1122333344444443321 12223333444445555555444 33455667788888
Q ss_pred EeccCCcccccCC-cccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCcc-CCCCCCcccCccccchhcccCC
Q 003199 290 IDLSYNSFSGPIA-NTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLL-SGPIPSGIGNLKKLNLLMLQSN 367 (840)
Q Consensus 290 L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N 367 (840)
++++.|......+ ..|..+++++.++++.|.+.+..+..+..++.|+.|+|++|.+ .+..|..|..+++|+.|+|++|
T Consensus 425 l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N 504 (635)
T 4g8a_A 425 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 504 (635)
T ss_dssp EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred hhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCC
Confidence 8888777665443 5678899999999999999999999999999999999999985 4468889999999999999999
Q ss_pred ccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccC---CCcccccCCCCCcc
Q 003199 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKE---GLVESFSGNPGLCV 441 (840)
Q Consensus 368 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~---~~~~~~~~n~~~c~ 441 (840)
+|++.+|.+|.++++|++|+|++|+|++..|..+..+ .++.|++++|++++..|..+... .....+.+|||.|.
T Consensus 505 ~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 505 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred ccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999999999999999999999999998888888877 67999999999999999876543 34578999999994
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.25 Aligned_cols=270 Identities=27% Similarity=0.349 Sum_probs=208.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-------KEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc-------cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 4688889999999999999964 47899999998543321 234457789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 99999999999999999998764 68999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... .........||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... .............
T Consensus 160 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~~~~~~~~~--- 230 (294)
T 4eqm_A 160 ALSET--SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAIKHIQDSVP--- 230 (294)
T ss_dssp TC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH----HHHHHHHHSSCCC---
T ss_pred ccccc--cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhccCC---
Confidence 76431 22233446799999999999999999999999999999999999999975311 0000000000000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhhcCCCCCCCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-TMNEVVQLLAEADPCRFESCK 819 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~~~~~~~~~ 819 (840)
........ +....+.+++.+|++.||++|| +++++.+.|+.+........+
T Consensus 231 -~~~~~~~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 231 -NVTTDVRK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp -CHHHHSCT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred -Ccchhccc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 00001111 1234567788899999999998 999999999887655544433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.25 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=204.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|...++..||||++..... ..+.+.+|++++++++||||+++++++.+..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-----------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-----------CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 56788899999999999999999888999999854321 1356889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 9999999999999999998755579999999999999999999999 9999999999999999999999999999986
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ... ... +.
T Consensus 170 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~~---~~~-------~~ 235 (283)
T 3gen_A 170 VLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET---AEH-------IA 235 (283)
T ss_dssp BCCH--HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHH---HHH-------HH
T ss_pred cccc--ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--hHH---HHH-------Hh
Confidence 5321 1112233456788999999998899999999999999999998 9999975311 000 000 00
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
........... ...+.+++.+||+.||++|||+++++++|.++
T Consensus 236 ~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 236 QGLRLYRPHLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp TTCCCCCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCCCcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00111111111 34567788899999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=372.25 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=205.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++...
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 46778899999999999999776 78999999985321 123345688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 99999999999999999998765578999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... ..........+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... ..
T Consensus 262 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~----~~---- 330 (377)
T 3cbl_A 262 EEADG-VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFV----EK---- 330 (377)
T ss_dssp ECTTS-EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHH----HT----
T ss_pred ecCCC-ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----Hc----
Confidence 54221 00111122345778999999988899999999999999999998 9999975311 1110000 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
......+. .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 331 --~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 331 --GGRLPCPE---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --TCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 00001111 12345677888999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=356.45 Aligned_cols=271 Identities=24% Similarity=0.342 Sum_probs=205.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.++|+..+.||+|+||+||+|...+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--------DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 467888999999999999999888899999999854321 122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++ |+|.+.+......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 92 RCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp SCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 99999999997 58888888776679999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-ccccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DTKEG 762 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 762 (840)
.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ......... .....
T Consensus 168 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 168 AFGI---PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPRE 243 (311)
T ss_dssp ETTS---CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTT
T ss_pred ecCC---CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHH
Confidence 7632 2223344578999999999876 5689999999999999999999999976432221 111111000 00000
Q ss_pred hhhh------cc---cccCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcC
Q 003199 763 IMEV------LD---KKLSGS-----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEAD 811 (840)
Q Consensus 763 ~~~~------~~---~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~ 811 (840)
.... .. ...... ......++.+++.+|++.||++|||++|++++ +++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 0000 00 000000 01123467788899999999999999999985 44443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.75 Aligned_cols=270 Identities=26% Similarity=0.325 Sum_probs=203.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|+..+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----------EEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC----------HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC----------HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 5678889999999999999974 368999999985322 2335678999999999999999999999
Q ss_pred Eec--CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 601 FSS--LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 601 ~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+.. ....++||||+++|+|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEc
Confidence 855 345799999999999999998876569999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++................++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 233 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQ 233 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCC
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccc
Confidence 9999987654322223334456778899999999999999999999999999999999998642100 0000000000
Q ss_pred ----cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 759 ----TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 759 ----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
..............+........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000001111111112233456778888999999999999999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.32 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=205.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|... +|+.||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 72 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----------TDQVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----------ccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence 357888999999999999999654 68999999984321 224568899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCCCeeeccc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV--NYQPKVADFG 681 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg 681 (840)
....++||||+++|+|.+++......+++.++..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 999999999999999999998766679999999999999999999999 99999999999999987 7899999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ....
T Consensus 150 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~---~~~~------- 213 (321)
T 1tki_A 150 QARQLKP----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--Q---QIIE------- 213 (321)
T ss_dssp TCEECCT----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--H---HHHH-------
T ss_pred CCeECCC----CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--H---HHHH-------
Confidence 9987632 2334556799999999999888899999999999999999999999975311 1 1110
Q ss_pred chhhhcccccCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 762 GIMEVLDKKLSG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 762 ~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.+....... .+.....++.+++.+|+..||++|||+.|++++-.
T Consensus 214 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 214 ---NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ---HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ---HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 011111100 01122356778888999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.06 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=203.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|..+ +|+.||||++...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 56888899999999999999665 7999999998543210 112345688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 99999999999999999998754 68999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ..........
T Consensus 154 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~--~~~~~~i~~~----- 220 (337)
T 1o6l_A 154 EGIS---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---H--ERLFELILME----- 220 (337)
T ss_dssp CSCC---TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---H--HHHHHHHHHC-----
T ss_pred hccc---CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---H--HHHHHHHHcC-----
Confidence 5422 1223445679999999999999999999999999999999999999997531 1 1111110000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
...++..+ ...+.+++.+|++.||++|| ++.|+++|
T Consensus 221 ---~~~~p~~~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 ---EIRFPRTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCC---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01122222 34566778899999999999 89999887
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=353.82 Aligned_cols=275 Identities=23% Similarity=0.272 Sum_probs=208.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---------cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 45788899999999999999665 689999999853321 12245678899999999999999999998765
Q ss_pred c--cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCCCe
Q 003199 605 Y--CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL----DVNYQPK 676 (840)
Q Consensus 605 ~--~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~k 676 (840)
. ..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||++ +.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEE
Confidence 5 6799999999999999998653 238999999999999999999999 999999999999999 7778899
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccc--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY--------SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
|+|||+++.... ........||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 157 L~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 157 LTDFGAARELED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp ECCCTTCEECCT----TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EccCCCceecCC----CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 999999987633 22334457999999999875 567899999999999999999999999753322211
Q ss_pred hhhhhhhhhccc-cchhhh---------cccccC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 749 IIYWVSIKVDTK-EGIMEV---------LDKKLS---GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 749 ~~~~~~~~~~~~-~~~~~~---------~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
............ ...... .....+ .........+.+++.+|++.||++|||++|++++..+....+.
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 111111111000 000000 000111 1224566678889999999999999999999999998777665
Q ss_pred C
Q 003199 816 E 816 (840)
Q Consensus 816 ~ 816 (840)
.
T Consensus 313 ~ 313 (319)
T 4euu_A 313 S 313 (319)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=368.58 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=206.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--------SARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 4668899999999999999999954 5799999999854432 123356788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCCeee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD---VNYQPKVA 678 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~ 678 (840)
.+....++||||+++|+|.+.+.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEc
Confidence 99999999999999999999998764 69999999999999999999999 9999999999999998 45789999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ....+......
T Consensus 156 DFG~a~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~ 228 (444)
T 3soa_A 156 DFGLAIEVEG---EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRLYQQIKAG 228 (444)
T ss_dssp CCSSCBCCCT---TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHT
T ss_pred cCceeEEecC---CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhC
Confidence 9999976543 2223345679999999999999899999999999999999999999997531 11111111000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. ....+.+......+.+++.+|++.||++|||+.|++++-
T Consensus 229 ~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 229 AY--------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp CC--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred CC--------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00 001111222345667788899999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.13 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=205.8
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.+.|...+.||+|+||.||+|... +|+.||||++.......... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR----GVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS----SBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc----hhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 3457888999999999999999654 79999999996554321111 112457889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CCeee
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY----QPKVA 678 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~ 678 (840)
+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999999997654 69999999999999999999999 9999999999999998876 79999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++.... ........||+.|+|||++.+..++.++||||+||++|||++|..||.+... . ........
T Consensus 162 DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~---~~~~~i~~ 232 (361)
T 2yab_A 162 DFGLAHEIED----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--Q---ETLANITA 232 (361)
T ss_dssp CCSSCEECCT----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--H---HHHHHHHT
T ss_pred ecCCceEcCC----CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHh
Confidence 9999987633 2233456799999999999988999999999999999999999999975311 0 01000000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... .+... +......+.+++.+|+..||++|||+.|++++-
T Consensus 233 ~~~~----~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 233 VSYD----FDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp TCCC----CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cCCC----CCchh---ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000 00000 011234567788899999999999999999763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=364.83 Aligned_cols=261 Identities=25% Similarity=0.317 Sum_probs=207.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|+..+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---------SEQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---------ChhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 56788899999999999999743 46789999984322 1233457889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
++.+....++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSS
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCC
Confidence 9999999999999999999999997643 358999999999999999999999 9999999999999999554
Q ss_pred ---CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003199 674 ---QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNI 749 (840)
Q Consensus 674 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 749 (840)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++ |+.||.... ....
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~~~ 295 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAG-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEV 295 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHS-SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH
T ss_pred CCceEEECCCcccccccccc-ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHH
Confidence 59999999998765432 2233445678999999999999999999999999999999998 999997531 1111
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
... +...............+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 296 ~~~-------------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 296 LEF-------------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHH-------------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 100 0000011111122345778888999999999999999999998765443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.28 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=204.7
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---------VDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---------cchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 357888999999999999999655 799999999854321 1223567889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeecc
Confidence 999999999999999999997654 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.+... ..........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............|....
T Consensus 153 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------ 225 (323)
T 3tki_A 153 TVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------ 225 (323)
T ss_dssp EECEET-TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC------
T ss_pred ceeccC-CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc------
Confidence 765432 12222345679999999999987765 7899999999999999999999976433222222221110
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
............+.+++.+|++.||++|||+.|++++-.
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 226 -------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp -------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 001111223345677888999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=360.67 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=205.8
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.+.|+..+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--------ARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4567899999999999999999965 47899999998544321 23346788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCCeee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN---YQPKVA 678 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~ 678 (840)
.+....++||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+||+++.+ +.+||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEe
Confidence 99999999999999999999997654 68999999999999999999999 999999999999999865 459999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+......
T Consensus 174 DfG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~~i~~~ 245 (362)
T 2bdw_A 174 DFGLAIEVND----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAG 245 (362)
T ss_dssp CCTTCBCCTT----CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT
T ss_pred ecCcceEecC----CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhC
Confidence 9999976643 222345679999999999999899999999999999999999999997531 11111111000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ......+......+.+++.+|++.||++||++.|++++
T Consensus 246 ~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AY--------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC--------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC--------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00011122234567788889999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.63 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=208.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.++|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||++++
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---------SADMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---------CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 357888899999999999999764 34899999985332 123456789999999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC-----------------------CCCChHHHHHHHHHHHHHHHHHhhcCCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL-----------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLS 655 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 655 (840)
+++.+....++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ +
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~ 193 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---R 193 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 99999999999999999999999997632 468999999999999999999999 9
Q ss_pred CeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-
Q 003199 656 PIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT- 734 (840)
Q Consensus 656 ~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t- 734 (840)
+|+||||||+||+++.++.+||+|||+++...... .........+|+.|+|||.+.+..++.++||||||+++|||++
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999999999999999999998764421 1122344568899999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 735 GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 735 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
|+.||.+... ... .. .+.+.............+.+++.+||+.||++||++.+++++|+++....
T Consensus 273 g~~p~~~~~~--~~~---~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 273 GLQPYYGMAH--EEV---IY----------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TCCTTTTSCH--HHH---HH----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCcCCCCCh--HHH---HH----------HHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9999975311 111 00 01111111111122346777888999999999999999999999887654
Q ss_pred C
Q 003199 815 F 815 (840)
Q Consensus 815 ~ 815 (840)
.
T Consensus 338 ~ 338 (343)
T 1luf_A 338 E 338 (343)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.07 Aligned_cols=260 Identities=24% Similarity=0.320 Sum_probs=206.8
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.+.|...+.||+|+||.||+|... +|+.||||++.......... ....+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR----GVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS----SBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 35577999999999999999999654 79999999986544321111 11246788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CCee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY----QPKV 677 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl 677 (840)
.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 99999999999999999999997654 68999999999999999999999 9999999999999999877 7999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .....
T Consensus 160 ~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~--~~~~~- 230 (326)
T 2y0a_A 160 IDFGLAHKIDF----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QET--LANVS- 230 (326)
T ss_dssp CCCTTCEECCT----TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHH--HHHHH-
T ss_pred EECCCCeECCC----CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHH--HHHHH-
Confidence 99999987632 1223446799999999999988999999999999999999999999975311 000 00000
Q ss_pred ccccchhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. ...... .+......+.+++.+|++.||++|||+.|++++-
T Consensus 231 ~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 231 AV--------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HT--------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred hc--------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 00 000000 0011234567788899999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.25 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=193.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++||||+++++++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---------SDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---------CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 568888999999999999996642 4579999874322 123456789999999999999999999998
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
. ....++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccc
Confidence 5 456789999999999999998776679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++..... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+... ......
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~-------- 229 (281)
T 1mp8_A 162 LSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGR-------- 229 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHH--------
T ss_pred cccccCcc--cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHH--------
Confidence 99876432 1222334457789999999988899999999999999999997 9999975321 111111
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+......+........+.+++.+|++.||++|||+.|++++|+++
T Consensus 230 -----i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 230 -----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111111112334567788899999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.93 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=201.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||.||+|.. .+|+.||||++...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-------KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-------HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-------chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4678889999999999999965 67999999998432211 112235688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+ +|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred CEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 9999999999 789999887654 69999999999999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+...... .. .+
T Consensus 157 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~----------~i 220 (336)
T 3h4j_B 157 IMTD----GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FK----------KV 220 (336)
T ss_dssp TTTT----SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BC----------CC
T ss_pred eccC----CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HH----------HH
Confidence 7643 223345679999999999988776 7899999999999999999999975321110 00 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. .....+.. ....+.+++.+|++.||.+|||++|++++-.
T Consensus 221 ~~-~~~~~p~~---~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 221 NS-CVYVMPDF---LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CS-SCCCCCTT---SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred Hc-CCCCCccc---CCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 00 00011112 2345667888999999999999999998743
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=374.05 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=205.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|...+.||+|+||.||+|..+++..||||++.... ...+.|.+|+.++++++||||+++++++. ..
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----------MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4677888999999999999999888999999985432 12467899999999999999999999986 56
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 7899999999999999997542 368899999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........+|+.|+|||++....++.++|||||||++|||++ |+.||.+... .......
T Consensus 333 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i---------- 398 (454)
T 1qcf_A 333 VIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL---------- 398 (454)
T ss_dssp GBCCH--HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH----------
T ss_pred EcCCC--ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----------
Confidence 75321 1111233456789999999998899999999999999999999 9999975311 1111000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
......+........+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 399 ---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ---ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 00000111122345677888899999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.02 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=198.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcE----EEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEV----VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|+..+.||+|+||+||+|... +|+. ||+|.+.... .....+.+.+|+.++++++||||++++++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---------CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 46788899999999999999754 5554 5777663221 12335678999999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.+.. .++|+||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccC
Confidence 98754 689999999999999998876689999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ........
T Consensus 162 g~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~----- 233 (327)
T 3poz_A 162 GLAKLLGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE----- 233 (327)
T ss_dssp THHHHHTTTC-C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH-----
T ss_pred cceeEccCCc-ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHH-----
Confidence 9998875422 2223334567889999999999999999999999999999999 9999975311 11111100
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
..............+.+++.+||+.||++||++.|++++|+.+..
T Consensus 234 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 --------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --------cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000011112233467788889999999999999999999987644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.67 Aligned_cols=256 Identities=26% Similarity=0.337 Sum_probs=207.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-----------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-----------CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 46778889999999999999988889999999854321 1356889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccc
Confidence 9999999999999999998776678999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .. .......
T Consensus 154 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~---~~~~~i~------- 219 (267)
T 3t9t_A 154 VLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NS---EVVEDIS------- 219 (267)
T ss_dssp BCCH--HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HH---HHHHHHH-------
T ss_pred cccc--cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--HH---HHHHHHh-------
Confidence 5321 1112233457788999999988899999999999999999999 899987531 11 1110000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.......+.. ....+.+++.+|++.||++|||+.+++++|+++..
T Consensus 220 ~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 220 TGFRLYKPRL---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCcCCCCcc---CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000111111 23456778889999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.13 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=199.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||+||+|...+|+.||||++...... ....+.+.+|++++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc--------cccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence 467888999999999999998888999999998543311 122356778999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++ +|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred eEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 99999999975 9999998765679999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-ccccch
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DTKEGI 763 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 763 (840)
... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ........... ......
T Consensus 150 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 150 FGI---PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred cCc---cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhc
Confidence 642 12223445789999999998764 5899999999999999999999999753211 00000000000 000000
Q ss_pred hh-----hccccc--------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 ME-----VLDKKL--------SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~-----~~~~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ..+... ..........+.+++.+|++.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000000 00011223456788889999999999999999876
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.13 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=202.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|... +|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-------VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-------ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 56888999999999999999654 689999999853321 1122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceee
Confidence 99999999999999999998764 69999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 164 ~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~--- 234 (384)
T 4fr4_A 164 MLPR----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFET--- 234 (384)
T ss_dssp ECCT----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHH---
T ss_pred eccC----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhh---
Confidence 6532 233455689999999999864 4589999999999999999999999975322111 111110000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-MNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~ 806 (840)
.....+.. ....+.+++.+|++.||++||+ +.++.++
T Consensus 235 -----~~~~~p~~---~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 235 -----TVVTYPSA---WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----CCCCCCTT---SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----cccCCCCc---CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 00111222 2345677888999999999998 7777764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.79 Aligned_cols=259 Identities=26% Similarity=0.351 Sum_probs=204.4
Q ss_pred HHhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCccee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKL 597 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 597 (840)
.++|...+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|++++.++ +||||+++
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---------THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---------CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 35788899999999999999963 356899999985332 123356789999999999 78999999
Q ss_pred eeEEecCcc-ceEEEeecCCCChHHHhhcCCC------------------------------------------------
Q 003199 598 YCYFSSLYC-NLLVYEYMPNGNLWDALHKGLV------------------------------------------------ 628 (840)
Q Consensus 598 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------ 628 (840)
++++.+... .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 8999999999999999976431
Q ss_pred -----------------CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCC
Q 003199 629 -----------------HLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691 (840)
Q Consensus 629 -----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 691 (840)
.+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~-~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-P 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-T
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccc-c
Confidence 18899999999999999999999 99999999999999999999999999999866432 2
Q ss_pred CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcccc
Q 003199 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770 (840)
Q Consensus 692 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 770 (840)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.||....... .... ... ......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~--~~~--------~~~~~~ 316 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR--RLK--------EGTRMR 316 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHH--HHH--------HTCCCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHH--HHH--------cCCCCC
Confidence 2233445678999999999999999999999999999999998 999997532111 1100 000 000111
Q ss_pred cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.... ....+.+++.+||+.||++|||+.|++++|+++
T Consensus 317 ~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 317 APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 234567788899999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.03 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=200.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc--cCCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN--IRHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~ 602 (840)
.++|+..+.||+|+||+||+|.. +|+.||||++.... ...+..|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-------------EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-------------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 45788899999999999999987 58999999984321 2344556666555 79999999999865
Q ss_pred c----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCEEEc
Q 003199 603 S----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH--------HGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 603 ~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlk~~Nill~ 670 (840)
. ....++||||+++|+|.+++... .+++..+..++.|++.||+||| + ++|+||||||+||+++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVK 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEEC
T ss_pred cccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEc
Confidence 4 34578999999999999999754 6899999999999999999999 7 8999999999999999
Q ss_pred CCCCCeeecccchhhhhccCCCC-cceecccccccccCccccccC------CCCccccchhHHHHHHHHHhC--------
Q 003199 671 VNYQPKVADFGIAKVLQARGGKD-STTTVIAGTYGYLAPEYAYSS------KATTKCDVYSFGVVLMELITG-------- 735 (840)
Q Consensus 671 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~tg-------- 735 (840)
.++.+||+|||+++......... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 99999999999997654321111 112345799999999998776 455799999999999999999
Q ss_pred --CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 736 --RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGS--FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 736 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+.||.................... ......+.. .......+.+++.+||+.||++|||+.|+++.|++++
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred cccccccccCCCCcchhhhhHHHhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 788765433322222211111000 011111111 1245677889999999999999999999999998763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.09 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=205.4
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.+.|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 118 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----------PLDKYTVKNEISIMNQLHHPKLINLHDAFE 118 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 346788999999999999999965 478999999985332 122456889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCCCeeecc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV--NYQPKVADF 680 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Df 680 (840)
+....++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 119 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEec
Confidence 9999999999999999999998766679999999999999999999999 99999999999999974 467999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... . ..........
T Consensus 196 G~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~-~~~~~i~~~~ 266 (387)
T 1kob_A 196 GLATKLNP----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----L-ETLQNVKRCD 266 (387)
T ss_dssp TTCEECCT----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----H-HHHHHHHHCC
T ss_pred ccceecCC----CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----H-HHHHHHHhCC
Confidence 99987632 2233455799999999999999999999999999999999999999975311 1 1110000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
. ..+ ...+......+.+++.+|++.||++|||+.|++++-
T Consensus 267 ~----~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 267 W----EFD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp C----CCC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred C----CCC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 0 001 111122345677888899999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=362.23 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=201.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||+||+|..+ +++.||||++....... ....+.+.+|..++.++ +||||+++++++.+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-------~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----------CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-------HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence 56888999999999999999665 68899999986543211 12234567889998887 89999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 999999999999999999998764 69999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc---hhhh-hhhhhcc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN---IIYW-VSIKVDT 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~-~~~~~~~ 759 (840)
+.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ......
T Consensus 201 ~~~~~---~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~- 276 (396)
T 4dc2_A 201 KEGLR---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE- 276 (396)
T ss_dssp BCCCC---TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-
T ss_pred eeccc---CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-
Confidence 75322 223345678999999999999999999999999999999999999999753221110 0000 000000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM------NEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 806 (840)
....++.. ...++.+++.+|++.||++||++ .|++++
T Consensus 277 -------~~~~~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 -------KQIRIPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -------CCCCCCTT---SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -------cccCCCCc---CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 01112222 23456678889999999999985 677766
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=351.22 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=201.8
Q ss_pred cCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----------QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----------hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 666778999999999999765 799999999854321 124568899999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 117 ~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp EEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 99999999999999998764 68999999999999999999999 99999999999999999999999999998765
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... . ...... ...
T Consensus 192 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~-~~~~~~-------~~~ 256 (321)
T 2c30_A 192 SKD---VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----V-QAMKRL-------RDS 256 (321)
T ss_dssp CSS---SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----H-HHHHHH-------HHS
T ss_pred ccC---ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H-HHHHHH-------hcC
Confidence 331 1223456799999999999999999999999999999999999999975311 1 111000 000
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
...... ........+.+++.+|++.||++|||+.|++++-.
T Consensus 257 ~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 257 PPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp SCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 011110 11122345677888999999999999999998743
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=362.14 Aligned_cols=258 Identities=26% Similarity=0.322 Sum_probs=206.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
++|...+.||+|+||.||+|... .+..||||++.... .....+.+.+|+++++++ +||||++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---------TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---------CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 57788899999999999999642 34679999985432 123456788999999999 8999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++++......++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+|||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 216 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRD 216 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCC
Confidence 9999999999999999999999999998653 358999999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||+++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcceEEEcCCCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998664321 1123344567889999999999999999999999999999999 999997
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
... .. ........ ......... ....+.+++.+||+.||++|||+.|++++|+++.
T Consensus 296 ~~~--~~---~~~~~~~~-------~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 296 GVP--VE---ELFKLLKE-------GHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp TCC--HH---HHHHHHHT-------TCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC--HH---HHHHHHHc-------CCCCCCCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 531 11 11110000 001111122 2345677888999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=361.15 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=198.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
.++|+..+.||+|+||+||+|..+ +|+.||||++..... ......+.+.+|..+++.+ .||||+++++++.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-------LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-------HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-------cchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 467888999999999999999654 689999999854321 1123356678899999988 6999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999999998764 69999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
|+.... ........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..........
T Consensus 171 a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~--- 239 (353)
T 3txo_A 171 CKEGIC---NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILND--- 239 (353)
T ss_dssp CBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC---
T ss_pred eeeccc---CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC---
Confidence 975322 22334556899999999999988899999999999999999999999975311 1111111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM------NEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 806 (840)
....+..+ ...+.+++.+|++.||++||++ .|+++|
T Consensus 240 -----~~~~p~~~---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 -----EVVYPTWL---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----CCCCCTTS---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----CCCCCCCC---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 01112222 2446678889999999999998 788775
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=360.87 Aligned_cols=278 Identities=24% Similarity=0.296 Sum_probs=207.7
Q ss_pred HhcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|+..+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG----------PDQQRDFQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC----------HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC----------HHHHHHHHHHHHHHHhcCCCceeEEEEE
Confidence 4678889999999999999974 468899999985332 2335678999999999999999999998
Q ss_pred Ee--cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 601 FS--SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 601 ~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+. +....++||||+++++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~ 169 (327)
T 3lxl_A 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIA 169 (327)
T ss_dssp EECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEEC
T ss_pred EecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEc
Confidence 86 4556789999999999999998755569999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++................||+.|+|||++.+..++.++||||||+++|||++|+.||............+.. ...
T Consensus 170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~ 248 (327)
T 3lxl_A 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER-DVP 248 (327)
T ss_dssp CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CC
T ss_pred ccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc-ccc
Confidence 9999987643222222334456888999999998888999999999999999999999998642110000000000 000
Q ss_pred cccchhhhccc-ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCC
Q 003199 759 TKEGIMEVLDK-KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFES 817 (840)
Q Consensus 759 ~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 817 (840)
........... ............+.+++.+|++.||++|||+.|++++|+.+.......
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 00000111111 111112233456778888999999999999999999999876554433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.93 Aligned_cols=260 Identities=19% Similarity=0.204 Sum_probs=205.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
.+|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------------APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------------SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------------hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4678889999999999999965 5799999999854321 12477899999999 89999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-----Ceee
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-----PKVA 678 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~ 678 (840)
....++||||+ +++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 999999998765579999999999999999999999 99999999999999998876 9999
Q ss_pred cccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 679 DFGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
|||+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ......
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~ 230 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQ 230 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHH
Confidence 999998764422211 12245689999999999999999999999999999999999999998642211 111111
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
....... ..........+ . ++.+++.+|++.||.+||++.++.+.|+++
T Consensus 231 ~i~~~~~---~~~~~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 231 KIGDTKR---ATPIEVLCENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHH---HSCHHHHTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhhhc---cCCHHHHhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000000 00000011111 2 677888899999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.38 Aligned_cols=262 Identities=27% Similarity=0.367 Sum_probs=200.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+.|+..+.||+|+||.||+|.... +..||||++.... .......+.+|+.++++++||||++++++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---------TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---------CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---------CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 346667899999999999996542 2369999985332 12335678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.+....++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCC
Confidence 999999999999999999999998766679999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~---~~----- 261 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV---MK----- 261 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH---HH-----
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHH---HH-----
Confidence 999876543222222334456789999999998899999999999999999999 9999965311 000 00
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
.+......+........+.+++.+||+.||++||++.+++++|+++....
T Consensus 262 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 262 -----AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -----HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00111111111223345778888999999999999999999998765433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=350.27 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=202.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|... +|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence 56888899999999999999664 799999999854321 1112346678899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcce
Confidence 99999999999999999998764 68999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. .. .........
T Consensus 155 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~-~~~~~i~~~----- 218 (318)
T 1fot_A 155 YVPD------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TM-KTYEKILNA----- 218 (318)
T ss_dssp ECSS------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HH-HHHHHHHHC-----
T ss_pred ecCC------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HH-HHHHHHHhC-----
Confidence 6432 2334679999999999999999999999999999999999999997531 11 111111100
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
....+..+ ..++.+++.+|++.||++|| ++.|+++|
T Consensus 219 ---~~~~p~~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 ---ELRFPPFF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCC---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 01112222 24566778899999999999 89999976
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=363.26 Aligned_cols=346 Identities=27% Similarity=0.364 Sum_probs=268.2
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
.+++|+.|++++|.++ .+|. +..+++|++|+|++| .+..+++ +..+++|++|++++|.+.+..+ ++++++|
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n---~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L 114 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN---QLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSS---CCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred HhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCC---ccCCchh--hhccccCCEEECCCCccccChh--hcCCCCC
Confidence 3678899999999988 5564 788899999999999 5566654 8888999999999999886544 8889999
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
++|+|++|.+++. +. +..+++|++|++++|+ ...++ .+..+++|++|+++ |.+.+.. .+..+++|+.|++++
T Consensus 115 ~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~--l~~~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~ 186 (466)
T 1o6v_A 115 TGLTLFNNQITDI-DP-LKNLTNLNRLELSSNT--ISDIS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISS 186 (466)
T ss_dssp CEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEE--ECCCG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCS
T ss_pred CEEECCCCCCCCC-hH-HcCCCCCCEEECCCCc--cCCCh-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcC
Confidence 9999999998854 33 8889999999999887 22343 48888899999986 4555332 388889999999999
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCC
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 254 (840)
|.+.+. ..+..+++|++|++++|++.+..+ +..+++|+.|++++|++++. ..+..+++|+.|++++|.+.+..+
T Consensus 187 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 260 (466)
T 1o6v_A 187 NKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 260 (466)
T ss_dssp SCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh
Confidence 988754 347888899999999999886544 67788899999999988754 356777788888888888776554
Q ss_pred cccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCc
Q 003199 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334 (840)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 334 (840)
+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ ++.+++|+.|+|++|++++..| +..+++
T Consensus 261 --~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~ 332 (466)
T 1o6v_A 261 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332 (466)
T ss_dssp --GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTT
T ss_pred --hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCcc
Confidence 7777888888888888874433 6777888888888888876544 6777888888888888876655 667778
Q ss_pred ccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 335 LVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 335 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 333 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 333 LQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 88888888888754 457777888888888888877666 7777888888888888875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=355.75 Aligned_cols=273 Identities=25% Similarity=0.311 Sum_probs=205.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+.|+..+.||+|+||.||+|.+ .+++.||||++..... ....+.+.+|+++++.++||||++++++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---------GNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---------chhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 3477889999999999999973 4689999999854321 1234678899999999999999999999
Q ss_pred EecC--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 601 FSSL--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 601 ~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+... ...++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEEC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEEC
Confidence 9876 66799999999999999997666679999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++................||..|+|||.+.+..++.++||||+|+++|||++|+.|+...................
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 99999876543222233445678889999999998899999999999999999999999864321000000000000000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
..............+........+.+++.+||+.||.+|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000000111111111122345677888899999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=349.09 Aligned_cols=249 Identities=21% Similarity=0.257 Sum_probs=194.3
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
..++|+..+.||+|+||+||+|... +|+.||||++...... ......+..|+..+.++ .||||+++++++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--------PKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS--------HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC--------hHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3468999999999999999999665 7999999987443211 12233445566655555 899999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+....++||||+ +++|.+++......++|..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999999 779999988776679999999999999999999999 899999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++..... ........||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..|.....
T Consensus 203 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~---- 266 (311)
T 3p1a_A 203 LLVELGT----AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQQLRQ---- 266 (311)
T ss_dssp TCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHHHHTT----
T ss_pred eeeeccc----CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHhc----
Confidence 9876532 223345569999999998876 7899999999999999999997766431 01111100
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... .....+.+++.+|++.||++|||+.|++++
T Consensus 267 ---~~~~~~~~~---~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 ---GYLPPEFTA---GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---TCCCHHHHT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cCCCccccc---CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 000011111 123567788889999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=346.92 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=200.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|... +|+.||||++...... ......+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 73 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--------EGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc--------CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC
Confidence 46888899999999999999664 7899999998544321 22346678999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++ ++.+.+......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 74 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 74 KKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp TEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 999999999975 6766666655579999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc-cccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD-TKEG 762 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 762 (840)
.... .........||+.|+|||++.+.. ++.++||||+||++|||++|..||................... ....
T Consensus 150 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 150 AFGI---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp ECCS---CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecCC---ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 6532 222334567899999999987765 7999999999999999999888864322111111111100000 0000
Q ss_pred hhhh---c----------ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 IMEV---L----------DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~~~~---~----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... . ..............+.+++.+|++.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0 000011112234566788889999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=366.67 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=201.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|.+. |+.||||++.... ..+.|.+|+.++++++||||+++++++.+..
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 46778899999999999999887 7899999985332 1356889999999999999999999987655
Q ss_pred -cceEEEeecCCCChHHHhhcCCC-CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 606 -CNLLVYEYMPNGNLWDALHKGLV-HLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 606 -~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 78999999999999999987543 37999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+ ..
T Consensus 337 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i---~~---- 401 (450)
T 1k9a_A 337 KEASS------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV---EK---- 401 (450)
T ss_dssp EECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHH---HT----
T ss_pred ccccc------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---Hc----
Confidence 75321 1223357889999999999999999999999999999998 99999754211 111110 00
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
-.....+ ......+.+++.+||+.||++|||+.++++.|+++..
T Consensus 402 ---~~~~~~p---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 402 ---GYKMDAP---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ---TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0001111 2233567778889999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=358.77 Aligned_cols=256 Identities=23% Similarity=0.264 Sum_probs=202.6
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.+.|+..+.||+|+||+||+|.. .+|+.||||++........ .....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS-----PGLSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS-----SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-----ccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456799999999999999999965 5799999999843321100 0112467889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---Ce
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---PK 676 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~k 676 (840)
+....++||||+++|+|.+.+... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEE
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEE
Confidence 999999999999999998887643 2358999999999999999999999 99999999999999987654 99
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... +..
T Consensus 174 l~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~--~~~-- 243 (351)
T 3c0i_A 174 LGGFGVAIQLGES---GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERL--FEG-- 243 (351)
T ss_dssp ECCCTTCEECCTT---SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHH--HHH--
T ss_pred EecCcceeEecCC---CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHH--HHH--
Confidence 9999999776431 222345679999999999999899999999999999999999999997521 110 100
Q ss_pred hccccchhhhcccccCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 VDTKEGIMEVLDKKLSG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+....... .+......+.+++.+|++.||++|||+.|++++
T Consensus 244 ---------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 244 ---------IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ---------HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00001100 001123567788889999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.07 Aligned_cols=272 Identities=22% Similarity=0.304 Sum_probs=214.7
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---------SMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---------CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---------CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 357888999999999999998654 36889999985322 123345788999999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC---------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL---------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 669 (840)
+++.+....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 99999999999999999999999987531 357899999999999999999999 999999999999999
Q ss_pred cCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003199 670 DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKN 748 (840)
Q Consensus 670 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~ 748 (840)
+.++.+||+|||+++...... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~ 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQ 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HH
T ss_pred cCCCeEEECcCcccccccccc-ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HH
Confidence 999999999999998764321 1122234467889999999998899999999999999999999 8999875310 11
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCCCCCCCCc
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKFPNKS 824 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~ 824 (840)
. .. .+...............+.+++.+|++.||++|||+.|++++|++.....+...+++..+
T Consensus 249 ~---~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~ 311 (322)
T 1p4o_A 249 V---LR----------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 311 (322)
T ss_dssp H---HH----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred H---HH----------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccccc
Confidence 1 00 011111111112233456778889999999999999999999998877766665554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.68 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=207.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
++|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++.+ .|+|++++++++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------------APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------------cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 4688889999999999999964 6799999998853321 12467899999999 79999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-----Ceee
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-----PKVA 678 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~ 678 (840)
....++||||+ +++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999999 999999998766679999999999999999999999 99999999999999987776 9999
Q ss_pred cccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 679 DFGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
|||+++......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~ 232 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYER 232 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHH
Confidence 999998765422211 12345679999999999999999999999999999999999999997642221111 1110
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
...... ......... .....+.+++.+||+.||++||+++++++.|+++...
T Consensus 233 ~~~~~~----~~~~~~~~~---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 233 IGEKKQ----STPLRELCA---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHH----HSCHHHHTT---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhhcc----CccHHHHHh---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 000000 000000111 1234677788899999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=353.26 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=202.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||.||+|..+ +|+.||||++...... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 81 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-------SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-------chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence 46888899999999999999765 6899999998643311 123356688899999988 89999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999999998754 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc---hhhhhhhhhccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN---IIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~ 760 (840)
+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 158 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~- 233 (345)
T 3a8x_A 158 KEGLR---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE- 233 (345)
T ss_dssp BCSCC---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-
T ss_pred ccccC---CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-
Confidence 75422 122344568999999999999999999999999999999999999999753211100 00000000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM------NEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~~ 806 (840)
....++.. ....+.+++.+|++.||++||++ .|+++|
T Consensus 234 ------~~~~~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 ------KQIRIPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ------CCCCCCTT---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ------CCCCCCCC---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00112222 23456678889999999999995 777766
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=368.14 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=200.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|+..+.||+|+||.||+|..+++..||||++..... ..+.|.+|++++++++||||+++++++.+ .
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-----------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 46778889999999999999998888999999854321 13568899999999999999999999876 6
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccce
Confidence 789999999999999999753 2358999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+... ......
T Consensus 329 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~----------- 393 (452)
T 1fmk_A 329 LIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----------- 393 (452)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH-----------
T ss_pred ecCCC--ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHH-----------
Confidence 76432 1222234457789999999998899999999999999999999 9999975311 111000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
+......+........+.+++.+||+.||++|||+.++++.|+++...
T Consensus 394 --i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 394 --VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 000000111122334677788899999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=373.27 Aligned_cols=255 Identities=25% Similarity=0.309 Sum_probs=206.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|.+. ++..||||++..... ..+.|.+|+.++++++||||++++++|...
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 45778889999999999999776 488999999854321 145789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999999999864 3468999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.... ..........+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .......
T Consensus 366 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~--------- 432 (495)
T 1opk_A 366 RLMTG--DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL--------- 432 (495)
T ss_dssp ECCTT--CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHH---------
T ss_pred eeccC--CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---------
Confidence 87633 11122233456789999999998899999999999999999999 9999975321 1111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
......... ......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 433 -~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 433 -EKDYRMERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -HTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HcCCCCCCC---CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 000011111 123356677888999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.75 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=199.6
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
..++|+..+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---------ELAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST---------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc---------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4678999999999999999999765 899999999854321 223567899999999999999999999985
Q ss_pred cCc---------------------------------------------------------cceEEEeecCCCChHHHhhc
Q 003199 603 SLY---------------------------------------------------------CNLLVYEYMPNGNLWDALHK 625 (840)
Q Consensus 603 ~~~---------------------------------------------------------~~~lV~e~~~~gsL~~~l~~ 625 (840)
+.. ..++||||+++|+|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 543 27899999999999999987
Q ss_pred CC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCC---------Cc
Q 003199 626 GL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK---------DS 694 (840)
Q Consensus 626 ~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------~~ 694 (840)
.. ...++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 155 RCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp CCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred ccCccchhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 53 235667789999999999999999 99999999999999999999999999999876432111 11
Q ss_pred ceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCC
Q 003199 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGS 774 (840)
Q Consensus 695 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 774 (840)
......||+.|+|||++.+..++.++||||||+++|||++|..|+... .. ..........+..
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~-------~~~~~~~~~~~~~ 294 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VR-------IITDVRNLKFPLL 294 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HH-------HHHHHHTTCCCHH
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HH-------HHHHhhccCCCcc
Confidence 223457999999999999999999999999999999999987764310 00 0111111122222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 775 FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 775 ~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......+.+++.+|++.||++|||+.|++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 33445667889999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=351.04 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=205.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---------SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---------CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 5678889999999999999964 345899999985322 1233567899999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC-----------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL-----------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSP 656 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 656 (840)
++.+....++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ 170 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MK 170 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CC
Confidence 9999999999999999999999998643 237899999999999999999999 99
Q ss_pred eEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-C
Q 003199 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-G 735 (840)
Q Consensus 657 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g 735 (840)
|+||||||+||+++.++.+||+|||+++...... .........+|+.|+|||.+.+..++.++||||||+++|||++ |
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999997664321 1122334567889999999988889999999999999999999 9
Q ss_pred CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 736 RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 736 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+.||.+... ........ ......... .....+.+++.+|++.||++||++.|++++|+++
T Consensus 250 ~~p~~~~~~--~~~~~~~~----------~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 250 GNPYPGIPP--ERLFNLLK----------TGHRMERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCSSTTCCG--GGHHHHHH----------TTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCH--HHHHHHhh----------cCCcCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999975321 11111000 000011111 2334577788899999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=343.22 Aligned_cols=254 Identities=29% Similarity=0.419 Sum_probs=192.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|... |+.||||++...... ......+.+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE------DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc------cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46778889999999999999876 899999998543321 11233567889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC---eEecCCCCCCEEEcC--------CCC
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP---IIHRDIKSTNILLDV--------NYQ 674 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dlk~~Nill~~--------~~~ 674 (840)
..++||||+++++|.+++... .+++..+..++.|++.||+|||+ ++ |+||||||+||+++. ++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred ceEEEEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcc
Confidence 999999999999999999754 68999999999999999999999 77 999999999999986 678
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+||+|||+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.
T Consensus 155 ~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~- 225 (271)
T 3dtc_A 155 LKITDFGLAREWHRT-----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYG- 225 (271)
T ss_dssp EEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHH-
T ss_pred eEEccCCcccccccc-----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHh-
Confidence 999999999865431 22245789999999999988999999999999999999999999975311 000000
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
... ......... .....+.+++.+|++.||++|||+.|++++|+++
T Consensus 226 ~~~-------~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VAM-------NKLALPIPS---TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHT-------SCCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhc-------CCCCCCCCc---ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000 000111112 2234567788899999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.73 Aligned_cols=265 Identities=20% Similarity=0.258 Sum_probs=208.1
Q ss_pred hcCccC-eeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 527 AMTEKN-KVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 527 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+|...+ .||+|+||.||+|... ++..||||++.... .....+.+.+|++++++++||||+++++++
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---------EKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---------chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 444554 8999999999999653 57889999985432 123456789999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
..+..++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccc
Confidence 4556899999999999999998766679999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i---~~--- 228 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI---EQ--- 228 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH---HT---
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH---hc---
Confidence 9876432222222334557899999999988889999999999999999998 9999975321 1111110 00
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCCCC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCK 819 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~ 819 (840)
........ .....+.+++.+||+.||++||++.+++++|+.+.........
T Consensus 229 ----~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 229 ----GKRMECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp ----TCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----CCcCCCCC---CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 00011112 2335677788899999999999999999999876554444433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=353.66 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=192.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-Cc---EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-GE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|...+.||+|+||.||+|.... ++ .||||++...... ....+.+.+|++++++++||||+++++++
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--------SSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC--------HHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 468888999999999999997653 32 7999998543211 22356789999999999999999999999
Q ss_pred ecCccc------eEEEeecCCCChHHHhhcCC-----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 602 SSLYCN------LLVYEYMPNGNLWDALHKGL-----VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 602 ~~~~~~------~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
...... ++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEc
Confidence 877655 89999999999999986432 258999999999999999999999 9999999999999999
Q ss_pred CCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003199 671 VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNI 749 (840)
Q Consensus 671 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 749 (840)
.++.+||+|||+++...... .........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+... ...
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~ 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEI 248 (323)
T ss_dssp TTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGH
T ss_pred CCCCEEEeeccccccccccc-cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHH
Confidence 99999999999998764321 1222334557889999999999999999999999999999999 9999975321 111
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
.. .................+.+++.+|++.||++|||+.++++.|+++-....
T Consensus 249 ~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 249 YN-------------YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HH-------------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HH-------------HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 10 011111111112233467788889999999999999999999997655544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=358.47 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=194.7
Q ss_pred ccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 530 EKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 162 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----------MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 356899999999999965 579999999985432 123467889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE--cCCCCCeeecccchhhh
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL--DVNYQPKVADFGIAKVL 686 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfg~a~~~ 686 (840)
+||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 9999999999999997765579999999999999999999999 999999999999999 56778999999999876
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (840)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .... .......
T Consensus 240 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~--~~~~-i~~~~~~---- 306 (373)
T 2x4f_A 240 KP----REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AE--TLNN-ILACRWD---- 306 (373)
T ss_dssp CT----TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HH--HHHH-HHHTCCC----
T ss_pred CC----ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HH--HHHH-HHhccCC----
Confidence 33 2223345799999999999888899999999999999999999999975311 10 0000 0000000
Q ss_pred cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 767 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ....+......+.+++.+|++.||.+|||+.|++++
T Consensus 307 ~---~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 307 L---EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp S---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 011112234567778889999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=354.14 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=203.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-------ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 56888899999999999999665 799999999844321 1122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccce
Confidence 99999999999999999998754 68999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 190 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~----- 253 (350)
T 1rdq_E 190 RVKG------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSG----- 253 (350)
T ss_dssp ECSS------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-----
T ss_pred eccC------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHHcC-----
Confidence 6532 2234679999999999999999999999999999999999999997531 11111110100
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~L 807 (840)
...++..+ ...+.+++.+|++.||++||+ ++|++++-
T Consensus 254 ---~~~~p~~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 254 ---KVRFPSHF---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp ---CCCCCTTC---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ---CCCCCCCC---CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 01112222 345667888999999999998 89998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.39 Aligned_cols=269 Identities=26% Similarity=0.347 Sum_probs=204.8
Q ss_pred cCccCeeeccCCcEEEEEEeC-----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
|+..+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|++++++++||||+++++++.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---------GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---------ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 378889999999999988653 68899999985432 1234567899999999999999999999998
Q ss_pred cC--ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 603 SL--YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 603 ~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+. ...++||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCG
T ss_pred cCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCc
Confidence 74 5678999999999999999875 48999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+++................+|+.|+|||.+.+..++.++||||||+++|||++|+.||............+........
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99987644222222334556888999999999889999999999999999999999998642110000000000000000
Q ss_pred cchhhhcccc-cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 761 EGIMEVLDKK-LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 761 ~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.....+... ...........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 259 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 259 -RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 011111111 11112233456778888999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.44 Aligned_cols=262 Identities=30% Similarity=0.409 Sum_probs=194.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+|+..+.||+|+||.||+|... ..||||++..... .....+.+.+|++++++++||||+++++++ ...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--------TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC--------CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 45778899999999999999765 3599999854332 133457789999999999999999999966 455
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccc
Confidence 6799999999999999998776679999999999999999999999 9999999999999999999999999999976
Q ss_pred hhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
..... .........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... ....... ..
T Consensus 170 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~---~~---- 240 (289)
T 3og7_A 170 KSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMV---GR---- 240 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHH---HH----
T ss_pred ccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHh---cc----
Confidence 54321 122334567999999999886 567889999999999999999999999753211 1111100 00
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.................+.+++.+|++.||++|||+.++++.|+++..
T Consensus 241 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 241 --GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 001111111112334567788889999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.86 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=196.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcE----EEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEV----VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|...+.||+|+||.||+|... +++. ||+|.+..... ....+.+.+|+.++++++||||++++++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---------PKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS---------CCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC---------HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 46788899999999999999654 5654 46666532221 1234678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.... .++|+||+.+|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccC
Confidence 98764 789999999999999998876679999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++...... .........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ........
T Consensus 162 G~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~----- 233 (327)
T 3lzb_A 162 GLAKLLGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE----- 233 (327)
T ss_dssp TC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH-----
T ss_pred cceeEccCcc-ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH-----
Confidence 9998764321 2222334557889999999999999999999999999999999 9999975321 11111100
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
..............+.+++.+||+.||.+||++.|+++.|+++..
T Consensus 234 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 --------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 000011111223456778889999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.83 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=206.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.. .++..||||++..... ....+.+.+|+.+++++ .||||++++
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---------SSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC---------HHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 6788899999999999999975 2456899999853321 12246788999999999 899999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCCC----------------------CCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLV----------------------HLDWPTRHKIAFGVAQGLAYLHHGLLSP 656 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 656 (840)
+++......++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 192 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KS 192 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 999999999999999999999999976532 37899999999999999999999 99
Q ss_pred eEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-C
Q 003199 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-G 735 (840)
Q Consensus 657 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g 735 (840)
|+||||||+||+++.++.+||+|||++...... ..........||+.|+|||.+.+..++.++||||||+++|||+| |
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccC-ccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876542 22223345567889999999988899999999999999999998 9
Q ss_pred CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 736 RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 736 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
+.||...... ........ ......... .....+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 272 ~~p~~~~~~~-~~~~~~~~----------~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 272 VNPYPGIPVD-ANFYKLIQ----------NGFKMDQPF---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCSSTTCCCS-HHHHHHHH----------TTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCcccCCcH-HHHHHHHh----------cCCCCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 9999764211 11111100 000111111 12345777888999999999999999999998765543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=356.28 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=201.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
.++|...+.||+|+||+||+|..+ +|+.||||++...... .....+.+..|..++..+ +||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-------MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-------hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 467888999999999999999765 6899999998543211 112245677888898877 8999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999999999998754 68999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ....+......
T Consensus 165 a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~---- 233 (345)
T 1xjd_A 165 CKENML---GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMD---- 233 (345)
T ss_dssp CBCCCC---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC----
T ss_pred hhhccc---CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHhC----
Confidence 975422 1223455689999999999999999999999999999999999999997531 11111111000
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN-EVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~~ 806 (840)
....+..+ ...+.+++.+|++.||++||++. +++++
T Consensus 234 -----~~~~p~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 234 -----NPFYPRWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -----CCCCCTTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----CCCCCccc---CHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11122222 34566788899999999999997 77654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=354.88 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=188.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|...+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++.+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------------DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------------hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 456888899999999999999765 68899999985322 13457789999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 680 (840)
....++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 999999999999999999998754 68999999999999999999999 99999999999999975 889999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+... ....
T Consensus 196 g~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~i-~~~~ 267 (349)
T 2w4o_A 196 GLSKIVEH----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QFMFRRI-LNCE 267 (349)
T ss_dssp C--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HHHHHHH-HTTC
T ss_pred ccccccCc----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HHHHHHH-HhCC
Confidence 99987532 22234567999999999999989999999999999999999999999753211 1011110 0000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ....+........+.+++.+|++.||++|||+.|++++
T Consensus 268 ~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 Y-------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp C-------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00111112234567788889999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=343.16 Aligned_cols=253 Identities=32% Similarity=0.475 Sum_probs=196.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||+||+|... ++.||||++... ...+.+.+|++++++++||||+++++++.+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------------SERKAFIVELRQLSRVNHPNIVKLYGACLN-- 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 46778889999999999999876 789999998422 124678899999999999999999998874
Q ss_pred cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-Ceeecccc
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-PKVADFGI 682 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfg~ 682 (840)
..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 4789999999999999998654 24788999999999999999999865568999999999999998887 79999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....|...
T Consensus 153 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~------- 218 (307)
T 2eva_A 153 ACDIQT------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRIMWAVH------- 218 (307)
T ss_dssp ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHHHHHHH-------
T ss_pred cccccc------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHHHHHHh-------
Confidence 976532 122346899999999999989999999999999999999999999753211 111111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
..............+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 219 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 219 -----NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -----TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -----cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000111111223456778889999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.03 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=195.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|.. .+++.||||++..... ........+.+|+.++++++||||+++++++...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-------TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-------CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 5788899999999999999965 6799999999854321 1234456789999999999999999999998776
Q ss_pred ccc----eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 YCN----LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ~~~----~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
... ++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeec
Confidence 544 99999999999999998764 68999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+++................||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+. .....
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~--~~~~~ 235 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQ--HVRED 235 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH--HHHCC
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHH--HhcCC
Confidence 9998765433333334456799999999999999999999999999999999999999975311 110000 00000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH-hhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL-LAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~-L~~~ 810 (840)
... ..... ......+.+++.+||+.||++||++.+++++ +...
T Consensus 236 ~~~----~~~~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 PIP----PSARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCC----HHHHS---TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCC----ccccc---CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000 00001 1123456778889999999999977666554 4443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.45 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=198.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcE----EEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEV----VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|...+.||+|+||+||+|... +++. ||+|.+...... .....+.+|+.++++++||||++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---------QSFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---------SCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---------HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45778889999999999999654 5554 777776433211 112345679999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+. ....++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 84 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 84 CP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred Ec-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCC
Confidence 86 456789999999999999998765578999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+++..... ..........||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ........ ..
T Consensus 160 g~a~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~---~~ 233 (325)
T 3kex_A 160 GVADLLPPD-DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLE---KG 233 (325)
T ss_dssp SGGGGSCCC-TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHH---TT
T ss_pred CcccccCcc-cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHH---cC
Confidence 999876442 22223345678889999999998999999999999999999999 9999976321 11111110 00
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
. ....... ....+.+++.+||+.||.+||++.+++++|+.+..
T Consensus 234 ~-------~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 E-------RLAQPQI---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp C-------BCCCCTT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C-------CCCCCCc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0001111 12245668889999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=339.87 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=202.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+++.||||++...... .........+.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE---GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTT---CCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccc---cchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4677888999999999999966 57999999998543321 1111122236789999999999999999999999765
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCC-----Cee
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLDVNYQ-----PKV 677 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl 677 (840)
. ++||||+++|+|.+.+......+++..+..++.|++.||+|||+ ++ |+||||||+||+++.++. +||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 5 69999999999999998776689999999999999999999999 88 999999999999988776 999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY--SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
+|||+++... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||..............
T Consensus 171 ~Dfg~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-- 242 (287)
T 4f0f_A 171 ADFGLSQQSV------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-- 242 (287)
T ss_dssp CCCTTCBCCS------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH--
T ss_pred CCCCcccccc------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH--
Confidence 9999987432 2344567999999999983 45578999999999999999999999975322111111100
Q ss_pred hhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 756 KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.. ......... .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 243 -~~------~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 -RE------EGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HH------SCCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -hc------cCCCCCCCc---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00 001111222 2234577788899999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.32 Aligned_cols=267 Identities=28% Similarity=0.390 Sum_probs=202.3
Q ss_pred HHHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc--CCCCcceee
Q 003199 521 QREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI--RHKNIVKLY 598 (840)
Q Consensus 521 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~ 598 (840)
...+.++|...+.||+|+||.||+|... |+.||||++.... ...+..|.+++... +||||++++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------------~~~~~~e~~~~~~~~~~h~~i~~~~ 97 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-------------EASWFRETEIYQTVLMRHENILGFI 97 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-------------HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-------------cchhhhHHHHHHHHhhcCCCeeeEE
Confidence 4556789999999999999999999876 8999999984321 22344455555554 899999999
Q ss_pred eEEecC----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCC--------CeEecCCCCCC
Q 003199 599 CYFSSL----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS--------PIIHRDIKSTN 666 (840)
Q Consensus 599 ~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~Dlk~~N 666 (840)
+++... ...++||||+++|+|.+++... .+++..+..++.|++.||+|||+ . +|+||||||+|
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGG
T ss_pred EEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHH
Confidence 999876 6789999999999999999775 58999999999999999999998 6 99999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCC-CcceecccccccccCccccccCCCCcc------ccchhHHHHHHHHHhC----
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYSSKATTK------CDVYSFGVVLMELITG---- 735 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~il~el~tg---- 735 (840)
|+++.++.+||+|||+++........ ........||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 99999999999999999765432111 112234579999999999987766655 9999999999999999
Q ss_pred ------CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 736 ------RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGS--FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 736 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
+.||.................. ........+.. ..+....+.+++.+||+.||++|||+.|++++|
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVC------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cccccccccHhhhcCCCCchhhhHHHHh------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 5666543222222111111100 00011111111 125567788999999999999999999999999
Q ss_pred hhcCC
Q 003199 808 AEADP 812 (840)
Q Consensus 808 ~~~~~ 812 (840)
+++..
T Consensus 327 ~~l~~ 331 (337)
T 3mdy_A 327 AKMSE 331 (337)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 87643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.94 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=194.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++...... ........+.+|+.+++.++||||+++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV------RNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------------HHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 5788899999999999999976 47899999998543211 1122345678899999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 99999999999999999999998654 68999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 167 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~-- 236 (327)
T 3a62_A 167 LCKESIHD---GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTIDKILKC-- 236 (327)
T ss_dssp CC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHT--
T ss_pred cccccccC---CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhC--
Confidence 99764321 2223456799999999999998999999999999999999999999975311 0111000000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 807 (840)
...++..+ ...+.+++.+|++.||++|| ++.|++++-
T Consensus 237 ------~~~~p~~~---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 237 ------KLNLPPYL---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp ------CCCCCTTS---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred ------CCCCCCCC---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 01112222 34566788899999999999 888998863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=363.82 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=203.7
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|..+ +++.||||++...... .......+.+|+.++..++||||+++++++.+
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-------KRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-------HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-------hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 367889999999999999999765 5889999998532211 11112347889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999999998755579999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
+.... ..........||+.|+|||++. ...++.++|||||||++|||++|+.||.+... ...... ...
T Consensus 223 ~~~~~--~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~~~-i~~ 295 (437)
T 4aw2_A 223 LKLME--DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGK-IMN 295 (437)
T ss_dssp EECCT--TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHH-HHT
T ss_pred hhccc--CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHHHh-hhh
Confidence 76533 1222334568999999999986 45789999999999999999999999975311 101100 000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT--RPTMNEVVQLL 807 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L 807 (840)
.. .....+.........+.+++.+|+..+|++ ||+++|++++=
T Consensus 296 ~~------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 296 HK------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HH------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred cc------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 00 000111111123345667778999888888 99999999873
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=362.85 Aligned_cols=324 Identities=21% Similarity=0.209 Sum_probs=213.3
Q ss_pred CEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeec
Q 003199 44 EVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123 (840)
Q Consensus 44 ~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L 123 (840)
+.++.+++ .+..+|... .++|+.|+|++|.+++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|
T Consensus 14 ~~v~c~~~---~l~~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 87 (477)
T 2id5_A 14 RAVLCHRK---RFVAVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGL 87 (477)
T ss_dssp TEEECCSC---CCSSCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEEEeCCC---CcCcCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEEC
Confidence 34555555 444555432 134555566666655555555555555566666555555555555555555555555
Q ss_pred ccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcc
Q 003199 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTG 203 (840)
Q Consensus 124 ~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 203 (840)
++|+ +....+..|.++++|++|+|++|.++...+..|..+++|++|+|++|.+.+..+..|.++++|++|+|++|++++
T Consensus 88 ~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 166 (477)
T 2id5_A 88 RSNR-LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166 (477)
T ss_dssp CSSC-CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS
T ss_pred CCCc-CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc
Confidence 5554 222222334555555555555555554445555555555555555555554444455555555555555555554
Q ss_pred cCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccC
Q 003199 204 EVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS 283 (840)
Q Consensus 204 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 283 (840)
..+..|..+++|+.|+|++|.+ .+..+..|..+++|++|++++|.+.+.+|..+..
T Consensus 167 ~~~~~l~~l~~L~~L~l~~n~i------------------------~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~ 222 (477)
T 2id5_A 167 IPTEALSHLHGLIVLRLRHLNI------------------------NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222 (477)
T ss_dssp CCHHHHTTCTTCCEEEEESCCC------------------------CEECTTCSCSCTTCCEEEEECCTTCCEECTTTTT
T ss_pred cChhHhcccCCCcEEeCCCCcC------------------------cEeChhhcccCcccceeeCCCCccccccCccccc
Confidence 3333444445555555555444 4455556777788888888887776677776666
Q ss_pred CCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhc
Q 003199 284 LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLM 363 (840)
Q Consensus 284 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 363 (840)
..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 223 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 302 (477)
T 2id5_A 223 GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302 (477)
T ss_dssp TCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred CccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence 67888888888888876667788888888888888888887777888888899999999998888888888899999999
Q ss_pred ccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 364 LQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 364 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus 303 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 303 VSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp CCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 99999988777788889999999999999886544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=361.16 Aligned_cols=258 Identities=23% Similarity=0.272 Sum_probs=201.9
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||+||+|..+ +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-------KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-------HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-------hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 357888999999999999999665 6899999998542211 01112347789999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999865 58999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK----ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
+.... ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..........
T Consensus 216 ~~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~ 288 (410)
T 3v8s_A 216 MKMNK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNH 288 (410)
T ss_dssp EECCT--TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTH
T ss_pred Eeecc--CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHHHHHHhc
Confidence 76533 1122334668999999999987655 78999999999999999999999975311 1111000000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT--RPTMNEVVQLLA 808 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~L~ 808 (840)
.. . . ..+ ........+.+++.+|++.+|.+ ||+++||++|-.
T Consensus 289 ~~---~-~--~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 289 KN---S-L--TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HH---H-C--CCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred cc---c-c--cCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 00 0 0 011 01112345667778999999988 999999999843
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.04 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=201.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
++|...+.||+|+||.||+|... |+.||||++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW--------STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC--------CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc--------CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 46788899999999999999886 89999999854321 123356799999999999999999999999877
Q ss_pred -ccceEEEeecCCCChHHHhhcCCC-CCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 -YCNLLVYEYMPNGNLWDALHKGLV-HLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
...++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+ ++||||||+||+++.++.++++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEec
Confidence 778999999999999999987642 58999999999999999999999 78 999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATT---KCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|++.... .....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ........
T Consensus 158 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~- 224 (271)
T 3kmu_A 158 DVKFSFQ--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMKVA- 224 (271)
T ss_dssp GSCCTTS--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----HHHHHHHH-
T ss_pred cceeeec--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----HHHHHHHH-
Confidence 8875432 22346899999999988765444 89999999999999999999975311 00000000
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
........... ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 225 ------~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 ------LEGLRPTIPPG---ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ------HSCCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------hcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00011112222 2345677888999999999999999999998865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.77 Aligned_cols=261 Identities=25% Similarity=0.321 Sum_probs=193.8
Q ss_pred cCccCeeeccCCcEEEEEEeC--CC--cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN--SG--EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
|...+.||+|+||.||+|... ++ ..||||.+.... .....+.+.+|+.++++++||||+++++++..
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---------CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 556678999999999999653 22 368999874322 12335678999999999999999999998754
Q ss_pred -CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 604 -LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 604 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
....++||||+++|+|.+++......+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccc
Confidence 567799999999999999998776678999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCC-CcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 683 AKVLQARGGK-DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 683 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
++........ ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...... ...... ....
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~---~~~~ 313 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---LQGR 313 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHH---HTTC
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHH---HcCC
Confidence 9876432111 112234567889999999999999999999999999999999 77787653211 111111 0000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
....+. .....+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 314 -------~~~~p~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 -------RLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------CCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001111 123457778889999999999999999999987654443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.14 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=207.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.+++++ +||||++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---------LTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---------HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh---------HHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 5688889999999999999964 3578999999853321 22356789999999999 899999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCCC-----------------CCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLV-----------------HLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++......++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++|+|||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~d 170 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 170 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCC
Confidence 999999999999999999999999976532 48999999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||+++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CccceEEEcCCCCEEEccccccccccccc-cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998764421 1122334567889999999999999999999999999999999 999997
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
..... ....... .......... .....+.+++.+|++.||.+|||+.|++++|+++.
T Consensus 250 ~~~~~-~~~~~~~----------~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 250 GMPVD-SKFYKMI----------KEGFRMLSPE---HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp TCCSS-HHHHHHH----------HHTCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccch-hHHHHHh----------ccCCCCCCcc---cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 53211 1111000 0001111111 22345677888999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.75 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=194.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccC----------------chhhHHHHHHHHHHHHHHhc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSAS----------------DTDQLQLDKGLKTEVETLGN 588 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~----------------~~~~~~~~~~~~~E~~~l~~ 588 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++.......... ........+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4688889999999999999965 578999999986543211000 00011224568899999999
Q ss_pred cCCCCcceeeeEEec--CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 003199 589 IRHKNIVKLYCYFSS--LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666 (840)
Q Consensus 589 l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 666 (840)
++||||+++++++.+ ....++||||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 999999999999986 56789999999999998876543 68999999999999999999999 999999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCC
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK---ATTKCDVYSFGVVLMELITGRKPVEDDF 743 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~ 743 (840)
|+++.++.+||+|||+++.... .........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKG---SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSS---SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCcccccc---ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999976543 122334567999999999987655 3788999999999999999999997531
Q ss_pred CCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+........ .. . +........+.+++.+||+.||++|||+.|++++
T Consensus 245 -----~~~~~~~~~~~~------~~--~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 -----IMCLHSKIKSQA------LE--F-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -----HHHHHHHHHHCC------CC--C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -----HHHHHHHHhccc------CC--C-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111111000000 00 0 0111223456778889999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.86 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=191.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||+|... +|+.||||++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----------IDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----------SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 46888999999999999999665 799999999854321 124577899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--Ceeecccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ--PKVADFGI 682 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfg~ 682 (840)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 99999999999999999997654 69999999999999999999999 99999999999999987765 99999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTK-CDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++.... ........||+.|+|||++.+..++.+ +||||+||++|||++|+.||........ .............
T Consensus 165 a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 165 SKSSVL----HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKY 239 (361)
T ss_dssp C-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCC
T ss_pred cccccc----cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCC
Confidence 975422 222344579999999999988777655 8999999999999999999976422111 1111111110000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..+. .......+.+++.+|++.||++|||+.|++++-
T Consensus 240 --------~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 240 --------SIPD-DIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp --------CCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred --------CCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 0111 011234567788899999999999999999884
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.35 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=204.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--------ARDFQKLEREARICRKLQHPNIVRLHDSIQE 76 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC--------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence 35788899999999999999965 46899999998543321 2334678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---Ceeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---PKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Df 680 (840)
....++||||+++++|.+.+.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+||
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 999999999999999999887764 68999999999999999999999 99999999999999986655 999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|++..... ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ... .........
T Consensus 153 g~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~--~~~~~~~~~ 224 (284)
T 3kk8_A 153 GLAIEVND----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRL--YAQIKAGAY 224 (284)
T ss_dssp TTCEECCS----SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH--HHHHHHTCC
T ss_pred eeeEEccc----CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHH--HHHHHhccc
Confidence 99976532 2233456799999999999999999999999999999999999999975311 111 111000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
....+........+.+++.+|++.||++|||+.|++++-.
T Consensus 225 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 225 --------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp --------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred --------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 0011111223345677888999999999999999998643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.43 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=205.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe--------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL--------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
++|+..+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+++++++ +||||++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---------TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---------cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 5788889999999999999975 356789999985332 123356788999999999 8999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
+++++.+....++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+|||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 182 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRD 182 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCC
Confidence 9999999999999999999999999998653 248999999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||+++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEEcCCCCEEEccccccccccccc-cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999999997654321 1122334467889999999988889999999999999999999 999997
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
+.. .... ..... ......... .....+.+++.+||+.||++|||+.|++++|+++..
T Consensus 262 ~~~--~~~~---~~~~~-------~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 262 GIP--VEEL---FKLLK-------EGHRMDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp TCC--HHHH---HHHHH-------HTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC--HHHH---HHHHh-------cCCCCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 531 1111 10000 000011111 223456778889999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=363.36 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=202.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
..|...+.||+|+||.||+|... +|+.||||++..... ........+.+|+.+++.++||||+++++++...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-------RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-------HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 46788899999999999999665 799999999853321 1122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchh
Confidence 99999999999999999998654 68999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+... ... ........
T Consensus 165 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~---~~~i~~~~--- 232 (476)
T 2y94_A 165 MMSD----GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTL---FKKICDGI--- 232 (476)
T ss_dssp ECCT----TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHH---HHHHHTTC---
T ss_pred hccc----cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHH---HHHHhcCC---
Confidence 7532 222345679999999999988765 7899999999999999999999975311 111 11000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+.. ....+.+++.+|++.||++|||+.|++++
T Consensus 233 -----~~~p~~---~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 -----FYTPQY---LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----CCCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----cCCCcc---CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 001111 22456778889999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.69 Aligned_cols=252 Identities=25% Similarity=0.287 Sum_probs=202.5
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
.++|...+.||+|+||+||+|..+ +|+.||||++...... .....+.+..|..++..+ .||+|+++++++.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-------cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 457888999999999999999765 5889999998543211 112345678899999988 7999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 9999999999999999999998754 68999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
++.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. . ..........
T Consensus 168 a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~--~~~~~~i~~~--- 236 (353)
T 2i0e_A 168 CKENIW---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---E--DELFQSIMEH--- 236 (353)
T ss_dssp CBCCCC---TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---H--HHHHHHHHHC---
T ss_pred cccccc---CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---H--HHHHHHHHhC---
Confidence 975322 1223445689999999999999999999999999999999999999997531 1 1111111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
....+.. ....+.+++.+|++.||++||+ +.+++++
T Consensus 237 -----~~~~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 -----NVAYPKS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCCCTT---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111222 2345667888999999999995 6888776
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.26 Aligned_cols=276 Identities=17% Similarity=0.234 Sum_probs=204.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC------CcEEEEEEecccccccccC-chhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS------GEVVAVKKLWSQRTKVSAS-DTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|.... ++.||||++.......... ..........+..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 468888999999999999997754 4789999985443110000 000011123455677788899999999999
Q ss_pred eEEecC----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CC
Q 003199 599 CYFSSL----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD--VN 672 (840)
Q Consensus 599 ~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~ 672 (840)
+++... ...++||||+ +++|.+++......+++.++..++.||+.||+|||+ ++|+||||||+|||++ .+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCC
Confidence 998764 4579999999 999999998876679999999999999999999999 9999999999999999 88
Q ss_pred CCCeeecccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 673 YQPKVADFGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
+.+||+|||+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-PK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-HH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-HH
Confidence 999999999998764422111 1223456999999999999999999999999999999999999999753222 11
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
...+.. ...........+..+.. ......+.+++..||+.||++||++.++++.|+++
T Consensus 270 ~~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 270 YVRDSK--IRYRENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHH--HHHHHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHH--HHhhhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 111111 11111122333322211 11134567788899999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=355.53 Aligned_cols=274 Identities=20% Similarity=0.262 Sum_probs=205.7
Q ss_pred HhcCccCeeecc--CCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 526 EAMTEKNKVGQG--GSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 526 ~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
.+|+..+.||+| +||.||+|... +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--------SNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--------ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 468889999999 99999999665 799999999854321 1234577889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
+....++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccc
Confidence 999999999999999999999765 2468999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCC----CcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 682 IAKVLQARGGK----DSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 682 ~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
.+......+.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+........ .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~ 252 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNG 252 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC---
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhcC
Confidence 98655332111 112233478999999999987 578999999999999999999999997632221110 00000
Q ss_pred hhcc--------ccc-------------hhhhcc----------cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003199 756 KVDT--------KEG-------------IMEVLD----------KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVV 804 (840)
Q Consensus 756 ~~~~--------~~~-------------~~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl 804 (840)
.... .+. ...... ....+........+.+++.+||+.||++|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0000 000 000000 000001112235678899999999999999999999
Q ss_pred HH--hhhcC
Q 003199 805 QL--LAEAD 811 (840)
Q Consensus 805 ~~--L~~~~ 811 (840)
++ +.++.
T Consensus 333 ~hp~f~~~~ 341 (389)
T 3gni_B 333 NHSFFKQIK 341 (389)
T ss_dssp TSGGGGGC-
T ss_pred cCHHHHHHh
Confidence 87 44443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.61 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=197.2
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++.+.|...+.||+|+||.||+|.. .++..||+|++...... ...+.+.+|++++++++||||+++++++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 89 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---------VPMEQIEAEIEVLKSLDHPNIIKIFEVF 89 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---------SCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---------hhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence 4567899999999999999999965 47899999998544321 1246788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCC
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQP 675 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~ 675 (840)
.+....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCE
T ss_pred ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCE
Confidence 9999999999999999999988543 2478999999999999999999999 999999999999999 456789
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........||+.|+|||.+. ..++.++||||||+++|||++|+.||..... . .....
T Consensus 167 kl~Dfg~a~~~~~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~---~~~~~ 236 (285)
T 3is5_A 167 KIIDFGLAELFKS----DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--E---EVQQK 236 (285)
T ss_dssp EECCCCCCCC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHH
T ss_pred EEEeeecceecCC----cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--H---HHHhh
Confidence 9999999976533 22234567999999999875 5789999999999999999999999975310 0 00000
Q ss_pred hhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ................+.+++.+|++.||++|||+.|++++
T Consensus 237 -~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 237 -AT-------YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -HH-------HCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -hc-------cCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00011111111123456778889999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=376.82 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=196.1
Q ss_pred eeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 533 KVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.||+|+||.||+|.+. ++..||||++..... ....+.+.+|++++++++|||||++++++.. +..++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---------KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS---------STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC---------hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 7999999999999653 466899999854321 1235678999999999999999999999976 56899
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+++|+|.+++......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999999999999998766679999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhcc
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 768 (840)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ ..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i-------------~~ 554 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI-------------EQ 554 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHH-------------HT
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHH-------------Hc
Confidence 222222233456789999999998999999999999999999998 9999976321 1111110 00
Q ss_pred cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 769 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.............+.+++.+||+.||++||++.++++.|+++.
T Consensus 555 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0011111223456778888999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.48 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=200.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|...+.||+|+||.||+|.... +..||||++.... .....+.+.+|+.++++++||||+++++++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---------TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---------CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---------CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 567888999999999999996542 3469999885432 123356789999999999999999999998
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+. ..++||||+++++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccC
Confidence 754 5689999999999999998766679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
++...... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ........ .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~---~-- 229 (281)
T 3cc6_A 159 LSRYIEDE--DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLE---K-- 229 (281)
T ss_dssp GGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHH---H--
T ss_pred CCcccccc--cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHh---c--
Confidence 99876432 1122334567889999999988899999999999999999998 9999975321 11111100 0
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
......... ....+.+++.+|++.||++|||+.|++++|+++
T Consensus 230 -----~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 230 -----GDRLPKPDL---CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -----TCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 000011111 234567788899999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.83 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=200.9
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +++.||||++.... .........+.+|++++++++||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-------HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-------cchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 357888999999999999999554 67899999984322 1122335678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~ 156 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 156 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEecccc
Confidence 999999999999999999998754 68999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+... .
T Consensus 157 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~-~------ 220 (279)
T 3fdn_A 157 VHAPS-----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRI-S------ 220 (279)
T ss_dssp SCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHH-H------
T ss_pred ccCCc-----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHHHHHH-H------
Confidence 65422 22344578999999999999899999999999999999999999997531 00000000 0
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
......+... ...+.+++.+|++.||++|||+.|++++-.
T Consensus 221 --~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 221 --RVEFTFPDFV---TEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp --HTCCCCCTTS---CHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred --hCCCCCCCcC---CHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 0111112222 245667888999999999999999998843
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.79 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=200.1
Q ss_pred HhcCccC-eeeccCCcEEEEEEe---CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKN-KVGQGGSGTVYKIDL---NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|...+ .||+|+||.||+|.. .+++.||||++..... .....+.+.+|+++++.++||||+++++++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--------DPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3566666 899999999999954 3468899999854321 123356789999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 5567889999999999999998764 68999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~---~~-- 235 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAML---EK-- 235 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH---HT--
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH---Hc--
Confidence 99876432222222333456789999999988889999999999999999999 9999975311 1111000 00
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
........ .....+.+++.+||+.||++||++.++++.|+++
T Consensus 236 -----~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 236 -----GERMGCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -----TCCCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00011112 2334677788899999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.08 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=203.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|...+.||+|+||.||+|...++..||||++..... ..+.+.+|++++++++||||+++++++.+ +
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-----------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 56788899999999999999988888999999854321 13568899999999999999999999874 4
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 5799999999999999997542 258999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+... ... ......
T Consensus 158 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~---~~~~~~----- 225 (279)
T 1qpc_A 158 LIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV---IQNLER----- 225 (279)
T ss_dssp ECSSS--CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH---HHHHHT-----
T ss_pred cccCc--ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHH---HHHHhc-----
Confidence 76431 1122234456789999999988889999999999999999999 9999975311 111 100000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
........ .....+.+++.+|++.||++|||+.++++.|+++.
T Consensus 226 --~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 226 --GYRMVRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --TCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ccCCCCcc---cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00111111 22346777888999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.42 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=184.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-------YKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-------hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 35788899999999999999965 5799999999843221 112234678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecce
Confidence 999999999999999999998766679999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . . . ..
T Consensus 160 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-~--~-~~------ 225 (278)
T 3cok_A 160 TQLKMP---HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L-N--K-VV------ 225 (278)
T ss_dssp EECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC------
T ss_pred eeccCC---CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H-H--H-Hh------
Confidence 765321 1122345789999999999988899999999999999999999999975321110 0 0 0 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..+...+.. ....+.+++.+|++.||++|||+.+++++
T Consensus 226 --~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 226 --LADYEMPSF---LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --SSCCCCCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --hcccCCccc---cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000111122 23456678889999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.74 Aligned_cols=255 Identities=25% Similarity=0.312 Sum_probs=207.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|+..+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----------THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 56788899999999999999665 58899999985322 2246788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999999999864 3458999999999999999999999 89999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
..... ..........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.... ........
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~--------- 225 (288)
T 3kfa_A 159 RLMTG--DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELL--------- 225 (288)
T ss_dssp GTSCS--SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHH---------
T ss_pred eeccC--CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---------
Confidence 87643 22233344567889999999998899999999999999999999 999997531 11111100
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.......... .....+.+++.+|++.||.+|||+.++++.|+.+.
T Consensus 226 -~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 226 -EKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -HTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hccCCCCCCC---CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 0001111111 22345777888999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.78 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=206.7
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.+.|...+.||+|+||.||+|... +|+.||||++.......... ....+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS----SBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc----chhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 35678999999999999999999654 78999999986544321111 11246788999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CCee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY----QPKV 677 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl 677 (840)
.+....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEE
Confidence 99999999999999999999998754 68999999999999999999999 9999999999999999887 7999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+++.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... .
T Consensus 161 ~Dfg~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i-~ 231 (321)
T 2a2a_A 161 IDFGLAHEIED----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANI-T 231 (321)
T ss_dssp CCCTTCEECCT----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHH-H
T ss_pred ccCccceecCc----cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----HHHHHHH-H
Confidence 99999976533 2223445799999999999988999999999999999999999999975311 0000000 0
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... ..+.... ......+.+++.+|++.||++|||+.|++++-
T Consensus 232 ~~~~----~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 232 SVSY----DFDEEFF---SHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp TTCC----CCCHHHH---TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred hccc----ccChhhh---cccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0000 0000000 11234567788899999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.39 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=179.4
Q ss_pred cCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCccce
Q 003199 531 KNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 608 (840)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 378999999999999664 7899999998422 2356778999999997 999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---CCeeecccchhh
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY---QPKVADFGIAKV 685 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfg~a~~ 685 (840)
+||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999998764 79999999999999999999999 9999999999999998765 799999999976
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC--cchhhhhhhhhccccch
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN--KNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 763 (840)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 159 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 225 (325)
T 3kn6_A 159 KPP---DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM---------- 225 (325)
T ss_dssp CCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH----------
T ss_pred cCC---CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH----------
Confidence 532 1223345678999999999999999999999999999999999999997642211 0111100
Q ss_pred hhhcccccC--C-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 764 MEVLDKKLS--G-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 764 ~~~~~~~~~--~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
..+...... . .+......+.+++.+|++.||++|||+.|++++-.
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 111111111 1 11223456788889999999999999999987643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.02 Aligned_cols=369 Identities=26% Similarity=0.281 Sum_probs=271.2
Q ss_pred ccccccccCCC-CCCCCCCCEEecCCCcCcccCCccccCCCCC-------------CEEeCCCCCCCccCCCCccccccc
Q 003199 2 SFMYLTGTLPD-FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNL-------------EVLSFNENPGFKLWKLPESSIFRL 67 (840)
Q Consensus 2 ~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L-------------~~L~L~~N~~~~l~~l~~~~~~~l 67 (840)
+.+.+ |.+|+ |+.+++|++|+|++|.+++.+|..++.+.+| ++|++++| .+..+|. -.
T Consensus 19 ~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~---~l~~lp~----~~ 90 (454)
T 1jl5_A 19 HSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL---GLSSLPE----LP 90 (454)
T ss_dssp ----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTS---CCSCCCS----CC
T ss_pred ccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCC---ccccCCC----Cc
Confidence 45666 78885 9999999999999999999999999988865 99999999 5555554 13
Q ss_pred ccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeee
Q 003199 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLD 147 (840)
Q Consensus 68 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~ 147 (840)
++|+.|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+ +. .+| .++++++|++|+
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~-l~-~lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQ-LE-KLP-ELQNSSFLKIID 159 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSC-CS-SCC-CCTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCC-CC-CCc-ccCCCCCCCEEE
Confidence 789999999999986 5653 3789999999999984 3322 2789999999998 33 477 599999999999
Q ss_pred ccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 148 MSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
+++|++++ +|.. .++|++|++++|++++. | .+.++++|++|++++|++++ +|... ++|++|++++|+++
T Consensus 160 l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDL---PPSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE- 228 (454)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-
T ss_pred CCCCcCcc-cCCC---cccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-
Confidence 99999995 5543 35899999999999874 4 58999999999999999985 44433 58999999999998
Q ss_pred cCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCC
Q 003199 228 PLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307 (840)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 307 (840)
.+| .+..+++|++|++++|.+.+ +|.. +++|+.|++++|++++ +|.. .++|+.|++++|++++... .
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~----~ 295 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----L 295 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC----C
T ss_pred ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccC----c
Confidence 556 48899999999999999986 3432 4789999999999984 5653 3789999999999987421 1
Q ss_pred CCCCceeecccceeeeccchhhccc-CcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEE
Q 003199 308 ARNLSELFMQRNQISGFIPSEIYRA-ISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVL 386 (840)
Q Consensus 308 l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 386 (840)
.++|+.|++++|++++. + .+ .+|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|++|
T Consensus 296 ~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L 362 (454)
T 1jl5_A 296 PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQL 362 (454)
T ss_dssp CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEE
T ss_pred CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEE
Confidence 36899999999999863 2 23 489999999999996 6654 588999999999998 4565 47899999
Q ss_pred ECcCccccc--cCCchhhcc--------------CCCeEEccCCCCcC--cCCccccc
Q 003199 387 DLSNNLLTG--YIPESLCEL--------------LPNSINFSNNRLSG--PIPLSLIK 426 (840)
Q Consensus 387 ~l~~N~l~~--~~p~~~~~~--------------~~~~l~l~~N~l~~--~~p~~~~~ 426 (840)
++++|++++ .+|.++..+ .++.|++++|+++| .+|.++..
T Consensus 363 ~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~ 420 (454)
T 1jl5_A 363 HVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVED 420 (454)
T ss_dssp ECCSSCCSSCCCCCTTCCEEECCC----------------------------------
T ss_pred ECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhhHhh
Confidence 999999998 788887765 35788999999987 77765443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.48 Aligned_cols=272 Identities=23% Similarity=0.279 Sum_probs=208.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---------cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 46788899999999999999665 699999999853321 12245678899999999999999999999775
Q ss_pred c--cceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCCCe
Q 003199 605 Y--CNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL----DVNYQPK 676 (840)
Q Consensus 605 ~--~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~k 676 (840)
. ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEE
Confidence 5 6799999999999999998653 238999999999999999999999 999999999999999 7777899
Q ss_pred eecccchhhhhccCCCCcceecccccccccCcccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS--------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
|+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 157 L~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 157 LTDFGAARELED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp ECCGGGCEECCC----GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EecCCCceEccC----CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999976532 223345679999999998865 56788999999999999999999999753332222
Q ss_pred hhhhhhhhhccc-cchhhh---------ccccc---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 749 IIYWVSIKVDTK-EGIMEV---------LDKKL---SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 749 ~~~~~~~~~~~~-~~~~~~---------~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
............ .....+ ..... ..........+.+++.+|++.||++||++.|+++.++++-..
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111111111100 000000 00011 112245667788899999999999999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.23 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=198.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|... +|+.||||++..... .....+.+.+|++++++++||||+++++++.+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--------DPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc--------chHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 357888999999999999999665 699999998844321 23345678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999999998887653 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc---
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT--- 759 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 759 (840)
+.... .........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ............
T Consensus 150 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 150 RLLTG---PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLIP 224 (311)
T ss_dssp EECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCH
T ss_pred hhccC---cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhccccc
Confidence 76542 1222345578999999999876 67899999999999999999999999753211 111000000000
Q ss_pred --------ccchhh--hcccccCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 760 --------KEGIME--VLDKKLSG----SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 760 --------~~~~~~--~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...... ..+..... .+......+.+++.+|++.||++|||++|++++-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 000000 00000000 0112344577899999999999999999999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.50 Aligned_cols=259 Identities=24% Similarity=0.250 Sum_probs=201.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|..+ +|+.||||++..... ......+.+.+|..++..++||||+++++++.+
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-------~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-------LKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-------HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-------hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 467888999999999999999764 799999999853221 111223457889999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++.+....+++..+..++.||+.||+|||+ ++||||||||+|||++.++++||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhh
Confidence 999999999999999999998765579999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY-------SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
+..... .........||+.|+|||++. +..++.++|||||||++|||++|+.||..... ...+.. .
T Consensus 210 ~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~-i 282 (412)
T 2vd5_A 210 LKLRAD--GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----AETYGK-I 282 (412)
T ss_dssp EECCTT--SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHH-H
T ss_pred eeccCC--CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----HHHHHH-H
Confidence 775431 122233468999999999986 35689999999999999999999999975311 111110 0
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHh
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATR---PTMNEVVQLL 807 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~evl~~L 807 (840)
..... .. ..+........++.+++.+|+. +|++| |+++|+++|=
T Consensus 283 ~~~~~---~~---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 283 VHYKE---HL---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HTHHH---HC---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred Hhccc---Cc---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 00000 00 0111011223456678889999 99998 5999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.53 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=195.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC--CCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH--KNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~ 603 (840)
+.|+..+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++| +||+++++++.+
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc--------chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 35788899999999999999888899999999854321 13345778999999999986 999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||| +.+|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++ ++.+||+|||++
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred CCEEEEEEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 999999999 55889999998764 68999999999999999999999 9999999999999997 578999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS-----------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
+..... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 155 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~ 230 (343)
T 3dbq_A 155 NQMQPD-TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKL 230 (343)
T ss_dssp CCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHH
T ss_pred cccCcc-cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHHHH
Confidence 876432 11222345679999999999864 6789999999999999999999999975311 11110
Q ss_pred hhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. .... ......+... ...+.+++.+||+.||.+|||+.|++++-.
T Consensus 231 ~~-~~~~------~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 231 HA-IIDP------NHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HH-HHCT------TSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HH-HhcC------CcccCCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 00 0000 0001111111 235667888999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=355.65 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=191.0
Q ss_pred HHHhcCcc-CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc-cCCCCcceeeeE
Q 003199 524 ILEAMTEK-NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN-IRHKNIVKLYCY 600 (840)
Q Consensus 524 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~ 600 (840)
+.+.|... +.||+|+||+||+|.. .+|+.||||++... ..+.+|++++.+ .+||||++++++
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------------~~~~~E~~~~~~~~~hp~iv~l~~~ 123 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------------PKARREVELHWRASQCPHIVRIVDV 123 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------------hhHHHHHHHHHHhcCCCCcceEeEE
Confidence 34556655 6899999999999965 47899999998321 235678887644 489999999998
Q ss_pred Eec----CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C
Q 003199 601 FSS----LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---N 672 (840)
Q Consensus 601 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~ 672 (840)
+.. ....++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. +
T Consensus 124 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~ 200 (400)
T 1nxk_A 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPN 200 (400)
T ss_dssp EEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTT
T ss_pred EeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCC
Confidence 865 567899999999999999998753 468999999999999999999999 99999999999999997 7
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
+.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 201 ~~~kl~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 201 AILKLTDFGFAKETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp CCEEECCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred ccEEEEecccccccCC----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 8899999999976532 223345678999999999999999999999999999999999999997643221110000
Q ss_pred hhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
...... .. .. ....+......+.+++.+||+.||++|||+.|++++-.
T Consensus 277 ~~i~~~-~~---~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 277 TRIRMG-QY---EF----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp HHHHHT-CC---CC----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHcC-cc---cC----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000000 00 00 01111223455777888999999999999999999854
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.14 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=204.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CC-----cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SG-----EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|...+.||+|+||.||+|... ++ ..||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---------HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---------ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 56888899999999999999754 23 479999985432 123356789999999999 899999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcC-------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKG-------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~ 665 (840)
+++......++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 193 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAAR 193 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccc
Confidence 9999999999999999999999998753 2357999999999999999999999 99999999999
Q ss_pred CEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 003199 666 NILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFG 744 (840)
Q Consensus 666 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~ 744 (840)
||+++.++.+||+|||+++..... ..........||+.|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGC-TTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECCCCeEEECccccccccccc-cceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999876442 12222334567889999999998899999999999999999999 9999975321
Q ss_pred CCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 745 DNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
. ........ .......... ....+.+++.+||+.||.+|||+.|++++|+++
T Consensus 273 ~-~~~~~~~~----------~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 273 N-SKFYKLVK----------DGYQMAQPAF---APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp S-HHHHHHHH----------HTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h-HHHHHHHh----------cCCCCCCCCC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1 11111000 0001111111 234567788899999999999999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.08 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=204.9
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.+..++|...+.||+|+||.||+|. ..+|+.||||++.......... ........+.+|+.++++++||||++++++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW--IEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSE--EEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3567899999999999999999996 4578999999986543221100 001112346679999999999999999999
Q ss_pred EecCccceEEEeecCCC-ChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 601 FSSLYCNLLVYEYMPNG-NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
+.+....++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 98 FENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999999777 9999998764 69999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
||+++.... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 174 fg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~------ 236 (335)
T 3dls_A 174 FGSAAYLER----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------T------ 236 (335)
T ss_dssp CTTCEECCT----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------G------
T ss_pred cccceECCC----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------H------
Confidence 999976533 223344679999999999988776 8899999999999999999999964210 0
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
..... ..+.. ....+.+++.+|++.||++|||+.+++++-.
T Consensus 237 ----~~~~~--~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 ----VEAAI--HPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ----TTTCC--CCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ----Hhhcc--CCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00000 01111 2245677888999999999999999999844
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=359.84 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=194.9
Q ss_pred HHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|. ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence 4678889999999999999995 4579999999985432 113345678899999999999999999999965
Q ss_pred Cc------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 LY------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.. ..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||
T Consensus 133 ~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEE
T ss_pred CCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEE
Confidence 43 46999999965 56666654 48999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+|+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ....+.....
T Consensus 206 ~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~----~~~~~~~i~~ 277 (464)
T 3ttj_A 206 LDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIE 277 (464)
T ss_dssp CCCCCC---------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH
T ss_pred EEEEeeeecCC----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHH
Confidence 99999987632 223445689999999999999999999999999999999999999997532 1111111000
Q ss_pred ccc--------------------------cchhhhccccc-CCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTK--------------------------EGIMEVLDKKL-SGSF---RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~--------------------------~~~~~~~~~~~-~~~~---~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
... ........... .... ......+.+++.+|++.||++|||++|+++|=
T Consensus 278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 00000000000 0000 11245688999999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.27 Aligned_cols=253 Identities=27% Similarity=0.359 Sum_probs=201.8
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 125 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-------cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 45688899999999999999965 5799999999854321 123345678999999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+. |++.+.+......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 999999999996 78888887655679999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ....... ....
T Consensus 202 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~-~~~~ 269 (348)
T 1u5q_A 202 SIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI-AQNE 269 (348)
T ss_dssp BSSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHH-HHSC
T ss_pred eecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH-HhcC
Confidence 76532 23457999999999884 56789999999999999999999999965311 0000000 0000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhh
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~ 809 (840)
........+ ...+.+++.+||+.||++|||+.+++++..-
T Consensus 270 ------~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 270 ------SPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp ------CCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ------CCCCCCCCC---CHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 000011122 2346678889999999999999999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.47 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=193.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|...+.||+|+||.||+|... ++..||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--------SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--------chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 56788899999999999999553 345899999854321 123356788999999999999999999999
Q ss_pred ecCcc-----ceEEEeecCCCChHHHhhc-----CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 003199 602 SSLYC-----NLLVYEYMPNGNLWDALHK-----GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV 671 (840)
Q Consensus 602 ~~~~~-----~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 671 (840)
.+... .++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence 77553 4899999999999999853 23468999999999999999999999 99999999999999999
Q ss_pred CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 003199 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750 (840)
Q Consensus 672 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~ 750 (840)
++.+||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMY 259 (313)
T ss_dssp TSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHH
T ss_pred CCcEEEeecCcceeccccc-ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHH
Confidence 9999999999998764321 1123344567889999999999999999999999999999999 8899875321 1111
Q ss_pred hhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.. ................+.+++.+||+.||++|||+.+++++|+++
T Consensus 260 ~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 DY-------------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HH-------------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-------------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 10 011111111122334677888899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.86 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=194.4
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..+.++|...+.||+|+||+||+|.. .+++.||||++........ ..........+.+|+.++++++||||++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG--SAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC----------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccc--ccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45678899999999999999999955 5789999999865432211 11112223457899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCCee
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN---YQPKV 677 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl 677 (840)
+... ..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.+ +.+||
T Consensus 209 ~~~~-~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 209 FDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp EESS-EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EecC-ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 8654 5789999999999999987664 68999999999999999999999 999999999999999754 45999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+|||+|+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 284 ~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~ 358 (419)
T 3i6u_A 284 TDFGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQIT 358 (419)
T ss_dssp CCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHH
T ss_pred eecccceecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHh
Confidence 99999987532 223345679999999999853 5688999999999999999999999975322111 111000
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... ......+......+.+++.+|++.||++|||+.|++++=
T Consensus 359 ---~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 359 ---SGKY-------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp ---TTCC-------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred ---cCCC-------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 0000 000000112235677888899999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=336.58 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=202.1
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++.++|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----------EDVDRFKQEIEIMKSLDHPNIIRLYETF 75 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----------SCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----------chHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45678999999999999999999655 578999999854321 1245688999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCCeee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKVA 678 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~ 678 (840)
.+....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 76 EDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred ecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999999999987754 68999999999999999999999 999999999999999 788899999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||++..... ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... .......
T Consensus 152 Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~--- 219 (277)
T 3f3z_A 152 DFGLAARFKP----GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKI--- 219 (277)
T ss_dssp CCTTCEECCT----TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH---
T ss_pred ecccceeccC----ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHHH---
Confidence 9999976532 223345579999999998765 489999999999999999999999975311 0000000
Q ss_pred cccchhhhcccccCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... ........+.+++.+|++.||++|||+.+++++
T Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 220 --------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --------HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --------HhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 001223567788889999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=375.72 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=195.8
Q ss_pred CeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 532 NKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
+.||+|+||+||+|.+. +++.||||+++.... .....+.+.+|++++++++|||||++++++.. +..+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--------DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--------CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 47999999999999553 568899999854321 12335779999999999999999999999965 4578
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 446 lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 9999999999999998754 68999999999999999999999 9999999999999999999999999999988754
Q ss_pred cCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 689 RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 689 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+... ...... +.
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~-------------i~ 586 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAM-------------LE 586 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH-------------HH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-------------HH
Confidence 3222233344567889999999999999999999999999999998 9999975321 111000 00
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
..............+.+++.+||+.||++||++.++++.|+++
T Consensus 587 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 587 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0111111122345677888899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.40 Aligned_cols=277 Identities=16% Similarity=0.196 Sum_probs=201.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccC-chhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSAS-DTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
++|...+.||+|+||.||+|... ++..||||++.......... ..........+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 46788899999999999999765 57899999986443211000 00011123457789999999999999999999
Q ss_pred Eec----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC--C
Q 003199 601 FSS----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY--Q 674 (840)
Q Consensus 601 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--~ 674 (840)
+.. ....++||||+ +++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCc
Confidence 977 67889999999 999999998765 78999999999999999999999 9999999999999999887 9
Q ss_pred CeeecccchhhhhccCCC----CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003199 675 PKVADFGIAKVLQARGGK----DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 750 (840)
+||+|||+++.+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999999876432211 1122456799999999999998999999999999999999999999964322111111
Q ss_pred hhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
...... .............. ......+.+++.+||+.||++||++.++++.|++...
T Consensus 272 -~~~~~~--~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 -TAKTNL--LDELPQSVLKWAPS--GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHH--HHTTTHHHHHHSCT--TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHhh--cccccHHHHhhccc--cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 110000 00001111000000 0123467778889999999999999999999998765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.02 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 600 (840)
.+.+.|+..+.||+|+||.||+|..+ +|+.||||++..... ...+|++++.++ +||||++++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------~~~~E~~~l~~~~~hp~iv~~~~~ 84 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------------DPTEEIEILLRYGQHPNIITLKDV 84 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------------CCHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------------ChHHHHHHHHHhcCCCCcCeEEEE
Confidence 45678999999999999999999654 789999999854321 123578888887 79999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-C---CCe
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-Y---QPK 676 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~---~~k 676 (840)
+.+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||++.++ + .+|
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 85 YDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEE
Confidence 999999999999999999999998764 68999999999999999999999 999999999999998543 3 499
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i 235 (342)
T 2qr7_A 161 ICDFGFAKQLRAE---NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARI 235 (342)
T ss_dssp ECCCTTCEECBCT---TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHH
T ss_pred EEECCCcccCcCC---CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHH
Confidence 9999999865432 222345678999999999988889999999999999999999999997532211 11111110
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
..... . .. .+.+......+.+++.+|++.||++||++.|++++-.
T Consensus 236 ~~~~~---~-~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 236 GSGKF---S-LS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHCCC---C-CC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ccCCc---c-cC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 00000 0 00 1111223345677888999999999999999998743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.03 Aligned_cols=270 Identities=25% Similarity=0.367 Sum_probs=192.4
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeee
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYC 599 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 599 (840)
+.+.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.+. ||||+++++
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--------NSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C--------CHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc--------ChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 45678899999999999999999954 5799999999843321 1234566789999999997 999999999
Q ss_pred EEecCc--cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 600 YFSSLY--CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 600 ~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
++...+ ..++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEe
Confidence 997543 6799999997 6999998874 68999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccC------------------CCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCC
Q 003199 678 ADFGIAKVLQARG------------------GKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKP 738 (840)
Q Consensus 678 ~Dfg~a~~~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p 738 (840)
+|||+|+.+.... ..........||+.|+|||++.+ ..++.++||||+||++|||++|+.|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999997653210 01122344679999999999876 6789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhh-hccccchhhh------------------cccccCCCcH-------------HHHHHHHHHH
Q 003199 739 VEDDFGDNKNIIYWVSIK-VDTKEGIMEV------------------LDKKLSGSFR-------------DEMIQVLRIA 786 (840)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------------------~~~~~~~~~~-------------~~~~~l~~l~ 786 (840)
|.+.... .......... ....+.+... ........+. .....+.+++
T Consensus 231 f~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 231 FPGSSTM-NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp CCCSSHH-HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCHH-HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 9753210 0000000000 0000000000 0000111111 1234677899
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 003199 787 IRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 787 ~~cl~~dP~~Rps~~evl~~ 806 (840)
.+|++.||++|||+.|+++|
T Consensus 310 ~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTS
T ss_pred HHhhccCcccCCCHHHHhCC
Confidence 99999999999999999988
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=366.08 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=204.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|... +|+.||||++...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-------KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK 256 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-------hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence 45778889999999999999664 7999999998543211 122345678999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||++
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccc
Confidence 99999999999999999997653 358999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 334 ~~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~i~~----- 403 (576)
T 2acx_A 334 VHVPE----GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE----- 403 (576)
T ss_dssp EECCT----TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHHHHH-----
T ss_pred eeccc----CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHHhhc-----
Confidence 76532 223345689999999999999899999999999999999999999997642211111 11111000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
........+ ...+.+++.+|++.||++|| ++.|+++|
T Consensus 404 ---~~~~~p~~~---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 ---VPEEYSERF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CCCCCCTTS---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---ccccCCccC---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 011122222 34566788899999999999 78999877
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.05 Aligned_cols=267 Identities=26% Similarity=0.354 Sum_probs=208.6
Q ss_pred HHHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhc--cCCCCcceee
Q 003199 521 QREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGN--IRHKNIVKLY 598 (840)
Q Consensus 521 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~ 598 (840)
...+.++|...+.||+|+||.||+|... |+.||||++... ....+.+|++++.. ++||||++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-------------~~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-------------EERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-------------GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-------------hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 4567789999999999999999999875 899999998422 13456778888877 7899999999
Q ss_pred eEEecCc----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCC
Q 003199 599 CYFSSLY----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH--------HGLLSPIIHRDIKSTN 666 (840)
Q Consensus 599 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlk~~N 666 (840)
+++.... ..++||||+++|+|.+++... .+++..+..++.|++.||+||| + .+|+||||||+|
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~N 177 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKN 177 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGG
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHH
Confidence 9998775 789999999999999999875 5899999999999999999999 6 899999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCC-cceecccccccccCccccccCC------CCccccchhHHHHHHHHHhC----
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKD-STTTVIAGTYGYLAPEYAYSSK------ATTKCDVYSFGVVLMELITG---- 735 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg---- 735 (840)
|+++.++.+||+|||+++......... .......||+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 999999999999999997664321110 1234557999999999987652 34789999999999999999
Q ss_pred ------CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 736 ------RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSF--RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 736 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
+.||............+...... ......+...+ .+....+.+++.+||+.||++|||+.|++++|
T Consensus 258 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CcccccccCccccCcCcccHHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67876543322222222211110 01111222211 24566788999999999999999999999999
Q ss_pred hhcCC
Q 003199 808 AEADP 812 (840)
Q Consensus 808 ~~~~~ 812 (840)
+++..
T Consensus 332 ~~i~~ 336 (342)
T 1b6c_B 332 SQLSQ 336 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.58 Aligned_cols=266 Identities=22% Similarity=0.260 Sum_probs=199.0
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
...++|...+.||+|+||.||+|... +++.||||++..... ......+.+.+|+.++++++||||+++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-------SDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-------GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-------cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 34577899999999999999999664 789999999854321 1234457789999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 99999999999999999999998754 68999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++...... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ..........
T Consensus 180 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~---~~~~~~~~~~ 251 (309)
T 2h34_A 180 IASATTDE--KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LS---VMGAHINQAI 251 (309)
T ss_dssp C------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HH---HHHHHHHSCC
T ss_pred cCcccccc--ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HH---HHHHHhccCC
Confidence 99776432 1222345578999999999999899999999999999999999999997531 00 1110110000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhhcCCCC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-TMNEVVQLLAEADPCR 814 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~~~~ 814 (840)
... ..... .....+.+++.+||+.||++|| +++++++.|+.+-...
T Consensus 252 ~~~----~~~~~---~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 252 PRP----STVRP---GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CCG----GGTST---TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCc----cccCC---CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 000 01111 2233566788899999999999 9999999998765444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.73 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=194.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||+||+|... +++.||||++...... .....+.+|++++++++||||+++++++.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---------GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---------ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 46888899999999999999665 7899999998543311 1112344699999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||++ |+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 69999998776679999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh--cccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV--DTKE 761 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~ 761 (840)
.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ........... ....
T Consensus 149 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 223 (324)
T 3mtl_A 149 AKSI---PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTEE 223 (324)
T ss_dssp CC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTT
T ss_pred cccC---CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChH
Confidence 6532 1223344578999999999876 5689999999999999999999999976321 11111100000 0000
Q ss_pred chhhhc---------ccccC-CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 762 GIMEVL---------DKKLS-GS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~---------~~~~~-~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...... .+... .. .......+.+++.+|++.||++|||++|++++=
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 000000 00000 00 011234667888999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.29 Aligned_cols=269 Identities=23% Similarity=0.266 Sum_probs=197.4
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC---CCCcceeee
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR---HKNIVKLYC 599 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~ 599 (840)
+.++|+..+.||+|+||+||+|.. .+|+.||||++......... ......+.+|++++++++ ||||+++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG-----GGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS-----SCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc-----cccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 356899999999999999999965 57899999998644321110 111234556777776664 999999999
Q ss_pred EEecCc-----cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 003199 600 YFSSLY-----CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY 673 (840)
Q Consensus 600 ~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~ 673 (840)
++.... ..++||||+. |+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTS
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCC
Confidence 997655 4789999996 69999998764 348999999999999999999999 9999999999999999999
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 158 ~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~ 232 (308)
T 3g33_A 158 TVKLADFGLARIYSY----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIF 232 (308)
T ss_dssp CEEECSCSCTTTSTT----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHH
T ss_pred CEEEeeCccccccCC----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 999999999986632 223345678999999999999999999999999999999999999997532110 000000
Q ss_pred hhh-hccccchh-------hhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIK-VDTKEGIM-------EVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~-~~~~~~~~-------~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ........ ........... .+....+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 00000000 00000000000 1223567788889999999999999999976
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.50 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=187.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|+.||||++...... ...+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---------GTPSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTT---------CSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---------ccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 56788899999999999999654 6899999998543311 1124577899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCC-----CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-----VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
...++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECC
T ss_pred CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECc
Confidence 99999999997 69999886532 358999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ............
T Consensus 152 fg~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~ 227 (317)
T 2pmi_A 152 FGLARAFGIP---VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGT 227 (317)
T ss_dssp CSSCEETTSC---CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCS
T ss_pred CccceecCCC---cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 9999876321 222344578999999999876 46899999999999999999999999753211 000000000000
Q ss_pred c-ccchhh---------hcccccCCCcH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 T-KEGIME---------VLDKKLSGSFR---------DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~-~~~~~~---------~~~~~~~~~~~---------~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ...... ........... .....+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000000 00000000111 123467788889999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.26 Aligned_cols=246 Identities=25% Similarity=0.296 Sum_probs=190.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHH-HhccCCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET-LGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||+||+|..+ +++.||||++...... .......+..|..+ ++.++||||+++++++.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-------~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------------CCBCCCCCTTBCCEEEEEEC
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-------hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 56888999999999999999665 6899999998654321 11223455667776 577899999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccc
Confidence 999999999999999999998754 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 187 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~---- 254 (373)
T 2r5t_A 187 KENIE---HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNK---- 254 (373)
T ss_dssp GGGBC---CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHS----
T ss_pred ccccc---CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhc----
Confidence 86432 2223456689999999999999999999999999999999999999997531 11111100100
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN 801 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 801 (840)
...+...+ ...+.+++.+|++.||++||++.
T Consensus 255 ----~~~~~~~~---~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 ----PLQLKPNI---TNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ----CCCCCSSS---CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ----ccCCCCCC---CHHHHHHHHHHcccCHHhCCCCC
Confidence 01112222 23566778899999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.85 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=199.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CC-------cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCccee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SG-------EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKL 597 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 597 (840)
++|...+.||+|+||.||+|... ++ ..||+|++.... ....+.+.+|++++++++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----------RNYSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----------GGGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----------HHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 46788899999999999999554 34 479999984322 2335678999999999999999999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ--- 674 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--- 674 (840)
++++.+....++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGG
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccc
Confidence 999999999999999999999999998876569999999999999999999999 99999999999999998887
Q ss_pred -----CeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 675 -----PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 675 -----~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
+||+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+..... ..
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~ 225 (289)
T 4fvq_A 155 GNPPFIKLSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQ 225 (289)
T ss_dssp TBCCEEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HH
T ss_pred cccceeeeccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hH
Confidence 99999999865422 233568899999999887 6789999999999999999996544432111 00
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
........ ........ ...+.+++.+||+.||++|||+.|++++|+++.....
T Consensus 226 --~~~~~~~~---------~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 226 --RKLQFYED---------RHQLPAPK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp --HHHHHHHT---------TCCCCCCS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred --HHHHHhhc---------cCCCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 00000000 00111111 2345678889999999999999999999998866444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.41 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=205.7
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
..++|+..+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---------VDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---------TTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---------hhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 4678999999999999999999665 789999999854321 123467889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEEecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCC
Confidence 9999999999999999999997653 68999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+...... ..........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||............|... .
T Consensus 152 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-- 225 (276)
T 2yex_A 152 ATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---K-- 225 (276)
T ss_dssp CEECEET-TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT---C--
T ss_pred ccccCCC-cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc---c--
Confidence 9765432 11122345678999999999987665 789999999999999999999997643322222222110 0
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............+.+++.+|++.||++|||+.|++++
T Consensus 226 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 --------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0001111223456778889999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=340.57 Aligned_cols=259 Identities=25% Similarity=0.327 Sum_probs=199.7
Q ss_pred hcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE-
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF- 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~- 601 (840)
.|...+.||+|+||.||+|...+ +..||||.+.... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 46677899999999999997542 2368999885322 123456788999999999999999999986
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++|+|.+++......+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccc
Confidence 45567799999999999999998766678999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCC-CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 682 IAKVLQARGG-KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 682 ~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
+++....... .........||+.|+|||.+.+..++.++||||+|+++|||++ |.+||...... ...... ...
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~---~~~ 248 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---LQG 248 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH---HTT
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH---hcC
Confidence 9976543211 1123344567889999999999999999999999999999999 55666543211 111100 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
. ....... ....+.+++.+|++.||++|||+.|+++.|+++..
T Consensus 249 ~-------~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 249 R-------RLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp C-------CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------CCCCCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0011111 23457778889999999999999999999987644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.52 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=202.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe--
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS-- 602 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-- 602 (840)
++|+..+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|++++++++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 57888899999999999999665 7899999998543211 233567899999999999999999999874
Q ss_pred cCccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCCEEEcCCCC
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSP-----IIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~ 674 (840)
.....++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSC
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCC
Confidence 456789999999999999998754 2348999999999999999999999 77 999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+||+|||.++..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ..
T Consensus 155 ~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~---~~ 226 (279)
T 2w5a_A 155 VKLGDFGLARILNHD---TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKEL---AG 226 (279)
T ss_dssp EEECCCCHHHHC------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HH
T ss_pred EEEecCchheeeccc---cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HHHH---HH
Confidence 999999999876431 122234578999999999998899999999999999999999999997531 0100 00
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.. .......+... ....+.+++.+||+.||++||++.|+++++....+
T Consensus 227 ~i-------~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 227 KI-------REGKFRRIPYR---YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HH-------HHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HH-------hhcccccCCcc---cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 00 00000111222 23456778889999999999999999998765443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.22 Aligned_cols=266 Identities=20% Similarity=0.198 Sum_probs=201.6
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++|++++..++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------------HPQLHIESKIYKMMQGGVGIPTIRWC 73 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------------CCCHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------------chHHHHHHHHHHHhcCCCCCCeeeee
Confidence 3457899999999999999999965 6789999998643321 12467899999999988877776665
Q ss_pred -ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCCee
Q 003199 602 -SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKV 677 (840)
Q Consensus 602 -~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl 677 (840)
......++||||+ +++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||
T Consensus 74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 74 GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred cCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEE
Confidence 6677779999999 999999998665679999999999999999999999 999999999999999 78899999
Q ss_pred ecccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 678 ADFGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
+|||+++......... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ..
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~ 228 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YE 228 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HH
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-hh
Confidence 9999998764422111 123456799999999999999999999999999999999999999976432211111 00
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
........ ......... ....+.+++.+|++.||++|||+.++++.|+++..
T Consensus 229 ~~~~~~~~----~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 229 RISEKKMS----TPIEVLCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHH----SCHHHHTTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhccccc----chhhhhhcc---CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00000000 000000111 13467788889999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.59 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=196.7
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--CCCcceeeeEEecC
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--HKNIVKLYCYFSSL 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 604 (840)
.|...+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~ 128 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence 4888899999999999999888899999999854321 1334577899999999996 59999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||| +.+++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred CEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 99999999 56899999998765 78999999999999999999999 9999999999999995 5799999999998
Q ss_pred hhhccCCCCcceecccccccccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-----------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
.+... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .. ...
T Consensus 203 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~-~~~ 277 (390)
T 2zmd_A 203 QMQPD-TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QI-SKL 277 (390)
T ss_dssp CC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HH-HHH
T ss_pred cccCC-CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HH-HHH
Confidence 76432 11122345679999999999865 4689999999999999999999999975311 10 000
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
....... .....+... ...+.+++.+||+.||++|||+.|++++-.
T Consensus 278 ~~~~~~~------~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 278 HAIIDPN------HEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHHCTT------SCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHhCcc------ccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 0000000 001111122 245677888999999999999999998743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=370.82 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=205.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|.+.++..||||++..... ..+.|.+|++++++++|+||+++++++.+ .
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-----------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 46778889999999999999998888999999854321 13568899999999999999999999876 6
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++... ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 789999999999999999753 2358999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... .........++..|+|||.+....++.++|||||||++|||++ |+.||.+... ......
T Consensus 412 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~----------- 476 (535)
T 2h8h_A 412 LIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----------- 476 (535)
T ss_dssp TCCCH--HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHH-----------
T ss_pred ecCCC--ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-----------
Confidence 65321 1111223456789999999998899999999999999999999 9999975311 111100
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
+...............+.+++.+||+.||++|||+.++++.|+++...
T Consensus 477 --i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 477 --VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 000000011112334577788899999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=348.76 Aligned_cols=267 Identities=24% Similarity=0.245 Sum_probs=202.2
Q ss_pred HHHHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 521 QREILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 521 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
..++.++|...+.||+|+||.||+|.. .+++.||||++....... ......+.+.+|++++++++||||+++++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-----INPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC--------CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-----cCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 357788999999999999999999965 578999999985432110 01233567899999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcC---------------------------------------CCCCChHHHHHHHH
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKG---------------------------------------LVHLDWPTRHKIAF 640 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~ 640 (840)
++.+....++||||+++|+|.+++... ...+++..++.++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 999999999999999999999988521 11235677889999
Q ss_pred HHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC--CCeeecccchhhhhccCCC-CcceecccccccccCcccccc--CC
Q 003199 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY--QPKVADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYS--SK 715 (840)
Q Consensus 641 ~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~ 715 (840)
|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.+...... ........||+.|+|||.+.+ ..
T Consensus 176 qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 99999999999 9999999999999998776 8999999999876442221 223345679999999999865 67
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCC
Q 003199 716 ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPA 795 (840)
Q Consensus 716 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 795 (840)
++.++||||||+++|||++|+.||...... ........... ....+.+......+.+++.+|++.||.
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChh
Confidence 899999999999999999999999753110 00000000000 000111122345677888899999999
Q ss_pred CCCCHHHHHHHh
Q 003199 796 TRPTMNEVVQLL 807 (840)
Q Consensus 796 ~Rps~~evl~~L 807 (840)
+||++.|++++-
T Consensus 321 ~Rps~~~~l~hp 332 (345)
T 3hko_A 321 ERFDAMRALQHP 332 (345)
T ss_dssp TSCCHHHHHHSH
T ss_pred HCCCHHHHhcCh
Confidence 999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.22 Aligned_cols=260 Identities=25% Similarity=0.335 Sum_probs=205.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCccee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKL 597 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 597 (840)
.++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++.++ +||||+++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---------THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---------CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 35788899999999999999963 356899999985432 123346788999999999 69999999
Q ss_pred eeEEecCc-cceEEEeecCCCChHHHhhcCCCC---------------CChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 598 YCYFSSLY-CNLLVYEYMPNGNLWDALHKGLVH---------------LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 598 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
++++.... ..++||||+++|+|.+++...... +++..+..++.|++.||+|||+ ++|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987654 489999999999999999875422 7899999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||+++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEECCCCCEEECCCccccccccC-ccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999876432 12223345568899999999999999999999999999999998 999997
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
...... ..... ... ......... ....+.+++.+||+.||++|||+.|++++|+++.
T Consensus 253 ~~~~~~-~~~~~--~~~--------~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 253 GVKIDE-EFCRR--LKE--------GTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp TCCCSH-HHHHH--HHH--------TCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhH-HHHHH--hcc--------CccCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 532111 11000 000 000111111 2345777888999999999999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=342.01 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=198.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|...+.||+|+||.||+|.. .+|+.||||++..... ........+.+|+.++++++||||+++++++..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-------MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 35788899999999999999965 5799999999854221 113345678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
....++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEec
Confidence 9999999999999999998864 23468999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+++..... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 181 g~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~ 254 (310)
T 2wqm_A 181 GLGRFFSSK---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCD 254 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHHHTTC
T ss_pred cceeeecCC---CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHhhccc
Confidence 999876431 12233457899999999999989999999999999999999999999753211 111111000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFE 816 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 816 (840)
....... .....+.+++.+||+.||++|||+.++++.|+++.+...+
T Consensus 255 ------~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 255 ------YPPLPSD---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ------SCCCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------CCCCccc---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0000011 1234567788899999999999999999999987655443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.11 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=194.9
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|.. .+|+.||||++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------------CCCCCSCTTSCCEEEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-------hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 35788899999999999999965 57999999998543211 12234567789999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. ++|+||||||+|||++.++.+||+|||+|
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999999999999997764 689999999999999999999962 68999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .........
T Consensus 297 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~---~~~~~i~~~---- 364 (446)
T 4ejn_A 297 KEGIK---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E---KLFELILME---- 364 (446)
T ss_dssp CTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHHHC----
T ss_pred eeccC---CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--H---HHHHHHHhC----
Confidence 76432 22234457899999999999999999999999999999999999999975311 1 111100000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQLL 807 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L 807 (840)
....+... ...+.+++.+|++.||++|| +++|+++|-
T Consensus 365 ----~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 365 ----EIRFPRTL---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ----CCCCCTTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCCCCccC---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 01112222 34567788899999999999 999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.78 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=201.0
Q ss_pred cCccCeeeccCCcEEEEEEeC-CC---cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 528 MTEKNKVGQGGSGTVYKIDLN-SG---EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
|...+.||+|+||+||+|... ++ ..||+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 445678999999999999653 23 379999984322 12345678899999999999999999999977
Q ss_pred Cccc-eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 604 LYCN-LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 604 ~~~~-~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
.+.. ++||||+.+|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 6655 89999999999999998866678999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCC-CCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGG-KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++....... .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..... ......... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~---~~-- 244 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLA---QG-- 244 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHH---TT--
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhh---cC--
Confidence 976543211 11233445688999999999999999999999999999999996655433211 111111100 00
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
....... .....+.+++.+|++.||.+|||+.++++.|+++..
T Consensus 245 -----~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 245 -----RRLPQPE---YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp -----CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCc---cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0001111 123457778889999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=343.85 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=207.0
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeee
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYC 599 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 599 (840)
..+.++|...+.||+|+||.||+|... +|+.||||++....... .........+.+.+|+.+++++ .||||+++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL--SPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC--CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 456678999999999999999999765 79999999985543221 1122334467789999999999 7999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
++......++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999999998654 68999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
||++..+.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 244 fG~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~- 314 (365)
T 2y7j_A 244 FGFSCHLEP----GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILML- 314 (365)
T ss_dssp CTTCEECCT----TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH-
T ss_pred cCcccccCC----CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHHHH-
Confidence 999976643 222345679999999998853 358899999999999999999999996531 11000
Q ss_pred hhhhccccchhhhcccccCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIKVDTKEGIMEVLDKKLSGS---FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. +........ +......+.+++.+|++.||++|||+.|++++
T Consensus 315 ~~----------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RM----------IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HH----------HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH----------HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 000000000 01123457788889999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.98 Aligned_cols=258 Identities=25% Similarity=0.323 Sum_probs=201.9
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +|+.||||++......... .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR----RGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS----SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc----cchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 467899999999999999999665 7999999998654422111 11224678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CCeeec
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY----QPKVAD 679 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~D 679 (840)
....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999999997654 68999999999999999999999 9999999999999998877 799999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||++..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.... ..
T Consensus 156 fg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~ 226 (283)
T 3bhy_A 156 FGIAHKIEA----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNIS-AV 226 (283)
T ss_dssp CTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH-TT
T ss_pred cccceeccC----CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----HHHHHHhH-hc
Confidence 999976532 2223445689999999999988999999999999999999999999975311 00010000 00
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ...... .......+.+++.+|++.||++|||+.|++++
T Consensus 227 ~~----~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 NY----DFDEEY---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CC----CCCHHH---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cc----CCcchh---cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00 000000 01123457788889999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=355.35 Aligned_cols=354 Identities=19% Similarity=0.169 Sum_probs=288.4
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEE
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 98 (840)
-+.++.++++++ .+|..+. ++|+.|+|++| .+..+++..|..+++|++|+|++|.+.+..|..|.++++|++|+
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n---~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 86 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKN---RIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLG 86 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSS---CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCC---ccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEE
Confidence 468999999999 7787664 68999999999 77888888999999999999999999999999999999999999
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccc
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 178 (840)
|++|+++...+..|..+++|++|+|++|+ +.+..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|+++
T Consensus 87 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 87 LRSNRLKLIPLGVFTGLSNLTKLDISENK-IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp CCSSCCCSCCTTSSTTCTTCCEEECTTSC-CCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCCCcCCccCcccccCCCCCCEEECCCCc-cccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 99999997666789999999999999998 56667888999999999999999999888999999999999999999999
Q ss_pred cccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccc
Q 003199 179 GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLA 258 (840)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 258 (840)
+..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.++.. ..
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~------------------------~~ 221 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN------------------------CL 221 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT------------------------TT
T ss_pred ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc------------------------cc
Confidence 888888999999999999999999888889999999999999998876544432 22
Q ss_pred cccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEE
Q 003199 259 RCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKI 338 (840)
Q Consensus 259 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 338 (840)
...+|++|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 222 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (477)
T 2id5_A 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL 301 (477)
T ss_dssp TTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEE
T ss_pred cCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEE
Confidence 23467777777777774333566777788888888888877777777778888888888888887777788888888888
Q ss_pred EcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc
Q 003199 339 DLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL 404 (840)
Q Consensus 339 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 404 (840)
+|++|+|++..+..|..+++|+.|+|++|++....+. ..-...+..+++.++...+.-|..+...
T Consensus 302 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~~~~g~ 366 (477)
T 2id5_A 302 NVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATPEFVQGK 366 (477)
T ss_dssp ECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEESGGGTTC
T ss_pred ECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch-HhHHhhhhccccCccCceeCCchHHcCC
Confidence 8888888866666777888888888888888643221 1112233445556666665556554433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=346.83 Aligned_cols=274 Identities=24% Similarity=0.294 Sum_probs=199.5
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
....++|...+.||+|+||.||+|... +|+.||||++....... ......+.+.+|+++++.++||||++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE-----AKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-----------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch-----hhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 445678999999999999999999765 68999999985432111 111123467889999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.+....++||||+++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 81 FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp ECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEec
Confidence 9999999999999975 8999888776678999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh-hhc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI-KVD 758 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~ 758 (840)
|+++..... ........||+.|+|||.+.+. .++.++|||||||++|||++|.+||.+.... ......... ...
T Consensus 157 g~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 157 GLAKSFGSP---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTP 232 (346)
T ss_dssp GGGSTTTSC---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred ccceeccCC---cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence 999876432 2233456789999999998654 5899999999999999999999998753210 000000000 000
Q ss_pred cccchhhh------cc-cccCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 759 TKEGIMEV------LD-KKLSGSF-----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 759 ~~~~~~~~------~~-~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
........ .. ....... ......+.+++.+|++.||++|||+.|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00000000 00 0000000 122356788888999999999999999999854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.57 Aligned_cols=266 Identities=20% Similarity=0.191 Sum_probs=204.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE-ec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF-SS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~ 603 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++.++|++++..+.++ ..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------------hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 5688889999999999999965 6799999999854321 12477899999999988877766655 55
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Df 680 (840)
....++||||+ +++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 67779999999 999999998665679999999999999999999999 999999999999999 48889999999
Q ss_pred cchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 681 GIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 681 g~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+++......... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... +....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~ 231 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERIS 231 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh-hhhhc
Confidence 9998764422111 123456799999999999999999999999999999999999999976432211110 00000
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
..... ......... ....+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 232 ~~~~~----~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 232 EKKMS----TPIEVLCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHH----SCHHHHTTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccC----CchHHHHhh---CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00000 000001111 22457778889999999999999999999987654443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=343.91 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=202.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|...+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.++++++||||+++++
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---------SEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---------chhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 5788899999999999999963 357799999984322 1233457889999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-- 671 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-- 671 (840)
++......++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSS
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCC
Confidence 9999999999999999999999998653 358999999999999999999999 99999999999999984
Q ss_pred -CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003199 672 -NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNI 749 (840)
Q Consensus 672 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~ 749 (840)
+..+||+|||+++...... .........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ....
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~ 254 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEV 254 (327)
T ss_dssp TTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH
T ss_pred CcceEEECcccccccccccc-ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHH
Confidence 4469999999998764321 1223345568899999999988899999999999999999998 999987531 1111
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
.... ... ....... .....+.+++.+||+.||++||++.+++++|+.+....
T Consensus 255 ~~~~---~~~-------~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 255 LEFV---TSG-------GRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHH---HTT-------CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHH---hcC-------CCCCCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1110 000 0011111 22345677888999999999999999999998765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=343.40 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=194.6
Q ss_pred HhcCcc-CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 526 EAMTEK-NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 526 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
+.|... +.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----------HIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----------CCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 356653 6799999999999965 4799999999854321 1245688899999885 7999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---Ceeec
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---PKVAD 679 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~D 679 (840)
+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 9999999999999999999998764 68999999999999999999999 99999999999999998776 89999
Q ss_pred ccchhhhhccCCC----CcceecccccccccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003199 680 FGIAKVLQARGGK----DSTTTVIAGTYGYLAPEYAYS-----SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750 (840)
Q Consensus 680 fg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 750 (840)
||+++.....+.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-- 235 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-- 235 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC--
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc--
Confidence 9999765432111 112234569999999999865 56889999999999999999999999764322110
Q ss_pred hhhhhhhc---cccchhhhcccccCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 751 YWVSIKVD---TKEGIMEVLDKKLSG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 751 ~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
|...... .......+......- ........+.+++.+|++.||++|||+.|++++-
T Consensus 236 -~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 236 -WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp -C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred -ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 1000000 000000011111100 0011235677888999999999999999999863
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.59 Aligned_cols=347 Identities=25% Similarity=0.345 Sum_probs=301.9
Q ss_pred cCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCC
Q 003199 38 FNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKN 117 (840)
Q Consensus 38 ~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~ 117 (840)
..+++|+.|++++| .+..++. +..+++|++|+|++|.+++..+ ++++++|++|+|++|.+++..+ +..+++
T Consensus 43 ~~l~~l~~L~l~~~---~i~~l~~--~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 113 (466)
T 1o6v_A 43 TDLDQVTTLQADRL---GIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113 (466)
T ss_dssp HHHHTCCEEECCSS---CCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTT
T ss_pred hHhccccEEecCCC---CCccCcc--hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCC
Confidence 45788999999999 5566653 8889999999999999986644 9999999999999999995544 999999
Q ss_pred CCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEcc
Q 003199 118 LRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLY 197 (840)
Q Consensus 118 L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 197 (840)
|++|+|++|+ +. .++. +..+++|++|++++|.+++. + .+..+++|+.|+++ |.+.+.. .+.++++|++|+++
T Consensus 114 L~~L~L~~n~-l~-~~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~ 185 (466)
T 1o6v_A 114 LTGLTLFNNQ-IT-DIDP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDIS 185 (466)
T ss_dssp CCEEECCSSC-CC-CCGG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECC
T ss_pred CCEEECCCCC-CC-CChH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECc
Confidence 9999999997 33 3443 89999999999999999953 3 58999999999997 5565443 38999999999999
Q ss_pred CCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccC
Q 003199 198 DNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSI 277 (840)
Q Consensus 198 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (840)
+|+++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+.+. ..+..+++|+.|++++|.+++..
T Consensus 186 ~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~ 259 (466)
T 1o6v_A 186 SNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 259 (466)
T ss_dssp SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccch
Confidence 9999854 458899999999999999997765 77889999999999999864 46889999999999999998654
Q ss_pred CccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCcc
Q 003199 278 PEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLK 357 (840)
Q Consensus 278 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 357 (840)
+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +..++
T Consensus 260 ~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~ 331 (466)
T 1o6v_A 260 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT 331 (466)
T ss_dssp G--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCT
T ss_pred h--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCc
Confidence 4 8899999999999999997655 8899999999999999997655 7899999999999999997766 78999
Q ss_pred ccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCCCCcCc
Q 003199 358 KLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGP 419 (840)
Q Consensus 358 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~ 419 (840)
+|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+ .++.|++++|++++.
T Consensus 332 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 332 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred cCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 999999999999865 478999999999999999998887 5555 568999999999973
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=342.40 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=201.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe--
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS-- 602 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-- 602 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE----------QQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS----------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC----------HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4688899999999999999965 579999999884322 234567889999999999999999999986
Q ss_pred --cCccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 603 --SLYCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 603 --~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.....++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEE
Confidence 34467899999999999998876 23468999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCC------cceecccccccccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 678 ADFGIAKVLQARGGKD------STTTVIAGTYGYLAPEYAYSSK---ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
+|||++.......... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.........
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999886542210000 0112345799999999987554 688999999999999999999998532111111
Q ss_pred hhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCC
Q 003199 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCR 814 (840)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~ 814 (840)
..... ......+........+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 256 ~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 256 VALAV-------------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHHHH-------------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hhHHh-------------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 11000 000000111122346778888999999999999999999999886543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=344.34 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=201.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEE--EEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVV--AVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
++|...+.||+|+||.||+|... +|..+ |||++..... ....+.+.+|+++++++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---------KDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc---------hHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 56788899999999999999654 56654 9998853221 12345688999999999 899999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 666 (840)
.+....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccce
Confidence 99999999999999999999997653 368999999999999999999999 999999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGD 745 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~ 745 (840)
|+++.++.+||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~- 247 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 247 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred EEEcCCCeEEEcccCcCccccc----cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence 9999999999999999874322 122234567889999999988889999999999999999998 9999975311
Q ss_pred CcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
...... . .......... .....+.+++.+|++.||++|||+.|++++|.++...+.
T Consensus 248 ----~~~~~~-~------~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 248 ----AELYEK-L------PQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ----HHHHHH-G------GGTCCCCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ----HHHHHH-h------hcCCCCCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011100 0 0000011111 223457778889999999999999999999987655544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=343.38 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=202.5
Q ss_pred HHHHHHhcCcc-CeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCccee
Q 003199 521 QREILEAMTEK-NKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKL 597 (840)
Q Consensus 521 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l 597 (840)
...+.+.|... +.||+|+||.||+|... +|+.||||++...... ......+.+|+.++..+. ||||+++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG--------QDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT--------EECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc--------hHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 34566777776 88999999999999655 7999999998544321 122457889999999995 6999999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CC
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NY 673 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~ 673 (840)
++++.+....++||||+++|+|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBC
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999999998654 3468999999999999999999999 99999999999999987 78
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
.+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 172 ~~kL~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~ 243 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGH----ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYL 243 (327)
T ss_dssp CEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred cEEEeeCccccccCC----ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHH
Confidence 999999999986632 2223446799999999999999999999999999999999999999975311 00000
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
... ..........+......+.+++.+|++.||++|||++|++++-
T Consensus 244 ~i~--------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 244 NIS--------QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HHH--------HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred HHH--------hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 000 0000011111222345567788899999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.79 Aligned_cols=248 Identities=15% Similarity=0.143 Sum_probs=197.2
Q ss_pred HhcCccCeeeccCCcEEEEE------EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC---CCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKI------DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR---HKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 596 (840)
+.|...+.||+|+||+||+| ...+++.||||++.... ...+..|+++++.++ |+|+++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------------PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------------HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------------hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 46778889999999999999 45578999999984322 235667777777776 999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhc----CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHK----GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV- 671 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~- 671 (840)
+++++...+..++||||+++|+|.+++.. ....++|..+..++.|++.||+|||+ ++||||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEeccc
Confidence 99999999999999999999999999974 23469999999999999999999999 99999999999999998
Q ss_pred ----------CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003199 672 ----------NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741 (840)
Q Consensus 672 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 741 (840)
++.+||+|||+|+.+... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLF-PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGS-CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhcc-CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765432 223344567799999999999999999999999999999999999999854
Q ss_pred CCCCCcchhhhhhhhhccccchhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhhhcC
Q 003199 742 DFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATR-PTMNEVVQLLAEAD 811 (840)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~R-ps~~evl~~L~~~~ 811 (840)
...... . ....... ...+ .+.+++..|+..+|.+| |+++++.+.|+++-
T Consensus 288 ~~~~~~--------------~----~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 288 NEGGEC--------------K----PEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EETTEE--------------E----ECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCce--------------e----echhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 211100 0 0111111 1223 34456668999999999 57888888887653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=361.55 Aligned_cols=257 Identities=26% Similarity=0.336 Sum_probs=203.5
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..+.++|...+.||+|+||+||+|... +|+.||||++...... ......+.+|++++++++||||++++++
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--------NKDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--------CSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--------chHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 356788999999999999999999654 7999999998543211 1124678899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCCee
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD---VNYQPKV 677 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl 677 (840)
+.+....++||||+++|+|.+.+.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++ .++.+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEE
Confidence 999999999999999999999887654 68999999999999999999999 9999999999999995 4567999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+++.... ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+... ... .....
T Consensus 166 ~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i~ 235 (486)
T 3mwu_A 166 IDFGLSTCFQQ----NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDI---LKRVE 235 (486)
T ss_dssp CSCSCTTTBCC----C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHH
T ss_pred EECCcCeECCC----CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHH
Confidence 99999986632 223345679999999998875 589999999999999999999999975311 111 00000
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... . ...+.+......+.+++.+|++.||++|||+.|++++-
T Consensus 236 ~~~~------~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 236 TGKY------A-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp HTCC------C-SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred hCCC------C-CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 0000 0 00111222345677888899999999999999999973
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.50 Aligned_cols=267 Identities=27% Similarity=0.352 Sum_probs=205.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
+.|+..+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|++++++++||||++++++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----------EEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC----------SHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC----------HHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 4577889999999999999973 468999999985422 2335678999999999999999999999
Q ss_pred EecCc--cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 601 FSSLY--CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 601 ~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+.... ..++||||+++++|.+++......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEe
Confidence 86644 6799999999999999998876679999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++................++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+......
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~~~~~ 261 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGN 261 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHHHHCT
T ss_pred cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHHhhcc
Confidence 999998764322111222344577889999999888899999999999999999999998763210 00000000
Q ss_pred cc------cchhhhccc-ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 759 TK------EGIMEVLDK-KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 759 ~~------~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.. ......+.. ...+........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 000011111 111111223456777888999999999999999999998753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=351.70 Aligned_cols=351 Identities=22% Similarity=0.224 Sum_probs=263.2
Q ss_pred CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCC
Q 003199 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNV 91 (840)
Q Consensus 12 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 91 (840)
.++.+++|++|+|++|.|++ +| .+..+++|++|+|++| .+..++ +..+++|++|++++|.+++. + ++++
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n---~l~~~~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l 105 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSN---NITTLD---LSQNTNLTYLACDSNKLTNL-D--VTPL 105 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSS---CCSCCC---CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred ChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCC---cCCeEc---cccCCCCCEEECcCCCCcee-e--cCCC
Confidence 46778999999999999995 46 6899999999999999 555554 88899999999999999864 3 8899
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|++|+|++|++++ +| +..+++|++|++++|+ +.+ ++ ++.+++|++|++++|+..+.+ .+..+++|+.|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~-l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNT-LTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp TTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSC-CSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCc-cce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 999999999999995 44 8899999999999998 333 43 788999999999999554444 478899999999
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~ 251 (840)
+++|+++++. +..+++|+.|++++|++++. .+..+++|+.|+|++|++++ +| +..+++|++|++++|.+.+
T Consensus 177 ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 177 CSFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CCSSCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCCccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 9999998753 78889999999999999865 48889999999999999987 44 7788889999999999887
Q ss_pred cCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccch----
Q 003199 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS---- 327 (840)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~---- 327 (840)
..+. .+++|+.|++++|+ |+.|++++|.+.+..| ++.+++|+.|+|++|...+.+|.
T Consensus 248 ~~~~---~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~ 308 (457)
T 3bz5_A 248 LDVS---TLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAG 308 (457)
T ss_dssp CCCT---TCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCC
T ss_pred cCHH---HCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCc
Confidence 6544 44555555554443 2334444444433333 23444555555555543333332
Q ss_pred ----hhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhc
Q 003199 328 ----EIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCE 403 (840)
Q Consensus 328 ----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 403 (840)
.+..+++|+.|++++|++++. + ++.+++|+.|++++|+|++ ++.|..|++++|.++|. + .+
T Consensus 309 L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~-~~-- 373 (457)
T 3bz5_A 309 ITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G-QT-- 373 (457)
T ss_dssp CSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E-EE--
T ss_pred ceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-c-ee--
Confidence 123346788888888888874 3 7888888888888888875 24566677888888876 2 11
Q ss_pred cCCCeEEccCCCCcCcCCcccc
Q 003199 404 LLPNSINFSNNRLSGPIPLSLI 425 (840)
Q Consensus 404 ~~~~~l~l~~N~l~~~~p~~~~ 425 (840)
..+..+++++|+++|.+|..+.
T Consensus 374 ~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 374 ITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp EECCCBCCBTTBEEEECCTTCB
T ss_pred eecCccccccCcEEEEcChhHh
Confidence 1346678899999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.83 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=202.5
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..+.++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----------FRDSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----------cchHHHHHHHHHHHhCCCCCeeehhhh
Confidence 345678999999999999999999664 799999999854321 123567899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCCee
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKV 677 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl 677 (840)
+.+....++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEE
Confidence 999999999999999999999987654 68999999999999999999999 999999999999999 77889999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+++.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... .... .
T Consensus 151 ~Dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~--~~~i-~ 220 (304)
T 2jam_A 151 TDFGLSKMEQN-----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKL--FEKI-K 220 (304)
T ss_dssp CSCSTTCCCCC-----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH--HHHH-H
T ss_pred ccCCcceecCC-----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH--HHHH-H
Confidence 99999865321 223345689999999999998999999999999999999999999975311 100 0000 0
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... . .. ..........+.+++.+|++.||++|||+.|++++-
T Consensus 221 ~~~~---~-~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 221 EGYY---E-FE---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HCCC---C-CC---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cCCC---C-CC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0000 0 00 111122335677788899999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=358.51 Aligned_cols=197 Identities=24% Similarity=0.340 Sum_probs=154.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS- 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 603 (840)
++|...+.||+|+||+||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT--------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 5788999999999999999954 479999999984322 123345778999999999999999999999843
Q ss_pred ----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 604 ----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 604 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
....++||||+ +|+|.+++.... .+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|
T Consensus 125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 125 DVEKFDELYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CTTTCCCEEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECC
T ss_pred CcccCceEEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecc
Confidence 35679999998 579999987754 69999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCC------------------------CcceecccccccccCcccc-ccCCCCccccchhHHHHHHHHHh
Q 003199 680 FGIAKVLQARGGK------------------------DSTTTVIAGTYGYLAPEYA-YSSKATTKCDVYSFGVVLMELIT 734 (840)
Q Consensus 680 fg~a~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t 734 (840)
||+|+........ ........||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999876432111 0123456789999999976 55679999999999999999999
Q ss_pred C
Q 003199 735 G 735 (840)
Q Consensus 735 g 735 (840)
|
T Consensus 280 g 280 (458)
T 3rp9_A 280 M 280 (458)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=336.28 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=194.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
++|+..+.||+|+||.||+|... |+.||||++.... ..+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh------------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 57888899999999999999876 8999999984322 235688999999999999999999987554
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccc
Confidence 57899999999999999997653 237899999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... .
T Consensus 165 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~----~----- 227 (278)
T 1byg_A 165 KEASS------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR----V----- 227 (278)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHH----H-----
T ss_pred ccccc------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----H-----
Confidence 76532 1223457889999999998899999999999999999998 9999975311 111100 0
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
.......... .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 228 -~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 228 -EKGYKMDAPD---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -TTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hcCCCCCCcc---cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 0000111112 223456778889999999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.93 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=204.1
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
.....+|+..+.||+|+||.||+|... +|+.||||++.... +.+.+|++++++++||||++++++
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~e~~~l~~l~h~~i~~~~~~ 72 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------------EKAEREVKALAKLDHVNIVHYNGC 72 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------------GGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------------HHHHHHHHHHHhCCCCCEEEEeee
Confidence 345678999999999999999999765 79999999985432 235679999999999999999998
Q ss_pred Eec----------------CccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 003199 601 FSS----------------LYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIK 663 (840)
Q Consensus 601 ~~~----------------~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 663 (840)
+.. ....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+|||||
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlk 149 (284)
T 2a19_B 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLK 149 (284)
T ss_dssp EEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred EeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCC
Confidence 854 44578999999999999999754 2468999999999999999999999 999999999
Q ss_pred CCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 003199 664 STNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF 743 (840)
Q Consensus 664 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 743 (840)
|+||+++.++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 150 p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~- 224 (284)
T 2a19_B 150 PSNIFLVDTKQVKIGDFGLVTSLKND----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET- 224 (284)
T ss_dssp GGGEEEEETTEEEECCCTTCEESSCC----SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-
T ss_pred HHHEEEcCCCCEEECcchhheecccc----ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-
Confidence 99999999999999999999776431 2233456899999999999989999999999999999999999886421
Q ss_pred CCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
..+. .......+...+. ..+.+++.+|++.||++|||+.|++++|+.+.....
T Consensus 225 ------~~~~----------~~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 225 ------SKFF----------TDLRDGIISDIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ------HHHH----------HHHHTTCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ------HHHH----------HHhhcccccccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0000 1111111222222 345678889999999999999999999998765443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=345.10 Aligned_cols=267 Identities=19% Similarity=0.266 Sum_probs=193.2
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
...++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|++++++++||||+++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--------EGVPGTAIREVSLLKELQHRNIIELKSVI 102 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc--------cccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence 3456899999999999999999954 57999999998543211 22345677899999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-----CCCCCe
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-----VNYQPK 676 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-----~~~~~k 676 (840)
.+....++||||++ |+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++ .++.+|
T Consensus 103 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 103 HHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EETTEEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred ecCCEEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEE
Confidence 99999999999997 59999998765 68999999999999999999999 9999999999999994 445599
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
|+|||+++.... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 178 l~Dfg~a~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~ 253 (329)
T 3gbz_A 178 IGDFGLARAFGI---PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEV 253 (329)
T ss_dssp ECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred ECcCCCccccCC---cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHH
Confidence 999999987643 12233455789999999998774 4899999999999999999999999753211 000000000
Q ss_pred h-hccccch---------hhhcccccCCCcHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 K-VDTKEGI---------MEVLDKKLSGSFRD-----EMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ~-~~~~~~~---------~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ....... .............. ....+.+++.+|++.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 0000000 00000000011111 23567788999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.30 Aligned_cols=270 Identities=24% Similarity=0.322 Sum_probs=194.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHH--HHHHHHhccCCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK--TEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
++|...+.||+|+||.||+|.. +++.||||++.... ...+. .|+..+..++||||+++++++..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-------------RQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-------------hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 4678889999999999999976 58999999984321 12233 34444556899999999985532
Q ss_pred -----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCC---------CeEecCCCCCCEEE
Q 003199 604 -----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS---------PIIHRDIKSTNILL 669 (840)
Q Consensus 604 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dlk~~Nill 669 (840)
....++||||+++|+|.+++... ..++..+..++.|++.||+|||+ . +|+||||||+|||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEE
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEE
Confidence 33568999999999999999876 45899999999999999999999 7 99999999999999
Q ss_pred cCCCCCeeecccchhhhhccCC-----CCcceecccccccccCcccccc-------CCCCccccchhHHHHHHHHHhCCC
Q 003199 670 DVNYQPKVADFGIAKVLQARGG-----KDSTTTVIAGTYGYLAPEYAYS-------SKATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 670 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~ 737 (840)
+.++.+||+|||+++.+..... .........||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999987643211 1122334579999999999876 456779999999999999999977
Q ss_pred CCCCCCCCCcchhhhhhhhhc--cccchh-----hhcccccCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 738 PVEDDFGDNKNIIYWVSIKVD--TKEGIM-----EVLDKKLSGS---FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
||............+...... ...... ......++.. .......+.+++.+||+.||++|||++|+++.|
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 764322211111111000000 000000 0001111111 123566788999999999999999999999999
Q ss_pred hhcCCCC
Q 003199 808 AEADPCR 814 (840)
Q Consensus 808 ~~~~~~~ 814 (840)
+++-...
T Consensus 314 ~~ll~~~ 320 (336)
T 3g2f_A 314 AELMMIW 320 (336)
T ss_dssp HHHHHCC
T ss_pred HHHHHHH
Confidence 8755433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.00 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=194.8
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec---
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS--- 603 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 603 (840)
|...+.||+|+||.||+|.. .++..||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC--------HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 56677899999999999965 47889999998543211 2335778999999999999999999998865
Q ss_pred -CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCCCeeec
Q 003199 604 -LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLD-VNYQPKVAD 679 (840)
Q Consensus 604 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~D 679 (840)
....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+||+++ .++.+||+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred CCceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEee
Confidence 456799999999999999998754 68999999999999999999999 77 99999999999998 789999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||++..... .......||+.|+|||.+. +.++.++||||+|+++|||++|+.||..... ...........
T Consensus 176 fg~~~~~~~-----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~ 245 (290)
T 1t4h_A 176 LGLATLKRA-----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSG 245 (290)
T ss_dssp TTGGGGCCT-----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTT
T ss_pred CCCcccccc-----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHHhcc
Confidence 999975422 2334557999999999876 4689999999999999999999999975311 11111100000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ........ ....+.+++.+||+.||++|||+.|++++
T Consensus 246 ~------~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 V------KPASFDKV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp C------CCGGGGGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C------CccccCCC---CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 00011111 12457788889999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=341.07 Aligned_cols=265 Identities=26% Similarity=0.382 Sum_probs=196.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--CCc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--SGE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||.||+|.+. +++ .||||++..... ......+.+.+|++++++++||||+++++++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-------SQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-------CCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 46888899999999999999653 333 689998853321 1123457789999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.... .++||||+++++|.+++......+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccc
Confidence 8765 789999999999999998765568999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~---~~~~~~~~~ 241 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQ---ILHKIDKEG 241 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH---HHHHHHTSC
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HH---HHHHHHccC
Confidence 99876443222223344567889999999988889999999999999999999 9999975311 11 110000000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
............+.+++.+|++.||++|||+.+++++|+++.+...
T Consensus 242 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 242 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ---------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 0001111233567788889999999999999999999998876554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.25 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=202.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||+||+|..+ +|+.||||++...... .......+.+|++++++++||||+++++++.+.
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-------KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-------hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 45777889999999999999765 7999999998543211 122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
...++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecc
Confidence 9999999999999999998764 2368999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 335 la~~~~~~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~-- 408 (543)
T 3c4z_A 335 LAVELKAG---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQ-- 408 (543)
T ss_dssp TCEECCTT---CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHC--
T ss_pred eeeeccCC---CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhc--
Confidence 99875431 1223345899999999999999999999999999999999999999976422111 11111111100
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM-----NEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 806 (840)
....+..+ ...+.+++.+|++.||++||++ .+++++
T Consensus 409 ------~~~~p~~~---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 ------AVTYPDKF---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ------CCCCCTTS---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ------ccCCCccc---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 01112222 3456677889999999999964 777765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.90 Aligned_cols=197 Identities=27% Similarity=0.339 Sum_probs=172.5
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-----CCCcceee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-----HKNIVKLY 598 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~ 598 (840)
.++|...+.||+|+||+||+|.. .+++.||||++... ......+..|+++++.+. ||||++++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----------KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----------hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 46788999999999999999966 57899999998421 233456778999999886 99999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC------
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV------ 671 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~------ 671 (840)
+++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 999999998753 358999999999999999999999 99999999999999975
Q ss_pred -------------------CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHH
Q 003199 672 -------------------NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMEL 732 (840)
Q Consensus 672 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el 732 (840)
++.+||+|||+|+.... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78899999999976432 22345789999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 003199 733 ITGRKPVEDD 742 (840)
Q Consensus 733 ~tg~~p~~~~ 742 (840)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.85 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=202.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|... +++.||||++..... ......+.+.+|++++++++||||+++++++.+.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-------EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-------chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 56888899999999999999665 688999999843221 1122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 99999999999999999998764 68999999999999999999999 999999999999999999999999999986
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . ........
T Consensus 163 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~-~~~~~~~~------ 226 (284)
T 2vgo_A 163 HAPS-----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----T-ETHRRIVN------ 226 (284)
T ss_dssp ECSS-----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H-HHHHHHHT------
T ss_pred cCcc-----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----h-HHHHHHhc------
Confidence 5422 223345789999999999998999999999999999999999999975311 0 00000000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.+...+..+ ...+.+++.+|++.||.+||++.+++++-
T Consensus 227 --~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 227 --VDLKFPPFL---SDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp --TCCCCCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred --cccCCCCcC---CHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 011122222 24566788899999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=360.97 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=198.7
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.+.+.|...+.||+|+||+||+|... ++..||||++...... ......+.+|+.+++.++||||+++++++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 105 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--------TSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------------CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--------chHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46678999999999999999999664 7899999998644321 11235688999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCCeee
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NYQPKVA 678 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~ 678 (840)
.+....++||||+++|+|.+.+.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEE
Confidence 99999999999999999999887654 68999999999999999999999 99999999999999976 4459999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++.... ........||+.|+|||++. ..++.++||||+||++|+|++|+.||.+... ... ......
T Consensus 182 DfG~a~~~~~----~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i~~ 251 (494)
T 3lij_A 182 DFGLSAVFEN----QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEI---LRKVEK 251 (494)
T ss_dssp CCTTCEECBT----TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHH
T ss_pred ECCCCeECCC----CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHh
Confidence 9999977632 22334567999999999876 5699999999999999999999999975311 111 100000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ....+.+......+.+++.+|++.||.+|||+.|++++
T Consensus 252 ~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 252 GKY-------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TCC-------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC-------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 00011112234557778889999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.06 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=193.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+.+|+.+++.++||||+++++++...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-------RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-------cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 46788899999999999999765 799999999843221 1123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred CeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccc
Confidence 99999999999999999997764 68999999999999999999999 899999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ............
T Consensus 160 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~--- 227 (276)
T 2h6d_A 160 MMSD----GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFKKIRGGV--- 227 (276)
T ss_dssp CCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC---
T ss_pred ccCC----CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhhcCc---
Confidence 6532 122334578999999999987765 689999999999999999999997531 111110000000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...+.. ....+.+++.+|++.||++|||+.|++++
T Consensus 228 -----~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -----FYIPEY---LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----ccCchh---cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011112 22456678889999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=360.16 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=205.5
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.++|...+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-------KTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-------SSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-------chHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4578999999999999999999665 79999999985443211 122467889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCCeeec
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKVAD 679 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~D 679 (840)
+....++||||+.+|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 9999999999999999999997764 68999999999999999999999 999999999999999 4678999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||+++.+.. ........||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.. .......+ ...
T Consensus 173 fg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i---~~~ 242 (484)
T 3nyv_A 173 FGLSTHFEA----SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKV---EKG 242 (484)
T ss_dssp TTHHHHBCC----CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---HHC
T ss_pred eeeeEEccc----ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH---HcC
Confidence 999987643 223345679999999998866 68999999999999999999999997531 11111100 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. . ...+.+......+.+++.+|++.||.+|||+.|++++-.
T Consensus 243 ~~------~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 243 KY------T-FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp CC------C-CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CC------C-CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 00 0 001112233456778888999999999999999998743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.07 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=203.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|...+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---------TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---------HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4588889999999999999965 57899999998543311 2246788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccce
Confidence 9999999999999999999764 68999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... .... .
T Consensus 168 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~---~~~~-------~ 232 (303)
T 3a7i_A 168 QLTDT---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKV---LFLI-------P 232 (303)
T ss_dssp ECBTT---BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHHH-------H
T ss_pred ecCcc---ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHH---HHHh-------h
Confidence 65431 2223456789999999999999999999999999999999999999975311 000 0000 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
..........+ ...+.+++.+||+.||++|||+.|++++..
T Consensus 233 ~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 233 KNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HSCCCCCCSSC---CHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCCCCCCcccc---CHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 00111122222 245667888999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.51 Aligned_cols=249 Identities=19% Similarity=0.299 Sum_probs=197.9
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY 600 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 600 (840)
...++|+..+.||+|+||.||+|... +++.||||++...... ......+.+|+..+..+ +||||++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--------SVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT--------SHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc--------cHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34578999999999999999999665 7999999998543211 12346678899999999 89999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCC---CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN----- 672 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----- 672 (840)
+.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcc
Confidence 999999999999999999999997641 468999999999999999999999 999999999999999844
Q ss_pred --------------CCCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCC
Q 003199 673 --------------YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 673 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~ 737 (840)
..+||+|||.+...... ....||+.|+|||.+.+. .++.++||||||+++|||++|.+
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 47899999999765431 223589999999998766 56789999999999999999988
Q ss_pred CCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 738 PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
|+... . .+..... ...+.++..+ ...+.+++.+|++.||++|||+.|++++-
T Consensus 230 ~~~~~----~---~~~~~~~--------~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 230 LPRNG----D---QWHEIRQ--------GRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp CCSSS----H---HHHHHHT--------TCCCCCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred CCcch----h---HHHHHHc--------CCCCCCCccc---CHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 76432 1 1111100 0011122222 34566788899999999999999999764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.70 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=194.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--------SELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc--------CHHHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence 35688889999999999999965 5799999999844321 13345678899999999999999999999976
Q ss_pred Cc------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 LY------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.. ..++||||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEE
Confidence 53 459999999 88999999874 68999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
+|||+++.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+.......
T Consensus 170 ~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~ 242 (367)
T 1cm8_A 170 LDFGLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVT 242 (367)
T ss_dssp CCCTTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred Eeeeccccccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence 99999976432 2334578999999999877 67999999999999999999999999753210 0000000000
Q ss_pred hccccch---------h---h----hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 VDTKEGI---------M---E----VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 ~~~~~~~---------~---~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... . . .....+...+......+.+++.+|++.||++|||+.|++++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000 0 0 00001111112234567788889999999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.41 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=204.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-------KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-------CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 56788899999999999999665 6889999998543211 123456788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 99999999999999999887654 68999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.... ..
T Consensus 164 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~----- 230 (294)
T 2rku_A 164 KVEYD---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIK-KN----- 230 (294)
T ss_dssp ECCST---TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH-TT-----
T ss_pred ecccC---ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh-hc-----
Confidence 65321 2223446789999999999988899999999999999999999999975311 00111100 00
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
....+... ...+.+++.+|++.||++|||+.|++++-
T Consensus 231 ---~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 ---EYSIPKHI---NPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---cCCCcccc---CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00111222 24566788899999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=345.21 Aligned_cols=266 Identities=26% Similarity=0.341 Sum_probs=198.9
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--------DKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS--------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC--------chHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 357888999999999999999665 689999999854321 13345668899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++++|.++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence 999999999999999888766543 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc----
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD---- 758 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 758 (840)
+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 172 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 172 RTLAAP---GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPR 247 (331)
T ss_dssp ---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred eeecCC---ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChh
Confidence 776432 2223445789999999998775 68999999999999999999999997532110 00000000000
Q ss_pred ------cccchhhhcccccC-CC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 ------TKEGIMEVLDKKLS-GS-----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ------~~~~~~~~~~~~~~-~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..........+... .. +......+.+++.+|++.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000000 00 11234567889999999999999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.60 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=185.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+.++...++.++||||+++++++.+.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--------SQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--------cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 5688899999999999999965 5799999999854321 122334455666668888999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 YCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
...++||||++ |+|.+++.. ....+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeec
Confidence 99999999997 588777654 34579999999999999999999999 7 9999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYA----YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+++.... ........||+.|+|||.+ .+..++.++||||+|+++|||++|+.||..... .........
T Consensus 155 g~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~ 227 (290)
T 3fme_A 155 GISGYLVD----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---PFQQLKQVV 227 (290)
T ss_dssp -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---HHHHHHHHH
T ss_pred CCcccccc----cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---hHHHHHHHh
Confidence 99987643 2223345799999999996 556789999999999999999999999974211 111111100
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ..... .......+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~--------~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 228 EEP--------SPQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HSC--------CCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccC--------CCCcc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 000 00000 11223456778889999999999999999885
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=349.03 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=201.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 600 (840)
++|...+.||+|+||.||+|.. .+|+.||||++........ ....+.+.+|+++++.+ .||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK------AKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE------ESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh------hhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 5788899999999999999976 4789999999864331110 01123456789999999 69999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeC
Confidence 999999999999999999999998754 68999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|+++.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 204 G~a~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 280 (355)
T 1vzo_A 204 GLSKEFVAD--ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILK 280 (355)
T ss_dssp SEEEECCGG--GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHH
T ss_pred CCCeecccC--CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhc
Confidence 999765321 1222345679999999999875 3478999999999999999999999975322211 1111111000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQLLAE 809 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~L~~ 809 (840)
........ ....+.+++.+||+.||++|| ++.|++++..-
T Consensus 281 --------~~~~~~~~---~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 281 --------SEPPYPQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp --------CCCCCCTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred --------cCCCCCcc---cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 01111222 234566788899999999999 99999988653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=358.67 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=201.4
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccc---cCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVS---ASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.+.+.|...+.||+|+||+||+|... +++.||||++........ ..........+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35578999999999999999999654 689999999865432110 00011123457789999999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---CC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY---QP 675 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~ 675 (840)
+++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999999987654 69999999999999999999999 9999999999999998776 68
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++.... ........||+.|+|||++. +.++.++||||+||++|+|++|+.||.+... .. ...
T Consensus 189 kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~---~~~- 257 (504)
T 3q5i_A 189 KIVDFGLSSFFSK----DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QD---IIK- 257 (504)
T ss_dssp EECCCTTCEECCT----TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHH-
T ss_pred EEEECCCCEEcCC----CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HH---HHH-
Confidence 9999999987633 22334567999999999876 4689999999999999999999999975311 11 110
Q ss_pred hhccccchhhhcccccCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 756 KVDTKEGIMEVLDKKLSGS---FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.+........ +......+.+++.+|++.||.+|||+.|++++-
T Consensus 258 ---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 258 ---------KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp ---------HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 0001111000 112235677888899999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.02 Aligned_cols=243 Identities=17% Similarity=0.153 Sum_probs=186.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHH---HHHhccCCCCcceee---
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV---ETLGNIRHKNIVKLY--- 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~--- 598 (840)
+.|...+.||+|+||.||+|.. .+|+.||||++...... .....+.+.+|+ +.+++++||||++++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-------PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-------CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-------chHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 4677788999999999999975 57999999998643211 122356788999 555666899999998
Q ss_pred ----eEEecCc-----------------cceEEEeecCCCChHHHhhcCCC------CCChHHHHHHHHHHHHHHHHHhh
Q 003199 599 ----CYFSSLY-----------------CNLLVYEYMPNGNLWDALHKGLV------HLDWPTRHKIAFGVAQGLAYLHH 651 (840)
Q Consensus 599 ----~~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~ 651 (840)
+++.+.. ..++||||+ +|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 5555443 268999999 6899999986421 23358888999999999999999
Q ss_pred cCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccC-----------CCCccc
Q 003199 652 GLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-----------KATTKC 720 (840)
Q Consensus 652 ~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~ 720 (840)
++|+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++
T Consensus 225 ---~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 225 ---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp ---TTEECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred ---CCeecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 999999999999999999999999999997532 13345567 999999999887 899999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 003199 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800 (840)
Q Consensus 721 Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 800 (840)
|||||||++|||++|+.||........ ...... .. .. ....+.+++.+||+.||++|||+
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~~---------------~~~~~~-~~-~~---~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALGG---------------SEWIFR-SC-KN---IPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------CC---------------SGGGGS-SC-CC---CCHHHHHHHHHHTCSSGGGCCCH
T ss_pred hHHHHHHHHHHHHHCCCCCcccccccc---------------hhhhhh-hc-cC---CCHHHHHHHHHHcCCCchhCCCH
Confidence 999999999999999999975321110 000000 00 11 23456778889999999999999
Q ss_pred HHHHHH
Q 003199 801 NEVVQL 806 (840)
Q Consensus 801 ~evl~~ 806 (840)
.|++++
T Consensus 355 ~e~l~h 360 (377)
T 3byv_A 355 LQAMET 360 (377)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.75 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=192.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 95 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS--------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC--------ChHHHHHHHHHHHHHHhcCCCCccceEEeecc
Confidence 35788899999999999999954 5789999999854321 12345678899999999999999999999976
Q ss_pred Cc------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 LY------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.. ..++||||++ |+|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp CCSTTTCCEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccccccceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEE
Confidence 54 6799999996 578888864 58999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+.....
T Consensus 169 ~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~ 240 (371)
T 2xrw_A 169 LDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIE 240 (371)
T ss_dssp CCCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC
T ss_pred EEeeccccccc----ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Confidence 99999986532 2223456799999999999998999999999999999999999999975321 111111100
Q ss_pred cccc--------------------------chhhhccccc-CCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKE--------------------------GIMEVLDKKL-SGS---FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~--------------------------~~~~~~~~~~-~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... .......... +.. .......+.+++.+|++.||++|||++|++++=
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000 0000000000 001 122356788999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.63 Aligned_cols=265 Identities=14% Similarity=0.138 Sum_probs=202.2
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC---------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS---------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 596 (840)
++|+..+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------------~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------------GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------------STHHHHHHHHHHHCCHHHHH
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------------chHHHHHHHHHHhcccchhh
Confidence 468888999999999999997653 789999998432 24678999999999999988
Q ss_pred ---------------eeeEEec-CccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 003199 597 ---------------LYCYFSS-LYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIH 659 (840)
Q Consensus 597 ---------------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 659 (840)
+++++.. ....++||||+ +++|.+++... ...+++.++..++.|++.||+|||+ ++|+|
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH 182 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVH 182 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBC
T ss_pred hhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccC
Confidence 5667665 67789999999 99999999875 3479999999999999999999999 99999
Q ss_pred cCCCCCCEEEcCCC--CCeeecccchhhhhccCCC----CcceecccccccccCccccccCCCCccccchhHHHHHHHHH
Q 003199 660 RDIKSTNILLDVNY--QPKVADFGIAKVLQARGGK----DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELI 733 (840)
Q Consensus 660 ~Dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 733 (840)
|||||+||+++.++ .+||+|||+++.+...... ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999998 8999999999876442211 11224457999999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 734 TGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 734 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
+|+.||.................... .....+... ........+.+++.+||+.||++|||+.++++.|+++...
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKFVDK---PGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHS---CCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hCCCCcccCCcCHHHHHHHHHhccCC---hhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 99999976432221111111100000 001111000 0011235677788899999999999999999999876544
Q ss_pred C
Q 003199 814 R 814 (840)
Q Consensus 814 ~ 814 (840)
.
T Consensus 338 ~ 338 (352)
T 2jii_A 338 L 338 (352)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=336.55 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=197.6
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
..+.++|...+.||+|+||.||+|.. .+++.||||++........ ..........+.+|++++++++||||++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG--SAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-----------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc--ccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 45667899999999999999999965 4689999999854432110 01112234568899999999999999999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---Cee
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ---PKV 677 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl 677 (840)
+.... .++||||+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||
T Consensus 84 ~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 84 FDAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp EESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred EcCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 87655 799999999999999987654 78999999999999999999999 99999999999999987654 999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+|||+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .......
T Consensus 159 ~Dfg~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~ 233 (322)
T 2ycf_A 159 TDFGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT 233 (322)
T ss_dssp CCCTTCEECCC----CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHH
T ss_pred ccCccceeccc----ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHH
Confidence 99999976522 22234467899999999873 4678999999999999999999999997532211 1111100
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... .............+.+++.+|++.||++||++.+++++
T Consensus 234 ---~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 ---SGKY-------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ---HTCC-------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---hCcc-------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 00000001123567788889999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.14 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=201.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|+..+.||+|+||.||+|.. .+|+.||||++....... .....+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--------GFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--------cchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 5788999999999999999966 579999999985443221 1134567899999999999999999998763
Q ss_pred --------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCe
Q 003199 605 --------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 605 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
...++||||++ |++.+.+......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~k 164 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLK 164 (351)
T ss_dssp --------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEE
T ss_pred ccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEE
Confidence 45789999997 58888887766679999999999999999999999 9999999999999999999999
Q ss_pred eecccchhhhhccCC-CCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 677 VADFGIAKVLQARGG-KDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
|+|||+++.+..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~ 242 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALIS 242 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH
Confidence 999999987643211 1223345678999999998876 4579999999999999999999999975321 11100000
Q ss_pred -hhhcc-ccchhhh--------c--ccccCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 755 -IKVDT-KEGIMEV--------L--DKKLSGSFRDE------MIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 755 -~~~~~-~~~~~~~--------~--~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..... ....... . .........+. ...+.+++.+|++.||++|||++|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 00000 0000000 0 00001111111 24577899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.32 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=204.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-------KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 56888899999999999999665 6889999998543211 123456788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 99999999999999999987654 68999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+......
T Consensus 190 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~------ 256 (335)
T 2owb_A 190 KVEYD---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKN------ 256 (335)
T ss_dssp ECCST---TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHT------
T ss_pred ecccC---cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHhcC------
Confidence 65321 2223456799999999999988999999999999999999999999975311 1111111000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...+...+ ...+.+++.+||+.||++|||+.|++++-
T Consensus 257 ---~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 257 ---EYSIPKHI---NPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---CCCCCccC---CHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 01112222 23566788899999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.87 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=202.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---------CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 46888899999999999999665 78999999985432 123456789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++++|.+++.... .+++..+..++.+++.||+|||+ . +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 99999999999999999998764 68999999999999999999998 6 8999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh-------
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK------- 756 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~------- 756 (840)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus 180 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 180 GQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAE 252 (360)
T ss_dssp HHHHHH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC---------
T ss_pred cccccc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCC
Confidence 776432 2234578999999999999999999999999999999999999997532100 00000000
Q ss_pred ------------------hccccchhh----hcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 757 ------------------VDTKEGIME----VLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 757 ------------------~~~~~~~~~----~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
........+ .......... ......+.+++.+|++.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 000000000 0000000000 11234577888899999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.67 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=198.5
Q ss_pred HHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 523 EILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 523 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
...+.|+..+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------------DLQEIIKEISIMQQCDSPHVVKYYGSY 93 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------------CCHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------------HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 34567889999999999999999665 69999999985432 124578899999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 170 (314)
T 3com_A 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFG 170 (314)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecc
Confidence 99999999999999999999997555579999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
++..... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 171 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-- 241 (314)
T 3com_A 171 VAGQLTD---TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAIFMIPTNP-- 241 (314)
T ss_dssp TCEECBT---TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSC--
T ss_pred cchhhhh---hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCC--
Confidence 9976533 12223445789999999999998999999999999999999999999975311 10000000000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.... .........+.+++.+|++.||.+|||+.+++++-
T Consensus 242 ------~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 242 ------PPTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp ------CCCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ------Cccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 0000 00111234577788899999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.26 Aligned_cols=255 Identities=11% Similarity=0.009 Sum_probs=181.5
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc--CCCCcceee-----
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI--RHKNIVKLY----- 598 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~----- 598 (840)
.|...+.||+|+||.||+|... +|+.||||++..... ......+.+.+|+.+++.+ +||||++++
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-------NSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-------THHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-------ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 4777889999999999999754 799999999965431 1233456677885544444 699988755
Q ss_pred --eEEecC-----------------ccceEEEeecCCCChHHHhhcCCCCCChHHH------HHHHHHHHHHHHHHhhcC
Q 003199 599 --CYFSSL-----------------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTR------HKIAFGVAQGLAYLHHGL 653 (840)
Q Consensus 599 --~~~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~ 653 (840)
+++... ...++||||++ |+|.+++......+.+..+ ..++.||+.||+|||+
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-- 212 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-- 212 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH--
Confidence 333322 33799999998 8999999875445667777 7888999999999999
Q ss_pred CCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCcccccc--CCCCccccchhHHHHHHH
Q 003199 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLME 731 (840)
Q Consensus 654 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~e 731 (840)
++|+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 213 -~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 213 -KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp -TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred -CCCccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999999986522 2224567799999999987 679999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhccccc-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 732 LITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKL-SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 732 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
|++|+.||.......... |..... ........ .+........+.+++.+||+.||++|||+.|++++
T Consensus 286 lltg~~Pf~~~~~~~~~~--~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGS--WKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHSSCSTTBCCTTCTTC--CCBCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHhCCCCCCCcCcccccc--hhhhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999997643221110 100000 00000000 01111234567778889999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=338.75 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=197.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||.||+|.. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 5788899999999999999954 579999999984321 356889999999997 9999999999987
Q ss_pred --CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeeecc
Q 003199 604 --LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVADF 680 (840)
Q Consensus 604 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Df 680 (840)
....++||||+++++|.+++. .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 567799999999999999885 37899999999999999999999 9999999999999999776 8999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc-
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD- 758 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 758 (840)
|+++.... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...................
T Consensus 176 g~a~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 176 GLAEFYHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp TTCEECCT----TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred CCceEcCC----CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence 99976533 223345578999999999877 678999999999999999999999996432211111111000000
Q ss_pred ------------cccchhhhcccc--------cC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 ------------TKEGIMEVLDKK--------LS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ------------~~~~~~~~~~~~--------~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............ .. .........+.+++.+|++.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000000 00 0011134567888889999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.09 Aligned_cols=260 Identities=20% Similarity=0.240 Sum_probs=202.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC-CCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH-KNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 603 (840)
++|...+.||+|+||.||+|.. .+++.||||++...... ..+.+|+++++.+.| +++..+..++..
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 5788899999999999999965 57999999987543311 236789999999987 556666666777
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL---DVNYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Df 680 (840)
....++||||+ +++|.+++......+++.+++.|+.||+.||+|||+ ++||||||||+|||+ +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeC
Confidence 88889999999 999999998765679999999999999999999999 999999999999999 68899999999
Q ss_pred cchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 681 GIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 681 g~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +....
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~ 229 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKIS 229 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH-HHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH-HHHHh
Confidence 9998765422211 122356799999999999999999999999999999999999999986432211111 11000
Q ss_pred hc-cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 757 VD-TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 757 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.. ...... .+.. ....++.+++.+||+.||++||++.+|++.|+++
T Consensus 230 ~~~~~~~~~-----~l~~---~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 230 EKKVATSIE-----ALCR---GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHSCHH-----HHHT---TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred hccccccHH-----HHhc---CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 000000 0001 1234677888899999999999999999998765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.72 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=197.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----------EEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----------HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 357888999999999999999765 68999999984332 1224678899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 999999999999999999988755679999999999999999999999 99999999999999999999999999998
Q ss_pred hhhhccCCCCcceecccccccccCcccc-----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYA-----YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
...... ........||+.|+|||++ .+..++.++||||||+++|||++|+.||..... .........
T Consensus 165 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~ 236 (302)
T 2j7t_A 165 AKNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAK 236 (302)
T ss_dssp HHHHHH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH
T ss_pred cccccc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHhc
Confidence 654321 1122345789999999988 356789999999999999999999999975311 000000000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. . ... ..........+.+++.+|++.||++|||+.+++++
T Consensus 237 ~-~------~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 237 S-D------PPT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp S-C------CCC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred c-C------Ccc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0 000 00111223456778889999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.92 Aligned_cols=203 Identities=26% Similarity=0.346 Sum_probs=167.5
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--------EDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 45788899999999999999955 578999999985322 123445778999999999999999999999876
Q ss_pred C-----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 L-----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
. ...++||||++ |+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEc
Confidence 5 56899999995 69999998754 69999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCC-------------------cceecccccccccCcccc-ccCCCCccccchhHHHHHHHHHhCCCC
Q 003199 679 DFGIAKVLQARGGKD-------------------STTTVIAGTYGYLAPEYA-YSSKATTKCDVYSFGVVLMELITGRKP 738 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p 738 (840)
|||+|+......... .......||+.|+|||++ ....++.++||||+||++|||++|..|
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 999998764321110 123567899999999986 566799999999999999999986666
Q ss_pred CC
Q 003199 739 VE 740 (840)
Q Consensus 739 ~~ 740 (840)
|.
T Consensus 252 ~~ 253 (432)
T 3n9x_A 252 HI 253 (432)
T ss_dssp TC
T ss_pred cc
Confidence 54
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=342.63 Aligned_cols=278 Identities=21% Similarity=0.243 Sum_probs=200.1
Q ss_pred HHHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEeccccccccc-CchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 521 QREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSA-SDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 521 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
...+.+.|...+.||+|+||.||+|...+|+.||||++......... .........+.+.+|++++++++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 34556789999999999999999998888999999998654322111 01122344578999999999999999999999
Q ss_pred EEec-----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 600 YFSS-----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 600 ~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
++.. ....++||||++ |+|.+.+......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCC
Confidence 9843 335699999997 78999888776679999999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 173 ~kl~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~ 247 (362)
T 3pg1_A 173 ITICDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNKIV 247 (362)
T ss_dssp EEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred EEEEecCccccccc----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 99999999975432 223345678999999998876 67899999999999999999999999753210 0000000
Q ss_pred hhhhcc---------ccchhhhccccc----CCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 754 SIKVDT---------KEGIMEVLDKKL----SGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 754 ~~~~~~---------~~~~~~~~~~~~----~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...... ............ .... ......+.+++.+|++.||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 000000 000000000000 0111 11235577889999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.40 Aligned_cols=262 Identities=26% Similarity=0.329 Sum_probs=205.9
Q ss_pred HHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEE
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYF 601 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 601 (840)
..++|...+.||+|+||.||+|... +|+.||||++....... ..........+.+.+|+++++++. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS-FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTT-CCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccc-cCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3467888999999999999999664 78999999985543211 111223344677899999999995 99999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
......++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999998754 68999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAY------SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
++..... ........||+.|+|||++. ...++.++||||||+++|||++|+.||.... .. .....
T Consensus 170 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~-~~~~~ 240 (298)
T 1phk_A 170 FSCQLDP----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QM-LMLRM 240 (298)
T ss_dssp TCEECCT----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH-HHHHH
T ss_pred chhhcCC----CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----HH-HHHHH
Confidence 9976532 22234457899999999874 4568899999999999999999999996531 11 11100
Q ss_pred hhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... ....+........+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 241 IMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 000000 00011122334567788889999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.47 Aligned_cols=266 Identities=22% Similarity=0.300 Sum_probs=200.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---------HQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 4688899999999999999965 478999999985321 123456788999999999999999999998654
Q ss_pred -----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 605 -----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 605 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
...++||||++ |+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp STTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECC
T ss_pred CccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEe
Confidence 36799999996 6999999775 58999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
||+++................||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... ...........
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~ 250 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGS 250 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCS
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCC
Confidence 9999876443222222345689999999998654 458999999999999999999999997642111 00000000000
Q ss_pred -cccchh--------hh---cccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 759 -TKEGIM--------EV---LDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 759 -~~~~~~--------~~---~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..+... .. ........+ ......+.+++.+|++.||++|||+.|++++=
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000 00 000000000 11235677889999999999999999999874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=345.40 Aligned_cols=338 Identities=18% Similarity=0.170 Sum_probs=273.8
Q ss_pred cCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCc
Q 003199 24 LSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNF 103 (840)
Q Consensus 24 Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 103 (840)
...+.+....+..++++++|++|+|++| .+..+| .+..+++|++|+|++|.+++. | ++.+++|++|+|++|.
T Consensus 25 ~~~~~~~~~~~~~~~~l~~L~~L~Ls~n---~l~~~~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~ 96 (457)
T 3bz5_A 25 AAAFEMQATDTISEEQLATLTSLDCHNS---SITDMT--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNK 96 (457)
T ss_dssp HHHTTCCTTSEEEHHHHTTCCEEECCSS---CCCCCT--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred HHhcCcCcccccChhHcCCCCEEEccCC---CcccCh--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCC
Confidence 3344455566778899999999999999 566665 589999999999999999864 3 8899999999999999
Q ss_pred ccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccch
Q 003199 104 ITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183 (840)
Q Consensus 104 i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 183 (840)
+++. | +..+++|++|++++|+ +. .+| +..+++|++|++++|++++. + +..+++|++|++++|+..+..
T Consensus 97 l~~~-~--~~~l~~L~~L~L~~N~-l~-~l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-- 164 (457)
T 3bz5_A 97 LTNL-D--VTPLTKLTYLNCDTNK-LT-KLD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-- 164 (457)
T ss_dssp CSCC-C--CTTCTTCCEEECCSSC-CS-CCC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--
T ss_pred Ccee-e--cCCCCcCCEEECCCCc-CC-eec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--
Confidence 9964 4 8899999999999997 33 344 88999999999999999964 3 888999999999999544343
Q ss_pred hhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCC
Q 003199 184 VIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNL 263 (840)
Q Consensus 184 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L 263 (840)
.+..+++|++|++++|++++ +| +..+++|+.|++++|++++. .+..+++|++|++++|++.+ +| +..+++|
T Consensus 165 ~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L 235 (457)
T 3bz5_A 165 DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQL 235 (457)
T ss_dssp CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCC
Confidence 47889999999999999996 34 78889999999999999865 37777888888888888877 34 7777888
Q ss_pred ceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCC
Q 003199 264 LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343 (840)
Q Consensus 264 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 343 (840)
+.|++++|++++.. +..+++|+.|++++| +|+.|++++|.+.+.+| +..+++|+.|+|++|
T Consensus 236 ~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n 296 (457)
T 3bz5_A 236 TYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHN 296 (457)
T ss_dssp SEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTC
T ss_pred CEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCC
Confidence 88888888887543 445677777777765 46678899998877776 467899999999999
Q ss_pred ccCCCCCC--------cccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCC
Q 003199 344 LLSGPIPS--------GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNR 415 (840)
Q Consensus 344 ~l~~~~p~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~ 415 (840)
...+.+|. .+.++++|+.|+|++|+|++. + ++.+++|+.||+++|+|++ +| .+..|++++|+
T Consensus 297 ~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l~------~L~~L~l~~n~ 366 (457)
T 3bz5_A 297 TQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-FS------SVGKIPALNNN 366 (457)
T ss_dssp TTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-CT------TGGGSSGGGTS
T ss_pred cccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-cc------ccccccccCCc
Confidence 87766654 256678999999999999974 3 8999999999999999997 33 23456789999
Q ss_pred CcCc
Q 003199 416 LSGP 419 (840)
Q Consensus 416 l~~~ 419 (840)
++|.
T Consensus 367 l~g~ 370 (457)
T 3bz5_A 367 FEAE 370 (457)
T ss_dssp EEEE
T ss_pred EEec
Confidence 9887
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=346.69 Aligned_cols=269 Identities=21% Similarity=0.308 Sum_probs=183.0
Q ss_pred HHHhcCc-cCeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 524 ILEAMTE-KNKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 524 ~~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
+.+.|.. .++||+|+||+||+|... +++.||||++..... ...+.+|++++++++||||+++++
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~E~~~l~~l~hpniv~~~~ 85 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------------SMSACREIALLRELKHPNVISLQK 85 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------------CHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------------CHHHHHHHHHHHhcCCCCeeeEee
Confidence 4455665 568999999999999765 578999999853321 135778999999999999999999
Q ss_pred EEe--cCccceEEEeecCCCChHHHhhcC--------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 003199 600 YFS--SLYCNLLVYEYMPNGNLWDALHKG--------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669 (840)
Q Consensus 600 ~~~--~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 669 (840)
++. .....++||||++ |+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll 161 (405)
T 3rgf_A 86 VFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILV 161 (405)
T ss_dssp EEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred EEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEE
Confidence 994 4677899999996 5888877532 1248999999999999999999999 999999999999999
Q ss_pred ----cCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 003199 670 ----DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFG 744 (840)
Q Consensus 670 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 744 (840)
+.++.+||+|||+|+................||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 677899999999998765422222334556899999999998874 589999999999999999999999975432
Q ss_pred CCcc--------hhhhhhhh-hccccchh-------------hhcccccCC-CcHH--------HHHHHHHHHHHccCCC
Q 003199 745 DNKN--------IIYWVSIK-VDTKEGIM-------------EVLDKKLSG-SFRD--------EMIQVLRIAIRCTSKS 793 (840)
Q Consensus 745 ~~~~--------~~~~~~~~-~~~~~~~~-------------~~~~~~~~~-~~~~--------~~~~l~~l~~~cl~~d 793 (840)
.... +....... ......+. ......... .... ....+.+++.+|++.|
T Consensus 242 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~d 321 (405)
T 3rgf_A 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321 (405)
T ss_dssp -----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSS
T ss_pred cccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCC
Confidence 1100 00000000 00000000 000000000 0000 1345778999999999
Q ss_pred CCCCCCHHHHHHHhh
Q 003199 794 PATRPTMNEVVQLLA 808 (840)
Q Consensus 794 P~~Rps~~evl~~L~ 808 (840)
|++|||++|++++=.
T Consensus 322 P~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 322 PIKRITSEQAMQDPY 336 (405)
T ss_dssp GGGSCCHHHHHTSGG
T ss_pred cccCCCHHHHhcChh
Confidence 999999999999854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=368.15 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=203.1
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
.++|...+.||+|+||+||+|... +++.||||++...... .....+.+..|..++..+ .||+|+++++++.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-------~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-------HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-------cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 467888999999999999999654 6899999998543211 112245677899999988 7999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecce
Confidence 9999999999999999999998764 69999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
|+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..........
T Consensus 489 a~~~~~---~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~--- 557 (674)
T 3pfq_A 489 CKENIW---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEH--- 557 (674)
T ss_dssp CEECCC---TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSS---
T ss_pred eecccc---CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhC---
Confidence 975422 22234567899999999999999999999999999999999999999975311 1111111110
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM-----NEVVQL 806 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~~ 806 (840)
...++.. ...++.+++.+|++.||++||++ +||+++
T Consensus 558 -----~~~~p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 -----NVAYPKS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -----CCCCCTT---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -----CCCCCcc---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 0111222 23456778889999999999997 788765
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.15 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=182.5
Q ss_pred HHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|+++++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS--------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc--------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3678889999999999999995 45799999999854321 12345678899999999999999999999865
Q ss_pred C------ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 L------YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
. ...++|+||+ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEE
Confidence 4 5679999999 78999988763 68999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
+|||+++.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..........
T Consensus 174 ~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~ 246 (367)
T 2fst_X 174 LDFGLARHTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLV 246 (367)
T ss_dssp CC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred eeccccccccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 99999976532 2334678999999999877 67899999999999999999999999753210 0000000000
Q ss_pred hcc-ccc--------hhhh---cccccCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 757 VDT-KEG--------IMEV---LDKKLSGSFR----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 757 ~~~-~~~--------~~~~---~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
... .+. .... +.......+. .....+.+++.+|++.||++|||+.|++++-
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 000 000 0000 0000011111 1235577888999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=331.86 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=194.4
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
|.....||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----------C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 44556899999999999965 578999999985432 1224668899999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecccch
Q 003199 607 NLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADFGIA 683 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a 683 (840)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999999999998653 346788999999999999999999 99999999999999987 899999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+..... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..... .....+ ...
T Consensus 171 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~-~~~----- 239 (295)
T 2clq_A 171 KRLAGI---NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--PQAAMF-KVG----- 239 (295)
T ss_dssp EESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS--HHHHHH-HHH-----
T ss_pred cccCCC---CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc--hhHHHH-hhc-----
Confidence 765321 22234457899999999987643 78999999999999999999999964211 100000 000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......+... ....+.+++.+||+.||++||++.+++++
T Consensus 240 --~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 240 --MFKVHPEIPES---MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --HHCCCCCCCTT---SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --ccccccccccc---CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011112222 23456678889999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.72 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=183.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---------QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------------CCCCCCCTTBCCEEEEEESS
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---------chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 4678889999999999999965 4789999998843321 12345688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhc-------CCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 605 YCNLLVYEYMPNGNLWDALHK-------GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
+..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEE
Confidence 999999999999999999874 22458999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCC--CCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 678 ADFGIAKVLQARGG--KDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+|||++......+. .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .... ..
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~-~~ 239 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLM-LT 239 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHH-HH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHH-HH
Confidence 99999987643211 1112344579999999998865 56899999999999999999999999753211 1100 00
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.............+...... ....+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKK---YGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCCC---CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhhh---hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000000111111112 23456778889999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.32 Aligned_cols=257 Identities=24% Similarity=0.304 Sum_probs=196.5
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE-
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF- 601 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~- 601 (840)
+..+|...+.||+|+||.||+|.. .+++.||||++...... ......+.+.+|++++++++||||+++++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR------RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH------HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc------ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 346789999999999999999966 47899999998543211 1123356789999999999999999999998
Q ss_pred -ecCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 602 -SSLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 602 -~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
.+....++||||++++ +.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeec
Confidence 4456789999999876 76766543 3468999999999999999999999 9999999999999999999999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK--ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
||++...... ..........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... .........
T Consensus 153 fg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~ 226 (305)
T 2wtk_C 153 LGVAEALHPF-AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIG 226 (305)
T ss_dssp CTTCEECCTT-CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHH
T ss_pred cccccccCcc-ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHh
Confidence 9999765432 1223334567999999999987644 3789999999999999999999997531 111111000
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. .......+ ...+.+++.+|++.||++|||+.|++++-
T Consensus 227 ~~--------~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 227 KG--------SYAIPGDC---GPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HC--------CCCCCSSS---CHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred cC--------CCCCCCcc---CHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 00 01112222 34566788899999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=365.80 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=200.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC----CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN----SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|...+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.++++++||||+++++++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---------SDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 56888899999999999999764 24579999874322 123456789999999999999999999998
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+ ...++||||+++|+|.+++......+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecC
Confidence 54 56899999999999999998776679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++..... .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+... ....... ..
T Consensus 537 ~a~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~i---~~-- 607 (656)
T 2j0j_A 537 LSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRI---EN-- 607 (656)
T ss_dssp CCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH---HH--
T ss_pred CCeecCCC--cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH---Hc--
Confidence 99876431 1222334567789999999998899999999999999999997 9999975311 1111000 00
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
......+. .....+.+++.+||+.||++|||+.++++.|+++
T Consensus 608 -----~~~~~~~~---~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 608 -----GERLPMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -----TCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00011112 2234667788899999999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.22 Aligned_cols=258 Identities=26% Similarity=0.321 Sum_probs=204.2
Q ss_pred hHHHHHHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 520 DQREILEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 520 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.+....++|+..+.||+|+||.||+|... +++.||||++...... ....+.+.+|++++++++||||++++
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--------NKDTSTILREVELLKKLDHPNIMKLF 87 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--------SSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--------hHHHHHHHHHHHHHHhccCCCccEEE
Confidence 45677889999999999999999999665 7899999998543321 12246788999999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN---YQP 675 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~ 675 (840)
+++.+....++||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+||+++.+ +.+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 88 EILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred EEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccE
Confidence 99999999999999999999999887654 68999999999999999999999 999999999999999754 469
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||++..... ........||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... . .....
T Consensus 164 kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~ 233 (287)
T 2wei_A 164 KIIDFGLSTCFQQ----NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--Y---DILKR 233 (287)
T ss_dssp EECSTTGGGTBCC----CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHH
T ss_pred EEeccCcceeecC----CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--H---HHHHH
Confidence 9999999986532 222334568999999998765 589999999999999999999999975311 1 11100
Q ss_pred hhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...... . ...+........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~------~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 234 VETGKY------A-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHCCC------C-CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHcCCC------C-CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000000 0 0001111223467788889999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.35 Aligned_cols=258 Identities=25% Similarity=0.286 Sum_probs=184.5
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEe--
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFS-- 602 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-- 602 (840)
+|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.++. ||||+++++++.
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE----------EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS----------HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc----------hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 678889999999999999975 478999999884332 233567889999999996 999999999983
Q ss_pred ------cCccceEEEeecCCCChHHHhhc--CCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCC
Q 003199 603 ------SLYCNLLVYEYMPNGNLWDALHK--GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLDVN 672 (840)
Q Consensus 603 ------~~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~ 672 (840)
.....++||||+. |+|.+++.. ....+++.+++.++.|++.||+|||+ .+ |+||||||+||+++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTT
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCC
Confidence 3445789999995 799998865 23469999999999999999999999 78 9999999999999999
Q ss_pred CCCeeecccchhhhhccCCCC---------cceecccccccccCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCC
Q 003199 673 YQPKVADFGIAKVLQARGGKD---------STTTVIAGTYGYLAPEYA---YSSKATTKCDVYSFGVVLMELITGRKPVE 740 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~tg~~p~~ 740 (840)
+.+||+|||+++......... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998764321111 111245689999999988 56678999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCC
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFE 816 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 816 (840)
..... .. . ............ ...+.+++.+||+.||++|||+.|++++|+++...+..
T Consensus 255 ~~~~~--~~---~----------~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 255 DGAKL--RI---V----------NGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp --------------------------CCCCTTCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred chhHH--Hh---h----------cCcccCCccccc---chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 53110 00 0 000000001111 12356688899999999999999999999877654443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.53 Aligned_cols=197 Identities=25% Similarity=0.337 Sum_probs=169.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc------CCCCccee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI------RHKNIVKL 597 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l 597 (840)
..+|+..+.||+|+||.||+|.. .+++.||||++... ......+.+|+++++.+ .|+||+++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----------cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 45688899999999999999954 56899999998432 12345566777777776 57799999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ-- 674 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-- 674 (840)
++++......++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCC
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcc
Confidence 999999999999999995 69999887754 358999999999999999999999 89999999999999999887
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
+||+|||+|+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 241 vkL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQ------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EEECCCTTCEETTC------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEeecccceecCC------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999965422 233457899999999999999999999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.71 Aligned_cols=271 Identities=23% Similarity=0.336 Sum_probs=199.9
Q ss_pred HhcCccCeeeccCCcEEEEEEe--CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc---CCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL--NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI---RHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~ 600 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++........ ....+.+|+.+++.+ .||||++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--------MPLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--------CBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--------CCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 5788899999999999999976 4688999999864432110 012344667666665 89999999999
Q ss_pred Ee-----cCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 601 FS-----SLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 601 ~~-----~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
+. .....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCC
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCC
Confidence 87 5667899999997 69999998653 358999999999999999999999 99999999999999999999
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........
T Consensus 159 ~kl~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~ 232 (326)
T 1blx_A 159 IKLADFGLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKIL 232 (326)
T ss_dssp EEECSCCSCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred EEEecCcccccccC----CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH
Confidence 99999999976532 2233456789999999999998999999999999999999999999975321 11000000
Q ss_pred hhh--ccccchh-------hhcc----cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCCC
Q 003199 755 IKV--DTKEGIM-------EVLD----KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPCR 814 (840)
Q Consensus 755 ~~~--~~~~~~~-------~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~~ 814 (840)
... ....... .... .............+.+++.+|++.||++|||+.|++++ +.++..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 000 0000000 0000 00000111233456778889999999999999999976 45555443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=338.60 Aligned_cols=364 Identities=24% Similarity=0.329 Sum_probs=266.2
Q ss_pred ccccccccCCC-CCCCCCC-------------CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCccccccc
Q 003199 2 SFMYLTGTLPD-FSPMQNL-------------RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRL 67 (840)
Q Consensus 2 ~~~~~~~~~~~-~~~l~~L-------------~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l 67 (840)
+.|.++|.+|. ++.+++| ++|++++|.++ .+|.. .++|++|++++| .+..+|. .+
T Consensus 42 ~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~---~~~L~~L~l~~n---~l~~lp~----~~ 110 (454)
T 1jl5_A 42 AWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCN---SLTELPE----LP 110 (454)
T ss_dssp HHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSS---CCSSCCC----CC
T ss_pred cCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC---cCCCCEEEccCC---cCCcccc----cc
Confidence 45677888887 8888764 99999999999 45552 479999999999 5556664 24
Q ss_pred ccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeee
Q 003199 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLD 147 (840)
Q Consensus 68 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~ 147 (840)
++|+.|++++|.+++. |.. .++|++|+|++|++++ +| .|..+++|++|++++|+ +. .+|..+ .+|++|+
T Consensus 111 ~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~-l~-~lp~~~---~~L~~L~ 179 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNS-LK-KLPDLP---PSLEFIA 179 (454)
T ss_dssp TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC-CS-CCCCCC---TTCCEEE
T ss_pred CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCc-Cc-ccCCCc---ccccEEE
Confidence 8999999999999853 321 2699999999999995 77 69999999999999998 33 466543 5899999
Q ss_pred ccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 148 MSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
+++|++++ +| .+..+++|++|++++|++++. |.. .++|++|++++|+++ .+| .+..+++|++|++++|++++
T Consensus 180 L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 180 AGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS
T ss_pred CcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc
Confidence 99999996 56 699999999999999999864 332 369999999999999 566 48999999999999999986
Q ss_pred cCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCC
Q 003199 228 PLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGN 307 (840)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 307 (840)
+|.. ..+|+.|++++|.+.+ +|.. +++|++|++++|++++ +|.. .++|+.|++++|++++.. .
T Consensus 252 -l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~i~-----~ 314 (454)
T 1jl5_A 252 -LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRSLC-----D 314 (454)
T ss_dssp -CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSEEC-----C
T ss_pred -cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCccc-----C
Confidence 3432 4789999999999987 4443 3799999999999985 3321 268999999999998632 2
Q ss_pred C-CCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCC--Ccchhcccc----
Q 003199 308 A-RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS--SIPNSLSSL---- 380 (840)
Q Consensus 308 l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l---- 380 (840)
+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|+|++|++++ .+|.++..+
T Consensus 315 ~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~ 386 (454)
T 1jl5_A 315 LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNS 386 (454)
T ss_dssp CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC
T ss_pred CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcc
Confidence 3 589999999999996 5554 579999999999999 4666 47899999999999998 788898888
Q ss_pred ---------cCCCEEECcCccccc--cCCchhhccCCCeEEccCCCCcCcCCcccc
Q 003199 381 ---------KSLNVLDLSNNLLTG--YIPESLCELLPNSINFSNNRLSGPIPLSLI 425 (840)
Q Consensus 381 ---------~~L~~L~l~~N~l~~--~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~ 425 (840)
++|+.||+++|++++ .+|.++ ..|.+.+|.+.+++|....
T Consensus 387 ~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl-----~~L~~~~~~~~~~~~~~~~ 437 (454)
T 1jl5_A 387 HLAEVPELPQNLKQLHVETNPLREFPDIPESV-----EDLRMNSERVVDPYEFAHE 437 (454)
T ss_dssp --------------------------------------------------------
T ss_pred cccccccccCcCCEEECCCCcCCccccchhhH-----hheeCcCcccCCccccCHH
Confidence 899999999999998 788765 4567788888888775433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=346.90 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=190.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
.+|+..+.||+|+||+||+|....+..||+|++...... ..+|+++++.++||||+++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------------~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------------KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 357888999999999999998877777999988543211 126999999999999999999985433
Q ss_pred ------cceEEEeecCCCChHHHhh--cCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCCe
Q 003199 606 ------CNLLVYEYMPNGNLWDALH--KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQPK 676 (840)
Q Consensus 606 ------~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~k 676 (840)
..++||||++++.+..... .....+++..+..++.|++.||+|||+ ++|+||||||+||+++ .++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEE
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEE
Confidence 3689999997654433322 223478999999999999999999999 9999999999999999 789999
Q ss_pred eecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
|+|||+|+.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... .......+.
T Consensus 183 L~DFG~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~ 257 (394)
T 4e7w_A 183 LIDFGSAKILIA----GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKV 257 (394)
T ss_dssp ECCCTTCEECCT----TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred EeeCCCcccccC----CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence 999999987632 2223456789999999998765 5899999999999999999999999764211 111111110
Q ss_pred hh-ccccchhh----hcccc---cC-CCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 KV-DTKEGIME----VLDKK---LS-GSFR-----DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ~~-~~~~~~~~----~~~~~---~~-~~~~-----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ...+.+.. ..... .. ..+. ....++.+++.+|++.||++|||+.|+++|
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 00000000 00000 00 1111 123567888999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.45 Aligned_cols=260 Identities=27% Similarity=0.261 Sum_probs=198.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--------CCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--------HKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~ 596 (840)
.+|...+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+++++.++ |+||++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----------CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 5788999999999999999954 57899999998422 233567889999999986 788999
Q ss_pred eeeEEe----cCccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEc
Q 003199 597 LYCYFS----SLYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNILLD 670 (840)
Q Consensus 597 l~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~ 670 (840)
+++++. .....++||||+ ++++.+.+... ...+++..+..++.||+.||+|||+ + +||||||||+|||++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEe
Confidence 999987 566789999999 66666666544 3569999999999999999999999 8 999999999999999
Q ss_pred CCC-------------------------------------------------CCeeecccchhhhhccCCCCcceecccc
Q 003199 671 VNY-------------------------------------------------QPKVADFGIAKVLQARGGKDSTTTVIAG 701 (840)
Q Consensus 671 ~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~g 701 (840)
.++ .+||+|||+++.... ......|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~~~g 255 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTEDIQ 255 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCSCCS
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCccCCC
Confidence 775 799999999976533 2334578
Q ss_pred cccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-hhhhhhhhhc--cc--c-------chhhhccc
Q 003199 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN-IIYWVSIKVD--TK--E-------GIMEVLDK 769 (840)
Q Consensus 702 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~--~~--~-------~~~~~~~~ 769 (840)
|+.|+|||++.+..++.++|||||||++|||++|+.||......... .......... .. . ........
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999999999999999999999999999999999764332211 0000000000 00 0 00000000
Q ss_pred --------------------ccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 770 --------------------KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 770 --------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......+....+.+++.+||+.||++|||++|++++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0001124556778899999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=345.71 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=191.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|...+.||+|+||+||+|.. .+|+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------------~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------------KNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------------HHHHHHHHHHcCCCCccchhheeee
Confidence 35788899999999999999954 68999999998543211 2369999999999999999999843
Q ss_pred --------------------------------------CccceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHH
Q 003199 604 --------------------------------------LYCNLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGV 642 (840)
Q Consensus 604 --------------------------------------~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i 642 (840)
....++||||++ |+|.+.+.. ....+++..+..++.|+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 234789999997 587776653 23479999999999999
Q ss_pred HHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccc
Q 003199 643 AQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKC 720 (840)
Q Consensus 643 ~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 720 (840)
+.||+|||+ .+|+||||||+||+++ .++.+||+|||+|+.... ........||+.|+|||.+.+. .++.++
T Consensus 151 ~~aL~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 151 FRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----SEPSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT----TSCCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC----CCCCcCcccCCCccCHHHhcCCCCCCcch
Confidence 999999999 9999999999999998 688999999999986533 2233455789999999988765 489999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-ccccchh-------hhccccc-CCCcH-----HHHHHHHHHH
Q 003199 721 DVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DTKEGIM-------EVLDKKL-SGSFR-----DEMIQVLRIA 786 (840)
Q Consensus 721 Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~~~~~~-~~~~~-----~~~~~l~~l~ 786 (840)
||||+||++|||++|+.||.+.... ........... ...+.+. ...-+.. ...+. .....+.+++
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 9999999999999999999763211 11111110000 0000000 0000000 01111 1234577888
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 003199 787 IRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 787 ~~cl~~dP~~Rps~~evl~~ 806 (840)
.+|++.||++|||+.|++++
T Consensus 303 ~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 89999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.28 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=196.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS--------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc--------chhHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 45788889999999999999954 5799999999854321 13345778899999999999999999999987
Q ss_pred Cccc------eEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 LYCN------LLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ~~~~------~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
.... ++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEE
T ss_pred cCCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEE
Confidence 6655 99999996 688888754 58999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 186 ~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~ 258 (371)
T 4exu_A 186 LDFGLARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT 258 (371)
T ss_dssp CSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred EecCccccccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence 99999976532 2334578999999999877 67899999999999999999999999753210 0000000000
Q ss_pred hccccc------------hhhhcccccCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 757 VDTKEG------------IMEVLDKKLSGSFR----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 757 ~~~~~~------------~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
...... ............+. .....+.+++.+|++.||++|||+.|++++=
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 000000 00000011111111 2245678889999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.40 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=196.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||.||+|...+ .||||++....... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE--------DQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC--------CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH--------HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 467788999999999999998763 49999986543211 11234667999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++++|.+++......+++..+..++.|++.||+|||+ ++|+||||||+||+++ ++.+||+|||+++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999998876679999999999999999999999 9999999999999998 67999999999876
Q ss_pred hhccC--CCCcceecccccccccCcccccc---------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 686 LQARG--GKDSTTTVIAGTYGYLAPEYAYS---------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 686 ~~~~~--~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
..... ..........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .....+.
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~- 254 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAIIWQ- 254 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHHHHH-
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH-
Confidence 53211 11223344568999999998864 457899999999999999999999997531 1111110
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCC
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRF 815 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 815 (840)
.. ......... ......+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 255 --~~------~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 255 --MG------TGMKPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp --HH------TTCCCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred --hc------cCCCCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 000011100 0122346678889999999999999999999998876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.63 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=189.4
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC-
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL- 604 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 604 (840)
.|+..+.||+|+||.||+|... +|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------------~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------------FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------------SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------------hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 5778889999999999999765 699999999854321 123699999999999999999988432
Q ss_pred -----ccceEEEeecCCCChHHHhh---cCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCC
Q 003199 605 -----YCNLLVYEYMPNGNLWDALH---KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQP 675 (840)
Q Consensus 605 -----~~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~ 675 (840)
...++||||+++ ++.+.+. .....+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeE
Confidence 235789999975 6666554 234579999999999999999999999 999999999999999965 568
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
||+|||+++.+.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+.....
T Consensus 197 kl~DFG~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVR----GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIK 271 (420)
T ss_dssp EECCCTTCEECCT----TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH
T ss_pred Eeccchhhhhccc----CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Confidence 9999999986532 1223345789999999998765 789999999999999999999999976321 111111111
Q ss_pred hhh-ccccchhh-------hcccccCC-CcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 755 IKV-DTKEGIME-------VLDKKLSG-SFR-----DEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 755 ~~~-~~~~~~~~-------~~~~~~~~-~~~-----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
... ...+.+.. ..-+.+.. .+. ....++.+++.+|++.||++||++.|+++|-
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 000 00000000 00000100 011 1235678888999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=336.38 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=190.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe--
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS-- 602 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-- 602 (840)
.+|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----------PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC----------hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 56888899999999999999665 58999999884322 234567889999999999999999998874
Q ss_pred ------------cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 603 ------------SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 603 ------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
+....++||||++ |+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEc
Confidence 3456789999997 6999999764 58999999999999999999999 9999999999999997
Q ss_pred -CCCCCeeecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003199 671 -VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKN 748 (840)
Q Consensus 671 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 748 (840)
+++.+||+|||+++................+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQ 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 5678999999999876432222223345567999999998765 67899999999999999999999999753210 00
Q ss_pred hhhhhhhh-hccccchhh-------hccccc--C-CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 749 IIYWVSIK-VDTKEGIME-------VLDKKL--S-GS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 749 ~~~~~~~~-~~~~~~~~~-------~~~~~~--~-~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ........+ ...... . .. .......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000000 000000000 000000 0 00 01124567788889999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.01 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=192.6
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
..++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----------EEKLSTILSEVMLLASLNHQYVVRYYAAWL 72 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----------HHHHHHHHHHHHHHHhcCchHHHHHHHHHH
Confidence 457899999999999999999965 47999999998421 233567889999999999999999999875
Q ss_pred c-------------CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 003199 603 S-------------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL 669 (840)
Q Consensus 603 ~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill 669 (840)
+ ....++||||+++|+|.+++......+++..++.++.|++.||+|||+ ++|+||||||+||++
T Consensus 73 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~ 149 (303)
T 1zy4_A 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFI 149 (303)
T ss_dssp ECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred hhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEE
Confidence 4 456789999999999999998766678899999999999999999999 999999999999999
Q ss_pred cCCCCCeeecccchhhhhccCC-----------CCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCC
Q 003199 670 DVNYQPKVADFGIAKVLQARGG-----------KDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 670 ~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~ 737 (840)
+.++.+||+|||+++....... .........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--- 226 (303)
T 1zy4_A 150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--- 226 (303)
T ss_dssp CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---
T ss_pred cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---
Confidence 9999999999999976542110 01223456789999999998764 68999999999999999998
Q ss_pred CCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 738 PVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
||... ............ .....+..+ ......+.+++.+|++.||.+|||+.+++++-
T Consensus 227 p~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 227 PFSTG----MERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp CCSSH----HHHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred ccCCc----hhHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 55321 000011100000 001111111 22334567788899999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.28 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=191.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFS 602 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 602 (840)
..+|+..+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----------EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----------cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 45688889999999999999966 4789999999853321 135678899999999 7999999999997
Q ss_pred c------CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 603 S------LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 603 ~------~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 6 457899999999999999998642 468999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 750 (840)
||+|||++...... ........||+.|+|||++. +..++.++||||||+++|||++|+.||..... ...
T Consensus 169 kl~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~ 242 (326)
T 2x7f_A 169 KLVDFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRA 242 (326)
T ss_dssp EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHH
T ss_pred EEeeCcCceecCcC---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHH
Confidence 99999999765431 12233457899999999986 56789999999999999999999999965311 000
Q ss_pred hhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.+ ..... .........+ ...+.+++.+||..||++||++.+++++
T Consensus 243 ~~-~~~~~-------~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LF-LIPRN-------PAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH-HHHHS-------CCCCCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH-HhhcC-------ccccCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000 0000011122 2456678889999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.57 Aligned_cols=310 Identities=22% Similarity=0.242 Sum_probs=191.0
Q ss_pred CCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCC
Q 003199 39 NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNL 118 (840)
Q Consensus 39 ~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L 118 (840)
.+++|+.|++++| .+..+|...|..+++|++|+|++|.+.+..+..|..+++|++|+|++|.+++..|..|..+++|
T Consensus 43 ~l~~l~~l~l~~~---~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 119 (390)
T 3o6n_A 43 TLNNQKIVTFKNS---TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119 (390)
T ss_dssp GGCCCSEEEEESC---EESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred ccCCceEEEecCC---chhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCC
Confidence 3566777777777 5666666666777777777777777776666667777777777777777776666666777777
Q ss_pred CeeecccCccccccCCc-ccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEcc
Q 003199 119 RQLELYYNQQLAGTIPE-ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLY 197 (840)
Q Consensus 119 ~~L~L~~n~~~~~~~p~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 197 (840)
++|+|++|+ +. .+|. .|..+++|++|+|++|.+++..+..|..+++|++|++++|++++.. +..+++|++|+++
T Consensus 120 ~~L~L~~n~-l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~ 194 (390)
T 3o6n_A 120 TVLVLERND-LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVS 194 (390)
T ss_dssp CEEECCSSC-CC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECC
T ss_pred CEEECCCCc-cC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecc
Confidence 777777665 22 3343 3466666777777777666655666666666666666666666442 4455666666666
Q ss_pred CCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccC
Q 003199 198 DNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSI 277 (840)
Q Consensus 198 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (840)
+|.+++. ...++|+.|++++|.++.. +.. ..++|+.|++++|.+++.
T Consensus 195 ~n~l~~~-----~~~~~L~~L~l~~n~l~~~-------------------------~~~--~~~~L~~L~l~~n~l~~~- 241 (390)
T 3o6n_A 195 YNLLSTL-----AIPIAVEELDASHNSINVV-------------------------RGP--VNVELTILKLQHNNLTDT- 241 (390)
T ss_dssp SSCCSEE-----ECCSSCSEEECCSSCCCEE-------------------------ECC--CCSSCCEEECCSSCCCCC-
T ss_pred ccccccc-----CCCCcceEEECCCCeeeec-------------------------ccc--ccccccEEECCCCCCccc-
Confidence 6666532 1223566666666655421 111 124566666666666532
Q ss_pred CccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCcc
Q 003199 278 PEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLK 357 (840)
Q Consensus 278 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 357 (840)
..+..+++|+.|++++|.+++..+..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..++
T Consensus 242 -~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~ 318 (390)
T 3o6n_A 242 -AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318 (390)
T ss_dssp -GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHT
T ss_pred -HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccC
Confidence 355666666666666666666666666666666666666666663 3444455666666666666665 3444555566
Q ss_pred ccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 358 KLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 358 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
+|+.|+|++|++++. + +..+++|+.|+|++|++++
T Consensus 319 ~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 319 RLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp TCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred cCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 666666666666533 2 4555666666666666654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.33 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=194.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--CCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--HKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 603 (840)
+.|...+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++ |+||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--------CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--------cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 45888899999999999999888899999999854331 1334577899999999997 5999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....++||| +.+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++ +.+||+|||++
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999999 56889999998764 68999999999999999999999 99999999999999965 78999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS-----------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
+...... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 174 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~- 248 (313)
T 3cek_A 174 NQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK- 248 (313)
T ss_dssp CC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHH-
T ss_pred ccccCcc-ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---HHH-
Confidence 8764321 1122334578999999999865 46888999999999999999999999753211 100
Q ss_pred hhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
....... .......... ...+.+++.+||+.||++||++.|++++-.
T Consensus 249 ~~~~~~~------~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 249 LHAIIDP------NHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHHCT------TSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHhc------ccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 0000000 0001111122 245677888999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.89 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=186.2
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLY 605 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 605 (840)
.|...+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +||||+++++++.+..
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 4677789999999997766666799999999854321 1245799999999 7999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C--CCCeeecc
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---N--YQPKVADF 680 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~Df 680 (840)
..++||||++ |+|.+++........+.++..++.||+.||+|||+ .+|+||||||+||+++. + ..+||+||
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 9999999995 69999998876567777888999999999999999 99999999999999953 2 35779999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccc---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhh
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAY---SSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+|+................||+.|+|||++. ...++.++|||||||++|||++ |..||..... .... ..
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~~---~~ 241 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQAN---IL 241 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHHH---HH
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHHH---HH
Confidence 99987643222223344567999999999987 4567889999999999999999 9999864311 0000 00
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ...............+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 242 LGA-------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTC-------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcc-------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 0000001112234456788889999999999999999965
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.71 Aligned_cols=268 Identities=23% Similarity=0.286 Sum_probs=186.1
Q ss_pred hHHHHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 520 DQREILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 520 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
......++|...+.||+|+||.||+|.. .+|+.||||++...... .....+|++.++.++||||++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~~l~~l~h~niv~~~ 85 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----------RNRELQIMQDLAVLHHPNIVQLQ 85 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----------CCHHHHHHHHHHHHCCTTBCCEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----------cHHHHHHHHHHHhcCCCCcccHH
Confidence 3456678999999999999999999966 47899999988443211 12345677888888999999999
Q ss_pred eEEecCcc-------ceEEEeecCCCChHHHhhc---CCCCCChHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCC
Q 003199 599 CYFSSLYC-------NLLVYEYMPNGNLWDALHK---GLVHLDWPTRHKIAFGVAQGLAYLH--HGLLSPIIHRDIKSTN 666 (840)
Q Consensus 599 ~~~~~~~~-------~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlk~~N 666 (840)
+++..... .++||||+++ ++.+.+.. ....+++..+..++.|++.||.||| + ++|+||||||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~N 161 (360)
T 3e3p_A 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHN 161 (360)
T ss_dssp EEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGG
T ss_pred HhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHH
Confidence 99865433 6899999976 55443332 3347899999999999999999999 7 999999999999
Q ss_pred EEEcC-CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCC
Q 003199 667 ILLDV-NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFG 744 (840)
Q Consensus 667 ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~ 744 (840)
|+++. ++.+||+|||+++.... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 162 Ill~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 162 VLVNEADGTLKLCDFGSAKKLSP----SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp EEEETTTTEEEECCCTTCBCCCT----TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeCCCCcEEEeeCCCceecCC----CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 99997 89999999999986643 22334557899999999986654 89999999999999999999999976321
Q ss_pred CCcchhhhhhhhhccccchhhhcc-----------------cccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 745 DNKNIIYWVSIKVDTKEGIMEVLD-----------------KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
. .....................+ .............+.+++.+|++.||++|||+.|++++-
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 238 A-GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp H-HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred H-HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 1 1111111100000000000000 000111111346788899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=334.89 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=195.1
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS--------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc--------chHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 4678889999999999999965 5799999999854321 133456788999999999999999999999776
Q ss_pred cc------ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 605 YC------NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 605 ~~------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
.. .++||||++ ++|.+++.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEe
Confidence 54 499999996 688887754 58999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|||+++.... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.... ...........
T Consensus 169 Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~ 241 (353)
T 3coi_A 169 DFGLARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTG 241 (353)
T ss_dssp STTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHC
T ss_pred ecccccCCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 9999976432 2334578999999998877 67899999999999999999999999753210 00000000000
Q ss_pred ccccc------------hhhhc----ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEG------------IMEVL----DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~------------~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
..... ..... ...+..........+.+++.+|++.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000 00000 0111111223345677888899999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=330.67 Aligned_cols=259 Identities=21% Similarity=0.295 Sum_probs=199.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe--CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC------ccee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL--NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN------IVKL 597 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l 597 (840)
++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++|++ ++++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----------CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 5788899999999999999965 36899999998422 233566788999999887765 9999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV----- 671 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----- 671 (840)
++++......++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEecccccc
Confidence 99999999999999999 899999997654 368899999999999999999999 99999999999999987
Q ss_pred --------------CCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCC
Q 003199 672 --------------NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 672 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 737 (840)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 66899999999976432 2234578999999999999899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhhccccch---------------------------hhhcc--cccCCCcHHHHHHHHHHHHH
Q 003199 738 PVEDDFGDNKNIIYWVSIKVDTKEGI---------------------------MEVLD--KKLSGSFRDEMIQVLRIAIR 788 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~--~~~~~~~~~~~~~l~~l~~~ 788 (840)
||....... ................ ..... .............+.+++.+
T Consensus 233 pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 233 VFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp SCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 997532110 0000000000000000 00000 00001112345678899999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 003199 789 CTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 789 cl~~dP~~Rps~~evl~~ 806 (840)
|++.||++|||+.|++++
T Consensus 312 ~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 312 MLEYDPAKRITLREALKH 329 (339)
T ss_dssp HTCSSTTTSCCHHHHTTS
T ss_pred HhCcCcccccCHHHHhcC
Confidence 999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.77 Aligned_cols=272 Identities=19% Similarity=0.248 Sum_probs=203.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccC-------chhhHHHHHHHHHHHHHHhccCCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSAS-------DTDQLQLDKGLKTEVETLGNIRHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 598 (840)
.+|...+.||+|+||.||+|.. +|+.||||++.......... ........+.+.+|+.++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788899999999999999988 89999999985433211000 000111236789999999999999999999
Q ss_pred eEEecCccceEEEeecCCCChHHH------hhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDA------LHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV 671 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~ 671 (840)
+++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||+|||+. ++|+||||||+||+++.
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECT
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcC
Confidence 999999999999999999999998 6542 35789999999999999999999973 68999999999999999
Q ss_pred CCCCeeecccchhhhhccCCCCcceecccccccccCccccccC-CCCc-cccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 003199 672 NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATT-KCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749 (840)
Q Consensus 672 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 749 (840)
++.+||+|||.+..... .......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||...... ...
T Consensus 188 ~~~~kl~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~ 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVD-----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VEL 261 (348)
T ss_dssp TSCEEECCCTTCEECBT-----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHH
T ss_pred CCcEEEecccccccccc-----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHH
Confidence 99999999999976532 134456799999999999877 5666 999999999999999999999754221 111
Q ss_pred hhhhhhh-hccccchhhhccccc----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 750 IYWVSIK-VDTKEGIMEVLDKKL----SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 750 ~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....... ............... ..........+.+++.+|++.||++|||+.|++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1110000 000000000000000 00002234567788889999999999999999985
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=349.52 Aligned_cols=333 Identities=18% Similarity=0.160 Sum_probs=156.8
Q ss_pred CCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCe
Q 003199 41 TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120 (840)
Q Consensus 41 ~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~ 120 (840)
.+++.|++++| .+..+|+..|..+++|++|+|++|.+.+..|..|+.+++|++|+|++|.|++..|..|+.+++|++
T Consensus 51 ~~l~~l~l~~~---~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 51 NNQKIVTFKNS---TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127 (597)
T ss_dssp CCCSEEEESSC---EESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCceEEEeeCC---CCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence 44455555554 444444444444555555555555554444444444555555555555544444444444444444
Q ss_pred eecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCc
Q 003199 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNS 200 (840)
Q Consensus 121 L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (840)
|+|++|. +....+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++.. +..+++|++|++++|.
T Consensus 128 L~L~~n~-l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 128 LVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNL 203 (597)
T ss_dssp EECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSC
T ss_pred EEeeCCC-CCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCc
Confidence 4444443 22211222344444444444444444444444444444444444444444321 2233444444444444
Q ss_pred CcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCcc
Q 003199 201 LTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEG 280 (840)
Q Consensus 201 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 280 (840)
+++. ...++|+.|++++|.+... +..
T Consensus 204 l~~l-----------------------------------------------------~~~~~L~~L~ls~n~l~~~-~~~ 229 (597)
T 3oja_B 204 LSTL-----------------------------------------------------AIPIAVEELDASHNSINVV-RGP 229 (597)
T ss_dssp CSEE-----------------------------------------------------ECCTTCSEEECCSSCCCEE-ECS
T ss_pred cccc-----------------------------------------------------cCCchhheeeccCCccccc-ccc
Confidence 4321 1122344444444444421 111
Q ss_pred ccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccc
Q 003199 281 ILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360 (840)
Q Consensus 281 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 360 (840)
+ .++|+.|+|++|.+++. ..++.+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++ +|..+..+++|+
T Consensus 230 ~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~ 304 (597)
T 3oja_B 230 V--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLK 304 (597)
T ss_dssp C--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCC
T ss_pred c--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCc
Confidence 1 13455555555555432 344555555555555555555555555555555555555555553 344444555555
Q ss_pred hhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcCCcccccCCCcccccCCCCCc
Q 003199 361 LLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLC 440 (840)
Q Consensus 361 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~n~~~c 440 (840)
.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..+. .++.|++++|+++|.++..+........+.+++..|
T Consensus 305 ~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C 381 (597)
T 3oja_B 305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH--TLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 381 (597)
T ss_dssp EEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTC--CCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCC
T ss_pred EEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcC--CCCEEEeeCCCCCChhHHHHHHHHhhhccccccccC
Confidence 5555555555 3444455555555555555555533211111 335555555555555443333333344566777788
Q ss_pred cc
Q 003199 441 VS 442 (840)
Q Consensus 441 ~~ 442 (840)
+.
T Consensus 382 ~~ 383 (597)
T 3oja_B 382 KI 383 (597)
T ss_dssp CT
T ss_pred Cc
Confidence 65
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.82 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=197.3
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---------KPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS---------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc---------cchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 356888899999999999999665 78999999984321 12345678899999999999999999998865
Q ss_pred C-----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 L-----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
. ...++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEE
Confidence 4 67799999996 6999998874 68999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCC-------cceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003199 679 DFGIAKVLQARGGKD-------STTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 750 (840)
|||+++......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ....
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~ 232 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RHQL 232 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHH
Confidence 999998764321111 11233578999999998754 6789999999999999999999999975321 0000
Q ss_pred hhhhhhhcccc-----------chhhhc---ccccCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 751 YWVSIKVDTKE-----------GIMEVL---DKKLSGS----FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 751 ~~~~~~~~~~~-----------~~~~~~---~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
........... ...+.. ....... +......+.+++.+|++.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00000000000 000000 0000000 112335677888999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.39 Aligned_cols=199 Identities=26% Similarity=0.284 Sum_probs=168.4
Q ss_pred HHhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CC-----Cccee
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HK-----NIVKL 597 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l 597 (840)
.++|...+.||+|+||+||+|... +++.||||++... ......+..|+.+++.++ |+ +++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----------HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 467889999999999999999654 7899999998432 123456677888888775 44 49999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCC
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD--VNYQ 674 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~ 674 (840)
++++......++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ +..+||||||||+|||++ .++.
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCc
Confidence 999999999999999995 59999998753 468999999999999999999994 127899999999999995 4778
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 742 (840)
+||+|||+|+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 200 ~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EEECCCTTCEETTC------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEeccCceeccc------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976532 223467899999999999999999999999999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.32 Aligned_cols=253 Identities=26% Similarity=0.329 Sum_probs=174.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHH-HHhccCCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVE-TLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~ 603 (840)
++|...+.||+|+||.||+|... +|+.||||++..... ......+..|+. +++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---------EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC---------HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC---------chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 46778889999999999999664 799999999854321 122334455555 7788899999999999999
Q ss_pred CccceEEEeecCCCChHHHhhc----CCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCCCeee
Q 003199 604 LYCNLLVYEYMPNGNLWDALHK----GLVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
.+..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEc
Confidence 9999999999975 88777653 23478999999999999999999999 7 99999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA----YSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
|||+++.... ........||+.|+|||++ .+..++.++||||||+++|||++|+.||............
T Consensus 169 Dfg~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--- 241 (327)
T 3aln_A 169 DFGISGQLVD----SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ--- 241 (327)
T ss_dssp CCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC---
T ss_pred cCCCceeccc----ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH---
Confidence 9999976633 1222344799999999998 4567899999999999999999999999753211110000
Q ss_pred hhhccccchhhhcccccCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 755 IKVDTKEGIMEVLDKKLSG-SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........+.. ........+.+++.+||+.||++|||+.+++++
T Consensus 242 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 242 --------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00000001110 011223467778889999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=341.49 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=184.7
Q ss_pred cCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 606 (840)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+...
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 4456789999999998877778999999988432 134567899999886 89999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCC------CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--------
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVH------LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-------- 672 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-------- 672 (840)
.++||||++ |+|.+++...... ..+..+..++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccc
Confidence 999999995 6999999865311 1344567899999999999999 999999999999999754
Q ss_pred -----CCCeeecccchhhhhccCCC-CcceecccccccccCcccccc-------CCCCccccchhHHHHHHHHHh-CCCC
Q 003199 673 -----YQPKVADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYS-------SKATTKCDVYSFGVVLMELIT-GRKP 738 (840)
Q Consensus 673 -----~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t-g~~p 738 (840)
+.+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 47999999999876432111 112234679999999999865 578999999999999999999 9999
Q ss_pred CCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 739 VEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
|.+..... ..... .... ..............++.+++.+|++.||++|||+.|++++
T Consensus 240 f~~~~~~~---~~i~~----~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 240 FGDKYSRE---SNIIR----GIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TCSTTTHH---HHHHH----TCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCchhhH---HHHhc----CCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 96532111 00000 0000 0000011123456678889999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.55 Aligned_cols=255 Identities=20% Similarity=0.258 Sum_probs=171.8
Q ss_pred HHHhcCccC-eeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 524 ILEAMTEKN-KVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 524 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
+.++|...+ .||+|+||.||+|... +|+.||||++.... . ...+....++.+.||||+++++++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~---~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----------K---ARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----------H---HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----------H---HHHHHHHHHHhcCCCChHHHHHHH
Confidence 345677754 6999999999999665 79999999984321 1 111222335566899999999998
Q ss_pred ec----CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CC
Q 003199 602 SS----LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---NY 673 (840)
Q Consensus 602 ~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~ 673 (840)
.. ....++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++. ++
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTC
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCc
Confidence 76 445799999999999999998753 468999999999999999999999 99999999999999976 45
Q ss_pred CCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 674 QPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 674 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
.+||+|||+++.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 169 ~~kl~Dfg~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQ-----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp CEEECCCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred eEEEeccccceeccc-----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 599999999976432 223345789999999999888899999999999999999999999975422111000000
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
.. .........+.+......+.+++.+|++.||++|||+.|++++-.
T Consensus 244 --~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 244 --RI------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred --hh------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00 000000011111223456778888999999999999999999643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.89 Aligned_cols=261 Identities=23% Similarity=0.250 Sum_probs=196.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-----------CCC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-----------HKN 593 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 593 (840)
.+|...+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+.+++++. |+|
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----------ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 4688889999999999999965 57899999998432 123456788999988886 899
Q ss_pred cceeeeEEecCc----cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCE
Q 003199 594 IVKLYCYFSSLY----CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNI 667 (840)
Q Consensus 594 iv~l~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Ni 667 (840)
|+++++++.... ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ + +|+||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHe
Confidence 999999987654 779999999 99999999764 2458999999999999999999999 8 999999999999
Q ss_pred EEc------CCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 003199 668 LLD------VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVED 741 (840)
Q Consensus 668 ll~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 741 (840)
+++ ..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred EEeccCCCcCcceEEEcccccccccCC------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 995 344799999999976533 22345789999999999999999999999999999999999999975
Q ss_pred CCCCCcc-----hhhhhhhhhcc-----------------ccch-----------hhhcccccCCCcHHHHHHHHHHHHH
Q 003199 742 DFGDNKN-----IIYWVSIKVDT-----------------KEGI-----------MEVLDKKLSGSFRDEMIQVLRIAIR 788 (840)
Q Consensus 742 ~~~~~~~-----~~~~~~~~~~~-----------------~~~~-----------~~~~~~~~~~~~~~~~~~l~~l~~~ 788 (840)
....... ........... .... ..... ............+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH-HTTCCCHHHHHHHHHHHGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh-hcccCCcchHHHHHHHHHH
Confidence 4321100 00000000000 0000 00000 0011224556788899999
Q ss_pred ccCCCCCCCCCHHHHHHHhh
Q 003199 789 CTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 789 cl~~dP~~Rps~~evl~~L~ 808 (840)
|++.||++|||++|++++-.
T Consensus 317 ~L~~dP~~Rpt~~ell~hp~ 336 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNHPW 336 (373)
T ss_dssp GGCSSTTTCBCHHHHHTCGG
T ss_pred HhccCccccCCHHHHhhChh
Confidence 99999999999999998744
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.20 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=179.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||.||+|... +|+.||||++..... .....+.+.++..+++.++||||+++++++.+.
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--------KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--------chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 56888899999999999999765 799999999854321 122234455566678888999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLS-PIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+ ++.+..........+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 9999999999 556665555444578999999999999999999998 6 9999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
..... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||..... ....+.... .
T Consensus 173 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~-~ 244 (318)
T 2dyl_A 173 GRLVD----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEVLTKVL-Q 244 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHHHH-H
T ss_pred hhccC----CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cHHHHHHHh-c
Confidence 76643 12233456899999999984 45688999999999999999999999975211 111111110 0
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ..... ........+.+++.+||+.||.+||++.+++++
T Consensus 245 ~~-------~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 245 EE-------PPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SC-------CCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cC-------CCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 00011 011123456778889999999999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=328.42 Aligned_cols=334 Identities=20% Similarity=0.187 Sum_probs=273.3
Q ss_pred ccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCe
Q 003199 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTD 145 (840)
Q Consensus 66 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~ 145 (840)
.+++++.|++++|.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+ +.+..|..|.++++|++
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSC-CCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCC-CCcCCHHHhcCCCCCCE
Confidence 46789999999999987666668889999999999999997777899999999999999997 55566677899999999
Q ss_pred eeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccc
Q 003199 146 LDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKL 225 (840)
Q Consensus 146 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 225 (840)
|+|++|.++...+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++. .+..+++|+.|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 99999999966556678899999999999999988888899999999999999999854 356678888999988887
Q ss_pred cccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCccc
Q 003199 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTV 305 (840)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 305 (840)
++ +...++|++|++++|.+... |.. ..++|+.|++++|++++. ..+
T Consensus 199 ~~-----------------------------~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l 244 (390)
T 3o6n_A 199 ST-----------------------------LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWL 244 (390)
T ss_dssp SE-----------------------------EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGG
T ss_pred cc-----------------------------cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHH
Confidence 62 22335788999999999844 433 247899999999999864 568
Q ss_pred CCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCE
Q 003199 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNV 385 (840)
Q Consensus 306 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 385 (840)
..+++|++|+|++|++++..|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.
T Consensus 245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence 889999999999999998888999999999999999999984 5666778899999999999998 56777888999999
Q ss_pred EECcCccccccCCchhhcc-CCCeEEccCCCCcCcCCcccccCCCcccccCCCCCccc
Q 003199 386 LDLSNNLLTGYIPESLCEL-LPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLCVS 442 (840)
Q Consensus 386 L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~~~p~~~~~~~~~~~~~~n~~~c~~ 442 (840)
|+|++|++++. | +..+ .++.|++++|++.+.....+........+.+++..|..
T Consensus 323 L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 323 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred EECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence 99999999854 3 2223 46889999999998766555444444556677777753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.81 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=191.1
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc----CCCCcce
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI----RHKNIVK 596 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~ 596 (840)
....++|...+.||+|+||.||+|.. .+|+.||||++........ ........+.+|+.++.++ +|+||++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW----SPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC------------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc----ccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 44567899999999999999999965 4789999999854432110 0111223456788888888 8999999
Q ss_pred eeeEEecCccceEEEee-cCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCC
Q 003199 597 LYCYFSSLYCNLLVYEY-MPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQ 674 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~ 674 (840)
+++++...+..++|+|| +.+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++ .++.
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCe
Confidence 99999999999999999 78999999998754 68999999999999999999999 8999999999999999 8899
Q ss_pred CeeecccchhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 675 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
+||+|||+++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 179 ~kl~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~- 245 (312)
T 2iwi_A 179 AKLIDFGSGALLHD-----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EI- 245 (312)
T ss_dssp EEECCCSSCEECCS-----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH-
T ss_pred EEEEEcchhhhccc-----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HH-
Confidence 99999999976532 22344568999999999877666 458999999999999999999996420 00
Q ss_pred hhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
... ....... ....+.+++.+|++.||++|||+.|++++-.
T Consensus 246 ---~~~--------~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 246 ---LEA--------ELHFPAH---VSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp ---HHT--------CCCCCTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ---hhh--------ccCCccc---CCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000 0011122 2345667888999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.99 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=197.7
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--CCCcceeeeE
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--HKNIVKLYCY 600 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~ 600 (840)
+.++|+..+.||+|+||.||+|.. .+|+.||||++.......... ....+.+.+|+.++++++ |+||++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE----LPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE----CTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh----hhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345688899999999999999964 578999999986543221000 011234567899999996 5999999999
Q ss_pred EecCccceEEEeecCC-CChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCCeee
Q 003199 601 FSSLYCNLLVYEYMPN-GNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD-VNYQPKVA 678 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~ 678 (840)
+......++|+||+.+ ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999999976 89999998754 68999999999999999999999 9999999999999999 78899999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|||+++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .
T Consensus 193 Dfg~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~----~ 256 (320)
T 3a99_A 193 DFGSGALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI----I 256 (320)
T ss_dssp CCTTCEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH----H
T ss_pred eCcccccccc-----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh----h
Confidence 9999976532 22334569999999999877665 688999999999999999999996420 00 0
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L 807 (840)
.. .......+ ...+.+++.+||+.||++|||+.|++++-
T Consensus 257 ~~--------~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 257 RG--------QVFFRQRV---SSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp HC--------CCCCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cc--------cccccccC---CHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00 00111222 24566788899999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.28 Aligned_cols=258 Identities=23% Similarity=0.303 Sum_probs=196.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CC-cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC------ccee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SG-EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN------IVKL 597 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l 597 (840)
++|+..+.||+|+||+||+|... ++ +.||||++... ....+.+.+|+.+++.++|++ ++.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----------GKYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----------ccchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 57888999999999999999654 44 78999998422 123466788999999998766 8999
Q ss_pred eeEEecCccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-------
Q 003199 598 YCYFSSLYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILL------- 669 (840)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill------- 669 (840)
++++......++||||+ ++++.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||++
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccc
Confidence 99999999999999999 677777776543 468999999999999999999999 999999999999999
Q ss_pred ------------cCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCC
Q 003199 670 ------------DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRK 737 (840)
Q Consensus 670 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 737 (840)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 5678999999999976432 2234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhh-ccccch---------------------------hhhccc--ccCCCcHHHHHHHHHHHH
Q 003199 738 PVEDDFGDNKNIIYWVSIKV-DTKEGI---------------------------MEVLDK--KLSGSFRDEMIQVLRIAI 787 (840)
Q Consensus 738 p~~~~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~~~~--~~~~~~~~~~~~l~~l~~ 787 (840)
||..... ........... ...... ...... ............+.+++.
T Consensus 238 pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 238 LFQTHEN--REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCCCSSH--HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCH--HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 9975321 11100000000 000000 000000 000111233457889999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 003199 788 RCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 788 ~cl~~dP~~Rps~~evl~~ 806 (840)
+|++.||++|||+.|++++
T Consensus 316 ~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHTCSSTTTSCCHHHHTTS
T ss_pred HHhcCChhhCcCHHHHhcC
Confidence 9999999999999999876
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.95 Aligned_cols=307 Identities=24% Similarity=0.333 Sum_probs=160.3
Q ss_pred CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCC
Q 003199 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVT 92 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 92 (840)
+..+++|++|++++|.++ .+|. +..+++|++|++++| .+..++. +..+++|++|++++|.++.. +.+..++
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n---~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~ 110 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGN---QITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLT 110 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSS---CCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCC---ccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCC
Confidence 344555666666666665 3332 555666666666666 3333333 55555555555555555432 2355555
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
+|++|+|++|.+++ .+. +..+++|+.|++++|. .... +..+..+++|++|++
T Consensus 111 ~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~-------------------------~~~~-~~~~~~l~~L~~L~l 162 (347)
T 4fmz_A 111 NLRELYLNEDNISD-ISP-LANLTKMYSLNLGANH-------------------------NLSD-LSPLSNMTGLNYLTV 162 (347)
T ss_dssp TCSEEECTTSCCCC-CGG-GTTCTTCCEEECTTCT-------------------------TCCC-CGGGTTCTTCCEEEC
T ss_pred cCCEEECcCCcccC-chh-hccCCceeEEECCCCC-------------------------Cccc-ccchhhCCCCcEEEe
Confidence 55555555555552 222 4455555555555553 3211 222444445555555
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 252 (840)
++|.+.+..+ +..+++|++|++++|++.+..+ +..+++|+.|++++|.+++..+
T Consensus 163 ~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~---------------------- 216 (347)
T 4fmz_A 163 TESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP---------------------- 216 (347)
T ss_dssp CSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG----------------------
T ss_pred cCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch----------------------
Confidence 5554443322 4455555555555555543221 4445555555555555442110
Q ss_pred CCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhccc
Q 003199 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRA 332 (840)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 332 (840)
+..+++|++|++++|++++. +. +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++. ..+..+
T Consensus 217 ----~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l 286 (347)
T 4fmz_A 217 ----VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNL 286 (347)
T ss_dssp ----GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred ----hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCC
Confidence 33344444444444444422 21 44555555555555555542 2355556666666666666543 345566
Q ss_pred CcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccc
Q 003199 333 ISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 333 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 394 (840)
++|+.|++++|++++..|..++.+++|+.|+|++|++++..| +..+++|++|++++|+|+
T Consensus 287 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 666677777776666666666667777777777777765555 666777777777777765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=341.54 Aligned_cols=314 Identities=20% Similarity=0.177 Sum_probs=238.0
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
.+.+++.|++++|.++...+..|..+++|+.|+|++| .+..+++..|..+++|+.|+|++|.+++..|..|+++++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n---~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 125 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL---QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS---CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC---CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCC
Confidence 4688999999999999777777899999999999999 7788888899999999999999999999888999999999
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
++|+|++|.|++..+..|..+++|++|+|++|. +.+..|..|..+++|++|+|++|.+++. .+..+++|+.|++++
T Consensus 126 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~ 201 (597)
T 3oja_B 126 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSY 201 (597)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-CCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCS
T ss_pred CEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc-CCCCChhhhhcCCcCcEEECcCCCCCCc---Chhhhhhhhhhhccc
Confidence 999999999996666678999999999999997 5667777899999999999999999964 266789999999999
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCC
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 254 (840)
|.+++. ...++|+.|++++|.+....+.. .++|+.|+|++|.+++ +
T Consensus 202 n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--------------------------~ 247 (597)
T 3oja_B 202 NLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--------------------------T 247 (597)
T ss_dssp SCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--------------------------C
T ss_pred Cccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--------------------------C
Confidence 999853 34568899999999887443322 2466777777766652 1
Q ss_pred cccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCc
Q 003199 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334 (840)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 334 (840)
..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++
T Consensus 248 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------------l~~~~~~l~~ 302 (597)
T 3oja_B 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-------------------------LNLYGQPIPT 302 (597)
T ss_dssp GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-------------------------EECSSSCCTT
T ss_pred hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-------------------------CCcccccCCC
Confidence 234455555555555555555555555555555555555554443 2344445556
Q ss_pred ccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 335 LVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 335 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
|+.|+|++|.++ .+|..++.+++|+.|+|++|+|++.. +..+++|+.|+|++|++++..+
T Consensus 303 L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHH
T ss_pred CcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhH
Confidence 666666666666 45555666667777777777776432 5567788888888888886543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.30 Aligned_cols=260 Identities=25% Similarity=0.295 Sum_probs=194.5
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
...+|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++.
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~ 82 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---------SPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---------CHHHHHHHHHHHHHHHhCCCCCCCceeeeec
Confidence 447899999999999999999965 578999999884321 1234567899999999999999999999876
Q ss_pred c------CccceEEEeecCCCChHHHhhcCC--CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 003199 603 S------LYCNLLVYEYMPNGNLWDALHKGL--VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674 (840)
Q Consensus 603 ~------~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 674 (840)
. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~ 159 (676)
T 3qa8_A 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQ 159 (676)
T ss_dssp TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSS
T ss_pred ccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCC
Confidence 5 667799999999999999998753 358999999999999999999999 99999999999999997765
Q ss_pred ---CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 003199 675 ---PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751 (840)
Q Consensus 675 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 751 (840)
+||+|||++..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....
T Consensus 160 ~~~vKL~DFG~a~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~ 231 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQ----GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQ 231 (676)
T ss_dssp SCEEEECSCCCCCBTTS----CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHH
T ss_pred ceeEEEccccccccccc----ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhh
Confidence 89999999987643 222345679999999999999999999999999999999999999996421 1111
Q ss_pred hhhhhhcccc---chhhh------cccc---cCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 003199 752 WVSIKVDTKE---GIMEV------LDKK---LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803 (840)
Q Consensus 752 ~~~~~~~~~~---~~~~~------~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev 803 (840)
|......... ..... .... ...........+.+++.+|+..||++|||+.|+
T Consensus 232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 1110000000 00000 0000 011122345677888889999999999999773
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.91 Aligned_cols=306 Identities=26% Similarity=0.363 Sum_probs=253.4
Q ss_pred ccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCC
Q 003199 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143 (840)
Q Consensus 64 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L 143 (840)
+..+++|+.|++++|.+.. ++ .+..+++|++|+|++|.+++ ++. +..+++|++|++++|. + ..+ ..+..+++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~-i-~~~-~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNK-I-TDI-SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC-C-CCC-GGGTTCTTC
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCc-c-cCc-hHHcCCCcC
Confidence 4567777777777777763 33 37778888888888888884 343 8888888888888886 2 233 368899999
Q ss_pred CeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccc
Q 003199 144 TDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223 (840)
Q Consensus 144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 223 (840)
++|++++|.+++. +. +..+++|++|++++|...... ..+..+++|++|++++|.+....+ +..+++|+.|++++|
T Consensus 113 ~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCc-hh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 9999999999854 33 889999999999999665443 448999999999999999985543 888999999999999
Q ss_pred cccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCc
Q 003199 224 KLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303 (840)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 303 (840)
.+.+ ++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+
T Consensus 188 ~l~~-------------------------~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~- 238 (347)
T 4fmz_A 188 QIED-------------------------ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238 (347)
T ss_dssp CCCC-------------------------CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred cccc-------------------------ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-
Confidence 8873 222 6778899999999999985443 8889999999999999997655
Q ss_pred ccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCC
Q 003199 304 TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSL 383 (840)
Q Consensus 304 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 383 (840)
+..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..|..+..+++|
T Consensus 239 -~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 88999999999999999864 4688999999999999999964 458899999999999999999999999999999
Q ss_pred CEEECcCccccccCCchhhcc-CCCeEEccCCCCc
Q 003199 384 NVLDLSNNLLTGYIPESLCEL-LPNSINFSNNRLS 417 (840)
Q Consensus 384 ~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~ 417 (840)
++|+|++|++++..| +..+ .++.|++++|+++
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999997766 5555 5789999999885
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=306.67 Aligned_cols=239 Identities=12% Similarity=0.044 Sum_probs=182.5
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
.+|...+.||+|+||.||+|... +|+.||||++...... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-------PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-------CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 46888899999999999999665 6899999998543321 133457789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++++|.+++..+ ....++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred CcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---
Confidence 9999999999999999999653 3556788999999999999999 999999999999999999999998543
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
|++| ++.++|||||||++|||++|+.||.+............ ........
T Consensus 175 --------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~- 224 (286)
T 3uqc_A 175 --------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER--DTAGQPIE- 224 (286)
T ss_dssp --------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB--CTTSCBCC-
T ss_pred --------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH--HhccCCCC-
Confidence 3333 68899999999999999999999986422110000000 00000000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFES 817 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 817 (840)
...... .....+.+++.+||+.||++| |+.|+++.|+++.......
T Consensus 225 ---~~~~~~---~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 225 ---PADIDR---DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp ---HHHHCT---TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred ---hhhccc---CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 000111 123456778889999999999 9999999999877655433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.52 Aligned_cols=288 Identities=21% Similarity=0.274 Sum_probs=188.1
Q ss_pred cccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeec
Q 003199 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDM 148 (840)
Q Consensus 69 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L 148 (840)
+|+.+++++|.++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|+ +.+..|..|.++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC-CCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCc-cCccCHhHhhCcCCCCEEEC
Confidence 3445555555554 3343332 455666666666655545556666666666666554 33444555666666666666
Q ss_pred cCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCc--ccCCcCCCCCCCcceecccccccc
Q 003199 149 SVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT--GEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
++|+++ .+|..+. ++|++|++++|+++...+..|.++++|++|++++|+++ +..+..+..+ +|+.|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 666666 3333333 56677777777766666666667777777777777764 2555666666 7777777777776
Q ss_pred ccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccC
Q 003199 227 GPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVG 306 (840)
Q Consensus 227 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 306 (840)
+ +|..+. ++|++|++++|++++..+..+..+++|+.|++++|++++..+..+.
T Consensus 186 ~-------------------------l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 238 (332)
T 2ft3_A 186 G-------------------------IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238 (332)
T ss_dssp S-------------------------CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGG
T ss_pred c-------------------------cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhh
Confidence 3 122221 4666777777777766666777777777777777777777777777
Q ss_pred CCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccC------ccccchhcccCCccC--CCcchhcc
Q 003199 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN------LKKLNLLMLQSNKLN--SSIPNSLS 378 (840)
Q Consensus 307 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~~~~~~ 378 (840)
.+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+..|.. ...|+.|++++|++. +..|.+|.
T Consensus 239 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp GCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence 7788888888888887 66777778888888888888888666666654 356888888888887 57778888
Q ss_pred cccCCCEEECcCcc
Q 003199 379 SLKSLNVLDLSNNL 392 (840)
Q Consensus 379 ~l~~L~~L~l~~N~ 392 (840)
.+++|+.|++++|+
T Consensus 318 ~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 318 CVTDRLAIQFGNYK 331 (332)
T ss_dssp TBCCSTTEEC----
T ss_pred ccchhhhhhccccc
Confidence 88999999988874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=343.04 Aligned_cols=238 Identities=22% Similarity=0.296 Sum_probs=189.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+|...+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||+++++++..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---------DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 57888999999999999999764 68999999885322 12345678899999999999999999999987
Q ss_pred Ccc-----ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 LYC-----NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~~~-----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
... .++||||+++++|.+++.. .++|.++..++.||+.||+|||+ ++||||||||+|||++.+ .+||+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEEC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEE
Confidence 665 6999999999999988765 68999999999999999999999 999999999999999986 89999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+++..... ....||+.|+|||++.+. ++.++|||||||++|||++|..||.......
T Consensus 224 DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------ 283 (681)
T 2pzi_A 224 DLGAVSRINSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------ 283 (681)
T ss_dssp CCTTCEETTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------
T ss_pred ecccchhcccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------
Confidence 99999765321 345799999999988765 4899999999999999999998876421100
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhh
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-MNEVVQLLAE 809 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~L~~ 809 (840)
. . ...........+.+++.+|++.||++||+ ++++.+.+..
T Consensus 284 ----~----~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ----L----P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----C----C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----c----c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 0 00001122356778899999999999995 5555555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.25 Aligned_cols=241 Identities=18% Similarity=0.151 Sum_probs=175.4
Q ss_pred hcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC-CCcceee------
Q 003199 527 AMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH-KNIVKLY------ 598 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~------ 598 (840)
.|...+.||+|+||+||+|. ..+|+.||||++...... .....+.+.+|+.+++.+.| +|...+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-------~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-------PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-------cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 35567789999999999996 557999999998533211 12234668899999999987 3221111
Q ss_pred ---------------eEEec-----CccceEEEeecCCCChHHHhh------cCCCCCChHHHHHHHHHHHHHHHHHhhc
Q 003199 599 ---------------CYFSS-----LYCNLLVYEYMPNGNLWDALH------KGLVHLDWPTRHKIAFGVAQGLAYLHHG 652 (840)
Q Consensus 599 ---------------~~~~~-----~~~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 652 (840)
.++.. ....+++|+++ +++|.+++. .....+++..+..++.|+++||+|||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~- 229 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH- 229 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence 11111 12345666665 789999884 223357888999999999999999999
Q ss_pred CCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCcccc----------ccCCCCccccc
Q 003199 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYA----------YSSKATTKCDV 722 (840)
Q Consensus 653 ~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv 722 (840)
++||||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++||
T Consensus 230 --~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 230 --YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp --TTEECSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred --CCcccCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 9999999999999999999999999999876532 2344567 999999998 55568899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 003199 723 YSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802 (840)
Q Consensus 723 ~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 802 (840)
|||||++|||++|+.||........ ........ .. ....+.+++.+||+.||++||++.+
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~---~~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALGG---------------SEWIFRSC--KN---IPQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CC---CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHhhc--cc---CCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999975321100 01111100 11 1245777888999999999999777
Q ss_pred HHH
Q 003199 803 VVQ 805 (840)
Q Consensus 803 vl~ 805 (840)
+++
T Consensus 361 ~l~ 363 (413)
T 3dzo_A 361 AME 363 (413)
T ss_dssp HTT
T ss_pred HHh
Confidence 654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.70 Aligned_cols=230 Identities=23% Similarity=0.309 Sum_probs=177.2
Q ss_pred HHHhcCcc-CeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHH-hccCCCCcceeeeE
Q 003199 524 ILEAMTEK-NKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL-GNIRHKNIVKLYCY 600 (840)
Q Consensus 524 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~ 600 (840)
+..+|... +.||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +...||||++++++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------------~~~~~~e~~~~~~~~~h~~i~~~~~~ 79 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------------CPKARREVELHWRASQCPHIVRIVDV 79 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------------SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------------cHHHHHHHHHHHHhccCCCchhHHhh
Confidence 34566666 6799999999999965 5789999999832 12456788887 55589999999999
Q ss_pred Eec----CccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C
Q 003199 601 FSS----LYCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---N 672 (840)
Q Consensus 601 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~ 672 (840)
+.. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. +
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTT
T ss_pred hhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCC
Confidence 876 677899999999999999998753 368999999999999999999999 99999999999999998 7
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
+.+||+|||++.... +..++.++|||||||++|||++|+.||...........
T Consensus 157 ~~~kl~Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-- 209 (299)
T 3m2w_A 157 AILKLTDFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-- 209 (299)
T ss_dssp CCEEECCCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--
T ss_pred CcEEEeccccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--
Confidence 889999999985431 23467899999999999999999999975322110000
Q ss_pred hhhhhccccchhhhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 753 VSIKVDTKEGIMEVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
............. ......+.+++.+|++.||++|||+.|++++-.
T Consensus 210 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 210 ----------MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp ----------SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----------HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0000000000000 122456778888999999999999999998743
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=298.12 Aligned_cols=289 Identities=20% Similarity=0.281 Sum_probs=165.5
Q ss_pred cccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeec
Q 003199 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDM 148 (840)
Q Consensus 69 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L 148 (840)
+|+.++++++.++ .+|..+. ++|++|+|++|.|++..+..|..+++|++|+|++|+ +.+..|..|..+++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC-CCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCc-CCeeCHHHhcCCCCCCEEEC
Confidence 4455555555554 3343332 355566666666654444455556666666665554 33334555566666666666
Q ss_pred cCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcc--cCCcCCCCCCCcceecccccccc
Q 003199 149 SVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTG--EVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|++.. ..+..+..+++|+.|++++|.++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 666665 3333332 566666666666666555566666666666666666642 44555566666666666666655
Q ss_pred ccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccC
Q 003199 227 GPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVG 306 (840)
Q Consensus 227 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 306 (840)
.. |..+. ++|++|++++|++++..|..+..+++|+.|++++|++++..+..+.
T Consensus 185 ~l-------------------------~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 185 TI-------------------------PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp SC-------------------------CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred cC-------------------------Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 21 11111 4555566666666555555566666666666666666655555566
Q ss_pred CCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccC------ccccchhcccCCccCC--Ccchhcc
Q 003199 307 NARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN------LKKLNLLMLQSNKLNS--SIPNSLS 378 (840)
Q Consensus 307 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~~~~~~ 378 (840)
.+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|.. ...|+.|++++|++.. ..|..|.
T Consensus 238 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~ 316 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316 (330)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccc
Confidence 6666666666666666 55556666666666666666666555555532 2566677777777653 4566777
Q ss_pred cccCCCEEECcCcc
Q 003199 379 SLKSLNVLDLSNNL 392 (840)
Q Consensus 379 ~l~~L~~L~l~~N~ 392 (840)
.+.+++.++|++|+
T Consensus 317 ~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 317 CVYVRAAVQLGNYK 330 (330)
T ss_dssp TCCCGGGEEC----
T ss_pred cccceeEEEecccC
Confidence 77777777777764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=297.25 Aligned_cols=294 Identities=19% Similarity=0.210 Sum_probs=212.7
Q ss_pred CCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCee
Q 003199 42 NLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQL 121 (840)
Q Consensus 42 ~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L 121 (840)
+|+.+++++| .+..+|... .++|+.|+|++|.+.+..|..|.++++|++|+|++|++++..|..|..+++|++|
T Consensus 34 ~l~~l~~~~~---~l~~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 34 HLRVVQCSDL---GLKAVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp ETTEEECCSS---CCSSCCSCC---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred cCCEEECCCC---CccccCCCC---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 5677777777 455565543 2567778888888877777788888888888888888887778888888888888
Q ss_pred ecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccc--ccchhhhcCCCCCEEEccCC
Q 003199 122 ELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG--EISSVIANSTTLTMLSLYDN 199 (840)
Q Consensus 122 ~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N 199 (840)
+|++|+ ...+|..+. ++|++|++++|.++...+..|..+++|++|++++|.++. ..+..|..+ +|++|++++|
T Consensus 108 ~L~~n~--l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n 182 (332)
T 2ft3_A 108 YISKNH--LVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA 182 (332)
T ss_dssp ECCSSC--CCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSS
T ss_pred ECCCCc--CCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCC
Confidence 888887 335665554 789999999999987767778889999999999998863 667777777 8999999999
Q ss_pred cCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCc
Q 003199 200 SLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPE 279 (840)
Q Consensus 200 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 279 (840)
++++ +|..+. ++|+.|+|++|++++..+..+..+++|+.|++++|.+.+..+..|..+++|++|++++|+++ .+|.
T Consensus 183 ~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 183 KLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp BCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred CCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 9985 555443 68899999999988777777777777777777777777766667777777777777777777 6666
Q ss_pred cccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccC--CCCCCcccCcc
Q 003199 280 GILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS--GPIPSGIGNLK 357 (840)
Q Consensus 280 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~ 357 (840)
.+..+++|+.|++++|++++..+..|....- ......|+.|++++|++. +..|..|..++
T Consensus 259 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~ 320 (332)
T 2ft3_A 259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320 (332)
T ss_dssp TGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBC
T ss_pred hhhcCccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccc
Confidence 6777777777777777777665555543210 001234566666666665 45556666677
Q ss_pred ccchhcccCCc
Q 003199 358 KLNLLMLQSNK 368 (840)
Q Consensus 358 ~L~~L~Ls~N~ 368 (840)
+|+.++|++|+
T Consensus 321 ~L~~l~l~~n~ 331 (332)
T 2ft3_A 321 DRLAIQFGNYK 331 (332)
T ss_dssp CSTTEEC----
T ss_pred hhhhhhccccc
Confidence 77777776664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=315.24 Aligned_cols=250 Identities=14% Similarity=0.180 Sum_probs=184.2
Q ss_pred HHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC---------CCCcc
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR---------HKNIV 595 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h~niv 595 (840)
.++|+..+.||+|+||+||+|.. +|+.||||++........ ........+.+.+|+.+++.++ ||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV--NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCB--TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCcccc--ccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 46788899999999999999987 689999999965532210 0011122456778888888875 66666
Q ss_pred eeeeE-----------------Eec-------------CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHH
Q 003199 596 KLYCY-----------------FSS-------------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645 (840)
Q Consensus 596 ~l~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~ 645 (840)
++.+. +.+ ....++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 65554 333 6788999999999987777754 368999999999999999
Q ss_pred HHHHh-hcCCCCeEecCCCCCCEEEcCCC--------------------CCeeecccchhhhhccCCCCcceeccccccc
Q 003199 646 LAYLH-HGLLSPIIHRDIKSTNILLDVNY--------------------QPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704 (840)
Q Consensus 646 l~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 704 (840)
|+||| + ++||||||||+|||++.++ .+||+|||+|+.... ....||+.
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~ 242 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDV 242 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCC
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeec
Confidence 99999 8 8999999999999999887 899999999986532 13479999
Q ss_pred ccCccccccCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchhh-hcccc-cCCCcHHHHHH
Q 003199 705 YLAPEYAYSSKATTKCDVYSFGVV-LMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME-VLDKK-LSGSFRDEMIQ 781 (840)
Q Consensus 705 y~aPE~~~~~~~~~~~Dv~slG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~ 781 (840)
|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|........ ... ..... ..........+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTDKM--LKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHHHH--HHTCCCSSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHHhh--hhhhccCcccchhhhhhcCHH
Confidence 99999988766 899999998777 7788889999843 11211110000 000 00111 11123456678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHH-HH
Q 003199 782 VLRIAIRCTSKSPATRPTMNEVV-QL 806 (840)
Q Consensus 782 l~~l~~~cl~~dP~~Rps~~evl-~~ 806 (840)
+.+++.+|++.| |++|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 889999999976 999998 64
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=293.73 Aligned_cols=275 Identities=22% Similarity=0.228 Sum_probs=170.7
Q ss_pred ccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeee
Q 003199 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLD 147 (840)
Q Consensus 68 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~ 147 (840)
++|+.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|+ ...+|..+. ++|++|+
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~l~~~~~--~~L~~L~ 127 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ--LKELPEKMP--KTLQELR 127 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC--CSBCCSSCC--TTCCEEE
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc--CCccChhhc--ccccEEE
Confidence 345555555555555555556666666666666666665556666666666666666665 224454443 5777777
Q ss_pred ccCCcccccCCccccCCCCCcEEEeecccccc--ccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccc
Q 003199 148 MSVNHLSGKIPESILRLPKLRVLQLYNNSLSG--EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKL 225 (840)
Q Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 225 (840)
+++|.+++..+..|.++++|++|++++|.+.. ..+..|.++++|++|++++|+++. +|..+. ++|++|+|++|++
T Consensus 128 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCC
T ss_pred CCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcC
Confidence 77777776666667778888888888887753 556777788888888888888874 444433 6788888888887
Q ss_pred cccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCccc
Q 003199 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTV 305 (840)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 305 (840)
++..+..+..+++|+.|++++|.+.+..+..+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 7665555555555555555555555555555666666666666666666 555556666666666666666665555444
Q ss_pred CCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCC--CCCCcccCccccchhcccCCc
Q 003199 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSG--PIPSGIGNLKKLNLLMLQSNK 368 (840)
Q Consensus 306 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 368 (840)
.... .......++.|++++|++.. ..|..|..+++++.++|++|+
T Consensus 284 ~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 284 CPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcc------------------cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3220 00112456666666666642 445566777777777777764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=301.50 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=106.6
Q ss_pred CCCeeecccCccccc--cCCcccCCCCCCCeeeccC-CcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCE
Q 003199 117 NLRQLELYYNQQLAG--TIPEELGNLTELTDLDMSV-NHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTM 193 (840)
Q Consensus 117 ~L~~L~L~~n~~~~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 193 (840)
+++.|+|++|. +.+ .+|..+..+++|++|+|++ |.+.+.+|..|..+++|++|+|++|++++..|..|.++++|++
T Consensus 51 ~l~~L~L~~~~-l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 51 RVNNLDLSGLN-LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCC-CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred eEEEEECCCCC-ccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 34444444443 222 3444444444444444442 4444444444444444444444444444444444444444444
Q ss_pred EEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCccccccc-CCceEEeeCce
Q 003199 194 LSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCK-NLLRFRVSNNH 272 (840)
Q Consensus 194 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~l~~N~ 272 (840)
|+|++|++++.+|..+..+++|++|+|++|++++ .+|..+..++ +|++|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~------------------------~~p~~l~~l~~~L~~L~L~~N~ 185 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISG------------------------AIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEE------------------------ECCGGGGCCCTTCCEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccC------------------------cCCHHHhhhhhcCcEEECcCCe
Confidence 4444444444444444444444444444444433 3333333333 44444444444
Q ss_pred eeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCc
Q 003199 273 LEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSG 352 (840)
Q Consensus 273 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 352 (840)
+++.+|..+..++ |+.|++++|++++..+..|..+++|+.|+|++|++++..|. +..+++|++|+|++|++++.+|..
T Consensus 186 l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 263 (313)
T 1ogq_A 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred eeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence 4444444444443 44444444444444444444444444444444444433222 333444444444444444444444
Q ss_pred ccCccccchhcccCCccCCCcchhcccccCCCEEECcCcc
Q 003199 353 IGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392 (840)
Q Consensus 353 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 392 (840)
+..+++|+.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 264 l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 264 LTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred HhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 444444444444444444444333 334444444444443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=295.87 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=226.7
Q ss_pred CCCcEEEccCCcccc--cCchhhhcCCCCCeeeccc-CccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCc
Q 003199 92 TSLTDLELTGNFITG--HIPPEIGLLKNLRQLELYY-NQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLR 168 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~L~~-n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (840)
.+++.|+|++|.+++ .+|..|..+++|++|+|++ |. +.+.+|..|..+++|++|+|++|.+++..|..|..+++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~-l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN-LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETT-EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCc-ccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 589999999999998 8999999999999999995 75 6778999999999999999999999989999999999999
Q ss_pred EEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCC-CcceeccccccccccCCccccCCCCchhhhcccc
Q 003199 169 VLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWS-PLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247 (840)
Q Consensus 169 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 247 (840)
+|+|++|.+++..|..|..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++..|
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~----------------- 191 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP----------------- 191 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECC-----------------
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCC-----------------
Confidence 999999999999999999999999999999999988999999998 99999999999886544
Q ss_pred cccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccch
Q 003199 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS 327 (840)
Q Consensus 248 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 327 (840)
..+..++ |+.|++++|.+++..|..+..+++|+.|+|++|++++..+. +..+++|++|+|++|++++.+|.
T Consensus 192 -------~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~ 262 (313)
T 1ogq_A 192 -------PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp -------GGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred -------hHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCCh
Confidence 4455555 88888888888888888888888888888888888866665 77889999999999999989999
Q ss_pred hhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCc-cCCC
Q 003199 328 EIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK-LNSS 372 (840)
Q Consensus 328 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~ 372 (840)
.+..+++|+.|+|++|++++.+|.. +.+++|+.|++++|+ +.|.
T Consensus 263 ~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 263 GLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred HHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 9999999999999999999888886 889999999999998 5543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-36 Score=339.27 Aligned_cols=380 Identities=19% Similarity=0.191 Sum_probs=235.1
Q ss_pred CCCCEEecCCCcCcccCCcc-ccCCCCCCEEeCCCCCCCccCCCC----cccccccccccEEEecCccccccCCccc-cC
Q 003199 17 QNLRRLDLSNNLFTGQFPLS-VFNLTNLEVLSFNENPGFKLWKLP----ESSIFRLTKLRIMVLATCALHGQIPASI-GN 90 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~-~~~l~~L~~L~L~~N~~~~l~~l~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~ 90 (840)
++|++|||++|.++...... +..+++|++|+|++|. +.... ...+..+++|++|+|++|.+....+..+ ..
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~---l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 79 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCG---LTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 79 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSC---CCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCC---CCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHH
Confidence 56788999999887544333 7778888888888884 33211 2346667888888888888765433332 23
Q ss_pred CC----CCcEEEccCCcccc----cCchhhhcCCCCCeeecccCccccccCCcc-----cCCCCCCCeeeccCCcccccC
Q 003199 91 VT----SLTDLELTGNFITG----HIPPEIGLLKNLRQLELYYNQQLAGTIPEE-----LGNLTELTDLDMSVNHLSGKI 157 (840)
Q Consensus 91 l~----~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~-----l~~l~~L~~L~L~~n~l~~~~ 157 (840)
++ +|++|+|++|.|++ .++..+..+++|++|+|++|. +.+..+.. ....++|++|+|++|.++...
T Consensus 80 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~-i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 80 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL-LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSB-CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCc-CchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 44 68888888888874 347777788888888888876 33222221 223567888888888877533
Q ss_pred ----CccccCCCCCcEEEeeccccccccchhhhc-----CCCCCEEEccCCcCccc----CCcCCCCCCCcceecccccc
Q 003199 158 ----PESILRLPKLRVLQLYNNSLSGEISSVIAN-----STTLTMLSLYDNSLTGE----VPQDLGQWSPLVVLDLSENK 224 (840)
Q Consensus 158 ----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~ 224 (840)
+..+..+++|++|++++|.+++..+..+.. .++|++|+|++|.++.. ++..+..+++|+.|+|++|+
T Consensus 159 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 238 (461)
T 1z7x_W 159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred HHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence 445566778888888888876554444432 56788888888877743 34556667777888888777
Q ss_pred ccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeecc----CCccccCCCcccEEeccCCccccc
Q 003199 225 LSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS----IPEGILSLPHVSIIDLSYNSFSGP 300 (840)
Q Consensus 225 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 300 (840)
+++.....++ +..+..+++|++|++++|.++.. ++..+..+++|+.|++++|.+++.
T Consensus 239 l~~~~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 239 LGDVGMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp CHHHHHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred CChHHHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence 7643211110 11122355666666666666532 344555566666666666666543
Q ss_pred CCcccCC-----CCCCceeecccceeeec----cchhhcccCcccEEEcCCCccCCCCCCcccC-----ccccchhcccC
Q 003199 301 IANTVGN-----ARNLSELFMQRNQISGF----IPSEIYRAISLVKIDLSDNLLSGPIPSGIGN-----LKKLNLLMLQS 366 (840)
Q Consensus 301 ~~~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~ 366 (840)
.+..+.. .++|++|+|++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|+.|+|++
T Consensus 300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence 3332222 25677777777776654 3455555667777777777766543433332 45677777777
Q ss_pred CccCC----CcchhcccccCCCEEECcCccccccCCchhhc------cCCCeEEccCCCCcCc
Q 003199 367 NKLNS----SIPNSLSSLKSLNVLDLSNNLLTGYIPESLCE------LLPNSINFSNNRLSGP 419 (840)
Q Consensus 367 N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------~~~~~l~l~~N~l~~~ 419 (840)
|++++ .+|..+..+++|++|||++|++++.-...+.. ..++.|++.++.+...
T Consensus 380 n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~ 442 (461)
T 1z7x_W 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHH
Confidence 77764 56666777777777777777776542222221 1345666666665543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-35 Score=335.70 Aligned_cols=356 Identities=18% Similarity=0.164 Sum_probs=251.8
Q ss_pred CCCCEEeCCCCCCCccCCCCcc-cccccccccEEEecCccccc----cCCccccCCCCCcEEEccCCcccccCchhh-hc
Q 003199 41 TNLEVLSFNENPGFKLWKLPES-SIFRLTKLRIMVLATCALHG----QIPASIGNVTSLTDLELTGNFITGHIPPEI-GL 114 (840)
Q Consensus 41 ~~L~~L~L~~N~~~~l~~l~~~-~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~-~~ 114 (840)
++|++|+|++| .+...+.. .+..+++|++|+|++|.+.. .++..+..+++|++|+|++|.+++..+..+ ..
T Consensus 3 ~~l~~L~Ls~~---~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 79 (461)
T 1z7x_W 3 LDIQSLDIQCE---ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 79 (461)
T ss_dssp EEEEEEEEESC---CCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred ccceehhhhhc---ccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHH
Confidence 46778888888 44443333 26677888888888888763 345667777888888888888775444333 33
Q ss_pred CC----CCCeeecccCcccc---ccCCcccCCCCCCCeeeccCCcccccCCcccc-----CCCCCcEEEeecccccccc-
Q 003199 115 LK----NLRQLELYYNQQLA---GTIPEELGNLTELTDLDMSVNHLSGKIPESIL-----RLPKLRVLQLYNNSLSGEI- 181 (840)
Q Consensus 115 l~----~L~~L~L~~n~~~~---~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~- 181 (840)
++ +|++|+|++|++.. ..++..+..+++|++|+|++|.++...+..+. ..++|++|+|++|++++..
T Consensus 80 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 159 (461)
T 1z7x_W 80 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159 (461)
T ss_dssp TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred HhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHH
Confidence 55 57777777776221 23466677777777777777777643333222 2456777777777776533
Q ss_pred ---chhhhcCCCCCEEEccCCcCcccCCcCCC-----CCCCcceeccccccccccCCccccCCCCchhhhcccccccccC
Q 003199 182 ---SSVIANSTTLTMLSLYDNSLTGEVPQDLG-----QWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVL 253 (840)
Q Consensus 182 ---~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 253 (840)
+..+..+++|++|+|++|.++...+..+. ..++|++|+|++|.+++.... .+
T Consensus 160 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l 219 (461)
T 1z7x_W 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--------------------DL 219 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--------------------HH
T ss_pred HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--------------------HH
Confidence 44555667777777777776643333332 244666777776666521100 24
Q ss_pred CcccccccCCceEEeeCceeeccC-----CccccCCCcccEEeccCCccccc----CCcccCCCCCCceeecccceeeec
Q 003199 254 PDSLARCKNLLRFRVSNNHLEGSI-----PEGILSLPHVSIIDLSYNSFSGP----IANTVGNARNLSELFMQRNQISGF 324 (840)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 324 (840)
+..+..+++|++|++++|.+++.. +..+..+++|+.|++++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 220 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence 556778899999999999987532 22334689999999999999864 466677799999999999999876
Q ss_pred cchhhccc-----CcccEEEcCCCccCCC----CCCcccCccccchhcccCCccCCCcchhccc-----ccCCCEEECcC
Q 003199 325 IPSEIYRA-----ISLVKIDLSDNLLSGP----IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS-----LKSLNVLDLSN 390 (840)
Q Consensus 325 ~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~l~~ 390 (840)
.+..+... ++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|+|++
T Consensus 300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence 66555543 6999999999999865 4566777899999999999998766665543 67999999999
Q ss_pred ccccc----cCCchhhcc-CCCeEEccCCCCcCc
Q 003199 391 NLLTG----YIPESLCEL-LPNSINFSNNRLSGP 419 (840)
Q Consensus 391 N~l~~----~~p~~~~~~-~~~~l~l~~N~l~~~ 419 (840)
|.+++ .+|..+... .++.|++++|++++.
T Consensus 380 n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 99996 778877766 578999999999864
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=274.37 Aligned_cols=259 Identities=20% Similarity=0.203 Sum_probs=138.0
Q ss_pred CCCeeeccCCcccccCCccccCCCCCcEEEeecccccccc--chhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceec
Q 003199 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI--SSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLD 219 (840)
Q Consensus 142 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 219 (840)
+|++|+|++|+++.+.+..|.++++|++|+|++|.++... +..+..+++|++|+|++|.++ .++..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 4555555555555333333455555555555555554221 344445555555555555555 2334455555555555
Q ss_pred cccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccc
Q 003199 220 LSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299 (840)
Q Consensus 220 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 299 (840)
+++|++++..+ ...+..+++|++|++++|.+.+..+..+..+++|+.|++++|.+++
T Consensus 108 l~~n~l~~~~~-----------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 108 FQHSNLKQMSE-----------------------FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CTTSEEESSTT-----------------------TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCCccccccc-----------------------chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 55555543221 0234444455555555555554445555555555555555555554
Q ss_pred -cCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcc
Q 003199 300 -PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLS 378 (840)
Q Consensus 300 -~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 378 (840)
..+..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 3455555566666666666666655555666666666666666666655555566666666666666666666666666
Q ss_pred ccc-CCCEEECcCccccccCCc-hhhcc--CCCeEEccCCCCcCcCCccc
Q 003199 379 SLK-SLNVLDLSNNLLTGYIPE-SLCEL--LPNSINFSNNRLSGPIPLSL 424 (840)
Q Consensus 379 ~l~-~L~~L~l~~N~l~~~~p~-~~~~~--~~~~l~l~~N~l~~~~p~~~ 424 (840)
.++ +|++|+|++|++++..+. ++..+ ....+.+..+.+.|..|..+
T Consensus 245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~ 294 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 294 (306)
T ss_dssp CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhh
Confidence 663 677777777777654321 11111 11233445556666666543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-31 Score=284.38 Aligned_cols=280 Identities=18% Similarity=0.172 Sum_probs=164.5
Q ss_pred CCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEE
Q 003199 91 VTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVL 170 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (840)
++.....++++|.++ .+|..+. ++|++|++++|+ +.+..+..|.++++|++|+|++|++++..+..|.++++|++|
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSC-CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCc-CcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 445556788888888 5665543 478888888876 444444467778888888888888877667777778888888
Q ss_pred EeeccccccccchhhhcCCCCCEEEccCCcCcccCC-cCCCCCCCcceeccccc-cccccCCccccCCCCchhhhccccc
Q 003199 171 QLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP-QDLGQWSPLVVLDLSEN-KLSGPLPAKVCSRGKLQYFLVLQNM 248 (840)
Q Consensus 171 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~n~ 248 (840)
+|++|++++..+..|.++++|++|+|++|+++...+ ..+..+++|++|++++| .+++..+.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~----------------- 168 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK----------------- 168 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT-----------------
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHH-----------------
Confidence 888888876666667777888888888887774433 36777777777777777 35433333
Q ss_pred ccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchh
Q 003199 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328 (840)
Q Consensus 249 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 328 (840)
.|..+++|++|++++|++++..|..+..+++|++|++++|+++......+..+++|+.|++++|++++..+..
T Consensus 169 -------~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 241 (353)
T 2z80_A 169 -------DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241 (353)
T ss_dssp -------TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-
T ss_pred -------HccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc
Confidence 3444444555555555554444444555555555555555544333333333444555555555444332222
Q ss_pred hc---ccCcccEEEcCCCccCC----CCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 329 IY---RAISLVKIDLSDNLLSG----PIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 329 ~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+++...+..|..+++|++|+|++|++++..|
T Consensus 242 l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 242 LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 21 12334445555554443 244445555566666666666653333334566666666666666665444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=278.93 Aligned_cols=205 Identities=18% Similarity=0.172 Sum_probs=123.8
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
.++.....++++|.++ .+|..+. ++|++|+|++| .+..++...|..+++|++|+|++|.+++..|..|+++++|
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n---~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNN---RITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTS---CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCC---cCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCC
Confidence 4455566777777777 5665554 46777777777 5556666667777777777777777776666667777777
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCc--ccCCCCCCCeeeccCC-cccccCCccccCCCCCcEEE
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE--ELGNLTELTDLDMSVN-HLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~--~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|+|++|++++..+..|..+++|++|+|++|+ ...+|. .+..+++|++|++++| .++...+..|.++++|++|+
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP--YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp CEEECCSSCCSSCCHHHHTTCTTCSEEECTTCC--CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CEEECCCCcCCcCCHhHhCCCccCCEEECCCCC--CcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 777777777764444446666666666666665 223333 4556666666666665 35544455555566666666
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
+++|++++..+..|..+++|++|++++|+++......+..+++|+.|+|++|++++
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTT
T ss_pred CCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccc
Confidence 66666655555555555556666665555543222223334555555555555553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=266.49 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=117.3
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccccc--CCccccCCCCCcEE
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ--IPASIGNVTSLTDL 97 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L 97 (840)
+.++++++.++ .+|..+. ++|++|+|++| .+..++...|..+++|++|+|++|.+... .+..+..+++|++|
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n---~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESN---KLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSS---CCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCC---ccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 46777777776 5555443 46677777766 45555555555555555555555555422 13344445555555
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCC-cccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP-EELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
+|++|.++ .+|..+..+++|++|++++|+ +.+..+ ..+..+++|++|++++|.+++..+..|..+++|++|++++|.
T Consensus 84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp ECCSCSEE-EEEEEEETCTTCCEEECTTSE-EESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred ECCCCccc-cChhhcCCCCCCCEEECCCCc-ccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 55555555 334444445555555555444 111111 234444444444444444444444444444444444444444
Q ss_pred ccc-ccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCc
Q 003199 177 LSG-EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255 (840)
Q Consensus 177 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 255 (840)
+++ ..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++ ..+.
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------~~~~ 217 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS------------------------LDTF 217 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB------------------------CCSG
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc------------------------cChh
Confidence 443 233344444444444444444443334444444444444444444432 2222
Q ss_pred ccccccCCceEEeeCceeeccCCccccCCC-cccEEeccCCccc
Q 003199 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLP-HVSIIDLSYNSFS 298 (840)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 298 (840)
.+..+++|++|++++|++++..|..+..++ +|+.|+|++|.++
T Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 344444455555555555444444444442 4444444444444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=276.89 Aligned_cols=252 Identities=21% Similarity=0.198 Sum_probs=189.3
Q ss_pred CCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEc
Q 003199 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196 (840)
Q Consensus 117 ~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 196 (840)
....++.+++. ...+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~--l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRG--LSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSC--CSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCC--cCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 34566666554 344555443 46777777777777666667777777777777777777666667777777777777
Q ss_pred cCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeC-ceeec
Q 003199 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN-NHLEG 275 (840)
Q Consensus 197 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-N~l~~ 275 (840)
++|+++.+.+..|..+++|++|+|++|+++. ..+..|..+++|++|++++ |.+..
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------~~~~~~~~l~~L~~L~l~~~~~l~~ 186 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIES------------------------IPSYAFNRVPSLMRLDLGELKKLEY 186 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCE------------------------ECTTTTTTCTTCCEEECCCCTTCCE
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcce------------------------eCHhHHhcCCcccEEeCCCCCCccc
Confidence 7777776555566667777777777776663 3444566777777777777 45554
Q ss_pred cCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccC
Q 003199 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN 355 (840)
Q Consensus 276 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 355 (840)
..+..|..+++|+.|+|++|++++. + .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..
T Consensus 187 i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 187 ISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264 (452)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred cChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcC
Confidence 4445677788888888888888764 2 4778888999999999998888888999999999999999999888888999
Q ss_pred ccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 356 LKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 356 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 9999999999999998888888999999999999999986543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=275.39 Aligned_cols=251 Identities=19% Similarity=0.195 Sum_probs=189.2
Q ss_pred CCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEc
Q 003199 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196 (840)
Q Consensus 117 ~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 196 (840)
..+.++.+++. ...+|..+. ++++.|+|++|+++.+.+..|.++++|++|+|++|.|+++.+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~--l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKN--LREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCC--CSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCC--cCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 45667777665 445666553 57788888888888777777788888888888888887777777888888888888
Q ss_pred cCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeC-ceeec
Q 003199 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN-NHLEG 275 (840)
Q Consensus 197 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-N~l~~ 275 (840)
++|+++.+.+..|..+++|++|+|++|+++... +..|..+++|++|++++ |.+..
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~------------------------~~~~~~l~~L~~L~l~~~~~l~~ 175 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIP------------------------SYAFNRIPSLRRLDLGELKRLSY 175 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEEC------------------------TTTTTTCTTCCEEECCCCTTCCE
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccC------------------------HHHhhhCcccCEeCCCCCCCcce
Confidence 888887666667777778888888877776433 34556666677777766 34443
Q ss_pred cCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccC
Q 003199 276 SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN 355 (840)
Q Consensus 276 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 355 (840)
..+..|..+++|+.|+|++|+++.. | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|.+
T Consensus 176 i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 253 (440)
T 3zyj_A 176 ISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253 (440)
T ss_dssp ECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred eCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence 3444666777777777777777743 2 3677788888888888888777888888888888888888888877888888
Q ss_pred ccccchhcccCCccCCCcchhcccccCCCEEECcCccccccC
Q 003199 356 LKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYI 397 (840)
Q Consensus 356 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 397 (840)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 888888888888888777778888889999999999887543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=260.07 Aligned_cols=256 Identities=21% Similarity=0.212 Sum_probs=204.7
Q ss_pred CCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccc
Q 003199 143 LTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSE 222 (840)
Q Consensus 143 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 222 (840)
-++++.+++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|+++++.+..|..+++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 367888888888 455443 46788888888888877777788888888888888888877777888888888888888
Q ss_pred cc-ccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccC
Q 003199 223 NK-LSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301 (840)
Q Consensus 223 N~-l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 301 (840)
|+ ++. ..+..|..+++|++|++++|.+++..|..+..+++|++|++++|++++..
T Consensus 90 n~~l~~------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 90 NAQLRS------------------------VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp CTTCCC------------------------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCccc------------------------cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence 86 653 33556777788888888888888777778888888888888888888877
Q ss_pred CcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhccccc
Q 003199 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLK 381 (840)
Q Consensus 302 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 381 (840)
+..|+.+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..+..+..++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 77888899999999999999877777788899999999999999988889999999999999999999987778899999
Q ss_pred CCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcCCcccc
Q 003199 382 SLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLI 425 (840)
Q Consensus 382 ~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~ 425 (840)
+|+.|+|++|++++..+.....-.++.+..+.|.+.|..|..+.
T Consensus 226 ~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred ccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHhC
Confidence 99999999999997655421111223445667777777776543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=259.68 Aligned_cols=254 Identities=18% Similarity=0.141 Sum_probs=139.0
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
+.++++++.++ .+|..+ .++|++|+|++|+ +.+..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~-i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCc-CCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56666666666 444332 3466666666665 3333334555666666666666666655555566666666666666
Q ss_pred cc-cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccC
Q 003199 175 NS-LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVL 253 (840)
Q Consensus 175 N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 253 (840)
|. +....+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++ ..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------~~ 145 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA------------------------LP 145 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC------------------------CC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc------------------------cC
Confidence 64 554445555555666666666666555545555555555555555555543 23
Q ss_pred CcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccC
Q 003199 254 PDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI 333 (840)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 333 (840)
+..|..+++|++|++++|++++..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..+..++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 33455555666666666666544444455556666666666666555555555555666666666665554444555555
Q ss_pred cccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhc
Q 003199 334 SLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSL 377 (840)
Q Consensus 334 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 377 (840)
+|+.|+|++|++....+. ......++.+..+.|.+....|..+
T Consensus 226 ~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp TCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHh
Confidence 566666666555432211 1112334444455555555555444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-31 Score=311.64 Aligned_cols=402 Identities=13% Similarity=0.087 Sum_probs=233.3
Q ss_pred CCCCCCCCEEecCCCcCc---ccCCcccc------------CCCCCCEEeCCCCCCCccCCCCcccccc-cc-cccEEEe
Q 003199 13 FSPMQNLRRLDLSNNLFT---GQFPLSVF------------NLTNLEVLSFNENPGFKLWKLPESSIFR-LT-KLRIMVL 75 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~---~~~p~~~~------------~l~~L~~L~L~~N~~~~l~~l~~~~~~~-l~-~L~~L~L 75 (840)
+..+++|+.|+|++|... +.+|..++ .+++|++|+|++| .+.......+.. ++ +|+.|+|
T Consensus 69 ~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~---~i~~~~~~~l~~~~~~~L~~L~L 145 (592)
T 3ogk_B 69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRM---IVSDLDLDRLAKARADDLETLKL 145 (592)
T ss_dssp HHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESC---BCCHHHHHHHHHHHGGGCCEEEE
T ss_pred HHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeecc---EecHHHHHHHHHhccccCcEEEC
Confidence 345677777777765321 22332222 6777777777777 343333333444 23 3777777
Q ss_pred cCccc-cc-cCCccccCCCCCcEEEccCCccccc----CchhhhcCCCCCeeecccCccc---cccCCcccCCCCCCCee
Q 003199 76 ATCAL-HG-QIPASIGNVTSLTDLELTGNFITGH----IPPEIGLLKNLRQLELYYNQQL---AGTIPEELGNLTELTDL 146 (840)
Q Consensus 76 ~~n~l-~~-~~~~~~~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~L~~n~~~---~~~~p~~l~~l~~L~~L 146 (840)
++|.- .. .++....++++|++|+|++|.+++. ++..+..+++|+.|+|++|... ...++..+.++++|++|
T Consensus 146 ~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L 225 (592)
T 3ogk_B 146 DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225 (592)
T ss_dssp ESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEE
T ss_pred cCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEE
Confidence 77762 11 1222234567777777777777654 3344566777777777777621 12334445567777777
Q ss_pred eccCCcccccCCccccCCCCCcEEEeeccccc---cccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccc
Q 003199 147 DMSVNHLSGKIPESILRLPKLRVLQLYNNSLS---GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223 (840)
Q Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 223 (840)
+|++|.+.+ ++..+..+++|+.|+++.+... ...+..+..+++|+.|+++++... .++..+..+++|++|+|++|
T Consensus 226 ~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~ 303 (592)
T 3ogk_B 226 KVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYA 303 (592)
T ss_dssp ECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTC
T ss_pred eccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCC
Confidence 777777774 5566777777777777654322 122344556667777777765443 45555666677777777777
Q ss_pred cccccCC-ccccCCCCchhhhcccccccccCCcccccccCCceEEeeC-----------ceeeccCC-ccccCCCcccEE
Q 003199 224 KLSGPLP-AKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN-----------NHLEGSIP-EGILSLPHVSII 290 (840)
Q Consensus 224 ~l~~~~~-~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-----------N~l~~~~~-~~~~~l~~L~~L 290 (840)
.+++... ..+..+++|+.|++..+...+.++..+..+++|++|++++ |.+++... ..+..+++|+.|
T Consensus 304 ~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L 383 (592)
T 3ogk_B 304 LLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYM 383 (592)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEE
T ss_pred cCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEE
Confidence 7654333 2345667777777763333333344445667777777772 45543211 122346677777
Q ss_pred eccCCcccccCCcccCC-CCCCceeecc----cceeeec-----cchhhcccCcccEEEcCCCc--cCCCCCCccc-Ccc
Q 003199 291 DLSYNSFSGPIANTVGN-ARNLSELFMQ----RNQISGF-----IPSEIYRAISLVKIDLSDNL--LSGPIPSGIG-NLK 357 (840)
Q Consensus 291 ~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~ 357 (840)
+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|+|++|. +++..+..++ .++
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred EeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 77777776655555544 6677777774 5566542 33345556777777776433 5444333333 366
Q ss_pred ccchhcccCCccCC-CcchhcccccCCCEEECcCccccccCCchh-hcc-CCCeEEccCCCCcCc
Q 003199 358 KLNLLMLQSNKLNS-SIPNSLSSLKSLNVLDLSNNLLTGYIPESL-CEL-LPNSINFSNNRLSGP 419 (840)
Q Consensus 358 ~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~~-~~~~l~l~~N~l~~~ 419 (840)
+|+.|+|++|++++ .++..+..+++|++|+|++|++++.....+ ..+ .++.|++++|+++..
T Consensus 464 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 67777777777764 234445666777777777777664432222 222 456777777776654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=262.58 Aligned_cols=235 Identities=19% Similarity=0.235 Sum_probs=176.1
Q ss_pred CCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceec
Q 003199 140 LTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLD 219 (840)
Q Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 219 (840)
.++++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..+..+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 356666666666666 45556666667777777777766 55566666777777777777766 5566666677777777
Q ss_pred cccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccc
Q 003199 220 LSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299 (840)
Q Consensus 220 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 299 (840)
|++|++.+.+|..+... ..++.|..+++|++|++++|+++ .+|..+..+++|+.|+|++|++++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 77766665555544321 22345677888888888888888 778888888888888888888885
Q ss_pred cCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhccc
Q 003199 300 PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS 379 (840)
Q Consensus 300 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 379 (840)
. +..++.+++|++|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..++++++|+.|+|++|++.+.+|..+..
T Consensus 221 l-~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 L-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp C-CGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred C-chhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 4 445788888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccCCCEEECcCcccc
Q 003199 380 LKSLNVLDLSNNLLT 394 (840)
Q Consensus 380 l~~L~~L~l~~N~l~ 394 (840)
+++|+.+++..|.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 888888888877765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-28 Score=271.46 Aligned_cols=248 Identities=24% Similarity=0.259 Sum_probs=216.2
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
....++.+++.++ .+|..+. ++++.|+|++|+ +....+..|.++++|++|+|++|.++.+.+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~-i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCC-CCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCc-CCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 4678999999999 6777664 789999999998 56666788999999999999999999888899999999999999
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccc-ccccCCccccCCCCchhhhcccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENK-LSGPLPAKVCSRGKLQYFLVLQNMFSG 251 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~n~~~~ 251 (840)
++|+|+.+.+..|..+++|++|+|++|+++.+.+..|..+++|+.|+|++|+ +..
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~------------------------ 175 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY------------------------ 175 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE------------------------
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcce------------------------
Confidence 9999998888899999999999999999998888899999999999999854 432
Q ss_pred cCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcc
Q 003199 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYR 331 (840)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 331 (840)
..+..|..+++|++|++++|+++ .+| .+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..
T Consensus 176 i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 253 (440)
T 3zyj_A 176 ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253 (440)
T ss_dssp ECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred eCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence 23345777788888888888887 555 4778888999999999998888888888999999999999998888888888
Q ss_pred cCcccEEEcCCCccCCCCCCcccCccccchhcccCCccC
Q 003199 332 AISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN 370 (840)
Q Consensus 332 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 370 (840)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 999999999999999777778888999999999999886
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=271.90 Aligned_cols=249 Identities=22% Similarity=0.239 Sum_probs=218.7
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
....++.+++.++ .+|..+. ++|+.|+|++|+ +.+..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~-i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCc-CceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 4678999999999 6776554 799999999998 66677889999999999999999999888899999999999999
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccc-cccccCCccccCCCCchhhhcccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN-KLSGPLPAKVCSRGKLQYFLVLQNMFSG 251 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~n~~~~ 251 (840)
++|+|+.+.+..|.++++|++|+|++|+++.+.+..|..+++|+.|+|++| .+..
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~------------------------ 186 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY------------------------ 186 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE------------------------
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccc------------------------
Confidence 999999888889999999999999999999888889999999999999985 4432
Q ss_pred cCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcc
Q 003199 252 VLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYR 331 (840)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 331 (840)
..+..|..+++|++|++++|+++ .+| .+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+..
T Consensus 187 i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 187 ISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264 (452)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred cChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcC
Confidence 23345777888888888888887 344 4778889999999999999888889999999999999999999888888999
Q ss_pred cCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCC
Q 003199 332 AISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS 371 (840)
Q Consensus 332 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 371 (840)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 9999999999999997777888899999999999998863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=290.10 Aligned_cols=195 Identities=17% Similarity=0.112 Sum_probs=138.0
Q ss_pred eeeccCCcEEEEE-EeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEEecCccceEE
Q 003199 533 KVGQGGSGTVYKI-DLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLV 610 (840)
Q Consensus 533 ~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 610 (840)
..+.|+.|.++.+ .+..|+.||||++..................+.|.+|+++|+++ .|+||+++++++++....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766664 34468999999996554333333444455678899999999999 699999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccC
Q 003199 611 YEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690 (840)
Q Consensus 611 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 690 (840)
|||++|++|.+.+.... .++. .+|+.||+.||+|+|+ +|||||||||+|||++++|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~-~l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~- 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-EIDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD- 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC-CCCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence 99999999999998765 4554 3589999999999999 99999999999999999999999999999876432
Q ss_pred CCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 003199 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKP 738 (840)
Q Consensus 691 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 738 (840)
.......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 223445789999999998865 567789999999998888766444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=257.93 Aligned_cols=225 Identities=23% Similarity=0.295 Sum_probs=146.1
Q ss_pred CCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEE
Q 003199 116 KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLS 195 (840)
Q Consensus 116 ~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 195 (840)
++++.|+|++|. ...+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..+.++++|++|+
T Consensus 81 ~~l~~L~L~~n~--l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 81 PGRVALELRSVP--LPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp TTCCEEEEESSC--CSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred cceeEEEccCCC--chhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 444444444444 2234444444444555555555444 34444455555555555555554 3344455555555555
Q ss_pred ccCCcCcccCCcCCC---------CCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceE
Q 003199 196 LYDNSLTGEVPQDLG---------QWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRF 266 (840)
Q Consensus 196 L~~N~l~~~~~~~l~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 266 (840)
|++|++.+.+|..+. ++++|++|+|++|+++ .+|..+..+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------~lp~~l~~l~~L~~L 211 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-------------------------SLPASIANLQNLKSL 211 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-------------------------CCCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-------------------------cchHhhcCCCCCCEE
Confidence 555444444444433 3566666666666655 445566777777777
Q ss_pred EeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccC
Q 003199 267 RVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS 346 (840)
Q Consensus 267 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 346 (840)
++++|+++ .+|..+..+++|+.|+|++|.+.+..|..++.+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++.
T Consensus 212 ~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp EEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred EccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 77777777 45666777888888888888887777878888888888888888887788888888888888888888888
Q ss_pred CCCCCcccCccccchhcccCCccC
Q 003199 347 GPIPSGIGNLKKLNLLMLQSNKLN 370 (840)
Q Consensus 347 ~~~p~~~~~l~~L~~L~Ls~N~l~ 370 (840)
+.+|..++++++|+.+++..|.+.
T Consensus 291 ~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 291 SRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhccHHHhhccCceEEeCCHHHHH
Confidence 888888888888888888777664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=272.26 Aligned_cols=266 Identities=27% Similarity=0.327 Sum_probs=159.2
Q ss_pred ccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeecc
Q 003199 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149 (840)
Q Consensus 70 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~ 149 (840)
++.|++++|.++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+ ...+|. .+++|++|+|+
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~--l~~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQ--LTSLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCC--CSCCCC---CCTTCCEEEEC
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCc--CCcCCC---CCCCCCEEECc
Confidence 444555555544 3344333 45555555555555 3333 34555555555554 223333 34555555555
Q ss_pred CCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccC
Q 003199 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPL 229 (840)
Q Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 229 (840)
+|++++ +|. .+++|+.|++++|+|+.++. .+++|++|+|++|++++ +|. .+.+|+.|++++|++++
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-- 175 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-- 175 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC--
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC--
Confidence 555553 222 34555555555555554322 13556666666665553 222 22445555666555552
Q ss_pred CccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCC
Q 003199 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309 (840)
Q Consensus 230 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 309 (840)
+| ..+++|+.|++++|+++ .+|.. +++|+.|++++|.++.... .++
T Consensus 176 -----------------------l~---~~~~~L~~L~Ls~N~l~-~l~~~---~~~L~~L~L~~N~l~~l~~----~~~ 221 (622)
T 3g06_A 176 -----------------------LP---MLPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSLPA----LPS 221 (622)
T ss_dssp -----------------------CC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCC----CCT
T ss_pred -----------------------Cc---ccCCCCcEEECCCCCCC-CCCCc---cchhhEEECcCCcccccCC----CCC
Confidence 22 22355666666666666 23332 3566777777777764332 246
Q ss_pred CCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECc
Q 003199 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS 389 (840)
Q Consensus 310 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 389 (840)
+|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|+
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 77778888887774 44 34577888888888888 4555 5678889999999998 678888999999999999
Q ss_pred CccccccCCchhhcc
Q 003199 390 NNLLTGYIPESLCEL 404 (840)
Q Consensus 390 ~N~l~~~~p~~~~~~ 404 (840)
+|++++.+|..+..+
T Consensus 293 ~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 293 GNPLSERTLQALREI 307 (622)
T ss_dssp SCCCCHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHhc
Confidence 999998888877765
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=272.23 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=155.2
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
++++|++++|.|+ .+|..+. ++|+.|+|++| .+..+|. .+++|++|+|++|.+++ +|. .+++|++|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N---~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L 106 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDN---NLTSLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLEL 106 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSC---CCSCCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCC---CCCCCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEE
Confidence 4777777777777 6666554 67777777777 4444444 34566666666666552 333 44556666
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
+|++|+|++ +|. .+++|+.|++++| +++. +|.. +++|++|+|++|++
T Consensus 107 ~Ls~N~l~~-l~~---~l~~L~~L~L~~N-------------------------~l~~-lp~~---l~~L~~L~Ls~N~l 153 (622)
T 3g06_A 107 SIFSNPLTH-LPA---LPSGLCKLWIFGN-------------------------QLTS-LPVL---PPGLQELSVSDNQL 153 (622)
T ss_dssp EECSCCCCC-CCC---CCTTCCEEECCSS-------------------------CCSC-CCCC---CTTCCEEECCSSCC
T ss_pred ECcCCcCCC-CCC---CCCCcCEEECCCC-------------------------CCCc-CCCC---CCCCCEEECcCCcC
Confidence 666665552 222 3444555555544 4442 2221 24455555555555
Q ss_pred ccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCccc
Q 003199 178 SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSL 257 (840)
Q Consensus 178 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 257 (840)
+++. . .+++|+.|++++|+++. +| ..+++|+.|+|++|++++. |.
T Consensus 154 ~~l~-~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l-------------------------~~-- 198 (622)
T 3g06_A 154 ASLP-A---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASL-------------------------PT-- 198 (622)
T ss_dssp SCCC-C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-------------------------CC--
T ss_pred CCcC-C---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCC-------------------------CC--
Confidence 4322 1 23455555555555553 23 2345555666666655521 11
Q ss_pred ccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccE
Q 003199 258 ARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVK 337 (840)
Q Consensus 258 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 337 (840)
.+++|+.|++++|.++ .+|.. +++|+.|+|++|++++.. ..+++|+.|+|++|+|++ +|. .+++|+.
T Consensus 199 -~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~ 265 (622)
T 3g06_A 199 -LPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLTS-LPM---LPSGLLS 265 (622)
T ss_dssp -CCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSC-CCC---CCTTCCE
T ss_pred -ccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCCc-CCc---ccccCcE
Confidence 1134555555555555 33322 355666666666666532 335667777777777763 443 4567888
Q ss_pred EEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhccccc
Q 003199 338 IDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLK 381 (840)
Q Consensus 338 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 381 (840)
|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+..++
T Consensus 266 L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp EECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred EeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 888888887 6677788888888888888888887777777665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-30 Score=271.09 Aligned_cols=245 Identities=20% Similarity=0.215 Sum_probs=116.0
Q ss_pred CCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccc-ccchhhh-------cCCCCCEEEccCCcCcccCCcCC--
Q 003199 140 LTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG-EISSVIA-------NSTTLTMLSLYDNSLTGEVPQDL-- 209 (840)
Q Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~l-- 209 (840)
.++|+.|++++|.+ .+|..+... |+.|+|++|.+.. ..+..+. ++++|++|+|++|++++..|..+
T Consensus 42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 117 (312)
T 1wwl_A 42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117 (312)
T ss_dssp EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence 34455555555555 233333322 5555555555521 2233222 45566666666666655555544
Q ss_pred CCCCCcceeccccccccccCCccccCC-----CCchhhhcccccccccCCcccccccCCceEEeeCceeecc--CCccc-
Q 003199 210 GQWSPLVVLDLSENKLSGPLPAKVCSR-----GKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS--IPEGI- 281 (840)
Q Consensus 210 ~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~- 281 (840)
..+++|++|+|++|++++. |..+..+ ++|++|++++|.+.+..+..|+.+++|++|++++|++.+. .+..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 5566666666666666543 3333332 3333333333333333334444455555555555554332 11122
Q ss_pred -cCCCcccEEeccCCcccc---cCCcccCCCCCCceeecccceeeeccc-hhhcccCcccEEEcCCCccCCCCCCcccCc
Q 003199 282 -LSLPHVSIIDLSYNSFSG---PIANTVGNARNLSELFMQRNQISGFIP-SEIYRAISLVKIDLSDNLLSGPIPSGIGNL 356 (840)
Q Consensus 282 -~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 356 (840)
..+++|++|+|++|++++ .....+..+++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..+.
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-- 273 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-- 273 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--
Confidence 445555555555555542 111223344555555555555554443 22333455555555555555 4444443
Q ss_pred cccchhcccCCccCCCcchhcccccCCCEEECcCcccc
Q 003199 357 KKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 357 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 394 (840)
++|+.|+|++|+|++. |. +..+++|++|+|++|+|+
T Consensus 274 ~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 274 AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 4555555555555543 33 555555555555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-30 Score=303.89 Aligned_cols=383 Identities=13% Similarity=0.052 Sum_probs=278.5
Q ss_pred CCCCCCEEecCCCcCcccCCccccCC--CCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccccc----CCccc
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNL--TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ----IPASI 88 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l--~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~ 88 (840)
.+++|++|+|++|.+++..+..+..+ .+|++|+|++|.......+ .....++++|++|+|++|.+.+. ++..+
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l-~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGL-LSIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHH-HHHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHH-HHHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence 68899999999998887777777664 4499999998841111011 11234788999999999988654 33345
Q ss_pred cCCCCCcEEEccCCccc----ccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCccc---ccCCccc
Q 003199 89 GNVTSLTDLELTGNFIT----GHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLS---GKIPESI 161 (840)
Q Consensus 89 ~~l~~L~~L~L~~n~i~----~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~---~~~~~~~ 161 (840)
..+++|++|+|++|.++ +.++..+..+++|+.|+|++|. ...+|..+..+++|++|+++.+... ...+..+
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~--~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l 266 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE--ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCB--GGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCcc--HHHHHHHHhhhhHHHhhcccccccccchHHHHHHh
Confidence 67889999999999987 3455667788999999999987 3346778888999999999864433 2334567
Q ss_pred cCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCC-cCCCCCCCcceeccccccccccCCccccCCCCch
Q 003199 162 LRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP-QDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240 (840)
Q Consensus 162 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 240 (840)
..+++|+.|+++++... ..+..+..+++|++|+|++|.++.... ..+..+++|+.|+++++-..+.++..+..+++|+
T Consensus 267 ~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~ 345 (592)
T 3ogk_B 267 VFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLK 345 (592)
T ss_dssp CCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCC
T ss_pred hccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCC
Confidence 77889999999887544 566778888999999999999764333 3357789999999994433333344446678899
Q ss_pred hhhccc-----------ccccccC-CcccccccCCceEEeeCceeeccCCccccC-CCcccEEecc----CCccccc---
Q 003199 241 YFLVLQ-----------NMFSGVL-PDSLARCKNLLRFRVSNNHLEGSIPEGILS-LPHVSIIDLS----YNSFSGP--- 300 (840)
Q Consensus 241 ~L~l~~-----------n~~~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~--- 300 (840)
.|++.+ |.++... +..+..+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++.
T Consensus 346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~ 425 (592)
T 3ogk_B 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD 425 (592)
T ss_dssp EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence 999983 5555432 233456889999999989888766666665 8889999996 6777764
Q ss_pred --CCcccCCCCCCceeecccc--eeeeccchhhcc-cCcccEEEcCCCccCC-CCCCcccCccccchhcccCCccCCC-c
Q 003199 301 --IANTVGNARNLSELFMQRN--QISGFIPSEIYR-AISLVKIDLSDNLLSG-PIPSGIGNLKKLNLLMLQSNKLNSS-I 373 (840)
Q Consensus 301 --~~~~~~~l~~L~~L~L~~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~ 373 (840)
.+..+..+++|+.|+|++| .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++|++++. +
T Consensus 426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 505 (592)
T 3ogk_B 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence 2334667889999999743 466655555554 7889999999999875 3444557789999999999998654 3
Q ss_pred chhcccccCCCEEECcCccccccCCchh
Q 003199 374 PNSLSSLKSLNVLDLSNNLLTGYIPESL 401 (840)
Q Consensus 374 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 401 (840)
+..+..+++|++|+|++|++++.-...+
T Consensus 506 ~~~~~~l~~L~~L~ls~n~it~~~~~~l 533 (592)
T 3ogk_B 506 AAAVTKLPSLRYLWVQGYRASMTGQDLM 533 (592)
T ss_dssp HHHHHHCSSCCEEEEESCBCCTTCTTGG
T ss_pred HHHHHhcCccCeeECcCCcCCHHHHHHH
Confidence 4445678999999999999886533333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=266.85 Aligned_cols=268 Identities=20% Similarity=0.207 Sum_probs=147.3
Q ss_pred ccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeecc
Q 003199 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149 (840)
Q Consensus 70 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~ 149 (840)
++.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|+ +.+..+ +..+++|++|+|+
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV-LYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSC-CEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCc-CCcchh--hhhcCCCCEEECc
Confidence 4555555555554444444555566666666666665555566666666666666655 222221 5555555555555
Q ss_pred CCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccC
Q 003199 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPL 229 (840)
Q Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 229 (840)
+|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..+..++
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~---------------- 144 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRS---------------- 144 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGS----------------
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccC----------------
Confidence 55555321 1244555555555544333222 23344444444444433333333344
Q ss_pred CccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCcccc-CCCcccEEeccCCcccccCCcccCCC
Q 003199 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIANTVGNA 308 (840)
Q Consensus 230 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l 308 (840)
+|++|++++|.+++..+..+. .+++|+.|+|++|++++... ...+
T Consensus 145 --------------------------------~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l 190 (317)
T 3o53_A 145 --------------------------------RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVF 190 (317)
T ss_dssp --------------------------------SEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCC
T ss_pred --------------------------------CCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--cccc
Confidence 444444444444433333332 34555555555555554322 2235
Q ss_pred CCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccC-CCcchhcccccCCCEEE
Q 003199 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN-SSIPNSLSSLKSLNVLD 387 (840)
Q Consensus 309 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 387 (840)
++|++|+|++|++++. |..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+
T Consensus 191 ~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~ 268 (317)
T 3o53_A 191 AKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268 (317)
T ss_dssp TTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHH
T ss_pred ccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEE
Confidence 6666666777766643 334667777777777777777 45666777777777777777776 56677777777788777
Q ss_pred Cc-CccccccCCch
Q 003199 388 LS-NNLLTGYIPES 400 (840)
Q Consensus 388 l~-~N~l~~~~p~~ 400 (840)
++ .+.++|..|..
T Consensus 269 l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 269 KQTVKKLTGQNEEE 282 (317)
T ss_dssp HHHHHHHHSSSSCC
T ss_pred CCCchhccCCchhc
Confidence 77 44666655543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-29 Score=265.76 Aligned_cols=193 Identities=18% Similarity=0.194 Sum_probs=98.7
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
.++.++++++.+....+..+..+++|++|+|++| .+..+++..|..+++|++|+|++|.+.+..+ +..+++|++|
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n---~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L 85 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN---PLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTS---CCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEE
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCC---ccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEE
Confidence 3555666666666444444555566666666666 4555555556666666666666666654433 5566666666
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
+|++|++++.. ..++|++|++++|+ +.+..+ ..+++|++|++++|++++..+..+..+++|++|+|++|.+
T Consensus 86 ~Ls~n~l~~l~-----~~~~L~~L~l~~n~-l~~~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 156 (317)
T 3o53_A 86 DLNNNYVQELL-----VGPSIETLHAANNN-ISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156 (317)
T ss_dssp ECCSSEEEEEE-----ECTTCCEEECCSSC-CSEEEE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred ECcCCcccccc-----CCCCcCEEECCCCc-cCCcCc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence 66666665321 22555555555554 222111 1234455555555555544444444555555555555555
Q ss_pred ccccchhh-hcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 178 SGEISSVI-ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 178 ~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
++..+..+ ..+++|++|+|++|++++. + ....+++|++|+|++|+++
T Consensus 157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 157 DTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp CEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC
T ss_pred CcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC
Confidence 54444333 2445555555555555432 1 1122444444444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-29 Score=264.72 Aligned_cols=251 Identities=21% Similarity=0.217 Sum_probs=164.0
Q ss_pred cCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccC-------CCCCCCeeeccCCcccccCCccc
Q 003199 89 GNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELG-------NLTELTDLDMSVNHLSGKIPESI 161 (840)
Q Consensus 89 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~-------~l~~L~~L~L~~n~l~~~~~~~~ 161 (840)
+..++|+.|++++|.+ .+|..+... |+.|+|++|++....+|..+. ++++|++|+|++|.+++..|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3344555556666665 344444433 666666666532334444443 56777777777777776666655
Q ss_pred --cCCCCCcEEEeeccccccccchhhhcC-----CCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccC--Ccc
Q 003199 162 --LRLPKLRVLQLYNNSLSGEISSVIANS-----TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPL--PAK 232 (840)
Q Consensus 162 --~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~ 232 (840)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|..+++|++|+|++|++.+.. +..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 6777777777777777765 5666665 77777777777777766677777777777777777765321 111
Q ss_pred ccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeec---cCCccccCCCcccEEeccCCcccccCC-cccCCC
Q 003199 233 VCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG---SIPEGILSLPHVSIIDLSYNSFSGPIA-NTVGNA 308 (840)
Q Consensus 233 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l 308 (840)
+ .+..+++|++|++++|++++ .....+..+++|+.|+|++|++++..+ ..+..+
T Consensus 195 ~----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 195 L----------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp S----------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred H----------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 1 12455666666666666652 111233456777777777777776553 445567
Q ss_pred CCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCC
Q 003199 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNS 371 (840)
Q Consensus 309 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 371 (840)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|++++
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 77888888888887 5666665 7888888888888865 55 7788888888888888874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=272.14 Aligned_cols=233 Identities=18% Similarity=0.173 Sum_probs=110.3
Q ss_pred CCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccc
Q 003199 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLS 221 (840)
Q Consensus 142 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 221 (840)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++..+ |..+++|++|+|++|.|++..+ .++|+.|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 55555555555555445555555555555555555554433 5555555555555555553221 1455555555
Q ss_pred cccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCcccc-CCCcccEEeccCCccccc
Q 003199 222 ENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGP 300 (840)
Q Consensus 222 ~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~ 300 (840)
+|.+++..+.. +++|+.|++++|.+.+..|..|..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 55555332211 12233333333333333344444445555555555555544444443 345555555555555443
Q ss_pred CCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccC-CCcchhccc
Q 003199 301 IANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN-SSIPNSLSS 379 (840)
Q Consensus 301 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~ 379 (840)
.+ +..+++|+.|+|++|+|++..| .+..+++|+.|+|++|.|++ +|..++.+++|+.|+|++|++. +.+|..+..
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 22 1224455555555555543222 24444455555555555542 3444444444555555555444 333444444
Q ss_pred ccCCCEEEC
Q 003199 380 LKSLNVLDL 388 (840)
Q Consensus 380 l~~L~~L~l 388 (840)
++.|+.|++
T Consensus 261 l~~L~~l~~ 269 (487)
T 3oja_A 261 NQRVQTVAK 269 (487)
T ss_dssp CHHHHHHHH
T ss_pred CCCCcEEec
Confidence 444444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=264.64 Aligned_cols=235 Identities=21% Similarity=0.237 Sum_probs=157.3
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
+|++|+|++|.+++..|..|..+++|++|+|++|. +.+..| +..+++|++|+|++|.|++..+ .++|++|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV-LYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSC-CEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCC-CCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 56666666666665555566666666666666665 222222 5555566666666665553221 245555555
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 252 (840)
++|.|++..+. .+++|++|+|++|.+++..|..+..+++|+.|+|++|.+ .+.
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l------------------------~~~ 159 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI------------------------DTV 159 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCC------------------------CEE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCC------------------------CCc
Confidence 55555544332 234455555555555544444455555555555555554 445
Q ss_pred CCcccc-cccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcc
Q 003199 253 LPDSLA-RCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYR 331 (840)
Q Consensus 253 ~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 331 (840)
.|..+. .+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++.++. +..+++|+.|+|++|.|++ +|..+..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhcc
Confidence 555554 67889999999999885532 34588999999999999976555 8889999999999999995 6777888
Q ss_pred cCcccEEEcCCCccC-CCCCCcccCccccchhcccC
Q 003199 332 AISLVKIDLSDNLLS-GPIPSGIGNLKKLNLLMLQS 366 (840)
Q Consensus 332 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~ 366 (840)
+++|+.|++++|.+. +.+|..+..++.|+.++++.
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence 999999999999998 67778888999999999863
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=235.50 Aligned_cols=208 Identities=20% Similarity=0.150 Sum_probs=125.7
Q ss_pred CCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcc
Q 003199 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245 (840)
Q Consensus 166 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 245 (840)
+|++|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++.
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----------------- 91 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL----------------- 91 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE-----------------
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc-----------------
Confidence 344444444444444444444444444444444444444444444444444444444444422
Q ss_pred cccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCccccc-CCcccCCCCCCceeecccceeeec
Q 003199 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP-IANTVGNARNLSELFMQRNQISGF 324 (840)
Q Consensus 246 ~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 324 (840)
.+..|..+++|++|++++|.+.+..+..+..+++|++|++++|++++. .|..|+.+++|++|+|++|++++.
T Consensus 92 -------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 92 -------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp -------CTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred -------ChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 222333444444444444444433333455555666666666666543 355666666777777777777666
Q ss_pred cchhhcccCccc----EEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 325 IPSEIYRAISLV----KIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 325 ~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
.+..+..+.+|+ .|++++|++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 666666666665 788899988865555554 4589999999999987777778899999999999999997665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-28 Score=286.85 Aligned_cols=397 Identities=17% Similarity=0.185 Sum_probs=219.4
Q ss_pred CCCCCCCCEEecCCCcCcc---cCC------------ccccCCCCCCEEeCCCCCCCccCCCCccccc-ccccccEEEec
Q 003199 13 FSPMQNLRRLDLSNNLFTG---QFP------------LSVFNLTNLEVLSFNENPGFKLWKLPESSIF-RLTKLRIMVLA 76 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~~---~~p------------~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~-~l~~L~~L~L~ 76 (840)
+..+++|+.|+|++|.... ..| ..+..+++|++|+|++| .+.......+. .+++|+.|+|+
T Consensus 62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~---~~~~~~~~~l~~~~~~L~~L~L~ 138 (594)
T 2p1m_B 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRM---VVTDDCLELIAKSFKNFKVLVLS 138 (594)
T ss_dssp HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESC---BCCHHHHHHHHHHCTTCCEEEEE
T ss_pred HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCc---EEcHHHHHHHHHhCCCCcEEeCC
Confidence 3456777777777765221 111 12345677777777777 33333333333 56777777777
Q ss_pred Cc-ccccc-CCccccCCCCCcEEEccCCcccccCchhhh----cCCCCCeeecccCc--cccccCCcccCCCCCCCeeec
Q 003199 77 TC-ALHGQ-IPASIGNVTSLTDLELTGNFITGHIPPEIG----LLKNLRQLELYYNQ--QLAGTIPEELGNLTELTDLDM 148 (840)
Q Consensus 77 ~n-~l~~~-~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~----~l~~L~~L~L~~n~--~~~~~~p~~l~~l~~L~~L~L 148 (840)
+| .+... ++..+.++++|++|+|++|.+++..+..+. .+++|+.|++++|. .....++..+..+++|++|+|
T Consensus 139 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L 218 (594)
T 2p1m_B 139 SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKL 218 (594)
T ss_dssp SCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEEC
T ss_pred CcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEec
Confidence 77 44322 333444677777777777777654444443 45577777777764 111111222334577777777
Q ss_pred cCC-cccccCCccccCCCCCcEEEeec-------cccccccchhhhcCCCCCEE-EccCCcCcccCCcCCCCCCCcceec
Q 003199 149 SVN-HLSGKIPESILRLPKLRVLQLYN-------NSLSGEISSVIANSTTLTML-SLYDNSLTGEVPQDLGQWSPLVVLD 219 (840)
Q Consensus 149 ~~n-~l~~~~~~~~~~l~~L~~L~L~~-------N~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~l~~l~~L~~L~ 219 (840)
++| .+.+ ++..+..+++|+.|+++. |.+.+. +..+.++++|+.| .+.+.... .++..+..+++|+.|+
T Consensus 219 ~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l-~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~ 295 (594)
T 2p1m_B 219 NRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGL-SVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLN 295 (594)
T ss_dssp CTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHH-HHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEE
T ss_pred CCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHH-HHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEE
Confidence 777 4443 556666677777777433 334432 2355666666666 33332221 2333333566777777
Q ss_pred cccccccccCCc-cccCCCCchhhhcccccccccCCcccccccCCceEEeeC---------ceeeccCCcccc-CCCccc
Q 003199 220 LSENKLSGPLPA-KVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN---------NHLEGSIPEGIL-SLPHVS 288 (840)
Q Consensus 220 L~~N~l~~~~~~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~---------N~l~~~~~~~~~-~l~~L~ 288 (840)
|++|.+++.... .+..+++|+.|.+.+|.....++.....+++|++|++.+ +.+++.....+. .+++|+
T Consensus 296 L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~ 375 (594)
T 2p1m_B 296 LSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375 (594)
T ss_dssp CTTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCC
T ss_pred ccCCCCCHHHHHHHHhcCCCcCEEeCcCccCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHH
Confidence 777776543222 234566777777776622112222233467777777733 344322222222 356777
Q ss_pred EEeccCCcccccCCcccC-CCCCCceeecc--c----ceeee-----ccchhhcccCcccEEEcCCCccCCCCCCcccC-
Q 003199 289 IIDLSYNSFSGPIANTVG-NARNLSELFMQ--R----NQISG-----FIPSEIYRAISLVKIDLSDNLLSGPIPSGIGN- 355 (840)
Q Consensus 289 ~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~- 355 (840)
.|+++.|.+++.....+. .+++|+.|+|+ + |.+++ .++..+..+++|+.|+|++ .+++..+..++.
T Consensus 376 ~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~ 454 (594)
T 2p1m_B 376 SVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTY 454 (594)
T ss_dssp EEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHH
T ss_pred HHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHh
Confidence 777777776654444443 46677777777 3 44441 1122245566777777766 555444444443
Q ss_pred ccccchhcccCCccCCCcchhc-ccccCCCEEECcCccccccCCchhhc-c-CCCeEEccCCCC
Q 003199 356 LKKLNLLMLQSNKLNSSIPNSL-SSLKSLNVLDLSNNLLTGYIPESLCE-L-LPNSINFSNNRL 416 (840)
Q Consensus 356 l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~-~-~~~~l~l~~N~l 416 (840)
+++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+..+.. + .++.|++++|++
T Consensus 455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 6667777777777765444444 55677777777777775443332222 2 456777777766
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=230.70 Aligned_cols=205 Identities=22% Similarity=0.255 Sum_probs=115.9
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
+|++|+|++|.|++..+..|.++++|++|+|++| .+..++...|..+++|++|+|++|.+++..+..|.++++|++|
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n---~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC---EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTC---CCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCC---cCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEE
Confidence 4666666666666555555666666666666666 4445555556666666666666666655555556666666666
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCc----EEEee
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLR----VLQLY 173 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~ 173 (840)
++++|.+++..+..+..+++|++|++++|++....+|..+..+++|++|+|++|++++..+..|..+++|+ .|+++
T Consensus 106 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls 185 (276)
T 2z62_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (276)
T ss_dssp ECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECC
T ss_pred ECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecC
Confidence 66666666444445556666666666665522223455555566666666666666554444554444444 55666
Q ss_pred ccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 174 NNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 174 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
+|.+++..+..+.. .+|++|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 186 ~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 186 LNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp SSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred CCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 66665444444333 25666666666665444444555566666666666555
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-28 Score=282.18 Aligned_cols=378 Identities=14% Similarity=0.086 Sum_probs=277.8
Q ss_pred CCCCCCEEecCCCcCcccCCcccc-CCCCCCEEeCCCCCCCccCCC-CcccccccccccEEEecCccccccCCccc----
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKL-PESSIFRLTKLRIMVLATCALHGQIPASI---- 88 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~-~l~~L~~L~L~~N~~~~l~~l-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---- 88 (840)
.+++|++|+|++|.+++..+..+. .+++|++|+|++|. .+... ....+.++++|++|+|++|.+++..+..+
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~--~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE--GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE--EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC--CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 578999999999999987777776 69999999999993 22221 12334579999999999999876544433
Q ss_pred cCCCCCcEEEccCCc--ccc-cCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCC-------cccccCC
Q 003199 89 GNVTSLTDLELTGNF--ITG-HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVN-------HLSGKIP 158 (840)
Q Consensus 89 ~~l~~L~~L~L~~n~--i~~-~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n-------~l~~~~~ 158 (840)
..+++|++|+|++|. +.. .++..+..+++|++|+|++|.... .++..+..+++|++|+++.+ .+.+ ++
T Consensus 181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~ 258 (594)
T 2p1m_B 181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LS 258 (594)
T ss_dssp TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HH
T ss_pred hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HH
Confidence 467799999999997 331 123334567999999999985333 37778889999999995544 4553 34
Q ss_pred ccccCCCCCcEE-EeeccccccccchhhhcCCCCCEEEccCCcCcccCC-cCCCCCCCcceeccccccccccCCc-cccC
Q 003199 159 ESILRLPKLRVL-QLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVP-QDLGQWSPLVVLDLSENKLSGPLPA-KVCS 235 (840)
Q Consensus 159 ~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~ 235 (840)
..+.++++|+.| .+.+... ...+..+..+++|++|+|++|.++.... ..+..+++|+.|++++| ++..... ....
T Consensus 259 ~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~ 336 (594)
T 2p1m_B 259 VALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST 336 (594)
T ss_dssp HHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred HHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence 478899999999 4544433 2445566688999999999999774322 23567899999999998 5432222 2335
Q ss_pred CCCchhhhccc---------ccccccCCcccc-cccCCceEEeeCceeeccCCcccc-CCCcccEEecc--C----Cccc
Q 003199 236 RGKLQYFLVLQ---------NMFSGVLPDSLA-RCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLS--Y----NSFS 298 (840)
Q Consensus 236 l~~L~~L~l~~---------n~~~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~ 298 (840)
+++|+.|++.+ +.+++.....+. .+++|++|.+..|.+++..+..+. .+++|+.|+++ + |.++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 78899998833 445443333333 489999999999999866555555 48999999999 4 5565
Q ss_pred ccC-----CcccCCCCCCceeecccceeeeccchhhcc-cCcccEEEcCCCccCCCCCCcc-cCccccchhcccCCccCC
Q 003199 299 GPI-----ANTVGNARNLSELFMQRNQISGFIPSEIYR-AISLVKIDLSDNLLSGPIPSGI-GNLKKLNLLMLQSNKLNS 371 (840)
Q Consensus 299 ~~~-----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~ 371 (840)
+.. +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++
T Consensus 417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 322 22356789999999988 777666666766 8899999999999976555544 668999999999999965
Q ss_pred Ccch-hcccccCCCEEECcCccccccCCc
Q 003199 372 SIPN-SLSSLKSLNVLDLSNNLLTGYIPE 399 (840)
Q Consensus 372 ~~~~-~~~~l~~L~~L~l~~N~l~~~~p~ 399 (840)
..+. ....+++|+.|+|++|+++.....
T Consensus 496 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 524 (594)
T 2p1m_B 496 KALLANASKLETMRSLWMSSCSVSFGACK 524 (594)
T ss_dssp HHHHHTGGGGGGSSEEEEESSCCBHHHHH
T ss_pred HHHHHHHHhCCCCCEEeeeCCCCCHHHHH
Confidence 4444 445689999999999999644333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-24 Score=223.31 Aligned_cols=205 Identities=28% Similarity=0.326 Sum_probs=181.5
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
.+.+.++++++.++ .+|..+. ++|+.|+|++| .+..++...|..+++|++|+|++|.++...+..|.++++|++
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n---~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~ 89 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSN---KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSS---CCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCE
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCC---CCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCE
Confidence 46889999999999 6777664 68999999999 777888888999999999999999999777777899999999
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
|+|++|.+++..+..|..+++|++|+|++|+ +....+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|+
T Consensus 90 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 168 (270)
T 2o6q_A 90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQ-LKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ 168 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCSSCCEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcCCcCCHhHcccccCCCEEECCCCc-cCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence 9999999997777888999999999999997 555556678999999999999999997777778999999999999999
Q ss_pred cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccccc
Q 003199 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP 228 (840)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 228 (840)
++++.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++...
T Consensus 169 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 169 LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 9988888899999999999999999977777788999999999999998743
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=257.26 Aligned_cols=195 Identities=16% Similarity=0.197 Sum_probs=150.4
Q ss_pred CccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
...+.||+|+||+||+|... ++.+|+|+....... ..........+.+.+|++++++++||||+++..++...+..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~--~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYR--DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTS--CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEeccccc--chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 44678999999999999554 789999987543211 111222334577899999999999999997766666777889
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
+||||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+|+....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999999876 56899999999999999 99999999999999999 999999999987633
Q ss_pred cCCCC----cceecccccccccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCC
Q 003199 689 RGGKD----STTTVIAGTYGYLAPEYAYS--SKATTKCDVYSFGVVLMELITGRKPVE 740 (840)
Q Consensus 689 ~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~ 740 (840)
..... .......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11000 01235689999999999876 568888999999999999988887764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-24 Score=224.28 Aligned_cols=206 Identities=20% Similarity=0.224 Sum_probs=154.7
Q ss_pred CCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcc
Q 003199 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245 (840)
Q Consensus 166 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 245 (840)
+++.+++++|.++.+ |..+ .++|++|+|++|+++.+.+..|..+++|++|+|++|+++.
T Consensus 17 ~~~~l~~~~~~l~~i-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------ 75 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAI-PSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT------------------ 75 (270)
T ss_dssp TTTEEECTTSCCSSC-CSCC--CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC------------------
T ss_pred CCCEEEccCCCCCcc-CCCC--CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe------------------
Confidence 456777777777643 3222 2467777777777766555566667777777777766653
Q ss_pred cccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeecc
Q 003199 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFI 325 (840)
Q Consensus 246 ~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 325 (840)
..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++..+..|+.+++|++|+|++|++++..
T Consensus 76 ------i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 76 ------LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp ------CCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ------eChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 33445667778888888888887666666777888888888888888777777888888888888888888666
Q ss_pred chhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 326 PSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 326 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.+..+
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 6667888888888888888887777778888888999999998887777778888889999999998876544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=228.36 Aligned_cols=228 Identities=25% Similarity=0.275 Sum_probs=167.4
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
.++..+++.++.+.+. ..+..+++|+.|++++| .+..++ .+..+++|++|++++|.+.+. ..+..+++|++
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~---~i~~~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 89 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNS---DIKSVQ--GIQYLPNVRYLALGGNKLHDI--SALKELTNLTY 89 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTS---CCCCCT--TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCE
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCC---Cccccc--ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCE
Confidence 3455566667766633 23556777888888887 444443 367778888888888887652 46777888888
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
|+|++|.+++..+..|..+++|++|+|++|+ +.+..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus 90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 168 (272)
T 3rfs_A 90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQ-LQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ 168 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCccCccChhHhcCCcCCCEEECCCCc-CCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCC
Confidence 8888888886666677888888888888886 444445557788888888888888887666677788888888888888
Q ss_pred cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcc
Q 003199 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256 (840)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 256 (840)
+++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++.+ .++.++.+.++.|.+.|.+|..
T Consensus 169 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 169 LQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCT
T ss_pred cCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCc
Confidence 887777777888888888888888887777777888888888888887763 3445677777777777776666
Q ss_pred ccccc
Q 003199 257 LARCK 261 (840)
Q Consensus 257 ~~~l~ 261 (840)
++.++
T Consensus 242 ~~~~~ 246 (272)
T 3rfs_A 242 AGSVA 246 (272)
T ss_dssp TSCBC
T ss_pred ccccC
Confidence 65544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=223.91 Aligned_cols=204 Identities=24% Similarity=0.285 Sum_probs=177.5
Q ss_pred CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCC
Q 003199 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNV 91 (840)
Q Consensus 12 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 91 (840)
.++.+++++++++++|+++ .+|..+. ++|+.|+|++| .+..+++..|..+++|+.|+|++|.+++..+. +.+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N---~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l 76 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSEN---LLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTL 76 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTS---CCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCC---cCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCC
Confidence 4678899999999999999 6776664 68999999999 67777888899999999999999999865443 788
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+ +.+..+..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~-l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSC-CCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCc-CcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 99999999999998 778888999999999999997 4555557789999999999999999987777888999999999
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
|++|+|+.+++..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 9999999888888899999999999999998 67777888889999999999886
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=224.44 Aligned_cols=205 Identities=21% Similarity=0.264 Sum_probs=159.9
Q ss_pred ccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCch
Q 003199 161 ILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240 (840)
Q Consensus 161 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 240 (840)
+.++++|+.+++++|.++.+++.. .++++.|+|++|++++..+..|..+++|+.|+|++|.|++.
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~---~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------ 70 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL------------ 70 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE------------
T ss_pred ccccCCccEEECCCCCCCcCCCCC---CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc------------
Confidence 456677777777777777444332 25677777777777766666677777777777777776632
Q ss_pred hhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccce
Q 003199 241 YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQ 320 (840)
Q Consensus 241 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 320 (840)
.+ ...+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|..+++|++|+|++|+
T Consensus 71 ------------~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 71 ------------QV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp ------------EC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred ------------cC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 11 256778899999999988 778888888999999999999988888888889999999999999
Q ss_pred eeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccccc
Q 003199 321 ISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 321 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+.
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 98777777788889999999999998666667788889999999999997 6677777778899999999988754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-24 Score=221.05 Aligned_cols=213 Identities=25% Similarity=0.269 Sum_probs=189.5
Q ss_pred CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCC
Q 003199 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNV 91 (840)
Q Consensus 12 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 91 (840)
.+..+++|+.|++++|.++ .++ .+..+++|++|+|++| .+..++ .+..+++|++|+|++|.+++..+..|+.+
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n---~l~~~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l 108 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGN---KLHDIS--ALKELTNLTYLILTGNQLQSLPNGVFDKL 108 (272)
T ss_dssp CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTS---CCCCCG--GGTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCC---CCCCch--hhcCCCCCCEEECCCCccCccChhHhcCC
Confidence 3567899999999999998 444 5889999999999999 455543 68899999999999999998888889999
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|++|+|++|++++..+..|..+++|++|+|++|+ +.+..+..+..+++|++|+|++|++++..+..|..+++|++|+
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ-LQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCc-cCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 999999999999998778889999999999999997 5555556689999999999999999988888889999999999
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 239 (840)
+++|++++..+..|..+++|++|+|++|++.+. +++|+.|+++.|.++|.+|..++.+...
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 999999999888899999999999999998743 5579999999999999999988876543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-25 Score=245.29 Aligned_cols=261 Identities=18% Similarity=0.208 Sum_probs=169.1
Q ss_pred eecccCccccccCCcccCCCCCCCeeeccCCcccccCC----ccccCCC-CCcEEEeeccccccccchhhhcC-----CC
Q 003199 121 LELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIP----ESILRLP-KLRVLQLYNNSLSGEISSVIANS-----TT 190 (840)
Q Consensus 121 L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~ 190 (840)
++|+.|. +.+.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 3 ~~ls~n~-~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHP-GSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCT-TCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccc-chHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 5666665 555666666666668888888888876555 6667777 78888888888777666666664 77
Q ss_pred CCEEEccCCcCcccCCcCC----CCC-CCcceeccccccccccCCccccCCCCchhhhcccccccccCCccccc-ccCCc
Q 003199 191 LTMLSLYDNSLTGEVPQDL----GQW-SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLAR-CKNLL 264 (840)
Q Consensus 191 L~~L~L~~N~l~~~~~~~l----~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-l~~L~ 264 (840)
|++|+|++|++++..+..+ ..+ ++|++|+|++|++++..+..++ ..+.. .++|+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~--------------------~~l~~~~~~L~ 141 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK--------------------QAFSNLPASIT 141 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH--------------------HHHTTSCTTCC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHH--------------------HHHHhCCCcee
Confidence 8888888887775554433 333 6777777777777654333221 12223 24677
Q ss_pred eEEeeCceeeccCC----ccccCCC-cccEEeccCCcccccCCcccC----CC-CCCceeecccceeeec----cchhhc
Q 003199 265 RFRVSNNHLEGSIP----EGILSLP-HVSIIDLSYNSFSGPIANTVG----NA-RNLSELFMQRNQISGF----IPSEIY 330 (840)
Q Consensus 265 ~L~l~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~----~p~~~~ 330 (840)
+|+|++|.+++..+ ..+..++ +|+.|+|++|++++..+..+. .. ++|++|+|++|+|++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 77777777764332 2334444 777788888877766554333 33 5788888888887752 444555
Q ss_pred cc-CcccEEEcCCCccCCCCC----CcccCccccchhcccCCccCCCc-------chhcccccCCCEEECcCccccccCC
Q 003199 331 RA-ISLVKIDLSDNLLSGPIP----SGIGNLKKLNLLMLQSNKLNSSI-------PNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 331 ~l-~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~-------~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
.. ++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|++.+..|
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 53 478888888888875433 33456677888888888854433 3356677778888888888876655
Q ss_pred chhh
Q 003199 399 ESLC 402 (840)
Q Consensus 399 ~~~~ 402 (840)
..+.
T Consensus 302 ~~~~ 305 (362)
T 3goz_A 302 IPIS 305 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=224.74 Aligned_cols=228 Identities=21% Similarity=0.193 Sum_probs=147.4
Q ss_pred CCCcEEEeeccccccccch---hhhcCCCCCEEEccCCcCcccCCcCC--CCCCCcceeccccccccccCCccccCCCCc
Q 003199 165 PKLRVLQLYNNSLSGEISS---VIANSTTLTMLSLYDNSLTGEVPQDL--GQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239 (840)
Q Consensus 165 ~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 239 (840)
..++.|.+.++.++..... .+..+++|++|+|++|.+.+..|..+ ..+++|++|+|++|++++..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~------- 136 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWL------- 136 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSH-------
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhh-------
Confidence 3467777777776532111 12345679999999999988888887 88899999999999888543310
Q ss_pred hhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCccccc---C-CcccCCCCCCceee
Q 003199 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP---I-ANTVGNARNLSELF 315 (840)
Q Consensus 240 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~ 315 (840)
....+..+++|++|++++|++.+..+..|..+++|++|+|++|++.+. . +..++.+++|++|+
T Consensus 137 -------------~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~ 203 (310)
T 4glp_A 137 -------------AELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLA 203 (310)
T ss_dssp -------------HHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCB
T ss_pred -------------HHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEE
Confidence 001233566777777777777666666677777777777777776531 1 22345677777777
Q ss_pred cccceeeeccch----hhcccCcccEEEcCCCccCCCCCCcccCc---cccchhcccCCccCCCcchhcccccCCCEEEC
Q 003199 316 MQRNQISGFIPS----EIYRAISLVKIDLSDNLLSGPIPSGIGNL---KKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL 388 (840)
Q Consensus 316 L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 388 (840)
|++|+++. ++. .+..+++|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|++|||
T Consensus 204 Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L 279 (310)
T 4glp_A 204 LRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL 279 (310)
T ss_dssp CCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred CCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence 77777752 222 23556777777777777776666666555 57777777777776 4555553 67777777
Q ss_pred cCccccccCCchhhcc-CCCeEEccCCCCcC
Q 003199 389 SNNLLTGYIPESLCEL-LPNSINFSNNRLSG 418 (840)
Q Consensus 389 ~~N~l~~~~p~~~~~~-~~~~l~l~~N~l~~ 418 (840)
++|+|++. |. +..+ .++.|++++|+++.
T Consensus 280 s~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 280 SSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 77777752 22 2222 44677777777753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-24 Score=237.27 Aligned_cols=255 Identities=17% Similarity=0.219 Sum_probs=127.1
Q ss_pred EecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCc----ccccccc-cccEEEecCccccccCCccccCC-----
Q 003199 22 LDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPE----SSIFRLT-KLRIMVLATCALHGQIPASIGNV----- 91 (840)
Q Consensus 22 L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l----- 91 (840)
++|+.|.+++.+|..+....+|++|+|++| .+...+. ..|..++ +|++|+|++|.+....+..+..+
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n---~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 79 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLN---NLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTS---CGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCC---CCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccC
Confidence 455556665555555544455666666666 4444444 4445555 55555555555554444444443
Q ss_pred CCCcEEEccCCcccccCchhhhc----C-CCCCeeecccCccccccCCcc----cCC-CCCCCeeeccCCcccccCC---
Q 003199 92 TSLTDLELTGNFITGHIPPEIGL----L-KNLRQLELYYNQQLAGTIPEE----LGN-LTELTDLDMSVNHLSGKIP--- 158 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~----l-~~L~~L~L~~n~~~~~~~p~~----l~~-l~~L~~L~L~~n~l~~~~~--- 158 (840)
++|++|+|++|.+++..+..+.. + ++|++|+|++|+ +.+..+.. +.. .++|++|+|++|.+++..+
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~-l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND-FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC-GGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCc-CCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 55666666666665444443333 2 556666666555 22222211 222 2456666666666653222
Q ss_pred -ccccCCC-CCcEEEeeccccccccchhhh----cC-CCCCEEEccCCcCccc----CCcCCCC-CCCcceecccccccc
Q 003199 159 -ESILRLP-KLRVLQLYNNSLSGEISSVIA----NS-TTLTMLSLYDNSLTGE----VPQDLGQ-WSPLVVLDLSENKLS 226 (840)
Q Consensus 159 -~~~~~l~-~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~----~~~~l~~-l~~L~~L~L~~N~l~ 226 (840)
..+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|+|+.. ++..+.. .++|++|+|++|+++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 2223333 566666666666544443322 23 3666666666665532 2222322 235666666666555
Q ss_pred ccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeec-------cCCccccCCCcccEEeccCCcccc
Q 003199 227 GPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEG-------SIPEGILSLPHVSIIDLSYNSFSG 299 (840)
Q Consensus 227 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~-------~~~~~~~~l~~L~~L~L~~N~l~~ 299 (840)
+..+..+ ...+..+++|+.|++++|.+.+ .++..+..+++|+.||+++|++.+
T Consensus 239 ~~~~~~l--------------------~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 239 GPSLENL--------------------KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CCCHHHH--------------------HHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred cHHHHHH--------------------HHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 3322111 1223444555556666555321 223345566667777777776664
Q ss_pred c
Q 003199 300 P 300 (840)
Q Consensus 300 ~ 300 (840)
.
T Consensus 299 ~ 299 (362)
T 3goz_A 299 S 299 (362)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=213.95 Aligned_cols=178 Identities=20% Similarity=0.247 Sum_probs=104.2
Q ss_pred CCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc-ccccCCccccCCCCCcEEEccC-CcccccCchhhhcCCCCC
Q 003199 42 NLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA-LHGQIPASIGNVTSLTDLELTG-NFITGHIPPEIGLLKNLR 119 (840)
Q Consensus 42 ~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~p~~~~~l~~L~ 119 (840)
+|++|+|++| .+..+++..|..+++|++|++++|. ++++.+..|.++++|++|+|++ |+++...+..|..+++|+
T Consensus 32 ~l~~L~l~~n---~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 32 STQTLKLIET---HLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TCCEEEEESC---CCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred cccEEEEeCC---cceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 5666666666 4555555556666666666666664 5555555566666666666665 666654455566666666
Q ss_pred eeecccCccccccCCcccCCCCCCC---eeeccCC-cccccCCccccCCCCCc-EEEeeccccccccchhhhcCCCCCEE
Q 003199 120 QLELYYNQQLAGTIPEELGNLTELT---DLDMSVN-HLSGKIPESILRLPKLR-VLQLYNNSLSGEISSVIANSTTLTML 194 (840)
Q Consensus 120 ~L~L~~n~~~~~~~p~~l~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L 194 (840)
+|++++|+ ...+|. +..+++|+ +|++++| .++.+.+..|..+++|+ .|++++|+++.+.+..|.. ++|++|
T Consensus 109 ~L~l~~n~--l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L 184 (239)
T 2xwt_C 109 FLGIFNTG--LKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAV 184 (239)
T ss_dssp EEEEEEEC--CCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEE
T ss_pred EEeCCCCC--Cccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEE
Confidence 66666665 222444 55555555 6666666 66655555566666666 6666666666444444444 566666
Q ss_pred EccCCc-CcccCCcCCCCC-CCcceecccccccc
Q 003199 195 SLYDNS-LTGEVPQDLGQW-SPLVVLDLSENKLS 226 (840)
Q Consensus 195 ~L~~N~-l~~~~~~~l~~l-~~L~~L~L~~N~l~ 226 (840)
+|++|+ ++.+.+..|..+ ++|+.|+|++|+++
T Consensus 185 ~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp ECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred EcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 666663 655545555555 66666666666655
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-23 Score=210.31 Aligned_cols=206 Identities=17% Similarity=0.220 Sum_probs=154.0
Q ss_pred cccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCc-CcccCCcCCCCCCCcceecccc-ccccccC
Q 003199 152 HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNS-LTGEVPQDLGQWSPLVVLDLSE-NKLSGPL 229 (840)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~ 229 (840)
.++ .+|. +. ++|++|++++|+++++.+..|.++++|++|+|++|+ ++.+.+..|.++++|++|+|++ |++++
T Consensus 22 ~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~-- 95 (239)
T 2xwt_C 22 DIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY-- 95 (239)
T ss_dssp SCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE--
T ss_pred Ccc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE--
Confidence 355 3454 33 378888888888887777777788888888888886 7766666777777777777777 77763
Q ss_pred CccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCccc---EEeccCC-cccccCCccc
Q 003199 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVS---IIDLSYN-SFSGPIANTV 305 (840)
Q Consensus 230 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~ 305 (840)
..+..|..+++|++|++++|++++ +|. +..+++|+ .|++++| ++++..+..|
T Consensus 96 ----------------------i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~ 151 (239)
T 2xwt_C 96 ----------------------IDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAF 151 (239)
T ss_dssp ----------------------ECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTT
T ss_pred ----------------------cCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccc
Confidence 344567777888888888888874 665 77777777 8888888 8887777788
Q ss_pred CCCCCCc-eeecccceeeeccchhhcccCcccEEEcCCCc-cCCCCCCcccCc-cccchhcccCCccCCCcchhcccccC
Q 003199 306 GNARNLS-ELFMQRNQISGFIPSEIYRAISLVKIDLSDNL-LSGPIPSGIGNL-KKLNLLMLQSNKLNSSIPNSLSSLKS 382 (840)
Q Consensus 306 ~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~ 382 (840)
..+++|+ .|++++|+++ .+|...+..++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|++++..+. .+++
T Consensus 152 ~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~ 227 (239)
T 2xwt_C 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEH 227 (239)
T ss_dssp TTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTT
T ss_pred cchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---Hhcc
Confidence 8888888 8888888888 444444444788888888885 886666778888 8888888888888754433 5677
Q ss_pred CCEEECcCc
Q 003199 383 LNVLDLSNN 391 (840)
Q Consensus 383 L~~L~l~~N 391 (840)
|+.|+++++
T Consensus 228 L~~L~l~~~ 236 (239)
T 2xwt_C 228 LKELIARNT 236 (239)
T ss_dssp CSEEECTTC
T ss_pred CceeeccCc
Confidence 888888876
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-23 Score=211.31 Aligned_cols=181 Identities=19% Similarity=0.233 Sum_probs=146.6
Q ss_pred CCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEe
Q 003199 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRV 268 (840)
Q Consensus 189 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l 268 (840)
...++++++++.++ .+|..+. ++|+.|+|++|.+++ ..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~------------------------~~~~~~~~l~~L~~L~L 66 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLAT------------------------LSDATFRGLTKLTWLNL 66 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCC------------------------CCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCc------------------------cCHhHhcCcccCCEEEC
Confidence 35677888888887 4555544 477788888887764 34445667778888888
Q ss_pred eCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCC
Q 003199 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGP 348 (840)
Q Consensus 269 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 348 (840)
++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.
T Consensus 67 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 67 DYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 88888877777778888888888888888877778888888888888888888877666778888999999999999877
Q ss_pred CCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccccc
Q 003199 349 IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 349 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
.+..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777888999999999999999988888899999999999999999876
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-25 Score=245.24 Aligned_cols=249 Identities=20% Similarity=0.222 Sum_probs=160.7
Q ss_pred cccCCcccCCCCCCCeeeccCCcccccCC----ccccCCCCCcEEEeecccc---ccccchhh-------hcCCCCCEEE
Q 003199 130 AGTIPEELGNLTELTDLDMSVNHLSGKIP----ESILRLPKLRVLQLYNNSL---SGEISSVI-------ANSTTLTMLS 195 (840)
Q Consensus 130 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l---~~~~~~~~-------~~l~~L~~L~ 195 (840)
...++..+..+++|++|+|++|.++...+ ..+..+++|++|+|++|.+ ++..|..+ ..+++|++|+
T Consensus 21 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~ 100 (386)
T 2ca6_A 21 EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVR 100 (386)
T ss_dssp HHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred HHHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEE
Confidence 34455667777888888888888876533 3366778888888887643 33334333 5677778888
Q ss_pred ccCCcCcc----cCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccc---------cC
Q 003199 196 LYDNSLTG----EVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARC---------KN 262 (840)
Q Consensus 196 L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l---------~~ 262 (840)
|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..+..+ ++
T Consensus 101 Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~--------------------~~l~~l~~~~~~~~~~~ 160 (386)
T 2ca6_A 101 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--------------------RALQELAVNKKAKNAPP 160 (386)
T ss_dssp CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--------------------HHHHHHHHHHHHHTCCC
T ss_pred CCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHH--------------------HHHHHHhhhhhcccCCC
Confidence 88777775 3455666677777777777777543322221 112222 67
Q ss_pred CceEEeeCceee-ccCC---ccccCCCcccEEeccCCcccc-----cCCcccCCCCCCceeecccceee----eccchhh
Q 003199 263 LLRFRVSNNHLE-GSIP---EGILSLPHVSIIDLSYNSFSG-----PIANTVGNARNLSELFMQRNQIS----GFIPSEI 329 (840)
Q Consensus 263 L~~L~l~~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~p~~~ 329 (840)
|++|++++|+++ +.++ ..+..+++|+.|+|++|+++. ..+..+..+++|+.|+|++|.++ ..+|..+
T Consensus 161 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l 240 (386)
T 2ca6_A 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240 (386)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred CcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence 777777777775 2333 345566777777777777762 23335667777777777777775 4566667
Q ss_pred cccCcccEEEcCCCccCCC----CCCcc--cCccccchhcccCCccCC----Ccchhc-ccccCCCEEECcCccccccCC
Q 003199 330 YRAISLVKIDLSDNLLSGP----IPSGI--GNLKKLNLLMLQSNKLNS----SIPNSL-SSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 330 ~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~p 398 (840)
..+++|+.|+|++|++++. ++..+ +.+++|+.|+|++|++++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred ccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 7777777777777777654 34444 336777777777777765 356655 556777777777777775543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-25 Score=245.03 Aligned_cols=248 Identities=21% Similarity=0.231 Sum_probs=120.2
Q ss_pred cCCccccCCCCCcEEEccCCcccccCch----hhhcCCCCCeeecccCc--cccccCCccc-------CCCCCCCeeecc
Q 003199 83 QIPASIGNVTSLTDLELTGNFITGHIPP----EIGLLKNLRQLELYYNQ--QLAGTIPEEL-------GNLTELTDLDMS 149 (840)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~n~i~~~~p~----~~~~l~~L~~L~L~~n~--~~~~~~p~~l-------~~l~~L~~L~L~ 149 (840)
.++..+..+++|++|+|++|.|++..+. .|..+++|++|+|++|. .+.+.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 3445555666667777777766654332 34456666666666652 1222333322 455666666666
Q ss_pred CCcccc----cCCccccCCCCCcEEEeeccccccccchhhhc----C---------CCCCEEEccCCcCcc-cCC---cC
Q 003199 150 VNHLSG----KIPESILRLPKLRVLQLYNNSLSGEISSVIAN----S---------TTLTMLSLYDNSLTG-EVP---QD 208 (840)
Q Consensus 150 ~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~N~l~~-~~~---~~ 208 (840)
+|.++. .++..+..+++|++|+|++|.++...+..+.. + ++|++|+|++|+++. ..+ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 666654 24445555666666666666665333322222 2 455555555555441 111 12
Q ss_pred CCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCccc
Q 003199 209 LGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVS 288 (840)
Q Consensus 209 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 288 (840)
+..+++|++|+|++|+++... +.. ..+..+..+++|+
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g-------------------~~~------------------------l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEG-------------------IEH------------------------LLLEGLAYCQELK 219 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHH-------------------HHH------------------------HHHTTGGGCTTCC
T ss_pred HHhCCCcCEEECcCCCCCHhH-------------------HHH------------------------HHHHHhhcCCCcc
Confidence 233344444444444433100 000 1222344444444
Q ss_pred EEeccCCccc----ccCCcccCCCCCCceeecccceeeec----cchhhc--ccCcccEEEcCCCccCC----CCCCcc-
Q 003199 289 IIDLSYNSFS----GPIANTVGNARNLSELFMQRNQISGF----IPSEIY--RAISLVKIDLSDNLLSG----PIPSGI- 353 (840)
Q Consensus 289 ~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~- 353 (840)
.|+|++|.++ ..++..+..+++|+.|+|++|++++. +|..+. .+++|+.|+|++|.+++ .+|..+
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~ 299 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHH
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHH
Confidence 4444444443 23334444455555555555555433 233332 25556666666666654 244444
Q ss_pred cCccccchhcccCCccCCCc
Q 003199 354 GNLKKLNLLMLQSNKLNSSI 373 (840)
Q Consensus 354 ~~l~~L~~L~Ls~N~l~~~~ 373 (840)
.++++|+.|+|++|++++..
T Consensus 300 ~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 300 EKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHCTTCCEEECTTSBSCTTS
T ss_pred hcCCCceEEEccCCcCCcch
Confidence 44566666666666666544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=218.91 Aligned_cols=202 Identities=21% Similarity=0.208 Sum_probs=90.3
Q ss_pred CCcEEEccCCcccccCchhh--hcCCCCCeeecccCccccccCC----cccCCCCCCCeeeccCCcccccCCccccCCCC
Q 003199 93 SLTDLELTGNFITGHIPPEI--GLLKNLRQLELYYNQQLAGTIP----EELGNLTELTDLDMSVNHLSGKIPESILRLPK 166 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~--~~l~~L~~L~L~~n~~~~~~~p----~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 166 (840)
+|++|+|++|.+++..|..+ ..+++|++|+|++|+ +.+..+ ..+..+++|++|+|++|++.+..+..|..+++
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~-i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVS-WATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCC-CSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeeccc-ccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 34555555555444444444 444555555555444 222111 12234455555555555555444455555555
Q ss_pred CcEEEeeccccccc---c-chhhhcCCCCCEEEccCCcCcccCCc----CCCCCCCcceeccccccccccCCccccCCCC
Q 003199 167 LRVLQLYNNSLSGE---I-SSVIANSTTLTMLSLYDNSLTGEVPQ----DLGQWSPLVVLDLSENKLSGPLPAKVCSRGK 238 (840)
Q Consensus 167 L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 238 (840)
|++|+|++|++.+. . +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-- 247 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC-- 247 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC--
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc--
Confidence 55555555554321 1 1112345555555555555542 111 12344555555555555554333222211
Q ss_pred chhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeeccc
Q 003199 239 LQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQR 318 (840)
Q Consensus 239 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 318 (840)
..+++|++|++++|+|+ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|+|++
T Consensus 248 -------------------~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 248 -------------------MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp -------------------CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred -------------------cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 11134444444444444 3343332 4455555555555433 11 34445555555555
Q ss_pred ceee
Q 003199 319 NQIS 322 (840)
Q Consensus 319 N~l~ 322 (840)
|+++
T Consensus 304 N~l~ 307 (310)
T 4glp_A 304 NPFL 307 (310)
T ss_dssp TTTS
T ss_pred CCCC
Confidence 5544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.6e-24 Score=228.33 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=160.3
Q ss_pred CCEEecCCCcCcccCCccccCC--CCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccccc-CCccccCCCCCc
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNL--TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ-IPASIGNVTSLT 95 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l--~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~ 95 (840)
++.|++++|.+. |..+..+ ++++.|++++| .+...+.. +..+++|+.|+|++|.+... ++..+..+++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n---~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~ 121 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRS---FMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQ 121 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTC---EECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCS
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCc---cccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCC
Confidence 667777777665 4556666 77777777777 44444443 44577777777777776644 566667777777
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccc-cCCcccCCCCCCCeeeccCC-ccccc-CCccccCCC-CCcEEE
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAG-TIPEELGNLTELTDLDMSVN-HLSGK-IPESILRLP-KLRVLQ 171 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~-~~p~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~ 171 (840)
+|+|++|.+++..+..+..+++|++|+|++|..+.+ .++..+..+++|++|+|++| .+++. ++..+..++ +|++|+
T Consensus 122 ~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~ 201 (336)
T 2ast_B 122 NLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLN 201 (336)
T ss_dssp EEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEE
T ss_pred EEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEE
Confidence 777777777766666777777777777777732332 34555666777777777777 66643 345566667 777777
Q ss_pred eecc--ccc-cccchhhhcCCCCCEEEccCCc-CcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccc
Q 003199 172 LYNN--SLS-GEISSVIANSTTLTMLSLYDNS-LTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247 (840)
Q Consensus 172 L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 247 (840)
|++| .++ +..+..+..+++|++|+|++|. +++..+..+..+++|+.|+|++|. +..+.
T Consensus 202 l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~---------------- 263 (336)
T 2ast_B 202 LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPE---------------- 263 (336)
T ss_dssp CCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGG----------------
T ss_pred eCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHH----------------
Confidence 7777 343 2345556667777777777776 555555566666777777777764 11111
Q ss_pred cccccCCcccccccCCceEEeeCceeeccCCccccCC-CcccEEeccCCcccccCCcccCC
Q 003199 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSL-PHVSIIDLSYNSFSGPIANTVGN 307 (840)
Q Consensus 248 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~ 307 (840)
....+..+++|++|++++| ++ ...+..+ ..|..|++++|++++..|..++.
T Consensus 264 -----~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 264 -----TLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp -----GGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred -----HHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 1124566777777777777 32 2233333 23666667777777777766654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=214.50 Aligned_cols=194 Identities=26% Similarity=0.342 Sum_probs=132.5
Q ss_pred CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCC
Q 003199 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVT 92 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 92 (840)
++.+++|++|++++|.++ .+| .+..+++|++|+|++| .+..++. +..+++|++|+|++|.+++. ..+..++
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n---~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~ 107 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN---QITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQ 107 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSS---CCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCT
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCC---cCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCC
Confidence 445677777777777777 444 4777777777777777 4555554 77777777777777777643 3577777
Q ss_pred CCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEe
Q 003199 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL 172 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (840)
+|++|+|++|++++ ++ .+..+++|++|++++|+ +. .++. +..+++|++|+|++|.+++..+ +..+++|+.|++
T Consensus 108 ~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~-l~-~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l 180 (308)
T 1h6u_A 108 SIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQ-IT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180 (308)
T ss_dssp TCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSC-CC-CCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCc-cC-cCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEEC
Confidence 77777777777774 33 27777777777777776 22 2332 6677777777777777774332 677777777777
Q ss_pred eccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 173 YNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 173 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
++|++++..+ +..+++|++|+|++|++++.. .+..+++|+.|+|++|+++
T Consensus 181 ~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred CCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 7777765443 667777777777777777543 3667777777777777776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.9e-24 Score=228.67 Aligned_cols=255 Identities=17% Similarity=0.167 Sum_probs=163.7
Q ss_pred CCcEEEccCCcccccCchhhhcC--CCCCeeecccCccccccCCcccCCCCCCCeeeccCCccccc-CCccccCCCCCcE
Q 003199 93 SLTDLELTGNFITGHIPPEIGLL--KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGK-IPESILRLPKLRV 169 (840)
Q Consensus 93 ~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~ 169 (840)
.++.|++++|.+. +..+..+ ++++.|++++|. +.+. +..+..+++|++|+|++|.+++. ++..+..+++|++
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~-l~~~-~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSF-MDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCE-ECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCcc-cccc-chhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 3667777777765 4556666 777777777776 3333 33355677777777777777654 5666777777777
Q ss_pred EEeeccccccccchhhhcCCCCCEEEccCC-cCccc-CCcCCCCCCCcceeccccc-cccccCCccccCCCCchhhhccc
Q 003199 170 LQLYNNSLSGEISSVIANSTTLTMLSLYDN-SLTGE-VPQDLGQWSPLVVLDLSEN-KLSGPLPAKVCSRGKLQYFLVLQ 246 (840)
Q Consensus 170 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~ 246 (840)
|+|++|.+++..+..+..+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++.
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~------------------ 184 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK------------------ 184 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH------------------
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH------------------
Confidence 777777777666667777777777777777 56532 3444556677777777777 66532
Q ss_pred ccccccCCccccccc-CCceEEeeCc--eee-ccCCccccCCCcccEEeccCCc-ccccCCcccCCCCCCceeecccce-
Q 003199 247 NMFSGVLPDSLARCK-NLLRFRVSNN--HLE-GSIPEGILSLPHVSIIDLSYNS-FSGPIANTVGNARNLSELFMQRNQ- 320 (840)
Q Consensus 247 n~~~~~~~~~~~~l~-~L~~L~l~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~- 320 (840)
.++..+..++ +|++|++++| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|+|++|.
T Consensus 185 -----~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~ 259 (336)
T 2ast_B 185 -----HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259 (336)
T ss_dssp -----HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred -----HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCC
Confidence 1233455556 6666666666 333 2344555566777777777776 555555666677777777777774
Q ss_pred eeeccchhhcccCcccEEEcCCCccCCCCCCcccCc-cccchhcccCCccCCCcchhccc
Q 003199 321 ISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNL-KKLNLLMLQSNKLNSSIPNSLSS 379 (840)
Q Consensus 321 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~ 379 (840)
+.......+..+++|+.|++++| ++ ...+..+ ..+..|++++|++++..|..++.
T Consensus 260 ~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 260 IIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 32222235667778888888877 32 2234444 34777778888888877776654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=201.47 Aligned_cols=178 Identities=23% Similarity=0.258 Sum_probs=98.8
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
+.++++++++.++ .+|..+. ++|+.|+|++| .+..+++..|..+++|++|+|++|.+.+..+..|..+++|++|
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n---~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 88 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQST---GLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL 88 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTS---CCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCC---CcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEE
Confidence 4566777777776 5555443 45666666666 4444554455555555555555555554444445555555555
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
+|++|++++..+.. |..+++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 89 ~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 89 GLANNQLASLPLGV-------------------------FDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp ECTTSCCCCCCTTT-------------------------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcccccChhH-------------------------hcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcC
Confidence 55555555433344 44555555555555555544444455555555555555555
Q ss_pred ccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 178 SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 178 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
+++.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 144 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 5555555555566666666666665555555555666666666666655
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.9e-22 Score=212.90 Aligned_cols=241 Identities=17% Similarity=0.158 Sum_probs=145.4
Q ss_pred CeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccc-ccchhhhcCCCCCE-EEc
Q 003199 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG-EISSVIANSTTLTM-LSL 196 (840)
Q Consensus 119 ~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~-L~L 196 (840)
+.++.++++ ...+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+ +.+++|.++++|.+ +.+
T Consensus 12 ~~v~C~~~~--Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESK--VTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTT--CCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCC--CCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 455666655 33556544 2466777777777765555566777777777777776643 33445666666554 444
Q ss_pred cCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeC-ceeec
Q 003199 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSN-NHLEG 275 (840)
Q Consensus 197 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-N~l~~ 275 (840)
+.|+++.+.+..|..+++|++|++++|+++...+. .+....++..|++.+ |++..
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~------------------------~~~~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV------------------------HKIHSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC------------------------TTCCBSSCEEEEEESCTTCCE
T ss_pred cCCcccccCchhhhhccccccccccccccccCCch------------------------hhcccchhhhhhhcccccccc
Confidence 55666666666666666777777776666644333 333444555555543 44553
Q ss_pred cCCccccCCC-cccEEeccCCcccccCCcccCCCCCCceeeccc-ceeeeccchhhcccCcccEEEcCCCccCCCCCCcc
Q 003199 276 SIPEGILSLP-HVSIIDLSYNSFSGPIANTVGNARNLSELFMQR-NQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI 353 (840)
Q Consensus 276 ~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 353 (840)
..+..|..+. .++.|+|++|+|+.+.+..|. ..+|++|++++ |.++.+.+..|..+++|+.|||++|+|+...+..+
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~ 222 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 222 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC
T ss_pred ccccchhhcchhhhhhccccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh
Confidence 4444455443 466677777777655544443 34566777653 55654444556777777777777777775555556
Q ss_pred cCccccchhcccCCccCCCcchhcccccCCCEEECcCcc
Q 003199 354 GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNL 392 (840)
Q Consensus 354 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 392 (840)
.++++|+.+++ +.++ .+| .+..+++|+.++++++.
T Consensus 223 ~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 223 ENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred ccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence 66666666655 3343 455 36778888888887654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=9.6e-22 Score=208.38 Aligned_cols=172 Identities=27% Similarity=0.376 Sum_probs=76.2
Q ss_pred ccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCC
Q 003199 88 IGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKL 167 (840)
Q Consensus 88 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 167 (840)
+..+++|++|+|++|.+++. +. +..+++|++|+|++|+ +. .++ .+..+++|++|+|++|++++. + .+..+++|
T Consensus 59 ~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~-l~-~~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L 131 (308)
T 1h6u_A 59 VQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNP-LK-NVS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNL 131 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCC-CS-CCG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTC
T ss_pred hhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCc-CC-Cch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCC
Confidence 34444444444444444422 22 4444444444444444 11 121 344445555555555555432 2 24455555
Q ss_pred cEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccc
Q 003199 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247 (840)
Q Consensus 168 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 247 (840)
++|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|++|++++|
T Consensus 132 ~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N 205 (308)
T 1h6u_A 132 QVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNN 205 (308)
T ss_dssp CEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTS
T ss_pred CEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCC
Confidence 555555555543322 4455555555555555553222 4555555555555555543211 222222222222222
Q ss_pred cccccCCcccccccCCceEEeeCceee
Q 003199 248 MFSGVLPDSLARCKNLLRFRVSNNHLE 274 (840)
Q Consensus 248 ~~~~~~~~~~~~l~~L~~L~l~~N~l~ 274 (840)
.+.+.. .+..+++|+.|++++|.++
T Consensus 206 ~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 206 QISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred ccCccc--cccCCCCCCEEEccCCeee
Confidence 222222 1445555555555555555
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-22 Score=212.97 Aligned_cols=152 Identities=18% Similarity=0.211 Sum_probs=86.5
Q ss_pred cEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCC-cccCCCCCCCe-eec
Q 003199 71 RIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP-EELGNLTELTD-LDM 148 (840)
Q Consensus 71 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p-~~l~~l~~L~~-L~L 148 (840)
++++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|++ .+.+| .+|.++++|.+ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i-~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV-LEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTT-CCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCC-CCccChhHhhcchhhhhhhcc
Confidence 34555566665 4454442 4566677777776644445566666666666666652 22232 34566666554 444
Q ss_pred cCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccC-CcCcccCCcCCCCCC-Ccceecccccccc
Q 003199 149 SVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYD-NSLTGEVPQDLGQWS-PLVVLDLSENKLS 226 (840)
Q Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~l~~l~-~L~~L~L~~N~l~ 226 (840)
+.|+++.+.|..|..+++|++|++++|+|....+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 55666655566666666666666666666655555555555566666644 455544444454443 3555566665555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=209.79 Aligned_cols=165 Identities=15% Similarity=0.103 Sum_probs=124.0
Q ss_pred cCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCc--------hhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASD--------TDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
|...+.||+|+||.||+|...+|+.||||++........... .+.......+.+|++++++++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 445689999999999999878899999999854332111000 011124567899999999999 4 66666
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeec
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVAD 679 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 679 (840)
++.. ...++||||+++|+|.+ +.. .....++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 5543 56699999999999988 422 2355799999999999999 9999999999999999 99999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCcccccc----------CCCCccccchh
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS----------SKATTKCDVYS 724 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~s 724 (840)
||+|+. +..|+|||++.. ..+...+|+|.
T Consensus 236 FG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 236 FPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999853 335788997643 34455556654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=186.69 Aligned_cols=181 Identities=20% Similarity=0.191 Sum_probs=108.0
Q ss_pred cEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccc
Q 003199 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247 (840)
Q Consensus 168 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 247 (840)
+.++++++.++.++... .++|++|+|++|++++..+..|..+++|++|+|++|++++
T Consensus 10 ~~v~c~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------- 66 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-------------------- 66 (208)
T ss_dssp TEEECCSSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC--------------------
T ss_pred CEEEecCCCccCCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc--------------------
Confidence 45566666665433222 3456666666666665555555666666666666666552
Q ss_pred cccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccch
Q 003199 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS 327 (840)
Q Consensus 248 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 327 (840)
..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+.
T Consensus 67 ----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 67 ----LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp ----CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ----cChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 2333455566666666666666644444556666666666666666665555566666666666666666655554
Q ss_pred hhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccC
Q 003199 328 EIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKS 382 (840)
Q Consensus 328 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 382 (840)
.+..+++|+.|+|++|.+.+ .+++|+.|+++.|+++|.+|..++.++.
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 55666666666666665543 3445666666666666666666665544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=212.95 Aligned_cols=187 Identities=29% Similarity=0.449 Sum_probs=105.4
Q ss_pred CCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccc
Q 003199 142 ELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLS 221 (840)
Q Consensus 142 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 221 (840)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+.+ | ..+++|++|+|++|+|++ +|. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~i-p---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISL-P---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCccc-c---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 56666666666664 444332 5566666666666532 2 234555555555555553 333 332 45555555
Q ss_pred cccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccC
Q 003199 222 ENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI 301 (840)
Q Consensus 222 ~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 301 (840)
+|+|++ +|. .+++|+.|++++|+|++ +|.
T Consensus 129 ~N~l~~-------------------------lp~---~l~~L~~L~Ls~N~l~~-lp~---------------------- 157 (571)
T 3cvr_A 129 NNQLTM-------------------------LPE---LPALLEYINADNNQLTM-LPE---------------------- 157 (571)
T ss_dssp SSCCSC-------------------------CCC---CCTTCCEEECCSSCCSC-CCC----------------------
T ss_pred CCcCCC-------------------------CCC---cCccccEEeCCCCccCc-CCC----------------------
Confidence 554441 111 23444455555554442 332
Q ss_pred CcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCcccc-------chhcccCCccCCCcc
Q 003199 302 ANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKL-------NLLMLQSNKLNSSIP 374 (840)
Q Consensus 302 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~~ 374 (840)
.+++|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|
T Consensus 158 -----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp 223 (571)
T 3cvr_A 158 -----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIP 223 (571)
T ss_dssp -----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCC
T ss_pred -----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecC
Confidence 24455555555555553 333 33 56666666666666 4444 443 55 88888888887 567
Q ss_pred hhcccccCCCEEECcCccccccCCchhhcc
Q 003199 375 NSLSSLKSLNVLDLSNNLLTGYIPESLCEL 404 (840)
Q Consensus 375 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 404 (840)
..+..+++|+.|+|++|+|++.+|..+..+
T Consensus 224 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp GGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred HHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 777778888888888888888888877765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.2e-20 Score=183.29 Aligned_cols=162 Identities=26% Similarity=0.245 Sum_probs=99.3
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|++|+|++|++++..+..|..+++|++|+|++|+ +.+..+..|..+++|++|+|++|++++..+..|..+++|++|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK-LQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCc-cCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 356666666666664444455666666666666665 2333333456666666666666666655555566666677777
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~ 251 (840)
|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.+ .+++|++|.++.|.+.|
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSG 179 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTT
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCc
Confidence 77776666666666666777777777777765555556667777777777776542 33456666666666666
Q ss_pred cCCccccccc
Q 003199 252 VLPDSLARCK 261 (840)
Q Consensus 252 ~~~~~~~~l~ 261 (840)
.+|..++.++
T Consensus 180 ~ip~~~~~l~ 189 (208)
T 2o6s_A 180 VVRNSAGSVA 189 (208)
T ss_dssp TBBCTTSSBC
T ss_pred eeeccCcccc
Confidence 6666555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=206.51 Aligned_cols=178 Identities=25% Similarity=0.348 Sum_probs=89.8
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
+|+.|+|++|+|++ +|..+. ++|+.|+|++| .+..+| ..+++|++|+|++|.+++ +|. +.. +|++|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N---~l~~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L 125 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQN---ALISLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHL 125 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSS---CCSCCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEE
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCC---CCcccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEE
Confidence 56666666666663 454442 56666666666 344444 234556666666666654 444 443 56666
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
+|++|+|++ +|. .+++|+.|+|++|+ + ..+|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|
T Consensus 126 ~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~-l-~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L 192 (571)
T 3cvr_A 126 DVDNNQLTM-LPE---LPALLEYINADNNQ-L-TMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLL 192 (571)
T ss_dssp ECCSSCCSC-CCC---CCTTCCEEECCSSC-C-SCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCC
T ss_pred ECCCCcCCC-CCC---cCccccEEeCCCCc-c-CcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCC
Confidence 666666653 333 45555555555554 2 22443 34555555555555553 333 33 5555555555555
Q ss_pred ccccchhhhcCCCC-------CEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 178 SGEISSVIANSTTL-------TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 178 ~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
+.+ |. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++
T Consensus 193 ~~l-p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 193 ESL-PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp SSC-CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred Cch-hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 522 22 222 33 55555555554 234444444555555555555443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=5.9e-20 Score=211.18 Aligned_cols=193 Identities=24% Similarity=0.282 Sum_probs=132.4
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCc
Q 003199 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLT 95 (840)
Q Consensus 16 l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 95 (840)
+.++..+.|+.+.+++..+ +..|++|+.|+|++| .+..++ .+..+++|+.|+|++|.+.+..| +..+++|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n---~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~ 90 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS---DIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLG 90 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTC---CCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCC
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCC---CCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCC
Confidence 3445566677777664433 556777777888777 444444 36777777777777777775443 77777777
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecc
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 175 (840)
.|+|++|.|++ +| .+..+++|+.|+|++|+ +. .+ ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|
T Consensus 91 ~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~-l~-~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N 163 (605)
T 1m9s_A 91 WLFLDENKIKD-LS-SLKDLKKLKSLSLEHNG-IS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN 163 (605)
T ss_dssp EEECCSSCCCC-CT-TSTTCTTCCEEECTTSC-CC-CC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSS
T ss_pred EEECcCCCCCC-Ch-hhccCCCCCEEEecCCC-CC-CC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCC
Confidence 77777777773 33 57777777777777776 22 23 3466777777777777777754 56777777777777777
Q ss_pred ccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccccc
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGP 228 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 228 (840)
.|.+..+ +..+++|++|+|++|+|++. ..+..+++|+.|+|++|++.+.
T Consensus 164 ~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 164 QISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred cCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 7776555 77777777777777777753 3567777777777777777643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=190.31 Aligned_cols=190 Identities=24% Similarity=0.282 Sum_probs=131.5
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
++..+.+..+.+++..+ +..+++|+.|++++| .+..++ .+..+++|++|+|++|.+++..+ +..+++|++|
T Consensus 25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~---~i~~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L 95 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS---DIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95 (291)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTS---CCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHhcCCCcccccc--hhhcCcccEEEccCC---CcccCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEE
Confidence 34445566666653322 456777777777777 444443 36677777777777777775433 7777778888
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
+|++|++++ +| .+..+++|++|+|++|+ +. .+ ..+..+++|++|+|++|++++. ..+..+++|+.|++++|++
T Consensus 96 ~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~-i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 96 FLDENKVKD-LS-SLKDLKKLKSLSLEHNG-IS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp ECCSSCCCC-GG-GGTTCTTCCEEECTTSC-CC-CC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred ECCCCcCCC-Ch-hhccCCCCCEEECCCCc-CC-CC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence 888887774 33 47777778888887776 22 23 3567777788888888887754 5677778888888888887
Q ss_pred ccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 178 SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 178 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
++..+ +..+++|++|+|++|++++. + .+..+++|+.|++++|+++.
T Consensus 169 ~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 169 SDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 76554 77778888888888887743 3 47777788888888887764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=181.90 Aligned_cols=136 Identities=24% Similarity=0.295 Sum_probs=108.3
Q ss_pred cCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEc
Q 003199 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340 (840)
Q Consensus 261 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 340 (840)
++|+.|++++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 56778888888887666667777888888888888888777778888888888888888888665556677888888888
Q ss_pred CCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccccc
Q 003199 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 341 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 88888877777888888888888888888877777788888888888888888754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-19 Score=206.07 Aligned_cols=184 Identities=23% Similarity=0.304 Sum_probs=158.0
Q ss_pred CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCC
Q 003199 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNV 91 (840)
Q Consensus 12 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 91 (840)
.+..|++|+.|+|++|.|+ .+| .+..+++|+.|+|++| .+..+++ +..+++|+.|+|++|.+.+. ..+..+
T Consensus 38 ~~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N---~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l 108 (605)
T 1m9s_A 38 TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGN---KLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDL 108 (605)
T ss_dssp CHHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTS---CCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTC
T ss_pred chhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCC---CCCCChh--hccCCCCCEEECcCCCCCCC--hhhccC
Confidence 3567899999999999998 555 5899999999999999 5666665 89999999999999999853 479999
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|++|+|++|.|++ + ..+..+++|+.|+|++|+ +. .+ ..+..+++|+.|+|++|.|++..| +..+++|+.|+
T Consensus 109 ~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~-l~-~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 109 KKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNK-IT-DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp TTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSC-CC-CC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCc-cC-Cc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 999999999999995 3 469999999999999998 33 33 678999999999999999997665 99999999999
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCC
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWS 213 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 213 (840)
|++|+|++. ..+..+++|+.|+|++|++.......+..+.
T Consensus 182 Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~ 221 (605)
T 1m9s_A 182 LSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLV 221 (605)
T ss_dssp CCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred CcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence 999999975 4689999999999999999865444444433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-19 Score=180.10 Aligned_cols=137 Identities=20% Similarity=0.234 Sum_probs=106.2
Q ss_pred CCceEEeeCceeeccCC-ccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEc
Q 003199 262 NLLRFRVSNNHLEGSIP-EGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340 (840)
Q Consensus 262 ~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 340 (840)
.+++|+|++|+|++..+ ..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 45677788887776544 34667778888888888887777777788888888888888887777777777888888888
Q ss_pred CCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 341 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 8888887777778888888888888888887777888888888888888888876554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=189.81 Aligned_cols=175 Identities=24% Similarity=0.312 Sum_probs=152.6
Q ss_pred CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCC
Q 003199 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNV 91 (840)
Q Consensus 12 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 91 (840)
.+..+++|++|++++|.++ .++ .+..+++|++|+|++| .+..+++ +..+++|+.|++++|.+++. ..+..+
T Consensus 41 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n---~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l 111 (291)
T 1h6t_A 41 TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGN---KLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDL 111 (291)
T ss_dssp CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSS---CCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTC
T ss_pred chhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCC---ccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccC
Confidence 3567889999999999999 445 4899999999999999 5666665 89999999999999999863 349999
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|++|+|++|++++. ..+..+++|+.|++++|+ +. .+ ..+..+++|++|+|++|.+++..+ +..+++|+.|+
T Consensus 112 ~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~-l~-~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 184 (291)
T 1h6t_A 112 KKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNK-IT-DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184 (291)
T ss_dssp TTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSC-CC-CC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCc-CC-cc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence 9999999999999953 579999999999999998 33 33 578999999999999999997654 99999999999
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCccc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGE 204 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 204 (840)
|++|.+++.. .+..+++|+.|++++|+++..
T Consensus 185 L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 185 LSKNHISDLR--ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCSSCCCBCG--GGTTCTTCSEEEEEEEEEECC
T ss_pred CCCCcCCCCh--hhccCCCCCEEECcCCcccCC
Confidence 9999999653 489999999999999999853
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-19 Score=193.56 Aligned_cols=176 Identities=24% Similarity=0.222 Sum_probs=93.8
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCccccc-ccccccEEEecCccccccCCccccCCCCCcEEE
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF-RLTKLRIMVLATCALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 98 (840)
+++++++++++ .+|..+. ..++.|+|++| .+..++...|. .+++|+.|+|++|.|++..+..|.++++|++|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N---~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 94 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHN---NLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD 94 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSS---CCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCC---CCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEE
Confidence 56777777777 5565443 34666777766 45555555555 555666666666665555555555555555555
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccc
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 178 (840)
|++|+|+...+..|..+++|+.|+|++| +|+.+.+..|..+++|+.|+|++|+|+
T Consensus 95 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-------------------------~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 95 LSSNHLHTLDEFLFSDLQALEVLLLYNN-------------------------HIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSS-------------------------CCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCcCCHHHhCCCcCCCEEECCCC-------------------------cccEECHHHhCCcccCCEEECCCCcCC
Confidence 5555555444444555555555555555 444444444444444444444444444
Q ss_pred cccchhh---hcCCCCCEEEccCCcCcccCCcCCCCCCC--cceecccccccc
Q 003199 179 GEISSVI---ANSTTLTMLSLYDNSLTGEVPQDLGQWSP--LVVLDLSENKLS 226 (840)
Q Consensus 179 ~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~l~~l~~--L~~L~L~~N~l~ 226 (840)
.+.+..| ..+++|++|+|++|+|+.+.+..+..++. |+.|+|++|++.
T Consensus 150 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 4333333 33555555555555555333334444444 355666666654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.9e-19 Score=177.27 Aligned_cols=137 Identities=22% Similarity=0.210 Sum_probs=109.5
Q ss_pred cCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEc
Q 003199 261 KNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDL 340 (840)
Q Consensus 261 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 340 (840)
++|++|+|++|.+++..|..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 67888888888888777777788888888888888887777777788888888888888888666666777888888888
Q ss_pred CCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 341 SDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 341 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 888887 677777888888888888888887666778888888888888888886654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=174.32 Aligned_cols=152 Identities=19% Similarity=0.289 Sum_probs=89.3
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEc
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLEL 99 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 99 (840)
+.++++++.++ .+|..+. ++|++|+|++| .+..+++ ..|..+++|++|+|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n---~i~~i~~------------------------~~~~~l~~L~~L~L 63 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQN---TIKVIPP------------------------GAFSPYKKLRRIDL 63 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSS---CCCEECT------------------------TSSTTCTTCCEEEC
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCC---cCCCcCH------------------------hHhhCCCCCCEEEC
Confidence 45666666666 4554433 45555555555 3444444 44555555555555
Q ss_pred cCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccc
Q 003199 100 TGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179 (840)
Q Consensus 100 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 179 (840)
++|+|++..|..|..+++|++|+|++|+ +....+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++
T Consensus 64 s~N~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 142 (220)
T 2v9t_B 64 SNNQISELAPDAFQGLRSLNSLVLYGNK-ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142 (220)
T ss_dssp CSSCCCEECTTTTTTCSSCCEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcCCCcCHHHhhCCcCCCEEECCCCc-CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCE
Confidence 5555554445555555555555555554 222222335566666666666666666666666667777777777777766
Q ss_pred ccchhhhcCCCCCEEEccCCcCc
Q 003199 180 EISSVIANSTTLTMLSLYDNSLT 202 (840)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~ 202 (840)
+.+..|..+++|++|+|++|++.
T Consensus 143 ~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 143 IAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCEE
T ss_pred ECHHHHhCCCCCCEEEeCCCCcC
Confidence 66666777777777777777765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.9e-19 Score=190.98 Aligned_cols=177 Identities=24% Similarity=0.205 Sum_probs=146.6
Q ss_pred cEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhh-cCCCCCeeecccCccccccCCcccCCCCCCCeeecc
Q 003199 71 RIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIG-LLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149 (840)
Q Consensus 71 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~ 149 (840)
++++++++.++ .+|..+. ..++.|+|++|+|++..+..|. .+++|+.|+|++|+ +.+..+..|.++++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~-i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSC-CCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCc-CCccChhhccCCCCCCEEECC
Confidence 45677777766 3555443 3578888888888877777777 88888888888887 455556678899999999999
Q ss_pred CCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCC---CCCCCcceecccccccc
Q 003199 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDL---GQWSPLVVLDLSENKLS 226 (840)
Q Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l---~~l~~L~~L~L~~N~l~ 226 (840)
+|+|+.+.+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+.+.+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999998878889999999999999999999989999999999999999999997555555 56999999999999999
Q ss_pred ccCCccccCCCC--chhhhcccccccc
Q 003199 227 GPLPAKVCSRGK--LQYFLVLQNMFSG 251 (840)
Q Consensus 227 ~~~~~~~~~l~~--L~~L~l~~n~~~~ 251 (840)
+..+..+..++. ++.|++.+|.+..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 877778888887 4889999998864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-18 Score=172.79 Aligned_cols=152 Identities=18% Similarity=0.228 Sum_probs=87.2
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCC-cccccccccccEEEecCccccccCCccccCCCCCcEEE
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP-ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 98 (840)
+.+++++|.++ .+|..+. ..+++|+|++| .+..++ ...|..+++|+.|+|++|.+++..+..|.++++|++|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N---~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 87 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNN---EFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSS---CCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCC---cCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence 57888888887 5666553 34577777777 455542 34456666666666666666655555666666666666
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccc
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 178 (840)
|++|+|++..+..|..+++|++|+|++|+ +.+..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+.
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSC-CCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCc-CCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 66666665545555555555555555554 33333444555555555555555555444444444555555555444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.4e-21 Score=220.27 Aligned_cols=107 Identities=24% Similarity=0.328 Sum_probs=61.0
Q ss_pred ccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccC
Q 003199 287 VSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366 (840)
Q Consensus 287 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 366 (840)
|+.|+|++|+|+++ |. |+.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .++.+++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 45555555555542 32 555555555555555555 445555556666666666666654 34 555566666666666
Q ss_pred CccCCCc-chhcccccCCCEEECcCccccccCC
Q 003199 367 NKLNSSI-PNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 367 N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
|+|++.. |..|..+++|+.|+|++|+|++.+|
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 6665554 5566666666666666666664433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=184.84 Aligned_cols=151 Identities=21% Similarity=0.292 Sum_probs=88.2
Q ss_pred ccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCC
Q 003199 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143 (840)
Q Consensus 64 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L 143 (840)
+..+++|+.|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|+.|+|++|+ ...+|.. .. ++|
T Consensus 37 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~--l~~l~~~-~~-~~L 108 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNR--LKNLNGI-PS-ACL 108 (263)
T ss_dssp HHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC--CSCCTTC-CC-SSC
T ss_pred hhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCc--cCCcCcc-cc-Ccc
Confidence 3344444444444444432 22 34445555555555555553222 5555555555555554 2223322 22 667
Q ss_pred CeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccc
Q 003199 144 TDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223 (840)
Q Consensus 144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 223 (840)
++|+|++|++++. ..+..+++|+.|+|++|++++.. .+..+++|++|+|++|++++. ..+..+++|+.|++++|
T Consensus 109 ~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N 182 (263)
T 1xeu_A 109 SRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQ 182 (263)
T ss_dssp CEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEE
T ss_pred cEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCC
Confidence 7777777777643 24667777777777777776542 567777777777777777754 56777777777777777
Q ss_pred ccccc
Q 003199 224 KLSGP 228 (840)
Q Consensus 224 ~l~~~ 228 (840)
++++.
T Consensus 183 ~~~~~ 187 (263)
T 1xeu_A 183 KCVNE 187 (263)
T ss_dssp EEECC
T ss_pred cccCC
Confidence 77644
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=8.7e-19 Score=171.67 Aligned_cols=174 Identities=19% Similarity=0.248 Sum_probs=134.0
Q ss_pred ceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCc-ccCCCCCCceeecccceeeeccchhhcccCcccEEEcCC
Q 003199 264 LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN-TVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342 (840)
Q Consensus 264 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 342 (840)
+.+++++|+++ .+|..+.. +|+.|++++|++++..+. .|+.+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888887 67776544 889999999999877764 588899999999999999988888999999999999999
Q ss_pred CccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcCCc
Q 003199 343 NLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPL 422 (840)
Q Consensus 343 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~ 422 (840)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+.......+....+.++...+..|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 99998888889999999999999999998889999999999999999999998776432211112223445555555565
Q ss_pred ccccCCCcccccCCCCCcc
Q 003199 423 SLIKEGLVESFSGNPGLCV 441 (840)
Q Consensus 423 ~~~~~~~~~~~~~n~~~c~ 441 (840)
.+... ....+..+...|.
T Consensus 168 ~l~~~-~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 168 KVRDV-QIKDLPHSEFKCS 185 (192)
T ss_dssp TTTTS-BGGGSCTTTCCCC
T ss_pred HHcCC-ChhhCcHhhcCcC
Confidence 44332 3334555555564
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-19 Score=184.35 Aligned_cols=171 Identities=20% Similarity=0.236 Sum_probs=144.7
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
.+.++..+++++|.++ .++ .+..+++|+.|++++| .+..++ .+..+++|+.|+|++|.+++..+ +..+++|
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n---~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L 87 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNS---NIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKL 87 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTS---CCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSC
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCC---Ccccch--HHhhCCCCCEEECCCCccCCChh--hccCCCC
Confidence 5677888999999998 444 6889999999999999 566665 58899999999999999986544 9999999
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
++|+|++|++++ +|.. .. ++|+.|+|++|+ +. .++ .+..+++|++|+|++|++++. + .+..+++|+.|+|++
T Consensus 88 ~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~-l~-~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~ 159 (263)
T 1xeu_A 88 EELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNE-LR-DTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHG 159 (263)
T ss_dssp CEEECCSSCCSC-CTTC-CC-SSCCEEECCSSC-CS-BSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTT
T ss_pred CEEECCCCccCC-cCcc-cc-CcccEEEccCCc-cC-CCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCC
Confidence 999999999995 4433 33 999999999998 33 343 688999999999999999964 3 688999999999999
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCccc
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGE 204 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 204 (840)
|++++. ..+..+++|+.|++++|++...
T Consensus 160 N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 160 NEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 999876 6789999999999999999854
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.3e-18 Score=169.54 Aligned_cols=152 Identities=22% Similarity=0.297 Sum_probs=70.4
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
.+++|++|++++|.|+ .+| .+..+++|++|++++| .+..++ .+..+++|++|++++|.+++..+..++.+++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n---~~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNI---HATNYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESC---CCSCCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCC---CCCcch--hhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3445555555555555 334 3555555555555555 232222 34445555555555555554444455555555
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
++|+|++|++++..|..+..+++|++|+|++|+. .+.+| .+..+++|++|++++|.+++ ++ .+..+++|++|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~-i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA-ITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTB-CCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCC-ccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 5555555555544444455555555555554431 11222 34444444444444444442 11 333444444444444
Q ss_pred ccc
Q 003199 175 NSL 177 (840)
Q Consensus 175 N~l 177 (840)
|+|
T Consensus 191 N~i 193 (197)
T 4ezg_A 191 QTI 193 (197)
T ss_dssp C--
T ss_pred ccc
Confidence 443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-19 Score=191.52 Aligned_cols=221 Identities=9% Similarity=0.045 Sum_probs=141.4
Q ss_pred CCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccc----ccccCCccccCCCCc
Q 003199 164 LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENK----LSGPLPAKVCSRGKL 239 (840)
Q Consensus 164 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L 239 (840)
+++|+.|+|.+ .++.+...+|.++++|++|++++|.+..+.+.+|.++.++..+.+..+. ........|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 66666666666 5555556666666666666666666655555666665555555554422 122223334333333
Q ss_pred h-hhhccccc-ccccCCcccccccCCceEEeeCceeeccCCcccc-CCCcccEEeccCCcccccCCcccCCCCCCceeec
Q 003199 240 Q-YFLVLQNM-FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGIL-SLPHVSIIDLSYNSFSGPIANTVGNARNLSELFM 316 (840)
Q Consensus 240 ~-~L~l~~n~-~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 316 (840)
+ .+.+.... +.......-....++..+.+.++-.. .....+. .+++|+.|+|++|+++.+...+|.++++|++|+|
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 3 12111110 00000000112345566666554222 1111111 2678999999998898888888999999999999
Q ss_pred ccceeeeccchhhcccCccc-EEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEEC
Q 003199 317 QRNQISGFIPSEIYRAISLV-KIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDL 388 (840)
Q Consensus 317 ~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 388 (840)
.+| ++.+.+.+|.++.+|+ .+++.+ .++...+.+|.++++|+.|++++|.++.+.+.+|.++++|+.|+.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 888 7777788888899998 999988 777667788999999999999999998777889999999998864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.6e-21 Score=217.88 Aligned_cols=190 Identities=24% Similarity=0.232 Sum_probs=95.1
Q ss_pred CCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCC----------ccCCCCcccccccccccEEE-ecCcccc
Q 003199 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGF----------KLWKLPESSIFRLTKLRIMV-LATCALH 81 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~----------~l~~l~~~~~~~l~~L~~L~-L~~n~l~ 81 (840)
+..+++|+.|+|++|.++ .+|..++++++|++|++++|... .....++..+..+++|+.|+ ++.|.+.
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence 467788888888888887 78888888888888888666100 01112222333333333333 2222211
Q ss_pred ccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccc
Q 003199 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI 161 (840)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (840)
+|+.+.+++|.|+.. |. ..|+.|+|++|+ ...+|. ++.+++|+.|+|++|.|+ .+|..|
T Consensus 424 -----------~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~--l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~ 482 (567)
T 1dce_A 424 -----------DLRSKFLLENSVLKM-EY-----ADVRVLHLAHKD--LTVLCH-LEQLLLVTHLDLSHNRLR-ALPPAL 482 (567)
T ss_dssp -----------HHHHHHHHHHHHHHH-HH-----TTCSEEECTTSC--CSSCCC-GGGGTTCCEEECCSSCCC-CCCGGG
T ss_pred -----------hhhhhhhhccccccc-Cc-----cCceEEEecCCC--CCCCcC-ccccccCcEeecCccccc-ccchhh
Confidence 122222223333211 10 134555555554 122343 455555555555555555 344455
Q ss_pred cCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccC-CcCCCCCCCcceecccccccc
Q 003199 162 LRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEV-PQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 162 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 226 (840)
..+++|+.|+|++|+|+++ | .+.++++|++|+|++|+|++.. |..+..+++|+.|+|++|+++
T Consensus 483 ~~l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 483 AALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp GGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred hcCCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 5555555555555555532 2 4455555555555555555443 445555555555555555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9e-19 Score=180.15 Aligned_cols=146 Identities=19% Similarity=0.231 Sum_probs=108.1
Q ss_pred cCccCeeeccCCcEEEEEEe-CCCcE--EEEEEecccccccccCc--------------hhhHHHHHHHHHHHHHHhccC
Q 003199 528 MTEKNKVGQGGSGTVYKIDL-NSGEV--VAVKKLWSQRTKVSASD--------------TDQLQLDKGLKTEVETLGNIR 590 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~ 590 (840)
|...+.||+|+||.||+|.. .+|+. ||||+++.......... .........+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45667899999999999977 67989 99998754321110000 001223356889999999998
Q ss_pred CCCc--ceeeeEEecCccceEEEeecCC-C----ChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHh-hcCCCCeEecCC
Q 003199 591 HKNI--VKLYCYFSSLYCNLLVYEYMPN-G----NLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH-HGLLSPIIHRDI 662 (840)
Q Consensus 591 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dl 662 (840)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.|+.||| + .+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 8864 334432 366899999942 4 66665432 235678899999999999999 8 89999999
Q ss_pred CCCCEEEcCCCCCeeecccchhhh
Q 003199 663 KSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 663 k~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.5e-18 Score=169.30 Aligned_cols=153 Identities=24% Similarity=0.286 Sum_probs=84.1
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEE
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 98 (840)
-+.++++++.++ .+|..+. ++|++|+|++| .+.+..|..|.++++|++|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n---------------------------~i~~~~~~~~~~l~~L~~L~ 70 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDN---------------------------QITKLEPGVFDSLINLKELY 70 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSS---------------------------CCCCCCTTTTTTCTTCCEEE
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCC---------------------------ccCccCHHHhhCccCCcEEE
Confidence 455666666666 5554332 55555555555 44444444455555555555
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccc
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 178 (840)
|++|+|+...+..|..+++|+.|+|++|+ +.+..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+
T Consensus 71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~-l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQ-LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC
T ss_pred CCCCCCCCcChhhcccCCCcCEEECCCCc-CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC
Confidence 55555543333444555555555555554 22222334455556666666666665 44555566666666666666666
Q ss_pred cccchhhhcCCCCCEEEccCCcCcc
Q 003199 179 GEISSVIANSTTLTMLSLYDNSLTG 203 (840)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~ 203 (840)
+..+..|..+++|++|+|++|.+..
T Consensus 149 ~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 149 SIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred ccCHHHHhCCCCCCEEEeeCCCccC
Confidence 5555556666666666666666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-18 Score=167.54 Aligned_cols=134 Identities=17% Similarity=0.187 Sum_probs=103.3
Q ss_pred ccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcc
Q 003199 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISL 335 (840)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 335 (840)
.+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..++.+++|++|+|++|++++..|..+..+++|
T Consensus 61 ~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L 138 (197)
T 4ezg_A 61 GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138 (197)
T ss_dssp TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSC
T ss_pred HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCC
Confidence 4667778888888888665 33467778888888888888887777778888888888888888887778888888888
Q ss_pred cEEEcCCCc-cCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 336 VKIDLSDNL-LSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 336 ~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
+.|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++.+
T Consensus 139 ~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 139 NSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888888887 65 444 57788888888888888875 33 67888888888888888763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-18 Score=182.63 Aligned_cols=265 Identities=13% Similarity=0.071 Sum_probs=188.2
Q ss_pred CCCCCEEecCCCcCc--ccCCccccCCCCCCEEeCCCCCCCccCCCCcccccc--------cccccEEEecCccccccCC
Q 003199 16 MQNLRRLDLSNNLFT--GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFR--------LTKLRIMVLATCALHGQIP 85 (840)
Q Consensus 16 l~~L~~L~Ls~n~i~--~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~--------l~~L~~L~L~~n~l~~~~~ 85 (840)
+++|++|||++|+|. ...+..+ +.+..+.+..| .++..+|.+ +++|+.|+|.+ .++.+.+
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~------~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~ 117 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN------FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIED 117 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT------EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECT
T ss_pred hccCeEEecCcceeEEecCccccc---ccccccccccc------ccCHHHhcccccccccccCCCcEEECCc-cccchhH
Confidence 788999999999998 3333223 33556666666 567888999 99999999999 8888888
Q ss_pred ccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCcc---ccccCCcccCCCCCCC-eeeccCCc-ccccCCcc
Q 003199 86 ASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ---LAGTIPEELGNLTELT-DLDMSVNH-LSGKIPES 160 (840)
Q Consensus 86 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~---~~~~~p~~l~~l~~L~-~L~L~~n~-l~~~~~~~ 160 (840)
.+|.++++|+.|+|++|.+....+.+|....++..+.+..+.. .......+|.++..|+ .+.+.... +.......
T Consensus 118 ~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~ 197 (329)
T 3sb4_A 118 AAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKA 197 (329)
T ss_dssp TTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHT
T ss_pred HHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhc
Confidence 8999999999999999999878888999988888887765321 1111233455666666 44443322 11111111
Q ss_pred ccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCch
Q 003199 161 ILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQ 240 (840)
Q Consensus 161 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 240 (840)
-....+++.+.+.++-...........+++|+.|+|++|+++.+.+.+|.++.+|+.|+|.+| ++.+.+.+|.++.+|+
T Consensus 198 ~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~ 276 (329)
T 3sb4_A 198 GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA 276 (329)
T ss_dssp TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence 123456677777665332111222234778888888888888777777888888888888877 7777777888888887
Q ss_pred -hhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEec
Q 003199 241 -YFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDL 292 (840)
Q Consensus 241 -~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 292 (840)
.+.+.. .+..+.+.+|.++++|+.|++++|.++...+.+|.++++|+.+..
T Consensus 277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 277 GTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 888877 676677888999999999999889888777778888888888753
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-18 Score=202.53 Aligned_cols=148 Identities=20% Similarity=0.183 Sum_probs=67.8
Q ss_pred CCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccC
Q 003199 198 DNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSI 277 (840)
Q Consensus 198 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 277 (840)
.|.+. ..+..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.+. .+|..|..+++|+.|+|++|+|+ .+
T Consensus 210 ~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 210 ENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 33433 34445555555555555555555 22222223333333333333333 44555556666666666666665 55
Q ss_pred CccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccC-cccEEEcCCCccCCCCC
Q 003199 278 PEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-SLVKIDLSDNLLSGPIP 350 (840)
Q Consensus 278 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p 350 (840)
|..|..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+. .+..|+|++|.+++.+|
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 555656666666666666555 3344455555555555555555555555443321 11224444444444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-16 Score=169.73 Aligned_cols=268 Identities=12% Similarity=0.157 Sum_probs=123.5
Q ss_pred CCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCe
Q 003199 41 TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120 (840)
Q Consensus 41 ~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~ 120 (840)
..++.+.+..+ +..++..+|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.|.. .++...+.+|..+++|+.
T Consensus 113 ~~l~~i~ip~~----i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 113 KGYNEIILPNS----VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp SSCSEEECCTT----CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred CCccEEEECCc----cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCe
Confidence 44555555433 444445555543 4555555444 444444455442 455555553 344344455555555555
Q ss_pred eecccCccccccCCc-ccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCC
Q 003199 121 LELYYNQQLAGTIPE-ELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDN 199 (840)
Q Consensus 121 L~L~~n~~~~~~~p~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 199 (840)
++|..|+ +. .++. +|. ..+|+.+.|..+ ++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.| .+
T Consensus 185 l~l~~n~-l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~ 257 (401)
T 4fdw_A 185 ADLSKTK-IT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PN 257 (401)
T ss_dssp EECTTSC-CS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ET
T ss_pred eecCCCc-ce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CC
Confidence 5555444 12 2222 232 355555555532 44444455555555555555543 34444455555 45555555 23
Q ss_pred cCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCc
Q 003199 200 SLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPE 279 (840)
Q Consensus 200 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 279 (840)
.++.+...+|.++++|+.+++.+|.+.. +....+...+|.++++|+.+.+.+ .++.....
T Consensus 258 ~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~ 317 (401)
T 4fdw_A 258 GVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIPE-SIRILGQG 317 (401)
T ss_dssp TCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCCT-TCCEECTT
T ss_pred CccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeCC-ceEEEhhh
Confidence 3444445555555555555555554430 000112333444444444444442 23333334
Q ss_pred cccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccC-cccEEEcCCCcc
Q 003199 280 GILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI-SLVKIDLSDNLL 345 (840)
Q Consensus 280 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l 345 (840)
+|.++++|+.+.|..| ++.+...+|.++ +|+.+++++|.+....+..|..++ ++..|++..+.+
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 4444444555544332 443444445444 455555555544443344444442 444555444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.3e-16 Score=168.39 Aligned_cols=268 Identities=11% Similarity=0.108 Sum_probs=204.1
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCC
Q 003199 14 SPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTS 93 (840)
Q Consensus 14 ~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 93 (840)
..+..++.+.+.++ ++.+...+|.+. +|+.+.|..| +..++..+|.+. +|+.+.+.+ .++.+.+.+|.++.+
T Consensus 110 ~~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~----i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~ 181 (401)
T 4fdw_A 110 EILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG----LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYN 181 (401)
T ss_dssp EECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT----CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTT
T ss_pred EecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC----ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCccc
Confidence 34578888888865 665778888885 7999999877 677888899884 799999986 777788889999999
Q ss_pred CcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEee
Q 003199 94 LTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY 173 (840)
Q Consensus 94 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 173 (840)
|+.++|.+|.++......|. ..+|+.+.|..+ +...-..+|.++++|+.+++..| ++.+...+|.+ .+|+.+.|
T Consensus 182 L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~--l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l- 255 (401)
T 4fdw_A 182 LKKADLSKTKITKLPASTFV-YAGIEEVLLPVT--LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL- 255 (401)
T ss_dssp CCEEECTTSCCSEECTTTTT-TCCCSEEECCTT--CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-
T ss_pred CCeeecCCCcceEechhhEe-ecccCEEEeCCc--hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-
Confidence 99999999999976667777 589999999855 35555668999999999999975 66677788888 78999999
Q ss_pred ccccccccchhhhcCCCCCEEEccCCcCc-----ccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccc
Q 003199 174 NNSLSGEISSVIANSTTLTMLSLYDNSLT-----GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248 (840)
Q Consensus 174 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 248 (840)
.|.++.+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|.+ .++.+..
T Consensus 256 p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~------------------ 316 (401)
T 4fdw_A 256 PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQ------------------ 316 (401)
T ss_dssp ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECT------------------
T ss_pred CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhh------------------
Confidence 56677788999999999999999998875 46677888888888888884 4554333
Q ss_pred ccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCC-CCceeecccceee
Q 003199 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR-NLSELFMQRNQIS 322 (840)
Q Consensus 249 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 322 (840)
.+|.++++|+.+.+.+| ++.....+|..+ +|+.+++.+|.+.......|.+++ +++.|++..+.+.
T Consensus 317 ------~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 317 ------GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ------TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ------hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 45555666666666444 443445556665 666666666666655556666553 5666666666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=7e-18 Score=199.09 Aligned_cols=162 Identities=21% Similarity=0.229 Sum_probs=109.6
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
++..|.+. ..|..|..+++|+.|+|++|. ...+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|.|
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~--l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQ--IFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp ----------------CCCCCCEEECTTSC--CSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCC--CCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 44455555 567778888888888888887 3367777778888888888888888 6788888888888888888888
Q ss_pred ccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCC-chhhhcccccccccCCcc
Q 003199 178 SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGK-LQYFLVLQNMFSGVLPDS 256 (840)
Q Consensus 178 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~n~~~~~~~~~ 256 (840)
+ .+|..|.++++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..+++.+|.+.+.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 8 55777888888888888888887 56777888888999999999888887777765432 234677778777766653
Q ss_pred cccccCCceEEeeCc
Q 003199 257 LARCKNLLRFRVSNN 271 (840)
Q Consensus 257 ~~~l~~L~~L~l~~N 271 (840)
|..|++++|
T Consensus 361 ------l~~l~l~~n 369 (727)
T 4b8c_D 361 ------RRFIEINTD 369 (727)
T ss_dssp ---------------
T ss_pred ------cceeEeecc
Confidence 445556655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-15 Score=167.88 Aligned_cols=334 Identities=8% Similarity=-0.022 Sum_probs=171.0
Q ss_pred CcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccC
Q 003199 29 FTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHI 108 (840)
Q Consensus 29 i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 108 (840)
++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +....
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~----i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~ 132 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST----VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIG 132 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT----CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEEC
T ss_pred EeEhHHHHhhCCCCceEEEeCCC----ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeec
Confidence 44444555666666666666533 45555566666666666666543 44444556666666666555543 33244
Q ss_pred chhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcC
Q 003199 109 PPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188 (840)
Q Consensus 109 p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 188 (840)
..+|.....+........ ......+|.++++|+.+.+..+-.. +....|.++.+|+.+.+..| ++.+...+|.++
T Consensus 133 ~~aF~~~~~~~~~~~~~~---~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~ 207 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGV---TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAEC 207 (394)
T ss_dssp TTTTTTCCCSEEECCTTC---CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTC
T ss_pred ceeeecccccccccCccc---cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccc
Confidence 455555543333322222 1122345666666666666544332 45556666666666666555 444555666666
Q ss_pred CCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEe
Q 003199 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRV 268 (840)
Q Consensus 189 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l 268 (840)
..|+.+.+..+... + ...+....+|+.+.+..+ ++.+....|.....++.+.+..+.. ......|..+..++.+.+
T Consensus 208 ~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~ 283 (394)
T 4fs7_A 208 ILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIY 283 (394)
T ss_dssp TTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEE
T ss_pred cccceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceecc
Confidence 66666666655443 2 222333455666655433 2223333444444444444433322 134445555566666555
Q ss_pred eCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCC
Q 003199 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGP 348 (840)
Q Consensus 269 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 348 (840)
..+.+. ...|....+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++..
T Consensus 284 ~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I 357 (394)
T 4fs7_A 284 GSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKI 357 (394)
T ss_dssp CSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEE
T ss_pred Cceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEe
Confidence 554332 234555556666655543 44444555666666666666433 44444555555555666655544 4434
Q ss_pred CCCcccCccccchhcccCCccCCCcchhcccccCCCE
Q 003199 349 IPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNV 385 (840)
Q Consensus 349 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 385 (840)
...+|.++.+|+.+++..+ ++ .+..+|.++++|+.
T Consensus 358 ~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 358 GANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred hHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 4445555555665555443 22 23345555555543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=153.11 Aligned_cols=136 Identities=17% Similarity=0.143 Sum_probs=117.2
Q ss_pred cCCceEEeeCceee-ccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEE
Q 003199 261 KNLLRFRVSNNHLE-GSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKID 339 (840)
Q Consensus 261 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 339 (840)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 67899999999997 67888888899999999999999876 7788899999999999999977888888899999999
Q ss_pred cCCCccCCCC-CCcccCccccchhcccCCccCCCcc---hhcccccCCCEEECcCccccccCCc
Q 003199 340 LSDNLLSGPI-PSGIGNLKKLNLLMLQSNKLNSSIP---NSLSSLKSLNVLDLSNNLLTGYIPE 399 (840)
Q Consensus 340 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~p~ 399 (840)
|++|++++.. +..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+. .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 9999998643 2678899999999999999986655 58899999999999999987 4554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.66 E-value=2e-15 Score=165.80 Aligned_cols=319 Identities=11% Similarity=0.031 Sum_probs=249.3
Q ss_pred ccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCC
Q 003199 55 KLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP 134 (840)
Q Consensus 55 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p 134 (840)
.++++...+|.++.+|+.+.|.. .++.+-..+|.++.+|+.++|..+ ++.....+|..+++|+.+.+..+- .....
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l--~~i~~ 133 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML--KSIGV 133 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC--CEECT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce--eeecc
Confidence 57788899999999999999975 477787889999999999999866 665677899999999999887653 43444
Q ss_pred cccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCC
Q 003199 135 EELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSP 214 (840)
Q Consensus 135 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 214 (840)
.+|.+...+........ ..+...+|.++++|+.+.+.++- ..+...+|.++.+|+.+.+..| ++.+...+|.++..
T Consensus 134 ~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~ 209 (394)
T 4fs7_A 134 EAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL 209 (394)
T ss_dssp TTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred eeeecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence 56777654443333332 33456789999999999998765 4477889999999999999887 66577889999999
Q ss_pred cceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccC
Q 003199 215 LVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSY 294 (840)
Q Consensus 215 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 294 (840)
|+.+.+..+... +...+.....|+.+.+..+ +......+|..+.+|+.+.+..+... .....|.....++.+....
T Consensus 210 L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~ 285 (394)
T 4fs7_A 210 LENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGS 285 (394)
T ss_dssp CCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECS
T ss_pred cceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCc
Confidence 999999877553 2333444466777766543 34455677888999999999888665 6677888888999888877
Q ss_pred CcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcc
Q 003199 295 NSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374 (840)
Q Consensus 295 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 374 (840)
+.+ ....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++..-..+|.++.+|+.+++..| ++.+..
T Consensus 286 ~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~ 359 (394)
T 4fs7_A 286 VIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGA 359 (394)
T ss_dssp SEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECT
T ss_pred eee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehH
Confidence 654 3457888899999999776 66677788889999999999755 66566678999999999999877 776677
Q ss_pred hhcccccCCCEEECcCc
Q 003199 375 NSLSSLKSLNVLDLSNN 391 (840)
Q Consensus 375 ~~~~~l~~L~~L~l~~N 391 (840)
.+|.++++|+.+++..|
T Consensus 360 ~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 360 NAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTBTTCTTCCEEEEEGG
T ss_pred HHhhCCCCCCEEEECCC
Confidence 89999999999998754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-16 Score=153.44 Aligned_cols=91 Identities=22% Similarity=0.318 Sum_probs=50.1
Q ss_pred cccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCccc
Q 003199 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLV 336 (840)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 336 (840)
|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..+..+++|+
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 129 (192)
T 1w8a_A 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCC
Confidence 44455555555555555544455555555555555555555555555555555555555555555555555555555555
Q ss_pred EEEcCCCccCC
Q 003199 337 KIDLSDNLLSG 347 (840)
Q Consensus 337 ~L~Ls~N~l~~ 347 (840)
.|+|++|++.+
T Consensus 130 ~L~L~~N~l~c 140 (192)
T 1w8a_A 130 SLNLASNPFNC 140 (192)
T ss_dssp EEECTTCCBCC
T ss_pred EEEeCCCCccC
Confidence 55555555553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.7e-16 Score=149.53 Aligned_cols=133 Identities=23% Similarity=0.262 Sum_probs=109.9
Q ss_pred CceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCC
Q 003199 263 LLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342 (840)
Q Consensus 263 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 342 (840)
.+.+++++|+++ .+|..+. ++|+.|++++|++++..+..|+.+++|++|+|++|++++..+..+..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467888888887 5565443 6888899999988887777788888999999999998877667778888999999999
Q ss_pred CccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 343 NLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 343 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
|++++..+..+..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99987777778888999999999999987767677888999999999999887665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=9.6e-17 Score=170.60 Aligned_cols=146 Identities=13% Similarity=0.096 Sum_probs=100.6
Q ss_pred cCccCeeeccCCcEEEEEEeCCCcEEEEEEeccccccccc----Cc------h--hhHHHHHHHHHHHHHHhccCCCCcc
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSA----SD------T--DQLQLDKGLKTEVETLGNIRHKNIV 595 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~------~--~~~~~~~~~~~E~~~l~~l~h~niv 595 (840)
|...+.||+|++|.||+|...+|+.||||+++........ .. . ..........+|+..+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 7788899999999999998889999999998543221000 00 0 0001111223566666666544432
Q ss_pred eeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-
Q 003199 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ- 674 (840)
Q Consensus 596 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~- 674 (840)
...-+.. ...++||||++++.|.+... .+....++.|++.+|.|||+ .|||||||||.|||+++++.
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence 1111111 23479999999988865432 22356788999999999999 99999999999999988763
Q ss_pred ---------Ceeecccchhh
Q 003199 675 ---------PKVADFGIAKV 685 (840)
Q Consensus 675 ---------~kl~Dfg~a~~ 685 (840)
+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 78999997644
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.3e-16 Score=150.71 Aligned_cols=130 Identities=26% Similarity=0.325 Sum_probs=99.8
Q ss_pred ceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCC
Q 003199 264 LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343 (840)
Q Consensus 264 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 343 (840)
+.+++++|.++ .+|..+. ++|+.|+|++|+++ .+|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46777788777 5665543 57888888888887 34467777888888888888888777777888888888888888
Q ss_pred ccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccC
Q 003199 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYI 397 (840)
Q Consensus 344 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 397 (840)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 888777777888888888888888888666667888888888888888887543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=147.48 Aligned_cols=129 Identities=16% Similarity=0.171 Sum_probs=112.2
Q ss_pred ccCCceEEeeCceee-ccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEE
Q 003199 260 CKNLLRFRVSNNHLE-GSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKI 338 (840)
Q Consensus 260 l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 338 (840)
.++|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..++.+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 468899999999998 77888888999999999999999876 778889999999999999997788888889999999
Q ss_pred EcCCCccCCC-CCCcccCccccchhcccCCccCCCcc---hhcccccCCCEEECcC
Q 003199 339 DLSDNLLSGP-IPSGIGNLKKLNLLMLQSNKLNSSIP---NSLSSLKSLNVLDLSN 390 (840)
Q Consensus 339 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~ 390 (840)
++++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999863 34778899999999999999987666 5788999999999874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=145.85 Aligned_cols=132 Identities=24% Similarity=0.266 Sum_probs=83.8
Q ss_pred CCCCEEeCCCCCCCccC--CCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCC
Q 003199 41 TNLEVLSFNENPGFKLW--KLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNL 118 (840)
Q Consensus 41 ~~L~~L~L~~N~~~~l~--~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L 118 (840)
++|++|+|++| .+. .+|. .+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|
T Consensus 24 ~~L~~L~l~~n---~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 97 (168)
T 2ell_A 24 AAVRELVLDNC---KSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97 (168)
T ss_dssp TSCSEEECCSC---BCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC
T ss_pred ccCCEEECCCC---CCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC
Confidence 44555555555 233 3332 245555566666666665543 556667777777777777775566666667777
Q ss_pred CeeecccCccccccCC--cccCCCCCCCeeeccCCcccccCC---ccccCCCCCcEEEeeccccccc
Q 003199 119 RQLELYYNQQLAGTIP--EELGNLTELTDLDMSVNHLSGKIP---ESILRLPKLRVLQLYNNSLSGE 180 (840)
Q Consensus 119 ~~L~L~~n~~~~~~~p--~~l~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~ 180 (840)
+.|+|++|+ + ..+| ..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+...
T Consensus 98 ~~L~Ls~N~-l-~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 98 THLNLSGNK-L-KDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CEEECBSSS-C-CSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred CEEeccCCc-c-CcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 777777776 2 2232 567777777888888887775444 3677778888888888877643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-15 Score=147.02 Aligned_cols=126 Identities=25% Similarity=0.272 Sum_probs=72.9
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecc
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 175 (840)
.+++++|.++ .+|..+. ++|+.|+|++|+ ...+|..|.++++|++|+|++|.|+++.+..|.++++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~--i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQ--FTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSC--CCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCc--CchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4455555554 3333321 345555555554 2244455555556666666666666555555666666666666666
Q ss_pred ccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
+|+++.+..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666665666666666666666666666555555666666666666666665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-15 Score=142.46 Aligned_cols=127 Identities=23% Similarity=0.301 Sum_probs=56.9
Q ss_pred ccccEEEecCcccc-ccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCee
Q 003199 68 TKLRIMVLATCALH-GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146 (840)
Q Consensus 68 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L 146 (840)
++|+.|++++|.+. +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|+ +.+.+|..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNR-VSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSC-CCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCc-ccchHHHHhhhCCCCCEE
Confidence 34455555555554 34444555555555555555555532 344444444444444443 222233333334444444
Q ss_pred eccCCccccc-CCccccCCCCCcEEEeeccccccccc---hhhhcCCCCCEEEcc
Q 003199 147 DMSVNHLSGK-IPESILRLPKLRVLQLYNNSLSGEIS---SVIANSTTLTMLSLY 197 (840)
Q Consensus 147 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~ 197 (840)
++++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 4444444432 12334444444444444444443333 334444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-14 Score=140.06 Aligned_cols=129 Identities=26% Similarity=0.264 Sum_probs=71.3
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
+.+++++|.++ .+|..+ .++|+.|++++|+ +.+..+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNK-LQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSC-CCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCc-ccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 34444444444 233222 2345555555554 2222233345555566666666666544444556666666666666
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccc
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 227 (840)
|+|++.++..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++.+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 66665555556666666666666666665544455666666666666666653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.1e-15 Score=144.18 Aligned_cols=134 Identities=17% Similarity=0.194 Sum_probs=109.3
Q ss_pred ccccccCCceEEeeCceeeccCCccccCC-CcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCc
Q 003199 256 SLARCKNLLRFRVSNNHLEGSIPEGILSL-PHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334 (840)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 334 (840)
.+..+.+|+.|++++|+++ .+|. +..+ ++|+.|++++|.+++. ..|+.+++|+.|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4667788999999999998 4554 4444 4899999999999875 67888999999999999998765566688899
Q ss_pred ccEEEcCCCccCCCCCC--cccCccccchhcccCCccCCCcch----hcccccCCCEEECcCccccc
Q 003199 335 LVKIDLSDNLLSGPIPS--GIGNLKKLNLLMLQSNKLNSSIPN----SLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 335 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~ 395 (840)
|+.|+|++|+++ .+|. .++.+++|+.|+|++|+++ .+|. .+..+++|+.||+++|.+..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999999997 4555 7888899999999999997 4555 48889999999999998763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=7.9e-15 Score=141.27 Aligned_cols=106 Identities=20% Similarity=0.193 Sum_probs=71.0
Q ss_pred cccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCc--ccCCCCCCCee
Q 003199 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPE--ELGNLTELTDL 146 (840)
Q Consensus 69 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~--~l~~l~~L~~L 146 (840)
+|+.|+|++|.+++. ..|+.+++|++|+|++|+|++..+..|..+++|+.|+|++|+ .+.+|. .+..+++|++|
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~--i~~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--LVELGDLDPLASLKSLTYL 118 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC--CCCGGGGGGGGGCTTCCEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCc--CCcchhhHhhhcCCCCCEE
Confidence 445555555555443 456667777777777777775544555777777777777776 244554 67777788888
Q ss_pred eccCCcccccCCcc----ccCCCCCcEEEeecccccc
Q 003199 147 DMSVNHLSGKIPES----ILRLPKLRVLQLYNNSLSG 179 (840)
Q Consensus 147 ~L~~n~l~~~~~~~----~~~l~~L~~L~L~~N~l~~ 179 (840)
++++|.++. .|.. +..+++|+.|++++|.+..
T Consensus 119 ~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 119 CILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp ECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 888888873 4543 7778888888888887763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.6e-13 Score=146.93 Aligned_cols=163 Identities=10% Similarity=0.075 Sum_probs=97.9
Q ss_pred cCCCCcccccccc-cccEEEecCccccccCCccccCCCCCcEEEccCCc---ccccCchhhhcCCCCCeeecccCccccc
Q 003199 56 LWKLPESSIFRLT-KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNF---ITGHIPPEIGLLKNLRQLELYYNQQLAG 131 (840)
Q Consensus 56 l~~l~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~---i~~~~p~~~~~l~~L~~L~L~~n~~~~~ 131 (840)
++.+...+|.+.. .|+.+.+..+ ++.+-..+|.++.+|+.+.+..|. ++.....+|..+.+|+.+.+..+- ..
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~~--~~ 127 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDSV--TE 127 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTTC--SE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCcc--ce
Confidence 4455556666653 4666666543 555666667777777777766553 444445666667777766665442 33
Q ss_pred cCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCC
Q 003199 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQ 211 (840)
Q Consensus 132 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 211 (840)
....+|.++.+|+.+.+..+- ..+....|..+.+|+.+.+..+ +..+...+|.+ ..|+.+.+..+-.. +...+|..
T Consensus 128 I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~ 203 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSE 203 (394)
T ss_dssp ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTT
T ss_pred ehhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhh
Confidence 334456677777777776443 3355566777777777777654 44455555654 56777777655443 55566666
Q ss_pred CCCcceeccccccc
Q 003199 212 WSPLVVLDLSENKL 225 (840)
Q Consensus 212 l~~L~~L~L~~N~l 225 (840)
+.+|.......+..
T Consensus 204 c~~l~~~~~~~~~~ 217 (394)
T 4gt6_A 204 CFALSTITSDSESY 217 (394)
T ss_dssp CTTCCEEEECCSSS
T ss_pred ccccceeccccccc
Confidence 66666666555543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.51 E-value=7.9e-13 Score=145.02 Aligned_cols=336 Identities=10% Similarity=0.088 Sum_probs=186.2
Q ss_pred cccCCccccCCC-CCCEEeCCCCCCCccCCCCcccccccccccEEEecCcc---ccccCCccccCCCCCcEEEccCCccc
Q 003199 30 TGQFPLSVFNLT-NLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA---LHGQIPASIGNVTSLTDLELTGNFIT 105 (840)
Q Consensus 30 ~~~~p~~~~~l~-~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~L~~n~i~ 105 (840)
+.+...+|.+.. .|+.+.+..+ ++.+...+|.++++|+.+.+..|. ++.+-..+|.++.+|+.+.+..+ ++
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s----vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~ 126 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT----VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT 126 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT----CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS
T ss_pred eEcCHhhccCCCCcCEEEEECCC----eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc
Confidence 334444555543 3666666543 455555666666666666665542 44444556666666666655544 33
Q ss_pred ccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhh
Q 003199 106 GHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVI 185 (840)
Q Consensus 106 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 185 (840)
......|....+|+.+.+..+- ......+|.++.+|+.+.+..+ +..+...+|.. ..|+.+.+..+-.. +...+|
T Consensus 127 ~I~~~aF~~c~~L~~i~lp~~~--~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af 201 (394)
T 4gt6_A 127 EIDSEAFHHCEELDTVTIPEGV--TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAF 201 (394)
T ss_dssp EECTTTTTTCTTCCEEECCTTC--CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTT
T ss_pred eehhhhhhhhccccccccccee--eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchh
Confidence 3445566666666666665442 2233345666666776666554 33344445543 45677766654332 555666
Q ss_pred hcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCce
Q 003199 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLR 265 (840)
Q Consensus 186 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~ 265 (840)
.++..|+......+.........+........... .+.....+..+.+. +.+......+|..+.+|+.
T Consensus 202 ~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~ 269 (394)
T 4gt6_A 202 SECFALSTITSDSESYPAIDNVLYEKSANGDYALI-----------RYPSQREDPAFKIP-NGVARIETHAFDSCAYLAS 269 (394)
T ss_dssp TTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEE-----------ECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCE
T ss_pred hhccccceecccccccccccceeeccccccccccc-----------ccccccccceEEcC-CcceEcccceeeecccccE
Confidence 77777777666655544211111111000000000 00001111111111 1223344566777778888
Q ss_pred EEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCcc
Q 003199 266 FRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLL 345 (840)
Q Consensus 266 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 345 (840)
+.+.++... ....+|..++.|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+ +
T Consensus 270 i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v 345 (394)
T 4gt6_A 270 VKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-V 345 (394)
T ss_dssp EECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-C
T ss_pred Eecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-c
Confidence 877766554 556677777888888875 4566666778888888888888765 66566777888888888888654 5
Q ss_pred CCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccc
Q 003199 346 SGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 346 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 394 (840)
+..-..+|.++.+|+.+++.+|... ..++....+|+.+.+..|.+.
T Consensus 346 ~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 346 TKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp CBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC-----------
T ss_pred CEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCEE
Confidence 5455567888888888888887653 256777788888887766543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-16 Score=155.02 Aligned_cols=132 Identities=25% Similarity=0.337 Sum_probs=74.0
Q ss_pred ccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcc
Q 003199 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISL 335 (840)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 335 (840)
.+..+++|++|++++|.+++ +| .+..+++|+.|++++|+++. +|..+..+++|+.|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 55666666666666666653 44 55555666666666666652 34444445566666666666654 23 45555666
Q ss_pred cEEEcCCCccCCCCC-CcccCccccchhcccCCccCCCcch----------hcccccCCCEEECcCcccc
Q 003199 336 VKIDLSDNLLSGPIP-SGIGNLKKLNLLMLQSNKLNSSIPN----------SLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 336 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~----------~~~~l~~L~~L~l~~N~l~ 394 (840)
+.|+|++|++++..+ ..+..+++|+.|++++|++++.+|. .+..+++|+.|| +|+++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 666666666653221 2455556666666666666544333 255666666665 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.6e-16 Score=156.45 Aligned_cols=152 Identities=25% Similarity=0.287 Sum_probs=87.6
Q ss_pred cccccEEEecCccccccCCc------cccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCC
Q 003199 67 LTKLRIMVLATCALHGQIPA------SIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNL 140 (840)
Q Consensus 67 l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l 140 (840)
...++.++++.+.+.+..|. .+..+++|++|+|++|.+++ +| .+..+++|+.|+|++|+ ...+|..+..+
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~--l~~l~~~~~~~ 92 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNL--IKKIENLDAVA 92 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEE--ECSCSSHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCC--cccccchhhcC
Confidence 34444444444444444443 56666666666666666663 44 66666666666666665 22455555555
Q ss_pred CCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccc-hhhhcCCCCCEEEccCCcCcccCCcC----------C
Q 003199 141 TELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEIS-SVIANSTTLTMLSLYDNSLTGEVPQD----------L 209 (840)
Q Consensus 141 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------l 209 (840)
++|++|+|++|++++ +| .+..+++|++|++++|++++... ..+..+++|++|++++|++.+..|.. +
T Consensus 93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 170 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence 666666666666664 23 45566666666666666664332 45666666666666666665443332 4
Q ss_pred CCCCCcceecccccccc
Q 003199 210 GQWSPLVVLDLSENKLS 226 (840)
Q Consensus 210 ~~l~~L~~L~L~~N~l~ 226 (840)
..+++|+.|| +|.++
T Consensus 171 ~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 171 KRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHCSSCSEEC--CGGGT
T ss_pred HhCCCcEEEC--CcccC
Confidence 5556666655 45444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1e-13 Score=132.43 Aligned_cols=109 Identities=26% Similarity=0.279 Sum_probs=83.8
Q ss_pred ccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccC
Q 003199 287 VSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQS 366 (840)
Q Consensus 287 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 366 (840)
.+.+++++|+++.++ ..+ .++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~ip-~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVP-TGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCC-SCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccC-ccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456667777766433 323 26677777777777777777778888888888888888877677778888888899999
Q ss_pred CccCCCcchhcccccCCCEEECcCccccccCC
Q 003199 367 NKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 367 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 398 (840)
|+|++..+..|..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 98887777778889999999999999886554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=129.39 Aligned_cols=106 Identities=21% Similarity=0.273 Sum_probs=74.2
Q ss_pred cEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCC
Q 003199 288 SIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSN 367 (840)
Q Consensus 288 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 367 (840)
+.+++++|+++.+ |..+ .++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~i-P~~~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLASV-PAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCcc-CCCc--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4555566655533 2222 256666777777776666666777777777777777777655556777888888888888
Q ss_pred ccCCCcchhcccccCCCEEECcCcccccc
Q 003199 368 KLNSSIPNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 368 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
+|++..+..|..+++|++|+|++|+|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 88866666688888888888888888854
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=4.6e-13 Score=127.85 Aligned_cols=108 Identities=21% Similarity=0.262 Sum_probs=94.6
Q ss_pred CceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCC
Q 003199 263 LLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342 (840)
Q Consensus 263 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 342 (840)
.+.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468899999998 5776663 7899999999999998899999999999999999999977777788999999999999
Q ss_pred CccCCCCCCcccCccccchhcccCCccCCCc
Q 003199 343 NLLSGPIPSGIGNLKKLNLLMLQSNKLNSSI 373 (840)
Q Consensus 343 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 373 (840)
|+|++..+..|..+++|+.|+|++|+++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999777778999999999999999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=125.01 Aligned_cols=104 Identities=21% Similarity=0.222 Sum_probs=67.1
Q ss_pred CeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccC
Q 003199 119 RQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYD 198 (840)
Q Consensus 119 ~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 198 (840)
+.+++++|+ ...+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++++..|..+++|++|+|++
T Consensus 15 ~~l~~~~n~--l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIR--LASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSC--CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCC--CCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 344555444 234444332 5666666666666666666666777777777777777766666666777777777777
Q ss_pred CcCcccCCcCCCCCCCcceecccccccc
Q 003199 199 NSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 199 N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
|+|+++.+..|..+++|+.|+|++|++.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 7777555555777777777777777766
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=7.9e-14 Score=150.77 Aligned_cols=183 Identities=19% Similarity=0.167 Sum_probs=100.7
Q ss_pred CCCCEEeCCCCCCCccCCCCccccccc-----ccccEEEecCccccccCCccc-cCCCCCcEEEccCCcccccCchhhh-
Q 003199 41 TNLEVLSFNENPGFKLWKLPESSIFRL-----TKLRIMVLATCALHGQIPASI-GNVTSLTDLELTGNFITGHIPPEIG- 113 (840)
Q Consensus 41 ~~L~~L~L~~N~~~~l~~l~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~p~~~~- 113 (840)
++|+.|+|++| .+.......+... ++|+.|+|++|.+.......+ ..+++|++|+|++|.|++.....+.
T Consensus 72 ~~L~~L~Ls~n---~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~ 148 (372)
T 3un9_A 72 SSLRQLNLAGV---RMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD 148 (372)
T ss_dssp TTCCEEECTTS---CCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH
T ss_pred hhCCEEEecCC---CCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH
Confidence 45666666666 3333222233322 466666666666643322222 2345667777777777644333332
Q ss_pred ----cCCCCCeeecccCcccc---ccCCcccCCCCCCCeeeccCCcccccC----CccccCCCCCcEEEeecccccccc-
Q 003199 114 ----LLKNLRQLELYYNQQLA---GTIPEELGNLTELTDLDMSVNHLSGKI----PESILRLPKLRVLQLYNNSLSGEI- 181 (840)
Q Consensus 114 ----~l~~L~~L~L~~n~~~~---~~~p~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~- 181 (840)
..++|++|+|++|.+.. ..++..+..+++|++|+|++|.|+... +..+...++|++|+|++|.|++..
T Consensus 149 ~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~ 228 (372)
T 3un9_A 149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA 228 (372)
T ss_dssp HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH
T ss_pred HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH
Confidence 34667777777776211 123334456677777777777776422 345566677888888888887533
Q ss_pred ---chhhhcCCCCCEEEccCCcCcccCCcCCCCC---C--Ccceec--ccccccc
Q 003199 182 ---SSVIANSTTLTMLSLYDNSLTGEVPQDLGQW---S--PLVVLD--LSENKLS 226 (840)
Q Consensus 182 ---~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l---~--~L~~L~--L~~N~l~ 226 (840)
...+...++|++|+|++|.|+......+..+ . .|+.+. +..|.++
T Consensus 229 ~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 229 LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 3345556788888888888874333322221 2 266666 6666665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.1e-14 Score=153.99 Aligned_cols=111 Identities=23% Similarity=0.228 Sum_probs=49.2
Q ss_pred CCCcEEEccCCcccccCchhhhcC-----CCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccc-----
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLL-----KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI----- 161 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l-----~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~----- 161 (840)
++|++|+|++|.|+......+... ++|+.|+|++|.+....+......+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456777777777764433333332 4556666655542111111111223345555555555543222222
Q ss_pred cCCCCCcEEEeecccccccc----chhhhcCCCCCEEEccCCcCc
Q 003199 162 LRLPKLRVLQLYNNSLSGEI----SSVIANSTTLTMLSLYDNSLT 202 (840)
Q Consensus 162 ~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 202 (840)
...++|++|+|++|.|+... +..+..+++|++|+|++|+|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 12344555555555544321 222234444555555555444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.29 E-value=2e-10 Score=125.26 Aligned_cols=317 Identities=9% Similarity=0.022 Sum_probs=163.5
Q ss_pred CCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccC
Q 003199 11 PDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGN 90 (840)
Q Consensus 11 ~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 90 (840)
|.|....+|+.+.+... ++.+...+|.++.+|+.+.|..+ +..+...+|.+. +|+.+.+..+ ++.+...+|..
T Consensus 40 ~~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~----v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~ 112 (379)
T 4h09_A 40 PWYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST----VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG 112 (379)
T ss_dssp TTGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT----CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT
T ss_pred cccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc----ceEechhhhcCC-CCceEECCce-eeEeccceecc
Confidence 34455566777777643 55456666777777777777543 556666666665 4555555433 44444455554
Q ss_pred CCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEE
Q 003199 91 VTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVL 170 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (840)
.+|+.+.+..+-.. .....|... +|+.+.+-.+- .......|.....++.+.+..+.........+.
T Consensus 113 -~~L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~v--~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-------- 179 (379)
T 4h09_A 113 -TDLDDFEFPGATTE-IGNYIFYNS-SVKRIVIPKSV--TTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-------- 179 (379)
T ss_dssp -CCCSEEECCTTCCE-ECTTTTTTC-CCCEEEECTTC--CEECSCTTTTCTTCCEEEECTTCSSEEEETTEE--------
T ss_pred -CCcccccCCCcccc-ccccccccc-eeeeeecccee--eccccchhcccccccccccccccceeeccccee--------
Confidence 35666666654332 333444433 44444444331 222233455555565555544332211000000
Q ss_pred EeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhccccccc
Q 003199 171 QLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFS 250 (840)
Q Consensus 171 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~ 250 (840)
.+.. ......+.....+..+.+..+.-. .....+....+|+.+.+..+ +.......|.....|+.+.+..+ +.
T Consensus 180 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~ 252 (379)
T 4h09_A 180 ---YNKN-KTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT 252 (379)
T ss_dssp ---EETT-SSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC
T ss_pred ---cccc-cceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc
Confidence 0000 011112233334444444333222 33334444445555544433 23334444444555555544433 33
Q ss_pred ccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhc
Q 003199 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIY 330 (840)
Q Consensus 251 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 330 (840)
.+...+|..+.+|+.+.+..+ ++......|..+.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.
T Consensus 253 ~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 330 (379)
T 4h09_A 253 SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFK 330 (379)
T ss_dssp EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhh
Confidence 344556666677777776543 44344556666777777777777776666677777777777777654 5555666777
Q ss_pred ccCcccEEEcCCCccCCCCCCcccCcc
Q 003199 331 RAISLVKIDLSDNLLSGPIPSGIGNLK 357 (840)
Q Consensus 331 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 357 (840)
++.+|+.+.+..+ ++..-..+|.++.
T Consensus 331 ~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 331 NCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 7777777777554 4434445565553
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.7e-10 Score=123.11 Aligned_cols=314 Identities=8% Similarity=0.028 Sum_probs=153.5
Q ss_pred ccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCC
Q 003199 37 VFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLK 116 (840)
Q Consensus 37 ~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~ 116 (840)
+....+|+.+.+..+ ++.++..+|.++.+|+.+.|..+ ++.+-..+|.+. +|+.+.+..+ ++.....+|.. .
T Consensus 42 ~~~~~~i~~v~ip~~----vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~ 113 (379)
T 4h09_A 42 YKDRDRISEVRVNSG----ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-T 113 (379)
T ss_dssp GGGGGGCSEEEECTT----EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-C
T ss_pred cccccCCEEEEeCCC----ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-C
Confidence 444566777777654 66667777777777777777543 555555666665 5666665543 33233444444 2
Q ss_pred CCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEc
Q 003199 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196 (840)
Q Consensus 117 ~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 196 (840)
+|+.+.+..+- ......+|.+ .+|+.+.+..+ ++.+....|..+..++.+.+..+.........+..
T Consensus 114 ~L~~i~lp~~~--~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~--------- 180 (379)
T 4h09_A 114 DLDDFEFPGAT--TEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLY--------- 180 (379)
T ss_dssp CCSEEECCTTC--CEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEE---------
T ss_pred CcccccCCCcc--cccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceec---------
Confidence 56666665442 2112222332 24444444332 22234445555555555555444332111111000
Q ss_pred cCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeecc
Q 003199 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGS 276 (840)
Q Consensus 197 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 276 (840)
+... .....+.....+..+.+..+.. ......+....+|+.+.+..+ +......+|..+.+|+.+.+..+ ++..
T Consensus 181 --~~~~-~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I 254 (379)
T 4h09_A 181 --NKNK-TILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSI 254 (379)
T ss_dssp --ETTS-SEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEE
T ss_pred --cccc-ceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEe
Confidence 0000 1122333444555555443322 233444445555555544333 33344455566666666666554 3334
Q ss_pred CCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCc
Q 003199 277 IPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNL 356 (840)
Q Consensus 277 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 356 (840)
...+|....+|+.+.+..+ ++.....+|.++++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++..-..+|.++
T Consensus 255 ~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C 332 (379)
T 4h09_A 255 GSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNC 332 (379)
T ss_dssp CTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred Cccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCC
Confidence 4445555556666655432 44444455555666666666555555455555555556666655433 433334455555
Q ss_pred cccchhcccCCccCCCcchhcccc
Q 003199 357 KKLNLLMLQSNKLNSSIPNSLSSL 380 (840)
Q Consensus 357 ~~L~~L~Ls~N~l~~~~~~~~~~l 380 (840)
.+|+.+.+..+ ++.+-..+|.++
T Consensus 333 ~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 333 KALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CCCCEEEECCc-cCEEchhHhhCC
Confidence 55555555433 433334444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=133.08 Aligned_cols=102 Identities=17% Similarity=0.210 Sum_probs=49.3
Q ss_pred EEeeCc-eeeccCCccccCCCcccEEeccC-CcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCC
Q 003199 266 FRVSNN-HLEGSIPEGILSLPHVSIIDLSY-NSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343 (840)
Q Consensus 266 L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 343 (840)
++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|+.+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 444554 454 3444 55555555555553 5555544445555555555555555555444444444555555555555
Q ss_pred ccCCCCCCcccCccccchhcccCCccC
Q 003199 344 LLSGPIPSGIGNLKKLNLLMLQSNKLN 370 (840)
Q Consensus 344 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 370 (840)
+|++..+..|..++ |+.|+|++|++.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 55433333333333 444444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=3e-11 Score=130.08 Aligned_cols=102 Identities=20% Similarity=0.173 Sum_probs=82.8
Q ss_pred CEEecCCC-cCcccCCccccCCCCCCEEeCCC-CCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 20 RRLDLSNN-LFTGQFPLSVFNLTNLEVLSFNE-NPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 20 ~~L~Ls~n-~i~~~~p~~~~~l~~L~~L~L~~-N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
..++++++ +++ .+|. +..+++|++|+|++ | .+..+++..|.+|++|+.|+|++|.|++..|..|.+|++|++|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n---~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 85 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQ---HLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCS---SCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCC---CCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEE
Confidence 45789988 888 6787 99999999999986 8 6777888888888888888888888888888888888888888
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 127 (840)
+|++|+|++..+..|..++ |+.|+|.+|.
T Consensus 86 ~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~ 114 (347)
T 2ifg_A 86 NLSFNALESLSWKTVQGLS-LQELVLSGNP 114 (347)
T ss_dssp ECCSSCCSCCCSTTTCSCC-CCEEECCSSC
T ss_pred eCCCCccceeCHHHcccCC-ceEEEeeCCC
Confidence 8888888865555665555 7788887776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-10 Score=118.52 Aligned_cols=146 Identities=14% Similarity=0.062 Sum_probs=112.0
Q ss_pred HHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeE
Q 003199 522 REILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCY 600 (840)
Q Consensus 522 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 600 (840)
......|+....++.|+.+.||++... ++.+++|+....... ....+.+|+++++.+. +..+.+++++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~----------~~~~~~~E~~~l~~l~~~~~vP~v~~~ 78 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----------TTYDVEREKDMMLWLEGKLPVPKVLHF 78 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT----------STTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC----------CHHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 445567877778888999999999755 689999987432100 0124778999998884 6778899999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL--------------------------- 653 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------- 653 (840)
+......++||||++|.++.+... +......++.++++++..||+..
T Consensus 79 ~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 79 ERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 988888999999999999887632 12234578899999999999811
Q ss_pred -----------------------------CCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 654 -----------------------------LSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 654 -----------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=3.9e-10 Score=116.01 Aligned_cols=128 Identities=16% Similarity=0.111 Sum_probs=95.4
Q ss_pred eccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC--cceeeeEEecCccceEEEe
Q 003199 535 GQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN--IVKLYCYFSSLYCNLLVYE 612 (840)
Q Consensus 535 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e 612 (840)
+.|..+.||++...+|+.+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 4566699999987778889999864321 123667888888886544 5568888887778899999
Q ss_pred ecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 003199 613 YMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL--------------------------------------- 653 (840)
Q Consensus 613 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 653 (840)
|++|.++. ... . ....++.++++.+..||+..
T Consensus 96 ~i~G~~l~--~~~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SSH----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TSC----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cCc----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998883 211 1 13367788888888888731
Q ss_pred ----------------CCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 654 ----------------LSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 654 ----------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799999874
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.94 E-value=4.4e-10 Score=120.23 Aligned_cols=183 Identities=15% Similarity=0.147 Sum_probs=93.4
Q ss_pred CCCCEEecCCCcCcc-c-------CCccccCCCCCCEEeCCCCCCCc--cCCC----CcccccccccccEEEecCccccc
Q 003199 17 QNLRRLDLSNNLFTG-Q-------FPLSVFNLTNLEVLSFNENPGFK--LWKL----PESSIFRLTKLRIMVLATCALHG 82 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~-~-------~p~~~~~l~~L~~L~L~~N~~~~--l~~l----~~~~~~~l~~L~~L~L~~n~l~~ 82 (840)
..++.|.+..+...+ . +..++..+++|+.|.+..+.... +.-+ -...+..+++|+.|.|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 456777777665442 1 13345567888888887652110 1000 1133456678888888776311
Q ss_pred cCCccccCCCCCcEEEccCCcccccCchhhh--cCCCCCeeecccCcccc-cc-----CCccc--CCCCCCCeeeccCCc
Q 003199 83 QIPASIGNVTSLTDLELTGNFITGHIPPEIG--LLKNLRQLELYYNQQLA-GT-----IPEEL--GNLTELTDLDMSVNH 152 (840)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~--~l~~L~~L~L~~n~~~~-~~-----~p~~l--~~l~~L~~L~L~~n~ 152 (840)
.++. +. +++|++|+|..|.+.......+. .+++|+.|+|+.+.... +. +...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2232 33 67788888887777644334444 57788888775321000 00 00111 134556666665555
Q ss_pred ccccCCcccc---CCCCCcEEEeeccccccccc----hhhhcCCCCCEEEccCCcCc
Q 003199 153 LSGKIPESIL---RLPKLRVLQLYNNSLSGEIS----SVIANSTTLTMLSLYDNSLT 202 (840)
Q Consensus 153 l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~ 202 (840)
+....+..+. .+++|++|+|+.|.|.+... ..+..+++|+.|+|++|.|+
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 5432211121 34555555555555554221 12233455555555555554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.2e-10 Score=120.40 Aligned_cols=179 Identities=15% Similarity=0.169 Sum_probs=124.3
Q ss_pred CCCCCCCCEEecCCCcCc---------ccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccccc
Q 003199 13 FSPMQNLRRLDLSNNLFT---------GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ 83 (840)
Q Consensus 13 ~~~l~~L~~L~Ls~n~i~---------~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 83 (840)
...+++|+.|.+.++... +.++..+..+++|+.|+|++|... .++. + .+++|+.|+|..|.+...
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l---~l~~--~-~~~~L~~L~L~~~~l~~~ 208 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL---SIGK--K-PRPNLKSLEIISGGLPDS 208 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC---BCCS--C-BCTTCSEEEEECSBCCHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc---eecc--c-cCCCCcEEEEecCCCChH
Confidence 445789999999765432 134556778899999999988322 3333 3 388999999999998754
Q ss_pred CCcccc--CCCCCcEEEccC--Ccccc-----cCchhh--hcCCCCCeeecccCccccccCCccc---CCCCCCCeeecc
Q 003199 84 IPASIG--NVTSLTDLELTG--NFITG-----HIPPEI--GLLKNLRQLELYYNQQLAGTIPEEL---GNLTELTDLDMS 149 (840)
Q Consensus 84 ~~~~~~--~l~~L~~L~L~~--n~i~~-----~~p~~~--~~l~~L~~L~L~~n~~~~~~~p~~l---~~l~~L~~L~L~ 149 (840)
....+. .+++|++|+|+. |...+ .+...+ ..+++|+.|+|++|.+ .+..+..+ ..+++|++|+|+
T Consensus 209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i-~~~~~~~la~a~~~~~L~~LdLs 287 (362)
T 2ra8_A 209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE-QNVVVEMFLESDILPQLETMDIS 287 (362)
T ss_dssp HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT-HHHHHHHHHHCSSGGGCSEEECC
T ss_pred HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC-chHHHHHHHhCccCCCCCEEECC
Confidence 434443 789999999863 22211 111223 2579999999998873 32222222 357899999999
Q ss_pred CCcccccC----CccccCCCCCcEEEeeccccccccchhhhc-CCCCCEEEccCCc
Q 003199 150 VNHLSGKI----PESILRLPKLRVLQLYNNSLSGEISSVIAN-STTLTMLSLYDNS 200 (840)
Q Consensus 150 ~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~ 200 (840)
.|.+++.. +..+..+++|+.|+|++|.|++.....+.. + ...++++.++
T Consensus 288 ~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp SSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 99998642 334456799999999999998665555554 3 5678888887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.9e-09 Score=113.18 Aligned_cols=144 Identities=17% Similarity=0.280 Sum_probs=105.1
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--CCCcceeeeEEecC---c
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--HKNIVKLYCYFSSL---Y 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~ 605 (840)
.+.++.|.++.||++... +..+++|+...+.... ......+.+|+.+++.+. +..+.+++.++.+. +
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-------LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-------CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 457899999999999876 4678888764101000 011345778999999886 45688899888776 4
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL-------------------------------- 653 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 653 (840)
..++||||++|..+.+... ..++..++..++.+++++|..||+..
T Consensus 115 ~~~~vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SCEEEEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CeEEEEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 4799999999877754221 24677888899999999999999721
Q ss_pred -----------------------CCCeEecCCCCCCEEEcCCCC--Ceeecccchhh
Q 003199 654 -----------------------LSPIIHRDIKSTNILLDVNYQ--PKVADFGIAKV 685 (840)
Q Consensus 654 -----------------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfg~a~~ 685 (840)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 58999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=8.4e-09 Score=108.46 Aligned_cols=187 Identities=21% Similarity=0.168 Sum_probs=120.2
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCC--cceeeeEEecCc--
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKN--IVKLYCYFSSLY-- 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~-- 605 (840)
.+.++.|....||++. +.+++|+.... .....+.+|+++++.+. +.. +.+++.......
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 4568999999999863 56888875211 22456888999998873 332 445555543333
Q ss_pred -cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 003199 606 -CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL------------------------------- 653 (840)
Q Consensus 606 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 653 (840)
..|+||||++|.++.+.... .++..++..++.+++..++.||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 34899999999888654332 4567778888888888888888611
Q ss_pred ------------------------CCCeEecCCCCCCEEEcC--CCCCeeecccchhhhhccCCCCccee----------
Q 003199 654 ------------------------LSPIIHRDIKSTNILLDV--NYQPKVADFGIAKVLQARGGKDSTTT---------- 697 (840)
Q Consensus 654 ------------------------~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~---------- 697 (840)
...++|+|++|.||++++ ...+.|+||+.+..-.. ..+-...
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~--~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP--DNDFISLMEDDEEYGME 243 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT--THHHHTTCCTTTSCCHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh--HHHHHHHHhhccccCHH
Confidence 134799999999999998 45678999998754211 0000000
Q ss_pred ---cccccccccC-ccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 003199 698 ---VIAGTYGYLA-PEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740 (840)
Q Consensus 698 ---~~~gt~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 740 (840)
......++.. |+... +.....+.|++|.++|++.+|..+|.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000001111 22111 11223689999999999999987763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=2.7e-08 Score=100.58 Aligned_cols=65 Identities=29% Similarity=0.351 Sum_probs=28.5
Q ss_pred cCcccEEEcCCCccCC--CCCCcccCccccchhcccCCccCCCcchhccccc--CCCEEECcCccccccCC
Q 003199 332 AISLVKIDLSDNLLSG--PIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLK--SLNVLDLSNNLLTGYIP 398 (840)
Q Consensus 332 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p 398 (840)
+++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.+|
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 3444444444444443 2233334444444455555544432 1122222 45555555555554444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=2.7e-08 Score=95.87 Aligned_cols=112 Identities=15% Similarity=0.195 Sum_probs=64.3
Q ss_pred CCCcccEEeccCC-ccccc----CCcccCCCCCCceeecccceeeec----cchhhcccCcccEEEcCCCccCCC----C
Q 003199 283 SLPHVSIIDLSYN-SFSGP----IANTVGNARNLSELFMQRNQISGF----IPSEIYRAISLVKIDLSDNLLSGP----I 349 (840)
Q Consensus 283 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 349 (840)
..+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|.+. +
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 3444555555555 44321 222334445566666666666532 233344445677777777776642 3
Q ss_pred CCcccCccccchhcc--cCCccCCC----cchhcccccCCCEEECcCcccc
Q 003199 350 PSGIGNLKKLNLLML--QSNKLNSS----IPNSLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 350 p~~~~~l~~L~~L~L--s~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 394 (840)
...+...+.|+.|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 344555667777777 67777643 2344555678888888888875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=1.7e-07 Score=90.28 Aligned_cols=118 Identities=14% Similarity=0.118 Sum_probs=56.4
Q ss_pred CCCCCCCEEecCCC-cCccc----CCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccc
Q 003199 14 SPMQNLRRLDLSNN-LFTGQ----FPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASI 88 (840)
Q Consensus 14 ~~l~~L~~L~Ls~n-~i~~~----~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 88 (840)
...+.|++|+|++| .|... +...+...++|++|+|++|. +.+-... .+...+
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~---i~~~g~~--------------------~l~~~L 89 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTR---SNDPVAF--------------------ALAEML 89 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSC---CCHHHHH--------------------HHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCC---CChHHHH--------------------HHHHHH
Confidence 44566666666666 66532 23344445566666666662 2111100 112233
Q ss_pred cCCCCCcEEEccCCccccc----CchhhhcCCCCCeeec--ccCccccc---cCCcccCCCCCCCeeeccCCccc
Q 003199 89 GNVTSLTDLELTGNFITGH----IPPEIGLLKNLRQLEL--YYNQQLAG---TIPEELGNLTELTDLDMSVNHLS 154 (840)
Q Consensus 89 ~~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~L--~~n~~~~~---~~p~~l~~l~~L~~L~L~~n~l~ 154 (840)
...++|++|+|++|.|++. +...+...++|++|+| ++|.+-.. .+...+...++|++|+|++|.+.
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3344555555555555532 2334444555666666 44541110 01223444556666666666664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.3e-07 Score=95.56 Aligned_cols=107 Identities=19% Similarity=0.265 Sum_probs=57.9
Q ss_pred CCCCCCCCE--EecCCCcCc---ccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCcc
Q 003199 13 FSPMQNLRR--LDLSNNLFT---GQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPAS 87 (840)
Q Consensus 13 ~~~l~~L~~--L~Ls~n~i~---~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 87 (840)
|...+.|+. ++++.|... ..++....++++|+.|+|++|.+..+..++ ..+..+++|+.|+|++|.|.+. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~-~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMS-SIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGT-THHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccch-hHHhhCCCCCEEECCCCccCCc--hh
Confidence 333344444 556666433 222222345677777777777443333322 3355667777777777777643 22
Q ss_pred ccCCC--CCcEEEccCCcccccCc-------hhhhcCCCCCeee
Q 003199 88 IGNVT--SLTDLELTGNFITGHIP-------PEIGLLKNLRQLE 122 (840)
Q Consensus 88 ~~~l~--~L~~L~L~~n~i~~~~p-------~~~~~l~~L~~L~ 122 (840)
+..+. +|++|+|++|.+.+..| ..+..+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 33333 67777777777765443 2355666666664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.9e-06 Score=86.31 Aligned_cols=134 Identities=17% Similarity=0.166 Sum_probs=96.6
Q ss_pred eeeccCCc-EEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEecCccceE
Q 003199 533 KVGQGGSG-TVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 609 (840)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +-.+.++++++.+.+..++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence 45667666 69997654 567889997521 12356778999888874 4447788999988889999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL------------------------------------ 653 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 653 (840)
|||++++.++.+..... ......++.+++..+..||+..
T Consensus 98 vme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99999998887655432 2234456667777777777421
Q ss_pred -------------------CCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 654 -------------------LSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 654 -------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0137899999999999987767799999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=5.5e-06 Score=86.73 Aligned_cols=135 Identities=18% Similarity=0.109 Sum_probs=92.5
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCC---CcceeeeEEe-cCcc
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK---NIVKLYCYFS-SLYC 606 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~ 606 (840)
.+.++.|....||+. |+.++||+... ......+.+|+++++.+.+. .+.+++.++. ..+.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS------------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS------------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC------------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 346888999999998 56788887411 12345788999999999642 3566677664 4455
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG---------------------------------- 652 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 652 (840)
.++||||++|..+.+.... .++..+...++.++++.|..||+.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 7899999999887653221 234444555555555555555542
Q ss_pred -----------------------CCCCeEecCCCCCCEEEcC---CCCC-eeecccchh
Q 003199 653 -----------------------LLSPIIHRDIKSTNILLDV---NYQP-KVADFGIAK 684 (840)
Q Consensus 653 -----------------------~~~~ivH~Dlk~~Nill~~---~~~~-kl~Dfg~a~ 684 (840)
....++|+|+++.||+++. ++.+ .|+||+.+.
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1235699999999999987 4554 799999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.3e-05 Score=86.12 Aligned_cols=82 Identities=7% Similarity=-0.012 Sum_probs=53.0
Q ss_pred Cee-eccCCcEEEEEEeC-------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-C--CCcceeeeE
Q 003199 532 NKV-GQGGSGTVYKIDLN-------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-H--KNIVKLYCY 600 (840)
Q Consensus 532 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~ 600 (840)
+.| +.|....+|+.... +++.+++|+........... ...+.+|+.+++.+. + -.+.+++.+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-------~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-------TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-------CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-------hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 457 88889999998654 26678888753221000000 123567888888774 3 356778888
Q ss_pred EecC---ccceEEEeecCCCChH
Q 003199 601 FSSL---YCNLLVYEYMPNGNLW 620 (840)
Q Consensus 601 ~~~~---~~~~lV~e~~~~gsL~ 620 (840)
+.+. ...++||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 7655 3568999999886654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.96 E-value=2.1e-06 Score=80.28 Aligned_cols=84 Identities=13% Similarity=0.144 Sum_probs=41.8
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCC----CCCCeeeccCCc-ccccCCccccCCCC
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNL----TELTDLDMSVNH-LSGKIPESILRLPK 166 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~ 166 (840)
.+|++|||++|.|++..-..+..+++|+.|+|++|..+++.--..+..+ ++|++|+|++|. |+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 3566777777666654444455566666666666543333222223332 245555555543 44332233444555
Q ss_pred CcEEEeecc
Q 003199 167 LRVLQLYNN 175 (840)
Q Consensus 167 L~~L~L~~N 175 (840)
|++|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.95 E-value=2.3e-06 Score=80.03 Aligned_cols=91 Identities=11% Similarity=0.087 Sum_probs=60.3
Q ss_pred CcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc-cccccchhhhcC----CCCCEEEccCCc-CcccCCc
Q 003199 134 PEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS-LSGEISSVIANS----TTLTMLSLYDNS-LTGEVPQ 207 (840)
Q Consensus 134 p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~ 207 (840)
|.....-.+|++|||++|.|+...-..+.++++|++|+|++|. |++.....++.+ ++|++|+|++|. |+...-.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4333233467778888777776555566777888888888874 666555555554 368888888764 6654444
Q ss_pred CCCCCCCcceecccccc
Q 003199 208 DLGQWSPLVVLDLSENK 224 (840)
Q Consensus 208 ~l~~l~~L~~L~L~~N~ 224 (840)
.+..+++|+.|+|+++.
T Consensus 134 ~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HGGGCTTCCEEEEESCT
T ss_pred HHhcCCCCCEEECCCCC
Confidence 56667778888877764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=3.2e-05 Score=82.46 Aligned_cols=31 Identities=29% Similarity=0.281 Sum_probs=27.6
Q ss_pred CCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 654 LSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 654 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3689999999999999888889999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00011 Score=79.98 Aligned_cols=82 Identities=12% Similarity=0.085 Sum_probs=47.9
Q ss_pred cCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC--C-CcceeeeEEecCcc
Q 003199 531 KNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH--K-NIVKLYCYFSSLYC 606 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~ 606 (840)
.+.+|.|..+.||++... +++.|+||........... ........+..|.++++.+.. + .+.+++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~---~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE---SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC----------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC---CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence 457999999999999654 4688999986432110000 000112345668888877642 3 34455544 3445
Q ss_pred ceEEEeecCCC
Q 003199 607 NLLVYEYMPNG 617 (840)
Q Consensus 607 ~~lV~e~~~~g 617 (840)
.++||||+++.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 68999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00026 Score=73.62 Aligned_cols=136 Identities=17% Similarity=0.119 Sum_probs=89.7
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC---CCCcceeeeEEecCccc
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR---HKNIVKLYCYFSSLYCN 607 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 607 (840)
.+.|+.|....+|+.... +..++||+.... ....+..|++.++.+. ...+.++++++...+..
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS-------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG-------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc-------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 457899999999998764 678889976321 1356788988888884 35688889888877888
Q ss_pred eEEEeecCCCChHH-----------HhhcCCC---------------------CCChHHHH---HHH-------------
Q 003199 608 LLVYEYMPNGNLWD-----------ALHKGLV---------------------HLDWPTRH---KIA------------- 639 (840)
Q Consensus 608 ~lV~e~~~~gsL~~-----------~l~~~~~---------------------~~~~~~~~---~i~------------- 639 (840)
++||||+++..+.. .++.... .-+|.+.. ++.
T Consensus 107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~ 186 (312)
T 3jr1_A 107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF 186 (312)
T ss_dssp EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence 99999999876421 2222110 12454322 011
Q ss_pred ---HHHH-HHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 640 ---FGVA-QGLAYLHH-GLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 640 ---~~i~-~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
..++ .....|.. .....+||+|+.+.|++++.++ +.|.||+
T Consensus 187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 0111 11223321 1235789999999999999887 8888974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.27 E-value=4.3e-05 Score=72.81 Aligned_cols=63 Identities=19% Similarity=0.223 Sum_probs=29.8
Q ss_pred ccCCCCCcEEEeeccccccc----cchhhhcCCCCCEEEccCCcCccc----CCcCCCCCCCcceeccccc
Q 003199 161 ILRLPKLRVLQLYNNSLSGE----ISSVIANSTTLTMLSLYDNSLTGE----VPQDLGQWSPLVVLDLSEN 223 (840)
Q Consensus 161 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N 223 (840)
+..-..|+.|+|++|+|.+. +..++...+.|++|+|++|+|... +...+..-+.|++|+|++|
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 33344555555555555432 223333445555555555555522 1223444445666666543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00077 Score=69.59 Aligned_cols=78 Identities=17% Similarity=0.212 Sum_probs=54.7
Q ss_pred cCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC---CCcceeeeEEecC
Q 003199 528 MTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH---KNIVKLYCYFSSL 604 (840)
Q Consensus 528 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~ 604 (840)
....+.+|.|..+.||+.+..||+.|+||+....... ....|..|+..|+.+.. -.+.+++++.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~----------~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--- 83 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA----------LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--- 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC----------CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc----------hhhHHHHHHHHHHHHHhhCCCCcceEEecc---
Confidence 3446679999999999999999999999986433211 12346788888888742 2345555542
Q ss_pred ccceEEEeecCCCCh
Q 003199 605 YCNLLVYEYMPNGNL 619 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL 619 (840)
..++||||++++..
T Consensus 84 -~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 -DRTLAMEWVDERPP 97 (288)
T ss_dssp -TTEEEEECCCCCCC
T ss_pred -CceEEEEeecccCC
Confidence 34799999987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0024 Score=69.85 Aligned_cols=79 Identities=14% Similarity=0.105 Sum_probs=47.4
Q ss_pred CCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccC---CCCccccchhHHHHHHH
Q 003199 655 SPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS---KATTKCDVYSFGVVLME 731 (840)
Q Consensus 655 ~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~e 731 (840)
..++|+|++|.|||++.++ ++++||+.+..-.. ..+.......-...|.+|+..... ......++.+....+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p--~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM--GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH--HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch--HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 7899999999999999876 99999998754211 000000000011346666544311 12234555677888888
Q ss_pred HHhCC
Q 003199 732 LITGR 736 (840)
Q Consensus 732 l~tg~ 736 (840)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00015 Score=69.14 Aligned_cols=62 Identities=18% Similarity=0.239 Sum_probs=26.4
Q ss_pred CCCCcEEEeecccccccc----chhhhcCCCCCEEEccCC---cCcc----cCCcCCCCCCCcceeccccccc
Q 003199 164 LPKLRVLQLYNNSLSGEI----SSVIANSTTLTMLSLYDN---SLTG----EVPQDLGQWSPLVVLDLSENKL 225 (840)
Q Consensus 164 l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N---~l~~----~~~~~l~~l~~L~~L~L~~N~l 225 (840)
-+.|++|+|++|.|.+.. ..++...+.|++|+|++| .+.. .+...+..-++|+.|+++.|.+
T Consensus 97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 344555555555544221 223333444555555543 2221 1122333344555555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00061 Score=60.61 Aligned_cols=58 Identities=22% Similarity=0.296 Sum_probs=46.1
Q ss_pred cEEEcCCCccC-CCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 336 VKIDLSDNLLS-GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 336 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
..++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 36788888886 34565443 468899999999987778888999999999999999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0011 Score=72.51 Aligned_cols=73 Identities=22% Similarity=0.344 Sum_probs=48.3
Q ss_pred cCeeeccCCcEEEEEEeCC--------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCc-ceeeeEE
Q 003199 531 KNKVGQGGSGTVYKIDLNS--------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNI-VKLYCYF 601 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~ 601 (840)
.+.|+.|....||++...+ ++.+++|+...... ...+..|..+++.+...++ .++++.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~------------~~~li~E~~~l~~L~~~g~~P~l~~~~ 145 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET------------ESHLVAESVIFTLLSERHLGPKLYGIF 145 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC------------HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc------------HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence 3468889899999997653 57899998732110 1234468888887753333 5667665
Q ss_pred ecCccceEEEeecCCCCh
Q 003199 602 SSLYCNLLVYEYMPNGNL 619 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL 619 (840)
.+ .+|+||++|.++
T Consensus 146 ~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 146 SG----GRLEEYIPSRPL 159 (429)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----CEEEEEeCCccc
Confidence 43 389999986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.001 Score=69.20 Aligned_cols=71 Identities=7% Similarity=0.019 Sum_probs=43.0
Q ss_pred cCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCc-ceeeeEEecCccceE
Q 003199 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNI-VKLYCYFSSLYCNLL 609 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 609 (840)
.+.|+.|....+|++ +.+++|+........ -...+|+.+++.+....+ .+++++. .+..++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-----------~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-----------INRANEAVAAREAAKAGVSPEVLHVD--PATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-----------CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-----------eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEE
Confidence 567999999999998 558888774321110 112357777766643333 4555543 334579
Q ss_pred EEeec-CCCCh
Q 003199 610 VYEYM-PNGNL 619 (840)
Q Consensus 610 V~e~~-~~gsL 619 (840)
|+||+ ++.++
T Consensus 85 v~e~i~~g~~l 95 (301)
T 3dxq_A 85 VTRYIAGAQTM 95 (301)
T ss_dssp EEECCTTCEEC
T ss_pred EEeecCCCccC
Confidence 99999 55444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0013 Score=69.58 Aligned_cols=31 Identities=32% Similarity=0.402 Sum_probs=26.6
Q ss_pred CCeEecCCCCCCEEEcCC----CCCeeecccchhh
Q 003199 655 SPIIHRDIKSTNILLDVN----YQPKVADFGIAKV 685 (840)
Q Consensus 655 ~~ivH~Dlk~~Nill~~~----~~~kl~Dfg~a~~ 685 (840)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 579999999999999874 6789999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0018 Score=69.26 Aligned_cols=138 Identities=20% Similarity=0.167 Sum_probs=80.7
Q ss_pred CeeeccCCcEEEEEEeC--------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEe
Q 003199 532 NKVGQGGSGTVYKIDLN--------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFS 602 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 602 (840)
+.+..|-...+|++... +++.+++|+.-. . ......+.+|..+++.+. +.-..++++++.
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~----------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-I----------LQGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-c----------cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 46777888999998764 257899998521 1 011344568888888874 332356676665
Q ss_pred cCccceEEEeecCCCChHH-----------------HhhcCC----CCCC--hHHHHHHHHHHHH---------------
Q 003199 603 SLYCNLLVYEYMPNGNLWD-----------------ALHKGL----VHLD--WPTRHKIAFGVAQ--------------- 644 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~-----------------~l~~~~----~~~~--~~~~~~i~~~i~~--------------- 644 (840)
+ .+||||++|..+.. .+|... .... |.++.++..++..
T Consensus 125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 4 39999998755431 112211 1122 4455555443321
Q ss_pred ----HHHHHh----h-cCCCCeEecCCCCCCEEEcCC----CCCeeecccchh
Q 003199 645 ----GLAYLH----H-GLLSPIIHRDIKSTNILLDVN----YQPKVADFGIAK 684 (840)
Q Consensus 645 ----~l~~LH----~-~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfg~a~ 684 (840)
.++.|. . .....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 2 122468999999999999876 688999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.002 Score=67.66 Aligned_cols=140 Identities=12% Similarity=0.093 Sum_probs=76.3
Q ss_pred CeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC--cceeeeE------Eec
Q 003199 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN--IVKLYCY------FSS 603 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~ 603 (840)
+.|+.|....+|++...+| .+++|+...... ...+..|+.++..+.... +.+++.. ...
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~------------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVE------------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC---------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCCC------------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 4567788899999987655 678898743110 123445666666664222 2333321 112
Q ss_pred CccceEEEeecCCCChHH--------------HhhcCCCC-----------CChHHHHH------------HHHHHHHHH
Q 003199 604 LYCNLLVYEYMPNGNLWD--------------ALHKGLVH-----------LDWPTRHK------------IAFGVAQGL 646 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~--------------~l~~~~~~-----------~~~~~~~~------------i~~~i~~~l 646 (840)
.+..++|++|++|..+.. .++..... ..|..... +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 345689999998754311 12211000 01322110 011234455
Q ss_pred HHHhhc----CCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 647 AYLHHG----LLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 647 ~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
++++.. ...+++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 555532 23578999999999999987656799998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.008 Score=63.15 Aligned_cols=138 Identities=13% Similarity=0.132 Sum_probs=77.3
Q ss_pred eeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCC--CcceeeeE-----EecCc
Q 003199 533 KVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHK--NIVKLYCY-----FSSLY 605 (840)
Q Consensus 533 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~ 605 (840)
.++ |....||++...+|+.+++|....... ....+..|..+++.+... .+++++.. ....+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-----------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g 100 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-----------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 100 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-----------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-----------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence 466 888899998777787899998742211 123455677777766422 23444443 11234
Q ss_pred cceEEEeecCCCChH-----H---------HhhcC--------CCCCChHHH----HHH---------------HHHHHH
Q 003199 606 CNLLVYEYMPNGNLW-----D---------ALHKG--------LVHLDWPTR----HKI---------------AFGVAQ 644 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~-----~---------~l~~~--------~~~~~~~~~----~~i---------------~~~i~~ 644 (840)
..++||||++|..+. . .++.. ....++... ..+ ...+..
T Consensus 101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 180 (328)
T 1zyl_A 101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE 180 (328)
T ss_dssp EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence 457899999875432 0 11110 011222111 001 111112
Q ss_pred HHHHHhhc----CCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 645 GLAYLHHG----LLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 645 ~l~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
.++.+... ....++|+|+++.||+++ + .+.++||+.+.
T Consensus 181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 23333221 225688999999999999 4 78999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0063 Score=66.83 Aligned_cols=74 Identities=18% Similarity=0.166 Sum_probs=46.1
Q ss_pred cCeeeccCCcEEEEEEeCC-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCc-ceeeeEEecCccce
Q 003199 531 KNKVGQGGSGTVYKIDLNS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNI-VKLYCYFSSLYCNL 608 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~ 608 (840)
.+.|+.|-...+|++...+ +..+++|+..... .. .. ...+|..+++.+...++ .++++++.. .
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~---~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~~----G 177 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE---II-------NREREKKISCILYNKNIAKKIYVFFTN----G 177 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS---CS-------CHHHHHHHHHHHTTSSSBCCEEEEETT----E
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh---hc-------CHHHHHHHHHHHHhcCCCCCEEEEeCC----e
Confidence 3468889999999998765 4788888763211 10 00 01468888888864444 567776632 3
Q ss_pred EEEeecCCCCh
Q 003199 609 LVYEYMPNGNL 619 (840)
Q Consensus 609 lV~e~~~~gsL 619 (840)
+||||++|.++
T Consensus 178 ~v~e~I~G~~l 188 (458)
T 2qg7_A 178 RIEEFMDGYAL 188 (458)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEeeCCccC
Confidence 69999987444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0032 Score=55.86 Aligned_cols=36 Identities=19% Similarity=0.148 Sum_probs=18.1
Q ss_pred CCcEEEeeccccccccchhhhcCCCCCEEEccCCcC
Q 003199 166 KLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSL 201 (840)
Q Consensus 166 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 201 (840)
+|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 345555555555544444455555555555555544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0032 Score=67.48 Aligned_cols=73 Identities=12% Similarity=0.157 Sum_probs=42.4
Q ss_pred CeeeccCCcEEEEEEeCC---------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC-cceeeeEE
Q 003199 532 NKVGQGGSGTVYKIDLNS---------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN-IVKLYCYF 601 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~ 601 (840)
+.++.|....+|++...+ ++.+++|+........ .....|.++++.+...+ +.++++..
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-----------~~~~~E~~~l~~L~~~g~~P~~~~~~ 107 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-----------YNTISEFEVYKTMSKYKIAPQLLNTF 107 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-----------SCHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-----------ecHHHHHHHHHHHHhcCCCCceEEec
Confidence 467888889999987654 2688888763321110 01346777777775333 34666544
Q ss_pred ecCccceEEEeecCCCCh
Q 003199 602 SSLYCNLLVYEYMPNGNL 619 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL 619 (840)
..++||||++|..+
T Consensus 108 ----~~~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 ----NGGRIEEWLYGDPL 121 (369)
T ss_dssp ----TTEEEEECCCSEEC
T ss_pred ----CCcEEEEEecCCcC
Confidence 23789999987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.22 E-value=0.025 Score=54.04 Aligned_cols=101 Identities=14% Similarity=0.079 Sum_probs=67.0
Q ss_pred CChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcce
Q 003199 617 GNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696 (840)
Q Consensus 617 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 696 (840)
-+|.+.|......++++++|.++.|.+.+|.-.-.. +.-..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 478999998888999999999999999998776221 1111233456889999999887663 1110
Q ss_pred ecccccccccCccccccCCCCccccchhHHHHHHHHHhCC
Q 003199 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736 (840)
Q Consensus 697 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 736 (840)
.....+.|||... ...+.+.=|||+|+++|.-+-=.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122456888653 45678899999999999988633
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.88 E-value=0.019 Score=60.49 Aligned_cols=31 Identities=19% Similarity=0.282 Sum_probs=27.1
Q ss_pred CCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 655 SPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 655 ~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.024 Score=61.32 Aligned_cols=74 Identities=9% Similarity=0.127 Sum_probs=46.1
Q ss_pred cCeeeccCCcEEEEEEeCC--------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC-cceeeeEE
Q 003199 531 KNKVGQGGSGTVYKIDLNS--------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN-IVKLYCYF 601 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~ 601 (840)
.+.+..|-...+|+....+ ++.+++|+..... .. . . +..+|..+++.+...+ ..++++.+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~--i-------dR~~E~~~l~~L~~~gi~P~l~~~~ 143 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-F--Y-------DSKVELDVFRYLSNINIAPNIIADF 143 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-C--C-------CHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-h--c-------CHHHHHHHHHHHHhcCCCCCEEEEc
Confidence 3467788899999987653 5789998863221 11 0 0 1245777777774222 34556543
Q ss_pred ecCccceEEEeecCCCCh
Q 003199 602 SSLYCNLLVYEYMPNGNL 619 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL 619 (840)
. .++||||++|..+
T Consensus 144 ~----~~~I~efI~G~~l 157 (424)
T 3mes_A 144 P----EGRIEEFIDGEPL 157 (424)
T ss_dssp T----TEEEEECCCSEEC
T ss_pred C----CCEEEEEeCCccC
Confidence 2 3789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.42 E-value=0.14 Score=55.09 Aligned_cols=29 Identities=28% Similarity=0.380 Sum_probs=24.2
Q ss_pred eEecCCCCCCEEE------cCCCCCeeecccchhh
Q 003199 657 IIHRDIKSTNILL------DVNYQPKVADFGIAKV 685 (840)
Q Consensus 657 ivH~Dlk~~Nill------~~~~~~kl~Dfg~a~~ 685 (840)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456789999998743
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=83.57 E-value=1.4 Score=29.75 Aligned_cols=11 Identities=36% Similarity=0.564 Sum_probs=5.1
Q ss_pred HHHhhhhhccc
Q 003199 481 LLLFLKRRFSK 491 (840)
Q Consensus 481 ~~~~~~~r~~~ 491 (840)
+++|++||+.+
T Consensus 31 ~~~~~RRR~~~ 41 (44)
T 2jwa_A 31 FGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHCSC
T ss_pred HHhheehhhhh
Confidence 34455555443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 840 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-30 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 9e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-68
Identities = 82/294 (27%), Positives = 129/294 (43%), Gaps = 34/294 (11%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
I Q + + ++G G GTVYK + VAVK L V+A QLQ
Sbjct: 5 IPDGQITVGQ------RIGSGSFGTVYKGKWHGD--VAVKML-----NVTAPTPQQLQA- 50
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
K EV L RH NI+ Y ++ +V ++ +L+ LH +
Sbjct: 51 --FKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI 107
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
IA AQG+ YLH IIHRD+KS NI L + K+ DFG+A V R
Sbjct: 108 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS-RWSGSHQF 163
Query: 697 TVIAGTYGYLAPEYAYSSKA---TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753
++G+ ++APE + + DVY+FG+VL EL+TG+ P + +N++ I ++
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFM 221
Query: 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
G + K+ + M +++ C K RP +++ +
Sbjct: 222 -----VGRGYLSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 8e-62
Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 38/294 (12%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
+ + +++E ++G G G V+ N VAVK L K + D
Sbjct: 10 VPRETLKLVE------RLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFL-- 56
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK-GLVHLDWPTR 635
E + ++H+ +V+LY + ++ EYM NG+L D L + L
Sbjct: 57 ----AEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 636 HKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST 695
+A +A+G+A++ IHRD+++ NIL+ K+ADFG+A++++ + +
Sbjct: 112 LDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTA 166
Query: 696 TTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755
+ APE T K DV+SFG++L E++T + N +I +
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNL-- 223
Query: 756 KVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ G V + C + P RPT + + +L +
Sbjct: 224 ----ERGYRMVRPDNCPEELYQ-------LMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-60
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 36/293 (12%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
I + ++ ++G G G V+ + + VA+K + + +
Sbjct: 2 IDPSELTFVQ------EIGSGQFGLVHLGYWLNKDKVAIKTI-----------REGAMSE 44
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
+ E E + + H +V+LY LV+E+M +G L D L T
Sbjct: 45 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL 104
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
+ V +G+AYL + +IHRD+ + N L+ N KV+DFG+ + + + +++
Sbjct: 105 GMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS 159
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756
T + +PE S+ ++K DV+SFGV++ E+ + K ++ N ++ +
Sbjct: 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDI--- 215
Query: 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
G + S I C + P RP + +++ LAE
Sbjct: 216 ---STGFRLYKPRLASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 8e-60
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 36/301 (11%)
Query: 531 KNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+ +G+G G V++ GE VAVK S+ + + E+ +R
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-----------SWFREAEIYQTVMLR 55
Query: 591 HKNIVKLYCYFS----SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
H+NI+ + + LV +Y +G+L+D L++ + K+A A GL
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGL 113
Query: 647 AYLHHGLLS-----PIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST-TTVIA 700
A+LH ++ I HRD+KS NIL+ N +AD G+A +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 701 GTYGYLAPEYAYSS------KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
GT Y+APE S ++ + D+Y+ G+V E+ V
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 755 IKVDTKEGIMEVLDKKLSGSFRD------EMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808
+E V ++KL + + + + +I C + A R T + + L+
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 809 E 809
+
Sbjct: 294 Q 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-59
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 52/306 (16%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+++G G G V+K SG V+A K + + + + E++ L
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---------AIRNQIIRELQVLHECN 62
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
IV Y F S + E+M G+L L K + K++ V +GL YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR 121
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
I+HRD+K +NIL++ + K+ DFG++ L DS GT Y++PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPER 174
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE--------- 761
+ + + D++S G+ L+E+ GR P+ +++ ++ D E
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 762 --------------GIMEVLDKKL--------SGSFRDEMIQVLRIAIRCTSKSPATRPT 799
I E+LD + SG F E + +C K+PA R
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 291
Query: 800 MNEVVQ 805
+ +++
Sbjct: 292 LKQLMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-59
Identities = 56/282 (19%), Positives = 109/282 (38%), Gaps = 32/282 (11%)
Query: 530 EKNKVGQGGSGTVYK---IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
++G G G+V + VA+K L + +DT+++ E + +
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMM------REAQIM 63
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ + IV+L + +LV E G L L + ++ V+ G+
Sbjct: 64 HQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YL +HRD+ + N+LL + K++DFG++K L A + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
APE K +++ DV+S+GV + E ++ G+KP + ++ ++ ++G
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFI------EQGKRM 231
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ + C RP V Q +
Sbjct: 232 ECPPECPPELYA-------LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 4e-59
Identities = 67/282 (23%), Positives = 108/282 (38%), Gaps = 32/282 (11%)
Query: 530 EKNKVGQGGSGTVYK---IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
E ++G G GTV K + VAVK L K A+D L E +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNEANDPALKDE---LLAEANVM 62
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
+ + IV++ + +LV E G L L + H+ ++ V+ G+
Sbjct: 63 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGM 120
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YL S +HRD+ + N+LL + K++DFG++K L+A T +
Sbjct: 121 KYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
APE K ++K DV+SFGV++ E + G+KP + + ++G
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAML------EKGERM 229
Query: 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
D + C + RP V L
Sbjct: 230 GCPAGCPREMYD-------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-59
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 517 ISFDQREI-LEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQL 575
++ D EI E++ + K+GQG G V+ N VA+K L
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----------KPGTMS 55
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH-KGLVHLDWPT 634
+ E + + +RH+ +V+LY S +V EYM G+L D L + +L P
Sbjct: 56 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQ 114
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
+A +A G+AY+ +HRD+++ NIL+ N KVADFG+A++++ + +
Sbjct: 115 LVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYT 169
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
+ APE A + T K DV+SFG++L EL T + N+ ++ V
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQV- 227
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ G + S D + +C K P RPT + L
Sbjct: 228 -----ERGYRMPCPPECPESLHD-------LMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G G G K + G+++ K+L S ++ ++ + L +EV L ++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEK----QMLVSEVNLLRELK 61
Query: 591 HKNIVKLYCYF-----SSLYCNLLVYEYMPNGNLWDALHKGL---VHLDWPTRHKIAFGV 642
H NIV+ Y ++LY +V EY G+L + KG +LD ++ +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLY---IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 643 AQGLAYLH--HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIA 700
L H ++HRD+K N+ LD K+ DFG+A++L S
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DTSFAKAFV 175
Query: 701 GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760
GT Y++PE K D++S G +L EL P K + + +
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKI------R 227
Query: 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
EG + + S + I R + RP++ E+++
Sbjct: 228 EGKFRRIPYRYSDELNE-------IITRMLNLKDYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-58
Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 44/293 (15%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
++ + ++L+ +G+G G V D G VAVK + + T
Sbjct: 4 LNMKELKLLQ------TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA------------ 44
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL-LVYEYMPNGNLWDALH-KGLVHLDWPT 634
+ E + +RH N+V+L L +V EYM G+L D L +G L
Sbjct: 45 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 104
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
K + V + + YL + +HRD+ + N+L+ + KV+DFG+ K S
Sbjct: 105 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SS 155
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
T + APE K +TK DV+SFG++L E+ + + K+++ V
Sbjct: 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRV- 213
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
++G + + + C A RP+ ++ + L
Sbjct: 214 -----EKGYKMDAPDGCPPAVYE-------VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-58
Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 35/281 (12%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++G+G TVYK +D + VA +L Q K++ S+ + K E E L +
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRF------KEEAEMLKGL 65
Query: 590 RHKNIVKLYCYFSSL----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
+H NIV+ Y + S C +LV E M +G L L + + + +G
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKG 124
Query: 646 LAYLHHGLLSPIIHRDIKSTNILL-DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYG 704
L +LH PIIHRD+K NI + K+ D G+A + + S + GT
Sbjct: 125 LQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-----ASFAKAVIGTPE 178
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
++APE Y K DVY+FG+ ++E+ T P + + T
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKP 231
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
DK ++ I C ++ R ++ +++
Sbjct: 232 ASFDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-58
Identities = 74/275 (26%), Positives = 117/275 (42%), Gaps = 33/275 (12%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G G VY + S ++A+K L + ++ ++ L+ EVE ++R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVL-------FKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
H NI++LY YF L+ EY P G ++ L K D +A L+Y H
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH 123
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
+IHRDIK N+LL + K+ADFG + S T + GT YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTTLCGTLDYLPPEM 175
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
K D++S GV+ E + G+ P E + Y +V+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT------FPDF 226
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
++ RD + R +P+ RP + EV++
Sbjct: 227 VTEGARD-------LISRLLKHNPSQRPMLREVLE 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 1e-57
Identities = 69/297 (23%), Positives = 122/297 (41%), Gaps = 35/297 (11%)
Query: 515 HRISFDQREI-LEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQ 572
++D+ E+ +T K+K+G G G VY+ + VAVK L +V
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------- 57
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH-KGLVHLD 631
+ E + I+H N+V+L + ++ E+M GNL D L +
Sbjct: 58 ----EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 113
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGG 691
+A ++ + YL IHRD+ + N L+ N+ KVADFG+++++ G
Sbjct: 114 AVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GD 168
Query: 692 KDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIY 751
+ + APE +K + K DV++FGV+L E+ T ++
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---- 224
Query: 752 WVSIKVDTKEGIMEVLDKKLSGSFRDEMI-QVLRIAIRCTSKSPATRPTMNEVVQLL 807
+ E+L+K + +V + C +P+ RP+ E+ Q
Sbjct: 225 -----------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-57
Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 36/293 (12%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLD 576
I L+ ++G G G V VA+K + + +
Sbjct: 1 IDPKDLTFLK------ELGTGQFGVVKYGKWRGQYDVAIKMI-----------KEGSMSE 43
Query: 577 KGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
E + + N+ H+ +V+LY + ++ EYM NG L + L +
Sbjct: 44 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 103
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
++ V + + YL +HRD+ + N L++ KV+DFG+++ + + +++
Sbjct: 104 EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS 158
Query: 697 TVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756
+ PE SK ++K D+++FGV++ E+ + K + F N +
Sbjct: 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHI--- 214
Query: 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+G+ S I C + RPT ++ + +
Sbjct: 215 ---AQGLRLYRPHLASEKVYT-------IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-57
Identities = 70/298 (23%), Positives = 111/298 (37%), Gaps = 34/298 (11%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYK----IDLNSGEVVAVKKLWSQRTKVSASDTDQ 572
I +LE K+G G G V + VAVK L Q
Sbjct: 5 IGEKDLRLLE------KLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-------KPDVLSQ 51
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
+ EV + ++ H+N+++LY + +V E P G+L D L K H
Sbjct: 52 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLL 110
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
T + A VA+G+ YL IHRD+ + N+LL K+ DFG+ + L
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
+ + APE + + D + FGV L E+ T + + I++
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHK 226
Query: 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
+ KEG + + + ++C + P RPT + L EA
Sbjct: 227 I-----DKEGERLPRPEDCPQDIYN-------VMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 2e-56
Identities = 63/299 (21%), Positives = 122/299 (40%), Gaps = 34/299 (11%)
Query: 518 SFDQREILEAMTEKNKVGQGGSGTVYK----IDLNSGEVVAVKKLWSQRTKVSASDTDQL 573
F + + + + +G G G V + VA+K L S T+
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--------- 68
Query: 574 QLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWP 633
+ + +E +G H N++ L + +++ E+M NG+L L +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 634 TRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKD 693
+ G+A G+ YL +HRD+ + NIL++ N KV+DFG+++ L+
Sbjct: 129 QLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 694 STTTVIA--GTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNII 750
+ T+ + + APE K T+ DV+S+G+V+ E+++ G +P D N+++I
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVI 243
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ ++ + + + C K RP ++V L +
Sbjct: 244 NAI------EQDYRLPPPMDCPSALHQ-------LMLDCWQKDRNHRPKFGQIVNTLDK 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-56
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 33/287 (11%)
Query: 529 TEKNKVGQGGSGTVYKIDLNSGE-----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEV 583
T + +G G G VYK L + VA+K L K ++ ++ E
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDF----LGEA 60
Query: 584 ETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVA 643
+G H NI++L S +++ EYM NG L L + + G+A
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 644 QGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTY 703
G+ YL + +HRD+ + NIL++ N KV+DFG+++VL+ TT+
Sbjct: 121 AGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763
+ APE K T+ DV+SFG+V+ E++T + + + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------------LSNHEV 222
Query: 764 MEVLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
M+ ++ D + ++ ++C + A RP ++V +L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 7e-56
Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 36/281 (12%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
++ ++G G G VY D+ + EVVA+KK+ + ++ Q + EV L
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKM----SYSGKQSNEKWQD---IIKEVRFLQ 70
Query: 588 NIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
+RH N ++ + + LV EY L + G QGLA
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
YLH +IHRD+K+ NILL K+ DFG A ++ GT ++A
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANSFVGTPYWMA 179
Query: 708 PEYAYSS---KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
PE + + K DV+S G+ +EL + P+ + + + +Y + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHI-----AQNESP 232
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ S FR+ C K P RPT +++
Sbjct: 233 ALQSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 1e-55
Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 56/305 (18%)
Query: 532 NKVGQGGSGTVYK------IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVET 585
+G+G G V++ + +VAVK L + + + + E
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---------DMQADFQREAAL 69
Query: 586 LGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHK-------------------- 625
+ + NIVKL + L++EYM G+L + L
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 626 ---GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682
G L + IA VA G+AYL +HRD+ + N L+ N K+ADFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD 742
++ + + + A ++ PE + ++ TT+ DV+++GVVL E+ +
Sbjct: 187 SRNIYSADYYKADGND-AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 743 FGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+E I V D + + +++ + C SK PA RP+
Sbjct: 246 M--------------AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 803 VVQLL 807
+ ++L
Sbjct: 292 IHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G G V ++ + E VAVK + +R + +K E+ +
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---------DCPENIKKEICINKMLN 61
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
H+N+VK Y + L EY G L+D + + + P + + G+ YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
I HRDIK N+LLD K++DFG+A V + ++ + GT Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMCGTLPYVAPEL 176
Query: 711 AYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
+ DV+S G+VL ++ G P + + W ++ K
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------EKKTYLNPWK 230
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
K+ + + + ++P+ R T+ ++ +
Sbjct: 231 KIDSAPLA-------LLHKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-55
Identities = 66/292 (22%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D EI+ ++G G G VYK + + + A K + DT + +
Sbjct: 12 DFWEIIG------ELGDGAFGKVYKAQNKETSVLAAAKVI----------DTKSEEELED 55
Query: 579 LKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKI 638
E++ L + H NIVKL F ++ E+ G + + + L +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 639 AFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTV 698
L YLH + IIHRD+K+ NIL ++ K+ADFG++
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN---TRTIQRRDS 169
Query: 699 IAGTYGYLAPEYAYSSKA-----TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753
GT ++APE + K DV+S G+ L+E+ P + + ++
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLL-- 225
Query: 754 SIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
K+ E + S +F+D +C K+ R T ++++Q
Sbjct: 226 --KIAKSEPPTLAQPSRWSSNFKD-------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-55
Identities = 76/330 (23%), Positives = 127/330 (38%), Gaps = 58/330 (17%)
Query: 502 LSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK------IDLNSGEVVAV 555
+ + PYD K ++ + +G G G V + I ++ VAV
Sbjct: 7 IDPTQLPYDHK--WEFPRNRLSFGK------TLGAGAFGKVVEATAYGLIKSDAAMTVAV 58
Query: 556 KKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLVYEYM 614
K L K SA T++ + L +E++ L + H NIV L + L++ EY
Sbjct: 59 KML-----KPSAHLTER----EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC 109
Query: 615 PNGNLWDALHK-----------------GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPI 657
G+L + L + + LD ++ VA+G+A+L
Sbjct: 110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNC 166
Query: 658 IHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT 717
IHRD+ + NILL K+ DFG+A+ ++ ++APE ++ T
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIK-NDSNYVVKGNARLPVKWMAPESIFNCVYT 225
Query: 718 TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRD 777
+ DV+S+G+ L EL + + + KEG + + D
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI------KEGFRMLSPEHAPAEMYD 279
Query: 778 EMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
I C P RPT ++VQL+
Sbjct: 280 -------IMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-53
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 32/275 (11%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+GQG SGTVY +D+ +G+ VA++++ + Q + + E+ + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM----------NLQQQPKKELIINEILVMRENK 75
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
+ NIV + +V EY+ G+L D + + +D + Q L +LH
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH 133
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
+ +IHRDIKS NILL ++ K+ DFG + + S + + GT ++APE
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAPEV 187
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
K D++S G++ +E+I G P ++ + +Y + T +K
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALY----LIATNGTPELQNPEK 241
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
LS FRD RC R + E++Q
Sbjct: 242 LSAIFRD-------FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-52
Identities = 63/306 (20%), Positives = 121/306 (39%), Gaps = 35/306 (11%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEV----VAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G G GTVYK + + GE VA+K+L + + +K + E +
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---------REATSPKANKEILDEAYVM 65
Query: 587 GNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
++ + ++ +L + L+ + MP G L D + + ++ +A+G+
Sbjct: 66 ASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
YL ++HRD+ + N+L+ K+ DFG+AK+L A K+ ++
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-EEKEYHAEGGKVPIKWM 180
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766
A E T + DV+S+GV + EL+T D I + ++G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSIL------EKGERLP 233
Query: 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE--ADPCRFESCKFPNKS 824
+ I ++C +RP E++ ++ DP R+ + +
Sbjct: 234 QPPICTIDVYM-------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 825 NKESSN 830
+ S
Sbjct: 287 HLPSPT 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-52
Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 39/297 (13%)
Query: 517 ISFDQREILEAMTEKNKVGQGGSGTVYK----IDLNSGEVVAVKKLWSQRTKVSASDTDQ 572
I ++ E+ +G+G G V++ N VA+K K SD+ +
Sbjct: 4 IQRERIELGR------CIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVR 52
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDW 632
+ E T+ H +IVKL + ++ E G L L LD
Sbjct: 53 ----EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL 107
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGK 692
+ A+ ++ LAYL +HRDI + N+L+ N K+ DFG+++ ++
Sbjct: 108 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DST 162
Query: 693 DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752
+ ++APE + T+ DV+ FGV + E++ N ++I
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGR 221
Query: 753 VSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ + G + + + +C + P+ RP E+ L+
Sbjct: 222 I------ENGERLPMPPNCPPTLYS-------LMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 73/313 (23%), Positives = 122/313 (38%), Gaps = 55/313 (17%)
Query: 514 FHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGE--VVAVKKLWSQRTKVSASDT 570
+ + ++ + + +G+G G V K G A+K++ K AS
Sbjct: 4 YPVLDWNDIKFQD------VIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKD 52
Query: 571 DQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVH 629
D + E+E L + H NI+ L L EY P+GNL D L K V
Sbjct: 53 DH----RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 108
Query: 630 ---------------LDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQ 674
L A VA+G+ YL IHRD+ + NIL+ NY
Sbjct: 109 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165
Query: 675 PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT 734
K+ADFG+++ + T+ ++A E S TT DV+S+GV+L E+++
Sbjct: 166 AKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 735 GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSP 794
+ E + + + + DE+ ++R +C + P
Sbjct: 222 LGGTPYCGMTC-----------AELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKP 267
Query: 795 ATRPTMNEVVQLL 807
RP+ +++ L
Sbjct: 268 YERPSFAQILVSL 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-52
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 32/285 (11%)
Query: 531 KNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETL 586
+G+G G VY L AVK L + + TE +
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------NRITDIGEVSQFLTEGIIM 82
Query: 587 GNIRHKNIVKLY-CYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQG 645
+ H N++ L S L+V YM +G+L + + + VA+G
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 646 LAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDST-TTVIAGTYG 704
+ +L +HRD+ + N +LD + KVADFG+A+ + + T
Sbjct: 143 MKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 705 YLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764
++A E + K TTK DV+SFGV+L EL+T P D + +I ++ +G
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL------LQGRR 252
Query: 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAE 809
+ + + + ++C RP+ +E+V ++
Sbjct: 253 LLQPEYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-52
Identities = 63/331 (19%), Positives = 113/331 (34%), Gaps = 63/331 (19%)
Query: 507 FPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK------IDLNSGEVVAVKKLWS 560
+ YD+K + E + +G G G V VAVK L
Sbjct: 26 YEYDLK--WEFPRENLEFGK------VLGSGAFGKVMNATAYGISKTGVSIQVAVKML-- 75
Query: 561 QRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLVYEYMPNGNL 619
K A +++ L +E++ + + H+NIV L + L++EY G+L
Sbjct: 76 ---KEKADSSEREAL----MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 620 WDALHK----------------------GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPI 657
+ L L L + A+ VA+G+ +L
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSC 185
Query: 658 IHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKAT 717
+HRD+ + N+L+ K+ DFG+A+ + + ++APE + T
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA-RLPVKWMAPESLFEGIYT 244
Query: 718 TKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRD 777
K DV+S+G++L E+ + + N + + G +
Sbjct: 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI------QNGFKMDQPFYATEEIYI 298
Query: 778 EMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808
I C + RP+ + L
Sbjct: 299 -------IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 1e-50
Identities = 70/342 (20%), Positives = 129/342 (37%), Gaps = 41/342 (11%)
Query: 504 SSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQR 562
++P V+ H D +I E ++G G G V++ + +G A K +
Sbjct: 10 KQYYPQPVEIKHDHVLDHYDIHE------ELGTGAFGVVHRVTERATGNNFAAKFV---- 59
Query: 563 TKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDA 622
T + ++ E++T+ +RH +V L+ F +++YE+M G L++
Sbjct: 60 ------MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 113
Query: 623 LHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV--NYQPKVADF 680
+ + + V +GL ++H +H D+K NI+ + + K+ DF
Sbjct: 114 VADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 170
Query: 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVE 740
G+ L + V GT + APE A D++S GV+ L++G P
Sbjct: 171 GLTAHLD----PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
Query: 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800
G+N + D +D ++ +R + P TR T+
Sbjct: 227 ---GENDDETLRNVKSCDWN------MDDSAFSGISEDGKDFIR---KLLLADPNTRMTI 274
Query: 801 NEVVQ---LLAEADPCRFESCKFPNKSNKESSNATKIKNPSE 839
++ ++ L P R + S TK E
Sbjct: 275 HQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (454), Expect = 2e-50
Identities = 63/309 (20%), Positives = 117/309 (37%), Gaps = 38/309 (12%)
Query: 500 ETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKL 558
E + + P V+ +D +ILE ++G G G V++ ++ +G V K +
Sbjct: 9 EDIWKKYVPQPVEVKQGSVYDYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKFI 62
Query: 559 WSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGN 618
+T +K E+ + + H ++ L+ F Y +L+ E++ G
Sbjct: 63 ----------NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112
Query: 619 LWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP--K 676
L+D + + +GL ++H I+H DIK NI+ + K
Sbjct: 113 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVK 169
Query: 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736
+ DFG+A L D V T + APE D+++ GV+ L++G
Sbjct: 170 IIDFGLATKLN----PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 737 KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPAT 796
P + D+ + V D+ S E ++ K P
Sbjct: 226 SPFAGE--DDLETLQNVKRCDWE-------FDEDAFSSVSPEAKDFIK---NLLQKEPRK 273
Query: 797 RPTMNEVVQ 805
R T+++ ++
Sbjct: 274 RLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (442), Expect = 1e-49
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 35/295 (11%)
Query: 519 FDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDK 577
++ E E +G+G S V + I + + AVK + +++ Q +L +
Sbjct: 2 YENYEPKE------ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ-ELRE 54
Query: 578 GLKTEVETLGNIR-HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRH 636
EV+ L + H NI++L + + LV++ M G L+D L + V L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETR 113
Query: 637 KIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTT 696
KI + + + LH I+HRD+K NILLD + K+ DFG + L
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD----PGEKL 166
Query: 697 TVIAGTYGYLAPEYAYSSKA------TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
+ GT YLAPE S + D++S GV++ L+ G P + ++
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLM 223
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ + + + + D + ++ R P R T E +
Sbjct: 224 LRMIMSGNYQ------FGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-49
Identities = 62/287 (21%), Positives = 123/287 (42%), Gaps = 33/287 (11%)
Query: 522 REILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLK 580
+E+ E +G+G G V++ ++ +S + K + KV +D + K
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-----KVKGTDQVLV------K 49
Query: 581 TEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAF 640
E+ L RH+NI+ L+ F S+ ++++E++ ++++ ++ L+
Sbjct: 50 KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 641 GVAQGLAYLHHGLLSPIIHRDIKSTNILLDV--NYQPKVADFGIAKVLQARGGKDSTTTV 698
V + L +LH I H DI+ NI+ + K+ +FG A+ L+ +
Sbjct: 110 QVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRL 162
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758
+ Y APE +T D++S G ++ L++G P + N+ II + ++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENI---MN 217
Query: 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ E K++S D + R K +R T +E +Q
Sbjct: 218 AEYTFDEEAFKEISIEAMD-FVD------RLLVKERKSRMTASEALQ 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 8e-49
Identities = 64/306 (20%), Positives = 121/306 (39%), Gaps = 43/306 (14%)
Query: 520 DQREI-LEAMTEKNKVGQGGSGTVYK------IDLNSGEVVAVKKLWSQRTKVSASDTDQ 572
D+ E+ E +T ++GQG G VY+ + VA+K + +AS ++
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 67
Query: 573 LQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALH-------- 624
++ E + ++V+L S L++ E M G+L L
Sbjct: 68 IEF----LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 625 -KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683
L ++A +A G+AYL+ + +HRD+ + N ++ ++ K+ DFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDF 743
+ + + +++PE TT DV+SFGVVL E+ T +
Sbjct: 181 RDIYETDYYRKGGKGL-LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239
Query: 744 GDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
N+ ++ +V EG + + + C +P RP+ E+
Sbjct: 240 -SNEQVLRFV------MEGGLLDKPDNCPDMLFE-------LMRMCWQYNPKMRPSFLEI 285
Query: 804 VQLLAE 809
+ + E
Sbjct: 286 ISSIKE 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 29/273 (10%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+G TV +L + A+K L + + E + + +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERDVMSRLD 66
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
H VKLY F Y NG L + K D + L YLH
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 125
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
IIHRD+K NILL+ + ++ DFG AK + + K + GT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSPEL 181
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
A D+++ G ++ +L+ G P N+ +I+ IK++ +K
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLEYD------FPEK 232
Query: 771 LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
RD +++ + R E+
Sbjct: 233 FFPKARD-LVE------KLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 7e-48
Identities = 75/325 (23%), Positives = 121/325 (37%), Gaps = 59/325 (18%)
Query: 507 FPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK--------IDLNSGEVVAVKKL 558
P D + + D+ + + +G+G G V N VAVK L
Sbjct: 2 LPEDPR--WELPRDRLVLGK------PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 53
Query: 559 WSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYFSSLYCNLLVYEYMPNG 617
K A++ D L +E+E + I +HKNI+ L + ++ EY G
Sbjct: 54 -----KSDATEKDLSDL----ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104
Query: 618 NLWDALH---------------KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDI 662
NL + L L A+ VA+G+ YL IHRD+
Sbjct: 105 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDL 161
Query: 663 KSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDV 722
+ N+L+ + K+ADFG+A+ + TT ++APE + T + DV
Sbjct: 162 AARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220
Query: 723 YSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQV 782
+SFGV+L E+ T + + + KEG +
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGV-PVEELFKLL------KEGHRMDKPSNCTNELYM----- 268
Query: 783 LRIAIRCTSKSPATRPTMNEVVQLL 807
+ C P+ RPT ++V+ L
Sbjct: 269 --MMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (425), Expect = 2e-47
Identities = 73/281 (25%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G GG V+ DL VAVK L R ++ + L+ + E + + H
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVL---RADLARDPSFYLRF----RREAQNAAALNH 66
Query: 592 KNIVKLYCYF----SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
IV +Y + +V EY+ L D +H + ++ Q L
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALN 125
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLA 707
+ H + IIHRD+K NI++ KV DFGIA+ + G + T + GT YL+
Sbjct: 126 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 708 PEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
PE A + DVYS G VL E++TG P D ++ Y V
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQH---VREDPIPPSAR 237
Query: 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-TMNEVVQLL 807
+ LS + ++ +K+P R T E+ L
Sbjct: 238 HEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADL 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 68/325 (20%), Positives = 116/325 (35%), Gaps = 56/325 (17%)
Query: 508 PYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK------IDLNSGEVVAVKKLWSQ 561
PYD + D+ ++ + +G+G G V + + VAVK L
Sbjct: 2 PYDASKW-EFPRDRLKLGK------PLGRGAFGQVIEADAFGIDKTATCRTVAVKML--- 51
Query: 562 RTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLY--CYFSSLYCNLLVYEYMPNGNL 619
K A+ ++ + L +E++ L +I H V +++ E+ GNL
Sbjct: 52 --KEGATHSEH----RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 105
Query: 620 WDALHK---------------GLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664
L L +F VA+G+ +L IHRD+ +
Sbjct: 106 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 162
Query: 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYS 724
NILL K+ DFG+A+ + ++APE + T + DV+S
Sbjct: 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 725 FGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLR 784
FGV+L E+ + ++ + KEG +
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEGTRMRAPDYTTPEMYQ------- 268
Query: 785 IAIRCTSKSPATRPTMNEVVQLLAE 809
+ C P+ RPT +E+V+ L
Sbjct: 269 TMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-45
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 33/279 (11%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI 589
++ +G G V D + ++VA+K + A + + ++ E+ L I
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKE----GSMENEIAVLHKI 64
Query: 590 RHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
+H NIV L + S L+ + + G L+D + + ++ F V + YL
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYL 123
Query: 650 HHGLLSPIIHRDIKSTNILL---DVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
H I+HRD+K N+L D + + ++DFG++K+ S + GT GY+
Sbjct: 124 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME----DPGSVLSTACGTPGYV 176
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEV 766
APE + D +S GV+ L+ G P + +N ++ +K + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF---YDENDAKLFEQILKAEYE------ 227
Query: 767 LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
D D +R K P R T + +Q
Sbjct: 228 FDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 2e-45
Identities = 56/271 (20%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G+GG G VY ++G++ A+K L K L + + +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCL----DKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
IV + F + + + M G+L L + V A + GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMH 124
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
+ +++RD+K NILLD + +++D G+A GT+GY+APE
Sbjct: 125 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-----KKKPHASVGTHGYMAPEV 176
Query: 711 AYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDK 769
A + D +S G +L +L+ G P +K+ I +++ + + L
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------LPD 230
Query: 770 KLSGSFRDEMIQVLRIAIRCTSKSPATRPTM 800
S R +++ + R
Sbjct: 231 SFSPELRS-LLE------GLLQRDVNRRLGC 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 39/278 (14%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR- 590
+G GG G+VY I ++ VA+K + K SD +L + EV L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 591 -HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYL 649
+++L +F +L+ E L + V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 650 HHGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
H+ ++HRDIK NIL+D+N + K+ DFG +L KD+ T GT Y P
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDGTRVYSPP 178
Query: 709 EY-AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767
E+ Y V+S G++L +++ G P F ++ II
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVF-----------F 223
Query: 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+++S + + C + P+ RPT E+
Sbjct: 224 RQRVSSECQH-------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 36/298 (12%)
Query: 514 FHRISFDQR-EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTD 571
F + + D + E ++G G V K + ++G A K + K +
Sbjct: 3 FRQENVDDYYDTGE------ELGSGQFAVVKKCREKSTGLQYAAKFI----KKRRTKSSR 52
Query: 572 QLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLD 631
+ + ++ EV L I+H N++ L+ + + +L+ E + G L+D L + L
Sbjct: 53 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLT 111
Query: 632 WPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD----VNYQPKVADFGIAKVLQ 687
+ + G+ YLH I H D+K NI+L + K+ DFG+A +
Sbjct: 112 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 688 ARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNK 747
+ I GT ++APE + D++S GV+ L++G P GD K
Sbjct: 169 ----FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL---GDTK 221
Query: 748 NIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
V+ + + S +D I+ R K P R T+ + +Q
Sbjct: 222 QETLANVSAVNYE--FEDEYFSNTSALAKD-FIR------RLLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (403), Expect = 3e-44
Identities = 47/289 (16%), Positives = 98/289 (33%), Gaps = 35/289 (12%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
++G+G G +++ +L + + VA+K + L+ E T +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE------------PRRSDAPQLRDEYRTYKLLAG 59
Query: 592 -KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
I +Y + N+LV + + G T A + + +H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH 118
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQP-----KVADFGIAKVLQARGGKDST----TTVIAG 701
+++RDIK N L+ V DFG+ K + K ++G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 702 TYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761
T Y++ + + + D+ + G V M + G P + Y ++ E
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE---RI--GE 230
Query: 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810
++L F +E + + + + P + + L ++
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-44
Identities = 63/274 (22%), Positives = 105/274 (38%), Gaps = 32/274 (11%)
Query: 531 KNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG-N 588
+G+G G V+ + + A+K L K D ++ E L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVEC---TMVEKRVLSLA 59
Query: 589 IRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAY 648
H + ++C F + V EY+ G+L + D A + GL +
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQF 118
Query: 649 LHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAP 708
LH I++RD+K NILLD + K+ADFG+ K D+ T GT Y+AP
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG---DAKTNTFCGTPDYIAP 172
Query: 709 EYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLD 768
E K D +SFGV+L E++ G+ P D + + + + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMD-------NPFYP 223
Query: 769 KKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+ L +D + ++ + P R +
Sbjct: 224 RWLEKEAKD-------LLVKLFVREPEKRLGVRG 250
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 8e-44
Identities = 55/284 (19%), Positives = 90/284 (31%), Gaps = 33/284 (11%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G G G +Y D+ +GE VA+K + L E + ++
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK------------TKHPQLHIESKIYKMMQG 61
Query: 592 KNIVK-LYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
+ + + N++V E + T +A + + Y+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH 120
Query: 651 HGLLSPIIHRDIKSTNIL---LDVNYQPKVADFGIAKVLQARGGKDST----TTVIAGTY 703
IHRD+K N L + DFG+AK + + GT
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 704 GYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763
Y + + + + D+ S G VLM G P + K Y E
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-----ISEKK 232
Query: 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLL 807
M + L + E L C S +P + + QL
Sbjct: 233 MSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-43
Identities = 65/326 (19%), Positives = 129/326 (39%), Gaps = 38/326 (11%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+ +G+G G V D + VA+KK+ S + + E++ L R
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKI---------SPFEHQTYCQRTLREIKILLRFR 64
Query: 591 HKNIVKLYCYFSSLYC----NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGL 646
H+NI+ + + ++ + ++ +L+ L HL + + +GL
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGL 122
Query: 647 AYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
Y+H + ++HRD+K +N+LL+ K+ DFG+A+V T T Y
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 707 APEYAYSSKATT-KCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765
APE +SK T D++S G +L E+++ R ++ + ++E +
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 766 VLDKK---------------LSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ---LL 807
+++ K + F + + L + + + +P R + + + L
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
Query: 808 AEADPCRFESCKFPNKSNKESSNATK 833
DP + P K + E + K
Sbjct: 300 QYYDPSDEPIAEAPFKFDMELDDLPK 325
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-43
Identities = 73/317 (23%), Positives = 116/317 (36%), Gaps = 35/317 (11%)
Query: 523 EILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKT 581
E L+ +G+G TVYK D N+ ++VA+KK+ K+ + +++
Sbjct: 1 EKLD------FLGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALR 49
Query: 582 EVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFG 641
E++ L + H NI+ L F LV+++M L L
Sbjct: 50 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-VLTPSHIKAYMLM 108
Query: 642 VAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAG 701
QGL YLH I+HRD+K N+LLD N K+ADFG+AK G + T
Sbjct: 109 TLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVV 162
Query: 702 TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDD------------FGDNKN 748
T Y APE + ++ D+++ G +L EL+ + D G
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222
Query: 749 IIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ--- 805
+ + L F +L + +P R T + ++
Sbjct: 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282
Query: 806 LLAEADPCRFESCKFPN 822
P PN
Sbjct: 283 FSNRPGPTPGCQLPRPN 299
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 9e-43
Identities = 67/296 (22%), Positives = 112/296 (37%), Gaps = 45/296 (15%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKG 578
D ++ +G G +G V + + + E A+K L Q
Sbjct: 11 DDYKVTS-----QVLGLGINGKVLQIFNKRTQEKFALKML---------------QDCPK 50
Query: 579 LKTEVETLGNI-RHKNIVKLYCYFSSLYCN----LLVYEYMPNGNLWDALHK-GLVHLDW 632
+ EVE + +IV++ + +LY L+V E + G L+ + G
Sbjct: 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110
Query: 633 PTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP---KVADFGIAKVLQAR 689
+I + + + YLH I HRD+K N+L K+ DFG AK
Sbjct: 111 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 165
Query: 690 GGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749
++ T T Y+APE K CD++S GV++ L+ G P F N +
Sbjct: 166 --SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGL 219
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+K + G E + + S +E+ ++R P R T+ E +
Sbjct: 220 AISPGMKTRIRMGQYEFPNPEWS-EVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (393), Expect = 1e-42
Identities = 64/275 (23%), Positives = 107/275 (38%), Gaps = 46/275 (16%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
+G G G V+ ++G A+K L +L+ + E L +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
H I++++ F ++ +Y+ G L+ L K + + A V L YLH
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH 121
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
II+RD+K NILLD N K+ DFG AK + T + GT Y+APE
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEV 172
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
+ D +SFG+++ E++ G P D M+ +K
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-------------------NTMKTYEKI 213
Query: 771 LSGSFR------DEMIQVLRIAIRCTSKSPATRPT 799
L+ R +++ +L R ++ + R
Sbjct: 214 LNAELRFPPFFNEDVKDLLS---RLITRDLSQRLG 245
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 3e-42
Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 39/302 (12%)
Query: 520 DQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGL 579
++ LE K+G+G G VYK N GE A+KK+ ++ + +
Sbjct: 2 EKYHGLE------KIGEGTYGVVYKAQNNYGETFALKKIRLEK--------EDEGIPSTT 47
Query: 580 KTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIA 639
E+ L ++H NIVKLY + +LV+E++ L L+ T
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFL 106
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVI 699
+ G+AY H ++HRD+K N+L++ + K+ADFG+A+ T I
Sbjct: 107 LQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEI 161
Query: 700 AGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDD-----------FGDNKN 748
+ S K +T D++S G + E++ G N
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 749 IIYWVSIKVDTKEGIMEVLDK-----KLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEV 803
W ++ K + + + I +L + P R T +
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278
Query: 804 VQ 805
++
Sbjct: 279 LE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 64/306 (20%), Positives = 116/306 (37%), Gaps = 37/306 (12%)
Query: 519 FDQR-EILEAMTEKNKVGQGGSGTVYK-IDL-NSGEVVAVKKLWSQRTKVSASDTDQLQL 575
DQ+ E + ++G+G G V+K DL N G VA+K++ +V +
Sbjct: 5 ADQQYECVA------EIGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLS 53
Query: 576 DKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN-----LLVYEYMPNGNLWDALHKGLVHL 630
+ L H N+V+L+ + + LV+E++ +
Sbjct: 54 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 113
Query: 631 DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
T + F + +GL +LH ++HRD+K NIL+ + Q K+ADFG+A++
Sbjct: 114 PTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--- 167
Query: 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV--EDDFGDNKN 748
T + T Y APE S T D++S G + E+ + D
Sbjct: 168 -FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226
Query: 749 IIY---------WVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT 799
I+ W ++ + + D + ++C + +PA R +
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286
Query: 800 MNEVVQ 805
+
Sbjct: 287 AYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 69/289 (23%), Positives = 111/289 (38%), Gaps = 29/289 (10%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+G+G G VYK + +GEVVA+KK+ DT+ + E+ L +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKI--------RLDTETEGVPSTAIREISLLKELN 59
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
H NIVKL + LV+E++ L + P F + QGLA+ H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPE- 709
++HRD+K N+L++ K+ADFG+A+ G T T T Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEI 173
Query: 710 YAYSSKATTKCDVYSFGVVLMELITGRKPVEDD-------------FGDNKNIIYWVSIK 756
+T D++S G + E++T R D ++ + V+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
D K + + S + + P R + +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 37/288 (12%)
Query: 516 RISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQ 574
+++ + + L+ +G+G G V + +G A+K L K D++
Sbjct: 1 KVTMNDFDYLK------LLGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVA 50
Query: 575 LDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPT 634
TE L N RH + L F + V EY G L+ L +
Sbjct: 51 H---TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEER 106
Query: 635 RHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDS 694
+ L YLH +++RDIK N++LD + K+ DFG+ K + G +
Sbjct: 107 ARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---A 160
Query: 695 TTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754
T GT YLAPE + D + GVV+ E++ GR P + ++ +
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHERLFELI 217
Query: 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+ + + + LS + ++ K P R
Sbjct: 218 LMEEIR------FPRTLSPEAKS-LLA------GLLKKDPKQRLGGGP 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 43/296 (14%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+G+G GTV+K + + E+VA+K++ D D + E+ L ++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV--------RLDDDDEGVPSSALREICLLKELK 59
Query: 591 HKNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLH 650
HKNIV+L+ S LV+E+ LD F + +GL + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
++HRD+K N+L++ N + K+A+FG+A+ + + +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVL 173
Query: 711 AYSSKATTKCDVYSFGVVLMELITGRKP---------------------VEDDFGDNKNI 749
+ +T D++S G + EL +P E+ + +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQ 805
+ + + + KL+ + RD ++Q +P R + E +Q
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRD-LLQ------NLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-39
Identities = 74/303 (24%), Positives = 112/303 (36%), Gaps = 49/303 (16%)
Query: 529 TEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG 587
T+ +G G G VY+ +SGE+VA+KK+ + + E++ +
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------------RFKNRELQIMR 68
Query: 588 NIRHKNIVKLYCYFSS------LYCNLLVYEYMPNGNLWDALH--KGLVHLDWPTRHKIA 639
+ H NIV+L +F S LV +Y+P A H + L
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 640 FGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGKDSTTTV 698
+ + + LAY+H I HRDIK N+LLD + K+ DFG AK L + +
Sbjct: 129 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSY 182
Query: 699 IAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN--KNII------ 750
I Y ++ T+ DV+S G VL EL+ G+ D G + II
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 751 ---YWVSIKVDTKEGIM-----EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+ + E K E I + R +P R T E
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLE 299
Query: 803 VVQ 805
Sbjct: 300 ACA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 45/317 (14%)
Query: 514 FHR--ISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDT 570
F+R ++ E+ + VG G G V +D +G VA+KKL
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--------YRPF 55
Query: 571 DQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS------LYCNLLVYEYMPNGNLWDALH 624
K E+ L ++RH+N++ L F+ LV +M G L
Sbjct: 56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM 113
Query: 625 KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684
K L + + + +GL Y+H + IIHRD+K N+ ++ + + K+ DFG+A+
Sbjct: 114 KH-EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169
Query: 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKP--VED 741
DS T T Y APE + + T D++S G ++ E+ITG+ D
Sbjct: 170 QA------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
Query: 742 DFGDNKNII---------YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI----R 788
K I+ + ++ D + M+ L + F + +A+ +
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283
Query: 789 CTSKSPATRPTMNEVVQ 805
R T E +
Sbjct: 284 MLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-36
Identities = 67/321 (20%), Positives = 115/321 (35%), Gaps = 36/321 (11%)
Query: 487 RRFSKQRAITEPDETLSSSFFP-YDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK- 544
++ S+Q ++ E F ++ S + DQ + ++ +G G G V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK------TLGTGSFGRVMLV 60
Query: 545 IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604
SG A+K L +L+ + E L + +VKL F
Sbjct: 61 KHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKS 664
+V EY+ G ++ L + P A + YLH +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 665 TNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYS 724
N+L+D +V DFG AK T + GT LAPE S D ++
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKR------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 725 FGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLR 784
GV++ E+ G P D I + S +D + +L+
Sbjct: 224 LGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVR-------FPSHFSSDLKDLLRNLLQ 274
Query: 785 IAIRCTSKSPATRPTMNEVVQ 805
+ + T + + +N++
Sbjct: 275 VDL--TKRFGNLKNGVNDIKN 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 60/301 (19%), Positives = 115/301 (38%), Gaps = 39/301 (12%)
Query: 532 NKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR 590
K+GQG G V+K +G+ VA+KK+ + K T E++ L ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--------ALREIKILQLLK 67
Query: 591 HKNIVKLYC--------YFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGV 642
H+N+V L Y LV+++ + + LV ++ +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQML 126
Query: 643 AQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQ-ARGGKDSTTTVIAG 701
GL Y+H + I+HRD+K+ N+L+ + K+ADFG+A+ A+ + + T
Sbjct: 127 LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 702 TYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760
T Y PE + D++ G ++ E+ T ++ + ++ + T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 761 EGIMEVLDKKLSGSFRDEMIQVLRIAI----------------RCTSKSPATRPTMNEVV 804
E V + +L Q ++ + PA R ++ +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 805 Q 805
Sbjct: 304 N 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-36
Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 33/292 (11%)
Query: 516 RISFDQREILEAMTEKNKVGQGGSGTVYK----IDLNSGEVVAVKKLWSQRTKVSASDTD 571
++ + E+L+ +G G G V+ ++G++ A+K L A T+
Sbjct: 20 KVGIENFELLK------VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 73
Query: 572 QLQLDKGLKTEVETLGNIRHK-NIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHL 630
+TE + L +IR +V L+ F + L+ +Y+ G L+ L +
Sbjct: 74 HT------RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---- 123
Query: 631 DWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARG 690
+ T H++ V + + L H II+RDIK NILLD N + DFG++K A
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183
Query: 691 GKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNII 750
+ + Y S D +S GV++ EL+TG P D KN
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQ 241
Query: 751 YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNE 802
+S ++ E +++S +D +IQ R K P R
Sbjct: 242 AEISRRILKSE---PPYPQEMSALAKD-LIQ------RLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 4e-34
Identities = 57/344 (16%), Positives = 122/344 (35%), Gaps = 58/344 (16%)
Query: 490 SKQRAITEPDETLSSSFFPYDVKSFHRISFDQREILEAMTEKNKVGQGGSGTVYK-IDLN 548
S+ R T+ + ++ Y+ + D +++ K+G+G V++ I++
Sbjct: 5 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVR------KLGRGKYSEVFEAINIT 58
Query: 549 SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSSLYCN 607
+ E V VK L + K +K E++ L N+R NI+ L
Sbjct: 59 NNEKVVVKILKPVK-------------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105
Query: 608 L--LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKST 665
LV+E++ N + L + + + L Y H I+HRD+K
Sbjct: 106 TPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPH 158
Query: 666 NILLDV-NYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVY 723
N+++D + + ++ D+G+A+ V + + PE + D++
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 214
Query: 724 SFGVVLMELITGRKP-------------VEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKK 770
S G +L +I ++P + G Y ++ ++L +
Sbjct: 215 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274
Query: 771 LSGSFRDEMIQVLRIAI---------RCTSKSPATRPTMNEVVQ 805
+ + + + + +R T E ++
Sbjct: 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-33
Identities = 63/316 (19%), Positives = 126/316 (39%), Gaps = 41/316 (12%)
Query: 513 SFHR--ISFDQREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASD 569
+F+R ++ E+ E + VG G G+V D +G VAVKKL +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--------SRP 54
Query: 570 TDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-----LYCNLLVYEYMPNGNLWDALH 624
+ K E+ L +++H+N++ L F+ + ++ + ++ +L + +
Sbjct: 55 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 625 KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684
L + + + +GL Y+H + IIHRD+K +N+ ++ + + K+ DFG+A+
Sbjct: 115 CQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169
Query: 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV--EDD 742
D T +A + D++S G ++ EL+TGR D
Sbjct: 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 743 FGDNKNII---------YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI----RC 789
K I+ I ++ ++ L + +F + I +A+ +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 790 TSKSPATRPTMNEVVQ 805
R T + +
Sbjct: 285 LVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-31
Identities = 64/327 (19%), Positives = 109/327 (33%), Gaps = 54/327 (16%)
Query: 514 FHRISFD--QREILEAMTEKNKVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDT 570
F+ + +L+ +G G G V D VA+KKL +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-----SRPFQNQ 57
Query: 571 DQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCN------LLVYEYMPNGNLWDALH 624
+ E+ + + HKNI+ L F+ LV E M
Sbjct: 58 THAKR---AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 114
Query: 625 KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684
LD + + + G+ +LH + IIHRD+K +NI++ + K+ DFG+A+
Sbjct: 115 ----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPV--EDD 742
G T T Y APE D++S G ++ E++ + D
Sbjct: 168 T----AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 743 FGDNKNII--------YWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAI------- 787
+I ++ T +E K +F L A
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283
Query: 788 ---------RCTSKSPATRPTMNEVVQ 805
+ PA R ++++ +Q
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 2e-30
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 9/220 (4%)
Query: 533 KVGQGGSGTVYK-IDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
K+G G TV+ D+ + VA+K + + A++ + L + + ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 592 KNIVKLYCYFSSLYCNL----LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLA 647
+I+KL +F+ N +V+E + L + +I+ + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 648 YLHHGLLSPIIHRDIKSTNILLDVN-YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYL 706
Y+H IIH DIK N+L+++ + IA + A + T I T Y
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI-QTREYR 196
Query: 707 APEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDN 746
+PE + D++S ++ ELITG E D G +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (251), Expect = 6e-24
Identities = 54/290 (18%), Positives = 101/290 (34%), Gaps = 16/290 (5%)
Query: 107 HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPK 166
+P ++ + L+L N+ + + NL L L + N +S P + L K
Sbjct: 24 KVPKDLP--PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 167 LRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
L L L N L + L + + V L Q + L + K S
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSS 139
Query: 227 GPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPH 286
G KL Y + + +P L +L + N + + L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 287 VSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS 346
++ + LS+NS S ++ N +L EL + N++ +P + + + L +N +S
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255
Query: 347 G------PIPSGIGNLKKLNLLMLQSNKLNSS--IPNSLSSLKSLNVLDL 388
P + + L SN + P++ + + L
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 1e-17
Identities = 50/285 (17%), Positives = 88/285 (30%), Gaps = 39/285 (13%)
Query: 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+ LDL NN T + + L L ++L
Sbjct: 31 PDTALLDLQNNKITE---------------------------IKDGDFKNLKNLHTLILI 63
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEE 136
+ P + + L L L+ N + L+ LR E +
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196
N + +L + SG + + KL +++ + +++ + +LT L L
Sbjct: 124 --NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHL 178
Query: 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256
N +T L + L L LS N +S + + L+ L N +P
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL-HLNNNKLVKVPGG 237
Query: 257 LARCKNLLRFRVSNNHLEG------SIPEGILSLPHVSIIDLSYN 295
LA K + + NN++ P S + L N
Sbjct: 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 1e-17
Identities = 57/283 (20%), Positives = 105/283 (37%), Gaps = 18/283 (6%)
Query: 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
++ L + N+ +L L L N I+ P L L +L L NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 128 QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN--NSLSGEISSVI 185
+PE++ +L + N ++ L ++ V++L SG +
Sbjct: 91 L--KELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 186 ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL 245
L+ + + D ++T +PQ L L L L NK++ A + L +
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 246 QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT- 304
N S V SLA +L ++NN L +P G+ ++ ++ L N+ S +N
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262
Query: 305 -----VGNARNLSELFMQRNQISGF-IPSEIYRAI-SLVKIDL 340
+ S + + N + + I +R + + L
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 22/116 (18%), Positives = 45/116 (38%)
Query: 309 RNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
+ + L +Q N+I+ + +L + L +N +S P L KL L L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSL 424
L +L+ L V + + + L +++ + + + SG +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 30/179 (16%), Positives = 62/179 (34%), Gaps = 14/179 (7%)
Query: 1 MSFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
F M+ L + +++ T + +L L + N K+ K+
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGN---KITKVD 187
Query: 61 ESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQ 120
+S+ L L + L+ ++ S+ N L +L L N + +P + K ++
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246
Query: 121 LELYYNQ-----QLAGTIPEELGNLTELTDLDMSVNHLS-GKIPESILR-LPKLRVLQL 172
+ L+ N P + + + N + +I S R + +QL
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 5e-23
Identities = 75/344 (21%), Positives = 126/344 (36%), Gaps = 27/344 (7%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
++ + NL +++ SNN T PL NLT L + N N + L +
Sbjct: 58 SIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGL 115
Query: 69 KLRIMVLATCALHGQIPA---------SIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR 119
L + + +I ++++L+ L G+ ++ L NL
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175
Query: 120 QLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179
LE + L LT L L + N +S P I L L L L N L
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD 233
Query: 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKL 239
+A+ T LT L L +N ++ P L + L L L N++S P +
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN 289
Query: 240 QYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
Q ++ KNL + N++ P + SL + + + N S
Sbjct: 290 LELNENQLED----ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
Query: 300 PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343
+++ N N++ L NQIS P + + ++ L+D
Sbjct: 344 V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.3 bits (220), Expect = 1e-19
Identities = 73/387 (18%), Positives = 131/387 (33%), Gaps = 53/387 (13%)
Query: 14 SPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNEN-----PGF----KLWKLPESSI 64
+ + + L + L NL ++F+ N KL + ++
Sbjct: 41 TDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 98
Query: 65 FRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELY 124
+ L I ++ L +L +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 125 YNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSV 184
+ T + L NLT L LD+S N +S + +L L L NN +S
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITPLG 216
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
I + L LSL N L L + L LDL+ N++S P
Sbjct: 217 ILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-------------- 258
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
L+ L ++ N + P + L ++ ++L+ N +
Sbjct: 259 ------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL--EDISP 302
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLML 364
+ N +NL+ L + N IS P + L ++ ++N +S S + NL +N L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 365 QSNKLNSSIPNSLSSLKSLNVLDLSNN 391
N+++ P L++L + L L++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.7 bits (208), Expect = 5e-18
Identities = 63/340 (18%), Positives = 124/340 (36%), Gaps = 29/340 (8%)
Query: 87 SIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146
+ + +LT + + N +T P + L L + + NQ T L NLT LT
Sbjct: 61 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118
Query: 147 DMSVNHLSGKIPESILRLPKLRVLQLY------------NNSLSGEISSVIANSTTLTML 194
+ + + + L +L + S +++ + + T+
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
L +S L + + L L + N++S P + + L + N
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--I 234
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
+LA NL ++NN + P L ++ + L N S +
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLA----GLTALT 288
Query: 315 FMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
++ N+ S I +L + L N +S P + +L KL L +NK+ S
Sbjct: 289 NLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDV 344
Query: 375 NSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNN 414
+SL++L ++N L +N ++ P + + + ++
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTPLANLTRI-TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.1 bits (204), Expect = 2e-17
Identities = 77/352 (21%), Positives = 137/352 (38%), Gaps = 35/352 (9%)
Query: 87 SIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146
S ++ +T L+ I + L NL Q+ NQ L P L NLT+L D+
Sbjct: 39 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ-LTDITP--LKNLTKLVDI 93
Query: 147 DMSVNHLSGKIPESILRLPKLR------VLQLYNNSLSGEISSVIANSTTLTMLSLYDNS 200
M+ N ++ P + L + + ++ + +S T++ +S
Sbjct: 94 LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGL 153
Query: 201 LTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV-------LQNMFSGVL 253
+ + Q + L L + + S + L N S +
Sbjct: 154 TSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT 213
Query: 254 PDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSE 313
P + NL ++ N L+ + SL +++ +DL+ N S + L+E
Sbjct: 214 PLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
Query: 314 LFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSI 373
L + NQIS P A++ ++++ + S I NLK L L L N ++
Sbjct: 268 LKLGANQISNISPLAGLTALTNLELNENQL----EDISPISNLKNLTYLTLYFNNISDIS 323
Query: 374 PNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--SINFSNNRLSGPIPLS 423
P +SSL L L +NN ++ SL L N ++ +N++S PL+
Sbjct: 324 P--VSSLTKLQRLFFANNKVSD--VSSLANL-TNINWLSAGHNQISDLTPLA 370
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 9e-12
Identities = 59/342 (17%), Positives = 113/342 (33%), Gaps = 47/342 (13%)
Query: 115 LKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174
L + L +L +T L + + + G + L L + N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVC 234
N L+ + N T L + + +N + P + L ++ PL
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 235 SRGKLQYFLVLQNMFSGVLPDSLARC-------------KNLLRFRVSNNHLEGSIPEGI 281
+ ++ + SL + R+ + + S +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 282 LSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLS 341
L ++ + + N S NL EL + NQ+ + +L +DL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 342 DNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSS--------------------LK 381
+N +S P + L KL L L +N++++ P + + LK
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 382 SLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLS 423
+L L L N ++ P S L + F+NN++S L+
Sbjct: 308 NLTYLTLYFNNISDISPVSSLTKL-QRLFFANNKVSDVSSLA 348
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 2e-08
Identities = 56/329 (17%), Positives = 104/329 (31%), Gaps = 66/329 (20%)
Query: 164 LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223
L + L +++ +S + +T L + + + L ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 224 KLSGPLPAKVCSR------------------GKLQYFLVLQNMFSGVLPDSLARCKNLLR 265
+L+ P K ++ + D L NL R
Sbjct: 77 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 266 FRVSNNHLEG-----------SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
+S+N + + G + +L+ +N V + L++L
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 315 FMQ------RNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK 368
NQIS P I +L ++ L+ N L + +L L L L +N+
Sbjct: 197 TNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 369 LNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--------------------- 407
+++ P LS L L L L N ++ P + L N
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 408 SINFSNNRLSGPIPLSLIKEGLVESFSGN 436
+ N +S P+S + + F+ N
Sbjct: 311 YLTLYFNNISDISPVSSLTKLQRLFFANN 339
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 27/201 (13%), Positives = 59/201 (29%), Gaps = 16/201 (7%)
Query: 532 NKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH 591
+G+G V+ VK T + D
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 592 KNIVKLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHK-IAFGVAQGLAYLH 650
+ + KL VY + N L + + ++ + + + +A +
Sbjct: 66 RALQKLQG-----LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 651 HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEY 710
H I+H D+ N+L+ + DF + + G ++ + Y + Y
Sbjct: 121 H---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176
Query: 711 AYSSKATTKCDVYSFGVVLME 731
+ D+ S +++
Sbjct: 177 RT------EKDINSAIDRILQ 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.4 bits (225), Expect = 1e-20
Identities = 72/268 (26%), Positives = 113/268 (42%), Gaps = 5/268 (1%)
Query: 138 GNLTELTDLDMSVNHLSGK--IPESILRLPKLRVLQLYNN-SLSGEISSVIANSTTLTML 194
+ +LD+S +L IP S+ LP L L + +L G I IA T L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 195 SLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254
+ +++G +P L Q LV LD S N LSG LP + S L N SG +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
DS L + + + +++ +DLS N G + G+ +N ++
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQK 225
Query: 315 FMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
F ++ + +L +DL +N + G +P G+ LK L+ L + N L IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 375 NSLSSLKSLNVLDLSNNLLTGYIPESLC 402
+L+ +V +NN P C
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.3 bits (204), Expect = 8e-18
Identities = 70/289 (24%), Positives = 117/289 (40%), Gaps = 26/289 (8%)
Query: 87 SIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDL 146
+ + +L+L+G + P IP L NL L L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYP-----------------------IPSSLANLPYLNFL 81
Query: 147 DMSVNH-LSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEV 205
+ + L G IP +I +L +L L + + ++SG I ++ TL L N+L+G +
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 206 PQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLR 265
P + LV + N++SG +P S KL + + NL
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF 201
Query: 266 FRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFI 325
+S N LEG S + I + VG ++NL+ L ++ N+I G +
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIH-LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 326 PSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
P + + L +++S N L G IP G GNL++ ++ +NK P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 2e-16
Identities = 61/282 (21%), Positives = 107/282 (37%), Gaps = 28/282 (9%)
Query: 163 RLPKLRVLQLYNNSLSG--EISSVIANSTTLTMLSLYDN-SLTGEVPQDLGQWSPLVVLD 219
+ ++ L L +L I S +AN L L + +L G +P + + + L L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 220 LSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPE 279
++ +SG +P + L N SG LP S++ NL+ N + G+IP+
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 280 GILSLPH-VSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKI 338
S + + +S N +G I T N + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 339 DLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIP 398
++ +G K LN L L++N++ ++P L+ LK L+ L++S N L G IP
Sbjct: 228 LAKNS--LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 399 ESLCELLPNSINFSNNRLSGPIPLSLIKEGLVESFSGNPGLC 440
+ N +S +++ N LC
Sbjct: 286 QGG--------NLQRFDVS--------------AYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 4e-13
Identities = 63/282 (22%), Positives = 101/282 (35%), Gaps = 31/282 (10%)
Query: 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLAT 77
+ LDLS +P+ SS+ L L + +
Sbjct: 51 RVNNLDLSGLNLPKPYPIP-------------------------SSLANLPYLNFLYIGG 85
Query: 78 CA-LHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEE 136
L G IP +I +T L L +T ++G IP + +K L L+ YN +GT+P
Sbjct: 86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL-SGTLPPS 144
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILRLPKLRV-LQLYNNSLSGEISSVIANSTTLTMLS 195
+ +L L + N +SG IP+S KL + + N L+G+I AN +
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
+ + + + + L + N G LP
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK--NLNGLDLRNNRIYGTLPQ 262
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSF 297
L + K L VS N+L G IP+G +L + + N
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 37/167 (22%), Positives = 60/167 (35%), Gaps = 6/167 (3%)
Query: 11 PDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKL 70
P S + NL + N +G P S + + L P +
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN---- 198
Query: 71 RIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLA 130
V + + + + T ++GL KNL L+L N+ +
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR-IY 257
Query: 131 GTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177
GT+P+ L L L L++S N+L G+IP+ L + V NN
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 0.001
Identities = 37/139 (26%), Positives = 67/139 (48%), Gaps = 3/139 (2%)
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEG--SIPEGILSLPHVSIIDLSYN-SFSGPIANTV 305
+ GVL D+ + + +S +L IP + +LP+++ + + + GPI +
Sbjct: 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
L L++ +SG IP + + +LV +D S N LSG +P I +L L +
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 366 SNKLNSSIPNSLSSLKSLN 384
N+++ +IP+S S L
Sbjct: 158 GNRISGAIPDSYGSFSKLF 176
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (215), Expect = 1e-19
Identities = 49/265 (18%), Positives = 86/265 (32%), Gaps = 7/265 (2%)
Query: 132 TIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTL 191
+P + + + N +S S L +L L++N L+ ++ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 192 TMLSLYDNSLTGEV-PQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFS 250
L L DN+ V P L L L L P LQY + N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
+ D+ NL + N + L + + L N + + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 311 LSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN 370
L L++ N +S + +L + L+DN + L S+++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 371 SSIPNSLSSLKSLNVLDLSNNLLTG 395
S+P L ++ L+ N L G
Sbjct: 262 CSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 3e-18
Identities = 50/265 (18%), Positives = 80/265 (30%), Gaps = 6/265 (2%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTE 142
+P I + + L GN I+ +NL L L+ N G
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 143 LTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202
L P + L +L L L L + L L L DN+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 203 GEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKN 262
L L L N++S L L+ QN + V P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 263 LLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQIS 322
L+ + N+L E + L + + L+ N + L + +++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVP 261
Query: 323 GFIPSEIYRAISLVKIDLSDNLLSG 347
+P + L L+ N L G
Sbjct: 262 CSLPQRL-AGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 5e-18
Identities = 52/291 (17%), Positives = 90/291 (30%), Gaps = 32/291 (10%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
+P P +R+ L N + S NL + + +
Sbjct: 25 AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTI--LWLHSNVLARIDAAAFTGLAL 81
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQ 128
++ + L PA+ + L L L + P L L+ L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN-A 140
Query: 129 LAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANS 188
L + +L LT L + N +S + L L L L+ N ++ +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 189 TTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNM 248
L L L+ N+L+ + L L L L++N +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--------ARPLW----- 247
Query: 249 FSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
L +FR S++ + S+P+ L + L+ N G
Sbjct: 248 ------------AWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (140), Expect = 8e-10
Identities = 51/258 (19%), Positives = 80/258 (31%), Gaps = 31/258 (12%)
Query: 187 NSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ 246
+ S L VP + + L N++S
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISH------------------- 46
Query: 247 NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI-ANTV 305
V S C+NL + +N L L + +DLS N+ + T
Sbjct: 47 -----VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
L L + R + P +L + L DN L +L L L L
Sbjct: 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSI--NFSNNRLSGPIPLS 423
N+++S + L SL+ L L N + P + +L F+NN + P
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 424 LIKEGLVE-SFSGNPGLC 440
L + NP +C
Sbjct: 222 APLRALQYLRLNDNPWVC 239
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 9e-10
Identities = 34/186 (18%), Positives = 49/186 (26%), Gaps = 19/186 (10%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
LP P ++ L LS NL ++ T L L+ + KL +
Sbjct: 24 ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 69 KLRIMVLATCALHGQ-----------------IPASIGNVTSLTDLELTGNFITGHIPPE 111
L L + L GQ +P +PP
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142
Query: 112 IGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171
+ + N L L L L L + N L IP+ L
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 172 LYNNSL 177
L+ N
Sbjct: 202 LHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 40/233 (17%), Positives = 72/233 (30%), Gaps = 32/233 (13%)
Query: 185 IANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244
++ + ++ +LT +P DL + +L LSEN L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYT----------------- 45
Query: 245 LQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
+L L + + L +G L + + + + T
Sbjct: 46 -------FSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQT 98
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLML 364
+ L + N+++ + L ++ L N L P + KL L L
Sbjct: 99 LPALTVL---DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 365 QSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLP-NSINFSNNRL 416
+N L L+ L++L+ L L N L IP+ N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 40/187 (21%), Positives = 62/187 (33%), Gaps = 23/187 (12%)
Query: 83 QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTE 142
+P + T L L+ N + + L QL L + + L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 143 LT--------------------DLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEIS 182
L LD+S N L+ ++ L +L+ L L N L
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 183 SVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYF 242
++ + L LSL +N+LT L L L L EN L +P L +
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200
Query: 243 LVLQNMF 249
+ N +
Sbjct: 201 FLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 34/277 (12%), Positives = 87/277 (31%), Gaps = 16/277 (5%)
Query: 144 TDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTG 203
LD++ +L + +L + + + + ++ + + + L ++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
Query: 204 E-VPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP-------- 254
+ L Q S L L L +LS P+ + L +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSEL 314
L F + H++ ++ ++ +++ N ++ V NL L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 315 FMQRN-QISGFIPSEIYRAISLVKIDLSD-NLLSGPIPSGIGNLKKLNLLMLQSNKLNSS 372
+ + + E ++ L + LS + +G + L L + + +
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 373 IPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSI 409
+ +L L + + + T ++ I
Sbjct: 241 LQLLKEALPHLQI---NCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 50/302 (16%), Positives = 89/302 (29%), Gaps = 40/302 (13%)
Query: 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCA 79
+ LDL+ P L + V++F F L E F +++ M L+
Sbjct: 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH--FSPFRVQHMDLSNSV 57
Query: 80 LHG-QIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEE-- 136
+ + + + L +L L G ++ I + NL +L L + +
Sbjct: 58 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 137 --LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTML 194
L EL + L L + + S + L
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 195 SLYDNS----LTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFS 250
D S L + Q+ Q + L L LS
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC-----------------------YDII 214
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
L L +V +G++ +LPH + ++ + F+ T+GN +N
Sbjct: 215 PETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKN 271
Query: 311 LS 312
Sbjct: 272 QE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 37/268 (13%), Positives = 80/268 (29%), Gaps = 39/268 (14%)
Query: 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSG 251
L L +L +V L ++ + + PL + S ++Q+ + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 252 V-LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
L L++C L + L I + ++ ++LS S A +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 311 LSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSG----------------------- 347
+ + F + A++ V ++ LSG
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 348 ----------PIPSGIGNLKKLNLLMLQS-NKLNSSIPNSLSSLKSLNVLDLSNNLLTGY 396
L L L L + L + +L L + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 397 IPESLCELLPNSINFSNNRLSGPIPLSL 424
+ + L E LP+ + + + + ++
Sbjct: 241 L-QLLKEALPH-LQINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 7e-05
Identities = 31/205 (15%), Positives = 61/205 (29%), Gaps = 9/205 (4%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENP-----GFKLWKLPESSIFRL 67
S L+ L L + ++ +NL L+ + + S + L
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 68 TKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127
+ + +T L N + + NL L+L +
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 128 QLAGTIPEELGNLTELTDLDMS-VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIA 186
L +E L L L +S + + + +P L+ LQ++ G + +
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 187 NSTTLTMLSLYDNSLTGEVPQDLGQ 211
L L + + T +G
Sbjct: 247 A---LPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 39/267 (14%), Positives = 81/267 (30%), Gaps = 38/267 (14%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
+ L + ++ +DLSN++ + +
Sbjct: 35 MDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILS-------------------------- 68
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELT--GNFITGHIPPEIGLLKNLRQLEL 123
+ +KL+ + L L I ++ ++L L L+ F + + L +L L
Sbjct: 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 128
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQL------YNNSL 177
+ + T ++++ + +S L R L + L
Sbjct: 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 188
Query: 178 SGEISSVIANSTTLTMLSLYD-NSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSR 236
+ L LSL + E +LG+ L L + G L +
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL 248
Query: 237 GKLQYFLVLQNMFSGVLPDSLARCKNL 263
LQ + + F+ + ++ KN
Sbjct: 249 PHLQ---INCSHFTTIARPTIGNKKNQ 272
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.8 bits (133), Expect = 3e-09
Identities = 29/227 (12%), Positives = 79/227 (34%), Gaps = 18/227 (7%)
Query: 164 LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSEN 223
L + ++++ ++ A+ +T LS + +T + + + L+ L+L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 224 KLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILS 283
+++ P K ++ + + L + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 284 LPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343
L + + +G ++ + + L + DN
Sbjct: 134 LYLDLNQITNISPLAGLTNLQ----------YLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390
+S P + +L L + L++N+++ P L++ +L ++ L+N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 4e-06
Identities = 37/203 (18%), Positives = 67/203 (33%), Gaps = 17/203 (8%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
+T T+ + + + L T + L NL L +N L L +
Sbjct: 31 VTDTVT-QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQITDLAPLKNLTKI 87
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI----------GLL 115
+L L + + + + T + + L
Sbjct: 88 TELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPL 147
Query: 116 KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175
L L+ + L NL++LT L N +S P + LP L + L NN
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNN 205
Query: 176 SLSGEISSVIANSTTLTMLSLYD 198
+S +AN++ L +++L +
Sbjct: 206 QISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 28/218 (12%), Positives = 68/218 (31%), Gaps = 22/218 (10%)
Query: 139 NLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYD 198
L + ++++ + ++ L + L + ++ I + L L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 199 NSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQ------------ 246
N +T P + L + K + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 247 --NMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304
+ + + +S + + S + +L ++ + N S
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSD 342
+ + NL E+ ++ NQIS P + +L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 30/218 (13%), Positives = 62/218 (28%), Gaps = 23/218 (10%)
Query: 90 NVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149
+ + + + +T + L + L + T E + L L L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV---TTIEGVQYLNNLIGLELK 71
Query: 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYD----------- 198
N ++ P L L I+ + + T +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 199 ---NSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
++ + LS + + KL N S + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLS 293
LA NL+ + NN + P + + ++ I+ L+
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 10/96 (10%)
Query: 315 FMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIP 374
N S I S SL ++++S+N L +P+ L++L N L + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHL-AEVP 320
Query: 375 NSLSSLKSLNVLDLSNNLLTG--YIPESLCELLPNS 408
+LK L + N L IPES+ +L NS
Sbjct: 321 ELPQNLKQ---LHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 10/90 (11%)
Query: 102 NFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI 161
N + I L +L +L + N+ + +P L L S NHL+ ++PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI--ELPALPPRLER---LIASFNHLA-EVPEL- 322
Query: 162 LRLPKLRVLQLYNNSLSGEISSVIANSTTL 191
L+ L + N L E + + L
Sbjct: 323 --PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 21/117 (17%), Positives = 39/117 (33%), Gaps = 33/117 (28%)
Query: 269 SNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSE 328
N I P + +++S N +P+
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-------------------------LPAL 302
Query: 329 IYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNV 385
R L ++ S N L+ +P NLK+L+ ++ N L P+ S++ L +
Sbjct: 303 PPR---LERLIASFNHLAE-VPELPQNLKQLH---VEYNPL-REFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 10/89 (11%)
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISS 183
YY + I L +L++S N L ++P P+L L N L+ E+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321
Query: 184 VIANSTTLTMLSLYDNSLTG--EVPQDLG 210
+ N L L + N L ++P+ +
Sbjct: 322 LPQN---LKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 18/80 (22%), Positives = 33/80 (41%), Gaps = 10/80 (12%)
Query: 64 IFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLEL 123
L + ++ L ++PA L L + N + +P L +NL+QL +
Sbjct: 280 CDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE---LPQNLKQLHV 331
Query: 124 YYNQQLAGTIPEELGNLTEL 143
YN L P+ ++ +L
Sbjct: 332 EYN-PLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 9/94 (9%)
Query: 196 LYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255
Y N+ + E+ L L++S NKL LPA +L+ + N + +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAE-VPE 321
Query: 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSI 289
+NL + V N L P+ S+ + +
Sbjct: 322 LP---QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 36/107 (33%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRI 72
+L L++SNN + P L L + SFN L
Sbjct: 280 CDLPPSLEELNVSNNKLI-ELPALPPRLERL-IASFN----------------HLA---- 317
Query: 73 MVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLR 119
++P N L L + N + P +++LR
Sbjct: 318 ----------EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 49/304 (16%), Positives = 89/304 (29%), Gaps = 22/304 (7%)
Query: 114 LLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY 173
L + +LEL ++PE +L L S N L+ ++PE L L V
Sbjct: 36 LDRQAHELELNNLG--LSSLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNN 89
Query: 174 NNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKV 233
+LS L S Q S + + +N LP
Sbjct: 90 LKALSDLPPL----------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139
Query: 234 CSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLS 293
S + + + E I++ ++
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 294 YNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI 353
+ N + + + + + + + L+ +S I SG+
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 354 GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSN 413
L + S+ S+ + SL+ L++SNN L +P L + S
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLE---ELNVSNNKLI-ELPALPPRL--ERLIASF 313
Query: 414 NRLS 417
N L+
Sbjct: 314 NHLA 317
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 4e-09
Identities = 14/81 (17%), Positives = 30/81 (37%), Gaps = 5/81 (6%)
Query: 333 ISLVKIDLSDNLLS-GPIPSGIGNLKKLNLLMLQSNKLN----SSIPNSLSSLKSLNVLD 387
+ + +D+ LS + L++ ++ L L I ++L +L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 388 LSNNLLTGYIPESLCELLPNS 408
L +N L + + L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTP 82
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 1e-08
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 10/90 (11%)
Query: 142 ELTDLDMSVNHLSGKIPESIL-RLPKLRVLQLYNNSLSGE----ISSVIANSTTLTMLSL 196
++ LD+ LS +L L + +V++L + L+ ISS + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 197 YDNSLTGEVPQDLGQW-----SPLVVLDLS 221
N L + Q + L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 9/82 (10%)
Query: 139 NLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQLYNNSLSGEISSVIA-----NST 189
+ L L ++ +S + ++L LR L L NN L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 190 TLTMLSLYDNSLTGEVPQDLGQ 211
L L LYD + E+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 6e-07
Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 9/92 (9%)
Query: 117 NLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQL 172
+++ L++ + E L L + + + L+ I ++ P L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 173 YNNSLSGEISSVIA-----NSTTLTMLSLYDN 199
+N L + S + LSL +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 8e-07
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 15/97 (15%)
Query: 355 NLKKLNLLMLQSNKLN----SSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN--- 407
L +L L ++ SS+ +L + SL LDLSNN L L E +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 408 ---SINFSNNRLSGPIPLSLIKEGLVESFSGNPGLCV 441
+ + S + L + L + P L V
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL--QALEKD---KPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 4/91 (4%)
Query: 93 SLTDLELTGNFITGHIPPEI-GLLKNLRQLELYYNQ---QLAGTIPEELGNLTELTDLDM 148
+ L++ ++ E+ LL+ + + L I L L +L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 149 SVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179
N L +L+ + ++ SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 13/78 (16%), Positives = 31/78 (39%), Gaps = 9/78 (11%)
Query: 355 NLKKLNLLMLQSNKLNSS-IPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPN-----S 408
+++ L++ Q +L+ + L L+ V+ L + LT + + L
Sbjct: 3 DIQSLDI---QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 409 INFSNNRLSGPIPLSLIK 426
+N +N L +++
Sbjct: 60 LNLRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 9e-06
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 12/92 (13%)
Query: 116 KNLRQLELYYNQ---QLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILR-----LPKL 167
LR L L ++ L L +LD+S N L ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 168 RVLQLYNNSLSGEISSVIA----NSTTLTMLS 195
L LY+ S E+ + + +L ++S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 290 IDLSYNSFS-GPIANTVGNARNLSELFMQRNQISGFIPSEIYRAI----SLVKIDLSDNL 344
+D+ S A + + + + ++ +I A+ +L +++L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 345 LSGPIPSGIGNLKKLNLLMLQSNKLNS 371
L + + +Q L +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 307 NARNLSELFMQRNQISGFIPSEIYRAI----SLVKIDLSDNLLSGPIPSGIG-----NLK 357
L L++ +S S + + SL ++DLS+N L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 358 KLNLLMLQSNKLNSSIPNSLSSLKSLN 384
L L+L + + + L +L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 16/105 (15%), Positives = 30/105 (28%), Gaps = 23/105 (21%)
Query: 260 CKNLLRFRVSNNHLEG----SIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELF 315
L +++ + S+ +L+ + +DLS N L E
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG------ILQLVESV 421
Query: 316 MQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLN 360
Q L ++ L D S + + L+K
Sbjct: 422 RQPG-------------CLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 13/108 (12%), Positives = 34/108 (31%), Gaps = 26/108 (24%)
Query: 18 NLRRLDLSNNLFTGQFPLSVF-NLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLA 76
+++ LD+ + + L +V+ ++ L E+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC------GLTEARC------------ 44
Query: 77 TCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEI--GLLKNLRQLE 122
I +++ +L +L L N + + GL +++
Sbjct: 45 -----KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 5e-08
Identities = 29/122 (23%), Positives = 54/122 (44%), Gaps = 8/122 (6%)
Query: 289 IIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGP 348
++ L++ + + ++ L + N++ P+ + L + SDN +
Sbjct: 2 VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDN--ALE 56
Query: 349 IPSGIGNLKKLNLLMLQSNKLNS-SIPNSLSSLKSLNVLDLSNNLLTG--YIPESLCELL 405
G+ NL +L L+L +N+L + L S L +L+L N L I E L E+L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 406 PN 407
P+
Sbjct: 117 PS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 8/115 (6%)
Query: 84 IPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTEL 143
+ + + +T L+L+ N + P L LR LE+ A + + NL L
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENVDGVANLPRL 67
Query: 144 TDLDMSVNHL-SGKIPESILRLPKLRVLQLYNNSLSGE---ISSVIANSTTLTML 194
+L + N L + ++ P+L +L L NSL E + +++ +
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 7/109 (6%)
Query: 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGK 156
L L +T + + L + L+L +N+ +P L L L L S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL--RALPPALAALRCLEVLQASDNA--LE 56
Query: 157 IPESILRLPKLRVLQLYNNSL-SGEISSVIANSTTLTMLSLYDNSLTGE 204
+ + LP+L+ L L NN L + + L +L+L NSL E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 16/114 (14%), Positives = 32/114 (28%), Gaps = 5/114 (4%)
Query: 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLT 68
L + + LDLS+N P ++ L L + +
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCL----EVLQASDNALENVDGVANLPR 66
Query: 69 KLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLE 122
+++ + + L L L GN + + L + L +
Sbjct: 67 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 4/107 (3%)
Query: 193 MLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGV 252
+L L LT V L Q + LDLS N+L PA + + L+ N V
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 253 LPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG 299
+ L +N + + + ++S P + +++L NS
Sbjct: 59 DGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.4 bits (121), Expect = 2e-07
Identities = 39/323 (12%), Positives = 99/323 (30%), Gaps = 35/323 (10%)
Query: 116 KNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGK----IPESILRLPKLRVLQ 171
K+L+ + ++ L + ++ +S N + + + E+I L + +
Sbjct: 8 KSLKLDAITTED--EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65
Query: 172 LYNNSL----------SGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLS 221
+ + + L + L DN+ + L +
Sbjct: 66 FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125
Query: 222 ENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD--SLARCKNLLRFRVSNNHLEGSIPE 279
+ L + ++ + N + P S+ +N L +
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185
Query: 280 GILSLPHVSIIDLSYNSFSGPIANTVGNARNL----SELFMQRNQISGFIPSEIYRAISL 335
+L + + + + + L + + S + + +L
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 336 VKIDLSDNLLSGPIPSGIGN------LKKLNLLMLQSNKLNSSIPNSLSS-----LKSLN 384
++ L+D LLS + + + L L LQ N++ +L + + L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 385 VLDLSNNLLT--GYIPESLCELL 405
L+L+ N + + + + E+
Sbjct: 306 FLELNGNRFSEEDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 41/307 (13%), Positives = 91/307 (29%), Gaps = 31/307 (10%)
Query: 83 QIPASIGNVTSLTDLELTGNFITG----HIPPEIGLLKNLRQLELYYNQ--QLAGTIPEE 136
+ A + S+ ++ L+GN I + I K+L E ++ IPE
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 137 LGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSL 196
L L + ++ + + + L ++ + +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 197 YDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVL----------- 245
V + PL + N+L + + L
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 246 --QNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIAN 303
+++ L L+ + ++ + S P++ + L+ S A
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 304 TVGNA------RNLSELFMQRNQISGFIPSEIYRAI-----SLVKIDLSDNLLSGPIPSG 352
V +A L L +Q N+I + I L+ ++L+ N S
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDV 320
Query: 353 IGNLKKL 359
+ ++++
Sbjct: 321 VDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 12/62 (19%), Positives = 21/62 (33%), Gaps = 1/62 (1%)
Query: 357 KKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRL 416
K L L + + S+ L S+ + LS N + L E + + +
Sbjct: 8 KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 417 SG 418
S
Sbjct: 67 SD 68
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.4 bits (116), Expect = 3e-07
Identities = 32/186 (17%), Positives = 71/186 (38%), Gaps = 8/186 (4%)
Query: 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGK-LQYFLVLQNMFS 250
T + L E+P+D+ L L++N+L + R L + +N +
Sbjct: 11 TTVDCTGRGLK-EIPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 251 GVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARN 310
G+ P++ ++ ++ N ++ + L L + ++L N S + + + +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 311 LSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN 370
L+ L + N + + L K L+ PS ++ + + L ++
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAE-WLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183
Query: 371 SSIPNS 376
S NS
Sbjct: 184 CSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 41/214 (19%), Positives = 72/214 (33%), Gaps = 31/214 (14%)
Query: 93 SLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNH 152
T ++ TG + IP +I L + +L L N+ + G L L L++ N
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 153 LSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQW 212
L+G P + ++ LQL N + + + L L+LYDN ++ +P
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 213 SPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNH 272
+ L L L + + L + ++
Sbjct: 126 NSL-------------------------TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGA 160
Query: 273 LEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVG 306
P + V I DL ++ F N+ G
Sbjct: 161 ARCGAPS---KVRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 5e-06
Identities = 25/147 (17%), Positives = 49/147 (33%), Gaps = 9/147 (6%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
L ++ R LDL L + + F++N ++ KL
Sbjct: 7 LIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN---EIRKLDGFP-- 60
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITG-HIPPEIGLLKNLRQLELY 124
L +L+ +++ + + LT+L LT N + + LK+L L +
Sbjct: 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 120
Query: 125 YN--QQLAGTIPEELGNLTELTDLDMS 149
N + + ++ LD
Sbjct: 121 RNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 14/66 (21%), Positives = 26/66 (39%), Gaps = 3/66 (4%)
Query: 340 LSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPE 399
L+ L+ + N + L L+ K+ I N ++L + +D S+N +
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 400 SLCELL 405
L L
Sbjct: 60 PLLRRL 65
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 7e-06
Identities = 26/171 (15%), Positives = 56/171 (32%), Gaps = 14/171 (8%)
Query: 14 SPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIM 73
+ + ++ ++ +N+ + L N+ L N N + L L
Sbjct: 43 NELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN 100
Query: 74 VLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKN----------LRQLEL 123
+ + + + + + L N L +L+
Sbjct: 101 KVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDT 160
Query: 124 YYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174
+ + L LT+L +L +S NH+S ++ L L VL+L++
Sbjct: 161 LSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 36/224 (16%), Positives = 82/224 (36%), Gaps = 20/224 (8%)
Query: 171 QLYNNSLSG--EISSVI--ANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226
L + +++ I + +L S+T V Q+ + + + + + + +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 227 GPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPH 286
+ + + N + + P + + L + S+
Sbjct: 60 SVQGIQYLP--NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLK------DL 111
Query: 287 VSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLS 346
+ LS N + + L L++ N+I+ + + ++ DN +S
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQIS 169
Query: 347 GPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSN 390
+P + L KL L L N + S + +L+ LK+L+VL+L +
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHI-SDLR-ALAGLKNLDVLELFS 209
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 5e-05
Identities = 34/228 (14%), Positives = 73/228 (32%), Gaps = 7/228 (3%)
Query: 168 RVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSG 227
RV + ++ EI S + L L + L +++S+N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 228 PLPAKVCSRGKLQYFLVLQNMFSGVL--PDSLARCKNLLRFRVSNNHLEGSIPEGILSLP 285
+ A V S + + ++ + + P++ NL +SN ++ +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 286 HVSIIDLSY--NSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDN 343
++D+ N + + VG + L++ +N I +N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 344 LLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391
L +L + +++S L +LK L N
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 9/44 (20%), Positives = 14/44 (31%)
Query: 133 IPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176
+ + LD+S + + L KLR YN
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 30/234 (12%), Positives = 63/234 (26%), Gaps = 10/234 (4%)
Query: 146 LDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEV 205
+ ++ +IP + L+ L + L + + N + +
Sbjct: 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 206 PQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFS----GVLPDSLARCK 261
D+ P + E + + +L + + + K
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 262 NLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQI 321
LL + + N + I+ L+ N + N +
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 322 SGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPN 375
+ A V +D+S + G+ NLKKL + K +P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 12/48 (25%), Positives = 14/48 (29%), Gaps = 5/48 (10%)
Query: 13 FSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLP 60
F LD+S + NL L S L KLP
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-----NLKKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 9e-04
Identities = 33/232 (14%), Positives = 66/232 (28%), Gaps = 8/232 (3%)
Query: 190 TLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMF 249
+ + ++ +T E+P DL + L KL G L+ + QN
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 250 SGVLPDSLARCKNL----LRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTV 305
V+ + + +N L +I + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 306 GNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQ 365
+ L ++ N + S + + V + L+ N + + L +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 366 SNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLS 417
+N L + +LD+S + +P E L S L
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLK 236
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 9e-05
Identities = 31/146 (21%), Positives = 52/146 (35%), Gaps = 3/146 (2%)
Query: 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVN 151
+ L T + + +NL +L + Q L +L L EL +L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 152 HLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT-GEVPQDLG 210
L P++ P+L L L N+L +S +L L L N L + L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 211 QWSPLVVLDLSENKLSGPLPAKVCSR 236
+W + + E KL +
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 20/152 (13%), Positives = 47/152 (30%), Gaps = 5/152 (3%)
Query: 259 RCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPI-ANTVGNARNLSELFMQ 317
R + + + +++ + + + + L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 318 RNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLN-SSIPNS 376
++ + P + L +++LS N L + L L+L N L+ S
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 377 LSSLKSLNVLDLSNNLLTGYIPESLCELLPNS 408
L + + + L + L +PN+
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAH-MPNA 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 8e-04
Identities = 26/139 (18%), Positives = 48/139 (34%), Gaps = 6/139 (4%)
Query: 107 HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPK 166
+ + + Q L +L L+ + ++ + +P+
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL---RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPE 66
Query: 167 LRVLQLYNNSLSG--EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENK 224
L L L NN L ++SS++ + L +L+L N L E D + L L L N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 225 LSGPLPAKVCSRGKLQYFL 243
LS + ++
Sbjct: 127 LSDTFRDQSTYISAIRERF 145
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 30/177 (16%), Positives = 52/177 (29%), Gaps = 19/177 (10%)
Query: 6 LTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIF 65
+T T+ + + + L + L NL ++F+ N + L +
Sbjct: 30 VTDTVS-QTDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNNQLTDITPLKNLTKL 86
Query: 66 RLTKLRIMVLATCALHGQIPASIGNVTS------------LTDLELTGNFITGHIPPEIG 113
+ +A + G LT+L
Sbjct: 87 VDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISAL 146
Query: 114 LLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVL 170
Q + + Q+ P L NLT L LD+S N +S + +L L L
Sbjct: 147 SGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 840 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.65 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.34 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=415.71 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=197.2
Q ss_pred hcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCcc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYC 606 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 606 (840)
+|+..+.||+|+||+||+|.+.+++.||||++.... ...+.|.+|++++++++|||||+++|+|.+.+.
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-----------CcHHHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 467788999999999999999889999999985322 113568999999999999999999999999999
Q ss_pred ceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhh
Q 003199 607 NLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVL 686 (840)
Q Consensus 607 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 686 (840)
.++||||+++|+|.+++......++|..+..++.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+..
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheec
Confidence 999999999999999998776679999999999999999999999 99999999999999999999999999999876
Q ss_pred hccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCcchhhhhhhhhccccchhh
Q 003199 687 QARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITG-RKPVEDDFGDNKNIIYWVSIKVDTKEGIME 765 (840)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 765 (840)
... .........||+.|+|||++.+..++.++|||||||++|||+|+ ++||... ......... . .
T Consensus 152 ~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i---~-------~ 217 (263)
T d1sm2a_ 152 LDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDI---S-------T 217 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHH---H-------H
T ss_pred cCC--CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHH---H-------h
Confidence 542 22233446789999999999999999999999999999999995 5555431 111111110 0 0
Q ss_pred hcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 766 VLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 766 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
-.....+. ....++.+++.+||+.||++||||+||+++|+++.
T Consensus 218 ~~~~~~p~---~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 218 GFRLYKPR---LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCcc---ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 00111111 22346778888999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=414.86 Aligned_cols=261 Identities=29% Similarity=0.400 Sum_probs=200.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|...+.||+|+||+||+|.++ ..||||++...... ....+.|.+|++++++++|||||++++++.+ .
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT--------PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P 76 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC--------TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC--------HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence 45778899999999999999865 36999998543321 2335679999999999999999999998865 4
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++......++|..+..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 6799999999999999998776679999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
.... ..........||+.|||||++.+ ..++.++|||||||++|||+||+.||.+... ..... .... .
T Consensus 154 ~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~-~~~~-~---- 224 (276)
T d1uwha_ 154 KSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQII-FMVG-R---- 224 (276)
T ss_dssp -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHH-HHHH-H----
T ss_pred cccc-CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHH-HHHh-c----
Confidence 6432 12233455679999999999864 3589999999999999999999999975321 11110 0000 0
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
....+.......+....+.+++.+||+.||++||||+|++++|+.+.
T Consensus 225 --~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 225 --GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp --TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00111111111223356777888999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=406.85 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=209.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||+||+|.+++++.||||+++.... ..++|.+|++++++++||||++++|+|.+..
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-----------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-----------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-----------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 35778899999999999999999899999999864331 1356899999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|++.+++......+++..+..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+|+.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhhee
Confidence 9999999999999999987776689999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+... ... .. .+.
T Consensus 150 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~---~~-~i~------ 215 (258)
T d1k2pa_ 150 VLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET---AE-HIA------ 215 (258)
T ss_dssp CSSS--SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHH---HH-HHH------
T ss_pred ccCC--CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHH---HH-HHH------
Confidence 6442 2223345679999999999999999999999999999999998 8999975321 111 10 000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.......+ ......+.+++.+||+.||++|||++|++++|.++
T Consensus 216 ~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 216 QGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred hCCCCCCc---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 00001111 12234677888899999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=411.42 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=202.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|++++++++|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---------VDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---------chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 4688899999999999999965 5799999999854321 12235688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceeEEEEeccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 99999999999999999997654 79999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
..... ..........||+.|||||++.+..+ +.++||||+||++|||++|+.||............+. ..
T Consensus 152 ~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~---~~----- 222 (271)
T d1nvra_ 152 VFRYN-NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EK----- 222 (271)
T ss_dssp ECEET-TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH---TT-----
T ss_pred eeccC-CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh---cC-----
Confidence 76432 12223445689999999999988776 6789999999999999999999975432211111110 00
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............++.+++.+|++.||++|||++|++++
T Consensus 223 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 -----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -----CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011112223456678889999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-49 Score=414.77 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=196.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc---EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE---VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
+.|+..+.||+|+||+||+|..+ +|+ .||||++..... ....+.|.+|++++++++|||||+++|++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT---------EKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC---------HHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 34566789999999999999764 332 588998743321 23356799999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+.+..++|||||++|+|.+++......++|.++..++.|||+||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcc
Confidence 99999999999999999999998876679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCC--cceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhc
Q 003199 682 IAKVLQARGGKD--STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 682 ~a~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
+|+......... .......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+.. .......
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~------ 245 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINA------ 245 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH------
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHHH------
Confidence 998775432211 12223568999999999999999999999999999999998 899997531 1111111
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+......+...+....+.+++.+||+.||++||||+||++.|+++-
T Consensus 246 -------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 246 -------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0011111112233456778888999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=407.13 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=204.7
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++|||||++++++.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-------EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-------cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 5688899999999999999966 4789999999853321 1123356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred CEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceee
Confidence 99999999999999999998764 69999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... .......||+.|||||++.+..++.++|||||||++|||++|+.||.+.. ....+... ...
T Consensus 155 ~~~~-----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i-~~~----- 219 (263)
T d2j4za1 155 HAPS-----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRI-SRV----- 219 (263)
T ss_dssp CCCC-----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHH-HTT-----
T ss_pred ecCC-----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC----HHHHHHHH-HcC-----
Confidence 6532 23345679999999999999999999999999999999999999997531 11111110 000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
...++... ..++.+++.+|++.||++|||++|+++|
T Consensus 220 ---~~~~p~~~---s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 ---EFTFPDFV---TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CCCCCccC---CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11122222 3456678889999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=408.96 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=190.9
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS- 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC--------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC--------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 5788899999999999999965 57999999998543311 2235678999999999999999999999864
Q ss_pred -CccceEEEeecCCCChHHHhhcC---CCCCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 -LYCNLLVYEYMPNGNLWDALHKG---LVHLDWPTRHKIAFGVAQGLAYLHHGL--LSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 -~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
....++||||+++|+|.+++.+. ...+++..++.++.|++.||+|||+.. ..+||||||||+|||++.++.+||
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 45678999999999999998642 347999999999999999999999821 124999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+|||+|+.+... ........||+.|||||++.+..++.++|||||||++|||+||+.||.+.. .... ... .
T Consensus 156 ~DFG~a~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~---~~~-i 226 (269)
T d2java1 156 GDFGLARILNHD---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKEL---AGK-I 226 (269)
T ss_dssp CCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHH---HHH-H
T ss_pred eeccceeecccC---CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--HHHH---HHH-H
Confidence 999999886432 222345689999999999999999999999999999999999999997531 1111 000 0
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......++..+ ..++.+++.+||+.||++|||++|++++
T Consensus 227 ------~~~~~~~~~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 ------REGKFRRIPYRY---SDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------HHTCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------HcCCCCCCCccc---CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000011122222 3456778889999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=409.56 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=202.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 4678889999999999999999988999999985322 113568999999999999999999998865 5
Q ss_pred cceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|.+++.... ..++|..+..|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceE
Confidence 6789999999999999776542 358999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... ..........||+.|||||++.++.++.++|||||||++|||+||..|+..... ........ .
T Consensus 158 ~~~~--~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i----------~ 224 (272)
T d1qpca_ 158 LIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNL----------E 224 (272)
T ss_dssp ECSS--SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH----------H
T ss_pred EccC--CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHH----------H
Confidence 7643 222333456789999999999988999999999999999999996555432211 11111110 0
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.......+.. ...++.+++.+||+.||++||||+||++.|+++
T Consensus 225 ~~~~~~~p~~---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 225 RGYRMVRPDN---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCccc---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 0011111222 234567788899999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=410.01 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=204.6
Q ss_pred hcCccC-eeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 527 AMTEKN-KVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 527 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
++...+ +||+|+||+||+|.++ ++..||||++.... .....+.|.+|++++++++|||||+++|++.
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---------CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 344555 4999999999999654 35579999985332 1233567999999999999999999999987
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGI 682 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~ 682 (840)
+ +..++||||+++|+|.+++......+++..+..++.||+.||+|||+ ++||||||||+||+++.++.+||+|||+
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchh
Confidence 5 45789999999999999987766679999999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 683 AKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 683 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
|+.+..............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+... ......+ ..
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i---~~--- 227 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI---EQ--- 227 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH---HT---
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH---Hc---
Confidence 9877543333333445678999999999999999999999999999999998 9999975321 1111110 00
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
-.....++ ....++.+++.+||+.||++|||+.+|++.|+..
T Consensus 228 ----~~~~~~p~---~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 228 ----GKRMECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----TCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCC---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00111122 2335677888899999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=408.39 Aligned_cols=259 Identities=27% Similarity=0.358 Sum_probs=199.1
Q ss_pred hcCccCeeeccCCcEEEEEEeCCC-----cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLNSG-----EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
.|+..+.||+|+||+||+|.+++. ..||||++..... ......|.+|++++++++|||||+++|++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---------EKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC---------hHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 467788999999999999976532 3799999843321 22345789999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+....++||||+.+|++.+.+......++|.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccc
Confidence 99999999999999999999888776789999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+|+.+..............||+.|||||++.++.++.++|||||||++|||++|..|+..... ......
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~---------- 224 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMK---------- 224 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHH----------
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHH----------
Confidence 998875432333334456789999999999999999999999999999999997666543211 111111
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.+.+....+...+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 225 ---~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 225 ---AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ---HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11111111112223456778899999999999999999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=407.69 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=203.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----------PKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----------hHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 3688899999999999999965 5799999999854321 1235688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.+. .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 9999999999999999988765 58999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ... .+. .....
T Consensus 165 ~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~-~~~--~~~~~---- 232 (293)
T d1yhwa1 165 QITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRA-LYL--IATNG---- 232 (293)
T ss_dssp ECCS---TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH-HHH--HHHHC----
T ss_pred eecc---ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HHH-HHH--HHhCC----
Confidence 7643 22234556799999999999999999999999999999999999999975311 111 010 00000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... + .........+.+++.+||+.||++|||+.|+++|
T Consensus 233 -~~~--~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 -TPE--L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -SCC--C-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCC--C-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 1112223456778889999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-49 Score=409.03 Aligned_cols=257 Identities=24% Similarity=0.293 Sum_probs=207.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.++ +|+.||||++..... ..+.|.+|++++++++|||||+++++|.+.
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----------hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 46788889999999999999765 689999999853321 135688999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
+..++||||+++|+|.+++... ...++|..+..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccce
Confidence 9999999999999999999764 4578999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... ..........||+.|+|||++.+..++.++|||||||++|||++|..|+..... ........
T Consensus 163 ~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i---------- 229 (287)
T d1opja_ 163 RLMTG--DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELL---------- 229 (287)
T ss_dssp TTCCS--SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHH----------
T ss_pred eecCC--CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHH----------
Confidence 87643 222333445689999999999999999999999999999999997777643211 11110000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
..-.....+. ....++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 230 ~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 230 EKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hcCCCCCCCc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0001111122 233467788889999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=405.85 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=197.2
Q ss_pred CeeeccCCcEEEEEEeC---CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccce
Q 003199 532 NKVGQGGSGTVYKIDLN---SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNL 608 (840)
Q Consensus 532 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 608 (840)
++||+|+||+||+|.++ +++.||||++..... .....+.|.+|++++++++|||||+++++|.+ +..+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--------DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--------CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEE
Confidence 47999999999999654 356899999843321 12335679999999999999999999999965 4568
Q ss_pred EEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhc
Q 003199 609 LVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQA 688 (840)
Q Consensus 609 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 688 (840)
+||||+++|+|.+++.... .++|.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 9999999999999998764 69999999999999999999999 9999999999999999999999999999987654
Q ss_pred cCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccchhhhc
Q 003199 689 RGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVL 767 (840)
Q Consensus 689 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (840)
............||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.. ....... +... .
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~----i~~~------~ 227 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAM----LEKG------E 227 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTT------C
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHH----HHcC------C
Confidence 3222333345679999999999999999999999999999999998 899997531 1111110 0000 0
Q ss_pred ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 768 DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 768 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
....+. ....++.+++.+||+.||++|||+++|++.|+..
T Consensus 228 ~~~~p~---~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCc---ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 011112 2335667788899999999999999999888753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=406.94 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=201.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
+.|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE----------EELEDYMVEIDILASCDHPNIVKLLDAFYYE 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS----------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH----------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 3577888999999999999965 5799999999854321 1234678899999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.+....+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhh
Confidence 99999999999999999987665579999999999999999999999 999999999999999999999999999997
Q ss_pred hhhccCCCCcceecccccccccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAY-----SSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
..... ........||+.|||||++. +..++.++|||||||++|||+||+.||.+... .... .... ..
T Consensus 159 ~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~--~~i~-~~ 230 (288)
T d2jfla1 159 KNTRT---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVL--LKIA-KS 230 (288)
T ss_dssp ECHHH---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHH--HHHH-HS
T ss_pred ccCCC---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHH--HHHH-cC
Confidence 65321 11233567999999999883 45689999999999999999999999975321 1111 1100 00
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. .+ ..........++.+++.+||+.||++|||++|+++|
T Consensus 231 ~-------~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 E-------PP-TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp C-------CC-CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-------CC-CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 001112233566778889999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=413.29 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=203.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.++++++|||||+++++|.+.
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---------PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---------TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC---------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 5688899999999999999965 5799999999854321 12346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. ++|+||||||+|||+++++.+||+|||+|+
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 99999999999999999998764 699999999999999999999971 389999999999999999999999999999
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc----
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK---- 760 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 760 (840)
.+... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.....................
T Consensus 154 ~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 154 QLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp HHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred ccCCC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 87542 223468999999999999999999999999999999999999999764221110000000000000
Q ss_pred -------------------cchhh----hcccccCCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 -------------------EGIME----VLDKKLSGSF-RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 -------------------~~~~~----~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....+ ......+... .....++.+++.+|++.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 0000000000 0112457788889999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=395.81 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=192.9
Q ss_pred ccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec----C
Q 003199 530 EKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS----L 604 (840)
Q Consensus 530 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~ 604 (840)
..++||+|+||+||+|.. .+++.||||++...... ....+.+.+|++++++++|||||++++++.+ .
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 345799999999999965 47899999998543311 2335678999999999999999999999864 3
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCCCeeeccc
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSP--IIHRDIKSTNILLD-VNYQPKVADFG 681 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfg 681 (840)
...++||||+++|+|.+++.+.. .+++.++..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 55789999999999999998764 68999999999999999999998 66 99999999999996 57899999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+|+... ........||+.|||||++.+ .++.++|||||||++|||++|+.||.+... .....+......
T Consensus 161 la~~~~-----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~~~- 229 (270)
T d1t4ha_ 161 LATLKR-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGV- 229 (270)
T ss_dssp GGGGCC-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTC-
T ss_pred cceecc-----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHcCC-
Confidence 997642 223345689999999998865 699999999999999999999999974311 111111000000
Q ss_pred chhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ...++.+++.+||+.||++|||++|+++|
T Consensus 230 -----~~~~~~~~---~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 -----KPASFDKV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----CCGGGGGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCcccCcc---CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00111111 22346678889999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=405.23 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=207.7
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-------cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 5688899999999999999965 5799999999853321 1122346789999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccce
Confidence 99999999999999999988764 69999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+... ..........||+.|||||++.+..++.++||||+||++|||++|+.||.+.. ........ ...
T Consensus 157 ~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i-~~~----- 225 (288)
T d1uu3a_ 157 VLSPE-SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKI-IKL----- 225 (288)
T ss_dssp ECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH-HTT-----
T ss_pred ecccC-CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----HHHHHHHH-HcC-----
Confidence 76432 12223345679999999999999999999999999999999999999997531 11001000 000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCCCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKF 820 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~ 820 (840)
...++..+ ..++.+++.+||+.||++|||++|++++-+-.....+...++
T Consensus 226 ---~~~~p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 226 ---EYDFPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp ---CCCCCTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ---CCCCCccC---CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 01122222 345667888999999999999999866544333333444333
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=405.80 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=190.0
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.+.|+..+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|++++++++|||||++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---------GKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---------hHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345688899999999999999965 47999999998543311 12356789999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCCeeec
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD---VNYQPKVAD 679 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~D 679 (840)
+....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+||++. +++.+||+|
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred ECCEEEEEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEec
Confidence 9999999999999999999997754 79999999999999999999999 9999999999999995 578999999
Q ss_pred ccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 680 FGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 680 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
||+|+.... ........||+.|||||++.+..++.++||||+||++|||++|+.||.+... ...+... ...
T Consensus 154 FG~a~~~~~----~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i-~~~ 224 (307)
T d1a06a_ 154 FGLSKMEDP----GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLFEQI-LKA 224 (307)
T ss_dssp C----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH-HTT
T ss_pred cceeEEccC----CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHH-hcc
Confidence 999986533 2233456799999999999999999999999999999999999999975311 1111111 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ... .+...+....+.+++.+|++.||++|||++|++++
T Consensus 225 ~~----~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EY----EFD---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC----CCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC----CCC---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 000 11112233556778889999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=406.61 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=202.6
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC-C-----cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS-G-----EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|+..+.||+|+||+||+|.... + ..||||++..... ......+.+|+.++.++ +|||||+++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---------SSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---------HHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 468888999999999999996542 2 3699998853321 22345788999999998 899999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC----------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL----------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSP 656 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 656 (840)
+++.+.+..++||||+++|+|.+++.... ..++|..++.++.||++||+|||+ ++
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~ 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KS 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 99999999999999999999999997642 248999999999999999999999 99
Q ss_pred eEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-C
Q 003199 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-G 735 (840)
Q Consensus 657 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g 735 (840)
||||||||+||+++.++.+||+|||+|+..... ..........||+.|||||++.+..++.++|||||||++|||+| |
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCC-CceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999999999876542 22223345678999999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 003199 736 RKPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLA 808 (840)
Q Consensus 736 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~ 808 (840)
+.||.+... .......+. .......+. ....++.+++.+||+.||++|||++||+++|.
T Consensus 264 ~~Pf~~~~~-~~~~~~~~~----------~~~~~~~p~---~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 264 VNPYPGIPV-DANFYKLIQ----------NGFKMDQPF---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSSTTCCC-SHHHHHHHH----------TTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCH-HHHHHHHHh----------cCCCCCCCC---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999975321 111111110 000111111 22346778888999999999999999999995
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=396.78 Aligned_cols=257 Identities=28% Similarity=0.388 Sum_probs=199.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..+.||+|+||+||+|..++++.||||++..... ..+.|.+|+.++++++|||||++++++.+ +
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-----------CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 56888999999999999999998888999999853321 13578999999999999999999999865 5
Q ss_pred cceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 606 CNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
..++||||+++|+|..++... ...++|.++..++.||+.||+|||+ .+|+||||||+|||+++++++||+|||+|+
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhh
Confidence 678999999999999888654 2468999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
..... .........||+.|+|||++.++.++.++|||||||++|||++|..|+..... ......++.
T Consensus 162 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~---------- 228 (285)
T d1fmka3 162 LIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE---------- 228 (285)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH----------
T ss_pred hccCC--CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHH----------
Confidence 76432 22333456799999999999999999999999999999999997666543211 111111110
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
......... ....++.+++.+||+.||++||||++|++.|++....
T Consensus 229 ~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RGYRMPCPP---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hcCCCCCCc---ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 000111122 2234577888899999999999999999999886544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-47 Score=408.02 Aligned_cols=254 Identities=21% Similarity=0.352 Sum_probs=206.8
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 93 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----------ESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456899999999999999999965 579999999985332 123467889999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCCCeeecc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV--NYQPKVADF 680 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Df 680 (840)
+....++|||||++|+|.+++......+++..+..++.||+.||+|||+ ++||||||||+|||++. ++.+||+||
T Consensus 94 ~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeec
Confidence 9999999999999999999997665579999999999999999999999 99999999999999964 578999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+|+.+.. ........||+.|||||++.+..++.++||||+||++|||++|+.||.+.. .... +... ....
T Consensus 171 G~a~~~~~----~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~--~~~i-~~~~ 241 (350)
T d1koaa2 171 GLTAHLDP----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDET--LRNV-KSCD 241 (350)
T ss_dssp TTCEECCT----TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH--HHHH-HHTC
T ss_pred chheeccc----ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHH--HHHH-HhCC
Confidence 99987632 334456789999999999999999999999999999999999999997531 1111 1111 1000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. .+ ..........+.+++.+|++.||++|||++|+++|
T Consensus 242 ~~----~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 WN----MD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC----SC---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CC----CC---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 01112223456778889999999999999999997
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=401.82 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=200.7
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|++++++++|||||++++++.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-------cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence 35689999999999999999964 5789999999854331 123445778999999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..++|||||++|++..++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred CCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccc
Confidence 99999999999999997766554 379999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS---SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+.... .....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+.. ......... ...
T Consensus 163 ~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~~~i~-~~~ 230 (309)
T d1u5ra_ 163 SIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIA-QNE 230 (309)
T ss_dssp BSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHH-HSC
T ss_pred cccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----HHHHHHHHH-hCC
Confidence 76532 234579999999999854 468999999999999999999999997531 111111100 000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........+ ...+.+++.+||+.||++|||++|+++|
T Consensus 231 ------~~~~~~~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 231 ------SPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------CCCCSCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCCCC---CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 000011122 3456678889999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.1e-47 Score=405.62 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=206.7
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.+.|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 97 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----------PLDKYTVKNEISIMNQLHHPKLINLHDAFED 97 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45788999999999999999965 579999999985432 1224568899999999999999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCCCeeeccc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD--VNYQPKVADFG 681 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfg 681 (840)
....++|||||++|+|.+++......+++.++..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||
T Consensus 98 ~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecc
Confidence 999999999999999999887766679999999999999999999999 9999999999999998 57899999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE 761 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 761 (840)
+|+.+.. ........||+.|+|||++.+..++.++||||+||++|||+||+.||.+... ... .... ...
T Consensus 175 la~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~--~~~i-~~~-- 243 (352)
T d1koba_ 175 LATKLNP----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LET--LQNV-KRC-- 243 (352)
T ss_dssp TCEECCT----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHH--HHHH-HHC--
T ss_pred cceecCC----CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHH--HHHH-HhC--
Confidence 9987643 3344567899999999999999999999999999999999999999975311 111 0000 000
Q ss_pred chhhhcccccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 762 GIMEVLDKKLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 762 ~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
+.... ..+.....++.+++.+|++.||++|||++|+++|
T Consensus 244 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 ------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111 1112234556778889999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=397.08 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=206.9
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.+.|+..+.||+|+||+||+|.. .+|+.||||++......... .....+.+.+|++++++++|||||++++++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR----RGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS----SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh----hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345789999999999999999966 57999999999654432211 1223567899999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CCeee
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY----QPKVA 678 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~ 678 (840)
+....++|||||++|+|.+++.... .+++..+..++.|++.||+|||+ ++||||||||+||+++.++ .+|++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred ECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 9999999999999999999998764 69999999999999999999999 9999999999999998776 48999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|||+|+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .. .+... ..
T Consensus 160 DfG~a~~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~--~~~~i-~~ 230 (293)
T d1jksa_ 160 DFGLAHKIDF----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE--TLANV-SA 230 (293)
T ss_dssp CCTTCEECTT----SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--HHHHH-HT
T ss_pred chhhhhhcCC----CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HH--HHHHH-Hh
Confidence 9999987633 2234456799999999999999999999999999999999999999975311 00 01000 00
Q ss_pred cccchhhhcccccCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGS-FRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.. ...... .......+.+++.+||+.||++|||++|++++
T Consensus 231 ~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VN--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TC--------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC--------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000 01123456778889999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-47 Score=396.62 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=206.9
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|+..+.||+|+||+||+|.++ +++.||||++.... .....+.|.+|++++++++||||+++++
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---------SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---------ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 46888899999999999999764 45789999984322 1234577999999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcCC-----------------------CCCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKGL-----------------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSP 656 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 656 (840)
+|.+....++||||+++|+|.+++.... ..++|..+..|+.|++.||+|||+ ++
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RK 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CC
Confidence 9999999999999999999999986431 248999999999999999999999 99
Q ss_pred eEecCCCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCC
Q 003199 657 IIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR 736 (840)
Q Consensus 657 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 736 (840)
||||||||+|||++.++.+||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999999999998775432 223344567899999999999999999999999999999999985
Q ss_pred -CCCCCCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 737 -KPVEDDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 737 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
+||.... ..... ..+.+....+.....+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 240 ~~p~~~~~--~~e~~-------------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 240 LQPYYGMA--HEEVI-------------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CCTTTTSC--HHHHH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCC--HHHHH-------------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5665421 11111 111111222222233456778899999999999999999999998763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=391.74 Aligned_cols=255 Identities=23% Similarity=0.299 Sum_probs=194.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC----CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS----GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|...+.||+|+||+||+|.+.. +..||||++.... .....+.+.+|++++++++|||||++++++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---------SDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 467888999999999999997642 3468888874322 123356799999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+ +..++||||+++|++.+++......+++..+..++.||++||+|||+ ++||||||||+||++++++.+||+|||
T Consensus 78 ~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 78 TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp CS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred ec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccch
Confidence 64 67899999999999999888776679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+|+..... .........||+.|+|||++.+..++.++|||||||++|||+| |++||.+... ......
T Consensus 154 ~a~~~~~~--~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~-------- 221 (273)
T d1mp8a_ 154 LSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGR-------- 221 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHH--------
T ss_pred hheeccCC--cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHH--------
Confidence 99876432 2233345678999999999999999999999999999999998 8999875321 111111
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+......+........+.+++.+||+.||++|||+.||+++|+++
T Consensus 222 -----i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 222 -----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111111122335677788899999999999999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=389.13 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=194.7
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-C
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-L 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 604 (840)
++|+..+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~------------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH------------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 45677889999999999999986 7899999985322 13568899999999999999999999854 4
Q ss_pred ccceEEEeecCCCChHHHhhcCC-CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGL-VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
...++||||+++|+|.+++.... ..++|..+..|+.||+.||+|||+ .+||||||||+||+++.++.+|++|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccc
Confidence 56799999999999999997642 358999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccccc
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTKEG 762 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 762 (840)
+.... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||... .......++.
T Consensus 151 ~~~~~------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~-------- 214 (262)
T d1byga_ 151 KEASS------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVE-------- 214 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHT--------
T ss_pred eecCC------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHH--------
Confidence 86532 2234567899999999999999999999999999999998 78887643 1112221111
Q ss_pred hhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 763 IMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
.-....... ....++.+++.+||+.||++||||.+++++|+++.
T Consensus 215 --~~~~~~~~~---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 215 --KGYKMDAPD---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp --TTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCCCCCc---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 001111222 22345677888999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=392.82 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=197.0
Q ss_pred HhcCccCeeeccCCcEEEEEEeC--CC--cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN--SG--EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||+||+|.+. ++ ..||||++..... ......+.|.+|++++++++|||||+++|++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-------~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-------SQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 46788899999999999999653 23 3789998744321 1223456799999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+ ...++||||+++|++.+++......+++..+..++.|+|.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccch
Confidence 76 46789999999999999887766679999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+++................||..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ......++ ...
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--~~~~~~~i---~~~- 230 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKI---DKE- 230 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH---HTS-
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--HHHHHHHH---HhC-
Confidence 99877543333333445668889999999999999999999999999999998 899997531 11111111 000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
....+........+.+++.+||+.||++||||.||++.|+++
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 000111122334677888899999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=397.96 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=198.7
Q ss_pred hcCccCeeeccCCcEEEEEEeC-CCc----EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEE
Q 003199 527 AMTEKNKVGQGGSGTVYKIDLN-SGE----VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYF 601 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 601 (840)
+|+..+.||+|+||+||+|.+. +|+ +||||++.... ..+..+.|.+|++++++++|||||+++|+|
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5788899999999999999664 454 58888774322 123456799999999999999999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeeccc
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFG 681 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 681 (840)
.+. ..++++||+.+|+|.+++......+++..+..++.|||.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 81 ~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 81 LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp ESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred ecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccc
Confidence 875 5678899999999999998877789999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 682 IAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 682 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
+|+..... ..........||+.|+|||++.++.++.++|||||||++|||+| |+.||.+... ......+.
T Consensus 157 la~~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~------ 227 (317)
T d1xkka_ 157 LAKLLGAE-EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE------ 227 (317)
T ss_dssp HHHHTTTT-CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHH------
T ss_pred cceecccc-cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH------
Confidence 99887542 22223344568999999999999999999999999999999998 8889875311 11111000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.....+........+.+++.+||+.||++|||+.|++++|+.+
T Consensus 228 -------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 228 -------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0010111122334577788899999999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=396.86 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=205.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-------CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence 5688899999999999999965 58999999998543211 122356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.+.. .+++..++.++.|++.||+|||+ ++||||||||+|||++++|.+||+|||+|+
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred cccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccc
Confidence 99999999999999999998765 68999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+... . .........
T Consensus 154 ~~~~---~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~---~~~~~i~~~----- 220 (337)
T d1o6la_ 154 EGIS---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E---RLFELILME----- 220 (337)
T ss_dssp CSCC---TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHHHC-----
T ss_pred cccc---CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--H---HHHHHHhcC-----
Confidence 6532 22234457899999999999999999999999999999999999999976311 1 111110000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
...++..+ ..++.+++.+|+++||++||+ +.|+++|
T Consensus 221 ---~~~~p~~~---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 ---EIRFPRTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCccC---CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11122222 345667888999999999995 8899886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-46 Score=392.46 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=203.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|+.++++++|||||++++++.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-------cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 5688899999999999999965 5799999999853321 1122356788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+++|++..++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred CeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccce
Confidence 99999999999999999888765 68899999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.. ...........
T Consensus 153 ~~~~------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~----- 216 (316)
T d1fota_ 153 YVPD------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNA----- 216 (316)
T ss_dssp ECSS------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHC-----
T ss_pred Eecc------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHcC-----
Confidence 7532 2335689999999999999999999999999999999999999997531 11111100000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
....++.. ..++.+++.+|++.||.+|| |++++++|
T Consensus 217 ---~~~~p~~~---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ---ELRFPPFF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCCCCTTS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCC---CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01112222 24466788899999999996 89999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-46 Score=383.81 Aligned_cols=260 Identities=26% Similarity=0.317 Sum_probs=207.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++........ .........+.+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF-SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccch-hHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 5788899999999999999965 5799999999865543211 12223445577899999999997 9999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
.+..++||||+++|+|.+++.... .+++.+++.++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999997765 79999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYS------SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
+.... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.. ... .... ..
T Consensus 158 ~~~~~----~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~-~~~~-i~ 228 (277)
T d1phka_ 158 CQLDP----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QML-MLRM-IM 228 (277)
T ss_dssp EECCT----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-HHHH-HH
T ss_pred eEccC----CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHH-HHHH-HH
Confidence 87643 223345679999999998853 357889999999999999999999997531 111 0000 01
Q ss_pred ccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 758 DTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.... ....+.......++.+++.+|++.||++|||++|++++
T Consensus 229 ~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCC-------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 00111222344567788889999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=391.79 Aligned_cols=272 Identities=25% Similarity=0.274 Sum_probs=199.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
+.|...+.||+|+||.||+|.+. |+.||||++.... .....+..|+..+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-----------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-----------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 45777889999999999999875 8999999984321 11122334666667889999999999997643
Q ss_pred ----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCCCe
Q 003199 606 ----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHG-----LLSPIIHRDIKSTNILLDVNYQPK 676 (840)
Q Consensus 606 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~k 676 (840)
..++||||+++|+|.+++++. .++|..+..++.|+|.||+|+|+. +.++||||||||+|||++.++.+|
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 568999999999999999875 589999999999999999999963 126999999999999999999999
Q ss_pred eecccchhhhhccCCC-CcceecccccccccCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 003199 677 VADFGIAKVLQARGGK-DSTTTVIAGTYGYLAPEYAYSSK------ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI 749 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 749 (840)
|+|||+++........ ........||+.|+|||++.+.. ++.++|||||||++|||+||..||..........
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999999876442211 12334567999999999986542 5779999999999999999998875432211111
Q ss_pred hhhhhhhhccccchhhhcc----cccCCCc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcC
Q 003199 750 IYWVSIKVDTKEGIMEVLD----KKLSGSF--RDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEAD 811 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~ 811 (840)
..................+ +.++..+ .+....+.+++.+||+.||++|||+.||+++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1000000000000011112 2222221 245567889999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=388.92 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=202.5
Q ss_pred cCeeeccCCcEEEEEEeCCC----cEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec-Cc
Q 003199 531 KNKVGQGGSGTVYKIDLNSG----EVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-LY 605 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 605 (840)
.++||+|+||+||+|.+.++ ..||||++.... .....+.|.+|++++++++||||++++|++.+ +.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC---------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc---------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 45799999999999976532 368999984321 13345789999999999999999999999865 55
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++||||+++|+|.+++.......++..+..++.|+++||.|+|+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhh
Confidence 7899999999999999998877778899999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCC-CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 686 LQARGGK-DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 686 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
....... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .....++ .....
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i---~~g~~--- 252 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL---LQGRR--- 252 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---HTTCC---
T ss_pred ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHH---HcCCC---
Confidence 6543222 12233457899999999999999999999999999999999988887643211 1111111 11110
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCC
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPC 813 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~ 813 (840)
...+. .....+.+++.+||+.||++||+|.||+++|+++...
T Consensus 253 ----~~~p~---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 ----LLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCcc---cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11111 2234577888899999999999999999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.9e-46 Score=386.54 Aligned_cols=262 Identities=25% Similarity=0.327 Sum_probs=199.2
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|+++++.++||||+++++++...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-------TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-------cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 5688899999999999999964 5899999999854321 1234456799999999999999999999998764
Q ss_pred c----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 Y----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
. ..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++||||||||+|||++.++..+++||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCC
T ss_pred cCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehh
Confidence 4 3789999999999999887765 69999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|.+.................||+.|+|||++.+..++.++||||+||++|||+||+.||.+.. . . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~-~-~~~~~~~~~~ 230 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---P-V-SVAYQHVRED 230 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---H-H-HHHHHHHHCC
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---H-H-HHHHHHHhcC
Confidence 998765433333344556789999999999999999999999999999999999999997531 1 1 1110011100
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhhc
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-TMNEVVQLLAEA 810 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~ 810 (840)
.. ........ ...++.+++.+|+++||++|| |++++.+.|.++
T Consensus 231 ~~----~~~~~~~~---~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 PI----PPSARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CC----CGGGTSSS---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC----CCchhccC---CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00 00011112 234566788899999999999 899999988765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=389.13 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=211.8
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYC 599 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 599 (840)
++|+..+.||+|+||+||+|.+. +++.||||++.... ..+....|.+|++++++++|||||++++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---------~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---------SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---------CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---------ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 57788899999999999999663 35789999984322 1233567899999999999999999999
Q ss_pred EEecCccceEEEeecCCCChHHHhhcC---------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 600 YFSSLYCNLLVYEYMPNGNLWDALHKG---------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 600 ~~~~~~~~~lV~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
++......++||||+++|+|.+++... ...+++..+..++.|+|+||.|||+ ++||||||||+|||++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVA 167 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEEC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeec
Confidence 999999999999999999999988643 1357899999999999999999999 9999999999999999
Q ss_pred CCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCcch
Q 003199 671 VNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR-KPVEDDFGDNKNI 749 (840)
Q Consensus 671 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~~~ 749 (840)
+++++||+|||+|+...... .........||+.|+|||.+.+..++.++||||||+++|||+||. .||.+. ..
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~ 241 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SN 241 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CH
T ss_pred CCceEEEeecccceeccCCc-ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CH
Confidence 99999999999998775432 222334456899999999999999999999999999999999984 676542 11
Q ss_pred hhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCCCCCCCCCC
Q 003199 750 IYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADPCRFESCKF 820 (840)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~ 820 (840)
..+.. .+.+....+........+.+++.+||+.||++||||.+|+++|++.....+...+|
T Consensus 242 ~~~~~----------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~ 302 (308)
T d1p4oa_ 242 EQVLR----------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302 (308)
T ss_dssp HHHHH----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred HHHHH----------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCC
Confidence 11111 11111221112223356778888999999999999999999998876555544443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=392.24 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=204.3
Q ss_pred HHHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEe
Q 003199 524 ILEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFS 602 (840)
Q Consensus 524 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 602 (840)
+.++|+..+.||+|+||+||+|.. .+|+.||||++.... .....+.+|+++++.++|||||++++++.
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 71 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----------TDQVLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----------HHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----------ccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 456789999999999999999965 478999999985432 11345789999999999999999999999
Q ss_pred cCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CCCeeecc
Q 003199 603 SLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVN--YQPKVADF 680 (840)
Q Consensus 603 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Df 680 (840)
+....|+|||||++|+|.+++......+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+||
T Consensus 72 ~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEccc
Confidence 9999999999999999999998776579999999999999999999999 999999999999999854 47899999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTK 760 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 760 (840)
|+++... .........||+.|+|||...+..++.++||||+||++|||++|+.||.+... . ..........
T Consensus 149 G~~~~~~----~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~-~~~~~i~~~~ 219 (321)
T d1tkia_ 149 GQARQLK----PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----Q-QIIENIMNAE 219 (321)
T ss_dssp TTCEECC----TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----H-HHHHHHHHTC
T ss_pred chhhccc----cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----H-HHHHHHHhCC
Confidence 9997653 23344556799999999999999999999999999999999999999975311 0 0111001000
Q ss_pred cchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 761 EGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... +... +.....++.+++.+|+..||++|||++|+++|
T Consensus 220 ~~~----~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YTF----DEEA---FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCC----CHHH---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC----Chhh---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000 01123456778889999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-45 Score=393.68 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=203.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ......+.+.+|+++++.++|||||++++++.+.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-------cCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 4788899999999999999965 5799999999853221 1122346788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence 99999999999999999998765 69999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccchh
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGIM 764 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (840)
.+.. ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.. .. .........
T Consensus 190 ~~~~------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~-~~~~~i~~~----- 253 (350)
T d1rdqe_ 190 RVKG------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PI-QIYEKIVSG----- 253 (350)
T ss_dssp ECSS------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH-HHHHHHHHC-----
T ss_pred eccc------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HH-HHHHHHhcC-----
Confidence 7632 2335679999999999999999999999999999999999999997531 11 111100000
Q ss_pred hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 765 EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 765 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
....+.. ...++.+++.+|++.||.+|+ |++|+++|
T Consensus 254 ---~~~~p~~---~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 ---KVRFPSH---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCCCTT---CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCcc---CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0111122 234566788899999999994 89999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-45 Score=395.76 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=199.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++....... ............|+++++.++|||||++++++.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~----~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM----KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch----hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 4688889999999999999965 479999999985332110 00111122334457788888999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999999998764 68999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
.+.. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||.+...... .........
T Consensus 156 ~~~~-----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~----- 223 (364)
T d1omwa3 156 DFSK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT----- 223 (364)
T ss_dssp ECSS-----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSS-----
T ss_pred ecCC-----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccc-----
Confidence 6533 22345679999999999865 5689999999999999999999999976422211 111100000
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPT-----MNEVVQL 806 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~ 806 (840)
.....+..+ ..++.+++.+||+.||++||| ++|+++|
T Consensus 224 ---~~~~~~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 ---MAVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCCSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011112222 345677888999999999999 7999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=388.11 Aligned_cols=256 Identities=26% Similarity=0.339 Sum_probs=199.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeC-CCc--EEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN-SGE--VVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCYF 601 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 601 (840)
++|+..+.||+|+||+||+|.++ +|. .||||++..... ....+.|.+|+++++++ +|||||+++++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---------KDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC---------hHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 56777889999999999999665 454 477787643221 12345689999999999 799999999999
Q ss_pred ecCccceEEEeecCCCChHHHhhcC---------------CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 003199 602 SSLYCNLLVYEYMPNGNLWDALHKG---------------LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTN 666 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N 666 (840)
.+.+..++||||+++|+|.++++.. ...++|..+..++.|||.||.|+|+ ++||||||||+|
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~N 157 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 157 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccce
Confidence 9999999999999999999999754 2468999999999999999999999 999999999999
Q ss_pred EEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCC
Q 003199 667 ILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGR-KPVEDDFGD 745 (840)
Q Consensus 667 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~ 745 (840)
||++.++.+||+|||+|+.... ........||..|+|||.+.+..++.++|||||||++|||++|. +||.+..
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-- 231 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-- 231 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred EEEcCCCceEEccccccccccc----cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--
Confidence 9999999999999999976533 22223456899999999999999999999999999999999975 4665421
Q ss_pred CcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhcCC
Q 003199 746 NKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEADP 812 (840)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~ 812 (840)
....... +..............++.+++.+||+.||++||||+||+++|+++..
T Consensus 232 ~~~~~~~-------------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 232 CAELYEK-------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHH-------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHH-------------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111110 11111111112233567778889999999999999999999987653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=386.22 Aligned_cols=258 Identities=25% Similarity=0.328 Sum_probs=193.4
Q ss_pred HhcCccCeeeccCCcEEEEEEeC------CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLN------SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|+..+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++.++ +|+||+.++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---------~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---------HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C---------HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC---------cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 56888999999999999999653 346899999853221 23345677888888877 689999999
Q ss_pred eEEecC-ccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 003199 599 CYFSSL-YCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDI 662 (840)
Q Consensus 599 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 662 (840)
+++.+. ...++||||+++|+|.+++.... ..++|.++..++.||++||+|||+ ++||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcC
Confidence 988654 46799999999999999997532 248899999999999999999999 99999999
Q ss_pred CCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCC
Q 003199 663 KSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITG-RKPVED 741 (840)
Q Consensus 663 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p~~~ 741 (840)
||+|||+++++.+||+|||+|+..... ..........||+.|+|||++.+..++.++|||||||++|||+|| ..||..
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSC-TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceeECCCCcEEEccCcchhhcccc-ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876432 122233456799999999999999999999999999999999996 567764
Q ss_pred CCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 742 DFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
... ....... .. .-.....+. ....++.+++.+||+.||++|||++|++++|+++
T Consensus 240 ~~~-~~~~~~~----~~------~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 VKI-DEEFCRR----LK------EGTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCC-SHHHHHH----HH------HTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCH-HHHHHHH----Hh------cCCCCCCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 311 1111110 00 000111112 2234577888899999999999999999999865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=384.05 Aligned_cols=257 Identities=27% Similarity=0.340 Sum_probs=201.3
Q ss_pred HhcCccCeeeccCCcEEEEEEeCC--------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcce
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNS--------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVK 596 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 596 (840)
++|...+.||+|+||.||+|...+ +..||||++..... ......+.+|+..+.++ +|||||+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---------EKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---------HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---------hHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 467788899999999999996532 24799999854321 23356788899999888 7999999
Q ss_pred eeeEEecCccceEEEeecCCCChHHHhhcCC---------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 597 LYCYFSSLYCNLLVYEYMPNGNLWDALHKGL---------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 597 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
++++|.+....++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrD 160 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRD 160 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeee
Confidence 9999999999999999999999999997542 358999999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+|||++.++.+||+|||+++...... .........||+.|+|||.+.++.++.++|||||||++|||++ |+.||.
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCC-TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ecccceeecCCCCeEeccchhhccccccc-cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 99999999999999999999998775532 2233455678999999999999999999999999999999998 788886
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
+... ...... . ........+.. ....+.+++.+||+.||++|||+.||++.|+++
T Consensus 240 ~~~~--~~~~~~----i------~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 240 GVPV--EELFKL----L------KEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp TCCH--HHHHHH----H------HTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCH--HHHHHH----H------HcCCCCCCCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 4311 111111 0 00011111222 234577888899999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=389.67 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=196.9
Q ss_pred HHHhcCccC-eeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceeeeE
Q 003199 524 ILEAMTEKN-KVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLYCY 600 (840)
Q Consensus 524 ~~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 600 (840)
+.++|.... .||+|+||+||+|.. .+|+.||||++.. .+.+.+|++++.++ +|||||+++++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------------~~~~~~E~~~~~~~~~hpnIv~l~~~ 73 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------------CPKARREVELHWRASQCPHIVRIVDV 73 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------------SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------------cHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 346787764 599999999999955 6799999999832 13466799887655 89999999999
Q ss_pred Eec----CccceEEEeecCCCChHHHhhcC-CCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C
Q 003199 601 FSS----LYCNLLVYEYMPNGNLWDALHKG-LVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV---N 672 (840)
Q Consensus 601 ~~~----~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~ 672 (840)
+.+ ....|+|||||++|+|.+++... ...+++.++..|+.||+.||+|||+ ++|+||||||+|||++. +
T Consensus 74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp EEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTT
T ss_pred EeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccc
Confidence 865 45679999999999999999764 3469999999999999999999999 99999999999999985 5
Q ss_pred CCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhh
Q 003199 673 YQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYW 752 (840)
Q Consensus 673 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 752 (840)
+.+||+|||+|+.... ........||+.|||||++.+..|+.++||||+||++|||+||+.||.+....... ..
T Consensus 151 ~~~Kl~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~ 224 (335)
T d2ozaa1 151 AILKLTDFGFAKETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG 224 (335)
T ss_dssp CCEEECCCTTCEECCC----CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred ccccccccceeeeccC----CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HH
Confidence 5799999999987643 22334567999999999999999999999999999999999999999754221110 00
Q ss_pred hhhhhccccchhhhcccccC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 753 VSIKVDTKEGIMEVLDKKLS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 753 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..... .. .....+ ........++.+++.+|++.||++|||+.|+++|
T Consensus 225 ~~~~i--~~-----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 MKTRI--RM-----GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CC--CS-----CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHH--hc-----CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000 00 000011 1122345667888999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=382.80 Aligned_cols=266 Identities=25% Similarity=0.304 Sum_probs=199.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--------EGVPSTAIREISLLKELNHPNIVKLLDVIHTE 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--------hHHHHHHHHHHHHHHhCCCCcEEEeccccccc
Confidence 5788899999999999999965 67999999998543211 12246788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||||+.++.+..........+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.|+
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcce
Confidence 99999999997654444444445579999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcccc-c
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKE-G 762 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 762 (840)
.... .........||+.|+|||.+.... ++.++||||+||++|||++|+.||.+..... .............+ .
T Consensus 151 ~~~~---~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 151 AFGV---PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVV 226 (298)
T ss_dssp HHCC---CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred eccC---CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhh
Confidence 7643 223344567999999999876655 5889999999999999999999997532100 00000000000000 0
Q ss_pred h---------hhhcccccCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 I---------MEVLDKKLSGSFR----DEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~---------~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ............. ....++.+++.+|++.||++|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0000000111111 223567788999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=388.00 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=199.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHh-ccCCCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLG-NIRHKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++...... .....+.+..|+.++. .++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-------~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-------MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-------ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 4688899999999999999965 47999999998532211 1122345556666654 6899999999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccch
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIA 683 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a 683 (840)
....|+||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchh
Confidence 999999999999999999998765 68999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhccccch
Q 003199 684 KVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDTKEGI 763 (840)
Q Consensus 684 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (840)
+.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ....+......
T Consensus 151 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~----- 218 (320)
T d1xjda_ 151 KENML---GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMD----- 218 (320)
T ss_dssp BCCCC---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-----
T ss_pred hhccc---ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-----
Confidence 86533 2233445689999999999999999999999999999999999999997531 11111111100
Q ss_pred hhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003199 764 MEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMN-EVVQ 805 (840)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~ 805 (840)
....+... ..++.+++.+|++.||++||++. |+++
T Consensus 219 ----~~~~p~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ----NPFYPRWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCCCTTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCCccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11112222 34567788899999999999995 7765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=382.73 Aligned_cols=263 Identities=25% Similarity=0.287 Sum_probs=193.9
Q ss_pred cCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCccceE
Q 003199 531 KNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 609 (840)
.++||+|+||+||+|.. .+|+.||||++...... .......+.+.+|+.++++++|||||++++++.+....++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC-----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh-----hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceee
Confidence 46899999999999965 57999999998543321 1111223568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhhhhcc
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 689 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 689 (840)
||||+.++++....... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 vmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 99999888777665544 478999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-ccccchhhh-
Q 003199 690 GGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DTKEGIMEV- 766 (840)
Q Consensus 690 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 766 (840)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+....+... .........
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTT
T ss_pred ---cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchh
Confidence 2233446799999999988654 57999999999999999999999997532100 0000000000 000000000
Q ss_pred ------cccccCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 767 ------LDKKLSGSF-----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 767 ------~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
......... .....++.+++.+|++.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000011111 1223567888999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=382.06 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=206.0
Q ss_pred HhcCccCeeeccCCcEEEEEEe------CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc-CCCCcceee
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL------NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI-RHKNIVKLY 598 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 598 (840)
++|+..+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+++++ +|||||+++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---------~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---------LTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---------HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC---------HHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 5778889999999999999965 2467899999854321 23356788999999999 699999999
Q ss_pred eEEecCccceEEEeecCCCChHHHhhcCC-----------------CCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 003199 599 CYFSSLYCNLLVYEYMPNGNLWDALHKGL-----------------VHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRD 661 (840)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 661 (840)
++|.+....++||||+++|+|.+++.... ..+++..+..++.||++||+|||+ +++||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrD 170 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 170 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecc
Confidence 99999999999999999999999987542 258999999999999999999999 9999999
Q ss_pred CCCCCEEEcCCCCCeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 003199 662 IKSTNILLDVNYQPKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELIT-GRKPVE 740 (840)
Q Consensus 662 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~ 740 (840)
|||+||+++.++.+|++|||.++..... ..........||+.|+|||.+.++.++.++|||||||++|||+| |.+||.
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSC-TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccccccCcccccccchheeccCC-CcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876542 22334455789999999999999999999999999999999999 555554
Q ss_pred CCCCCCcchhhhhhhhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 741 DDFGDNKNIIYWVSIKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.. .....+...+.. -.....+ ......+.+++.+||+.||++||||+||+++|+++
T Consensus 250 ~~-~~~~~~~~~i~~----------~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 250 GM-PVDSKFYKMIKE----------GFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TC-CSSHHHHHHHHH----------TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-CHHHHHHHHHhc----------CCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 32 111111111110 0111111 12335677888899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=380.97 Aligned_cols=274 Identities=22% Similarity=0.298 Sum_probs=200.8
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CC-CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhcc---CCCCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NS-GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNI---RHKNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~ 600 (840)
++|+..+.||+|+||+||+|.. ++ ++.||||++........ ....+.+|+.+++.+ +||||++++++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--------~~~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--------MPLSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--------CBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--------HHHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 5788999999999999999965 44 67799999865432211 012344567666655 79999999998
Q ss_pred Eec-----CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 601 FSS-----LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 601 ~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
|.. ....+++|||++++++..........+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~ 155 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQI 155 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred ecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCe
Confidence 843 346789999999888776666666679999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 676 KVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
||+|||+++... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ........
T Consensus 156 kl~dfg~~~~~~----~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 230 (305)
T d1blxa_ 156 KLADFGLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 230 (305)
T ss_dssp EECSCCSCCCCC----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred eecchhhhhhhc----ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHh
Confidence 999999987642 2334456789999999999999999999999999999999999999997532100 00000000
Q ss_pred hh-ccccch-------hhhc----ccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCCCCC
Q 003199 756 KV-DTKEGI-------MEVL----DKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADPCRF 815 (840)
Q Consensus 756 ~~-~~~~~~-------~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~~~~ 815 (840)
.. ...... .... ..............+.+++.+|++.||++|||++|+++| +++++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke 304 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence 00 000000 0000 000001111223456678889999999999999999987 677766543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=376.89 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=195.4
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--CCCcceeeeEEe
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--HKNIVKLYCYFS 602 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 602 (840)
.+|+..+.||+|+||+||+|.. .+|+.||||++.......... ......+.+|+.++++++ |||||++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE----LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE----CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh----hhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 4688889999999999999965 579999999986543221110 111233567999999986 899999999999
Q ss_pred cCccceEEEeecCC-CChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCCeeecc
Q 003199 603 SLYCNLLVYEYMPN-GNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-NYQPKVADF 680 (840)
Q Consensus 603 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Df 680 (840)
+.+..++||||+.+ +++.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eCCeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999999976 67888887654 69999999999999999999999 99999999999999985 478999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKA-TTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+|+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .. ...
T Consensus 156 G~a~~~~~-----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i-------~~~ 219 (273)
T d1xwsa_ 156 GSGALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI-------IRG 219 (273)
T ss_dssp TTCEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH-------HHC
T ss_pred ccceeccc-----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH-------hhc
Confidence 99976432 23345679999999999987765 577999999999999999999997420 00 000
Q ss_pred ccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
....+..++ .++.+++.+|++.||++|||++|++++
T Consensus 220 --------~~~~~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 --------QVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------CCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------ccCCCCCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011222222 356678889999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.2e-44 Score=372.38 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=198.1
Q ss_pred HhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecCc
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSLY 605 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 605 (840)
++|+..++||+|+||+||+|..++|+.||||++...... ....+.+.+|+.++++++|||||++++++....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC--------hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 478889999999999999998889999999998554321 122467889999999999999999999999999
Q ss_pred cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchhh
Q 003199 606 CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAKV 685 (840)
Q Consensus 606 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~ 685 (840)
..++|+||+.++.+....... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+|++|||.|..
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEeccccccee
Confidence 999999999876666665544 479999999999999999999999 9999999999999999999999999999987
Q ss_pred hhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh-ccccch
Q 003199 686 LQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV-DTKEGI 763 (840)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 763 (840)
.... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+..... .......... ......
T Consensus 150 ~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 150 FGIP---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred cccC---ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhc
Confidence 6432 2233445689999999998754 56899999999999999999999997532100 0000000000 000000
Q ss_pred ---------hhhccccc----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 764 ---------MEVLDKKL----SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 764 ---------~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
........ ..........+.+++.+|++.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00011223466788889999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=371.18 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=196.7
Q ss_pred HhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|. ..+|+.||||++.... .....+.+.+|++++++++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---------HQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 468889999999999999995 4689999999984322 123356788999999999999999999998664
Q ss_pred c----cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 605 Y----CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 605 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
. ..+++++|+.+|+|.+++... .+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEccc
Confidence 3 235566777799999999765 68999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT 759 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 759 (840)
|+|+................||+.|+|||.+.. ..++.++||||+||++|||++|+.||...... ...+.......
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~ 230 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILG 230 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhcc
Confidence 999876543333333455779999999999854 45789999999999999999999999754211 00010000000
Q ss_pred ccc-----------hhh---hcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 760 KEG-----------IME---VLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 760 ~~~-----------~~~---~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
... ... .........+ .....++.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000 0000000111 1122467789999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=369.23 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=194.9
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++|||||+++++|...
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 5788899999999999999965 5799999999853321 123456788999999999999999999999765
Q ss_pred c------cceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 605 Y------CNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 605 ~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
+ ..++||||+ +++|....... .+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+|++
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~ 163 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKIL 163 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccc
Confidence 4 469999999 67788777654 69999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKV 757 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 757 (840)
|||+|+.... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... ...........
T Consensus 164 Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~ 236 (346)
T d1cm8a_ 164 DFGLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTG 236 (346)
T ss_dssp CCTTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred cccceeccCC------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccC
Confidence 9999976532 23456799999999998764 5689999999999999999999999753210 00000000000
Q ss_pred cc------------ccchh----hhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcCC
Q 003199 758 DT------------KEGIM----EVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEADP 812 (840)
Q Consensus 758 ~~------------~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~~ 812 (840)
.. ..... ......+..........+.+++.+|++.||++|||++|+++| ++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 00 00000 000001111112223456788889999999999999999997 665543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=364.11 Aligned_cols=269 Identities=21% Similarity=0.282 Sum_probs=194.0
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
..+|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--------EGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--------TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--------hHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 36788999999999999999965 58999999998554322 1223567889999999999999999998755
Q ss_pred --------CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCC
Q 003199 604 --------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQP 675 (840)
Q Consensus 604 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 675 (840)
....++||||++++.+...... ...++...+..++.|++.||+|||+ ++||||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCE
T ss_pred ccccccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcE
Confidence 3457899999987766544443 4478999999999999999999999 999999999999999999999
Q ss_pred eeecccchhhhhccCC-CCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 003199 676 KVADFGIAKVLQARGG-KDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV 753 (840)
Q Consensus 676 kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 753 (840)
|++|||+++....... .........||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... .......
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~ 235 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALIS 235 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHH
Confidence 9999999976543211 11223345799999999998765 6899999999999999999999999753210 0000000
Q ss_pred hhhhccccch-hh--------hc--ccccCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 754 SIKVDTKEGI-ME--------VL--DKKLSGSFRDE------MIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 754 ~~~~~~~~~~-~~--------~~--~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
.......... .. .. .........+. ...+.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000 00 00 00001111111 2356788999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-41 Score=357.52 Aligned_cols=261 Identities=20% Similarity=0.198 Sum_probs=195.6
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCccee-eeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKL-YCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~ 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... .+.+..|+++++.++|+|++.. .+++.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------------SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------------CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 3588889999999999999965 5789999998754321 1236789999999987765555 555677
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCCeeecc
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD---VNYQPKVADF 680 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Df 680 (840)
....++||||+ ++++.+.+......+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+|++||
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeecc
Confidence 78889999999 667777776666689999999999999999999999 9999999999999986 3557999999
Q ss_pred cchhhhhccCCC----CcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhh
Q 003199 681 GIAKVLQARGGK----DSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIK 756 (840)
Q Consensus 681 g~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 756 (840)
|+|+.+...... ........||+.|||||.+.+..++.++|||||||++|||+||+.||............ ....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~~~~ 229 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERIS 229 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-HHHH
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-HHhh
Confidence 999887543221 12334567999999999999999999999999999999999999999764322211111 0000
Q ss_pred hccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 757 VDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 757 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
.... ........+. .+.++.+++.+||+.+|++||+++++.+.|+++
T Consensus 230 ~~~~----~~~~~~~~~~---~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 230 EKKM----STPIEVLCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHH----HSCHHHHTTT---SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cccC----CCChhHhccC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 0000011111 224567788899999999999999998888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=370.29 Aligned_cols=262 Identities=29% Similarity=0.392 Sum_probs=190.6
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec--
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS-- 603 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 603 (840)
.|+..++||+|+||+||+|.. .+|+.||||++...... +.+|++++++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------------~~~Ei~il~~l~h~niv~~~~~~~~~~ 86 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------------KNRELQIMRKLDHCNIVRLRYFFYSSG 86 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------------CCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------------HHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence 577888999999999999966 47999999998543311 2369999999999999999999843
Q ss_pred ----CccceEEEeecCCCChHHHhh--cCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCe
Q 003199 604 ----LYCNLLVYEYMPNGNLWDALH--KGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPK 676 (840)
Q Consensus 604 ----~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~k 676 (840)
..+.++||||++++.+..... .....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+|
T Consensus 87 ~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp -CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEE
T ss_pred ccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCcee
Confidence 234689999997664443332 234479999999999999999999999 9999999999999999775 889
Q ss_pred eecccchhhhhccCCCCcceecccccccccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 003199 677 VADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYS-SKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI 755 (840)
Q Consensus 677 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 755 (840)
|+|||+++.... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+......
T Consensus 164 l~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~ 238 (350)
T d1q5ka_ 164 LCDFGSAKQLVR----GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKV 238 (350)
T ss_dssp ECCCTTCEECCT----TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH
T ss_pred EecccchhhccC----CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHH
Confidence 999999987633 223345679999999998765 56899999999999999999999999753211 000000000
Q ss_pred hhc-cccchhhh----ccccc---------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhc
Q 003199 756 KVD-TKEGIMEV----LDKKL---------SGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEA 810 (840)
Q Consensus 756 ~~~-~~~~~~~~----~~~~~---------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~ 810 (840)
... ..+..... .+... .........++.+++.+|++.||++|||+.|+++| ++++
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 00000000 00000 00011233457788889999999999999999986 4444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-41 Score=353.78 Aligned_cols=261 Identities=18% Similarity=0.216 Sum_probs=202.7
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC-CCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH-KNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+|++.++.+.| +|++.+++++..
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------------APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------------cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 4688889999999999999965 4789999998743321 1235678888888865 899999999999
Q ss_pred CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCCCeee
Q 003199 604 LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDV-----NYQPKVA 678 (840)
Q Consensus 604 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~ 678 (840)
....++||||+ +++|.+++......+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 789999998776689999999999999999999999 99999999999999974 5679999
Q ss_pred cccchhhhhccCCCC----cceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhh
Q 003199 679 DFGIAKVLQARGGKD----STTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVS 754 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 754 (840)
|||+|+.+....... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.......... ....
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~~~ 227 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYER 227 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-HHHH
Confidence 999998875432211 23345679999999999999999999999999999999999999997543222111 1111
Q ss_pred hhhccccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhhc
Q 003199 755 IKVDTKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQLLAEA 810 (840)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~ 810 (840)
....... .....+.+.+ +.++.+++..|+..+|++||+++.+.+.|+++
T Consensus 228 i~~~~~~----~~~~~l~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 228 IGEKKQS----TPLRELCAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHH----SCHHHHTTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHhccCC----CChHHhcCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000000 0001111122 24566777899999999999999998888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=356.21 Aligned_cols=266 Identities=22% Similarity=0.271 Sum_probs=202.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEecC
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSSL 604 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 604 (840)
++|+..+.||+|+||+||+|.. .+|+.||||+++..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 73 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--------EGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC--------hHHHHHHHHHHHHHHhcCcCCEEeeccccccc
Confidence 4688899999999999999965 58999999998543311 23456788999999999999999999999999
Q ss_pred ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 605 YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 605 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|++.++++...+.... .+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.|+
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceeEEeeecccccccccccccc-ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhh
Confidence 99999999999999888776654 78999999999999999999999 999999999999999999999999999998
Q ss_pred hhhccCCCCcceecccccccccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhcc-ccc
Q 003199 685 VLQARGGKDSTTTVIAGTYGYLAPEYAYSSK-ATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVDT-KEG 762 (840)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 762 (840)
.... .........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+............... ...
T Consensus 150 ~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 150 AFGI---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp ECCS---CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccC---CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence 7643 222334456788999999887655 68999999999999999999999754221111110000000000 000
Q ss_pred h------hhh-------cccccCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 763 I------MEV-------LDKKLSGSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 763 ~------~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
. ... ...............+.+++.+|++.||.+|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000 0000111112233456778889999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-41 Score=358.59 Aligned_cols=257 Identities=19% Similarity=0.287 Sum_probs=194.5
Q ss_pred HhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcceeeeEEec
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIVKLYCYFSS 603 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 603 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++.... .+.+.+|+++++.+. ||||+++++++..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 5799999999999999999965 579999999984322 346788999999995 9999999999874
Q ss_pred --CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CCeeecc
Q 003199 604 --LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNY-QPKVADF 680 (840)
Q Consensus 604 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Df 680 (840)
....++||||+++++|..... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred cCCCceeEEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeeccc
Confidence 456789999999999977643 58999999999999999999999 9999999999999998765 5899999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhh----
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSI---- 755 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---- 755 (840)
|+|+.... ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||................
T Consensus 175 G~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 175 GLAEFYHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp GGCEECCT----TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred ccceeccC----CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 99987643 2234556789999999998765 47999999999999999999999997532211100000000
Q ss_pred ---------hhccccchhhhcccc--------cC-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 756 ---------KVDTKEGIMEVLDKK--------LS-GSFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 756 ---------~~~~~~~~~~~~~~~--------~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
............... .. ........++.+++.+|++.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 00 0111223567788899999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-42 Score=361.26 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=200.3
Q ss_pred HhcCccCeeeccCCcEEEEEEe----CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCC-CCcceeeeE
Q 003199 526 EAMTEKNKVGQGGSGTVYKIDL----NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRH-KNIVKLYCY 600 (840)
Q Consensus 526 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~ 600 (840)
++|+..+.||+|+||+||+|.. .+|+.||||++........ ....+.+.+|++++++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK------AKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE------ESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc------hHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 5688999999999999999954 2589999999864432111 1113456789999999977 899999999
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
+.+....++||||+.+|+|.+++.... .++...+..++.|++.|++|+|+ .+||||||||+||+++.++.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeec
Confidence 999999999999999999999998765 57889999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhhhhhhc
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS--KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWVSIKVD 758 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 758 (840)
|+|+.+... .........|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+........... .....
T Consensus 174 G~a~~~~~~--~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~-~~~~~ 250 (322)
T d1vzoa_ 174 GLSKEFVAD--ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRILK 250 (322)
T ss_dssp SEEEECCGG--GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-HHHHH
T ss_pred cchhhhccc--ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-Hhccc
Confidence 999876432 22334456799999999998654 46889999999999999999999997653322211111 10000
Q ss_pred cccchhhhcccccCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003199 759 TKEGIMEVLDKKLSGSFRDEMIQVLRIAIRCTSKSPATRP-----TMNEVVQL 806 (840)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~ 806 (840)
. ....+. .....+.+++.+|+++||++|| +++|+++|
T Consensus 251 ~--------~~~~~~---~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 S--------EPPYPQ---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C--------CCCCCT---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred C--------CCCCcc---cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 111112 2345666788899999999999 48999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=360.17 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=189.6
Q ss_pred HHhcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|+.++++++|||||++++++..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--------QTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS--------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC--------HHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 35788999999999999999965 57999999998543311 2335678899999999999999999999854
Q ss_pred ------CccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCee
Q 003199 604 ------LYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKV 677 (840)
Q Consensus 604 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 677 (840)
....|+||||+.++ +.+.+.. .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|+
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEE
T ss_pred ccccccCceeEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceee
Confidence 35779999999655 4444443 58999999999999999999999 99999999999999999999999
Q ss_pred ecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch--------
Q 003199 678 ADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNI-------- 749 (840)
Q Consensus 678 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------- 749 (840)
+|||+++.... ........||+.|+|||++.+..+++++||||+||++|||++|+.||.+........
T Consensus 161 ~df~~~~~~~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 161 LDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp CCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred echhhhhcccc----ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 99999876533 234455679999999999999999999999999999999999999997532100000
Q ss_pred ---hhhhhhh-------hc----cccchhhhccccc-CC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003199 750 ---IYWVSIK-------VD----TKEGIMEVLDKKL-SG---SFRDEMIQVLRIAIRCTSKSPATRPTMNEVVQL 806 (840)
Q Consensus 750 ---~~~~~~~-------~~----~~~~~~~~~~~~~-~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~ 806 (840)
..|.... .. ............. .. ........+.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 00 0000011111111 11 112345678899999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=352.11 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=196.0
Q ss_pred HHhcCccCeeeccCCcEEEEEE-eCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCcceeeeEEec
Q 003199 525 LEAMTEKNKVGQGGSGTVYKID-LNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCYFSS 603 (840)
Q Consensus 525 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 603 (840)
.++|+..+.||+|+||+||+|. ..+|+.||||++..... .....+.+.+|++++++++|||+|++++++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS--------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc--------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3568899999999999999996 46899999999854321 12335678899999999999999999999854
Q ss_pred C-----ccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeee
Q 003199 604 L-----YCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVA 678 (840)
Q Consensus 604 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 678 (840)
. ...++|++|+.+|+|.+++..+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCcccccccccccccc
Confidence 3 3447778888899999999764 69999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhccCCCCcceecccccccccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhhh-hhh
Q 003199 679 DFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSS-KATTKCDVYSFGVVLMELITGRKPVEDDFGDNKNIIYWV-SIK 756 (840)
Q Consensus 679 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~ 756 (840)
|||.|.... .......||+.|+|||...+. .++.++||||+||++|||++|+.||.+... ....... ...
T Consensus 164 dfg~a~~~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~ 235 (348)
T d2gfsa1 164 DFGLARHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLV 235 (348)
T ss_dssp CC----CCT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH
T ss_pred ccchhcccC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhc
Confidence 999997543 233456799999999987665 468999999999999999999999975311 0000000 000
Q ss_pred hcccc---------c---hhhhcccccCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhhcC
Q 003199 757 VDTKE---------G---IMEVLDKKLSGSF----RDEMIQVLRIAIRCTSKSPATRPTMNEVVQL--LAEAD 811 (840)
Q Consensus 757 ~~~~~---------~---~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~ 811 (840)
..... . ............+ ......+.+++.+|++.||++|||++|+++| +.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000 0 0000000000011 1123456788899999999999999999986 55443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-35 Score=319.32 Aligned_cols=282 Identities=21% Similarity=0.226 Sum_probs=194.6
Q ss_pred hcCccCeeeccCCcEEEEEEe-CCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-----------CCCc
Q 003199 527 AMTEKNKVGQGGSGTVYKIDL-NSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-----------HKNI 594 (840)
Q Consensus 527 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni 594 (840)
+|+..+.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.+++.+. |+||
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----------cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 488899999999999999965 589999999985321 22355677888887775 5789
Q ss_pred ceeeeEEec--CccceEEEeecCCCChHHH--hhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 003199 595 VKLYCYFSS--LYCNLLVYEYMPNGNLWDA--LHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLD 670 (840)
Q Consensus 595 v~l~~~~~~--~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~ 670 (840)
+++++++.. ....+++++++..+..... .......+++..+..++.||+.|++|||+. .+|+||||||+|||++
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLME 160 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeee
Confidence 999988754 3455667777655543332 223345789999999999999999999973 7899999999999998
Q ss_pred CCCC------CeeecccchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 003199 671 VNYQ------PKVADFGIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVLMELITGRKPVEDDFG 744 (840)
Q Consensus 671 ~~~~------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 744 (840)
.++. ++++|||.|..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||.....
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccCcccccceeeEeeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 6654 89999999876532 23456799999999999999999999999999999999999999975432
Q ss_pred CCc-c----hhhhhhhhhcc-------ccchhhhcc-----c---------------ccCCCcHHHHHHHHHHHHHccCC
Q 003199 745 DNK-N----IIYWVSIKVDT-------KEGIMEVLD-----K---------------KLSGSFRDEMIQVLRIAIRCTSK 792 (840)
Q Consensus 745 ~~~-~----~~~~~~~~~~~-------~~~~~~~~~-----~---------------~~~~~~~~~~~~l~~l~~~cl~~ 792 (840)
... . ........... ........+ . ............+.+++.+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 110 0 00000000000 000000000 0 01112245667889999999999
Q ss_pred CCCCCCCHHHHHHH--hhhcCCCCCCCCCCCCCccccCC
Q 003199 793 SPATRPTMNEVVQL--LAEADPCRFESCKFPNKSNKESS 829 (840)
Q Consensus 793 dP~~Rps~~evl~~--L~~~~~~~~~~~~~~~~~~~~~~ 829 (840)
||++|||++|+++| +++.. +.+....|.+..-.++
T Consensus 315 dP~~Rpta~e~L~Hp~f~~~~--~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 315 DPRKRADAGGLVNHPWLKDTL--GMEEIRVPDRELYGSG 351 (362)
T ss_dssp STTTCBCHHHHHTCGGGTTCT--TCTTCCCTTSCTTCBS
T ss_pred ChhHCcCHHHHhcCcccCCCC--CcccCCCCCcccCCCC
Confidence 99999999999987 55333 3334444444433333
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5e-29 Score=271.80 Aligned_cols=210 Identities=24% Similarity=0.353 Sum_probs=107.4
Q ss_pred CCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhh
Q 003199 164 LPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFL 243 (840)
Q Consensus 164 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 243 (840)
.+.........|... ....+..+++++.|++++|.+++..+ +..+++|+.|++++|+++.. ..+..+++|+.++
T Consensus 174 ~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 247 (384)
T d2omza2 174 LTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 247 (384)
T ss_dssp CTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred ccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhc
Confidence 333444444444432 23345556666666666666654332 34455666666666665532 2344444455555
Q ss_pred cccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeee
Q 003199 244 VLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISG 323 (840)
Q Consensus 244 l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 323 (840)
+.+|.+.+..+ +..+++|+.|++++|++++. + .+..++.++.++++.|++++. ..+..+++++.|++++|++++
T Consensus 248 l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~ 321 (384)
T d2omza2 248 LANNQISNLAP--LSGLTKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISD 321 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSC
T ss_pred cccCccCCCCc--ccccccCCEeeccCcccCCC-C-ccccccccccccccccccccc--cccchhcccCeEECCCCCCCC
Confidence 55554443322 44555555555555555422 1 244555555555555555532 224455555555555555554
Q ss_pred ccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCc
Q 003199 324 FIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391 (840)
Q Consensus 324 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 391 (840)
.. .+..+++|+.|++++|+|++ ++ .++++++|+.|+|++|+|++..| +.++++|+.|+|++|
T Consensus 322 l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 322 IS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred Cc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 32 24555555555555555553 22 35555555555555555554333 555555555555555
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.6e-30 Score=275.00 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=118.4
Q ss_pred CCCeeecccCccccc--cCCcccCCCCCCCeeeccC-CcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCE
Q 003199 117 NLRQLELYYNQQLAG--TIPEELGNLTELTDLDMSV-NHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTM 193 (840)
Q Consensus 117 ~L~~L~L~~n~~~~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 193 (840)
+++.|+|++|. +.+ .+|..++++++|++|+|++ |++++.+|..|.++++|++|+|++|++.+..+..+..+..|+.
T Consensus 51 ~v~~L~L~~~~-l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLN-LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCC-CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEECCCCC-CCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 45556666554 222 3555566666666666654 5555555555666666666666666665555555555566666
Q ss_pred EEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCcee
Q 003199 194 LSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHL 273 (840)
Q Consensus 194 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l 273 (840)
+++++|++.+.+|..+..++.|+.+++++|.+.+.+|..+..+..+ ++.+++++|++
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l 186 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------FTSMTISRNRL 186 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------CCEEECCSSEE
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccc-----------------------ccccccccccc
Confidence 6666665555555555555555555555555554444443333322 13344444444
Q ss_pred eccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcc
Q 003199 274 EGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGI 353 (840)
Q Consensus 274 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 353 (840)
++..|..+..+..+ .+++++|.+.+.++..+..+++|+.+++++|.+.+.+ ..+..+++|+.|+|++|+++|.+|..|
T Consensus 187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHH
Confidence 44333333333222 3444444444444444444444444444444443222 223333444444444444444444444
Q ss_pred cCccccchhcccCCccCCCcchhcccccCCCEEECcCc
Q 003199 354 GNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNN 391 (840)
Q Consensus 354 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 391 (840)
+++++|+.|+|++|+|+|.+|. ++++++|+.+++++|
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N 301 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSS
T ss_pred hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCC
Confidence 4444444444444444443332 233444444444444
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.2e-29 Score=268.05 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=222.7
Q ss_pred CCCCcEEEccCCcccc--cCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCc
Q 003199 91 VTSLTDLELTGNFITG--HIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLR 168 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (840)
-.+++.|+|++|.+.+ .+|..+++|++|++|+|++++.+.+.+|..|+++++|++|+|++|++.+..+..+..+.+|+
T Consensus 49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 3479999999999987 47899999999999999973337788999999999999999999999999999999999999
Q ss_pred EEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCc-ceeccccccccccCCccccCCCCchhhhcccc
Q 003199 169 VLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPL-VVLDLSENKLSGPLPAKVCSRGKLQYFLVLQN 247 (840)
Q Consensus 169 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 247 (840)
.+++++|.+.+..|..+.+++.|+++++++|.+.+.+|..+..+..+ +.+++++|++++..+.
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~---------------- 192 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP---------------- 192 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCG----------------
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccc----------------
Confidence 99999999999999999999999999999999999999999888776 8899999998865544
Q ss_pred cccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccch
Q 003199 248 MFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPS 327 (840)
Q Consensus 248 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 327 (840)
.+..+. +..++++++...+.+|..+..+++|+.+++++|.+.+.++ .++.+++|+.|+|++|++++.+|.
T Consensus 193 --------~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~ 262 (313)
T d1ogqa_ 193 --------TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp --------GGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCG
T ss_pred --------cccccc-cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCCh
Confidence 344443 3468888888888888888888888889998888886654 578889999999999999999999
Q ss_pred hhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCc-cCCC
Q 003199 328 EIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNK-LNSS 372 (840)
Q Consensus 328 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~ 372 (840)
.+.++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|.
T Consensus 263 ~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 263 GLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred HHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 999999999999999999988885 6789999999999997 5554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=4.4e-28 Score=264.19 Aligned_cols=356 Identities=23% Similarity=0.278 Sum_probs=273.7
Q ss_pred EecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEccC
Q 003199 22 LDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLELTG 101 (840)
Q Consensus 22 L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 101 (840)
..++.+.+++.+. ...+.+|++|++++|. |.++ +.+..+++|++|+|++|.|++.. .++++++|++|++++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~---I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~ 97 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLG---IKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNN 97 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSC---CCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCC---CCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccc
Confidence 4677777775544 3567788999999884 4444 24778888999999999888543 388899999999999
Q ss_pred CcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccccc
Q 003199 102 NFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEI 181 (840)
Q Consensus 102 n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 181 (840)
|+|++. + .+..+++|+.|++++|. ..+ + ........+..+....|.+....+..................
T Consensus 98 n~i~~i-~-~l~~l~~L~~L~~~~~~-~~~-~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~----- 167 (384)
T d2omza2 98 NQIADI-T-PLANLTNLTGLTLFNNQ-ITD-I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD----- 167 (384)
T ss_dssp SCCCCC-G-GGTTCTTCCEEECCSSC-CCC-C-GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----
T ss_pred cccccc-c-ccccccccccccccccc-ccc-c-ccccccccccccccccccccccccccccccccccccccccch-----
Confidence 999854 3 38889999999998886 222 2 234556778888888888875443333322222222222222
Q ss_pred chhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCccccccc
Q 003199 182 SSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCK 261 (840)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~ 261 (840)
...+.............|... ....+..+++++.+++++|.+++..| +....+|+.|++.+|.+... +.+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~ 241 (384)
T d2omza2 168 LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLT 241 (384)
T ss_dssp CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCT
T ss_pred hhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhccc
Confidence 234566777777888887765 44567788999999999999997654 45668899999999998753 4688999
Q ss_pred CCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcC
Q 003199 262 NLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLS 341 (840)
Q Consensus 262 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 341 (840)
+|+.|++++|.+++.. .+..+++|+.|++++|++++.. .+..++.++.+.+++|++++. ..+..+++++.|+++
T Consensus 242 ~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls 315 (384)
T d2omza2 242 NLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLY 315 (384)
T ss_dssp TCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECC
T ss_pred ccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECC
Confidence 9999999999998543 3788999999999999998654 377899999999999999853 457888999999999
Q ss_pred CCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhcc-CCCeEEccCC
Q 003199 342 DNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCEL-LPNSINFSNN 414 (840)
Q Consensus 342 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~l~l~~N 414 (840)
+|++++.. .+..+++|+.|+|++|+|++ ++ .+..+++|++|+|++|+|++..| +..+ .++.|++++|
T Consensus 316 ~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 316 FNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 99999754 38889999999999999984 44 68999999999999999997655 5666 6789999987
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=4.4e-26 Score=239.62 Aligned_cols=268 Identities=23% Similarity=0.336 Sum_probs=143.8
Q ss_pred ccEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeecc
Q 003199 70 LRIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMS 149 (840)
Q Consensus 70 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~ 149 (840)
+++++-+++.++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|. +....|..|.++++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~-~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC-CCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccc-ccccchhhhhCCCccCEeccc
Confidence 445555555555 3454443 456667777776664444456666666666666665 333345556666666666666
Q ss_pred CCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccC
Q 003199 150 VNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPL 229 (840)
Q Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 229 (840)
+|+++. +|..+ ...|+.|++.+|.+..+.+..+.....+..++...|......
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~------------------------ 140 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG------------------------ 140 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG------------------------
T ss_pred CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccC------------------------
Confidence 666663 33222 245666666666666555555555555555555555432110
Q ss_pred CccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCC
Q 003199 230 PAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNAR 309 (840)
Q Consensus 230 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 309 (840)
..+..+..+++|+.+++++|.+. .+|..+ +++|+.|++++|.++...+..|..++
T Consensus 141 ----------------------~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~ 195 (305)
T d1xkua_ 141 ----------------------IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195 (305)
T ss_dssp ----------------------BCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCT
T ss_pred ----------------------CCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccc
Confidence 11122333344444444444443 223222 34455555555555555555555555
Q ss_pred CCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchh------cccccCC
Q 003199 310 NLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNS------LSSLKSL 383 (840)
Q Consensus 310 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~------~~~l~~L 383 (840)
.++.|++++|.+++..+..+..+++|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+...... +..+.+|
T Consensus 196 ~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L 274 (305)
T d1xkua_ 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274 (305)
T ss_dssp TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCC
T ss_pred cccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCC
Confidence 5555555555555555555555556666666666655 34555556666666666666665432222 2345667
Q ss_pred CEEECcCcccc
Q 003199 384 NVLDLSNNLLT 394 (840)
Q Consensus 384 ~~L~l~~N~l~ 394 (840)
+.|+|++|+++
T Consensus 275 ~~L~L~~N~~~ 285 (305)
T d1xkua_ 275 SGVSLFSNPVQ 285 (305)
T ss_dssp SEEECCSSSSC
T ss_pred CEEECCCCcCc
Confidence 77777777764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=9.1e-26 Score=237.15 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=141.6
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEE
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDL 97 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 97 (840)
.++++|-++++++ .+|..+. +++++|+|++| ++..+++..|.++++|++|++++|.+....|..|.++++|++|
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N---~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L 84 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNN---KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 84 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSS---CCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCC---cCCCcChhHhhccccccccccccccccccchhhhhCCCccCEe
Confidence 5678888888888 6676663 57888888888 6667776667777777777777777776666667777777777
Q ss_pred EccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccc
Q 003199 98 ELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSL 177 (840)
Q Consensus 98 ~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 177 (840)
++++|+|+ .+|.. ... .|..|++.+|.+....+..+.....+..++...|..
T Consensus 85 ~l~~n~l~-~l~~~--~~~-------------------------~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 85 YLSKNQLK-ELPEK--MPK-------------------------TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136 (305)
T ss_dssp ECCSSCCS-BCCSS--CCT-------------------------TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred cccCCccC-cCccc--hhh-------------------------hhhhhhccccchhhhhhhhhhccccccccccccccc
Confidence 77777766 33322 123 444455555555544444444555555555555543
Q ss_pred c--cccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCc
Q 003199 178 S--GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPD 255 (840)
Q Consensus 178 ~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 255 (840)
. ...+..|..+++|+.+++++|.+.. ++..+ .++|+.|++++|.+++..+..|..+..++.|.+++|.+.+..+.
T Consensus 137 ~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~ 213 (305)
T d1xkua_ 137 KSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213 (305)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred cccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccc
Confidence 2 2334456666666666666666653 33322 35666666666666544444333333333333333333334444
Q ss_pred ccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCccccc
Q 003199 256 SLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGP 300 (840)
Q Consensus 256 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 300 (840)
.+..+++|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+.+
T Consensus 214 ~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 214 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp TGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred cccccccceeeeccccccc-ccccccccccCCCEEECCCCccCcc
Confidence 5555555555555555555 3455555555555555555555543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.5e-26 Score=235.45 Aligned_cols=253 Identities=21% Similarity=0.212 Sum_probs=178.8
Q ss_pred eeccCCcccccCCccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccc-ccc
Q 003199 146 LDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLS-ENK 224 (840)
Q Consensus 146 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~-~N~ 224 (840)
++.++++++ .+|..+. +.+++|+|++|+|+.+.+..|.++++|++|++++|++..+.+..+..+..+..++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 445555555 3343332 345666666666665555556666666666666666665555555555555555443 233
Q ss_pred ccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcc
Q 003199 225 LSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANT 304 (840)
Q Consensus 225 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 304 (840)
++ ...+..|.++++|++|++++|.+....+..+...++|+.+++++|+++++.+..
T Consensus 93 ~~------------------------~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 93 LR------------------------SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (284)
T ss_dssp CC------------------------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred cc------------------------cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH
Confidence 33 234556667777777777777776555666777788888888888888777788
Q ss_pred cCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCC
Q 003199 305 VGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLN 384 (840)
Q Consensus 305 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 384 (840)
|..+++|+.|++++|++++..+..|..+++|+.+++++|++++..|..|.++++|+.|++++|++.+..+..|..+++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 88888888888888888888788888888999999999999888888899999999999999999988888999999999
Q ss_pred EEECcCccccccCCchhhccCCCeEEccCCCCcCcCCcccc
Q 003199 385 VLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIPLSLI 425 (840)
Q Consensus 385 ~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p~~~~ 425 (840)
+|+|++|++.+..+.......++.+....+.+.|..|..+.
T Consensus 229 ~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 229 YLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp EEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred EEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHHc
Confidence 99999999987655322111234455566777777776543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9e-26 Score=234.37 Aligned_cols=268 Identities=18% Similarity=0.150 Sum_probs=140.9
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEee-c
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY-N 174 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~ 174 (840)
.++.+++.++ .+|..+. +++++|+|++|+ +....+.+|.++++|++|++++|++..+.+..+..+..++.+... .
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~-i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCc-CCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 3455555555 3443332 344555555554 222222344455555555555555544444444444444444432 3
Q ss_pred cccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCC
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLP 254 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 254 (840)
|.++.+.+..|.++++|++|++++|.+....+..+....+|+.+++++|+++ ++.+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~------------------------~i~~ 146 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ------------------------ALPD 146 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC------------------------CCCT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc------------------------ccCh
Confidence 3344444444444445555555554444333444444444444444444444 3444
Q ss_pred cccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCc
Q 003199 255 DSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAIS 334 (840)
Q Consensus 255 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 334 (840)
.+|..+++|+.|++++|++++..+..|..+++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|..+++
T Consensus 147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~ 226 (284)
T d1ozna_ 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence 55666666666666666666555666666666666666666666666666666666666666666666666666666666
Q ss_pred ccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 335 LVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 335 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
|+.|+|++|++...-+ ...-...++.+....+++....|..+.+ ...++++.+.|+|
T Consensus 227 L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 227 LQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 6666666666653221 1111233555566666666555555443 2333455555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.7e-23 Score=214.48 Aligned_cols=205 Identities=23% Similarity=0.277 Sum_probs=181.9
Q ss_pred CCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccC
Q 003199 11 PDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGN 90 (840)
Q Consensus 11 ~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 90 (840)
.+++....+.+.|.++++++ .+|..+. ++|++|+|++| .+..+++..|.++++|++|+|++|.|+.. | .++.
T Consensus 4 C~~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N---~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~ 75 (266)
T d1p9ag_ 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSEN---LLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGT 75 (266)
T ss_dssp SEEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTS---CCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSC
T ss_pred cEEcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCC---cCCCcCHHHhhcccccccccccccccccc-c-cccc
Confidence 34567778888999999999 6787664 58999999999 77888889999999999999999999854 3 4678
Q ss_pred CCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEE
Q 003199 91 VTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVL 170 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (840)
+++|++|+|++|+++ ..+..+..+++|+.|++++|. +....+..+..+.++++|++++|.++.+.+..+..+++|+.|
T Consensus 76 l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~-~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l 153 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (266)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSC-CCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccccccccccccc-ccccccccccccccccccccc-cceeeccccccccccccccccccccceeccccccccccchhc
Confidence 999999999999999 567889999999999999997 455556678889999999999999998888888899999999
Q ss_pred EeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 171 QLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 171 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 154 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 99999999998899999999999999999999 67888888999999999999886
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.1e-23 Score=212.55 Aligned_cols=203 Identities=22% Similarity=0.280 Sum_probs=156.6
Q ss_pred CCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhh
Q 003199 163 RLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYF 242 (840)
Q Consensus 163 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 242 (840)
....+.+.+.+++.|+.+ |..+ .++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.
T Consensus 8 ~~~~~~~v~C~~~~L~~i-P~~l--p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~--------------- 69 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--------------- 69 (266)
T ss_dssp CSTTCCEEECTTSCCSSC-CSCC--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE---------------
T ss_pred ccCCCeEEEccCCCCCee-CcCc--CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc---------------
Confidence 344555667777777643 3322 1456777777777765555566666777777777766652
Q ss_pred hcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceee
Q 003199 243 LVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQIS 322 (840)
Q Consensus 243 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 322 (840)
++ .++.+++|++|++++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++
T Consensus 70 ----------l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 70 ----------LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp ----------EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred ----------cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc
Confidence 22 2456788899999999988 56777888899999999999998888888888899999999999998
Q ss_pred eccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCcccccc
Q 003199 323 GFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGY 396 (840)
Q Consensus 323 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 396 (840)
...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.+.
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 777777788889999999999998877788888999999999999998 6777777888999999999988754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.2e-23 Score=199.91 Aligned_cols=179 Identities=15% Similarity=0.144 Sum_probs=123.1
Q ss_pred CccCeeeccCCcEEEEEEeCCCcEEEEEEeccccccccc--------CchhhHHHHHHHHHHHHHHhccCCCCcceeeeE
Q 003199 529 TEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSA--------SDTDQLQLDKGLKTEVETLGNIRHKNIVKLYCY 600 (840)
Q Consensus 529 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 600 (840)
...++||+|+||+||+|...+|+.||||+++........ ..............|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999998888999999987543221100 001112234556778999999999999988765
Q ss_pred EecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCCeeecc
Q 003199 601 FSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGLLSPIIHRDIKSTNILLDVNYQPKVADF 680 (840)
Q Consensus 601 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 680 (840)
. ..++||||++++.+. .+++.....++.|++.|++|||+ ++|+||||||+|||+++++ ++++||
T Consensus 83 ~----~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEECCC
T ss_pred c----CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEEEEC
Confidence 3 247999999876543 24556678899999999999999 9999999999999999764 899999
Q ss_pred cchhhhhccCCCCcceecccccccccCccccccCCCCccccchhHHHHH
Q 003199 681 GIAKVLQARGGKDSTTTVIAGTYGYLAPEYAYSSKATTKCDVYSFGVVL 729 (840)
Q Consensus 681 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il 729 (840)
|.|.....+.. ......+... -.+ ...+.|..++|+||..--+
T Consensus 147 G~a~~~~~~~~----~~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW----REILERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH----HHHHHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc----HHHHHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 99876532110 0000000000 001 1235678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=5.9e-20 Score=196.52 Aligned_cols=304 Identities=24% Similarity=0.285 Sum_probs=192.6
Q ss_pred CCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 17 QNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 17 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
.+|++|||++|+++ .+|+. +++|++|+|++| +|+++|.. +.+|+.|++++|.++. ++. + .+.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N---~l~~lp~~----~~~L~~L~l~~n~l~~-l~~-l--p~~L~~ 102 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCN---SLTELPEL----PQSLKSLLVDNNNLKA-LSD-L--PPLLEY 102 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSS---CCSSCCCC----CTTCCEEECCSSCCSC-CCS-C--CTTCCE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCC---CCcccccc----hhhhhhhhhhhcccch-hhh-h--cccccc
Confidence 36899999999998 67864 578999999999 66666642 4678888999998873 232 1 135889
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 176 (840)
|+|++|.+. .+|. +..+++|+.|++++|. ....+. ....+..+.+..+.... ...+..++.++.|++++|.
T Consensus 103 L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~--~~~~~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 103 LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNS--LKKLPD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EECCSSCCS-SCCC-CTTCTTCCEEECCSSC--CSCCCC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSC
T ss_pred ccccccccc-cccc-hhhhccceeecccccc--cccccc---ccccccchhhccccccc--cccccccccceeccccccc
Confidence 999999988 4553 5778889999988876 223332 34567777777776652 3457778888888888888
Q ss_pred cccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcc
Q 003199 177 LSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDS 256 (840)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 256 (840)
+..... .....+.+...++.+. .. ..+..++.|+.+++++|..... +.
T Consensus 174 ~~~~~~----~~~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~~~-~~------------------------- 221 (353)
T d1jl5a_ 174 LKKLPD----LPLSLESIVAGNNILE-EL-PELQNLPFLTTIYADNNLLKTL-PD------------------------- 221 (353)
T ss_dssp CSSCCC----CCTTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSSCCSSC-CS-------------------------
T ss_pred cccccc----cccccccccccccccc-cc-cccccccccccccccccccccc-cc-------------------------
Confidence 764322 2234566777766665 23 3456677888888888776521 11
Q ss_pred cccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCccc
Q 003199 257 LARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLV 336 (840)
Q Consensus 257 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 336 (840)
...++..+.+.+|.+. ..+. ....+...++..+.+.+... -.......++..|.+.+. + ..+++|+
T Consensus 222 --~~~~l~~~~~~~~~~~-~~~~---~~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~-~---~~~~~L~ 287 (353)
T d1jl5a_ 222 --LPPSLEALNVRDNYLT-DLPE---LPQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL-C---DLPPSLE 287 (353)
T ss_dssp --CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE-C---CCCTTCC
T ss_pred --cccccccccccccccc-cccc---cccccccccccccccccccc----ccchhcccccccCccccc-c---ccCCCCC
Confidence 1234555666666654 2222 22345555555554442111 012344555666655532 1 2245677
Q ss_pred EEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCc
Q 003199 337 KIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPE 399 (840)
Q Consensus 337 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 399 (840)
+|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.
T Consensus 288 ~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 288 ELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp EEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred EEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 7777777777 45543 456777777777776 45532 456777788888777 4553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=4.7e-19 Score=189.36 Aligned_cols=306 Identities=25% Similarity=0.276 Sum_probs=206.4
Q ss_pred ccccccccCCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccc
Q 003199 2 SFMYLTGTLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 2 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~ 81 (840)
+.+.++ .+|++ .++|++|+|++|+|+ .+|.. +.+|+.|++++|.+..+..+| +.|++|++++|.+.
T Consensus 46 s~~~L~-~lp~~--~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~lp-------~~L~~L~L~~n~l~ 111 (353)
T d1jl5a_ 46 NNLGLS-SLPEL--PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSDLP-------PLLEYLGVSNNQLE 111 (353)
T ss_dssp TTSCCS-CCCSC--CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCSCC-------TTCCEEECCSSCCS
T ss_pred CCCCCC-CCCCC--CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhhhc-------cccccccccccccc
Confidence 344554 46763 579999999999999 77865 468999999999666555443 46999999999998
Q ss_pred ccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccc
Q 003199 82 GQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESI 161 (840)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (840)
. +|. ++.+++|++|++++|.+.. .+. ....+..+.+..+.. .....+..++.++.|++++|.+.. .+.
T Consensus 112 ~-lp~-~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~---~~~~~l~~l~~l~~L~l~~n~~~~-~~~-- 179 (353)
T d1jl5a_ 112 K-LPE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQL---EELPELQNLPFLTAIYADNNSLKK-LPD-- 179 (353)
T ss_dssp S-CCC-CTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC---SSCCCCTTCTTCCEEECCSSCCSS-CCC--
T ss_pred c-ccc-hhhhccceeeccccccccc-ccc---ccccccchhhccccc---cccccccccccceecccccccccc-ccc--
Confidence 4 554 6889999999999999983 333 346677888876652 234567889999999999999884 332
Q ss_pred cCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchh
Q 003199 162 LRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQY 241 (840)
Q Consensus 162 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 241 (840)
.....+.+...++.+... ..+..++.|+.+++++|.... .+. ...++..+.+.+|.+.... .
T Consensus 180 -~~~~~~~l~~~~~~~~~~--~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~-~---------- 241 (353)
T d1jl5a_ 180 -LPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP-E---------- 241 (353)
T ss_dssp -CCTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC-C----------
T ss_pred -cccccccccccccccccc--ccccccccccccccccccccc-ccc---ccccccccccccccccccc-c----------
Confidence 233456777777777632 246789999999999999873 343 3456788888888776321 1
Q ss_pred hhcccccccccCCcccccccCCceEEeeCceeeccCCccccCC-CcccEEeccCCcccccCCcccCCCCCCceeecccce
Q 003199 242 FLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSL-PHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQ 320 (840)
Q Consensus 242 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 320 (840)
..+++...++..+.+.+ +..+ ......++..|.+.+. ...+++|++|+|++|+
T Consensus 242 -----------------~~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~ 295 (353)
T d1jl5a_ 242 -----------------LPQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNK 295 (353)
T ss_dssp -----------------CCTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSC
T ss_pred -----------------ccccccccccccccccc-----cccccchhcccccccCccccc----cccCCCCCEEECCCCc
Confidence 11233444444444331 1111 2334455566655532 2235677888888887
Q ss_pred eeeccchhhcccCcccEEEcCCCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECc
Q 003199 321 ISGFIPSEIYRAISLVKIDLSDNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLS 389 (840)
Q Consensus 321 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 389 (840)
|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|... .+|+.|.+.
T Consensus 296 l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 296 LI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred cC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 77 44533 467888888888887 45643 456888888888887 556532 356666554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.1e-19 Score=179.89 Aligned_cols=220 Identities=15% Similarity=0.072 Sum_probs=155.9
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccC-CccccCCCCCcEE
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQI-PASIGNVTSLTDL 97 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L 97 (840)
.++++.++++++ .+|..+. +++++|+|++| .+..++...|.++++|++|++++|.+...+ +.+|.+++++++|
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n---~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLT---KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESC---CCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCC---cCCccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 367888888888 7776553 57889999998 677778888888889999999888886543 4578888888888
Q ss_pred Ecc-CCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCC-CCcEEEeecc
Q 003199 98 ELT-GNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLP-KLRVLQLYNN 175 (840)
Q Consensus 98 ~L~-~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N 175 (840)
.+. .|.+....+..|..+++|+.|++++|++........+..++.+..+...++.+..+.+..|.+++ .++.|++++|
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n 163 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccc
Confidence 775 46777677778888888888888888732222222344556666667777777766667777664 6788888888
Q ss_pred ccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhc
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLV 244 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 244 (840)
+++.+....|....-++.+++++|+++.+.+..|.++++|++|+|++|+|+...+..|.++.+|+++++
T Consensus 164 ~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 888666655544333334456777888655666788888888888888887554444555555554443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=8.8e-19 Score=176.48 Aligned_cols=218 Identities=15% Similarity=0.145 Sum_probs=107.8
Q ss_pred cEEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccC
Q 003199 71 RIMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSV 150 (840)
Q Consensus 71 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~ 150 (840)
+.++.++..++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.......+..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34455555554 3443332 35666666666666444445666666666666666522222233456666666666543
Q ss_pred -CcccccCCccccCCCCCcEEEeeccccccccc-hhhhcCCCCCEEEccCCcCcccCCcCCCCCC-Ccceeccccccccc
Q 003199 151 -NHLSGKIPESILRLPKLRVLQLYNNSLSGEIS-SVIANSTTLTMLSLYDNSLTGEVPQDLGQWS-PLVVLDLSENKLSG 227 (840)
Q Consensus 151 -n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~ 227 (840)
|++....+..|.++++|++|++++|.+....+ ..+..+..+..+..+++++..+.+..|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 45555555666666666666666666653322 2233445555555566666655555555543 56666666666664
Q ss_pred cCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEe
Q 003199 228 PLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIID 291 (840)
Q Consensus 228 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 291 (840)
..+..|......+.+.+.+|.+....++.|.++++|++|++++|+|+...+..|.++++|+.++
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence 3332222111111222233333333333444445555555555554432233344444444433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=2e-19 Score=173.86 Aligned_cols=177 Identities=19% Similarity=0.235 Sum_probs=139.8
Q ss_pred CceEEeeCceeeccCCccccCCCcccEEeccCCcccc-cCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcC
Q 003199 263 LLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSG-PIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLS 341 (840)
Q Consensus 263 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 341 (840)
.+.++.++++++ .+|..+. +++++|+|++|+|+. ..+..|..+++|+.|+|++|++....+..+..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 356888888888 6777663 688899999999975 456778889999999999999998888888889999999999
Q ss_pred CCccCCCCCCcccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccccCCchhhccCCCeEEccCCCCcCcCC
Q 003199 342 DNLLSGPIPSGIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTGYIPESLCELLPNSINFSNNRLSGPIP 421 (840)
Q Consensus 342 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~l~l~~N~l~~~~p 421 (840)
+|+|++..|.+|.++++|+.|+|++|+|++..+.+|..+++|++|+|++|++.+..+..+....+..+.+..|.+.+..|
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 99999877888999999999999999999888888999999999999999998655433322223455677788888777
Q ss_pred cccccCCCcccccCCCCCcccc
Q 003199 422 LSLIKEGLVESFSGNPGLCVSV 443 (840)
Q Consensus 422 ~~~~~~~~~~~~~~n~~~c~~~ 443 (840)
..+... ....+..|...|...
T Consensus 167 ~~l~~~-~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 167 SKVRDV-QIKDLPHSEFKCSSE 187 (192)
T ss_dssp TTTTTS-BGGGSCTTTCCCCCC
T ss_pred hhhcCC-EeeecCHhhCcCCCC
Confidence 655433 445667777777543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=5.2e-19 Score=176.12 Aligned_cols=187 Identities=23% Similarity=0.327 Sum_probs=100.1
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEc
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLEL 99 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 99 (840)
..++++.+.+++.. .+..+.+|+.|++.+| .+.+++ .+..+++|++|++++|.+++..| +..+++|++|++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~---~i~~l~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGT---GVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTS---CCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCC---CCCcch--hHhcCCCCcEeecCCceeecccc--cccccccccccc
Confidence 34555556555432 3445566666666666 344442 25566666666666666654322 566666666666
Q ss_pred cCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecccccc
Q 003199 100 TGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLSG 179 (840)
Q Consensus 100 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 179 (840)
++|.++. ++ .+..+++|+.++++.+. ..+ ...+...+.+..+.++.+.+... ..+..+++|+.|++++|.+.+
T Consensus 93 ~~n~~~~-i~-~l~~l~~L~~l~l~~~~-~~~--~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 93 SGNPLKN-VS-AIAGLQSIKTLDLTSTQ-ITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CSCCCSC-CG-GGTTCTTCCEEECTTSC-CCC--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred ccccccc-cc-ccccccccccccccccc-ccc--cchhccccchhhhhchhhhhchh--hhhcccccccccccccccccc
Confidence 6666652 22 35556666666666554 111 12344555566666666555532 234555556666666665543
Q ss_pred ccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccccccc
Q 003199 180 EISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLS 226 (840)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 226 (840)
.. .+.++++|++|+|++|+++++ ..+.++++|++|+|++|+++
T Consensus 166 ~~--~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 166 LT--PLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCC
T ss_pred ch--hhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCC
Confidence 22 255556666666666665532 12555555666666655555
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.2e-18 Score=170.26 Aligned_cols=191 Identities=25% Similarity=0.304 Sum_probs=160.5
Q ss_pred CCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCC
Q 003199 12 DFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNV 91 (840)
Q Consensus 12 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 91 (840)
.++.+.+|+.|++++|+|+ .++ .+..+++|++|++++| .+..+. .+..+++|+.+++++|.++.. +.+..+
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n---~i~~~~--~l~~l~~l~~l~~~~n~~~~i--~~l~~l 106 (227)
T d1h6ua2 36 TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN---QITDLA--PLKNLTKITELELSGNPLKNV--SAIAGL 106 (227)
T ss_dssp CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSS---CCCCCG--GGTTCCSCCEEECCSCCCSCC--GGGTTC
T ss_pred CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCc---eeeccc--ccccccccccccccccccccc--cccccc
Confidence 3466889999999999999 454 5899999999999999 555544 389999999999999998743 468899
Q ss_pred CCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEE
Q 003199 92 TSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQ 171 (840)
Q Consensus 92 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (840)
++|+.|++++|...+. ..+...+.++.+.++.+. +.. ...+...++|++|++++|.+... ..+.++++|+.|+
T Consensus 107 ~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~-~~~--~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~ 179 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQ-ITN--ISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLK 179 (227)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSC-CCC--CGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred cccccccccccccccc--chhccccchhhhhchhhh-hch--hhhhccccccccccccccccccc--hhhcccccceecc
Confidence 9999999999998743 457888999999998886 222 23477889999999999999853 3488999999999
Q ss_pred eeccccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccc
Q 003199 172 LYNNSLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSE 222 (840)
Q Consensus 172 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 222 (840)
|++|+++++. .+.++++|++|+|++|+++++. .+.++++|+.|++++
T Consensus 180 Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 180 ADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred cCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 9999998653 4899999999999999999653 388999999999974
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.9e-21 Score=216.31 Aligned_cols=379 Identities=19% Similarity=0.187 Sum_probs=192.2
Q ss_pred CCCEEecCCCcCccc-CCccccCCCCCCEEeCCCCCCCccCCCC----cccccccccccEEEecCcccccc----CCccc
Q 003199 18 NLRRLDLSNNLFTGQ-FPLSVFNLTNLEVLSFNENPGFKLWKLP----ESSIFRLTKLRIMVLATCALHGQ----IPASI 88 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~-~p~~~~~l~~L~~L~L~~N~~~~l~~l~----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~ 88 (840)
+|++||++.|+|++. +...+..+++|+.|+|++|. +++.. ...+..+++|++|+|++|.|+.. +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~---i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCG---LTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSC---CCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCC---CCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHH
Confidence 578899999998843 24456678888888888883 33211 12356677888888888877521 22223
Q ss_pred c-CCCCCcEEEccCCccccc----CchhhhcCCCCCeeecccCccccccC----Cccc-CCCCCCCeeeccCCcccccC-
Q 003199 89 G-NVTSLTDLELTGNFITGH----IPPEIGLLKNLRQLELYYNQQLAGTI----PEEL-GNLTELTDLDMSVNHLSGKI- 157 (840)
Q Consensus 89 ~-~l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~----p~~l-~~l~~L~~L~L~~n~l~~~~- 157 (840)
. ...+|++|+|++|+|++. ++..+..+++|++|+|++|.+ .... ...+ ........+......+....
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i-~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 158 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL-GDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 158 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC-HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccc-hhhhhhhhhhcccccccccccccccccccchhhh
Confidence 2 234688888888888743 345566777888888887762 2110 1111 11223333444333332111
Q ss_pred ---CccccCCCCCcEEEeeccccccccch----hh-hcCCCCCEEEccCCcCcccC----CcCCCCCCCcceeccccccc
Q 003199 158 ---PESILRLPKLRVLQLYNNSLSGEISS----VI-ANSTTLTMLSLYDNSLTGEV----PQDLGQWSPLVVLDLSENKL 225 (840)
Q Consensus 158 ---~~~~~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l 225 (840)
...+.....++.++++++.+...... .+ ........+++..+.+.... ...+...+.++.+++++|++
T Consensus 159 ~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~ 238 (460)
T d1z7xw1 159 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 238 (460)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccc
Confidence 11223345667777776665422111 11 22334556666666554211 11223345566666666655
Q ss_pred cccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCceeeccC----CccccCCCcccEEeccCCcccccC
Q 003199 226 SGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSI----PEGILSLPHVSIIDLSYNSFSGPI 301 (840)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~ 301 (840)
...... ......+.....++.+++++|.+.... ...+...+.++.+++++|.+++..
T Consensus 239 ~~~~~~-------------------~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~ 299 (460)
T d1z7xw1 239 GDVGMA-------------------ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 299 (460)
T ss_dssp HHHHHH-------------------HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred cccccc-------------------hhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 321000 011112223345555555555554211 112233455556666666554321
Q ss_pred Ccc-----cCCCCCCceeecccceeeeccchh----hcccCcccEEEcCCCccCCC----CCCccc-CccccchhcccCC
Q 003199 302 ANT-----VGNARNLSELFMQRNQISGFIPSE----IYRAISLVKIDLSDNLLSGP----IPSGIG-NLKKLNLLMLQSN 367 (840)
Q Consensus 302 ~~~-----~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N 367 (840)
... ......|+.+++++|.++...... +....+|++|+|++|++++. ++..+. ..+.|+.|+|++|
T Consensus 300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 300 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 111 112345666666666665432222 23334566666666666432 122221 2445666677766
Q ss_pred ccCCC----cchhcccccCCCEEECcCccccccCCchhhc------cCCCeEEccCCCCcCc
Q 003199 368 KLNSS----IPNSLSSLKSLNVLDLSNNLLTGYIPESLCE------LLPNSINFSNNRLSGP 419 (840)
Q Consensus 368 ~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------~~~~~l~l~~N~l~~~ 419 (840)
+|+.. +...+..+++|++|||++|+|+......+.. ..++.+++.+|.+...
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 66532 2334555566777777777666433333321 1345666666666543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.3e-18 Score=166.29 Aligned_cols=174 Identities=20% Similarity=0.242 Sum_probs=99.2
Q ss_pred CEEEccCCcCcccCCcCCCCCCCcceeccccccccccCCccccCCCCchhhhcccccccccCCcccccccCCceEEeeCc
Q 003199 192 TMLSLYDNSLTGEVPQDLGQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNN 271 (840)
Q Consensus 192 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N 271 (840)
++++.++++++ .+|..+. +++++|+|++|+|++. ..+..|..+++|+.|+|++|
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~-----------------------~~~~~f~~l~~L~~L~L~~N 64 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRI-----------------------SSDGLFGRLPHLVKLELKRN 64 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSB-----------------------CCSCSGGGCTTCCEEECCSS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCccc-----------------------ccccccCCCceEeeeecccc
Confidence 35556666665 3444332 3566666666666532 12334555666666666666
Q ss_pred eeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecccceeeeccchhhcccCcccEEEcCCCccCCCCCC
Q 003199 272 HLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQRNQISGFIPSEIYRAISLVKIDLSDNLLSGPIPS 351 (840)
Q Consensus 272 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 351 (840)
.+....+..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|.+.... .
T Consensus 65 ~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~ 143 (192)
T d1w8aa_ 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-H 143 (192)
T ss_dssp CCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-G
T ss_pred ccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-c
Confidence 666555566666666666666666666666666666666666666666666655666666666666666666665322 1
Q ss_pred cccCccccchhcccCCccCCCcchhcccccCCCEEECcCccccc
Q 003199 352 GIGNLKKLNLLMLQSNKLNSSIPNSLSSLKSLNVLDLSNNLLTG 395 (840)
Q Consensus 352 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 395 (840)
...-...++.+.+..|.++...|..+ ..++.++|+.|.|+.
T Consensus 144 ~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 144 LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred hHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 11112345566666666665555433 344555666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=8.4e-18 Score=164.67 Aligned_cols=184 Identities=24% Similarity=0.274 Sum_probs=122.4
Q ss_pred CCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEE
Q 003199 19 LRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLE 98 (840)
Q Consensus 19 L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 98 (840)
+....++.+.+++.++. ..+.+|++|++++| .+..++ .+..+++|++|+|++|.+++.. .++.+++|++|+
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~---~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~ 96 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNS---DIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF 96 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTS---CCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCC---CCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence 33445666666644442 34667777788777 444443 3667777777777777776532 356777788888
Q ss_pred ccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeeccccc
Q 003199 99 LTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 99 L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 178 (840)
+++|+|++ +| .+..+++|+.|++++|. ...+ ..+..+++|+.+++++|.+++ +..+..+++|+++++++|+++
T Consensus 97 l~~n~i~~-l~-~l~~l~~L~~L~l~~~~--~~~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 97 LDENKVKD-LS-SLKDLKKLKSLSLEHNG--ISDI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp CCSSCCCC-GG-GGTTCTTCCEEECTTSC--CCCC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred cccccccc-cc-ccccccccccccccccc--cccc-ccccccccccccccccccccc--ccccccccccccccccccccc
Confidence 88887773 33 47777777777777775 2222 356677777777777777763 234666777777777777777
Q ss_pred cccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCcceecccc
Q 003199 179 GEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVLDLSE 222 (840)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 222 (840)
++. .+.++++|++|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 170 ~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 170 DIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 543 36777777777777777774 33 477777777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.9e-18 Score=166.54 Aligned_cols=183 Identities=25% Similarity=0.321 Sum_probs=115.4
Q ss_pred CCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCc
Q 003199 16 MQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLT 95 (840)
Q Consensus 16 l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 95 (840)
+.++..+.++.+.+++.++ ...+.+|+.|++++|. +.+++ .+..+++|++|++++|.+++..| ++++++|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~---i~~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~ 87 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG---IKSID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 87 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSC---CCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCC---CCCcc--ccccCCCcCcCccccccccCccc--ccCCcccc
Confidence 3444456677777764433 3456778888888883 44432 36667777777777777764432 67777777
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecc
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 175 (840)
+|++++|.+.. ++ .+..+++|+.|++++|.. . . ...+..+++|+.|++++|++.. + ..+..+++|+.|++++|
T Consensus 88 ~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~-~-~-~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 88 DILMNNNQIAD-IT-PLANLTNLTGLTLFNNQI-T-D-IDPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSN 160 (199)
T ss_dssp EEECCSSCCCC-CG-GGTTCTTCSEEECCSSCC-C-C-CGGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSS
T ss_pred ccccccccccc-cc-cccccccccccccccccc-c-c-ccccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccc
Confidence 77777777763 33 366777777777776652 1 1 2346667777777777777663 2 24666777777777777
Q ss_pred ccccccchhhhcCCCCCEEEccCCcCcccCCcCCCCCCCccee
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSLTGEVPQDLGQWSPLVVL 218 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 218 (840)
++++.. .+.++++|++|++++|+++++ +.++++++|++|
T Consensus 161 ~l~~l~--~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 161 QVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp CCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccCCc--cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 776442 366677777777777776642 235566666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.9e-20 Score=208.16 Aligned_cols=353 Identities=18% Similarity=0.176 Sum_probs=203.5
Q ss_pred CCCEEeCCCCCCCccCCCC-cccccccccccEEEecCccccc----cCCccccCCCCCcEEEccCCcccccCchhhh---
Q 003199 42 NLEVLSFNENPGFKLWKLP-ESSIFRLTKLRIMVLATCALHG----QIPASIGNVTSLTDLELTGNFITGHIPPEIG--- 113 (840)
Q Consensus 42 ~L~~L~L~~N~~~~l~~l~-~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~--- 113 (840)
+|+.||+++| ++.+.. ...+..+++|++|+|++|.++. .++..+..+++|++|+|++|.|++.....+.
T Consensus 3 ~l~~ld~~~~---~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCE---ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESC---CCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEeeCC---cCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHH
Confidence 5777888887 443322 2235567777777777777762 2344556677777777777777632211221
Q ss_pred -c-CCCCCeeecccCccccc----cCCcccCCCCCCCeeeccCCcccccCCccc----c-CCCCCcEEEeeccccccc--
Q 003199 114 -L-LKNLRQLELYYNQQLAG----TIPEELGNLTELTDLDMSVNHLSGKIPESI----L-RLPKLRVLQLYNNSLSGE-- 180 (840)
Q Consensus 114 -~-l~~L~~L~L~~n~~~~~----~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~----~-~l~~L~~L~L~~N~l~~~-- 180 (840)
. ..+|++|+|++|+ +.+ .++..+..+++|++|+|++|.++......+ . .......+......+...
T Consensus 80 ~~~~~~L~~L~L~~n~-it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 158 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCC-LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 158 (460)
T ss_dssp CSTTCCCCEEECTTSC-CBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred hcCCCCCCEEECCCCC-ccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhh
Confidence 1 2356666666665 221 123445566666666666666653211111 1 112233333333333211
Q ss_pred --cchhhhcCCCCCEEEccCCcCcccCCc----CC-CCCCCcceeccccccccccCCccccCCCCchhhhcccccccccC
Q 003199 181 --ISSVIANSTTLTMLSLYDNSLTGEVPQ----DL-GQWSPLVVLDLSENKLSGPLPAKVCSRGKLQYFLVLQNMFSGVL 253 (840)
Q Consensus 181 --~~~~~~~l~~L~~L~L~~N~l~~~~~~----~l-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 253 (840)
....+.....++.++++++.+...... .+ ........+++..+.+..... ...
T Consensus 159 ~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~--------------------~~~ 218 (460)
T d1z7xw1 159 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC--------------------RDL 218 (460)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH--------------------HHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccchhh--------------------hcc
Confidence 112233445666666665554411000 00 011122334444333321000 011
Q ss_pred CcccccccCCceEEeeCceeec-----cCCccccCCCcccEEeccCCcccccC----CcccCCCCCCceeecccceeeec
Q 003199 254 PDSLARCKNLLRFRVSNNHLEG-----SIPEGILSLPHVSIIDLSYNSFSGPI----ANTVGNARNLSELFMQRNQISGF 324 (840)
Q Consensus 254 ~~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~ 324 (840)
...+...+.++.+++++|.+.. ..+........++.+++++|.+.... ...+...+.++.+++++|.++..
T Consensus 219 ~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~ 298 (460)
T d1z7xw1 219 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 298 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred cccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1234566789999999998742 22334445778999999999987432 23445688999999999999754
Q ss_pred cchhhc-----ccCcccEEEcCCCccCCCCCCcc----cCccccchhcccCCccCCC----cchhcc-cccCCCEEECcC
Q 003199 325 IPSEIY-----RAISLVKIDLSDNLLSGPIPSGI----GNLKKLNLLMLQSNKLNSS----IPNSLS-SLKSLNVLDLSN 390 (840)
Q Consensus 325 ~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~l~~ 390 (840)
....+. ....|+.+++++|.++......+ ...++|+.|+|++|+|++. ++..+. ..+.|++|+|++
T Consensus 299 ~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~ 378 (460)
T d1z7xw1 299 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 378 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCC
Confidence 333322 34579999999999975433333 3456899999999999753 333343 467799999999
Q ss_pred cccccc----CCchhhcc-CCCeEEccCCCCcC
Q 003199 391 NLLTGY----IPESLCEL-LPNSINFSNNRLSG 418 (840)
Q Consensus 391 N~l~~~----~p~~~~~~-~~~~l~l~~N~l~~ 418 (840)
|.|+.. ++..+... .++.|++++|+++.
T Consensus 379 n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 379 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 999853 33333332 57899999999975
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.5e-17 Score=158.02 Aligned_cols=163 Identities=29% Similarity=0.376 Sum_probs=138.8
Q ss_pred CCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCC
Q 003199 14 SPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTS 93 (840)
Q Consensus 14 ~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 93 (840)
..+++|++|++++|.|+ .++ .+..+++|++|+|++| ++..+++ +.++++|+.|++++|.+... + .+.++++
T Consensus 37 ~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N---~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~ 107 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN---QLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTN 107 (199)
T ss_dssp HHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSS---CCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTT
T ss_pred HHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccc---cccCccc--ccCCcccccccccccccccc-c-ccccccc
Confidence 45789999999999999 443 4889999999999999 5666654 89999999999999998743 3 4889999
Q ss_pred CcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEee
Q 003199 94 LTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLY 173 (840)
Q Consensus 94 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 173 (840)
|+.|++++|.+... ..+..+++|+.|++++|+ + ..+ +.+..+++|++|++++|++++. ..+.++++|++|+++
T Consensus 108 L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~-l-~~~-~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls 180 (199)
T d2omxa2 108 LTGLTLFNNQITDI--DPLKNLTNLNRLELSSNT-I-SDI-SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDIS 180 (199)
T ss_dssp CSEEECCSSCCCCC--GGGTTCTTCSEEECCSSC-C-CCC-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred cccccccccccccc--cccchhhhhHHhhhhhhh-h-ccc-ccccccccccccccccccccCC--ccccCCCCCCEEECC
Confidence 99999999999843 458899999999999997 2 333 4688999999999999999964 358999999999999
Q ss_pred ccccccccchhhhcCCCCCEE
Q 003199 174 NNSLSGEISSVIANSTTLTML 194 (840)
Q Consensus 174 ~N~l~~~~~~~~~~l~~L~~L 194 (840)
+|+++++ +.++++++|++|
T Consensus 181 ~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 181 SNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp SSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCCCC--ccccCCCCCCcC
Confidence 9999864 358899999986
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.7e-17 Score=160.04 Aligned_cols=166 Identities=25% Similarity=0.323 Sum_probs=141.2
Q ss_pred CCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCC
Q 003199 15 PMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSL 94 (840)
Q Consensus 15 ~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 94 (840)
.+.+|++|++++|.|+. ++ .+..+++|++|+|++| ++..++ .+..+++|++|++++|.+++. | .+..+++|
T Consensus 44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n---~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L 114 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGN---KLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKL 114 (210)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSS---CCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTC
T ss_pred HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCc---cccCcc--ccccCcccccccccccccccc-c-cccccccc
Confidence 47789999999999994 44 3889999999999999 566655 378899999999999999853 3 58899999
Q ss_pred cEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeec
Q 003199 95 TDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYN 174 (840)
Q Consensus 95 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 174 (840)
+.|++++|.+.. + ..+..+++|+.++++.|. +.+ +..+..+++|+++++++|++++.. .+.++++|++|+|++
T Consensus 115 ~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~-l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~ 187 (210)
T d1h6ta2 115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNK-ITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSK 187 (210)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSC-CCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred cccccccccccc-c-cccccccccccccccccc-ccc--cccccccccccccccccccccccc--cccCCCCCCEEECCC
Confidence 999999999983 3 468999999999999997 322 345778999999999999999643 488999999999999
Q ss_pred cccccccchhhhcCCCCCEEEccC
Q 003199 175 NSLSGEISSVIANSTTLTMLSLYD 198 (840)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~ 198 (840)
|+|+++ + .+.++++|++|+|++
T Consensus 188 N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 188 NHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp SCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred CCCCCC-h-hhcCCCCCCEEEccC
Confidence 999864 3 589999999999974
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.2e-15 Score=138.69 Aligned_cols=132 Identities=21% Similarity=0.261 Sum_probs=72.4
Q ss_pred cCCCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccc
Q 003199 9 TLPDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASI 88 (840)
Q Consensus 9 ~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 88 (840)
..|.|.++.+|++|+|++|+|+ .++..+..+++|+.|+|++| .|.+++ .|..+++|++|++++|.++...+..+
T Consensus 10 ~~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N---~i~~l~--~~~~l~~L~~L~ls~N~i~~l~~~~~ 83 (162)
T d1a9na_ 10 QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN---EIRKLD--GFPLLRRLKTLLVNNNRICRIGEGLD 83 (162)
T ss_dssp TSCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSS---CCCEEC--CCCCCSSCCEEECCSSCCCEECSCHH
T ss_pred hhHhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCC---CCCccC--CcccCcchhhhhcccccccCCCcccc
Confidence 3456667777777777777777 45666666777777777777 333332 24444555555555555543333333
Q ss_pred cCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCC----ccccCC
Q 003199 89 GNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIP----ESILRL 164 (840)
Q Consensus 89 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l 164 (840)
..+++|++|+|++|+|+.. ++ ...+..+++|++|++++|.++. .| ..+..+
T Consensus 84 ~~l~~L~~L~L~~N~i~~~-~~-----------------------l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~l 138 (162)
T d1a9na_ 84 QALPDLTELILTNNSLVEL-GD-----------------------LDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKV 138 (162)
T ss_dssp HHCTTCCEEECCSCCCCCG-GG-----------------------GGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHC
T ss_pred ccccccccceecccccccc-cc-----------------------ccccccccccchhhcCCCcccc-ccchHHHHHHHC
Confidence 4444444444444444421 10 1234555666666666666653 22 235566
Q ss_pred CCCcEEE
Q 003199 165 PKLRVLQ 171 (840)
Q Consensus 165 ~~L~~L~ 171 (840)
++|++||
T Consensus 139 p~L~~LD 145 (162)
T d1a9na_ 139 PQVRVLD 145 (162)
T ss_dssp TTCSEET
T ss_pred CCcCeeC
Confidence 7777665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1e-15 Score=157.15 Aligned_cols=202 Identities=19% Similarity=0.238 Sum_probs=134.3
Q ss_pred CEEecCCCcCcccCCccccCC--CCCCEEeCCCCCCCccCCCCcccccccccccEEEecCcccccc-CCccccCCCCCcE
Q 003199 20 RRLDLSNNLFTGQFPLSVFNL--TNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQ-IPASIGNVTSLTD 96 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l--~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~ 96 (840)
+.|||+++.+. |+.+..+ ..+..+.++++ .+.. +........+|++|+|++|.+... +...+.++++|++
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~---~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~ 75 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRS---FMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 75 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTC---EECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeecccc---cccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccc
Confidence 57899988765 3333332 23556666665 3322 222234556899999999888643 3455778899999
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCccccc-cCCcccCCCCCCCeeeccCCc-cccc-CCccccC-CCCCcEEEe
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAG-TIPEELGNLTELTDLDMSVNH-LSGK-IPESILR-LPKLRVLQL 172 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~-~~p~~l~~l~~L~~L~L~~n~-l~~~-~~~~~~~-l~~L~~L~L 172 (840)
|+|++|.+++..+..+..+++|++|+|+++..+.+ .+.....++++|++|++++|. ++.. ....+.. .++|+.|++
T Consensus 76 L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l 155 (284)
T d2astb2 76 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 155 (284)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred ccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhh
Confidence 99999998877778888889999999988653432 122234567889999998863 4321 1122322 468899998
Q ss_pred ecc--ccccc-cchhhhcCCCCCEEEccCC-cCcccCCcCCCCCCCcceeccccc-ccccc
Q 003199 173 YNN--SLSGE-ISSVIANSTTLTMLSLYDN-SLTGEVPQDLGQWSPLVVLDLSEN-KLSGP 228 (840)
Q Consensus 173 ~~N--~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~ 228 (840)
+++ .+++. ....+.++++|++|+|++| .+++.....+.++++|++|+|++| .+++.
T Consensus 156 ~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~ 216 (284)
T d2astb2 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216 (284)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGG
T ss_pred cccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChH
Confidence 865 34432 2334467888999999885 466666667778888888888884 56543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=6e-16 Score=158.89 Aligned_cols=40 Identities=15% Similarity=0.009 Sum_probs=17.3
Q ss_pred ccCCCCCCceeecccc-eeeeccchhhcccCcccEEEcCCC
Q 003199 304 TVGNARNLSELFMQRN-QISGFIPSEIYRAISLVKIDLSDN 343 (840)
Q Consensus 304 ~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N 343 (840)
.+..+++|++|+|++| .+++.....+.++++|+.|+++++
T Consensus 195 ~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred hhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3334444444444442 333333334444455555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=7.3e-15 Score=136.24 Aligned_cols=127 Identities=24% Similarity=0.200 Sum_probs=82.1
Q ss_pred ccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCC
Q 003199 88 IGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKL 167 (840)
Q Consensus 88 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 167 (840)
|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+ ...++ .|..+++|++|++++|+++.+.+..+..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~--i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE--IRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSC--CCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCC--CCccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 455666777777777777 445556667777777777776 22332 46667777777777777775555555667777
Q ss_pred cEEEeeccccccccc-hhhhcCCCCCEEEccCCcCcccCCc----CCCCCCCcceec
Q 003199 168 RVLQLYNNSLSGEIS-SVIANSTTLTMLSLYDNSLTGEVPQ----DLGQWSPLVVLD 219 (840)
Q Consensus 168 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~l~~l~~L~~L~ 219 (840)
++|++++|+|+.... ..+..+++|++|++++|+++. .+. .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 777777777764422 456677777777777777763 222 345566677666
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=9.4e-16 Score=162.67 Aligned_cols=93 Identities=22% Similarity=0.186 Sum_probs=43.3
Q ss_pred ccccCCCCCcEEEccCCcccccC----chhhhcCCCCCeeecccCccc--cc-------cCCcccCCCCCCCeeeccCCc
Q 003199 86 ASIGNVTSLTDLELTGNFITGHI----PPEIGLLKNLRQLELYYNQQL--AG-------TIPEELGNLTELTDLDMSVNH 152 (840)
Q Consensus 86 ~~~~~l~~L~~L~L~~n~i~~~~----p~~~~~l~~L~~L~L~~n~~~--~~-------~~p~~l~~l~~L~~L~L~~n~ 152 (840)
.++.....|++|+|++|.|.... ...+...++|+.|+++.+... .. .+...+...++|++|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 34444555666666666654321 223344555666665544310 00 011223345556666666665
Q ss_pred cccc----CCccccCCCCCcEEEeeccccc
Q 003199 153 LSGK----IPESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 153 l~~~----~~~~~~~l~~L~~L~L~~N~l~ 178 (840)
++.. +...+...++|+.|++++|.+.
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred cccccccchhhhhcccccchheeccccccc
Confidence 5432 1122334455555555555553
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=4.1e-14 Score=124.53 Aligned_cols=101 Identities=26% Similarity=0.384 Sum_probs=48.3
Q ss_pred EEEecCccccccCCccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCC
Q 003199 72 IMVLATCALHGQIPASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVN 151 (840)
Q Consensus 72 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n 151 (840)
+|+|++|.++. ++ .++.+++|++|++++|+|+ .+|+.|+.+++|+.|++++|+ ...+| .+..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~--i~~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA--LENVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC--CCCCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccc--ccccC-ccccccccCeEECCCC
Confidence 34444444442 22 2445555555555555555 344445555555555555554 12222 2445555555555555
Q ss_pred cccccC-CccccCCCCCcEEEeeccccc
Q 003199 152 HLSGKI-PESILRLPKLRVLQLYNNSLS 178 (840)
Q Consensus 152 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 178 (840)
+|++.. ...+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 555322 133445555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=7.6e-16 Score=163.40 Aligned_cols=249 Identities=17% Similarity=0.199 Sum_probs=120.3
Q ss_pred CchhhhcCCCCCeeecccCccccc---cCCcccCCCCCCCeeeccCCccccc----------CCccccCCCCCcEEEeec
Q 003199 108 IPPEIGLLKNLRQLELYYNQQLAG---TIPEELGNLTELTDLDMSVNHLSGK----------IPESILRLPKLRVLQLYN 174 (840)
Q Consensus 108 ~p~~~~~l~~L~~L~L~~n~~~~~---~~p~~l~~l~~L~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~L~~ 174 (840)
+...+....+|+.|+|++|.+-.. .+-..+...++|+.|+++++..... +...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 445566777788888887752111 1223456667777777776654321 112234456666666666
Q ss_pred cccccc----cchhhhcCCCCCEEEccCCcCcccCCcCC-------------CCCCCcceeccccccccccCCccccCCC
Q 003199 175 NSLSGE----ISSVIANSTTLTMLSLYDNSLTGEVPQDL-------------GQWSPLVVLDLSENKLSGPLPAKVCSRG 237 (840)
Q Consensus 175 N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 237 (840)
|.++.. ....+...++|++|++++|.+.......+ ...+.|+.+++++|+++.....
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~------ 176 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK------ 176 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH------
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccc------
Confidence 666543 22334455666666666666542110000 1122333444444333211000
Q ss_pred CchhhhcccccccccCCcccccccCCceEEeeCceeeccCCccccCCCcccEEeccCCcccccCCcccCCCCCCceeecc
Q 003199 238 KLQYFLVLQNMFSGVLPDSLARCKNLLRFRVSNNHLEGSIPEGILSLPHVSIIDLSYNSFSGPIANTVGNARNLSELFMQ 317 (840)
Q Consensus 238 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 317 (840)
.+...+..+++|++|+|++|+++.... .......+...++|+.|+|+
T Consensus 177 --------------~l~~~l~~~~~L~~L~L~~n~i~~~g~-------------------~~~l~~~l~~~~~L~~L~Ls 223 (344)
T d2ca6a1 177 --------------EWAKTFQSHRLLHTVKMVQNGIRPEGI-------------------EHLLLEGLAYCQELKVLDLQ 223 (344)
T ss_dssp --------------HHHHHHHHCTTCCEEECCSSCCCHHHH-------------------HHHHHTTGGGCTTCCEEECC
T ss_pred --------------cccchhhhhhhhccccccccccccccc-------------------ccchhhhhcchhhhcccccc
Confidence 111122333444444444444431100 00112233444555555555
Q ss_pred cceeeec----cchhhcccCcccEEEcCCCccCCCCCCc----cc--CccccchhcccCCccCCC----cchhcc-cccC
Q 003199 318 RNQISGF----IPSEIYRAISLVKIDLSDNLLSGPIPSG----IG--NLKKLNLLMLQSNKLNSS----IPNSLS-SLKS 382 (840)
Q Consensus 318 ~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~ 382 (840)
+|.++.. +...+..+++|++|+|++|.|++..... +. ....|+.|+|++|+|+.. +...+. .+++
T Consensus 224 ~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~ 303 (344)
T d2ca6a1 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303 (344)
T ss_dssp SSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred cccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCC
Confidence 5555422 2233445555666666666655321111 11 124577777777777532 223332 4677
Q ss_pred CCEEECcCccccc
Q 003199 383 LNVLDLSNNLLTG 395 (840)
Q Consensus 383 L~~L~l~~N~l~~ 395 (840)
|+.|+|++|++..
T Consensus 304 L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 304 LLFLELNGNRFSE 316 (344)
T ss_dssp CCEEECTTSBSCT
T ss_pred CCEEECCCCcCCC
Confidence 8888888888863
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.7e-13 Score=120.48 Aligned_cols=100 Identities=23% Similarity=0.248 Sum_probs=60.1
Q ss_pred CEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcEEEc
Q 003199 20 RRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTDLEL 99 (840)
Q Consensus 20 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 99 (840)
|+|+|++|+|+ .++ .+.++++|++|++++| ++..+|+ .|..+++|++|++++|.|++. | .++.+++|++|++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N---~l~~lp~-~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l 72 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHN---RLRALPP-ALAALRCLEVLQASDNALENV-D-GVANLPRLQELLL 72 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSS---CCCCCCG-GGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEEC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCC---ccCcchh-hhhhhhccccccccccccccc-C-ccccccccCeEEC
Confidence 56788888887 444 3677777777777777 5555553 356666666666666666532 2 3566666666666
Q ss_pred cCCcccccC-chhhhcCCCCCeeecccCc
Q 003199 100 TGNFITGHI-PPEIGLLKNLRQLELYYNQ 127 (840)
Q Consensus 100 ~~n~i~~~~-p~~~~~l~~L~~L~L~~n~ 127 (840)
++|+|++.. ...+..+++|+.|++++|+
T Consensus 73 ~~N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CCCccCCCCCchhhcCCCCCCEEECCCCc
Confidence 666665322 1344455555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=7.4e-13 Score=121.63 Aligned_cols=113 Identities=19% Similarity=0.110 Sum_probs=90.5
Q ss_pred CCCCCCCCCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccC
Q 003199 11 PDFSPMQNLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGN 90 (840)
Q Consensus 11 ~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 90 (840)
|+.+.+...+.++++++++. ..|..+..+++|++|++++|+ .+..++...|.++++|+.|+|++|+|+.+.+.+|..
T Consensus 2 P~~C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~--~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~ 78 (156)
T d2ifga3 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQ--HLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHF 78 (156)
T ss_dssp CSSSCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCS--SCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGS
T ss_pred cCCCCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCc--cccccCchhhccccccCcceeeccccCCcccccccc
Confidence 45556667788999999988 778889899999999998763 477888888888888888888888888888888888
Q ss_pred CCCCcEEEccCCcccccCchhhhcCCCCCeeecccCc
Q 003199 91 VTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127 (840)
Q Consensus 91 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 127 (840)
+++|++|+|++|+|+...+..|.. .+|+.|+|++|.
T Consensus 79 l~~L~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np 114 (156)
T d2ifga3 79 TPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNP 114 (156)
T ss_dssp CSCCCEEECCSSCCSCCCSTTTCS-CCCCEEECCSSC
T ss_pred cccccceeccCCCCcccChhhhcc-ccccccccCCCc
Confidence 888888888888888444444444 468888888886
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.34 E-value=1.1e-14 Score=140.14 Aligned_cols=112 Identities=28% Similarity=0.278 Sum_probs=61.5
Q ss_pred ccccCCCCCcEEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCC
Q 003199 86 ASIGNVTSLTDLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLP 165 (840)
Q Consensus 86 ~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 165 (840)
.++..+++|++|+|++|+|+. ++ .|..+++|+.|+|++|+ ...+|..+..+++|++|++++|+++.+ ..+..++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~--i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNL--IKKIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEE--ECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccc--ccccccccccccccccccccccccccc--ccccccc
Confidence 445555555555555555552 22 35555556666665554 223443333344566666666666532 2355566
Q ss_pred CCcEEEeeccccccccc-hhhhcCCCCCEEEccCCcCcc
Q 003199 166 KLRVLQLYNNSLSGEIS-SVIANSTTLTMLSLYDNSLTG 203 (840)
Q Consensus 166 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 203 (840)
+|+.|+|++|+|+.... ..+..+++|++|+|++|++..
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 66666666666654322 345666666666666666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=2.2e-14 Score=137.91 Aligned_cols=100 Identities=22% Similarity=0.290 Sum_probs=50.7
Q ss_pred CCEEecCCC--cCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccCCccccCCCCCcE
Q 003199 19 LRRLDLSNN--LFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQIPASIGNVTSLTD 96 (840)
Q Consensus 19 L~~L~Ls~n--~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 96 (840)
++.++++++ .++ .+|.++..|++|++|+|++| +|.+++ .+..+++|++|+|++|.|+ .+|..+..+++|+.
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n---~I~~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~ 97 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTN---NIEKIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEE---EESCCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCE
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECccc---CCCCcc--cccCCccccChhhcccccc-cccccccccccccc
Confidence 445555543 233 44555666666666666666 444443 2555555555555555554 23333333344555
Q ss_pred EEccCCcccccCchhhhcCCCCCeeecccCc
Q 003199 97 LELTGNFITGHIPPEIGLLKNLRQLELYYNQ 127 (840)
Q Consensus 97 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~ 127 (840)
|++++|+|+. + ..+..+++|+.|+|++|+
T Consensus 98 L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~ 126 (198)
T d1m9la_ 98 LWISYNQIAS-L-SGIEKLVNLRVLYMSNNK 126 (198)
T ss_dssp EECSEEECCC-H-HHHHHHHHSSEEEESEEE
T ss_pred cccccccccc-c-ccccccccccccccccch
Confidence 5555555552 1 234445555555555444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=2.5e-12 Score=118.00 Aligned_cols=104 Identities=24% Similarity=0.200 Sum_probs=43.6
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCCcccCCCCCCCeeeccCCcccccCCccccCCCCCcEEEeecc
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIPEELGNLTELTDLDMSVNHLSGKIPESILRLPKLRVLQLYNN 175 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 175 (840)
.++++++.+. ..|..+..+++|++|++++|+.+...-+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444444 333344444444444443332222222233444444444444444444444444444444444444444
Q ss_pred ccccccchhhhcCCCCCEEEccCCcC
Q 003199 176 SLSGEISSVIANSTTLTMLSLYDNSL 201 (840)
Q Consensus 176 ~l~~~~~~~~~~l~~L~~L~L~~N~l 201 (840)
+|+.+.++.|..+ +|++|+|++|++
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred CCcccChhhhccc-cccccccCCCcc
Confidence 4443333333322 344444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=4.2e-09 Score=96.75 Aligned_cols=64 Identities=31% Similarity=0.349 Sum_probs=30.2
Q ss_pred CCCCCCeeeccCCcccccC--CccccCCCCCcEEEeeccccccccchhhhcCCCCCEEEccCCcCc
Q 003199 139 NLTELTDLDMSVNHLSGKI--PESILRLPKLRVLQLYNNSLSGEISSVIANSTTLTMLSLYDNSLT 202 (840)
Q Consensus 139 ~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 202 (840)
.+++|++|+|++|+|+.+. +..+..+++|+.|+|++|.|+....-.+.....|++|++++|++.
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 4455555555555555321 122344555555555555555433323333344555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=1.3e-08 Score=93.44 Aligned_cols=121 Identities=18% Similarity=0.066 Sum_probs=67.5
Q ss_pred CCCEEecCCCcCcccCCccccCCCCCCEEeCCCCCCCccCCCCcccccccccccEEEecCccccccC--CccccCCCCCc
Q 003199 18 NLRRLDLSNNLFTGQFPLSVFNLTNLEVLSFNENPGFKLWKLPESSIFRLTKLRIMVLATCALHGQI--PASIGNVTSLT 95 (840)
Q Consensus 18 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~~~~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~ 95 (840)
+.+.|+++++... + .+..+..+..|+...| .... ....+..+++|++|+|++|.|+... +..+..+++|+
T Consensus 23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~---~~~~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~ 94 (162)
T d1koha1 23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSS---MAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94 (162)
T ss_dssp SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHH---HHHH-HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCC
T ss_pred hhCeeecccCCCC---c-hhhhccchhhcchhhh---Hhhh-hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccc
Confidence 4556666665432 1 2333444444444443 1111 1233456677777777777776432 34456677777
Q ss_pred EEEccCCcccccCchhhhcCCCCCeeecccCccccccCC-------cccCCCCCCCeee
Q 003199 96 DLELTGNFITGHIPPEIGLLKNLRQLELYYNQQLAGTIP-------EELGNLTELTDLD 147 (840)
Q Consensus 96 ~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~~~~~~~p-------~~l~~l~~L~~L~ 147 (840)
.|+|++|.|+...+-.+....+|+.|++++|.+ ..... ..+..+++|+.||
T Consensus 95 ~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl-~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSL-SDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTT-SSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccccccCccccchhhhhhhccccceeecCCCCc-CcCcccchhHHHHHHHHCCCCCEEC
Confidence 888888887754443444555677788877762 22222 1245677777775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=1.2e-06 Score=87.16 Aligned_cols=151 Identities=15% Similarity=0.069 Sum_probs=101.4
Q ss_pred cchhHHHHHHhcCccCeeeccCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-CCCcc
Q 003199 517 ISFDQREILEAMTEKNKVGQGGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-HKNIV 595 (840)
Q Consensus 517 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 595 (840)
++.+.....+.|...+..+.++.+.||+.... ++.++||+........ ...+.+|...+..+. +--+.
T Consensus 5 ~~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~----------~~~~~~E~~~l~~l~~~vpvP 73 (263)
T d1j7la_ 5 ISPELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT----------TYDVEREKDMMLWLEGKLPVP 73 (263)
T ss_dssp SCHHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS----------TTCHHHHHHHHHHHTTTSCCC
T ss_pred cCHHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc----------hhhHHHHHHHHHHHhccCCCC
Confidence 44456677777777666555666789998654 6677888764332111 123566777777663 44467
Q ss_pred eeeeEEecCccceEEEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhhcC----------------------
Q 003199 596 KLYCYFSSLYCNLLVYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHHGL---------------------- 653 (840)
Q Consensus 596 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------- 653 (840)
+++.+....+..++||+++++..+.+..... .....++.++++.++.||+..
T Consensus 74 ~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 74 KVLHFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp CEEEEEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred cEEEEEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 7888888888889999999998876544321 123335556666666666421
Q ss_pred ----------------------------------CCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 654 ----------------------------------LSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 654 ----------------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987666799998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=1.1e-05 Score=79.60 Aligned_cols=130 Identities=18% Similarity=0.155 Sum_probs=82.7
Q ss_pred eeeccCC-cEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC--CCCcceeeeEEecCccceE
Q 003199 533 KVGQGGS-GTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR--HKNIVKLYCYFSSLYCNLL 609 (840)
Q Consensus 533 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 609 (840)
.+..|.. +.||+....++..+++|...... ...+..|...++.+. .-.+.+++++..+....++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3445543 67999988888889999763322 113556777776664 2336677888888888899
Q ss_pred EEeecCCCChHHHhhcCCCCCChHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 003199 610 VYEYMPNGNLWDALHKGLVHLDWPTRHKIAFGVAQGLAYLHH-------------------------------------- 651 (840)
Q Consensus 610 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------------------------------------- 651 (840)
||+|++|.++.+.. . ....++.++++.+..||+
T Consensus 84 v~~~i~G~~~~~~~------~---~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp EEECCSSEETTTSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEeeecccccccc------c---cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence 99999886653210 0 011112223333333332
Q ss_pred -------------cC----CCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 652 -------------GL----LSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 652 -------------~~----~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
.. ...++|+|+.|.|||++++..+.|+||+.+.
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 10 1237999999999999987667799998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.65 E-value=1.3e-05 Score=73.20 Aligned_cols=37 Identities=19% Similarity=0.188 Sum_probs=15.5
Q ss_pred CCCCCeeeccCCccccc----CCccccCCCCCcEEEeeccc
Q 003199 140 LTELTDLDMSVNHLSGK----IPESILRLPKLRVLQLYNNS 176 (840)
Q Consensus 140 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~ 176 (840)
.+.|++|+|++|.++.. +...+...++|++|+|++|.
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCc
Confidence 34444444444444421 11223334445555554443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.64 E-value=6.8e-06 Score=75.05 Aligned_cols=62 Identities=11% Similarity=0.088 Sum_probs=29.9
Q ss_pred cCcccEEEcCCCccCCC----CCCcccCccccchhcccCCccCCC-------cchhcccccCCCEEECcCccc
Q 003199 332 AISLVKIDLSDNLLSGP----IPSGIGNLKKLNLLMLQSNKLNSS-------IPNSLSSLKSLNVLDLSNNLL 393 (840)
Q Consensus 332 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~l~~N~l 393 (840)
.+.|+.|+|++|.+++. +-.++...+.|+.|+|++|++... +...+...++|+.|+++.+..
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 34455555555554421 111233344555555655544321 233444556677777766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00061 Score=71.08 Aligned_cols=84 Identities=14% Similarity=0.121 Sum_probs=47.5
Q ss_pred cCeeeccCCcEEEEEEeC-CCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccC-C--CCcceeeeEEecCcc
Q 003199 531 KNKVGQGGSGTVYKIDLN-SGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIR-H--KNIVKLYCYFSSLYC 606 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~ 606 (840)
.+.||.|....||++... +++.|+||.-........... .........|++.++.+. + ..+.+++.+ +.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~---~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW---PLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCC---CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCC---CCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 346899999999999765 467899997532111100000 001122345777776552 2 345556554 4456
Q ss_pred ceEEEeecCCCCh
Q 003199 607 NLLVYEYMPNGNL 619 (840)
Q Consensus 607 ~~lV~e~~~~gsL 619 (840)
.++||||+++..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6899999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.96 E-value=7.9e-05 Score=67.69 Aligned_cols=89 Identities=13% Similarity=0.131 Sum_probs=48.8
Q ss_pred CCCCCCceeecccceeeec----cchhhcccCcccEEEcCCCccCCC----CCCcccCccccch--hcccCCccCC----
Q 003199 306 GNARNLSELFMQRNQISGF----IPSEIYRAISLVKIDLSDNLLSGP----IPSGIGNLKKLNL--LMLQSNKLNS---- 371 (840)
Q Consensus 306 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~---- 371 (840)
...++|++|+|++|.++.. +...+...++++.+++++|.+... +...+...++|+. |++++|++..
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~ 122 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 122 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence 3445555555555555432 122333445666666666666432 2233445566665 4445666643
Q ss_pred CcchhcccccCCCEEECcCcccc
Q 003199 372 SIPNSLSSLKSLNVLDLSNNLLT 394 (840)
Q Consensus 372 ~~~~~~~~l~~L~~L~l~~N~l~ 394 (840)
.+...+...++|+.|+++.|...
T Consensus 123 ~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 123 EIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeCcCCCCc
Confidence 23445567788888888877553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.93 E-value=0.00016 Score=65.51 Aligned_cols=65 Identities=9% Similarity=-0.004 Sum_probs=35.6
Q ss_pred CCCCCCCEEecCC-CcCccc----CCccccCCCCCCEEeCCCCCCCccCCCCc----ccccccccccEEEecCcccc
Q 003199 14 SPMQNLRRLDLSN-NLFTGQ----FPLSVFNLTNLEVLSFNENPGFKLWKLPE----SSIFRLTKLRIMVLATCALH 81 (840)
Q Consensus 14 ~~l~~L~~L~Ls~-n~i~~~----~p~~~~~l~~L~~L~L~~N~~~~l~~l~~----~~~~~l~~L~~L~L~~n~l~ 81 (840)
.+.++|++|+|++ +.|+.. +..++...++|++|+|++|. +..-.. ..+...+.++.+++.+|.+.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~---l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTR---SNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSC---CCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCc---ccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3557788888876 456522 34445567777777777773 222111 12333445555555555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.59 E-value=0.0028 Score=64.00 Aligned_cols=135 Identities=13% Similarity=0.108 Sum_probs=76.0
Q ss_pred cCCcEEEEEEeCCCcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCCc--ceee-----eEEecCccceE
Q 003199 537 GGSGTVYKIDLNSGEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKNI--VKLY-----CYFSSLYCNLL 609 (840)
Q Consensus 537 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~l 609 (840)
+.--.||++...+|+.|++|+...... ..+++..|...+..+....+ +..+ ..+......+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~-----------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~ 101 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW-----------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 101 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS-----------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC-----------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEE
Confidence 334689999999999999998743321 13456778887777753222 1111 12234556688
Q ss_pred EEeecCCCChH-----H---------Hhhc----C----CCCCCh-------------------HHHHHHHHHHHHHHHH
Q 003199 610 VYEYMPNGNLW-----D---------ALHK----G----LVHLDW-------------------PTRHKIAFGVAQGLAY 648 (840)
Q Consensus 610 V~e~~~~gsL~-----~---------~l~~----~----~~~~~~-------------------~~~~~i~~~i~~~l~~ 648 (840)
|++|++|..+. . .++. . ....++ ..+..+...+...++.
T Consensus 102 l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 181 (325)
T d1zyla1 102 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 181 (325)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999764321 0 0110 0 001111 1111222222333333
Q ss_pred Hh----hcCCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 649 LH----HGLLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 649 LH----~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
+. +....++||+|+.+.|||++++ ..++||+-+.
T Consensus 182 l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 182 VTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred HHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 32 2233578999999999999754 4588998774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.31 E-value=0.0076 Score=62.57 Aligned_cols=73 Identities=21% Similarity=0.293 Sum_probs=47.2
Q ss_pred cCeeeccCCcEEEEEEeCC--------CcEEEEEEecccccccccCchhhHHHHHHHHHHHHHHhccCCCC-cceeeeEE
Q 003199 531 KNKVGQGGSGTVYKIDLNS--------GEVVAVKKLWSQRTKVSASDTDQLQLDKGLKTEVETLGNIRHKN-IVKLYCYF 601 (840)
Q Consensus 531 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~ 601 (840)
++.|+.|-.-.+|++...+ ++.|.+++.-... ..-...+|..+++.+.-.+ ..++++++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~------------~~idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE------------TESHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC------------CHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc------------hhhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3578889999999997654 3456666652111 0123456888888775334 45777776
Q ss_pred ecCccceEEEeecCCCCh
Q 003199 602 SSLYCNLLVYEYMPNGNL 619 (840)
Q Consensus 602 ~~~~~~~lV~e~~~~gsL 619 (840)
.+ .+|+||+++..+
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 53 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.34 E-value=0.02 Score=57.13 Aligned_cols=32 Identities=25% Similarity=0.295 Sum_probs=27.6
Q ss_pred CCCCeEecCCCCCCEEEcCCCCCeeecccchh
Q 003199 653 LLSPIIHRDIKSTNILLDVNYQPKVADFGIAK 684 (840)
Q Consensus 653 ~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~ 684 (840)
...++||+|+.+.||+++.+...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 34689999999999999988777899999874
|